Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - GAMG [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - hTERT-RPE1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - JURKAT [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - OE19 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - SuSa [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" "Single Cell Type RNA - Alveolar cells type 1 [NX]" "Single Cell Type RNA - Alveolar cells type 2 [NX]" "Single Cell Type RNA - B-cells [NX]" "Single Cell Type RNA - Basal glandular cells [NX]" "Single Cell Type RNA - Basal keratinocytes [NX]" "Single Cell Type RNA - Bipolar cells [NX]" "Single Cell Type RNA - Cardiomyocytes [NX]" "Single Cell Type RNA - Cholangiocytes [NX]" "Single Cell Type RNA - Ciliated cells [NX]" "Single Cell Type RNA - Club cells [NX]" "Single Cell Type RNA - Collecting duct cells [NX]" "Single Cell Type RNA - Cone photoreceptor cells [NX]" "Single Cell Type RNA - Cytotrophoblasts [NX]" "Single Cell Type RNA - Distal tubular cells [NX]" "Single Cell Type RNA - Ductal cells [NX]" "Single Cell Type RNA - Early spermatids [NX]" "Single Cell Type RNA - Endothelial cells [NX]" "Single Cell Type RNA - Enterocytes [NX]" "Single Cell Type RNA - Erythroid cells [NX]" "Single Cell Type RNA - Exocrine glandular cells [NX]" "Single Cell Type RNA - Extravillous trophoblasts [NX]" "Single Cell Type RNA - Fibroblasts [NX]" "Single Cell Type RNA - Glandular cells [NX]" "Single Cell Type RNA - granulocytes [NX]" "Single Cell Type RNA - Hepatocytes [NX]" "Single Cell Type RNA - Hofbauer cells [NX]" "Single Cell Type RNA - Horizontal cells [NX]" "Single Cell Type RNA - Intestinal endocrine cells [NX]" "Single Cell Type RNA - Ito cells [NX]" "Single Cell Type RNA - Kupffer cells [NX]" "Single Cell Type RNA - Late spermatids [NX]" "Single Cell Type RNA - Leydig cells [NX]" "Single Cell Type RNA - Macrophages [NX]" "Single Cell Type RNA - Melanocytes [NX]" "Single Cell Type RNA - monocytes [NX]" "Single Cell Type RNA - Mucus-secreting cells [NX]" "Single Cell Type RNA - Muller glia cells [NX]" "Single Cell Type RNA - Pancreatic endocrine cells [NX]" "Single Cell Type RNA - Paneth cells [NX]" "Single Cell Type RNA - Peritubular cells [NX]" "Single Cell Type RNA - Proximal tubular cells [NX]" "Single Cell Type RNA - Rod photoreceptor cells [NX]" "Single Cell Type RNA - Sertoli cells [NX]" "Single Cell Type RNA - Smooth muscle cells [NX]" "Single Cell Type RNA - Spermatocytes [NX]" "Single Cell Type RNA - Spermatogonia [NX]" "Single Cell Type RNA - Suprabasal keratinocytes [NX]" "Single Cell Type RNA - Syncytiotrophoblasts [NX]" "Single Cell Type RNA - T-cells [NX]" "Single Cell Type RNA - Undifferentiated cells [NX]" "Single Cell Type RNA - Urothelial cells [NX]" AADAT "KAT2, KATII, KYAT2" ENSG00000109576 "Aminoadipate aminotransferase" Q8N5Z0 4 170060222-170091699 "Enzymes, Predicted intracellular proteins" "Aminotransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "liver: 56.5" "Cell type enhanced" "Detected in many" 16 "Extravillous trophoblasts: 60.6;Hepatocytes: 22.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA037502 Enhanced Approved "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA037502: AB_10671759" "unprognostic (1.90e-1)" "unprognostic (1.82e-2)" "prognostic favorable (5.59e-4)" "unprognostic (4.21e-2)" "unprognostic (1.30e-1)" "unprognostic (1.06e-1)" "unprognostic (7.41e-2)" "unprognostic (1.03e-2)" "unprognostic (2.97e-2)" "unprognostic (3.38e-2)" "unprognostic (1.23e-2)" "unprognostic (3.55e-1)" "unprognostic (1.35e-1)" "unprognostic (1.23e-2)" "unprognostic (1.39e-1)" "unprognostic (7.28e-3)" "unprognostic (1.17e-2)" 3.0 3.1 9.2 2.2 9.0 0.9 4.7 0.8 10.8 8.3 4.7 10.3 2.9 1.9 9.7 5.8 2.8 5.7 3.9 2.8 7.2 6.4 6.3 56.5 4.7 1.1 8.2 8.0 4.7 4.6 7.6 8.9 2.2 6.0 13.3 5.0 6.6 1.7 5.4 3.6 1.8 2.0 7.0 7.0 2.0 3.2 7.2 9.2 0.9 7.0 1.2 1.3 5.5 4.9 0.4 0.4 0.0 0.7 0.0 0.7 0.0 2.2 5.5 16.7 0.0 3.3 13.0 6.0 5.7 2.8 3.3 3.3 5.3 0.6 0.0 0.9 6.3 4.3 1.9 7.4 2.7 2.3 0.0 6.4 0.0 6.2 8.9 2.7 0.0 2.4 5.3 1.6 2.7 3.5 9.1 3.1 7.5 0.9 0.1 12.6 5.6 2.7 0.1 12.6 6.2 5.0 0.0 5.2 0.0 2.9 10.0 13.5 15.7 4.5 1.1 5.4 5.6 0.0 1.1 2.1 8.4 9.0 9.5 8.8 0.0 0.0 0.0 8.4 0.0 9.8 0.0 0.7 0.0 0.0 0.1 0.2 0.0 0.3 0.3 0.4 0.4 0.3 0.0 0.0 0.0 0.2 0.0 0.7 0.0 9.2 9.0 0.8 10.8 7.2 6.4 8.2 8.0 6.0 9.2 0.0 5.1 0.0 2.6 0.8 5.1 1.1 2.5 14.7 3.4 0.0 2.0 1.4 0.0 1.3 0.4 0.5 0.0 0.0 1.9 60.6 2.4 3.6 0.0 22.9 1.4 0.0 6.4 0.0 0.3 0.6 1.1 0.6 1.7 0.0 1.3 3.2 0.9 0.0 2.1 6.5 8.2 6.5 2.2 2.4 12.5 0.4 4.7 0.0 2.3 1.4 AAK1 "DKFZp686K16132, KIAA1048" ENSG00000115977 "AP2 associated kinase 1" Q2M2I8 2 69457997-69674349 "Enzymes, Predicted intracellular proteins" Endocytosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "parathyroid gland: 109.7" "Cell type enhanced" "Detected in all" 9 "Cone photoreceptor cells: 732.4;Rod photoreceptor cells: 621.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017931, HPA020289" Enhanced Approved "Vesicles,Plasma membrane,Cytosol" NA No "Vesicles, Plasma membrane" Cytosol "HPA017931: AB_1844406, HPA020289: AB_1844407" "unprognostic (2.11e-3)" "unprognostic (3.18e-2)" "unprognostic (3.67e-1)" "unprognostic (1.01e-3)" "unprognostic (5.06e-2)" "unprognostic (4.04e-2)" "unprognostic (4.23e-2)" "unprognostic (1.14e-1)" "unprognostic (3.52e-1)" "prognostic unfavorable (3.19e-4)" "unprognostic (1.24e-1)" "unprognostic (7.65e-2)" "unprognostic (4.18e-2)" "unprognostic (1.30e-1)" "unprognostic (5.40e-2)" "unprognostic (6.76e-3)" "unprognostic (1.18e-1)" 5.1 5.9 11.0 5.7 11.9 7.8 6.9 25.2 26.5 4.8 4.2 3.9 6.3 3.8 4.7 7.1 3.8 4.9 4.3 7.9 14.4 12.8 7.2 3.1 7.5 6.8 9.4 11.6 3.3 6.7 109.7 10.3 6.9 10.2 5.0 4.6 4.7 3.6 12.3 6.8 3.7 3.7 5.4 9.3 5.5 5.4 4.1 6.9 4.7 16.0 2.1 5.3 4.9 5.8 1.0 0.8 4.1 3.9 2.8 5.6 1.3 16.8 10.1 9.3 9.0 8.9 9.9 29.9 13.7 10.9 8.3 7.4 10.2 6.7 0.6 3.4 17.9 11.4 7.9 7.1 7.1 17.0 12.5 3.0 9.1 6.1 6.9 8.1 6.4 21.7 8.5 6.3 15.6 20.3 6.8 17.6 8.6 1.9 9.5 14.4 2.8 5.9 3.4 4.4 3.1 5.6 3.9 10.0 1.4 6.6 35.3 3.1 4.9 7.9 6.1 7.1 6.4 3.6 9.1 17.5 18.7 12.5 13.4 13.5 9.3 2.4 1.0 15.6 10.9 12.7 2.5 1.4 0.6 4.5 0.6 4.2 0.4 4.0 3.0 0.8 1.0 5.6 4.5 4.1 2.8 3.9 0.7 3.1 1.3 11.0 11.9 25.2 26.5 14.4 12.8 9.4 11.6 10.2 6.9 32.8 38.8 3.0 17.4 14.2 235.7 71.2 99.3 10.7 23.9 136.1 732.4 65.1 36.5 37.7 19.2 43.8 67.4 23.3 57.5 45.9 24.0 51.4 20.7 30.1 51.9 289.2 69.3 93.9 98.0 23.3 35.4 45.1 10.1 50.5 26.9 42.5 48.8 26.4 43.9 53.7 621.3 19.4 29.2 45.9 51.3 8.7 178.4 135.1 14.6 50.6 ABCA12 "DKFZP434G232, ICR2B, LI2" ENSG00000144452 "ATP binding cassette subfamily A member 12" Q86UK0 2 214931542-215138428 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 23.1;tongue: 29.3" "Group enriched" "Detected in some" 7 "Basal keratinocytes: 11.4;Suprabasal keratinocytes: 33.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTCEpi: 28.7;SK-BR-3: 13.4;T-47d: 7.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "cerebral cortex: 1.6;hippocampal formation: 1.8" HPA078239 Approved "Nucleoli,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoli, Cytosol" "HPA078239: AB_2732373" "unprognostic (6.12e-2)" "unprognostic (4.33e-2)" "unprognostic (1.43e-1)" "unprognostic (2.03e-1)" "unprognostic (2.49e-1)" "unprognostic (2.13e-1)" "unprognostic (2.09e-4)" "unprognostic (6.52e-3)" "unprognostic (3.75e-2)" "unprognostic (1.11e-1)" "unprognostic (6.35e-4)" "unprognostic (2.50e-2)" "unprognostic (7.69e-2)" "unprognostic (5.92e-2)" "unprognostic (2.64e-2)" "unprognostic (2.36e-1)" "unprognostic (5.08e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 6.9 0.1 0.1 6.2 0.3 0.0 1.4 0.0 0.0 4.4 8.4 0.1 0.0 0.0 0.6 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 6.1 4.9 0.0 0.1 0.4 0.0 0.3 0.0 0.1 23.1 0.0 0.0 0.1 0.0 0.1 0.7 0.0 0.1 0.0 29.3 6.1 0.1 3.7 0.0 0.2 0.8 0.0 0.0 0.1 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.7 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 28.7 0.0 2.1 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.4 0.0 2.0 0.0 13.4 0.0 0.1 7.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 11.4 0.0 0.4 0.0 0.0 3.4 0.0 0.0 0.8 0.0 0.0 1.4 0.0 0.0 0.0 0.0 2.1 0.3 0.4 0.0 0.0 0.3 1.6 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.5 1.1 0.0 0.7 0.0 0.0 0.0 0.2 0.5 0.2 33.8 2.9 0.0 0.0 2.2 ABCB1 "ABC20, CD243, CLCS, GP170, MDR1, P-gp, PGY1" ENSG00000085563 "ATP binding cassette subfamily B member 1" P08183 7 87503633-87713323 "Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport Translocase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 57.8;intestine: 49.6" "Cell type enhanced" "Detected in many" 13 "Cholangiocytes: 104.4;Enterocytes: 174.5;Paneth cells: 77.2" "Cancer enhanced" "Detected in many" "renal cancer: 14.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 19.2" "Group enriched" "Detected in many" 8 "NK-cells: 11.4;T-cells: 19.2" "Cell line enhanced" "Detected in some" "CACO-2: 30.1;HEK 293: 9.3;HEL: 16.7;Hep G2: 8.2;RPTEC TERT1: 11.5;SH-SY5Y: 36.8" "CAB001716, HPA002199, HPA074614" Enhanced Approved "Nucleoplasm,Plasma membrane,Focal adhesion sites" NA NA "Nucleoplasm, Plasma membrane" "Focal adhesion sites" "CAB001716: , HPA002199: AB_1844428, HPA074614: " "unprognostic (5.38e-3)" "unprognostic (2.45e-2)" "unprognostic (1.42e-1)" "unprognostic (1.06e-1)" "unprognostic (2.25e-2)" "unprognostic (9.99e-5)" "unprognostic (2.23e-3)" "unprognostic (5.65e-3)" "unprognostic (1.14e-1)" "unprognostic (5.17e-2)" "prognostic favorable (3.33e-4)" "unprognostic (5.19e-1)" "prognostic favorable (2.95e-4)" "unprognostic (2.06e-1)" "unprognostic (1.50e-1)" "unprognostic (3.83e-1)" "unprognostic (6.12e-2)" 2.6 57.8 9.4 3.2 11.5 1.2 3.4 5.1 10.5 5.5 22.7 3.8 2.0 14.4 9.4 3.5 2.0 3.2 9.0 1.8 9.2 6.6 19.1 15.6 3.8 2.2 9.4 5.7 2.2 1.5 1.7 1.3 3.1 11.1 2.7 10.7 7.6 1.5 2.1 1.1 1.3 49.6 5.7 9.0 2.4 1.7 1.3 8.6 0.1 2.4 1.4 2.2 2.6 5.9 1.9 0.0 0.1 0.0 11.4 19.2 1.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 30.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 9.3 16.7 1.9 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 11.5 0.1 0.4 36.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.9 0.0 0.4 3.2 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 7.8 0.0 19.2 0.4 2.0 4.7 0.0 1.9 1.2 4.8 0.1 11.4 0.0 0.0 0.0 1.5 9.4 11.5 5.1 10.5 9.2 6.6 9.4 5.7 11.1 8.6 0.0 4.8 5.9 0.1 0.7 0.6 2.8 104.4 1.4 1.2 47.1 0.0 5.0 5.0 10.2 21.6 23.1 174.5 23.3 1.6 0.1 0.5 0.1 3.5 32.6 0.4 0.0 0.0 3.7 1.2 2.5 0.9 0.8 0.0 0.0 8.9 0.0 11.4 77.2 0.0 44.0 0.9 0.0 0.8 0.5 0.4 0.5 8.2 27.3 1.7 0.1 ABCC4 "EST170205, MOAT-B, MOATB, MRP4" ENSG00000125257 "ATP binding cassette subfamily C member 4" O15439 13 95019829-95301475 "Plasma proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "prostate: 35.0" "Cell type enhanced" "Detected in many" 7 "Glandular cells: 38.5;granulocytes: 53.1;Proximal tubular cells: 32.7" "Cancer enriched" "Detected in all" 8 "prostate cancer: 90.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 4 "HEL: 61.8;HMC-1: 67.7;RPTEC TERT1: 18.2" "Low region specificity" "Detected in all" HPA002476 Enhanced Approved "Nucleoli,Golgi apparatus,Plasma membrane" NA NA "Nucleoli, Plasma membrane" "Golgi apparatus" "HPA002476: AB_1844434" "unprognostic (8.77e-2)" "unprognostic (1.94e-2)" "unprognostic (1.48e-1)" "prognostic unfavorable (9.89e-4)" "unprognostic (2.83e-2)" "unprognostic (1.23e-1)" "unprognostic (7.45e-3)" "unprognostic (2.40e-2)" "unprognostic (9.96e-2)" "unprognostic (2.60e-2)" "unprognostic (1.28e-1)" "unprognostic (2.55e-2)" "prognostic favorable (2.25e-10)" "unprognostic (7.44e-3)" "unprognostic (1.67e-1)" "unprognostic (5.55e-2)" "unprognostic (2.35e-2)" 3.2 1.7 3.8 11.8 4.7 2.9 6.2 1.0 4.6 4.4 11.6 10.3 3.9 4.1 5.8 16.4 3.0 8.6 10.3 3.5 5.7 3.9 19.6 1.9 13.8 7.4 6.6 2.2 7.2 3.5 7.0 2.8 1.8 7.4 35.0 7.3 6.0 3.3 5.2 7.6 4.5 7.4 11.1 6.5 3.8 8.2 3.8 7.0 3.4 6.6 3.1 5.8 25.6 13.4 3.6 4.1 1.0 4.8 4.1 3.6 3.4 4.5 8.0 1.3 2.4 2.5 3.3 0.3 3.6 3.7 3.3 2.8 11.1 3.4 2.5 2.4 4.9 2.4 6.2 2.0 1.8 4.1 7.5 3.1 61.8 2.5 2.2 5.1 7.0 67.7 2.5 0.8 2.3 4.8 4.7 4.2 2.8 6.4 0.1 4.4 1.4 1.3 1.1 1.5 5.5 1.9 1.9 3.7 6.6 18.2 10.3 3.3 2.4 1.2 0.2 2.5 1.5 0.0 3.8 6.9 3.5 2.2 2.9 4.3 0.0 0.0 1.0 6.6 4.0 1.7 0.6 1.2 0.4 3.2 1.2 2.7 3.6 2.6 3.6 4.1 2.7 1.6 3.5 1.0 4.1 4.8 0.7 3.3 3.4 3.8 4.7 1.0 4.6 5.7 3.9 6.6 2.2 7.4 7.0 8.9 28.3 3.7 6.2 3.8 0.0 3.1 5.1 6.7 11.4 22.7 21.6 0.1 0.0 5.2 3.2 11.3 1.4 0.0 2.6 0.4 3.9 38.5 53.1 0.0 3.8 0.0 0.0 2.5 1.0 1.7 6.4 6.3 1.7 19.0 3.2 0.3 4.1 9.3 1.8 32.7 0.7 0.0 3.9 0.6 9.1 6.6 0.2 2.2 7.8 3.7 ABCC5 "EST277145, MOAT-C, MRP5, SMRP" ENSG00000114770 "ATP binding cassette subfamily C member 5" O15440 3 183919934-184018015 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Cone photoreceptor cells: 184.6;Rod photoreceptor cells: 122.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 48.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044067, HPA052295" Uncertain Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" Nucleoplasm "HPA044067: AB_2678797, HPA052295: AB_2681789" "unprognostic (9.39e-2)" "unprognostic (6.23e-3)" "unprognostic (3.83e-2)" "unprognostic (1.10e-3)" "unprognostic (2.28e-2)" "unprognostic (2.07e-1)" "prognostic unfavorable (6.78e-8)" "unprognostic (4.46e-2)" "unprognostic (6.07e-3)" "unprognostic (1.02e-1)" "unprognostic (5.91e-3)" "prognostic unfavorable (3.40e-4)" "unprognostic (1.10e-1)" "unprognostic (9.05e-3)" "unprognostic (1.64e-1)" "unprognostic (3.33e-2)" "unprognostic (1.24e-2)" 7.9 11.2 24.7 9.6 26.2 12.0 6.7 42.8 28.6 7.7 11.4 12.0 13.4 6.8 14.1 7.0 17.1 6.1 11.6 16.0 19.1 13.7 12.8 3.6 9.4 7.3 20.5 18.5 11.8 4.9 22.4 20.5 10.8 21.7 10.6 14.4 31.1 7.4 9.3 41.0 14.5 8.5 10.5 12.9 16.3 48.5 9.4 20.9 9.3 5.5 7.3 7.4 18.1 12.7 4.2 3.5 15.8 4.5 5.0 7.0 4.5 7.3 4.1 9.4 11.2 9.4 10.7 14.6 6.0 4.7 5.4 5.9 6.3 5.7 8.0 14.1 5.7 8.2 29.9 11.6 6.6 7.1 8.7 11.2 16.9 10.3 5.7 3.9 5.1 13.2 17.0 6.7 5.8 3.8 11.1 6.3 23.7 15.7 11.1 9.2 19.5 14.1 5.9 9.7 13.4 7.9 9.8 3.1 4.7 19.6 48.0 17.2 10.2 6.1 33.9 10.1 12.7 20.5 1.6 7.2 6.3 6.2 8.0 8.2 4.3 8.3 7.4 4.6 10.3 6.4 10.7 4.5 7.7 7.0 2.1 4.5 3.2 4.0 3.1 3.5 4.2 4.6 6.3 15.8 5.0 3.5 1.3 5.0 4.5 24.7 26.2 42.8 28.6 19.1 13.7 20.5 18.5 21.7 20.9 8.9 4.0 1.9 12.9 7.9 34.3 31.9 2.5 56.2 46.6 41.8 184.6 2.7 6.6 5.0 4.8 6.7 9.5 0.0 4.0 3.9 8.0 10.9 4.7 2.4 39.9 31.8 56.9 5.5 27.9 2.2 7.5 11.2 11.8 6.4 6.3 9.4 6.1 9.3 7.4 2.7 122.3 0.0 8.6 3.1 14.7 10.7 3.8 5.0 7.2 50.3 ABHD3 LABH3 ENSG00000158201 "Abhydrolase domain containing 3" Q8WU67 18 21650897-21704805 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Phospholipid metabolism" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "REH: 54.7;RPMI-8226: 60.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010729 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" Vesicles "HPA010729: AB_1844449" "unprognostic (1.46e-1)" "unprognostic (4.61e-2)" "unprognostic (2.37e-2)" "unprognostic (3.52e-1)" "unprognostic (8.46e-2)" "unprognostic (3.14e-3)" "unprognostic (3.54e-3)" "unprognostic (1.52e-1)" "prognostic unfavorable (8.52e-4)" "unprognostic (6.21e-2)" "unprognostic (1.98e-1)" "unprognostic (6.37e-2)" "unprognostic (1.73e-1)" "unprognostic (2.15e-2)" "unprognostic (1.00e-1)" "unprognostic (3.98e-2)" "unprognostic (4.58e-2)" 9.2 5.4 12.0 14.2 10.7 8.6 20.7 19.5 11.1 6.4 34.2 4.8 5.1 23.8 6.0 5.4 12.7 7.8 13.5 7.1 8.8 8.5 8.7 21.7 12.8 21.3 11.5 5.0 9.4 8.8 10.7 11.8 10.8 16.6 6.9 37.1 14.7 10.3 4.1 10.1 3.8 45.3 5.5 12.3 17.9 19.0 4.4 10.8 20.9 12.9 6.7 13.7 9.2 25.5 7.1 6.1 33.0 23.3 7.1 17.6 9.1 7.5 5.5 5.4 3.4 3.4 2.3 0.0 5.0 2.0 3.5 4.8 5.7 7.8 21.7 9.1 1.6 16.0 25.1 8.7 4.1 5.0 13.6 6.0 2.3 9.3 9.8 5.2 10.2 7.9 2.0 4.8 5.2 2.4 1.8 2.3 7.5 6.0 12.9 3.1 3.0 9.9 11.4 2.6 24.2 12.9 54.7 4.1 60.9 9.8 7.3 4.5 2.0 11.3 10.1 2.8 6.1 3.1 18.1 1.8 3.5 5.0 6.1 7.6 14.6 9.4 22.3 4.4 13.4 7.9 29.1 10.2 11.4 11.1 17.9 8.5 7.1 10.0 10.6 6.1 5.1 8.2 10.3 33.0 7.1 23.3 4.2 17.6 9.1 12.0 10.7 19.5 11.1 8.8 8.5 11.5 5.0 16.6 10.8 8.9 9.4 22.4 33.1 29.8 13.4 3.6 45.9 16.0 7.9 3.5 45.2 23.7 1.7 47.1 3.1 9.6 90.1 0.0 24.3 19.9 15.1 42.5 11.5 26.1 56.1 0.0 34.9 12.3 24.7 1.1 6.9 28.6 30.4 17.2 46.9 9.4 35.8 46.5 6.0 7.7 13.6 12.9 15.9 3.5 8.5 13.2 78.8 38.3 23.5 28.7 ABI1 "ABI-1, E3B1, SSH3BP1" ENSG00000136754 "Abl interactor 1" Q8IZP0 10 26746593-26861087 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 218.7;Suprabasal keratinocytes: 236.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008375, HPA068407" Approved Approved "Plasma membrane" NA NA 400000 "Plasma membrane" "CAB008375: AB_592744, HPA068407: AB_2685983" "unprognostic (2.83e-3)" "unprognostic (8.69e-2)" "unprognostic (1.12e-1)" "unprognostic (3.96e-1)" "unprognostic (2.51e-2)" "unprognostic (9.24e-3)" "unprognostic (1.88e-3)" "unprognostic (2.03e-1)" "unprognostic (6.04e-2)" "unprognostic (4.38e-1)" "unprognostic (2.40e-2)" "unprognostic (5.48e-2)" "unprognostic (1.98e-1)" "unprognostic (1.07e-1)" "unprognostic (1.79e-1)" "unprognostic (1.37e-1)" "unprognostic (1.18e-1)" 24.0 14.0 32.0 28.1 32.6 54.1 21.4 28.2 35.5 22.5 22.7 19.8 14.8 24.8 23.9 15.4 45.1 20.3 21.6 14.1 47.3 23.1 21.9 17.8 22.5 32.1 25.0 26.4 25.3 17.0 19.1 14.4 22.7 20.9 19.1 24.8 26.7 30.9 17.0 16.6 33.0 26.0 21.6 27.5 25.5 23.9 12.4 20.5 43.5 18.8 27.3 40.9 25.2 30.3 36.1 26.8 51.5 28.0 20.5 44.5 31.5 23.7 13.3 10.9 10.7 16.6 20.4 16.4 24.1 16.4 17.8 20.8 15.6 28.1 43.6 12.4 25.5 11.4 26.7 13.1 15.6 19.9 29.1 11.7 19.1 9.1 11.0 11.3 9.2 19.4 13.9 19.9 17.4 10.4 20.8 21.5 14.6 14.1 27.9 18.2 10.2 21.7 8.8 9.0 14.8 6.4 23.6 20.3 28.1 18.9 11.0 9.1 9.7 20.0 19.6 20.1 14.6 12.6 14.8 26.7 13.7 16.8 17.3 12.3 6.3 10.0 51.9 19.7 23.8 9.8 35.5 23.8 51.5 27.0 28.0 25.8 36.1 25.9 30.0 26.8 28.6 24.4 26.5 37.9 20.5 26.7 22.3 44.5 31.5 32.0 32.6 28.2 31.9 47.3 23.1 25.0 26.4 20.9 20.5 38.7 33.6 47.0 115.9 218.7 9.0 20.7 33.1 77.6 58.0 24.4 2.0 30.2 11.6 46.6 9.9 39.4 52.3 0.0 46.0 39.6 47.2 106.9 56.6 23.6 68.6 15.9 43.1 35.0 76.6 4.2 20.4 67.7 87.7 83.8 48.7 42.6 61.4 46.3 20.8 31.5 9.7 32.3 49.1 12.1 8.5 236.6 64.5 62.5 39.1 163.3 ABLIM3 KIAA0843 ENSG00000173210 "Actin binding LIM protein family member 3" O94929 5 149141483-149260542 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 58.4" "Cell type enhanced" "Detected in many" 12 "Cardiomyocytes: 57.0;Hepatocytes: 97.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 2.2" "Lineage enhanced" "Detected in single" "granulocytes: 2.2" "Cell line enhanced" "Detected in many" "ASC TERT1: 25.1;HHSteC: 25.7;HSkMC: 29.6;hTERT-HME1: 29.6;hTERT-RPE1: 24.8;TIME: 32.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003245 Approved Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Nucleoplasm, Plasma membrane" "Cell Junctions" "HPA003245: AB_1078083" "unprognostic (1.07e-1)" "unprognostic (1.31e-1)" "unprognostic (9.87e-2)" "unprognostic (1.75e-1)" "unprognostic (8.74e-2)" "unprognostic (4.19e-2)" "unprognostic (9.48e-3)" "unprognostic (4.37e-3)" "unprognostic (1.05e-1)" "unprognostic (1.09e-2)" "unprognostic (4.17e-3)" "unprognostic (2.42e-1)" "prognostic unfavorable (1.28e-4)" "unprognostic (3.12e-2)" "unprognostic (8.10e-2)" "unprognostic (2.45e-3)" "unprognostic (1.20e-1)" 45.9 6.0 7.9 3.5 9.8 1.2 35.0 29.7 12.5 9.1 4.7 11.6 7.0 2.9 4.9 8.9 15.6 5.8 6.1 58.4 8.5 10.2 17.0 48.1 9.1 4.8 9.9 5.9 2.6 2.4 39.3 3.1 26.1 14.3 6.5 4.7 7.7 3.0 9.9 24.3 3.5 3.7 8.7 14.0 5.0 2.7 2.3 3.3 0.1 4.2 8.9 4.5 8.8 14.6 0.0 0.6 2.2 0.3 0.0 0.0 6.8 7.2 1.5 0.0 0.0 13.1 25.1 0.0 5.1 14.3 2.9 5.1 0.0 5.1 0.0 0.8 6.4 15.6 0.1 0.0 5.9 5.8 0.0 0.0 0.0 0.3 0.1 25.7 0.0 0.0 29.6 1.6 10.5 29.6 24.8 13.1 0.0 0.0 2.3 17.0 2.8 0.0 0.0 0.0 0.4 20.1 0.0 0.0 0.0 16.4 5.0 2.0 0.0 1.0 0.3 2.7 0.4 0.4 0.0 32.8 6.2 1.4 6.4 8.6 0.0 0.0 0.0 10.8 0.0 17.6 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.6 0.0 6.8 7.9 9.8 29.7 12.5 8.5 10.2 9.9 5.9 14.3 3.3 0.0 3.0 4.7 1.0 1.3 1.1 57.0 28.1 4.0 1.2 0.0 0.0 0.1 5.0 6.8 1.8 20.2 0.0 0.0 3.0 0.6 2.1 2.2 1.1 97.0 9.3 27.0 0.0 20.3 11.9 0.0 0.3 0.8 5.0 0.0 0.0 19.7 14.9 0.0 0.7 18.3 21.8 0.0 2.3 1.7 2.3 1.4 0.3 0.0 0.0 4.9 AC004691.2 ENSG00000250424 7 30852273-30923812 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.3;ASC diff: 1.1;SH-SY5Y: 1.9;SK-BR-3: 1.3" "HPA019206, HPA030130" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA019206: AB_1844965, HPA030130: AB_10601565" "unprognostic (2.15e-1)" "unprognostic (3.12e-1)" "unprognostic (1.83e-1)" "unprognostic (1.66e-1)" "unprognostic (2.72e-4)" "unprognostic (5.13e-2)" "unprognostic (3.44e-2)" "unprognostic (2.15e-1)" "unprognostic (2.88e-2)" "unprognostic (3.76e-1)" "unprognostic (2.49e-1)" "unprognostic (3.71e-2)" 0.8 0.2 0.0 0.0 0.4 0.2 0.6 0.0 0.3 1.1 1.3 1.4 1.4 1.5 0.7 2.4 3.1 0.8 0.0 0.1 0.5 0.0 1.1 0.0 0.0 0.6 2.2 0.0 0.3 0.0 0.7 0.2 0.7 1.2 0.4 0.3 0.4 2.3 0.0 0.0 0.9 0.1 0.7 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.3 0.0 0.4 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 1.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.6 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC005324.3 ENSG00000251537 17 15571491-15651653 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 23.3;tongue: 21.1;vagina: 17.9" "Group enriched" "Detected in some" 11 "Club cells: 1.2;Pancreatic endocrine cells: 2.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 3.5;CAPAN-2: 3.1;HaCaT: 6.6;HeLa: 3.1;OE19: 2.2" "HPA023623, HPA066431" Uncertain Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA023623: AB_1858273, HPA066431: AB_2685668" "unprognostic (3.45e-2)" "unprognostic (1.41e-1)" "unprognostic (1.93e-1)" "unprognostic (2.48e-1)" "unprognostic (1.24e-2)" "unprognostic (3.52e-2)" "unprognostic (2.87e-3)" "unprognostic (1.93e-1)" "unprognostic (2.98e-2)" "unprognostic (4.39e-2)" "unprognostic (4.81e-3)" "unprognostic (6.35e-3)" "unprognostic (1.80e-11)" "unprognostic (1.95e-1)" "unprognostic (1.36e-1)" "unprognostic (5.30e-2)" "unprognostic (3.09e-1)" 7.5 2.8 0.9 1.5 1.0 1.0 7.7 0.9 1.0 5.3 2.2 1.3 0.0 2.1 0.7 1.5 23.3 0.8 4.0 2.6 0.8 0.9 0.9 1.0 2.1 1.6 3.7 0.0 0.7 1.0 0.8 0.7 12.4 2.7 1.4 0.9 0.2 2.4 1.1 2.9 4.4 1.6 2.1 1.5 1.0 2.8 1.8 1.0 1.6 1.8 21.1 17.5 3.2 17.9 0.6 0.6 0.0 0.1 0.0 0.5 0.0 0.6 3.5 0.1 0.1 0.0 0.3 0.0 0.2 0.3 0.0 0.1 0.1 3.1 0.1 0.1 1.0 0.0 6.6 0.0 0.0 0.1 1.0 0.2 0.0 3.1 0.0 0.0 0.1 0.0 0.0 0.7 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.1 0.0 0.4 1.0 0.0 0.0 0.6 0.4 0.1 0.2 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.3 0.9 0.0 0.2 0.0 0.6 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.6 0.6 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.9 1.0 0.9 1.0 0.8 0.9 3.7 0.0 2.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC005726.1 ENSG00000258472 17 28455752-28614197 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 16.8" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 8.9;Alveolar cells type 2: 10.4;Ciliated cells: 10.7;Club cells: 10.3;Collecting duct cells: 3.5;granulocytes: 5.8;Proximal tubular cells: 9.0;Syncytiotrophoblasts: 4.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 6.5;CACO-2: 2.1;Karpas-707: 3.5;PC-3: 3.2;THP-1: 3.5" HPA046590 Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" Nucleoplasm "HPA046590: AB_2679710" "unprognostic (1.26e-2)" "unprognostic (1.82e-1)" "unprognostic (6.04e-3)" "unprognostic (1.19e-1)" "unprognostic (1.14e-1)" "unprognostic (2.23e-3)" "unprognostic (2.76e-3)" "unprognostic (7.25e-2)" "unprognostic (5.96e-2)" "unprognostic (4.58e-2)" "unprognostic (9.22e-3)" "unprognostic (3.17e-3)" "unprognostic (1.49e-4)" "unprognostic (1.25e-1)" "unprognostic (2.65e-1)" "unprognostic (7.50e-2)" "unprognostic (3.79e-4)" 0.5 0.6 6.3 0.4 16.4 1.6 0.5 3.5 16.8 2.8 0.9 0.0 0.0 1.6 1.3 0.6 1.4 2.3 2.4 1.0 5.1 3.6 0.9 1.5 3.6 0.5 1.6 6.6 0.8 3.6 0.2 3.1 0.4 6.9 1.0 0.2 3.6 0.5 0.2 0.6 0.5 0.5 0.8 1.1 0.5 1.0 0.6 2.1 0.0 2.6 0.0 1.3 3.5 0.5 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 6.5 0.2 0.8 0.0 0.0 0.2 0.3 0.0 0.2 0.0 2.1 0.0 0.0 0.1 0.0 0.1 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 1.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.5 3.5 0.0 0.5 0.0 1.0 0.0 0.0 3.2 0.3 0.0 0.0 0.2 1.3 0.0 0.4 0.3 0.9 0.0 0.0 0.6 3.5 0.0 0.8 0.0 0.0 0.1 0.5 0.2 0.0 0.0 0.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 6.3 16.4 3.5 16.8 5.1 3.6 1.6 6.6 6.9 2.1 8.9 10.4 0.0 0.0 0.0 0.0 0.0 0.0 10.7 10.3 3.5 0.0 1.3 1.7 1.1 0.0 0.0 0.0 0.0 1.7 0.7 0.0 0.0 5.8 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.0 0.0 0.0 0.8 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 AC138696.1 ENSG00000264668 8 143247110-143276403 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC diff: 4.8" "HPA047232, HPA056268" Uncertain Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Plasma membrane" NA NA "Nucleoli, Nucleoli rim" "Nucleoplasm, Plasma membrane" "HPA047232: , HPA056268: AB_2683082" "unprognostic (2.24e-2)" "unprognostic (2.10e-1)" "unprognostic (3.56e-3)" "unprognostic (1.87e-1)" "unprognostic (8.68e-3)" "unprognostic (1.14e-1)" "unprognostic (1.51e-1)" "unprognostic (9.80e-2)" "unprognostic (4.20e-1)" "unprognostic (3.27e-2)" "unprognostic (1.34e-1)" "unprognostic (1.03e-2)" "unprognostic (2.20e-2)" "unprognostic (3.99e-1)" "unprognostic (2.59e-2)" "unprognostic (4.06e-1)" 3.6 4.8 6.2 2.5 4.4 1.5 2.5 5.8 7.3 3.3 3.8 4.7 2.5 2.6 5.7 2.7 2.8 7.8 2.0 2.7 6.2 4.8 2.6 1.9 2.7 2.5 4.8 3.0 5.8 6.8 4.6 4.5 2.2 4.2 3.0 2.2 3.8 3.6 3.9 4.7 1.8 3.1 3.2 3.7 2.7 2.7 3.5 3.6 1.5 2.7 1.5 2.6 3.6 4.4 0.6 0.6 0.0 0.2 0.9 2.1 0.1 1.4 0.0 0.0 0.8 4.8 0.3 0.5 1.4 3.0 1.6 0.6 0.0 1.9 0.2 0.8 0.3 0.3 0.7 0.0 0.6 0.5 0.0 1.4 0.3 0.0 0.0 0.0 0.3 0.7 2.8 1.3 0.0 1.0 0.5 0.9 1.1 0.0 0.1 0.0 0.0 3.3 0.0 3.0 0.4 0.9 1.6 2.8 0.2 0.0 0.0 0.0 2.1 0.0 0.0 0.7 0.0 1.0 0.9 0.0 0.0 0.7 3.0 0.1 2.3 0.8 1.6 1.1 0.3 0.4 0.0 0.0 0.0 0.1 0.0 2.1 0.2 0.0 0.1 0.0 0.6 0.3 0.0 0.0 0.9 0.2 0.6 0.3 0.1 6.2 4.4 5.8 7.3 6.2 4.8 4.8 3.0 4.2 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACOT9 "ACATE2, CGI-16, MT-ACT48" ENSG00000123130 "Acyl-CoA thioesterase 9" Q9Y305 X 23702253-23766475 "Predicted intracellular proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "monocytes: 296.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035533 Supported Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA035533: AB_10696506" "unprognostic (5.69e-2)" "unprognostic (6.34e-2)" "unprognostic (1.59e-1)" "unprognostic (2.09e-1)" "unprognostic (1.53e-2)" "unprognostic (1.27e-2)" "prognostic unfavorable (3.23e-4)" "unprognostic (1.12e-1)" "unprognostic (1.89e-1)" "unprognostic (2.50e-1)" "unprognostic (9.75e-3)" "unprognostic (3.49e-2)" "unprognostic (2.15e-3)" "unprognostic (6.53e-2)" "unprognostic (1.68e-1)" "unprognostic (1.44e-1)" "unprognostic (1.14e-1)" 19.1 15.9 6.3 14.1 7.7 10.5 29.2 6.5 13.6 15.4 16.3 5.4 17.6 11.5 21.2 16.1 12.0 14.5 15.5 35.7 5.7 7.7 12.8 15.5 23.6 36.0 7.3 8.6 13.4 16.6 9.1 7.8 13.3 12.7 12.8 12.7 13.9 16.3 23.0 28.8 10.4 12.5 35.7 13.8 15.8 15.0 7.1 4.5 3.8 15.1 11.4 9.7 15.9 14.4 5.5 16.4 11.1 26.5 6.0 10.0 8.4 26.1 17.9 7.8 17.1 12.8 14.7 3.9 20.8 18.0 20.6 20.0 15.8 23.7 1.3 13.3 23.1 27.8 16.0 9.8 26.4 28.7 6.1 14.9 8.9 18.7 11.4 17.3 3.4 11.3 12.9 18.1 24.1 27.5 13.5 30.1 0.2 5.6 9.0 22.2 9.1 4.8 8.4 11.3 10.3 21.8 5.1 29.7 11.1 24.4 9.7 1.5 7.5 22.6 9.5 13.3 30.2 10.7 4.6 27.9 17.2 11.4 24.9 11.3 2.2 5.1 0.1 12.7 3.4 14.5 9.1 16.1 11.1 5.6 22.2 7.6 5.5 7.0 6.3 16.4 4.6 2.3 5.3 8.4 6.0 26.5 2.8 10.0 8.4 6.3 7.7 6.5 13.6 5.7 7.7 7.3 8.6 12.7 4.5 44.7 33.0 11.4 38.4 17.9 4.3 37.2 15.3 28.1 35.2 15.7 23.6 3.6 5.0 60.6 0.7 35.1 10.5 0.0 45.6 9.3 28.3 31.5 35.9 11.3 39.9 4.8 2.4 35.6 33.3 0.0 16.7 63.3 32.1 296.6 8.7 10.0 62.9 11.8 24.1 25.0 9.3 25.8 20.3 1.8 9.6 9.4 2.5 22.3 9.4 32.8 ACTN1 ENSG00000072110 "Actinin alpha 1" P12814 14 68874143-68979440 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Actin-binding "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Extravillous trophoblasts: 304.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 71.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004303, HPA006035" Approved Approved "Plasma membrane,Actin filaments,Focal adhesion sites" NA NA 780000000 "Plasma membrane, Actin filaments, Focal adhesion sites" "CAB004303: AB_626633, HPA006035: AB_1078095" "unprognostic (4.40e-2)" "unprognostic (1.03e-3)" "unprognostic (2.49e-2)" "unprognostic (1.96e-1)" "unprognostic (1.19e-1)" "prognostic unfavorable (2.49e-4)" "unprognostic (6.19e-3)" "prognostic unfavorable (7.63e-5)" "unprognostic (3.62e-1)" "unprognostic (3.23e-2)" "unprognostic (3.16e-2)" "unprognostic (1.71e-1)" "prognostic unfavorable (9.08e-10)" "unprognostic (2.87e-2)" "unprognostic (2.00e-1)" "unprognostic (6.05e-3)" "prognostic unfavorable (8.00e-4)" 27.6 10.8 18.7 33.1 28.4 31.0 38.8 4.1 20.0 30.5 101.8 3.1 43.7 11.6 80.3 24.6 48.3 38.7 53.3 31.2 9.9 6.2 11.2 20.3 23.9 23.1 4.7 15.0 27.8 12.4 2.3 7.9 22.0 8.7 43.2 26.4 11.1 30.1 72.7 7.1 14.6 25.9 135.4 10.3 19.4 52.3 9.5 9.6 7.0 9.3 9.9 11.3 81.1 53.1 0.0 8.8 71.8 12.5 0.7 22.0 14.9 85.1 26.3 16.2 12.3 28.8 19.1 60.9 75.3 72.2 79.3 59.3 21.0 19.8 0.0 26.5 74.3 32.0 37.2 12.8 79.4 100.3 0.4 3.8 11.6 13.8 17.5 52.0 8.3 1.4 24.3 15.6 49.2 56.1 57.1 43.4 4.8 5.5 0.1 62.1 24.2 0.9 17.7 12.7 21.5 20.1 5.8 30.2 3.2 30.2 22.5 5.8 7.0 65.4 9.9 18.2 51.2 14.8 16.9 54.7 112.7 44.9 13.0 65.5 11.7 4.5 0.3 32.6 11.5 59.2 11.2 12.5 25.6 1.1 5.7 1.4 0.0 4.6 2.5 8.8 0.0 22.0 18.7 71.8 0.7 1.6 0.4 1.8 14.9 18.7 28.4 4.1 20.0 9.9 6.2 4.7 15.0 8.7 9.6 35.7 33.8 3.4 113.1 106.0 70.3 54.6 48.4 36.1 29.6 40.1 231.7 130.6 3.3 153.8 29.8 133.1 4.5 46.7 126.5 304.9 96.9 72.4 7.0 87.3 76.3 17.5 37.0 130.8 82.0 7.0 33.1 65.6 28.7 116.4 48.6 4.7 162.5 31.6 230.9 6.3 85.7 174.6 230.4 9.7 11.7 52.2 56.0 17.5 44.3 58.4 ACTR10 "ACTR11, Arp10, Arp11, HARP11" ENSG00000131966 "Actin related protein 10 homolog" Q9NZ32 14 58200080-58235636 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000699 Approved "Vesicles,Plasma membrane,Focal adhesion sites" NA NA "Vesicles, Plasma membrane, Focal adhesion sites" "HPA000699: " "prognostic unfavorable (3.24e-4)" "unprognostic (4.61e-2)" "unprognostic (6.22e-3)" "unprognostic (2.03e-2)" "unprognostic (4.42e-1)" "unprognostic (1.36e-2)" "prognostic unfavorable (2.71e-5)" "unprognostic (3.20e-1)" "unprognostic (9.30e-2)" "unprognostic (1.53e-1)" "unprognostic (4.86e-1)" "unprognostic (2.36e-1)" "prognostic favorable (8.48e-8)" "unprognostic (1.01e-2)" "unprognostic (2.39e-1)" "unprognostic (2.43e-2)" "unprognostic (8.48e-2)" 31.5 22.8 23.8 12.5 27.2 15.8 23.4 16.2 32.3 16.4 23.3 13.6 16.1 10.1 18.2 18.3 18.3 17.6 14.8 27.3 21.8 28.4 20.5 15.4 17.7 16.7 32.5 26.7 19.4 18.5 19.2 18.9 21.3 33.7 22.2 15.2 14.6 35.8 17.6 21.4 26.4 12.8 21.0 18.5 17.5 14.1 13.8 9.7 14.6 18.2 13.2 14.4 13.7 16.3 7.4 5.9 15.8 9.8 7.2 12.0 5.1 3.4 1.9 3.9 1.6 13.4 6.5 2.0 2.7 3.1 4.5 5.3 2.9 4.0 5.1 3.9 5.7 2.5 3.5 5.1 4.0 6.1 2.8 12.9 2.0 3.7 5.5 11.4 3.5 3.0 8.3 5.9 3.8 7.5 3.7 5.8 3.1 1.6 4.2 8.4 9.4 4.7 13.2 2.0 3.3 18.0 3.2 6.9 3.1 7.9 4.4 2.2 2.5 5.2 4.1 12.7 4.7 7.2 6.0 4.9 4.6 9.4 4.2 2.3 2.4 1.5 5.4 5.0 2.8 2.6 15.8 7.3 10.3 8.4 8.9 12.0 7.4 9.6 8.2 5.3 5.6 10.0 10.2 9.9 7.2 9.8 5.9 6.7 5.1 23.8 27.2 16.2 32.3 21.8 28.4 32.5 26.7 33.7 9.7 56.6 43.6 39.5 61.8 47.4 67.4 72.6 38.2 44.2 33.0 48.8 27.5 94.0 106.1 72.0 6.3 50.9 47.7 46.7 52.4 64.0 71.0 55.6 42.7 28.7 68.6 54.0 32.2 47.3 34.9 8.2 81.7 44.1 70.9 56.9 42.7 84.3 64.7 24.6 75.3 91.6 58.2 77.6 61.8 118.4 56.8 56.2 130.4 42.6 34.0 48.5 ACTR6 "ARP6, FLJ13433" ENSG00000075089 "ARP6 actin related protein 6 homolog" Q9GZN1 12 100199122-100241865 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038587, HPA038588" Uncertain Approved "Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "HPA038587: AB_10670781, HPA038588: AB_10672719" "unprognostic (1.24e-2)" "unprognostic (8.43e-3)" "unprognostic (1.81e-1)" "unprognostic (1.14e-1)" "unprognostic (1.70e-1)" "unprognostic (1.24e-2)" "prognostic unfavorable (7.70e-9)" "unprognostic (4.11e-2)" "unprognostic (1.09e-1)" "unprognostic (1.05e-1)" "unprognostic (6.98e-2)" "unprognostic (3.99e-1)" "unprognostic (5.32e-2)" "unprognostic (4.30e-2)" "unprognostic (3.22e-1)" "unprognostic (6.67e-3)" "unprognostic (3.40e-2)" 7.6 8.0 12.6 6.6 13.8 5.6 20.5 14.8 20.2 10.3 9.9 10.2 6.9 7.5 8.6 7.2 10.4 9.6 5.9 8.1 15.2 15.7 12.3 12.5 8.2 11.6 13.8 15.4 9.9 5.9 15.8 14.0 11.6 21.2 11.0 10.6 6.7 7.7 12.2 8.3 6.8 9.2 8.3 12.8 9.6 7.3 13.9 14.6 13.4 9.6 5.8 11.9 11.6 8.6 6.1 6.1 4.6 5.8 7.9 10.9 6.6 18.0 7.1 9.0 11.0 9.0 11.1 18.5 5.1 8.9 8.5 5.8 5.1 5.3 9.5 7.1 8.0 8.0 5.9 13.2 8.3 15.5 9.0 11.9 5.8 7.2 5.4 9.8 8.9 6.0 6.6 10.1 7.2 9.3 13.0 11.5 13.9 10.1 3.8 11.8 3.9 11.9 10.0 8.8 7.0 8.9 7.3 8.8 11.1 11.5 10.4 7.9 13.8 9.3 19.8 9.1 9.6 12.9 8.5 5.8 5.2 3.8 6.9 5.4 6.4 16.2 12.2 3.6 5.9 7.5 3.8 2.8 4.6 8.0 5.8 9.9 6.0 8.8 7.5 4.1 6.1 10.9 10.0 2.1 7.9 4.5 6.1 7.7 6.6 12.6 13.8 14.8 20.2 15.2 15.7 13.8 15.4 21.2 14.6 14.9 15.3 10.1 32.9 20.4 31.8 31.3 5.1 32.1 14.8 22.7 17.7 49.3 39.7 17.9 95.8 19.5 8.9 23.3 10.5 57.0 22.6 20.7 32.3 13.7 20.8 31.8 12.0 14.7 19.9 23.7 18.7 18.5 30.4 19.8 9.8 24.1 12.4 10.7 21.2 53.1 29.9 32.3 25.4 36.4 22.6 17.2 80.3 33.8 11.3 26.9 ADAM33 "C20orf153, dJ964F7.1, DKFZp434K0521" ENSG00000149451 "ADAM metallopeptidase domain 33" Q9BZ11 20 3667965-3682246 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" Asthma "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 55.7;smooth muscle: 58.0" "Cell type enhanced" "Detected in some" 12 "Fibroblasts: 23.2;Leydig cells: 21.0;Peritubular cells: 9.6;Smooth muscle cells: 15.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "plasmacytoid DC: 1.2" "Lineage enriched" "Detected in single" 12 "dendritic cells: 1.2" "Cell line enhanced" "Detected in some" "ASC diff: 31.3;ASC TERT1: 40.6;BJ: 13.8;BJ hTERT+: 23.7;fHDF/TERT166: 14.1;U-2197: 18.9" "Region enhanced" "Detected in single" "cerebral cortex: 1.0" "Low region specificity" "Detected in all" "HPA067152, HPA071758" Approved Approved "Nuclear speckles,Plasma membrane" NA NA "Plasma membrane" "Nuclear speckles" "HPA067152: AB_2685791, HPA071758: " "unprognostic (1.10e-1)" "unprognostic (3.02e-2)" "unprognostic (2.24e-2)" "unprognostic (3.35e-3)" "unprognostic (4.39e-3)" "unprognostic (7.43e-4)" "unprognostic (7.14e-3)" "unprognostic (1.67e-1)" "unprognostic (1.78e-3)" "unprognostic (1.28e-1)" "unprognostic (1.26e-1)" "unprognostic (3.56e-1)" "unprognostic (2.75e-11)" "unprognostic (1.05e-2)" "unprognostic (1.92e-1)" "unprognostic (3.21e-5)" "unprognostic (3.10e-3)" 10.0 1.5 4.6 9.2 2.6 0.0 20.2 2.8 2.7 55.7 29.5 2.2 20.9 4.7 44.3 12.3 17.0 16.9 17.5 5.3 5.0 0.9 0.9 0.5 3.6 2.2 4.9 3.0 11.8 1.6 0.0 1.6 5.4 7.0 22.8 5.5 3.7 4.2 27.1 3.5 4.8 9.1 58.0 3.3 1.9 9.9 5.4 3.5 0.1 4.0 10.1 2.0 24.9 36.7 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.3 40.6 0.1 13.8 23.7 4.1 8.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 6.9 0.0 1.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.0 0.1 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 18.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 4.6 2.6 2.8 2.7 5.0 0.9 4.9 3.0 7.0 3.5 0.0 0.0 0.0 0.1 4.8 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.2 23.2 0.2 0.0 0.0 0.5 0.0 0.0 3.1 0.0 0.0 21.0 0.6 3.3 0.0 0.0 3.3 0.0 0.0 9.6 0.0 0.0 6.5 15.1 0.6 0.5 2.8 0.5 0.0 0.0 0.0 ADAMTS1 "C3-C5, KIAA1346, METH1" ENSG00000154734 "ADAM metallopeptidase with thrombospondin type 1 motif 1" Q9UHI8 21 26835747-26845409 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Heparin-binding, Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 112.8" "Cell type enhanced" "Detected in many" 9 "Extravillous trophoblasts: 211.3;Sertoli cells: 207.0;Smooth muscle cells: 366.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "gdT-cell: 8.0;NK-cell: 9.0" "Group enriched" "Detected in many" 85 "NK-cells: 9.0;T-cells: 8.0" "Cell line enhanced" "Detected in many" "ASC diff: 62.1;BJ: 72.4;hTEC/SVTERT24-B: 49.9;hTERT-HME1: 45.5;RPTEC TERT1: 42.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "CAB016394, HPA031498" Approved Approved "Plasma membrane" "Secreted to extracellular matrix" NA NA 1900000 "Plasma membrane" "CAB016394: AB_626637, HPA031498: AB_2673907" "unprognostic (6.82e-2)" "unprognostic (1.35e-1)" "unprognostic (1.21e-1)" "unprognostic (1.64e-1)" "unprognostic (1.18e-2)" "prognostic unfavorable (5.13e-4)" "unprognostic (1.03e-1)" "unprognostic (3.28e-1)" "unprognostic (2.37e-2)" "unprognostic (5.39e-2)" "unprognostic (1.75e-1)" "unprognostic (4.55e-2)" "unprognostic (9.70e-3)" "unprognostic (8.27e-3)" "unprognostic (1.12e-1)" "unprognostic (6.76e-2)" "unprognostic (1.57e-1)" 70.6 13.4 8.2 18.7 14.0 0.7 29.0 6.3 9.2 22.0 18.2 9.5 4.8 3.3 27.7 25.8 30.0 45.8 62.3 40.9 7.6 4.8 15.4 22.8 25.0 10.9 12.7 3.7 112.8 9.3 6.3 7.6 56.8 13.2 23.3 16.5 7.8 5.8 8.1 25.7 6.1 16.2 46.4 10.2 7.2 16.8 12.8 11.4 0.0 14.3 18.1 2.7 32.7 45.3 0.0 0.0 0.0 0.0 9.0 8.0 1.4 0.0 0.0 1.1 0.0 62.1 15.4 3.8 72.4 25.3 12.5 8.3 0.0 0.0 0.0 5.0 22.9 0.3 1.3 0.8 3.7 22.1 0.0 23.0 0.0 7.5 0.0 11.9 2.9 0.0 17.2 0.0 49.9 45.5 3.0 5.1 0.7 1.2 0.0 37.1 0.0 0.3 0.0 4.1 0.0 2.9 0.0 28.6 0.2 42.4 4.0 0.0 5.6 3.4 0.0 0.4 2.7 0.1 0.7 5.2 17.8 0.9 27.8 10.7 0.1 0.0 0.0 14.7 0.0 5.4 0.0 0.0 0.0 8.0 0.0 0.8 0.0 0.3 0.6 0.0 0.0 0.0 1.5 0.0 9.0 0.0 0.0 0.0 1.4 8.2 14.0 6.3 9.2 7.6 4.8 12.7 3.7 13.2 11.4 6.0 31.4 0.0 31.2 107.6 0.5 151.1 7.6 5.3 14.8 54.1 0.0 44.4 1.7 29.9 1.3 165.7 0.0 0.0 18.6 211.3 148.2 23.5 2.3 1.3 14.7 0.0 0.0 124.0 6.0 2.2 100.9 4.8 50.6 1.0 0.0 31.7 24.2 0.0 39.3 2.2 2.2 207.0 366.0 0.5 1.0 36.4 45.9 5.0 0.0 13.3 ADAMTS2 "ADAM-TS2, ADAMTS-3, hPCPNI, NPI, PCINP" ENSG00000087116 "ADAM metallopeptidase with thrombospondin type 1 motif 2" O95450 5 179110851-179345430 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 16 "Ito cells: 28.8;Kupffer cells: 58.6;Sertoli cells: 25.8;Smooth muscle cells: 16.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 14.0;ASC TERT1: 14.0;BJ: 12.3;fHDF/TERT166: 14.5;HHSteC: 45.5;HSkMC: 36.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA028363, HPA028444" Uncertain Approved "Vesicles,Plasma membrane" "Secreted to extracellular matrix" NA NA "Plasma membrane" Vesicles "HPA028363: , HPA028444: AB_10601964" "unprognostic (6.78e-2)" "unprognostic (7.83e-2)" "unprognostic (1.13e-1)" "unprognostic (5.50e-2)" "unprognostic (8.85e-3)" "unprognostic (4.80e-2)" "unprognostic (1.09e-1)" "unprognostic (2.22e-2)" "unprognostic (1.58e-1)" "unprognostic (1.91e-2)" "unprognostic (2.08e-1)" "unprognostic (2.45e-1)" "prognostic unfavorable (1.71e-8)" "unprognostic (1.32e-3)" "unprognostic (1.03e-2)" "unprognostic (7.16e-3)" "unprognostic (1.48e-2)" 24.2 4.3 0.9 5.8 0.7 0.7 29.1 0.9 2.3 16.3 10.1 0.4 3.9 2.7 12.0 9.5 6.0 7.2 9.5 10.1 0.7 1.2 4.2 7.4 13.1 25.9 1.0 1.3 6.3 2.7 1.0 8.7 15.1 2.4 6.0 2.6 3.8 2.5 3.8 3.8 4.6 4.6 13.8 0.7 16.5 4.2 4.3 0.5 0.8 3.2 5.9 1.2 8.8 14.7 1.4 1.3 2.1 0.3 0.8 0.6 0.1 0.0 0.0 0.0 0.3 14.0 14.0 0.0 12.3 2.1 4.7 5.0 0.0 0.0 0.0 0.1 14.5 0.3 0.0 0.7 0.0 2.0 0.0 0.7 0.0 0.0 0.9 45.5 0.0 0.0 36.3 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.9 0.5 0.0 0.0 0.1 0.8 0.0 4.0 0.0 7.9 1.2 10.3 0.0 0.1 0.0 0.0 0.3 0.1 0.0 1.5 0.3 0.4 0.6 0.2 0.3 0.6 0.5 0.4 1.3 1.4 0.5 0.5 2.1 0.8 0.1 0.8 0.5 0.1 0.9 0.7 0.9 2.3 0.7 1.2 1.0 1.3 2.4 0.5 0.0 0.6 0.0 0.3 1.9 0.0 1.2 2.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 1.4 0.0 0.0 0.0 0.1 13.5 0.2 1.1 0.5 3.9 0.0 0.0 28.8 58.6 2.1 4.6 2.9 0.0 0.0 0.0 0.0 0.8 0.0 12.0 0.0 0.0 25.8 16.1 0.5 2.6 2.4 0.0 0.0 0.0 0.1 ADAMTSL4 "DKFZP434K1772, TSRC1" ENSG00000143382 "ADAMTS like 4" Q6UY14 1 150549369-150560937 "Disease related genes, Predicted secreted proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "placenta: 157.1" "Cell type enhanced" "Detected in many" 13 "Cytotrophoblasts: 113.3;Extravillous trophoblasts: 39.4;Syncytiotrophoblasts: 83.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "classical monocyte: 1.6;intermediate monocyte: 1.8;neutrophil: 2.3;non-classical monocyte: 3.5" "Group enriched" "Detected in many" 5 "granulocytes: 2.3;monocytes: 3.5" "Cell line enhanced" "Detected in many" "ASC TERT1: 30.2;BEWO: 63.6;HSkMC: 14.2;K-562: 20.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA006279 Approved Approved "Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA 47000000 "Plasma membrane, Cytosol" "HPA006279: AB_1078102" "unprognostic (2.00e-2)" "unprognostic (1.24e-2)" "prognostic unfavorable (1.86e-4)" "unprognostic (8.09e-4)" "prognostic unfavorable (2.43e-4)" "unprognostic (1.09e-1)" "unprognostic (1.65e-1)" "unprognostic (7.52e-2)" "unprognostic (3.56e-2)" "unprognostic (1.68e-2)" "unprognostic (1.28e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (4.35e-7)" "unprognostic (1.90e-1)" "unprognostic (5.23e-2)" "unprognostic (1.44e-2)" "unprognostic (7.40e-3)" 14.4 2.4 0.8 8.9 1.4 2.2 13.2 0.7 1.1 11.0 8.2 1.5 3.9 2.2 9.7 8.1 19.7 11.1 6.6 10.7 1.0 0.2 3.4 14.9 13.3 2.3 1.4 0.4 14.5 1.8 0.2 1.3 157.1 3.4 9.4 2.4 19.1 5.7 2.3 21.1 5.4 6.0 17.4 2.2 3.9 8.9 3.3 1.1 0.8 3.8 15.5 4.8 19.1 15.9 0.0 0.5 2.3 3.5 0.0 0.1 0.6 6.7 0.1 0.1 1.2 6.2 30.2 63.6 6.5 5.7 3.9 2.2 0.5 2.6 0.0 1.3 4.4 0.0 3.4 0.2 0.9 1.6 0.5 0.1 1.9 0.7 2.7 5.0 0.0 0.9 14.2 0.2 0.9 2.2 3.3 0.0 0.0 20.3 0.2 0.6 0.1 0.0 0.3 1.1 0.1 0.2 0.0 0.0 0.0 0.6 0.2 0.0 0.2 2.0 5.0 0.0 3.3 1.4 3.5 1.2 0.2 1.8 2.7 0.1 0.6 0.1 1.4 0.2 1.2 0.1 0.0 1.6 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.3 0.0 3.5 0.0 0.0 0.6 0.8 1.4 0.7 1.1 1.0 0.2 1.4 0.4 3.4 1.1 0.0 1.0 0.8 2.1 2.2 1.0 2.0 7.6 1.4 0.0 0.0 0.0 113.3 0.0 1.1 0.4 3.5 0.0 0.0 0.5 39.4 15.5 1.3 2.3 9.2 28.7 0.0 0.0 1.3 22.6 0.0 27.9 16.5 3.3 25.2 0.0 2.4 7.4 0.0 3.2 0.0 2.4 0.0 1.4 0.0 0.9 2.5 83.2 0.0 0.1 1.7 ADAP1 "CENTA1, GCS1L" ENSG00000105963 "ArfGAP with dual PH domains 1" O75689 7 897901-955407 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.8;intestine: 30.8" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 56.4;Mucus-secreting cells: 30.1;Paneth cells: 34.3;Undifferentiated cells: 26.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 31.2;CAPAN-2: 22.5;HMC-1: 21.6;OE19: 57.2;THP-1: 36.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007033, HPA012049" Enhanced Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA007033: AB_1846529, HPA012049: AB_1846527" "unprognostic (2.45e-1)" "unprognostic (7.15e-2)" "prognostic unfavorable (5.25e-4)" "unprognostic (4.41e-2)" "unprognostic (1.97e-1)" "prognostic unfavorable (9.13e-4)" "unprognostic (3.06e-1)" "unprognostic (9.10e-3)" "unprognostic (1.70e-2)" "unprognostic (1.38e-1)" "unprognostic (5.74e-2)" "unprognostic (1.69e-1)" "prognostic favorable (4.13e-5)" "unprognostic (5.88e-2)" "unprognostic (1.58e-1)" "unprognostic (1.41e-1)" "unprognostic (1.79e-2)" 3.0 2.1 32.9 8.9 25.9 8.1 1.2 13.8 41.8 3.6 30.8 30.3 1.7 16.7 2.6 1.3 4.5 4.2 6.2 3.9 36.1 17.7 6.5 1.6 5.8 3.3 28.0 20.1 0.7 5.4 3.7 1.3 3.0 19.3 1.9 20.6 0.9 3.0 3.1 0.8 2.0 22.8 7.7 36.1 7.4 16.3 1.1 19.3 0.0 4.8 0.4 2.3 5.1 1.0 1.3 5.5 3.4 11.7 1.6 6.8 3.7 31.2 1.1 0.0 1.1 0.4 0.0 0.3 1.0 0.0 0.3 0.1 12.4 22.5 0.0 3.1 0.1 0.0 14.3 1.7 2.4 0.1 0.1 1.3 0.0 1.9 7.0 0.5 0.2 21.6 0.5 6.7 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 10.0 0.0 8.4 1.0 57.2 0.0 4.2 0.0 0.1 1.7 7.6 0.9 0.3 0.9 0.4 0.1 0.1 8.1 36.7 0.1 0.2 0.9 0.0 0.1 0.0 0.0 0.0 0.0 6.5 1.1 1.1 7.6 3.4 6.8 8.1 3.3 1.3 2.0 6.1 5.5 1.1 0.6 3.1 3.4 1.6 11.7 0.4 0.9 3.7 32.9 25.9 13.8 33.4 36.1 17.7 28.0 20.1 19.3 19.3 0.0 13.0 3.2 2.5 0.9 4.2 7.7 7.6 8.1 2.3 7.0 0.0 0.1 8.3 3.7 0.0 0.5 56.4 0.0 4.0 0.4 1.4 2.0 6.9 0.4 11.1 0.0 15.5 0.0 21.6 0.0 0.0 13.7 10.1 0.0 30.1 1.2 12.4 34.3 0.0 5.9 0.6 0.0 1.0 0.3 0.9 1.1 0.6 4.4 26.9 3.3 ADCK5 FLJ35454 ENSG00000173137 "AarF domain containing kinase 5" Q3MIX3 8 144373101-144393242 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 43.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025692, HPA028679" Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA025692: AB_10599486, HPA028679: AB_10600226" "unprognostic (6.76e-2)" "unprognostic (1.66e-1)" "unprognostic (1.68e-2)" "unprognostic (8.96e-2)" "unprognostic (1.68e-2)" "unprognostic (1.00e-1)" "unprognostic (2.31e-3)" "unprognostic (6.45e-2)" "unprognostic (2.70e-1)" "unprognostic (4.25e-2)" "unprognostic (6.60e-2)" "unprognostic (2.03e-2)" "unprognostic (1.33e-3)" "unprognostic (1.39e-2)" "unprognostic (1.20e-1)" "unprognostic (3.47e-1)" "unprognostic (2.90e-2)" 4.1 10.0 4.8 8.9 4.5 4.5 4.3 11.5 9.1 4.6 18.3 2.8 7.6 19.1 5.8 4.2 7.2 4.2 6.3 3.8 3.9 4.1 4.8 6.9 3.7 5.0 3.4 8.4 5.5 5.6 4.7 4.1 3.7 4.5 4.7 4.0 4.6 7.4 4.7 5.6 8.3 17.0 2.7 2.4 6.7 5.6 7.7 3.8 6.8 4.1 4.9 6.1 5.1 5.0 4.7 6.3 2.5 5.4 1.8 4.1 2.8 3.9 4.9 1.1 3.4 0.9 0.8 5.7 3.3 1.9 2.7 0.9 5.3 4.2 1.7 2.4 0.7 0.9 5.2 0.2 3.6 0.2 4.4 1.6 4.5 3.6 5.9 2.7 1.0 3.5 1.4 2.1 0.9 0.8 1.5 1.8 3.1 2.9 3.1 1.5 10.3 3.2 4.4 0.7 3.4 3.7 4.3 1.7 3.1 1.8 3.7 0.7 1.8 4.9 3.9 2.8 0.9 3.4 3.0 1.3 1.4 5.2 3.5 2.2 1.4 0.4 1.6 3.2 3.9 2.0 1.8 4.2 2.5 2.3 5.4 3.0 1.8 2.8 1.8 6.3 4.7 2.9 1.5 0.7 1.8 5.0 4.0 4.1 2.8 4.8 4.5 11.5 9.1 3.9 4.1 3.4 8.4 4.5 3.8 3.0 1.7 2.2 3.4 3.7 9.2 2.0 7.6 6.7 1.2 5.2 15.7 3.5 3.3 7.7 6.5 4.1 43.3 0.0 6.3 9.4 3.9 2.3 9.2 6.7 7.0 3.2 8.1 3.7 3.8 8.6 5.5 5.2 3.3 11.8 26.0 5.8 9.0 14.0 6.7 5.1 15.2 12.9 3.3 13.4 10.4 4.4 2.1 5.7 20.0 2.2 ADGRG7 "FLJ14454, GPR128" ENSG00000144820 "Adhesion G protein-coupled receptor G7" Q96K78 3 100609589-100695479 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 31 "intestine: 58.4;liver: 26.9" "Cell type enhanced" "Detected in some" 25 "Collecting duct cells: 1.8;Enterocytes: 2.6;Hepatocytes: 10.4;Paneth cells: 4.0" "Cancer enhanced" "Detected in some" "stomach cancer: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "BEWO: 2.9;CACO-2: 4.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA056451 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA056451: " "unprognostic (1.65e-1)" "unprognostic (1.10e-1)" "unprognostic (2.79e-1)" "unprognostic (8.46e-3)" "unprognostic (1.26e-1)" "unprognostic (6.71e-2)" "unprognostic (9.37e-3)" "unprognostic (2.84e-5)" "unprognostic (1.17e-1)" "unprognostic (2.16e-1)" "unprognostic (6.77e-2)" 0.1 0.2 0.1 0.5 0.1 1.2 0.1 0.1 0.1 0.9 17.1 0.1 0.1 25.7 0.3 0.1 0.2 0.9 0.3 0.2 0.1 0.1 0.1 26.9 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.2 0.4 1.7 0.1 0.1 0.1 0.1 0.2 58.4 0.8 0.1 0.1 0.0 0.2 0.1 0.1 0.2 0.1 0.1 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.2 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 ADGRL2 "KIAA0786, LEC1, LPHH1, LPHN2" ENSG00000117114 "Adhesion G protein-coupled receptor L2" O95490 1 81306160-81992436 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 51.9;Cardiomyocytes: 43.9;Hepatocytes: 33.8;Horizontal cells: 31.8;Ito cells: 40.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 63.8;hTEC/SVTERT24-B: 31.7;NTERA-2: 26.8;SH-SY5Y: 42.7;U-2197: 29.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043447 Approved "Plasma membrane,Cell Junctions" NA NA 280000 "Plasma membrane, Cell Junctions" "HPA043447: AB_2678486" "unprognostic (2.54e-2)" "unprognostic (6.29e-3)" "unprognostic (2.57e-1)" "prognostic unfavorable (1.33e-4)" "unprognostic (3.22e-1)" "unprognostic (1.61e-1)" "prognostic unfavorable (9.92e-4)" "unprognostic (3.55e-2)" "unprognostic (9.84e-2)" "unprognostic (2.42e-1)" "unprognostic (7.81e-2)" "unprognostic (8.01e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (3.00e-4)" "unprognostic (2.76e-1)" "unprognostic (3.38e-3)" "unprognostic (1.41e-2)" 8.9 10.5 21.1 3.6 20.9 0.0 8.8 1.5 45.8 7.5 7.0 1.4 1.2 2.7 6.1 8.6 12.0 12.0 11.5 17.6 12.2 6.6 10.9 18.7 32.7 3.5 3.5 22.8 18.8 4.9 20.3 11.8 24.4 6.2 15.6 5.4 9.4 19.1 10.1 2.0 6.3 6.1 6.0 3.2 10.0 7.6 2.0 3.3 0.6 22.4 15.0 5.0 6.5 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 2.4 63.8 0.0 7.9 9.1 0.8 1.5 3.5 0.6 0.7 0.0 0.0 0.0 17.5 8.1 1.8 2.5 5.0 6.7 0.5 0.1 10.4 0.0 1.8 4.4 3.0 0.0 0.1 7.7 0.4 31.7 3.2 4.4 10.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 26.8 0.0 1.9 0.0 8.8 0.0 14.5 0.9 3.2 42.7 0.0 1.8 0.0 18.9 0.1 18.8 6.8 6.5 7.4 29.2 2.2 0.0 0.0 0.0 3.7 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.1 20.9 1.5 45.8 12.2 6.6 3.5 22.8 6.2 3.3 3.0 2.1 0.0 6.5 0.0 51.9 43.9 10.2 0.0 5.7 5.2 5.9 0.3 0.0 3.7 1.0 27.2 0.0 0.0 1.5 0.2 9.1 8.9 0.0 33.8 0.7 31.8 0.0 40.5 6.0 1.3 21.6 0.9 0.0 0.0 1.1 20.6 1.0 0.0 16.6 7.0 2.4 19.4 3.7 0.5 3.0 0.0 0.3 0.0 0.7 2.4 ADH1A ADH1 ENSG00000187758 "Alcohol dehydrogenase 1A (class I), alpha polypeptide" P07327 4 99276367-99291028 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 322 "liver: 250.3" "Cell type enriched" "Detected in some" 10 "Hepatocytes: 212.0" "Cancer enriched" "Detected in some" 251 "liver cancer: 165.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "ASC diff: 11.2" "CAB009562, HPA047814, HPA060902" Enhanced Approved "Plasma membrane,Cytosol" NA NA 12000000 "Plasma membrane, Cytosol" "CAB009562: AB_2257984, HPA047814: AB_2680163, HPA060902: AB_2684384" "unprognostic (5.89e-2)" "unprognostic (6.16e-2)" "unprognostic (1.20e-1)" "unprognostic (2.07e-1)" "unprognostic (4.40e-1)" "prognostic favorable (2.38e-4)" "unprognostic (2.78e-3)" "unprognostic (4.25e-1)" "unprognostic (4.79e-3)" "unprognostic (6.21e-2)" "unprognostic (9.36e-2)" "unprognostic (3.25e-2)" "unprognostic (1.40e-1)" "unprognostic (2.86e-2)" 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 250.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 11.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 20.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 212.0 0.0 0.0 0.0 7.4 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 ADH1B ADH2 ENSG00000196616 "Alcohol dehydrogenase 1B (class I), beta polypeptide" P00325 4 99304964-99352760 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adipose tissue: 253.5;liver: 466.3" "Cell type enriched" "Detected in many" 38 "Hepatocytes: 3603.2" "Cancer enriched" "Detected in many" 31 "liver cancer: 223.1" "Group enriched" "Detected in some" 5 "midbrain: 2.3;pons and medulla: 1.6" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 7 "ASC diff: 394.3" "HPA047814, HPA060902" Supported Approved "Plasma membrane,Cytosol" NA NA 16000000 "Plasma membrane, Cytosol" "HPA047814: AB_2680163, HPA060902: AB_2684384" "unprognostic (5.13e-2)" "unprognostic (9.80e-3)" "unprognostic (6.59e-2)" "unprognostic (5.56e-2)" "unprognostic (9.49e-2)" "unprognostic (5.53e-2)" "unprognostic (1.54e-3)" "unprognostic (1.04e-2)" "unprognostic (6.51e-2)" "unprognostic (2.73e-2)" "unprognostic (7.47e-3)" "unprognostic (7.79e-2)" "prognostic unfavorable (7.87e-4)" "unprognostic (4.60e-3)" "unprognostic (2.33e-1)" "unprognostic (2.58e-1)" "unprognostic (1.60e-2)" 253.5 12.3 0.2 21.8 0.0 0.4 78.7 0.2 0.4 18.3 60.0 0.4 5.7 3.5 12.8 14.4 33.5 22.3 31.9 24.2 0.3 0.0 9.2 466.3 43.8 17.5 2.3 0.1 18.0 8.7 0.8 5.3 0.9 1.6 30.7 10.1 2.3 11.2 3.9 20.5 11.9 25.4 30.8 2.4 5.9 10.9 18.0 0.2 0.2 16.1 9.7 2.0 42.3 76.0 0.6 0.2 1.2 0.3 0.8 0.4 0.0 0.0 0.0 0.0 0.0 394.3 57.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.3 0.2 0.1 0.1 0.2 0.4 0.1 0.0 0.6 0.3 0.4 1.2 0.8 0.1 0.2 0.1 0.0 0.2 0.0 0.2 0.0 0.3 0.0 2.3 0.1 1.6 0.2 0.0 4.3 14.0 0.4 19.8 0.0 8.9 66.2 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.4 9.2 0.0 46.7 0.0 0.0 81.0 0.3 1.1 3603.2 0.1 0.0 0.0 93.9 77.5 0.0 51.2 1.0 27.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 6.5 43.7 0.0 0.0 11.4 0.1 12.5 0.0 0.1 ADH7 ADH-4 ENSG00000196344 "Alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide" P40394 4 99412261-99435737 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "esophagus: 75.0;lymphoid tissue: 30.7;tongue: 68.7" "Group enriched" "Detected in some" 15 "Ciliated cells: 8.1;Club cells: 10.3" "Group enriched" "Detected in some" 17 "cervical cancer: 18.4;head and neck cancer: 18.9;lung cancer: 22.4;urothelial cancer: 5.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "ASC TERT1: 4.0;HaCaT: 4.5" "Not detected" "Not detected" HPA039695 Enhanced Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039695: AB_10795681" "unprognostic (1.02e-2)" "unprognostic (8.64e-2)" "unprognostic (4.86e-2)" "unprognostic (5.66e-3)" "unprognostic (4.50e-2)" "unprognostic (1.66e-1)" "unprognostic (2.02e-1)" "unprognostic (1.88e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 75.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.2 0.0 0.1 0.0 0.0 9.4 0.0 0.0 0.1 0.0 68.7 30.7 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 8.1 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 ADRM1 "ARM1, GP110, Rpn13" ENSG00000130706 "Adhesion regulating molecule 1" Q16186 20 62302093-62308862 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 11 "Late spermatids: 1352.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CACO-2: 113.5" "Low region specificity" "Detected in all" HPA042266 Supported Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA042266: AB_10794044" "unprognostic (5.49e-2)" "unprognostic (5.14e-3)" "unprognostic (7.34e-2)" "unprognostic (6.16e-2)" "unprognostic (2.06e-2)" "unprognostic (1.06e-1)" "unprognostic (1.77e-3)" "unprognostic (2.14e-2)" "unprognostic (3.56e-2)" "unprognostic (2.13e-3)" "unprognostic (8.98e-2)" "unprognostic (3.50e-1)" "prognostic unfavorable (9.02e-6)" "unprognostic (4.15e-2)" "unprognostic (1.09e-1)" "unprognostic (3.22e-1)" "unprognostic (8.47e-2)" 22.9 22.9 14.8 23.4 16.8 30.5 17.0 24.1 29.3 14.7 16.9 18.8 12.4 24.0 19.9 15.3 23.9 14.0 20.4 24.6 14.6 15.1 21.7 54.5 15.7 22.1 15.5 13.4 17.2 34.9 9.5 13.4 27.6 21.4 14.8 7.9 14.8 21.0 18.3 86.6 26.4 19.5 17.3 15.4 23.5 20.1 30.0 10.1 23.8 16.4 29.1 29.4 17.3 14.6 79.2 67.2 69.4 78.0 51.7 77.6 70.9 33.9 38.1 10.7 22.8 10.2 7.5 29.1 22.5 15.3 42.2 16.9 113.5 36.0 18.3 41.1 12.8 24.1 38.4 13.4 33.0 13.0 21.3 27.5 44.4 27.6 59.8 17.3 22.9 42.4 9.5 20.3 27.5 11.0 7.0 16.3 18.2 32.4 20.0 9.7 45.7 28.7 44.9 36.2 16.5 56.9 23.1 18.8 29.0 11.3 25.6 19.2 23.9 24.2 38.5 27.0 7.6 26.8 25.3 23.9 42.2 44.7 41.1 45.0 42.7 33.6 24.4 44.4 23.1 30.5 48.3 66.3 69.4 66.0 78.0 58.9 79.2 59.8 62.7 67.2 75.5 45.1 51.4 62.2 51.7 65.0 62.7 77.6 70.9 14.8 16.8 24.1 29.3 14.6 15.1 15.5 13.4 21.4 10.1 32.8 25.1 83.4 87.4 131.7 31.3 16.5 53.5 32.1 30.7 62.8 17.7 212.4 97.8 167.4 291.0 91.6 138.0 46.7 184.0 146.0 94.9 83.7 41.5 89.8 134.3 31.8 55.5 94.5 71.8 1352.6 67.0 102.8 92.8 165.1 52.2 58.4 189.2 105.2 81.7 101.6 22.8 64.7 95.7 129.4 168.8 129.5 353.8 81.2 63.5 120.7 AFG1L "AFG1, LACE1" ENSG00000135537 "AFG1 like ATPase" Q8WV93 6 108294894-108526796 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 8 "Ciliated cells: 10.7;Club cells: 9.1;Distal tubular cells: 8.3;Proximal tubular cells: 6.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030154, HPA030155, HPA030659" Approved Approved "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane, Cytosol" "HPA030154: AB_10600769, HPA030155: AB_10601232, HPA030659: AB_10602415" "unprognostic (9.76e-5)" "unprognostic (1.72e-1)" "unprognostic (1.68e-1)" "unprognostic (3.76e-2)" "unprognostic (1.62e-1)" "unprognostic (7.04e-2)" "unprognostic (2.57e-1)" "unprognostic (5.53e-2)" "unprognostic (2.35e-3)" "unprognostic (1.48e-1)" "unprognostic (2.73e-2)" "unprognostic (9.61e-2)" "unprognostic (8.40e-8)" "unprognostic (2.03e-2)" "unprognostic (2.03e-1)" "unprognostic (1.41e-1)" "unprognostic (1.23e-1)" 4.9 7.3 7.6 6.5 6.6 4.3 5.7 6.2 7.3 4.1 5.7 7.3 6.9 8.9 3.7 4.9 5.5 5.1 4.8 9.4 6.3 4.9 11.0 7.6 9.1 4.8 7.3 7.4 4.1 5.2 11.6 6.9 4.7 6.1 3.9 7.0 5.5 4.7 5.4 9.0 4.2 6.3 4.0 5.6 4.4 6.0 25.4 6.5 5.6 6.6 4.1 4.5 4.8 4.3 5.7 3.0 5.1 7.2 4.2 4.4 1.7 3.5 1.9 4.7 8.2 4.8 7.1 4.6 3.9 5.9 6.6 6.5 7.4 4.4 6.3 5.3 6.1 7.8 2.0 5.9 5.9 7.4 3.6 3.5 7.5 2.4 8.6 4.8 6.6 3.7 6.6 4.9 4.9 8.0 4.2 3.5 4.8 7.5 3.0 6.1 3.3 1.2 6.2 3.0 6.0 3.7 4.4 6.3 3.6 8.2 3.9 5.1 4.5 3.3 4.7 8.7 6.5 3.8 13.0 4.3 4.0 1.0 3.5 4.5 2.1 3.2 4.9 5.0 7.9 6.1 0.0 3.1 5.1 2.0 2.2 2.6 4.8 3.2 3.8 2.7 5.7 4.4 2.9 0.8 4.2 7.2 3.0 4.1 1.7 7.6 6.6 6.2 7.3 6.3 4.9 7.3 7.4 6.1 6.5 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 10.7 9.1 3.5 0.0 5.1 8.3 2.7 0.0 0.0 0.0 0.0 3.3 4.1 0.0 0.0 2.3 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 1.9 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 AGRN AGRIN ENSG00000188157 Agrin O00468 1 1020123-1056118 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Differentiation "Developmental protein" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Cholangiocytes: 79.0;Collecting duct cells: 148.3;Ductal cells: 85.5;Pancreatic endocrine cells: 62.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CAPAN-2: 46.4;EFO-21: 54.1;HaCaT: 47.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040090 Approved Approved "Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA 15000000 Cytosol "Plasma membrane" "HPA040090: AB_10805603" "unprognostic (8.04e-2)" "unprognostic (8.25e-3)" "unprognostic (1.42e-3)" "unprognostic (1.23e-1)" "unprognostic (3.26e-2)" "unprognostic (2.41e-2)" "prognostic unfavorable (4.62e-4)" "unprognostic (2.82e-3)" "unprognostic (1.32e-1)" "unprognostic (3.33e-2)" "unprognostic (9.49e-3)" "unprognostic (1.06e-1)" "unprognostic (8.46e-2)" "unprognostic (8.49e-2)" "unprognostic (2.07e-2)" "unprognostic (4.08e-1)" "unprognostic (1.31e-2)" 10.2 2.8 13.0 5.3 12.4 2.9 8.3 2.3 24.0 11.3 8.5 20.5 8.9 9.8 8.2 14.5 8.8 11.4 37.2 8.1 10.9 8.3 36.0 9.3 18.1 2.3 9.3 7.0 7.6 25.2 5.7 5.0 11.0 12.7 8.7 2.5 13.6 26.5 10.8 4.7 18.6 11.2 3.9 7.7 7.2 14.1 7.5 8.1 6.4 27.0 9.5 7.6 13.7 6.2 0.0 0.1 0.0 0.5 0.0 1.1 0.1 27.0 16.8 3.3 10.9 0.5 0.7 29.4 13.7 4.4 9.2 5.6 14.1 46.4 0.5 54.1 2.1 4.5 47.1 1.1 16.9 1.1 1.0 6.4 0.0 22.0 14.8 3.9 0.3 5.5 2.4 7.3 2.9 6.4 12.8 1.6 0.4 5.6 0.1 0.7 22.2 0.2 3.8 7.0 8.7 12.3 4.3 6.4 4.0 16.1 12.1 0.8 6.5 27.8 30.1 26.5 3.3 26.5 2.1 23.9 11.3 40.0 1.5 11.0 0.3 0.2 1.0 7.1 2.5 3.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.1 13.0 12.4 2.3 22.0 10.9 8.3 9.3 7.0 12.7 8.1 23.8 9.1 2.4 7.5 13.4 0.8 2.2 79.0 5.3 14.8 148.3 7.9 1.1 1.7 85.5 0.1 17.9 18.6 0.0 14.5 4.6 5.6 15.4 2.3 8.9 3.9 4.8 6.4 13.5 2.1 0.8 5.2 3.1 23.6 27.1 10.4 10.0 62.9 14.0 2.5 11.3 5.4 6.5 8.5 0.5 9.6 5.3 1.0 1.0 18.4 13.7 AIFM2 "AMID, FLJ14497, PRG3" ENSG00000042286 "Apoptosis inducing factor, mitochondria associated 2" Q9BRQ8 10 70098223-70132934 "Predicted intracellular proteins" "DNA-binding, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 41.9" "Cell type enhanced" "Detected in many" 5 "monocytes: 59.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 57.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028961, HPA042309, HPA075576" Approved Supported "Vesicles,Plasma membrane,Cytosol" NA NA Vesicles "Plasma membrane, Cytosol" "HPA028961: AB_2672844, HPA042309: AB_10796575, HPA075576: " "unprognostic (6.62e-2)" "unprognostic (2.73e-1)" "unprognostic (4.29e-1)" "prognostic favorable (2.80e-4)" "unprognostic (7.26e-3)" "unprognostic (2.57e-2)" "unprognostic (7.95e-3)" "unprognostic (2.80e-1)" "unprognostic (5.31e-2)" "unprognostic (8.90e-2)" "unprognostic (2.23e-1)" "unprognostic (1.53e-1)" "unprognostic (4.49e-1)" "unprognostic (4.59e-3)" "unprognostic (2.17e-1)" "unprognostic (1.11e-1)" "prognostic favorable (2.92e-4)" 32.9 7.8 3.1 6.6 5.9 1.3 41.9 5.0 3.7 3.5 9.0 2.1 22.1 7.6 4.5 9.6 9.1 4.0 7.6 19.7 2.8 4.1 10.2 18.2 8.1 4.0 2.9 2.4 7.5 3.6 3.9 3.1 5.2 3.5 6.4 5.9 9.2 5.8 15.2 9.1 2.8 9.9 7.8 3.7 5.9 6.5 3.1 2.1 1.0 10.8 6.4 7.3 11.8 15.7 3.4 0.7 1.5 1.0 7.8 3.5 1.2 8.8 15.4 0.4 4.0 9.3 3.5 0.1 3.5 8.8 7.3 8.3 11.9 17.2 1.3 9.1 4.9 9.7 9.6 4.3 1.2 2.0 17.2 0.7 0.0 9.1 57.7 20.0 0.1 2.2 4.7 2.9 11.7 2.5 4.6 3.2 0.6 6.7 7.6 3.7 11.2 0.4 0.4 1.6 7.1 5.0 0.2 1.4 4.2 3.9 6.5 1.3 0.3 6.5 5.7 10.0 0.6 0.2 2.4 4.0 0.1 9.0 5.4 10.3 5.7 10.6 2.4 4.9 0.3 4.8 1.5 0.9 1.0 3.5 0.8 3.1 3.4 1.2 3.0 0.7 2.9 1.7 2.7 1.0 7.8 1.0 0.5 2.4 1.2 3.1 5.9 5.0 3.7 2.8 4.1 2.9 2.4 3.5 2.1 6.0 13.1 2.2 11.6 2.1 5.5 11.7 10.2 9.4 10.3 17.4 0.0 12.6 3.3 35.2 19.5 2.3 32.9 0.0 19.3 2.5 6.3 12.0 11.5 20.2 10.5 1.6 11.5 2.5 1.8 33.7 4.9 3.5 8.5 59.5 6.0 4.5 31.0 17.5 4.2 11.5 1.7 19.4 13.0 3.2 3.2 1.3 15.6 5.1 9.0 14.8 AKAP10 "D-AKAP2, MGC9414, PRKA10" ENSG00000108599 "A-kinase anchoring protein 10" O43572 17 19904302-19978343 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SuSa: 45.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028901 Approved Supported "Plasma membrane,Cytosol" Yes No "Plasma membrane, Cytosol" "HPA028901: AB_10602227" "unprognostic (2.17e-2)" "unprognostic (3.48e-2)" "unprognostic (5.33e-1)" "unprognostic (1.40e-1)" "unprognostic (1.50e-1)" "unprognostic (5.51e-2)" "unprognostic (1.59e-3)" "unprognostic (3.88e-1)" "unprognostic (7.69e-3)" "unprognostic (1.89e-1)" "unprognostic (3.59e-2)" "unprognostic (3.21e-2)" "unprognostic (3.21e-2)" "unprognostic (2.49e-2)" "unprognostic (7.15e-2)" "unprognostic (2.16e-2)" "unprognostic (5.20e-2)" 20.5 24.2 22.5 19.4 25.5 16.1 21.2 22.8 27.9 21.2 19.4 17.4 13.4 16.1 22.3 15.9 18.5 19.2 18.4 14.4 20.1 17.9 22.7 14.9 18.5 24.3 22.4 23.2 24.3 16.2 28.0 20.3 20.3 19.2 19.5 20.3 16.1 17.8 21.3 13.7 17.5 18.5 22.9 19.0 28.6 20.2 22.9 24.2 25.9 26.0 9.1 20.5 22.2 22.7 7.3 6.1 24.4 10.3 5.1 7.9 3.0 8.7 10.5 7.0 4.9 9.3 11.8 13.0 10.2 11.0 11.4 13.7 11.4 5.3 7.5 6.9 8.1 9.9 9.3 9.0 8.5 15.6 6.2 7.7 6.4 10.3 5.5 8.8 4.6 10.6 9.9 10.7 10.4 12.9 12.8 9.1 9.2 4.1 3.8 11.8 6.3 8.6 6.9 4.6 12.2 3.6 5.7 23.0 3.9 9.5 5.6 2.4 7.2 11.7 5.5 9.7 45.2 13.4 5.2 8.0 8.8 7.3 7.5 9.4 4.7 5.0 9.2 11.7 5.6 8.5 3.6 7.3 8.8 6.7 10.3 6.1 6.0 6.5 7.2 6.1 7.3 7.9 7.0 24.4 5.1 9.3 4.6 4.9 3.0 22.5 25.5 22.8 27.9 20.1 17.9 22.4 23.2 19.2 24.2 3.0 10.5 23.8 8.2 6.3 24.2 7.7 10.2 18.7 13.6 5.2 15.7 11.8 1.7 8.1 10.1 10.0 11.8 0.0 6.2 9.3 8.2 12.9 9.3 11.1 14.2 31.8 6.9 16.0 28.9 8.5 14.1 22.0 5.0 21.6 10.6 10.9 7.0 14.8 13.1 4.5 23.0 19.4 9.9 15.1 25.3 6.8 11.7 17.3 10.3 9.8 AL132780.3 ENSG00000259132 14 22946270-22982258 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in single" 30 "Alveolar cells type 1: 3.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 28.1" HPA029803 Approved Approved "Plasma membrane,Focal adhesion sites" NA NA "Plasma membrane, Focal adhesion sites" "HPA029803: AB_10601428" 4.8 6.2 4.5 4.7 5.5 6.6 5.3 3.5 2.4 16.1 7.1 2.3 7.1 5.5 12.4 9.2 16.2 6.6 11.2 6.0 4.6 3.8 20.4 24.5 10.5 7.9 5.3 1.9 11.8 13.8 0.0 3.5 18.1 3.8 13.1 6.1 10.4 5.7 16.0 6.2 8.8 4.5 3.5 4.5 11.3 4.5 6.0 1.9 10.3 22.1 7.7 9.6 5.0 7.9 3.3 5.7 10.2 5.9 1.1 4.1 2.8 4.1 8.9 6.2 2.0 6.1 7.2 4.0 0.7 5.8 3.7 3.8 3.0 3.1 0.0 2.4 6.8 2.1 1.6 2.9 3.1 2.6 0.0 0.7 1.3 6.8 28.1 4.0 3.2 2.6 3.2 8.2 2.9 7.0 8.1 5.1 7.4 0.0 6.1 4.0 16.8 7.0 12.0 3.0 6.9 1.9 3.4 4.4 3.8 10.3 8.4 3.5 2.0 2.8 3.6 1.7 4.5 5.5 7.1 1.0 4.7 3.4 1.9 3.5 6.0 7.3 6.3 1.6 3.2 2.9 0.5 5.9 2.1 2.5 4.2 1.2 2.7 1.8 2.1 5.7 3.3 3.4 1.7 10.2 1.1 2.9 2.6 4.1 2.8 4.5 5.5 3.5 2.4 4.6 3.8 5.3 1.9 3.8 1.9 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL358113.1 ENSG00000285130 9 69035750-69255187 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 2.9;Ciliated cells: 2.7;Club cells: 1.2" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 11 "dendritic cells: 1.3;monocytes: 2.8;T-cells: 2.6" "Cell line enhanced" "Detected in some" "HaCaT: 2.9;HUVEC TERT2: 2.2;REH: 9.8;U-2 OS: 2.2" "HPA001813, HPA068304, HPA070714" Uncertain Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Nucleoplasm, Plasma membrane, Cell Junctions" "HPA001813: AB_1080764, HPA068304: AB_2685970, HPA070714: AB_2732161" 1.6 4.3 2.5 1.9 2.1 2.6 2.8 3.6 2.5 1.6 2.8 3.0 2.7 1.6 2.2 1.6 1.6 3.4 1.6 5.8 1.3 2.1 8.8 2.1 3.2 2.8 1.7 3.7 9.4 1.6 1.7 1.6 2.4 4.0 1.6 2.9 2.8 3.2 7.5 1.6 3.0 4.5 1.6 3.1 3.1 3.4 2.1 0.0 2.6 2.0 2.1 2.4 1.3 0.1 1.3 0.1 2.8 0.0 2.6 0.4 0.4 0.0 0.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 1.7 0.3 0.0 2.9 0.2 1.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.0 2.2 1.5 0.1 0.0 0.2 0.0 1.2 0.2 0.8 0.0 0.1 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.1 0.0 2.2 0.0 0.4 0.0 0.4 0.6 0.0 0.0 0.0 0.0 1.0 0.0 0.2 2.6 0.2 0.1 1.3 0.1 1.0 0.1 0.6 0.3 0.1 0.0 2.8 1.3 2.6 0.4 3.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 2.7 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 ALDH3A1 ALDH3 ENSG00000108602 "Aldehyde dehydrogenase 3 family member A1" P30838 17 19737984-19748943 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 88.2;lymphoid tissue: 70.3;stomach 1: 49.9;tongue: 106.6" "Cell type enhanced" "Detected in many" 15 "Basal keratinocytes: 39.2;Ciliated cells: 100.4;Club cells: 55.7;Suprabasal keratinocytes: 28.0;Urothelial cells: 32.1" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "pons and medulla: 1.8" "Cell type enhanced" "Detected in some" "NK-cell: 2.4" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 22 "A549: 261.5;OE19: 326.9" "Not detected" "Not detected" "Not detected" "Not detected" "CAB045957, HPA051150, HPA063783" Enhanced Supported "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "Nucleoplasm, Vesicles" "CAB045957: AB_11127164, HPA051150: AB_2681364, HPA063783: AB_2685122" "unprognostic (3.11e-5)" "unprognostic (1.20e-2)" "unprognostic (1.08e-1)" "unprognostic (7.04e-3)" "unprognostic (4.36e-3)" "prognostic favorable (7.55e-5)" "unprognostic (3.12e-1)" "unprognostic (3.84e-1)" "unprognostic (2.10e-1)" "unprognostic (1.67e-1)" "unprognostic (2.69e-3)" "unprognostic (5.54e-2)" "unprognostic (1.72e-1)" "unprognostic (3.84e-2)" "unprognostic (1.83e-1)" "unprognostic (2.88e-2)" "unprognostic (7.23e-2)" 0.7 0.1 0.2 0.8 0.4 0.0 0.5 0.2 0.3 1.3 0.9 0.8 0.3 1.3 0.2 0.4 88.2 1.2 3.8 0.2 0.4 0.0 0.4 0.4 26.0 0.2 0.2 0.3 0.6 0.2 0.0 0.3 0.2 1.8 0.5 0.6 0.5 26.7 0.3 0.4 16.2 0.6 0.3 0.3 0.3 49.9 0.3 0.2 0.2 0.2 106.6 70.3 1.6 3.9 1.1 0.3 0.0 0.0 2.4 0.7 0.1 0.0 261.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 13.1 0.0 0.1 0.0 0.1 1.5 0.0 0.6 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 326.9 1.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.3 1.1 0.0 0.7 0.0 2.4 0.0 0.0 0.0 0.1 0.2 0.4 0.2 0.3 0.4 0.0 0.2 0.3 1.8 0.2 3.0 5.6 0.0 23.3 39.2 0.0 0.4 2.5 100.4 55.7 0.0 0.0 0.0 0.0 0.8 1.3 0.4 3.3 0.0 0.4 0.0 0.6 2.6 2.3 0.0 0.2 0.0 1.7 0.6 0.8 1.9 0.9 1.1 0.0 0.0 4.2 1.9 5.8 5.9 1.8 4.4 0.1 0.0 0.3 0.7 7.3 28.0 0.0 0.0 7.5 32.1 ALOXE3 "E-LOX, eLOX3" ENSG00000179148 "Arachidonate lipoxygenase 3" Q9BYJ1 17 8095900-8119047 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Dioxygenase, Isomerase, Lyase, Oxidoreductase" "Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "skin 1: 30.2" "Cell type enhanced" "Detected in some" 12 "Basal glandular cells: 1.6;Glandular cells: 2.0;Pancreatic endocrine cells: 3.6;Spermatogonia: 1.5;Suprabasal keratinocytes: 1.6" "Cancer enhanced" "Detected in some" "head and neck cancer: 3.9" "Group enriched" "Detected in many" 8 "basal ganglia: 1.1;cerebellum: 1.4;cerebral cortex: 2.3;pons and medulla: 1.1" "Group enriched" "Detected in some" 5 "gdT-cell: 1.0;naive CD4 T-cell: 2.7" "Lineage enriched" "Detected in single" 28 "T-cells: 2.7" "Cell line enhanced" "Detected in some" "A-431: 6.6;HBEC3-KT: 10.8;hTCEpi: 8.0;hTERT-HME1: 15.1;T-47d: 4.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA023120, HPA078597" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA023120: AB_10959300, HPA078597: AB_2732385" "unprognostic (2.40e-1)" "unprognostic (3.01e-2)" "unprognostic (1.87e-3)" "unprognostic (2.09e-4)" "unprognostic (1.07e-2)" "unprognostic (4.06e-2)" "unprognostic (3.56e-4)" "unprognostic (3.60e-1)" "unprognostic (4.65e-2)" "unprognostic (3.82e-2)" "unprognostic (3.72e-1)" "unprognostic (3.66e-5)" "unprognostic (9.81e-2)" "unprognostic (2.55e-1)" "unprognostic (1.08e-2)" "unprognostic (2.88e-2)" 0.1 0.0 0.1 0.1 1.1 0.0 1.6 1.4 2.3 1.2 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 1.1 0.1 0.0 0.1 0.1 0.1 0.1 30.2 0.1 0.1 0.1 0.1 0.0 0.4 0.1 0.1 0.1 0.1 1.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 2.7 0.2 6.6 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.1 0.4 0.1 0.5 0.2 0.2 0.1 3.2 0.5 0.9 10.8 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 8.0 0.2 15.1 0.0 0.0 1.0 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.2 2.2 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.7 0.0 0.0 4.8 0.0 0.1 0.0 2.3 0.0 0.3 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 2.7 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.1 1.4 2.3 0.1 0.1 0.1 0.1 1.1 0.1 0.0 0.0 0.0 1.6 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.8 0.9 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.1 0.5 1.5 1.6 0.9 0.0 0.0 0.7 ALPI ENSG00000163295 "Alkaline phosphatase, intestinal" P09923 2 232456123-232460032 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 406 "intestine: 133.2" "Group enriched" "Detected in some" 6 "Enterocytes: 45.5;Paneth cells: 17.5" "Cancer enhanced" "Detected in many" "liver cancer: 4.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 12 "CACO-2: 12.7" "HPA038764, HPA038765, HPA051699" Supported Approved "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "HPA038764: AB_2676194, HPA038765: AB_2676195, HPA051699: AB_2681577" "unprognostic (1.01e-1)" "unprognostic (7.71e-2)" "unprognostic (4.14e-2)" "unprognostic (1.47e-1)" "unprognostic (9.57e-4)" "unprognostic (8.07e-2)" "unprognostic (1.71e-1)" "unprognostic (9.99e-2)" 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 63.0 0.0 0.0 57.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 1.3 0.0 0.1 0.0 0.1 0.1 133.2 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 17.5 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 ALPP ENSG00000163283 "Alkaline phosphatase, placental" P05187 2 232378534-232382889 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Hydrolase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "placenta: 240.2" "Group enriched" "Detected in some" 19 "Alveolar cells type 1: 11.9;Club cells: 3.4;Syncytiotrophoblasts: 5.6" "Cancer enhanced" "Detected in many" "endometrial cancer: 15.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "HaCaT: 88.1;SiHa: 24.3" "CAB026327, HPA038764, HPA038765, HPA051699" Enhanced Approved "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "CAB026327: , HPA038764: AB_2676194, HPA038765: AB_2676195, HPA051699: AB_2681577" "unprognostic (4.86e-2)" "unprognostic (5.19e-3)" "unprognostic (6.67e-3)" "unprognostic (2.60e-1)" "unprognostic (2.44e-3)" "unprognostic (1.26e-2)" "prognostic unfavorable (4.33e-4)" "unprognostic (1.44e-1)" "unprognostic (4.09e-1)" "unprognostic (2.12e-1)" "unprognostic (1.27e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 14.5 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 240.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.0 0.5 1.6 0.5 1.1 0.5 0.3 0.4 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 9.9 0.0 0.0 0.0 0.0 88.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 24.3 8.6 0.0 0.8 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.7 0.5 0.2 0.5 0.3 0.3 0.3 0.1 1.0 0.4 0.4 1.6 1.1 0.5 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 3.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 5.6 0.0 0.0 0.0 ALPPL2 ENSG00000163286 "Alkaline phosphatase, placental like 2" P10696 2 232406843-232410714 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 4.2;lung: 9.4" "Cell type enhanced" "Detected in some" 28 "Alveolar cells type 1: 6.0;Ciliated cells: 1.4;Club cells: 2.3" "Cancer enhanced" "Detected in many" "endometrial cancer: 49.1;testis cancer: 64.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "CAPAN-2: 21.4;HaCaT: 15.7;SuSa: 25.7" "CAB020698, HPA038764, HPA038765, HPA051699" Approved Approved "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "CAB020698: , HPA038764: AB_2676194, HPA038765: AB_2676195, HPA051699: AB_2681577" "unprognostic (1.39e-1)" "unprognostic (6.63e-3)" "unprognostic (1.27e-2)" "unprognostic (2.89e-1)" "unprognostic (1.46e-1)" "unprognostic (1.26e-1)" "unprognostic (1.69e-3)" "unprognostic (1.65e-1)" "unprognostic (2.67e-1)" "unprognostic (6.72e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.0 0.0 0.0 0.2 1.5 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 1.5 0.0 0.0 0.0 1.9 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.6 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.4 21.4 0.0 0.0 0.0 0.0 15.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.2 0.0 25.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 ALS2CR12 ENSG00000155749 "Amyotrophic lateral sclerosis 2 chromosome region 12" Q96Q35 2 201288271-201357398 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.3;epididymis: 14.4;testis: 29.9" "Group enriched" "Detected in some" 6 "Ciliated cells: 99.0;Early spermatids: 82.1" "Not detected" "Not detected" "Region enhanced" "Detected in many" "pons and medulla: 14.3" "Cell type enhanced" "Detected in many" "neutrophil: 7.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-MEL-30: 7.0;U-2197: 9.6" "Low region specificity" "Detected in many" HPA035793 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA035793: AB_10602429" "unprognostic (1.45e-1)" "unprognostic (1.91e-1)" "unprognostic (9.72e-2)" "unprognostic (2.95e-2)" "unprognostic (1.53e-1)" "unprognostic (8.33e-2)" "unprognostic (1.32e-1)" "unprognostic (8.40e-3)" "unprognostic (1.40e-5)" "unprognostic (1.37e-1)" "unprognostic (3.62e-2)" "unprognostic (1.14e-1)" "unprognostic (6.23e-2)" "unprognostic (1.13e-1)" "unprognostic (2.73e-2)" "unprognostic (2.23e-1)" "unprognostic (8.25e-2)" 0.8 0.9 1.5 0.7 3.6 4.3 0.5 0.7 1.1 0.9 0.6 7.6 0.4 0.3 0.7 14.4 1.1 9.9 0.9 4.7 2.1 2.6 1.3 0.7 3.7 1.4 1.0 1.3 5.3 0.7 1.2 1.3 0.9 14.3 0.4 0.9 0.5 0.7 0.7 1.4 1.1 0.9 0.9 0.9 0.8 0.5 29.9 1.3 0.4 1.7 0.4 0.5 0.6 0.4 1.8 0.5 7.3 1.1 2.8 1.5 0.4 0.3 0.4 2.1 1.5 5.7 2.2 0.1 1.5 0.5 1.3 0.9 0.0 0.5 0.7 1.2 2.2 1.0 2.0 0.8 0.2 0.6 1.2 0.2 0.3 2.5 0.7 1.1 2.1 1.9 1.1 0.6 1.3 0.3 1.7 0.2 2.5 1.0 2.9 1.3 0.0 1.1 1.8 0.6 0.8 1.2 0.5 1.0 1.3 0.8 0.5 0.5 1.3 1.6 0.0 7.0 2.2 1.5 2.5 1.6 2.9 1.7 9.6 1.0 1.6 3.1 1.0 2.8 1.0 1.3 5.4 1.1 1.0 1.5 0.5 0.7 0.6 1.0 0.9 0.5 1.8 1.2 1.4 7.3 2.8 0.6 0.4 0.6 0.4 1.5 3.6 0.7 1.0 2.1 2.6 1.0 1.3 14.3 1.3 0.0 0.3 0.0 0.0 0.5 5.4 5.7 0.0 99.0 9.1 0.0 9.8 0.0 3.3 0.0 82.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 1.1 0.0 0.3 1.6 0.0 0.0 0.0 16.0 0.6 0.0 0.0 1.0 0.0 0.8 0.1 0.0 0.0 0.0 1.4 0.0 0.0 2.3 0.5 0.0 0.0 0.0 0.0 0.1 AMACR "P504S, RACE" ENSG00000242110 "Alpha-methylacyl-CoA racemase" Q9UHK6 5 33986178-34008108 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Isomerase "Disease mutation, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 68.0;liver: 63.6" "Cell type enhanced" "Detected in many" 10 "Hepatocytes: 17.8;Late spermatids: 18.9;Proximal tubular cells: 33.2" "Cancer enhanced" "Detected in all" "prostate cancer: 34.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 59.8;U-266/84: 31.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001809, HPA019527, HPA020912" Enhanced Supported "Vesicles,Plasma membrane" NA NA 65000 "Vesicles, Plasma membrane" "CAB001809: AB_2305454, HPA019527: AB_10669651, HPA020912: AB_10670034" "unprognostic (8.96e-2)" "unprognostic (5.20e-3)" "prognostic favorable (7.11e-4)" "unprognostic (9.55e-2)" "unprognostic (1.39e-1)" "unprognostic (9.12e-3)" "unprognostic (1.68e-1)" "unprognostic (5.41e-2)" "unprognostic (1.50e-1)" "unprognostic (1.60e-1)" "unprognostic (5.59e-5)" "unprognostic (1.95e-2)" "unprognostic (5.52e-3)" "unprognostic (6.32e-2)" "unprognostic (3.41e-1)" "unprognostic (2.18e-1)" "unprognostic (1.50e-1)" 2.8 8.3 5.2 2.7 8.2 0.9 2.8 4.7 7.8 4.4 14.1 4.3 6.5 6.2 4.0 3.6 8.2 2.3 11.0 3.5 4.5 6.8 68.0 63.6 3.3 2.0 4.5 4.5 2.9 5.1 5.4 4.3 3.2 7.0 13.9 15.5 5.5 25.4 5.4 6.0 2.6 7.4 3.7 3.8 2.9 15.9 2.1 2.1 3.8 3.3 3.4 3.3 5.7 4.5 7.8 10.2 11.2 14.2 9.9 10.0 6.8 4.1 6.6 3.7 4.8 2.6 4.1 6.4 5.5 4.1 2.5 1.9 21.6 5.0 1.3 2.9 7.8 9.7 1.9 0.9 4.0 2.6 4.1 3.5 3.1 4.8 6.2 1.8 1.9 1.0 6.2 2.0 3.3 1.2 3.6 2.8 2.7 1.2 4.9 7.5 3.0 1.6 2.4 3.3 3.0 10.8 1.9 6.3 2.1 11.3 20.7 2.1 2.9 9.1 6.5 5.5 3.2 5.0 1.9 5.2 8.4 1.9 2.1 4.4 59.8 31.1 2.4 2.4 3.9 6.2 0.3 7.1 10.2 10.0 8.8 8.4 7.8 8.7 7.8 10.2 7.0 8.1 6.1 11.2 9.9 14.2 5.3 8.9 6.8 5.2 8.2 4.7 7.8 4.5 6.8 4.5 4.5 7.0 2.1 3.0 2.6 0.0 0.4 0.3 3.3 0.9 7.6 4.0 5.7 1.8 0.0 0.9 5.0 0.7 8.1 0.8 5.0 0.0 3.3 0.9 1.1 0.6 0.0 17.8 0.9 4.8 4.1 1.3 1.2 18.9 0.6 0.8 0.0 1.8 4.5 10.6 2.4 3.5 2.1 33.2 0.8 0.0 0.5 0.7 0.7 0.5 0.2 0.8 4.0 0.3 AMDHD1 MGC35366 ENSG00000139344 "Amidohydrolase domain containing 1" Q96NU7 12 95943293-95968716 "Enzymes, Predicted intracellular proteins" "Histidine metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "liver: 99.0" "Cell type enriched" "Detected in many" 5 "Hepatocytes: 125.2" "Cancer enriched" "Detected in many" 14 "liver cancer: 23.4" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 19.5;HMC-1: 21.5;Karpas-707: 26.6;SiHa: 17.8;SK-BR-3: 20.0;U-266/70: 21.5;U-266/84: 25.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA039720, HPA040149" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" No NA 410000 Cytosol "Nucleoplasm, Plasma membrane" "HPA039720: AB_10672967, HPA040149: " "unprognostic (4.81e-2)" "unprognostic (2.91e-1)" "unprognostic (1.53e-1)" "unprognostic (2.09e-2)" "unprognostic (1.80e-2)" "unprognostic (2.88e-2)" "unprognostic (2.33e-2)" "unprognostic (6.62e-3)" "unprognostic (1.06e-1)" "unprognostic (7.01e-2)" "unprognostic (3.35e-3)" "unprognostic (1.17e-1)" "unprognostic (4.63e-3)" "unprognostic (3.98e-2)" "unprognostic (1.70e-1)" "unprognostic (4.08e-3)" "unprognostic (2.61e-1)" 1.1 5.7 0.5 2.4 0.8 2.0 0.9 0.5 1.3 0.7 0.7 0.6 0.4 1.9 0.9 0.5 0.8 0.5 0.7 1.1 0.6 0.5 4.4 99.0 1.3 1.4 0.5 0.4 0.7 1.1 0.0 1.2 0.6 1.0 0.7 0.0 0.8 1.3 0.7 11.3 2.2 1.9 0.6 0.6 2.9 1.9 6.2 0.5 0.7 0.6 0.7 0.7 0.8 0.9 1.5 1.2 3.7 3.8 5.7 1.6 1.4 19.5 4.3 0.3 2.8 0.1 0.0 4.4 0.6 0.2 0.3 0.6 1.9 2.5 1.7 1.9 0.0 1.1 3.7 0.1 0.0 0.1 6.8 0.7 1.9 3.0 3.8 0.0 2.5 21.5 0.0 0.1 0.3 0.0 0.1 0.1 1.7 1.3 26.6 0.0 3.0 1.6 4.8 2.0 0.7 1.0 3.5 0.1 2.2 0.0 1.8 2.2 3.2 17.8 20.0 2.3 0.0 2.1 3.6 0.0 2.8 9.7 3.5 2.4 21.5 25.2 2.7 1.9 5.2 3.1 0.3 1.6 3.7 1.2 1.4 1.1 1.5 0.6 1.6 1.2 1.0 1.0 1.1 1.2 5.7 3.8 0.6 0.3 1.4 0.5 0.8 0.5 0.6 0.6 0.5 0.5 0.4 1.0 0.5 0.0 0.3 2.2 0.2 0.3 0.0 0.4 0.0 0.0 1.2 3.5 0.0 0.5 3.3 0.1 0.6 0.3 0.0 0.0 1.0 0.1 0.3 0.0 0.0 125.2 4.1 1.6 1.7 11.1 3.7 0.0 0.3 1.1 3.3 0.0 0.0 1.9 0.3 0.0 0.0 23.2 0.0 0.0 0.0 1.2 1.9 0.3 0.2 2.9 0.0 0.1 AMIGO2 "ALI1, DEGA" ENSG00000139211 "Adhesion molecule with Ig like domain 2" Q86SJ2 12 47075707-47079951 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 43.4" "Cell type enhanced" "Detected in many" 8 "Intestinal endocrine cells: 58.0;Ito cells: 30.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 40.9;fHDF/TERT166: 39.3;hTERT-RPE1: 69.7;LHCN-M2: 39.3;RT4: 53.8;U-2 OS: 32.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054004, HPA059601" Uncertain Approved "Golgi apparatus,Plasma membrane,Cytosol" NA Yes 160000 "Golgi apparatus, Plasma membrane" Cytosol "HPA054004: AB_2682339, HPA059601: AB_2684078" "unprognostic (2.63e-1)" "unprognostic (6.00e-3)" "unprognostic (1.10e-2)" "unprognostic (3.91e-2)" "unprognostic (3.86e-1)" "unprognostic (1.07e-2)" "unprognostic (3.65e-2)" "unprognostic (1.67e-1)" "unprognostic (3.17e-1)" "unprognostic (3.30e-1)" "prognostic unfavorable (1.80e-4)" "unprognostic (2.98e-2)" "unprognostic (4.87e-2)" "unprognostic (1.16e-2)" "unprognostic (2.95e-1)" "unprognostic (7.47e-2)" "unprognostic (2.29e-3)" 5.6 11.9 5.4 4.0 8.8 1.4 14.5 1.6 6.5 18.3 20.3 3.5 1.9 1.6 19.7 12.4 3.1 21.2 12.4 3.4 2.7 7.5 4.3 2.9 11.9 6.7 2.9 5.1 43.4 2.3 2.0 9.5 7.6 16.2 12.8 5.6 6.7 3.1 7.1 1.5 2.3 7.1 21.0 3.0 9.8 3.5 13.1 3.6 1.6 2.5 4.1 4.5 16.6 15.1 2.8 7.4 0.1 0.2 6.6 14.2 4.3 9.0 22.5 1.4 0.0 0.5 0.0 3.7 3.1 8.5 1.0 0.8 0.0 40.9 0.0 10.3 39.3 25.8 13.6 0.0 25.1 1.2 1.7 0.1 0.0 2.2 0.0 0.8 0.2 0.3 0.2 4.4 26.9 13.3 69.7 3.2 0.2 1.7 0.0 39.3 0.4 0.7 0.0 0.9 4.5 5.7 0.0 10.1 0.0 11.6 53.8 4.1 0.0 16.2 1.9 0.1 0.8 2.4 0.2 0.8 0.5 32.6 0.3 25.1 0.3 0.0 0.0 2.1 0.7 0.6 0.0 0.1 0.0 4.0 0.2 5.4 2.8 6.2 6.2 0.6 1.3 14.2 11.1 0.1 6.6 0.0 7.4 3.6 4.3 5.4 8.8 1.6 6.5 2.7 7.5 2.9 5.1 16.2 3.6 8.9 1.9 5.9 10.4 2.2 21.1 0.8 0.0 2.7 6.8 1.8 0.0 0.7 1.7 4.3 1.2 4.5 0.0 0.0 17.0 23.1 6.7 5.2 6.9 0.8 4.4 0.0 58.0 30.7 3.8 0.9 2.3 2.3 1.7 8.2 2.5 14.9 26.7 0.8 0.7 0.0 4.1 0.0 25.5 0.3 0.7 0.4 7.1 4.4 0.2 13.4 AMPH ENSG00000078053 Amphiphysin P49418 7 38383704-38631567 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 57.2" "Group enriched" "Detected in many" 4 "Bipolar cells: 53.7;Cone photoreceptor cells: 82.5;Rod photoreceptor cells: 54.5" "Cancer enhanced" "Detected in many" "glioma: 3.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 31.2;ASC TERT1: 18.5;BJ hTERT+ SV40 Large T+: 12.1;BJ hTERT+ SV40 Large T+ RasG12V: 14.4;GAMG: 21.3;HBF TERT88: 11.1;U-138 MG: 11.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008559, HPA019828, HPA019829" Enhanced Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "CAB008559: AB_1611845, HPA019828: AB_1844801, HPA019829: AB_1844802" "unprognostic (1.76e-2)" "unprognostic (1.59e-1)" "unprognostic (5.94e-2)" "unprognostic (7.36e-2)" "unprognostic (3.24e-3)" "unprognostic (2.92e-1)" "unprognostic (4.90e-2)" "unprognostic (2.55e-2)" "unprognostic (4.37e-1)" "unprognostic (1.08e-1)" "prognostic favorable (9.96e-4)" "unprognostic (5.06e-2)" "unprognostic (5.81e-5)" "unprognostic (1.23e-2)" "unprognostic (5.63e-2)" "unprognostic (8.03e-2)" "unprognostic (1.68e-3)" 3.8 2.4 17.4 2.5 17.7 1.0 2.8 29.7 57.2 7.7 2.2 1.8 0.0 1.4 5.1 4.7 4.5 5.7 4.2 6.5 13.5 16.0 3.7 1.4 1.6 1.3 10.4 20.4 1.7 2.9 1.2 12.6 1.0 26.5 2.4 2.5 4.8 1.5 4.2 2.9 1.3 1.9 5.0 4.9 1.9 2.0 3.5 1.5 0.0 1.2 0.2 1.1 2.9 1.7 0.2 1.6 0.0 0.8 0.7 2.9 0.2 0.0 0.0 7.9 0.0 31.2 18.5 0.0 1.1 0.0 12.1 14.4 0.0 0.0 0.0 0.0 2.2 21.3 0.0 0.0 0.0 11.1 0.0 0.9 0.1 0.0 0.0 0.0 0.1 0.0 10.8 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.2 0.0 0.1 0.0 0.1 4.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 2.3 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 11.8 8.4 4.1 4.5 0.0 0.1 0.0 8.0 0.1 10.6 0.0 0.8 0.0 2.9 0.2 1.7 0.0 1.0 1.5 0.2 0.2 0.4 2.0 0.0 0.7 0.2 1.6 0.2 0.2 17.4 17.7 29.7 32.9 13.5 16.0 10.4 20.4 26.5 1.5 0.0 0.0 0.5 0.1 0.2 53.7 6.3 0.0 0.0 0.0 0.0 82.5 0.0 1.7 0.1 7.7 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 1.6 0.0 5.5 14.2 10.2 2.6 0.0 0.0 0.0 0.0 4.7 0.1 0.0 4.6 0.0 54.5 6.5 3.0 0.4 3.0 0.3 0.0 0.0 0.0 0.0 ANKEF1 "ANKRD5, dJ839B4.6, FLJ21669" ENSG00000132623 "Ankyrin repeat and EF-hand domain containing 1" Q9NU02 20 9986126-10058303 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 25.0;testis: 22.7" "Group enriched" "Detected in many" 13 "Early spermatids: 319.3;Late spermatids: 291.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/84: 17.8" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA041151 Approved Approved "Nucleoli fibrillar center,Plasma membrane,Cytosol" NA NA "Nucleoli fibrillar center, Plasma membrane, Cytosol" "HPA041151: AB_10796569" "unprognostic (4.72e-2)" "unprognostic (9.86e-2)" "unprognostic (2.31e-2)" "unprognostic (2.09e-1)" "unprognostic (5.38e-4)" "unprognostic (2.54e-1)" "unprognostic (1.83e-3)" "prognostic unfavorable (1.81e-4)" "unprognostic (3.21e-2)" "unprognostic (1.12e-1)" "unprognostic (3.28e-1)" "unprognostic (6.73e-2)" "prognostic favorable (4.44e-4)" "unprognostic (3.90e-2)" "unprognostic (1.65e-1)" "prognostic unfavorable (1.58e-4)" "unprognostic (3.11e-1)" 5.6 2.9 1.4 2.3 2.4 0.5 3.7 5.7 2.0 2.7 3.1 0.8 11.3 2.9 1.9 4.2 4.7 4.9 4.0 3.2 2.3 2.5 5.7 6.7 2.3 1.3 1.5 1.1 3.6 25.0 5.3 13.6 1.7 4.1 3.4 3.0 3.0 4.2 13.0 1.7 2.9 3.6 1.0 1.2 1.8 5.1 22.7 1.0 3.2 8.6 2.5 3.9 2.1 2.6 2.5 1.6 0.7 0.1 1.5 5.4 1.3 10.0 10.3 1.4 2.5 2.1 1.2 5.9 1.9 0.1 1.8 0.9 5.9 9.1 0.0 3.1 0.4 10.8 8.7 1.8 12.0 2.2 0.0 1.6 1.3 2.0 5.5 1.4 1.1 0.2 3.7 8.6 1.5 1.7 4.2 1.5 3.9 3.8 8.9 0.4 3.1 1.6 0.0 4.3 12.0 2.4 0.0 0.0 6.8 4.4 6.5 7.7 3.9 4.6 10.2 0.0 3.6 8.9 0.9 1.1 1.3 1.4 0.1 1.9 9.2 17.8 1.5 2.6 0.3 1.7 0.0 0.0 0.0 2.8 0.1 5.4 2.5 3.3 2.6 0.2 2.3 4.1 3.0 0.7 1.5 0.0 1.6 3.8 1.3 1.4 2.4 5.7 2.0 2.3 2.5 1.5 1.1 4.1 1.0 3.0 4.1 0.0 2.1 0.2 1.2 1.5 0.0 24.1 2.3 7.0 0.0 1.9 1.7 4.0 319.3 0.7 2.2 0.0 5.4 1.5 0.2 1.6 1.1 7.8 1.1 3.2 5.1 0.0 0.3 291.0 3.1 1.4 0.0 0.0 4.6 1.0 5.4 4.5 3.9 2.1 4.8 0.0 0.1 5.0 2.4 0.3 1.3 1.3 3.4 1.3 ANKFN1 FLJ38335 ENSG00000153930 "Ankyrin repeat and fibronectin type III domain containing 1" Q8N957 17 55882301-56511659 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 11.8;cervix, uterine: 19.9;fallopian tube: 10.9" "Cell type enhanced" "Detected in some" 22 "Ciliated cells: 34.8;Early spermatids: 13.6;Late spermatids: 7.4;Sertoli cells: 6.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 8.1;MOLT-4: 16.8;T-47d: 5.8;U-2197: 5.6" "Low region specificity" "Detected in many" "HPA021566, HPA022538, HPA048953" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA021566: AB_1844828, HPA022538: AB_1844829, HPA048953: " "unprognostic (6.64e-2)" "unprognostic (1.29e-1)" "unprognostic (3.52e-2)" "unprognostic (9.38e-5)" "unprognostic (2.39e-1)" "unprognostic (2.31e-3)" "unprognostic (3.84e-2)" "unprognostic (1.68e-1)" "unprognostic (3.31e-1)" "unprognostic (1.21e-1)" "unprognostic (1.24e-2)" "unprognostic (6.81e-3)" "unprognostic (3.44e-8)" "unprognostic (1.24e-1)" "unprognostic (1.69e-1)" "unprognostic (4.93e-2)" "unprognostic (9.51e-2)" 3.9 1.0 5.5 0.5 10.2 0.5 1.2 2.6 4.7 19.9 0.7 11.4 0.5 0.7 0.8 3.4 0.7 10.9 0.9 0.5 6.8 4.6 0.7 0.6 2.0 0.6 6.3 3.7 0.5 0.5 0.5 1.0 2.1 11.8 0.9 0.8 0.0 0.7 0.8 0.6 5.2 0.8 0.5 7.5 0.6 1.1 3.6 10.0 0.0 0.6 0.0 0.5 3.2 5.3 0.2 0.5 0.1 0.1 0.3 0.4 0.0 0.0 0.0 0.1 0.0 1.3 0.2 0.3 0.0 2.9 0.2 0.3 0.0 0.1 0.3 0.2 0.7 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 8.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 2.2 0.1 0.4 16.8 0.0 0.0 0.9 0.7 0.1 0.0 0.1 0.0 0.1 1.5 0.0 1.7 0.0 0.3 0.1 5.8 0.0 0.0 0.0 0.4 5.6 0.1 1.5 0.3 0.0 0.8 0.0 0.4 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.4 0.0 0.2 0.0 0.3 0.1 0.3 0.1 0.5 0.0 0.0 5.5 10.2 2.6 4.7 6.8 4.6 6.3 3.7 11.8 10.0 0.0 0.6 0.0 0.1 0.5 0.0 0.6 0.0 34.8 0.0 0.0 0.0 0.3 0.0 0.0 13.6 0.0 0.0 0.0 0.0 0.7 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.6 0.0 1.7 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.0 6.5 0.3 5.9 2.1 0.4 2.4 0.0 0.0 0.9 ANKLE2 "KIAA0692, Lem4, LEMD7" ENSG00000176915 "Ankyrin repeat and LEM domain containing 2" Q86XL3 12 132725503-132761888 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Mitosis" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Urothelial cells: 154.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003602, HPA074838" Uncertain Supported "Endoplasmic reticulum,Plasma membrane" NA NA "Endoplasmic reticulum, Plasma membrane" "HPA003602: AB_1858349, HPA074838: " "unprognostic (4.43e-2)" "unprognostic (6.92e-2)" "unprognostic (7.97e-2)" "unprognostic (9.84e-3)" "unprognostic (1.97e-2)" "unprognostic (5.81e-2)" "prognostic unfavorable (3.97e-6)" "unprognostic (3.19e-2)" "unprognostic (1.11e-2)" "unprognostic (2.49e-1)" "unprognostic (4.76e-2)" "unprognostic (6.10e-2)" "prognostic unfavorable (1.90e-8)" "unprognostic (1.42e-1)" "unprognostic (1.42e-1)" "unprognostic (6.92e-3)" "unprognostic (2.09e-1)" 20.1 26.4 14.9 21.3 17.6 27.2 21.8 23.3 20.4 15.6 15.4 19.6 15.1 14.6 18.9 16.8 23.7 18.6 17.0 16.5 12.4 10.7 16.3 16.3 21.6 24.1 16.0 11.3 20.7 18.1 17.2 22.3 18.3 15.2 17.2 13.9 16.7 19.1 15.7 19.9 27.3 22.8 18.5 13.4 27.4 16.8 43.7 14.1 31.4 17.4 15.8 27.9 16.4 28.6 4.8 3.3 7.7 2.2 4.7 5.5 1.4 19.7 18.5 19.4 12.0 11.3 17.8 24.3 24.2 18.1 24.3 18.7 21.1 13.6 15.6 12.7 21.2 16.3 23.9 16.9 22.1 23.3 6.6 21.0 19.8 31.1 9.9 12.6 21.2 14.0 16.5 22.6 23.1 17.2 45.1 17.3 12.9 17.8 6.1 24.8 14.2 19.8 35.2 16.4 9.8 17.8 22.8 12.7 6.5 17.5 25.9 23.9 14.7 31.2 13.2 10.6 19.0 23.2 15.4 24.7 29.3 21.1 15.5 26.9 11.5 11.3 19.1 22.7 14.2 16.4 1.4 2.2 7.7 3.6 2.1 4.8 4.8 5.3 5.5 3.3 4.3 5.0 4.1 1.3 4.7 2.2 3.2 4.7 1.4 14.9 17.6 23.3 20.4 12.4 10.7 16.0 11.3 15.2 14.1 68.5 24.5 25.4 82.7 59.8 30.8 22.9 28.1 20.1 55.7 29.6 43.2 25.0 1.7 29.1 63.9 32.7 20.2 0.0 28.1 29.6 26.8 92.4 18.4 12.1 17.7 30.2 20.0 19.0 15.1 14.0 23.3 33.1 32.1 42.3 16.9 24.7 66.6 20.9 26.5 6.4 38.7 25.8 34.8 131.6 52.4 63.7 30.6 37.3 18.6 154.8 ANKRD35 FLJ25124 ENSG00000198483 "Ankyrin repeat domain 35" Q8N283 1 145866560-145885866 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 42.4" "Cell type enhanced" "Detected in many" 9 "Leydig cells: 33.6;Muller glia cells: 39.3;Peritubular cells: 47.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "classical monocyte: 5.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC TERT1: 11.0;THP-1: 7.4;TIME: 9.4;U-87 MG: 9.4;U-937: 8.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA035453 Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA035453: AB_10672864" "prognostic favorable (9.35e-4)" "prognostic favorable (2.90e-4)" "unprognostic (2.07e-1)" "unprognostic (7.39e-3)" "unprognostic (1.77e-2)" "unprognostic (1.02e-2)" "unprognostic (3.27e-1)" "unprognostic (3.58e-2)" "unprognostic (3.03e-1)" "unprognostic (1.79e-1)" "unprognostic (2.98e-1)" "unprognostic (5.86e-2)" "unprognostic (9.29e-10)" "unprognostic (8.80e-3)" "unprognostic (2.18e-1)" "unprognostic (5.92e-2)" "unprognostic (8.69e-3)" 2.1 1.2 3.3 1.0 3.7 0.4 3.6 12.1 7.4 16.1 1.7 0.8 0.3 0.5 2.1 1.3 11.4 2.5 1.1 0.8 3.4 3.6 0.4 1.4 0.8 0.5 3.7 3.4 2.8 0.5 0.2 0.3 0.3 8.0 2.5 0.8 0.3 4.2 2.3 5.2 42.4 0.7 1.8 2.0 0.4 1.2 0.8 0.3 0.7 0.3 14.9 13.6 2.3 7.7 0.0 1.3 0.3 5.5 1.5 2.9 1.9 0.1 0.0 0.0 0.0 2.5 11.0 0.3 1.6 4.0 0.5 1.3 0.4 0.0 0.0 0.3 1.3 0.0 0.2 0.0 0.0 0.2 0.0 0.0 3.2 0.0 0.0 1.3 3.1 0.1 3.8 0.5 0.3 0.1 0.1 0.5 0.0 0.0 0.0 2.4 0.0 0.0 4.2 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 7.4 9.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 9.4 8.2 0.0 0.0 5.5 0.0 2.0 2.0 0.3 0.0 0.8 2.9 0.7 0.0 0.6 1.9 0.3 1.5 0.4 1.3 1.5 1.9 3.3 3.7 12.1 7.4 3.4 3.6 3.7 3.4 8.0 0.3 0.0 0.0 0.0 14.7 4.0 1.5 1.2 2.5 4.0 1.2 1.8 0.0 0.1 0.0 0.0 3.6 1.0 0.0 0.0 0.4 0.1 20.2 8.0 19.5 8.6 8.7 0.0 0.0 1.8 1.6 4.7 33.6 1.1 5.0 0.0 0.0 39.3 0.1 0.0 47.7 0.0 1.4 0.0 5.2 0.0 0.9 10.8 0.2 7.5 0.0 12.9 ANKRD42 "FLJ37874, PPP1R79, SARP" ENSG00000137494 "Ankyrin repeat domain 42" Q8N9B4 11 83193739-83260694 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 41.8" "Cell type enhanced" "Detected in many" 9 "Ciliated cells: 73.6;Early spermatids: 123.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 27.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039917 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" No No "Nucleoplasm, Cytosol" "Plasma membrane" "HPA039917: AB_10672894" "unprognostic (6.59e-2)" "unprognostic (9.00e-2)" "unprognostic (1.00e-1)" "unprognostic (1.31e-3)" "unprognostic (9.12e-2)" "unprognostic (3.78e-1)" "unprognostic (1.67e-2)" "unprognostic (1.03e-1)" "unprognostic (1.11e-1)" "unprognostic (2.11e-1)" "unprognostic (2.99e-2)" "unprognostic (1.59e-1)" "unprognostic (1.09e-2)" "unprognostic (3.10e-3)" "unprognostic (1.79e-1)" "unprognostic (4.25e-1)" "unprognostic (1.90e-1)" 5.6 14.5 13.9 5.4 22.1 8.3 7.1 4.8 15.1 8.2 5.4 3.0 11.6 5.8 6.9 22.2 5.6 17.2 8.7 5.4 18.1 13.4 12.3 5.2 7.4 4.5 8.2 12.4 9.9 8.6 16.8 17.9 4.5 13.1 8.4 4.8 6.5 6.7 10.3 6.1 6.2 5.3 6.7 8.7 4.8 6.4 41.8 5.3 1.0 13.0 1.5 4.5 6.8 16.1 7.1 4.8 7.9 11.1 5.8 4.3 2.1 3.9 6.9 3.3 6.8 10.7 11.2 3.0 8.1 6.3 4.8 3.0 4.2 4.8 1.7 10.5 7.2 9.7 8.5 3.5 5.5 4.0 2.2 2.8 2.8 9.4 2.7 7.4 7.8 6.6 6.6 6.6 12.1 6.5 9.4 4.9 2.8 8.1 1.6 6.9 5.8 1.1 8.6 2.8 6.1 4.4 1.9 5.0 2.0 16.0 4.7 2.7 3.5 10.5 6.6 2.1 4.6 9.9 4.4 7.1 7.5 5.2 27.2 3.7 2.1 4.7 3.3 5.9 4.9 3.1 7.9 3.6 4.3 4.1 4.1 2.8 7.1 3.7 4.3 4.8 5.2 1.9 3.0 3.0 5.8 11.1 2.0 1.4 2.1 13.9 22.1 4.8 15.1 18.1 13.4 8.2 12.4 13.1 5.3 8.9 13.6 3.2 17.5 10.0 3.0 6.7 7.6 73.6 7.9 7.0 37.3 2.7 8.3 6.6 123.0 7.1 3.6 0.0 5.8 2.7 8.7 10.0 12.8 3.8 4.4 1.6 2.9 9.2 8.2 53.0 8.1 9.0 6.8 6.4 3.2 6.7 5.4 3.6 9.9 11.4 21.3 12.9 8.7 38.6 18.1 13.4 4.6 7.0 3.1 11.2 ANKRD45 "CT117, FLJ45235" ENSG00000183831 "Ankyrin repeat domain 45" Q5TZF3 1 173609561-173669862 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 14.6;fallopian tube: 24.8;parathyroid gland: 16.8;pituitary gland: 7.9;testis: 20.8" "Group enriched" "Detected in some" 5 "Ciliated cells: 33.5;Cone photoreceptor cells: 35.3;Early spermatids: 19.6;Late spermatids: 9.9;Spermatocytes: 28.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 12.0;BJ hTERT+: 4.2;BJ hTERT+ SV40 Large T+: 3.8;BJ hTERT+ SV40 Large T+ RasG12V: 6.5;GAMG: 4.1;HBF TERT88: 4.3;SH-SY5Y: 10.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031655, HPA031656, HPA031657" Enhanced Approved "Plasma membrane,Centrosome,Cytosol" NA NA Cytosol "Plasma membrane, Centrosome" "HPA031655: AB_10610975, HPA031656: AB_10600331, HPA031657: AB_10602196" "unprognostic (1.93e-1)" "unprognostic (1.22e-1)" "unprognostic (2.21e-2)" "unprognostic (1.90e-1)" "unprognostic (1.29e-3)" "unprognostic (4.02e-1)" "unprognostic (3.57e-2)" "unprognostic (2.69e-3)" "unprognostic (4.15e-2)" "unprognostic (6.93e-2)" "unprognostic (2.45e-1)" "unprognostic (3.05e-2)" "unprognostic (4.49e-2)" "unprognostic (8.80e-3)" "unprognostic (2.91e-2)" "unprognostic (5.15e-2)" "unprognostic (1.61e-1)" 0.5 1.3 5.9 0.4 14.6 0.5 0.6 1.1 7.0 2.8 0.7 9.0 1.3 0.4 3.3 2.5 0.5 24.8 1.0 0.9 7.7 4.7 2.7 0.5 2.8 0.4 2.4 5.3 2.4 1.0 16.8 7.9 0.4 9.2 1.9 0.5 1.8 0.4 1.2 0.4 0.4 0.5 2.4 2.7 1.3 0.5 20.8 4.2 0.0 1.3 0.0 0.4 0.6 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.5 12.0 0.0 0.0 1.0 2.1 0.1 4.2 3.8 6.5 0.0 0.0 0.0 0.1 0.0 4.1 0.0 0.0 0.0 4.3 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.5 0.0 2.3 0.0 0.4 0.1 0.0 0.2 0.2 0.5 0.0 0.0 0.0 0.4 0.2 0.1 0.1 0.0 0.3 0.4 0.0 1.6 10.8 0.0 0.0 0.2 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.1 0.9 0.0 2.2 0.1 1.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.9 14.6 1.1 7.0 7.7 4.7 2.4 5.3 9.2 4.2 0.0 1.7 0.0 0.2 0.2 0.5 0.7 0.0 33.5 1.2 5.2 35.3 0.2 1.7 0.6 19.6 1.5 0.0 0.0 0.4 0.2 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.6 0.0 9.9 1.7 0.0 0.0 0.0 0.0 2.8 0.1 0.0 0.4 0.5 1.8 0.0 0.3 28.6 4.9 0.0 0.1 0.0 0.0 0.1 ANKS1B "AIDA-1, ANKS2, cajalin-2, EB-1" ENSG00000185046 "Ankyrin repeat and sterile alpha motif domain containing 1B" Q7Z6G8 12 98726457-99984654 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 66.2;skeletal muscle: 28.2" "Cell type enhanced" "Detected in many" 21 "Early spermatids: 136.4;Horizontal cells: 28.6;Late spermatids: 63.3" "Cancer enhanced" "Detected in some" "glioma: 1.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 12.1;ASC TERT1: 7.1;SCLC-21H: 13.2" "HPA044628, HPA078230" Enhanced Supported "Vesicles,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Vesicles "HPA044628: , HPA078230: " "unprognostic (5.50e-2)" "unprognostic (3.26e-2)" "unprognostic (1.01e-2)" "unprognostic (6.87e-3)" "unprognostic (1.18e-1)" "unprognostic (1.14e-4)" "unprognostic (7.94e-2)" "unprognostic (2.47e-1)" "unprognostic (1.84e-2)" "unprognostic (3.03e-2)" "unprognostic (4.97e-4)" "unprognostic (2.81e-1)" "unprognostic (1.14e-3)" "unprognostic (1.64e-2)" "unprognostic (1.15e-2)" "unprognostic (1.09e-2)" "unprognostic (3.75e-3)" 2.3 4.5 21.4 1.7 41.2 1.2 3.7 21.0 66.2 3.3 2.3 27.5 0.0 1.5 3.3 2.4 3.9 4.4 2.2 2.2 28.3 17.3 5.4 1.8 2.0 1.6 20.3 24.8 9.7 2.1 1.9 4.4 2.7 16.0 4.1 2.1 0.1 3.8 3.7 28.2 1.9 1.6 3.3 25.8 2.0 1.8 7.6 23.0 0.0 6.3 0.0 1.3 2.1 0.8 2.1 2.4 5.3 3.1 3.1 8.3 1.3 0.3 2.5 12.1 2.9 4.9 7.1 0.7 0.0 1.2 0.9 0.9 0.3 0.9 1.0 0.5 1.8 3.7 0.5 0.1 0.1 0.3 1.5 0.8 0.1 0.8 0.0 0.0 0.1 0.6 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.3 0.9 0.2 0.7 0.5 0.5 3.5 0.1 2.2 0.9 0.0 0.3 0.1 0.0 13.2 1.4 1.1 3.9 1.5 1.0 4.5 0.1 0.1 1.1 1.1 0.7 0.7 0.1 0.7 0.6 1.1 0.3 1.1 5.3 1.4 2.1 1.7 2.1 2.5 1.9 2.9 1.6 1.3 2.1 2.4 2.3 3.9 3.1 3.1 2.4 8.3 1.3 21.4 41.2 21.0 27.9 28.3 17.3 20.3 24.8 16.0 23.0 3.0 3.8 0.0 1.1 1.0 13.7 2.5 0.0 5.3 2.3 8.7 17.7 0.3 0.0 0.1 136.4 0.7 0.0 0.0 0.0 0.2 3.2 0.4 1.1 0.2 0.5 28.6 0.0 0.6 0.0 63.3 1.1 0.8 5.0 0.0 0.0 1.7 0.0 0.0 5.6 2.6 2.8 6.5 1.4 4.7 4.5 1.3 0.7 1.0 0.0 0.6 ANXA2 "ANX2, ANX2L4, CAL1H, LIP2, LPC2D" ENSG00000182718 "Annexin A2" P07355 15 60347134-60402883 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Host-virus interaction" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB004311, HPA046964, HPA061798" Enhanced Approved "Plasma membrane,Cytosol" "Secreted to blood" NA NA 16000000 "Plasma membrane" Cytosol "CAB004311: AB_626677, HPA046964: AB_2732537, HPA061798: AB_2732671" "unprognostic (1.61e-1)" "unprognostic (1.31e-3)" "unprognostic (1.84e-1)" "prognostic favorable (6.88e-5)" "unprognostic (4.06e-3)" "unprognostic (5.42e-3)" "prognostic unfavorable (2.54e-5)" "prognostic unfavorable (7.51e-4)" "unprognostic (2.94e-1)" "unprognostic (4.10e-3)" "prognostic unfavorable (8.47e-6)" "unprognostic (5.16e-2)" "prognostic unfavorable (2.11e-6)" "unprognostic (7.74e-2)" "unprognostic (2.55e-1)" "unprognostic (7.41e-2)" "prognostic unfavorable (6.59e-5)" 91.7 29.8 4.9 23.5 7.1 6.6 50.1 4.5 5.6 65.1 39.1 8.6 38.2 26.4 38.3 40.3 158.8 26.2 54.9 29.9 4.7 5.5 36.7 28.5 62.0 46.6 10.8 5.7 23.3 94.3 29.7 12.8 84.1 25.7 29.5 35.2 31.7 74.7 27.9 22.7 77.3 71.9 37.1 15.1 32.6 25.6 18.7 7.1 14.6 31.0 122.7 81.4 34.0 87.4 35.5 209.6 183.3 138.0 15.2 83.9 150.8 144.7 161.6 8.5 3.8 116.8 187.4 37.1 173.0 111.6 109.9 96.5 76.6 69.9 0.3 142.5 223.8 82.7 154.9 38.0 324.9 120.6 30.8 4.0 2.9 77.8 29.7 70.4 0.1 2.1 91.5 88.7 78.1 168.4 132.2 204.9 2.1 11.5 16.9 234.8 16.8 0.6 8.5 18.5 123.9 125.9 1.7 46.9 8.1 194.9 88.2 11.2 6.3 68.4 15.6 67.9 92.0 33.4 6.0 233.6 93.8 127.8 314.4 169.8 6.3 20.7 2.8 88.3 1.6 186.5 183.3 138.0 17.7 33.4 122.6 36.5 35.5 38.5 38.5 209.6 16.9 4.5 18.1 3.9 15.2 129.1 32.0 83.9 150.8 4.9 7.1 4.5 5.6 4.7 5.5 10.8 5.7 25.7 7.1 1989.1 372.8 135.8 2699.6 2231.6 2.1 19.9 922.3 1675.6 1452.5 532.1 0.0 1604.6 11.6 3597.2 77.7 904.5 724.0 23.3 2130.9 2200.2 1229.1 3363.5 101.8 70.0 1517.4 0.0 99.2 465.3 432.0 90.7 714.0 1131.8 1344.5 1757.5 521.7 18.0 3399.7 582.2 600.4 22.4 6.8 181.1 774.1 7.0 17.7 2032.4 961.8 162.4 580.5 3656.9 APC "DP2, DP2.5, DP3, PPP1R46" ENSG00000134982 "APC, WNT signaling pathway regulator" P25054 5 112707498-112846239 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Wnt signaling pathway" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 40.9" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 169.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013349, HPA013362" Supported Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Golgi apparatus" "HPA013349: AB_1844913, HPA013362: " "unprognostic (4.80e-2)" "unprognostic (1.19e-1)" "unprognostic (3.72e-2)" "unprognostic (1.14e-1)" "unprognostic (1.10e-1)" "unprognostic (7.09e-3)" "unprognostic (1.62e-1)" "unprognostic (8.10e-3)" "unprognostic (2.35e-1)" "unprognostic (4.85e-3)" "unprognostic (1.27e-1)" "unprognostic (4.18e-2)" "unprognostic (1.02e-2)" "unprognostic (1.07e-1)" "unprognostic (3.35e-1)" "unprognostic (2.23e-2)" "unprognostic (1.96e-1)" 7.2 5.4 40.9 6.4 21.7 8.5 6.3 19.1 39.7 6.8 7.1 10.3 2.0 6.6 6.3 3.9 8.4 5.0 5.5 7.4 37.9 12.9 6.9 6.2 6.7 5.6 23.6 20.7 7.6 4.6 13.8 7.2 5.5 39.1 5.9 6.9 4.0 4.0 4.9 7.0 6.1 8.8 8.1 19.1 6.2 5.4 5.3 20.6 3.6 6.5 2.7 6.2 6.2 3.9 3.8 3.0 12.9 2.9 3.0 3.4 1.1 8.3 7.7 12.9 9.4 10.6 8.9 5.3 13.6 6.5 7.6 9.0 6.1 6.8 16.2 13.2 17.3 11.7 6.9 13.2 11.1 12.5 9.7 9.0 12.3 11.2 4.7 5.2 6.2 6.7 7.4 7.7 12.8 8.5 5.3 10.5 7.8 15.1 5.6 10.9 5.8 7.1 3.1 4.6 4.6 2.8 6.0 16.0 7.9 7.0 10.7 13.1 7.9 12.9 5.0 5.5 5.5 7.0 5.1 16.7 15.4 7.4 15.1 10.3 4.4 6.6 6.4 8.5 11.5 8.6 10.4 2.9 5.0 3.4 1.4 2.9 3.1 1.8 2.1 2.3 3.8 2.9 2.8 12.9 3.0 2.5 3.0 1.6 1.1 40.9 21.7 19.1 31.4 37.9 12.9 23.6 20.7 39.1 20.6 47.6 17.6 10.8 8.3 10.0 169.9 48.4 12.7 20.1 26.1 0.0 62.8 4.4 0.0 16.7 6.3 21.0 24.6 0.0 17.0 5.3 10.2 10.3 18.5 12.1 13.8 74.7 26.4 28.8 14.9 4.4 16.4 14.8 16.9 19.0 15.5 21.8 16.3 25.9 18.4 4.2 37.9 38.8 14.3 14.9 26.7 10.2 2.4 10.7 14.2 7.6 APLP1 APLP ENSG00000105290 "Amyloid beta precursor like protein 1" P51693 19 35867899-35879791 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell adhesion, Endocytosis" Heparin-binding Neurodegeneration "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 147.5" "Group enriched" "Detected in many" 4 "Bipolar cells: 142.9;Horizontal cells: 152.6" "Cancer enhanced" "Detected in many" "glioma: 63.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 25.4;AN3-CA: 47.1;EFO-21: 24.9;HMC-1: 24.3;SCLC-21H: 27.4;SH-SY5Y: 27.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028970, HPA028971" Enhanced Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA 3900000 "Golgi apparatus, Plasma membrane" Nucleoplasm "HPA028970: AB_2672847, HPA028971: AB_10601334" "unprognostic (1.33e-2)" "unprognostic (2.07e-1)" "unprognostic (9.36e-3)" "prognostic unfavorable (3.87e-4)" "unprognostic (7.32e-3)" "unprognostic (1.26e-2)" "unprognostic (1.04e-3)" "unprognostic (2.24e-2)" "unprognostic (4.98e-2)" "unprognostic (6.16e-2)" "unprognostic (2.35e-2)" "unprognostic (1.13e-1)" "unprognostic (2.57e-11)" "unprognostic (1.38e-3)" "unprognostic (7.12e-2)" "unprognostic (5.43e-2)" "prognostic unfavorable (2.65e-5)" 2.6 15.6 37.0 2.9 47.9 1.6 1.6 13.1 147.5 2.4 2.6 91.6 0.0 2.0 2.3 2.1 2.2 2.3 4.3 6.0 53.2 37.4 2.4 1.5 2.4 2.1 54.6 24.6 1.9 32.1 5.6 17.6 1.9 38.4 2.3 2.6 3.3 2.4 2.4 1.5 2.0 2.4 2.9 118.2 1.7 9.6 5.7 36.9 0.0 2.2 0.0 2.2 2.1 0.1 1.5 0.4 2.2 0.7 3.0 0.6 0.2 1.4 10.6 25.4 47.1 2.4 1.0 3.3 2.2 1.1 2.5 0.3 2.5 1.4 0.2 24.9 5.5 8.2 0.7 7.8 0.5 1.7 17.7 0.9 0.1 3.1 1.4 0.7 0.0 24.3 1.1 0.6 1.0 0.0 9.4 0.8 1.8 0.9 0.4 7.2 2.3 0.0 0.0 1.2 4.3 6.2 2.4 0.1 0.3 0.4 0.3 27.4 27.8 8.2 1.1 0.3 7.2 6.1 1.3 0.6 17.1 9.8 9.6 1.4 1.1 0.4 0.1 11.2 0.3 8.6 2.2 0.7 0.4 0.4 0.5 0.3 0.7 0.4 0.6 0.2 1.5 0.5 0.6 2.1 3.0 0.7 0.4 0.2 0.2 37.0 47.9 13.1 54.6 53.2 37.4 54.6 24.6 38.4 36.9 6.0 0.0 0.0 2.4 1.1 142.9 4.8 0.0 0.0 0.0 0.0 11.8 0.3 0.0 2.1 25.2 2.8 0.0 0.0 3.8 4.1 2.1 1.8 0.0 0.0 0.4 152.6 33.6 1.3 0.3 8.5 1.1 0.5 5.0 0.0 0.0 11.9 4.4 0.0 0.0 0.0 24.2 0.0 1.7 9.7 22.2 0.5 0.3 0.0 0.0 1.2 APMAP "BSCv, C20orf3" ENSG00000101474 "Adipocyte plasma membrane associated protein" Q9HDC9 20 24962925-24992979 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 93.8;liver: 100.5" "Cell type enhanced" "Detected in all" 11 "Cytotrophoblasts: 255.8;Hepatocytes: 247.3;Syncytiotrophoblasts: 628.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 5 "granulocytes: 93.8;NK-cells: 43.2;T-cells: 53.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012863, HPA064700" Uncertain Approved "Plasma membrane" NA NA 80000000 "Plasma membrane" "HPA012863: AB_1845683, HPA064700: AB_2685328" "unprognostic (4.07e-3)" "unprognostic (2.50e-2)" "unprognostic (1.20e-1)" "unprognostic (8.16e-2)" "unprognostic (6.79e-2)" "unprognostic (2.14e-2)" "unprognostic (1.10e-2)" "unprognostic (4.09e-2)" "unprognostic (3.10e-2)" "unprognostic (1.19e-2)" "unprognostic (6.46e-2)" "unprognostic (1.54e-1)" "unprognostic (7.99e-3)" "unprognostic (8.26e-2)" "unprognostic (1.67e-1)" "unprognostic (1.23e-1)" "unprognostic (3.51e-2)" 43.5 13.0 14.8 12.4 16.1 44.5 23.1 47.3 22.7 11.7 12.3 15.7 17.9 8.9 14.8 31.8 7.5 13.0 13.4 10.2 18.2 20.9 12.9 100.5 14.4 15.9 15.4 17.2 12.3 12.2 18.9 20.2 28.3 17.0 12.5 12.4 11.6 10.6 18.7 9.8 14.0 9.3 13.8 13.7 16.9 10.2 19.9 15.4 10.6 57.9 5.7 9.2 13.0 10.6 5.2 13.9 93.8 13.9 43.2 53.4 40.1 22.9 39.8 20.5 30.7 39.9 21.8 20.8 30.0 32.9 29.0 30.1 23.5 40.8 9.5 35.1 36.0 53.0 42.4 18.7 34.9 34.1 12.7 14.6 10.5 14.4 47.7 31.4 20.5 25.3 29.5 49.5 34.0 24.5 40.0 41.2 15.7 12.4 42.9 28.1 34.5 14.1 23.1 12.9 36.7 36.3 11.7 68.1 19.8 30.9 21.1 33.6 13.0 30.9 53.5 33.2 22.3 19.0 17.2 36.1 34.9 31.3 29.5 44.7 24.4 27.0 10.5 18.4 31.2 33.1 7.4 13.9 26.1 53.4 13.4 33.0 5.1 15.1 38.8 13.9 5.2 11.9 30.9 93.8 43.2 9.0 6.8 9.9 40.1 14.8 16.1 47.3 22.7 18.2 20.9 15.4 17.2 17.0 15.4 17.9 28.3 27.4 38.9 21.6 49.0 14.5 45.9 24.1 21.6 47.1 9.8 255.8 14.9 60.3 22.9 34.6 17.0 23.3 39.8 32.6 32.9 31.8 34.7 247.3 84.5 15.9 17.2 38.6 45.7 27.7 60.1 81.5 43.9 161.5 17.3 35.4 35.7 19.9 77.1 13.0 18.3 38.8 34.0 52.1 79.8 17.6 628.2 145.4 24.7 24.2 APOD ENSG00000189058 "Apolipoprotein D" P05090 3 195568702-195584205 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "breast: 840.7" "Group enriched" "Detected in many" 5 "Leydig cells: 1923.5;Melanocytes: 975.2;Peritubular cells: 934.8" "Cancer enhanced" "Detected in all" "melanoma: 925.2" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "memory B-cell: 6.7" "Lineage enriched" "Detected in single" 10 "B-cells: 6.7" "Group enriched" "Detected in some" 7 "ASC diff: 239.5;ASC TERT1: 129.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040520 Enhanced Approved "Plasma membrane" "Secreted to blood" NA NA 98900000000 220000000000 "Plasma membrane" "HPA040520: AB_2677020" "prognostic favorable (5.51e-4)" "unprognostic (7.62e-3)" "unprognostic (7.85e-3)" "unprognostic (3.34e-3)" "unprognostic (2.20e-1)" "unprognostic (1.02e-2)" "unprognostic (3.09e-2)" "unprognostic (2.06e-3)" "unprognostic (1.26e-1)" "unprognostic (3.45e-1)" "unprognostic (3.38e-1)" "unprognostic (3.19e-1)" "unprognostic (6.90e-3)" "prognostic unfavorable (6.02e-4)" "unprognostic (1.38e-1)" "prognostic unfavorable (4.12e-4)" "unprognostic (1.71e-3)" 134.4 15.2 39.7 5.7 39.9 3.4 840.7 14.7 66.1 75.0 16.4 79.7 10.9 12.9 36.6 30.0 46.1 42.9 36.4 124.7 45.5 29.2 8.5 3.5 11.8 6.5 96.9 28.2 19.4 28.3 9.0 14.3 59.6 50.9 39.7 13.1 99.1 152.5 35.1 110.4 66.0 7.2 30.4 81.6 3.6 28.7 32.0 56.5 0.0 87.7 42.2 6.6 62.1 95.7 6.7 0.1 0.4 0.6 0.0 0.1 0.1 0.0 0.1 0.0 0.0 239.5 129.1 0.3 2.0 0.5 0.0 0.0 13.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 6.5 1.4 0.0 1.1 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.4 2.0 0.1 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 25.9 0.4 0.1 0.0 0.1 0.1 0.0 6.7 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.6 0.1 0.0 0.1 39.7 39.9 14.7 39.5 45.5 29.2 96.9 28.2 50.9 56.5 0.0 8.3 0.0 14.6 128.8 0.0 31.1 0.0 40.2 104.6 5.2 0.0 4.1 0.0 0.2 9.1 55.0 0.0 0.0 0.0 5.0 271.0 22.1 0.0 0.0 12.4 0.0 44.5 30.1 0.3 22.5 1923.5 6.2 975.2 1.8 0.9 0.0 1.9 0.0 934.8 0.1 0.0 19.4 80.9 3.8 3.8 89.6 4.9 0.0 0.6 37.7 APOLD1 "DKFZP434F0318, FLJ25138" ENSG00000178878 "Apolipoprotein L domain containing 1" Q96LR9 12 12725917-12829975 "Predicted membrane proteins" "Angiogenesis, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 109.5" "Cell type enhanced" "Detected in many" 9 "Endothelial cells: 140.0;Erythroid cells: 70.0;Ito cells: 65.7;Muller glia cells: 64.4;Sertoli cells: 109.9;Smooth muscle cells: 101.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 26.2;HDLM-2: 13.2;hTERT-RPE1: 10.9" "Group enriched" "Detected in many" 5 "basal ganglia: 5.8;olfactory region: 24.7" "Low region specificity" "Detected in all" "HPA052462, HPA058882" Approved Approved "Nucleoplasm,Plasma membrane" No No "Nucleoplasm, Plasma membrane" "HPA052462: AB_2681841, HPA058882: AB_2683844" "unprognostic (1.98e-1)" "unprognostic (8.36e-3)" "unprognostic (5.28e-2)" "unprognostic (1.28e-3)" "unprognostic (1.37e-1)" "unprognostic (1.16e-2)" "unprognostic (5.58e-3)" "unprognostic (8.07e-2)" "unprognostic (3.46e-1)" "unprognostic (4.23e-2)" "unprognostic (1.35e-1)" "unprognostic (3.23e-2)" "unprognostic (4.30e-3)" "unprognostic (3.42e-3)" "unprognostic (1.81e-1)" "unprognostic (6.18e-2)" "unprognostic (1.15e-2)" 109.5 8.8 11.2 9.2 17.7 0.6 34.4 9.8 17.5 25.5 9.0 7.7 2.9 2.5 7.1 7.0 18.8 14.0 18.7 22.3 13.0 11.8 7.4 9.3 7.1 3.4 16.6 3.3 10.0 12.8 17.2 4.7 44.8 16.7 7.2 7.1 8.1 4.4 3.7 16.6 7.4 6.0 28.0 13.9 4.7 5.3 5.4 12.4 5.7 34.4 9.9 3.3 10.9 7.1 2.3 1.7 4.8 0.9 0.8 2.7 0.3 4.3 0.1 26.2 0.8 0.8 1.5 0.2 4.2 7.0 4.3 6.3 1.7 4.6 1.3 0.4 1.6 1.5 1.4 1.0 0.2 7.3 13.2 1.0 0.4 1.3 0.0 1.6 0.6 0.4 1.0 1.2 1.5 3.4 10.9 3.2 2.4 0.4 1.8 2.2 0.9 0.7 0.7 0.1 1.0 0.8 2.0 0.5 0.6 0.5 0.4 2.3 2.4 4.0 0.4 9.6 0.4 0.1 2.1 3.9 1.0 1.4 5.8 3.8 1.3 0.6 1.0 1.5 2.8 4.9 4.8 0.9 0.7 0.9 0.4 1.1 2.2 2.0 1.3 0.6 2.3 1.6 1.0 4.4 0.8 0.6 1.7 2.7 0.3 11.2 17.7 9.8 17.5 13.0 11.8 16.6 3.3 16.7 12.4 6.0 4.0 21.4 2.2 16.1 4.2 7.0 7.6 8.1 9.1 0.0 3.9 1.5 0.0 0.9 1.6 140.0 1.1 70.0 0.4 1.1 8.4 3.7 7.0 1.6 5.1 3.2 3.5 65.7 14.5 1.1 4.0 5.7 27.0 3.6 4.7 64.4 0.8 0.0 0.4 0.3 3.3 109.9 101.3 3.2 0.7 13.6 0.8 20.8 6.3 2.8 AQP5 ENSG00000161798 "Aquaporin 5" P55064 12 49961870-49965681 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "salivary gland: 217.9;testis: 76.2" "Group enriched" "Detected in many" 8 "Early spermatids: 1235.0;Late spermatids: 3096.0" "Cancer enhanced" "Detected in many" "endometrial cancer: 87.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 22 "OE19: 70.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA065008 Enhanced Approved "Plasma membrane" NA NA "Plasma membrane" "HPA065008: AB_2685401" "unprognostic (4.67e-3)" "unprognostic (5.00e-2)" "unprognostic (3.30e-1)" "unprognostic (6.00e-3)" "unprognostic (1.92e-3)" "prognostic favorable (1.75e-5)" "unprognostic (4.13e-3)" "unprognostic (1.02e-2)" "unprognostic (9.39e-2)" "unprognostic (3.70e-3)" "unprognostic (2.88e-3)" "unprognostic (2.46e-3)" "unprognostic (1.69e-4)" "unprognostic (2.53e-1)" "unprognostic (5.28e-2)" "unprognostic (2.51e-3)" "unprognostic (9.11e-3)" 0.2 0.1 0.4 0.2 1.1 0.0 3.8 0.4 0.3 3.0 0.3 0.4 0.3 3.2 0.6 0.8 3.8 0.1 15.6 1.0 0.3 0.3 0.2 0.2 2.3 0.2 0.7 0.2 0.2 0.8 0.1 0.4 0.2 0.3 0.5 0.0 0.4 217.9 0.6 0.9 23.5 0.3 0.6 0.2 0.2 12.0 76.2 0.3 0.2 0.3 2.8 11.5 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 70.7 0.0 3.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.4 0.3 0.3 0.3 0.7 0.2 0.3 0.3 53.6 1.9 0.0 0.4 1.1 0.5 0.3 0.0 8.1 37.5 7.0 0.0 0.0 0.0 0.0 1235.0 0.0 0.0 0.0 0.2 0.0 0.4 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3096.0 26.4 0.0 280.0 0.0 0.0 45.4 4.3 0.0 18.0 0.0 1.4 19.4 0.3 76.9 15.2 0.6 0.0 0.0 0.0 0.7 ARAP1 CENTD2 ENSG00000186635 "ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1" Q96P48 11 72685069-72793599 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 49.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020703, HPA070383" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA 39000 "Nucleoplasm, Plasma membrane" "Vesicles, Cytosol" "CAB020703: , HPA070383: AB_2686262" "unprognostic (3.60e-2)" "unprognostic (7.68e-2)" "unprognostic (6.19e-2)" "unprognostic (5.98e-2)" "unprognostic (5.76e-2)" "unprognostic (1.64e-2)" "prognostic unfavorable (6.45e-4)" "unprognostic (4.01e-2)" "unprognostic (4.07e-1)" "unprognostic (5.95e-2)" "prognostic favorable (2.04e-5)" "unprognostic (1.84e-1)" "unprognostic (1.05e-3)" "unprognostic (6.93e-2)" "unprognostic (2.57e-2)" "prognostic favorable (6.41e-4)" "unprognostic (7.56e-3)" 19.2 29.6 28.8 32.9 29.1 51.1 17.9 34.0 37.5 19.6 16.8 26.6 20.0 17.4 23.7 20.0 21.1 30.3 26.1 20.3 27.7 14.4 20.9 16.6 35.5 27.8 27.5 17.8 28.8 18.9 14.3 31.0 20.9 23.0 21.3 11.2 18.1 19.9 19.0 12.9 27.5 23.6 17.1 25.6 53.8 16.2 23.5 32.3 18.8 24.7 14.0 18.6 28.4 19.6 3.3 7.4 24.0 22.5 6.1 4.4 6.4 7.2 15.5 5.9 7.2 25.3 17.2 8.9 10.0 18.1 11.4 11.4 21.1 19.4 16.2 20.2 16.8 15.5 24.6 9.0 23.9 4.9 19.0 10.6 13.7 14.6 29.1 17.5 9.3 38.5 18.3 25.5 18.7 9.0 14.3 12.1 11.9 11.4 6.5 5.3 15.0 14.1 32.4 3.7 13.1 10.0 13.8 9.0 7.9 10.7 23.2 6.2 12.5 7.3 10.9 32.3 7.9 9.5 21.2 14.3 16.2 11.3 16.4 6.1 10.5 5.1 8.5 8.6 13.9 8.6 7.5 11.0 13.3 4.4 18.7 2.6 3.3 2.9 3.3 7.4 2.6 2.3 2.7 24.0 6.1 22.5 2.5 3.1 6.4 28.8 29.1 34.0 37.5 27.7 14.4 27.5 17.8 23.0 32.3 26.8 28.8 11.5 8.0 6.5 4.1 2.0 5.1 8.1 3.4 15.7 31.4 7.0 8.3 13.1 49.1 4.4 11.6 0.0 6.4 7.7 16.7 4.7 10.4 10.2 37.8 0.0 22.3 12.9 43.1 4.4 19.2 39.0 8.5 10.8 13.9 8.6 10.7 7.0 14.2 4.7 2.9 0.0 6.1 0.3 2.5 4.6 4.1 6.7 12.1 6.7 ARF1 ENSG00000143761 "ADP ribosylation factor 1" P84077 1 228082660-228099212 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" CAB007742 Uncertain Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "CAB007742: AB_562043" "unprognostic (9.54e-2)" "unprognostic (1.35e-2)" "unprognostic (2.30e-2)" "unprognostic (2.50e-3)" "unprognostic (2.33e-1)" "prognostic unfavorable (1.55e-4)" "unprognostic (4.65e-2)" "unprognostic (1.78e-1)" "unprognostic (3.73e-1)" "unprognostic (8.95e-3)" "unprognostic (6.74e-2)" "unprognostic (2.96e-2)" "unprognostic (5.85e-2)" "unprognostic (2.69e-2)" "unprognostic (1.56e-1)" "unprognostic (8.57e-2)" "unprognostic (1.94e-1)" 72.0 70.1 64.8 51.0 82.5 111.1 59.3 50.0 116.9 76.0 76.7 53.5 63.6 73.6 71.1 63.3 81.1 66.8 58.5 101.1 70.3 65.9 81.7 135.9 77.4 55.6 52.7 56.5 73.5 109.2 64.9 79.7 129.6 61.4 70.1 55.7 67.8 106.7 68.6 96.5 57.5 91.6 54.7 45.9 81.5 66.0 73.0 33.8 75.6 102.9 60.5 76.5 72.6 57.6 37.4 73.3 111.7 70.0 41.5 64.7 110.7 64.1 44.4 36.5 36.2 42.2 53.4 60.7 56.9 61.0 63.3 55.6 52.5 61.8 32.7 61.2 60.6 29.5 41.6 44.7 55.7 31.8 48.1 71.3 31.8 31.3 52.2 81.7 45.9 47.5 51.0 68.0 58.3 61.5 54.0 62.4 37.4 60.9 75.1 60.9 46.2 46.6 68.0 46.8 90.7 90.9 37.8 32.3 101.9 44.7 33.3 51.6 45.6 36.7 111.5 63.4 13.2 76.6 93.4 55.8 46.6 37.0 67.7 85.3 71.0 39.6 44.9 64.1 39.2 93.9 104.5 70.0 77.2 53.1 66.5 64.7 37.4 45.7 49.1 54.5 34.9 36.2 39.4 111.7 41.5 63.0 73.3 51.8 110.7 64.8 82.5 50.0 116.9 70.3 65.9 52.7 56.5 61.4 33.8 160.8 159.4 184.0 242.8 233.2 114.0 114.2 104.4 214.2 168.4 109.9 43.2 328.6 195.6 344.6 194.6 176.5 349.6 46.7 355.5 480.3 217.0 287.7 192.9 110.7 362.5 149.4 220.8 138.7 177.0 322.5 212.3 230.8 285.1 408.4 315.0 144.2 328.8 293.4 213.6 122.7 61.1 226.4 208.9 174.2 166.0 249.9 565.9 208.8 250.8 292.8 ARHGAP18 "bA307O14.2, MacGAP" ENSG00000146376 "Rho GTPase activating protein 18" Q8N392 6 129576132-129710225 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Ciliated cells: 362.7;granulocytes: 240.9;Syncytiotrophoblasts: 177.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 92.9;LHCN-M2: 26.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031595 Approved Approved "Nuclear speckles,Plasma membrane,Cytosol" NA NA 840000 "Plasma membrane, Cytosol" "Nuclear speckles" "HPA031595: AB_10959905" "unprognostic (6.39e-2)" "unprognostic (1.60e-1)" "unprognostic (5.45e-2)" "unprognostic (5.49e-2)" "unprognostic (3.05e-1)" "unprognostic (3.17e-1)" "unprognostic (9.32e-3)" "unprognostic (1.25e-2)" "unprognostic (2.98e-2)" "unprognostic (3.12e-2)" "prognostic unfavorable (2.54e-4)" "unprognostic (4.08e-1)" "unprognostic (2.29e-3)" "unprognostic (2.22e-1)" "unprognostic (3.05e-2)" "unprognostic (5.52e-2)" "unprognostic (1.08e-1)" 23.8 32.2 4.1 14.1 4.0 1.7 19.7 2.5 2.4 9.6 19.5 2.9 12.0 13.3 7.8 25.8 5.8 15.7 11.8 16.9 4.4 6.8 33.2 4.5 38.8 15.5 4.1 1.4 8.0 38.2 10.6 22.0 16.7 12.2 9.6 8.2 10.4 16.7 24.2 12.1 5.4 40.6 6.5 9.0 15.8 15.1 10.9 3.8 5.1 12.7 12.1 6.4 10.3 5.8 2.9 11.8 13.0 5.9 2.5 5.8 6.0 1.9 4.3 0.4 0.6 4.2 6.0 3.5 14.6 11.2 6.5 4.3 2.2 3.2 1.6 7.2 9.8 2.0 2.5 3.1 4.8 12.1 1.5 1.3 10.4 3.4 12.8 6.0 1.5 92.9 3.8 0.7 11.7 10.5 13.6 18.4 0.0 5.5 4.0 26.1 0.5 0.0 1.5 0.4 3.6 1.0 0.0 2.0 3.0 19.8 1.1 0.0 0.0 1.2 2.0 7.2 2.2 2.2 1.8 14.0 6.8 0.9 0.5 11.7 1.8 1.3 1.0 2.3 2.8 9.4 8.9 5.2 13.0 5.3 5.9 3.3 2.9 2.8 5.8 4.8 1.7 0.5 2.9 4.0 2.5 3.1 11.8 2.7 6.0 4.1 4.0 2.5 2.4 4.4 6.8 4.1 1.4 12.2 3.8 53.6 36.1 12.9 16.2 11.6 0.0 3.1 15.3 362.7 50.0 36.6 2.0 73.2 127.6 38.7 17.9 35.4 23.6 0.0 105.3 16.5 19.2 20.3 240.9 4.4 101.2 0.0 12.6 11.6 45.7 13.8 3.4 131.1 6.8 18.0 19.9 14.3 82.5 24.6 1.1 20.3 0.6 25.8 11.9 3.4 1.2 11.3 177.5 25.4 28.3 15.9 ARHGAP23 KIAA1501 ENSG00000275832 "Rho GTPase activating protein 23" Q9P227 17 38419280-38512392 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 52.4" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 56.6;Ito cells: 51.5" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 77.1;RT4: 30.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019818, HPA047291" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane" Cytosol "HPA019818: AB_1844993, HPA047291: AB_2680012" "unprognostic (3.35e-1)" "unprognostic (5.11e-2)" "unprognostic (6.43e-2)" "prognostic unfavorable (6.87e-5)" "unprognostic (9.53e-2)" "unprognostic (1.46e-1)" "unprognostic (1.80e-1)" "unprognostic (1.99e-1)" "unprognostic (5.56e-2)" "unprognostic (1.50e-3)" "prognostic unfavorable (3.24e-4)" "unprognostic (3.67e-2)" "prognostic unfavorable (5.38e-5)" "unprognostic (8.36e-2)" "unprognostic (5.83e-2)" "unprognostic (4.57e-2)" "unprognostic (2.25e-1)" 4.3 2.7 11.7 3.5 32.1 4.2 1.7 3.6 20.1 4.4 1.4 52.4 0.0 1.0 5.1 1.5 13.3 4.0 3.6 7.8 12.6 1.6 0.5 5.7 1.3 42.3 12.6 6.1 0.8 1.5 0.0 9.5 20.2 3.7 0.9 0.9 0.7 6.6 2.1 16.3 1.1 5.5 16.3 10.5 0.5 5.2 39.0 1.4 0.9 0.5 5.0 11.6 2.3 0.0 0.8 0.0 0.1 0.0 0.1 0.1 8.2 4.4 4.0 1.3 2.5 8.5 5.0 11.3 12.8 10.0 5.8 14.7 14.5 0.1 9.4 26.3 5.0 77.1 0.4 16.0 7.1 0.9 0.8 0.0 14.1 0.1 12.8 0.8 0.0 4.9 3.1 7.2 4.6 8.2 10.2 1.5 0.1 2.2 5.6 0.0 2.4 1.5 2.4 0.3 1.7 4.3 8.7 2.7 4.2 30.0 0.9 2.3 6.8 0.0 0.1 5.9 1.7 1.9 14.8 16.9 5.9 3.4 3.0 1.7 1.7 0.4 4.2 2.0 14.9 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 11.9 1.0 0.0 14.3 8.9 56.6 16.3 2.5 1.4 15.9 3.5 0.0 20.8 0.0 2.6 6.7 24.5 0.0 23.3 1.2 2.1 14.3 5.3 0.0 0.2 4.2 25.4 0.0 51.5 3.7 15.8 8.3 0.9 1.7 0.0 0.2 7.5 4.4 0.0 6.7 0.0 3.3 0.0 7.2 17.6 1.9 22.6 13.8 0.0 0.0 35.6 ARHGAP24 "DKFZP564B1162, FilGAP, FLJ33877" ENSG00000138639 "Rho GTPase activating protein 24" Q8N264 4 85475114-86002670 "Predicted intracellular proteins" "Angiogenesis, Differentiation" "Developmental protein, GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 62.5" "Cell type enhanced" "Detected in many" 7 "B-cells: 105.7;Distal tubular cells: 192.3;Proximal tubular cells: 165.1;Syncytiotrophoblasts: 194.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 8.0;memory B-cell: 23.1;naive B-cell: 18.4;plasmacytoid DC: 6.5" "Group enriched" "Detected in many" 4 "B-cells: 23.1;dendritic cells: 6.5;monocytes: 8.0" "Cell line enhanced" "Detected in many" "ASC diff: 36.4;ASC TERT1: 22.1;HHSteC: 21.3;HUVEC TERT2: 39.2;RPTEC TERT1: 22.0;TIME: 27.6;U-138 MG: 19.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014288 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA014288: AB_1844994" "unprognostic (2.19e-1)" "unprognostic (1.30e-1)" "unprognostic (1.14e-1)" "unprognostic (2.95e-2)" "unprognostic (2.81e-1)" "unprognostic (9.22e-2)" "unprognostic (5.75e-3)" "unprognostic (4.28e-3)" "unprognostic (3.66e-1)" "unprognostic (1.33e-1)" "unprognostic (5.91e-2)" "unprognostic (6.45e-2)" "prognostic favorable (1.67e-11)" "unprognostic (1.75e-2)" "unprognostic (6.86e-2)" "unprognostic (2.50e-2)" "unprognostic (8.75e-4)" 21.3 1.9 5.3 16.4 7.9 10.7 17.6 1.8 9.4 5.8 6.2 8.4 2.4 4.8 9.2 7.3 7.7 3.9 7.1 16.8 6.3 7.3 62.5 6.0 9.9 23.8 11.0 3.3 4.1 21.5 6.9 8.2 13.9 9.0 6.7 4.3 8.7 9.0 5.8 7.6 6.2 8.7 13.2 19.8 33.6 15.9 2.8 6.7 2.1 17.8 6.5 24.2 13.0 5.2 23.1 6.5 2.8 8.0 0.0 0.0 1.4 0.9 1.9 1.4 0.0 36.4 22.1 1.5 6.9 9.2 1.7 2.7 0.0 0.0 0.9 2.4 15.4 2.1 0.0 0.0 2.9 3.6 0.0 0.3 1.1 0.2 0.0 21.3 0.1 0.0 16.1 0.3 3.3 1.5 7.8 39.2 0.0 2.0 0.1 14.9 0.0 0.0 0.0 0.1 0.4 3.6 0.1 7.3 3.6 22.0 0.0 0.7 0.7 0.7 1.1 2.4 1.6 0.1 0.0 27.6 19.7 0.4 1.4 0.1 0.1 0.0 1.2 3.3 0.7 6.4 0.0 8.0 0.0 0.0 1.5 0.0 23.1 0.0 0.0 1.9 18.4 0.0 0.0 2.8 0.0 1.1 6.5 0.0 1.4 5.3 7.9 1.8 9.4 6.3 7.3 11.0 3.3 9.0 6.7 53.6 24.5 105.7 2.4 7.2 3.7 22.1 43.3 25.4 10.3 43.6 5.9 36.9 192.3 7.0 17.7 4.9 0.0 0.0 10.3 22.3 17.9 2.2 1.1 6.6 10.1 104.9 2.4 5.5 24.7 6.8 15.5 12.9 18.6 0.0 2.5 40.3 7.3 2.9 11.7 165.1 6.2 6.5 14.0 5.2 4.1 5.5 194.7 0.9 3.0 1.7 ARHGAP29 PARG1 ENSG00000137962 "Rho GTPase activating protein 29" Q52LW3 1 94148988-94275068 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Endothelial cells: 271.0;Glandular cells: 419.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 27 "classical monocyte: 1.6;intermediate monocyte: 2.6;non-classical monocyte: 3.7" "Lineage enriched" "Detected in single" 38 "monocytes: 3.7" "Cell line enhanced" "Detected in many" "A-431: 48.5;hTERT-HME1: 43.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026534 Approved Approved "Nucleoplasm,Plasma membrane,Centrosome,Cytosol" NA NA "Nucleoplasm, Centrosome" "Plasma membrane, Cytosol" "HPA026534: AB_1844998" "unprognostic (2.49e-1)" "unprognostic (1.52e-3)" "unprognostic (3.16e-2)" "prognostic unfavorable (6.26e-5)" "unprognostic (8.53e-2)" "unprognostic (2.94e-2)" "unprognostic (1.23e-1)" "unprognostic (1.11e-1)" "unprognostic (8.02e-2)" "unprognostic (2.89e-2)" "prognostic unfavorable (9.63e-4)" "unprognostic (4.42e-1)" "unprognostic (2.36e-2)" "unprognostic (3.81e-3)" "unprognostic (1.94e-1)" "unprognostic (1.13e-1)" "unprognostic (4.61e-3)" 28.1 3.2 7.2 6.8 10.6 0.3 24.4 34.9 11.5 11.9 7.4 2.3 9.0 2.8 10.3 8.1 6.9 8.2 9.1 15.9 7.8 5.2 27.7 21.1 23.0 8.2 6.7 3.6 11.5 6.5 12.8 7.4 22.9 10.0 12.2 4.7 11.7 20.7 10.4 10.3 13.5 5.4 8.0 6.4 26.0 8.8 7.7 7.0 2.2 22.7 8.9 3.8 10.6 14.8 0.0 0.0 0.0 3.7 0.0 0.0 0.3 48.5 2.0 3.0 0.0 10.6 25.2 10.8 16.3 26.5 13.8 20.2 5.8 2.4 0.0 36.7 32.6 15.8 10.4 0.1 11.1 28.5 0.0 1.6 0.2 2.8 2.6 1.0 0.0 0.0 4.9 2.0 10.5 43.7 16.3 37.2 0.0 0.0 0.0 13.7 1.6 0.9 0.0 3.9 0.2 33.4 0.6 2.5 0.0 29.1 4.3 0.0 0.6 10.0 7.8 0.7 12.2 2.3 0.1 33.3 8.4 11.5 12.9 12.5 0.0 0.0 0.0 1.6 0.0 0.4 0.0 1.6 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.3 7.2 10.6 34.9 11.5 7.8 5.2 6.7 3.6 10.0 7.0 47.6 17.3 2.9 135.8 20.8 9.7 19.9 25.5 9.4 33.0 123.9 17.7 21.9 46.4 71.3 49.8 271.0 0.0 0.0 14.7 90.4 34.4 419.1 3.5 51.3 2.6 87.4 0.0 176.8 18.6 16.2 22.7 5.6 25.3 0.0 0.9 95.2 37.1 0.0 20.5 47.5 80.7 187.5 197.8 66.2 123.5 15.1 11.8 4.3 0.4 45.2 ARHGAP33 "FLJ39019, SNX26, TCGAP" ENSG00000004777 "Rho GTPase activating protein 33" O14559 19 35774532-35788822 "Predicted intracellular proteins" "Protein transport, Transport" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 23.6;Cone photoreceptor cells: 23.6;Horizontal cells: 19.1;Rod photoreceptor cells: 29.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HMC-1: 33.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA030117, HPA030118" Supported Approved "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane" "Actin filaments, Cytosol" "HPA030117: AB_10599306, HPA030118: AB_10601238" "unprognostic (1.44e-3)" "unprognostic (3.40e-2)" "unprognostic (1.07e-1)" "unprognostic (3.33e-2)" "unprognostic (2.66e-1)" "unprognostic (2.82e-3)" "unprognostic (3.61e-3)" "unprognostic (4.80e-2)" "unprognostic (1.45e-1)" "unprognostic (2.99e-2)" "unprognostic (2.97e-3)" "unprognostic (2.40e-2)" "prognostic unfavorable (3.09e-8)" "unprognostic (5.70e-2)" "unprognostic (2.66e-1)" "unprognostic (1.38e-1)" "unprognostic (1.19e-2)" 4.8 7.6 17.2 6.6 21.9 27.8 4.0 18.1 27.1 6.0 3.8 22.0 2.8 6.8 8.4 2.9 3.6 6.1 4.9 4.5 14.9 11.7 3.8 2.0 4.7 8.7 18.4 13.8 11.8 7.3 6.2 13.2 3.3 12.7 5.8 2.9 6.8 8.9 6.2 4.7 12.9 6.0 4.0 15.4 7.8 7.2 18.2 17.9 12.2 6.8 2.3 4.2 3.1 5.3 0.1 0.0 0.7 0.0 0.0 0.4 0.0 4.9 3.1 8.9 6.7 0.3 0.9 0.7 4.0 0.5 1.5 1.1 1.3 3.7 2.9 1.5 1.1 1.3 1.3 1.1 1.1 0.6 9.0 2.0 4.2 4.1 1.2 0.4 1.5 33.6 1.3 0.2 1.2 0.4 1.3 0.9 11.6 2.0 12.7 1.3 3.8 10.2 4.1 2.0 1.8 1.4 14.0 1.4 1.4 0.7 0.8 8.9 5.5 1.8 3.3 0.6 1.2 4.7 4.1 1.7 6.4 6.3 3.3 4.7 11.3 2.1 2.9 2.3 4.9 4.0 0.0 0.0 0.3 0.4 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 17.2 21.9 18.1 27.1 14.9 11.7 18.4 13.8 12.7 17.9 0.0 0.6 0.0 0.8 1.4 23.6 1.7 5.1 4.0 4.5 1.8 23.6 0.3 0.0 0.4 8.0 0.8 0.3 0.0 0.6 1.0 1.4 0.6 4.7 0.8 1.0 19.1 3.4 0.0 0.3 6.3 3.7 0.0 0.0 0.0 1.7 10.1 0.6 0.0 2.8 0.0 29.9 0.0 2.3 11.6 5.6 1.5 0.3 4.8 2.5 0.3 ARHGAP36 FLJ30058 ENSG00000147256 "Rho GTPase activating protein 36" Q6ZRI8 X 131058242-131089883 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 58.4;brain: 25.5;pituitary gland: 50.3" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 21 "thyroid cancer: 62.5" "Region enriched" "Detected in many" 5 "hypothalamus: 25.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 164 "SH-SY5Y: 64.4" "Region enhanced" "Detected in many" "hypothalamus: 104.3" "Group enriched" "Detected in many" 5 "basal ganglia: 19.8;hypothalamus: 57.8;midbrain: 27.1;pons and medulla: 20.1" "HPA002064, HPA076209" Enhanced Approved "Nucleoplasm,Vesicles,Plasma membrane" Yes NA Nucleoplasm "Vesicles, Plasma membrane" "HPA002064: AB_1078891, HPA076209: " "unprognostic (2.92e-2)" "unprognostic (7.71e-9)" "unprognostic (2.19e-1)" "unprognostic (8.15e-2)" "unprognostic (1.67e-1)" "unprognostic (1.78e-1)" "unprognostic (2.73e-1)" "unprognostic (1.40e-2)" "unprognostic (1.34e-2)" "unprognostic (2.31e-1)" 6.9 58.4 1.4 0.2 3.6 0.1 1.0 0.0 2.7 0.5 0.2 0.0 0.0 0.1 0.1 2.0 0.3 0.2 0.2 0.1 1.0 25.5 0.1 0.1 0.1 0.1 0.5 0.0 0.1 0.1 0.1 50.3 0.3 5.4 0.3 0.2 0.6 0.2 0.2 13.7 0.1 0.1 0.1 0.8 0.1 0.2 0.6 0.0 0.5 0.5 4.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 64.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 3.6 0.0 0.4 1.0 25.5 0.5 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 ARHGAP9 "10C, MGC1295" ENSG00000123329 "Rho GTPase activating protein 9" Q9BRR9 12 57472255-57488814 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 76.9;bone marrow: 48.1;lymphoid tissue: 50.4" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 56.4;Hofbauer cells: 36.3;Kupffer cells: 39.0;Macrophages: 34.2;T-cells: 110.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "neutrophil: 76.9" "Lineage enriched" "Detected in all" 4 "granulocytes: 76.9" "Cell line enhanced" "Detected in some" "HEL: 11.2;HMC-1: 50.1;THP-1: 14.4;U-937: 11.4" "Low region specificity" "Detected in some" HPA078822 Approved "Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Cell Junctions" "HPA078822: " "unprognostic (1.02e-2)" "unprognostic (4.01e-3)" "unprognostic (1.91e-2)" "prognostic favorable (6.61e-5)" "unprognostic (1.24e-1)" "unprognostic (2.38e-3)" "unprognostic (4.79e-2)" "unprognostic (5.56e-3)" "unprognostic (1.28e-2)" "unprognostic (2.80e-1)" "unprognostic (3.05e-2)" "unprognostic (3.64e-1)" "prognostic unfavorable (7.90e-9)" "unprognostic (1.60e-1)" "unprognostic (6.32e-2)" "unprognostic (9.13e-2)" "unprognostic (6.91e-2)" 5.1 2.5 5.1 33.0 8.0 48.1 4.4 3.7 4.8 1.8 5.4 2.5 0.5 3.6 1.6 1.7 2.7 4.4 4.8 2.4 4.2 1.8 3.5 3.8 11.2 24.1 8.1 0.6 1.2 2.2 0.3 1.5 2.3 5.8 2.5 5.1 2.4 6.0 1.3 0.9 1.4 18.6 2.6 8.5 50.4 3.9 8.8 6.4 19.0 2.6 3.2 28.5 4.7 2.2 8.9 18.9 76.9 17.0 13.1 13.3 11.8 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 5.9 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.3 0.0 11.2 0.0 0.0 0.4 6.5 50.1 0.3 0.0 0.0 0.1 0.0 0.0 5.9 0.2 3.3 0.0 0.0 8.9 8.9 0.4 0.0 0.0 3.7 4.3 1.8 0.0 0.0 1.6 1.4 0.0 0.0 0.1 0.2 0.0 14.4 0.3 0.0 0.1 0.0 0.0 4.0 2.7 5.4 0.1 11.4 0.2 8.4 16.6 45.1 9.0 17.0 6.2 7.1 9.9 8.1 13.9 8.9 13.3 9.6 76.9 13.1 12.8 18.9 12.1 11.8 5.1 8.0 3.7 4.8 4.2 1.8 8.1 0.6 5.8 6.4 0.0 23.5 22.6 0.0 1.3 0.0 1.2 0.0 4.0 2.3 0.0 2.0 0.3 0.0 0.0 56.4 1.8 0.0 0.0 0.0 0.4 1.3 0.2 11.5 1.1 36.3 0.0 0.0 4.3 39.0 28.4 1.7 34.2 0.0 10.0 0.0 0.0 0.2 0.0 0.0 0.3 0.7 0.0 0.5 28.8 8.5 1.3 0.2 110.8 0.1 0.1 ARHGEF12 "KIAA0382, LARG" ENSG00000196914 "Rho guanine nucleotide exchange factor 12" Q9NZN5 11 120336914-120489936 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "GTPase activation, Guanine-nucleotide releasing factor" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.2" "Group enriched" "Detected in many" 5 "granulocytes: 2.2;NK-cells: 1.5;T-cells: 1.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018911, CAB025581" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "CAB025581: , HPA018911: AB_1845003" "unprognostic (1.55e-1)" "unprognostic (1.29e-1)" "unprognostic (6.91e-3)" "unprognostic (1.28e-1)" "unprognostic (7.28e-2)" "unprognostic (5.39e-2)" "unprognostic (1.56e-1)" "unprognostic (5.55e-2)" "unprognostic (4.79e-2)" "unprognostic (7.77e-2)" "unprognostic (4.34e-3)" "unprognostic (4.78e-2)" "prognostic favorable (5.43e-6)" "unprognostic (1.29e-1)" "unprognostic (4.38e-2)" "unprognostic (2.13e-1)" "unprognostic (1.48e-1)" 17.6 19.2 27.6 8.3 32.5 5.9 19.6 40.4 41.5 21.7 16.4 12.4 15.7 14.9 17.5 15.9 17.8 18.6 17.3 23.4 21.8 17.7 41.2 38.8 24.1 6.5 15.8 26.3 16.3 16.9 55.8 17.2 25.4 21.1 16.8 17.8 20.7 16.7 20.0 24.1 29.0 14.8 18.6 10.8 12.4 19.0 6.7 13.0 3.0 31.3 15.0 10.9 19.4 22.9 0.3 0.3 2.2 0.1 1.5 1.0 0.4 13.2 11.1 14.9 14.3 20.2 20.2 6.2 15.6 17.7 9.5 12.1 13.0 9.7 1.1 19.2 27.8 16.8 9.9 19.1 19.7 18.6 10.9 9.4 21.5 12.0 9.9 18.1 0.0 16.0 19.3 14.3 20.8 23.2 21.0 28.7 11.7 18.1 44.1 23.9 9.2 0.0 0.0 4.1 17.1 9.6 4.7 17.1 4.2 23.3 23.0 11.0 13.6 21.8 18.3 5.7 9.3 15.6 1.7 28.4 21.1 9.0 13.7 11.3 13.0 5.2 7.3 8.7 2.8 15.9 2.2 0.0 0.0 1.0 0.1 0.2 0.3 0.6 0.6 0.0 0.3 0.0 0.5 0.0 1.5 0.1 0.3 0.7 0.4 27.6 32.5 40.4 41.5 21.8 17.7 15.8 26.3 21.1 13.0 68.5 79.7 12.3 48.8 80.4 124.2 79.1 58.6 52.2 67.1 92.5 174.7 13.7 29.9 34.0 5.0 74.1 47.9 23.3 43.8 8.3 45.2 80.8 10.5 105.8 6.1 85.8 36.4 81.0 27.2 11.5 27.6 17.4 49.0 10.8 44.1 42.4 44.6 49.0 31.5 60.7 84.8 25.8 70.9 13.5 11.9 74.4 24.0 17.5 34.8 95.3 ARHGEF28 "p190RhoGEF, RGNEF, RIP2" ENSG00000214944 "Rho guanine nucleotide exchange factor 28" Q8N1W1 5 73626158-73941993 "Predicted intracellular proteins" Differentiation "Guanine-nucleotide releasing factor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 43.0" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 46.8;Muller glia cells: 36.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 1.2;memory CD8 T-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTERT-HME1: 38.4;LHCN-M2: 35.3;TIME: 22.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA037602 Enhanced Approved "Plasma membrane,Microtubules,Cytosol" NA NA "Microtubules, Cytosol" "Plasma membrane" "HPA037602: AB_10672282" "unprognostic (1.97e-1)" "prognostic favorable (5.31e-4)" "unprognostic (7.66e-2)" "unprognostic (1.53e-1)" "unprognostic (3.33e-3)" "unprognostic (3.18e-2)" "unprognostic (1.42e-1)" "unprognostic (1.05e-1)" "unprognostic (5.37e-1)" "unprognostic (3.63e-1)" "unprognostic (2.62e-1)" "unprognostic (3.04e-1)" "prognostic favorable (1.91e-6)" "unprognostic (1.07e-1)" "unprognostic (1.55e-2)" "unprognostic (1.62e-2)" "prognostic favorable (8.98e-4)" 3.4 17.7 3.0 2.7 1.4 0.0 7.7 2.3 2.3 9.7 6.7 1.1 8.6 2.3 11.9 9.7 7.1 7.5 12.0 1.5 1.4 1.9 43.0 5.5 5.5 0.3 1.7 3.2 14.5 19.2 0.2 7.0 1.1 2.5 5.1 2.8 4.3 20.0 9.5 0.9 11.1 3.9 2.7 3.3 2.0 14.8 2.0 1.0 4.1 10.5 6.0 6.0 3.4 6.2 0.0 0.0 0.0 0.0 0.6 1.2 0.1 11.1 7.9 0.0 1.0 1.0 1.4 0.0 4.1 8.2 5.2 5.2 2.3 4.8 0.0 8.8 1.4 11.9 3.8 0.5 6.6 7.9 0.1 1.1 0.2 1.2 10.1 8.3 0.0 0.0 1.3 2.7 8.1 38.4 9.8 17.0 0.2 0.0 0.0 35.3 1.0 0.0 0.0 0.1 2.9 3.2 0.0 2.1 1.3 14.2 6.8 0.7 1.5 2.0 0.3 0.2 0.0 1.7 0.0 22.6 2.6 3.5 0.2 3.8 0.4 0.0 0.0 3.9 0.5 1.6 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.9 0.0 0.6 0.0 0.0 0.0 0.1 3.0 1.4 2.3 2.3 1.4 1.9 1.7 3.2 2.5 1.0 26.8 13.1 0.0 12.3 22.9 0.7 1.8 28.1 46.8 12.5 29.6 0.0 0.1 13.3 12.3 2.9 8.5 3.0 0.0 9.6 0.2 1.3 9.3 1.1 6.7 0.3 12.7 10.9 1.8 0.3 1.7 9.5 1.3 1.7 1.0 9.6 36.2 17.9 5.7 5.3 18.3 1.0 6.5 3.8 0.7 0.4 22.3 0.1 0.0 6.9 14.9 ARID4A "RBBP1, RBP-1, RBP1" ENSG00000032219 "AT-rich interaction domain 4A" P29374 14 58298385-58373887 "Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048899 Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA048899: " "unprognostic (1.57e-1)" "unprognostic (9.39e-2)" "unprognostic (5.17e-2)" "unprognostic (2.69e-1)" "unprognostic (3.70e-2)" "prognostic favorable (1.91e-4)" "unprognostic (2.71e-1)" "prognostic favorable (7.82e-4)" "unprognostic (2.08e-2)" "unprognostic (6.92e-2)" "unprognostic (3.27e-1)" "unprognostic (3.72e-2)" "unprognostic (9.32e-2)" "unprognostic (2.32e-1)" "unprognostic (2.64e-1)" "unprognostic (4.11e-2)" "unprognostic (3.52e-2)" 15.1 8.5 17.3 15.1 22.2 34.5 13.4 45.9 27.0 12.8 12.0 7.9 12.7 10.2 11.6 9.7 10.1 10.7 10.7 10.0 13.3 11.5 11.3 21.7 12.0 15.8 9.6 18.7 15.3 11.4 17.2 22.9 11.3 17.3 10.8 10.6 6.4 10.8 13.5 10.6 13.2 12.3 12.5 11.0 15.3 10.2 7.9 15.0 15.0 12.6 4.5 12.8 13.8 11.9 15.1 7.5 42.7 14.1 10.7 11.1 3.6 6.7 5.7 16.0 7.9 7.9 9.6 8.1 8.1 6.9 5.5 8.7 6.7 10.7 16.3 8.6 6.8 5.3 7.8 7.0 3.9 8.1 11.4 4.5 7.4 6.4 6.4 4.8 15.5 10.7 7.2 4.3 5.3 5.5 8.8 8.7 9.5 8.3 13.5 5.8 9.1 11.2 14.0 3.1 6.6 6.9 11.6 13.8 4.8 5.9 12.0 13.8 11.9 13.7 6.9 9.6 8.2 11.8 14.3 12.3 9.4 7.4 7.5 3.7 4.4 3.3 15.0 5.6 9.9 4.7 19.3 7.6 21.7 8.5 7.8 9.5 11.6 10.3 8.8 5.6 15.1 11.1 10.8 42.7 10.7 14.1 7.5 7.2 3.6 17.3 22.2 45.9 27.0 13.3 11.5 9.6 18.7 17.3 15.0 77.4 85.3 20.4 20.9 34.1 91.9 45.6 15.3 8.1 40.9 26.2 49.1 16.0 16.6 19.0 13.5 41.6 29.5 23.3 19.0 18.3 27.2 20.2 63.6 37.6 29.9 106.5 21.9 33.2 40.4 5.3 33.6 50.9 25.3 68.5 30.9 64.2 20.9 36.8 33.9 11.9 63.2 19.4 25.5 37.6 24.7 29.2 17.0 54.9 29.8 15.5 ARID5B "FLJ21150, MRF2" ENSG00000150347 "AT-rich interaction domain 5B" Q14865 10 61901300-62096944 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 88.6" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 860.1;Smooth muscle cells: 627.3;Syncytiotrophoblasts: 769.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 45.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015037 Uncertain Approved "Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol" NA NA "Endoplasmic reticulum" "Nucleoplasm, Plasma membrane, Cytosol" "HPA015037: AB_1845015" "unprognostic (3.31e-1)" "unprognostic (1.99e-2)" "unprognostic (2.94e-2)" "unprognostic (1.86e-1)" "unprognostic (1.17e-1)" "unprognostic (5.60e-2)" "unprognostic (1.50e-2)" "unprognostic (4.90e-2)" "unprognostic (3.90e-1)" "unprognostic (6.03e-2)" "unprognostic (1.97e-1)" "unprognostic (5.75e-1)" "unprognostic (1.20e-2)" "unprognostic (1.15e-1)" "unprognostic (2.58e-1)" "unprognostic (1.94e-1)" "unprognostic (3.93e-2)" 43.3 5.6 7.8 13.8 9.9 4.2 22.6 3.3 11.5 27.5 14.0 9.5 4.4 6.8 29.4 10.4 14.0 15.6 27.2 16.0 5.9 5.1 14.6 5.7 14.6 14.4 11.8 6.5 18.6 4.3 14.7 11.4 22.4 9.4 16.6 8.2 6.9 14.5 7.3 88.6 15.0 12.1 29.4 10.4 12.7 9.4 7.7 10.5 8.6 7.5 11.7 18.0 22.5 17.1 21.2 1.0 4.3 3.6 5.7 14.7 2.6 0.8 0.3 2.3 5.9 5.2 14.0 0.4 16.9 45.7 12.1 9.5 20.5 0.9 1.4 4.1 16.2 1.7 5.6 8.1 2.5 14.6 5.3 2.4 0.8 4.1 5.1 9.7 0.2 10.1 17.6 1.3 7.1 8.1 10.4 1.4 2.9 0.7 2.3 3.9 2.9 5.5 0.4 0.4 3.9 5.4 6.7 3.9 0.4 7.9 9.2 1.3 1.7 7.5 4.1 4.9 5.5 3.5 0.2 1.3 6.7 9.1 10.1 4.2 0.1 0.0 4.4 5.8 0.3 2.1 4.3 0.6 0.4 7.3 1.4 0.9 19.0 10.5 6.3 1.0 21.2 6.9 4.5 1.2 5.7 3.6 0.5 14.7 2.6 7.8 9.9 3.3 11.5 5.9 5.1 11.8 6.5 9.4 10.5 122.1 57.7 77.2 286.1 860.1 43.7 59.7 12.7 50.9 120.6 48.8 0.0 138.5 84.6 43.9 23.9 62.4 4.7 23.3 12.8 104.6 292.5 224.3 23.2 5.1 46.6 69.9 34.9 106.8 33.2 10.0 140.4 39.6 131.6 60.5 13.2 19.3 30.6 20.9 57.0 145.5 2.8 129.4 627.3 5.7 0.5 417.5 769.7 77.6 30.2 122.9 ARL13A ARL13 ENSG00000174225 "ADP ribosylation factor like GTPase 13A" Q5H913 X 100969708-100990829 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "testis: 16.6" "Group enriched" "Detected in some" 23 "Early spermatids: 58.2;Late spermatids: 44.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 6.7" "HPA037377, HPA037378" Uncertain Approved "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane" "Actin filaments, Cytosol" "HPA037377: AB_2675442, HPA037378: AB_10670932" "unprognostic (4.40e-2)" "unprognostic (1.05e-1)" "unprognostic (1.02e-1)" "unprognostic (1.08e-2)" "unprognostic (1.93e-1)" "unprognostic (9.06e-3)" "unprognostic (2.58e-1)" "unprognostic (3.95e-2)" "unprognostic (1.82e-1)" "unprognostic (1.06e-1)" "unprognostic (1.18e-1)" "unprognostic (1.51e-2)" "unprognostic (4.50e-3)" "unprognostic (1.46e-1)" "unprognostic (2.46e-1)" "unprognostic (9.37e-4)" "unprognostic (2.14e-1)" 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.7 0.1 0.1 0.6 0.0 0.5 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 1.2 0.4 0.1 0.1 0.2 0.3 16.6 0.1 0.1 0.7 0.1 0.1 0.1 0.1 0.8 0.2 0.0 0.4 0.1 0.5 0.0 1.1 1.9 0.1 0.6 0.0 0.0 0.5 0.3 0.1 0.0 0.0 6.7 0.7 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.4 1.2 1.1 0.7 0.0 1.7 0.1 0.0 0.0 0.0 0.4 0.4 0.3 0.9 0.3 0.0 0.1 0.7 0.0 0.2 0.0 0.4 1.6 0.0 0.1 0.7 0.0 0.4 0.0 0.1 1.2 0.3 0.1 0.0 0.3 2.0 0.6 0.3 0.0 0.0 0.3 0.2 0.2 1.3 0.3 0.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.5 0.1 0.0 0.1 0.4 0.2 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.5 0.6 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.3 1.5 0.0 0.0 0.0 0.0 0.0 ARL15 "ARFRP2, FLJ20051" ENSG00000185305 "ADP ribosylation factor like GTPase 15" Q9NXU5 5 53883945-54310582 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 46.4;Syncytiotrophoblasts: 35.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044604, HPA063820" Uncertain Approved "Golgi apparatus,Plasma membrane,Cell Junctions" NA NA "Golgi apparatus" "Plasma membrane, Cell Junctions" "HPA044604: AB_10960542, HPA063820: AB_2685131" "unprognostic (2.18e-1)" "unprognostic (4.32e-2)" "unprognostic (1.82e-2)" "unprognostic (2.41e-2)" "unprognostic (1.08e-1)" "unprognostic (3.70e-1)" "unprognostic (8.52e-3)" "unprognostic (1.16e-2)" "unprognostic (3.05e-2)" "unprognostic (6.56e-2)" "unprognostic (4.26e-3)" "unprognostic (3.86e-1)" "unprognostic (2.48e-3)" "unprognostic (1.35e-1)" "unprognostic (9.15e-2)" "unprognostic (5.60e-2)" "unprognostic (1.08e-1)" 22.0 19.9 13.4 13.1 10.5 2.2 20.1 15.7 22.4 29.9 15.6 5.9 8.7 13.9 32.2 9.9 13.2 12.7 20.5 20.1 19.7 13.2 23.9 12.8 14.4 13.9 11.3 11.2 9.8 7.8 3.5 28.0 31.4 12.3 14.3 15.4 15.3 19.6 12.1 5.2 16.9 12.7 26.7 15.1 15.2 11.1 14.2 10.5 17.4 13.4 13.9 10.8 19.1 13.6 2.0 5.0 7.4 3.5 1.4 4.8 2.3 1.9 3.9 6.0 10.1 6.0 5.3 7.5 6.3 9.5 6.3 13.5 14.9 4.9 17.4 10.3 6.1 7.1 4.8 9.0 10.3 8.9 2.3 9.4 24.0 5.5 1.3 1.5 2.3 28.1 7.5 7.1 10.4 7.2 10.1 15.2 4.5 21.5 2.8 4.1 4.2 4.4 2.2 2.0 0.8 2.5 4.0 6.4 0.4 8.9 21.0 7.6 3.9 8.0 4.4 5.0 12.1 4.8 2.9 7.7 3.9 6.1 2.9 4.5 1.1 1.1 19.9 6.0 6.4 6.4 2.7 3.5 4.6 2.9 3.2 1.7 2.0 2.0 2.1 5.0 1.6 2.1 1.7 7.4 1.4 2.3 0.7 4.8 2.3 13.4 10.5 15.7 22.4 19.7 13.2 11.3 11.2 12.3 10.5 3.0 7.7 0.9 6.9 8.7 5.0 6.3 7.6 4.0 3.4 12.2 13.7 46.4 18.3 2.8 1.8 27.5 4.9 0.0 4.2 2.6 5.0 4.8 2.3 4.0 7.5 1.6 20.1 17.8 7.6 1.1 4.0 7.4 1.7 0.0 6.7 2.8 5.6 8.2 3.5 5.7 2.8 6.5 3.5 0.7 2.8 8.8 35.7 4.3 6.6 6.0 ARMC12 "C6orf81, FLJ25390" ENSG00000157343 "Armadillo repeat containing 12" Q5T9G4 6 35737032-35749079 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 60.2" "Group enriched" "Detected in some" 65 "Early spermatids: 374.1;Late spermatids: 785.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 3.2;plasmacytoid DC: 2.9" "Group enriched" "Detected in many" 11 "dendritic cells: 2.9;monocytes: 1.0;T-cells: 3.2" "Cell line enhanced" "Detected in many" "ASC diff: 7.3;HSkMC: 9.7;MOLT-4: 6.6;U-698: 7.2" "Not detected" "Not detected" "HPA030895, HPA075457, HPA075777" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA030895: AB_10602114, HPA075457: , HPA075777: " "unprognostic (1.94e-4)" "unprognostic (2.21e-1)" "unprognostic (3.24e-1)" "unprognostic (1.32e-2)" "unprognostic (2.34e-1)" "unprognostic (1.19e-1)" "unprognostic (2.52e-1)" "unprognostic (2.12e-1)" "unprognostic (4.48e-1)" "unprognostic (3.52e-2)" "unprognostic (6.36e-4)" "unprognostic (8.99e-2)" "unprognostic (1.17e-12)" "unprognostic (6.53e-2)" "unprognostic (1.82e-1)" "unprognostic (1.49e-1)" "unprognostic (2.09e-1)" 0.5 0.4 0.9 0.5 1.2 0.7 0.7 0.5 0.9 0.6 0.5 0.5 0.5 0.0 0.5 5.8 0.5 0.6 0.8 0.5 0.7 0.9 0.5 1.4 0.5 1.1 0.7 0.5 1.0 0.5 0.1 4.8 0.5 0.5 1.1 0.3 0.6 0.5 1.0 0.5 0.5 0.5 0.6 0.5 0.8 0.1 60.2 0.5 0.5 0.7 0.5 0.6 0.5 0.5 0.1 2.9 0.0 1.0 0.2 3.2 0.4 0.0 0.5 3.2 3.8 7.3 3.4 0.0 0.1 0.2 0.3 0.4 0.1 0.2 0.7 0.1 0.1 1.1 0.1 1.1 0.2 0.2 1.6 0.9 0.4 0.1 0.1 3.8 0.0 0.0 9.7 2.3 0.1 1.3 3.7 0.7 2.8 0.1 4.5 1.1 0.4 6.6 0.8 0.5 0.0 0.2 3.0 0.0 0.0 0.8 0.0 0.9 3.2 0.0 0.0 0.5 1.5 2.0 0.3 0.0 0.6 0.3 0.1 0.0 1.0 0.3 7.2 0.3 4.0 0.3 0.0 1.0 0.0 0.1 0.0 1.2 0.0 1.2 0.5 0.7 0.1 0.7 3.2 0.0 0.2 0.1 2.9 0.0 0.4 0.9 1.2 0.5 0.6 0.7 0.9 0.7 0.5 0.5 0.5 0.0 0.0 0.0 1.7 0.8 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 374.1 0.6 0.0 0.0 0.0 0.0 0.4 0.5 0.0 2.4 0.0 0.0 0.0 0.0 1.6 785.6 7.8 0.0 0.0 0.0 0.1 0.8 0.0 0.0 3.9 0.1 0.1 0.0 0.5 8.9 5.4 0.1 0.0 0.0 0.0 0.3 ARMCX5 "FLJ12969, GASP5" ENSG00000125962 "Armadillo repeat containing, X-linked 5" Q6P1M9 X 102599168-102604159 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RH-30: 42.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000996 Approved Approved "Nuclear speckles,Plasma membrane,Cytosol" NA NA "Nuclear speckles, Cytosol" "Plasma membrane" "HPA000996: AB_1078212" "unprognostic (7.71e-2)" "unprognostic (2.43e-2)" "unprognostic (1.20e-1)" "unprognostic (3.50e-2)" "unprognostic (1.54e-1)" "unprognostic (5.05e-2)" "unprognostic (4.07e-2)" "prognostic favorable (6.58e-5)" "unprognostic (1.12e-1)" "unprognostic (2.76e-2)" "unprognostic (2.83e-1)" "unprognostic (3.28e-3)" "unprognostic (1.17e-1)" "unprognostic (2.40e-1)" "unprognostic (1.17e-2)" "unprognostic (2.83e-1)" "unprognostic (5.24e-2)" 8.6 13.2 11.4 7.0 17.3 6.4 13.8 24.3 19.8 11.2 9.5 8.7 13.1 7.9 13.3 12.5 10.1 11.9 7.5 7.8 11.1 6.3 10.0 15.5 8.3 6.9 8.1 12.9 16.5 25.3 14.5 26.4 6.1 12.8 16.6 11.9 9.2 13.4 11.0 6.1 9.9 10.4 10.8 7.0 10.2 11.7 6.1 8.4 9.5 15.3 7.0 9.6 10.4 9.8 9.7 9.3 2.5 9.8 7.1 15.9 8.5 8.1 7.3 17.4 9.2 7.8 8.8 9.8 8.0 6.2 9.4 16.7 8.7 10.1 0.0 9.8 8.0 10.7 7.1 15.5 7.6 10.7 0.0 6.2 8.2 9.3 7.2 10.1 14.9 9.6 10.9 9.9 8.1 9.8 7.6 9.5 0.0 7.9 0.0 12.4 7.2 10.5 1.8 7.8 14.0 14.0 10.4 42.6 0.0 7.0 11.3 8.3 7.4 14.3 7.5 11.4 5.2 5.1 7.2 9.6 7.0 6.2 7.9 5.7 0.0 5.8 0.0 5.5 15.2 17.9 0.0 9.5 2.5 12.0 9.8 11.5 9.7 11.3 9.4 9.3 6.0 15.9 12.3 0.8 7.1 6.0 8.1 7.7 8.5 11.4 17.3 24.3 19.8 11.1 6.3 8.1 12.9 12.8 8.4 6.0 5.8 4.7 10.7 4.9 16.0 3.5 5.1 17.4 9.1 8.7 19.6 4.9 18.3 7.9 0.2 7.2 7.4 0.0 8.5 3.0 5.2 9.0 1.1 8.3 5.4 1.6 9.2 6.2 7.3 0.0 7.8 6.7 8.5 1.8 11.4 6.2 7.8 2.9 5.6 9.1 19.3 0.0 6.2 1.7 6.1 5.0 3.1 6.2 8.6 9.4 ARPC5 "ARC16, dJ127C7.3, p16-Arc" ENSG00000162704 "Actin related protein 2/3 complex subunit 5" O15511 1 183620846-183635757 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 154.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022013, HPA031972" Approved Approved "Vesicles,Plasma membrane,Cell Junctions,Cytosol" NA NA 15000000 "Vesicles, Plasma membrane, Cell Junctions, Cytosol" "HPA022013: AB_1845045, HPA031972: " "unprognostic (3.82e-1)" "unprognostic (8.78e-2)" "unprognostic (1.43e-1)" "unprognostic (2.36e-2)" "unprognostic (1.74e-1)" "unprognostic (1.85e-2)" "prognostic unfavorable (3.63e-4)" "unprognostic (5.90e-3)" "unprognostic (3.84e-2)" "unprognostic (3.17e-3)" "unprognostic (1.14e-1)" "unprognostic (1.29e-1)" "prognostic unfavorable (1.21e-10)" "unprognostic (3.03e-2)" "unprognostic (4.66e-2)" "unprognostic (1.49e-2)" "unprognostic (2.48e-1)" 46.6 25.1 24.9 57.5 24.3 25.2 28.9 13.8 24.8 26.6 42.3 26.5 18.6 40.8 39.0 26.7 44.5 29.3 24.6 36.8 28.2 22.3 28.8 29.7 52.3 58.3 28.4 18.7 27.3 21.5 12.4 18.2 84.8 20.0 23.2 29.2 17.0 25.4 16.5 16.4 25.2 47.3 32.8 46.0 79.9 35.6 21.7 23.5 61.2 27.5 22.7 52.8 30.6 30.8 27.4 68.9 154.0 96.6 30.7 40.7 124.3 51.8 28.8 24.8 17.0 20.5 29.3 59.3 71.3 55.0 31.1 25.4 26.0 36.8 47.7 81.2 41.0 20.1 36.1 17.4 24.3 16.5 68.7 15.6 28.8 39.2 22.4 33.4 41.8 56.3 35.4 25.9 37.6 29.9 35.7 36.4 33.8 21.9 39.6 40.2 21.3 39.0 11.3 23.6 40.3 11.1 36.3 22.0 46.0 17.4 26.9 10.8 28.9 74.3 32.1 27.6 27.1 32.2 37.4 81.1 45.4 23.6 50.8 68.6 47.2 52.1 32.7 35.8 30.2 34.9 79.3 80.0 124.1 34.8 89.8 27.7 27.4 34.2 35.5 68.9 24.4 37.1 37.6 154.0 30.7 96.6 32.5 40.7 124.3 24.9 24.3 13.8 21.1 28.2 22.3 28.4 18.7 20.0 23.5 348.4 174.9 170.6 139.1 221.2 29.2 25.0 142.7 81.7 120.6 78.5 13.7 419.1 140.9 316.3 26.2 168.2 202.4 0.0 245.8 625.6 206.8 137.2 247.7 72.7 547.8 36.5 193.8 182.3 533.2 18.6 116.5 649.2 241.3 607.8 124.2 50.0 287.4 192.9 172.5 110.5 24.5 239.3 277.9 83.0 95.6 214.0 166.8 309.6 117.5 206.4 ASAP1 "CENTB4, DDEF1, KIAA1249, PAP, ZG14P" ENSG00000153317 "ArfGAP with SH3 domain, ankyrin repeat and PH domain 1" Q9ULH1 8 130052104-130443660 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 9 "Early spermatids: 156.9;Late spermatids: 319.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 13.0" "Group enriched" "Detected in many" 5 "dendritic cells: 4.1;granulocytes: 13.0;monocytes: 6.6" "Cell line enhanced" "Detected in all" "TIME: 62.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011136, CAB037292, HPA048565" Approved Approved "Plasma membrane,Centrosome,Cytosol" NA NA 25000 "Plasma membrane, Centrosome, Cytosol" "CAB037292: AB_476723, HPA011136: AB_2668438, HPA048565: AB_2680445" "unprognostic (1.20e-2)" "unprognostic (1.15e-2)" "unprognostic (7.68e-2)" "prognostic unfavorable (5.81e-5)" "unprognostic (1.77e-1)" "unprognostic (3.33e-2)" "prognostic unfavorable (5.63e-8)" "prognostic unfavorable (3.56e-5)" "unprognostic (3.34e-1)" "unprognostic (5.27e-2)" "unprognostic (8.56e-3)" "unprognostic (1.10e-1)" "prognostic unfavorable (1.50e-7)" "unprognostic (3.79e-2)" "unprognostic (1.19e-1)" "unprognostic (7.38e-2)" "unprognostic (1.22e-3)" 34.1 17.2 10.5 9.5 12.5 29.7 19.8 6.4 21.8 19.3 8.9 9.1 6.6 4.4 15.6 18.9 10.5 11.8 14.5 17.5 10.0 11.0 7.9 7.6 26.2 12.9 11.3 8.0 15.2 6.8 21.7 8.2 27.3 15.2 9.9 7.2 13.9 6.2 13.9 13.0 12.1 8.4 16.6 11.9 26.1 8.0 21.7 9.7 5.6 12.3 10.6 14.5 12.9 21.2 1.5 4.1 13.0 6.6 0.7 1.6 1.1 15.5 11.7 17.1 9.6 14.9 22.1 13.7 16.7 29.1 20.4 21.8 5.9 5.9 3.6 11.9 24.2 13.6 3.9 8.7 14.6 28.6 5.6 5.3 6.2 6.9 7.6 38.2 2.7 1.9 20.7 4.8 10.8 18.0 22.1 21.4 2.1 3.2 14.4 17.8 4.6 3.5 2.7 4.3 7.7 10.6 5.0 3.0 2.4 5.2 8.4 4.9 15.9 12.3 7.5 8.8 15.0 6.3 6.1 62.6 16.4 7.9 6.4 24.5 13.2 3.0 2.5 12.1 3.9 18.2 0.0 2.4 1.6 0.7 2.4 0.4 1.5 1.2 1.0 4.1 1.3 1.6 1.0 13.0 0.7 6.6 0.4 0.8 1.1 10.5 12.5 6.4 14.6 10.0 11.0 11.3 8.0 15.2 9.7 3.0 7.5 14.3 18.6 42.4 18.5 31.3 12.7 2.7 13.6 3.5 15.7 35.8 3.3 9.1 156.9 106.7 3.5 23.3 7.5 32.0 42.0 21.7 9.2 7.4 54.2 58.8 12.6 90.9 55.3 319.2 36.2 54.3 42.2 55.9 3.9 9.5 9.1 3.5 51.6 3.4 7.2 77.6 58.7 29.0 94.8 39.3 39.0 12.9 3.5 17.4 ASB5 ENSG00000164122 "Ankyrin repeat and SOCS box containing 5" Q8WWX0 4 176213673-176277571 "Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "skeletal muscle: 133.4" "Cell type enriched" "Detected in some" 5 "Late spermatids: 229.8" "Cancer enhanced" "Detected in some" "prostate cancer: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 16 "LHCN-M2: 165.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA028870 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA028870: AB_10611679" "unprognostic (1.76e-1)" "prognostic unfavorable (5.67e-4)" "unprognostic (1.90e-1)" "unprognostic (7.38e-2)" "unprognostic (1.32e-1)" "unprognostic (1.06e-2)" "unprognostic (4.28e-2)" "unprognostic (1.65e-1)" "unprognostic (6.80e-3)" 2.3 0.0 0.3 0.3 0.2 0.0 0.0 0.2 0.2 0.3 3.5 0.0 0.0 0.1 0.2 6.3 7.9 0.0 0.4 1.3 0.2 0.2 0.3 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.0 9.6 1.3 0.0 8.0 0.1 133.4 0.0 0.5 23.5 1.0 0.0 2.0 2.2 0.0 0.0 2.3 31.4 2.2 15.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.0 0.0 3.6 7.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 165.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.2 0.2 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 229.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.9 0.7 0.0 0.0 0.0 0.0 0.0 ASIC4 "ACCN4, BNAC4" ENSG00000072182 "Acid sensing ion channel subunit family member 4" Q96FT7 2 219514170-219538772 "Predicted membrane proteins" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 17.7;pituitary gland: 20.6" "Group enriched" "Detected in some" 10 "Bipolar cells: 200.8;Cone photoreceptor cells: 163.0" "Cancer enriched" "Detected in single" 38 "glioma: 8.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 30 "HEL: 19.1;HMC-1: 5.8;K-562: 10.9;SH-SY5Y: 5.2" "Region enhanced" "Detected in many" "basal ganglia: 65.5" "Low region specificity" "Detected in many" "HPA036042, HPA057078" Approved "Nucleoplasm,Golgi apparatus,Plasma membrane,Centriolar satellite" NA NA "Golgi apparatus, Centriolar satellite" "Nucleoplasm, Plasma membrane" "HPA036042: AB_10672998, HPA057078: " "unprognostic (3.48e-1)" "unprognostic (1.44e-1)" "unprognostic (2.55e-1)" "unprognostic (1.61e-2)" "unprognostic (2.62e-1)" "unprognostic (8.74e-2)" "unprognostic (3.04e-2)" "unprognostic (2.54e-1)" "unprognostic (6.53e-2)" "unprognostic (1.90e-2)" "unprognostic (9.46e-3)" "unprognostic (1.88e-1)" "unprognostic (7.80e-8)" "unprognostic (3.82e-2)" "unprognostic (2.30e-1)" "unprognostic (5.51e-1)" "unprognostic (2.48e-2)" 0.8 3.3 4.9 0.6 4.7 0.5 0.6 6.9 17.7 1.0 0.5 1.6 0.0 0.5 0.8 0.6 0.5 0.6 0.6 0.6 3.9 4.5 0.5 0.6 0.9 0.6 4.8 2.9 0.5 0.5 0.5 20.6 0.6 3.0 0.6 0.5 4.9 0.6 0.8 0.5 0.6 0.5 0.7 1.9 0.6 0.7 1.6 3.1 0.0 0.5 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.2 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 4.7 6.9 4.9 3.9 4.5 4.8 2.9 3.0 3.1 0.0 0.0 0.0 1.6 0.1 200.8 0.8 0.0 0.0 0.0 0.0 163.0 1.8 0.0 0.0 2.8 0.1 0.3 0.0 0.3 0.7 0.7 0.5 18.4 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 8.4 0.0 2.9 0.4 0.0 9.5 0.0 0.4 0.2 0.6 0.3 2.4 0.0 0.4 0.3 ASPM "ASP, Calmbp1, FLJ10517, FLJ10549, MCPH5" ENSG00000066279 "Abnormal spindle microtubule assembly" Q8IZT6 1 197084128-197146694 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Calmodulin-binding "Cancer-related genes, Disease mutation, Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 62.8" "Cell type enhanced" "Detected in many" 16 "Erythroid cells: 70.0;Spermatocytes: 32.6;Spermatogonia: 30.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "plasmacytoid DC: 1.5;T-reg: 2.4" "Group enriched" "Detected in many" 5 "dendritic cells: 1.5;T-cells: 2.4" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" CAB017816 Approved "Plasma membrane,Cytosol" NA Yes "Plasma membrane, Cytosol" "CAB017816: " "unprognostic (3.24e-1)" "unprognostic (1.56e-1)" "unprognostic (2.81e-2)" "prognostic unfavorable (1.97e-4)" "unprognostic (3.67e-1)" "unprognostic (3.47e-2)" "prognostic unfavorable (1.25e-4)" "prognostic unfavorable (2.41e-4)" "unprognostic (4.67e-3)" "unprognostic (9.29e-2)" "prognostic unfavorable (2.40e-4)" "unprognostic (1.03e-1)" "unprognostic (0.00e+0)" "unprognostic (7.31e-3)" "unprognostic (1.23e-1)" "unprognostic (4.94e-2)" "unprognostic (3.66e-2)" 0.7 0.7 0.2 12.4 0.4 13.8 1.5 0.2 0.4 1.2 2.8 0.2 0.2 2.8 0.3 1.5 8.7 0.2 0.4 0.6 0.2 0.2 0.5 1.3 1.9 7.0 0.3 0.2 0.5 0.3 0.0 0.2 1.8 0.5 0.4 2.8 0.3 1.5 0.2 0.5 4.6 3.1 0.8 0.5 4.3 1.7 6.3 0.2 62.8 0.3 5.0 6.9 1.2 2.3 0.0 1.5 0.0 0.0 0.3 2.4 0.0 20.1 11.3 18.3 11.2 1.1 2.5 6.9 16.1 11.3 16.0 12.7 7.8 15.7 20.5 5.7 12.6 7.0 20.3 15.7 6.4 20.0 18.5 11.9 14.4 26.5 7.5 0.2 21.5 10.3 0.2 0.6 12.8 9.0 4.1 16.8 16.6 18.0 24.4 16.4 7.9 17.2 10.0 8.3 16.2 3.1 13.2 25.2 15.1 5.8 5.5 9.6 13.7 22.9 11.8 5.1 11.8 13.2 8.9 12.8 9.9 9.7 17.0 29.2 7.0 9.5 11.9 7.8 5.9 20.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.5 2.4 0.0 0.2 0.4 0.2 0.4 0.2 0.2 0.3 0.2 0.5 0.2 0.0 0.6 3.7 0.6 5.5 0.0 1.0 0.0 0.0 1.2 1.8 0.0 6.4 0.0 0.3 2.9 0.3 0.3 70.0 0.0 13.2 1.3 0.7 1.1 1.0 9.3 0.0 0.0 1.8 4.0 3.3 0.6 3.1 0.0 1.0 1.5 0.5 0.4 0.0 1.4 0.0 0.3 0.0 0.0 32.6 30.2 3.0 3.1 4.9 4.9 1.7 ATG13 KIAA0652 ENSG00000175224 "Autophagy related 13" O75143 11 46617527-46674818 "Cancer-related genes, Predicted intracellular proteins, Transporters" Autophagy "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039350 Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA039350: AB_10673142" "unprognostic (3.66e-1)" "unprognostic (1.14e-1)" "unprognostic (1.51e-1)" "unprognostic (1.65e-1)" "unprognostic (5.36e-2)" "unprognostic (2.31e-1)" "prognostic unfavorable (8.59e-5)" "unprognostic (1.05e-1)" "unprognostic (1.10e-1)" "unprognostic (1.27e-1)" "unprognostic (1.35e-1)" "unprognostic (7.57e-2)" "unprognostic (2.44e-2)" "unprognostic (2.41e-1)" "unprognostic (2.14e-1)" "unprognostic (7.68e-2)" "unprognostic (3.47e-1)" 13.8 15.8 20.2 11.9 27.3 25.8 12.5 32.8 37.0 13.2 12.6 39.5 9.2 14.3 12.9 16.8 14.9 16.6 14.5 17.8 19.5 16.3 14.3 21.1 11.5 13.6 31.8 18.2 15.6 19.7 24.4 23.1 13.5 27.2 12.8 12.0 21.3 17.0 13.5 20.9 16.3 12.4 12.3 15.7 16.2 16.5 60.6 34.9 14.8 18.6 8.8 15.8 12.5 13.0 15.8 20.0 38.9 24.0 17.0 24.7 20.3 13.8 25.5 19.6 11.5 27.3 32.1 19.8 16.2 28.7 20.0 25.7 17.3 13.9 13.0 11.5 24.4 26.0 17.0 18.8 21.9 20.3 24.6 35.9 14.0 17.8 30.4 30.7 18.6 24.3 38.6 26.2 13.8 30.5 28.6 19.7 30.4 24.4 29.8 17.9 20.8 18.5 27.6 24.5 25.5 22.1 17.7 25.4 22.8 13.4 15.3 18.7 18.8 22.4 18.0 23.9 19.7 25.7 38.5 19.4 24.7 15.1 22.7 17.6 27.2 30.1 16.5 30.6 16.9 18.1 21.2 20.7 26.9 21.3 24.0 17.2 15.8 19.2 16.8 20.0 12.7 16.6 18.3 38.9 17.0 18.7 14.9 24.7 20.3 20.2 27.3 32.8 37.0 19.5 16.3 31.8 18.2 27.2 34.9 14.9 15.2 10.4 10.0 8.2 22.0 12.4 5.1 2.7 10.3 12.2 37.3 8.7 6.6 16.3 35.8 11.7 19.0 46.7 28.1 18.9 8.4 17.1 8.1 19.4 13.5 31.8 17.2 12.9 15.2 36.4 10.6 13.5 11.8 22.6 19.5 15.2 26.0 12.2 10.6 11.2 29.7 12.9 13.7 31.1 10.4 10.0 22.1 10.9 10.4 14.3 ATG7 "APG7L, DKFZp434N0735, GSA7" ENSG00000197548 "Autophagy related 7" O95352 3 11272309-11557665 "Predicted intracellular proteins, Transporters" "Autophagy, Biological rhythms, Protein transport, Transport, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 78.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 13.1;classical monocyte: 39.7;eosinophil: 24.5;intermediate monocyte: 22.9;myeloid DC: 23.8;neutrophil: 31.3;non-classical monocyte: 16.3" "Group enriched" "Detected in all" 5 "dendritic cells: 23.8;granulocytes: 31.3;monocytes: 39.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007639, CAB018771" Supported Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 13000 Cytosol "Nucleoplasm, Plasma membrane" "CAB018771: AB_2062165, HPA007639: AB_1845162" "unprognostic (3.97e-2)" "unprognostic (2.83e-2)" "prognostic favorable (9.66e-4)" "unprognostic (1.18e-2)" "unprognostic (2.79e-1)" "unprognostic (5.19e-2)" "prognostic unfavorable (1.41e-4)" "unprognostic (1.82e-1)" "unprognostic (2.40e-1)" "unprognostic (1.80e-3)" "unprognostic (2.30e-2)" "unprognostic (2.67e-1)" "prognostic favorable (9.55e-4)" "unprognostic (1.61e-1)" "unprognostic (3.65e-2)" "unprognostic (1.16e-1)" "unprognostic (1.50e-1)" 27.0 18.6 14.8 21.1 21.9 37.5 16.6 14.1 29.2 16.4 15.2 26.2 13.4 11.6 28.9 15.9 18.9 17.4 15.1 12.3 14.0 13.1 13.1 11.8 18.4 18.8 14.8 17.1 15.5 13.1 18.7 23.0 18.7 21.6 12.9 17.8 19.3 16.6 11.6 15.8 22.2 16.9 18.3 16.6 19.7 13.1 19.7 13.9 17.7 12.7 12.2 21.6 16.5 15.2 4.0 23.8 31.3 39.7 5.9 4.8 14.2 18.4 14.6 6.5 3.4 11.5 15.2 32.4 17.4 22.7 17.4 20.3 6.2 16.8 8.5 10.6 15.4 18.1 5.7 7.2 24.4 30.0 7.5 9.1 6.1 14.1 7.4 15.2 17.6 20.3 15.6 11.3 33.7 21.2 18.0 24.0 5.4 9.0 7.0 24.1 12.0 5.0 8.2 5.1 8.5 18.9 6.3 7.8 7.5 13.1 13.3 5.8 5.7 12.4 10.5 6.7 8.4 11.4 17.2 16.3 14.3 10.4 9.4 24.3 4.5 11.7 14.3 23.2 16.6 19.3 13.1 39.7 24.5 4.8 22.9 3.7 4.0 4.0 4.5 23.8 3.7 3.5 4.2 31.3 5.9 16.3 4.2 3.4 14.2 14.8 21.9 14.1 29.2 14.0 13.1 14.8 17.1 21.6 13.9 0.0 9.8 6.1 6.1 9.8 11.1 3.9 0.0 12.0 5.7 7.0 17.7 13.7 6.6 10.0 41.0 10.5 6.9 23.3 11.3 14.0 8.9 5.5 14.9 7.8 50.1 19.1 10.9 20.9 20.3 78.6 9.5 19.9 3.3 9.0 7.0 9.3 12.7 7.0 9.2 5.4 12.5 6.5 5.1 19.5 11.5 6.8 16.0 10.0 7.3 7.3 ATIC "AICARFT, IMPCHASE, PURH" ENSG00000138363 "5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase" P31939 2 215311817-215349773 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Purine biosynthesis" "Hydrolase, Multifunctional enzyme, Transferase" "Cancer-related genes, Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 144.4;Extravillous trophoblasts: 132.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013462, HPA021012" Supported Approved "Plasma membrane,Cytosol" NA NA 3400000 Cytosol "Plasma membrane" "CAB013462: , HPA021012: AB_1845169" "unprognostic (1.41e-2)" "unprognostic (2.18e-1)" "unprognostic (1.13e-2)" "unprognostic (8.46e-2)" "unprognostic (2.90e-1)" "unprognostic (3.81e-2)" "prognostic unfavorable (1.99e-7)" "unprognostic (1.86e-2)" "unprognostic (5.07e-2)" "unprognostic (1.83e-1)" "unprognostic (6.31e-3)" "unprognostic (9.21e-2)" "prognostic unfavorable (8.77e-4)" "unprognostic (1.00e-1)" "unprognostic (1.30e-1)" "unprognostic (4.18e-2)" "unprognostic (4.39e-3)" 19.4 27.4 21.1 23.0 28.4 16.9 24.8 12.1 32.3 20.6 26.7 29.1 18.1 23.4 27.9 15.6 19.1 21.9 19.1 18.2 20.3 21.1 23.1 35.6 17.3 36.1 29.7 19.9 23.4 32.9 25.1 21.1 31.1 24.4 21.9 35.9 19.5 14.4 29.4 35.5 17.0 20.6 26.7 21.7 29.0 20.4 15.0 28.0 46.3 16.1 13.5 35.3 27.6 18.0 21.7 13.4 2.9 8.9 19.6 22.8 10.0 20.5 31.1 17.4 29.5 23.4 23.7 8.7 21.0 18.3 24.0 27.6 60.0 32.2 29.9 26.0 21.9 33.8 21.6 38.2 31.7 34.5 22.3 36.9 36.4 26.7 53.7 30.3 45.6 18.7 20.0 24.3 32.1 38.8 16.6 16.0 29.0 47.0 25.0 33.0 30.3 39.7 22.2 66.8 32.9 17.5 36.9 25.0 26.8 25.5 33.2 27.3 18.9 16.9 20.8 23.7 40.4 34.1 16.2 14.1 20.4 21.1 26.3 13.2 31.6 41.2 62.1 17.7 25.4 29.4 2.9 6.0 0.1 13.2 8.9 22.8 21.7 18.6 20.0 13.4 13.2 18.9 17.5 0.7 19.6 7.4 11.7 17.7 10.0 21.1 28.4 12.1 32.3 20.3 21.1 29.7 19.9 24.4 28.0 11.9 17.1 19.3 23.5 13.4 9.6 18.5 25.5 26.8 19.4 22.7 3.9 144.4 23.2 32.2 0.8 6.3 13.5 0.0 42.8 132.7 23.3 16.1 24.3 18.7 46.4 9.5 18.5 4.3 15.0 0.0 22.2 18.7 28.7 32.5 29.9 20.6 30.0 21.0 32.2 44.0 12.8 25.8 19.8 3.2 40.3 7.4 79.8 21.5 52.7 17.4 ATOX1 HAH1 ENSG00000177556 "Antioxidant 1 copper chaperone" O00244 5 151742316-151772532 "Predicted intracellular proteins" "Copper transport, Ion transport, Transport" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Hepatocytes: 744.7;Proximal tubular cells: 898.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055036 Approved "Nucleoplasm,Plasma membrane" NA NA 27000 Nucleoplasm "Plasma membrane" "HPA055036: " "unprognostic (5.55e-2)" "unprognostic (1.60e-1)" "unprognostic (3.84e-1)" "unprognostic (1.82e-1)" "unprognostic (8.11e-2)" "unprognostic (3.34e-2)" "unprognostic (2.33e-1)" "unprognostic (8.60e-2)" "unprognostic (3.58e-2)" "unprognostic (2.53e-2)" "prognostic favorable (9.57e-4)" "unprognostic (2.72e-1)" "unprognostic (7.15e-2)" "unprognostic (8.18e-2)" "unprognostic (2.57e-2)" "unprognostic (1.87e-1)" "unprognostic (2.22e-1)" 27.0 37.2 43.1 25.6 40.4 23.4 39.1 22.8 38.5 29.0 23.9 29.7 32.3 30.2 21.4 37.6 28.4 24.5 33.4 27.7 37.5 45.7 50.5 96.1 21.3 48.9 54.3 37.0 16.2 29.0 31.5 23.0 25.6 35.2 25.7 24.4 25.0 34.7 29.8 12.8 26.3 31.6 28.1 46.5 34.1 21.0 28.7 33.8 24.5 36.3 29.7 44.8 27.2 22.1 22.5 49.9 43.3 54.8 20.1 22.8 24.2 14.1 23.3 13.7 9.5 36.6 30.0 18.1 25.6 29.0 25.8 35.2 31.5 30.6 28.5 31.2 43.8 57.9 13.2 16.6 64.1 21.2 18.3 28.4 12.5 15.1 32.0 34.1 17.2 14.3 38.7 13.5 32.3 21.3 19.1 37.7 17.9 10.3 84.2 39.0 34.7 12.7 38.2 7.8 31.7 48.9 7.8 15.8 44.0 24.7 12.3 18.0 10.6 21.9 62.6 95.4 16.2 30.6 21.1 42.2 26.8 21.3 32.6 44.3 69.6 61.1 17.0 36.3 11.7 110.2 27.5 48.7 43.3 18.3 54.8 16.7 22.5 16.6 15.8 39.1 16.2 13.2 14.3 36.4 20.1 37.4 49.9 22.8 24.2 43.1 40.4 22.8 38.5 37.5 45.7 54.3 37.0 35.2 33.8 53.6 54.1 119.1 60.7 60.1 20.6 93.1 175.8 60.2 37.5 200.7 13.7 132.7 459.3 179.7 119.0 146.1 314.3 70.0 138.4 184.0 143.5 107.5 72.6 744.7 575.7 23.8 144.8 249.2 183.4 241.2 76.8 138.6 226.0 621.2 138.5 98.0 246.1 221.7 97.2 898.1 22.2 90.5 140.1 71.6 147.1 93.1 99.3 57.9 140.1 99.5 ATP12A "#945, 2, ATP1AL1, HK" ENSG00000075673 "ATPase H+/K+ transporting non-gastric alpha2 subunit" P54707 13 24680411-24712493 "Enzymes, Plasma proteins, Predicted membrane proteins, Transporters" "Hydrogen ion transport, Ion transport, Potassium transport, Transport" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 12.3;lymphoid tissue: 38.4" "Group enriched" "Detected in some" 7 "Ciliated cells: 5.3;Club cells: 18.2" "Cancer enhanced" "Detected in many" "testis cancer: 12.3" "Region enhanced" "Detected in single" "cerebral cortex: 1.3" "Cell type enriched" "Detected in single" 5 "T-reg: 1.7" "Lineage enriched" "Detected in single" 18 "T-cells: 1.7" "Cell line enriched" "Detected in some" 8 "SuSa: 11.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA039526 Approved Approved "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane, Cytosol" "Actin filaments" "HPA039526: AB_10673534" "unprognostic (8.33e-3)" "unprognostic (3.58e-2)" "unprognostic (2.93e-1)" "unprognostic (5.21e-3)" "unprognostic (2.58e-1)" "unprognostic (1.21e-2)" "unprognostic (8.03e-3)" "unprognostic (2.64e-1)" "unprognostic (1.50e-1)" "unprognostic (1.18e-1)" "unprognostic (3.39e-1)" "unprognostic (2.24e-1)" "unprognostic (1.78e-1)" "unprognostic (1.67e-1)" "unprognostic (6.80e-2)" "unprognostic (8.22e-3)" 0.1 0.1 0.1 0.0 0.1 0.0 0.8 0.2 1.3 0.4 0.1 0.0 0.0 0.0 0.2 0.2 12.3 0.1 0.0 0.1 0.3 0.2 8.8 0.1 6.1 0.0 0.1 0.0 0.1 1.0 0.0 0.2 5.8 0.4 0.3 2.2 0.0 0.4 0.0 0.1 9.8 0.1 0.0 0.1 0.1 0.1 1.0 0.0 1.2 0.2 2.9 38.4 0.1 0.6 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.5 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.1 0.2 1.3 0.3 0.2 0.1 0.0 0.4 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.3 0.0 5.3 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.2 ATP13A3 AFURS1 ENSG00000133657 "ATPase 13A3" Q9H7F0 3 194402672-194498364 "Predicted membrane proteins" Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029471 Approved Approved "Nucleoli,Plasma membrane,Cytosol" NA NA Nucleoli "Plasma membrane, Cytosol" "HPA029471: AB_10600784" "unprognostic (5.07e-2)" "unprognostic (3.53e-2)" "unprognostic (2.94e-1)" "unprognostic (5.31e-2)" "unprognostic (3.20e-2)" "unprognostic (3.55e-1)" "unprognostic (1.57e-1)" "unprognostic (9.87e-2)" "unprognostic (1.32e-1)" "unprognostic (1.51e-1)" "prognostic unfavorable (1.60e-4)" "unprognostic (2.70e-2)" "prognostic unfavorable (1.63e-4)" "unprognostic (1.22e-1)" "unprognostic (1.65e-1)" "unprognostic (1.34e-2)" "unprognostic (3.77e-1)" 27.1 14.4 9.0 20.8 12.7 17.5 22.8 15.3 13.8 12.1 13.4 10.8 17.2 11.4 16.2 13.2 12.4 11.3 17.1 37.8 9.6 8.1 29.7 56.9 22.1 11.6 10.1 8.3 13.2 11.4 37.6 10.6 28.9 10.6 11.8 12.6 12.9 16.7 15.9 11.8 7.7 15.0 12.1 9.0 17.1 16.3 8.8 8.4 18.9 37.1 12.0 12.7 17.8 16.1 1.9 2.4 2.3 2.3 2.2 4.7 1.0 49.1 5.6 10.0 9.5 11.4 17.8 24.4 16.9 18.4 18.4 33.5 30.8 12.0 19.4 50.3 24.3 61.0 16.7 9.6 16.8 42.8 64.7 8.3 10.7 7.4 6.5 19.8 34.8 28.1 8.1 7.5 38.2 24.9 30.2 9.5 12.0 12.3 39.3 22.3 8.4 14.0 6.9 9.5 16.1 9.7 12.8 21.6 11.6 15.6 15.7 15.4 8.1 17.9 18.6 12.5 8.8 35.7 24.4 12.4 22.5 18.7 44.6 31.5 25.9 46.7 34.5 44.6 20.7 15.5 1.8 1.7 2.3 1.8 2.3 2.2 1.9 1.7 2.8 2.4 1.1 2.5 2.5 0.3 2.2 0.9 1.6 4.7 1.0 9.0 12.7 15.3 13.8 9.6 8.1 10.1 8.3 10.6 8.4 47.6 35.1 27.9 35.7 73.3 24.1 34.6 96.8 24.1 37.5 47.1 19.6 25.7 3.3 56.7 1.9 46.6 20.8 0.0 60.7 16.3 46.0 62.6 8.1 112.9 37.1 14.3 29.4 49.1 35.1 1.1 9.5 48.5 59.1 8.2 21.5 10.3 76.7 20.4 12.4 39.8 13.3 12.9 36.0 14.0 7.0 62.2 54.0 20.1 19.9 58.3 ATP2C2 "KIAA0703, SPCA2" ENSG00000064270 "ATPase secretory pathway Ca2+ transporting 2" O75185 16 84368527-84464187 "Enzymes, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 23.0;salivary gland: 35.8" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 42.2;Ciliated cells: 72.3;Mucus-secreting cells: 62.9;Undifferentiated cells: 69.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 24 "neutrophil: 2.7" "Lineage enriched" "Detected in single" 24 "granulocytes: 2.7" "Cell line enhanced" "Detected in some" "MCF7: 14.5;OE19: 26.0;RT4: 11.4;SK-BR-3: 20.2;T-47d: 6.7" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA052262, HPA075812" Approved Approved "Plasma membrane,Focal adhesion sites" NA NA "Plasma membrane, Focal adhesion sites" "HPA052262: AB_2681776, HPA075812: AB_2686765" "unprognostic (2.28e-2)" "unprognostic (6.13e-2)" "unprognostic (3.34e-2)" "prognostic favorable (6.20e-6)" "unprognostic (2.04e-1)" "unprognostic (2.41e-2)" "unprognostic (8.36e-2)" "unprognostic (1.72e-1)" "unprognostic (9.92e-2)" "unprognostic (1.89e-2)" "unprognostic (5.08e-2)" "unprognostic (2.16e-1)" "unprognostic (8.37e-3)" "unprognostic (1.17e-1)" "unprognostic (1.02e-1)" "unprognostic (4.32e-4)" "unprognostic (1.39e-1)" 0.3 0.0 2.1 8.0 1.5 6.1 2.5 0.2 2.0 3.5 23.0 0.5 1.9 16.3 1.8 1.9 2.7 4.0 18.8 0.4 1.8 1.9 2.6 0.2 21.9 0.2 1.3 0.7 1.3 0.5 0.0 2.9 4.8 0.7 7.9 21.9 1.0 35.8 0.2 0.9 15.2 14.5 0.5 0.6 0.2 3.4 0.4 0.4 0.3 8.2 2.2 8.1 4.8 7.8 0.0 0.0 2.7 0.0 0.0 0.1 0.0 3.6 0.2 0.4 0.0 0.0 0.0 3.9 0.1 0.0 0.0 0.0 3.4 3.2 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.5 0.0 0.0 0.0 26.0 0.1 0.0 0.0 0.1 0.0 11.4 2.9 0.0 0.0 20.2 0.1 0.5 6.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 2.1 1.5 0.2 2.0 1.8 1.9 1.3 0.7 0.7 0.4 29.8 42.2 0.0 12.3 0.6 1.4 0.6 2.5 72.3 29.6 0.0 0.0 1.9 0.0 7.2 3.0 0.6 15.4 0.0 2.3 2.2 0.3 21.6 9.2 0.0 0.2 0.0 32.8 0.0 0.0 1.1 0.0 0.7 1.7 0.0 62.9 1.3 3.1 17.3 0.0 1.9 5.6 0.0 0.5 0.7 0.6 1.0 20.1 0.0 69.5 9.5 ATP6V0A2 "a2, ATP6a2, ATP6N1D, J6B7, Stv1, TJ6, TJ6M, TJ6s, Vph1" ENSG00000185344 "ATPase H+ transporting V0 subunit a2" Q9Y487 12 123712318-123761755 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "granulocytes: 71.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 13.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 37.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044279 Approved Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA044279: AB_10961274" "unprognostic (2.60e-1)" "unprognostic (8.79e-3)" "unprognostic (3.60e-2)" "unprognostic (1.50e-1)" "unprognostic (2.70e-1)" "unprognostic (2.29e-2)" "unprognostic (2.06e-4)" "unprognostic (1.40e-1)" "unprognostic (3.77e-2)" "unprognostic (1.75e-1)" "unprognostic (8.85e-3)" "unprognostic (1.63e-1)" "unprognostic (1.26e-1)" "unprognostic (7.48e-2)" "unprognostic (1.12e-1)" "unprognostic (3.47e-1)" "unprognostic (1.58e-1)" 13.5 9.4 7.2 13.0 9.9 15.5 11.5 16.2 9.8 8.9 13.1 13.0 9.0 16.0 13.4 8.8 9.1 10.4 10.4 13.6 8.0 7.9 8.9 13.7 13.1 16.6 12.8 6.9 9.7 18.1 8.1 10.4 10.2 9.1 9.8 12.0 9.8 24.5 10.0 13.0 20.5 15.8 12.3 9.4 13.1 15.9 15.9 10.8 24.0 10.3 8.6 17.5 11.0 10.3 2.3 3.4 13.1 1.5 2.1 2.7 0.9 3.3 8.4 8.8 11.8 5.2 5.0 5.4 4.0 4.7 5.2 5.7 6.2 2.7 12.8 2.8 5.4 5.5 7.1 11.4 4.2 3.9 8.7 6.4 18.4 6.7 3.6 8.2 11.7 37.8 4.5 3.7 6.1 6.6 5.2 4.5 10.1 11.1 2.3 5.7 9.2 11.0 14.3 9.2 5.0 5.6 10.6 7.6 4.1 5.0 8.3 5.3 9.0 6.8 4.7 6.0 4.7 4.9 8.5 6.5 6.6 2.5 8.1 6.7 7.6 8.4 11.9 5.5 7.1 5.6 6.4 0.9 13.1 2.1 0.9 1.5 1.3 2.1 1.8 1.1 2.3 1.9 2.7 2.4 2.1 1.5 3.4 1.4 0.9 7.2 9.9 16.2 9.8 8.0 7.9 12.8 6.9 9.1 10.8 6.0 14.1 16.0 6.8 9.0 18.1 7.9 17.8 8.1 9.1 8.7 11.8 4.7 0.0 7.4 7.9 8.9 10.5 0.0 9.5 4.6 8.0 12.1 71.8 9.5 7.4 11.1 12.7 14.1 10.8 3.1 8.1 11.7 1.7 10.0 10.1 12.2 6.7 8.0 8.9 3.7 27.6 6.5 8.9 19.5 11.5 12.4 5.7 13.1 9.9 10.6 ATP6V1H "CGI-11, SFD, SFDalpha, SFDbeta, VMA13" ENSG00000047249 "ATPase H+ transporting V1 subunit H" Q9UI12 8 53715557-53843558 "Predicted intracellular proteins, Transporters" "Host-virus interaction, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009532, HPA023421" Approved Supported "Plasma membrane,Actin filaments,Cytosol" NA NA 48000 "Actin filaments, Cytosol" "Plasma membrane" "CAB009532: AB_667834, HPA023421: AB_1845202" "unprognostic (1.67e-3)" "unprognostic (2.53e-2)" "unprognostic (1.41e-2)" "unprognostic (2.16e-2)" "unprognostic (2.38e-1)" "unprognostic (2.25e-2)" "prognostic unfavorable (7.81e-4)" "unprognostic (2.01e-1)" "unprognostic (1.95e-1)" "unprognostic (6.39e-3)" "unprognostic (1.56e-1)" "unprognostic (5.30e-2)" "prognostic favorable (1.46e-7)" "unprognostic (1.06e-1)" "unprognostic (3.37e-2)" "unprognostic (1.38e-2)" "unprognostic (1.64e-1)" 14.1 25.1 42.2 9.7 41.5 14.0 15.8 22.5 46.2 14.6 12.1 12.0 10.5 8.3 13.7 19.3 18.1 13.1 11.6 17.2 39.0 25.5 36.6 11.3 13.8 11.1 21.4 30.0 15.0 11.7 27.0 20.0 14.0 30.0 19.6 12.0 12.7 16.4 18.2 17.3 14.4 8.3 14.6 14.7 10.2 13.3 10.8 11.3 15.3 30.0 11.5 12.3 15.3 11.0 12.0 16.3 30.6 17.0 18.8 17.7 9.3 19.2 13.5 12.3 13.3 21.9 14.0 10.5 21.4 19.2 24.6 24.8 12.5 22.3 12.2 20.1 17.2 33.6 30.2 20.3 26.5 21.7 19.1 16.5 13.4 14.1 15.2 31.8 8.6 15.0 20.9 32.9 16.8 26.3 23.1 16.4 14.0 16.9 6.0 31.2 13.4 13.5 13.6 12.1 15.8 8.0 11.7 5.0 7.7 34.8 25.8 9.9 16.4 12.3 22.1 33.3 14.4 28.1 7.3 19.1 10.9 10.0 26.0 11.6 12.8 12.8 14.2 26.3 11.7 11.8 19.0 11.5 30.6 11.5 13.0 13.1 12.0 14.2 13.7 16.3 10.8 13.8 14.3 13.8 18.8 17.0 13.4 17.7 9.3 42.2 41.5 22.5 46.2 39.0 25.5 21.4 30.0 30.0 11.3 35.7 20.6 45.5 34.9 26.3 65.4 25.0 28.1 28.1 37.5 55.8 106.0 58.8 89.5 44.6 6.6 20.4 29.0 0.0 27.2 36.4 26.2 27.6 15.1 20.3 58.3 58.8 33.9 30.7 34.6 6.2 40.0 49.3 28.7 37.9 16.0 52.6 36.9 27.5 45.3 44.2 68.3 19.4 20.3 15.0 47.2 27.5 83.6 39.2 19.6 31.1 ATXN10 "E46L, FLJ37990, SCA10" ENSG00000130638 "Ataxin 10" Q9UBB4 22 45671798-45845307 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049531 Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA049531: AB_2680806" "unprognostic (5.73e-2)" "unprognostic (1.97e-1)" "unprognostic (1.27e-2)" "unprognostic (5.76e-2)" "unprognostic (3.01e-2)" "unprognostic (7.50e-2)" "unprognostic (1.19e-3)" "unprognostic (3.18e-1)" "unprognostic (2.15e-2)" "unprognostic (5.07e-2)" "unprognostic (8.38e-2)" "unprognostic (3.51e-1)" "unprognostic (1.23e-2)" "unprognostic (1.18e-1)" "unprognostic (6.22e-2)" "unprognostic (7.48e-2)" "unprognostic (6.98e-2)" 18.1 33.3 40.2 20.6 40.5 20.9 38.5 31.7 75.3 28.5 20.6 20.9 22.0 13.8 28.8 23.9 27.5 33.6 23.3 42.3 44.5 42.4 32.0 37.0 30.5 38.8 35.6 41.2 35.4 33.5 39.7 32.6 28.1 38.1 28.3 21.8 18.0 22.6 30.1 47.5 18.3 13.6 29.7 38.3 18.3 18.5 31.5 22.3 34.0 37.2 21.8 28.7 26.8 21.8 23.3 52.2 28.1 40.4 25.2 31.0 33.3 41.3 21.4 41.6 25.1 19.1 28.8 22.4 47.3 50.5 33.8 37.2 10.7 27.8 42.7 19.6 47.3 17.4 24.7 30.0 31.5 36.6 7.8 31.0 20.0 41.3 20.5 27.6 53.4 15.0 29.6 22.0 17.6 27.7 41.4 24.7 19.8 14.6 23.7 51.2 17.6 29.0 24.0 27.5 23.4 16.6 42.0 16.0 34.6 43.1 39.6 23.1 36.2 29.4 17.7 32.0 32.9 26.7 28.6 22.5 34.3 12.8 12.2 15.5 23.4 14.1 34.4 21.3 22.5 36.3 19.0 31.7 28.1 23.4 37.6 31.0 23.3 23.3 28.3 52.2 22.6 25.7 24.8 1.5 25.2 40.4 18.5 21.9 33.3 40.2 40.5 31.7 75.3 44.5 42.4 35.6 41.2 38.1 22.3 32.8 25.7 30.5 107.7 44.9 67.9 77.5 68.8 58.9 42.1 55.8 19.6 90.0 58.0 72.1 42.5 42.6 15.9 46.7 60.7 89.4 55.5 67.5 38.2 48.6 63.4 66.7 57.9 33.2 52.7 30.9 53.2 45.5 23.6 62.3 32.0 70.5 50.1 24.6 71.1 51.6 43.1 45.3 38.1 108.0 105.2 36.3 43.7 34.8 46.1 79.0 ATXN3 "ATX3, JOS, MJD, SCA3" ENSG00000066427 "Ataxin 3" P54252 14 92044496-92106625 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB021976, HPA024123, HPA069338" Uncertain Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Nucleoplasm, Nucleoli" "Plasma membrane" "CAB021976: , HPA024123: AB_1845133, HPA069338: AB_2686124" "unprognostic (1.06e-2)" "unprognostic (2.93e-1)" "unprognostic (1.22e-1)" "unprognostic (3.67e-2)" "unprognostic (5.76e-2)" "unprognostic (1.57e-1)" "unprognostic (1.42e-1)" "unprognostic (9.85e-3)" "unprognostic (1.69e-1)" "unprognostic (6.75e-2)" "unprognostic (1.04e-2)" "unprognostic (3.06e-2)" "unprognostic (2.03e-2)" "unprognostic (8.94e-3)" "unprognostic (4.22e-1)" "unprognostic (1.64e-1)" "unprognostic (1.11e-1)" 17.8 10.3 10.2 9.1 11.6 14.3 12.8 18.7 12.1 16.0 11.8 12.2 11.9 6.4 17.9 12.4 17.7 9.5 11.2 10.4 9.0 9.9 9.9 16.0 12.3 11.6 16.3 9.5 14.0 10.3 11.9 17.2 11.7 13.8 15.8 11.7 8.6 11.4 10.2 6.1 21.0 8.7 20.6 16.5 12.6 9.0 14.8 14.3 16.2 11.5 12.0 15.6 15.4 13.6 9.8 14.5 11.4 18.8 7.0 8.5 5.3 5.6 11.1 10.1 9.3 14.7 14.4 19.7 6.4 10.5 8.2 11.5 8.1 15.7 11.5 12.8 10.5 9.7 9.9 7.7 14.1 18.2 13.1 2.3 4.9 5.4 11.8 12.1 8.6 8.8 11.6 12.6 14.3 15.0 11.0 12.6 12.9 6.5 8.6 12.4 22.0 9.0 7.8 7.1 18.8 9.2 7.2 18.5 6.5 10.5 12.8 3.4 6.0 15.6 6.6 8.8 14.1 12.3 6.1 6.7 8.1 11.9 5.2 3.4 7.5 12.5 10.6 6.0 8.5 4.7 11.4 13.4 9.4 5.9 14.5 7.0 7.1 6.9 6.5 14.5 9.8 7.6 8.5 11.3 7.0 18.8 8.4 6.8 5.3 10.2 11.6 18.7 12.1 9.0 9.9 16.3 9.5 13.8 14.3 14.9 14.3 18.1 26.1 22.6 32.4 17.3 17.8 12.0 12.5 40.1 47.1 17.4 13.3 17.7 18.3 43.4 11.7 0.0 15.0 23.8 25.4 29.1 23.2 19.1 20.8 25.4 15.4 39.3 27.2 18.5 62.7 31.8 21.9 30.7 16.0 20.6 17.6 17.5 61.2 14.6 45.6 45.3 35.8 30.5 60.9 26.5 21.2 23.0 19.4 25.1 ATXN7L3 DKFZp761G2113 ENSG00000087152 "Ataxin 7 like 3" Q14CW9 17 44191805-44200113 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064316 Supported Approved "Nuclear speckles,Plasma membrane" NA NA "Nuclear speckles" "Plasma membrane" "HPA064316: AB_2685243" "unprognostic (2.37e-2)" "unprognostic (8.87e-3)" "unprognostic (1.10e-1)" "unprognostic (3.74e-2)" "unprognostic (3.75e-2)" "unprognostic (1.23e-1)" "prognostic unfavorable (4.03e-4)" "unprognostic (2.86e-3)" "unprognostic (6.74e-3)" "unprognostic (1.09e-1)" "unprognostic (1.50e-1)" "unprognostic (1.00e-1)" "prognostic unfavorable (2.87e-4)" "unprognostic (1.21e-3)" "unprognostic (9.05e-2)" "unprognostic (3.75e-2)" "unprognostic (1.40e-1)" 14.0 12.9 36.7 18.9 25.1 23.8 11.9 23.0 53.1 13.2 16.1 11.3 16.7 19.1 14.3 16.9 22.3 14.2 14.9 12.4 30.7 24.8 12.4 12.6 14.3 20.8 22.7 32.1 13.2 13.7 16.3 17.1 18.8 23.6 13.0 15.3 7.9 16.9 18.5 11.3 19.0 16.5 16.1 15.1 17.6 15.5 17.0 14.1 13.9 14.3 11.3 21.3 16.7 22.4 5.1 4.4 6.7 3.2 1.3 4.8 2.6 16.9 28.7 31.8 20.6 22.2 22.1 17.3 20.9 23.3 26.7 25.3 21.9 19.3 29.8 16.8 23.4 24.7 18.7 24.7 19.6 22.5 34.7 24.6 20.2 23.7 24.3 21.9 31.5 41.1 24.9 30.0 22.4 23.7 28.4 25.8 23.1 27.0 18.7 17.5 12.8 37.7 24.0 23.8 15.3 22.6 26.1 30.7 22.3 21.5 24.4 20.2 25.7 12.3 10.9 21.3 46.2 26.7 28.1 22.1 27.0 28.3 14.0 19.4 22.7 29.4 36.1 17.8 13.7 15.7 1.4 3.2 3.7 4.8 2.2 2.9 3.6 3.8 3.0 2.7 5.1 2.9 3.6 6.7 1.3 2.3 4.4 2.0 2.6 36.7 25.1 23.0 53.1 30.7 24.8 22.7 32.1 23.6 14.1 3.0 3.0 4.8 4.4 6.4 16.5 5.3 5.1 4.0 4.5 17.4 15.7 5.1 3.3 6.5 12.7 8.0 14.8 0.0 11.2 6.0 6.2 6.9 2.3 7.3 7.3 27.0 13.8 12.3 10.8 25.8 8.3 7.6 5.0 10.8 11.9 7.6 11.5 11.5 5.3 3.6 13.1 6.5 6.2 6.4 8.9 9.3 11.4 5.4 9.3 7.5 AVEN PDCD12 ENSG00000169857 "Apoptosis and caspase activation inhibitor" Q9NQS1 15 33866227-34039176 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 31.9;Extravillous trophoblasts: 35.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 6.1" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020863 Approved Approved "Plasma membrane,Actin filaments,Centrosome" NA NA "Plasma membrane, Actin filaments" Centrosome "HPA020863: AB_1845219" "unprognostic (1.54e-3)" "unprognostic (1.99e-1)" "unprognostic (8.93e-2)" "unprognostic (5.77e-2)" "unprognostic (5.57e-2)" "unprognostic (2.05e-1)" "unprognostic (1.18e-1)" "unprognostic (6.32e-3)" "unprognostic (1.70e-1)" "unprognostic (1.40e-1)" "unprognostic (4.14e-3)" "unprognostic (1.79e-1)" "prognostic unfavorable (5.29e-10)" "unprognostic (7.66e-3)" "unprognostic (2.40e-1)" "unprognostic (1.63e-1)" "unprognostic (2.84e-3)" 11.0 11.1 7.1 8.7 7.7 5.2 16.1 14.4 8.8 9.6 12.4 6.8 8.6 9.0 13.4 9.5 11.5 8.9 10.6 35.0 6.9 8.7 5.8 16.7 8.0 6.0 8.6 6.8 10.3 41.0 3.6 9.0 15.0 8.3 10.6 12.2 5.4 9.8 11.8 25.7 9.3 9.9 15.3 8.1 7.3 10.9 14.1 6.1 9.9 5.4 11.6 9.4 11.6 15.0 1.2 6.1 0.2 1.7 1.2 2.3 0.3 8.3 13.6 14.1 4.6 11.5 13.1 8.4 21.4 19.2 17.1 11.0 3.7 5.9 7.8 13.2 18.0 13.1 5.7 6.4 13.9 14.1 7.6 4.2 13.5 8.9 10.4 17.2 13.5 9.9 10.9 27.5 10.0 24.4 20.6 18.3 4.1 13.3 11.5 23.8 8.9 5.3 23.3 6.6 11.3 4.7 8.1 7.9 16.7 13.9 11.1 7.5 9.1 11.9 6.2 5.8 6.1 6.7 15.0 12.9 15.1 5.2 6.4 17.6 11.3 8.9 16.5 7.2 16.0 8.0 0.0 0.8 0.0 1.6 1.7 2.0 1.2 1.7 0.6 0.6 0.6 0.8 1.1 0.2 1.2 0.7 6.1 2.3 0.3 7.1 7.7 14.4 8.8 6.9 8.7 8.6 6.8 8.3 6.1 3.0 4.0 3.0 6.2 5.0 5.4 31.9 2.5 1.4 0.0 0.0 5.9 9.7 0.0 1.4 6.8 7.1 6.7 0.0 7.3 35.3 5.0 10.6 0.0 15.8 6.4 7.9 4.6 4.3 1.6 4.8 6.9 2.7 3.3 3.6 7.2 6.7 6.3 7.0 9.9 3.0 5.5 6.5 3.8 2.1 8.3 8.4 7.9 5.7 6.2 9.5 AVPI1 "PP5395, VIP32, VIT32" ENSG00000119986 "Arginine vasopressin induced 1" Q5T686 10 97677424-97687323 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 211.2;Syncytiotrophoblasts: 162.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 29.0;HHSteC: 30.0;hTCEpi: 56.5;SK-MEL-30: 45.6;U-2197: 33.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037649 Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA037649: AB_10671879" "unprognostic (4.57e-2)" "unprognostic (3.28e-2)" "unprognostic (3.04e-2)" "unprognostic (4.79e-2)" "unprognostic (2.73e-1)" "unprognostic (1.25e-1)" "unprognostic (4.37e-3)" "unprognostic (4.60e-2)" "unprognostic (7.34e-3)" "unprognostic (8.56e-3)" "unprognostic (2.29e-3)" "unprognostic (1.23e-1)" "unprognostic (3.91e-3)" "unprognostic (4.04e-1)" "unprognostic (2.03e-1)" "unprognostic (8.66e-2)" "unprognostic (3.83e-3)" 21.5 27.4 5.1 4.7 8.5 3.3 11.0 6.3 17.7 13.0 18.6 3.6 4.8 10.7 5.8 8.2 16.3 6.5 19.9 8.5 5.5 5.8 5.6 29.9 17.1 1.7 7.3 5.6 43.3 10.8 4.1 7.2 19.3 8.0 15.3 15.0 13.6 10.7 13.8 8.3 35.5 15.3 8.5 12.6 11.9 12.7 8.4 2.5 1.3 8.2 9.7 7.6 22.0 16.6 3.5 12.4 2.3 7.1 2.0 5.0 3.0 9.0 23.9 0.1 3.5 5.0 2.3 4.9 4.4 24.4 6.1 9.3 4.4 11.4 0.2 3.2 2.5 4.4 9.6 1.8 7.7 2.3 0.2 2.1 0.6 29.0 12.3 30.0 0.6 0.7 3.6 56.5 4.6 12.1 5.6 0.8 0.8 1.3 0.5 3.3 7.8 0.4 0.7 0.8 2.5 2.2 0.3 2.7 0.3 6.0 5.0 0.4 1.0 15.4 5.5 45.6 0.8 4.2 0.7 1.3 1.5 2.9 33.0 1.1 1.1 0.7 0.1 5.5 1.9 0.9 0.0 7.1 2.3 5.0 6.1 2.3 3.5 3.3 3.7 12.4 2.2 3.6 4.4 0.7 2.0 0.5 2.4 2.9 3.0 5.1 8.5 6.3 17.7 5.5 5.8 7.3 5.6 8.0 2.5 17.9 14.7 1.4 58.4 85.3 9.6 6.7 30.6 13.4 17.0 36.6 5.9 126.4 36.5 16.0 51.3 6.0 96.5 0.0 21.5 57.2 30.8 25.7 5.8 38.1 39.2 12.7 30.5 22.7 16.7 211.2 9.5 40.5 79.2 9.0 38.3 125.0 29.4 66.6 13.8 9.1 12.7 6.5 29.8 2.7 1.6 94.7 162.8 9.6 58.7 83.6 B3GALT2 beta3Gal-T2 ENSG00000162630 "Beta-1,3-galactosyltransferase 2" O43825 1 193179045-193186654 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.9;gallbladder: 19.0;heart muscle: 25.1" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 47.7;Cardiomyocytes: 27.8;Cholangiocytes: 15.3;Leydig cells: 29.4;Peritubular cells: 19.8" "Cancer enhanced" "Detected in some" "glioma: 2.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "MAIT T-cell: 11.9" "Lineage enriched" "Detected in single" 57 "T-cells: 11.9" "Group enriched" "Detected in some" 4 "AF22: 16.4;ASC TERT1: 7.5;LHCN-M2: 11.1;WM-115: 19.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078659 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA078659: AB_2686887" "unprognostic (1.83e-2)" "unprognostic (3.81e-2)" "unprognostic (1.91e-2)" "unprognostic (1.17e-1)" "unprognostic (3.67e-1)" "unprognostic (1.58e-3)" "unprognostic (2.34e-3)" "unprognostic (2.43e-3)" "unprognostic (1.63e-1)" "unprognostic (2.44e-1)" "unprognostic (6.14e-4)" "unprognostic (4.41e-2)" "unprognostic (8.10e-3)" "unprognostic (2.72e-1)" "unprognostic (1.36e-1)" "unprognostic (1.89e-1)" "unprognostic (4.56e-3)" 0.7 2.0 11.3 1.3 8.9 0.7 0.9 1.4 32.9 0.8 1.7 1.2 0.9 1.6 0.6 1.8 1.2 0.7 19.0 25.1 10.1 7.9 1.7 0.8 2.6 0.7 5.7 19.1 13.8 0.8 0.4 0.9 0.9 5.0 6.5 2.0 0.3 0.5 7.1 0.6 0.7 4.1 0.8 6.5 1.4 2.1 1.4 4.7 0.0 1.8 0.0 1.6 2.0 0.7 0.0 0.2 0.1 0.0 0.0 11.9 0.3 0.0 0.0 16.4 0.0 0.4 7.5 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 3.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 1.4 1.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.4 0.0 0.0 0.0 0.2 0.0 11.9 0.0 2.7 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 2.3 0.3 11.3 8.9 1.4 32.9 10.1 7.9 5.7 19.1 5.0 4.7 0.0 0.3 0.0 0.0 0.2 47.7 27.8 15.3 4.0 0.0 1.8 3.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.3 2.3 0.0 0.2 7.9 2.9 1.3 0.3 0.0 29.4 0.1 0.0 0.0 0.3 1.7 0.4 0.0 19.8 0.0 5.8 0.0 0.4 0.0 0.0 0.3 0.0 5.1 0.4 0.0 BANK1 "BANK, FLJ20706" ENSG00000153064 "B cell scaffold protein with ankyrin repeats 1" Q8NDB2 4 101411286-102074812 "Disease related genes, Predicted intracellular proteins" "B-cell activation" "Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 61.4;intestine: 18.0;lymphoid tissue: 67.0" "Cell type enriched" "Detected in many" 6 "B-cells: 268.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 15 "memory B-cell: 61.4;naive B-cell: 46.2" "Lineage enriched" "Detected in many" 17 "B-cells: 61.4" "Cell line enhanced" "Detected in some" "Daudi: 10.4;HEL: 8.1;HL-60: 7.3;U-266/70: 25.0" "Low region specificity" "Detected in many" HPA037002 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA037002: AB_10672383" "unprognostic (1.59e-2)" "unprognostic (2.08e-2)" "unprognostic (6.43e-2)" "unprognostic (1.60e-1)" "unprognostic (1.28e-3)" "unprognostic (1.73e-2)" "unprognostic (4.89e-2)" "unprognostic (1.62e-2)" "unprognostic (1.01e-1)" "unprognostic (9.97e-2)" "unprognostic (4.25e-2)" "unprognostic (7.89e-2)" "unprognostic (2.80e-1)" "unprognostic (2.18e-1)" "unprognostic (2.75e-2)" "unprognostic (6.09e-3)" "unprognostic (1.75e-1)" 3.3 2.9 0.7 45.4 0.9 2.0 1.9 2.1 0.7 0.7 1.3 0.7 1.4 0.7 0.4 1.2 6.0 1.0 1.6 0.9 0.8 0.7 2.0 0.5 4.9 30.3 0.7 0.2 0.9 0.6 0.0 3.7 0.5 0.6 2.2 1.1 0.5 7.7 1.8 0.4 0.6 18.0 0.3 0.8 67.0 2.5 1.3 0.7 4.8 5.5 0.4 42.3 6.5 1.1 61.4 2.0 3.6 0.3 0.2 0.0 2.1 0.0 2.3 0.0 0.0 2.7 1.1 0.0 0.1 0.0 0.3 0.5 0.0 3.6 10.4 1.0 0.0 0.0 0.1 0.1 1.1 0.3 0.0 0.0 8.1 2.1 0.0 0.1 7.3 0.0 0.5 0.3 0.0 0.0 0.9 0.1 0.0 0.0 3.1 0.5 0.4 0.0 0.4 0.0 0.3 4.4 0.1 0.5 0.0 0.3 4.8 2.1 0.0 0.2 0.1 0.0 0.0 0.4 1.9 1.0 0.0 0.5 0.0 0.0 25.0 0.0 1.7 0.1 4.1 0.0 1.5 0.3 3.6 0.0 0.1 0.0 61.4 0.0 0.0 2.0 46.2 0.0 0.0 0.1 0.2 0.0 1.0 0.0 2.1 0.7 0.9 2.1 0.7 0.8 0.7 0.7 0.2 0.6 0.7 41.7 21.9 268.2 2.1 0.1 0.2 0.4 0.0 2.7 17.0 3.5 0.0 1.8 0.0 0.2 1.9 0.4 0.0 0.0 0.2 0.6 1.0 5.2 1.1 0.0 1.2 0.0 0.0 0.0 2.7 1.8 0.0 7.7 5.0 0.0 0.0 1.1 2.5 0.2 0.4 2.4 0.0 0.0 0.0 1.4 3.2 1.0 0.2 2.5 0.4 4.0 BBOF1 "C14orf45, CCDC176" ENSG00000119636 "Basal body orientation factor 1" Q8ND07 14 74019353-74082863 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 37.7" "Cell type enhanced" "Detected in many" 17 "Ciliated cells: 326.6;Early spermatids: 164.7;Late spermatids: 84.6;Spermatocytes: 82.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-87 MG: 15.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA003090, HPA003136, HPA075108" Approved Approved "Nucleoplasm,Plasma membrane,Centriolar satellite" NA NA "Nucleoplasm, Plasma membrane" "Centriolar satellite" "HPA003090: AB_1845571, HPA003136: AB_1078330, HPA075108: " "unprognostic (1.84e-2)" "unprognostic (1.31e-1)" "unprognostic (5.71e-2)" "prognostic favorable (6.34e-4)" "unprognostic (1.11e-2)" "unprognostic (1.29e-2)" "unprognostic (1.28e-2)" "unprognostic (2.08e-1)" "unprognostic (1.85e-1)" "unprognostic (4.62e-2)" "unprognostic (1.01e-1)" "unprognostic (3.89e-1)" "unprognostic (1.40e-3)" "unprognostic (6.14e-2)" "unprognostic (2.57e-1)" "unprognostic (7.93e-2)" "unprognostic (6.04e-3)" 5.3 3.5 9.4 4.1 12.5 6.0 8.4 4.3 12.5 7.7 6.5 4.4 8.5 2.5 8.2 16.4 6.1 24.1 6.6 4.8 11.5 8.2 10.6 2.8 7.6 2.2 7.3 9.2 5.8 3.2 6.1 17.4 3.0 22.3 6.4 4.2 5.8 4.4 8.9 5.3 3.7 2.7 7.7 13.8 1.8 3.9 37.7 6.7 2.5 14.5 2.6 2.6 7.0 3.4 1.5 5.0 2.4 0.1 2.1 4.2 3.0 4.8 2.8 1.2 8.0 5.4 12.0 1.0 4.2 6.0 4.3 4.1 1.0 3.3 4.7 1.2 5.1 1.8 1.2 1.6 0.7 4.9 0.7 0.9 0.5 2.7 1.0 4.6 2.3 0.3 5.7 4.0 9.6 1.2 6.8 1.5 8.9 2.5 0.9 3.1 3.8 7.4 1.2 0.4 0.4 2.0 2.7 3.1 0.8 7.4 1.2 4.9 3.1 8.2 3.3 2.2 1.3 8.5 0.2 3.5 5.3 3.8 7.1 1.2 1.8 4.2 2.9 15.7 0.3 1.5 2.4 0.1 0.2 3.4 0.0 4.0 1.3 3.2 2.2 0.2 1.5 4.2 3.4 2.4 2.1 0.0 5.0 0.6 3.0 9.4 12.5 4.3 12.5 11.5 8.2 7.3 9.2 22.3 6.7 11.9 7.2 0.0 4.2 0.0 7.2 0.0 5.1 326.6 55.7 3.5 27.5 1.6 13.3 7.3 164.7 2.2 0.4 23.3 3.1 2.2 3.0 3.9 1.1 2.5 2.0 6.4 2.4 4.9 0.6 84.6 10.0 1.7 0.0 1.0 3.2 5.7 2.4 0.0 5.6 14.4 27.4 0.0 0.0 82.2 13.0 0.0 0.8 3.2 0.8 2.8 BCAR1 "CAS, CASS1, Crkas, P130Cas" ENSG00000050820 "BCAR1, Cas family scaffolding protein" P56945 16 75228187-75268053 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Diabetes mellitus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000443, HPA042282" Approved Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB000443: , HPA042282: AB_2677929" "unprognostic (5.44e-2)" "unprognostic (2.96e-1)" "unprognostic (1.61e-2)" "unprognostic (1.67e-2)" "unprognostic (2.17e-1)" "unprognostic (5.43e-3)" "prognostic unfavorable (9.11e-5)" "prognostic unfavorable (1.24e-4)" "unprognostic (2.15e-1)" "unprognostic (3.49e-2)" "unprognostic (5.18e-2)" "unprognostic (1.77e-2)" "prognostic favorable (4.55e-8)" "unprognostic (3.38e-1)" "unprognostic (3.60e-2)" "unprognostic (8.20e-2)" "unprognostic (2.20e-1)" 16.6 12.3 14.3 8.4 19.5 1.8 11.5 29.1 26.7 16.7 22.7 31.5 9.1 28.6 17.5 11.0 9.6 10.8 20.4 17.8 14.2 9.4 21.3 17.3 15.9 4.9 18.9 13.5 11.3 31.0 9.2 13.2 28.1 13.9 10.9 7.9 14.6 25.7 12.5 37.4 7.2 25.7 8.6 10.4 28.9 28.7 17.3 20.1 0.2 11.8 9.7 6.3 13.3 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 16.4 8.0 2.6 3.1 2.8 15.4 13.0 7.5 9.5 7.5 21.0 14.1 0.8 17.2 14.4 10.6 8.1 2.7 14.9 2.7 0.0 9.2 0.0 10.0 17.5 7.8 0.0 6.7 8.7 7.4 11.3 5.6 5.6 25.7 0.0 8.3 0.4 5.6 22.4 0.0 0.6 10.6 7.1 10.9 0.3 3.6 3.4 8.7 12.1 9.8 14.1 12.4 2.9 5.0 4.0 6.7 2.2 23.2 16.0 13.9 3.9 19.1 3.5 1.9 0.2 10.1 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 19.5 29.1 26.7 14.2 9.4 18.9 13.5 13.9 20.1 20.8 5.8 2.2 51.8 24.8 13.4 20.7 25.5 4.0 13.6 21.0 5.9 38.1 23.2 45.7 13.5 54.0 56.1 0.0 53.7 20.9 26.0 47.8 9.2 17.9 5.5 12.7 33.5 42.4 1.2 18.0 15.3 2.5 30.4 1.0 35.4 12.3 55.9 52.6 31.5 30.0 4.7 19.4 67.4 14.0 14.7 15.4 30.2 0.0 22.6 54.5 BCAR3 "AND-34, NSP2, SH2D3B" ENSG00000137936 "BCAR3, NSP family adaptor protein" O75815 1 93561786-93847150 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 59.5" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 102.8;Extravillous trophoblasts: 70.7;Sertoli cells: 71.1;Urothelial cells: 114.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 4.4;memory B-cell: 4.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-HME1: 46.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014858 Approved Approved "Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane, Cytosol" Centrosome "HPA014858: AB_1845302" "unprognostic (9.16e-2)" "unprognostic (2.06e-2)" "unprognostic (2.79e-2)" "unprognostic (1.09e-1)" "unprognostic (9.60e-3)" "prognostic unfavorable (8.41e-4)" "prognostic unfavorable (5.42e-4)" "prognostic unfavorable (8.92e-7)" "unprognostic (2.44e-1)" "unprognostic (3.66e-1)" "prognostic unfavorable (4.38e-4)" "unprognostic (1.51e-2)" "prognostic favorable (3.08e-7)" "unprognostic (2.13e-1)" "unprognostic (1.14e-1)" "unprognostic (7.05e-2)" "unprognostic (1.87e-1)" 26.0 10.4 10.1 11.6 14.2 0.9 23.1 8.6 8.1 10.2 14.1 10.0 6.2 12.4 5.7 5.9 8.9 9.4 15.5 10.6 10.6 8.0 15.5 11.0 12.8 11.8 11.7 5.6 11.2 4.1 4.5 4.6 59.5 10.6 11.2 15.7 10.1 20.5 14.5 19.5 13.3 14.8 10.6 9.7 5.4 15.2 7.3 8.0 2.6 10.0 6.6 11.7 12.7 17.7 4.5 1.7 4.4 1.1 0.0 0.3 0.1 15.3 6.6 12.4 0.9 5.4 4.2 10.7 15.9 27.8 13.1 8.1 1.1 11.5 2.5 5.5 24.5 17.1 9.6 0.3 20.6 11.5 1.1 0.3 0.0 4.8 2.8 9.7 0.1 0.0 5.0 22.8 13.6 46.2 12.7 14.4 0.3 0.4 0.1 35.5 2.3 0.3 0.0 3.9 6.7 22.9 1.0 17.9 0.3 34.4 19.5 0.4 1.0 7.7 8.3 9.9 5.0 9.3 0.6 16.9 19.6 5.0 8.3 21.0 1.3 0.5 0.3 2.9 0.0 7.1 4.4 0.0 0.1 0.0 1.1 0.0 4.5 0.1 0.0 0.8 2.5 0.0 0.3 0.0 0.0 0.0 1.7 0.3 0.1 10.1 14.2 8.6 8.1 10.6 8.0 11.7 5.6 10.6 8.0 3.0 7.4 7.4 102.8 8.8 1.0 6.7 7.6 10.7 9.1 14.0 0.0 23.0 23.2 11.1 8.4 17.3 20.2 0.0 5.6 70.7 9.3 24.4 3.5 9.4 10.3 20.6 14.3 5.5 4.3 11.2 9.5 8.1 18.6 16.2 20.7 4.3 17.7 20.7 1.1 15.6 0.4 71.1 19.3 3.2 2.9 8.9 15.8 0.0 10.0 114.7 BCL2L12 ENSG00000126453 "BCL2 like 12" Q9HB09 19 49665142-49673916 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Extravillous trophoblasts: 106.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020856 Approved Approved "Vesicles,Plasma membrane" NA NA Vesicles "Plasma membrane" "HPA020856: AB_1845320" "unprognostic (2.59e-1)" "unprognostic (3.96e-2)" "unprognostic (2.24e-1)" "unprognostic (5.72e-2)" "unprognostic (3.64e-1)" "unprognostic (3.68e-2)" "unprognostic (6.80e-3)" "unprognostic (3.87e-3)" "unprognostic (6.12e-2)" "unprognostic (8.90e-2)" "unprognostic (1.60e-2)" "unprognostic (2.33e-2)" "prognostic unfavorable (8.75e-5)" "unprognostic (8.67e-2)" "unprognostic (3.62e-2)" "unprognostic (2.37e-1)" "unprognostic (2.56e-1)" 6.7 6.5 2.8 15.3 3.3 12.6 7.9 1.2 3.2 8.8 11.8 2.9 9.3 8.3 8.2 9.1 14.0 7.2 11.3 9.5 3.3 1.8 8.1 15.3 12.0 15.5 3.7 2.2 9.2 18.0 3.2 2.6 21.5 3.8 9.0 5.8 6.3 10.6 9.4 12.5 6.5 9.0 8.1 3.4 14.8 8.9 10.0 3.8 29.8 6.6 18.1 15.1 8.4 7.0 13.9 22.4 13.4 9.8 12.0 13.6 5.6 33.1 20.2 16.4 30.6 4.2 4.1 19.1 18.9 7.6 19.0 20.3 28.1 18.2 18.7 9.1 6.3 10.6 16.5 14.9 12.4 10.4 23.4 32.6 17.3 13.8 19.5 3.8 17.7 21.1 5.0 6.0 21.2 6.1 3.8 12.6 24.6 44.0 24.2 10.0 18.8 21.3 30.7 21.0 19.7 26.2 27.6 17.4 20.2 8.2 16.3 0.3 9.6 19.3 26.1 13.4 12.2 10.9 22.8 7.6 21.4 25.5 15.0 30.9 20.4 31.4 35.7 9.1 25.2 21.2 9.6 6.8 13.4 11.4 9.8 13.6 13.9 12.3 11.0 6.0 11.6 11.9 11.6 9.2 12.0 7.1 22.4 12.4 5.6 2.8 3.3 1.2 3.2 3.3 1.8 3.7 2.2 3.8 3.8 8.9 13.3 13.7 29.2 28.6 0.8 4.5 12.7 6.7 12.5 5.2 0.0 53.9 6.6 22.6 5.5 10.2 6.1 46.7 22.6 106.1 23.2 19.8 9.2 12.4 31.8 0.0 6.4 6.7 8.8 2.7 6.1 15.4 25.3 28.9 12.9 3.3 26.4 8.7 5.6 8.2 1.1 12.9 10.8 10.4 18.7 16.9 46.6 12.9 19.6 19.6 BCR "ALL, BCR1, CML, D22S11, D22S662, PHL" ENSG00000186716 "BCR, RhoGEF and GTPase activating protein" P11274 22 23179704-23318037 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "GTPase activation, Guanine-nucleotide releasing factor, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ito cells: 62.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "K-562: 44.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010421, CAB018545, HPA038337" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "CAB010421: AB_2274682, CAB018545: AB_2063918, HPA038337: AB_10675795" "unprognostic (7.46e-3)" "unprognostic (2.43e-2)" "unprognostic (2.15e-3)" "unprognostic (1.16e-1)" "unprognostic (5.35e-2)" "unprognostic (1.45e-1)" "unprognostic (5.08e-2)" "unprognostic (1.44e-1)" "unprognostic (7.55e-2)" "unprognostic (1.81e-1)" "unprognostic (9.46e-2)" "unprognostic (2.39e-2)" "prognostic favorable (9.15e-10)" "unprognostic (1.47e-1)" "unprognostic (7.10e-2)" "unprognostic (4.10e-2)" "unprognostic (7.43e-2)" 14.5 8.4 24.0 9.1 41.2 26.7 10.5 14.2 26.5 13.6 9.7 10.3 10.6 8.7 9.2 13.9 19.3 10.8 8.3 7.8 20.9 13.0 16.3 8.3 11.3 10.9 16.0 15.6 8.8 12.9 14.5 14.9 15.7 14.2 7.0 6.8 8.3 15.5 9.7 3.4 12.8 8.7 9.0 9.5 9.1 14.0 9.6 15.4 11.8 16.6 5.5 9.2 9.2 8.8 1.5 0.8 1.2 1.0 2.8 6.6 2.5 19.0 8.2 12.7 13.0 7.6 5.2 19.2 6.9 6.5 6.4 5.2 14.4 7.7 13.3 12.9 5.9 6.2 19.6 1.3 19.2 1.8 25.4 13.2 11.6 11.3 11.4 9.9 10.7 6.1 4.4 13.0 9.5 8.4 11.4 22.3 9.6 44.4 6.3 2.9 12.5 10.0 8.4 10.7 15.1 8.1 13.2 5.1 8.7 9.9 12.1 11.7 11.1 12.6 10.9 5.2 8.5 6.9 8.8 25.1 3.8 0.4 6.2 5.7 1.4 5.8 4.7 9.9 8.1 5.9 0.0 1.0 0.0 6.6 0.4 2.3 1.4 3.3 3.3 0.8 1.5 2.6 3.6 1.2 2.8 1.0 0.8 1.6 2.5 24.0 41.2 14.2 24.9 20.9 13.0 16.0 15.6 14.2 15.4 8.9 11.5 3.0 9.5 13.7 24.0 7.3 20.4 2.7 19.4 17.4 21.6 10.5 8.3 12.4 3.9 22.4 11.1 0.0 14.1 5.9 7.3 10.2 10.4 18.4 6.0 22.3 19.1 62.0 10.8 7.7 8.1 5.4 5.0 6.4 12.0 13.4 21.8 5.8 5.3 14.3 8.0 0.0 8.6 1.6 6.8 13.8 9.0 9.2 11.2 11.5 BEND6 "bA203B9.1, C6orf65, FLJ30162" ENSG00000151917 "BEN domain containing 6" Q5SZJ8 6 56955126-57027342 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.0" "Group enriched" "Detected in many" 8 "Bipolar cells: 68.2;Horizontal cells: 39.7" "Cancer enriched" "Detected in many" 6 "glioma: 4.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "plasmacytoid DC: 11.1" "Lineage enriched" "Detected in many" 5 "dendritic cells: 11.1" "Cell line enhanced" "Detected in many" "ASC TERT1: 20.2;fHDF/TERT166: 18.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031605, HPA052973" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA031605: AB_10602395, HPA052973: AB_2682002" "unprognostic (4.27e-1)" "unprognostic (7.05e-2)" "unprognostic (4.42e-2)" "unprognostic (1.18e-6)" "unprognostic (2.44e-1)" "unprognostic (2.10e-1)" "unprognostic (1.17e-1)" "unprognostic (1.77e-2)" "unprognostic (9.41e-3)" "unprognostic (1.57e-1)" "unprognostic (8.82e-2)" "unprognostic (1.94e-2)" "unprognostic (9.84e-6)" "unprognostic (9.27e-3)" "unprognostic (1.51e-1)" "unprognostic (4.79e-2)" "unprognostic (2.98e-3)" 1.5 3.1 12.0 2.0 10.7 1.0 1.1 29.2 29.7 5.8 1.7 2.5 0.6 0.8 3.2 1.3 1.8 1.1 5.2 3.1 11.2 10.0 1.0 0.5 1.0 1.2 11.3 8.6 2.9 0.8 2.8 1.1 2.7 33.0 3.4 2.2 0.2 1.0 3.4 4.3 1.5 1.2 4.8 7.2 1.2 1.3 1.5 4.1 0.0 1.3 0.0 1.3 3.9 1.6 0.0 11.1 0.0 0.0 2.1 0.0 0.1 3.4 1.5 0.8 0.4 12.1 20.2 3.3 10.4 10.1 4.7 5.4 0.1 1.6 0.0 3.4 18.4 6.5 0.4 1.2 0.5 5.9 1.5 0.6 2.2 4.9 0.2 3.2 6.3 0.1 8.7 2.9 6.4 2.9 8.0 3.1 8.7 2.8 6.0 9.4 3.5 3.8 1.6 2.9 0.1 0.8 0.0 0.1 1.6 1.7 3.4 4.1 4.1 6.9 0.9 0.8 4.2 0.2 3.8 3.9 14.2 0.4 9.6 2.2 8.3 9.1 2.7 8.3 4.4 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 2.1 0.0 11.1 0.0 0.1 12.0 10.7 29.2 20.8 11.2 10.0 11.3 8.6 33.0 4.1 0.0 0.0 0.0 0.2 0.8 68.2 3.6 0.0 0.0 1.2 0.0 3.9 0.4 0.0 0.2 0.4 0.0 0.0 0.0 0.3 1.2 6.9 0.6 0.0 0.0 0.1 39.7 0.0 1.8 0.0 0.6 1.7 2.1 3.3 0.0 0.0 3.7 0.3 0.0 2.8 0.3 4.1 0.0 1.9 0.5 4.1 0.9 0.0 0.0 0.0 0.0 BLVRB "FLR, SDR43U1" ENSG00000090013 "Biliverdin reductase B" P30043 19 40447765-40465840 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 137.6" "Cell type enhanced" "Detected in all" 13 "Erythroid cells: 2523.0;Hofbauer cells: 895.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "classical monocyte: 73.4" "Group enriched" "Detected in all" 7 "dendritic cells: 54.8;monocytes: 73.4" "Cell line enhanced" "Detected in many" "A549: 81.2;K-562: 73.7;OE19: 64.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041698, HPA041937" Enhanced Supported "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" No No 440000000 Cytosol "Nucleoplasm, Vesicles, Plasma membrane" "HPA041698: AB_10796781, HPA041937: AB_10794308" "unprognostic (1.86e-1)" "unprognostic (1.14e-2)" "unprognostic (4.23e-1)" "unprognostic (1.50e-1)" "unprognostic (2.08e-1)" "unprognostic (2.46e-1)" "unprognostic (9.92e-2)" "unprognostic (1.20e-2)" "unprognostic (8.56e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (3.90e-4)" "unprognostic (2.30e-1)" "unprognostic (2.70e-1)" "unprognostic (2.02e-1)" "unprognostic (5.11e-2)" "unprognostic (1.25e-1)" "unprognostic (3.92e-2)" 36.9 17.9 10.9 12.8 12.2 137.6 28.9 3.5 10.9 17.0 26.7 7.7 18.5 20.9 14.1 19.6 45.3 14.6 19.0 31.0 8.2 8.6 31.8 72.4 37.3 30.0 11.7 9.6 21.3 19.4 5.7 5.6 32.2 13.8 22.9 7.7 17.5 27.1 22.1 43.4 16.7 26.4 22.1 9.7 47.1 31.1 7.6 7.9 6.6 24.3 42.9 24.4 29.9 22.1 8.6 54.8 9.1 73.4 4.0 5.3 34.4 34.2 81.2 1.1 12.1 11.3 10.9 9.6 4.3 12.7 5.9 11.5 15.9 31.1 11.5 33.5 7.7 19.2 11.0 4.1 9.4 1.2 19.5 3.5 17.5 12.2 9.6 26.1 0.2 5.1 10.6 17.9 7.9 4.4 6.0 6.2 4.3 73.7 20.9 6.9 53.2 0.9 1.0 0.3 64.3 22.7 8.1 3.8 18.6 7.4 23.1 0.0 1.8 13.1 34.7 13.2 1.6 33.7 2.6 6.7 15.8 16.9 24.2 2.3 11.4 13.4 4.3 41.1 6.9 6.1 5.0 73.4 2.6 4.6 33.7 4.4 8.6 4.0 4.0 54.8 5.4 4.2 3.3 9.1 4.0 16.9 11.5 5.3 34.4 10.9 12.2 3.5 10.9 8.2 8.6 11.7 9.6 13.8 7.9 205.4 126.9 50.2 283.1 114.9 10.9 116.8 180.9 95.0 73.9 92.5 5.9 76.7 225.5 197.9 7.2 54.2 483.6 2523.0 231.2 82.2 103.0 212.9 41.6 520.7 895.0 9.5 43.0 55.9 549.4 16.6 115.1 152.9 136.7 94.6 130.3 62.8 228.4 480.5 88.4 302.1 11.3 32.3 73.1 2.1 3.6 114.0 62.5 43.7 144.8 253.2 BSDC1 "FLJ10276, RP4-811H24.7" ENSG00000160058 "BSD domain containing 1" Q9NW68 1 32365103-32394731 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 36.4" "Lineage enriched" "Detected in all" 4 "granulocytes: 36.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031358, HPA031360" Approved Supported "Golgi apparatus,Plasma membrane" NA NA "Golgi apparatus" "Plasma membrane" "HPA031358: AB_2673841, HPA031360: AB_10601120" "unprognostic (1.42e-1)" "unprognostic (8.97e-2)" "unprognostic (2.91e-2)" "unprognostic (3.86e-2)" "unprognostic (2.48e-1)" "prognostic favorable (8.82e-5)" "unprognostic (3.40e-1)" "unprognostic (2.06e-2)" "unprognostic (1.61e-1)" "unprognostic (1.04e-1)" "unprognostic (9.56e-3)" "unprognostic (5.92e-2)" "unprognostic (1.95e-3)" "unprognostic (1.92e-3)" "unprognostic (2.68e-1)" "unprognostic (2.37e-1)" "unprognostic (2.07e-1)" 21.9 34.7 30.5 16.8 33.9 45.6 22.8 44.0 41.2 20.7 20.5 34.4 30.8 20.7 25.9 36.8 19.9 22.5 23.4 19.6 27.7 27.1 20.1 41.4 19.6 16.6 27.8 27.2 32.0 37.1 44.5 26.4 28.1 32.5 24.8 24.3 22.2 30.4 21.2 19.0 25.1 23.9 22.8 28.9 20.1 21.4 40.4 27.3 16.2 23.9 16.1 20.3 19.5 19.8 8.4 6.8 36.4 5.8 5.2 6.8 5.4 17.5 9.5 19.6 18.2 28.0 23.5 15.9 20.1 27.4 25.6 25.8 13.9 16.2 12.7 23.1 29.1 18.7 16.2 15.4 15.1 20.5 24.2 19.5 10.2 17.9 15.8 26.1 12.8 17.6 23.7 33.8 23.3 16.2 31.3 22.0 17.4 27.4 21.9 18.4 9.2 14.9 11.5 17.2 13.2 15.4 12.3 14.8 17.1 18.7 13.6 28.7 15.8 18.8 19.6 19.2 30.9 15.8 11.3 21.9 16.1 13.6 22.3 16.9 24.8 29.4 9.3 20.7 14.0 12.0 36.4 4.9 17.2 6.5 5.8 6.8 5.9 5.8 5.4 4.6 8.4 6.8 5.9 8.1 5.2 5.1 6.8 6.1 5.4 30.5 33.9 44.0 41.2 27.7 27.1 27.8 27.2 32.5 27.3 29.8 15.2 36.9 49.2 25.2 48.7 17.1 35.7 14.7 10.3 24.4 78.5 42.9 16.6 31.5 87.7 26.6 52.4 70.0 38.4 26.0 26.1 51.5 20.7 49.0 18.0 81.0 38.5 52.8 18.7 78.5 50.6 15.3 30.4 26.2 43.0 35.7 38.9 31.6 44.6 22.6 66.5 38.8 25.9 28.6 41.1 22.6 80.7 37.0 35.7 42.7 BTN2A1 "BT2.1, BTF1, BTN2.1" ENSG00000112763 "Butyrophilin subfamily 2 member A1" Q7KYR7 6 26457904-26476621 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA019208 Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA019208: AB_1845492" "unprognostic (1.86e-1)" "unprognostic (3.48e-1)" "unprognostic (1.20e-1)" "unprognostic (2.87e-1)" "unprognostic (2.29e-1)" "unprognostic (6.17e-2)" "unprognostic (5.74e-3)" "unprognostic (1.22e-2)" "unprognostic (1.03e-1)" "unprognostic (3.26e-2)" "unprognostic (6.90e-3)" "unprognostic (5.14e-2)" "prognostic unfavorable (5.90e-5)" "unprognostic (1.97e-1)" "unprognostic (4.89e-2)" "unprognostic (7.92e-2)" "prognostic favorable (4.52e-5)" 15.3 16.7 10.8 16.3 13.7 18.5 17.2 42.2 16.2 14.8 15.8 13.2 17.4 12.2 18.8 15.0 11.5 14.9 12.7 15.6 11.2 14.6 13.1 8.5 17.2 16.3 14.4 10.2 15.8 8.9 7.7 16.9 23.2 16.1 16.5 14.6 12.0 11.1 19.3 12.1 9.5 13.9 21.1 15.6 23.5 12.4 13.0 15.0 11.3 10.8 7.3 14.4 21.4 13.4 4.8 4.7 28.8 4.8 4.8 8.1 3.4 7.4 6.8 13.4 8.3 6.0 4.9 0.6 16.3 13.8 20.1 18.4 6.0 5.0 6.1 22.6 11.6 26.5 3.4 10.6 4.2 19.3 8.8 10.4 3.7 7.3 7.4 9.4 5.2 9.8 6.8 4.0 22.4 7.3 11.9 7.2 12.1 5.8 9.7 17.2 3.2 9.2 8.7 4.6 2.1 5.5 7.6 13.2 6.4 7.5 3.7 14.0 7.7 5.2 6.7 11.6 8.7 2.2 4.6 9.5 15.1 8.1 13.1 18.3 7.9 18.2 5.1 6.0 10.4 23.8 16.7 4.8 15.5 6.5 2.7 5.9 4.8 5.4 7.1 4.3 3.9 5.0 6.4 28.8 4.8 4.1 4.7 8.1 3.4 10.8 13.7 42.2 16.2 11.2 14.6 14.4 10.2 16.1 15.0 14.9 14.3 13.4 6.9 7.1 9.0 16.8 10.2 32.1 10.3 8.7 5.9 5.1 3.3 9.6 2.6 19.4 10.6 0.0 11.3 9.3 14.7 9.5 23.2 5.8 10.2 3.2 8.6 19.0 18.7 4.1 11.8 17.0 10.1 16.2 13.7 6.4 12.3 11.2 12.0 4.7 2.2 38.8 21.7 8.8 11.7 7.0 9.8 21.7 12.1 11.1 BTRC "beta-TrCP1, betaTrCP, bTrCP, bTrCP1, FBXW1A, Fwd1" ENSG00000166167 "Beta-transducin repeat containing E3 ubiquitin protein ligase" Q9Y297 10 101354033-101557321 "Predicted intracellular proteins" "Biological rhythms, Host-virus interaction, Ubl conjugation pathway, Wnt signaling pathway" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031156, CAB032986" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "CAB032986: AB_2243598, HPA031156: AB_2673764" "unprognostic (1.43e-1)" "unprognostic (2.35e-2)" "unprognostic (8.88e-2)" "unprognostic (2.09e-1)" "unprognostic (3.55e-1)" "unprognostic (2.73e-1)" "unprognostic (2.41e-2)" "unprognostic (9.25e-2)" "unprognostic (3.22e-1)" "unprognostic (1.59e-2)" "unprognostic (8.80e-3)" "unprognostic (5.05e-1)" "unprognostic (2.81e-3)" "unprognostic (1.33e-1)" "unprognostic (2.95e-2)" "unprognostic (3.07e-2)" "unprognostic (2.23e-1)" 6.6 11.2 16.0 7.3 23.1 3.6 11.8 16.2 28.0 10.2 6.6 10.7 13.7 5.4 8.8 14.5 11.5 10.8 8.1 18.6 15.7 18.3 11.6 7.1 6.8 5.3 14.3 15.3 15.5 8.6 21.5 17.3 10.4 13.5 12.2 7.0 11.9 9.0 8.7 14.1 9.0 5.4 9.7 10.2 7.5 6.4 17.9 9.0 6.3 11.4 7.1 7.5 7.3 9.8 5.2 4.8 3.9 3.7 5.1 8.1 3.4 6.3 9.7 13.7 15.8 13.4 11.7 4.9 9.1 14.8 9.6 8.0 6.8 5.0 10.4 9.3 7.8 9.9 9.9 11.2 9.9 10.4 6.8 8.9 7.5 6.1 8.8 7.1 11.0 4.1 7.1 11.6 8.2 14.7 19.0 11.8 9.7 8.1 3.5 9.2 5.4 7.4 5.5 6.3 7.1 7.7 9.3 19.2 2.1 8.8 4.1 10.2 8.7 6.0 2.7 8.5 16.6 7.4 3.8 9.9 5.1 8.0 6.5 6.4 5.8 12.6 6.6 5.0 5.5 3.4 3.8 3.7 3.9 6.1 3.1 6.1 5.2 6.5 5.5 4.8 4.4 8.1 6.5 2.4 5.1 3.1 2.4 5.6 3.4 16.0 23.1 16.2 23.3 15.7 18.3 14.3 15.3 13.5 9.0 3.0 10.3 4.2 3.6 4.9 29.4 27.1 10.2 12.0 10.3 3.5 27.5 9.5 6.6 8.4 26.8 6.6 4.5 0.0 6.3 6.2 8.2 6.1 12.8 4.9 4.9 15.9 2.9 5.5 2.8 14.1 8.3 3.3 1.7 3.6 4.1 14.1 7.2 3.5 9.9 8.0 24.9 6.5 3.1 31.8 17.1 6.1 10.4 5.1 4.5 5.9 BZW2 "HSPC028, MST017, MSTP017" ENSG00000136261 "Basic leucine zipper and W2 domains 2" Q9Y6E2 7 16646131-16706523 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 104.4;skeletal muscle: 89.7" "Cell type enhanced" "Detected in many" 12 "Extravillous trophoblasts: 786.3;Syncytiotrophoblasts: 638.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022813, HPA026709" Enhanced Approved "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane, Actin filaments, Cytosol" "HPA022813: AB_1845511, HPA026709: AB_10600752" "unprognostic (2.27e-3)" "unprognostic (1.77e-3)" "unprognostic (5.91e-2)" "unprognostic (4.79e-3)" "unprognostic (2.80e-2)" "unprognostic (7.08e-3)" "prognostic unfavorable (7.86e-8)" "unprognostic (9.13e-3)" "unprognostic (8.49e-3)" "unprognostic (2.81e-2)" "unprognostic (1.83e-3)" "unprognostic (3.37e-2)" "prognostic unfavorable (6.01e-4)" "unprognostic (1.00e-1)" "unprognostic (1.66e-1)" "unprognostic (6.77e-2)" "unprognostic (1.25e-1)" 10.6 7.2 4.2 7.8 8.5 10.1 13.5 3.4 8.9 7.9 13.6 3.4 22.0 7.7 7.6 7.6 17.9 7.1 6.1 70.8 4.4 2.8 8.4 10.2 8.1 11.4 3.5 5.8 6.4 12.3 1.8 5.7 104.4 2.5 9.8 16.2 13.2 10.1 25.3 89.7 16.8 8.0 16.6 2.8 8.4 15.6 3.5 3.4 14.5 13.6 41.1 11.1 16.8 10.3 17.2 37.3 1.7 20.3 20.1 23.6 16.3 17.0 16.5 28.1 40.6 13.8 24.4 25.2 24.3 32.0 24.1 25.6 40.0 25.9 39.7 29.0 18.8 17.6 35.5 33.1 27.8 31.9 5.3 19.1 24.8 18.7 22.5 14.3 33.8 15.6 18.7 15.1 21.0 38.8 18.7 34.3 29.2 47.3 8.6 19.5 20.0 17.1 39.2 28.7 50.3 34.2 20.6 18.4 41.8 22.8 31.1 36.0 21.2 9.6 85.9 12.8 33.8 37.8 29.4 19.5 19.1 24.1 28.0 26.8 16.5 17.2 56.0 9.3 42.6 68.2 0.9 17.4 1.7 11.0 20.3 17.9 17.2 16.1 14.9 37.3 15.8 23.6 19.5 0.7 20.1 14.5 14.4 11.9 16.3 4.2 8.5 3.4 8.9 4.4 2.8 3.5 5.8 2.5 3.4 20.8 55.0 24.4 57.3 51.2 48.9 247.1 10.2 32.1 46.6 45.4 60.9 187.5 49.7 33.5 5.3 35.0 23.9 0.0 56.6 786.3 42.5 23.4 20.7 12.2 59.0 6.4 29.3 9.8 28.9 4.8 11.2 28.7 23.6 49.5 35.3 13.3 39.9 31.7 9.2 14.7 83.3 6.5 31.1 4.7 3.8 45.0 638.0 16.2 80.3 79.3 C10orf90 "bA422P15.2, FATS, FLJ32938" ENSG00000154493 "Chromosome 10 open reading frame 90" Q96M02 10 126424997-126670446 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 30.9;breast: 9.2;salivary gland: 18.6;testis: 12.3" "Group enriched" "Detected in some" 27 "Early spermatids: 96.0;Late spermatids: 93.2" "Cancer enriched" "Detected in some" 5 "melanoma: 4.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "MAIT T-cell: 2.7" "Lineage enriched" "Detected in single" 28 "T-cells: 2.7" "Cell line enhanced" "Detected in some" "SK-MEL-30: 49.5;U-2197: 15.1;U-266/84: 10.6;U-87 MG: 15.7;WM-115: 12.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA038648, HPA075229" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA038648: AB_10672721, HPA075229: " "unprognostic (1.21e-2)" "unprognostic (3.34e-1)" "unprognostic (7.50e-2)" "unprognostic (2.05e-2)" "unprognostic (1.66e-1)" "unprognostic (9.30e-2)" "unprognostic (1.98e-3)" "unprognostic (5.06e-2)" "unprognostic (9.34e-3)" "unprognostic (3.73e-2)" "unprognostic (9.52e-2)" "unprognostic (1.22e-1)" "unprognostic (5.06e-11)" "unprognostic (2.69e-3)" "unprognostic (9.91e-3)" "unprognostic (1.26e-1)" "unprognostic (2.88e-1)" 1.9 0.8 7.5 1.0 21.5 0.8 9.2 1.4 18.7 0.9 0.9 30.9 0.0 0.7 0.8 0.8 0.9 0.7 1.1 0.8 10.8 5.9 0.9 0.8 0.8 0.7 26.0 5.9 0.9 1.1 0.7 0.5 1.3 14.4 0.9 1.0 1.7 18.6 0.7 0.9 1.9 0.8 0.8 17.2 0.8 0.7 12.3 28.0 0.0 1.3 0.0 2.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.1 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 49.5 0.0 0.0 0.1 0.0 2.0 0.0 15.1 0.3 0.0 10.6 0.0 15.7 0.0 12.4 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 21.5 1.4 11.3 10.8 5.9 26.0 5.9 14.4 28.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 96.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 93.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.6 0.4 0.0 3.5 0.0 0.0 0.0 C11orf42 MGC34805 ENSG00000180878 "Chromosome 11 open reading frame 42" Q8N5U0 11 6205566-6211132 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 27.9" "Group enriched" "Detected in some" 136 "Early spermatids: 149.9;Late spermatids: 529.8" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "cerebellum: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 4.2;HeLa: 4.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA063404 Enhanced Approved "Nuclear membrane,Vesicles,Plasma membrane" NA NA "Plasma membrane" "Nuclear membrane, Vesicles" "HPA063404: AB_2685006" "unprognostic (4.79e-2)" "unprognostic (1.83e-1)" "unprognostic (3.18e-1)" "unprognostic (2.56e-1)" "unprognostic (1.39e-3)" "unprognostic (3.49e-3)" "unprognostic (2.05e-1)" "unprognostic (5.39e-2)" "unprognostic (1.26e-1)" "unprognostic (3.50e-2)" "unprognostic (9.30e-2)" "unprognostic (6.47e-3)" "unprognostic (7.02e-2)" "unprognostic (1.09e-1)" "unprognostic (1.56e-1)" "unprognostic (2.07e-2)" "unprognostic (4.74e-2)" 0.1 0.0 0.1 0.1 0.2 0.0 0.1 1.0 1.2 0.1 0.2 0.1 0.1 1.1 0.3 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 2.0 0.9 0.1 0.1 0.1 0.3 27.9 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.5 0.4 0.0 0.1 0.0 0.5 2.5 0.4 1.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 2.1 0.8 0.6 0.1 0.0 0.3 1.9 0.0 0.0 0.0 0.6 4.2 0.0 4.8 0.2 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.6 0.0 1.5 0.9 0.4 0.0 0.8 0.9 0.4 1.5 0.3 1.3 0.8 1.2 0.2 0.0 0.4 1.2 0.3 0.2 1.1 0.5 0.6 0.4 0.9 0.4 1.0 0.4 2.0 0.3 0.5 1.1 0.4 0.7 1.8 0.4 0.0 0.4 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 149.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 529.8 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 1.9 0.9 0.0 0.0 0.0 0.0 0.0 C12orf73 "DKFZp547P055, FLJ13975" ENSG00000204954 "Chromosome 12 open reading frame 73" Q69YU5 12 103950202-103965708 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 43.8" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 59.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038883 Uncertain Approved "Plasma membrane,Centrosome,Mitochondria" "Secreted - unknown location" NA NA "Centrosome, Mitochondria" "Plasma membrane" "HPA038883: AB_10794735" "unprognostic (9.24e-2)" "unprognostic (3.26e-3)" "unprognostic (3.66e-3)" "unprognostic (7.20e-2)" "unprognostic (3.28e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (6.98e-4)" "unprognostic (8.96e-2)" "unprognostic (1.86e-2)" "unprognostic (3.79e-2)" "unprognostic (3.03e-3)" "unprognostic (2.07e-1)" "unprognostic (1.33e-2)" "unprognostic (1.13e-1)" "unprognostic (1.40e-2)" "unprognostic (6.27e-2)" "prognostic favorable (1.61e-4)" 6.7 11.4 14.3 8.3 14.5 4.4 9.7 15.5 17.5 7.2 7.4 11.4 7.2 7.7 9.5 13.2 7.0 8.9 5.5 11.1 13.0 14.6 9.4 8.3 5.8 10.0 13.3 13.3 11.5 9.7 9.4 21.0 7.3 13.6 10.7 9.5 8.3 8.3 11.1 43.8 9.0 7.7 7.9 14.1 7.0 9.9 10.1 13.8 11.4 11.5 12.9 10.2 6.6 6.9 11.7 11.3 8.6 5.1 12.0 14.5 3.9 5.9 11.1 16.9 10.3 4.9 6.4 11.0 6.4 3.9 7.2 5.9 11.8 5.2 7.0 8.6 3.9 6.3 9.6 10.0 8.2 5.5 10.1 20.3 10.6 16.3 14.8 7.2 15.6 9.7 5.7 9.4 3.6 6.4 17.6 6.6 20.6 13.6 4.8 6.6 6.8 17.3 23.6 8.2 5.7 19.0 10.0 6.3 6.9 9.4 8.0 27.7 9.5 6.5 11.3 14.9 7.6 19.3 8.5 3.3 8.8 4.9 6.5 6.5 13.1 20.1 14.7 10.0 8.9 7.7 7.3 5.1 8.6 10.5 4.2 10.4 11.7 9.8 10.0 7.2 10.7 14.5 13.5 1.4 12.0 3.8 11.3 13.8 3.9 14.3 14.5 15.5 17.5 13.0 14.6 13.3 13.3 13.6 13.8 6.0 5.0 6.7 8.5 5.4 16.5 14.9 7.6 13.4 5.7 8.7 0.0 9.7 23.2 20.3 59.5 6.7 9.2 0.0 10.6 10.4 7.6 8.0 9.2 11.6 14.8 7.9 10.9 6.2 8.3 25.4 8.1 7.1 1.7 11.8 10.9 12.3 16.5 3.5 8.1 17.7 13.1 6.5 7.2 23.1 21.2 4.5 7.4 4.9 11.5 7.0 C12orf76 FLJ40142 ENSG00000174456 "Chromosome 12 open reading frame 76" Q8N812 12 110027028-110073686 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 47.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA039713, HPA042013" Uncertain Approved "Plasma membrane,Actin filaments" NA NA "Actin filaments" "Plasma membrane" "HPA039713: AB_2676640, HPA042013: AB_2677797" "unprognostic (9.20e-2)" "unprognostic (3.31e-2)" "unprognostic (2.35e-3)" "unprognostic (9.54e-2)" "unprognostic (3.50e-2)" "unprognostic (1.14e-1)" "unprognostic (1.75e-2)" "prognostic favorable (6.44e-5)" "unprognostic (1.39e-1)" "unprognostic (1.47e-1)" "unprognostic (8.86e-3)" "unprognostic (1.75e-1)" "prognostic unfavorable (5.74e-5)" "unprognostic (2.09e-1)" "unprognostic (7.85e-2)" "unprognostic (4.12e-2)" "unprognostic (1.26e-1)" 5.7 8.8 34.6 8.4 26.1 11.6 9.4 19.7 47.6 6.6 6.1 32.6 2.5 7.6 8.1 14.0 5.9 12.0 6.7 5.3 36.1 33.5 8.5 7.9 9.7 11.4 36.2 21.2 11.9 8.4 5.1 7.5 9.4 26.1 7.5 6.4 5.9 7.7 7.9 8.3 14.6 7.4 5.3 38.7 11.1 9.2 9.8 27.4 4.8 11.1 1.8 7.9 6.3 5.0 14.0 12.8 31.3 9.4 14.3 16.3 11.1 6.3 9.4 11.4 10.3 8.2 16.9 12.6 5.6 3.2 5.4 4.1 7.7 6.2 7.8 6.7 2.5 4.2 12.6 4.7 4.6 4.1 11.6 10.0 7.8 14.3 15.5 7.8 12.7 15.3 13.5 15.4 4.7 8.7 19.7 8.5 12.7 11.6 20.5 5.6 6.8 6.4 20.9 8.9 4.0 8.6 12.2 7.0 12.6 9.8 6.2 22.9 12.4 7.0 5.2 12.5 12.0 11.4 6.6 10.8 8.3 6.0 6.3 3.3 9.4 10.8 6.4 9.1 7.3 4.7 31.3 9.4 11.2 8.3 6.2 9.2 14.0 13.1 9.3 8.8 11.8 16.3 10.6 12.8 14.3 6.1 12.8 12.6 11.1 34.6 26.1 19.7 35.1 36.1 33.5 36.2 21.2 26.1 27.4 29.8 14.2 10.7 13.8 7.0 23.3 6.3 20.4 36.1 10.3 15.7 2.0 24.1 29.9 10.0 16.2 13.1 6.3 0.0 13.2 8.0 13.6 10.2 4.7 17.3 22.8 30.2 5.8 16.5 19.2 9.0 24.2 16.1 18.6 15.4 11.0 32.3 9.6 7.0 31.8 32.3 20.5 6.5 14.4 26.2 10.1 7.4 10.1 20.8 10.7 5.8 C14orf37 UT2 ENSG00000139971 "Chromosome 14 open reading frame 37" Q86TY3 14 57999735-58298139 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.5" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 32.1;Club cells: 20.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 11.2;AN3-CA: 7.0;fHDF/TERT166: 12.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001580, HPA001789" Enhanced Approved "Plasma membrane" NA NA 270000 "Plasma membrane" "HPA001580: AB_2666366, HPA001789: AB_1078328" "unprognostic (2.56e-2)" "unprognostic (2.04e-2)" "unprognostic (1.20e-3)" "unprognostic (8.56e-2)" "unprognostic (1.15e-1)" "unprognostic (6.97e-3)" "unprognostic (1.94e-1)" "unprognostic (7.84e-3)" "unprognostic (2.66e-1)" "unprognostic (2.32e-1)" "unprognostic (2.42e-1)" "unprognostic (1.01e-1)" "unprognostic (3.87e-8)" "unprognostic (5.22e-6)" "unprognostic (4.93e-2)" "unprognostic (8.74e-4)" "unprognostic (3.01e-4)" 2.8 5.3 11.4 1.5 11.7 1.8 2.4 10.1 14.0 4.1 2.3 3.9 1.1 1.6 6.7 4.0 1.9 4.7 3.9 6.3 8.6 4.6 16.5 2.2 1.8 1.1 5.1 7.8 9.3 2.4 9.2 5.8 1.4 21.5 4.0 2.7 3.9 2.0 3.3 1.2 2.5 1.8 5.0 3.3 1.3 3.0 5.1 5.0 0.0 3.4 0.3 0.9 2.6 3.0 0.3 0.6 0.5 0.3 0.1 0.0 0.0 0.0 0.0 11.2 7.0 5.5 2.3 0.0 2.2 1.7 0.4 0.3 0.5 0.1 0.0 0.7 12.2 1.4 0.1 3.5 0.0 0.5 0.1 1.1 0.0 0.0 0.5 0.2 0.0 5.6 2.4 0.2 0.2 0.2 3.1 0.5 0.9 0.1 0.3 1.4 0.3 0.0 0.0 5.2 0.0 2.3 1.6 0.3 2.7 4.5 0.5 1.3 0.1 0.1 0.0 0.3 3.3 0.3 0.2 0.1 1.7 4.2 0.6 2.9 0.4 0.3 0.0 3.5 0.3 1.2 0.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.4 0.1 0.0 0.6 0.0 0.0 11.4 11.7 10.1 14.0 8.6 4.6 5.1 7.8 21.5 5.0 3.0 6.5 0.0 7.4 1.3 3.5 0.0 0.0 32.1 20.5 0.0 0.0 0.2 0.0 0.0 1.7 3.0 0.0 0.0 0.0 0.3 4.5 1.3 4.7 2.0 0.1 0.0 0.0 3.1 2.6 0.0 9.2 1.1 3.3 0.0 2.3 9.4 0.0 0.0 9.9 0.0 2.7 0.0 1.4 2.3 2.3 1.8 0.2 1.3 0.3 5.4 C14orf93 "FLJ12154, RTFC" ENSG00000100802 "Chromosome 14 open reading frame 93" Q9H972 14 22985908-23010166 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Intestinal endocrine cells: 15.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002569 Approved Approved "Nucleoplasm,Plasma membrane" "Secreted - unknown location" NA NA "Nucleoplasm, Plasma membrane" "HPA002569: AB_1078334" "prognostic favorable (5.05e-4)" "unprognostic (1.31e-2)" "unprognostic (2.97e-2)" "unprognostic (2.23e-3)" "unprognostic (2.30e-2)" "unprognostic (1.30e-1)" "unprognostic (1.24e-2)" "unprognostic (1.02e-1)" "unprognostic (1.88e-1)" "unprognostic (1.29e-1)" "unprognostic (4.86e-3)" "unprognostic (7.45e-2)" "unprognostic (2.01e-3)" "unprognostic (1.10e-1)" "unprognostic (2.49e-1)" "unprognostic (2.14e-1)" "unprognostic (7.11e-2)" 10.4 6.1 10.2 11.8 7.3 12.4 9.8 14.3 7.9 12.0 12.2 8.3 16.7 8.1 10.8 13.5 10.3 11.1 10.3 7.2 9.6 4.6 10.3 9.7 8.7 10.3 6.8 5.9 12.2 15.9 12.9 18.9 5.4 7.4 11.0 10.9 9.1 9.8 10.2 7.3 20.3 9.4 8.4 11.0 12.9 9.5 5.8 9.0 22.7 16.3 7.8 14.6 11.6 9.5 9.7 8.8 21.3 11.3 8.8 12.4 6.6 3.9 7.4 6.3 8.8 10.2 22.9 8.8 4.6 7.2 3.7 4.9 4.6 11.7 11.1 4.4 4.2 5.2 8.4 3.8 11.7 3.5 4.3 2.7 7.0 9.0 10.5 8.9 5.0 6.0 16.5 9.2 5.5 7.0 13.5 6.8 7.2 7.5 2.4 3.8 11.1 6.4 9.4 2.1 8.5 5.2 10.4 6.0 6.7 4.8 6.0 23.0 10.0 6.2 6.0 6.3 7.1 9.3 8.9 3.8 7.0 9.3 3.1 4.6 8.6 2.3 7.6 4.8 6.3 7.1 11.7 7.5 21.3 8.3 6.9 7.3 9.7 6.8 8.6 8.8 9.4 10.2 9.8 10.7 8.8 11.3 6.2 12.4 6.6 10.2 7.3 14.3 7.9 9.6 4.6 6.8 5.9 7.4 9.0 8.9 0.6 4.7 4.8 2.7 1.2 2.8 2.5 5.3 1.2 0.0 3.9 3.0 6.6 2.8 0.5 2.9 2.9 0.0 2.6 4.3 2.4 2.0 6.9 1.1 3.3 0.0 15.1 1.3 2.7 1.0 4.0 3.4 5.0 0.0 5.2 2.9 3.4 7.0 3.9 3.0 1.9 6.5 3.1 1.5 7.9 1.4 2.5 4.3 4.9 1.4 C16orf74 MGC17624 ENSG00000154102 "Chromosome 16 open reading frame 74" Q96GX8 16 85690084-85751129 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 44.6" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 47.6;Cone photoreceptor cells: 55.0;Rod photoreceptor cells: 69.6;Syncytiotrophoblasts: 62.1;Urothelial cells: 43.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "naive B-cell: 26.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 34.3;hTCEpi: 29.3;T-47d: 30.5" "Low region specificity" "Detected in all" HPA049367 Uncertain Approved "Plasma membrane,Centrosome" NA NA "Plasma membrane" Centrosome "HPA049367: AB_2680730" "unprognostic (1.16e-1)" "unprognostic (2.21e-2)" "unprognostic (6.74e-3)" "unprognostic (2.15e-3)" "unprognostic (3.65e-2)" "prognostic unfavorable (1.71e-4)" "unprognostic (1.08e-3)" "unprognostic (4.22e-3)" "prognostic unfavorable (4.08e-4)" "unprognostic (5.06e-2)" "prognostic unfavorable (1.54e-5)" "unprognostic (3.40e-1)" "unprognostic (1.76e-3)" "unprognostic (2.51e-1)" "unprognostic (3.55e-1)" "unprognostic (2.15e-2)" "unprognostic (9.07e-3)" 2.7 0.7 6.3 5.6 3.9 9.3 6.8 0.6 3.3 4.7 3.0 1.4 10.8 1.5 2.1 3.7 6.8 1.5 2.4 1.8 9.2 1.7 2.0 0.8 2.0 11.7 2.0 2.1 0.9 2.1 3.9 1.0 44.6 1.6 7.1 1.3 18.8 4.5 9.5 1.5 6.3 4.2 3.9 1.5 12.9 3.0 1.4 1.5 0.4 4.7 6.2 10.3 18.9 10.0 26.3 8.8 10.3 8.2 3.3 8.3 5.4 12.2 4.1 0.1 1.7 1.9 2.1 5.1 1.5 2.0 4.8 1.3 3.1 11.5 0.1 17.4 1.2 2.0 17.7 0.7 34.3 2.7 0.0 2.7 0.0 1.8 0.3 5.2 0.3 0.0 4.5 29.3 4.6 20.1 3.6 15.6 2.1 0.0 0.0 0.1 10.3 0.0 18.7 1.1 13.2 11.8 0.5 0.0 1.0 0.0 14.0 3.9 1.0 6.2 3.2 3.1 1.4 30.5 5.2 15.9 3.1 8.0 1.3 4.4 4.3 3.1 13.5 0.0 4.4 0.6 0.0 8.2 10.3 0.6 2.7 2.2 20.4 4.5 3.6 8.8 26.3 7.6 4.7 3.2 3.3 0.8 0.1 8.3 5.4 6.3 3.9 0.6 3.3 9.2 1.7 2.0 2.1 1.6 1.5 3.0 0.6 38.4 47.6 8.2 17.9 1.2 0.0 1.4 3.4 1.8 55.0 38.4 3.3 2.8 1.3 2.1 0.0 0.0 1.0 13.5 4.8 4.1 0.0 0.0 4.3 14.3 0.0 1.3 0.8 0.0 3.1 1.6 18.6 0.0 0.0 8.8 2.2 0.0 3.2 1.7 69.6 0.0 3.4 0.9 6.4 6.0 62.1 0.9 0.0 43.2 C17orf58 ENSG00000186665 "Chromosome 17 open reading frame 58" Q2M2W7 17 67991101-67996431 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 31.5" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 110.1" HPA023036 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA023036: AB_10601144" "unprognostic (1.41e-1)" "unprognostic (1.22e-1)" "unprognostic (6.66e-2)" "unprognostic (1.35e-1)" "unprognostic (1.00e-1)" "unprognostic (7.65e-3)" "prognostic unfavorable (8.99e-4)" "unprognostic (7.45e-2)" "unprognostic (2.20e-1)" "unprognostic (2.27e-2)" "unprognostic (6.22e-2)" "unprognostic (6.69e-2)" "prognostic unfavorable (1.31e-10)" "unprognostic (1.16e-2)" "unprognostic (1.04e-1)" "unprognostic (5.00e-2)" "unprognostic (1.01e-1)" 11.1 6.8 10.7 6.2 9.3 3.5 17.3 8.8 11.5 29.0 8.3 5.7 8.3 4.1 15.4 8.1 6.5 8.1 6.6 8.9 7.7 6.3 6.3 9.1 6.2 3.1 7.4 5.0 6.3 10.4 5.2 3.6 33.3 5.2 7.8 7.5 5.7 5.3 4.0 6.9 3.7 6.1 11.8 5.5 5.1 6.6 4.8 4.4 1.1 6.9 4.5 6.8 11.0 11.7 3.6 5.2 9.5 6.3 3.2 3.0 2.2 5.3 5.3 5.3 6.5 3.8 9.8 4.2 2.2 6.4 3.9 6.4 3.1 7.0 7.1 5.1 1.8 7.0 2.8 12.0 4.8 9.6 12.8 12.1 4.6 2.0 9.7 6.1 3.9 8.5 5.3 5.8 3.8 8.9 4.4 18.4 6.3 9.8 11.1 3.8 7.1 0.7 5.2 6.0 13.0 5.6 1.7 5.8 9.5 4.9 3.6 3.9 7.2 3.4 31.5 11.5 6.8 8.9 4.6 3.4 3.4 3.5 2.4 4.6 22.3 16.3 6.3 8.5 6.9 5.9 9.5 3.8 6.3 3.0 3.6 1.0 3.6 1.1 2.4 5.2 0.8 0.5 1.2 1.5 3.2 6.3 0.2 0.5 2.2 10.7 9.3 8.8 11.5 7.7 6.3 7.4 5.0 5.2 4.4 0.0 1.7 3.7 5.6 4.2 8.6 4.4 5.1 18.7 2.3 10.4 9.8 23.3 19.9 9.6 0.6 13.6 8.0 0.0 8.1 18.2 27.4 13.3 12.7 13.1 15.0 4.8 3.5 11.1 7.5 1.4 3.4 8.9 8.5 27.9 13.0 29.6 8.9 10.5 4.9 15.0 13.6 6.5 10.3 6.0 3.6 7.3 12.8 4.6 9.5 6.0 C17orf62 "FLJ90469, MGC4368" ENSG00000178927 "Chromosome 17 open reading frame 62" Q9BQA9 17 82442589-82450829 "Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "B-cells: 93.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045696 Uncertain Approved "Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Cell Junctions" "HPA045696: AB_2679421" "unprognostic (1.87e-2)" "unprognostic (6.92e-3)" "unprognostic (2.25e-1)" "unprognostic (2.15e-3)" "unprognostic (5.75e-2)" "unprognostic (2.05e-3)" "unprognostic (3.81e-3)" "unprognostic (4.86e-2)" "unprognostic (1.66e-1)" "unprognostic (1.44e-1)" "unprognostic (3.49e-3)" "unprognostic (7.99e-2)" "prognostic unfavorable (6.83e-11)" "unprognostic (1.47e-1)" "unprognostic (5.51e-2)" "unprognostic (7.78e-2)" "unprognostic (9.14e-3)" 19.9 17.3 16.8 35.8 25.2 16.4 20.0 8.6 20.4 16.2 16.2 20.8 10.5 12.1 16.5 13.1 17.1 16.0 22.9 12.1 15.2 12.1 17.5 29.1 20.2 48.3 26.8 12.4 17.6 21.3 12.9 15.7 14.9 20.6 19.5 13.6 12.2 14.7 12.7 6.5 13.9 21.1 20.2 19.0 53.7 16.4 8.3 20.9 26.0 13.8 8.2 42.3 29.2 13.3 30.6 33.0 74.9 44.2 24.2 25.9 34.6 14.2 20.9 11.5 19.0 18.2 19.2 11.2 12.9 15.7 19.0 22.7 7.8 14.5 36.4 11.9 18.3 23.9 14.5 7.9 9.7 13.1 25.9 6.4 9.9 6.9 9.0 18.9 11.1 29.2 22.1 14.1 16.3 9.2 18.4 24.6 28.2 8.3 27.3 16.0 15.9 46.1 9.3 8.7 19.8 11.2 35.2 6.9 27.9 14.0 18.2 9.9 18.7 23.3 27.2 16.6 21.7 28.0 44.7 8.4 14.8 14.5 24.3 13.7 49.9 16.6 26.7 19.4 18.1 13.1 43.8 34.1 44.0 25.9 44.2 20.0 30.2 23.9 25.0 31.4 30.6 20.2 19.6 74.9 24.2 39.6 33.0 24.8 34.6 16.8 25.2 8.6 20.4 15.2 12.1 26.8 12.4 20.6 20.9 29.8 24.8 93.2 8.2 9.8 16.7 0.0 17.8 9.4 13.6 0.0 9.8 23.8 0.0 0.0 1.1 17.6 29.5 23.3 0.0 27.8 22.4 13.1 32.4 21.3 69.8 25.4 24.9 19.0 53.5 1.5 24.7 43.5 18.6 0.0 20.3 22.1 0.0 28.1 17.0 0.0 12.0 0.0 11.4 10.4 7.3 7.8 23.1 58.6 15.2 7.1 C18orf21 "HsT3108, PNAS-124, PNAS-131" ENSG00000141428 "Chromosome 18 open reading frame 21" Q32NC0 18 35972083-35979286 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 94.7;Spermatocytes: 73.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065505, HPA067322" Uncertain Approved "Nucleoli,Plasma membrane" NA NA "Nucleoli, Plasma membrane" "HPA065505: AB_2685498, HPA067322: AB_2685822" "unprognostic (7.31e-2)" "unprognostic (2.14e-3)" "unprognostic (9.88e-2)" "unprognostic (8.66e-3)" "unprognostic (2.04e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (1.38e-6)" "unprognostic (2.53e-3)" "unprognostic (1.83e-2)" "prognostic favorable (1.81e-6)" "unprognostic (2.88e-2)" "unprognostic (1.24e-1)" "unprognostic (1.16e-1)" "unprognostic (1.21e-2)" "unprognostic (5.15e-3)" "unprognostic (2.35e-3)" "unprognostic (5.97e-2)" 14.1 16.1 13.4 16.7 12.5 53.0 18.4 23.1 25.8 13.0 12.8 7.9 17.6 15.2 15.0 17.7 15.0 12.9 11.7 15.2 12.4 12.5 14.0 14.5 11.3 17.1 11.7 14.7 16.4 22.0 12.9 16.9 14.8 13.0 13.4 12.3 8.1 16.5 17.8 28.7 13.6 14.1 15.8 10.6 17.2 16.7 28.7 11.7 22.9 14.8 21.4 15.7 17.8 14.8 18.5 15.1 40.6 16.5 16.5 21.7 10.6 13.3 9.1 19.8 13.6 12.7 19.4 13.3 18.4 17.5 22.1 22.5 7.7 9.1 10.7 19.7 13.5 15.3 13.7 13.8 14.1 24.6 16.2 14.1 11.2 10.8 17.3 18.4 34.0 14.0 18.7 23.0 19.5 19.8 20.6 18.0 17.2 18.1 17.4 14.5 14.9 22.4 23.6 16.6 6.2 10.0 15.2 16.9 20.8 14.9 14.7 12.7 19.0 12.3 9.9 29.4 18.9 14.4 15.3 12.8 21.8 10.4 8.0 16.2 24.4 21.7 23.5 11.1 17.7 11.4 40.6 16.5 18.3 14.6 16.5 14.6 18.5 15.9 13.7 15.1 16.1 12.3 16.0 14.9 16.5 15.3 14.6 21.7 10.6 13.4 12.5 23.1 25.8 12.4 12.5 11.7 14.7 13.0 11.7 17.9 6.7 15.9 8.2 10.5 9.1 10.8 5.1 2.7 11.4 1.8 5.9 15.8 10.0 17.5 94.7 8.7 9.3 0.0 24.9 24.6 8.9 7.3 13.9 9.4 18.9 7.9 6.9 8.6 16.8 46.0 20.8 13.1 11.8 10.8 13.0 8.4 18.6 11.5 15.9 17.0 11.1 0.0 8.6 73.2 36.1 10.8 11.0 12.8 16.6 7.1 C19orf33 "H2RSP, IMUP, IMUP-1, IMUP-2" ENSG00000167644 "Chromosome 19 open reading frame 33" Q9GZP8 19 38304161-38305009 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 88.4;intestine: 105.8;tongue: 78.5" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 1588.2;Exocrine glandular cells: 683.1;Mucus-secreting cells: 800.2;Pancreatic endocrine cells: 1532.5;Paneth cells: 1006.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 11 "myeloid DC: 15.1" "Lineage enriched" "Detected in many" 11 "dendritic cells: 15.1" "Cell line enhanced" "Detected in some" "A-431: 70.1;A549: 108.2;CAPAN-2: 66.8;HBEC3-KT: 64.8;hTCEpi: 67.9;OE19: 57.5;PC-3: 61.8" "HPA054406, HPA059696" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" No No "Nucleoplasm, Cytosol" "Plasma membrane" "HPA054406: AB_2682478, HPA059696: AB_2684105" "unprognostic (9.31e-2)" "unprognostic (2.06e-1)" "unprognostic (4.34e-2)" "unprognostic (1.44e-2)" "unprognostic (3.92e-3)" "unprognostic (2.37e-2)" "unprognostic (9.49e-2)" "prognostic unfavorable (5.42e-4)" "unprognostic (2.09e-1)" "unprognostic (1.74e-2)" "prognostic unfavorable (5.05e-4)" "unprognostic (6.92e-2)" "unprognostic (5.50e-2)" "unprognostic (4.82e-2)" "unprognostic (1.61e-1)" "unprognostic (3.63e-2)" "unprognostic (6.01e-2)" 6.9 0.6 0.5 16.4 0.7 0.3 5.0 0.5 0.8 14.5 58.8 0.6 3.5 34.6 3.9 4.3 88.4 18.2 45.2 9.9 0.8 0.3 5.8 1.0 34.8 0.6 0.7 1.4 4.9 0.8 0.0 2.0 10.0 1.7 10.3 18.2 1.2 21.5 6.8 2.8 53.3 105.8 2.9 3.1 1.9 28.7 1.5 0.5 1.5 4.4 78.5 39.2 16.2 35.1 0.1 15.1 1.4 0.6 0.3 0.4 14.6 70.1 108.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 66.8 0.0 40.1 0.0 0.0 26.3 0.0 64.8 0.0 0.0 0.0 0.0 22.7 1.8 0.5 0.0 0.0 0.0 67.9 0.0 43.6 0.1 1.1 0.0 0.0 0.0 0.0 18.1 0.0 0.1 0.1 57.5 61.8 0.0 0.0 0.0 41.0 20.8 0.1 0.0 41.0 29.7 0.0 0.1 9.2 0.2 14.6 0.0 20.4 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.0 1.1 0.6 1.4 0.3 0.0 0.3 0.1 0.2 0.1 15.1 0.1 0.4 0.3 0.9 0.3 0.0 0.9 0.0 14.6 0.5 0.7 0.5 0.8 0.8 0.3 0.7 1.4 1.7 0.5 497.3 155.5 7.0 25.1 200.2 0.0 1.4 298.1 195.4 353.8 52.4 0.0 5.2 1.7 144.5 0.4 9.8 1588.2 0.0 683.1 1.0 5.6 22.7 39.1 0.0 1.3 0.0 73.3 4.9 1.6 2.8 3.7 8.2 1.7 4.6 800.2 0.0 1532.5 1006.5 0.0 21.6 0.0 0.0 5.0 1.4 1.9 304.5 2.6 0.0 506.3 112.5 C19orf48 "BC006151, MGC13170" ENSG00000167747 "Chromosome 19 open reading frame 48" Q6RUI8 19 50797704-50804929 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA042000 Uncertain Approved "Plasma membrane" NA Yes "Plasma membrane" "HPA042000: AB_10797377" "unprognostic (2.25e-1)" "unprognostic (2.82e-2)" "unprognostic (5.39e-2)" "unprognostic (7.92e-2)" "unprognostic (2.86e-1)" "unprognostic (1.69e-1)" "prognostic unfavorable (8.80e-5)" "unprognostic (6.59e-3)" "unprognostic (1.84e-3)" "unprognostic (2.84e-1)" "unprognostic (1.14e-2)" "unprognostic (2.97e-1)" "unprognostic (6.84e-3)" "unprognostic (1.29e-1)" "unprognostic (3.67e-2)" "unprognostic (1.40e-1)" "unprognostic (1.16e-1)" 5.0 9.7 6.5 11.0 6.2 20.7 9.6 7.0 8.9 7.2 9.3 7.0 4.1 6.8 7.8 6.9 13.2 13.5 9.5 4.1 4.0 3.4 7.4 12.0 8.0 22.2 6.8 8.7 13.0 40.7 3.2 4.0 7.5 5.2 32.1 5.8 6.9 8.3 5.6 6.4 15.9 6.4 6.7 5.1 8.8 7.0 19.8 5.0 23.6 17.9 9.1 12.5 5.1 7.3 29.0 20.8 2.8 8.7 12.4 21.6 9.9 21.4 34.1 16.1 10.1 3.1 9.6 14.9 19.4 13.3 28.7 28.7 41.1 20.0 36.8 9.0 7.5 11.1 15.3 26.8 27.3 9.9 11.5 64.7 24.5 14.5 23.9 8.7 25.6 12.4 15.6 28.4 29.9 32.6 7.0 15.3 36.3 26.8 18.4 13.3 18.5 34.3 31.0 12.9 26.4 43.7 25.8 26.3 34.8 9.3 35.9 26.6 12.8 19.4 25.3 26.4 6.1 14.9 25.2 7.2 13.3 24.6 8.1 26.3 10.8 12.2 30.3 8.1 23.3 17.8 1.0 6.0 2.8 9.9 8.7 14.0 29.0 14.1 11.2 11.8 27.3 21.6 16.1 0.4 12.4 6.3 20.8 14.5 9.9 6.5 6.2 7.0 8.9 4.0 3.4 6.8 8.7 5.2 5.0 3.0 6.9 49.4 35.3 51.9 8.7 4.7 12.7 1.4 6.8 17.4 5.9 84.7 28.2 25.6 6.7 15.8 10.0 23.3 94.0 106.2 23.6 54.8 8.1 11.5 36.1 0.0 23.0 6.7 8.8 12.6 16.4 21.5 16.9 39.7 66.4 9.7 47.0 14.0 7.1 15.2 7.0 6.5 21.7 27.2 39.4 60.1 51.8 15.0 100.4 27.5 C19orf71 LOC100128569 ENSG00000183397 "Chromosome 19 open reading frame 71" A6NCJ1 19 3539154-3544030 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "testis: 88.8" "Group enriched" "Detected in some" 58 "Early spermatids: 515.2;Late spermatids: 237.4" "Cancer enriched" "Detected in all" 5 "melanoma: 23.7" "Region enriched" "Detected in all" 4 "cerebellum: 9.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "HeLa: 27.3;SK-MEL-30: 16.6;WM-115: 59.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA048654 Uncertain Approved "Endoplasmic reticulum,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "Endoplasmic reticulum" "HPA048654: AB_2680480" "unprognostic (1.06e-1)" "unprognostic (1.21e-1)" "unprognostic (7.04e-3)" "unprognostic (7.37e-2)" "unprognostic (4.74e-2)" "prognostic favorable (2.35e-4)" "unprognostic (4.21e-1)" "unprognostic (2.00e-1)" "unprognostic (7.23e-2)" "unprognostic (3.13e-2)" "prognostic favorable (2.03e-5)" "unprognostic (6.19e-2)" "prognostic favorable (2.02e-5)" "unprognostic (5.52e-3)" "unprognostic (1.02e-1)" "unprognostic (3.84e-2)" "unprognostic (1.97e-3)" 1.6 2.3 1.6 4.1 2.2 5.1 1.6 9.8 2.2 1.7 1.6 2.0 1.6 4.7 2.5 1.9 1.6 2.6 1.6 1.6 1.6 1.3 3.5 1.6 2.1 4.9 1.8 1.9 2.8 4.2 0.0 4.5 1.6 1.7 2.2 0.0 1.6 7.6 1.6 1.6 7.4 3.9 1.6 1.6 5.2 3.2 88.8 1.8 1.6 6.3 1.6 1.6 1.7 1.6 0.3 0.5 0.0 0.2 0.0 0.7 0.1 5.3 4.4 1.4 2.0 0.0 0.0 2.9 3.4 0.0 0.0 0.0 2.7 1.6 0.9 2.6 0.0 7.4 4.8 0.0 0.2 0.0 5.4 2.6 0.7 27.3 0.8 0.0 0.7 3.4 0.0 0.0 0.1 0.0 1.6 0.0 2.5 3.7 4.9 0.0 3.8 1.1 1.7 1.2 0.1 1.3 1.8 2.1 5.0 0.0 2.1 3.4 3.1 5.9 3.0 16.6 0.7 3.3 1.7 4.5 2.7 3.6 8.2 3.1 3.9 1.0 1.4 8.1 3.2 59.5 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.6 0.7 0.0 0.0 0.2 0.5 0.0 0.1 1.6 2.2 9.8 2.2 1.6 1.3 1.8 1.9 1.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 515.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 237.4 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.5 0.0 0.0 6.5 0.0 2.8 1.5 0.0 0.1 0.0 0.0 0.0 C1orf189 ENSG00000163263 "Chromosome 1 open reading frame 189" Q5VU69 1 154199372-154206333 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "epididymis: 11.9;fallopian tube: 41.8;testis: 21.0" "Cell type enhanced" "Detected in some" 31 "Ciliated cells: 28.1;Early spermatids: 63.9;Late spermatids: 12.8" "Cancer enhanced" "Detected in many" "endometrial cancer: 5.2" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "neutrophil: 3.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" HPA045779 Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Nucleoplasm, Golgi apparatus, Plasma membrane" "HPA045779: AB_2679448" "unprognostic (8.23e-3)" "unprognostic (5.55e-3)" "unprognostic (2.39e-2)" "unprognostic (2.01e-3)" "unprognostic (2.50e-3)" "unprognostic (2.02e-1)" "unprognostic (8.15e-2)" "unprognostic (1.62e-1)" "unprognostic (2.24e-2)" "unprognostic (8.78e-3)" "unprognostic (1.36e-2)" "unprognostic (7.40e-2)" "unprognostic (3.20e-2)" "unprognostic (3.75e-2)" "unprognostic (2.06e-1)" "unprognostic (9.79e-2)" "unprognostic (3.05e-2)" 0.1 0.0 0.4 0.1 0.6 0.5 0.1 0.1 0.2 2.2 0.1 0.8 0.1 0.0 0.7 11.9 0.1 41.8 0.1 0.1 0.8 1.1 0.1 0.3 5.6 0.1 0.1 0.1 4.2 0.1 0.0 0.1 0.1 0.9 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 21.0 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.8 0.3 3.2 1.0 0.0 1.6 0.3 0.1 0.0 1.8 0.0 1.4 0.0 1.0 0.6 0.8 2.1 0.0 3.4 0.9 1.3 0.4 0.0 0.2 0.5 1.4 2.3 0.0 1.4 2.1 0.8 2.7 2.3 2.1 0.6 0.8 2.6 1.9 0.8 0.0 0.0 0.0 1.4 1.2 0.4 1.0 3.7 0.8 0.3 3.3 1.3 3.8 0.4 1.5 0.9 0.0 0.0 0.9 0.0 0.0 0.0 2.7 0.3 2.5 0.0 1.9 0.0 2.0 1.3 1.2 2.3 2.3 0.5 0.4 0.5 0.0 0.0 0.1 1.5 0.2 1.0 0.0 0.2 0.1 0.4 0.3 0.8 0.2 1.6 3.2 0.0 0.5 0.0 0.4 0.3 0.4 0.6 0.1 0.2 0.8 1.1 0.1 0.1 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.1 0.0 0.0 0.0 0.0 0.0 0.0 63.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 C1orf35 "MGC4174, MMTAG2" ENSG00000143793 "Chromosome 1 open reading frame 35" Q9BU76 1 228100726-228105411 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046175 Approved Approved "Nuclear speckles,Plasma membrane,Cytosol" NA NA "Nuclear speckles, Plasma membrane" Cytosol "HPA046175: AB_10959459" "unprognostic (1.12e-1)" "unprognostic (2.91e-1)" "prognostic unfavorable (7.71e-4)" "unprognostic (6.41e-2)" "unprognostic (1.21e-1)" "unprognostic (2.64e-2)" "unprognostic (5.44e-3)" "unprognostic (1.81e-1)" "unprognostic (1.39e-1)" "prognostic favorable (7.38e-4)" "unprognostic (6.12e-2)" "unprognostic (1.39e-1)" "prognostic unfavorable (1.79e-6)" "unprognostic (2.70e-1)" "unprognostic (8.58e-2)" "unprognostic (5.56e-2)" "unprognostic (3.70e-2)" 10.1 12.7 14.3 15.6 17.0 12.7 12.0 23.9 15.7 12.5 11.2 11.6 16.1 12.5 13.7 10.6 17.3 14.9 8.1 8.0 13.8 10.0 10.6 10.2 11.0 12.5 17.7 13.6 19.0 21.0 12.5 10.0 12.4 15.0 13.2 6.4 10.4 19.1 16.1 14.0 24.1 11.3 13.3 9.2 12.6 13.2 8.8 13.2 14.6 12.4 6.9 12.0 12.8 13.9 20.2 26.7 21.9 18.4 17.6 21.5 10.3 9.6 10.7 6.9 4.1 3.7 3.8 16.1 7.4 3.4 6.6 4.9 9.7 9.2 9.4 16.2 2.6 4.6 10.8 6.5 7.2 2.5 10.7 34.4 5.8 7.5 9.5 6.3 13.0 7.4 3.4 8.6 6.3 6.1 3.9 7.3 10.9 14.8 5.2 4.9 11.3 17.3 16.7 13.5 12.2 25.0 12.3 10.9 15.6 5.8 7.2 12.1 11.4 7.0 11.2 9.6 2.1 13.3 12.3 6.3 5.3 7.7 13.8 15.7 9.7 5.0 8.7 6.4 7.7 8.2 6.3 16.3 21.9 16.2 18.4 20.9 20.2 18.1 17.7 20.4 16.7 21.5 18.1 2.2 17.6 17.5 26.7 18.0 10.3 14.3 17.0 23.9 15.7 13.8 10.0 17.7 13.6 15.0 13.2 20.8 19.0 30.7 27.5 59.3 48.2 15.4 12.7 17.4 11.4 36.6 17.7 65.7 38.1 35.0 3.0 27.0 34.4 23.3 34.3 47.2 35.1 28.5 24.3 19.5 36.1 44.5 25.2 28.3 24.7 2.6 47.5 35.5 30.4 27.1 35.6 37.2 33.3 33.4 43.9 30.1 49.8 64.7 30.0 35.6 47.1 70.4 23.7 36.7 41.6 21.3 C1orf54 FLJ23221 ENSG00000118292 "Chromosome 1 open reading frame 54" Q8WWF1 1 150268200-150280916 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Kupffer cells: 98.9;Leydig cells: 88.1;Macrophages: 71.5;Peritubular cells: 97.9;Smooth muscle cells: 69.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "myeloid DC: 36.2" "Lineage enriched" "Detected in many" 5 "dendritic cells: 36.2" "Cell line enhanced" "Detected in many" "AF22: 20.9;AN3-CA: 31.6;ASC diff: 22.4;ASC TERT1: 37.5;HSkMC: 30.3;HUVEC TERT2: 29.2" "Low region specificity" "Detected in all" "HPA026518, HPA043874" Approved Approved "Plasma membrane" "Secreted to blood" NA NA "Plasma membrane" "HPA026518: AB_1845647, HPA043874: AB_2732511" "unprognostic (4.64e-3)" "unprognostic (6.81e-3)" "unprognostic (4.01e-3)" "unprognostic (5.69e-3)" "unprognostic (2.22e-1)" "unprognostic (1.72e-1)" "unprognostic (1.51e-2)" "unprognostic (1.88e-1)" "unprognostic (1.26e-1)" "unprognostic (1.33e-1)" "unprognostic (3.45e-1)" "unprognostic (3.21e-1)" "prognostic unfavorable (2.43e-4)" "unprognostic (3.16e-2)" "unprognostic (8.06e-2)" "unprognostic (1.33e-2)" "unprognostic (4.48e-2)" 16.0 8.8 16.4 19.0 19.3 4.5 13.8 5.8 10.5 11.9 14.0 4.5 19.1 5.8 19.8 21.1 11.0 17.1 21.6 13.8 13.7 13.7 12.7 12.0 11.8 21.5 21.8 8.3 8.3 6.8 2.0 6.7 24.4 14.0 15.3 11.1 10.9 9.8 30.4 13.4 4.5 8.1 24.1 20.4 27.3 8.3 5.7 14.8 4.9 8.3 17.1 11.2 22.0 14.3 0.3 36.2 0.4 7.7 0.2 1.5 2.2 0.5 0.1 20.9 31.6 22.4 37.5 0.6 3.4 5.0 0.9 3.0 0.2 0.6 0.2 1.1 3.0 0.4 0.9 0.0 0.1 1.1 0.3 3.7 0.6 0.5 0.3 4.6 1.1 0.8 30.3 1.5 6.3 0.5 3.7 29.2 0.5 0.4 4.1 3.2 1.2 0.2 7.2 1.7 0.0 1.1 5.2 0.5 0.4 0.3 1.6 0.4 0.4 0.4 0.2 2.3 4.2 0.4 15.8 0.2 7.5 0.6 0.2 0.3 1.7 1.4 0.3 16.6 0.9 0.2 0.0 7.7 0.3 0.2 6.8 0.9 0.3 1.5 0.6 36.2 0.3 1.5 0.8 0.4 0.2 1.9 0.7 0.6 2.2 16.4 19.3 5.8 10.5 13.7 13.7 21.8 8.3 14.0 14.8 3.0 5.0 2.4 2.0 5.7 0.8 6.2 2.5 0.0 2.3 21.0 0.0 1.0 64.6 0.5 7.4 64.6 2.1 0.0 2.0 0.7 22.1 1.8 1.1 0.8 45.5 0.0 1.2 49.1 98.9 15.7 88.1 71.5 11.8 20.8 1.1 11.1 1.5 0.8 97.9 2.6 1.3 32.3 69.0 16.6 1.3 4.4 3.0 2.5 1.2 5.5 C1orf68 "LEP7, XP32" ENSG00000198854 "Chromosome 1 open reading frame 68" Q5T750 1 152719522-152720470 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "skin 1: 123.1" "Cell type enriched" "Detected in some" 14 "Suprabasal keratinocytes: 68.4" "Group enriched" "Detected in some" 13 "head and neck cancer: 2.4;melanoma: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "HaCaT: 6.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA057942 Approved "Plasma membrane,Cytosol" NA NA 61000 "Plasma membrane" Cytosol "HPA057942: " "unprognostic (1.73e-1)" "unprognostic (7.46e-2)" "unprognostic (9.34e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 123.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 68.4 0.0 0.0 0.0 0.0 C1orf74 "FLJ25078, URLC4" ENSG00000162757 "Chromosome 1 open reading frame 74" Q96LT6 1 209779208-209784559 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Urothelial cells: 11.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028496 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA028496: AB_10602698" "unprognostic (3.25e-1)" "prognostic unfavorable (8.52e-6)" "unprognostic (8.41e-3)" "unprognostic (9.96e-2)" "unprognostic (1.28e-1)" "unprognostic (1.19e-1)" "unprognostic (1.75e-2)" "unprognostic (9.98e-2)" "unprognostic (3.82e-2)" "unprognostic (1.39e-2)" "unprognostic (4.95e-1)" "unprognostic (2.81e-1)" "unprognostic (6.31e-2)" "unprognostic (1.10e-1)" "unprognostic (2.67e-2)" "unprognostic (1.07e-1)" "unprognostic (5.40e-2)" 2.5 3.9 5.7 5.5 8.5 2.3 5.8 10.4 8.9 2.7 3.8 5.8 4.0 3.3 2.3 5.2 10.4 2.8 2.3 4.1 3.7 2.9 4.9 4.1 2.2 9.8 5.1 4.6 2.5 4.5 4.5 6.5 3.4 4.8 4.6 5.2 3.9 5.1 2.7 2.3 15.0 4.1 2.4 4.9 4.9 3.9 3.9 5.0 4.9 3.2 0.0 5.7 3.9 4.7 6.3 5.5 5.9 1.9 2.8 2.9 1.9 5.6 3.0 1.9 1.1 2.6 3.0 4.4 3.2 4.2 4.0 4.1 6.0 4.4 6.0 1.9 2.1 2.4 11.5 1.2 9.4 4.7 5.9 3.9 4.0 2.2 0.5 3.6 5.5 1.8 1.8 8.3 4.9 8.1 3.3 2.3 8.2 7.8 4.4 3.4 2.9 4.6 5.7 8.0 4.0 5.1 4.9 9.1 8.4 3.4 4.9 7.7 8.2 4.4 3.4 4.9 4.6 5.3 2.9 2.2 3.4 3.9 3.5 5.2 4.0 4.1 6.6 3.0 4.6 4.7 5.9 1.6 1.4 2.9 1.9 2.1 3.8 1.4 2.3 3.2 6.3 2.4 2.8 1.1 2.8 1.0 5.5 1.2 1.9 5.7 8.5 10.4 8.9 3.7 2.9 5.1 4.6 4.8 5.0 3.0 2.1 1.4 6.1 1.9 1.4 2.0 0.0 1.4 1.2 0.0 0.0 3.1 6.6 1.7 0.0 0.6 2.0 0.0 1.8 5.7 0.6 4.8 1.1 2.0 2.3 1.6 3.5 1.3 0.3 0.2 2.3 0.8 0.0 1.8 4.4 2.3 2.7 2.6 0.0 4.8 1.2 0.0 0.4 3.7 3.6 4.3 3.3 0.0 2.9 11.4 C1QBP "gC1Q-R, gC1qR, HABP1, p32, SF2p32" ENSG00000108561 "Complement C1q binding protein" Q07021 17 5432777-5448830 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Adaptive immunity, Apoptosis, Complement pathway, Host-virus interaction, Immunity, Innate immunity, mRNA processing, mRNA splicing, Ribosome biogenesis, Transcription, Transcription regulation" "Cancer-related genes, Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026483 Supported Approved "Plasma membrane,Mitochondria" "Intracellular and membrane" NA NA 930000 "Plasma membrane" Mitochondria "HPA026483: AB_1847108" "unprognostic (2.18e-1)" "unprognostic (1.74e-1)" "unprognostic (3.80e-2)" "unprognostic (6.40e-2)" "unprognostic (2.60e-1)" "unprognostic (6.76e-2)" "unprognostic (7.47e-2)" "unprognostic (4.62e-2)" "unprognostic (2.40e-3)" "unprognostic (6.03e-2)" "unprognostic (4.60e-3)" "unprognostic (3.08e-2)" "unprognostic (7.80e-3)" "unprognostic (1.20e-1)" "unprognostic (3.13e-1)" "unprognostic (3.28e-1)" "unprognostic (3.97e-1)" 24.1 51.6 34.0 51.0 31.4 36.3 42.3 25.8 46.2 22.0 48.8 21.1 22.5 33.9 25.8 25.7 51.1 27.1 33.0 47.1 34.8 35.4 48.4 69.0 26.6 81.1 35.4 25.1 25.2 51.9 32.7 31.2 26.7 36.6 23.8 52.2 24.9 25.1 28.0 55.0 27.3 30.0 29.2 27.8 43.8 26.4 21.3 17.2 55.4 28.1 71.9 46.0 25.5 25.4 59.5 68.1 9.9 35.8 39.0 55.6 65.7 49.5 77.1 27.3 44.0 20.4 25.2 36.9 38.0 31.1 88.6 54.6 73.7 16.6 106.5 37.7 28.7 32.0 44.4 87.6 51.6 82.0 24.3 150.8 49.0 40.0 85.6 32.5 59.7 39.0 27.7 47.5 48.7 70.4 21.4 45.1 63.3 58.2 27.3 34.4 34.6 84.7 43.2 61.5 56.3 46.1 67.6 38.6 58.1 51.1 37.6 21.9 41.1 31.2 40.2 53.0 28.6 25.4 30.3 26.5 28.5 26.0 32.3 82.6 14.3 21.8 46.8 27.2 57.5 43.6 9.9 34.7 8.3 40.1 35.8 52.5 59.5 45.0 39.9 68.1 49.4 55.6 46.3 2.8 39.0 26.9 56.9 34.3 65.7 34.0 31.4 25.8 46.2 34.8 35.4 35.4 25.1 36.6 17.2 26.8 23.3 138.5 155.3 215.9 60.0 72.6 68.8 16.0 27.3 78.5 25.5 269.8 265.2 184.9 64.3 105.7 64.2 23.3 178.3 380.4 101.4 99.0 62.2 125.2 179.0 57.2 76.1 74.3 73.1 64.4 110.7 119.7 148.5 174.1 146.5 91.7 174.3 77.2 92.6 338.8 60.8 84.1 121.5 45.2 160.8 223.2 149.7 85.6 301.5 214.0 C2orf72 LOC257407 ENSG00000204128 "Chromosome 2 open reading frame 72" A6NCS6 2 231037490-231049719 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 22.5;placenta: 23.9" "Cell type enhanced" "Detected in many" 16 "Cholangiocytes: 33.1;Hepatocytes: 111.5;Paneth cells: 62.8" "Cancer enhanced" "Detected in many" "liver cancer: 40.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 13.1;CACO-2: 3.0;EFO-21: 4.9;OE19: 5.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044962 Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA044962: AB_10960863" "unprognostic (4.90e-2)" "unprognostic (7.03e-2)" "unprognostic (2.15e-1)" "unprognostic (7.44e-3)" "unprognostic (2.88e-2)" "unprognostic (6.41e-2)" "unprognostic (3.38e-1)" "unprognostic (6.51e-2)" "unprognostic (6.25e-3)" "unprognostic (1.84e-1)" "prognostic favorable (5.27e-4)" "unprognostic (2.65e-1)" "prognostic unfavorable (4.74e-4)" "unprognostic (2.78e-1)" "unprognostic (7.23e-3)" "unprognostic (2.70e-2)" "unprognostic (5.19e-2)" 1.0 0.9 6.5 0.9 8.4 0.8 1.6 1.7 10.1 0.8 7.8 9.9 0.0 2.3 0.8 1.1 0.9 0.9 1.8 0.8 7.7 4.7 1.4 22.5 1.2 0.8 5.1 7.9 0.8 6.1 1.7 1.7 23.9 8.2 2.0 2.5 0.8 1.0 0.9 0.8 0.8 2.6 1.0 2.2 0.8 4.2 0.9 5.9 0.0 0.8 0.0 0.8 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.0 0.0 0.0 13.1 0.0 0.0 0.1 0.0 3.0 0.0 0.0 4.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 5.6 0.1 0.0 0.0 0.3 0.0 0.0 0.1 2.2 0.1 1.5 0.8 0.8 0.9 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 8.4 1.7 10.1 7.7 4.7 5.1 7.9 8.2 5.9 0.0 0.0 1.9 0.0 0.1 0.6 0.3 33.1 0.0 0.0 0.0 0.0 1.4 1.7 2.0 7.3 0.0 15.3 0.0 1.8 9.0 0.0 0.9 0.0 111.5 0.5 0.0 4.7 3.7 2.5 25.8 0.3 0.0 1.7 0.0 13.2 9.7 1.0 62.8 3.9 1.4 0.3 0.0 0.1 0.5 0.9 0.0 4.3 0.0 24.3 0.1 C3orf14 HT021 ENSG00000114405 "Chromosome 3 open reading frame 14" Q9HBI5 3 62318973-62336213 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 111.9;Spermatocytes: 148.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 21.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 106.9" "Low region specificity" "Detected in all" HPA048286 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA048286: AB_2680340" "unprognostic (8.00e-2)" "unprognostic (1.32e-1)" "unprognostic (7.81e-2)" "unprognostic (3.69e-3)" "unprognostic (6.91e-2)" "unprognostic (9.19e-2)" "unprognostic (5.76e-5)" "unprognostic (1.57e-3)" "unprognostic (2.67e-1)" "unprognostic (9.61e-2)" "unprognostic (1.08e-1)" "unprognostic (3.67e-1)" "prognostic favorable (4.33e-5)" "unprognostic (8.19e-2)" "unprognostic (1.73e-2)" "unprognostic (1.01e-1)" "unprognostic (1.59e-1)" 3.8 14.7 28.2 5.6 23.6 1.0 35.0 16.4 31.2 5.0 3.9 7.7 2.5 3.3 5.5 6.8 11.0 4.1 6.8 4.6 20.9 22.0 9.6 2.9 6.4 5.0 19.9 20.5 8.2 6.3 2.3 19.0 4.8 25.9 17.8 4.1 4.1 5.0 5.6 1.0 12.0 2.7 6.8 15.2 3.0 6.1 20.9 8.1 1.2 9.2 3.8 8.2 13.5 3.4 3.7 6.7 5.2 21.0 0.7 6.1 2.1 0.0 5.8 7.0 0.0 5.1 7.4 5.4 9.5 5.7 12.0 11.9 0.0 8.5 0.0 0.0 6.4 24.7 1.5 0.0 6.0 9.2 0.0 4.0 5.1 0.0 0.0 3.4 0.0 11.2 3.3 8.1 13.5 11.1 0.2 5.8 0.0 0.6 0.1 11.8 106.9 0.0 0.0 8.8 8.4 12.0 0.0 0.0 2.9 9.8 16.3 12.3 10.4 6.3 22.6 8.7 6.1 9.2 5.8 0.1 5.9 0.0 27.4 9.4 5.8 0.0 0.0 5.7 0.0 20.5 5.2 4.3 0.4 0.2 14.3 0.1 3.7 3.6 2.8 4.6 1.1 1.0 0.7 0.3 0.7 21.0 6.7 6.1 2.1 28.2 23.6 16.4 31.2 20.9 22.0 19.9 20.5 25.9 8.1 20.8 10.2 2.7 19.7 32.6 31.2 4.5 7.6 4.0 19.4 21.0 3.9 16.3 51.4 31.3 111.9 11.7 2.6 0.0 47.7 18.9 20.3 22.1 1.1 3.0 27.0 35.0 84.0 4.9 7.8 44.2 13.0 19.5 43.9 83.8 2.6 27.9 29.7 0.0 9.9 34.8 23.1 0.0 15.5 148.6 37.5 25.1 8.2 4.4 3.8 17.0 C3orf38 MGC26717 ENSG00000179021 "Chromosome 3 open reading frame 38" Q5JPI3 3 88149743-88168729 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 8 "Early spermatids: 252.0;Late spermatids: 238.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 59.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034736, HPA034737" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA034736: AB_2674307, HPA034737: AB_10671505" "unprognostic (1.93e-1)" "unprognostic (1.40e-1)" "unprognostic (3.75e-3)" "unprognostic (1.48e-2)" "unprognostic (1.74e-2)" "unprognostic (2.41e-2)" "unprognostic (2.26e-3)" "unprognostic (1.54e-1)" "unprognostic (1.80e-2)" "prognostic favorable (3.55e-4)" "unprognostic (9.28e-3)" "prognostic unfavorable (4.12e-4)" "unprognostic (1.95e-2)" "unprognostic (2.88e-3)" "unprognostic (1.63e-1)" "unprognostic (4.57e-2)" "unprognostic (3.67e-2)" 12.2 11.7 13.7 12.8 16.1 35.2 12.3 12.9 12.8 11.6 11.9 13.6 8.4 9.5 11.5 10.7 14.6 10.7 9.4 9.7 11.3 11.1 10.2 13.5 10.6 19.2 15.1 9.4 12.1 9.3 7.1 15.8 12.5 11.4 11.2 11.2 9.0 10.6 10.2 9.7 11.6 11.4 10.9 11.3 17.0 10.1 33.2 13.5 29.5 11.6 9.0 17.1 12.4 11.6 20.0 17.7 25.8 24.2 17.1 17.4 15.3 6.4 6.7 13.2 7.0 8.8 8.0 6.1 10.5 12.6 15.7 21.3 7.7 8.9 8.7 9.4 9.7 7.5 4.7 9.5 7.7 13.6 15.6 4.5 10.6 5.2 6.5 12.6 14.5 9.2 11.4 7.8 10.5 9.0 10.3 9.0 9.5 6.7 10.0 17.0 7.5 14.6 6.1 16.0 12.1 7.6 9.2 4.6 8.2 10.4 8.8 4.0 5.8 9.6 5.3 15.8 11.2 10.2 11.1 8.2 9.8 10.7 59.4 11.5 9.2 13.6 12.9 7.6 11.5 9.2 25.8 16.8 17.5 13.5 24.2 17.4 20.0 12.6 13.8 17.7 15.9 12.6 12.8 7.5 17.1 19.7 12.3 15.1 15.3 13.7 16.1 12.9 12.8 11.3 11.1 15.1 9.4 11.4 13.5 17.9 6.9 32.0 16.6 10.4 21.8 5.6 0.0 14.7 11.4 5.2 21.6 19.3 16.6 14.7 252.0 8.7 11.8 0.0 12.0 18.8 15.4 14.2 13.9 7.4 23.4 6.4 15.5 8.6 17.2 238.1 15.3 21.8 15.1 27.1 10.7 22.8 11.6 13.3 14.2 9.8 21.7 12.9 12.2 25.9 12.0 12.3 21.4 28.7 9.0 18.6 C4orf22 ENSG00000197826 "Chromosome 4 open reading frame 22" Q6V702 4 80335720-80963756 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 22.0;fallopian tube: 19.8;testis: 34.8" "Cell type enhanced" "Detected in some" 25 "Ciliated cells: 163.3;Early spermatids: 74.5;Spermatocytes: 40.9" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "basal ganglia: 8.4;pons and medulla: 22.0" "Cell type enhanced" "Detected in some" "memory B-cell: 1.2;naive B-cell: 2.1" "Lineage enhanced" "Detected in single" "B-cells: 2.1" "Cell line enhanced" "Detected in some" "A-431: 3.2;BJ: 4.0;hTERT-RPE1: 6.3;LHCN-M2: 2.4;SCLC-21H: 2.7;U-251 MG: 2.6" "Low region specificity" "Detected in many" HPA043383 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA043383: AB_10797140" "unprognostic (4.77e-4)" "unprognostic (1.52e-1)" "unprognostic (4.06e-2)" "unprognostic (1.45e-2)" "unprognostic (7.24e-2)" "unprognostic (3.27e-1)" "unprognostic (6.93e-2)" "unprognostic (5.90e-2)" "unprognostic (2.67e-3)" "unprognostic (1.47e-1)" "unprognostic (2.79e-1)" "unprognostic (1.79e-2)" "unprognostic (4.61e-2)" 0.1 0.1 1.4 0.1 8.4 0.1 0.3 0.6 0.2 0.9 0.1 5.1 0.1 0.3 0.4 7.8 0.2 19.8 0.3 0.1 2.8 2.5 0.4 0.1 5.9 0.3 0.1 0.1 3.5 0.1 0.1 1.2 0.1 22.0 0.2 0.1 0.3 0.2 0.2 0.1 0.2 0.1 0.2 0.4 0.1 0.1 34.8 2.4 2.9 0.7 0.0 0.2 0.1 0.0 2.1 0.5 0.1 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.3 1.9 0.0 4.0 0.7 0.1 0.1 0.0 0.0 1.1 0.0 1.4 0.2 0.0 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 6.3 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 2.6 0.0 0.0 1.0 1.9 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 1.4 8.4 0.6 0.2 2.8 2.5 0.1 0.1 22.0 2.4 0.0 1.0 0.0 0.1 0.0 0.6 0.0 0.0 163.3 23.9 0.0 0.0 0.0 0.0 0.0 74.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 1.5 0.0 0.0 40.9 2.3 0.0 0.0 0.0 0.0 0.0 C7orf43 FLJ10925 ENSG00000146826 "Chromosome 7 open reading frame 43" Q8WVR3 7 100154420-100158715 "Predicted intracellular proteins" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019359, HPA029463, HPA029464" Approved Enhanced "Vesicles,Plasma membrane,Centriolar satellite" NA NA Vesicles "Plasma membrane, Centriolar satellite" "HPA019359: AB_1848677, HPA029463: AB_10600001, HPA029464: AB_10600205" "unprognostic (1.57e-2)" "unprognostic (1.24e-1)" "unprognostic (6.19e-3)" "unprognostic (2.59e-1)" "unprognostic (5.23e-2)" "unprognostic (1.06e-1)" "unprognostic (9.36e-3)" "unprognostic (5.68e-3)" "unprognostic (6.97e-3)" "unprognostic (1.25e-1)" "prognostic favorable (6.19e-5)" "unprognostic (2.42e-2)" "unprognostic (1.85e-2)" "unprognostic (4.26e-2)" "unprognostic (2.81e-1)" "unprognostic (3.26e-1)" "unprognostic (6.54e-3)" 7.0 10.4 10.6 23.0 11.3 12.2 12.2 24.8 23.2 6.7 14.0 9.4 13.6 16.2 9.6 10.8 12.1 8.4 10.5 6.4 12.8 13.9 12.3 12.9 19.0 21.4 10.8 10.6 5.7 11.6 18.7 14.5 21.6 14.6 10.2 13.5 8.8 13.5 10.8 10.1 28.1 16.4 6.9 6.0 25.8 14.9 26.8 6.9 17.6 12.2 7.4 14.0 8.5 7.8 2.1 0.7 5.2 1.7 0.5 2.6 1.0 4.8 6.3 7.5 12.6 4.7 2.5 8.4 9.1 7.2 6.4 4.6 4.9 5.8 6.2 8.4 6.9 9.9 9.5 3.5 7.3 2.5 11.6 6.8 4.6 7.9 4.3 5.6 5.8 21.8 5.1 5.0 6.2 4.8 4.6 5.5 6.4 10.1 11.3 8.3 15.2 13.1 12.4 8.3 9.1 9.2 7.9 3.4 6.9 5.5 5.6 9.5 10.1 8.2 24.0 4.8 5.2 4.8 7.0 7.6 12.7 10.8 16.8 7.0 16.9 15.9 6.3 7.1 8.0 13.4 1.7 1.0 3.5 2.0 1.6 1.4 0.9 2.6 1.8 0.7 2.1 1.5 2.2 5.2 0.5 1.7 0.6 0.2 1.0 10.6 11.3 24.8 23.2 12.8 13.9 10.8 10.6 14.6 6.9 0.0 3.2 2.9 4.0 4.9 7.5 1.4 0.0 4.0 1.2 7.0 0.0 4.8 0.0 4.6 3.5 3.1 8.8 0.0 7.3 5.9 2.3 5.6 0.0 1.5 7.0 11.1 4.1 5.5 5.6 2.5 2.0 5.4 0.0 9.0 5.1 5.0 9.1 10.1 1.1 2.1 5.1 6.5 2.3 14.0 5.9 9.5 16.2 4.4 5.3 4.8 C8orf37 "BBS21, CORD16, FLJ30600, RP64" ENSG00000156172 "Chromosome 8 open reading frame 37" Q96NL8 8 95244919-95269201 "Disease related genes, Predicted intracellular proteins" "Bardet-Biedl syndrome, Ciliopathy, Cone-rod dystrophy, Disease mutation, Obesity, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024198 Approved Approved "Plasma membrane,Cell Junctions,Cytosol" NA NA Cytosol "Plasma membrane, Cell Junctions" "HPA024198: AB_1845775" "unprognostic (7.90e-2)" "unprognostic (1.98e-2)" "unprognostic (5.68e-2)" "prognostic unfavorable (4.63e-4)" "unprognostic (2.72e-3)" "unprognostic (4.20e-3)" "unprognostic (2.04e-2)" "unprognostic (8.94e-2)" "unprognostic (1.81e-1)" "unprognostic (1.76e-1)" "unprognostic (6.11e-3)" "unprognostic (2.32e-1)" "unprognostic (1.09e-1)" "unprognostic (6.72e-3)" "unprognostic (2.02e-1)" "unprognostic (1.33e-2)" "unprognostic (3.29e-1)" 4.8 5.6 7.9 5.8 9.9 2.4 6.4 9.8 8.0 6.7 3.1 10.5 2.9 2.6 6.5 8.6 3.3 10.5 4.0 7.0 8.7 7.1 6.6 4.9 4.3 5.6 7.4 6.9 13.0 3.8 10.1 9.9 4.9 7.9 5.6 2.8 4.6 4.3 7.1 2.9 4.2 3.3 6.2 9.2 4.4 3.2 4.5 9.5 3.8 6.7 1.6 5.1 4.0 4.4 3.9 1.9 2.3 1.4 2.7 2.3 0.8 4.0 6.7 5.5 2.9 1.9 5.2 1.6 1.8 4.1 2.3 3.1 1.0 9.0 8.2 4.3 3.0 5.8 3.4 2.3 4.6 5.1 2.6 2.1 6.4 4.0 3.0 2.2 1.3 3.6 5.2 2.2 2.7 7.7 6.0 3.5 4.9 3.3 4.8 3.0 3.1 6.8 1.6 1.7 8.3 4.6 3.6 2.9 2.1 5.1 1.8 5.4 5.2 3.7 0.7 3.1 4.3 6.4 1.2 2.9 2.9 3.7 2.5 1.8 4.4 4.2 5.5 5.6 3.1 3.6 1.3 1.4 0.6 1.2 0.9 2.1 1.9 1.4 1.3 1.9 3.9 1.4 2.3 2.3 2.7 0.7 0.9 0.5 0.8 7.9 9.9 9.8 8.0 8.7 7.1 7.4 6.9 7.9 9.5 3.0 1.6 0.8 3.1 0.8 1.6 3.9 0.0 9.4 4.5 7.0 2.0 2.0 6.6 1.5 8.2 1.0 0.0 0.0 2.4 2.4 2.2 1.7 0.0 3.2 1.2 3.2 0.0 1.3 1.6 8.0 2.8 1.1 1.7 2.8 0.0 5.7 1.0 0.0 2.8 3.7 3.6 0.0 2.1 4.4 3.6 1.6 0.7 0.0 0.4 1.0 C9orf153 bA507D14.1 ENSG00000187753 "Chromosome 9 open reading frame 153" Q5TBE3 9 86220265-86259657 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 24.5" "Group enriched" "Detected in some" 70 "Early spermatids: 170.5;Late spermatids: 185.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTCEpi: 4.5" HPA079466 Approved "Nucleoplasm,Nuclear bodies,Vesicles,Plasma membrane" NA NA "Nuclear bodies, Plasma membrane" "Nucleoplasm, Vesicles" "HPA079466: " "unprognostic (2.03e-1)" "unprognostic (1.79e-1)" "unprognostic (1.13e-2)" "unprognostic (2.33e-2)" "unprognostic (1.78e-1)" "unprognostic (5.30e-3)" "unprognostic (7.49e-2)" "unprognostic (2.75e-2)" "unprognostic (3.37e-1)" "unprognostic (6.85e-2)" "unprognostic (9.70e-2)" "unprognostic (1.49e-1)" "unprognostic (2.01e-6)" "unprognostic (9.43e-2)" "unprognostic (1.92e-1)" "unprognostic (9.64e-2)" "unprognostic (2.10e-1)" 0.1 0.2 0.1 0.1 0.1 2.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.5 0.1 0.1 0.8 0.1 0.1 0.1 0.1 0.2 0.2 0.4 0.1 0.1 0.1 0.1 0.0 0.6 0.8 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 24.5 0.3 0.1 0.2 0.1 0.1 0.1 0.1 0.4 0.5 0.6 0.2 0.8 1.1 0.0 0.6 2.2 0.0 1.2 0.1 1.3 1.6 1.2 0.0 0.0 0.8 0.0 2.5 2.4 0.9 2.3 1.7 0.5 1.2 2.0 1.6 0.6 1.0 0.1 2.8 0.4 0.1 0.4 1.1 0.3 4.5 1.5 0.0 0.0 1.0 2.8 0.0 1.9 1.7 0.1 0.8 0.4 0.7 0.1 1.6 0.4 0.8 3.0 0.3 0.0 0.3 0.1 0.0 0.0 0.4 1.1 0.0 0.6 0.2 0.9 2.1 0.2 0.8 2.0 0.3 0.7 0.1 0.5 1.0 0.6 0.2 0.1 1.1 0.0 0.4 0.2 0.1 0.0 0.0 0.4 0.8 0.3 0.0 0.8 0.0 0.5 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 170.5 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 185.9 2.6 0.0 1.7 0.0 0.0 0.6 0.1 0.0 0.7 0.0 0.0 0.0 0.2 1.8 1.3 0.1 0.1 0.0 0.0 0.3 CA14 ENSG00000118298 "Carbonic anhydrase 14" Q9ULX7 1 150257159-150265078 "Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Lyase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.9;retina: 29.4;seminal vesicle: 16.5;skeletal muscle: 24.1" "Group enriched" "Detected in some" 16 "Cardiomyocytes: 44.5;Melanocytes: 50.6;Muller glia cells: 123.0" "Group enriched" "Detected in many" 7 "glioma: 4.9;melanoma: 23.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 7 "AF22: 28.7;AN3-CA: 17.0;NTERA-2: 22.3;SK-MEL-30: 57.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008482 Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA008482: AB_1078395" "unprognostic (3.06e-2)" "unprognostic (1.67e-1)" "unprognostic (2.10e-2)" "unprognostic (3.25e-2)" "prognostic favorable (8.47e-4)" "unprognostic (7.28e-2)" "unprognostic (4.48e-2)" "unprognostic (1.49e-1)" "unprognostic (2.10e-1)" "unprognostic (2.47e-1)" "unprognostic (5.46e-2)" "unprognostic (1.73e-1)" "unprognostic (5.89e-3)" "unprognostic (1.91e-1)" "unprognostic (1.49e-1)" "unprognostic (1.22e-1)" "unprognostic (5.80e-2)" 0.1 0.3 4.6 0.2 5.2 0.9 0.3 1.4 6.8 0.1 1.7 10.8 0.1 0.3 0.1 0.5 1.6 1.3 0.7 4.4 6.4 4.1 0.3 6.3 0.2 0.2 11.3 3.2 1.4 0.3 0.8 0.1 0.3 4.4 3.2 0.7 29.4 0.6 16.5 24.1 3.7 0.6 0.5 20.9 0.3 0.8 0.5 2.7 0.1 0.9 0.1 0.1 0.2 0.1 2.8 2.2 2.1 2.0 0.2 1.6 0.2 0.2 0.0 28.7 17.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.1 22.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.1 57.1 4.1 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.2 1.3 0.1 0.1 0.1 0.0 0.0 0.9 1.3 1.6 2.0 0.6 2.0 1.0 1.2 0.2 2.8 1.2 1.3 2.1 0.2 0.5 2.2 0.0 0.2 4.6 5.2 1.4 4.7 6.4 4.1 11.3 3.2 4.4 2.7 3.0 0.3 0.0 0.2 1.9 1.4 44.5 0.0 0.0 1.2 0.0 0.0 0.4 0.0 0.4 0.0 0.1 0.0 0.0 0.6 0.0 0.4 0.1 0.0 3.8 0.1 0.0 0.0 0.0 0.3 0.0 0.9 0.0 50.6 0.0 0.0 123.0 1.2 0.0 3.2 0.0 4.5 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.4 CACNA1E "BII, CACH6, CACNL1A6, Cav2.3" ENSG00000198216 "Calcium voltage-gated channel subunit alpha1 E" Q15878 1 181317690-181808084 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 30.8" "Cell type enhanced" "Detected in single" 15 "Cardiomyocytes: 1.4" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "neutrophil: 1.8" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.8" "Cell line enhanced" "Detected in some" "CACO-2: 4.0;NB-4: 2.5;NTERA-2: 2.9;SCLC-21H: 2.3;U-266/70: 7.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042515, CAB079032" Approved Approved "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane" "Actin filaments, Cytosol" "CAB079032: , HPA042515: " "unprognostic (3.96e-3)" "unprognostic (1.89e-1)" "unprognostic (1.05e-2)" "unprognostic (1.54e-5)" "unprognostic (6.56e-2)" "unprognostic (3.16e-2)" "unprognostic (4.30e-3)" "unprognostic (1.18e-1)" "unprognostic (2.40e-1)" "unprognostic (9.48e-3)" "unprognostic (1.04e-1)" "unprognostic (2.06e-1)" "unprognostic (9.85e-7)" "unprognostic (1.74e-2)" "unprognostic (2.07e-2)" "unprognostic (1.16e-1)" "unprognostic (3.75e-2)" 0.6 3.0 17.9 2.1 19.7 3.1 0.5 3.9 22.5 0.6 0.8 1.3 0.0 0.6 0.6 4.4 1.1 2.3 0.6 0.6 30.8 5.8 3.8 0.6 0.6 1.4 2.4 10.6 0.5 0.6 0.5 0.2 0.8 4.2 0.5 0.8 0.5 0.5 0.5 0.6 0.5 1.1 1.0 5.2 0.9 0.8 2.8 2.4 0.0 0.6 0.0 1.0 0.6 0.1 0.2 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 1.5 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 2.9 0.1 0.0 0.0 0.0 1.1 1.4 0.0 2.3 0.1 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.1 0.1 0.0 0.0 7.1 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 17.9 19.7 3.9 22.5 30.8 5.8 2.4 10.6 4.2 2.4 0.0 0.0 0.0 0.0 0.1 0.8 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 CACNG4 "MGC11138, MGC24983" ENSG00000075461 "Calcium voltage-gated channel auxiliary subunit gamma 4" Q9UBN1 17 66964910-67033398 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.8;prostate: 16.5" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 1: 3.0;Glandular cells: 3.0;Intestinal endocrine cells: 7.5;Muller glia cells: 3.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "SH-SY5Y: 97.2" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "basal ganglia: 159.8" "HPA005803, HPA065370" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA005803: AB_2667439, HPA065370: AB_2685480" "unprognostic (1.27e-1)" "unprognostic (3.16e-1)" "unprognostic (8.87e-2)" "unprognostic (1.05e-2)" "unprognostic (6.42e-2)" "unprognostic (8.64e-3)" "unprognostic (2.91e-1)" "unprognostic (7.08e-2)" "unprognostic (3.37e-2)" "unprognostic (3.85e-2)" "unprognostic (6.03e-2)" "unprognostic (3.87e-2)" "unprognostic (2.38e-10)" "unprognostic (8.57e-3)" "unprognostic (1.23e-1)" "unprognostic (8.71e-2)" "unprognostic (4.28e-1)" 0.7 1.8 16.0 0.8 32.3 0.7 8.1 3.5 37.8 1.2 0.9 11.4 0.2 1.0 1.2 0.8 0.8 6.2 1.2 0.7 9.6 12.9 0.8 0.7 8.0 0.7 7.5 7.1 0.7 1.2 4.9 0.1 1.6 6.8 16.5 0.8 0.1 0.9 2.4 0.8 0.9 0.9 2.0 4.2 0.7 1.7 0.9 10.3 0.0 0.7 0.0 0.7 1.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.0 3.9 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.0 0.0 10.3 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 3.9 1.7 0.0 0.0 0.1 2.1 0.0 2.7 3.9 97.2 0.9 2.5 0.0 10.0 9.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 32.3 3.5 13.0 9.6 12.9 7.5 7.1 6.8 10.3 3.0 2.2 0.0 1.1 0.0 0.0 1.1 0.0 1.4 2.3 0.0 0.0 0.1 0.0 0.1 2.1 0.0 0.0 0.0 0.2 0.1 0.2 3.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.5 CALML5 CLSP ENSG00000178372 "Calmodulin like 5" Q9NZT1 10 5498697-5499555 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "salivary gland: 129.5;skin 1: 212.5" "Cell type enriched" "Detected in some" 6 "Suprabasal keratinocytes: 341.5" "Group enriched" "Detected in many" 6 "breast cancer: 97.6;cervical cancer: 189.1;head and neck cancer: 206.0;melanoma: 222.1;urothelial cancer: 82.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 21 "A-431: 95.2" "Not detected" "Not detected" HPA040725 Enhanced Approved "Plasma membrane,Cytosol" NA NA 75000000 "Plasma membrane, Cytosol" "HPA040725: AB_10793863" "unprognostic (7.68e-3)" "unprognostic (5.06e-3)" "unprognostic (5.64e-2)" "prognostic favorable (2.59e-5)" "unprognostic (4.82e-2)" "unprognostic (2.67e-1)" "unprognostic (1.37e-1)" "unprognostic (8.27e-2)" "unprognostic (1.14e-1)" "unprognostic (2.79e-1)" "unprognostic (1.71e-1)" "unprognostic (4.99e-2)" 0.2 0.0 0.2 0.2 0.2 0.0 8.0 0.3 0.2 6.7 0.2 0.2 0.2 0.0 1.0 0.2 4.8 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 129.5 0.2 1.8 212.5 0.2 0.2 0.2 0.2 0.0 0.2 0.2 3.1 0.2 10.9 8.2 0.2 19.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 95.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.2 24.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 341.5 0.0 0.0 0.0 1.4 CAMK2A "CAMKA, CaMKIINalpha, KIAA0968" ENSG00000070808 "Calcium/calmodulin dependent protein kinase II alpha" Q9UQM7 5 150219491-150290291 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 21 "brain: 105.7;skeletal muscle: 50.1" "Cell type enhanced" "Detected in some" 20 "Basal keratinocytes: 3.1;Cardiomyocytes: 11.0;Fibroblasts: 2.8;Melanocytes: 3.3" "Cancer enriched" "Detected in single" 13 "glioma: 6.0" "Group enriched" "Detected in all" 6 "amygdala: 60.7;basal ganglia: 50.6;cerebral cortex: 99.6;hippocampal formation: 74.6;olfactory region: 39.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 2.7;SCLC-21H: 9.6;SuSa: 2.6;U-87 MG: 8.1" "Group enriched" "Detected in all" 4 "amygdala: 1311.6;basal ganglia: 698.1;cerebral cortex: 1576.4;hippocampal formation: 1569.1" "Low region specificity" "Detected in all" "CAB004330, HPA051783, HPA051785, HPA053973" Supported Approved "Plasma membrane,Cell Junctions,Cytosol" NA NA 21000 "Plasma membrane" "Cell Junctions, Cytosol" "CAB004330: AB_626788, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328" "unprognostic (7.20e-3)" "unprognostic (6.47e-3)" "unprognostic (6.16e-3)" "unprognostic (4.85e-2)" "unprognostic (4.25e-2)" "unprognostic (1.06e-3)" "unprognostic (1.13e-1)" "unprognostic (6.19e-3)" "unprognostic (3.07e-1)" "unprognostic (1.05e-1)" "unprognostic (4.49e-2)" "unprognostic (1.41e-2)" "unprognostic (2.00e-8)" "unprognostic (2.71e-4)" "unprognostic (1.68e-1)" "unprognostic (1.70e-2)" "unprognostic (1.36e-3)" 1.3 1.7 60.7 1.3 50.6 1.3 1.1 1.4 105.7 1.8 1.3 3.7 0.0 1.2 2.1 1.4 1.9 1.7 1.3 3.7 74.6 10.5 1.6 1.2 1.5 1.2 5.1 39.8 1.3 1.1 1.1 0.4 1.3 2.4 1.6 1.3 0.0 1.2 1.4 50.1 1.6 1.3 2.5 1.7 1.2 1.3 1.2 2.3 0.0 1.2 0.0 1.1 1.4 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.6 0.0 0.5 1.3 0.8 0.7 0.0 0.1 0.0 0.2 0.6 0.1 2.7 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.2 0.5 0.2 1.7 0.0 1.1 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.2 0.0 0.0 9.6 0.0 0.1 0.2 0.3 2.6 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.2 0.1 0.0 8.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 60.7 50.6 1.4 99.6 74.6 10.5 5.1 39.8 2.4 2.3 0.0 0.0 0.0 0.0 3.1 0.1 11.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.3 0.0 0.0 0.4 0.8 0.0 0.0 1.1 0.0 0.2 1.3 0.2 0.0 0.0 0.0 CAMK2D CAMKD ENSG00000145349 "Calcium/calmodulin dependent protein kinase II delta" Q13557 4 113451032-113761927 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 243.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 67.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026281, HPA051783, HPA051785, HPA053973" Approved Approved "Plasma membrane,Cell Junctions,Cytosol" NA NA 140000 "Plasma membrane" "Cell Junctions, Cytosol" "HPA026281: AB_1845944, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328" "unprognostic (2.14e-2)" "unprognostic (3.17e-1)" "unprognostic (2.13e-1)" "unprognostic (7.49e-2)" "unprognostic (2.19e-1)" "unprognostic (5.09e-1)" "unprognostic (4.26e-2)" "unprognostic (1.17e-1)" "unprognostic (2.26e-1)" "unprognostic (2.62e-1)" "unprognostic (7.81e-2)" "unprognostic (7.91e-3)" "unprognostic (2.62e-2)" "unprognostic (1.46e-1)" "unprognostic (9.68e-2)" "unprognostic (1.87e-1)" "unprognostic (1.90e-2)" 22.8 12.9 47.7 18.3 13.0 2.8 23.5 50.2 30.6 11.0 18.2 7.4 28.6 13.6 11.6 9.4 15.6 9.6 14.8 77.1 17.9 21.4 9.6 17.6 14.7 17.5 14.0 23.8 12.9 7.4 33.7 7.0 9.3 12.5 16.3 19.0 9.9 9.4 48.3 48.5 10.8 19.2 26.2 16.0 8.4 17.6 9.4 8.5 11.2 11.6 9.8 14.5 21.5 22.6 18.5 11.2 0.6 8.8 6.4 9.7 5.2 1.0 14.5 16.1 5.4 35.2 67.4 5.7 34.1 22.8 13.4 11.6 9.8 4.1 20.9 5.0 23.7 17.0 0.5 10.0 5.3 13.7 8.0 2.5 0.0 5.3 11.2 17.9 0.0 0.0 43.0 7.3 10.4 25.8 21.3 11.9 2.6 0.8 9.3 25.3 3.9 2.1 0.8 2.3 13.9 5.4 4.0 18.9 0.1 13.7 9.9 4.3 4.4 4.6 6.9 4.6 14.0 0.1 5.6 7.1 35.5 8.4 15.1 6.7 7.3 3.6 17.9 18.3 1.3 16.7 0.0 8.8 0.0 5.1 5.1 9.7 8.0 5.0 5.6 11.2 18.5 5.8 4.9 0.6 6.4 1.7 0.0 9.3 5.2 47.7 13.0 50.2 25.6 17.9 21.4 14.0 23.8 12.5 8.5 38.7 29.9 22.6 16.0 16.4 72.0 243.3 58.6 20.1 28.4 27.9 82.5 0.4 5.0 6.4 2.9 29.8 57.0 0.0 17.5 0.4 34.7 31.3 9.3 49.4 15.8 68.3 99.5 19.6 16.8 4.5 18.7 21.0 5.0 2.8 82.1 41.3 11.4 45.6 18.7 17.7 71.5 6.5 33.3 2.9 4.4 27.9 0.9 17.5 41.1 16.3 CAMK2G CAMKG ENSG00000148660 "Calcium/calmodulin dependent protein kinase II gamma" Q13555 10 73812501-73874591 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 73.0" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 94.2;Cytotrophoblasts: 130.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Lineage enriched" "Detected in all" 4 "granulocytes: 39.8" "Cell line enhanced" "Detected in all" "PC-3: 46.3;SK-BR-3: 58.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040656, HPA051783, HPA051785, HPA053973" Approved Approved "Plasma membrane,Cell Junctions,Cytosol" NA NA 170000 "Plasma membrane" "Cell Junctions, Cytosol" "HPA040656: AB_2677065, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328" "unprognostic (8.63e-3)" "unprognostic (2.01e-1)" "unprognostic (1.05e-1)" "unprognostic (3.46e-3)" "unprognostic (4.27e-2)" "unprognostic (1.82e-2)" "unprognostic (2.19e-2)" "unprognostic (2.36e-1)" "unprognostic (2.48e-1)" "unprognostic (6.25e-2)" "unprognostic (2.92e-2)" "unprognostic (1.08e-1)" "unprognostic (1.73e-2)" "unprognostic (2.48e-1)" "unprognostic (8.28e-2)" "unprognostic (9.64e-2)" "unprognostic (4.62e-2)" 9.1 8.8 27.4 9.4 20.7 17.4 6.8 22.2 53.8 9.0 37.3 13.3 9.7 19.7 20.1 9.1 20.6 13.2 10.6 6.7 22.8 24.4 11.6 5.9 10.7 8.9 26.8 31.2 6.4 5.7 8.0 6.0 15.8 38.6 18.5 15.5 8.5 12.4 29.8 73.0 9.1 18.1 29.6 29.8 11.0 14.2 3.8 13.4 4.4 6.4 7.6 8.7 26.5 10.8 4.2 7.1 39.8 5.6 9.8 9.2 5.0 11.1 8.0 7.3 13.9 5.3 8.7 8.6 7.6 13.2 10.6 8.7 12.5 12.0 8.2 8.1 9.8 4.1 17.4 5.7 6.5 8.4 7.5 6.8 5.6 6.2 5.6 2.6 7.6 9.5 4.6 5.9 10.5 7.3 16.3 9.0 10.6 6.1 12.4 5.8 7.8 12.7 11.4 5.3 6.8 46.3 11.6 7.6 4.3 5.5 16.2 3.8 8.8 4.4 58.3 3.7 5.6 10.9 4.8 11.0 7.9 12.7 4.2 10.3 3.8 4.5 7.7 8.4 21.9 2.8 8.5 5.6 39.8 7.5 2.3 9.2 4.2 8.4 8.0 7.1 3.9 8.1 7.9 36.4 9.8 4.0 2.4 8.1 5.0 27.4 20.7 22.2 53.8 22.8 24.4 26.8 31.2 38.6 13.4 14.9 9.4 11.5 7.6 8.4 55.8 6.1 15.3 6.7 9.1 7.0 94.2 130.5 11.6 10.6 1.9 18.0 50.5 0.0 17.2 36.6 11.5 7.3 16.1 7.8 22.8 25.4 23.0 12.3 13.6 2.3 11.8 10.5 11.8 5.4 20.0 16.3 16.9 51.8 17.7 27.0 74.1 45.3 50.6 0.5 10.6 11.0 67.9 22.4 26.2 10.7 CAP2 ENSG00000112186 "Cyclase associated actin cytoskeleton regulatory protein 2" P40123 6 17393216-17557792 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 165.7" "Cell type enhanced" "Detected in many" 14 "Cardiomyocytes: 110.1;Ciliated cells: 48.2;Sertoli cells: 32.3;Smooth muscle cells: 40.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "MAIT T-cell: 2.9" "Lineage enriched" "Detected in single" 29 "T-cells: 2.9" "Cell line enhanced" "Detected in many" "LHCN-M2: 32.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050530, HPA054147" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA050530: AB_2681159, HPA054147: AB_2682400" "unprognostic (7.27e-2)" "unprognostic (5.71e-3)" "unprognostic (1.63e-2)" "unprognostic (1.55e-1)" "unprognostic (4.86e-1)" "unprognostic (2.23e-2)" "unprognostic (9.94e-2)" "unprognostic (3.58e-2)" "unprognostic (7.72e-2)" "unprognostic (1.65e-1)" "unprognostic (6.43e-2)" "unprognostic (2.30e-1)" "unprognostic (1.59e-1)" "unprognostic (1.06e-2)" "unprognostic (1.47e-1)" "unprognostic (8.05e-2)" "unprognostic (1.75e-3)" 5.8 4.1 13.8 3.0 20.1 0.7 3.9 7.5 26.4 5.6 7.7 1.9 2.0 1.9 9.2 5.9 7.0 5.8 3.8 31.2 19.9 8.7 3.3 2.0 2.1 1.1 5.3 17.3 2.1 1.6 3.2 1.7 6.2 8.6 8.4 3.6 2.9 2.5 10.1 165.7 0.9 2.6 13.1 2.0 1.6 3.3 1.1 1.3 0.0 2.3 14.5 1.3 4.6 6.4 0.0 0.0 0.0 0.0 0.0 2.9 0.1 5.1 8.1 15.7 18.7 0.1 0.0 3.4 18.5 13.5 15.2 13.9 2.6 2.3 0.0 17.4 19.8 21.3 2.7 6.9 6.9 22.1 0.0 2.6 0.0 5.2 8.8 1.5 0.0 0.0 1.1 3.4 7.7 3.3 24.9 0.7 0.0 0.0 0.0 32.1 8.3 0.0 0.0 5.9 0.2 4.6 1.7 20.8 0.3 8.0 2.1 2.0 3.9 6.2 20.1 10.9 30.1 22.2 3.7 0.0 12.3 11.7 0.3 16.2 0.0 0.0 0.0 4.1 0.0 16.8 0.0 0.0 0.0 0.1 0.0 2.9 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 13.8 20.1 7.5 26.4 19.9 8.7 5.3 17.3 8.6 1.3 3.0 1.0 0.0 3.5 1.6 13.5 110.1 2.5 48.2 5.7 1.8 3.9 14.9 3.3 2.4 0.1 1.0 0.0 0.0 0.6 10.7 8.2 1.4 0.0 1.8 1.9 7.9 5.8 4.9 0.0 0.0 0.6 0.0 0.0 0.0 1.1 5.0 3.6 2.0 4.6 16.1 2.0 32.3 40.1 0.1 2.1 0.6 31.4 0.0 1.5 0.7 CAPS "CAPS1, MGC126562" ENSG00000105519 Calcyphosine 19 5911707-5915877 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 71.4;fallopian tube: 116.0" "Cell type enriched" "Detected in many" 8 "Ciliated cells: 1030.6" "Cancer enriched" "Detected in all" 5 "endometrial cancer: 171.3" "Region enhanced" "Detected in all" "pons and medulla: 71.4" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 36.6;U-266/70: 10.1" "Low region specificity" "Detected in many" HPA043520 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA043520: AB_10964138" "unprognostic (2.06e-1)" "unprognostic (1.13e-2)" "unprognostic (7.94e-3)" "prognostic favorable (7.63e-5)" "unprognostic (5.18e-1)" "prognostic favorable (8.60e-4)" "unprognostic (7.07e-2)" "unprognostic (2.46e-3)" "unprognostic (1.51e-1)" "unprognostic (1.82e-1)" "unprognostic (4.70e-2)" "unprognostic (9.99e-2)" "unprognostic (4.01e-2)" "unprognostic (8.47e-2)" "unprognostic (3.25e-1)" "unprognostic (6.86e-3)" "unprognostic (5.96e-3)" 2.6 4.1 8.0 4.3 14.7 4.3 2.8 1.4 3.3 12.4 3.3 34.4 15.6 3.1 9.1 49.4 2.8 116.0 13.6 2.0 13.4 6.6 8.9 5.0 25.4 4.4 8.0 7.8 26.7 6.5 2.5 7.5 17.7 71.4 9.4 2.0 3.3 7.7 12.7 2.0 5.7 5.0 2.9 7.5 7.6 9.4 2.1 17.9 0.4 7.8 0.9 2.5 8.8 11.3 4.9 4.0 5.2 2.2 5.3 4.8 2.4 1.1 1.1 0.7 3.5 1.3 1.8 2.2 0.6 0.4 0.2 0.3 0.8 7.5 0.8 2.2 0.9 0.5 1.4 0.3 0.3 0.1 2.4 1.0 0.6 2.2 2.0 1.2 0.6 1.8 2.3 2.1 0.2 0.5 2.5 0.5 2.6 0.5 2.9 0.4 2.1 1.4 2.0 0.6 8.8 5.7 1.7 0.3 2.3 1.0 3.2 0.7 2.6 0.5 36.6 3.7 2.0 2.3 2.3 1.0 0.6 0.4 2.7 9.7 10.1 3.4 0.7 4.3 1.0 1.4 3.3 2.2 1.6 4.8 1.8 2.6 3.1 3.0 3.6 2.1 4.9 2.4 2.0 5.2 5.3 1.6 4.0 3.2 2.4 8.0 14.7 1.4 3.3 13.4 6.6 8.0 7.8 71.4 17.9 11.9 16.8 0.8 29.9 4.2 2.2 1.9 0.0 1030.6 124.0 115.1 3.9 21.6 29.9 26.7 4.7 3.8 3.9 0.0 5.2 16.2 21.6 27.6 5.8 0.0 4.6 6.4 18.4 0.0 0.0 4.0 4.4 4.4 10.1 1.8 19.7 7.2 24.2 2.9 4.6 3.6 3.9 6.5 4.2 0.5 0.4 3.6 17.2 0.0 7.4 100.9 CASP4 "ICE(rel)II, ICH-2, TX" ENSG00000196954 "Caspase 4" P49662 11 104942866-104969436 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Immunity, Inflammatory response, Innate immunity, Necrosis" "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "blood: 82.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA027588, CAB037167" Approved Approved "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA Cytosol "Plasma membrane" "CAB037167: AB_258864, HPA027588: AB_10603781" "unprognostic (1.19e-2)" "unprognostic (3.73e-1)" "unprognostic (3.44e-1)" "unprognostic (1.99e-2)" "unprognostic (7.19e-3)" "unprognostic (2.63e-2)" "unprognostic (1.26e-2)" "unprognostic (1.56e-2)" "unprognostic (5.31e-2)" "unprognostic (2.71e-1)" "unprognostic (2.38e-3)" "unprognostic (8.39e-3)" "prognostic unfavorable (3.27e-11)" "unprognostic (6.75e-2)" "unprognostic (1.34e-1)" "unprognostic (1.79e-2)" "unprognostic (4.08e-3)" 10.6 6.3 0.5 9.7 0.5 6.1 9.4 0.0 0.0 4.7 3.5 8.9 3.5 5.9 14.1 5.8 7.3 4.9 0.5 0.5 6.7 16.5 14.0 10.5 1.0 7.5 16.8 0.0 3.0 10.7 5.8 4.0 11.2 1.9 1.6 10.4 8.8 4.3 2.0 19.0 8.2 0.2 4.2 11.3 8.2 8.0 20.5 29.3 82.8 43.2 29.6 35.7 46.8 6.4 2.1 0.0 2.8 13.7 31.4 5.3 11.0 21.6 17.8 25.0 5.3 29.1 3.3 23.8 14.3 21.5 10.7 0.0 19.1 17.0 3.8 0.1 8.6 1.6 13.9 33.8 8.7 4.2 28.5 28.6 21.2 29.7 21.3 30.9 0.1 0.2 0.0 13.5 0.6 5.0 10.2 0.0 14.4 6.3 3.8 4.1 2.9 14.9 10.2 0.1 0.0 10.2 7.2 10.1 0.2 2.9 12.7 16.0 18.8 6.5 16.5 7.7 0.0 0.0 0.0 9.6 19.8 13.1 14.9 39.1 7.0 31.5 43.2 34.6 20.5 24.2 30.1 29.3 20.0 14.8 22.0 82.8 29.6 33.5 4.9 35.7 46.8 56.6 57.5 87.2 53.6 49.6 0.0 3.6 40.8 72.3 54.6 21.0 0.0 113.8 13.3 118.8 0.5 68.8 12.0 0.0 164.0 65.7 45.5 29.4 33.5 26.8 101.8 0.0 20.1 65.1 148.5 1.3 27.0 95.5 28.7 63.1 28.2 1.9 153.2 9.9 19.4 30.9 0.1 6.5 22.7 0.2 0.6 40.1 96.9 117.6 17.5 68.0 CAV3 "LGMD1C, LQT9, VIP-21, VIP21" ENSG00000182533 "Caveolin 3" P56539 3 8733800-8841808 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cardiomyopathy, Disease mutation, Limb-girdle muscular dystrophy, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "skeletal muscle: 65.8;tongue: 44.6" "Cell type enhanced" "Detected in some" 28 "Cardiomyocytes: 18.9;Early spermatids: 4.4;Sertoli cells: 6.5" "Cancer enhanced" "Detected in single" "head and neck cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "RH-30: 46.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" "CAB017518, CAB018557, HPA054488" Enhanced Approved "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "CAB017518: AB_628860, CAB018557: AB_626814, HPA054488: AB_2682504" "unprognostic (1.79e-1)" "unprognostic (1.43e-1)" "unprognostic (1.40e-2)" "unprognostic (6.43e-2)" "unprognostic (8.79e-2)" "unprognostic (3.05e-3)" "unprognostic (8.38e-3)" "unprognostic (9.79e-2)" "unprognostic (1.36e-1)" 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 6.3 2.3 0.0 0.3 10.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.7 1.3 0.1 65.8 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.1 44.6 1.5 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 18.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 1.4 0.0 0.1 0.3 0.0 0.0 0.0 0.0 CAVIN3 "cavin-3, HSRBC, MGC20400, PRKCDBP, SRBC" ENSG00000170955 "Caveolae associated protein 3" Q969G5 11 6318946-6320647 "Predicted intracellular proteins" "Biological rhythms" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 73.7" "Cell type enhanced" "Detected in many" 18 "Exocrine glandular cells: 224.8;Extravillous trophoblasts: 73.0;monocytes: 53.3;Pancreatic endocrine cells: 141.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "classical monocyte: 8.1;myeloid DC: 22.4" "Group enriched" "Detected in many" 5 "dendritic cells: 22.4;monocytes: 8.1" "Cell line enhanced" "Detected in many" "A-431: 30.2;BJ: 29.1;HaCaT: 23.3;NTERA-2: 19.3;TIME: 34.5;U-87 MG: 32.7;WM-115: 34.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055136, HPA073327" Supported Approved "Plasma membrane" NA NA "Plasma membrane" "HPA055136: AB_2682711, HPA073327: AB_2686595" "unprognostic (7.92e-2)" "prognostic unfavorable (3.75e-5)" "unprognostic (3.12e-2)" "unprognostic (2.30e-1)" "unprognostic (4.69e-2)" "unprognostic (2.69e-1)" "unprognostic (2.24e-2)" "unprognostic (1.19e-3)" "unprognostic (2.49e-2)" "unprognostic (6.03e-3)" "unprognostic (3.37e-1)" "unprognostic (6.66e-2)" "prognostic unfavorable (5.21e-6)" "unprognostic (3.85e-2)" "unprognostic (1.70e-1)" "unprognostic (1.62e-1)" "unprognostic (1.96e-2)" 30.2 5.1 0.9 14.2 1.6 0.8 12.6 0.8 2.9 38.3 16.1 1.8 14.2 5.8 31.6 32.2 20.3 13.4 15.3 16.8 0.9 1.0 8.6 2.6 9.8 6.8 2.2 3.5 14.0 5.6 1.0 1.7 22.0 2.8 20.9 2.3 11.1 5.0 11.0 12.1 6.8 7.9 34.7 1.3 9.8 11.3 73.7 0.4 0.7 5.5 14.5 4.3 26.5 16.5 0.0 22.4 0.1 8.1 0.1 3.1 2.7 30.2 2.8 0.0 0.1 1.2 5.2 0.0 29.1 9.0 4.0 4.1 0.0 0.0 0.0 9.7 4.1 0.4 23.3 0.0 1.8 0.5 7.6 0.0 0.0 3.0 0.0 3.1 0.0 0.1 3.4 2.4 1.5 1.2 0.0 7.0 0.0 0.0 0.2 2.5 0.0 0.0 0.0 19.3 0.1 0.5 0.0 0.0 0.0 3.5 0.0 0.0 0.0 10.4 0.0 6.3 0.1 0.0 0.1 34.5 0.0 0.1 11.3 0.1 0.0 0.2 0.0 32.7 0.0 34.7 0.0 8.1 0.0 0.0 0.5 0.0 0.0 0.4 0.0 22.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 3.1 2.7 0.9 1.6 0.8 2.9 0.9 1.0 2.2 3.5 2.8 0.4 11.9 5.8 0.0 0.0 0.0 0.0 0.0 0.0 18.7 14.8 15.7 0.0 3.0 33.2 6.0 0.0 0.0 0.0 0.0 224.8 73.0 0.0 0.0 0.0 0.0 19.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 53.3 0.0 0.0 141.7 0.0 0.0 23.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 CBWD1 ENSG00000172785 "COBW domain containing 1" Q9BRT8 9 121038-179147 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 54.7" "HPA042759, HPA042813" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA042759: AB_2678149, HPA042813: AB_2678181" "unprognostic (3.75e-2)" "unprognostic (3.47e-2)" "unprognostic (5.23e-2)" "unprognostic (4.15e-2)" "unprognostic (1.39e-1)" "unprognostic (2.67e-2)" "unprognostic (3.91e-2)" "unprognostic (3.72e-1)" "unprognostic (4.15e-2)" "unprognostic (2.07e-3)" "unprognostic (1.82e-1)" "unprognostic (4.68e-2)" "unprognostic (5.80e-7)" "unprognostic (7.19e-2)" "unprognostic (1.04e-1)" "unprognostic (8.94e-2)" "unprognostic (4.98e-3)" 6.3 14.1 5.5 5.3 6.7 3.8 7.2 5.5 4.5 4.9 5.5 4.6 4.5 8.3 10.4 5.0 3.5 7.0 4.9 6.9 16.3 10.1 5.7 4.1 5.9 5.5 10.5 7.5 7.6 8.3 7.2 5.7 8.6 4.5 7.5 7.1 4.1 4.2 4.8 5.6 6.1 6.3 10.0 7.3 6.9 5.1 8.2 28.0 7.0 28.2 4.5 7.6 15.6 12.7 4.8 7.0 3.7 9.2 8.4 15.6 6.7 4.4 9.4 7.2 7.0 4.9 11.7 8.8 2.4 5.7 2.2 3.4 6.4 10.2 20.0 11.9 0.1 11.4 21.5 10.0 33.8 5.3 7.4 3.1 2.2 18.5 6.1 10.0 6.0 3.9 25.9 7.7 15.3 7.3 54.7 7.0 11.2 10.5 14.1 10.7 22.3 12.2 36.3 12.7 7.7 13.8 5.1 5.1 18.1 10.9 32.4 10.4 5.0 7.1 6.4 5.8 3.1 4.2 13.4 12.4 18.1 5.8 1.2 25.3 7.0 4.2 28.2 6.8 8.2 7.6 6.7 28.0 5.6 6.7 7.3 3.8 4.5 21.3 7.4 6.6 15.6 50.6 47.9 33.7 27.4 42.4 48.0 46.0 25.5 38.8 59.1 33.2 102.1 83.3 29.9 60.1 37.4 22.4 21.9 0.0 103.4 31.0 20.3 19.4 30.2 16.0 28.7 36.5 30.0 18.4 26.3 13.0 16.7 36.5 30.4 85.6 35.3 24.9 55.6 28.1 12.4 58.7 53.6 32.3 38.2 33.7 19.8 44.3 104.4 16.0 55.5 21.8 CBWD2 ENSG00000136682 "COBW domain containing 2" Q8IUF1 2 113437691-113496189 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 27.4" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 97.9;monocytes: 81.2;Suprabasal keratinocytes: 104.9" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA042759, HPA042813" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA042759: AB_2678149, HPA042813: AB_2678181" "unprognostic (4.67e-2)" "unprognostic (2.17e-1)" "unprognostic (4.14e-1)" "prognostic unfavorable (3.22e-5)" "unprognostic (7.69e-2)" "unprognostic (2.17e-1)" "unprognostic (2.16e-3)" "unprognostic (1.31e-3)" "unprognostic (3.69e-2)" "unprognostic (1.72e-2)" "unprognostic (5.85e-2)" "unprognostic (1.39e-1)" "unprognostic (8.50e-2)" "unprognostic (1.90e-1)" "unprognostic (4.90e-2)" "unprognostic (3.21e-1)" "unprognostic (7.57e-3)" 2.0 5.7 3.2 2.6 6.0 0.3 4.3 7.0 4.1 5.6 3.6 0.9 4.1 4.9 5.9 2.1 2.5 9.1 3.1 4.5 8.9 6.6 1.8 1.3 3.2 3.0 3.6 7.7 5.3 3.4 4.1 3.6 4.3 5.0 15.0 1.7 2.2 5.0 1.6 2.3 3.3 1.2 6.2 2.5 4.2 2.5 7.8 26.5 13.8 27.4 7.5 10.4 17.5 8.0 4.8 5.4 6.1 14.1 6.5 10.1 6.3 4.0 5.0 6.5 8.2 5.0 10.6 19.3 6.6 22.7 6.8 5.6 7.0 6.7 3.6 15.0 8.8 8.7 15.3 4.7 3.7 4.2 6.1 4.3 7.2 4.3 9.5 8.9 5.7 5.0 11.6 7.2 8.6 11.7 12.5 6.4 15.4 10.7 5.6 14.1 27.8 13.1 13.0 14.8 4.3 16.3 2.4 2.7 18.9 7.7 10.8 10.6 4.2 5.9 2.5 6.0 4.5 18.7 5.6 6.9 23.0 9.9 4.2 27.4 13.8 5.2 27.1 5.6 7.3 7.9 6.1 26.5 7.8 6.8 6.2 7.5 7.5 21.2 6.5 10.4 17.5 8.9 15.6 26.1 9.5 97.9 11.0 42.0 15.3 37.5 18.2 14.0 15.7 14.3 33.2 23.7 12.9 14.6 8.4 0.0 12.5 11.1 14.6 8.9 15.1 10.6 8.4 12.7 2.4 6.7 8.8 11.8 10.0 23.9 25.3 81.2 8.2 9.5 12.7 12.9 16.3 23.0 12.3 0.0 15.5 16.8 11.1 104.9 21.6 10.9 14.4 9.7 CBWD3 bA561O23.1 ENSG00000196873 "COBW domain containing 3" Q5JTY5 9 68232003-68300015 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "blood: 34.4" "Low cell type specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA042759, HPA042813" Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA042759: AB_2678149, HPA042813: AB_2678181" "unprognostic (1.72e-2)" "unprognostic (2.15e-1)" "unprognostic (1.95e-1)" "unprognostic (9.71e-3)" "unprognostic (9.99e-2)" "unprognostic (6.38e-2)" "unprognostic (3.44e-2)" "unprognostic (1.79e-2)" "unprognostic (3.54e-2)" "unprognostic (1.81e-1)" "unprognostic (1.05e-2)" "unprognostic (2.05e-2)" "unprognostic (1.05e-3)" "unprognostic (3.77e-2)" "unprognostic (1.67e-1)" "unprognostic (4.43e-3)" "unprognostic (5.16e-4)" 3.8 6.0 4.4 6.6 4.9 4.0 6.5 5.7 5.1 2.7 4.7 4.2 2.9 2.1 5.4 3.0 1.8 2.9 4.8 4.4 7.7 11.1 2.9 5.7 4.5 3.6 10.7 4.2 5.0 5.5 4.1 3.2 3.7 3.6 5.2 4.9 7.6 2.8 3.9 5.0 6.3 3.2 5.1 4.3 4.5 3.5 20.3 24.4 34.4 33.9 5.7 14.0 19.9 21.3 15.9 7.8 12.1 5.8 1.9 10.3 10.7 4.2 4.5 5.3 4.4 21.0 24.7 10.4 7.7 21.0 26.2 14.3 21.0 12.4 38.0 9.2 9.5 36.2 21.0 7.4 17.9 11.9 4.8 6.5 8.2 10.8 9.0 10.5 28.3 17.3 20.2 6.6 13.7 20.9 23.9 11.4 25.5 26.7 9.5 24.3 26.9 5.1 9.2 12.1 7.8 17.6 10.6 13.1 15.1 7.6 20.8 5.0 7.0 17.9 11.5 20.5 11.9 47.4 30.3 21.0 26.5 12.6 9.1 33.9 24.8 11.6 27.2 10.0 20.3 10.8 11.9 24.4 18.4 11.7 10.9 34.4 5.7 19.0 18.3 14.0 19.9 23.8 25.9 16.0 14.0 12.9 27.1 24.2 7.6 40.2 34.2 10.4 27.5 11.9 1.7 5.1 3.3 7.5 11.7 0.0 10.0 6.7 4.7 7.5 11.6 7.3 4.6 11.1 4.1 7.4 13.0 1.7 4.6 8.7 5.0 22.6 6.5 4.3 6.9 14.0 2.8 5.0 34.5 6.5 5.3 10.1 5.0 18.7 12.9 10.2 8.1 9.5 CBWD5 ENSG00000147996 "COBW domain containing 5" Q5RIA9 9 65668805-65734041 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA042759, HPA042813" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA042759: AB_2678149, HPA042813: AB_2678181" "unprognostic (1.34e-1)" "unprognostic (3.62e-2)" "unprognostic (8.18e-2)" "unprognostic (4.23e-3)" "unprognostic (5.25e-3)" "unprognostic (1.02e-3)" "unprognostic (5.32e-3)" "unprognostic (9.24e-2)" "unprognostic (2.07e-1)" "unprognostic (1.54e-2)" "unprognostic (1.11e-2)" "unprognostic (6.46e-3)" "unprognostic (1.03e-1)" "unprognostic (4.61e-3)" "unprognostic (1.17e-1)" "unprognostic (5.68e-2)" "unprognostic (3.87e-1)" 4.1 6.0 5.2 3.7 6.8 2.5 9.2 8.2 3.7 2.8 3.3 5.4 1.7 4.8 3.3 1.7 2.2 2.4 6.2 6.0 7.6 17.9 1.9 2.6 4.8 2.1 6.6 2.9 4.0 2.9 4.3 5.5 2.2 3.8 2.1 2.8 4.4 2.5 2.6 5.7 2.2 2.1 5.1 4.4 5.4 1.5 5.5 11.7 7.7 14.0 2.5 5.5 9.3 15.0 16.2 5.8 7.4 8.9 4.1 7.0 10.7 7.2 8.5 8.7 2.1 13.9 20.5 6.9 6.2 12.2 11.1 26.3 8.5 16.1 3.3 6.3 5.7 26.2 36.4 6.7 12.9 3.7 7.2 9.9 7.8 6.3 10.7 15.3 7.9 8.1 15.3 8.6 18.2 6.4 13.7 7.1 26.0 17.5 11.2 8.0 20.5 13.5 9.9 7.7 7.8 8.7 6.8 3.1 10.7 31.8 8.6 4.3 3.8 14.2 11.7 12.2 5.0 13.4 4.9 16.1 14.9 14.5 1.6 11.6 7.7 3.4 14.0 3.7 5.5 5.5 4.7 11.7 2.9 5.1 4.1 7.1 2.5 8.5 4.9 4.1 9.3 38.7 47.5 48.4 29.8 57.9 38.4 30.2 33.1 36.1 52.4 19.2 64.8 36.3 18.3 30.3 7.7 18.2 41.3 23.3 34.0 18.7 12.4 16.5 9.3 42.4 14.1 33.4 16.1 15.4 24.3 4.1 19.5 26.9 28.7 55.1 26.5 9.8 28.6 45.6 16.3 31.8 56.7 6.5 25.0 26.5 16.8 74.8 42.2 19.8 27.6 26.5 CBWD6 CBWD7 ENSG00000215126 "COBW domain containing 6" Q4V339 9 41131306-41199261 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in many" "blood: 9.3;liver: 6.1" "Cell type enhanced" "Detected in many" 11 "Basal keratinocytes: 34.9;Melanocytes: 13.5;Suprabasal keratinocytes: 37.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "LHCN-M2: 12.5;PC-3: 19.4" "HPA042759, HPA042813" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA042759: AB_2678149, HPA042813: AB_2678181" "unprognostic (9.48e-2)" "unprognostic (6.02e-2)" "unprognostic (1.62e-2)" "unprognostic (1.91e-2)" "unprognostic (1.30e-2)" "unprognostic (6.28e-2)" "unprognostic (5.92e-2)" "unprognostic (3.71e-2)" "unprognostic (2.07e-2)" "unprognostic (1.12e-1)" "unprognostic (4.24e-2)" "unprognostic (1.09e-1)" "unprognostic (2.28e-4)" "unprognostic (5.65e-2)" "unprognostic (1.65e-1)" "unprognostic (1.01e-2)" "unprognostic (9.94e-4)" 0.1 5.2 2.2 0.4 2.4 2.0 2.8 1.0 2.0 0.2 0.3 1.2 0.1 0.0 0.2 0.0 1.6 1.3 2.8 1.5 2.1 6.1 0.1 0.0 1.2 0.2 1.3 0.0 0.5 0.0 0.6 0.0 2.8 2.5 4.3 0.4 0.9 0.0 1.2 0.3 0.2 0.1 0.3 0.2 0.2 0.1 4.8 4.0 2.5 9.3 0.6 4.3 2.8 1.4 0.3 0.6 0.3 0.7 1.9 1.2 7.9 8.9 9.2 0.0 3.0 0.9 1.9 0.4 6.4 0.4 1.3 11.7 0.2 0.3 1.9 7.5 0.5 4.2 2.1 0.0 2.3 0.7 0.2 1.1 6.1 7.6 0.7 7.0 0.6 1.0 1.1 12.5 1.2 3.4 0.6 1.9 3.2 19.4 0.8 7.8 2.6 8.2 0.5 0.9 1.0 1.9 0.7 0.9 1.8 0.6 1.2 11.7 0.1 0.9 0.4 0.8 3.5 0.6 10.3 1.2 0.8 0.9 1.6 5.9 2.5 0.8 6.8 1.4 4.8 4.3 3.5 3.3 1.8 3.0 3.4 0.9 0.6 9.3 4.0 1.8 2.8 3.0 6.2 0.0 0.0 34.9 0.0 0.0 0.0 2.7 4.5 5.2 0.0 4.4 3.3 3.7 0.0 0.0 0.0 0.0 4.3 5.7 3.1 0.0 8.1 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 4.0 13.5 2.8 0.0 0.0 4.1 0.0 0.0 7.2 0.0 0.0 2.6 0.0 0.0 37.5 5.3 0.0 0.0 0.0 CC2D1A "FLJ20241, MRT3" ENSG00000132024 "Coiled-coil and C2 domain containing 1A" Q6P1N0 19 13906201-13930879 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 103.9;Rod photoreceptor cells: 91.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005436, CAB015220" Supported Supported "Nucleoli fibrillar center,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "Nucleoli fibrillar center" "CAB015220: , HPA005436: AB_1078884" "unprognostic (8.66e-2)" "unprognostic (1.31e-2)" "unprognostic (2.55e-1)" "unprognostic (2.34e-1)" "unprognostic (1.07e-1)" "prognostic favorable (7.02e-4)" "unprognostic (7.00e-2)" "unprognostic (1.59e-3)" "unprognostic (1.17e-1)" "unprognostic (2.82e-2)" "unprognostic (2.61e-3)" "unprognostic (4.07e-2)" "unprognostic (1.23e-3)" "unprognostic (6.67e-3)" "unprognostic (1.97e-1)" "unprognostic (9.22e-2)" "unprognostic (1.71e-2)" 11.2 9.5 19.1 14.5 18.7 9.1 12.0 30.5 22.2 11.4 28.7 13.6 15.3 43.2 10.1 10.0 18.2 16.9 16.6 10.4 17.8 21.3 12.6 16.2 11.9 9.5 15.8 20.1 11.5 30.0 17.3 18.7 12.2 16.1 14.2 14.7 13.3 32.7 16.9 18.7 28.6 35.3 11.1 12.6 11.3 21.0 10.1 13.7 10.6 12.0 13.6 13.7 13.1 14.1 2.4 3.0 4.1 5.2 1.6 4.8 2.0 22.0 9.4 3.1 12.8 6.3 5.2 9.9 7.7 9.5 12.5 12.0 12.8 6.7 11.6 12.7 7.7 7.4 16.2 5.8 11.8 4.3 16.9 32.1 5.7 11.5 8.0 10.5 4.8 17.0 6.3 14.3 7.7 5.1 7.8 8.5 11.7 5.9 9.6 4.0 23.4 11.2 12.9 7.0 19.3 16.7 11.5 7.0 9.2 8.5 16.9 11.5 6.7 10.2 15.5 11.6 2.4 11.4 9.0 7.9 9.6 4.9 21.2 9.3 16.3 7.2 6.1 12.2 15.9 8.7 3.9 3.2 4.1 4.8 5.2 1.9 2.4 2.3 2.1 3.0 1.3 1.2 2.7 2.8 1.6 4.8 2.5 1.9 2.0 19.1 18.7 30.5 22.2 17.8 21.3 15.8 20.1 16.1 13.7 8.9 8.8 14.0 13.1 8.0 56.5 6.9 20.4 12.0 12.5 10.4 88.4 18.0 8.3 19.1 1.3 9.0 103.9 0.0 24.0 9.0 8.9 14.8 17.3 8.9 12.5 28.6 32.1 8.0 8.2 4.2 59.5 10.5 6.8 15.4 39.0 14.3 21.2 66.6 82.0 4.7 91.0 12.9 7.6 7.7 11.1 12.0 17.8 16.6 42.1 15.7 CCDC107 MGC31967 ENSG00000159884 "Coiled-coil domain containing 107" Q8WV48 9 35658290-35661511 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016857, HPA050442" Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" Nucleoplasm "HPA016857: AB_10669751, HPA050442: AB_2681128" "unprognostic (3.70e-3)" "unprognostic (7.07e-3)" "unprognostic (3.60e-2)" "unprognostic (2.63e-2)" "unprognostic (7.77e-2)" "unprognostic (1.34e-1)" "unprognostic (1.86e-1)" "unprognostic (4.09e-2)" "unprognostic (4.13e-1)" "unprognostic (1.72e-2)" "unprognostic (1.32e-2)" "unprognostic (1.26e-1)" "unprognostic (8.33e-2)" "unprognostic (1.89e-1)" "unprognostic (5.15e-1)" "unprognostic (1.96e-1)" "unprognostic (5.75e-2)" 42.1 23.4 11.1 15.4 10.3 5.4 50.3 17.2 12.9 17.5 35.2 8.5 18.1 15.0 24.9 28.6 22.4 18.2 31.5 31.3 10.2 11.0 13.0 15.0 14.0 14.1 9.7 7.9 15.3 80.2 7.6 10.5 10.8 8.4 22.8 13.7 11.5 14.6 24.5 29.3 9.6 16.0 44.8 9.7 13.5 24.2 9.2 8.8 19.3 14.0 8.8 10.9 38.9 24.1 20.7 32.5 7.6 11.0 16.4 46.9 18.3 7.9 7.2 6.0 7.5 30.2 19.4 3.5 13.4 12.2 8.6 8.1 3.3 2.4 5.2 6.0 17.6 22.3 2.6 4.4 6.5 6.4 15.3 7.1 2.4 10.9 8.1 7.1 3.7 9.5 11.4 7.7 9.2 7.2 16.1 6.0 8.8 3.2 10.0 10.8 5.1 4.2 5.6 4.4 5.7 22.2 6.1 1.4 4.1 28.6 4.3 3.9 6.5 6.9 9.7 6.6 4.7 5.1 4.7 7.5 13.9 7.7 10.0 12.2 4.5 6.6 10.3 25.6 6.0 12.1 7.6 10.6 5.1 36.1 11.0 46.9 20.7 31.7 31.4 11.8 20.1 15.5 21.3 2.1 16.4 6.4 32.5 35.2 18.3 11.1 10.3 17.2 12.9 10.2 11.0 9.7 7.9 8.4 8.8 62.5 23.5 48.4 32.4 62.4 31.1 0.6 61.1 25.4 15.9 78.5 7.9 12.3 14.9 64.0 5.7 40.2 115.3 0.0 122.5 55.2 43.7 39.9 34.5 68.4 86.5 30.2 84.6 43.0 48.7 20.1 55.0 66.1 108.0 39.7 73.5 46.8 82.6 80.7 96.2 54.7 32.0 116.4 97.8 27.9 59.2 58.5 11.6 95.8 40.0 23.7 CCDC136 "DKFZP434G156, KIAA1793, NAG6" ENSG00000128596 "Coiled-coil domain containing 136" Q96JN2 7 128790757-128822132 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Fertilization, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 34.7;testis: 109.6" "Group enriched" "Detected in many" 4 "Early spermatids: 629.8;Late spermatids: 1449.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-87 MG: 18.6;U-937: 27.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010646, HPA071015" Enhanced Approved Approved "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Golgi apparatus, Vesicles" "Plasma membrane" "HPA010646: , HPA071015: AB_2686334" "unprognostic (2.07e-2)" "unprognostic (2.32e-2)" "unprognostic (1.29e-4)" "unprognostic (4.65e-2)" "unprognostic (4.52e-1)" "unprognostic (2.16e-1)" "unprognostic (1.66e-2)" "unprognostic (2.53e-1)" "unprognostic (5.43e-4)" "unprognostic (2.58e-2)" "unprognostic (8.44e-3)" "unprognostic (4.35e-1)" "unprognostic (1.18e-4)" "unprognostic (5.27e-3)" "unprognostic (4.85e-2)" "unprognostic (1.19e-1)" "unprognostic (8.93e-3)" 2.1 4.0 11.2 2.6 11.7 1.8 2.4 34.7 28.7 2.9 6.5 8.3 2.6 2.4 3.9 2.9 2.5 2.8 2.8 4.9 12.5 20.0 1.5 1.5 1.9 3.0 15.3 16.6 2.8 1.8 1.8 3.8 2.2 11.2 9.9 3.5 13.9 2.0 11.0 3.5 1.6 2.6 17.3 9.7 1.9 2.4 109.6 7.4 0.7 1.7 0.0 2.4 6.4 2.0 0.1 0.6 1.3 0.3 2.7 1.6 0.3 0.7 0.9 7.2 4.8 3.9 3.4 1.2 2.7 3.6 2.8 2.6 1.0 0.6 3.6 0.3 3.7 11.4 1.5 4.6 0.5 2.6 10.2 4.6 6.3 1.7 0.0 1.3 0.7 13.6 3.7 0.5 3.0 0.2 2.5 1.6 6.0 2.2 3.8 1.1 1.4 4.6 1.9 10.0 0.0 2.9 11.4 1.3 1.7 0.2 1.3 4.2 12.6 1.7 2.0 2.8 2.7 0.1 1.7 1.4 4.5 2.6 2.1 2.1 2.2 0.9 3.8 18.6 27.4 1.1 0.0 0.3 1.3 1.4 0.0 1.6 0.0 1.5 1.1 0.6 0.1 0.0 1.0 0.1 2.7 0.1 0.1 0.0 0.3 11.2 11.7 34.7 28.7 12.5 20.0 15.3 16.6 11.2 7.4 0.0 0.3 0.0 0.8 0.5 255.8 6.5 2.5 2.7 1.2 0.0 92.3 0.1 0.0 0.5 629.8 1.6 0.0 0.0 1.3 0.2 0.9 1.2 0.0 0.0 5.0 38.1 0.0 0.6 0.8 1449.2 16.7 0.9 0.0 1.0 0.0 22.8 0.8 0.0 7.1 0.0 16.0 6.5 2.8 193.1 9.4 0.4 0.3 2.2 0.0 0.4 CCDC144NL MGC87631 ENSG00000205212 "Coiled-coil domain containing 144 family, N-terminal like" Q6NUI1 17 20836447-20896140 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "brain: 13.1;testis: 10.6" "Group enriched" "Detected in some" 4 "Early spermatids: 7.2;Rod photoreceptor cells: 7.5;Spermatocytes: 25.8;Spermatogonia: 7.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory CD4 T-cell: 1.2" "Lineage enriched" "Detected in single" 5 "T-cells: 1.2" "Cell line enriched" "Detected in some" 5 "U-2 OS: 26.7" HPA023457 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA023457: AB_2671217" "unprognostic (1.29e-1)" "unprognostic (6.71e-2)" "unprognostic (1.21e-1)" "unprognostic (3.53e-1)" "unprognostic (7.53e-2)" "unprognostic (5.17e-2)" "unprognostic (6.33e-2)" "unprognostic (1.08e-1)" "unprognostic (1.22e-1)" "unprognostic (2.28e-1)" 0.3 0.9 0.9 0.2 13.1 0.5 1.0 2.4 6.6 0.3 0.4 1.4 0.0 0.5 1.5 0.3 0.3 0.9 0.2 0.5 1.2 1.1 0.3 0.6 0.5 0.5 1.7 1.4 1.3 0.4 0.2 1.2 0.8 4.5 1.6 0.5 0.6 0.3 1.8 0.8 0.3 0.2 1.2 4.5 0.4 0.5 10.6 0.0 0.4 0.4 0.0 0.7 0.9 0.2 0.0 0.1 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 2.4 0.0 0.0 26.7 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.2 0.0 1.2 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.9 13.1 2.4 6.6 1.2 1.1 1.7 1.4 4.5 0.0 0.0 0.3 0.0 0.6 0.2 1.7 0.4 0.0 0.0 0.0 0.0 2.0 0.5 0.0 0.0 7.2 0.7 0.0 0.0 0.0 1.6 0.9 0.5 0.0 0.0 0.4 1.6 1.2 0.0 0.0 1.3 2.8 0.3 1.7 0.0 0.0 1.4 0.1 0.0 1.1 0.3 7.5 0.0 0.9 25.8 7.3 0.3 0.1 0.0 0.0 0.4 CCDC15 FLJ13215 ENSG00000149548 "Coiled-coil domain containing 15" Q0P6D6 11 124954121-125041489 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 16.2;testis: 19.4" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 34.8;Erythroid cells: 23.3;Spermatocytes: 93.6;Spermatogonia: 24.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA040450, HPA041738" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA040450: AB_10794031, HPA041738: AB_10794675" "unprognostic (2.38e-1)" "unprognostic (3.93e-2)" "unprognostic (8.81e-2)" "unprognostic (1.85e-1)" "unprognostic (2.50e-1)" "unprognostic (4.59e-4)" "unprognostic (2.12e-3)" "unprognostic (1.43e-1)" "unprognostic (1.46e-2)" "unprognostic (2.04e-2)" "unprognostic (9.05e-3)" "unprognostic (3.25e-2)" "unprognostic (9.38e-3)" "unprognostic (1.33e-2)" "unprognostic (3.14e-1)" "unprognostic (5.04e-2)" "unprognostic (1.66e-1)" 1.9 1.3 2.2 2.5 3.9 3.2 5.2 1.2 2.4 1.6 2.2 2.2 0.3 1.3 2.2 2.9 2.4 2.1 1.5 0.9 1.9 1.2 1.2 2.4 2.6 2.0 1.6 0.8 1.7 2.3 1.7 3.8 1.6 1.6 3.0 1.6 1.5 7.7 2.2 0.8 3.7 1.8 1.2 3.3 2.5 1.5 19.4 2.3 16.2 1.3 2.6 2.9 2.6 2.2 1.5 1.1 6.7 1.7 2.3 3.9 1.3 4.7 0.9 6.4 0.0 0.5 1.8 0.0 5.2 6.4 4.9 6.1 0.1 4.0 5.6 4.6 1.8 9.8 3.8 2.7 3.5 8.9 4.7 1.1 6.9 0.8 1.5 0.2 2.0 4.0 0.4 2.5 10.2 5.1 0.9 3.7 7.2 4.6 5.8 10.3 1.0 4.2 2.3 1.5 4.1 5.9 5.3 11.7 1.8 0.7 2.0 3.6 3.2 3.0 0.3 1.3 3.2 7.3 1.8 2.6 10.1 2.3 4.4 6.4 1.4 1.5 4.9 1.4 11.3 6.7 6.7 1.3 1.7 2.4 1.7 2.5 0.8 2.2 3.9 0.4 1.5 3.1 3.4 0.8 2.3 1.7 1.1 3.7 1.3 2.2 3.9 1.2 2.4 1.9 1.2 1.6 0.8 1.6 2.3 3.0 1.4 0.9 1.3 4.4 4.7 0.6 0.0 4.0 3.4 0.0 0.0 0.4 0.0 2.0 34.8 3.0 0.0 23.3 2.9 0.2 1.7 1.4 9.2 1.0 2.8 3.2 1.2 0.6 3.3 21.2 4.0 2.6 3.3 0.0 1.2 3.4 1.3 0.0 2.1 0.7 2.5 6.5 2.0 93.6 24.9 3.3 0.1 2.2 0.6 0.3 CCDC154 "C16orf29, LOC645811" ENSG00000197599 "Coiled-coil domain containing 154" A6NI56 16 1434383-1444556 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 10.8" "Cell type enhanced" "Detected in many" 19 "Cone photoreceptor cells: 7.9;Early spermatids: 36.6;Spermatocytes: 12.0" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 7.5;SCLC-21H: 26.6;U-266/70: 4.8" "Not detected" "Not detected" "Region enriched" "Detected in single" 6 "cerebellum: 5.4" "HPA041158, HPA043535, HPA048237" Uncertain Approved "Golgi apparatus,Plasma membrane" NA NA "Plasma membrane" "Golgi apparatus" "HPA041158: , HPA043535: AB_2678536, HPA048237: AB_2680323" "unprognostic (2.40e-1)" "unprognostic (1.42e-2)" "unprognostic (5.97e-4)" "unprognostic (3.28e-2)" "unprognostic (1.97e-1)" "unprognostic (5.76e-3)" "unprognostic (7.96e-2)" "unprognostic (3.01e-3)" "unprognostic (1.67e-1)" "unprognostic (5.34e-2)" "unprognostic (4.19e-5)" "unprognostic (2.35e-2)" "unprognostic (8.02e-6)" "unprognostic (9.33e-2)" "unprognostic (1.43e-1)" "unprognostic (2.33e-1)" "unprognostic (9.35e-5)" 0.6 1.5 0.6 1.5 1.1 1.6 0.5 4.5 1.4 1.0 0.7 2.6 1.3 0.4 0.0 1.5 0.7 0.2 0.7 0.9 1.2 0.4 0.4 2.5 0.5 1.3 1.1 0.0 3.9 0.6 2.9 0.0 1.2 0.8 1.2 2.9 1.2 0.2 0.7 3.4 3.7 10.8 2.8 0.6 0.2 0.6 0.7 0.0 0.8 0.1 0.0 1.1 0.0 7.5 0.3 0.2 0.5 0.3 0.1 0.4 0.1 0.0 0.0 0.0 0.2 0.6 0.1 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.2 0.3 0.3 0.1 0.4 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.9 0.4 0.0 0.5 0.0 3.8 0.2 0.0 0.1 2.2 0.1 0.1 0.0 0.1 26.6 0.4 0.1 0.1 1.1 0.1 0.8 1.9 0.0 0.4 0.1 0.3 0.0 4.8 1.2 0.0 0.0 3.8 0.2 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 1.1 0.0 0.7 0.2 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 3.3 0.5 2.5 1.4 0.0 3.5 7.9 0.0 0.0 0.0 36.6 0.0 0.0 0.0 0.3 0.0 0.2 0.1 1.1 0.0 0.7 6.4 0.0 0.0 0.8 4.4 1.4 0.5 1.7 0.0 0.0 3.2 0.0 0.0 0.4 0.2 3.9 0.0 1.0 12.0 1.3 0.4 0.0 0.0 0.0 0.1 CCDC24 MGC45441 ENSG00000159214 "Coiled-coil domain containing 24" Q8N4L8 1 43991359-43996528 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 52.2;Intestinal endocrine cells: 34.9;Spermatocytes: 48.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 6.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 15.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA035424, HPA061710" Uncertain Approved "Nucleoli,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoli, Cytosol" "HPA035424: AB_2674619, HPA061710: AB_2684591" "prognostic favorable (3.06e-5)" "unprognostic (1.47e-1)" "unprognostic (1.13e-2)" "unprognostic (1.05e-1)" "unprognostic (1.65e-2)" "prognostic favorable (3.18e-4)" "prognostic unfavorable (1.70e-4)" "unprognostic (1.92e-2)" "unprognostic (6.38e-2)" "unprognostic (2.81e-1)" "unprognostic (7.00e-3)" "unprognostic (3.00e-1)" "unprognostic (1.74e-2)" "unprognostic (6.91e-2)" "unprognostic (1.51e-1)" "unprognostic (7.84e-2)" "unprognostic (2.15e-3)" 1.8 5.5 9.3 2.6 9.8 1.1 5.1 3.0 9.8 7.2 5.0 3.2 18.9 3.7 4.9 6.6 2.6 20.3 13.1 1.5 6.4 8.0 8.9 3.0 3.2 2.6 5.5 9.6 3.4 6.0 9.6 14.5 2.4 5.2 7.2 4.1 6.5 8.4 14.7 1.5 0.9 3.3 3.4 3.3 3.0 4.9 15.4 1.7 0.6 8.8 1.0 2.5 4.7 2.1 6.8 0.8 1.4 4.0 0.5 0.6 0.5 5.1 3.1 1.4 1.6 1.4 1.0 3.1 0.2 2.2 1.6 2.8 2.0 15.0 4.2 5.9 0.6 4.6 5.3 0.8 7.4 1.5 4.4 1.8 2.1 1.9 0.6 1.6 0.7 3.7 0.3 0.7 5.2 0.5 5.0 1.3 1.6 0.9 1.6 2.2 4.5 0.3 1.6 3.1 4.7 2.6 1.3 0.0 0.8 6.2 2.0 3.4 3.0 4.6 2.6 2.9 3.1 7.8 0.1 0.4 2.4 7.0 1.8 0.7 0.6 2.0 0.9 6.3 0.6 2.0 0.0 0.7 1.4 0.6 4.0 0.3 6.8 0.2 0.2 0.8 3.0 0.0 0.0 0.6 0.5 3.1 0.6 0.0 0.5 9.3 9.8 3.0 9.8 6.4 8.0 5.5 9.6 5.2 1.7 3.0 7.4 0.5 8.2 1.0 8.8 0.8 12.7 52.2 19.4 8.7 5.9 4.7 18.3 7.1 16.4 0.7 6.3 0.0 6.4 1.7 3.3 6.8 2.3 2.1 2.9 3.2 34.9 1.8 3.2 8.5 2.0 1.8 3.3 4.6 12.1 9.5 5.4 8.6 2.8 8.0 14.2 0.0 2.4 48.8 19.5 0.6 2.1 0.0 13.0 8.4 CCDC28A "C6orf80, CCRL1AP, DKFZp586D0623" ENSG00000024862 "Coiled-coil domain containing 28A" Q8IWP9 6 138773509-138793319 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 140.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055125 Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA055125: AB_2682705" "unprognostic (1.51e-1)" "unprognostic (6.88e-3)" "unprognostic (2.70e-1)" "unprognostic (6.67e-2)" "unprognostic (7.96e-2)" "unprognostic (9.66e-3)" "unprognostic (1.16e-1)" "unprognostic (2.58e-3)" "unprognostic (3.80e-1)" "unprognostic (8.34e-3)" "unprognostic (4.29e-3)" "unprognostic (1.02e-1)" "prognostic favorable (1.11e-5)" "unprognostic (1.63e-1)" "unprognostic (1.06e-1)" "unprognostic (2.28e-2)" "unprognostic (2.37e-2)" 12.9 30.8 25.4 19.8 28.7 20.9 17.9 22.6 27.9 15.6 17.4 13.3 18.7 18.5 11.5 24.8 12.4 22.6 16.8 11.0 31.4 32.2 36.5 40.5 17.4 19.2 22.2 21.7 14.2 22.2 25.5 19.2 19.3 28.3 16.1 15.4 16.4 31.6 20.8 17.4 11.0 21.3 13.9 16.1 18.3 16.5 15.0 13.4 18.2 33.9 9.3 19.8 19.3 12.5 30.0 29.3 73.5 27.3 30.6 44.5 24.5 3.4 6.2 4.7 8.6 8.9 12.5 9.6 5.7 10.0 7.5 12.4 5.3 6.8 14.8 11.1 5.6 10.7 6.0 7.7 7.9 12.3 17.1 17.2 12.0 7.7 10.6 14.1 20.8 12.7 8.0 10.1 5.4 16.2 15.6 12.3 21.1 12.1 20.8 8.5 7.6 17.0 27.4 4.3 13.9 6.5 10.3 4.7 13.7 9.0 5.1 5.9 9.1 7.5 6.9 16.4 9.8 3.3 23.0 9.4 5.9 6.8 11.0 8.6 27.9 24.6 10.9 6.4 12.9 5.2 33.2 27.3 33.7 26.0 27.0 23.2 30.0 27.6 28.3 29.3 29.7 32.1 29.5 73.5 30.6 22.9 25.8 44.5 24.5 25.4 28.7 22.6 27.9 31.4 32.2 22.2 21.7 28.3 13.4 29.8 34.4 36.3 23.6 11.8 15.2 9.4 15.3 60.2 20.5 34.9 17.7 69.7 104.5 12.9 140.9 19.6 31.3 0.0 27.6 36.9 20.0 38.9 41.6 41.9 35.0 9.5 23.7 28.3 38.3 64.6 15.5 34.4 30.4 35.1 32.2 20.5 17.7 32.0 14.2 100.3 12.5 12.9 12.2 40.2 30.3 13.0 91.1 37.6 22.2 27.7 CCDC59 "BR22, HSPC128, TAP26" ENSG00000133773 "Coiled-coil domain containing 59" Q9P031 12 82223681-82358805 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038555 Approved Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Plasma membrane" NA NA "Nucleoli, Nucleoli rim" "Nucleoplasm, Plasma membrane" "HPA038555: AB_10669543" "unprognostic (1.61e-1)" "unprognostic (6.28e-3)" "unprognostic (1.27e-1)" "unprognostic (2.11e-2)" "unprognostic (1.13e-1)" "unprognostic (6.73e-2)" "unprognostic (1.42e-3)" "unprognostic (1.50e-2)" "unprognostic (1.86e-2)" "unprognostic (1.22e-2)" "unprognostic (2.62e-1)" "unprognostic (5.56e-2)" "prognostic unfavorable (1.39e-6)" "unprognostic (5.73e-2)" "unprognostic (2.01e-1)" "unprognostic (8.86e-2)" "unprognostic (1.02e-2)" 17.9 10.2 11.3 14.2 16.3 54.9 18.9 14.9 14.7 17.6 16.9 8.9 7.7 7.5 14.8 17.4 17.0 17.2 11.2 14.5 11.5 12.5 16.0 15.4 12.6 13.7 14.8 12.4 18.8 12.5 2.6 18.2 18.7 13.5 18.7 12.5 6.5 12.7 13.3 23.5 12.7 18.9 14.5 16.5 17.3 12.1 18.4 14.9 15.3 19.9 17.9 18.1 21.4 20.9 18.9 18.6 17.9 14.0 13.1 23.6 6.7 11.5 11.0 9.1 6.5 10.1 8.8 14.2 10.5 12.2 18.6 15.2 22.1 6.6 13.6 5.4 10.5 13.1 7.4 41.5 20.1 15.8 14.3 22.1 13.3 6.5 14.6 29.9 17.6 7.7 15.3 17.1 19.6 24.7 15.7 15.2 24.7 25.2 7.0 11.4 20.9 16.2 24.1 14.4 11.0 25.5 12.3 13.6 11.1 9.8 11.6 15.5 7.5 12.1 6.5 15.3 10.6 14.0 23.4 7.1 9.3 7.1 6.5 19.2 11.2 12.5 26.1 6.6 14.1 12.4 12.7 9.3 16.8 11.6 9.6 19.8 15.2 18.6 16.9 9.6 18.9 22.1 17.6 17.9 13.1 14.0 18.6 23.6 6.7 11.3 16.3 14.9 14.7 11.5 12.5 14.8 12.4 13.5 14.9 62.5 48.8 69.0 103.9 76.2 31.5 38.7 38.2 61.6 62.6 41.8 21.6 67.1 109.5 41.0 58.5 55.4 25.5 23.3 49.8 74.4 49.4 61.8 76.2 47.2 50.6 41.3 34.3 57.1 55.3 15.9 49.5 60.8 45.5 44.1 52.3 38.3 47.8 48.0 50.5 57.2 38.9 19.4 54.7 185.8 116.5 78.5 122.8 77.6 53.2 81.7 CCDC62 "CT109, ERAP75, FLJ40344, TSP-NY" ENSG00000130783 "Coiled-coil domain containing 62" Q6P9F0 12 122774327-122827528 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "testis: 44.3" "Group enriched" "Detected in some" 7 "Early spermatids: 148.4;Late spermatids: 50.4;Spermatocytes: 78.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "U-2 OS: 7.7" "Low region specificity" "Detected in all" "HPA039021, HPA058741" Approved Supported "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA039021: AB_10673604, HPA058741: AB_2683805" "unprognostic (3.39e-2)" "unprognostic (4.16e-2)" "unprognostic (1.46e-2)" "unprognostic (7.48e-2)" "unprognostic (1.58e-2)" "unprognostic (9.37e-2)" "unprognostic (1.65e-1)" "unprognostic (7.09e-2)" "unprognostic (1.97e-1)" "unprognostic (1.48e-1)" "unprognostic (2.21e-4)" "unprognostic (5.23e-1)" "unprognostic (6.39e-6)" "unprognostic (2.78e-2)" "unprognostic (6.18e-2)" "unprognostic (7.27e-2)" "unprognostic (3.25e-4)" 0.2 0.2 0.3 0.1 0.3 0.1 0.1 0.3 0.7 0.2 0.1 0.1 0.1 0.0 0.1 0.8 0.1 0.0 0.1 0.1 0.7 0.2 0.1 0.3 0.1 0.6 0.1 0.2 0.1 0.1 0.1 0.4 0.1 0.2 0.1 0.0 0.1 0.1 0.5 0.3 0.2 0.1 0.1 0.2 0.3 0.0 44.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.0 1.1 2.4 0.6 0.8 1.9 0.4 0.4 0.5 0.3 1.0 0.1 0.7 0.9 0.2 0.3 0.8 0.3 0.3 0.7 1.6 0.2 0.0 0.4 0.3 0.5 0.2 0.4 0.7 0.7 2.6 0.3 0.2 0.0 1.7 2.1 0.3 1.0 1.1 0.4 0.2 0.1 1.8 0.9 0.8 1.1 0.3 0.2 3.4 0.4 0.1 1.9 2.0 0.8 0.3 0.6 0.3 1.5 0.0 0.3 0.9 1.2 0.6 0.1 1.7 0.4 0.9 7.7 0.4 0.4 1.0 0.7 0.7 0.0 0.7 0.5 1.5 0.6 0.4 0.5 0.3 0.9 0.3 0.3 0.4 0.2 1.0 0.8 0.7 2.4 0.8 0.3 1.1 1.9 0.4 0.3 0.3 0.3 0.7 0.7 0.2 0.1 0.2 0.2 0.1 0.0 0.0 0.0 0.1 0.5 1.2 0.8 0.0 0.0 0.0 0.0 3.9 0.1 0.0 0.1 148.4 0.2 0.0 0.0 0.2 0.4 0.3 0.5 0.0 0.0 0.1 1.6 0.0 0.0 0.3 50.4 2.8 0.0 1.7 0.0 0.0 0.8 0.1 0.0 2.5 0.0 1.1 12.9 0.0 78.8 3.0 0.6 0.0 0.0 0.1 0.1 CCDC69 "DKFZP434C171, FLJ13705" ENSG00000198624 "Coiled-coil domain containing 69" A6NI79 5 151181052-151224145 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 99.8" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 65.4;Cardiomyocytes: 112.2;Ciliated cells: 64.3;Kupffer cells: 76.6;T-cells: 67.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 34.9;Daudi: 53.9;U-266/70: 34.5;U-698: 34.8" "Low region specificity" "Detected in many" "HPA043648, HPA052896" Uncertain Approved "Golgi apparatus,Plasma membrane,Actin filaments" NA NA "Plasma membrane" "Golgi apparatus, Actin filaments" "HPA043648: AB_10795877, HPA052896: AB_2681983" "prognostic favorable (3.21e-4)" "unprognostic (2.60e-2)" "unprognostic (1.28e-1)" "unprognostic (2.78e-2)" "unprognostic (5.62e-2)" "unprognostic (8.63e-3)" "unprognostic (3.07e-2)" "unprognostic (6.48e-2)" "unprognostic (2.00e-1)" "unprognostic (9.29e-2)" "unprognostic (3.85e-2)" "unprognostic (1.55e-2)" "unprognostic (3.67e-1)" "unprognostic (4.31e-2)" "unprognostic (3.69e-1)" "unprognostic (2.93e-1)" "unprognostic (2.01e-1)" 31.6 33.7 2.1 33.4 3.2 10.9 99.8 1.7 4.7 7.3 43.4 2.5 6.6 5.7 12.2 7.3 28.1 12.7 14.0 57.6 2.2 2.5 3.8 12.6 23.7 23.2 4.3 0.9 11.4 15.3 5.3 6.1 21.4 8.4 17.2 5.8 9.0 5.5 8.7 87.1 4.5 14.9 53.0 5.1 21.7 15.6 6.7 2.2 13.3 5.1 18.8 17.7 37.2 58.4 11.4 20.4 18.0 10.7 11.9 11.7 8.3 2.1 0.2 0.1 1.8 34.9 3.7 1.2 0.4 3.4 0.6 0.5 0.4 0.2 53.9 1.9 0.1 0.9 0.1 0.8 0.6 0.2 0.0 0.7 6.8 0.0 3.3 5.7 2.5 9.9 8.9 0.0 0.2 0.0 0.6 3.4 0.2 6.5 12.1 0.0 0.0 11.5 6.3 2.0 0.0 4.4 9.8 0.2 3.3 0.1 1.5 0.0 0.2 0.6 0.9 0.4 0.9 0.5 6.3 8.4 0.2 1.7 0.1 0.4 34.5 16.1 34.8 0.4 6.1 0.0 18.0 10.7 12.3 11.7 8.6 10.2 5.9 9.1 11.0 9.3 11.4 7.3 6.7 9.2 11.9 8.2 20.4 6.6 8.3 2.1 3.2 1.7 4.7 2.2 2.5 4.3 0.9 8.4 2.2 11.9 65.4 52.4 2.4 2.3 0.6 112.2 2.5 64.3 13.6 1.8 0.0 6.2 0.0 2.4 0.4 52.5 0.0 0.0 17.5 5.9 5.8 3.7 33.5 30.4 6.9 6.4 1.7 19.0 76.6 1.3 5.2 14.3 10.1 13.6 0.0 2.5 9.5 0.0 7.4 2.4 1.2 12.9 12.8 0.2 0.5 1.1 29.6 67.1 0.2 18.4 CCDC8 "3M3, DKFZp564K0322, PPP1R20" ENSG00000169515 "Coiled-coil domain containing 8" Q9H0W5 19 46410372-46413584 "Disease related genes, Predicted intracellular proteins" Dwarfism "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 39.4" "Cell type enhanced" "Detected in many" 11 "Cardiomyocytes: 25.5;Distal tubular cells: 33.2;Leydig cells: 65.6;Peritubular cells: 54.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 9 "neutrophil: 3.6" "Lineage enriched" "Detected in single" 9 "granulocytes: 3.6" "Cell line enhanced" "Detected in many" "AF22: 12.0;AN3-CA: 14.3;HSkMC: 13.1;K-562: 12.5;RH-30: 16.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA041993 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA041993: AB_10795388" "unprognostic (3.05e-3)" "unprognostic (2.16e-1)" "unprognostic (2.28e-2)" "unprognostic (1.13e-1)" "unprognostic (1.39e-3)" "unprognostic (3.69e-1)" "unprognostic (6.64e-2)" "unprognostic (5.16e-2)" "unprognostic (7.77e-2)" "unprognostic (1.62e-1)" "unprognostic (1.15e-1)" "unprognostic (5.72e-2)" "prognostic favorable (1.72e-5)" "unprognostic (5.43e-3)" "unprognostic (5.77e-2)" "unprognostic (4.09e-2)" "unprognostic (4.18e-3)" 2.7 13.3 3.0 2.1 3.8 0.6 7.6 0.9 2.3 18.9 2.4 5.1 6.2 0.8 15.5 17.3 2.9 19.0 9.7 18.9 3.1 2.3 7.9 0.7 7.1 0.9 2.4 2.9 39.4 19.2 8.5 9.9 5.6 4.6 12.1 1.1 10.0 8.7 7.5 3.0 2.2 1.6 6.7 2.0 1.8 1.7 9.0 2.6 4.2 11.8 2.6 1.4 4.8 5.8 0.4 0.3 3.6 0.4 0.2 0.2 0.1 1.2 0.1 12.0 14.3 3.2 4.0 5.8 6.1 0.0 1.4 0.6 0.0 0.1 0.1 8.2 4.8 0.2 0.1 0.1 9.5 0.6 0.0 6.0 0.0 0.1 0.6 10.7 0.0 0.1 13.1 0.0 3.4 10.0 0.2 0.0 0.1 12.5 0.0 4.4 0.0 0.0 0.8 8.7 0.0 0.0 0.4 16.2 0.0 10.5 0.0 1.9 0.1 0.0 0.0 0.0 9.7 0.1 2.9 1.1 0.8 3.2 0.2 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.3 0.4 0.2 0.2 0.2 0.2 0.4 0.1 0.1 0.1 0.4 0.2 0.2 3.6 0.2 0.3 0.3 0.1 0.1 3.0 3.8 0.9 2.3 3.1 2.3 2.4 2.9 4.6 2.6 0.0 0.6 0.0 5.7 0.8 0.0 25.5 10.2 2.7 6.8 10.4 0.0 5.8 33.2 11.1 0.3 0.4 0.0 0.0 0.9 7.8 9.9 0.5 1.1 0.0 1.5 0.0 0.0 1.3 0.0 1.3 65.6 0.9 1.7 0.0 0.0 13.3 5.9 0.0 54.5 0.8 0.4 12.9 7.2 0.3 4.5 0.1 1.7 0.0 0.0 0.5 CCDC97 "FLJ40267, MGC20255" ENSG00000142039 "Coiled-coil domain containing 97" Q96F63 19 41310189-41324883 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043320, HPA043572" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA043320: AB_10964344, HPA043572: AB_10962488" "unprognostic (9.25e-3)" "unprognostic (7.26e-2)" "unprognostic (1.68e-1)" "unprognostic (5.10e-2)" "unprognostic (1.04e-1)" "unprognostic (1.51e-2)" "prognostic unfavorable (1.09e-4)" "unprognostic (8.40e-2)" "unprognostic (1.91e-2)" "unprognostic (2.44e-1)" "unprognostic (5.93e-3)" "unprognostic (4.51e-2)" "unprognostic (2.16e-1)" "unprognostic (2.96e-1)" "unprognostic (4.08e-1)" "unprognostic (7.92e-2)" "unprognostic (1.65e-2)" 20.4 15.3 15.5 20.7 18.8 21.5 16.8 16.1 24.7 21.3 16.7 26.7 17.8 15.1 21.3 26.6 22.9 24.5 15.8 16.4 14.6 14.1 16.5 13.3 15.4 23.2 16.0 16.2 27.4 20.6 20.8 21.9 22.9 18.6 19.0 12.6 20.9 21.1 17.2 28.8 21.5 18.4 15.6 21.0 24.2 17.3 39.9 16.8 27.7 17.9 20.4 27.2 17.7 19.7 13.6 7.6 14.6 13.3 11.5 16.8 8.3 13.1 28.9 15.3 17.8 20.2 16.2 11.1 8.9 7.2 14.1 12.1 17.1 12.7 12.6 9.6 7.4 9.5 9.0 21.0 17.7 10.8 23.0 20.3 11.5 13.0 11.2 15.4 19.0 24.9 15.7 22.8 16.4 13.8 11.6 9.7 13.9 14.6 24.1 13.4 9.6 17.3 4.6 7.1 16.0 10.4 19.6 12.2 9.1 12.9 25.2 13.8 12.2 19.8 21.9 8.7 10.7 14.9 14.5 11.5 12.2 12.3 6.3 14.7 24.8 21.2 12.1 11.6 14.0 16.1 9.0 8.3 9.7 15.3 9.2 16.8 11.3 10.3 10.9 6.8 13.6 11.4 10.0 14.6 11.5 13.3 7.6 8.5 8.3 15.5 18.8 16.1 24.7 14.6 14.1 16.0 16.2 18.6 16.8 11.9 7.9 9.3 10.0 4.0 11.7 5.9 10.2 6.7 3.4 8.7 11.8 9.6 6.6 10.7 2.5 7.5 12.9 0.0 22.5 4.4 7.6 7.8 16.1 4.9 13.4 9.5 11.1 10.4 11.6 7.8 11.8 7.7 1.7 18.0 11.1 6.4 17.7 2.9 10.6 7.2 8.8 0.0 8.3 20.6 11.7 5.1 15.3 16.0 9.6 10.9 CCNT2 ENSG00000082258 "Cyclin T2" O60583 2 134918235-134959342 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Host-virus interaction, Transcription, Transcription regulation" Cyclin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005559 Supported Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA005559: AB_1078608" "unprognostic (2.49e-2)" "unprognostic (1.19e-1)" "unprognostic (9.57e-2)" "unprognostic (1.25e-1)" "unprognostic (4.92e-2)" "unprognostic (2.65e-3)" "unprognostic (1.85e-2)" "unprognostic (1.00e-2)" "unprognostic (1.61e-2)" "unprognostic (1.21e-2)" "unprognostic (2.79e-1)" "prognostic unfavorable (2.44e-4)" "prognostic unfavorable (1.25e-5)" "unprognostic (2.33e-1)" "unprognostic (8.51e-2)" "unprognostic (9.94e-2)" "prognostic favorable (3.28e-4)" 15.8 14.1 21.0 15.2 19.9 32.5 21.1 30.5 22.2 16.4 14.2 16.9 17.8 17.6 22.6 20.9 15.4 16.1 12.9 14.2 16.1 14.3 12.9 20.8 17.5 18.9 18.6 16.2 22.8 24.0 25.1 29.6 17.9 20.0 18.0 16.7 11.5 16.9 19.4 14.5 20.3 17.2 18.0 17.1 19.8 18.9 15.8 19.1 23.0 18.7 9.4 18.2 18.9 19.5 3.8 4.9 6.9 4.5 6.2 8.4 3.4 6.7 3.4 22.1 8.2 11.0 11.2 16.8 9.3 7.7 8.9 11.1 9.1 7.8 11.1 7.1 7.7 4.3 8.8 13.2 7.0 13.0 5.9 8.9 11.9 8.7 12.8 10.8 10.7 10.6 10.2 14.0 8.7 10.8 11.5 13.0 8.4 9.9 11.4 10.3 4.6 11.8 16.0 17.9 5.6 7.0 11.5 7.9 8.8 13.7 18.7 15.1 12.5 6.9 8.0 10.7 16.8 8.4 13.1 11.8 11.5 12.6 4.9 6.8 8.1 4.9 11.6 7.1 8.6 9.7 6.9 3.7 4.5 4.3 4.5 5.3 3.8 4.8 5.1 4.9 3.1 8.4 6.4 4.8 6.2 2.3 4.5 5.9 3.4 21.0 19.9 30.5 22.2 16.1 14.3 18.6 16.2 20.0 19.1 23.8 24.2 24.6 28.3 13.4 32.7 19.5 17.8 9.4 20.5 14.0 31.4 9.1 6.6 13.6 4.7 18.2 17.4 0.0 13.0 7.4 12.5 26.7 10.5 18.4 8.6 39.7 17.7 20.3 12.9 11.8 13.0 20.9 8.5 14.4 14.5 16.7 12.3 17.5 20.8 4.8 32.8 19.4 11.3 16.8 19.9 15.8 11.4 20.0 14.3 38.3 CCNYL1 FLJ40432 ENSG00000163249 "Cyclin Y like 1" Q8N7R7 2 207711540-207761839 "Predicted intracellular proteins" Cyclin "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Paneth cells: 67.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 41.9" HPA046825 Approved Approved "Plasma membrane" Yes No "Plasma membrane" "HPA046825: AB_10963934" "unprognostic (2.59e-2)" "unprognostic (1.23e-1)" "unprognostic (1.03e-2)" "unprognostic (1.20e-3)" "unprognostic (1.78e-1)" "unprognostic (1.59e-1)" "unprognostic (1.31e-3)" "unprognostic (5.48e-2)" "unprognostic (1.65e-1)" "unprognostic (1.41e-2)" "unprognostic (7.12e-3)" "unprognostic (7.99e-2)" "unprognostic (3.92e-2)" "unprognostic (8.08e-2)" "unprognostic (7.91e-2)" "unprognostic (2.37e-2)" "unprognostic (1.96e-3)" 17.5 8.0 9.8 12.2 10.7 10.6 14.5 4.8 12.8 12.6 18.1 11.2 11.5 13.3 8.8 8.2 24.6 8.0 10.0 11.7 8.0 7.2 15.9 18.4 14.5 11.9 9.1 10.1 6.3 21.6 6.9 8.3 16.8 9.3 7.9 16.4 7.9 12.1 10.0 10.1 5.8 16.3 10.8 11.7 12.1 14.8 18.3 8.1 10.9 14.4 6.6 13.9 10.8 13.9 4.1 1.8 4.6 3.8 1.9 2.7 0.9 11.8 5.1 6.9 9.9 9.4 10.6 41.9 7.3 12.4 7.6 8.3 23.0 11.2 4.5 7.0 13.3 18.5 8.3 8.2 13.5 7.4 1.6 6.2 6.0 5.9 19.3 8.8 5.6 7.2 5.0 5.6 9.3 10.7 6.8 24.5 5.4 2.9 4.8 10.0 6.0 4.9 5.0 13.7 5.1 5.7 4.2 6.9 3.6 8.1 8.9 1.6 5.4 9.0 3.8 11.0 17.5 3.5 14.2 13.0 8.6 8.7 10.8 4.9 2.7 3.7 6.9 9.7 6.4 7.3 1.7 3.8 1.5 1.1 1.9 1.4 1.2 1.9 1.9 1.8 4.1 1.5 2.7 4.6 1.9 1.7 1.7 1.3 0.9 9.8 10.7 4.8 12.8 8.0 7.2 9.1 10.1 9.3 8.1 3.0 15.5 8.5 12.6 10.9 5.7 7.0 2.5 1.4 6.8 22.7 9.8 11.1 1.7 5.7 7.7 11.7 30.0 0.0 12.6 29.2 8.9 12.4 5.7 13.2 14.5 4.8 9.2 21.5 16.1 7.4 2.6 14.3 8.5 20.8 7.5 9.7 10.6 67.0 3.5 9.8 12.9 0.0 9.2 17.0 7.8 9.3 6.4 7.2 6.0 16.0 CCT3 "Cctg, TRIC5" ENSG00000163468 "Chaperonin containing TCP1 subunit 3" P49368 1 156308968-156367873 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006543 Approved Approved "Plasma membrane,Cytosol" NA NA 4000000 "Plasma membrane, Cytosol" "HPA006543: AB_1078426" "unprognostic (2.14e-2)" "unprognostic (3.20e-3)" "unprognostic (1.66e-1)" "unprognostic (6.00e-3)" "unprognostic (8.39e-3)" "unprognostic (3.14e-3)" "prognostic unfavorable (3.87e-7)" "unprognostic (4.43e-3)" "unprognostic (2.78e-1)" "unprognostic (1.16e-1)" "unprognostic (5.44e-2)" "unprognostic (1.74e-1)" "prognostic unfavorable (6.34e-4)" "unprognostic (7.16e-2)" "unprognostic (5.76e-2)" "unprognostic (5.67e-2)" "unprognostic (1.10e-1)" 38.8 68.8 37.6 41.8 43.2 26.9 51.2 54.5 51.4 35.1 42.1 46.2 33.8 37.9 50.4 34.8 56.1 52.2 29.2 41.5 36.7 41.6 60.8 61.9 30.9 48.1 43.5 32.8 53.0 59.0 56.7 55.9 39.2 43.0 38.1 50.0 35.3 34.4 41.4 66.4 38.2 39.5 59.7 41.2 41.6 41.9 49.8 47.6 62.1 60.0 49.9 60.7 44.8 82.4 34.8 39.3 14.2 30.5 30.8 45.1 43.9 50.4 57.6 39.3 37.7 43.7 32.5 51.3 47.2 37.5 74.7 46.0 57.0 46.8 83.4 55.0 39.5 47.6 47.6 124.4 61.4 63.9 44.7 78.3 52.9 46.8 45.0 32.2 65.4 44.5 41.2 36.8 67.1 62.5 36.7 63.2 50.4 90.7 30.2 44.3 46.9 86.0 40.1 79.6 99.6 83.5 69.2 39.8 90.3 54.8 32.0 53.3 55.0 43.5 76.7 42.1 66.0 67.8 80.1 43.6 30.4 45.4 31.8 84.1 56.1 99.6 124.1 35.4 41.7 49.3 14.2 25.3 11.2 31.2 30.5 41.6 34.1 34.7 34.2 39.3 34.8 45.1 37.8 3.6 30.8 30.2 25.5 35.5 43.9 37.6 43.2 54.5 51.4 36.7 41.6 43.5 32.8 43.0 47.6 50.6 46.8 129.4 183.9 128.7 109.7 102.4 58.6 127.2 85.3 85.5 100.1 202.7 96.2 186.6 88.8 105.6 80.4 23.3 158.9 172.8 109.3 142.8 72.6 72.7 143.2 69.9 120.2 69.3 70.6 169.9 77.3 80.0 106.3 208.2 75.5 134.0 167.6 87.7 82.7 157.7 195.7 116.4 117.4 367.9 233.1 139.6 154.4 96.5 112.5 146.5 CD164L2 ENSG00000174950 "CD164 molecule like 2" Q6UWJ8 1 27379176-27383380 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 26.8" "Cell type enriched" "Detected in some" 8 "Ciliated cells: 62.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.6;HaCaT: 3.6;HBEC3-KT: 3.9;hTCEpi: 5.4;SK-BR-3: 4.9;T-47d: 2.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062915 Enhanced Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA062915: AB_2684903" "unprognostic (8.97e-3)" "unprognostic (2.15e-2)" "unprognostic (3.56e-2)" "unprognostic (1.36e-2)" "unprognostic (1.04e-1)" "prognostic favorable (1.64e-5)" "unprognostic (7.81e-3)" "unprognostic (4.47e-2)" "unprognostic (1.39e-1)" "unprognostic (1.65e-2)" "unprognostic (4.07e-2)" "unprognostic (5.91e-6)" "unprognostic (1.33e-2)" "unprognostic (6.42e-2)" "unprognostic (1.34e-2)" "unprognostic (2.71e-2)" 0.1 0.1 0.2 0.1 0.5 0.0 2.3 0.1 0.4 3.2 0.4 0.7 1.2 0.0 0.4 12.6 13.4 26.8 0.1 0.1 0.4 0.4 0.4 0.3 7.4 0.1 0.1 0.6 3.3 0.3 0.4 5.8 0.1 1.1 2.4 0.2 1.0 12.9 0.3 0.1 8.1 0.1 0.1 0.1 0.1 0.2 1.0 0.4 0.1 0.9 5.9 6.0 0.1 5.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 3.6 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 5.4 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.7 2.0 0.1 0.0 0.0 0.1 1.0 0.0 1.0 0.0 0.0 4.9 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.1 0.4 0.4 0.4 0.1 0.6 1.1 0.4 0.0 3.0 0.0 8.0 2.6 0.0 0.6 0.0 62.9 4.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 3.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 2.5 0.0 0.0 0.0 3.1 CD248 "CD164L1, TEM1" ENSG00000174807 "CD248 molecule" Q9HCU0 11 66314487-66317044 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 71.0" "Cell type enhanced" "Detected in many" 14 "Fibroblasts: 70.0;Leydig cells: 69.3;Sertoli cells: 32.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 6 "naive CD8 T-cell: 17.8" "Lineage enriched" "Detected in single" 122 "T-cells: 17.8" "Cell line enhanced" "Detected in some" "ASC diff: 68.1;ASC TERT1: 67.2;BJ: 29.4;BJ hTERT+: 44.3;fHDF/TERT166: 59.3;HSkMC: 71.6;U-2197: 107.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" HPA051856 Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA 27000000 "Plasma membrane" Nucleoplasm "HPA051856: AB_2681640" "unprognostic (2.26e-1)" "unprognostic (1.72e-1)" "unprognostic (8.95e-2)" "unprognostic (2.77e-2)" "unprognostic (1.14e-2)" "unprognostic (2.61e-1)" "unprognostic (7.21e-3)" "unprognostic (1.36e-2)" "unprognostic (1.01e-1)" "unprognostic (2.82e-2)" "unprognostic (6.31e-2)" "unprognostic (4.77e-2)" "prognostic unfavorable (2.69e-7)" "unprognostic (1.90e-2)" "unprognostic (2.92e-2)" "unprognostic (1.25e-1)" "unprognostic (1.30e-2)" 59.2 3.5 0.8 14.4 2.5 0.0 55.2 0.6 2.2 21.2 7.6 1.9 6.3 2.7 14.1 22.9 14.8 17.7 12.3 18.2 1.2 0.5 5.3 1.7 9.3 16.2 1.3 1.6 15.6 4.9 1.4 2.3 71.0 2.1 10.6 2.7 11.5 4.6 8.0 6.7 13.3 7.5 27.6 1.2 1.9 7.5 8.0 0.7 4.1 9.4 6.6 4.5 19.5 17.6 0.1 0.0 0.0 0.0 0.0 17.8 1.9 0.0 0.0 0.6 0.0 68.1 67.2 0.0 29.4 44.3 2.2 2.0 0.0 0.0 0.0 0.7 59.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 13.5 0.0 0.0 71.6 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.3 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.1 107.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 2.3 0.0 0.1 2.8 17.8 0.0 0.0 0.0 0.0 0.0 1.9 0.8 2.5 0.6 2.2 1.2 0.5 1.3 1.6 2.1 0.7 0.0 0.0 0.0 0.0 11.1 0.0 2.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.2 0.3 2.5 0.0 0.0 0.0 2.5 70.0 0.0 0.0 0.0 5.5 0.0 0.0 4.3 0.0 0.4 69.3 0.0 11.8 1.0 0.0 3.6 0.4 0.0 19.1 0.0 0.0 32.3 12.2 0.1 0.0 7.2 3.7 0.0 0.0 0.0 CD300A "CMRF-35-H9, CMRF35H, IGSF12, IRC1, IRC2, Irp60" ENSG00000167851 "CD300a molecule" Q9UGN4 17 74466416-74484796 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 81.1;brain: 28.7;lymphoid tissue: 57.8" "Group enriched" "Detected in some" 4 "granulocytes: 57.8;Hofbauer cells: 101.1;Kupffer cells: 71.3;Macrophages: 86.9;T-cells: 25.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 5 "HMC-1: 42.2;NB-4: 17.2;RPMI-8226: 33.2" "HPA010971, HPA011645" Approved Approved "Vesicles,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 2800000 "Plasma membrane" "Vesicles, Cytosol" "HPA010971: , HPA011645: AB_1846988" "unprognostic (1.99e-1)" "unprognostic (4.60e-2)" "unprognostic (3.88e-2)" "unprognostic (3.30e-2)" "unprognostic (2.73e-1)" "unprognostic (2.01e-1)" "unprognostic (1.04e-2)" "unprognostic (2.63e-1)" "unprognostic (1.11e-1)" "unprognostic (1.17e-2)" "unprognostic (7.87e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (1.91e-5)" "unprognostic (5.97e-2)" "unprognostic (5.45e-3)" "unprognostic (1.36e-1)" "unprognostic (5.72e-2)" 8.6 4.5 9.8 16.0 17.7 11.9 4.4 2.2 11.5 2.0 4.8 3.7 0.0 6.0 1.9 1.3 2.1 2.1 7.7 3.4 7.3 4.2 3.0 7.5 10.6 19.0 20.1 0.3 1.5 2.1 0.3 3.0 6.9 12.6 2.8 4.7 2.3 3.0 1.3 1.1 2.3 7.4 6.0 28.7 57.8 2.4 1.5 17.4 4.1 1.9 0.5 6.0 5.4 2.1 2.2 19.4 81.1 45.7 52.1 29.5 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 2.0 42.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.5 17.2 0.0 0.0 0.0 0.0 0.0 33.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.4 0.0 81.1 20.4 57.3 29.5 45.7 6.2 2.2 6.1 8.7 19.4 0.6 2.3 7.1 71.6 52.1 44.2 18.1 0.3 19.2 9.8 17.7 2.2 11.5 7.3 4.2 20.1 0.3 12.6 17.4 0.0 11.9 15.7 0.0 0.8 0.0 0.4 2.5 0.0 1.2 0.0 0.0 0.7 0.0 0.1 0.0 0.5 0.0 0.0 0.0 1.0 0.5 0.1 57.8 0.8 101.1 0.0 0.0 3.1 71.3 0.0 0.0 86.9 3.3 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.2 0.0 0.5 0.5 1.3 25.9 0.0 0.1 CD300LB "CLM7, TREM5" ENSG00000178789 "CD300 molecule like family member b" A8K4G0 17 74521174-74531474 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" Immunity Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adipose tissue: 20.7;blood: 30.7;bone marrow: 8.8;lymphoid tissue: 10.9" "Group enriched" "Detected in some" 8 "Hofbauer cells: 6.5;Kupffer cells: 10.1;Macrophages: 10.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "eosinophil: 30.7" "Group enriched" "Detected in many" 52 "dendritic cells: 10.5;granulocytes: 30.7;monocytes: 13.0" "Group enriched" "Detected in some" 6 "HL-60: 4.6;NB-4: 6.0;THP-1: 4.7;U-937: 2.8" HPA060449 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA060449: " "unprognostic (1.39e-1)" "unprognostic (2.44e-2)" "unprognostic (1.37e-1)" "unprognostic (4.39e-2)" "unprognostic (3.59e-2)" "unprognostic (1.15e-1)" "unprognostic (6.41e-2)" "unprognostic (7.69e-2)" "unprognostic (2.05e-1)" "unprognostic (2.95e-2)" "unprognostic (6.24e-2)" "unprognostic (3.32e-1)" "unprognostic (2.49e-4)" "unprognostic (2.92e-2)" "unprognostic (1.79e-2)" "unprognostic (7.08e-2)" "unprognostic (4.01e-2)" 20.7 0.9 0.2 10.9 0.5 8.8 2.0 0.4 0.5 0.6 0.8 0.3 0.1 0.7 0.7 1.0 1.1 1.2 2.8 1.6 1.5 0.4 1.2 1.0 4.4 6.5 1.2 0.1 2.0 2.3 0.0 0.7 1.1 1.0 0.8 1.1 1.6 1.2 0.1 0.3 0.4 2.0 2.2 0.6 6.6 0.7 0.7 0.1 0.9 0.6 0.1 2.2 2.6 0.7 0.0 10.5 30.7 13.0 0.3 0.1 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.4 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.7 2.8 0.0 0.6 13.0 30.7 0.0 5.6 0.1 0.0 0.0 0.0 10.5 0.0 0.0 0.1 13.8 0.3 0.7 6.6 0.0 4.2 0.2 0.5 0.4 0.5 1.5 0.4 1.2 0.1 1.0 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.5 0.0 0.0 0.6 10.1 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 CD34 ENSG00000174059 "CD34 molecule" P28906 1 207880972-207911402 "CD markers, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Endothelial cells: 214.1;Ito cells: 81.0;Leydig cells: 135.4;Peritubular cells: 115.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "HUVEC TERT2: 32.6;MOLT-4: 32.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000018, HPA036722, HPA036723" Enhanced Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA 69000000 "Plasma membrane, Cell Junctions" Nucleoplasm "CAB000018: AB_2063006, HPA036722: AB_2675271, HPA036723: AB_2675272" "unprognostic (3.82e-1)" "unprognostic (1.67e-1)" "unprognostic (1.04e-1)" "unprognostic (3.09e-1)" "unprognostic (1.24e-1)" "prognostic favorable (5.93e-5)" "unprognostic (1.25e-2)" "unprognostic (7.74e-2)" "unprognostic (7.65e-2)" "unprognostic (3.53e-1)" "unprognostic (1.37e-3)" "unprognostic (6.95e-2)" "prognostic unfavorable (8.47e-4)" "unprognostic (1.51e-2)" "unprognostic (1.30e-1)" "unprognostic (1.60e-1)" "unprognostic (1.01e-2)" 61.9 8.8 4.6 12.8 7.6 1.9 37.5 3.1 6.7 38.3 15.9 5.2 20.5 5.0 41.4 40.3 33.8 22.3 20.6 51.2 5.4 4.9 18.8 2.2 25.0 11.9 8.1 6.7 20.7 8.6 7.8 3.6 78.9 6.3 21.0 7.4 12.8 12.4 20.5 39.7 21.2 12.1 42.3 4.7 9.2 11.3 23.1 4.7 3.5 25.8 35.9 11.0 33.6 33.1 0.6 1.7 1.6 0.3 0.6 0.5 1.5 0.0 0.0 0.1 0.0 1.6 0.1 0.1 0.2 1.2 0.3 0.9 0.0 0.0 0.0 3.2 0.3 0.1 0.0 0.0 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 32.6 0.5 0.0 0.0 0.8 0.0 32.1 0.1 0.2 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.2 1.1 0.0 4.9 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 1.6 0.2 0.3 0.5 0.2 0.5 0.3 0.3 0.2 0.2 0.6 0.3 0.3 1.1 0.6 0.3 1.7 0.2 1.5 4.6 7.6 3.1 6.7 5.4 4.9 8.1 6.7 6.3 4.7 3.0 8.5 0.0 0.1 14.8 0.4 12.3 2.5 0.0 0.0 3.5 2.0 0.2 0.0 0.2 10.9 214.1 0.0 0.0 0.2 0.3 22.6 0.2 1.1 0.5 0.3 0.0 0.0 81.0 0.3 4.2 135.4 2.2 16.9 0.0 0.0 0.3 0.2 0.0 115.6 0.0 0.0 6.5 4.1 0.7 0.5 11.3 0.1 0.0 0.0 0.3 CD37 TSPAN26 ENSG00000104894 "CD37 molecule" P11049 19 49335171-49343335 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 163.4;lymphoid tissue: 109.6" "Cell type enhanced" "Detected in many" 18 "B-cells: 979.0;granulocytes: 262.7;Hofbauer cells: 303.3;Kupffer cells: 224.9;Macrophages: 253.6;T-cells: 359.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 67.2;HMC-1: 66.6;RPMI-8226: 23.9;THP-1: 23.9;U-698: 14.8;U-937: 17.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB002492, HPA032120, HPA032121" Enhanced Approved "Golgi apparatus,Plasma membrane" NA NA "Golgi apparatus" "Plasma membrane" "CAB002492: AB_563554, HPA032120: AB_2674162, HPA032121: AB_2674163" "unprognostic (4.30e-3)" "unprognostic (2.39e-3)" "unprognostic (8.85e-2)" "prognostic favorable (4.51e-4)" "unprognostic (5.46e-2)" "unprognostic (4.59e-3)" "unprognostic (1.76e-1)" "unprognostic (6.23e-2)" "unprognostic (5.34e-2)" "unprognostic (2.23e-1)" "unprognostic (1.22e-1)" "unprognostic (3.06e-1)" "unprognostic (2.45e-3)" "unprognostic (7.12e-2)" "unprognostic (3.35e-2)" "unprognostic (7.22e-2)" "unprognostic (7.71e-2)" 7.3 3.1 3.4 62.9 4.8 48.7 3.7 1.0 3.1 1.9 4.2 8.5 0.0 3.2 2.0 2.2 5.9 2.9 5.2 10.4 3.8 3.8 4.3 2.7 25.3 109.6 6.9 1.7 2.5 1.6 0.5 1.9 5.4 4.7 3.5 1.7 2.7 10.7 1.4 1.1 2.0 39.3 1.7 14.5 88.1 5.1 2.9 5.0 47.9 3.4 1.7 86.8 10.2 2.4 163.4 53.7 84.4 62.8 27.9 43.5 58.8 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 67.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 10.7 0.0 11.8 0.0 0.1 0.0 2.0 66.6 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.6 3.7 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.6 0.0 23.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 23.9 0.1 0.0 0.2 0.0 0.0 0.0 0.0 14.8 0.0 17.8 0.0 42.8 58.2 71.7 34.3 53.4 34.7 137.2 41.8 36.4 41.1 163.4 43.5 36.3 84.4 27.9 62.8 53.7 40.9 58.8 3.4 4.8 1.0 3.1 3.8 3.8 6.9 1.7 4.7 5.0 8.9 20.5 979.0 1.1 10.4 12.4 1.2 2.5 1.4 4.5 1.8 5.9 1.6 0.0 0.3 98.9 4.3 0.4 0.0 0.0 1.5 5.4 0.5 262.7 2.5 303.3 0.0 1.2 14.1 224.9 158.6 2.6 253.6 27.0 43.3 0.5 1.1 0.0 5.3 0.7 2.5 5.2 0.0 0.5 1.1 0.9 10.3 2.4 359.8 0.4 0.9 CD46 "MCP, MGC26544, MIC10, TLX, TRA2.10" ENSG00000117335 "CD46 molecule" P15529 1 207752057-207795513 "Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins" "Complement pathway, Fertilization, Host-virus interaction, Immunity, Innate immunity" "Host cell receptor for virus entry, Receptor" "Cancer-related genes, Disease mutation, Hemolytic uremic syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 41.7;eosinophil: 63.7;neutrophil: 69.8" "Lineage enriched" "Detected in all" 5 "granulocytes: 69.8" "Low cell line specificity" "Detected in all" "CAB010401, HPA016903" Enhanced Approved "Plasma membrane" NA NA 1000000 "Plasma membrane" "CAB010401: AB_2291289, HPA016903: AB_1846309" "unprognostic (1.42e-2)" "prognostic unfavorable (8.54e-5)" "unprognostic (3.94e-2)" "unprognostic (2.14e-2)" "unprognostic (3.28e-2)" "unprognostic (6.30e-2)" "unprognostic (1.91e-2)" "unprognostic (1.82e-1)" "unprognostic (1.25e-1)" "unprognostic (2.74e-1)" "unprognostic (8.79e-2)" "unprognostic (2.50e-1)" "unprognostic (6.78e-3)" "prognostic favorable (2.38e-4)" "unprognostic (1.76e-1)" "unprognostic (8.23e-2)" "unprognostic (1.49e-2)" 38.0 78.0 13.0 22.9 20.5 18.5 57.0 12.9 17.8 27.5 35.4 25.3 64.3 32.9 39.7 32.6 43.2 30.4 25.2 20.6 16.1 15.5 50.8 57.8 43.6 25.0 21.4 13.2 27.6 47.9 86.6 32.7 119.6 29.1 47.0 28.5 26.7 68.4 60.5 18.8 18.4 39.8 25.0 21.8 26.9 33.9 16.5 20.7 20.3 25.3 21.8 30.3 37.2 27.0 7.7 8.1 69.8 14.1 7.5 13.5 14.9 26.7 15.1 14.2 6.5 44.8 44.4 21.6 20.1 29.2 13.3 18.0 14.8 71.2 4.1 20.5 20.0 18.3 36.3 10.6 27.6 20.3 20.5 15.1 8.9 16.6 26.6 28.5 19.3 31.0 38.1 41.1 20.0 15.8 31.4 37.1 16.3 18.6 17.9 20.4 12.6 9.2 17.0 16.2 16.0 15.1 6.2 22.6 25.2 54.3 53.0 14.4 9.8 25.4 57.2 33.0 29.6 45.0 16.6 31.8 14.3 12.7 30.0 22.8 24.1 29.0 12.4 20.9 12.8 13.4 41.7 13.5 63.7 9.2 14.0 12.5 7.7 11.7 10.1 8.1 6.0 13.5 11.2 69.8 7.5 14.1 4.2 10.1 14.9 13.0 20.5 12.9 17.8 16.1 15.5 21.4 13.2 29.1 20.7 187.6 224.8 34.3 81.1 47.1 61.8 56.5 86.6 227.5 213.9 137.9 62.8 190.0 13.3 67.0 176.4 91.0 82.1 0.0 68.5 62.2 54.2 160.9 108.9 100.2 53.0 38.1 69.8 78.5 81.8 23.7 43.7 72.9 59.1 50.5 91.2 28.9 65.3 92.2 41.4 61.7 79.1 51.8 66.9 13.8 23.3 40.1 287.4 51.1 85.2 127.3 CD93 "C1qR(P), C1QR1, C1qRP, CDw93, dJ737E23.1, ECSM3, MXRA4" ENSG00000125810 "CD93 molecule" Q9NPY3 20 23079349-23086340 "CD markers, Plasma proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Endothelial cells: 232.0;Ito cells: 170.6;Kupffer cells: 149.3;Macrophages: 59.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 14.4;neutrophil: 17.4" "Group enriched" "Detected in many" 40 "dendritic cells: 5.5;granulocytes: 17.4;monocytes: 14.4" "Group enriched" "Detected in some" 4 "HUVEC TERT2: 58.4;TIME: 73.9;U-937: 98.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA009300, HPA012368" Enhanced Approved "Vesicles,Plasma membrane" NA NA 440000000 "Vesicles, Plasma membrane" "HPA009300: AB_1846342, HPA012368: AB_1846341" "unprognostic (2.05e-1)" "unprognostic (2.85e-1)" "unprognostic (1.07e-1)" "unprognostic (4.83e-2)" "unprognostic (2.31e-1)" "unprognostic (2.66e-2)" "unprognostic (6.45e-2)" "unprognostic (2.77e-1)" "unprognostic (4.51e-1)" "unprognostic (3.74e-2)" "unprognostic (2.61e-1)" "unprognostic (1.81e-1)" "prognostic unfavorable (2.74e-4)" "unprognostic (8.81e-3)" "unprognostic (6.13e-2)" "unprognostic (4.49e-2)" "unprognostic (3.11e-2)" 50.5 6.1 2.4 15.0 3.4 4.7 31.4 1.0 3.0 13.6 8.1 1.7 3.9 3.2 14.3 12.5 10.0 13.6 14.2 33.3 2.4 2.2 10.8 10.9 34.8 25.3 4.1 1.2 11.6 5.9 5.1 4.3 48.9 5.3 9.7 4.3 4.9 5.9 3.9 16.2 6.8 7.7 15.4 4.3 17.5 7.5 6.9 3.3 6.9 12.3 9.3 4.5 15.6 12.2 0.0 5.5 17.4 14.4 0.0 0.3 4.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.4 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.1 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.4 73.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 98.9 0.0 0.0 14.4 0.2 0.2 10.3 0.0 0.0 0.1 0.0 5.5 0.0 0.0 0.0 17.4 0.0 4.2 0.7 0.3 4.7 2.4 3.4 1.0 3.0 2.4 2.2 4.1 1.2 5.3 3.3 3.0 11.9 3.7 0.6 13.4 0.0 7.3 10.2 5.3 6.8 0.0 0.0 0.2 0.0 0.2 0.4 232.0 0.0 0.0 0.0 0.4 6.5 2.9 4.7 1.3 16.2 0.0 0.0 170.6 149.3 0.2 1.7 59.8 8.5 0.0 0.0 0.1 0.1 0.0 26.2 0.2 0.0 19.4 15.3 0.0 0.2 8.8 0.3 2.9 0.0 0.9 CDCA4 "FLJ20764, Hepp" ENSG00000170779 "Cell division cycle associated 4" Q9BXL8 14 105009573-105021148 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 38.3" "Cell type enhanced" "Detected in many" 8 "Extravillous trophoblasts: 133.3;Spermatogonia: 64.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA064971 Supported "Nucleoplasm,Plasma membrane,Cytosol" NA Yes Nucleoplasm "Plasma membrane, Cytosol" "HPA064971: AB_2685395" "unprognostic (2.22e-3)" "unprognostic (1.84e-1)" "unprognostic (2.69e-1)" "unprognostic (9.93e-3)" "unprognostic (1.42e-1)" "unprognostic (8.36e-2)" "prognostic unfavorable (4.19e-4)" "prognostic unfavorable (7.94e-4)" "unprognostic (4.20e-2)" "unprognostic (8.54e-2)" "prognostic unfavorable (6.67e-4)" "unprognostic (6.73e-2)" "prognostic unfavorable (1.47e-6)" "unprognostic (2.15e-1)" "unprognostic (1.55e-1)" "unprognostic (7.50e-2)" "unprognostic (1.24e-2)" 4.5 2.6 1.7 11.5 2.6 38.3 4.1 8.3 3.2 8.7 3.7 2.6 4.5 4.1 5.6 4.0 16.6 4.1 4.2 2.4 1.5 1.3 2.8 3.0 5.1 9.1 2.7 1.4 5.0 6.2 1.6 1.9 12.4 3.3 4.6 2.7 3.3 5.3 2.2 1.3 21.8 4.4 3.1 2.3 6.7 3.6 12.8 2.3 24.9 5.1 11.2 15.0 3.7 8.8 7.4 4.2 8.3 4.3 10.6 14.7 5.5 15.2 15.9 18.4 13.9 3.1 5.2 24.1 22.8 7.0 17.9 15.7 19.4 19.5 20.0 12.5 8.0 13.7 24.5 12.8 26.3 10.5 21.9 10.1 12.7 13.6 16.2 3.9 22.4 10.7 3.7 8.2 13.8 13.0 6.0 12.1 17.5 13.9 20.8 12.4 37.4 20.8 15.1 13.6 13.3 36.4 20.2 26.8 7.4 6.0 17.7 10.8 13.3 21.8 8.8 17.5 8.5 17.2 15.1 18.7 15.9 20.2 21.7 30.2 7.7 9.5 20.5 13.3 11.4 26.2 0.9 3.6 8.3 10.9 3.9 13.3 7.4 11.4 14.7 3.9 5.2 6.8 8.0 1.3 10.6 4.3 4.2 8.9 5.5 1.7 2.6 8.3 3.2 1.5 1.3 2.7 1.4 3.3 2.3 0.0 2.1 10.4 19.9 57.1 3.0 0.6 0.0 8.1 3.4 1.8 0.0 53.6 3.3 12.9 6.4 9.0 1.1 23.3 6.2 133.3 12.5 7.7 28.8 2.1 21.5 12.7 2.9 7.4 6.2 4.3 7.8 10.6 16.9 10.8 4.4 3.4 9.1 3.5 5.6 1.4 2.7 6.5 10.3 31.0 64.2 58.6 21.6 17.5 6.0 48.5 CDH8 ENSG00000150394 "Cadherin 8" P55286 16 61647242-62037035 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 29.6;seminal vesicle: 9.5" "Group enriched" "Detected in some" 4 "Bipolar cells: 10.1;Ciliated cells: 4.0;Early spermatids: 3.8;Spermatogonia: 2.6" "Cancer enhanced" "Detected in single" "testis cancer: 0.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "basophil: 1.0" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "AF22: 7.0;fHDF/TERT166: 6.1;HaCaT: 13.9;LHCN-M2: 16.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014908, HPA076441" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA014908: AB_1845908, HPA076441: " "unprognostic (1.91e-1)" "unprognostic (2.41e-1)" "unprognostic (4.02e-2)" "unprognostic (7.70e-2)" "unprognostic (1.96e-1)" "unprognostic (3.26e-2)" "unprognostic (1.83e-1)" "unprognostic (8.71e-2)" "unprognostic (3.66e-2)" "unprognostic (5.41e-2)" "unprognostic (2.85e-1)" "unprognostic (6.59e-2)" "unprognostic (2.91e-4)" "unprognostic (6.02e-2)" "unprognostic (4.06e-1)" "unprognostic (2.26e-1)" "unprognostic (1.06e-1)" 0.9 0.9 13.0 0.7 20.4 0.7 1.2 0.5 29.6 1.4 0.8 5.5 0.0 1.2 0.9 1.1 1.0 0.7 1.1 1.1 10.4 7.7 0.8 0.7 0.9 0.7 9.3 12.2 3.7 0.7 0.8 0.9 1.3 12.8 1.4 0.9 0.0 1.4 9.5 1.4 0.9 1.0 1.4 7.7 0.8 0.8 1.2 5.6 0.0 1.0 0.0 0.8 1.7 0.3 0.0 0.0 1.0 0.2 0.1 0.1 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 6.1 0.0 13.9 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.3 0.0 16.8 0.0 0.0 0.0 1.3 0.0 1.3 0.0 0.0 1.0 0.0 1.8 0.1 0.1 0.0 0.0 0.0 2.2 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.1 0.0 0.1 0.0 13.0 20.4 0.5 17.8 10.4 7.7 9.3 12.2 12.8 5.6 0.0 0.3 0.0 0.7 0.1 10.1 1.1 0.0 4.0 1.2 0.0 0.0 0.9 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.2 0.5 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.2 0.0 0.4 1.2 2.6 0.1 0.2 0.0 0.0 0.6 CDIPT "PIS, PIS1" ENSG00000103502 "CDP-diacylglycerol--inositol 3-phosphatidyltransferase" O14735 16 29858357-29863736 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056597 Enhanced Approved "Nucleoplasm,Nuclear membrane,Plasma membrane" NA NA "Nucleoplasm, Nuclear membrane, Plasma membrane" "HPA056597: AB_2683182" "unprognostic (7.81e-2)" "prognostic favorable (9.40e-4)" "unprognostic (1.93e-3)" "unprognostic (8.08e-3)" "unprognostic (1.50e-2)" "unprognostic (2.84e-2)" "unprognostic (7.60e-2)" "unprognostic (1.09e-2)" "unprognostic (7.03e-2)" "unprognostic (8.75e-2)" "unprognostic (5.56e-3)" "unprognostic (1.61e-1)" "unprognostic (6.17e-2)" "unprognostic (3.36e-2)" "unprognostic (6.95e-2)" "unprognostic (1.56e-1)" "unprognostic (2.48e-1)" 40.4 40.8 24.3 20.2 28.1 15.3 42.9 50.7 39.5 37.1 37.2 21.5 33.9 24.8 33.4 23.0 39.4 30.1 34.5 44.4 23.1 27.9 34.8 66.3 27.1 22.4 24.1 26.4 52.7 40.0 47.1 24.9 43.7 21.8 36.8 16.1 29.3 42.2 38.8 21.0 29.6 32.6 31.8 21.0 25.6 29.5 20.2 16.4 30.4 47.1 19.9 17.3 41.8 42.8 4.8 6.1 20.6 6.5 8.2 8.4 2.7 12.5 27.3 7.7 15.4 42.0 29.1 22.8 22.1 24.8 15.7 15.7 15.9 24.2 8.4 41.9 25.4 13.9 19.8 12.4 14.3 7.2 21.1 25.0 6.0 20.4 23.2 29.3 8.9 15.7 49.2 25.2 21.1 9.7 24.9 19.6 16.1 9.0 21.9 14.1 40.1 12.1 17.7 18.3 13.2 20.3 23.7 9.6 24.5 20.7 12.1 31.7 17.8 11.7 24.9 17.4 14.1 18.6 24.4 17.0 23.3 7.4 18.9 11.3 16.3 18.4 6.0 25.4 14.5 14.0 7.5 6.5 20.6 6.9 4.6 4.6 4.7 6.4 7.3 3.0 4.8 6.3 5.9 16.4 8.2 5.7 6.1 8.4 2.7 24.3 28.1 50.7 39.5 23.1 27.9 24.1 26.4 21.8 16.4 23.8 21.2 20.5 35.7 36.7 46.6 49.2 30.6 18.7 10.3 43.6 43.2 92.1 34.9 59.1 22.5 43.2 44.6 46.7 62.9 107.9 45.5 34.0 13.8 36.5 56.9 55.6 35.8 33.2 37.3 11.0 71.1 25.7 21.9 47.7 34.8 54.4 41.4 37.1 58.0 30.1 42.9 45.3 43.2 8.6 14.0 44.4 61.2 40.6 37.0 35.3 CDRT15 ENSG00000223510 "CMT1A duplicated region transcript 15" Q96T59 17 14235673-14236862 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 5.1;testis: 19.0" "Group enriched" "Detected in some" 16 "Early spermatids: 60.5;Late spermatids: 42.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "T-reg: 2.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HEK 293: 6.9" HPA055952 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA055952: AB_2682983" "unprognostic (3.27e-2)" "unprognostic (1.77e-2)" "unprognostic (8.61e-2)" "unprognostic (9.33e-2)" "unprognostic (5.15e-3)" "unprognostic (2.90e-1)" "unprognostic (6.16e-3)" "unprognostic (1.98e-1)" "unprognostic (1.15e-3)" "unprognostic (2.66e-1)" "unprognostic (2.55e-1)" "unprognostic (1.99e-1)" "unprognostic (5.30e-7)" "unprognostic (1.55e-1)" "unprognostic (1.52e-1)" "unprognostic (6.81e-2)" "unprognostic (2.38e-2)" 0.1 0.3 0.0 1.5 0.0 0.5 0.1 0.3 0.1 0.2 0.2 0.9 0.1 0.0 0.4 0.2 0.4 0.2 0.1 0.1 0.1 0.5 0.2 3.8 0.1 0.4 0.2 0.0 0.1 0.0 0.2 0.0 0.9 0.0 0.1 5.1 1.0 0.0 0.3 1.1 0.4 19.0 0.5 0.0 0.2 0.2 0.2 0.3 0.5 0.1 0.0 2.0 0.0 1.3 2.3 1.6 3.7 0.0 0.0 0.9 1.4 0.0 0.0 0.1 4.4 0.6 3.7 0.9 0.0 0.5 1.7 0.0 0.0 0.0 3.7 6.9 2.1 3.8 3.1 0.0 1.7 2.7 0.0 0.0 0.0 0.0 1.4 0.0 1.8 1.7 0.8 0.0 0.9 1.8 2.7 1.5 2.6 2.3 1.4 0.7 1.5 0.0 1.9 1.8 3.3 0.4 1.0 0.6 5.2 0.8 0.9 2.0 6.0 0.8 1.4 1.6 1.2 1.4 1.7 0.9 2.8 4.3 0.0 0.1 0.5 0.4 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.5 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.2 0.9 0.0 0.0 0.0 0.0 0.0 CEP55 "C10orf3, CT111, FLJ10540" ENSG00000138180 "Centrosomal protein 55" Q53EZ4 10 93496632-93529092 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 52.9;testis: 19.3" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 15.9;Extravillous trophoblasts: 14.7;Hofbauer cells: 10.9;Spermatocytes: 35.6;Spermatogonia: 19.5" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 9 "T-reg: 4.4" "Lineage enriched" "Detected in single" 24 "T-cells: 4.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA023430 Approved Supported "Plasma membrane,Midbody,Centriolar satellite" Yes Yes "Plasma membrane, Centriolar satellite" Midbody "HPA023430: AB_10960212" "unprognostic (9.85e-2)" "unprognostic (1.12e-2)" "unprognostic (1.04e-1)" "unprognostic (1.29e-1)" "unprognostic (5.15e-2)" "unprognostic (4.26e-2)" "prognostic unfavorable (3.20e-9)" "prognostic unfavorable (1.45e-4)" "unprognostic (1.50e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (2.66e-5)" "unprognostic (3.99e-2)" "prognostic unfavorable (0.00e+0)" "prognostic favorable (3.15e-4)" "unprognostic (7.86e-2)" "unprognostic (1.49e-1)" "unprognostic (1.63e-1)" 3.2 1.4 0.5 12.1 0.4 3.1 3.6 0.3 0.6 2.0 5.2 0.3 0.2 4.6 0.8 1.5 11.6 0.6 2.5 0.7 0.4 0.5 1.5 0.7 4.4 10.1 0.6 0.2 0.8 0.6 0.0 0.7 3.8 0.5 0.8 6.5 0.4 2.3 0.2 0.7 3.0 5.2 3.5 1.1 4.8 3.2 19.3 0.3 52.9 0.7 10.8 11.0 2.7 3.3 0.1 0.1 0.0 0.0 0.0 4.4 0.0 51.9 20.8 13.8 17.6 1.5 3.2 7.7 28.6 20.3 27.2 28.2 22.1 28.0 13.9 12.7 18.5 18.3 29.7 16.7 14.0 32.7 41.8 8.7 5.2 12.9 7.5 0.1 9.0 12.2 0.7 1.0 29.0 35.4 8.1 25.0 23.1 4.7 26.4 30.7 12.0 23.7 13.7 5.4 16.2 15.2 10.3 22.7 7.6 12.3 6.5 5.7 8.0 22.0 6.8 17.3 11.0 17.9 9.2 15.6 17.3 24.2 23.6 46.9 11.8 16.0 17.0 13.5 34.0 15.4 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.4 0.0 0.5 0.4 0.3 0.6 0.4 0.5 0.6 0.2 0.5 0.3 0.0 2.2 0.8 0.6 3.2 0.0 0.4 5.1 0.0 0.0 0.0 0.0 0.9 0.0 0.6 15.9 0.0 0.3 0.0 0.2 14.7 0.4 0.1 0.0 0.2 10.9 0.0 0.0 2.5 4.1 3.8 0.3 5.4 0.0 0.0 1.4 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.1 35.6 19.5 1.1 1.3 1.9 2.3 0.9 CEP57L1 "bA487F23.2, C6orf182, MGC21731" ENSG00000183137 "Centrosomal protein 57 like 1" Q8IYX8 6 109095110-109163932 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Spermatocytes: 72.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040378 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA040378: AB_10794028" "unprognostic (5.93e-3)" "unprognostic (4.95e-2)" "unprognostic (1.40e-2)" "unprognostic (2.13e-2)" "unprognostic (1.11e-1)" "unprognostic (3.41e-2)" "unprognostic (4.69e-3)" "unprognostic (3.63e-2)" "unprognostic (7.25e-2)" "unprognostic (1.27e-1)" "unprognostic (2.33e-1)" "unprognostic (9.97e-2)" "unprognostic (2.42e-5)" "unprognostic (2.37e-1)" "unprognostic (2.00e-1)" "unprognostic (8.48e-2)" "unprognostic (1.72e-1)" 11.9 9.3 10.6 7.3 13.5 8.9 11.4 13.9 16.1 11.3 8.8 8.1 8.6 8.4 9.6 10.9 8.0 7.1 9.3 10.4 8.9 6.9 8.1 11.8 8.4 8.1 10.2 10.5 9.3 7.5 18.5 13.5 9.7 13.5 7.1 11.1 7.0 7.4 7.3 7.8 6.8 7.6 10.7 12.8 7.2 7.8 24.6 11.8 6.3 8.7 6.1 6.9 7.6 9.1 7.4 6.9 14.6 10.3 13.4 8.2 5.2 8.3 3.6 11.0 11.2 10.5 17.4 8.9 19.3 10.5 17.1 19.6 5.5 7.3 7.4 8.9 9.8 15.0 4.4 7.6 7.1 27.1 9.4 7.4 15.9 8.7 5.7 9.7 13.0 7.0 10.0 5.5 14.6 14.6 9.5 14.9 25.1 28.8 25.8 15.7 5.6 14.5 11.3 3.6 6.8 7.1 12.0 8.3 7.4 8.1 3.5 8.5 6.9 9.4 7.1 6.3 7.6 8.9 20.8 7.2 11.3 6.8 11.9 20.1 7.5 8.5 11.8 10.7 20.1 9.1 14.6 6.3 7.4 6.1 7.1 6.2 4.0 6.0 8.2 6.7 7.4 5.8 8.2 3.6 13.4 10.3 6.9 8.0 5.2 10.6 13.5 13.9 16.1 8.9 6.9 10.2 10.5 13.5 11.8 6.0 4.0 2.2 6.5 3.0 6.0 8.1 2.5 12.0 7.9 5.2 19.6 7.0 6.6 6.5 36.0 8.7 4.2 23.3 4.7 11.0 11.8 3.3 4.7 4.9 8.4 4.8 5.2 6.7 4.4 26.1 16.1 5.9 8.5 8.2 2.6 9.4 5.0 5.5 11.7 10.4 12.0 12.9 12.8 72.6 5.0 3.9 7.1 6.9 4.5 3.0 CFAP58 "bA554P13.1, C10orf80, CCDC147, FLJ35908" ENSG00000120051 "Cilia and flagella associated protein 58" Q5T655 10 104353764-104455090 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 10.9;testis: 17.5" "Cell type enhanced" "Detected in some" 22 "Ciliated cells: 104.4;Early spermatids: 40.7;Late spermatids: 47.0" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "pons and medulla: 6.8" "Cell type enriched" "Detected in single" 6 "neutrophil: 5.5" "Lineage enriched" "Detected in single" 55 "granulocytes: 5.5" "Cell line enhanced" "Detected in many" "BJ hTERT+: 5.2;U-2 OS: 10.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA036555, HPA071938" Approved Approved "Vesicles,Plasma membrane,Cytosol" NA NA Vesicles "Plasma membrane, Cytosol" "HPA036555: AB_10673622, HPA071938: " "unprognostic (5.32e-1)" "unprognostic (2.59e-1)" "unprognostic (6.26e-2)" "unprognostic (1.57e-3)" "unprognostic (5.41e-3)" "unprognostic (1.01e-1)" "unprognostic (9.62e-2)" "unprognostic (5.64e-2)" "unprognostic (3.11e-1)" "unprognostic (2.18e-1)" "unprognostic (8.93e-2)" "unprognostic (3.15e-1)" "unprognostic (1.65e-1)" "unprognostic (3.97e-2)" "unprognostic (6.81e-2)" "unprognostic (4.19e-2)" "unprognostic (1.59e-1)" 0.3 0.5 0.8 0.6 2.0 0.4 0.3 0.7 1.0 3.0 0.3 2.9 0.3 0.1 2.3 0.3 0.3 10.9 0.3 3.0 1.4 1.5 0.3 0.3 2.1 0.3 0.3 0.3 2.0 0.3 1.5 1.9 0.4 6.8 0.4 0.0 0.6 0.3 0.4 1.4 0.2 0.3 0.8 0.3 0.3 0.1 17.5 0.7 0.3 0.8 0.3 0.4 0.3 0.7 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.1 0.2 0.6 0.2 1.7 5.2 1.0 2.8 0.0 0.0 4.0 0.4 0.6 3.0 0.3 0.0 0.3 3.2 0.4 0.2 0.9 1.2 0.0 0.6 0.5 0.7 0.6 2.2 0.8 2.8 2.2 1.7 0.1 1.1 1.2 1.4 0.0 0.0 1.1 0.3 0.0 0.0 0.4 0.3 0.5 0.6 0.0 0.6 0.4 0.0 0.2 0.9 1.2 0.3 0.6 3.4 1.1 10.9 0.6 3.0 0.4 0.1 0.2 1.2 1.3 3.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.8 2.0 0.7 1.0 1.4 1.5 0.3 0.3 6.8 0.7 0.0 0.3 0.0 0.1 0.0 0.0 6.1 0.0 104.4 17.0 0.0 0.0 0.1 0.0 0.2 40.7 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 3.1 0.0 47.0 0.6 0.0 0.0 0.0 0.0 0.6 0.4 0.0 1.1 0.0 0.3 0.0 0.6 14.9 1.9 0.0 0.1 0.0 0.0 0.1 CFAP65 "CCDC108, DKFZp434O0527, MGC35338" ENSG00000181378 "Cilia and flagella associated protein 65" Q6ZU64 2 219002846-219041527 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 16.3;fallopian tube: 29.2;testis: 20.4" "Group enriched" "Detected in many" 4 "Ciliated cells: 53.5;Early spermatids: 163.7;Late spermatids: 138.9" "Cancer enhanced" "Detected in single" "endometrial cancer: 1.1" "Region enhanced" "Detected in many" "pons and medulla: 16.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "OE19: 2.4;SCLC-21H: 1.5;SH-SY5Y: 4.0;U-87 MG: 2.0" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "midbrain: 13.1" "HPA055156, HPA063406" Uncertain Approved "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane, Cytosol" "HPA055156: AB_2682720, HPA063406: " "unprognostic (3.95e-2)" "unprognostic (1.80e-1)" "unprognostic (9.88e-3)" "prognostic favorable (6.08e-5)" "unprognostic (2.18e-2)" "unprognostic (1.04e-2)" "unprognostic (2.20e-1)" "unprognostic (3.76e-3)" "unprognostic (3.71e-1)" "unprognostic (3.03e-1)" "unprognostic (5.58e-3)" "unprognostic (1.43e-1)" "unprognostic (6.62e-3)" "unprognostic (8.04e-2)" "unprognostic (2.81e-2)" "unprognostic (9.60e-2)" "unprognostic (6.60e-2)" 0.2 0.4 1.8 0.3 6.4 0.3 0.3 0.0 2.1 2.2 0.4 5.4 0.3 0.3 0.9 6.0 0.2 29.2 0.6 0.2 2.9 3.2 0.5 0.2 3.6 0.3 0.4 1.2 4.2 0.6 0.3 6.1 0.2 16.3 0.3 0.5 2.8 0.4 0.4 0.2 0.2 0.7 0.2 0.6 0.3 0.6 20.4 2.5 0.0 1.3 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.0 0.5 0.5 0.0 1.1 0.2 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 1.2 0.9 0.0 0.1 0.5 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.5 0.0 0.1 0.0 0.0 0.1 2.4 0.1 0.0 0.0 0.0 1.2 0.0 1.5 4.0 0.0 0.1 0.7 0.6 1.1 0.1 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 1.8 6.4 0.0 2.1 2.9 3.2 0.4 1.2 16.3 2.5 0.0 3.4 0.0 0.1 0.0 0.7 0.0 7.6 53.5 12.5 0.0 11.8 0.0 0.0 0.4 163.7 0.0 0.5 0.0 1.3 0.0 0.0 1.4 0.0 0.0 0.1 0.0 28.1 0.0 0.0 138.9 0.6 0.0 0.0 0.0 25.9 0.8 1.4 0.0 0.7 0.9 20.7 0.0 0.0 15.4 4.1 0.0 0.0 0.0 3.4 0.0 CFL2 NEM7 ENSG00000165410 "Cofilin 2" Q9Y281 14 34706769-34714823 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Disease mutation, Nemaline myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 88.5;skeletal muscle: 185.9" "Cell type enhanced" "Detected in many" 11 "Cardiomyocytes: 498.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037078, HPA045599" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 90000000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB037078: AB_259128, HPA045599: AB_2679383" "unprognostic (1.05e-1)" "unprognostic (1.28e-1)" "unprognostic (1.29e-2)" "unprognostic (1.59e-1)" "unprognostic (3.02e-2)" "unprognostic (2.80e-3)" "unprognostic (3.82e-1)" "unprognostic (2.02e-1)" "unprognostic (3.02e-1)" "unprognostic (2.92e-2)" "unprognostic (2.48e-2)" "unprognostic (1.27e-1)" "unprognostic (1.65e-2)" "unprognostic (3.13e-3)" "unprognostic (9.59e-2)" "unprognostic (1.89e-2)" "prognostic unfavorable (2.16e-5)" 14.0 16.5 15.9 8.8 17.7 5.0 6.7 13.6 16.6 13.7 23.2 25.8 9.2 4.7 21.3 10.2 20.7 11.2 7.2 88.5 19.0 14.5 8.7 33.0 7.8 3.7 22.7 10.6 12.9 3.0 9.3 4.5 10.3 28.9 22.4 8.6 7.8 5.4 31.8 185.9 2.6 6.7 38.1 24.6 4.2 11.9 6.9 20.1 0.5 9.0 30.8 3.4 34.7 9.3 8.5 2.9 3.6 1.8 3.2 5.8 1.6 17.8 16.1 10.4 6.7 10.6 39.5 5.8 31.2 36.0 29.9 31.9 12.1 7.7 6.4 12.8 49.7 22.4 3.5 22.1 6.6 52.7 0.9 9.2 1.3 19.1 28.6 17.3 1.6 1.0 29.9 2.3 25.5 14.1 21.0 29.6 0.9 2.0 5.1 36.7 5.0 1.3 0.9 3.4 3.1 24.8 1.1 32.9 1.0 10.8 3.7 2.1 8.9 20.3 4.4 10.5 8.0 9.7 1.6 26.0 29.8 19.8 14.0 14.9 7.1 4.6 2.4 10.9 2.4 7.0 3.6 1.8 2.1 3.7 1.8 5.8 8.5 4.3 4.0 2.9 5.0 3.4 3.5 0.7 3.2 0.8 2.8 3.6 1.6 15.9 17.7 13.6 16.6 19.0 14.5 22.7 10.6 28.9 20.1 98.3 34.5 15.9 86.3 17.7 51.4 498.3 15.3 6.7 14.8 21.0 19.6 25.2 51.4 41.2 2.2 46.0 0.9 0.0 34.0 52.6 52.9 52.5 5.7 99.2 13.2 73.1 9.1 43.6 14.0 6.5 52.9 10.4 28.7 7.2 3.4 80.2 30.0 4.2 92.6 79.1 57.2 32.3 125.1 51.4 51.5 16.9 17.8 14.9 3.7 53.3 CHMP2A "BC-2, CHMP2, VPS2, VPS2A" ENSG00000130724 "Charged multivesicular body protein 2A" O43633 19 58551566-58555124 "Predicted intracellular proteins" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041153, HPA042031" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 49000 Cytosol "Nucleoplasm, Plasma membrane" "HPA041153: AB_10964358, HPA042031: AB_10961727" "unprognostic (1.80e-1)" "unprognostic (4.70e-2)" "unprognostic (7.29e-2)" "unprognostic (1.44e-3)" "unprognostic (6.60e-2)" "unprognostic (2.54e-1)" "unprognostic (3.86e-2)" "unprognostic (2.60e-1)" "unprognostic (1.01e-1)" "unprognostic (1.45e-2)" "unprognostic (2.69e-1)" "unprognostic (1.45e-1)" "unprognostic (2.98e-1)" "unprognostic (2.21e-1)" "unprognostic (3.09e-2)" "unprognostic (4.23e-2)" "unprognostic (2.71e-2)" 40.7 59.6 52.5 37.3 56.7 55.1 41.2 36.3 44.8 39.0 53.2 37.8 50.4 43.5 36.9 61.7 57.4 41.9 60.4 80.6 45.0 40.1 64.8 66.5 36.4 55.8 48.2 38.7 36.9 59.8 46.9 39.1 79.2 38.5 35.2 49.2 33.0 62.4 64.8 75.7 54.9 72.0 42.4 48.5 43.4 45.2 29.4 35.1 34.0 49.8 53.9 44.4 42.5 34.0 17.5 30.5 117.2 34.7 17.0 29.4 24.9 18.0 48.6 15.7 14.4 24.3 30.5 19.4 16.7 34.7 8.9 9.7 14.3 26.9 4.8 24.7 27.9 25.8 14.7 12.9 31.9 7.6 16.1 106.0 11.8 35.6 21.9 47.1 19.5 18.5 35.3 45.3 13.9 44.7 30.4 25.8 22.8 14.0 23.1 26.9 30.5 24.7 18.1 6.5 50.0 37.3 10.7 13.5 36.2 38.8 41.0 18.5 31.4 27.2 36.4 20.0 10.3 27.9 20.0 29.0 45.6 6.6 13.2 19.3 58.9 64.4 15.7 32.1 23.2 29.9 33.5 34.7 46.6 20.2 31.7 17.0 17.5 22.3 22.7 30.5 15.8 15.7 17.7 117.2 17.0 31.6 27.8 29.4 24.9 52.5 56.7 36.3 44.8 45.0 40.1 48.2 38.7 38.5 35.1 92.3 99.1 97.2 231.9 147.1 67.2 100.3 152.8 155.2 81.9 157.1 15.7 253.5 374.7 261.4 89.0 137.1 466.3 70.0 457.0 242.2 112.6 224.1 116.8 190.9 235.9 49.3 149.1 122.8 143.9 66.0 134.3 151.3 204.1 239.9 215.7 135.6 375.5 326.1 125.2 436.3 71.4 84.1 139.8 101.7 97.9 173.4 384.7 105.5 183.9 310.0 CIB3 KIP3 ENSG00000141977 "Calcium and integrin binding family member 3" Q96Q77 19 16161368-16173525 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 5.4;bone marrow: 4.8;testis: 3.8" "Group enriched" "Detected in some" 8 "Cardiomyocytes: 22.7;Late spermatids: 6.6" "Cancer enriched" "Detected in single" 7 "breast cancer: 0.9" "Cell type enhanced" "Detected in some" "eosinophil: 5.4" "Lineage enriched" "Detected in single" 9 "granulocytes: 5.4" "Cell line enhanced" "Detected in some" "HMC-1: 9.2;MCF7: 4.4;NB-4: 2.8;THP-1: 2.6;U-937: 4.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA043553, HPA043995" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA043553: AB_10964566, HPA043995: " "unprognostic (8.43e-2)" "unprognostic (7.26e-5)" "unprognostic (3.18e-2)" "unprognostic (2.62e-1)" "unprognostic (5.32e-2)" "unprognostic (1.95e-2)" "unprognostic (1.25e-1)" "unprognostic (3.14e-1)" "unprognostic (2.93e-2)" "unprognostic (3.05e-1)" "unprognostic (5.68e-2)" "unprognostic (3.42e-1)" "unprognostic (1.54e-2)" 0.0 0.0 0.0 0.8 0.0 4.8 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 3.8 0.0 0.7 0.1 0.0 0.1 0.6 5.4 0.5 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 9.2 0.3 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 4.4 0.0 2.8 0.4 0.0 0.3 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 4.1 0.0 1.9 0.1 5.4 0.0 0.5 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 1.2 0.0 0.1 0.4 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 22.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.1 0.0 0.0 0.0 0.0 0.0 CIP2A KIAA1524 ENSG00000163507 "Cell proliferation regulating inhibitor of protein phosphatase 2A" Q8TCG1 3 108549869-108589644 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 21.5" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 8.9;Exocrine glandular cells: 6.4;Extravillous trophoblasts: 10.7;Hofbauer cells: 6.7;monocytes: 5.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039570 Approved Supported "Plasma membrane,Cytosol" NA Yes Cytosol "Plasma membrane" "HPA039570: AB_10796329" "unprognostic (2.02e-1)" "unprognostic (1.54e-2)" "unprognostic (2.31e-3)" "prognostic unfavorable (6.24e-5)" "unprognostic (3.10e-2)" "unprognostic (1.07e-2)" "unprognostic (1.91e-7)" "unprognostic (2.80e-3)" "unprognostic (2.53e-3)" "unprognostic (1.24e-1)" "prognostic unfavorable (9.18e-4)" "unprognostic (6.85e-2)" "prognostic unfavorable (1.42e-4)" "unprognostic (9.11e-3)" "unprognostic (3.73e-1)" "unprognostic (2.11e-1)" "unprognostic (1.25e-1)" 2.1 2.3 2.5 8.5 6.3 10.4 3.6 6.3 6.2 3.2 3.1 2.6 0.8 2.0 3.2 1.8 4.0 1.8 2.0 2.7 2.9 2.1 2.2 1.6 2.2 10.2 2.0 3.2 3.8 1.8 1.8 3.0 3.3 2.4 3.0 4.4 2.2 2.3 1.4 2.0 1.9 2.7 2.5 2.4 5.5 2.0 8.5 1.5 21.5 1.9 1.5 8.0 4.0 2.7 1.9 0.3 0.7 1.1 0.0 1.6 0.6 18.9 5.6 15.9 10.2 0.7 1.5 6.5 14.4 6.8 17.1 20.1 6.8 8.5 12.8 5.0 5.2 13.0 9.7 5.4 5.1 31.2 4.0 5.3 15.3 7.8 5.1 0.2 9.8 11.0 0.6 1.0 13.3 5.5 2.8 7.6 5.9 9.4 20.7 16.7 3.9 11.8 8.8 16.4 7.1 9.8 13.6 14.8 7.0 5.2 5.3 7.7 10.2 10.6 4.2 5.9 9.7 7.1 7.0 5.5 17.6 19.9 5.3 17.3 4.8 5.3 21.2 7.8 10.7 17.9 0.6 0.3 0.7 0.0 0.5 1.3 1.2 0.7 0.3 0.0 1.9 0.7 1.6 0.0 0.0 1.1 0.3 0.8 0.6 2.5 6.3 6.3 6.2 2.9 2.1 2.0 3.2 2.4 1.5 8.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 2.7 4.5 3.5 0.0 2.5 1.7 2.4 0.0 0.0 0.0 0.0 6.4 10.7 0.0 0.0 3.5 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 5.4 0.0 0.0 3.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 CLCA4 CaCC2 ENSG00000016602 "Chloride channel accessory 4" Q14CN2 1 86547078-86580754 "Predicted membrane proteins" Transport "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "esophagus: 182.1;intestine: 64.2" "Cell type enriched" "Detected in some" 4 "Urothelial cells: 115.2" "Cancer enhanced" "Detected in many" "cervical cancer: 21.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 988 "RT4: 98.7" "HPA017045, HPA064770" Uncertain Approved "Nucleoplasm,Plasma membrane,Aggresome" "Intracellular and membrane" NA NA 210000 "Plasma membrane" "Nucleoplasm, Aggresome" "HPA017045: AB_2291679, HPA064770: " "unprognostic (1.38e-4)" "unprognostic (1.52e-1)" "prognostic favorable (7.47e-4)" "unprognostic (2.73e-2)" "unprognostic (7.03e-2)" "prognostic favorable (8.63e-4)" "unprognostic (7.59e-2)" "unprognostic (3.35e-1)" "unprognostic (1.26e-1)" "unprognostic (6.01e-2)" "unprognostic (1.20e-1)" "unprognostic (2.57e-2)" "unprognostic (2.29e-1)" "unprognostic (5.69e-2)" "unprognostic (3.43e-2)" 0.2 0.1 2.2 8.8 3.0 0.1 0.6 0.0 2.0 12.3 64.2 2.0 0.0 0.1 0.3 0.1 182.1 0.1 0.1 0.1 2.2 0.6 0.1 0.1 0.1 0.1 3.2 1.6 0.1 0.0 0.1 0.0 0.1 3.0 1.8 38.4 0.0 5.9 0.1 0.1 4.5 6.1 0.8 2.4 0.1 0.1 0.1 5.0 0.0 0.1 8.6 21.5 9.0 13.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 98.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 3.0 0.0 2.0 2.2 0.6 3.2 1.6 3.0 5.0 0.0 0.0 0.0 13.3 3.0 0.0 0.2 0.0 2.7 5.7 1.8 0.0 0.0 0.0 0.0 0.3 0.0 18.6 0.0 0.0 0.0 0.0 3.9 9.2 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 26.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.5 0.0 0.0 4.1 115.2 CLCN6 "CLC-6, KIAA0046" ENSG00000011021 "Chloride voltage-gated channel 6" P51797 1 11806096-11843144 "Plasma proteins, Predicted membrane proteins" "Antiport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA032097 Approved Approved "Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "HPA032097: AB_10670827" "unprognostic (3.14e-2)" "unprognostic (1.14e-1)" "unprognostic (2.46e-1)" "unprognostic (8.83e-2)" "unprognostic (2.08e-1)" "unprognostic (3.84e-3)" "unprognostic (1.51e-3)" "unprognostic (6.49e-2)" "unprognostic (7.76e-2)" "unprognostic (6.61e-3)" "unprognostic (1.71e-3)" "unprognostic (3.44e-1)" "unprognostic (2.13e-2)" "unprognostic (6.91e-2)" "unprognostic (1.45e-1)" "unprognostic (1.69e-1)" "unprognostic (3.65e-2)" 11.2 14.6 18.9 11.5 18.7 12.2 8.6 18.0 27.9 9.2 8.7 22.4 8.6 9.6 12.8 14.2 6.3 10.7 8.1 15.7 15.0 20.6 10.0 9.1 10.6 11.1 16.4 17.8 21.4 6.6 8.4 14.8 9.6 32.4 11.3 7.8 13.1 6.7 8.7 11.2 10.0 9.1 10.8 15.9 10.6 8.5 16.1 14.5 4.3 10.7 5.0 9.5 7.7 8.2 10.1 3.2 4.2 4.6 2.0 3.2 1.1 5.6 5.3 12.0 10.1 12.9 13.4 3.7 4.7 9.2 6.6 10.3 8.1 13.8 8.1 3.9 4.4 16.4 8.4 7.9 8.8 5.9 3.6 4.2 8.4 10.5 10.7 16.7 4.7 7.9 9.2 5.2 12.4 7.0 8.0 5.9 8.4 10.6 11.7 6.7 3.1 4.8 12.7 8.0 2.7 4.2 6.1 6.6 7.4 8.7 4.7 5.2 8.3 3.2 5.1 11.0 8.8 4.5 8.4 7.1 6.2 7.0 10.5 3.3 7.0 4.3 20.8 7.6 9.4 4.5 4.2 4.6 1.5 2.6 3.7 1.5 8.0 2.1 3.2 2.7 10.1 2.3 2.1 3.9 2.0 4.6 3.2 1.4 1.1 18.9 18.7 18.0 27.9 15.0 20.6 16.4 17.8 32.4 14.5 17.9 20.5 11.3 3.3 3.1 18.5 21.8 10.2 8.1 6.8 3.5 13.7 3.2 0.0 3.6 12.5 5.6 5.4 0.0 3.9 2.2 5.2 4.1 2.3 5.5 6.5 25.4 6.3 8.0 8.2 7.4 6.9 10.1 1.7 5.4 2.9 7.8 4.2 3.5 6.7 3.0 16.0 0.0 4.2 9.7 9.4 2.8 3.4 2.5 3.0 3.5 CLDN23 CLDNL ENSG00000253958 "Claudin 23" Q96B33 8 8701938-8704106 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Enterocytes: 128.5;Paneth cells: 76.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "myeloid DC: 3.4;plasmacytoid DC: 3.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 9.8;Daudi: 7.8;RT4: 8.3;SK-BR-3: 8.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA070578 Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA070578: " "unprognostic (1.86e-1)" "unprognostic (1.53e-1)" "prognostic favorable (3.46e-4)" "unprognostic (2.97e-1)" "unprognostic (8.32e-2)" "unprognostic (3.04e-1)" "unprognostic (3.44e-1)" "unprognostic (2.05e-2)" "unprognostic (2.14e-1)" "unprognostic (1.14e-1)" "unprognostic (1.97e-2)" "unprognostic (8.25e-3)" "prognostic favorable (9.65e-8)" "unprognostic (7.76e-2)" "unprognostic (3.17e-2)" "unprognostic (9.59e-2)" "unprognostic (1.33e-3)" 9.1 1.0 0.3 7.1 1.4 0.3 6.1 0.4 0.6 2.6 14.8 0.5 3.8 5.5 1.0 6.3 2.8 1.4 10.6 1.4 0.9 0.2 6.5 13.3 8.7 3.1 1.1 0.3 2.6 3.2 1.5 0.7 15.7 1.7 3.3 8.8 2.8 6.0 2.5 0.9 10.0 20.0 0.5 0.3 2.4 18.0 1.5 0.5 0.4 8.8 4.3 3.0 6.0 5.3 0.5 3.9 0.8 2.4 0.0 0.0 0.6 0.2 3.2 0.0 0.2 1.0 0.1 9.8 2.4 1.9 2.6 4.0 1.9 5.2 7.8 0.0 0.1 1.0 3.1 0.0 0.1 0.2 1.5 0.0 0.0 1.0 0.1 4.6 0.0 0.1 1.3 1.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.3 4.0 0.1 0.2 2.5 0.4 1.6 0.0 0.0 0.0 1.2 8.3 0.4 1.2 3.2 8.5 0.1 1.0 1.2 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.2 0.8 0.0 2.4 0.0 0.5 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.1 3.9 0.0 0.6 0.3 1.4 0.4 0.6 0.9 0.2 1.1 0.3 1.7 0.5 8.9 1.9 1.3 6.7 0.1 0.0 0.5 20.4 6.7 1.2 1.8 0.0 15.9 6.6 19.6 0.0 1.0 128.5 0.0 9.5 15.2 3.5 2.8 4.6 6.8 15.3 0.0 7.5 8.0 1.9 0.0 0.3 2.9 3.3 1.0 23.5 0.2 20.1 76.4 0.4 3.8 1.1 6.5 2.1 0.0 0.0 0.5 7.9 0.0 18.9 10.5 CLEC4F "CLECSF13, FLJ39110, KCLR" ENSG00000152672 "C-type lectin domain family 4 member F" Q8N1N0 2 70808643-70820600 "Predicted membrane proteins" Endocytosis Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 17 "Cone photoreceptor cells: 9.8;Horizontal cells: 4.8;Rod photoreceptor cells: 7.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 9 "intermediate monocyte: 7.9;non-classical monocyte: 5.8" "Lineage enriched" "Detected in single" 11 "monocytes: 7.9" "Cell line enhanced" "Detected in some" "AN3-CA: 6.0;BEWO: 2.1;HAP1: 1.7;SH-SY5Y: 1.4;T-47d: 3.1" "Not detected" "Not detected" HPA056101 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA056101: " "unprognostic (8.14e-3)" "unprognostic (3.73e-2)" "unprognostic (2.07e-2)" "unprognostic (2.46e-1)" "unprognostic (4.91e-2)" "unprognostic (5.41e-2)" "unprognostic (3.66e-2)" "unprognostic (2.07e-2)" "unprognostic (9.29e-2)" "unprognostic (3.45e-1)" "unprognostic (2.68e-4)" "unprognostic (2.62e-1)" "unprognostic (1.93e-1)" "unprognostic (1.91e-1)" "unprognostic (2.44e-2)" "unprognostic (9.59e-2)" "unprognostic (2.44e-1)" 3.1 0.0 0.5 3.2 0.5 0.0 2.1 0.7 0.7 1.8 4.2 0.5 6.8 2.5 2.9 1.4 1.5 1.5 7.0 1.5 0.5 0.1 1.2 2.4 9.0 1.8 1.2 0.5 1.3 0.5 0.0 1.4 0.5 0.5 2.9 1.3 0.8 3.3 2.7 1.4 2.3 7.6 2.0 0.5 6.8 0.7 2.0 0.5 0.9 0.6 0.5 2.0 1.5 2.5 0.0 0.7 0.0 7.9 0.0 0.0 0.6 0.0 0.1 0.1 6.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.3 3.1 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.6 0.5 0.5 0.7 0.5 0.5 0.1 1.2 0.5 0.5 0.5 0.0 0.3 0.0 0.0 0.2 0.4 0.3 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.8 0.0 0.0 0.3 0.7 0.0 1.7 0.0 1.8 0.0 0.7 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 CLUL1 ENSG00000079101 "Clusterin like 1" Q15846 18 596988-650334 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 45.2" "Cell type enriched" "Detected in many" 7 "Rod photoreceptor cells: 335.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 24.6" "Not detected" "Not detected" "CAB025264, HPA075240" Enhanced Approved "Endoplasmic reticulum,Plasma membrane" "Secreted in other tissues" NA NA "Endoplasmic reticulum" "Plasma membrane" "CAB025264: , HPA075240: AB_2732286" "unprognostic (1.75e-2)" "unprognostic (9.15e-2)" "unprognostic (1.50e-1)" "unprognostic (1.51e-1)" "unprognostic (7.81e-3)" "unprognostic (3.00e-3)" "unprognostic (1.96e-1)" "unprognostic (2.97e-3)" "unprognostic (8.38e-3)" "unprognostic (3.76e-2)" "unprognostic (4.85e-3)" "unprognostic (4.96e-3)" "unprognostic (6.36e-4)" "unprognostic (1.32e-1)" "unprognostic (7.89e-2)" "unprognostic (1.29e-3)" "unprognostic (2.37e-2)" 0.5 1.4 5.0 0.5 3.8 4.3 3.1 4.5 6.6 2.1 1.0 1.4 1.0 0.6 1.9 0.7 1.6 2.4 2.5 0.4 5.9 6.4 7.5 0.7 1.8 0.8 4.9 2.0 7.4 1.6 2.5 6.1 0.7 5.1 12.0 0.0 45.2 3.1 1.6 0.1 0.8 1.7 0.4 5.3 0.1 3.9 3.4 2.8 0.3 9.4 0.1 0.4 2.1 0.3 1.0 1.3 2.1 0.3 0.1 2.0 0.5 2.6 3.9 7.5 5.1 0.0 0.0 4.5 2.9 0.2 0.0 0.0 3.1 1.5 3.1 0.7 0.0 2.7 1.1 0.0 0.4 0.0 2.5 7.0 5.2 2.1 24.6 0.0 1.7 1.0 0.2 0.0 0.0 0.0 1.3 0.3 7.7 7.3 9.1 0.0 0.8 3.1 5.6 0.5 3.2 1.8 6.3 3.5 11.0 0.8 0.8 6.6 4.6 2.9 1.8 2.2 6.3 2.4 0.8 0.6 3.0 4.4 2.1 1.4 5.2 9.1 6.5 2.4 3.4 2.6 0.9 0.3 0.2 0.2 0.0 0.1 1.0 0.4 0.2 0.5 0.1 0.1 0.8 2.1 0.1 0.0 1.3 2.0 0.5 5.0 3.8 4.5 5.7 5.9 6.4 4.9 2.0 5.1 2.8 0.0 1.6 0.0 3.4 0.0 23.9 0.1 0.0 4.0 2.3 0.0 19.6 0.4 1.7 0.2 0.4 0.2 0.0 0.0 0.2 0.1 0.1 8.5 0.0 0.0 0.2 15.9 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 46.9 0.0 0.0 1.1 0.3 335.8 6.5 0.0 8.4 4.5 0.1 0.3 0.0 0.0 1.4 CMTM4 CKLFSF4 ENSG00000183723 "CKLF like MARVEL transmembrane domain containing 4" Q8IZR5 16 66614750-66696707 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 39.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014704, HPA023890" Enhanced Approved "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Golgi apparatus, Vesicles, Plasma membrane" "HPA014704: AB_1847005, HPA023890: AB_1847007" "unprognostic (2.65e-3)" "unprognostic (1.16e-1)" "unprognostic (6.17e-3)" "unprognostic (3.43e-1)" "unprognostic (5.13e-1)" "unprognostic (8.30e-2)" "unprognostic (2.88e-2)" "unprognostic (2.65e-1)" "unprognostic (3.35e-3)" "unprognostic (6.06e-3)" "unprognostic (2.07e-2)" "unprognostic (3.08e-1)" "prognostic favorable (4.72e-9)" "unprognostic (1.41e-1)" "unprognostic (2.31e-1)" "unprognostic (4.94e-2)" "unprognostic (1.00e-1)" 2.7 4.8 18.9 3.3 18.2 2.9 6.6 8.3 22.1 4.8 16.1 13.5 8.7 12.6 3.2 21.8 4.5 11.5 4.8 3.3 20.0 16.2 18.3 2.5 6.5 1.3 17.0 13.0 2.5 15.1 31.7 9.4 4.3 12.5 6.8 13.4 5.2 10.7 6.9 2.7 7.2 15.8 4.2 13.3 1.8 18.5 6.3 10.3 0.0 39.3 0.5 2.1 4.3 2.6 0.2 1.3 0.1 1.2 0.2 0.9 0.2 9.6 8.3 4.8 11.9 1.6 2.4 20.2 4.1 3.5 2.2 3.6 14.6 11.0 0.4 7.1 2.4 3.0 12.3 11.8 4.6 3.3 0.8 10.8 0.9 3.0 8.8 3.5 0.8 1.9 4.0 8.2 2.5 5.2 7.5 1.2 1.3 4.9 2.7 3.2 10.6 0.1 1.9 5.7 17.1 5.4 2.1 6.4 2.9 9.5 8.7 11.5 4.4 16.6 9.2 5.7 3.6 9.8 2.0 2.5 4.0 4.7 1.1 4.1 0.9 1.9 0.5 5.0 2.0 4.9 0.0 1.2 0.0 0.3 0.3 0.0 0.0 0.1 0.9 1.3 0.2 0.1 0.2 0.1 0.2 0.7 1.3 0.7 0.2 18.9 18.2 8.3 22.1 20.0 16.2 17.0 13.0 12.5 10.3 20.8 12.0 0.0 6.0 4.6 10.9 5.9 25.5 21.4 7.9 22.7 7.9 4.2 11.6 14.5 1.6 3.0 26.2 0.0 20.6 27.7 3.1 19.1 4.6 5.0 2.0 28.6 37.5 1.3 3.0 2.1 2.3 1.5 3.3 0.0 24.3 22.6 24.1 11.5 2.8 20.3 9.2 6.5 4.7 4.7 6.8 4.8 2.4 0.0 32.7 12.7 CMTM7 "CKLFSF7, FLJ30992" ENSG00000153551 "CKLF like MARVEL transmembrane domain containing 7" Q96FZ5 3 32391671-32483067 "Predicted membrane proteins, Transporters" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Hofbauer cells: 104.7;Kupffer cells: 102.2;Macrophages: 86.9;monocytes: 120.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 39.8;hTERT-RPE1: 41.0" "Low region specificity" "Detected in all" HPA077409 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA077409: AB_2686838" "unprognostic (2.27e-3)" "unprognostic (3.16e-2)" "unprognostic (3.98e-2)" "unprognostic (1.15e-1)" "unprognostic (5.42e-2)" "unprognostic (3.16e-2)" "prognostic unfavorable (3.21e-4)" "unprognostic (3.03e-2)" "unprognostic (3.92e-2)" "unprognostic (2.60e-1)" "unprognostic (6.55e-3)" "unprognostic (1.64e-1)" "prognostic unfavorable (1.00e-6)" "unprognostic (5.86e-2)" "unprognostic (2.51e-1)" "unprognostic (3.79e-1)" "unprognostic (3.12e-2)" 14.5 6.5 3.3 18.9 5.7 23.8 43.1 4.5 2.2 10.0 6.2 4.3 11.0 3.1 7.7 12.3 4.8 24.5 14.6 8.3 2.8 2.8 14.8 5.9 25.1 47.5 5.9 1.0 9.3 27.6 0.9 2.8 11.4 4.7 12.8 5.9 6.1 8.7 17.6 4.0 6.4 10.9 7.0 10.3 32.4 8.2 5.8 4.6 45.9 24.5 3.3 23.1 16.5 12.4 10.0 24.8 24.4 47.0 4.9 36.2 22.1 0.1 4.5 9.8 11.9 9.2 9.1 27.9 4.4 5.3 8.0 7.4 5.0 39.8 0.0 13.8 5.3 9.9 5.0 12.1 20.5 7.1 0.0 9.6 5.3 0.0 11.6 37.6 1.3 8.5 9.6 2.7 8.2 13.1 41.0 18.0 0.0 4.4 12.0 5.9 0.1 0.0 12.3 11.8 2.0 20.9 25.6 3.7 24.4 11.3 8.8 0.5 10.2 0.6 0.7 22.8 4.4 6.2 13.8 10.3 7.6 7.6 8.3 15.4 3.4 1.2 0.0 2.7 16.7 15.9 5.5 47.0 24.4 5.3 44.1 3.2 10.0 17.9 10.9 24.8 7.0 19.5 13.5 18.0 4.9 37.2 10.5 36.2 22.1 3.3 5.7 4.5 2.2 2.8 2.8 5.9 1.0 4.7 4.6 23.8 14.7 40.7 17.6 8.8 0.2 1.5 15.3 14.7 23.9 17.4 0.0 19.8 0.0 83.6 0.1 15.7 1.3 23.3 13.6 6.7 16.0 11.2 28.9 1.0 104.7 1.6 16.6 18.4 102.2 1.0 1.4 86.9 23.6 120.0 3.4 1.3 59.3 8.6 1.1 24.0 0.2 6.5 14.5 1.2 7.2 4.8 5.7 43.6 3.0 10.2 CMYA5 "C5orf10, DKFZp451G223, myospryn, SPRYD2, TRIM76" ENSG00000164309 "Cardiomyopathy associated 5" Q8N3K9 5 79689877-79800240 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "heart muscle: 119.1;skeletal muscle: 329.3" "Cell type enriched" "Detected in many" 15 "Cardiomyocytes: 3073.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 2.6;RT4: 3.1;THP-1: 10.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA074081, HPA077831" Enhanced Approved "Nuclear speckles,Vesicles,Plasma membrane,Cytosol" NA NA "Nuclear speckles, Cytosol" "Vesicles, Plasma membrane" "HPA074081: , HPA077831: " "unprognostic (5.53e-2)" "unprognostic (9.91e-3)" "unprognostic (1.21e-2)" "unprognostic (1.49e-2)" "unprognostic (9.01e-4)" "unprognostic (7.00e-2)" "unprognostic (7.39e-2)" "unprognostic (1.20e-1)" "unprognostic (1.64e-1)" "unprognostic (1.75e-1)" "unprognostic (5.04e-1)" "unprognostic (1.93e-1)" "unprognostic (1.93e-2)" "unprognostic (6.30e-3)" "unprognostic (3.88e-2)" "unprognostic (7.69e-2)" "unprognostic (9.74e-2)" 2.4 0.2 0.3 0.0 0.3 0.0 0.9 0.3 0.4 0.4 0.4 0.0 0.0 0.0 1.4 2.6 2.0 0.5 0.2 119.1 0.3 0.3 0.6 0.3 0.3 0.0 0.3 0.0 3.6 0.2 2.2 1.1 0.3 0.3 1.4 0.0 0.0 2.4 0.5 329.3 0.5 0.2 1.1 0.4 0.2 0.3 0.2 0.1 0.0 2.3 54.0 2.5 0.8 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 1.0 1.0 1.3 0.4 0.1 0.1 0.2 0.2 0.4 0.1 0.0 1.9 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.4 0.0 0.2 0.0 0.1 1.6 0.4 0.1 0.0 0.0 0.0 0.6 0.0 0.1 0.0 2.6 0.1 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.1 3.1 0.1 0.0 0.1 0.0 0.2 0.2 2.0 10.7 0.0 0.1 0.4 0.0 0.3 0.2 0.1 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.4 0.3 0.3 0.3 0.0 0.3 0.1 8.9 3.2 0.0 15.7 1.1 1.4 3073.8 2.5 8.1 15.9 24.4 0.0 14.8 14.9 0.5 0.1 0.7 0.0 0.0 0.4 2.5 3.7 5.2 1.1 2.0 1.8 205.0 1.7 0.6 0.3 1.1 13.8 1.1 0.0 0.0 0.0 10.8 0.4 0.0 12.7 11.5 2.6 0.0 0.9 0.2 1.1 4.6 27.5 0.5 0.0 12.0 CNGA1 "CNCG, CNCG1, CNG1, RCNC1, RCNCa, RP49" ENSG00000198515 "Cyclic nucleotide gated channel alpha 1" P29973 4 47935977-48016672 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sensory transduction, Transport, Vision" "Ion channel, Ligand-gated ion channel" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 23.7" "Cell type enriched" "Detected in many" 9 "Rod photoreceptor cells: 880.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 13.4;RT4: 10.7;U-2 OS: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA076168 Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" Nucleoplasm "HPA076168: AB_2686781" "unprognostic (2.68e-2)" "unprognostic (4.90e-2)" "unprognostic (1.33e-1)" "unprognostic (8.59e-2)" "unprognostic (2.07e-1)" "unprognostic (1.11e-2)" "unprognostic (1.76e-2)" "unprognostic (3.85e-2)" "unprognostic (1.12e-1)" "unprognostic (1.98e-2)" "unprognostic (3.18e-1)" "unprognostic (2.91e-1)" "unprognostic (5.48e-6)" "unprognostic (1.86e-1)" "unprognostic (1.04e-1)" "unprognostic (4.66e-2)" "unprognostic (8.23e-2)" 4.9 1.1 0.6 2.7 1.0 0.1 2.9 0.3 0.5 5.7 6.1 0.2 1.6 2.1 0.6 12.1 13.7 3.9 1.5 1.0 0.6 0.6 4.9 23.7 0.5 0.0 1.3 0.0 1.6 2.1 5.2 4.2 21.3 0.4 6.2 2.3 14.7 4.9 1.7 4.2 5.3 12.7 0.5 0.9 8.2 2.5 1.4 0.2 0.1 2.2 3.6 2.7 8.2 8.8 0.7 2.7 1.2 0.4 1.9 1.6 0.1 3.2 1.2 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.0 0.2 2.9 13.4 0.1 0.7 0.0 3.6 2.1 0.3 0.4 0.1 0.0 0.9 0.0 0.3 1.0 0.0 0.1 0.3 0.1 0.6 0.0 0.1 1.6 0.0 1.1 0.9 0.7 0.2 1.3 0.1 0.2 0.6 2.0 3.1 0.1 0.0 0.1 0.6 10.7 0.3 0.1 0.2 0.6 0.2 0.3 1.2 0.0 0.6 0.3 4.2 0.1 0.1 0.9 1.0 0.1 0.1 0.1 2.4 0.2 0.4 0.0 0.5 0.4 0.1 0.3 0.2 1.6 0.3 0.7 0.3 0.6 1.2 1.9 0.2 2.7 0.1 0.1 0.6 1.0 0.3 0.5 0.6 0.6 1.3 0.0 0.4 0.2 0.0 0.0 0.0 1.4 0.1 78.5 0.4 2.5 0.0 0.0 59.3 86.4 0.0 0.0 7.8 0.4 0.1 8.4 0.0 5.9 0.0 0.2 4.0 0.0 30.0 1.3 42.9 0.0 0.0 1.5 0.0 0.3 0.0 0.0 0.0 3.2 100.9 1.6 10.5 0.0 0.3 880.8 0.0 3.1 0.3 1.3 2.4 0.2 0.0 2.9 15.6 CNKSR2 "CNK2, KIAA0902, KSR2" ENSG00000149970 "Connector enhancer of kinase suppressor of Ras 2" Q8WXI2 X 21372801-21654695 "Predicted intracellular proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 38.4" "Cell type enhanced" "Detected in many" 21 "Cone photoreceptor cells: 19.6;Horizontal cells: 22.3;Rod photoreceptor cells: 86.9" "Cancer enhanced" "Detected in some" "glioma: 2.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 2.9;naive CD4 T-cell: 3.0" "Group enriched" "Detected in many" 5 "B-cells: 2.9;T-cells: 3.0" "Cell line enhanced" "Detected in some" "A549: 6.8;AF22: 4.8;NTERA-2: 11.1;PC-3: 5.7;RH-30: 10.3;U-251 MG: 6.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001502 Approved "Golgi apparatus,Plasma membrane" NA NA "Golgi apparatus, Plasma membrane" "HPA001502: AB_1078542" "unprognostic (1.33e-2)" "unprognostic (1.00e-3)" "unprognostic (5.35e-2)" "unprognostic (4.90e-4)" "unprognostic (1.26e-1)" "unprognostic (5.40e-2)" "unprognostic (4.35e-3)" "unprognostic (2.58e-2)" "unprognostic (3.47e-1)" "unprognostic (7.16e-2)" "unprognostic (1.35e-2)" "unprognostic (2.01e-1)" "unprognostic (1.78e-2)" "unprognostic (2.72e-2)" "unprognostic (3.93e-2)" "unprognostic (2.27e-2)" "unprognostic (4.13e-2)" 2.0 5.2 23.5 1.4 29.6 1.3 2.1 31.3 38.4 1.4 1.2 1.7 0.0 1.1 1.4 1.8 1.1 2.3 1.2 1.7 26.4 4.4 1.0 2.0 2.8 2.4 3.1 20.8 1.9 4.9 1.0 1.0 1.1 1.8 2.2 1.1 3.5 1.7 1.2 7.4 1.1 1.2 1.2 1.7 1.8 1.3 1.8 5.0 0.6 1.2 0.0 2.6 1.3 0.7 2.9 0.1 0.6 0.0 0.0 3.0 0.3 0.0 6.8 4.8 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.7 0.0 0.0 1.4 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.0 2.0 0.1 11.1 0.0 5.7 0.0 10.3 0.0 0.0 0.0 4.7 1.9 0.0 0.1 0.2 2.9 0.0 0.6 0.0 0.1 2.2 0.0 6.8 3.6 0.0 3.6 1.0 0.0 2.7 0.1 0.0 0.6 0.1 0.0 0.4 1.1 0.6 0.0 0.0 2.9 3.0 1.0 0.0 0.0 0.0 0.1 0.8 0.3 23.5 29.6 31.3 24.4 26.4 4.4 3.1 20.8 1.8 5.0 14.9 2.2 0.5 0.5 1.1 11.3 5.6 0.0 0.0 10.3 0.0 19.6 0.0 0.0 0.4 0.2 0.0 0.4 0.0 1.9 0.0 1.4 2.1 1.1 2.4 0.1 22.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 12.8 0.8 0.0 1.4 0.0 86.9 0.0 0.8 0.9 8.7 1.6 0.0 0.0 0.1 0.0 CNNM1 ACDP1 ENSG00000119946 "Cyclin and CBS domain divalent metal cation transport mediator 1" Q9NRU3 10 99329099-99394330 "Predicted membrane proteins" "Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.5;testis: 16.8" "Group enriched" "Detected in many" 4 "Bipolar cells: 30.2;Early spermatids: 76.6;Horizontal cells: 47.7;Late spermatids: 66.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "naive CD4 T-cell: 1.3" "Lineage enriched" "Detected in single" 6 "T-cells: 1.3" "Cell line enhanced" "Detected in some" "A549: 17.4;BJ hTERT+: 6.6;BJ hTERT+ SV40 Large T+: 6.1;BJ hTERT+ SV40 Large T+ RasG12V: 10.4;HAP1: 7.8;OE19: 6.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040408 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA040408: AB_10793963" "unprognostic (9.04e-4)" "unprognostic (2.93e-1)" "unprognostic (1.70e-1)" "unprognostic (7.60e-4)" "unprognostic (4.08e-3)" "unprognostic (9.51e-2)" "unprognostic (6.01e-2)" "unprognostic (2.27e-2)" "unprognostic (6.03e-2)" "unprognostic (1.94e-1)" "unprognostic (3.09e-2)" "unprognostic (2.45e-1)" "unprognostic (8.94e-2)" "unprognostic (1.50e-1)" "unprognostic (4.03e-1)" "unprognostic (2.37e-2)" "unprognostic (2.03e-1)" 0.6 2.5 3.4 0.7 15.5 0.5 1.3 8.1 12.7 2.0 1.0 0.3 1.1 1.2 2.1 3.7 1.4 2.4 1.0 0.5 2.8 5.0 2.4 0.8 0.6 0.5 2.1 7.1 5.4 1.7 0.4 4.2 0.5 4.8 3.6 1.2 0.7 1.0 2.1 0.5 2.5 1.2 1.5 1.0 0.5 1.6 16.8 2.3 0.0 0.5 0.2 0.6 2.2 1.2 0.1 0.1 0.2 0.0 0.1 1.3 0.0 0.0 17.4 0.0 0.0 0.0 0.0 0.0 2.5 6.6 6.1 10.4 0.0 4.0 0.0 0.0 1.2 0.1 1.6 7.8 0.0 4.4 0.0 0.8 1.7 2.6 3.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.9 0.0 0.1 0.0 0.0 0.3 2.3 0.2 0.0 0.8 6.7 0.7 0.0 0.0 0.0 0.8 0.0 2.0 5.6 1.8 0.4 0.8 0.5 0.0 0.0 0.0 0.6 0.1 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.3 0.1 0.2 0.1 0.0 0.1 0.0 0.0 3.4 15.5 8.1 12.4 2.8 5.0 2.1 7.1 4.8 2.3 0.0 0.0 0.0 3.4 2.1 30.2 1.1 0.0 0.0 0.0 1.8 13.7 0.0 0.0 0.4 76.6 0.7 0.0 0.0 1.3 0.0 0.5 2.4 0.0 0.0 0.0 47.7 0.0 2.5 0.0 66.1 2.0 0.0 1.7 0.0 0.0 0.8 1.8 0.0 2.5 0.5 3.3 0.0 0.3 1.1 1.4 0.9 0.0 0.0 0.0 2.2 CNTD1 "CNTD, FLJ40137" ENSG00000176563 "Cyclin N-terminal domain containing 1" Q8N815 17 42798792-42811587 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 11 "testis: 31.0" "Group enriched" "Detected in many" 12 "Ciliated cells: 80.3;Early spermatids: 53.3;Late spermatids: 75.8;Spermatocytes: 135.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 2.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 6.3;ASC diff: 4.3;SiHa: 3.3;T-47d: 2.4" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA023324 Approved "Nucleoplasm,Plasma membrane,Focal adhesion sites" NA NA Nucleoplasm "Plasma membrane, Focal adhesion sites" "HPA023324: AB_1848931" "unprognostic (5.92e-2)" "unprognostic (1.99e-3)" "unprognostic (3.66e-2)" "unprognostic (2.13e-2)" "unprognostic (1.25e-1)" "unprognostic (6.29e-3)" "unprognostic (6.61e-2)" "unprognostic (1.09e-2)" "unprognostic (7.82e-2)" "unprognostic (6.18e-2)" "unprognostic (1.36e-2)" "unprognostic (2.07e-1)" "unprognostic (5.89e-7)" "unprognostic (1.52e-1)" "unprognostic (1.90e-1)" "unprognostic (2.35e-1)" "unprognostic (1.81e-4)" 0.2 0.1 0.7 0.0 1.4 0.0 1.6 0.2 1.7 0.2 0.6 0.4 0.0 0.0 0.1 0.9 0.1 0.5 0.0 0.1 1.5 0.3 1.2 0.1 0.3 0.0 0.5 0.8 0.3 0.8 0.0 0.1 0.0 0.9 1.1 1.5 0.1 0.5 0.0 0.2 0.1 0.2 0.7 0.8 0.1 2.3 31.0 1.6 0.0 0.1 0.0 0.0 0.2 0.1 0.9 0.1 2.7 0.3 0.1 0.3 0.3 6.3 0.7 0.5 1.3 4.3 1.5 0.0 0.0 0.3 0.4 1.4 0.0 0.0 0.0 0.2 1.2 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.6 0.0 0.0 1.1 0.2 0.0 0.4 0.6 1.3 0.0 0.0 0.2 0.6 0.0 0.2 0.0 0.2 0.0 0.4 0.7 0.0 0.0 0.0 3.3 0.3 0.8 0.1 2.4 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.3 0.1 0.1 0.5 0.4 0.0 0.3 0.0 0.3 0.2 0.3 0.4 0.1 0.0 0.1 0.9 0.0 0.0 2.7 0.1 0.1 0.0 0.0 0.3 0.7 1.4 0.2 1.7 1.5 0.3 0.5 0.8 0.9 1.6 3.0 2.9 0.0 0.4 0.3 1.6 0.8 0.0 80.3 3.4 0.0 0.0 0.2 5.0 0.2 53.3 0.3 0.5 0.0 0.3 0.3 0.6 7.4 5.8 0.9 0.3 6.4 0.0 0.0 1.0 75.8 2.3 0.7 0.0 0.0 4.6 1.2 0.3 0.0 1.1 0.3 0.4 6.5 0.9 135.1 2.7 0.5 0.2 0.5 2.1 0.9 COBL KIAA0633 ENSG00000106078 "Cordon-bleu WH2 repeat protein" O75128 7 51016212-51316818 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 68.7" "Cell type enhanced" "Detected in many" 7 "Muller glia cells: 114.1;Rod photoreceptor cells: 71.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 46 "plasmacytoid DC: 4.6" "Lineage enriched" "Detected in single" 46 "dendritic cells: 4.6" "Cell line enhanced" "Detected in many" "BEWO: 15.1;HeLa: 27.0;OE19: 23.9;RPMI-8226: 20.7;SuSa: 16.0;U-266/84: 15.3" "Low region specificity" "Detected in many" "HPA019033, HPA019167" Enhanced Approved "Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" "HPA019033: AB_2083648, HPA019167: AB_1847070" "unprognostic (8.09e-2)" "unprognostic (1.08e-2)" "unprognostic (1.43e-1)" "unprognostic (1.62e-3)" "unprognostic (3.13e-1)" "unprognostic (5.33e-3)" "unprognostic (2.90e-1)" "unprognostic (5.29e-2)" "unprognostic (1.70e-1)" "unprognostic (1.17e-1)" "unprognostic (3.51e-2)" "unprognostic (3.92e-2)" "prognostic favorable (5.21e-12)" "unprognostic (7.64e-2)" "unprognostic (1.79e-1)" "unprognostic (2.08e-1)" "unprognostic (5.41e-3)" 1.8 1.3 27.5 1.8 26.1 0.7 9.5 12.5 23.8 3.9 11.6 27.9 2.2 11.6 2.0 4.4 9.5 12.7 5.8 32.8 27.7 14.5 8.3 12.3 8.8 0.7 23.8 13.8 2.6 11.4 24.7 5.2 3.4 10.8 9.4 7.3 2.8 26.9 3.7 68.7 10.7 20.7 2.2 25.0 0.8 7.4 2.5 16.8 0.0 5.5 12.2 3.1 1.0 2.3 0.0 4.6 0.0 0.0 0.0 0.0 0.0 5.5 4.1 0.0 0.1 0.0 0.0 15.1 0.0 0.0 0.0 0.0 9.9 8.9 0.0 0.4 0.0 0.6 10.4 5.7 0.0 0.0 0.0 4.4 0.0 27.0 2.1 0.0 0.0 0.0 0.7 1.3 0.0 0.0 0.0 0.0 0.8 2.8 0.1 0.0 3.5 0.0 0.0 4.0 23.9 3.4 0.0 0.2 20.7 8.1 0.0 5.4 0.1 1.9 12.1 1.7 16.0 8.7 0.0 0.0 0.0 4.9 0.1 0.4 0.0 15.3 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 27.5 26.1 12.5 19.0 27.7 14.5 23.8 13.8 10.8 16.8 35.7 15.8 2.2 2.5 15.9 1.6 66.3 17.8 37.5 19.4 8.7 55.0 16.7 0.0 19.8 2.6 1.4 61.6 0.0 8.3 8.0 1.8 28.8 9.3 24.7 1.8 0.0 17.9 0.6 0.6 2.7 0.6 1.8 15.1 1.8 27.0 114.1 19.3 28.1 0.4 14.7 71.8 0.0 1.0 0.5 5.5 31.1 33.6 1.3 11.7 6.4 COL4A5 "ASLN, ATS" ENSG00000188153 "Collagen type IV alpha 5 chain" P29400 X 108439844-108697545 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Alport syndrome, Cancer-related genes, Deafness, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.2" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 25.8;Basal keratinocytes: 23.9;Peritubular cells: 34.6;Urothelial cells: 22.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 28.5;HHSteC: 32.8;HUVEC TERT2: 30.8;TIME: 29.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA077177 Approved "Vesicles,Plasma membrane" "Secreted to extracellular matrix" NA NA "Plasma membrane" Vesicles "HPA077177: " "unprognostic (2.58e-2)" "unprognostic (2.57e-2)" "unprognostic (3.64e-2)" "unprognostic (3.98e-2)" "unprognostic (1.11e-1)" "unprognostic (1.61e-1)" "unprognostic (1.97e-2)" "unprognostic (7.27e-2)" "unprognostic (2.70e-1)" "unprognostic (2.20e-1)" "unprognostic (1.60e-1)" "unprognostic (1.26e-1)" "prognostic unfavorable (2.41e-5)" "unprognostic (2.10e-3)" "unprognostic (1.70e-1)" "unprognostic (2.61e-2)" "unprognostic (1.06e-1)" 3.3 2.7 13.1 1.7 27.7 0.3 5.8 1.8 16.1 16.9 3.7 47.2 9.5 2.7 31.4 18.2 6.9 19.3 12.6 5.9 13.9 6.2 5.9 1.7 5.9 0.9 46.6 15.7 11.5 2.8 22.3 10.2 9.7 19.5 18.0 4.1 5.8 3.7 23.9 4.8 17.5 3.1 32.8 20.5 2.8 17.7 2.8 40.5 0.0 5.4 0.9 0.9 23.9 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 8.8 15.8 5.0 6.2 3.6 0.1 0.9 3.9 4.8 7.9 7.9 0.6 1.3 0.0 0.6 2.9 7.1 4.4 14.9 6.1 2.1 3.8 1.1 28.5 0.9 32.8 0.0 4.5 17.0 18.1 5.9 12.7 15.4 30.8 0.0 0.0 0.0 4.6 0.6 0.0 0.1 4.7 0.0 5.3 0.0 0.0 0.0 12.0 8.8 0.0 0.0 23.0 0.7 1.9 23.3 4.3 0.0 29.1 3.2 1.0 2.1 1.3 0.6 0.0 0.0 2.8 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 27.7 1.8 16.1 13.9 6.2 46.6 15.7 19.5 40.5 6.0 5.3 0.0 25.8 23.9 0.3 8.9 0.0 4.0 11.4 19.2 0.0 0.6 0.0 0.2 0.1 2.9 0.0 0.0 0.8 0.3 8.5 8.2 1.1 0.4 0.4 0.0 0.0 4.9 0.3 1.2 18.7 0.8 1.7 0.0 0.0 13.0 0.5 0.0 34.6 0.0 0.4 6.5 18.6 0.3 0.7 13.9 0.6 0.0 0.0 22.6 COL6A2 ENSG00000142173 "Collagen type VI alpha 2 chain" P12110 21 46098097-46132849 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Congenital muscular dystrophy, Disease mutation, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 19 "Fibroblasts: 1607.7;Leydig cells: 560.6;Peritubular cells: 443.7;Smooth muscle cells: 512.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "gdT-cell: 7.6;MAIT T-cell: 5.1;memory CD8 T-cell: 3.8;naive CD8 T-cell: 2.1" "Lineage enriched" "Detected in single" 14 "T-cells: 7.6" "Cell line enhanced" "Detected in many" "ASC diff: 95.7;ASC TERT1: 177.1;BJ: 85.2;BJ hTERT+: 79.3;HHSteC: 93.9;HSkMC: 126.5;U-138 MG: 92.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA007029, HPA030920, HPA038799" Enhanced Approved "Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA 8900000 Cytosol "Plasma membrane" "HPA007029: AB_1078549, HPA030920: AB_2673659, HPA038799: AB_2676214" "unprognostic (3.53e-1)" "unprognostic (3.76e-2)" "unprognostic (3.20e-2)" "unprognostic (4.87e-2)" "unprognostic (2.92e-2)" "unprognostic (1.38e-1)" "unprognostic (2.39e-1)" "unprognostic (5.28e-3)" "unprognostic (2.11e-2)" "unprognostic (1.68e-2)" "unprognostic (1.56e-1)" "unprognostic (2.01e-1)" "prognostic unfavorable (8.72e-14)" "unprognostic (2.13e-2)" "unprognostic (7.61e-2)" "unprognostic (2.31e-2)" "unprognostic (2.22e-3)" 81.2 8.7 1.5 65.0 2.7 0.2 116.7 1.8 2.7 103.5 112.6 4.7 75.0 15.3 127.2 160.3 55.5 66.5 179.8 90.6 2.1 1.3 9.6 9.1 38.7 38.3 3.2 3.8 76.1 14.8 2.7 11.8 52.6 8.8 81.0 9.8 23.5 33.4 81.4 30.6 37.8 38.1 231.3 5.8 23.6 49.0 33.2 1.8 9.8 19.9 58.5 17.2 107.2 76.1 0.0 0.0 0.0 0.0 0.5 7.6 0.7 0.7 0.9 2.8 2.5 95.7 177.1 0.8 85.2 79.3 21.6 9.9 0.1 3.3 0.0 6.4 61.1 13.9 0.0 0.6 0.0 1.7 0.0 0.9 0.0 0.0 0.0 93.9 0.0 0.3 126.5 0.0 40.8 0.8 0.0 0.0 0.0 0.0 0.0 8.6 0.4 0.0 0.1 1.5 0.0 10.4 0.0 5.4 0.1 0.0 0.0 0.0 4.4 3.3 0.0 0.0 1.6 0.1 0.5 0.0 92.4 10.8 34.0 21.0 0.0 0.0 0.0 47.2 0.0 13.1 0.0 0.0 0.0 7.6 0.0 5.1 0.0 0.7 3.8 0.0 0.0 0.8 2.1 0.0 0.5 0.0 0.0 0.1 0.7 1.5 2.7 1.8 2.7 2.1 1.3 3.2 3.8 8.8 1.8 3.0 1.1 0.0 4.5 146.1 0.1 6.7 0.0 0.0 1.2 7.0 0.0 14.3 0.0 14.0 3.2 42.2 0.0 0.0 0.3 22.5 1607.7 10.7 0.0 0.9 32.2 0.0 0.0 166.3 6.8 7.6 560.6 4.3 172.1 3.6 0.0 3.9 6.9 0.0 443.7 0.2 0.4 291.1 512.9 2.7 10.7 122.7 33.8 8.7 0.2 2.5 COLQ EAD ENSG00000206561 "Collagen like tail subunit of asymmetric acetylcholinesterase" Q9Y215 3 15450133-15521751 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Neurotransmitter degradation" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 31.8;lymphoid tissue: 19.6" "Cell type enhanced" "Detected in some" 11 "Ciliated cells: 6.7;Early spermatids: 4.2;Horizontal cells: 6.4;Late spermatids: 11.3;Peritubular cells: 4.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 5 "cerebellum: 11.4" "Cell type enriched" "Detected in some" 6 "MAIT T-cell: 31.8" "Lineage enriched" "Detected in single" 35 "T-cells: 31.8" "Group enriched" "Detected in some" 5 "BEWO: 17.3;HDLM-2: 5.6;U-937: 8.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA045876 Approved "Plasma membrane,Cell Junctions" "Secreted to blood" NA NA "Plasma membrane" "Cell Junctions" "HPA045876: AB_2679479" "unprognostic (4.08e-3)" "unprognostic (2.61e-2)" "unprognostic (2.13e-3)" "unprognostic (2.37e-1)" "unprognostic (2.11e-1)" "unprognostic (4.62e-2)" "unprognostic (1.27e-2)" "unprognostic (1.15e-1)" "unprognostic (1.52e-1)" "unprognostic (1.99e-1)" "unprognostic (1.28e-3)" "unprognostic (4.68e-1)" "unprognostic (7.00e-5)" "unprognostic (6.58e-2)" "unprognostic (1.97e-1)" "unprognostic (1.05e-1)" "unprognostic (1.30e-4)" 2.7 0.7 0.9 0.7 1.1 1.3 0.9 11.4 2.1 2.4 2.3 0.4 0.2 0.8 3.2 2.7 1.3 8.8 1.8 15.9 1.5 1.2 0.5 0.9 2.1 19.6 0.9 1.1 2.3 0.6 10.0 1.1 0.5 2.1 2.0 0.5 2.0 1.1 1.4 14.3 0.9 1.4 1.1 1.5 3.8 1.5 2.0 0.4 3.8 1.0 0.6 3.3 1.3 1.4 0.0 0.2 0.0 0.4 0.9 31.8 1.7 0.1 0.5 2.0 1.2 1.5 1.0 17.3 0.3 0.5 0.4 0.6 0.0 0.3 0.1 0.7 0.3 0.1 0.2 0.3 0.4 0.5 5.6 1.2 0.6 0.7 0.2 0.2 0.4 1.2 0.8 0.4 0.8 0.3 0.8 0.3 1.5 0.0 0.6 0.8 0.3 0.6 1.8 0.2 0.0 0.6 0.8 0.2 0.4 0.4 0.4 0.6 1.8 0.2 0.1 0.4 1.9 1.2 0.8 0.1 0.2 1.1 1.9 0.6 1.7 1.5 0.1 0.1 8.7 0.1 0.0 0.4 0.0 5.5 0.0 31.8 0.0 2.7 3.9 0.0 0.0 0.3 0.3 0.0 0.9 0.0 0.2 0.1 1.7 0.9 1.1 11.4 2.1 1.5 1.2 0.9 1.1 2.1 0.4 0.0 1.1 0.0 0.1 0.2 0.3 0.7 0.0 6.7 2.3 0.0 0.0 0.2 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.1 0.4 0.2 0.0 0.8 0.2 6.4 1.2 2.5 0.0 11.3 1.7 0.0 0.0 0.0 0.0 0.4 0.2 0.0 4.2 0.0 0.6 0.0 0.2 0.7 0.2 0.1 1.9 1.3 0.0 0.0 COMTD1 FLJ23841 ENSG00000165644 "Catechol-O-methyltransferase domain containing 1" Q86VU5 10 75233969-75236030 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 57.2" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 363.3;Exocrine glandular cells: 216.7;Paneth cells: 207.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 14.9;HEK 293: 22.9;PC-3: 31.9;RPMI-8226: 17.8;U-266/70: 15.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042165 Approved Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Golgi apparatus" "Plasma membrane, Cytosol" "HPA042165: AB_10794042" "unprognostic (2.53e-2)" "unprognostic (1.23e-1)" "unprognostic (1.49e-1)" "unprognostic (9.07e-2)" "unprognostic (2.44e-1)" "unprognostic (1.36e-1)" "unprognostic (1.03e-1)" "unprognostic (1.90e-1)" "unprognostic (3.23e-2)" "unprognostic (8.08e-3)" "unprognostic (9.35e-2)" "unprognostic (6.74e-2)" "prognostic favorable (1.88e-4)" "unprognostic (1.33e-1)" "unprognostic (1.73e-1)" "unprognostic (1.12e-1)" "unprognostic (2.35e-1)" 2.5 5.2 1.3 5.8 1.4 2.9 5.7 3.6 2.2 4.8 14.1 0.5 9.7 17.9 2.0 5.9 20.0 1.6 6.4 8.0 1.2 1.6 12.6 14.9 4.4 4.1 1.9 1.7 2.2 57.2 3.2 5.3 7.8 2.2 3.1 2.1 3.2 21.2 9.1 19.6 7.3 22.9 1.9 1.0 3.4 16.1 1.5 0.6 2.7 7.0 14.4 6.0 2.4 7.5 6.6 15.7 3.8 9.3 7.3 12.5 7.1 4.9 0.9 0.2 0.9 0.2 0.4 14.9 1.4 0.4 0.1 0.3 1.2 4.4 14.0 2.8 0.3 0.7 7.1 0.4 1.2 0.0 2.1 22.9 0.5 1.3 2.4 0.7 2.7 2.4 0.3 1.9 0.0 1.2 0.3 0.0 1.8 5.6 2.7 0.0 3.3 3.9 8.3 0.7 3.9 31.9 7.3 0.7 17.8 1.0 0.2 5.4 1.3 1.5 11.5 3.0 0.1 6.7 0.3 1.2 0.3 4.3 0.5 1.6 15.3 3.2 6.8 0.3 2.3 0.3 0.0 8.9 3.8 12.1 9.3 12.5 6.6 11.7 12.2 10.1 4.7 3.8 6.7 1.8 7.3 8.9 15.7 9.0 7.1 1.3 1.4 3.6 1.7 1.2 1.6 1.9 1.7 2.2 0.6 17.9 14.4 22.9 33.2 26.2 5.2 26.2 48.4 2.7 4.5 50.6 9.8 24.6 122.7 126.7 1.3 10.8 363.3 0.0 216.7 64.2 12.7 34.1 12.7 75.5 32.8 1.6 38.7 19.0 24.7 2.2 8.9 19.4 35.4 37.9 104.6 5.8 134.6 207.0 6.7 96.3 26.7 32.3 19.1 2.1 2.3 33.4 25.4 25.5 104.0 43.9 COPRS "C17orf79, COPR5, HSA272196, TTP1" ENSG00000172301 "Coordinator of PRMT5 and differentiation stimulator" Q9NQ92 17 31851864-31859337 "Predicted intracellular proteins" "Myogenesis, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Spermatocytes: 410.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" HPA052552 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA052552: AB_2681868" "unprognostic (1.65e-2)" "unprognostic (4.88e-2)" "unprognostic (2.46e-1)" "unprognostic (4.01e-3)" "unprognostic (3.12e-2)" "unprognostic (1.12e-2)" "prognostic unfavorable (3.69e-4)" "unprognostic (6.88e-2)" "unprognostic (3.10e-1)" "unprognostic (4.44e-2)" "unprognostic (5.28e-3)" "unprognostic (1.01e-2)" "unprognostic (1.19e-3)" "unprognostic (1.02e-1)" "unprognostic (1.35e-1)" "unprognostic (1.48e-1)" "unprognostic (3.11e-2)" 20.9 19.0 32.6 9.7 31.0 6.3 30.3 23.0 37.6 15.3 24.2 11.8 15.6 8.0 15.2 57.3 10.5 24.9 14.9 24.7 28.2 35.5 22.7 31.0 12.3 9.2 29.7 31.3 24.3 20.7 12.2 18.9 9.4 23.9 27.5 13.6 16.0 14.6 23.5 19.9 7.8 7.9 21.2 16.0 8.1 14.1 75.0 14.4 2.6 28.1 11.2 12.7 16.1 18.5 5.8 4.5 3.5 3.5 0.0 3.0 0.4 21.0 27.8 14.0 14.3 22.9 22.1 9.8 23.7 29.8 27.2 27.8 17.4 5.7 12.0 13.3 28.3 53.7 12.7 24.6 14.2 30.9 4.1 36.9 3.3 16.0 20.4 23.4 11.2 9.6 14.1 18.7 36.6 20.1 29.7 14.5 16.1 16.3 10.0 29.6 18.3 16.6 35.6 10.6 13.7 14.0 13.3 26.0 21.7 15.9 13.1 12.6 9.8 14.0 6.8 21.6 12.7 22.3 12.0 8.1 71.6 19.4 25.5 32.8 17.1 15.9 12.1 37.4 10.4 9.6 3.5 3.5 0.0 1.1 3.3 3.0 3.8 1.1 0.2 4.5 5.8 0.6 0.7 1.2 0.0 1.6 1.8 1.5 0.4 32.6 31.0 23.0 37.6 28.2 35.5 29.7 31.3 23.9 14.4 20.8 8.8 21.9 52.7 30.6 43.8 64.8 45.9 28.1 9.1 82.0 9.8 25.3 190.6 93.7 161.6 50.8 5.1 0.0 70.1 45.2 52.1 108.4 3.5 85.5 75.8 25.4 18.9 44.2 26.0 212.9 57.8 35.0 55.6 70.3 14.8 79.2 64.6 3.5 61.2 173.3 30.2 19.4 62.1 410.0 65.8 27.7 22.9 10.1 19.7 32.5 COQ7 "CAT5, CLK-1" ENSG00000167186 "Coenzyme Q7, hydroxylase" Q99807 16 19067599-19080095 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ubiquinone biosynthesis" "Monooxygenase, Oxidoreductase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "neutrophil: 45.2" "Lineage enriched" "Detected in all" 8 "granulocytes: 45.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067252, HPA071922" Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA067252: AB_2685813, HPA071922: AB_2686473" "unprognostic (1.37e-1)" "unprognostic (6.89e-3)" "unprognostic (1.59e-2)" "unprognostic (6.08e-2)" "unprognostic (2.44e-2)" "unprognostic (9.03e-2)" "unprognostic (1.31e-1)" "unprognostic (4.42e-2)" "unprognostic (1.15e-1)" "unprognostic (7.27e-3)" "unprognostic (2.15e-1)" "unprognostic (8.32e-2)" "prognostic favorable (8.23e-12)" "unprognostic (2.19e-1)" "unprognostic (2.76e-1)" "unprognostic (3.14e-2)" "unprognostic (5.27e-2)" 9.1 14.2 13.5 7.8 12.9 4.0 12.6 11.3 18.5 11.2 12.8 12.8 15.2 11.4 14.7 17.4 11.9 15.0 13.9 21.1 12.1 13.0 13.5 11.4 14.6 11.1 12.2 12.0 19.4 12.2 23.7 15.1 9.4 12.9 17.1 12.5 16.5 11.3 14.7 37.3 7.5 12.1 11.1 12.4 8.7 11.8 34.7 10.7 9.4 15.3 24.7 7.6 12.1 10.0 5.1 5.3 45.2 4.0 4.1 4.4 1.8 12.6 13.6 11.8 6.9 6.7 7.1 9.9 7.4 6.1 10.2 10.5 8.6 10.6 9.6 36.1 5.7 11.0 13.4 16.4 9.3 7.4 8.2 16.6 5.1 12.5 26.4 8.3 12.2 11.3 5.9 8.2 9.4 6.9 8.4 8.2 11.6 14.0 9.0 7.1 22.7 12.7 9.9 9.0 4.9 7.3 15.6 13.1 12.3 8.8 8.5 17.2 9.8 6.9 15.3 8.6 6.0 14.1 16.6 8.9 10.8 6.3 7.9 10.6 8.4 13.6 10.5 11.6 7.1 6.9 10.8 4.0 5.8 3.5 3.5 3.3 5.1 3.2 3.1 4.3 5.0 4.4 3.9 45.2 4.1 3.9 5.3 2.0 1.8 13.5 12.9 11.3 18.5 12.1 13.0 12.2 12.0 12.9 10.7 14.9 9.3 38.9 25.6 9.7 30.8 19.0 22.9 21.4 9.1 15.7 37.3 18.0 38.1 20.5 10.9 11.3 47.3 0.0 15.9 14.6 13.0 14.3 25.3 8.9 20.1 19.1 23.1 13.5 18.7 6.2 17.3 15.3 10.1 9.0 30.7 39.8 11.7 24.3 13.1 19.5 53.8 19.4 15.1 77.6 54.5 10.8 26.9 33.1 29.9 22.2 CORIN "ATC2, CRN, Lrp4, PRSC, TMPRSS10" ENSG00000145244 "Corin, serine peptidase" Q9Y5Q5 4 47593998-47838106 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "epididymis: 11.6;heart muscle: 39.5" "Cell type enriched" "Detected in some" 5 "Cardiomyocytes: 50.9" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 5 "pons and medulla: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "ASC TERT1: 32.6" "Region enhanced" "Detected in some" "basal ganglia: 2.7" "Low region specificity" "Detected in single" HPA070941 Approved "Nuclear bodies,Plasma membrane,Actin filaments" "Intracellular and membrane" Yes No "Plasma membrane" "Nuclear bodies, Actin filaments" "HPA070941: AB_2686324" "unprognostic (1.05e-1)" "unprognostic (2.52e-1)" "unprognostic (1.14e-1)" "unprognostic (1.93e-1)" "unprognostic (2.10e-1)" "unprognostic (3.18e-1)" "unprognostic (3.58e-4)" "unprognostic (3.19e-1)" "unprognostic (3.67e-2)" "unprognostic (8.22e-2)" "unprognostic (9.78e-2)" "unprognostic (6.53e-2)" "unprognostic (1.18e-1)" "unprognostic (2.86e-2)" "unprognostic (5.18e-2)" "unprognostic (7.22e-2)" "unprognostic (1.33e-2)" 0.3 0.1 0.3 0.0 0.1 0.0 0.8 0.1 0.1 3.1 0.1 0.1 2.6 0.0 3.4 11.6 0.7 1.2 4.5 39.5 0.0 0.2 2.0 0.0 1.3 0.0 0.2 0.0 0.6 0.1 0.0 1.5 0.6 1.6 1.7 0.0 0.4 0.3 4.6 0.2 5.3 0.4 0.5 0.0 3.5 0.3 3.7 0.0 0.2 0.1 1.7 0.4 0.8 3.2 0.2 0.0 0.5 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.2 7.5 32.6 0.0 1.4 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.5 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 1.0 0.0 0.2 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.0 0.2 0.2 0.0 1.6 0.0 0.0 6.9 0.0 0.2 3.4 0.8 50.9 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 4.5 0.3 0.0 0.0 0.0 0.0 9.3 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.8 4.4 0.0 5.0 0.0 0.0 0.7 0.0 0.0 2.5 0.0 0.1 0.0 4.2 3.0 4.6 2.4 0.0 0.0 0.0 0.2 CORO2A "IR10, WDR2" ENSG00000106789 "Coronin 2A" Q92828 9 98120975-98192640 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 27.7;intestine: 36.1" "Cell type enhanced" "Detected in many" 7 "Cholangiocytes: 38.2;Enterocytes: 69.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "granulocytes: 10.9;monocytes: 7.0;T-cells: 11.1" "Cell line enhanced" "Detected in many" "BEWO: 32.3;OE19: 26.3;SK-BR-3: 21.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041161, HPA041302" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA041161: AB_10795537, HPA041302: AB_10794195" "unprognostic (4.49e-3)" "unprognostic (3.44e-2)" "unprognostic (3.14e-1)" "unprognostic (1.78e-1)" "unprognostic (3.39e-3)" "unprognostic (1.64e-1)" "unprognostic (3.73e-2)" "unprognostic (5.73e-2)" "unprognostic (2.79e-1)" "unprognostic (1.52e-1)" "unprognostic (4.50e-3)" "unprognostic (2.85e-1)" "prognostic unfavorable (6.56e-4)" "unprognostic (4.16e-2)" "unprognostic (1.40e-2)" "unprognostic (1.87e-2)" "unprognostic (6.40e-3)" 1.6 0.8 1.2 6.9 1.8 8.1 2.9 9.3 2.4 3.9 22.0 0.7 1.3 20.8 2.0 2.2 13.6 2.7 27.7 1.5 1.3 3.0 1.4 2.9 7.5 1.6 2.6 1.3 1.5 1.4 2.8 5.2 3.5 3.3 9.0 7.9 1.2 5.4 1.9 0.9 6.3 36.1 1.9 0.6 3.8 6.6 11.4 0.6 5.6 1.1 3.6 6.6 7.7 6.2 0.6 0.7 10.9 7.0 1.5 11.1 1.4 3.9 1.4 0.3 0.9 0.6 0.6 32.3 0.3 0.3 1.0 1.6 8.9 0.6 0.0 4.5 0.6 1.5 11.0 3.7 6.0 0.6 3.2 0.8 0.1 5.6 7.9 1.3 3.6 0.3 0.2 7.4 0.5 9.1 0.3 0.3 4.7 3.1 1.8 0.1 2.9 0.7 3.6 4.1 26.3 1.0 2.8 0.0 0.1 0.6 11.1 0.8 1.1 2.0 21.8 0.7 7.6 2.5 6.0 0.3 0.1 4.8 0.1 1.1 0.3 1.8 0.3 0.2 1.2 1.3 7.7 1.5 10.9 2.4 3.0 5.5 0.6 4.1 3.8 0.5 0.6 2.7 3.5 1.1 1.5 7.0 0.7 11.1 1.4 1.2 1.8 9.3 2.4 1.3 3.0 2.6 1.3 3.3 0.6 11.9 23.8 0.9 17.5 6.0 1.5 1.2 38.2 20.1 35.2 0.0 3.9 8.5 0.0 3.0 2.2 1.9 69.1 0.0 4.5 31.7 3.1 14.5 0.0 3.2 5.8 1.6 6.9 1.3 11.0 3.0 0.0 4.9 0.0 0.0 14.0 0.5 13.8 17.3 0.4 1.4 1.5 0.0 1.9 0.5 3.2 8.7 13.3 8.7 25.7 26.0 CORO2B "ClipinC, KIAA0925" ENSG00000103647 "Coronin 2B" Q9UQ03 15 68578969-68727806 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 53.5;fallopian tube: 27.4" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 32.6;Ciliated cells: 14.7;Cone photoreceptor cells: 35.3;Rod photoreceptor cells: 20.9" "Group enriched" "Detected in many" 8 "glioma: 34.7;melanoma: 21.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 13 "memory B-cell: 1.2;naive B-cell: 4.5" "Lineage enriched" "Detected in single" 21 "B-cells: 4.5" "Cell line enhanced" "Detected in many" "ASC diff: 12.9;ASC TERT1: 27.8;HSkMC: 20.0;hTEC/SVTERT24-B: 16.3;U-87 MG: 27.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017960 Enhanced Supported Approved "Plasma membrane,Focal adhesion sites" NA NA "Plasma membrane, Focal adhesion sites" "HPA017960: AB_1847167" "unprognostic (1.35e-1)" "unprognostic (2.63e-2)" "unprognostic (2.81e-3)" "unprognostic (4.71e-3)" "unprognostic (3.28e-1)" "unprognostic (8.11e-5)" "unprognostic (4.77e-2)" "unprognostic (1.24e-1)" "unprognostic (3.68e-2)" "unprognostic (1.81e-1)" "unprognostic (1.33e-3)" "unprognostic (4.12e-2)" "unprognostic (1.26e-1)" "unprognostic (1.10e-2)" "unprognostic (5.83e-2)" "unprognostic (3.59e-2)" "unprognostic (1.87e-2)" 10.9 4.4 15.7 3.2 30.1 1.9 4.8 33.7 53.5 6.5 3.4 27.3 0.8 2.4 7.5 3.9 2.7 27.4 6.3 7.2 23.0 15.1 5.5 2.0 5.8 3.5 20.9 18.8 18.4 2.9 1.6 1.5 4.7 23.6 3.2 2.9 11.8 3.4 6.9 3.8 5.6 3.3 8.4 35.0 3.6 2.0 2.2 17.5 0.0 4.6 0.6 1.9 3.0 1.6 4.5 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.3 12.3 1.0 12.9 27.8 0.0 6.2 6.9 1.1 1.5 0.1 1.4 1.5 0.7 1.0 1.7 0.0 0.4 0.1 4.5 0.0 0.5 0.0 0.0 0.6 4.7 0.0 0.1 20.0 0.1 16.3 1.0 9.7 0.4 0.0 0.0 0.0 11.4 0.0 0.0 0.0 3.0 0.0 0.0 1.0 0.0 0.5 1.7 0.0 7.1 0.1 0.1 0.0 3.6 2.4 0.0 1.4 0.1 3.7 4.1 0.7 8.2 0.0 0.0 1.5 27.8 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.2 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 30.1 33.7 29.3 23.0 15.1 20.9 18.8 23.6 17.5 0.0 0.0 0.0 0.3 0.9 32.6 1.1 0.0 14.7 0.0 7.0 35.3 0.0 0.0 3.8 0.2 1.5 0.0 0.0 0.5 0.0 2.6 0.1 0.0 0.0 0.2 0.0 3.5 5.5 0.3 0.0 7.2 0.0 6.8 0.0 0.0 9.5 0.4 0.0 0.4 0.0 20.9 6.5 2.3 0.2 0.4 0.6 0.0 0.0 0.0 0.1 COX6B2 "COXVIB2, CT59, FLJ32865" ENSG00000160471 "Cytochrome c oxidase subunit 6B2" Q6YFQ2 19 55349306-55354814 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 66.5" "Cell type enhanced" "Detected in some" 24 "Early spermatids: 23.6;Late spermatids: 19.1;Spermatocytes: 77.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "neutrophil: 5.7" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "CAPAN-2: 22.6;SCLC-21H: 9.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA035014 Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA035014: AB_10601261" "unprognostic (7.43e-3)" "unprognostic (8.72e-2)" "unprognostic (1.42e-1)" "unprognostic (5.75e-2)" "unprognostic (2.59e-2)" "unprognostic (9.23e-3)" "unprognostic (1.88e-2)" "unprognostic (6.45e-3)" "unprognostic (1.02e-1)" "unprognostic (6.82e-2)" "prognostic unfavorable (9.70e-5)" "unprognostic (8.11e-2)" "unprognostic (1.81e-6)" "unprognostic (9.91e-2)" "unprognostic (1.47e-1)" "unprognostic (1.02e-2)" "unprognostic (2.02e-1)" 0.3 0.0 0.4 0.6 0.6 0.7 0.5 0.3 0.6 0.2 3.3 0.2 0.2 0.0 0.2 0.8 0.5 0.4 0.2 0.2 0.2 0.5 0.5 0.2 0.2 0.6 0.4 0.2 0.4 0.2 0.0 0.4 0.2 0.6 0.2 3.5 0.7 0.6 0.2 0.2 1.8 0.2 0.2 0.7 0.2 0.0 66.5 0.3 0.2 0.2 0.2 1.2 0.2 0.4 1.3 1.4 5.7 1.0 1.6 0.9 0.8 2.7 0.4 0.1 0.1 0.0 0.0 0.2 0.4 0.1 0.3 0.5 0.1 22.6 0.1 0.2 0.2 0.3 1.8 0.7 0.2 0.2 0.8 0.7 0.0 1.7 0.1 0.3 0.2 1.8 0.2 2.5 0.4 0.5 1.7 0.0 0.1 0.4 0.2 0.0 0.5 0.1 0.2 0.6 2.3 0.5 0.1 0.0 0.2 0.0 0.4 9.7 0.3 0.3 0.1 0.0 0.6 0.4 0.0 0.4 0.3 0.5 0.1 0.2 1.5 1.2 0.1 0.1 0.3 0.2 1.9 1.0 1.0 0.8 0.5 0.5 0.7 0.7 0.6 0.3 1.3 0.7 0.9 5.7 1.6 0.7 1.4 0.6 0.8 0.4 0.6 0.3 0.6 0.2 0.5 0.4 0.2 0.6 0.3 0.0 0.3 0.0 0.6 0.5 2.1 0.4 0.0 0.0 0.0 0.0 3.9 0.5 0.0 0.6 23.6 0.0 3.2 0.0 0.6 0.2 0.4 0.2 0.0 0.0 0.1 3.2 1.2 0.0 0.0 19.1 0.6 0.0 0.0 0.0 1.3 0.9 5.6 3.5 0.0 0.0 4.1 0.0 0.0 77.8 1.3 0.4 0.3 0.0 4.4 2.5 CPEB3 KIAA0940 ENSG00000107864 "Cytoplasmic polyadenylation element binding protein 3" Q8NE35 10 92046692-92291087 "Predicted intracellular proteins" "Translation regulation" "Activator, Repressor, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 33.4;liver: 39.5" "Group enriched" "Detected in many" 4 "Early spermatids: 216.8;Late spermatids: 321.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 6.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 16.1;U-266/70: 9.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070942 Approved "Nucleoplasm,Plasma membrane,Midbody,Cytosol" NA No Cytosol "Nucleoplasm, Plasma membrane, Midbody" "HPA070942: " "unprognostic (4.90e-2)" "unprognostic (2.12e-2)" "unprognostic (3.00e-1)" "unprognostic (5.66e-2)" "unprognostic (1.92e-1)" "unprognostic (2.95e-5)" "prognostic favorable (5.06e-5)" "unprognostic (4.09e-4)" "unprognostic (2.73e-1)" "unprognostic (2.40e-1)" "unprognostic (1.47e-2)" "unprognostic (2.42e-2)" "prognostic favorable (3.84e-9)" "unprognostic (3.33e-2)" "unprognostic (7.42e-2)" "unprognostic (1.36e-2)" "unprognostic (1.40e-1)" 3.1 6.1 11.9 3.0 10.9 2.9 5.0 33.4 24.6 4.0 3.8 4.4 5.5 4.8 3.3 6.8 6.0 3.3 3.4 7.0 10.7 11.5 7.0 39.5 3.6 3.0 10.3 15.1 5.8 5.4 6.6 8.6 2.8 16.4 6.5 4.2 3.0 10.2 8.0 23.4 5.3 4.6 3.4 4.6 4.1 4.5 20.5 7.0 0.3 9.3 5.4 3.4 3.3 4.5 1.8 0.9 6.5 1.5 0.5 0.7 0.5 1.2 0.3 0.4 2.7 0.7 0.7 1.1 1.2 0.9 1.7 1.4 0.9 2.7 1.4 1.3 0.5 0.8 3.4 1.1 0.9 0.9 1.6 1.4 1.9 1.8 1.0 2.0 0.9 2.0 0.7 2.1 1.0 3.1 1.5 1.5 1.9 1.3 16.1 0.7 0.9 1.2 1.1 0.2 1.8 1.3 1.6 2.3 2.8 1.6 0.5 2.0 0.7 1.1 3.1 2.0 1.4 3.9 2.0 1.2 0.8 0.9 0.6 1.0 9.0 2.4 1.5 0.4 3.0 0.2 6.5 1.1 2.2 0.7 1.4 0.5 1.8 0.4 0.7 0.9 0.5 0.4 0.4 1.3 0.5 1.5 0.6 0.3 0.5 11.9 10.9 33.4 24.6 10.7 11.5 10.3 15.1 16.4 7.0 6.0 6.5 0.8 3.2 7.8 25.2 21.8 5.1 2.7 3.4 12.2 47.1 1.8 5.0 2.1 216.8 6.0 7.5 0.0 2.3 1.3 3.9 15.1 3.5 66.1 4.2 28.6 19.0 11.6 22.6 321.1 5.5 7.7 5.0 6.4 9.1 2.5 3.1 3.5 7.4 2.5 21.8 0.0 3.1 11.2 6.8 12.2 1.0 2.5 5.2 5.3 CPZ ENSG00000109625 "Carboxypeptidase Z" Q66K79 4 8592660-8619759 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Wnt signaling pathway" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 63.2" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 29.5;BJ: 17.0;BJ hTERT+: 22.9;hTERT-RPE1: 13.7;RH-30: 25.1;U-2197: 18.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA078608 Approved "Plasma membrane" "Secreted to extracellular matrix" NA NA "Plasma membrane" "HPA078608: " "unprognostic (2.58e-1)" "unprognostic (7.16e-2)" "unprognostic (4.83e-2)" "unprognostic (1.42e-1)" "unprognostic (7.77e-2)" "unprognostic (2.20e-2)" "unprognostic (2.98e-1)" "unprognostic (7.77e-2)" "unprognostic (2.30e-1)" "unprognostic (1.95e-2)" "unprognostic (1.41e-1)" "unprognostic (1.59e-1)" "unprognostic (7.23e-8)" "unprognostic (4.30e-3)" "unprognostic (3.58e-2)" "unprognostic (6.13e-4)" "unprognostic (5.51e-2)" 4.3 0.9 0.3 2.8 1.1 0.0 5.4 1.1 1.6 15.7 1.8 1.5 27.1 0.1 7.9 24.1 3.0 7.4 12.9 2.4 0.4 0.3 1.5 0.8 2.9 0.7 1.5 0.4 63.2 1.1 0.3 2.3 18.9 2.3 4.1 0.5 4.4 0.8 20.6 0.3 5.5 1.2 10.3 1.3 0.7 1.7 4.4 0.1 1.6 3.5 0.1 2.2 9.8 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.1 0.0 0.7 2.2 0.2 29.5 17.0 22.9 6.4 2.6 0.7 0.3 0.0 1.6 9.3 0.1 0.0 0.0 0.0 2.4 0.0 1.2 0.0 0.1 0.3 2.0 0.0 0.0 4.2 0.0 0.0 0.0 13.7 0.0 0.0 0.4 0.0 0.4 2.5 0.0 0.0 3.9 0.1 9.3 0.0 25.1 0.0 0.0 0.5 0.0 0.0 0.6 0.2 0.0 3.8 0.1 0.0 0.0 0.9 1.2 18.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.1 1.1 1.6 0.4 0.3 1.5 0.4 2.3 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 CREB5 "CRE-BPA, H_GS165L15.1" ENSG00000146592 "CAMP responsive element binding protein 5" Q02930 7 28299321-28825894 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 53.3;brain: 38.0" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 116.6;Macrophages: 74.2;monocytes: 74.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "neutrophil: 53.3" "Lineage enriched" "Detected in many" 7 "granulocytes: 53.3" "Cell line enhanced" "Detected in many" "HL-60: 32.2;Karpas-707: 13.5;U-2 OS: 14.2;U-2197: 15.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA050020, HPA061622" Approved "Nucleoplasm,Vesicles,Plasma membrane" NA Yes Nucleoplasm "Vesicles, Plasma membrane" "HPA050020: AB_2680993, HPA061622: AB_2684569" "unprognostic (3.59e-2)" "unprognostic (3.80e-1)" "unprognostic (1.06e-1)" "unprognostic (6.46e-2)" "unprognostic (1.01e-1)" "unprognostic (4.90e-3)" "unprognostic (2.01e-3)" "unprognostic (2.87e-1)" "unprognostic (3.31e-1)" "unprognostic (1.04e-1)" "unprognostic (3.49e-1)" "unprognostic (2.67e-1)" "unprognostic (4.91e-3)" "unprognostic (6.61e-2)" "unprognostic (3.95e-1)" "unprognostic (1.60e-1)" "unprognostic (1.52e-3)" 20.0 3.6 12.1 15.4 19.5 11.5 9.0 10.4 17.8 4.6 5.6 38.0 0.9 2.8 16.3 6.9 7.7 4.7 23.1 10.4 16.7 8.7 6.6 4.6 9.5 6.1 17.9 12.1 2.4 7.0 1.5 2.8 19.5 18.3 3.1 4.3 1.1 6.5 3.0 6.2 5.5 4.2 9.8 14.6 12.6 3.2 2.3 22.7 0.0 3.8 7.0 2.5 5.5 5.0 0.3 4.8 53.3 7.8 0.0 0.0 1.5 0.0 0.3 3.9 0.2 0.2 5.7 0.1 0.3 0.8 2.4 3.6 2.2 1.4 9.9 0.7 0.9 2.4 0.4 0.1 3.4 7.6 0.0 2.7 10.7 2.1 0.2 0.2 32.2 0.4 0.7 0.7 10.2 11.0 0.5 1.6 0.0 1.2 13.5 0.8 0.0 0.0 0.0 4.9 0.0 3.9 0.2 3.7 0.2 4.9 1.0 0.4 2.8 0.1 0.2 1.1 5.7 0.1 0.7 0.4 4.7 14.2 15.5 4.5 0.8 2.2 0.1 5.2 0.2 8.0 0.0 7.8 0.0 0.0 2.7 0.0 0.3 0.0 0.0 4.8 0.0 0.0 0.0 53.3 0.0 0.8 0.0 0.0 1.5 12.1 19.5 10.4 15.6 16.7 8.7 17.9 12.1 18.3 22.7 6.0 11.1 4.5 116.6 19.5 0.0 14.1 22.9 5.3 6.8 12.2 0.0 2.5 1.7 61.9 0.4 14.9 0.0 0.0 23.7 9.2 31.3 32.4 13.9 0.5 8.1 4.8 0.0 7.4 46.4 1.1 5.5 74.2 28.7 74.9 0.0 16.6 30.3 0.0 0.4 18.3 0.6 19.4 10.7 12.5 3.3 11.5 20.7 1.3 0.0 28.7 CRIP1 CRIP ENSG00000213145 "Cysteine rich protein 1" P50238 14 105486317-105488947 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 15 "Alveolar cells type 1: 911.2;Ciliated cells: 2667.4;Club cells: 874.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 110.7;CAPAN-2: 61.7;HaCaT: 66.8;HDLM-2: 47.3;HeLa: 54.3;OE19: 188.5;T-47d: 86.8" "Low region specificity" "Detected in all" HPA042462 Approved Approved "Nuclear speckles,Plasma membrane,Centrosome,Cytosol" NA NA "Nuclear speckles, Cytosol" "Plasma membrane, Centrosome" "HPA042462: AB_10794277" "unprognostic (2.97e-3)" "unprognostic (1.27e-3)" "unprognostic (1.34e-2)" "unprognostic (1.17e-2)" "unprognostic (2.39e-1)" "unprognostic (2.93e-3)" "unprognostic (4.33e-1)" "unprognostic (3.33e-1)" "unprognostic (3.20e-2)" "unprognostic (2.60e-2)" "unprognostic (2.87e-1)" "unprognostic (9.16e-2)" "unprognostic (3.26e-3)" "unprognostic (5.10e-2)" "unprognostic (2.66e-1)" "unprognostic (7.51e-3)" "unprognostic (2.14e-1)" 44.3 3.3 3.8 37.5 4.9 5.5 97.2 3.2 4.0 37.7 44.0 4.5 65.3 25.7 20.0 83.0 28.4 23.7 33.8 45.5 4.5 4.7 20.4 2.6 56.7 53.0 4.7 4.5 11.2 4.2 1.1 7.3 38.5 4.8 11.7 13.2 9.9 21.8 71.0 12.9 48.8 106.3 25.9 5.1 16.6 20.3 7.5 1.9 24.2 32.0 83.4 58.3 18.4 18.9 111.4 79.3 56.3 49.4 56.9 121.1 75.8 0.0 110.7 0.7 0.1 1.9 1.4 10.3 0.2 0.0 1.5 0.0 3.4 61.7 33.4 0.6 29.5 0.4 66.8 0.0 0.0 0.1 47.3 0.0 2.6 54.3 18.6 0.4 0.0 0.0 0.6 0.0 3.6 0.0 0.1 0.0 10.8 0.0 0.0 0.0 0.9 1.7 0.3 1.0 188.5 5.7 26.2 0.0 6.9 0.0 0.0 2.9 0.2 0.4 0.1 0.0 0.1 86.8 15.9 0.2 0.0 0.1 0.8 0.0 0.0 0.0 2.8 0.0 0.0 0.1 19.4 43.3 56.3 47.7 38.5 32.7 111.4 92.1 51.4 79.3 43.6 21.9 25.7 2.9 56.9 49.4 62.1 121.1 75.8 3.8 4.9 3.2 4.0 4.5 4.7 4.7 4.5 4.8 1.9 911.2 276.7 125.9 1.0 165.7 0.0 0.8 2.5 2667.4 874.7 48.8 0.0 0.5 1.7 9.2 2.8 10.9 494.0 0.0 2.8 3.1 16.3 0.4 486.4 0.8 53.8 0.0 73.6 27.0 188.7 20.7 23.3 296.9 350.9 697.9 172.6 0.2 20.6 407.1 8.9 2.2 0.0 219.9 30.1 0.1 10.4 219.9 1.3 239.7 156.7 2.6 CRIP2 "CRP2, ESP1" ENSG00000182809 "Cysteine rich protein 2" P52943 14 105472962-105480170 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "heart muscle: 180.3" "Cell type enhanced" "Detected in many" 9 "Cardiomyocytes: 702.6;Endothelial cells: 478.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory CD4 T-cell: 24.0;T-reg: 29.2" "Group enriched" "Detected in many" 19 "B-cells: 17.9;T-cells: 29.2" "Cell line enhanced" "Detected in many" "A549: 38.5;EFO-21: 39.4;HUVEC TERT2: 36.8;MCF7: 56.5;SK-BR-3: 44.3;T-47d: 37.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042664 Approved Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA 490000 Nucleoli "Nucleoplasm, Plasma membrane" "HPA042664: AB_10797017" "unprognostic (2.68e-1)" "unprognostic (6.53e-3)" "unprognostic (2.11e-3)" "unprognostic (2.19e-1)" "unprognostic (2.39e-1)" "unprognostic (2.14e-1)" "unprognostic (1.63e-2)" "unprognostic (2.56e-1)" "unprognostic (3.20e-3)" "unprognostic (9.68e-2)" "unprognostic (6.96e-2)" "unprognostic (1.14e-1)" "unprognostic (2.04e-2)" "unprognostic (6.25e-2)" "unprognostic (2.35e-2)" "unprognostic (2.39e-2)" "unprognostic (8.26e-3)" 22.8 11.5 27.5 9.1 24.6 1.6 16.9 3.6 30.3 20.2 10.1 9.4 33.7 7.9 15.3 30.6 25.6 29.5 24.5 180.3 22.6 18.7 20.0 6.9 28.5 9.3 13.5 16.9 12.5 12.6 4.3 20.4 29.1 10.4 14.6 3.8 8.8 18.4 28.0 10.7 28.4 9.1 24.9 10.3 13.0 11.3 10.9 7.8 1.0 17.8 23.8 13.3 23.8 17.5 17.9 0.9 0.2 0.5 1.2 29.2 3.4 0.4 38.5 5.6 15.3 0.9 4.0 1.6 1.7 0.4 0.5 0.1 1.2 7.1 0.0 39.4 12.6 0.8 22.0 0.7 9.3 0.0 0.2 0.2 0.0 24.2 14.6 4.1 0.0 3.3 1.9 0.8 0.9 5.3 7.2 36.8 0.0 0.0 0.3 5.5 56.5 0.1 0.1 1.5 7.8 23.1 0.0 0.7 1.6 25.9 0.1 8.5 21.4 2.5 44.3 0.3 0.9 37.9 0.0 14.3 12.8 6.0 0.3 7.1 0.1 0.1 0.1 3.7 0.0 25.7 0.0 0.5 0.0 2.4 0.2 2.3 14.4 24.0 5.3 0.9 17.9 5.9 1.6 0.2 1.2 0.1 0.1 29.2 3.4 27.5 24.6 3.6 30.3 22.6 18.7 13.5 16.9 10.4 7.8 145.9 41.3 6.5 66.0 136.0 2.2 702.6 96.8 105.7 131.9 179.7 3.9 0.9 131.0 90.2 30.6 478.7 0.0 0.0 80.2 15.4 145.8 41.0 7.0 27.0 2.6 89.0 24.2 229.6 13.7 62.0 25.9 11.3 148.5 2.8 0.0 55.2 33.3 0.0 13.8 9.8 3.7 271.7 208.1 5.9 44.5 172.0 26.8 6.4 0.0 77.0 CRK ENSG00000167193 "CRK proto-oncogene, adaptor protein" P46108 17 1420689-1463162 "Predicted intracellular proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010485, HPA068087" Approved Approved "Plasma membrane" NA NA 390000 "Plasma membrane" "CAB010485: AB_2085043, HPA068087: AB_2685950" "unprognostic (6.82e-3)" "unprognostic (1.94e-1)" "unprognostic (8.70e-3)" "unprognostic (5.34e-2)" "unprognostic (2.43e-1)" "unprognostic (3.32e-2)" "unprognostic (2.48e-1)" "unprognostic (1.67e-2)" "unprognostic (6.65e-2)" "unprognostic (1.88e-1)" "unprognostic (2.65e-1)" "unprognostic (5.35e-2)" "unprognostic (1.96e-1)" "unprognostic (1.67e-1)" "unprognostic (3.77e-1)" "unprognostic (1.56e-1)" "unprognostic (3.93e-2)" 37.1 22.1 23.3 15.9 23.7 4.2 40.0 25.1 23.4 23.3 27.2 21.2 31.5 21.4 26.0 27.5 25.9 19.0 27.5 22.0 23.0 21.6 26.0 40.5 25.6 14.6 25.3 18.4 21.4 22.1 22.6 11.8 33.6 24.2 22.4 28.6 18.0 21.2 27.3 27.8 18.1 26.9 29.3 24.0 17.6 21.6 17.9 26.4 13.6 32.5 20.2 15.8 28.8 40.7 5.5 4.7 16.3 4.6 3.0 4.2 1.7 15.1 23.7 17.7 18.8 29.9 25.2 16.5 26.3 22.2 20.8 19.4 30.5 9.0 7.4 13.2 30.1 14.5 23.5 23.4 19.0 30.7 3.7 16.0 8.2 15.5 16.7 27.8 3.5 7.3 24.4 22.5 21.5 27.2 16.0 25.5 7.0 13.7 7.0 29.0 15.3 3.7 4.0 16.0 16.9 11.9 8.0 8.9 6.7 27.3 16.4 6.5 17.2 25.0 15.6 17.9 17.4 15.3 5.9 27.1 21.0 12.0 22.1 25.8 3.3 5.1 4.6 17.7 6.9 22.8 5.4 4.4 5.4 3.6 4.6 3.6 4.1 3.8 3.1 4.7 5.5 2.9 4.2 16.3 3.0 4.6 4.4 2.6 1.7 23.3 23.7 25.1 22.3 23.0 21.6 25.3 18.4 24.2 26.4 62.5 51.7 22.8 58.7 132.8 40.3 28.2 50.9 33.5 30.7 31.4 25.5 52.9 34.9 58.9 3.3 65.0 75.5 0.0 56.8 51.0 50.5 60.3 7.0 58.9 38.4 50.9 47.8 90.2 42.1 4.2 40.6 35.6 50.6 43.3 51.7 40.4 59.0 54.7 41.4 30.5 36.0 45.3 60.8 22.7 53.5 146.7 71.1 17.3 46.2 81.9 CROCC "ROLT, rootletin" ENSG00000058453 "Ciliary rootlet coiled-coil, rootletin" Q5TZA2 1 16740273-16972979 "Predicted intracellular proteins" "Cell cycle, Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "salivary gland: 135.2" "Cell type enriched" "Detected in many" 4 "Rod photoreceptor cells: 111.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA021191, HPA021762" Enhanced Supported "Plasma membrane,Centrosome" NA NA "Plasma membrane, Centrosome" "HPA021191: AB_1856395, HPA021762: AB_1856396" "unprognostic (9.07e-3)" "unprognostic (9.03e-2)" "unprognostic (6.04e-2)" "prognostic favorable (8.34e-5)" "unprognostic (3.27e-1)" "unprognostic (1.25e-3)" "unprognostic (1.42e-3)" "prognostic favorable (7.92e-4)" "unprognostic (2.05e-1)" "unprognostic (7.75e-2)" "unprognostic (3.36e-3)" "unprognostic (5.75e-2)" "prognostic unfavorable (7.97e-4)" "unprognostic (1.58e-1)" "unprognostic (9.83e-2)" "unprognostic (6.05e-2)" "unprognostic (1.76e-3)" 5.0 3.8 3.2 3.2 7.0 2.1 2.5 12.9 3.0 3.9 2.8 5.4 2.2 2.4 5.1 2.4 3.2 9.9 2.3 2.1 4.6 3.5 2.4 1.8 3.9 3.2 2.1 2.5 5.0 4.2 3.0 3.6 2.2 11.3 3.3 0.6 30.6 135.2 2.9 8.2 14.4 3.1 1.8 2.3 6.4 3.5 1.9 4.3 2.1 2.5 2.3 1.8 2.9 3.8 1.1 0.6 1.7 0.8 1.3 2.8 0.6 4.1 1.7 3.2 3.2 2.3 2.1 1.3 3.0 1.0 1.0 1.1 0.2 1.9 10.9 2.8 1.2 0.3 5.0 0.8 2.2 0.1 0.9 5.8 5.0 5.3 0.8 3.9 0.3 5.1 1.8 5.2 0.9 0.9 1.7 1.6 7.9 0.7 2.8 0.3 3.5 3.3 1.2 11.6 0.9 2.7 3.1 4.2 3.7 0.7 1.2 9.9 10.6 3.2 2.1 9.7 1.0 4.2 1.4 4.4 2.8 3.7 7.0 2.3 5.0 3.6 2.2 2.8 0.7 3.3 0.0 0.4 1.7 1.6 0.8 2.8 0.7 1.3 1.3 0.2 1.1 1.1 0.9 0.1 1.3 0.3 0.6 1.3 0.6 3.2 7.0 12.9 3.0 4.6 3.5 2.1 2.5 11.3 4.3 0.0 5.8 0.5 4.2 5.6 20.9 3.2 2.5 14.7 3.4 5.2 25.5 1.1 0.0 4.8 3.5 6.8 0.7 0.0 2.0 5.8 4.5 2.1 1.1 2.4 2.0 3.2 3.5 6.7 2.2 1.9 17.8 2.2 5.0 2.8 3.7 11.9 3.2 2.3 12.0 1.3 111.2 0.0 9.2 1.4 13.2 4.4 0.9 3.8 2.5 1.4 CRTC1 "FLJ14027, KIAA0616, MECT1, TORC1" ENSG00000105662 "CREB regulated transcription coactivator 1" Q6UUV9 19 18683677-18782333 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Biological rhythms, Host-virus interaction, Transcription, Transcription regulation" Activator "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 40.7" "Cell type enhanced" "Detected in many" 6 "Horizontal cells: 41.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022035, HPA063619" Enhanced Supported "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" "Plasma membrane, Cytosol" "HPA022035: AB_1847255, HPA063619: " "unprognostic (5.95e-3)" "unprognostic (2.57e-1)" "unprognostic (9.94e-2)" "unprognostic (8.62e-3)" "unprognostic (9.07e-2)" "unprognostic (1.57e-2)" "unprognostic (1.04e-1)" "unprognostic (5.57e-2)" "unprognostic (2.27e-1)" "unprognostic (6.68e-2)" "prognostic favorable (1.80e-5)" "unprognostic (3.37e-2)" "prognostic favorable (3.83e-5)" "unprognostic (6.83e-3)" "unprognostic (1.02e-1)" "unprognostic (2.51e-2)" "unprognostic (2.03e-2)" 8.6 7.7 26.0 7.4 38.8 3.2 3.8 40.7 30.1 5.0 4.4 6.5 4.3 6.5 6.8 5.6 3.1 10.5 5.5 5.6 17.7 7.8 6.6 4.5 5.7 6.3 6.4 18.1 6.7 10.0 8.4 11.3 6.4 6.0 7.0 2.6 5.1 8.8 9.4 12.4 5.5 6.2 4.3 4.8 8.1 8.0 7.5 10.2 1.9 7.4 1.1 3.7 4.6 3.5 4.1 3.8 1.8 3.4 1.1 3.0 1.3 4.4 8.1 5.9 9.4 5.5 4.6 16.7 4.9 3.3 4.7 4.5 5.4 5.8 6.2 10.4 4.6 3.3 4.8 1.8 3.0 1.1 2.7 14.1 5.2 7.2 8.9 5.3 7.1 14.6 7.5 2.9 4.0 1.2 6.2 2.6 6.4 4.1 5.7 2.6 16.1 4.6 8.1 7.6 2.3 11.9 7.3 2.6 6.8 2.9 7.9 10.8 9.7 5.5 5.2 5.8 2.0 5.8 4.3 4.7 5.3 8.2 9.7 5.6 3.8 3.0 4.1 6.2 7.7 4.0 1.5 3.4 1.8 1.7 1.3 1.8 2.3 2.7 3.0 3.0 4.1 2.3 1.8 1.7 1.1 1.9 3.8 1.8 1.3 26.0 38.8 40.7 30.1 17.7 7.8 6.4 18.1 6.0 10.2 0.0 4.0 4.2 9.5 2.4 24.9 14.0 5.1 2.7 2.3 17.4 25.5 8.5 10.0 3.6 0.7 4.5 5.1 0.0 5.3 2.1 5.4 3.0 2.3 3.4 7.8 41.3 18.4 1.3 5.4 1.7 8.6 3.7 3.3 1.8 6.9 8.9 2.6 8.6 4.6 4.3 14.1 0.0 8.2 2.9 7.2 1.8 8.7 5.1 4.8 2.5 CRYBG3 DKFZp667G2110 ENSG00000080200 "Crystallin beta-gamma domain containing 3" Q68DQ2 3 97822040-97944963 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 113.3;Early spermatids: 95.6;Late spermatids: 103.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 1.9;classical monocyte: 3.0;intermediate monocyte: 1.8;myeloid DC: 2.6;non-classical monocyte: 1.9;plasmacytoid DC: 7.1" "Group enriched" "Detected in many" 6 "dendritic cells: 7.1;granulocytes: 1.9;monocytes: 3.0" "Cell line enhanced" "Detected in many" "SCLC-21H: 28.3" "Low region specificity" "Detected in many" HPA075635 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA075635: " "unprognostic (1.88e-1)" "unprognostic (7.62e-3)" "unprognostic (2.54e-1)" "unprognostic (4.56e-2)" "unprognostic (7.60e-2)" "unprognostic (2.70e-2)" "unprognostic (2.45e-2)" "unprognostic (7.10e-2)" "unprognostic (3.41e-3)" "unprognostic (6.59e-2)" "unprognostic (2.80e-2)" "unprognostic (7.86e-2)" "prognostic favorable (7.07e-4)" "unprognostic (1.78e-2)" "unprognostic (1.58e-1)" "unprognostic (1.14e-2)" "unprognostic (6.38e-3)" 19.9 5.1 6.4 13.4 20.9 1.9 13.1 1.6 13.0 14.6 19.2 8.2 12.1 6.0 10.4 7.4 13.9 9.0 8.6 14.9 9.1 5.3 8.2 5.3 11.3 6.5 28.4 5.1 8.7 8.5 10.2 7.4 15.8 15.0 12.9 11.9 4.7 10.6 9.0 21.5 19.5 8.4 10.1 20.3 7.8 11.1 19.2 20.5 2.0 39.7 12.3 7.0 11.2 16.9 0.5 7.1 1.9 3.0 0.1 0.6 0.5 11.4 4.3 2.5 3.0 8.0 8.6 4.5 4.1 3.6 3.0 4.5 0.3 3.8 0.1 1.4 6.9 4.6 7.4 4.9 3.4 5.7 14.0 2.7 2.8 1.9 1.4 4.2 4.2 0.7 5.6 3.5 3.7 4.2 4.8 5.7 0.9 0.2 2.2 5.1 0.1 1.5 0.4 2.2 3.3 4.0 0.0 8.8 1.4 4.3 7.6 28.3 2.0 8.6 3.3 2.8 1.7 3.0 4.6 7.7 6.5 5.0 3.7 4.9 3.6 0.1 2.6 6.8 2.5 4.1 1.9 3.0 0.1 0.3 1.8 0.5 0.2 0.6 0.4 2.6 0.5 0.2 0.4 0.0 0.1 1.9 7.1 0.1 0.5 6.4 20.9 1.6 13.0 9.1 5.3 28.4 5.1 15.0 20.5 29.8 18.7 0.0 5.9 4.5 113.3 36.3 2.5 36.1 27.3 17.4 5.9 2.9 1.7 7.7 95.6 22.6 3.2 0.0 11.4 8.6 6.2 6.7 0.0 5.0 6.0 12.7 12.2 15.4 14.3 103.5 7.8 11.0 8.5 13.6 8.9 36.4 13.1 10.4 4.2 1.7 7.3 38.8 8.2 40.4 6.8 5.4 1.9 0.0 4.4 6.4 CRYL1 "GDH, lambda-CRY, MGC149525, MGC149526" ENSG00000165475 "Crystallin lambda 1" Q9Y2S2 13 20403666-20525873 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 104.0;liver: 80.8" "Cell type enhanced" "Detected in many" 15 "Distal tubular cells: 411.1;Hepatocytes: 272.9;Proximal tubular cells: 848.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 28.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040403 Enhanced Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Plasma membrane" NA NA 210000 "Nucleoplasm, Nucleoli" "Golgi apparatus, Plasma membrane" "HPA040403: AB_10795632" "unprognostic (1.84e-1)" "unprognostic (1.25e-1)" "unprognostic (3.25e-2)" "prognostic favorable (1.76e-5)" "unprognostic (3.10e-1)" "unprognostic (1.03e-1)" "unprognostic (1.09e-3)" "unprognostic (4.75e-3)" "unprognostic (1.19e-1)" "unprognostic (4.09e-2)" "unprognostic (2.12e-2)" "unprognostic (8.80e-2)" "prognostic favorable (2.30e-9)" "unprognostic (9.00e-2)" "unprognostic (1.30e-1)" "unprognostic (2.39e-2)" "unprognostic (3.11e-1)" 9.8 8.9 21.5 8.8 22.9 3.5 7.0 10.4 17.4 11.8 35.1 26.7 18.9 61.0 9.2 18.0 7.4 9.3 16.1 9.3 18.8 19.8 104.0 80.8 6.8 5.9 24.5 12.3 7.3 15.4 5.3 10.4 5.6 16.8 11.2 16.5 17.2 13.1 20.1 5.4 4.1 45.7 8.0 32.0 6.5 12.0 2.7 16.4 3.2 11.9 5.6 5.5 8.6 5.9 9.3 25.7 1.8 24.3 6.0 15.6 17.5 3.3 2.9 2.5 18.4 14.1 16.3 2.5 4.7 8.5 2.1 1.7 1.1 3.1 0.0 9.1 6.5 4.8 0.8 2.5 4.2 2.1 8.1 2.0 5.9 0.3 23.0 8.1 1.9 5.4 9.6 2.7 1.5 9.7 7.6 22.3 8.7 0.4 2.3 5.5 12.1 5.1 3.0 0.1 28.9 4.5 2.6 1.6 0.4 17.8 7.1 1.8 2.2 2.8 1.3 21.2 1.3 9.1 7.6 21.3 2.6 1.2 6.3 2.9 3.3 0.6 0.0 4.9 3.3 10.5 1.8 21.8 1.4 10.5 24.3 8.5 9.3 14.0 10.0 25.7 9.1 11.0 10.2 0.7 6.0 20.1 2.8 15.6 17.5 21.5 22.9 10.4 17.4 18.8 19.8 24.5 12.3 16.8 16.4 6.0 6.4 19.9 13.2 9.2 5.0 9.8 48.4 10.7 6.8 73.3 11.8 18.1 411.1 21.5 2.6 23.7 181.3 0.0 27.8 9.4 16.4 23.5 24.3 272.9 59.4 1.6 8.7 49.1 76.7 2.9 24.2 36.1 35.4 11.8 69.9 93.7 32.1 152.6 22.6 848.9 10.8 19.4 12.3 0.9 0.2 8.2 17.4 15.3 78.8 12.2 CST6 ENSG00000175315 "Cystatin E/M" Q15828 11 66011841-66013505 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Thiol protease inhibitor" "Cancer-related genes, Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skin 1: 124.5" "Cell type enhanced" "Detected in many" 16 "Alveolar cells type 1: 86.4;Ciliated cells: 56.2;Collecting duct cells: 55.8;Pancreatic endocrine cells: 216.2" "Cancer enhanced" "Detected in many" "thyroid cancer: 171.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "classical monocyte: 1.6" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 6 "A-431: 26.8;CAPAN-2: 74.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB019316, HPA044963" Enhanced Approved "Plasma membrane,Cytosol" "Secreted in other tissues" NA NA 110000000 "Plasma membrane" Cytosol "CAB019316: , HPA044963: AB_2679158" "unprognostic (3.01e-2)" "unprognostic (5.10e-2)" "unprognostic (1.14e-1)" "unprognostic (3.59e-2)" "unprognostic (5.00e-2)" "unprognostic (2.60e-1)" "unprognostic (1.65e-1)" "unprognostic (8.38e-2)" "unprognostic (5.02e-1)" "unprognostic (8.89e-3)" "unprognostic (1.29e-3)" "unprognostic (1.46e-1)" "unprognostic (1.74e-3)" "unprognostic (5.89e-3)" "unprognostic (1.83e-1)" "unprognostic (1.64e-2)" "unprognostic (2.59e-2)" 0.6 0.2 0.1 1.5 0.1 0.2 8.7 0.4 0.2 5.5 0.2 0.0 1.4 0.1 0.3 0.8 11.3 4.3 0.7 2.4 0.1 0.2 1.0 0.1 27.2 1.2 0.1 0.0 1.3 0.2 0.5 0.4 26.5 0.2 0.9 0.1 1.1 1.3 26.5 0.7 124.5 0.2 0.2 0.2 0.2 0.2 1.0 0.0 2.8 14.6 13.6 4.4 0.5 3.7 0.4 0.9 0.0 1.6 0.0 0.2 0.7 26.8 0.0 0.0 0.1 0.0 0.0 8.0 0.2 0.0 0.0 0.0 0.1 74.8 0.0 0.4 0.9 0.0 0.9 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.0 0.0 7.5 0.1 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.7 0.1 0.1 0.4 0.1 0.1 0.2 0.1 0.0 0.2 0.0 86.4 6.7 0.0 1.2 1.0 0.0 1.0 0.0 56.2 26.1 55.8 0.0 5.9 0.0 14.5 0.1 0.1 0.0 0.0 19.3 11.2 1.9 1.4 21.8 0.0 43.3 0.0 0.0 0.0 0.3 0.5 0.0 6.5 5.0 1.8 0.0 0.8 216.2 0.0 0.4 0.2 0.0 0.0 0.4 1.4 16.7 24.1 53.7 0.0 0.0 5.4 CTNNBIP1 "ICAT, MGC15093" ENSG00000178585 "Catenin beta interacting protein 1" Q9NSA3 1 9848276-9910336 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 116.5" "Cell type enhanced" "Detected in many" 7 "Suprabasal keratinocytes: 254.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042617, HPA067089" Enhanced Approved "Plasma membrane,Cell Junctions,Mitochondria" NA NA "Plasma membrane, Cell Junctions, Mitochondria" "HPA042617: AB_2678081, HPA067089: " "unprognostic (2.71e-1)" "unprognostic (4.46e-2)" "unprognostic (1.94e-1)" "prognostic favorable (5.68e-6)" "unprognostic (3.08e-1)" "unprognostic (2.63e-2)" "unprognostic (2.22e-2)" "unprognostic (1.19e-1)" "unprognostic (2.23e-2)" "unprognostic (2.62e-1)" "unprognostic (2.17e-2)" "unprognostic (1.77e-1)" "unprognostic (1.24e-3)" "unprognostic (3.62e-2)" "unprognostic (3.22e-2)" "unprognostic (8.63e-2)" "unprognostic (4.37e-2)" 12.6 4.0 10.1 4.3 8.1 7.7 18.3 21.4 14.8 16.6 5.8 10.1 10.9 7.4 4.8 31.3 49.0 5.2 4.8 13.7 10.1 9.5 5.6 4.8 15.2 4.0 8.4 11.3 5.5 14.1 4.0 6.6 11.0 13.7 9.9 4.2 13.3 15.5 16.5 13.1 116.5 5.8 4.5 9.2 3.3 8.8 11.8 6.5 4.8 7.9 33.9 13.5 5.6 21.7 1.9 6.8 12.9 5.4 8.8 2.9 2.3 26.2 3.9 24.2 18.4 3.6 6.1 7.7 5.2 9.2 7.7 4.9 1.9 33.5 8.1 15.1 6.7 7.9 13.4 2.8 30.9 3.5 20.4 4.3 5.2 1.2 24.4 7.6 3.9 3.1 6.8 30.6 9.8 10.0 6.6 20.7 15.3 9.2 3.8 4.7 16.1 8.7 14.6 12.8 21.2 6.8 10.0 7.1 5.2 3.9 9.0 26.6 16.8 11.8 10.8 15.7 8.6 13.2 9.7 13.5 5.0 6.1 7.5 11.4 8.4 10.9 9.5 1.8 20.0 19.7 2.7 5.4 12.9 2.9 1.9 1.7 1.9 1.5 2.4 6.8 1.6 1.4 1.4 4.0 8.8 1.2 2.1 1.2 2.3 10.1 8.1 21.4 14.8 10.1 9.5 8.4 11.3 13.7 6.5 26.8 11.5 11.8 34.8 91.7 8.4 11.6 22.9 1.4 7.9 17.4 7.9 61.2 28.2 16.0 101.0 18.1 20.6 23.3 16.2 34.6 26.7 52.4 0.0 22.9 49.6 15.9 47.1 16.0 32.6 19.5 13.8 30.5 45.5 5.4 34.9 106.1 27.9 25.8 21.5 23.0 12.2 45.3 22.1 72.3 36.2 254.8 40.5 18.1 24.3 54.7 CTSV "CTSL2, CTSU" ENSG00000136943 "Cathepsin V" O60911 9 97029679-97039643 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 154.7" "Cell type enhanced" "Detected in many" 12 "Cytotrophoblasts: 114.1;Extravillous trophoblasts: 136.0;Syncytiotrophoblasts: 56.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "NK-cell: 4.2;plasmacytoid DC: 15.7" "Group enriched" "Detected in many" 42 "dendritic cells: 15.7;NK-cells: 4.2" "Group enriched" "Detected in many" 9 "BEWO: 92.0;SuSa: 118.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB017112 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 260000 "Nucleoli fibrillar center, Cytosol" "Nucleoplasm, Plasma membrane" "CAB017112: " "unprognostic (2.40e-1)" "unprognostic (2.74e-2)" "unprognostic (1.50e-1)" "prognostic favorable (8.41e-4)" "unprognostic (7.29e-2)" "unprognostic (5.59e-2)" "prognostic unfavorable (2.83e-5)" "unprognostic (7.04e-3)" "unprognostic (6.06e-2)" "unprognostic (1.39e-2)" "prognostic unfavorable (2.87e-4)" "unprognostic (1.86e-2)" "unprognostic (1.78e-1)" "unprognostic (2.41e-2)" "unprognostic (1.33e-1)" "unprognostic (3.04e-3)" "prognostic unfavorable (2.39e-4)" 0.7 0.0 0.4 0.6 0.7 0.0 3.5 0.4 1.0 23.0 1.4 2.0 0.4 0.5 1.5 1.5 9.8 0.6 0.5 0.2 0.8 0.6 9.7 0.4 0.6 0.2 1.5 0.7 0.4 1.1 1.1 0.9 8.7 1.6 0.5 1.6 4.3 5.0 0.6 0.5 25.0 0.6 0.2 3.0 0.2 1.1 32.4 1.0 154.7 0.7 6.3 2.7 0.2 9.9 0.2 15.7 0.2 0.0 4.2 0.0 0.1 5.9 1.8 2.0 5.3 0.1 0.0 92.0 0.0 0.0 1.3 1.0 12.1 5.9 0.0 0.5 0.0 8.8 11.4 9.8 7.2 1.9 0.0 1.3 0.2 0.6 1.8 0.0 0.0 0.8 0.0 2.4 0.3 0.3 0.1 0.4 1.7 0.2 0.0 2.3 2.2 0.1 0.0 12.2 12.0 1.7 0.0 4.4 0.1 1.8 0.7 0.5 0.9 6.0 2.1 2.1 118.9 3.8 0.7 0.0 0.3 6.0 0.0 0.6 1.2 3.2 0.1 0.3 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.2 4.2 0.0 15.7 0.0 0.1 0.4 0.7 0.4 1.0 0.8 0.6 1.5 0.7 1.6 1.0 0.0 0.6 1.5 13.2 27.0 4.4 0.8 0.0 0.0 3.4 1.8 9.8 114.1 1.7 1.2 1.5 1.5 1.2 0.0 0.7 136.0 2.6 7.1 0.0 0.0 11.8 0.0 1.7 0.6 0.0 9.6 3.7 1.6 0.0 0.0 0.9 4.5 0.6 1.7 1.1 11.1 26.0 6.5 0.8 34.6 32.6 10.5 56.3 0.0 3.7 6.4 CTXN1 FLJ25968 ENSG00000178531 "Cortexin 1" P60606 19 7924485-7926166 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "brain: 91.1" "Cell type enhanced" "Detected in many" 7 "Glandular cells: 14.7;Late spermatids: 13.4;Spermatogonia: 10.4" "Cancer enhanced" "Detected in all" "ovarian cancer: 138.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 33.9;HEK 293: 23.6;NTERA-2: 25.7;REH: 19.5;SCLC-21H: 20.0;SH-SY5Y: 33.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA016669 Uncertain Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA Nucleoplasm "Plasma membrane, Cell Junctions" "HPA016669: AB_1847330" "unprognostic (1.49e-2)" "unprognostic (3.52e-2)" "unprognostic (1.79e-2)" "unprognostic (2.47e-1)" "unprognostic (1.22e-1)" "unprognostic (1.82e-2)" "unprognostic (5.42e-2)" "unprognostic (2.17e-1)" "unprognostic (2.58e-1)" "unprognostic (2.28e-2)" "unprognostic (1.69e-3)" "unprognostic (3.31e-2)" "unprognostic (1.56e-3)" "unprognostic (4.84e-2)" "unprognostic (3.09e-2)" "unprognostic (3.76e-2)" "unprognostic (9.41e-2)" 2.1 4.8 47.7 2.5 91.1 1.6 2.1 0.0 74.2 5.2 6.1 5.0 3.6 2.6 17.5 5.1 2.4 16.4 1.8 1.6 49.4 16.8 3.1 1.5 3.0 1.6 15.7 20.1 2.7 2.1 2.3 6.5 2.0 4.0 5.5 2.1 0.0 2.1 16.5 1.6 2.8 2.1 7.1 1.5 2.0 2.2 6.1 8.3 0.0 1.8 0.0 1.6 2.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 2.8 7.3 33.9 0.0 0.1 1.7 2.9 0.8 1.4 0.8 0.8 1.7 0.0 5.8 0.7 0.8 12.3 1.6 0.3 0.0 1.0 23.6 0.2 1.9 0.5 0.3 0.6 0.6 0.0 0.9 0.5 0.3 3.5 1.9 3.2 7.1 0.1 0.1 13.7 6.2 4.6 25.7 0.8 11.9 19.5 0.0 2.2 5.2 0.5 20.0 33.6 1.8 0.9 3.1 0.6 7.4 0.2 2.8 0.7 11.9 1.3 1.6 0.2 0.3 1.6 2.8 1.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.7 91.1 0.0 63.8 49.4 16.8 15.7 20.1 4.0 8.3 0.0 0.0 0.0 3.6 1.0 0.2 0.2 0.0 0.0 0.0 8.7 3.9 0.1 3.3 5.0 7.3 0.5 0.0 0.0 0.3 0.4 0.9 14.7 0.0 0.0 0.2 0.0 8.7 0.6 0.0 13.4 1.1 0.1 1.7 0.0 0.0 0.1 2.0 0.2 1.8 7.2 0.4 0.0 4.2 3.6 10.4 1.8 0.2 0.0 0.0 5.9 CUEDC1 ENSG00000180891 "CUE domain containing 1" Q9NWM3 17 57861243-57955323 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 60.9;Rod photoreceptor cells: 59.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 10 "plasmacytoid DC: 17.6" "Lineage enriched" "Detected in many" 10 "dendritic cells: 17.6" "Cell line enhanced" "Detected in many" "T-47d: 37.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023050, HPA024836" Approved Approved "Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane, Cytosol" Centrosome "HPA023050: AB_1847332, HPA024836: AB_1847333" "unprognostic (4.46e-1)" "unprognostic (3.76e-3)" "unprognostic (4.77e-2)" "unprognostic (4.87e-3)" "unprognostic (4.04e-1)" "unprognostic (3.56e-2)" "prognostic unfavorable (2.65e-5)" "unprognostic (6.69e-2)" "unprognostic (1.53e-2)" "unprognostic (6.65e-2)" "unprognostic (1.28e-3)" "unprognostic (1.37e-1)" "prognostic favorable (8.46e-4)" "unprognostic (1.96e-1)" "unprognostic (2.69e-2)" "unprognostic (2.52e-2)" "unprognostic (2.65e-2)" 9.8 10.6 11.7 8.6 19.3 5.2 9.3 8.5 16.6 22.3 18.5 39.1 11.8 5.0 13.4 13.9 21.2 21.6 12.9 24.2 12.6 12.1 12.0 3.7 13.7 4.4 30.0 8.0 6.4 11.6 7.1 11.5 7.8 18.5 13.0 7.2 19.3 19.1 18.4 48.9 5.5 7.3 19.2 18.7 6.6 12.2 2.9 28.3 2.5 11.2 15.8 4.7 15.4 10.4 0.0 17.6 1.8 1.3 0.1 0.0 0.1 8.3 25.9 27.1 4.8 4.4 8.1 0.9 5.9 12.0 12.5 9.0 4.7 32.2 0.1 24.2 11.4 10.6 6.7 2.9 12.7 4.4 16.3 5.0 0.3 16.8 3.9 10.7 0.1 2.0 8.3 7.7 7.2 6.1 11.0 6.0 0.1 0.3 0.1 11.4 4.7 0.4 0.2 0.9 9.6 7.1 0.8 7.0 1.2 8.5 5.5 11.2 6.1 2.5 2.7 10.2 4.8 37.5 0.9 7.6 33.4 21.1 9.1 13.1 0.0 0.1 0.1 14.5 1.1 26.6 0.6 0.4 1.8 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.7 0.1 1.3 17.6 0.0 0.1 11.7 19.3 8.5 15.4 12.6 12.1 30.0 8.0 18.5 28.3 17.9 5.1 1.3 13.8 3.7 32.2 15.6 10.2 12.0 10.3 21.0 60.9 0.6 6.6 20.2 0.3 8.4 4.5 0.0 22.5 0.2 10.6 18.5 0.0 2.9 14.5 9.5 3.4 2.5 9.7 2.3 6.4 6.8 5.0 3.6 4.6 25.1 20.7 0.0 4.9 7.1 59.5 6.5 10.4 0.0 0.4 2.0 0.6 0.0 5.5 15.4 CUTA "ACHAP, C6orf82" ENSG00000112514 "CutA divalent cation tolerance homolog" O60888 6 33416442-33418317 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016787, HPA064369" Uncertain Approved "Plasma membrane,Focal adhesion sites" "Secreted to blood" NA NA 35000000 "Plasma membrane, Focal adhesion sites" "CAB016787: , HPA064369: AB_2685248" "unprognostic (7.03e-2)" "unprognostic (5.44e-2)" "unprognostic (4.56e-2)" "unprognostic (8.91e-2)" "unprognostic (1.86e-1)" "unprognostic (1.03e-1)" "unprognostic (1.98e-2)" "prognostic favorable (8.50e-4)" "unprognostic (1.87e-1)" "unprognostic (2.78e-2)" "unprognostic (1.27e-3)" "unprognostic (1.91e-1)" "unprognostic (5.55e-2)" "unprognostic (9.90e-2)" "unprognostic (1.54e-1)" "unprognostic (7.94e-2)" "unprognostic (2.74e-1)" 26.6 65.6 47.9 28.3 60.1 33.5 47.6 37.7 73.7 47.7 37.9 36.8 53.9 42.1 40.1 78.5 30.5 46.0 48.8 49.6 45.2 44.9 46.3 61.6 39.0 77.4 46.5 37.8 57.7 66.6 43.8 86.1 45.7 39.8 38.8 28.9 34.2 74.3 69.7 34.6 32.7 37.2 32.4 47.0 36.0 38.7 27.3 31.6 52.2 69.7 30.3 31.3 42.6 28.9 56.5 31.4 27.1 32.0 49.9 69.8 60.8 43.8 26.3 42.1 53.3 31.7 31.2 20.4 40.1 75.1 77.6 82.7 26.2 27.4 31.0 31.2 45.9 56.4 26.8 27.3 40.8 43.8 26.2 60.5 32.3 43.6 68.6 41.3 25.1 24.6 41.3 34.5 37.3 31.5 54.0 20.8 32.9 39.6 63.1 56.7 34.1 38.0 53.5 37.7 38.0 34.7 41.8 25.1 81.9 53.4 19.1 82.4 42.0 24.0 41.8 72.8 25.2 30.7 52.8 22.9 42.0 35.7 29.8 41.8 62.0 61.6 33.9 36.3 55.6 34.1 27.1 32.0 16.5 45.7 22.9 63.2 56.5 67.6 52.7 31.4 44.2 68.5 53.2 4.6 49.9 16.8 27.1 69.8 60.8 47.9 60.1 37.7 73.7 45.2 44.9 46.5 37.8 39.8 31.6 122.1 105.5 178.5 242.5 204.8 84.5 113.4 239.5 131.2 121.7 300.1 64.8 309.8 240.4 162.1 64.8 93.9 157.7 23.3 122.9 203.5 204.8 237.5 167.3 299.7 277.3 73.1 280.4 131.3 162.9 285.6 185.2 150.2 300.3 80.2 266.0 150.8 114.3 196.4 180.0 440.5 69.0 90.5 220.1 100.6 65.6 201.4 203.1 245.2 291.8 203.9 CX3CR1 "CCRL1, CMKBRL1, CMKDR1, GPR13, V28" ENSG00000168329 "C-X3-C motif chemokine receptor 1" P49238 3 39263494-39281735 "Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Host-virus interaction" "G-protein coupled receptor, Receptor, Transducer" "Age-related macular degeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 69.2;brain: 51.6" "Cell type enhanced" "Detected in some" 17 "Kupffer cells: 14.4;Macrophages: 26.4;Sertoli cells: 6.5;T-cells: 15.2" "Cancer enhanced" "Detected in many" "glioma: 21.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 69.2" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 20 "RPMI-8226: 114.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032478, HPA046587" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "CAB032478: AB_638830, HPA046587: AB_2679708" "unprognostic (2.00e-1)" "unprognostic (5.12e-2)" "unprognostic (2.65e-1)" "unprognostic (2.42e-2)" "unprognostic (6.52e-2)" "unprognostic (3.01e-3)" "unprognostic (2.64e-1)" "unprognostic (1.16e-2)" "unprognostic (3.98e-2)" "unprognostic (1.57e-3)" "unprognostic (1.13e-2)" "unprognostic (1.04e-1)" "unprognostic (3.05e-2)" "unprognostic (1.36e-2)" "unprognostic (8.59e-2)" "unprognostic (7.71e-3)" "unprognostic (1.12e-1)" 2.3 3.8 14.9 6.0 17.3 0.9 4.8 2.5 34.1 2.7 1.2 51.6 0.0 1.2 2.7 4.2 1.4 5.9 2.5 2.2 12.4 11.9 2.5 1.9 9.0 1.8 21.8 7.4 1.8 1.8 5.2 2.5 4.3 21.8 3.7 1.2 3.5 6.4 7.0 5.2 2.4 1.2 3.3 33.5 10.3 1.5 1.8 16.3 0.8 2.4 0.7 4.7 2.8 1.3 0.1 15.7 3.5 69.2 6.5 46.5 29.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 114.8 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 5.6 0.0 1.2 15.9 0.2 46.5 43.3 0.5 0.1 10.4 25.2 15.7 0.1 3.7 22.7 3.5 6.5 69.2 1.1 0.2 29.8 14.9 17.3 2.5 19.9 12.4 11.9 21.8 7.4 21.8 16.3 0.0 0.3 0.0 0.0 0.5 0.0 0.4 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 4.7 0.0 3.5 0.0 0.0 0.6 14.4 0.0 0.3 26.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 6.5 0.0 0.7 0.2 0.5 0.0 15.2 0.0 0.0 CYB5D2 MGC32124 ENSG00000167740 "Cytochrome b5 domain containing 2" Q8WUJ1 17 4143168-4187310 "Predicted intracellular proteins, Predicted secreted proteins" Neurogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 40.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011032, HPA042299" Approved Approved "Endoplasmic reticulum,Plasma membrane" "Secreted - unknown location" NA NA "Endoplasmic reticulum, Plasma membrane" "HPA011032: , HPA042299: AB_10793879" "unprognostic (2.57e-2)" "unprognostic (2.89e-2)" "unprognostic (4.16e-2)" "prognostic favorable (6.19e-4)" "unprognostic (1.88e-2)" "unprognostic (1.75e-2)" "prognostic favorable (4.98e-6)" "unprognostic (1.57e-1)" "unprognostic (2.47e-1)" "unprognostic (9.71e-3)" "prognostic favorable (7.76e-5)" "unprognostic (2.04e-1)" "prognostic favorable (2.03e-10)" "unprognostic (2.01e-3)" "unprognostic (8.73e-2)" "unprognostic (1.82e-1)" "unprognostic (2.97e-1)" 13.1 17.3 18.7 5.1 26.4 3.6 15.0 20.6 27.5 15.0 8.1 21.8 14.6 13.3 13.9 27.1 9.8 17.4 14.5 10.3 17.8 21.6 22.9 25.3 8.6 7.4 19.7 26.1 19.5 17.0 28.5 18.5 9.9 19.1 12.0 6.8 17.3 17.5 16.8 12.2 11.7 10.3 7.8 21.7 7.9 12.3 54.1 17.1 4.8 20.6 7.1 6.8 12.0 8.6 9.4 13.0 14.7 12.7 5.9 12.5 9.0 7.9 10.7 6.2 6.5 40.1 11.8 2.6 7.7 16.7 5.7 5.8 3.1 5.3 2.6 7.0 8.9 4.8 11.3 2.6 3.6 2.3 8.5 12.9 2.4 6.7 5.3 7.3 1.0 4.9 15.4 8.6 3.1 6.2 11.9 10.2 5.8 2.5 15.8 4.3 9.8 3.7 1.6 2.2 6.8 5.8 4.5 5.5 6.3 13.1 4.2 5.0 4.2 8.7 5.1 11.4 7.2 13.5 1.6 13.7 8.3 2.1 7.6 4.0 3.0 2.3 2.0 10.2 2.2 3.2 0.6 12.7 14.7 7.2 10.4 8.1 9.4 11.4 8.8 12.0 9.4 10.8 9.7 11.7 5.9 9.4 13.0 12.5 9.0 18.7 26.4 20.6 27.5 17.8 21.6 19.7 26.1 19.1 17.1 11.9 9.3 19.5 18.9 47.7 26.3 8.5 56.0 45.5 11.4 29.6 55.0 44.7 44.7 26.6 19.7 31.6 18.6 0.0 23.9 24.3 20.3 8.4 10.5 31.1 17.8 38.1 13.3 29.4 21.3 23.3 26.7 17.5 13.5 14.4 13.8 34.2 24.3 17.3 26.9 34.9 30.0 0.0 21.2 83.1 23.6 37.5 32.3 15.2 15.8 7.8 CYP24A1 "CP24, CYP24, P450-CC24" ENSG00000019186 "Cytochrome P450 family 24 subfamily A member 1" Q07973 20 54153449-54173973 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 38.8;lymphoid tissue: 25.8;urinary bladder: 31.2" "Cell type enhanced" "Detected in some" 11 "Basal glandular cells: 21.1;Basal keratinocytes: 20.3;Club cells: 29.6;Proximal tubular cells: 33.5;Suprabasal keratinocytes: 17.1;Urothelial cells: 39.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.1;memory CD8 T-cell: 2.0" "Lineage enriched" "Detected in single" 20 "T-cells: 2.0" "Group enriched" "Detected in some" 16 "A549: 95.1;Hep G2: 27.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA022261, HPA063771" Enhanced Supported "Nucleoplasm,Plasma membrane,Mitochondria" NA Yes "Nucleoplasm, Mitochondria" "Plasma membrane" "HPA022261: AB_1847427, HPA063771: AB_2685120" "unprognostic (1.19e-7)" "unprognostic (1.73e-1)" "unprognostic (2.24e-2)" "unprognostic (7.69e-3)" "unprognostic (3.30e-1)" "unprognostic (2.30e-2)" "unprognostic (1.11e-2)" "unprognostic (2.12e-1)" "unprognostic (2.09e-2)" "unprognostic (5.37e-3)" "unprognostic (1.23e-1)" "unprognostic (6.05e-2)" "unprognostic (5.98e-2)" "unprognostic (1.36e-1)" "unprognostic (4.38e-2)" "unprognostic (2.12e-1)" 0.1 0.1 0.4 0.2 0.7 0.0 2.5 0.1 0.4 2.5 0.1 0.0 0.3 0.0 11.2 0.4 4.4 0.3 0.0 0.1 0.4 0.8 38.8 0.3 1.6 0.1 0.2 0.0 0.1 0.1 0.0 0.7 7.0 0.3 7.0 0.0 0.1 0.3 1.5 0.1 1.0 0.1 0.6 0.2 0.1 0.1 0.3 0.0 0.4 1.4 5.9 25.8 31.2 14.4 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.1 95.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.9 0.0 0.7 0.0 0.2 3.6 0.0 0.0 0.0 0.0 0.0 0.0 1.3 27.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 1.6 0.3 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.1 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.7 0.1 0.4 0.4 0.8 0.2 0.0 0.3 0.0 0.0 0.0 1.5 21.1 20.3 0.0 0.3 0.0 8.1 29.6 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 6.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 33.5 0.0 0.0 0.0 0.0 0.0 17.1 0.1 0.0 0.0 39.9 DAAM1 KIAA0666 ENSG00000100592 "Dishevelled associated activator of morphogenesis 1" Q9Y4D1 14 59188646-59371405 "Plasma proteins, Predicted intracellular proteins" "Wnt signaling pathway" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Basal keratinocytes: 415.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 18.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HaCaT: 27.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026605, HPA064789" Uncertain Approved "Plasma membrane,Cytosol" NA NA 450000 "Plasma membrane, Cytosol" "HPA026605: AB_1847464, HPA064789: AB_2685352" "unprognostic (2.81e-1)" "unprognostic (9.70e-2)" "unprognostic (3.85e-2)" "unprognostic (2.74e-1)" "unprognostic (2.32e-1)" "unprognostic (1.84e-1)" "unprognostic (1.76e-2)" "unprognostic (2.48e-1)" "unprognostic (2.02e-1)" "unprognostic (6.40e-2)" "unprognostic (1.98e-1)" "unprognostic (4.64e-2)" "prognostic favorable (3.77e-4)" "unprognostic (5.01e-2)" "unprognostic (3.29e-1)" "unprognostic (1.39e-1)" "unprognostic (3.15e-2)" 13.8 8.0 13.8 9.4 9.3 3.7 9.3 17.3 13.3 14.6 11.4 6.3 7.4 4.5 16.9 7.0 19.2 8.4 6.0 17.3 10.2 6.7 6.0 10.7 9.7 8.8 5.6 13.6 8.6 8.2 25.6 9.6 12.4 8.7 10.9 7.8 16.9 12.0 10.5 6.0 25.6 7.7 19.5 10.0 10.2 9.1 5.8 7.2 4.1 7.1 14.1 13.8 15.3 13.1 10.7 18.3 4.9 3.1 6.9 3.8 1.9 13.1 1.3 9.1 2.3 6.0 4.2 11.8 1.7 1.7 3.5 3.7 6.8 10.9 13.6 3.5 4.1 7.2 27.2 8.5 6.6 2.9 6.0 3.0 5.1 3.4 8.1 3.7 5.7 2.7 2.8 6.7 3.0 2.9 7.0 7.7 6.7 8.3 6.7 2.1 11.3 4.8 2.8 4.9 8.1 3.9 4.5 7.7 1.3 4.5 10.3 14.1 3.1 11.5 16.8 10.2 6.1 22.3 1.2 7.7 2.7 5.3 6.1 1.5 1.5 1.7 15.9 3.6 1.0 6.5 4.9 2.1 2.5 2.6 2.4 3.1 10.7 3.3 2.4 2.4 4.7 2.7 2.7 2.6 6.9 3.1 18.3 3.8 1.9 13.8 9.3 17.3 13.3 10.2 6.7 5.6 13.6 8.7 7.2 32.8 24.8 21.7 108.9 415.1 111.0 118.9 30.6 65.6 52.4 27.9 290.6 30.5 19.9 42.3 28.7 59.1 37.1 186.9 81.9 21.8 46.3 89.2 25.4 41.2 26.6 184.3 84.3 111.7 17.1 11.1 55.8 14.9 86.0 24.4 50.3 117.4 130.6 38.6 69.6 11.3 180.1 32.3 49.5 32.1 44.8 290.2 28.6 20.2 36.8 75.2 DAW1 "FLJ25955, ODA16, WDR69" ENSG00000123977 "Dynein assembly factor with WD repeats 1" Q8N136 2 227871054-227924344 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 14.9;fallopian tube: 24.4;testis: 49.9" "Group enriched" "Detected in some" 12 "Ciliated cells: 69.6;Early spermatids: 83.7;Late spermatids: 157.9;Spermatocytes: 115.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "GAMG: 6.2;HUVEC TERT2: 15.2;U-2197: 28.5" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "midbrain: 25.4" HPA046118 Approved Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" NA NA Nucleoplasm "Nuclear bodies, Plasma membrane" "HPA046118: AB_10961428" "unprognostic (1.23e-1)" "unprognostic (1.42e-1)" "unprognostic (1.95e-1)" "unprognostic (1.66e-1)" "unprognostic (4.37e-1)" "unprognostic (1.23e-1)" "unprognostic (5.63e-3)" "unprognostic (2.90e-2)" "unprognostic (9.92e-3)" "unprognostic (1.54e-5)" "unprognostic (1.52e-1)" "unprognostic (6.83e-3)" "unprognostic (1.70e-1)" "unprognostic (3.08e-1)" 0.4 0.1 2.5 0.3 14.9 0.4 0.5 0.0 1.8 0.7 0.3 3.1 0.0 0.1 0.3 3.1 0.6 24.4 0.4 0.4 3.9 3.0 0.3 0.5 2.4 0.3 0.3 2.7 1.3 0.1 0.7 0.2 0.8 14.3 0.2 0.2 0.0 0.3 0.2 2.6 0.3 0.2 0.2 0.3 0.3 0.2 49.9 1.1 0.0 0.2 0.0 0.3 0.3 0.0 0.5 0.5 1.2 0.5 0.2 0.8 0.0 0.6 0.0 0.1 0.0 0.2 0.9 0.4 0.6 0.3 0.6 0.4 3.7 0.3 0.2 0.0 0.1 6.2 0.1 0.0 0.1 1.8 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.1 1.3 0.0 0.7 0.5 4.1 15.2 0.0 0.1 0.2 0.2 0.0 0.0 0.4 0.3 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.2 0.1 0.5 0.0 0.0 0.2 0.1 0.3 1.5 0.1 1.4 28.5 0.0 0.0 0.1 0.2 2.7 0.0 0.2 1.2 0.0 0.2 0.2 0.5 0.8 0.3 0.4 0.4 0.0 0.5 0.6 0.3 0.0 0.2 0.5 0.5 0.6 0.0 2.5 14.9 0.0 1.8 3.9 3.0 0.3 2.7 14.3 1.1 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 69.6 9.1 0.0 3.9 0.0 0.0 0.0 83.7 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 157.9 3.1 0.0 0.0 0.0 0.0 0.2 1.7 0.0 2.5 0.0 0.2 0.0 0.0 115.4 1.4 0.1 0.2 0.0 0.0 0.0 DBN1 D0S117E ENSG00000113758 "Drebrin 1" Q16643 5 177456608-177474401 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Actin-binding, Developmental protein" "Alzheimer disease, Amyloidosis, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ductal cells: 78.5;Pancreatic endocrine cells: 52.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 12.7" "Group enriched" "Detected in many" 8 "dendritic cells: 5.1;granulocytes: 6.0;T-cells: 12.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051452, HPA056940" Enhanced Supported Supported "Plasma membrane,Actin filaments" NA NA 17000000 "Plasma membrane, Actin filaments" "HPA051452: AB_2681489, HPA056940: AB_2683279" "unprognostic (3.81e-2)" "unprognostic (6.60e-3)" "unprognostic (2.88e-2)" "unprognostic (7.57e-3)" "unprognostic (9.32e-2)" "unprognostic (5.68e-2)" "unprognostic (2.01e-3)" "unprognostic (4.29e-2)" "unprognostic (1.73e-2)" "unprognostic (7.92e-2)" "unprognostic (2.94e-2)" "unprognostic (3.64e-1)" "prognostic favorable (8.28e-4)" "unprognostic (1.53e-1)" "unprognostic (4.56e-2)" "unprognostic (1.05e-1)" "unprognostic (1.76e-3)" 21.4 9.0 21.7 15.0 42.4 5.4 13.5 12.0 46.0 25.7 21.7 8.8 8.7 8.6 37.4 15.0 19.2 16.2 21.5 13.9 24.2 20.9 15.1 2.7 12.1 7.3 11.9 22.1 20.2 13.2 9.1 17.1 6.7 20.3 14.9 5.8 9.3 24.8 23.0 21.3 12.7 10.0 29.5 8.6 7.8 17.0 14.4 9.4 19.8 20.0 11.0 4.4 20.6 12.0 0.2 5.1 6.0 0.9 0.1 12.7 1.5 3.0 10.3 34.3 59.8 8.2 12.9 10.6 36.6 9.4 21.5 18.0 35.4 10.8 0.0 26.2 28.4 7.3 4.8 15.1 26.6 10.2 0.8 13.1 19.9 13.4 14.7 28.9 7.5 3.7 16.8 7.0 24.0 7.2 21.6 35.4 24.5 9.1 4.8 15.7 4.3 20.4 11.4 49.6 1.0 23.1 61.2 37.1 6.0 16.1 4.3 40.4 54.9 12.0 5.3 20.4 11.6 14.6 7.7 54.7 24.1 32.7 5.3 17.0 1.1 0.5 32.0 10.1 7.0 14.7 6.0 0.9 0.7 9.2 0.5 12.7 0.1 0.2 6.6 1.4 0.2 0.3 4.5 2.5 0.1 0.4 5.1 0.0 1.5 21.7 42.4 12.0 40.8 24.2 20.9 11.9 22.1 20.3 9.4 3.0 1.0 0.5 10.4 9.2 7.6 3.4 5.1 6.7 3.4 8.7 3.9 0.8 1.7 78.5 15.9 26.1 0.8 0.0 37.0 2.4 27.1 6.4 10.4 0.0 1.4 39.7 39.0 20.3 3.2 27.6 46.3 4.1 8.5 2.8 1.6 12.7 52.8 0.0 38.5 2.6 3.7 19.4 17.6 6.1 15.6 6.4 0.7 7.5 3.6 7.2 DCAF16 "C4orf30, FLJ20280" ENSG00000163257 "DDB1 and CUL4 associated factor 16" Q9NXF7 4 17800655-17810758 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042487 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA042487: AB_10795505" "unprognostic (2.23e-3)" "unprognostic (1.05e-1)" "unprognostic (1.19e-1)" "unprognostic (3.97e-1)" "unprognostic (8.02e-2)" "unprognostic (2.14e-1)" "prognostic unfavorable (6.40e-4)" "prognostic favorable (5.78e-4)" "unprognostic (5.31e-2)" "unprognostic (3.30e-1)" "unprognostic (1.45e-2)" "unprognostic (3.19e-2)" "unprognostic (1.78e-1)" "unprognostic (8.72e-2)" "unprognostic (1.68e-1)" "unprognostic (2.23e-3)" "prognostic favorable (7.67e-4)" 13.0 13.1 12.7 12.1 20.5 23.3 19.8 19.4 19.7 18.5 13.1 22.5 9.9 12.0 26.9 16.5 11.5 16.1 11.3 11.8 13.9 15.7 11.3 6.8 12.6 16.7 14.4 16.2 29.6 16.0 17.8 25.8 14.8 19.0 16.9 14.8 17.1 15.2 13.0 16.2 22.4 14.0 17.2 16.0 13.3 13.6 19.2 16.3 30.6 15.7 7.0 18.3 16.3 14.6 4.8 3.0 9.7 2.8 3.6 6.3 2.2 12.2 2.6 14.3 15.0 4.1 7.2 7.9 8.0 9.5 9.6 11.4 7.5 10.0 13.9 6.4 7.4 7.8 6.2 8.4 8.5 14.3 4.7 7.7 19.4 8.8 12.2 9.9 17.0 7.9 9.4 7.0 12.2 12.1 6.5 6.6 13.7 20.8 23.1 5.5 4.6 18.7 16.4 11.8 3.6 7.7 19.8 16.4 8.9 4.1 9.7 21.4 17.2 8.5 2.3 9.2 7.6 8.4 4.7 8.3 11.2 8.8 12.3 10.1 10.3 4.1 17.3 9.2 11.9 7.5 9.7 2.4 3.4 4.5 2.8 5.9 3.7 5.0 4.9 1.5 4.8 6.3 5.9 1.8 3.6 1.9 3.0 3.4 2.2 12.7 20.5 19.4 19.7 13.9 15.7 14.4 16.2 19.0 16.3 17.9 19.0 9.0 15.5 22.6 11.8 14.8 15.3 21.4 17.0 8.7 5.9 14.1 11.6 8.6 14.8 12.1 7.1 23.3 6.7 7.7 16.1 12.3 16.2 5.7 6.4 14.3 16.8 11.6 9.7 9.1 19.5 9.6 10.1 5.4 16.5 23.4 8.7 5.8 20.8 5.0 13.6 12.9 13.2 24.2 17.2 18.4 10.3 15.2 13.0 14.3 DCBLD2 "CLCP1, ESDN" ENSG00000057019 "Discoidin, CUB and LCCL domain containing 2" Q96PD2 3 98795941-98901689 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 66.0;Cone photoreceptor cells: 72.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-HME1: 59.8;hTERT-RPE1: 84.9;LHCN-M2: 99.6;RPTEC TERT1: 62.4;U-87 MG: 76.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016909 Approved Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA 1800000 "Plasma membrane, Cytosol" "Golgi apparatus" "HPA016909: AB_1847510" "unprognostic (1.66e-1)" "unprognostic (1.45e-1)" "unprognostic (4.46e-2)" "unprognostic (2.64e-1)" "unprognostic (5.97e-3)" "unprognostic (9.29e-3)" "unprognostic (8.31e-3)" "unprognostic (1.06e-3)" "unprognostic (1.42e-1)" "unprognostic (1.63e-1)" "prognostic unfavorable (1.52e-4)" "unprognostic (2.43e-1)" "prognostic unfavorable (3.32e-5)" "prognostic unfavorable (2.87e-4)" "unprognostic (7.76e-2)" "unprognostic (3.93e-2)" "unprognostic (1.59e-3)" 13.1 14.6 4.5 6.4 7.2 1.1 19.3 9.7 9.6 12.0 13.1 5.1 8.1 2.7 16.8 9.2 8.8 13.9 11.7 24.2 4.5 6.2 11.3 9.2 13.1 3.2 6.7 3.5 19.0 6.4 17.6 12.7 9.9 6.5 11.2 6.8 19.3 11.1 14.7 6.6 7.7 5.2 16.7 7.1 2.1 8.6 33.8 7.3 8.1 18.7 6.3 3.6 15.1 6.8 0.6 1.2 1.7 0.5 0.1 1.1 0.2 6.8 50.2 6.7 5.3 9.0 21.4 2.9 15.5 7.4 10.6 12.0 4.2 21.9 0.0 48.8 26.6 32.5 6.4 3.0 25.2 24.4 0.1 1.0 2.4 1.6 6.4 5.5 1.1 1.1 8.4 3.9 30.4 59.8 84.9 6.9 0.9 0.4 0.6 99.6 1.8 0.9 0.6 4.7 0.0 17.4 1.0 12.7 0.6 62.4 1.8 1.8 3.1 4.2 0.8 18.1 4.8 3.4 0.9 11.4 27.3 21.9 6.9 54.2 0.8 1.1 0.9 76.2 0.4 11.8 1.2 0.5 1.7 0.0 0.1 0.0 0.6 0.1 0.1 0.5 0.2 1.1 0.1 0.9 0.1 0.3 1.2 0.0 0.2 4.5 7.2 9.7 9.6 4.5 6.2 6.7 3.5 6.5 7.3 29.8 44.4 4.5 12.4 20.3 11.2 66.0 12.7 18.7 20.5 17.4 72.6 9.6 0.0 20.3 2.5 7.1 0.9 0.0 7.0 8.2 18.1 10.1 36.9 18.7 3.5 12.7 3.5 4.9 1.6 3.6 20.4 2.6 8.5 1.8 7.3 44.0 17.8 3.5 47.4 6.9 49.1 0.0 19.1 15.8 23.3 13.7 3.3 0.0 10.7 5.9 DCHS1 "CDH25, CDHR6, FIB1, FLJ11790, KIAA1773, PCDH16" ENSG00000166341 "Dachsous cadherin-related 1" Q96JQ0 11 6621323-6655854 "Disease related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Deafness, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 22 "Endothelial cells: 12.7;Fibroblasts: 17.1;Ito cells: 63.3;Melanocytes: 15.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 19.2;HUVEC TERT2: 26.7;REH: 12.9;SH-SY5Y: 18.7;TIME: 11.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA017970, HPA050246" Approved Approved "Plasma membrane" NA NA 75000 "Plasma membrane" "HPA017970: AB_2669718, HPA050246: AB_2681062" "unprognostic (2.42e-1)" "unprognostic (1.13e-1)" "unprognostic (8.93e-2)" "unprognostic (3.52e-2)" "unprognostic (1.83e-1)" "unprognostic (1.38e-3)" "unprognostic (2.52e-2)" "unprognostic (4.55e-3)" "unprognostic (2.63e-2)" "unprognostic (2.93e-2)" "unprognostic (5.96e-2)" "unprognostic (6.87e-2)" "prognostic unfavorable (9.32e-4)" "unprognostic (5.62e-2)" "unprognostic (2.28e-1)" "unprognostic (1.60e-2)" "unprognostic (1.24e-3)" 9.0 2.0 4.1 7.7 4.7 0.5 6.8 5.2 4.4 26.1 12.9 4.4 9.0 3.8 23.9 4.7 5.0 10.4 9.1 8.0 4.0 4.5 3.4 5.6 7.7 3.9 2.5 3.4 13.7 3.3 1.6 2.7 9.7 3.3 12.0 3.4 9.7 3.3 12.0 3.5 3.4 6.0 16.0 1.6 10.2 6.8 2.6 2.5 5.8 3.3 2.6 2.6 10.9 11.9 0.0 1.4 0.1 0.0 0.0 0.9 0.4 0.0 0.0 19.2 0.1 0.0 0.0 0.1 0.6 4.9 3.1 3.5 0.1 0.0 0.1 2.9 5.5 0.2 0.0 1.5 0.0 2.1 0.0 0.5 0.4 0.0 0.0 0.2 0.1 0.0 0.6 0.1 1.4 0.0 0.0 26.7 0.0 0.1 0.0 1.1 0.0 0.6 0.3 2.8 0.0 0.0 12.9 0.0 0.0 0.0 0.0 1.4 18.7 0.0 0.1 0.1 2.1 0.0 0.7 11.4 0.0 5.9 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.8 0.9 0.1 0.0 0.0 1.4 0.0 0.4 4.1 4.7 5.2 4.4 4.0 4.5 2.5 3.4 3.3 2.5 0.0 0.3 0.0 0.2 2.6 0.4 2.8 5.1 0.0 0.0 0.0 0.0 0.2 0.0 0.8 2.2 12.7 0.0 0.0 0.3 0.3 17.1 0.2 0.0 0.0 1.8 0.0 0.0 63.3 6.0 2.9 1.1 0.4 15.1 0.0 0.7 0.5 0.2 0.0 1.8 0.0 0.3 0.0 2.2 2.7 0.5 1.5 0.2 0.0 1.0 0.0 DCHS2 "CDH27, CDHJ, CDHR7, FLJ20047, PCDH23, PCDHJ" ENSG00000197410 "Dachsous cadherin-related 2" 4 154231742-154495570 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "endometrium 1: 8.6" "Group enriched" "Detected in some" 7 "Early spermatids: 20.6;Horizontal cells: 23.8;Intestinal endocrine cells: 6.4;Late spermatids: 14.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "U-2 OS: 8.0" "Low region specificity" "Detected in many" HPA064159 Uncertain Approved "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA064159: AB_2685201" "unprognostic (1.38e-2)" "unprognostic (1.51e-1)" "unprognostic (5.74e-3)" "unprognostic (5.93e-2)" "unprognostic (7.43e-3)" "unprognostic (1.29e-1)" "unprognostic (2.27e-4)" "unprognostic (1.18e-1)" "unprognostic (4.00e-1)" "unprognostic (1.61e-1)" "unprognostic (2.53e-3)" "unprognostic (1.62e-1)" "unprognostic (1.06e-3)" "unprognostic (3.13e-1)" "unprognostic (2.62e-1)" "unprognostic (1.49e-1)" "unprognostic (1.68e-3)" 0.9 1.6 3.4 1.3 7.0 1.1 1.0 0.6 4.8 2.6 4.0 1.9 1.1 1.3 8.6 1.5 1.0 2.0 1.6 0.8 3.5 2.6 0.9 0.7 1.1 0.8 3.0 2.3 1.9 0.6 1.1 1.7 0.8 4.6 1.6 1.5 2.7 0.8 3.6 1.0 2.1 1.0 3.0 7.0 0.8 4.9 2.6 2.9 0.0 1.0 0.0 0.9 2.3 1.2 0.3 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 1.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 8.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 3.4 7.0 0.6 4.8 3.5 2.6 3.0 2.3 4.6 2.9 0.0 0.0 0.0 0.2 0.3 0.0 1.7 0.0 1.4 2.3 0.0 0.0 0.0 0.0 0.0 20.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 23.8 6.4 0.0 0.0 14.1 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.2 0.3 0.0 0.0 0.0 0.0 DCUN1D2 "C13orf17, FLJ10704, FLJ20092" ENSG00000150401 "Defective in cullin neddylation 1 domain containing 2" Q6PH85 13 113455819-113490952 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "brain: 24.0;heart muscle: 59.1;skeletal muscle: 65.6" "Cell type enhanced" "Detected in many" 11 "Cardiomyocytes: 67.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SCLC-21H: 32.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039349 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039349: AB_10673240" "unprognostic (3.09e-1)" "unprognostic (1.35e-1)" "unprognostic (1.78e-1)" "unprognostic (4.69e-2)" "unprognostic (7.43e-2)" "unprognostic (7.68e-2)" "unprognostic (4.33e-2)" "unprognostic (1.15e-1)" "unprognostic (1.40e-1)" "unprognostic (2.02e-2)" "prognostic favorable (5.65e-5)" "unprognostic (1.21e-2)" "unprognostic (7.20e-2)" "unprognostic (3.57e-2)" "unprognostic (1.28e-1)" "unprognostic (3.69e-2)" "unprognostic (1.25e-2)" 4.9 4.5 6.2 6.0 7.0 7.8 4.6 24.0 13.3 4.1 4.3 6.5 3.4 3.1 6.2 6.6 4.7 4.0 4.9 59.1 5.9 7.2 4.3 4.0 3.8 4.6 7.2 5.9 5.5 4.5 3.5 7.1 5.2 9.7 3.9 4.5 6.2 4.5 4.5 65.6 9.1 5.4 5.2 8.5 4.9 4.3 5.6 6.1 5.3 3.3 7.5 4.9 3.8 3.7 3.5 2.7 10.9 2.2 2.8 4.1 1.8 6.9 4.3 7.2 5.5 5.3 4.7 5.6 5.4 6.6 5.1 5.8 15.3 4.2 5.0 1.7 6.2 8.0 10.0 7.8 4.1 7.3 3.2 13.1 8.4 19.6 4.1 2.8 12.9 6.3 6.9 6.8 5.7 4.6 3.5 4.3 6.9 4.7 4.8 4.9 4.9 8.7 21.2 4.6 5.0 6.8 9.2 12.0 6.6 3.8 4.5 32.2 7.2 4.1 14.5 4.0 5.3 8.3 6.1 7.1 6.7 9.1 5.1 7.7 14.2 6.0 10.0 15.3 5.7 4.5 10.9 1.9 3.6 3.1 1.7 4.1 3.5 2.8 1.9 2.7 1.9 3.0 1.6 1.5 2.8 2.2 0.3 2.9 1.8 6.2 7.0 24.0 13.3 5.9 7.2 7.2 5.9 9.7 6.1 14.9 17.0 2.7 1.7 5.3 7.7 67.8 0.0 5.3 13.6 3.5 15.7 2.0 1.7 1.6 5.2 4.6 3.6 0.0 1.2 1.1 4.5 2.6 4.7 3.9 1.2 17.5 6.3 6.2 4.0 4.5 6.6 3.5 5.0 0.0 4.3 4.4 1.8 0.0 5.3 2.1 9.9 0.0 3.3 3.4 4.8 6.5 2.2 2.6 3.7 2.5 DDAH1 DDAH ENSG00000153904 "Dimethylarginine dimethylaminohydrolase 1" O94760 1 85318481-85578363 "Enzymes, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 61.6" "Cell type enhanced" "Detected in many" 8 "Proximal tubular cells: 219.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 1.3;naive B-cell: 1.0" "Lineage enhanced" "Detected in single" "B-cells: 1.3" "Cell line enhanced" "Detected in many" "OE19: 36.9;SH-SY5Y: 35.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006308, HPA071064" Enhanced Approved "Nucleoli,Plasma membrane,Cytosol" NA NA 140000 "Plasma membrane, Cytosol" Nucleoli "HPA006308: AB_1847532, HPA071064: " "unprognostic (1.44e-2)" "unprognostic (2.43e-1)" "prognostic favorable (5.99e-4)" "unprognostic (6.82e-2)" "unprognostic (1.04e-1)" "unprognostic (1.62e-2)" "unprognostic (2.55e-1)" "unprognostic (3.85e-2)" "unprognostic (2.57e-1)" "unprognostic (1.02e-2)" "unprognostic (3.62e-2)" "unprognostic (1.56e-1)" "prognostic favorable (5.21e-6)" "unprognostic (5.37e-2)" "unprognostic (9.06e-2)" "unprognostic (5.81e-2)" "unprognostic (1.56e-2)" 4.3 14.3 43.9 5.8 44.9 0.7 6.6 14.4 37.2 7.7 22.1 20.7 4.3 21.1 6.0 33.8 4.9 18.4 12.2 6.4 29.5 24.1 61.6 39.9 11.8 1.1 24.9 37.0 3.4 13.8 13.0 7.2 3.1 13.8 13.1 21.4 4.1 8.5 6.2 13.8 2.8 19.9 7.4 8.1 4.1 15.6 9.3 11.0 0.0 14.1 1.0 1.2 6.0 3.0 1.3 0.4 0.0 0.0 0.0 0.0 0.0 18.3 2.3 6.5 1.2 10.9 9.2 0.8 21.7 13.2 7.7 8.2 26.1 4.9 0.0 9.1 24.6 7.6 5.3 23.5 4.5 9.9 0.0 9.0 0.0 6.2 9.1 3.9 16.7 1.0 7.7 0.4 6.5 4.1 9.8 12.3 0.0 0.0 1.8 19.8 1.5 0.8 0.0 7.8 36.9 6.8 0.0 15.2 0.2 33.0 13.7 18.3 35.6 2.8 16.5 2.6 9.7 8.9 1.2 24.0 6.8 5.5 1.6 15.1 0.0 0.0 0.0 0.3 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 43.9 44.9 14.4 37.2 29.5 24.1 24.9 37.0 13.8 11.0 32.8 31.3 4.2 4.0 12.2 2.7 11.4 68.8 30.8 13.6 66.3 3.9 1.7 106.1 15.6 17.1 4.5 78.7 0.0 26.7 0.8 23.5 37.8 0.0 94.3 0.9 0.0 32.8 9.2 2.2 18.4 14.7 1.5 11.8 1.0 77.8 59.7 34.2 73.6 70.4 219.6 8.0 12.9 18.9 5.0 5.6 12.5 0.7 3.3 85.4 6.5 DDIAS "C11orf82, FLJ25416, FLJ38838, noxin" ENSG00000165490 "DNA damage induced apoptosis suppressor" Q8IXT1 11 82899975-82958277 "Predicted intracellular proteins" "Apoptosis, Cell cycle, Growth arrest" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 17.6;testis: 16.3" "Cell type enhanced" "Detected in some" 12 "Kupffer cells: 5.3;Spermatocytes: 12.0;Spermatogonia: 15.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA038540, HPA038541" Approved Approved "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane, Cytosol" "HPA038540: AB_10672648, HPA038541: AB_2676071" "unprognostic (2.53e-1)" "unprognostic (2.27e-1)" "unprognostic (5.04e-3)" "unprognostic (1.25e-2)" "unprognostic (1.20e-1)" "unprognostic (5.32e-2)" "unprognostic (3.86e-6)" "unprognostic (4.65e-3)" "unprognostic (1.01e-3)" "unprognostic (8.24e-3)" "unprognostic (2.04e-4)" "unprognostic (4.72e-2)" "unprognostic (1.11e-16)" "unprognostic (7.17e-3)" "unprognostic (9.59e-2)" "unprognostic (1.89e-1)" "unprognostic (9.13e-2)" 1.3 1.0 0.8 6.1 0.8 7.0 1.7 0.8 1.2 1.9 2.3 1.2 0.2 1.3 1.5 2.6 5.5 1.0 0.4 2.6 0.9 0.7 1.0 2.3 3.1 5.0 0.8 0.6 1.3 0.9 0.0 0.5 2.5 1.0 0.9 2.0 0.2 2.1 0.2 10.1 2.3 1.9 1.5 0.9 5.5 1.1 16.3 0.9 17.6 0.8 9.5 5.9 1.8 1.8 2.0 4.5 5.8 10.7 1.9 0.7 3.2 6.0 9.6 9.9 7.2 1.0 1.5 7.3 11.5 4.9 12.8 14.9 9.4 7.6 7.4 17.3 2.6 10.1 11.6 16.7 7.2 17.7 13.4 9.0 10.5 4.9 4.2 0.1 12.9 9.3 0.3 0.7 16.1 7.4 1.1 6.0 9.2 10.6 12.8 11.3 8.8 12.1 10.5 11.8 16.7 11.0 9.0 19.2 9.5 2.7 10.1 7.4 10.0 7.1 7.2 2.7 10.1 7.8 5.4 2.8 12.8 17.4 33.7 14.0 7.3 19.1 25.7 4.0 9.3 12.1 0.6 10.7 3.9 0.5 8.3 0.3 1.1 0.3 0.7 4.5 2.0 0.7 0.4 5.8 1.9 7.8 1.4 0.5 3.2 0.8 0.8 0.8 1.2 0.9 0.7 0.8 0.6 1.0 0.9 0.0 0.0 4.6 0.8 0.0 0.0 0.8 2.5 0.0 0.0 0.0 0.0 1.4 0.0 0.5 2.7 0.0 0.0 0.0 0.5 4.3 0.0 0.3 0.0 0.5 2.2 0.0 0.0 1.3 5.3 1.6 0.3 1.6 0.0 0.0 0.2 0.0 0.3 0.0 0.7 0.2 0.0 0.0 0.3 12.0 15.1 0.0 0.2 0.0 0.6 0.9 DDX58 "DKFZp434J1111, FLJ13599, RIG-I" ENSG00000107201 "DExD/H-box helicase 58" O95786 9 32455705-32526324 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" "Helicase, Hydrolase, RNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 45.5;BJ hTERT+ SV40 Large T+ RasG12V: 47.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB012643, HPA047193" Uncertain Approved "Plasma membrane,Cytosol" No No "Plasma membrane" Cytosol "CAB012643: , HPA047193: AB_2679978" "unprognostic (1.10e-1)" "unprognostic (4.65e-2)" "unprognostic (6.56e-2)" "prognostic unfavorable (5.46e-4)" "unprognostic (2.45e-1)" "unprognostic (2.37e-1)" "unprognostic (8.15e-2)" "unprognostic (4.57e-2)" "unprognostic (2.82e-1)" "unprognostic (6.48e-3)" "unprognostic (1.00e-2)" "unprognostic (3.35e-1)" "prognostic unfavorable (4.66e-4)" "unprognostic (2.22e-2)" "unprognostic (3.68e-2)" "unprognostic (1.05e-2)" "unprognostic (1.26e-1)" 27.7 8.2 5.7 14.5 7.9 5.6 11.3 4.2 5.7 9.9 9.5 5.2 9.1 7.2 12.7 11.7 10.8 7.6 10.3 7.1 6.0 5.1 14.7 8.5 13.7 14.3 6.3 4.5 9.2 7.7 6.6 10.2 14.8 7.5 12.1 8.1 5.5 12.4 5.8 8.3 10.7 16.1 10.8 7.7 13.8 8.0 4.5 6.4 35.4 13.0 7.4 9.7 9.9 9.4 4.9 2.0 24.8 5.7 6.1 6.5 3.0 2.9 1.1 1.6 0.9 3.9 4.1 2.5 1.8 8.9 45.5 47.6 1.2 2.6 0.8 3.2 1.6 14.7 2.4 1.8 2.0 6.4 7.3 0.6 2.8 2.5 2.0 3.2 1.8 2.2 2.8 0.7 5.2 1.6 3.5 8.3 2.2 0.6 0.6 6.0 0.4 2.6 4.7 1.3 0.6 1.3 2.4 1.2 0.3 6.9 1.6 1.2 0.8 2.6 1.1 5.0 1.1 1.9 1.6 9.4 1.4 1.3 1.1 0.9 0.1 0.5 0.6 2.0 0.8 0.9 8.5 3.8 10.3 6.2 5.7 5.5 4.8 5.6 5.6 2.0 4.9 5.1 5.6 24.8 6.1 3.9 0.1 6.5 3.0 5.7 7.9 4.2 5.7 6.0 5.1 6.3 4.5 7.5 6.4 20.8 9.1 5.4 4.4 3.8 3.7 4.4 2.5 8.1 6.8 1.8 2.0 4.5 0.0 17.2 2.0 14.5 14.6 0.0 10.6 6.7 5.1 4.6 4.7 6.4 5.0 6.4 2.9 8.6 6.9 0.0 6.1 6.7 0.0 2.8 2.9 9.4 12.8 5.8 5.6 6.5 2.7 6.5 6.6 0.5 1.5 4.6 2.1 9.2 1.9 4.3 DDX60L FLJ31033 ENSG00000181381 "DExD/H-box 60 like" Q5H9U9 4 168356735-168537786 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 22.5" "Group enriched" "Detected in all" 4 "granulocytes: 22.5;monocytes: 7.8" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 23.3" "HPA043211, HPA055501" Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA043211: AB_10794390, HPA055501: AB_2682838" "unprognostic (8.86e-2)" "unprognostic (2.77e-1)" "unprognostic (1.16e-1)" "unprognostic (2.45e-1)" "unprognostic (2.38e-1)" "unprognostic (3.20e-2)" "unprognostic (1.05e-1)" "unprognostic (7.94e-2)" "unprognostic (1.78e-1)" "unprognostic (4.19e-2)" "prognostic unfavorable (3.04e-5)" "unprognostic (1.70e-1)" "prognostic unfavorable (2.94e-4)" "unprognostic (1.13e-1)" "unprognostic (8.80e-2)" "unprognostic (8.93e-2)" "unprognostic (1.69e-1)" 12.7 5.0 2.8 13.1 3.1 33.0 9.9 1.4 3.2 7.2 8.4 3.2 2.7 6.0 9.2 7.9 3.8 6.9 6.7 6.0 2.4 2.4 4.5 6.0 25.8 17.7 3.8 1.4 7.3 5.1 4.4 5.2 32.6 3.4 5.0 6.5 6.8 7.0 5.7 3.3 4.3 14.0 5.3 4.2 11.9 9.5 2.7 3.1 25.3 5.8 3.5 8.1 4.9 6.8 1.6 2.4 22.5 7.8 1.7 3.7 1.6 6.1 3.6 1.4 0.6 3.7 10.8 7.0 6.2 13.1 23.3 16.2 0.0 14.5 0.1 0.3 6.3 12.7 2.4 0.6 3.7 6.8 3.5 0.5 13.6 4.0 0.3 4.5 5.5 3.4 3.0 1.1 8.4 0.7 4.9 16.4 3.1 0.2 0.1 14.9 0.1 4.9 3.5 0.3 0.6 3.1 2.7 3.2 0.0 2.2 3.6 0.2 1.9 11.0 1.3 6.2 0.2 1.0 7.8 17.5 1.2 8.2 2.9 2.1 5.9 0.9 0.0 4.1 16.5 1.8 1.6 4.0 3.5 2.7 6.3 3.7 0.9 2.7 2.7 2.4 1.6 2.2 2.3 22.5 1.7 7.8 0.0 3.6 1.6 2.8 3.1 1.4 3.2 2.4 2.4 3.8 1.4 3.4 3.1 8.9 7.9 0.0 2.1 0.9 1.3 8.1 5.1 12.0 3.4 3.5 21.6 4.5 0.0 6.8 10.7 13.1 11.6 0.0 8.7 29.4 7.0 2.6 8.1 5.4 22.5 0.0 0.0 9.2 23.2 3.6 3.1 29.7 0.0 26.2 13.2 3.2 17.0 14.0 3.9 3.3 16.8 6.5 3.3 0.5 1.3 2.0 5.9 8.7 3.8 1.4 DFFA "DFF-45, DFF1, DFF45, ICAD" ENSG00000160049 "DNA fragmentation factor subunit alpha" O00273 1 10456522-10472526 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002679, HPA018859, HPA019938, HPA025230" Supported Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB002679: , HPA018859: AB_1847622, HPA019938: AB_1847625, HPA025230: AB_1847623" "unprognostic (1.23e-1)" "unprognostic (2.63e-1)" "unprognostic (1.06e-1)" "unprognostic (3.59e-2)" "unprognostic (1.57e-2)" "unprognostic (1.81e-1)" "prognostic unfavorable (9.46e-4)" "unprognostic (1.55e-1)" "unprognostic (9.24e-3)" "unprognostic (3.57e-2)" "unprognostic (1.50e-1)" "unprognostic (1.91e-1)" "prognostic favorable (1.57e-9)" "unprognostic (1.21e-2)" "unprognostic (3.46e-2)" "unprognostic (3.89e-2)" "unprognostic (1.88e-1)" 17.8 19.9 22.9 15.6 23.0 7.9 20.9 20.4 20.7 16.6 15.1 22.5 19.1 16.5 18.4 14.4 24.2 18.6 15.3 17.2 20.7 19.9 23.7 18.9 15.5 15.6 26.4 18.9 22.5 19.8 25.7 17.2 27.2 26.1 17.0 17.3 15.0 16.3 18.4 16.8 14.8 14.7 22.4 24.1 14.8 16.8 13.4 21.9 16.7 18.0 13.0 21.4 18.7 26.1 14.1 10.7 7.2 9.9 14.1 14.4 8.9 14.6 14.6 12.6 14.3 10.7 10.2 6.1 20.9 13.5 21.8 16.3 34.9 19.4 31.3 13.5 17.6 12.2 12.1 24.3 24.8 22.1 12.4 16.8 15.6 15.2 13.9 17.5 19.0 10.4 12.7 12.5 34.4 27.8 12.0 16.6 15.7 27.8 7.1 15.4 18.6 18.7 8.6 11.0 11.1 17.1 16.1 15.1 15.8 19.6 11.3 14.9 14.5 19.5 17.0 23.0 11.4 10.9 6.6 17.3 10.3 14.0 18.8 13.8 8.8 12.3 45.6 10.9 18.1 15.5 1.3 9.9 7.2 14.4 8.0 10.9 14.1 9.7 12.4 9.2 13.7 10.2 12.3 1.5 14.1 9.7 10.7 13.5 8.9 22.9 23.0 20.4 20.7 20.7 19.9 26.4 18.9 26.1 21.9 41.7 29.3 39.4 29.8 30.6 18.3 22.1 28.1 32.1 35.2 17.4 102.1 83.5 31.5 40.0 25.0 27.1 15.1 0.0 33.8 52.0 19.4 20.0 24.3 27.7 36.5 19.1 32.8 30.7 19.8 58.1 27.9 18.5 10.1 44.1 12.4 21.1 39.9 7.0 30.4 45.1 30.9 19.4 20.0 31.2 30.4 35.5 55.5 24.9 25.7 31.2 DHPS MIG13 ENSG00000095059 "Deoxyhypusine synthase" P49366 19 12675717-12681902 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hypusine biosynthesis" Transferase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014461, HPA029413" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA014461: AB_1847651, HPA029413: AB_10602217" "unprognostic (4.17e-2)" "unprognostic (2.55e-2)" "unprognostic (2.05e-2)" "unprognostic (2.61e-1)" "unprognostic (3.10e-1)" "unprognostic (1.01e-2)" "unprognostic (3.06e-1)" "unprognostic (2.42e-1)" "unprognostic (1.85e-1)" "unprognostic (3.59e-2)" "unprognostic (1.20e-2)" "unprognostic (4.85e-2)" "unprognostic (3.05e-2)" "unprognostic (2.46e-3)" "unprognostic (1.32e-1)" "unprognostic (1.56e-1)" "unprognostic (8.83e-2)" 16.4 30.3 26.9 18.6 31.2 17.0 24.8 43.3 38.8 20.7 25.7 27.5 25.3 23.1 20.9 16.9 21.3 32.3 18.2 26.0 26.3 28.0 23.4 30.3 18.9 24.2 27.5 28.0 34.8 32.0 28.8 32.6 23.2 22.4 24.1 24.5 20.2 24.8 24.6 65.1 25.6 21.5 24.5 29.1 19.5 24.2 13.3 26.3 31.9 24.9 22.9 26.9 23.5 19.2 39.6 29.5 35.8 30.5 27.8 38.1 29.7 20.6 15.3 24.8 13.1 11.1 18.5 5.8 13.3 19.5 25.4 25.6 10.9 10.1 21.4 15.1 14.5 23.4 12.6 17.0 18.8 17.6 18.8 12.0 14.3 16.7 14.2 13.7 17.1 22.9 14.8 23.2 15.3 26.5 25.8 17.8 42.8 13.0 15.3 18.5 41.1 30.4 24.8 19.4 27.0 26.0 20.2 9.3 30.9 19.5 11.1 32.4 43.9 13.4 19.5 22.6 15.7 18.0 28.6 8.9 29.9 12.1 29.2 20.2 48.8 52.5 14.5 18.4 21.0 28.2 14.5 27.0 35.8 24.7 24.2 25.9 39.6 28.9 25.6 29.0 36.9 38.1 28.1 9.7 27.8 30.5 29.5 34.3 29.7 26.9 31.2 43.3 38.8 26.3 28.0 27.5 28.0 22.4 26.3 38.7 21.2 44.9 67.5 49.3 77.6 7.7 22.9 34.8 9.1 31.4 43.2 43.4 72.9 48.6 15.6 35.9 36.2 0.0 32.3 43.6 36.5 53.0 23.1 29.4 38.0 39.7 39.6 18.4 36.3 21.8 41.7 38.3 47.2 71.3 54.9 114.9 45.5 63.3 32.5 75.5 92.9 45.3 55.6 29.6 70.0 44.5 60.1 50.3 52.4 59.7 DHRS7B "CGI-93, DKFZp566O084, MGC8916, SDR32C1" ENSG00000109016 "Dehydrogenase/reductase 7B" Q6IAN0 17 21123364-21193265 "Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012132, HPA016873" Uncertain Approved "Plasma membrane,Cell Junctions,Cytosol" NA NA "Plasma membrane, Cell Junctions, Cytosol" "HPA012132: AB_1847658, HPA016873: AB_1847657" "unprognostic (1.90e-1)" "unprognostic (3.16e-2)" "unprognostic (2.71e-1)" "prognostic favorable (1.98e-8)" "unprognostic (9.83e-2)" "unprognostic (1.18e-1)" "unprognostic (3.46e-1)" "unprognostic (1.45e-1)" "unprognostic (5.02e-3)" "unprognostic (2.76e-1)" "unprognostic (1.70e-1)" "unprognostic (2.81e-1)" "prognostic favorable (3.95e-5)" "unprognostic (1.20e-2)" "unprognostic (6.26e-2)" "unprognostic (9.20e-2)" "unprognostic (3.97e-1)" 15.9 17.8 14.0 10.3 14.5 2.5 16.2 11.1 15.2 17.6 14.2 11.9 16.7 14.4 13.5 25.3 12.8 15.4 16.3 17.9 11.8 13.2 23.1 18.4 13.9 14.0 14.5 14.8 11.8 18.9 31.2 11.4 14.2 12.9 14.8 15.2 16.5 17.5 10.5 23.7 15.7 18.3 12.7 11.1 11.5 14.7 30.5 9.1 8.0 19.7 15.8 10.9 10.7 12.8 4.2 11.7 15.0 20.4 4.1 5.7 7.5 8.6 10.2 3.7 8.1 10.0 6.8 6.5 8.2 4.6 6.0 11.0 12.8 9.1 3.6 12.6 7.0 4.7 12.2 5.4 13.5 8.5 6.9 17.6 5.0 7.5 11.0 5.5 2.7 3.7 5.3 9.0 7.7 11.7 3.0 5.8 6.4 3.0 4.5 7.0 17.7 3.0 10.8 5.2 28.1 4.4 5.0 9.9 6.3 20.0 10.5 2.0 4.4 10.2 9.1 8.8 31.4 6.1 5.7 2.9 5.0 3.5 15.1 9.3 2.5 3.8 6.7 7.9 10.3 7.5 9.7 18.9 15.0 3.8 17.9 3.4 4.2 3.8 2.5 11.7 3.6 4.1 3.6 13.5 4.1 20.4 5.0 5.7 7.5 14.0 14.5 11.1 15.2 11.8 13.2 14.5 14.8 12.9 9.1 14.9 14.9 16.4 24.6 14.4 20.5 12.2 25.5 28.1 14.8 27.9 29.5 44.8 14.9 40.1 48.5 21.9 30.7 23.3 34.3 26.4 19.3 22.8 8.1 16.3 25.9 17.5 6.9 28.8 12.3 16.2 20.8 11.7 18.6 19.8 19.0 29.9 27.5 22.4 32.9 21.4 35.7 6.5 16.9 44.2 20.3 16.3 43.1 16.6 21.2 17.9 DIAPH1 "DFNA1, hDIA1, LFHL1" ENSG00000131504 "Diaphanous related formin 1" O60610 5 141515016-141619055 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" Hearing Actin-binding "Cancer-related genes, Deafness, Disease mutation, Epilepsy, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 79.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 106.8" "Low region specificity" "Detected in all" "HPA004916, HPA076913" Approved Approved "Plasma membrane" NA NA 10000000 "Plasma membrane" "HPA004916: AB_1847668, HPA076913: " "unprognostic (6.79e-2)" "unprognostic (2.99e-1)" "unprognostic (2.12e-3)" "unprognostic (3.73e-2)" "unprognostic (4.18e-2)" "unprognostic (1.54e-1)" "unprognostic (2.08e-1)" "unprognostic (4.54e-3)" "unprognostic (2.03e-1)" "unprognostic (1.27e-2)" "prognostic unfavorable (7.81e-5)" "unprognostic (2.88e-3)" "prognostic favorable (1.29e-5)" "unprognostic (1.64e-2)" "unprognostic (1.84e-2)" "unprognostic (7.00e-2)" "unprognostic (1.65e-1)" 14.5 10.0 5.2 22.3 10.4 27.9 10.6 8.8 7.8 11.6 17.1 3.9 11.4 14.2 9.9 16.8 26.5 9.1 15.7 21.3 5.1 6.3 30.1 48.7 22.4 21.7 3.8 4.3 9.7 20.2 17.6 22.1 28.2 7.2 7.8 11.0 8.8 18.0 13.8 79.8 19.1 24.1 9.6 3.4 20.2 15.5 12.1 2.9 44.2 14.9 23.8 34.1 12.3 13.3 5.9 8.6 19.2 9.3 8.2 22.7 9.3 25.7 16.7 9.7 12.8 7.8 10.5 13.4 10.6 11.3 12.4 13.0 57.1 24.7 28.8 16.3 15.6 19.7 28.8 21.6 36.1 15.7 15.5 12.0 49.8 22.1 18.6 7.4 34.6 106.8 6.7 19.2 17.8 18.0 5.7 16.2 44.1 17.5 20.3 12.2 25.2 38.4 45.2 9.6 13.6 11.1 43.2 16.0 15.9 23.8 28.5 12.9 6.9 26.3 35.0 10.5 9.1 14.6 16.8 9.4 17.5 9.3 9.6 21.5 10.2 16.2 20.0 9.5 27.8 10.8 12.7 8.6 19.2 22.7 9.2 15.2 5.9 14.4 17.6 8.6 5.0 10.5 17.3 9.4 8.2 9.3 6.6 11.9 9.3 5.2 10.4 8.8 7.8 5.1 6.3 3.8 4.3 7.2 2.9 44.7 41.4 32.0 39.1 46.8 17.7 17.9 22.9 24.1 60.3 41.8 51.1 15.3 5.0 57.1 16.9 35.0 40.0 0.0 84.2 26.5 20.2 67.6 45.1 77.8 16.2 6.4 5.2 9.2 34.1 6.8 10.9 53.5 18.6 17.2 18.0 10.9 93.8 28.1 10.3 13.0 72.6 12.9 19.6 15.4 23.7 52.1 43.6 55.8 23.9 92.4 DIO2 "SelY, TXDI2" ENSG00000211448 "Iodothyronine deiodinase 2" Q92813 14 80197527-80387757 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Thyroid hormones biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 67.7;thyroid gland: 128.7" "Group enriched" "Detected in many" 14 "Extravillous trophoblasts: 495.6;Muller glia cells: 220.7" "Cancer enhanced" "Detected in many" "thyroid cancer: 34.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 26.7;fHDF/TERT166: 14.7;HeLa: 30.6;HHSteC: 15.2;SiHa: 55.9;SK-BR-3: 11.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048002 Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Nucleoplasm, Vesicles" "Plasma membrane" "HPA048002: AB_2680230" "unprognostic (1.22e-1)" "unprognostic (1.69e-1)" "prognostic favorable (1.67e-4)" "prognostic favorable (4.62e-6)" "unprognostic (2.76e-1)" "unprognostic (1.22e-1)" "unprognostic (2.22e-1)" "unprognostic (2.17e-1)" "unprognostic (2.07e-1)" "unprognostic (8.78e-2)" "unprognostic (3.68e-2)" "unprognostic (2.48e-1)" "unprognostic (1.00e-3)" "unprognostic (5.08e-2)" "unprognostic (3.43e-1)" "unprognostic (8.40e-2)" "unprognostic (7.15e-2)" 1.3 1.8 13.0 0.9 12.3 0.7 6.1 1.0 19.7 67.7 1.2 1.6 1.9 1.2 15.6 1.1 36.1 0.9 2.5 4.7 14.2 2.7 2.4 0.7 1.2 1.0 4.1 7.6 0.7 1.3 0.9 35.9 5.9 13.2 5.0 1.3 13.1 17.7 12.4 3.0 3.3 1.2 2.4 1.2 0.9 2.5 2.5 1.4 0.0 128.7 15.8 12.0 2.6 13.7 0.0 0.1 0.7 0.1 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.1 0.4 0.0 26.7 5.7 2.4 0.3 0.0 0.1 0.0 0.1 14.7 0.1 0.5 0.9 0.0 1.9 0.0 0.0 0.0 30.6 0.0 15.2 0.0 0.0 1.7 0.0 0.5 0.0 1.3 0.5 0.0 0.0 0.2 0.1 0.6 0.0 0.0 0.5 0.0 0.1 0.2 1.2 0.0 0.0 0.2 0.0 0.0 55.9 11.7 0.1 2.5 0.0 0.0 0.3 0.1 2.4 5.6 6.7 0.9 0.0 0.0 2.5 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 13.0 12.3 1.0 19.7 14.2 2.7 4.1 7.6 13.2 1.4 0.0 0.3 0.0 0.1 2.6 2.9 1.1 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 18.5 1.4 0.0 0.0 0.0 495.6 26.0 0.2 0.0 0.0 8.2 1.6 0.0 0.6 1.0 9.6 3.1 0.3 5.0 0.0 0.0 220.7 0.6 0.0 3.9 0.0 6.2 0.0 8.2 3.3 0.6 2.6 23.6 0.0 0.0 0.0 DIS3L "DIS3L1, FLJ38088, KIAA1955, MGC4562" ENSG00000166938 "DIS3 like exosome 3'-5' exoribonuclease" Q8TF46 15 66293217-66333898 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041805 Approved Supported "Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane, Cytosol" Centrosome "HPA041805: AB_10796783" "unprognostic (2.57e-1)" "unprognostic (5.37e-2)" "unprognostic (1.12e-1)" "unprognostic (3.99e-2)" "unprognostic (3.16e-1)" "unprognostic (1.40e-1)" "unprognostic (1.68e-1)" "unprognostic (2.94e-2)" "unprognostic (2.27e-2)" "unprognostic (1.28e-2)" "unprognostic (1.59e-3)" "unprognostic (1.86e-1)" "unprognostic (3.42e-3)" "unprognostic (2.66e-1)" "unprognostic (6.18e-2)" "unprognostic (9.58e-2)" "unprognostic (3.40e-1)" 13.7 15.4 18.7 14.7 16.6 11.8 14.5 15.7 16.4 13.7 11.8 20.7 19.1 9.0 14.7 15.5 10.6 15.5 10.0 20.1 17.3 17.0 14.2 15.2 10.8 14.0 19.4 10.8 16.2 24.4 24.9 18.9 9.0 17.7 14.7 10.3 15.4 14.4 16.3 29.4 9.4 9.0 15.2 19.6 11.1 10.5 15.4 14.0 19.3 18.0 9.4 12.8 12.5 9.7 9.1 10.5 7.8 13.1 14.1 13.2 8.0 8.6 19.6 5.9 7.8 7.4 10.1 8.3 6.4 7.0 9.5 8.0 9.6 5.8 30.6 7.0 7.7 8.4 14.6 14.6 5.1 7.0 8.0 13.4 18.0 12.7 10.9 5.6 17.4 6.3 4.1 5.8 2.6 8.5 5.5 7.3 9.9 10.4 7.4 8.5 6.3 7.8 10.2 9.3 6.9 10.8 11.7 25.5 17.9 3.1 9.8 10.1 9.8 13.0 4.3 7.2 5.9 6.4 11.6 9.5 11.0 10.4 4.5 11.0 6.5 20.3 14.7 3.7 23.0 4.4 7.8 5.9 5.1 9.9 7.1 12.8 8.5 9.5 13.2 10.5 9.1 11.6 9.6 0.7 14.1 13.1 7.5 8.8 8.0 18.7 16.6 15.7 16.4 17.3 17.0 19.4 10.8 17.7 14.0 6.0 14.4 12.9 4.8 3.8 15.3 28.6 17.8 10.7 9.1 3.5 3.9 14.6 5.0 4.9 5.0 7.1 4.3 0.0 3.1 3.8 8.8 4.7 16.1 15.7 8.3 9.5 2.9 3.7 8.2 7.9 18.4 10.3 1.7 10.0 8.9 16.6 3.3 5.8 19.1 8.4 19.5 19.4 8.5 27.9 15.2 4.6 3.1 10.4 13.5 2.7 DLG2 "chapsyn-110, PPP1R58, PSD-93, PSD93" ENSG00000150672 "Discs large MAGUK scaffold protein 2" Q15700 11 83455012-85627922 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 44.7" "Group enriched" "Detected in many" 5 "Bipolar cells: 223.8;Cone photoreceptor cells: 259.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive B-cell: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 7.5;CACO-2: 4.7;NTERA-2: 5.2;SCLC-21H: 5.2;SH-SY5Y: 7.8;SK-BR-3: 4.7;SuSa: 6.6;T-47d: 19.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021307, HPA023896, CAB072341" Enhanced Approved Approved "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "CAB072341: , HPA021307: AB_1846625, HPA023896: AB_2671353" "unprognostic (2.61e-3)" "unprognostic (2.81e-2)" "unprognostic (4.05e-2)" "unprognostic (9.03e-2)" "unprognostic (3.25e-1)" "unprognostic (1.09e-1)" "unprognostic (9.44e-3)" "unprognostic (7.78e-2)" "unprognostic (4.32e-1)" "unprognostic (4.61e-2)" "unprognostic (9.28e-3)" "unprognostic (4.84e-1)" "unprognostic (7.66e-6)" "unprognostic (2.92e-2)" "unprognostic (2.41e-1)" "unprognostic (6.52e-2)" "unprognostic (8.89e-2)" 1.4 11.0 20.0 1.4 30.7 0.7 2.5 9.3 44.7 2.4 1.7 39.5 0.6 1.5 3.3 4.4 7.8 6.0 2.3 2.8 19.9 9.9 3.7 2.8 1.9 1.3 28.7 21.2 6.2 3.3 14.6 7.9 2.7 25.7 4.3 1.5 2.9 3.1 5.4 1.2 19.5 1.5 2.6 19.7 2.6 1.5 6.6 37.3 0.0 15.6 0.0 2.9 1.5 2.1 1.3 0.5 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.5 0.0 0.0 0.1 7.5 0.0 0.0 0.0 0.0 4.7 0.1 0.0 0.1 0.0 0.1 0.2 1.4 0.0 0.0 0.0 0.1 0.0 4.2 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.4 0.0 0.1 5.2 0.0 0.0 0.0 0.7 0.4 0.0 0.0 5.2 7.8 0.0 4.7 0.0 6.6 19.3 0.0 0.0 0.3 0.9 0.2 0.0 0.0 0.0 3.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.3 0.0 0.0 0.0 0.5 0.0 0.2 20.0 30.7 9.3 34.9 19.9 9.9 28.7 21.2 25.7 37.3 3.0 7.2 0.0 3.1 3.0 223.8 7.2 0.0 1.4 3.4 7.0 259.2 6.2 8.3 0.7 16.5 2.8 0.9 0.0 0.4 0.4 3.3 2.5 0.0 3.8 3.0 22.3 4.1 0.6 0.3 12.1 7.2 0.0 1.7 1.0 0.1 17.1 0.3 0.0 6.0 2.3 52.8 6.5 1.9 8.1 3.3 7.4 1.7 1.0 0.4 0.9 DLGAP3 "DAP3, SAPAP3" ENSG00000116544 "DLG associated protein 3" O95886 1 34865436-34929585 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 28.7" "Cell type enhanced" "Detected in some" 11 "Early spermatids: 11.5;Hofbauer cells: 7.8;Horizontal cells: 20.6;Late spermatids: 13.7" "Group enriched" "Detected in some" 5 "endometrial cancer: 1.0;glioma: 1.5;ovarian cancer: 1.9;testis cancer: 5.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 3.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 9.6;NTERA-2: 5.2;SCLC-21H: 15.5;SH-SY5Y: 3.0" "Group enriched" "Detected in all" 4 "amygdala: 128.4;basal ganglia: 124.0;cerebral cortex: 122.6;hippocampal formation: 84.0;thalamus: 55.9" "Low region specificity" "Detected in all" "HPA026445, HPA027304" Enhanced Approved "Endoplasmic reticulum,Plasma membrane,Midbody" NA NA "Endoplasmic reticulum" "Plasma membrane, Midbody" "HPA026445: AB_1847733, HPA027304: " "unprognostic (8.63e-2)" "unprognostic (8.58e-2)" "unprognostic (1.48e-1)" "unprognostic (5.77e-7)" "unprognostic (4.01e-2)" "unprognostic (5.51e-2)" "unprognostic (2.95e-2)" "unprognostic (8.78e-2)" "unprognostic (2.66e-1)" "unprognostic (1.69e-1)" "unprognostic (1.27e-4)" "unprognostic (2.13e-1)" "unprognostic (1.97e-2)" "unprognostic (6.12e-2)" "unprognostic (1.47e-1)" "unprognostic (2.26e-1)" "unprognostic (2.21e-1)" 1.3 1.5 17.4 1.8 20.0 2.8 1.1 14.6 28.7 0.9 1.2 3.3 0.0 1.4 1.0 1.0 0.9 1.0 1.1 1.0 17.7 5.5 1.3 1.0 1.1 1.4 5.4 9.6 1.0 2.2 1.0 1.9 1.0 2.3 1.0 1.0 0.7 1.1 1.5 1.0 1.1 1.3 1.0 1.1 2.5 1.3 6.7 5.0 0.0 1.0 0.0 1.2 1.0 0.0 0.3 3.2 0.4 2.3 0.1 0.8 0.9 0.1 0.3 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.2 9.6 0.2 0.0 1.2 0.0 1.6 0.0 0.0 0.2 0.2 0.7 0.3 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.2 0.0 1.6 0.0 0.0 5.2 0.0 0.0 0.5 0.0 0.2 0.0 0.5 15.5 3.0 0.1 0.1 0.0 0.2 0.3 0.1 0.1 0.1 1.7 0.0 0.0 0.2 0.3 1.9 0.1 0.1 0.1 0.4 2.3 0.0 0.2 1.4 0.8 0.3 0.5 0.5 3.2 0.3 0.2 0.8 0.0 0.1 0.1 0.9 0.7 0.9 17.4 20.0 14.6 22.4 17.7 5.5 5.4 9.6 2.3 5.0 0.0 0.0 0.0 0.6 0.2 4.0 1.1 0.0 0.0 0.0 1.8 3.9 0.1 3.3 0.4 11.5 0.1 0.8 0.0 0.5 0.2 0.2 0.2 0.0 0.0 7.8 20.6 1.2 0.0 7.3 13.7 0.9 1.0 0.0 0.0 0.2 1.3 0.3 0.0 0.0 0.7 2.2 0.0 0.1 2.7 3.4 0.3 0.0 0.8 0.7 0.1 DLL3 SCDO1 ENSG00000090932 "Delta like canonical Notch ligand 3" Q9NYJ7 19 39498895-39508481 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Notch signaling pathway" "Developmental protein" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 38.5" "Cell type enriched" "Detected in some" 6 "Spermatogonia: 37.2" "Group enriched" "Detected in many" 11 "glioma: 29.2;melanoma: 15.5;testis cancer: 8.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 5.4;naive CD8 T-cell: 3.3" "Group enriched" "Detected in many" 13 "B-cells: 5.4;T-cells: 3.3" "Cell line enriched" "Detected in some" 5 "SK-MEL-30: 42.1" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA056533 Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA056533: " "unprognostic (2.52e-1)" "unprognostic (3.81e-1)" "unprognostic (3.13e-2)" "prognostic unfavorable (2.94e-4)" "unprognostic (9.85e-2)" "unprognostic (1.41e-2)" "unprognostic (1.65e-3)" "unprognostic (1.85e-1)" "unprognostic (4.82e-2)" "unprognostic (6.58e-2)" "unprognostic (1.06e-2)" "unprognostic (4.20e-2)" "unprognostic (3.82e-4)" "unprognostic (4.94e-2)" "unprognostic (5.13e-2)" "unprognostic (4.15e-2)" "unprognostic (2.97e-1)" 0.6 0.6 8.9 0.7 10.1 0.6 0.6 1.4 38.5 0.5 0.6 10.3 0.0 0.5 0.6 0.5 0.5 0.5 0.5 0.6 6.5 6.8 0.5 0.6 0.6 0.7 4.5 1.9 0.6 0.5 0.6 3.2 0.5 4.3 0.6 0.5 0.0 0.6 0.5 0.5 0.6 0.6 0.5 3.6 0.6 0.6 1.2 2.3 0.0 0.7 0.0 0.6 0.6 0.0 5.4 0.3 0.0 0.0 0.0 3.3 0.4 0.0 2.0 0.4 1.0 0.0 0.0 0.3 0.5 0.0 0.3 0.1 0.3 0.4 0.0 2.0 0.0 0.8 0.0 1.2 0.5 0.1 0.6 3.1 0.1 0.0 0.2 0.1 0.5 2.4 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.5 0.0 0.2 0.0 0.1 0.0 0.4 0.0 3.2 0.3 0.1 0.1 0.1 0.1 7.4 7.6 1.5 0.0 42.1 0.1 0.0 0.1 0.0 0.0 1.4 0.1 0.5 0.7 0.0 0.4 0.0 0.2 1.2 0.0 0.0 0.0 0.9 0.0 0.4 5.4 0.2 1.3 0.3 1.2 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.4 8.9 10.1 1.4 4.8 6.5 6.8 4.5 1.9 4.3 2.3 0.0 0.0 0.0 0.2 0.2 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.5 0.0 0.0 0.0 0.5 0.4 0.0 0.2 0.0 0.0 0.2 0.0 2.9 0.0 0.0 1.6 1.1 0.0 1.7 0.0 0.0 0.5 0.2 0.0 1.4 0.0 0.6 6.5 0.0 5.4 37.2 0.1 0.2 0.0 0.0 0.0 DMWD "D19S593E, DMR-N9, gene59" ENSG00000185800 "DM1 locus, WD repeat containing" Q09019 19 45782947-45792802 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 56.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA068172, HPA069843" Approved Approved "Plasma membrane,Actin filaments" NA NA "Plasma membrane, Actin filaments" "HPA068172: AB_2685964, HPA069843: AB_2686212" "unprognostic (6.49e-2)" "unprognostic (3.35e-1)" "unprognostic (1.03e-2)" "unprognostic (1.65e-3)" "unprognostic (3.10e-2)" "unprognostic (2.39e-1)" "prognostic unfavorable (1.47e-4)" "unprognostic (5.11e-3)" "unprognostic (7.61e-2)" "unprognostic (7.26e-3)" "unprognostic (1.31e-2)" "unprognostic (2.16e-1)" "unprognostic (1.81e-1)" "unprognostic (1.85e-1)" "unprognostic (1.97e-1)" "unprognostic (1.18e-2)" "unprognostic (4.59e-2)" 20.1 15.5 24.2 12.9 29.4 7.3 11.0 17.1 34.2 12.1 17.7 19.2 6.6 10.8 21.7 9.0 13.2 14.5 16.6 29.0 20.2 16.2 9.6 5.8 13.6 11.5 17.8 19.1 17.0 13.4 13.7 20.3 16.7 18.8 14.7 8.7 14.8 13.6 14.9 31.8 13.1 10.4 16.9 9.9 15.0 13.1 17.8 16.7 11.2 11.8 6.7 8.5 14.6 11.8 4.3 0.7 1.8 1.9 4.8 3.8 0.9 17.0 19.1 17.3 12.0 10.6 13.5 13.3 15.1 10.6 13.4 12.2 11.3 9.6 7.2 8.8 16.9 16.4 13.0 9.0 7.4 7.0 21.2 16.9 6.2 19.0 9.8 13.2 0.7 10.1 12.6 9.2 12.5 17.9 15.4 11.5 4.6 15.1 16.4 10.5 14.1 8.6 4.9 7.8 11.3 12.5 8.9 6.2 7.9 8.3 16.4 17.3 19.3 16.1 12.6 10.7 8.0 10.9 4.2 24.1 15.5 15.4 10.3 22.3 23.6 14.5 8.2 16.2 1.1 18.0 1.3 0.7 0.5 3.8 1.6 3.0 1.7 3.2 3.0 0.7 4.3 1.2 2.4 1.8 4.8 1.9 0.6 1.9 0.9 24.2 29.4 17.1 34.2 20.2 16.2 17.8 19.1 18.8 16.7 6.0 6.6 1.5 12.2 7.4 31.0 23.8 10.2 4.0 3.4 8.7 56.9 6.0 5.0 6.2 15.1 13.0 8.6 23.3 9.1 8.1 11.8 9.7 11.5 5.4 1.6 49.3 25.2 17.8 4.3 46.1 15.8 1.5 5.0 0.0 8.7 25.5 10.8 5.8 15.9 6.2 37.8 12.9 12.3 8.6 12.3 6.0 4.6 5.0 6.9 9.5 DNAAF1 "CILD13, FLJ25330, LRRC50, ODA7, swt" ENSG00000154099 "Dynein axonemal assembly factor 1" Q8NEP3 16 84145287-84178767 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 21.3;testis: 49.6" "Cell type enriched" "Detected in many" 4 "Ciliated cells: 520.6" "Cancer enhanced" "Detected in many" "endometrial cancer: 3.1" "Group enriched" "Detected in many" 5 "amygdala: 3.5;basal ganglia: 9.4;hippocampal formation: 4.6;hypothalamus: 6.5;pons and medulla: 11.1" "Cell type enhanced" "Detected in some" "neutrophil: 5.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Hep G2: 3.5;Karpas-707: 8.8;PC-3: 2.7;SK-BR-3: 2.5;U-266/70: 7.4;U-266/84: 4.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" "HPA041166, HPA074239" Enhanced Approved "Nuclear speckles,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "Nuclear speckles" "HPA041166: AB_10794190, HPA074239: AB_2732250" "unprognostic (5.25e-3)" "unprognostic (2.40e-2)" "unprognostic (2.77e-2)" "prognostic favorable (2.14e-4)" "unprognostic (1.42e-1)" "unprognostic (9.99e-2)" "unprognostic (1.25e-1)" "unprognostic (4.48e-2)" "unprognostic (7.71e-2)" "unprognostic (1.58e-1)" "unprognostic (3.31e-5)" "unprognostic (2.70e-2)" "unprognostic (4.61e-3)" "unprognostic (1.77e-1)" "unprognostic (1.56e-1)" "unprognostic (1.27e-4)" "unprognostic (7.51e-4)" 0.8 1.2 3.5 0.6 9.4 1.5 0.5 0.1 1.5 2.1 0.6 5.3 1.5 0.4 1.0 13.3 0.9 21.3 0.5 0.4 4.6 6.5 0.7 2.0 3.7 0.9 0.5 1.5 4.2 0.4 0.7 6.1 1.5 11.1 0.4 0.4 0.9 0.5 0.6 0.6 0.5 0.6 0.4 1.0 7.2 0.5 49.6 1.2 0.0 1.2 0.0 0.4 0.8 0.0 0.5 1.0 5.5 0.8 0.9 2.1 0.9 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 3.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.3 0.0 0.1 1.3 0.2 0.0 0.0 2.5 0.1 0.1 0.9 0.0 0.0 0.4 0.0 0.0 0.0 7.4 4.8 0.7 0.2 0.4 0.0 3.6 0.8 0.4 0.4 0.6 0.1 0.0 0.2 0.1 0.4 0.5 0.8 0.8 5.5 0.9 0.4 1.0 2.1 0.9 3.5 9.4 0.1 1.5 4.6 6.5 0.5 1.5 11.1 1.2 0.0 17.2 2.2 1.6 0.6 1.4 0.6 2.5 520.6 108.1 3.5 51.1 0.2 0.0 1.0 67.6 1.4 0.0 0.0 0.3 0.4 0.9 0.8 3.5 0.4 1.9 0.0 0.0 3.1 2.7 16.2 1.1 4.8 82.7 1.0 0.0 2.1 1.3 0.0 0.4 0.7 53.5 0.0 0.4 118.6 19.6 0.3 0.3 0.0 0.0 0.7 DNAAF4 "CILD25, DYX1C1, EKN1, FLJ37882" ENSG00000256061 "Dynein axonemal assembly factor 4" Q8WXU2 15 55410525-55508234 "Disease related genes, Predicted intracellular proteins" Neurogenesis "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 26.6" "Cell type enriched" "Detected in some" 7 "Ciliated cells: 187.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 17.1" "Low region specificity" "Detected in all" HPA051048 Uncertain Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA051048: AB_2681325" "unprognostic (5.97e-4)" "unprognostic (3.60e-2)" "unprognostic (1.69e-1)" "unprognostic (7.45e-4)" "unprognostic (1.74e-1)" "unprognostic (5.30e-3)" "unprognostic (4.05e-2)" "unprognostic (3.08e-2)" "unprognostic (8.24e-2)" "unprognostic (2.91e-1)" "unprognostic (9.47e-2)" "unprognostic (1.75e-1)" "unprognostic (5.29e-2)" "unprognostic (3.85e-2)" "unprognostic (3.06e-2)" "unprognostic (1.34e-1)" "unprognostic (1.84e-1)" 1.8 3.0 11.4 1.8 14.7 1.6 4.9 1.8 8.0 4.3 2.1 3.2 5.9 1.1 7.0 15.3 1.8 15.7 3.4 1.6 9.2 7.8 7.2 1.0 6.2 1.5 4.2 8.9 4.8 3.5 13.6 26.6 1.2 9.1 3.2 1.5 6.9 2.4 3.2 1.3 2.4 1.3 3.1 3.7 2.0 1.7 14.6 4.5 0.1 14.3 0.9 1.3 2.8 2.0 2.9 4.2 4.3 1.8 0.7 1.1 0.4 6.5 4.4 4.7 10.1 1.9 3.3 1.5 0.9 2.4 3.1 3.6 0.9 2.6 0.5 4.2 2.0 5.0 1.8 1.8 2.6 3.7 2.0 2.1 2.3 2.8 1.5 1.8 5.0 4.1 2.0 5.5 7.5 2.8 4.9 7.0 2.1 0.7 0.3 4.6 2.3 0.9 4.3 2.6 10.1 3.6 0.8 2.3 0.8 17.1 2.3 4.8 10.5 4.3 1.1 5.8 4.4 6.0 1.2 2.3 5.0 2.5 4.1 4.8 1.8 4.8 1.4 8.2 1.0 1.1 0.0 1.8 1.3 0.6 1.2 0.4 2.9 0.9 0.7 1.2 2.6 1.1 0.8 4.3 0.7 1.2 4.2 0.9 0.4 11.4 14.7 1.8 8.0 9.2 7.8 4.2 8.9 9.1 4.5 11.9 15.9 0.0 0.0 0.0 0.0 0.0 0.0 187.4 28.4 12.2 0.0 1.6 5.0 11.3 0.0 0.0 0.0 0.0 4.4 1.1 0.0 0.0 2.3 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 3.9 0.0 0.0 19.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 DNAH17 "DNAHL1, DNEL2, FLJ40457" ENSG00000187775 "Dynein axonemal heavy chain 17" Q9UFH2 17 78423697-78577394 "Predicted intracellular proteins" "Motor protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 45 "testis: 39.4" "Cell type enhanced" "Detected in some" 19 "Bipolar cells: 44.2;Cone photoreceptor cells: 82.5;Early spermatids: 36.7;Late spermatids: 24.9" "Cancer enhanced" "Detected in some" "head and neck cancer: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HeLa: 10.0;MOLT-4: 4.8" "Not detected" "Not detected" "HPA024354, HPA076261" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane" Cytosol "HPA024354: AB_1847911, HPA076261: AB_2732305" "unprognostic (4.98e-4)" "unprognostic (2.26e-1)" "unprognostic (2.30e-3)" "unprognostic (8.70e-3)" "unprognostic (6.66e-2)" "unprognostic (9.23e-2)" "unprognostic (3.72e-3)" "unprognostic (8.41e-2)" "unprognostic (2.66e-1)" "unprognostic (1.11e-1)" "unprognostic (1.20e-3)" "unprognostic (8.35e-3)" "unprognostic (1.58e-10)" "unprognostic (5.25e-2)" "unprognostic (1.54e-1)" "unprognostic (5.12e-1)" "unprognostic (6.04e-3)" 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.8 0.1 0.0 39.4 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.1 1.0 0.0 10.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.1 4.8 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.1 0.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 6.0 0.3 0.5 0.2 0.6 44.2 2.0 0.0 0.0 0.0 0.0 82.5 0.0 0.0 0.0 36.7 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 1.2 24.9 0.6 1.3 0.0 0.0 0.0 0.8 0.1 0.0 0.4 0.0 7.2 0.0 0.2 16.2 0.5 0.1 0.0 0.0 0.0 0.1 DNAJA4 PRO1472 ENSG00000140403 "DnaJ heat shock protein family (Hsp40) member A4" Q8WW22 15 78264086-78282196 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 63.2;skeletal muscle: 69.0" "Group enriched" "Detected in many" 5 "Early spermatids: 661.6;Late spermatids: 1220.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 17.7;HeLa: 18.6;RT4: 34.6;SCLC-21H: 22.3;SiHa: 17.4;THP-1: 16.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004646, HPA041790" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB004646: AB_426011, HPA041790: AB_2677674" "unprognostic (8.41e-2)" "unprognostic (2.48e-1)" "unprognostic (3.00e-2)" "unprognostic (8.20e-3)" "unprognostic (1.14e-3)" "unprognostic (1.99e-1)" "unprognostic (2.28e-2)" "unprognostic (2.46e-1)" "unprognostic (5.86e-2)" "unprognostic (7.78e-2)" "unprognostic (2.31e-2)" "unprognostic (1.28e-1)" "prognostic favorable (1.08e-7)" "unprognostic (1.89e-1)" "unprognostic (2.84e-1)" "unprognostic (9.01e-2)" "unprognostic (2.93e-2)" 7.3 10.1 29.6 7.6 33.7 28.6 7.6 20.1 25.8 8.6 8.7 10.5 10.4 7.8 5.1 25.3 9.1 21.7 6.6 63.2 22.3 33.8 7.7 1.9 7.0 6.0 26.0 28.1 3.6 3.2 9.5 11.9 5.5 29.2 15.4 10.6 7.2 6.8 9.6 69.0 15.5 9.0 10.7 16.0 5.1 10.8 26.8 14.9 2.0 6.3 15.2 6.9 12.6 62.3 1.9 1.1 2.7 1.0 0.4 4.7 1.6 13.3 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.5 0.2 0.0 17.7 0.0 0.1 1.3 0.0 12.8 0.0 0.0 0.0 0.0 0.0 7.9 18.6 0.0 4.0 0.0 8.6 1.5 1.7 1.0 0.0 0.0 2.7 0.0 0.0 0.0 0.1 13.4 0.0 0.0 0.0 5.8 0.1 0.0 0.0 0.0 0.0 34.6 22.3 0.0 17.4 3.5 1.5 1.0 13.4 16.0 0.2 0.0 3.7 1.6 0.1 0.2 0.9 0.0 0.0 1.7 0.0 0.0 0.8 2.7 1.8 0.9 2.6 1.9 2.5 2.5 1.1 0.4 4.7 3.9 0.0 0.4 1.0 0.6 1.4 1.6 29.6 33.7 20.1 25.8 22.3 33.8 26.0 28.1 29.2 14.9 6.0 4.5 10.8 119.2 25.5 16.8 36.3 2.5 131.2 36.4 7.0 76.6 1.2 1.7 1.2 661.6 9.0 34.2 93.5 2.1 3.7 10.3 173.0 37.9 0.2 13.8 6.4 96.0 7.4 7.3 1220.8 9.5 17.6 49.0 1.8 23.3 9.8 3.7 22.8 10.6 5.0 21.2 6.5 7.7 27.5 21.6 40.8 5.7 8.5 16.9 141.9 DNAJB13 "RSPH16A, TSARG6" ENSG00000187726 "DnaJ heat shock protein family (Hsp40) member B13" P59910 11 73950319-73970366 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" Chaperone "Ciliopathy, Disease mutation, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "fallopian tube: 30.4;testis: 10.8" "Group enriched" "Detected in some" 6 "Ciliated cells: 66.9;Early spermatids: 65.2;Late spermatids: 44.5" "Cancer enhanced" "Detected in some" "ovarian cancer: 2.9" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 8.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA052465, HPA061330" Enhanced Approved "Plasma membrane" NA NA "Plasma membrane" "HPA052465: AB_2681842, HPA061330: AB_2732659" "unprognostic (1.07e-1)" "unprognostic (3.23e-2)" "unprognostic (3.27e-3)" "unprognostic (1.56e-2)" "unprognostic (1.03e-1)" "unprognostic (1.20e-4)" "unprognostic (1.30e-2)" "unprognostic (1.72e-4)" "unprognostic (5.00e-2)" "unprognostic (4.73e-2)" "unprognostic (6.30e-2)" "unprognostic (1.22e-1)" "prognostic unfavorable (2.10e-6)" "unprognostic (3.32e-2)" "unprognostic (1.41e-1)" "unprognostic (9.44e-2)" "unprognostic (2.40e-2)" 0.0 0.0 1.2 0.4 1.4 2.1 0.0 0.0 0.1 4.7 0.0 0.1 1.0 3.2 0.0 30.4 1.1 0.0 1.6 1.5 0.6 0.0 1.9 1.0 0.0 0.0 0.3 0.0 0.5 0.1 0.3 0.0 0.4 1.6 0.0 0.2 1.4 0.0 0.2 0.5 0.0 10.8 0.1 0.0 0.0 0.0 1.6 3.4 3.1 0.8 0.6 1.7 0.4 0.4 0.9 1.4 1.7 0.1 0.4 0.8 0.3 0.0 0.4 0.1 1.8 0.7 1.8 4.0 0.7 0.8 1.3 0.3 0.0 0.1 5.1 0.8 2.1 1.9 0.7 0.0 1.1 1.6 0.0 0.8 0.4 0.0 1.1 0.0 2.6 0.7 5.2 1.0 0.8 1.3 1.8 0.6 0.5 2.9 0.8 2.8 1.8 8.3 1.6 0.8 2.1 1.0 4.3 0.4 0.9 0.8 1.5 0.3 0.6 1.3 1.9 0.7 4.3 3.5 3.5 0.6 0.5 0.5 3.1 0.8 1.1 1.2 0.2 0.4 1.6 1.2 0.7 0.7 1.5 1.0 1.7 1.4 0.6 0.3 3.4 1.1 0.4 3.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 66.9 3.4 1.8 0.0 0.0 0.0 1.1 65.2 0.0 0.0 0.0 0.0 0.1 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.5 1.1 0.0 1.7 0.0 0.0 0.2 0.1 0.0 1.1 0.1 0.5 0.0 0.0 9.7 0.9 0.0 0.0 0.0 0.0 0.6 DNAJC6 "KIAA0473, PARK19" ENSG00000116675 "DnaJ heat shock protein family (Hsp40) member C6" O75061 1 65248219-65415869 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Chaperone, Hydrolase, Protein phosphatase" "Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 91.4" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 29.6;Cardiomyocytes: 26.1;Erythroid cells: 23.3;Horizontal cells: 49.3;Rod photoreceptor cells: 21.6" "Cancer enhanced" "Detected in many" "glioma: 5.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "gdT-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HDLM-2: 21.2;HEL: 56.7;K-562: 22.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031182, HPA054917" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA031182: AB_10611957, HPA054917: AB_2682641" "unprognostic (6.99e-2)" "unprognostic (2.00e-3)" "unprognostic (3.19e-1)" "unprognostic (7.94e-7)" "unprognostic (1.59e-1)" "unprognostic (7.61e-3)" "unprognostic (1.87e-4)" "unprognostic (2.98e-1)" "unprognostic (1.89e-1)" "unprognostic (4.14e-1)" "unprognostic (4.22e-3)" "unprognostic (1.53e-1)" "prognostic favorable (2.81e-4)" "unprognostic (1.43e-2)" "unprognostic (1.12e-1)" "unprognostic (1.36e-1)" "unprognostic (8.67e-3)" 2.1 12.1 18.6 2.2 28.5 5.0 2.0 24.2 91.4 2.2 2.8 26.9 0.0 2.3 1.9 1.8 1.7 2.4 2.3 9.0 25.0 26.7 8.5 1.6 2.7 1.6 28.8 23.8 1.9 3.4 2.1 7.5 8.0 40.5 2.5 3.0 2.2 1.7 2.1 1.6 2.1 2.3 2.2 28.7 3.2 2.9 3.2 21.1 0.0 3.0 0.0 1.7 1.8 0.6 0.5 0.5 0.0 0.0 0.6 1.5 0.3 3.5 1.0 0.0 1.6 0.8 0.2 8.4 7.1 11.6 11.7 11.5 0.9 0.1 3.4 0.6 2.9 2.9 0.9 5.1 1.1 9.2 21.2 2.4 56.7 1.9 0.2 0.0 1.9 1.4 1.0 0.8 1.1 5.0 2.2 0.2 2.8 22.0 0.4 2.4 0.6 0.7 0.0 2.3 0.0 0.8 0.0 1.7 0.1 8.9 0.0 14.2 9.7 4.1 5.6 1.9 14.1 2.7 0.1 2.2 1.7 1.2 0.2 2.0 2.1 1.4 1.0 4.8 1.4 2.9 0.0 0.0 0.0 1.5 0.0 0.1 0.5 0.5 0.9 0.0 0.0 0.4 0.6 0.0 0.6 0.0 0.5 0.0 0.3 18.6 28.5 24.2 37.4 25.0 26.7 28.8 23.8 40.5 21.1 0.0 0.3 0.0 0.2 1.1 29.6 26.1 0.0 0.0 0.0 0.0 13.7 4.8 1.7 0.8 1.8 0.7 0.0 23.3 0.6 1.9 1.7 1.3 0.0 0.0 1.1 49.3 6.9 0.0 0.0 1.4 0.0 0.8 6.8 1.8 1.3 3.1 0.4 0.0 0.0 5.9 21.6 0.0 2.3 1.0 2.3 0.3 6.2 0.0 0.5 0.1 DPYSL2 "CRMP2, DHPRP2, DRP-2, DRP2" ENSG00000092964 "Dihydropyrimidinase like 2" Q16555 8 26514022-26658178 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 137.0" "Cell type enhanced" "Detected in many" 5 "Ito cells: 240.0" "Cancer enhanced" "Detected in all" "glioma: 89.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 24.0;intermediate monocyte: 26.7;myeloid DC: 25.5;non-classical monocyte: 16.2;plasmacytoid DC: 15.1" "Group enriched" "Detected in many" 6 "dendritic cells: 25.5;monocytes: 26.7" "Cell line enhanced" "Detected in many" "ASC diff: 61.4;Karpas-707: 63.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002381, CAB018719" Supported Supported "Plasma membrane,Cytosol" NA NA 3900000 Cytosol "Plasma membrane" "CAB018719: AB_2085366, HPA002381: AB_1847244" "unprognostic (2.88e-2)" "unprognostic (1.01e-2)" "unprognostic (9.51e-2)" "unprognostic (3.16e-3)" "unprognostic (8.23e-2)" "unprognostic (1.68e-2)" "unprognostic (1.51e-1)" "unprognostic (9.95e-3)" "unprognostic (5.48e-2)" "unprognostic (1.39e-1)" "unprognostic (1.79e-2)" "unprognostic (4.13e-2)" "unprognostic (5.58e-2)" "unprognostic (9.32e-3)" "unprognostic (1.23e-1)" "unprognostic (3.27e-2)" "prognostic unfavorable (5.41e-5)" 31.6 21.7 53.5 13.4 48.1 3.0 21.3 51.8 137.0 14.6 12.2 54.7 3.9 7.1 14.2 8.1 12.0 14.7 18.0 27.2 52.9 48.6 12.1 11.2 45.3 9.9 56.5 45.4 25.8 7.5 5.1 7.2 25.6 46.9 9.8 12.4 8.2 6.5 10.3 10.9 10.2 9.7 19.9 70.1 19.0 8.5 7.5 44.9 5.8 7.7 5.2 12.3 14.0 13.1 3.2 25.5 0.6 26.7 4.0 4.6 8.8 4.7 23.1 22.8 12.1 61.4 28.3 2.2 9.3 21.8 8.9 11.6 9.0 6.9 7.1 6.8 29.2 18.0 4.6 23.9 9.3 8.5 16.1 2.0 8.1 8.8 12.6 39.4 1.7 3.3 35.1 13.5 24.4 14.2 28.8 17.9 5.6 0.2 63.2 8.9 3.0 13.7 1.7 17.8 15.3 4.5 18.3 9.1 4.7 15.0 5.5 10.4 21.9 11.3 0.1 6.1 15.7 1.7 3.2 32.2 20.3 8.2 16.8 4.0 8.9 9.1 5.6 29.4 10.6 10.3 0.4 24.0 0.2 3.5 26.7 1.2 3.2 3.1 2.3 25.5 1.7 1.6 2.1 0.6 4.0 16.2 15.1 4.6 8.8 53.5 48.1 51.8 68.4 52.9 48.6 56.5 45.4 46.9 44.9 122.1 67.9 17.3 0.8 35.8 104.6 86.8 104.4 17.4 31.8 21.0 29.5 12.9 3.3 17.3 2.6 134.9 3.1 0.0 1.6 9.2 59.6 1.1 19.7 13.4 46.2 133.5 58.3 240.0 207.1 6.4 100.9 92.1 114.7 101.8 73.9 141.1 9.7 3.6 84.1 17.3 36.8 135.8 60.8 3.1 8.5 29.5 3.8 8.7 6.6 1.1 DQX1 FLJ23757 ENSG00000144045 "DEAQ-box RNA dependent ATPase 1" Q8TE96 2 74518131-74526336 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "intestine: 41.0" "Cell type enhanced" "Detected in some" 15 "Enterocytes: 21.9;Mucus-secreting cells: 12.7;Paneth cells: 11.8;Undifferentiated cells: 10.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.4" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "HBEC3-KT: 5.9;Hep G2: 16.6;hTCEpi: 6.1;OE19: 14.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA039158 Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039158: AB_10960125" "unprognostic (2.17e-1)" "unprognostic (1.43e-1)" "unprognostic (1.20e-2)" "unprognostic (9.95e-2)" "unprognostic (2.20e-1)" "unprognostic (1.18e-1)" "unprognostic (6.49e-2)" "unprognostic (3.93e-1)" "unprognostic (4.54e-2)" "unprognostic (1.68e-1)" "unprognostic (7.67e-2)" "unprognostic (2.21e-2)" "unprognostic (0.00e+0)" "unprognostic (1.13e-2)" "unprognostic (1.36e-1)" "unprognostic (1.29e-1)" "unprognostic (6.16e-3)" 0.1 0.0 0.1 2.1 0.2 0.0 0.1 0.1 0.1 0.8 13.3 0.2 0.1 14.7 0.1 0.1 3.7 0.2 3.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 1.0 0.1 0.2 5.1 0.1 0.6 0.1 0.1 1.5 41.0 0.3 0.1 0.2 2.9 0.1 0.1 0.2 0.1 0.7 1.5 1.1 1.4 0.7 1.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.6 0.1 5.9 0.0 0.0 0.3 0.4 0.1 16.6 0.0 0.2 0.3 0.0 6.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.1 0.3 14.1 0.0 0.1 0.1 0.1 0.0 1.1 0.0 0.1 0.0 2.3 0.0 1.1 0.6 0.0 0.0 0.7 0.1 0.1 0.0 0.1 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.3 0.0 5.3 1.2 0.0 2.0 1.2 0.0 0.0 0.0 0.0 21.9 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.5 0.1 11.8 0.0 0.0 0.8 0.0 0.0 0.1 0.2 0.0 0.9 0.0 10.6 0.2 DRD1 ENSG00000184845 "Dopamine receptor D1" P21728 5 175440039-175444208 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "brain: 34.5" "Group enriched" "Detected in some" 13 "Bipolar cells: 40.8;Horizontal cells: 31.8" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 5 "basal ganglia: 34.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "RT4: 24.2" "Region enriched" "Detected in many" 9 "basal ganglia: 147.4" "Region enriched" "Detected in many" 13 "basal ganglia: 95.6" "HPA013393, HPA017304" Supported Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA013393: AB_1847833, HPA017304: " "unprognostic (2.74e-2)" "unprognostic (6.36e-3)" "unprognostic (2.02e-1)" "unprognostic (1.07e-1)" "unprognostic (7.63e-3)" "unprognostic (1.28e-1)" "unprognostic (1.15e-6)" "unprognostic (6.69e-2)" "unprognostic (1.05e-1)" "unprognostic (1.24e-1)" "unprognostic (1.49e-1)" "unprognostic (2.74e-2)" "unprognostic (8.60e-4)" "unprognostic (5.86e-2)" "unprognostic (5.43e-1)" "unprognostic (6.00e-3)" "unprognostic (1.10e-2)" 0.7 1.5 1.9 0.2 34.5 0.0 0.1 0.1 12.0 0.7 0.7 0.4 0.0 0.5 0.4 0.7 0.7 0.6 1.1 0.3 1.0 0.6 0.7 2.6 1.8 0.1 0.5 1.6 0.3 0.0 0.0 0.1 2.5 0.3 2.7 0.9 2.1 0.1 1.2 0.1 0.1 0.3 0.4 0.1 0.4 0.4 0.1 6.8 0.1 0.1 0.0 0.4 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 24.2 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 34.5 0.1 5.3 1.0 0.6 0.5 1.6 0.3 6.8 0.0 0.0 0.0 0.0 0.1 40.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 31.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 2.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DRP2 ENSG00000102385 "Dystrophin related protein 2" Q13474 X 101219769-101264497 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 20.3" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 2.3;Intestinal endocrine cells: 1.7;Peritubular cells: 2.1" "Cancer enhanced" "Detected in single" "glioma: 1.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RH-30: 11.3;TIME: 19.0;U-87 MG: 4.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002949 Approved "Nuclear speckles,Plasma membrane" NA NA "Nuclear speckles, Plasma membrane" "HPA002949: AB_1078706" "unprognostic (8.47e-4)" "unprognostic (3.56e-3)" "unprognostic (1.01e-2)" "unprognostic (5.58e-4)" "unprognostic (1.74e-2)" "unprognostic (2.47e-2)" "unprognostic (7.93e-3)" "unprognostic (2.94e-3)" "unprognostic (1.27e-2)" "unprognostic (5.46e-3)" "unprognostic (1.42e-1)" "unprognostic (4.61e-2)" "unprognostic (4.44e-16)" "unprognostic (3.71e-4)" "unprognostic (4.22e-1)" "unprognostic (9.03e-2)" "unprognostic (1.25e-1)" 1.1 1.5 9.3 1.2 17.2 1.1 0.8 0.4 20.3 1.7 2.8 1.2 0.0 1.1 2.5 2.7 1.3 1.0 1.3 0.9 5.8 4.2 0.7 0.6 0.8 0.8 4.6 10.1 4.4 0.6 0.6 2.4 0.7 2.6 4.1 1.8 0.5 0.7 3.1 0.7 0.8 1.2 2.2 3.1 0.7 0.7 1.6 2.2 0.9 0.6 0.0 0.8 1.1 1.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.7 2.4 0.1 0.1 0.2 0.1 0.5 0.1 0.4 1.0 0.0 0.4 0.3 0.3 0.1 0.7 0.0 0.3 0.0 0.8 0.1 0.2 0.2 0.5 0.0 0.2 0.1 0.5 1.5 0.0 0.8 0.0 0.1 1.4 0.5 0.0 1.0 1.6 0.0 1.3 0.5 0.1 0.1 0.1 0.3 11.3 0.0 0.0 0.0 0.0 0.5 0.1 0.2 0.0 0.5 0.0 0.1 19.0 0.2 0.7 0.2 0.4 0.0 0.1 0.0 4.6 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 9.3 17.2 0.4 20.3 5.8 4.2 4.6 10.1 2.6 2.2 0.0 0.0 0.0 0.0 0.1 2.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DSEL "C18orf4, DE-epi2, FLJ11477, NCAG1" ENSG00000171451 "Dermatan sulfate epimerase-like" Q8IZU8 18 67506582-67516980 "Predicted membrane proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cholangiocytes: 43.3;Extravillous trophoblasts: 69.4;Fibroblasts: 40.8" "Cancer enhanced" "Detected in many" "glioma: 6.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 3.2" "Lineage enriched" "Detected in single" 5 "T-cells: 3.2" "Cell line enhanced" "Detected in many" "BJ: 19.9;BJ hTERT+: 11.5;LHCN-M2: 24.9;U-138 MG: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060942 Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA060942: AB_2684392" "unprognostic (2.49e-1)" "unprognostic (5.00e-1)" "unprognostic (1.67e-1)" "unprognostic (1.19e-5)" "unprognostic (1.56e-1)" "unprognostic (2.71e-1)" "unprognostic (2.40e-3)" "unprognostic (7.11e-2)" "unprognostic (4.91e-1)" "unprognostic (2.83e-1)" "unprognostic (2.19e-2)" "unprognostic (2.47e-1)" "unprognostic (7.95e-3)" "unprognostic (3.25e-2)" "unprognostic (1.24e-1)" "unprognostic (9.70e-3)" "unprognostic (1.16e-4)" 10.2 3.4 8.8 3.2 15.5 1.6 9.4 7.9 12.8 10.9 4.5 15.7 2.5 2.2 5.7 4.0 3.1 7.1 8.3 5.1 8.6 8.4 9.0 7.1 6.0 1.9 13.2 4.5 7.6 3.6 3.6 1.3 11.5 9.7 4.8 3.5 2.4 2.3 4.9 1.9 3.2 2.7 7.4 11.1 4.5 3.1 3.4 10.9 0.0 2.8 1.1 1.6 3.6 8.4 0.2 0.1 0.6 0.1 0.3 3.2 0.3 0.0 0.0 2.4 0.0 4.7 7.0 0.3 19.9 11.5 5.1 2.2 0.0 0.0 0.0 0.0 10.1 1.3 0.1 0.4 0.9 4.9 0.0 0.0 0.0 2.2 0.0 4.0 0.0 0.0 7.0 1.3 3.1 7.4 1.9 1.0 0.0 0.0 0.2 24.9 0.0 0.0 0.0 0.3 0.0 2.1 0.2 5.3 0.0 2.3 0.0 0.9 1.1 1.8 0.0 0.0 1.1 0.0 0.0 1.7 25.9 0.8 1.8 2.2 0.1 0.0 0.0 5.4 0.0 2.2 0.6 0.1 0.2 0.2 0.0 1.7 0.1 0.8 1.2 0.0 0.2 0.5 3.2 0.5 0.3 0.1 0.1 0.2 0.3 8.8 15.5 7.9 9.9 8.6 8.4 13.2 4.5 9.7 10.9 6.0 14.4 2.0 8.0 10.3 9.4 14.3 43.3 0.0 2.3 10.4 3.9 2.4 0.0 7.9 1.1 11.3 0.5 0.0 2.0 69.4 40.8 6.6 4.6 12.9 2.2 3.2 6.3 16.0 2.1 1.4 22.7 2.9 6.8 0.0 0.1 14.3 5.4 0.0 34.6 18.8 4.2 12.9 12.3 13.1 11.7 11.5 7.4 2.5 0.6 5.4 DUS1L "DUS1, PP3111" ENSG00000169718 "Dihydrouridine synthase 1 like" Q6P1R4 17 82057506-82065887 "Predicted intracellular proteins" "tRNA processing" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 101.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023384 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA023384: AB_1847879" "unprognostic (4.42e-2)" "unprognostic (2.19e-2)" "unprognostic (4.30e-2)" "unprognostic (3.03e-2)" "unprognostic (1.73e-3)" "unprognostic (1.84e-1)" "unprognostic (4.01e-2)" "unprognostic (5.17e-2)" "unprognostic (1.10e-1)" "unprognostic (4.16e-3)" "unprognostic (5.23e-3)" "unprognostic (3.13e-1)" "prognostic unfavorable (5.89e-5)" "unprognostic (4.17e-2)" "unprognostic (8.57e-2)" "unprognostic (3.47e-1)" "unprognostic (1.70e-3)" 21.4 17.5 12.4 29.1 16.5 37.1 20.2 21.4 20.3 17.7 29.5 14.1 26.8 30.8 18.1 23.4 26.0 18.5 27.9 23.8 13.0 10.9 19.8 54.6 21.5 31.2 18.9 16.0 20.1 59.6 15.2 23.5 16.5 12.9 26.9 14.8 16.0 45.4 18.9 44.1 40.8 28.0 19.6 10.5 30.9 28.9 23.7 12.4 28.0 22.8 26.2 30.4 17.0 18.5 5.0 10.6 6.3 6.0 7.9 9.8 2.9 36.1 23.4 8.1 9.6 6.4 6.5 26.1 12.8 5.8 12.5 8.9 21.3 16.3 29.7 15.0 7.1 8.5 24.4 10.0 13.1 5.0 11.7 61.0 18.8 32.5 36.9 14.4 29.1 23.4 9.7 16.6 8.2 10.4 5.9 14.0 26.8 32.4 15.0 6.3 56.7 40.3 25.1 9.8 17.9 34.1 30.9 9.6 31.9 9.2 23.9 43.4 27.3 9.8 41.1 26.2 8.1 24.0 28.0 10.6 20.3 20.6 17.3 32.2 37.6 10.4 24.0 12.8 21.8 13.9 4.2 5.0 6.3 6.0 5.1 8.7 5.0 6.1 7.0 4.8 5.0 9.8 8.1 1.7 7.9 6.0 10.6 9.8 2.9 12.4 16.5 21.4 20.3 13.0 10.9 18.9 16.0 12.9 12.4 26.8 15.5 15.7 16.5 19.6 29.0 16.2 30.6 10.7 11.4 10.4 27.5 14.3 6.6 10.9 65.7 16.2 40.4 0.0 32.9 16.0 11.3 33.5 3.5 72.7 18.4 17.5 41.5 12.9 19.6 101.1 13.3 17.2 10.1 13.6 53.1 17.1 30.1 25.9 12.7 20.2 46.0 12.9 13.7 20.7 9.8 24.8 13.0 12.8 54.9 32.6 DUSP15 "bA243J16.5, bA243J16.6, C20orf57, FLJ20645, VHY" ENSG00000149599 "Dual specificity phosphatase 15" Q9H1R2 20 31847637-31870747 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 75.1" "Group enriched" "Detected in many" 5 "Distal tubular cells: 232.1;Early spermatids: 237.5;Late spermatids: 743.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 14 "naive B-cell: 1.6" "Lineage enriched" "Detected in single" 14 "B-cells: 1.6" "Cell line enhanced" "Detected in some" "CACO-2: 5.4;REH: 17.7;SH-SY5Y: 5.1;SK-MEL-30: 4.4;U-2 OS: 4.3" "Low region specificity" "Detected in all" HPA076649 Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA076649: AB_2686811" "unprognostic (3.84e-2)" "unprognostic (2.30e-1)" "unprognostic (2.28e-1)" "unprognostic (9.01e-3)" "unprognostic (3.88e-2)" "unprognostic (2.36e-1)" "unprognostic (1.47e-2)" "unprognostic (2.24e-2)" "unprognostic (1.43e-1)" "unprognostic (1.76e-1)" "unprognostic (1.48e-5)" "unprognostic (7.31e-2)" "prognostic favorable (5.40e-7)" "unprognostic (2.79e-2)" "unprognostic (1.93e-1)" "unprognostic (3.11e-3)" "unprognostic (2.55e-1)" 1.1 2.1 2.8 0.6 4.0 0.5 1.3 1.2 3.7 1.6 0.8 4.2 6.9 0.9 1.4 10.4 0.6 0.7 1.1 2.7 2.8 3.1 15.4 0.6 0.8 1.0 4.9 2.3 2.1 1.8 10.6 2.7 1.1 5.9 1.9 0.5 5.3 2.1 9.3 2.4 0.7 1.0 2.3 5.2 1.0 1.1 75.1 1.4 0.0 3.5 0.1 0.6 0.7 0.8 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.2 1.6 0.0 0.3 0.0 0.0 0.0 0.9 0.0 5.4 0.1 1.1 2.2 0.3 3.0 0.0 0.4 0.0 0.0 0.0 0.6 0.5 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.3 0.0 3.8 0.7 0.0 0.0 17.7 2.1 0.1 0.0 0.0 2.5 5.1 2.9 0.0 4.4 0.2 1.3 1.1 0.0 0.0 4.3 0.0 0.0 1.9 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 4.0 1.2 3.7 2.8 3.1 4.9 2.3 5.9 1.4 0.0 0.0 0.0 1.0 0.6 0.5 2.0 2.5 0.0 0.0 17.4 3.9 0.0 232.1 1.7 237.5 0.7 0.0 0.0 0.9 0.1 2.4 0.7 0.0 0.0 0.5 6.4 1.7 3.1 0.0 743.6 8.1 0.8 6.8 1.0 0.0 2.7 0.9 0.0 10.3 33.5 0.2 0.0 1.0 85.0 5.2 0.1 0.1 0.0 0.0 0.1 DXO DOM3Z ENSG00000204348 "Decapping exoribonuclease" O77932 6 31969810-31972292 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 32.8" "Group enriched" "Detected in many" 5 "Early spermatids: 374.6;Late spermatids: 209.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 14.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046708 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA046708: AB_2679764" "unprognostic (4.56e-2)" "unprognostic (2.21e-1)" "unprognostic (1.80e-1)" "unprognostic (4.07e-3)" "unprognostic (1.93e-1)" "unprognostic (2.00e-3)" "unprognostic (3.43e-3)" "unprognostic (4.18e-3)" "unprognostic (3.10e-2)" "unprognostic (2.64e-3)" "prognostic favorable (5.87e-4)" "unprognostic (4.29e-2)" "prognostic unfavorable (4.77e-6)" "unprognostic (9.17e-2)" "unprognostic (7.24e-2)" "unprognostic (2.01e-1)" "unprognostic (2.23e-3)" 4.3 18.4 8.3 8.0 11.0 4.2 7.0 15.5 12.4 7.1 5.0 6.5 8.6 7.8 6.4 6.4 4.0 7.9 6.0 8.4 7.7 6.5 8.5 8.7 5.1 4.3 9.0 6.5 10.5 12.3 9.4 12.4 4.7 7.4 7.6 4.2 5.8 5.5 6.8 5.6 3.4 4.1 6.3 4.9 7.2 7.6 32.8 7.3 3.4 8.8 4.7 4.3 6.4 5.5 2.2 3.2 1.5 1.9 3.0 3.3 1.5 3.0 1.3 0.5 14.3 1.7 1.0 1.5 1.7 2.7 4.5 3.7 2.2 2.9 1.0 3.2 5.8 0.8 4.1 1.5 3.2 1.6 1.9 4.4 2.0 2.9 2.9 3.9 0.0 2.7 2.2 2.9 1.8 3.0 2.2 6.6 1.1 2.5 3.2 1.8 4.4 0.1 2.4 0.7 1.9 0.1 0.1 2.0 1.8 5.3 0.8 7.4 5.6 3.3 1.4 3.7 0.5 0.0 4.5 0.9 0.8 4.9 2.8 3.7 1.9 3.4 2.4 2.6 4.6 2.2 0.0 1.0 1.5 1.1 1.9 3.3 1.4 1.4 1.8 3.2 2.2 1.3 1.6 0.6 3.0 1.2 1.2 0.6 1.5 8.3 11.0 15.5 9.4 7.7 6.5 9.0 6.5 7.4 7.3 6.0 11.1 11.2 13.5 7.6 12.9 6.5 7.6 8.1 6.8 3.5 15.7 12.3 16.6 7.5 374.6 6.3 6.1 0.0 10.8 7.9 10.8 9.4 5.8 9.7 5.9 4.8 15.5 6.7 4.9 209.7 16.4 6.7 11.8 4.6 7.0 16.2 6.4 8.6 11.7 11.7 14.7 12.9 10.8 58.1 11.8 4.8 16.8 13.1 6.8 7.3 EEF1AKMT1 N6AMT2 ENSG00000150456 "EEF1A lysine methyltransferase 1" Q8WVE0 13 20728731-20773958 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 20.8;Cytotrophoblasts: 17.3;Distal tubular cells: 23.2;Proximal tubular cells: 28.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040417, HPA042543" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA040417: AB_2676973, HPA042543: AB_2678045" "unprognostic (4.14e-1)" "unprognostic (5.11e-2)" "unprognostic (8.57e-2)" "prognostic favorable (1.82e-4)" "unprognostic (9.14e-2)" "unprognostic (3.44e-1)" "unprognostic (2.24e-1)" "unprognostic (1.65e-1)" "unprognostic (1.11e-1)" "unprognostic (1.41e-1)" "unprognostic (1.51e-2)" "unprognostic (1.39e-1)" "unprognostic (2.39e-3)" "unprognostic (3.51e-1)" "unprognostic (1.06e-1)" "unprognostic (5.81e-2)" "unprognostic (4.31e-2)" 12.1 14.1 15.2 8.9 13.8 3.9 13.4 20.9 14.1 12.2 9.4 9.5 8.6 5.9 14.8 19.9 8.0 15.2 8.4 12.4 12.2 14.7 11.5 17.3 7.8 8.1 14.3 14.7 14.5 10.3 9.1 19.1 8.5 11.7 14.1 8.1 10.6 12.8 12.7 15.5 7.2 5.9 12.5 16.2 8.1 8.1 8.2 14.0 11.3 12.9 8.2 8.6 8.9 8.6 10.7 8.8 0.7 4.4 13.1 11.2 5.7 5.8 4.5 3.8 6.2 16.0 16.6 9.3 7.8 5.9 6.8 3.6 6.3 6.6 9.5 5.8 8.4 3.1 4.8 5.1 6.6 7.1 6.1 4.5 12.2 2.1 12.0 8.8 24.1 2.5 11.3 5.9 5.1 11.4 7.7 12.2 8.3 7.1 1.3 19.3 16.2 8.0 21.5 6.5 10.7 3.4 10.1 4.1 1.8 9.7 6.8 8.7 5.2 6.6 3.3 8.6 3.3 3.5 22.3 7.1 4.7 0.0 10.5 3.4 1.8 3.4 10.3 4.0 16.7 3.3 0.0 4.4 0.7 7.7 3.3 8.1 10.7 9.0 7.6 7.2 4.9 11.2 9.8 0.6 13.1 3.4 8.8 9.5 5.7 15.2 13.8 20.9 14.1 12.2 14.7 14.3 14.7 11.7 14.0 20.8 8.6 0.0 0.0 0.0 0.0 0.0 0.0 13.4 14.8 7.0 0.0 17.3 23.2 10.0 0.0 0.0 0.0 0.0 9.0 11.0 0.0 0.0 3.5 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 6.4 0.0 0.0 7.5 0.0 0.0 28.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 EFCAB1 FLJ11767 ENSG00000034239 "EF-hand calcium binding domain 1" Q9HAE3 8 48710789-48735311 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 61.9" "Group enriched" "Detected in many" 21 "Ciliated cells: 342.6;Early spermatids: 456.6;Late spermatids: 332.2" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.9" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 4.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 9.1;ASC diff: 4.0;ASC TERT1: 9.3;CAPAN-2: 4.5;hTEC/SVTERT24-B: 3.8;SCLC-21H: 7.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023527, HPA069955" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA023527: AB_2231065, HPA069955: AB_2686220" "unprognostic (5.29e-3)" "unprognostic (7.39e-3)" "unprognostic (1.05e-1)" "unprognostic (2.67e-3)" "unprognostic (4.67e-2)" "unprognostic (2.77e-1)" "unprognostic (9.81e-2)" "unprognostic (1.62e-1)" "unprognostic (2.52e-2)" "unprognostic (1.85e-1)" "unprognostic (5.94e-3)" "unprognostic (7.81e-2)" "unprognostic (4.87e-3)" "unprognostic (4.81e-2)" "unprognostic (1.99e-1)" "unprognostic (2.51e-1)" "unprognostic (3.47e-3)" 0.6 1.5 5.4 0.5 9.5 0.9 2.5 0.2 4.1 8.1 0.8 14.0 10.3 0.9 8.6 19.0 0.9 61.9 0.9 0.6 9.1 8.4 0.6 0.9 16.5 0.5 2.7 3.9 13.7 1.8 0.4 2.0 0.8 23.9 4.2 0.7 1.9 1.8 4.6 0.5 3.5 1.1 2.7 1.4 0.6 0.8 19.7 3.0 0.0 0.5 0.3 0.6 1.4 2.1 1.0 0.0 4.1 0.0 1.1 1.1 0.3 9.1 0.0 1.2 0.0 4.0 9.3 0.0 0.1 0.9 0.0 0.3 0.0 4.5 0.0 0.0 0.2 0.0 2.5 0.0 1.1 0.3 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.1 3.3 0.3 3.8 1.6 0.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.5 0.0 0.3 0.1 0.0 0.0 0.0 2.1 7.2 0.5 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.5 0.0 1.1 1.0 0.7 0.8 0.0 0.8 0.5 0.3 4.1 1.1 0.0 0.0 0.7 0.3 5.4 9.5 0.2 4.1 9.1 8.4 2.7 3.9 23.9 3.0 0.0 5.1 0.0 6.6 6.1 0.0 0.4 0.0 342.6 18.2 0.0 0.0 0.3 0.0 0.1 456.6 0.1 0.0 0.0 1.3 0.1 1.9 2.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 332.2 4.4 1.2 1.7 0.0 0.0 0.0 2.0 0.0 5.3 0.0 0.0 0.0 0.8 5.7 4.4 1.6 0.2 0.0 0.0 1.8 EFCAB2 "CFAP200, DRC8, MGC12458" ENSG00000203666 "EF-hand calcium binding domain 2" Q5VUJ9 1 244969705-245127164 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 161.9;Early spermatids: 83.3;Late spermatids: 104.3;Spermatocytes: 117.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 10.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 34.8;THP-1: 30.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031206, HPA031207" Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA031206: AB_10599710, HPA031207: AB_10599946" "unprognostic (1.36e-2)" "unprognostic (9.04e-2)" "unprognostic (1.09e-1)" "unprognostic (2.84e-2)" "unprognostic (3.13e-2)" "unprognostic (1.21e-1)" "unprognostic (4.47e-2)" "unprognostic (9.86e-2)" "unprognostic (2.85e-2)" "unprognostic (3.02e-1)" "unprognostic (4.34e-3)" "unprognostic (8.41e-2)" "unprognostic (1.48e-2)" "unprognostic (2.25e-2)" "unprognostic (1.64e-1)" "prognostic unfavorable (6.51e-4)" "unprognostic (4.88e-2)" 11.0 12.5 16.7 5.6 18.6 10.8 14.7 20.1 15.5 11.6 7.3 23.6 13.9 3.0 18.7 19.5 9.6 32.1 13.1 13.7 18.0 14.3 12.5 6.5 11.2 7.8 22.3 12.3 10.6 12.1 14.6 20.6 14.7 16.3 9.2 11.3 11.8 7.4 16.0 15.5 6.1 6.5 13.2 20.9 6.4 10.5 24.4 21.9 5.4 23.7 13.5 9.1 11.5 16.0 3.6 10.8 4.9 1.8 2.9 0.8 1.2 3.1 4.0 9.1 2.3 3.3 7.8 11.1 4.0 4.3 5.2 4.8 10.2 8.6 11.0 8.7 5.0 5.5 2.5 3.6 2.3 3.2 1.1 2.2 5.3 15.9 4.5 7.0 5.4 34.8 6.7 4.9 7.0 6.6 6.2 7.9 0.3 20.3 9.0 4.4 3.3 1.1 14.9 11.6 4.5 3.0 20.8 1.4 2.9 13.2 5.4 7.2 9.7 7.0 2.7 5.8 10.7 2.6 30.7 1.2 6.4 2.4 3.5 14.5 3.1 5.1 7.3 5.1 15.6 5.1 1.2 1.7 2.8 0.5 1.8 0.8 3.6 0.7 0.4 5.5 3.3 0.6 0.6 4.9 2.9 1.3 10.8 0.8 1.2 16.7 18.6 20.1 15.5 18.0 14.3 22.3 12.3 16.3 21.9 3.0 12.6 4.7 9.1 4.5 12.5 54.7 0.0 161.9 21.6 22.7 13.7 12.8 43.1 5.7 83.3 11.4 2.6 0.0 9.5 40.1 10.4 6.8 0.0 6.8 9.8 4.8 18.1 8.0 14.2 104.3 8.3 9.8 6.8 6.4 6.3 12.5 5.9 5.8 6.0 14.4 20.0 6.5 11.8 117.5 31.9 2.6 28.6 6.2 6.0 8.8 EFCAB7 "KIAA1799, RP4-534K7.1" ENSG00000203965 "EF-hand calcium binding domain 7" A8K855 1 63523372-63572693 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 25.4;Sertoli cells: 25.8;Spermatocytes: 58.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 9.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029611, HPA029612, HPA029613" Enhanced Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Nucleoli, Nucleoli rim" "Plasma membrane, Cytosol" "HPA029611: AB_10599972, HPA029612: AB_10600533, HPA029613: AB_10601004" "unprognostic (8.81e-2)" "unprognostic (5.24e-2)" "unprognostic (5.13e-2)" "unprognostic (1.64e-1)" "prognostic favorable (3.65e-4)" "unprognostic (1.70e-2)" "unprognostic (6.53e-4)" "unprognostic (2.99e-1)" "unprognostic (5.81e-3)" "unprognostic (1.69e-1)" "unprognostic (6.28e-2)" "unprognostic (1.66e-1)" "unprognostic (3.78e-2)" "unprognostic (2.18e-1)" "unprognostic (6.97e-2)" "unprognostic (9.90e-2)" "unprognostic (2.73e-1)" 4.3 8.4 12.7 3.5 16.7 3.1 9.3 24.5 19.5 9.4 5.1 3.7 6.4 3.2 9.6 9.8 5.7 12.6 7.2 9.7 11.4 11.8 8.8 2.8 6.2 5.2 8.1 10.8 12.8 4.9 16.3 31.6 5.1 13.7 8.7 5.0 3.5 5.3 8.2 10.8 4.9 3.4 7.5 9.4 4.2 5.0 20.0 10.2 11.5 9.1 2.4 5.2 7.3 12.9 3.3 1.7 9.8 3.3 1.8 2.9 1.1 6.0 5.1 6.7 4.3 7.1 10.6 3.4 3.9 4.3 6.8 8.4 1.6 4.8 4.3 9.4 2.2 13.9 5.6 5.7 3.7 8.2 7.9 4.0 3.4 9.5 3.5 4.5 4.7 3.1 5.7 9.2 8.0 5.4 10.8 5.7 7.9 4.3 7.0 4.4 1.3 9.0 3.2 2.9 4.2 5.1 5.8 10.1 4.2 10.4 3.2 14.4 5.5 7.5 4.2 9.6 9.4 4.3 3.4 1.5 3.8 3.4 11.4 3.7 4.7 8.1 4.9 7.0 3.4 5.6 9.8 0.7 0.2 2.1 0.4 2.9 3.3 2.4 2.5 1.3 2.8 2.5 2.4 0.1 1.8 3.3 1.7 2.7 1.1 12.7 16.7 24.5 19.5 11.4 11.8 8.1 10.8 13.7 10.2 11.9 2.6 2.9 5.2 2.7 8.3 6.2 0.0 25.4 4.5 5.2 3.9 2.9 6.6 2.9 17.3 2.1 0.5 0.0 0.6 1.6 3.0 1.5 2.3 0.8 2.1 0.0 1.7 2.5 2.4 3.2 10.0 1.1 1.7 1.8 1.4 5.8 1.1 0.0 12.7 4.6 10.5 25.8 2.3 58.1 17.7 1.9 1.0 1.3 1.7 0.7 EFHC2 "FLJ22843, MRX74" ENSG00000183690 "EF-hand domain containing 2" Q5JST6 X 44147882-44343672 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.6;fallopian tube: 20.8" "Group enriched" "Detected in many" 4 "Ciliated cells: 64.3;Early spermatids: 62.9" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "pons and medulla: 20.6" "Group enriched" "Detected in some" 5 "basophil: 14.1;NK-cell: 6.6" "Group enriched" "Detected in many" 5 "granulocytes: 14.1;NK-cells: 6.6" "Cell line enhanced" "Detected in some" "CAPAN-2: 5.2;HEL: 5.4;HMC-1: 18.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA034492 Approved Supported Approved "Nucleoplasm,Nucleoli fibrillar center,Plasma membrane" NA NA "Nucleoplasm, Nucleoli fibrillar center" "Plasma membrane" "HPA034492: AB_10671227" "unprognostic (1.93e-1)" "unprognostic (7.80e-3)" "unprognostic (7.35e-2)" "unprognostic (2.75e-1)" "unprognostic (6.83e-3)" "unprognostic (5.07e-2)" "unprognostic (4.29e-2)" "unprognostic (1.75e-2)" "unprognostic (3.50e-2)" "unprognostic (2.90e-2)" "unprognostic (3.88e-2)" "unprognostic (1.86e-2)" "unprognostic (7.89e-2)" "unprognostic (1.06e-1)" "unprognostic (6.13e-4)" "unprognostic (1.64e-3)" "unprognostic (4.97e-2)" 0.7 0.6 4.0 0.8 6.2 1.9 1.2 1.6 3.1 4.6 1.6 6.5 3.7 0.6 5.4 12.6 2.9 20.8 3.0 6.0 4.8 3.9 2.0 0.1 4.5 0.5 1.5 2.0 5.2 0.3 0.9 6.9 1.3 20.6 2.9 0.6 0.6 9.6 5.8 0.1 4.7 0.8 2.6 1.4 0.6 1.6 10.1 3.1 0.4 3.7 1.4 0.9 1.7 1.4 0.1 0.4 14.1 0.0 6.6 2.1 1.4 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 5.2 0.0 0.1 0.0 1.7 0.0 0.4 0.0 0.1 0.0 0.1 5.4 0.0 0.0 0.0 0.0 18.0 0.3 0.3 0.3 0.0 0.2 0.0 0.8 1.5 0.0 0.0 0.0 0.0 2.3 0.6 0.0 0.1 0.3 0.0 0.0 1.5 0.0 0.3 0.6 0.0 0.0 0.0 0.1 1.0 0.0 0.1 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 14.1 0.0 0.0 2.1 0.0 0.8 0.1 0.8 0.1 0.4 0.1 0.7 1.0 1.9 6.6 0.0 0.0 0.0 1.4 4.0 6.2 1.6 3.1 4.8 3.9 1.5 2.0 20.6 3.1 0.0 4.6 0.0 5.2 2.7 0.1 12.2 5.1 64.3 2.3 0.0 2.0 0.0 1.7 0.5 62.9 0.0 1.3 0.0 5.3 0.0 1.0 0.7 15.1 0.0 0.2 0.0 0.0 0.0 0.0 12.0 6.4 0.2 0.0 0.0 1.3 4.9 0.7 0.0 6.7 0.0 0.0 6.5 2.1 8.6 10.4 2.5 0.2 0.5 3.5 6.5 EHD3 PAST3 ENSG00000013016 "EH domain containing 3" Q9NZN3 2 31234337-31269447 "Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.4;esophagus: 29.1" "Cell type enriched" "Detected in many" 5 "Ito cells: 172.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "memory B-cell: 17.8;naive B-cell: 4.4" "Lineage enriched" "Detected in many" 9 "B-cells: 17.8" "Cell line enhanced" "Detected in many" "BJ: 25.6;BJ hTERT+: 63.5;HEL: 24.6;U-266/70: 15.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049890, HPA049986, HPA066751" Approved Approved "Plasma membrane" NA NA 41000000 "Plasma membrane" "HPA049890: AB_2680936, HPA049986: AB_2680983, HPA066751: AB_2685713" "unprognostic (3.44e-1)" "unprognostic (8.88e-2)" "unprognostic (2.21e-1)" "unprognostic (3.79e-2)" "unprognostic (3.70e-2)" "unprognostic (1.89e-1)" "unprognostic (5.49e-2)" "unprognostic (1.21e-1)" "unprognostic (3.74e-2)" "unprognostic (9.72e-2)" "unprognostic (9.92e-3)" "unprognostic (1.06e-1)" "prognostic unfavorable (1.02e-4)" "unprognostic (4.88e-3)" "unprognostic (9.41e-2)" "unprognostic (4.79e-3)" "unprognostic (4.92e-3)" 2.7 7.1 15.0 5.6 16.3 2.0 3.3 10.6 37.4 5.6 2.2 7.3 0.0 1.9 3.9 3.4 29.1 4.9 3.6 14.8 16.7 8.9 15.0 10.8 4.8 6.3 9.6 21.6 2.9 1.4 8.7 6.0 11.3 13.3 5.7 2.1 2.8 4.8 4.9 2.3 3.0 2.9 4.8 9.4 5.8 1.9 1.6 6.6 1.2 2.5 1.5 10.4 7.8 4.2 17.8 0.4 1.0 1.9 0.6 1.7 7.8 0.5 2.7 1.5 1.3 2.5 3.9 0.2 25.6 63.5 2.5 2.3 0.0 0.3 0.2 0.9 8.4 2.2 0.2 0.0 1.7 1.8 1.0 2.3 24.6 0.1 0.0 8.8 0.0 0.0 6.2 0.7 2.4 1.0 6.7 0.0 0.0 0.0 0.1 1.8 4.0 0.3 0.0 5.8 0.0 1.3 0.8 0.1 0.5 1.9 2.9 0.7 3.9 0.2 0.4 0.0 4.9 0.3 0.0 0.0 1.9 1.8 0.1 2.0 15.9 2.0 0.0 4.9 0.0 4.0 0.4 0.4 0.3 1.7 0.8 0.9 17.8 0.9 1.1 0.4 4.4 0.8 0.4 1.0 0.6 1.9 0.0 0.4 7.8 15.0 16.3 10.6 32.7 16.7 8.9 9.6 21.6 13.3 6.6 0.0 0.0 23.6 1.4 0.7 9.2 18.9 2.5 0.0 1.2 0.0 0.0 3.5 0.0 0.3 0.0 5.2 0.0 0.0 0.2 7.3 2.3 0.8 0.0 0.8 1.4 0.0 1.7 172.5 21.8 0.0 1.1 0.2 0.0 1.0 0.0 8.1 0.2 0.0 2.8 0.2 5.4 19.4 3.3 0.2 2.1 0.6 36.7 2.5 0.0 3.2 EHD4 PAST4 ENSG00000103966 "EH domain containing 4" Q9H223 15 41895939-41972578 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Basal glandular cells: 159.2;Urothelial cells: 196.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 34.2;TIME: 56.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049890, HPA049986, HPA052729, HPA066751" Approved Approved "Plasma membrane" NA NA 410000 "Plasma membrane" "HPA049890: AB_2680936, HPA049986: AB_2680983, HPA052729: AB_2681928, HPA066751: AB_2685713" "unprognostic (1.45e-1)" "unprognostic (1.37e-1)" "unprognostic (4.34e-3)" "unprognostic (3.36e-2)" "unprognostic (3.46e-2)" "unprognostic (4.48e-3)" "unprognostic (1.52e-1)" "unprognostic (3.36e-3)" "unprognostic (2.25e-1)" "unprognostic (3.74e-1)" "unprognostic (6.93e-2)" "unprognostic (2.35e-1)" "unprognostic (5.05e-2)" "unprognostic (3.49e-2)" "unprognostic (3.19e-2)" "unprognostic (8.27e-2)" "unprognostic (2.72e-1)" 26.1 5.0 3.3 12.9 5.0 8.0 17.9 1.9 5.6 11.4 11.4 4.7 11.3 4.7 20.8 16.4 18.1 10.5 17.4 35.4 4.3 2.6 14.5 22.8 19.9 24.3 7.2 2.0 14.1 14.1 13.9 6.5 14.4 7.5 14.1 9.3 17.4 11.1 12.0 10.5 16.1 16.0 11.6 7.1 11.1 10.0 7.5 4.3 5.3 19.1 9.0 13.7 14.4 10.1 2.6 13.3 7.7 12.7 3.6 6.8 6.2 9.0 3.1 3.1 3.1 1.5 2.2 2.7 4.8 10.3 8.6 12.2 13.3 5.2 1.9 13.1 6.1 17.2 9.2 4.5 10.6 6.4 11.3 3.8 2.7 4.7 2.2 3.8 1.2 8.1 1.8 4.2 8.7 9.7 3.3 34.2 2.8 2.9 2.1 6.9 3.8 1.3 1.4 2.3 8.9 11.0 0.0 8.1 2.9 7.8 18.5 5.1 2.1 3.5 7.7 5.5 3.1 7.5 1.8 56.2 2.7 5.3 10.1 23.5 6.0 9.6 3.9 3.4 3.0 23.5 0.9 12.7 7.7 3.8 11.2 5.8 2.0 6.0 4.8 13.3 2.6 2.6 3.7 2.1 3.6 4.4 2.2 6.8 6.2 3.3 5.0 1.9 5.6 4.3 2.6 7.2 2.0 7.5 4.3 6.0 46.5 24.5 159.2 72.5 5.0 32.5 17.8 40.2 56.9 41.8 29.5 8.6 6.6 63.9 12.4 61.2 81.9 0.0 54.9 17.5 15.6 38.0 61.1 7.7 74.1 1.6 21.7 51.5 26.4 26.1 6.9 48.1 18.6 75.7 16.5 47.6 58.7 45.6 4.6 3.1 21.5 12.9 18.4 4.2 8.8 69.8 14.5 13.8 23.0 196.5 EIF2B2 "EIF-2Bbeta, EIF2B" ENSG00000119718 "Eukaryotic translation initiation factor 2B subunit beta" P49770 14 75002911-75012366 "Disease related genes, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Syncytiotrophoblasts: 138.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005841, CAB037105, HPA048028" Enhanced Approved "Nucleoplasm,Plasma membrane,Focal adhesion sites" NA NA "Plasma membrane, Focal adhesion sites" Nucleoplasm "CAB037105: AB_1840834, HPA005841: AB_1078725, HPA048028: AB_2680235" "unprognostic (1.10e-1)" "unprognostic (4.41e-2)" "unprognostic (5.70e-2)" "unprognostic (6.71e-2)" "unprognostic (7.64e-2)" "unprognostic (3.45e-3)" "prognostic unfavorable (2.26e-6)" "unprognostic (1.48e-1)" "unprognostic (1.23e-1)" "unprognostic (1.65e-2)" "unprognostic (4.95e-2)" "unprognostic (1.01e-1)" "prognostic favorable (2.95e-4)" "unprognostic (4.15e-2)" "unprognostic (2.74e-1)" "unprognostic (1.44e-1)" "unprognostic (3.28e-2)" 11.8 20.1 11.6 9.2 12.3 9.1 11.6 11.0 16.4 13.2 13.9 13.2 9.2 9.8 11.6 15.8 14.3 10.4 12.6 15.0 11.5 12.0 19.6 18.8 10.3 11.6 13.6 11.4 12.3 12.9 32.3 11.9 20.4 15.7 13.6 12.2 11.7 11.1 14.8 29.0 12.5 13.1 11.0 14.8 12.1 10.9 20.1 11.0 17.7 33.4 11.2 12.7 14.9 9.7 4.2 5.1 7.7 3.9 6.5 8.1 4.8 5.1 6.3 5.1 5.8 5.9 4.9 6.8 3.3 5.5 6.5 7.6 7.9 5.3 4.6 2.1 5.2 4.1 3.9 7.9 7.7 9.8 2.8 5.9 4.0 5.5 5.4 7.7 3.0 4.8 4.5 7.4 8.3 8.6 5.6 22.3 4.0 3.6 4.5 13.9 15.2 4.7 3.7 3.6 6.4 9.3 3.0 6.0 3.8 9.2 6.2 5.5 4.4 3.5 5.0 7.4 6.6 8.1 2.8 5.7 5.0 4.9 2.2 4.2 7.7 6.3 5.4 5.5 3.7 3.8 7.7 3.9 2.8 6.7 3.9 5.6 4.2 5.9 5.4 5.1 4.1 4.4 4.6 2.2 6.5 3.7 4.2 8.1 4.8 11.6 12.3 11.0 16.4 11.5 12.0 13.6 11.4 15.7 11.0 17.9 8.6 15.1 16.5 15.8 25.7 16.1 28.1 10.7 14.8 24.4 43.2 42.7 34.9 31.8 7.6 18.8 14.3 0.0 28.8 47.0 15.5 14.3 20.8 10.5 29.7 27.0 15.0 12.9 16.5 7.8 14.7 14.0 13.5 34.3 9.1 24.2 26.4 12.4 15.2 35.2 27.5 25.8 21.2 39.0 22.8 19.2 138.4 13.8 17.8 15.9 EIF5B "DKFZp434I036, FLJ10524, IF2, KIAA0741" ENSG00000158417 "Eukaryotic translation initiation factor 5B" O60841 2 99337353-99401326 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Hydrolase, Initiation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034648, HPA040095" Approved Approved "Plasma membrane,Cytosol" NA NA 11000 Cytosol "Plasma membrane" "HPA034648: AB_10601902, HPA040095: AB_2676843" "unprognostic (1.23e-1)" "unprognostic (6.94e-2)" "unprognostic (2.01e-1)" "unprognostic (5.03e-2)" "unprognostic (4.65e-2)" "unprognostic (5.88e-3)" "prognostic unfavorable (7.15e-10)" "unprognostic (6.80e-2)" "unprognostic (9.84e-3)" "prognostic favorable (8.99e-4)" "unprognostic (1.68e-2)" "unprognostic (2.36e-1)" "prognostic unfavorable (1.42e-6)" "unprognostic (6.89e-2)" "unprognostic (3.24e-2)" "unprognostic (1.43e-1)" "unprognostic (7.93e-3)" 24.5 16.0 25.2 22.4 32.6 11.5 22.6 27.7 26.0 23.7 25.1 10.5 19.9 14.8 19.4 28.7 30.8 14.5 15.0 61.7 26.0 22.3 28.8 32.1 17.9 19.2 26.9 23.0 22.3 24.6 26.8 27.5 26.4 28.5 26.0 20.3 7.1 22.3 29.1 105.8 25.3 19.3 31.5 37.6 27.0 20.7 22.6 33.8 17.8 18.2 29.2 22.8 40.1 31.9 15.9 20.2 11.6 12.1 14.1 14.9 4.5 34.1 17.1 19.5 25.4 23.7 28.1 32.4 30.2 19.0 20.1 20.1 39.3 24.4 39.2 26.2 22.4 23.9 19.6 34.1 29.2 35.6 23.6 20.4 47.1 17.5 51.7 18.8 46.0 29.1 18.9 20.6 27.9 28.6 17.3 29.2 24.1 51.9 19.6 28.9 27.7 29.1 42.7 30.4 22.5 25.2 25.5 29.1 31.9 41.2 28.7 16.6 15.7 16.4 37.8 24.3 38.8 15.3 30.4 32.0 31.3 30.7 16.3 26.8 14.6 20.6 32.0 22.7 51.1 23.0 11.6 8.8 9.8 12.7 9.5 14.9 15.3 13.4 12.5 6.4 15.9 13.2 14.0 2.3 14.1 12.1 20.2 9.0 4.5 25.2 32.6 27.7 26.0 26.0 22.3 26.9 23.0 28.5 33.8 101.3 209.4 134.1 138.3 285.5 99.2 532.6 145.2 179.3 205.9 326.2 47.1 126.1 122.7 191.6 558.1 145.8 91.2 116.8 202.2 178.1 139.3 179.5 165.5 428.2 118.4 73.1 151.6 136.2 112.7 88.6 115.3 122.6 135.0 171.3 133.7 81.8 227.8 86.3 165.2 160.8 108.6 271.7 161.7 293.6 551.3 283.8 151.7 127.0 125.6 200.5 ELMO3 "CED-12, CED12, ELMO-3, FLJ13824" ENSG00000102890 "Engulfment and cell motility 3" Q96BJ8 16 67199111-67204029 "Predicted intracellular proteins" "Apoptosis, Phagocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 67.1;Paneth cells: 44.1;Undifferentiated cells: 45.7" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "cerebellum: 6.7" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 17.0;CAPAN-2: 24.9;HaCaT: 23.6;T-47d: 23.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA021484 Approved Approved "Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" "HPA021484: AB_1848129" "unprognostic (4.49e-3)" "unprognostic (2.04e-1)" "unprognostic (1.10e-2)" "unprognostic (8.08e-2)" "unprognostic (1.39e-1)" "unprognostic (6.16e-3)" "unprognostic (3.14e-1)" "unprognostic (8.17e-3)" "unprognostic (1.73e-1)" "unprognostic (8.06e-2)" "unprognostic (3.40e-2)" "unprognostic (6.95e-3)" "prognostic favorable (2.77e-5)" "unprognostic (3.47e-1)" "unprognostic (2.66e-1)" "unprognostic (1.84e-1)" "unprognostic (1.97e-2)" 1.1 0.8 0.6 7.8 1.8 2.5 4.6 6.7 1.4 2.8 30.3 0.5 32.0 18.9 2.6 9.8 13.1 4.8 16.0 0.9 0.7 0.8 13.3 3.9 6.9 1.4 0.5 0.5 1.2 26.6 6.5 28.7 13.7 1.0 13.2 5.1 0.9 25.1 28.8 0.5 19.1 37.7 1.7 0.5 2.8 12.8 8.7 0.6 1.1 18.2 9.7 9.2 6.8 6.0 1.2 0.8 2.1 0.4 0.4 1.0 0.1 10.8 1.2 1.2 1.5 0.2 0.3 17.0 0.6 0.3 0.8 0.7 7.1 24.9 1.5 0.8 0.3 0.3 23.6 1.1 10.9 0.2 0.7 1.4 1.5 2.0 2.3 0.5 0.9 3.9 0.2 8.0 0.6 0.6 0.8 0.8 1.3 1.5 0.8 0.4 9.0 0.9 4.5 1.6 10.2 1.0 2.2 1.2 2.4 1.0 1.5 8.3 1.9 1.6 7.4 0.7 0.7 23.3 1.7 1.4 1.9 2.3 1.2 1.1 2.5 0.8 2.8 1.0 2.1 0.9 0.0 0.4 1.0 1.0 0.0 0.1 1.2 0.8 0.1 0.5 1.1 0.6 0.2 2.1 0.4 0.1 0.8 0.5 0.1 0.6 1.8 6.7 1.4 0.7 0.8 0.5 0.5 1.0 0.6 0.0 12.5 2.4 11.4 7.8 0.8 1.1 12.7 1.4 2.3 19.2 0.0 26.3 14.9 16.5 19.0 1.4 67.1 0.0 20.8 12.4 1.0 6.3 4.6 3.9 3.1 0.0 12.6 1.3 1.3 26.2 0.9 1.4 3.3 2.8 31.8 0.4 23.9 44.1 0.7 23.7 1.3 0.0 0.4 7.9 2.5 11.8 14.1 0.0 45.7 8.1 ELN "SVAS, WBS, WS" ENSG00000049540 Elastin P15502 7 74027789-74069907 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 13 "Fibroblasts: 53.4;Ito cells: 49.1;Leydig cells: 102.4;Peritubular cells: 139.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 16.9;BJ: 23.4;fHDF/TERT166: 33.6;U-2197: 133.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "CAB010750, HPA018111, HPA056941" Supported Approved "Plasma membrane" "Secreted to extracellular matrix" NA NA 2900000 "Plasma membrane" "CAB010750: AB_476930, HPA018111: AB_1848109, HPA056941: AB_2683280" "unprognostic (1.51e-2)" "unprognostic (4.86e-2)" "unprognostic (2.50e-2)" "unprognostic (1.11e-1)" "unprognostic (1.57e-2)" "unprognostic (2.72e-2)" "unprognostic (3.70e-3)" "unprognostic (1.23e-1)" "unprognostic (3.33e-2)" "unprognostic (2.00e-3)" "unprognostic (2.88e-1)" "unprognostic (1.09e-1)" "unprognostic (2.18e-3)" "unprognostic (1.79e-2)" "unprognostic (3.90e-2)" "prognostic unfavorable (6.29e-4)" "unprognostic (1.62e-3)" 35.0 8.8 4.3 14.9 3.6 0.0 24.8 27.8 5.8 23.3 12.1 12.9 9.1 3.2 22.3 26.0 30.1 17.1 30.8 41.5 5.4 3.0 8.3 3.7 49.7 7.5 4.4 9.2 10.6 35.3 0.7 6.1 22.5 13.7 25.1 4.6 34.3 16.8 14.5 6.0 23.6 9.2 34.7 9.9 10.7 16.0 8.1 6.4 0.9 11.9 10.3 4.4 34.0 21.7 0.4 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.3 0.1 0.0 16.9 0.1 0.1 23.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 33.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 1.3 0.1 0.1 0.0 9.0 0.1 0.0 0.0 4.6 11.0 0.0 0.2 0.0 1.7 0.1 0.0 0.0 0.0 0.0 133.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 4.3 3.6 27.8 5.8 5.4 3.0 4.4 9.2 13.7 6.4 0.0 8.3 0.0 13.2 9.7 0.9 8.9 2.5 4.0 5.7 7.0 2.0 0.1 0.0 0.2 2.5 26.4 0.0 0.0 3.5 0.2 53.4 1.2 0.0 2.1 0.4 6.4 1.7 49.1 0.3 4.2 102.4 1.0 13.5 0.0 1.3 17.8 1.5 0.0 139.3 0.0 0.7 0.0 31.5 0.9 1.1 9.5 0.1 0.0 0.0 0.8 EMP3 YMP ENSG00000142227 "Epithelial membrane protein 3" P54852 19 48321509-48330553 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 165.9" "Cell type enhanced" "Detected in many" 8 "Fibroblasts: 530.6;Hofbauer cells: 548.3;Kupffer cells: 540.8;Macrophages: 782.1;Melanocytes: 1059.5" "Cancer enhanced" "Detected in all" "melanoma: 195.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 116.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062030 Approved "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA062030: " "unprognostic (5.06e-3)" "unprognostic (4.41e-1)" "unprognostic (1.83e-1)" "unprognostic (9.28e-3)" "unprognostic (1.33e-2)" "unprognostic (4.83e-3)" "unprognostic (1.49e-2)" "unprognostic (1.02e-1)" "unprognostic (9.31e-2)" "unprognostic (4.72e-2)" "unprognostic (3.41e-2)" "unprognostic (1.79e-1)" "prognostic unfavorable (2.31e-7)" "prognostic unfavorable (3.13e-4)" "unprognostic (1.16e-1)" "unprognostic (2.41e-1)" "unprognostic (2.90e-3)" 27.6 23.4 10.4 26.5 12.6 66.2 28.7 7.2 8.4 50.6 40.3 9.2 14.6 8.4 45.9 22.6 26.9 26.1 21.1 37.9 10.8 6.9 15.6 7.0 36.1 48.0 15.2 6.7 41.4 6.4 2.2 6.1 29.9 12.7 30.7 15.4 24.7 11.3 23.1 13.2 16.3 20.8 46.7 19.1 27.8 19.2 18.2 8.2 16.2 11.6 13.4 25.6 36.8 30.6 44.9 54.8 165.9 91.0 59.7 119.1 124.8 5.6 63.2 3.5 10.1 56.2 87.8 0.1 39.0 71.1 51.7 45.8 6.1 20.4 0.7 8.8 86.6 26.7 1.0 3.7 4.2 31.8 18.6 1.6 27.0 16.6 3.7 47.2 13.3 28.3 47.6 0.8 53.0 36.6 38.4 22.1 6.1 17.8 46.4 79.0 0.9 2.0 116.0 4.7 1.2 16.0 1.6 12.2 27.4 44.3 0.0 0.1 0.2 17.7 0.1 10.1 6.8 0.2 20.4 36.4 46.8 20.3 36.9 30.6 24.5 30.4 1.7 27.7 17.6 31.7 165.9 77.2 105.6 109.2 91.0 90.4 44.9 114.8 106.6 54.8 35.4 65.7 78.2 85.7 59.7 86.6 40.8 119.1 124.8 10.4 12.6 7.2 8.4 10.8 6.9 15.2 6.7 12.7 8.2 0.0 5.0 254.5 67.7 246.9 2.2 3.9 15.3 5.3 11.4 31.4 0.0 10.5 5.0 62.4 5.0 137.6 1.3 0.0 9.8 19.7 530.6 38.3 254.8 4.7 548.3 0.0 5.8 114.8 540.8 9.1 310.7 782.1 1059.5 206.4 2.9 65.0 72.6 17.3 204.0 6.5 3.3 103.5 237.6 9.8 4.5 166.0 16.9 200.3 2.6 22.6 ENG "CD105, END, HHT1, ORW, ORW1" ENSG00000106991 Endoglin P17813 9 127815012-127854756 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins" "Angiogenesis, Cell adhesion" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 17 "Endothelial cells: 336.5;Ito cells: 724.3;Leydig cells: 451.1;Peritubular cells: 1336.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 12.2;intermediate monocyte: 17.7;myeloid DC: 6.4;NK-cell: 4.6;non-classical monocyte: 13.0" "Group enriched" "Detected in many" 4 "dendritic cells: 6.4;monocytes: 17.7;NK-cells: 4.6" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 36.6;HUVEC TERT2: 68.4;TIME: 139.4;U-138 MG: 34.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000096, HPA011862, HPA067440, CAB072873" Enhanced Supported "Nuclear bodies,Plasma membrane" NA NA 260000000 "Plasma membrane" "Nuclear bodies" "CAB000096: AB_563482, CAB072873: AB_2665725, HPA011862: AB_1846217, HPA067440: AB_2685840" "unprognostic (2.28e-1)" "unprognostic (1.13e-1)" "unprognostic (3.87e-2)" "unprognostic (2.96e-2)" "unprognostic (1.77e-1)" "prognostic favorable (6.61e-4)" "prognostic favorable (5.62e-6)" "unprognostic (2.15e-1)" "unprognostic (4.06e-1)" "unprognostic (3.87e-2)" "unprognostic (2.20e-2)" "unprognostic (8.98e-2)" "prognostic unfavorable (4.26e-4)" "unprognostic (3.33e-3)" "unprognostic (7.35e-2)" "unprognostic (2.84e-1)" "unprognostic (1.27e-1)" 40.3 19.3 6.4 26.6 10.5 5.5 52.7 3.9 8.6 26.3 14.0 7.6 18.5 11.2 27.0 25.2 17.2 23.2 28.3 105.4 8.0 5.0 40.8 26.8 66.7 44.1 10.6 7.0 66.4 9.6 8.6 12.5 60.2 10.1 23.1 6.4 35.5 9.9 51.7 24.1 10.1 14.5 23.1 8.7 52.4 11.6 37.2 7.7 6.7 35.4 19.3 11.0 20.3 44.8 1.1 6.4 0.3 17.7 4.6 2.3 4.6 0.1 0.1 1.0 0.0 17.2 11.8 30.3 19.9 14.3 10.6 6.2 0.0 0.1 0.1 9.7 36.6 8.0 0.3 0.0 3.2 3.5 0.0 0.0 5.6 11.3 0.6 13.3 2.6 0.0 20.1 0.7 13.8 5.0 0.1 68.4 0.1 0.0 0.1 12.4 0.1 0.0 0.2 0.2 0.0 0.5 8.8 1.7 0.1 0.0 0.0 0.1 0.2 10.5 9.2 2.7 0.7 1.8 4.0 139.4 34.9 1.9 22.7 0.0 0.7 0.1 0.1 9.4 7.0 11.4 0.0 12.2 0.3 1.3 17.7 0.4 0.4 2.1 2.3 6.4 1.1 1.3 2.0 0.3 4.6 13.0 2.4 0.8 4.6 6.4 10.5 3.9 8.6 8.0 5.0 10.6 7.0 10.1 7.7 3.0 23.1 25.1 2.3 10.6 2.5 16.5 22.9 8.1 3.4 3.5 3.9 24.4 0.0 8.3 7.0 336.5 0.0 23.3 1.0 249.8 36.6 1.4 15.0 5.1 119.5 0.0 2.4 724.3 66.8 29.3 451.1 50.7 23.6 46.9 1.1 3.1 2.0 0.0 1336.5 0.0 4.1 71.1 20.8 3.7 4.9 7.3 314.8 5.7 0.2 1.1 EPB41L4A NBL4 ENSG00000129595 "Erythrocyte membrane protein band 4.1 like 4A" Q9HCS5 5 112142441-112419316 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cholangiocytes: 68.8;Ciliated cells: 42.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 20.0;HeLa: 22.6;RT4: 13.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA036580 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA036580: AB_10669908" "unprognostic (1.40e-1)" "unprognostic (1.90e-1)" "unprognostic (1.92e-3)" "unprognostic (3.64e-2)" "unprognostic (4.73e-2)" "unprognostic (5.59e-3)" "unprognostic (4.40e-2)" "unprognostic (8.38e-2)" "unprognostic (1.90e-1)" "unprognostic (3.97e-2)" "unprognostic (1.22e-1)" "unprognostic (1.23e-3)" "prognostic favorable (3.65e-5)" "unprognostic (1.68e-1)" "unprognostic (3.35e-2)" "unprognostic (2.73e-1)" "unprognostic (1.92e-1)" 21.4 3.7 3.5 5.0 4.0 2.1 19.0 2.1 6.1 7.3 3.0 1.7 22.1 1.9 6.1 11.3 13.6 6.2 11.7 9.3 4.0 3.1 10.0 4.8 21.9 6.9 3.7 2.0 4.9 4.2 14.3 4.3 8.9 3.7 5.3 3.8 10.5 7.7 22.0 6.8 7.2 3.2 5.9 4.3 6.7 4.3 4.8 1.9 2.1 15.7 8.2 6.9 5.5 12.2 3.6 0.5 1.3 1.2 0.4 4.8 0.9 0.5 3.5 9.2 0.9 0.0 0.0 1.9 1.3 0.0 0.0 0.0 1.9 7.8 3.8 20.0 0.0 0.5 4.7 0.6 4.3 0.0 0.6 3.2 6.1 22.6 1.2 0.1 1.6 2.0 0.0 1.9 0.0 0.0 1.0 5.8 1.1 1.2 3.6 0.0 1.1 2.8 2.1 1.7 0.7 0.7 1.4 7.0 0.8 5.4 13.6 7.7 4.0 6.8 3.4 2.7 6.7 10.2 0.8 10.0 0.4 1.6 1.2 2.7 3.6 0.7 2.9 0.9 3.2 0.5 1.3 0.4 0.2 4.8 0.6 2.7 3.6 1.5 1.4 0.5 3.3 2.4 4.7 0.5 0.4 1.2 0.3 1.4 0.9 3.5 4.0 2.1 3.9 4.0 3.1 3.7 2.0 3.7 1.9 26.8 7.7 4.2 14.0 5.4 4.0 7.6 68.8 42.8 27.3 14.0 3.9 6.0 10.0 12.3 16.7 18.0 2.6 0.0 6.8 0.9 6.7 12.1 8.1 1.7 2.1 1.6 1.2 30.1 5.6 14.1 1.7 1.3 3.3 4.6 6.3 7.7 10.4 10.5 1.8 20.3 31.5 0.0 4.7 1.6 6.1 7.0 2.1 1.7 4.5 16.3 EPB41L4B EHM2 ENSG00000095203 "Erythrocyte membrane protein band 4.1 like 4B" Q9H329 9 109171975-109320964 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 28.1;pancreas: 59.8" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 67.5;Hepatocytes: 107.1;Intestinal endocrine cells: 49.7;Mucus-secreting cells: 52.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 16.0;hTCEpi: 25.1;OE19: 30.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042862 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA042862: AB_10794534" "prognostic unfavorable (1.02e-4)" "unprognostic (6.58e-2)" "unprognostic (2.33e-2)" "unprognostic (1.20e-1)" "unprognostic (2.31e-2)" "unprognostic (1.74e-1)" "unprognostic (2.40e-2)" "unprognostic (6.19e-2)" "unprognostic (2.72e-2)" "unprognostic (1.40e-1)" "unprognostic (3.60e-1)" "unprognostic (6.20e-2)" "unprognostic (8.82e-4)" "unprognostic (1.46e-3)" "unprognostic (1.43e-1)" "unprognostic (4.65e-2)" "unprognostic (1.29e-1)" 6.5 4.2 7.3 1.2 14.6 0.0 4.8 4.9 11.4 1.1 18.4 1.5 7.1 15.1 0.7 5.9 0.7 3.2 1.8 3.5 2.9 3.5 1.9 28.1 1.7 0.2 1.6 6.8 4.7 59.8 3.3 0.9 1.1 2.7 2.2 18.7 2.4 8.0 3.5 2.2 5.6 16.1 0.3 2.2 0.2 9.4 2.7 1.3 0.4 14.6 1.3 1.2 1.2 1.3 0.8 0.0 0.1 0.0 0.0 0.0 0.0 4.2 5.3 0.3 0.4 0.4 0.0 16.0 0.5 0.2 1.8 0.9 9.0 4.2 0.0 1.1 0.5 4.5 6.9 10.6 5.6 2.0 4.4 2.5 0.0 1.7 12.8 1.1 0.2 0.0 0.1 25.1 0.7 8.6 0.5 0.1 3.9 0.1 0.0 2.6 10.7 0.1 0.1 6.9 30.4 7.8 0.0 0.0 0.2 6.4 6.4 6.6 0.7 1.7 11.1 0.0 3.3 2.6 0.0 0.2 3.8 3.9 1.2 1.5 0.0 0.0 0.0 2.8 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 14.6 4.9 11.4 2.9 3.5 1.6 6.8 2.7 1.3 6.0 3.2 0.8 4.6 10.2 8.3 14.9 22.9 16.0 5.7 7.0 0.0 3.3 0.0 3.2 8.7 0.7 67.5 0.0 18.0 1.6 2.2 9.9 0.0 107.1 0.5 36.5 49.7 4.3 1.6 1.5 12.4 0.2 1.7 0.0 52.8 1.8 12.8 37.4 2.5 0.6 1.0 0.0 0.4 1.4 14.8 21.0 1.6 0.0 34.5 5.7 ERAP1 "A-LAP, ARTS-1, ERAAP1, KIAA0525, PILS-AP" ENSG00000164307 "Endoplasmic reticulum aminopeptidase 1" Q9NZ08 5 96760810-96808100 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025095, HPA042317" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to blood" NA NA 27000000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB025095: , HPA042317: AB_2677946" "unprognostic (2.33e-3)" "unprognostic (3.45e-1)" "unprognostic (1.84e-3)" "unprognostic (1.34e-1)" "unprognostic (1.86e-1)" "unprognostic (4.38e-1)" "unprognostic (1.88e-3)" "unprognostic (5.37e-2)" "unprognostic (1.45e-1)" "unprognostic (7.94e-2)" "unprognostic (4.52e-2)" "unprognostic (3.23e-1)" "unprognostic (7.09e-2)" "unprognostic (1.36e-1)" "unprognostic (3.93e-2)" "unprognostic (1.19e-1)" "unprognostic (5.14e-2)" 23.8 13.6 9.3 22.7 11.9 11.6 23.3 14.2 14.6 14.5 23.8 10.1 11.2 30.8 14.7 13.4 12.3 14.3 19.9 16.1 9.7 6.8 13.3 23.7 17.8 16.4 13.5 7.6 15.5 16.5 11.1 39.4 28.2 11.4 13.4 21.9 8.5 13.9 15.2 23.1 17.7 39.7 10.6 17.1 19.5 16.5 5.4 13.8 55.5 13.5 9.8 17.8 15.9 14.1 14.9 15.2 19.8 17.5 19.8 21.8 10.7 7.4 4.7 6.4 6.0 35.4 34.7 18.6 5.5 17.7 13.3 23.3 5.9 27.0 22.3 11.5 10.6 18.7 7.6 5.3 11.2 8.3 40.2 2.2 7.2 3.2 4.0 40.6 3.4 13.4 14.4 4.9 15.2 4.7 19.6 18.2 14.5 3.7 21.6 7.9 3.5 32.0 3.6 3.2 0.9 3.1 23.8 8.7 11.1 9.9 11.5 2.4 1.6 8.7 5.9 8.5 4.6 5.1 16.6 14.5 11.4 3.9 1.9 9.0 8.1 15.1 17.3 12.2 11.8 6.7 19.8 13.2 15.6 21.2 11.4 19.7 13.0 18.5 18.2 9.5 14.9 21.8 17.4 14.4 19.8 17.5 15.2 12.3 10.7 9.3 11.9 14.2 14.6 9.7 6.8 13.5 7.6 11.4 13.8 8.9 12.3 13.7 12.1 22.1 11.6 8.5 10.2 22.7 14.8 8.7 2.0 8.0 0.0 10.8 20.0 11.3 25.8 0.0 13.4 9.1 16.1 9.2 14.0 27.0 16.2 3.2 9.9 18.4 31.2 5.2 9.2 18.5 6.8 21.6 25.9 9.7 11.2 17.5 15.2 5.0 7.2 0.0 9.5 1.2 0.7 9.7 7.7 20.0 19.1 12.2 ERMN "ERMIN, JN, KIAA1189" ENSG00000136541 Ermin Q8TAM6 2 157318625-157327713 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 106.7" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 2: 2.2;Early spermatids: 1.2;Kupffer cells: 1.2;Macrophages: 1.1;T-cells: 1.9" "Group enriched" "Detected in some" 12 "endometrial cancer: 2.2;glioma: 9.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 6 "HAP1: 21.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038295, HPA038296" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA038295: AB_10805353, HPA038296: AB_10796217" "unprognostic (7.89e-2)" "unprognostic (9.06e-3)" "unprognostic (2.71e-2)" "prognostic favorable (6.93e-6)" "unprognostic (1.06e-1)" "unprognostic (2.02e-2)" "unprognostic (9.14e-2)" "unprognostic (1.79e-1)" "unprognostic (4.57e-2)" "unprognostic (4.40e-2)" "unprognostic (1.07e-1)" "unprognostic (5.49e-2)" "unprognostic (1.46e-3)" "unprognostic (2.84e-2)" "unprognostic (7.96e-2)" "unprognostic (9.97e-3)" "unprognostic (5.76e-2)" 1.6 1.4 29.1 2.9 50.5 9.7 1.6 2.7 106.7 1.4 1.8 52.4 0.0 1.8 1.6 1.5 1.7 1.4 1.9 1.6 40.9 21.4 1.5 1.5 2.0 3.1 75.1 18.4 1.5 1.6 1.4 0.1 1.4 54.5 1.5 1.9 4.3 2.4 1.5 1.7 1.9 1.9 1.6 100.9 2.5 2.2 1.7 69.5 0.0 1.6 0.0 2.7 1.7 0.1 1.7 1.3 3.9 1.6 2.4 2.1 0.7 0.1 0.3 0.3 0.2 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.1 0.2 1.2 0.0 2.0 0.0 0.3 21.3 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.0 0.7 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 2.8 0.4 0.2 0.8 2.3 0.3 0.1 0.5 0.0 0.4 0.5 0.0 1.0 0.4 0.6 0.0 0.1 0.0 0.3 0.7 1.3 0.0 0.2 0.1 0.2 0.6 3.5 2.0 0.6 1.8 1.0 1.0 2.6 1.6 1.1 2.1 1.2 1.0 0.7 0.8 0.6 0.6 1.7 1.5 1.6 3.9 2.4 1.0 1.3 0.9 0.7 29.1 50.5 2.7 27.9 40.9 21.4 75.1 18.4 54.5 69.5 0.0 2.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 1.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 1.9 0.0 0.0 ETNK1 "EKI, EKI1" ENSG00000139163 "Ethanolamine kinase 1" Q9HBU6 12 22625075-22690665 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 201.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010712, HPA029407" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA010712: AB_2668349, HPA029407: AB_2673026" "unprognostic (2.06e-1)" "unprognostic (7.48e-2)" "unprognostic (1.23e-3)" "unprognostic (2.19e-1)" "unprognostic (8.79e-3)" "unprognostic (1.31e-2)" "prognostic unfavorable (5.85e-4)" "unprognostic (3.98e-3)" "unprognostic (8.30e-2)" "unprognostic (7.97e-3)" "unprognostic (2.01e-1)" "unprognostic (1.64e-2)" "unprognostic (4.53e-3)" "unprognostic (2.77e-1)" "unprognostic (2.91e-1)" "unprognostic (3.01e-1)" "prognostic favorable (1.75e-4)" 15.7 17.7 15.2 41.1 19.4 13.7 16.9 19.7 22.2 12.9 33.2 16.4 14.6 27.2 16.6 24.1 14.7 13.1 27.3 10.4 15.6 23.9 22.0 30.2 19.6 18.5 17.2 15.8 17.2 14.9 15.8 30.6 13.4 18.9 13.8 19.5 15.9 16.7 14.7 8.2 17.8 24.5 10.0 17.1 18.3 53.7 22.3 17.5 33.4 17.6 8.2 16.5 14.2 18.6 16.2 10.7 28.1 17.6 14.0 15.7 13.4 6.7 14.0 15.6 14.4 11.3 11.4 11.6 8.0 6.0 8.3 8.6 10.8 17.1 20.1 7.2 5.2 8.7 5.1 13.7 3.8 15.0 16.7 11.1 16.6 6.2 9.3 10.8 15.9 15.3 7.4 3.7 11.2 9.5 13.3 10.3 7.9 19.9 8.5 11.0 4.6 17.3 32.4 30.2 8.7 9.2 15.6 13.8 16.1 13.8 9.2 5.0 8.8 8.7 7.6 12.5 22.4 11.8 15.4 8.8 6.6 10.6 8.9 12.0 6.2 7.7 21.6 8.4 10.4 11.0 28.1 11.7 12.1 12.9 17.5 12.7 16.2 14.1 11.9 10.7 13.0 15.7 15.5 11.5 14.0 17.6 9.7 15.3 13.4 15.2 19.4 19.7 22.2 15.6 23.9 17.2 15.8 18.9 17.5 44.7 25.1 40.9 63.3 128.1 40.4 11.0 53.5 72.3 35.2 41.8 47.1 27.9 23.2 26.3 201.9 28.7 55.0 0.0 39.6 20.3 28.6 70.5 33.5 38.4 37.5 25.4 103.9 27.6 78.9 26.1 22.5 44.7 64.1 22.6 52.6 21.4 29.0 46.1 20.1 26.4 35.5 38.8 44.3 47.7 15.1 148.8 63.0 39.2 36.0 60.2 EVA1A "FAM176A, FLJ13391, TMEM166" ENSG00000115363 "Eva-1 homolog A, regulator of programmed cell death" Q9H8M9 2 75469302-75569722 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Autophagy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 69.4;pancreas: 32.3" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 71.0;Proximal tubular cells: 53.7;Syncytiotrophoblasts: 104.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 1.1;naive CD8 T-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 27.2;U-138 MG: 36.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008055 Approved Supported "Vesicles,Plasma membrane" NA NA Vesicles "Plasma membrane" "HPA008055: AB_1080308" "unprognostic (2.72e-1)" "unprognostic (2.61e-2)" "unprognostic (4.14e-3)" "unprognostic (1.01e-1)" "unprognostic (1.36e-2)" "unprognostic (3.60e-2)" "unprognostic (5.02e-2)" "unprognostic (1.77e-2)" "unprognostic (1.77e-1)" "prognostic favorable (5.67e-4)" "unprognostic (7.33e-2)" "unprognostic (1.22e-1)" "prognostic favorable (5.80e-4)" "unprognostic (8.19e-2)" "unprognostic (4.37e-2)" "unprognostic (2.43e-2)" "unprognostic (9.07e-2)" 0.6 0.3 0.3 0.7 0.5 0.0 1.2 0.3 0.2 3.7 0.6 0.1 11.4 0.5 1.6 5.1 0.5 1.3 0.4 0.6 0.3 0.3 23.6 69.4 15.2 0.1 0.8 0.0 0.8 32.3 0.8 0.8 26.6 0.5 0.6 0.2 5.7 14.3 13.5 0.9 1.5 1.1 0.7 0.4 5.9 0.4 2.2 0.3 3.3 1.2 0.8 0.8 0.3 0.6 0.8 0.0 0.0 0.0 0.0 1.1 0.7 0.3 4.6 0.5 0.1 1.0 7.1 0.5 21.7 14.6 19.4 9.9 0.1 0.4 0.0 2.0 27.2 17.8 3.0 0.5 4.6 12.2 0.0 0.3 0.0 0.8 14.4 0.7 0.0 0.0 5.0 2.7 23.9 11.0 19.5 12.0 0.0 0.0 0.0 14.8 0.0 0.0 0.0 1.0 0.0 7.5 2.4 0.0 0.0 10.7 0.1 0.3 0.5 2.0 0.1 16.6 0.7 0.0 0.1 9.8 36.5 15.3 0.6 22.6 0.2 0.0 0.0 20.7 0.0 19.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.1 1.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.5 0.3 0.2 0.3 0.3 0.8 0.0 0.5 0.3 38.7 30.7 2.7 9.2 2.5 0.8 0.2 0.0 1.4 36.4 10.4 0.0 33.7 23.2 27.0 11.0 1.3 0.0 0.0 14.2 17.5 2.1 5.2 0.0 71.0 3.2 0.0 1.7 3.7 0.6 8.2 0.3 0.8 27.0 0.0 0.0 0.0 15.1 0.0 0.7 53.7 0.0 0.0 1.0 1.7 0.4 0.6 104.4 0.0 0.0 10.0 EXOC1 "BM-102, FLJ10893, SEC3, SEC3L1, Sec3p" ENSG00000090989 "Exocyst complex component 1" Q9NV70 4 55853616-55905034 "Predicted intracellular proteins, Transporters" "Antiviral defense, Exocytosis, Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037706, HPA044873" Uncertain Approved "Plasma membrane,Microtubules,Cytosol" NA NA "Plasma membrane" "Microtubules, Cytosol" "HPA037706: AB_10670525, HPA044873: AB_2679125" "unprognostic (7.10e-3)" "unprognostic (4.48e-2)" "unprognostic (8.85e-2)" "unprognostic (9.22e-2)" "unprognostic (9.81e-2)" "unprognostic (2.63e-1)" "prognostic unfavorable (2.63e-4)" "unprognostic (2.84e-3)" "unprognostic (4.65e-2)" "unprognostic (2.04e-2)" "unprognostic (4.03e-3)" "unprognostic (1.55e-1)" "unprognostic (1.94e-1)" "unprognostic (3.11e-1)" "unprognostic (2.93e-2)" "unprognostic (6.24e-2)" "prognostic favorable (5.50e-5)" 21.2 19.7 20.7 21.0 24.0 12.9 25.3 22.8 40.7 18.4 20.2 18.2 14.6 18.9 20.8 24.6 32.7 18.3 17.9 19.8 26.9 23.6 18.7 11.4 26.2 29.2 24.7 22.8 18.2 14.9 29.7 20.0 23.4 30.7 16.8 22.4 12.9 20.3 19.2 14.6 31.6 20.5 18.4 29.1 23.7 17.5 18.5 21.5 19.1 19.0 15.8 21.9 18.8 21.4 7.3 11.7 16.4 18.1 10.1 9.2 6.3 11.5 6.7 12.1 13.9 20.9 26.2 8.1 16.3 16.5 13.4 14.1 4.6 20.2 11.2 11.5 17.5 16.2 13.9 9.8 13.0 19.3 5.9 6.8 10.3 8.4 5.4 19.7 11.2 14.7 21.1 17.8 13.9 15.4 17.4 21.8 8.7 14.8 11.0 29.0 7.3 8.1 11.4 7.6 16.6 12.8 9.5 9.0 9.0 14.9 12.7 9.0 16.0 9.8 16.1 13.5 10.8 10.2 12.1 26.2 16.6 13.6 14.2 14.0 13.3 6.6 9.9 21.6 12.5 15.7 15.2 12.1 10.4 5.8 15.7 7.5 7.3 8.2 8.2 11.7 6.7 7.4 5.4 16.4 10.1 18.1 5.3 9.2 6.3 20.7 24.0 22.8 40.7 26.9 23.6 24.7 22.8 30.7 21.5 38.7 29.4 13.7 12.5 30.9 45.5 26.4 20.4 44.2 26.1 21.0 29.5 53.7 16.6 18.4 31.3 32.2 30.4 0.0 17.4 27.7 28.1 16.9 34.8 9.7 35.9 27.0 21.4 41.7 40.5 10.6 19.8 36.1 38.8 19.8 26.7 45.2 26.5 28.1 22.3 14.0 30.3 32.3 21.4 27.7 34.1 34.9 42.8 18.8 25.1 19.6 EXOC3L1 "EXOC3L, FLJ35539, FLJ35587" ENSG00000179044 "Exocyst complex component 3 like 1" Q86VI1 16 67184366-67190204 "Predicted intracellular proteins" Exocytosis "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 26.6" "Cell type enhanced" "Detected in many" 13 "Endothelial cells: 11.7;Ito cells: 32.5;Leydig cells: 14.4;Peritubular cells: 17.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "neutrophil: 1.8;non-classical monocyte: 2.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 3.1;HUVEC TERT2: 5.8;SCLC-21H: 11.1;SuSa: 3.8;TIME: 4.0" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA029574 Uncertain Approved "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA029574: AB_10602495" "unprognostic (1.15e-2)" "unprognostic (4.91e-2)" "unprognostic (6.87e-3)" "unprognostic (2.09e-3)" "unprognostic (2.33e-1)" "unprognostic (2.46e-2)" "unprognostic (6.77e-2)" "unprognostic (3.98e-2)" "unprognostic (1.55e-1)" "unprognostic (1.26e-2)" "unprognostic (6.48e-3)" "unprognostic (2.88e-1)" "unprognostic (6.64e-3)" "unprognostic (3.40e-1)" "unprognostic (1.23e-1)" "unprognostic (3.26e-1)" "unprognostic (1.35e-1)" 4.5 2.4 0.3 1.8 0.9 0.0 2.4 0.4 1.2 1.4 0.6 0.3 0.3 0.8 3.6 0.8 1.2 0.9 1.5 4.5 1.3 0.2 3.3 1.4 8.7 1.8 0.3 0.8 2.0 1.0 0.4 1.1 6.0 1.0 1.6 0.3 2.4 1.1 0.5 1.8 0.7 1.0 0.8 1.0 26.6 0.7 1.0 0.3 0.3 4.1 1.0 0.5 1.0 0.5 0.0 0.7 1.8 2.0 0.0 0.0 0.3 0.2 0.1 1.2 0.4 0.0 0.1 3.1 0.4 0.0 0.0 0.0 1.4 0.3 0.1 1.7 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.3 0.8 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 5.8 0.6 0.5 0.0 0.1 0.2 0.3 0.1 0.5 0.1 0.6 1.3 1.2 0.2 0.0 0.2 11.1 1.3 1.5 0.3 0.1 3.8 1.0 0.1 4.0 0.2 0.2 0.2 0.1 0.2 0.1 0.1 0.8 0.0 0.3 0.0 1.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.8 0.0 2.0 0.0 0.0 0.3 0.3 0.9 0.4 1.2 1.3 0.2 0.3 0.8 1.0 0.3 0.0 0.0 0.0 1.6 0.8 1.7 0.8 0.0 0.0 0.0 3.5 0.0 0.4 6.6 0.7 1.6 11.7 4.2 0.0 3.3 2.5 0.2 0.3 0.0 0.8 0.8 3.2 1.2 32.5 1.5 3.1 14.4 0.3 0.0 1.0 3.3 0.2 0.5 1.7 17.3 0.1 0.8 0.0 0.1 0.4 0.9 1.8 0.7 0.0 2.3 1.3 EXOC7 "BLOM4, EXO70, Exo70p, KIAA1067, YJL085W" ENSG00000182473 "Exocyst complex component 7" Q9UPT5 17 76081017-76121576 "Predicted intracellular proteins, Transporters" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022840, HPA022842" Supported Approved "Vesicles,Plasma membrane,Cytosol" NA NA Cytosol "Vesicles, Plasma membrane" "HPA022840: AB_1848316, HPA022842: AB_1848317" "unprognostic (5.20e-2)" "unprognostic (1.08e-1)" "unprognostic (1.63e-1)" "unprognostic (1.27e-1)" "unprognostic (1.80e-1)" "unprognostic (3.49e-2)" "unprognostic (2.37e-2)" "unprognostic (1.88e-1)" "unprognostic (1.30e-1)" "unprognostic (1.02e-1)" "unprognostic (2.47e-2)" "unprognostic (7.39e-3)" "unprognostic (1.53e-2)" "unprognostic (1.73e-1)" "unprognostic (1.19e-1)" "unprognostic (1.05e-1)" "unprognostic (1.18e-1)" 23.2 22.2 30.5 18.2 37.1 27.5 20.4 27.8 46.2 23.8 24.4 33.0 20.8 19.1 28.7 20.8 31.8 32.6 21.3 27.5 29.2 23.5 21.0 22.6 21.2 17.6 20.9 28.2 31.5 24.1 40.5 29.3 24.0 34.6 30.0 17.0 27.0 29.2 27.9 24.0 21.8 21.6 31.1 21.7 21.4 19.6 14.5 23.0 23.7 29.5 14.1 26.4 30.2 20.5 12.8 13.7 29.6 34.4 15.5 17.9 19.0 21.6 27.0 24.9 20.2 23.7 16.8 25.9 19.9 26.7 36.2 26.2 22.7 14.7 11.3 14.7 34.8 22.9 17.9 15.0 19.4 24.3 9.7 20.3 18.6 21.2 23.9 16.5 20.7 19.4 23.5 15.4 28.0 13.7 25.7 40.0 20.5 12.4 11.5 22.5 20.0 33.3 9.2 13.1 16.3 28.8 18.0 42.7 11.4 20.8 45.1 13.6 31.8 22.6 16.8 15.5 25.0 27.5 17.1 26.1 38.8 23.4 25.6 21.9 15.9 5.8 10.4 23.2 9.4 20.0 21.1 19.2 29.6 17.9 26.6 12.3 12.4 13.7 15.3 13.7 12.8 14.5 12.2 22.2 15.5 34.4 5.9 14.8 19.0 30.5 37.1 27.8 46.2 29.2 23.5 20.9 28.2 34.6 23.0 17.9 34.9 47.7 30.5 17.5 78.7 6.4 35.7 32.1 27.3 38.4 135.5 45.1 28.2 34.4 17.9 25.1 47.9 23.3 32.5 23.9 29.3 37.9 39.4 22.8 32.8 63.5 46.8 27.6 25.9 31.6 34.5 25.7 23.6 33.3 34.6 62.0 34.4 38.6 36.0 28.6 102.9 45.3 31.0 26.8 16.6 17.3 59.5 38.9 27.8 37.5 F2RL1 "GPR11, PAR2" ENSG00000164251 "F2R like trypsin receptor 1" P55085 5 76818933-76835315 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Immunity, Inflammatory response, Innate immunity" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 64.1" "Cell type enhanced" "Detected in many" 9 "Basal keratinocytes: 97.5;Enterocytes: 75.9;Suprabasal keratinocytes: 147.0;Urothelial cells: 93.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 5 "pons and medulla: 7.8" "Cell type enriched" "Detected in many" 4 "neutrophil: 24.9" "Lineage enriched" "Detected in many" 4 "granulocytes: 24.9" "Cell line enhanced" "Detected in many" "PC-3: 34.7;RPTEC TERT1: 57.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB012989, HPA014091" Approved Approved "Plasma membrane" NA Yes "Plasma membrane" "CAB012989: AB_2533199, HPA014091: AB_2668939" "unprognostic (1.29e-2)" "unprognostic (4.05e-2)" "prognostic favorable (3.88e-4)" "unprognostic (1.98e-2)" "unprognostic (8.22e-2)" "prognostic unfavorable (5.88e-4)" "unprognostic (1.36e-1)" "prognostic unfavorable (8.92e-4)" "unprognostic (6.13e-2)" "unprognostic (4.07e-1)" "unprognostic (2.16e-3)" "unprognostic (1.52e-2)" "prognostic favorable (5.86e-7)" "unprognostic (1.11e-1)" "unprognostic (1.74e-1)" "unprognostic (3.76e-2)" "unprognostic (9.73e-2)" 0.6 1.1 1.0 7.2 1.4 0.1 2.9 0.4 0.8 2.4 34.0 1.1 25.3 17.4 1.0 2.2 6.4 2.9 13.6 3.6 1.1 0.9 28.9 7.4 2.8 3.7 0.8 0.4 1.2 16.6 1.3 3.2 2.8 7.8 6.0 21.4 1.1 7.1 23.7 0.3 24.8 64.1 0.7 1.5 3.5 16.8 0.8 0.5 0.6 9.6 5.8 3.1 5.3 3.9 0.3 2.7 24.9 5.7 0.3 2.3 2.0 8.7 14.4 1.2 0.0 0.4 1.1 9.3 0.4 4.8 0.2 0.7 12.4 22.6 0.0 19.5 1.0 22.3 15.0 7.6 6.7 0.4 0.0 7.1 0.2 0.3 8.8 3.1 0.0 0.0 1.6 19.2 2.2 14.4 2.3 23.9 2.2 0.1 0.0 0.0 4.7 1.0 0.0 1.6 4.9 34.7 0.0 0.0 0.2 57.6 16.2 0.6 0.1 3.4 3.5 0.0 14.5 1.5 0.0 15.7 0.0 9.1 0.0 0.0 1.3 0.2 0.0 5.1 0.0 0.4 4.6 5.7 1.0 0.3 1.9 1.2 0.3 2.3 1.2 2.7 0.1 2.2 1.3 24.9 0.3 0.3 0.3 0.6 2.0 1.0 1.4 0.4 0.8 1.1 0.9 0.8 0.4 7.8 0.5 8.9 3.0 2.0 18.2 97.5 0.0 0.3 35.7 18.7 11.4 29.6 0.0 4.8 1.7 20.1 0.0 0.6 75.9 0.0 13.1 6.2 3.7 19.6 2.3 8.5 0.7 0.0 12.6 1.8 2.4 0.0 0.0 1.1 1.7 0.0 43.8 0.0 29.3 35.1 0.0 20.2 1.6 0.0 1.0 0.0 1.4 147.0 1.7 0.0 39.6 93.4 FABP2 I-FABP ENSG00000145384 "Fatty acid binding protein 2" P12104 4 119317250-119322390 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 47 "intestine: 358.6" "Group enriched" "Detected in some" 5 "Enterocytes: 422.5;Mucus-secreting cells: 344.1;Paneth cells: 175.6" "Group enriched" "Detected in some" 9 "colorectal cancer: 3.2;pancreatic cancer: 1.6;stomach cancer: 2.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "basophil: 2.1;neutrophil: 7.6" "Lineage enriched" "Detected in single" 8 "granulocytes: 7.6" "Cell line enhanced" "Detected in some" "BEWO: 2.9;Hep G2: 2.5;NB-4: 3.9;RPMI-8226: 3.3;SH-SY5Y: 2.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA034607, CAB047325, CAB047326" Enhanced Approved "Plasma membrane,Actin filaments,Cytosol" NA NA 46000 "Actin filaments, Cytosol" "Plasma membrane" "CAB047325: , CAB047326: , HPA034607: AB_10601317" "unprognostic (3.94e-2)" "unprognostic (1.10e-1)" "unprognostic (1.05e-1)" "unprognostic (4.58e-1)" "unprognostic (1.51e-2)" "unprognostic (2.61e-2)" "unprognostic (1.69e-4)" "unprognostic (1.93e-1)" "unprognostic (1.02e-1)" 0.1 0.2 0.1 0.8 0.1 0.0 0.1 0.1 0.1 0.1 47.0 0.0 0.0 50.0 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 5.9 0.1 0.1 0.0 0.1 0.1 358.6 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.5 0.5 7.6 0.7 0.9 0.5 0.0 0.2 0.3 0.2 0.4 0.0 0.0 2.9 0.4 0.0 0.0 0.0 0.4 0.4 0.4 0.1 0.0 0.3 0.3 0.0 0.2 0.1 0.1 0.3 0.1 0.5 2.5 0.0 0.5 0.4 0.2 0.0 0.2 0.1 0.1 0.0 0.2 0.3 0.5 0.0 0.1 0.4 3.9 0.2 0.2 0.5 0.3 0.3 3.3 0.0 0.5 1.0 2.6 0.1 0.4 0.0 0.2 0.3 0.1 0.9 0.4 0.4 1.5 0.2 0.7 0.3 0.6 0.3 0.3 0.1 2.1 0.7 0.7 0.4 0.3 0.4 0.2 0.4 0.3 0.2 0.5 0.5 0.5 7.6 0.9 0.2 0.5 0.5 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 422.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 344.1 0.0 0.0 175.6 0.0 18.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 64.7 0.0 FABP5 "E-FABP, KFABP, PA-FABP" ENSG00000164687 "Fatty acid binding protein 5" Q01469 8 81280363-81284777 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 237.0;tongue: 204.1;vagina: 141.9" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 2: 1256.0;Hofbauer cells: 2357.3;monocytes: 1172.2" "Cancer enhanced" "Detected in all" "cervical cancer: 268.3;head and neck cancer: 288.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 93.8;MOLT-4: 91.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "CAB017831, CAB040577, HPA051895" Enhanced Supported "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 28000000 Cytosol "Plasma membrane" "CAB017831: , CAB040577: , HPA051895: AB_2681654" "unprognostic (8.76e-2)" "unprognostic (7.28e-2)" "unprognostic (1.54e-2)" "unprognostic (9.04e-2)" "unprognostic (1.33e-3)" "unprognostic (1.37e-1)" "unprognostic (1.95e-3)" "unprognostic (4.03e-3)" "unprognostic (2.71e-1)" "unprognostic (3.13e-1)" "unprognostic (6.16e-2)" "unprognostic (3.57e-2)" "prognostic unfavorable (4.69e-10)" "unprognostic (1.99e-1)" "unprognostic (3.72e-1)" "unprognostic (1.61e-1)" "unprognostic (6.60e-2)" 41.4 1.5 8.5 11.8 13.2 8.5 37.3 5.5 8.9 78.7 20.6 7.9 2.2 8.0 5.7 3.1 237.0 2.1 8.5 27.1 8.5 9.8 1.6 2.7 24.8 15.1 7.6 5.0 2.0 8.7 0.7 1.9 30.0 19.1 4.4 18.2 4.2 32.9 1.6 9.4 42.9 9.7 4.5 23.0 14.9 15.6 3.8 10.6 6.6 4.4 204.1 25.7 19.5 141.9 6.8 20.3 2.5 5.9 8.2 5.2 4.3 5.8 16.7 10.2 0.0 48.8 4.6 0.0 11.9 0.6 9.3 11.8 0.2 8.0 93.8 6.8 2.9 0.1 5.4 24.8 19.1 8.0 47.6 53.9 33.8 11.9 25.2 4.3 32.3 8.8 3.5 39.3 11.5 23.7 9.4 53.4 24.9 9.7 10.2 5.6 5.6 91.6 16.5 13.5 57.9 64.9 40.9 0.0 9.9 15.0 72.5 42.4 16.1 5.8 1.9 4.4 18.5 0.1 16.6 7.6 0.0 26.5 0.1 0.1 12.6 4.9 66.8 4.3 31.0 14.9 2.5 5.0 0.3 2.3 5.9 3.7 6.8 2.7 5.2 20.3 3.3 1.3 4.5 2.0 8.2 2.0 20.1 3.5 4.3 8.5 13.2 5.5 8.9 8.5 9.8 7.6 5.0 19.1 10.6 268.0 1256.0 87.2 58.7 107.4 21.2 2.8 2.5 100.4 708.6 21.0 43.2 16.9 3.3 27.1 23.0 313.1 94.4 0.0 20.3 209.8 84.3 44.5 54.3 0.8 2357.3 20.6 189.4 31.9 161.8 37.2 5.8 624.3 195.7 1172.2 116.5 252.2 31.0 459.1 4.9 0.8 41.8 355.7 66.0 131.8 169.3 147.4 22.5 71.0 321.9 172.7 FAIM "FAIM1, FLJ10582" ENSG00000158234 "Fas apoptotic inhibitory molecule" Q9NVQ4 3 138608606-138633376 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "seminal vesicle: 61.9" "Cell type enhanced" "Detected in many" 8 "Rod photoreceptor cells: 189.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-698: 45.4" "Low region specificity" "Detected in all" "HPA042440, HPA052209" Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA042440: AB_2677999, HPA052209: AB_2681761" "unprognostic (6.45e-2)" "unprognostic (8.21e-3)" "unprognostic (5.97e-2)" "unprognostic (1.11e-1)" "unprognostic (3.24e-1)" "unprognostic (8.31e-2)" "prognostic unfavorable (3.96e-5)" "unprognostic (4.84e-2)" "unprognostic (4.15e-2)" "unprognostic (9.23e-3)" "unprognostic (2.29e-1)" "unprognostic (2.63e-2)" "prognostic favorable (6.63e-4)" "unprognostic (4.76e-2)" "unprognostic (3.51e-1)" "unprognostic (3.43e-1)" "unprognostic (6.98e-2)" 13.7 6.6 12.3 6.7 11.6 2.6 19.0 7.8 9.9 24.5 6.8 10.2 38.5 4.7 9.6 15.1 8.8 28.5 9.0 4.7 12.2 12.5 15.4 6.0 7.6 7.2 13.9 7.1 8.4 27.5 7.2 15.4 6.1 10.7 11.4 6.0 9.1 7.2 61.9 6.1 6.2 4.2 7.2 19.6 3.7 6.7 5.4 9.1 13.2 15.2 9.3 9.6 10.3 13.2 13.9 5.0 11.1 2.6 13.9 9.1 3.4 26.9 5.3 0.5 4.8 5.2 9.8 19.4 8.3 5.0 8.8 7.6 9.1 7.9 0.0 7.4 10.9 10.2 7.1 23.1 4.7 10.0 22.1 24.1 5.1 14.6 13.1 5.8 0.0 1.6 13.7 9.3 3.3 5.1 5.4 9.5 1.9 3.3 6.9 5.4 10.2 0.1 22.8 10.5 0.8 5.3 27.2 6.3 0.7 14.0 13.4 9.1 7.7 14.8 8.2 20.8 6.0 13.9 6.7 5.8 1.8 4.2 9.0 4.0 0.0 0.1 45.4 7.3 0.0 7.2 11.1 2.4 1.7 9.1 2.6 8.5 13.9 5.0 7.2 5.0 7.9 3.4 8.5 0.3 13.9 1.7 3.5 5.4 3.4 12.3 11.6 7.8 8.2 12.2 12.5 13.9 7.1 10.7 9.1 17.9 15.6 9.3 23.8 9.6 27.4 4.5 63.7 87.0 36.4 24.4 62.8 37.0 26.6 49.3 9.6 10.8 2.0 0.0 43.5 25.4 17.6 19.1 40.4 10.2 24.6 14.3 20.3 8.6 3.5 11.1 16.1 5.5 15.1 23.4 8.3 34.0 31.2 0.0 18.7 19.0 189.9 0.0 19.6 16.8 2.2 11.4 12.2 9.6 11.5 23.3 FAM129A "C1orf24, GIG39, NIBAN" ENSG00000135842 "Family with sequence similarity 129 member A" Q9BZQ8 1 184790724-184974550 "Cancer-related genes, Predicted intracellular proteins" "Stress response, Translation regulation" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 129.1;urinary bladder: 90.3" "Group enriched" "Detected in many" 5 "Cardiomyocytes: 641.6;monocytes: 234.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 5 "neutrophil: 32.7" "Lineage enriched" "Detected in many" 6 "granulocytes: 32.7" "Cell line enhanced" "Detected in many" "Karpas-707: 29.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA028172, HPA028231, HPA028657" Approved Supported "Plasma membrane,Cytosol" NA NA 40000 "Plasma membrane, Cytosol" "HPA028172: AB_10599602, HPA028231: AB_10601886, HPA028657: AB_10601680" "unprognostic (4.61e-3)" "unprognostic (3.45e-2)" "unprognostic (1.64e-3)" "unprognostic (9.46e-2)" "unprognostic (2.77e-1)" "unprognostic (3.87e-1)" "unprognostic (3.23e-2)" "unprognostic (1.30e-2)" "unprognostic (1.68e-1)" "unprognostic (6.32e-2)" "unprognostic (4.12e-1)" "unprognostic (1.32e-1)" "unprognostic (2.94e-3)" "unprognostic (9.01e-3)" "unprognostic (4.38e-2)" "unprognostic (3.73e-2)" "prognostic unfavorable (4.52e-4)" 10.1 3.5 1.1 16.9 1.8 2.3 7.8 0.8 1.3 13.0 39.3 1.0 14.9 2.5 14.6 11.0 32.3 10.7 30.4 52.2 1.1 1.1 1.8 1.2 6.1 10.7 3.0 0.5 8.0 27.3 0.8 1.9 2.9 1.7 34.6 5.1 13.8 59.3 14.7 21.4 4.1 8.3 129.1 2.1 6.5 30.0 4.1 1.3 4.9 4.7 14.7 8.7 90.3 20.3 0.5 2.3 32.7 1.5 2.6 5.3 0.8 13.8 0.1 0.0 0.0 9.9 15.1 0.5 7.1 14.7 6.2 7.8 0.0 5.9 0.0 4.7 18.3 1.6 15.7 0.8 0.5 10.0 27.6 1.1 5.8 2.9 0.0 23.2 18.8 6.6 13.8 22.7 18.0 21.9 4.4 0.0 2.1 1.3 29.4 0.2 0.0 0.6 3.3 3.8 0.0 1.5 4.4 3.4 0.2 8.5 0.2 0.8 0.7 0.1 0.0 10.2 2.5 3.1 6.0 1.1 12.3 0.0 2.2 14.6 24.7 9.7 2.9 24.1 7.9 12.0 7.1 1.5 4.7 2.5 0.9 2.1 0.5 2.2 2.3 2.3 0.1 0.2 0.9 32.7 2.6 0.3 0.2 5.3 0.8 1.1 1.8 0.8 1.3 1.1 1.1 3.0 0.5 1.7 1.3 8.9 24.2 6.6 12.3 11.2 0.1 641.6 7.6 9.4 48.9 1.8 0.0 0.2 0.0 2.5 0.0 17.7 0.0 0.0 61.8 0.9 15.1 45.2 2.3 0.0 13.2 4.8 1.7 11.6 31.3 0.2 10.0 78.8 13.5 234.4 0.1 0.0 33.4 0.0 6.7 0.3 0.0 84.1 72.3 0.0 0.1 7.3 0.3 29.8 0.6 15.6 FAM163B C9orf166 ENSG00000196990 "Family with sequence similarity 163 member B" P0C2L3 9 133578415-133586197 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 41.7" "Cell type enriched" "Detected in some" 4 "Late spermatids: 15.1" "Cancer enriched" "Detected in some" 6 "glioma: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 21 "SH-SY5Y: 40.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA067336 Enhanced Approved "Nuclear bodies,Plasma membrane,Cytosol" NA NA "Nuclear bodies, Plasma membrane, Cytosol" "HPA067336: AB_2685825" "unprognostic (2.94e-2)" "unprognostic (6.87e-3)" "unprognostic (2.65e-2)" "unprognostic (2.70e-1)" "unprognostic (1.23e-2)" "unprognostic (9.05e-2)" "unprognostic (1.02e-2)" "unprognostic (3.48e-2)" "unprognostic (1.43e-1)" "unprognostic (1.16e-1)" "unprognostic (3.31e-3)" "unprognostic (7.61e-2)" "unprognostic (5.75e-4)" "unprognostic (1.07e-1)" "unprognostic (9.54e-2)" "unprognostic (1.65e-1)" "unprognostic (4.73e-4)" 0.1 8.2 10.0 0.0 2.7 0.0 0.0 3.2 41.7 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.4 1.2 6.1 3.9 0.1 2.7 0.0 1.3 3.3 0.0 0.1 0.0 0.0 0.6 0.0 0.4 0.4 0.7 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.5 0.1 0.0 0.0 0.0 1.8 40.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM171A1 "C10orf38, FLJ12884" ENSG00000148468 "Family with sequence similarity 171 member A1" Q5VUB5 10 15211643-15371062 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 43.9" "Cell type enhanced" "Detected in many" 12 "Cholangiocytes: 104.4;Ito cells: 41.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "gdT-cell: 2.6;MAIT T-cell: 6.8;memory CD4 T-cell: 3.8;memory CD8 T-cell: 3.3;naive CD4 T-cell: 7.4;naive CD8 T-cell: 3.7" "Lineage enriched" "Detected in single" 23 "T-cells: 7.4" "Cell line enhanced" "Detected in many" "TIME: 42.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051345 Approved Approved "Nucleoplasm,Plasma membrane" NA NA 96000 "Plasma membrane" Nucleoplasm "HPA051345: AB_2681449" "unprognostic (3.60e-2)" "unprognostic (7.15e-2)" "unprognostic (2.21e-1)" "unprognostic (5.28e-2)" "unprognostic (1.57e-1)" "unprognostic (4.11e-2)" "unprognostic (9.84e-2)" "unprognostic (9.19e-2)" "unprognostic (2.28e-1)" "unprognostic (3.97e-2)" "unprognostic (3.09e-2)" "unprognostic (1.87e-1)" "prognostic favorable (2.71e-5)" "unprognostic (3.08e-1)" "unprognostic (1.86e-1)" "prognostic unfavorable (4.90e-6)" "unprognostic (3.28e-2)" 6.9 3.7 22.1 5.5 37.9 0.2 4.6 11.1 31.8 8.8 16.1 25.3 6.5 13.7 9.7 4.8 4.7 11.8 9.3 7.0 24.1 17.5 17.8 6.2 5.3 3.7 25.1 14.3 10.9 13.8 8.9 1.9 2.9 21.5 8.4 12.9 2.5 10.0 9.4 5.1 2.4 8.9 9.0 43.9 8.5 10.3 2.4 21.9 0.6 4.3 1.1 4.6 6.0 6.2 0.0 0.0 0.0 0.0 0.3 7.4 1.3 0.0 6.3 13.0 5.0 5.3 10.1 0.1 7.9 1.5 4.0 3.5 1.1 7.4 0.0 9.6 20.5 9.1 0.6 9.3 0.1 4.5 2.6 14.6 18.4 2.0 18.2 5.8 0.0 14.9 7.9 1.9 10.9 1.6 14.6 20.0 2.7 7.2 0.0 12.7 0.5 3.1 0.0 12.5 3.5 3.5 12.4 6.9 1.9 5.0 0.0 9.0 11.5 4.4 0.1 0.0 14.5 0.0 0.2 42.6 5.5 23.2 19.9 8.3 2.7 0.7 0.0 12.2 0.0 4.2 0.0 0.0 0.0 2.6 0.0 6.8 0.0 3.8 3.3 0.0 0.0 7.4 3.7 0.0 0.3 0.0 0.0 0.7 1.3 22.1 37.9 11.1 23.1 24.1 17.5 25.1 14.3 21.5 21.9 0.0 0.0 0.0 3.3 1.1 3.8 5.1 104.4 2.7 2.3 14.0 0.0 0.1 3.3 17.1 0.6 18.9 12.0 0.0 10.5 0.1 8.9 13.8 1.1 18.3 0.3 6.4 20.2 41.1 4.4 1.0 4.9 0.0 1.7 1.0 25.9 1.5 15.9 8.6 5.3 4.1 1.1 0.0 6.2 2.3 3.5 1.6 0.1 1.3 31.1 2.1 FAM193A "C4orf8, RES4-22" ENSG00000125386 "Family with sequence similarity 193 member A" P78312 4 2536631-2732565 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 45.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043116 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA043116: AB_10795767" "unprognostic (1.56e-1)" "unprognostic (1.95e-1)" "unprognostic (2.54e-1)" "unprognostic (1.17e-3)" "unprognostic (1.97e-1)" "unprognostic (3.66e-3)" "unprognostic (6.34e-3)" "unprognostic (1.02e-1)" "unprognostic (7.16e-2)" "unprognostic (4.84e-1)" "prognostic favorable (4.80e-4)" "unprognostic (1.38e-2)" "unprognostic (2.15e-1)" "unprognostic (5.58e-2)" "unprognostic (3.47e-2)" "unprognostic (5.55e-2)" "unprognostic (4.96e-3)" 17.1 14.1 17.8 25.5 17.7 22.4 19.7 33.0 23.2 17.4 14.5 18.2 21.3 15.3 23.5 16.0 12.1 16.4 17.2 11.9 16.7 14.3 12.4 13.7 20.2 17.3 18.0 11.8 23.7 17.4 20.4 21.5 15.3 16.1 16.4 11.9 18.8 16.4 19.3 18.1 16.6 15.8 16.0 13.9 17.0 14.7 29.1 17.2 26.3 15.4 13.7 16.0 14.6 30.7 2.5 3.9 5.7 6.3 3.2 2.9 1.0 7.1 9.0 16.7 9.5 10.2 10.5 9.1 11.0 9.4 10.8 9.1 9.1 11.7 14.0 6.8 11.9 13.3 6.2 11.6 7.8 8.9 8.7 7.6 21.0 11.1 9.4 12.4 12.6 14.8 11.5 8.3 10.6 10.8 9.8 10.6 8.4 14.7 15.5 8.8 7.5 20.5 20.5 13.7 7.1 10.2 20.3 8.8 6.9 7.2 9.4 14.7 12.6 9.3 6.5 9.5 9.4 12.0 13.0 14.3 16.5 9.8 8.9 14.2 15.7 11.5 13.6 9.3 10.6 11.7 5.7 2.2 1.8 2.2 1.5 1.5 1.5 1.9 2.9 1.4 2.5 1.9 2.7 4.2 3.2 6.3 3.9 1.4 1.0 17.8 17.7 33.0 23.2 16.7 14.3 18.0 11.8 16.1 17.2 11.9 15.6 2.7 6.0 8.4 24.2 13.1 0.0 4.0 21.6 1.8 45.2 5.9 1.7 7.9 6.7 12.6 11.6 0.0 6.5 5.7 10.8 9.1 8.1 4.9 7.5 14.3 13.8 10.4 8.2 11.0 15.8 11.3 13.5 8.2 9.0 15.4 8.7 9.0 13.8 2.2 24.7 6.5 10.0 29.8 28.5 8.7 4.7 6.4 8.9 6.4 FAM210B "C20orf108, dJ1167H4.1, DKFZP434A1114" ENSG00000124098 "Family with sequence similarity 210 member B" Q96KR6 20 56358915-56368663 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Erythrocyte maturation" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Erythroid cells: 233.6;Peritubular cells: 146.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-MEL-30: 73.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042652 Approved Approved "Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "HPA042652: AB_2678098" "unprognostic (3.29e-1)" "prognostic favorable (5.44e-4)" "unprognostic (3.24e-2)" "unprognostic (1.66e-3)" "unprognostic (1.26e-1)" "unprognostic (3.34e-2)" "unprognostic (9.45e-2)" "prognostic favorable (4.26e-4)" "unprognostic (1.77e-1)" "unprognostic (2.24e-2)" "unprognostic (7.60e-2)" "unprognostic (2.90e-1)" "prognostic favorable (1.44e-10)" "unprognostic (1.08e-1)" "unprognostic (3.27e-2)" "unprognostic (1.84e-1)" "unprognostic (3.00e-1)" 19.8 47.7 13.2 9.3 22.8 30.5 29.0 13.4 12.3 23.4 18.1 10.9 24.0 10.7 22.3 24.7 24.4 18.5 29.5 48.1 13.0 12.9 15.2 43.2 16.3 11.8 15.2 9.3 50.5 21.8 13.1 15.1 17.6 13.7 30.9 13.8 21.4 29.0 33.5 54.2 17.5 15.0 19.9 11.1 12.2 16.3 11.1 9.7 5.9 19.8 25.7 12.3 22.8 30.9 1.9 2.8 10.3 5.6 2.2 4.0 1.5 4.8 1.9 7.5 18.2 21.7 24.6 14.6 6.0 13.4 10.9 12.6 3.4 2.4 0.4 3.1 10.2 6.3 14.1 4.0 17.2 18.4 0.7 6.3 3.0 4.4 32.5 14.3 0.3 1.9 21.0 19.3 6.2 8.8 12.7 17.5 2.6 22.5 3.2 13.3 5.0 2.5 1.3 6.3 7.1 11.8 0.0 15.5 3.8 5.6 5.7 10.4 18.7 14.5 31.7 73.1 16.7 14.0 2.7 12.1 9.8 6.5 15.6 3.6 2.5 2.6 0.1 7.8 1.9 6.3 3.3 3.8 10.3 2.9 5.6 2.2 1.9 3.4 4.0 2.8 1.8 3.6 3.4 1.7 2.2 2.4 2.4 3.7 1.5 13.2 22.8 13.4 12.3 13.0 12.9 15.2 9.3 13.7 9.7 14.9 21.1 2.2 74.0 22.0 7.6 52.5 68.8 1.4 14.8 15.7 37.3 61.4 54.7 24.7 0.6 24.8 25.3 233.6 16.9 19.6 25.7 58.3 19.5 106.8 25.0 1.6 48.9 44.2 41.8 2.6 61.9 18.3 35.4 32.5 26.7 25.1 32.5 7.0 146.3 38.9 16.9 19.4 28.4 1.2 10.4 28.4 35.0 13.1 32.1 44.8 FAM222A "C12orf34, FLJ14721" ENSG00000139438 "Family with sequence similarity 222 member A" Q5U5X8 12 109714228-109770507 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.9" "Cell type enhanced" "Detected in many" 13 "Cone photoreceptor cells: 31.4;Early spermatids: 23.4;Horizontal cells: 73.1;Rod photoreceptor cells: 48.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 4 "SH-SY5Y: 51.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040181, HPA058774" Uncertain Approved "Nucleoplasm,Plasma membrane,Focal adhesion sites,Mitochondria" NA NA "Nucleoplasm, Plasma membrane" "Focal adhesion sites, Mitochondria" "HPA040181: AB_10796448, HPA058774: " "unprognostic (8.59e-3)" "prognostic favorable (1.82e-5)" "unprognostic (1.43e-1)" "unprognostic (1.57e-1)" "unprognostic (1.92e-1)" "unprognostic (2.05e-2)" "unprognostic (1.46e-2)" "unprognostic (1.03e-1)" "unprognostic (6.66e-2)" "unprognostic (8.17e-2)" "prognostic favorable (4.81e-4)" "unprognostic (1.15e-1)" "unprognostic (4.16e-2)" "prognostic favorable (8.59e-4)" "unprognostic (3.93e-2)" "unprognostic (2.77e-1)" "unprognostic (1.24e-1)" 1.8 16.0 7.3 2.3 17.4 2.0 3.0 15.1 25.5 1.6 3.3 37.9 0.0 10.0 1.5 2.7 2.1 1.4 2.6 4.4 11.7 9.6 7.7 2.7 1.8 1.7 23.2 7.9 7.8 6.9 1.5 13.1 1.3 15.1 2.3 3.0 10.3 7.3 2.1 2.8 4.7 5.1 1.8 27.8 6.3 8.0 17.4 23.0 0.0 1.4 0.0 2.1 1.4 2.4 0.2 0.6 0.9 0.2 0.0 0.2 0.0 0.9 1.3 0.7 1.6 0.4 0.0 0.5 0.2 0.1 0.7 0.1 12.0 0.2 0.1 1.0 0.3 0.7 0.5 0.8 0.0 0.2 7.7 1.8 1.5 0.4 2.7 0.1 1.1 1.6 0.0 0.0 0.1 0.0 0.2 0.0 0.8 0.5 0.2 0.1 4.8 0.3 1.5 1.3 1.4 2.4 1.0 3.5 0.5 1.5 0.6 8.5 51.4 1.1 1.6 3.4 0.2 1.9 1.3 0.1 0.2 1.4 0.6 1.0 1.3 1.7 1.0 0.1 0.8 1.7 0.0 0.2 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 7.3 17.4 15.1 13.7 11.7 9.6 23.2 7.9 15.1 23.0 0.0 0.0 0.5 0.6 1.9 21.6 6.1 2.5 0.0 0.0 1.8 31.4 0.1 6.6 1.4 23.4 0.8 0.6 0.0 0.7 0.1 1.7 1.4 0.0 1.3 0.3 73.1 7.5 0.0 0.0 11.0 1.1 0.3 6.8 0.0 4.1 10.0 0.8 0.0 0.4 0.6 48.4 0.0 1.4 0.7 2.6 1.6 0.7 0.0 0.8 0.2 FAM45A ENSG00000119979 "Family with sequence similarity 45 member A" Q8TCE6 10 119104086-119137984 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041159 Approved "Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane, Centrosome, Cytosol" "HPA041159: AB_10793871" "unprognostic (1.75e-2)" "unprognostic (1.05e-1)" "unprognostic (1.05e-1)" "unprognostic (2.73e-2)" "unprognostic (1.90e-1)" "unprognostic (3.12e-1)" "unprognostic (1.88e-2)" "unprognostic (2.13e-1)" "unprognostic (3.08e-1)" "unprognostic (3.05e-2)" "unprognostic (4.46e-2)" "unprognostic (2.64e-2)" "unprognostic (6.68e-2)" "unprognostic (2.92e-1)" "unprognostic (1.38e-2)" "unprognostic (2.65e-1)" "unprognostic (3.20e-2)" 12.2 13.2 16.2 8.5 20.0 17.0 9.5 10.2 17.6 11.6 12.5 10.2 6.5 7.6 9.4 10.7 16.0 9.0 8.5 10.8 13.5 10.4 16.6 18.9 8.6 6.8 10.6 17.6 17.3 8.8 11.6 5.4 10.8 18.4 8.9 11.0 7.7 10.7 8.3 14.0 12.0 9.7 9.8 13.5 8.4 9.7 7.1 11.5 10.1 14.8 10.8 9.9 13.1 14.7 2.3 9.9 30.2 19.2 3.8 10.0 6.0 8.3 9.8 12.5 14.5 21.4 21.4 5.5 11.9 29.8 10.7 10.3 9.5 11.2 5.9 4.5 14.6 11.2 12.7 10.6 10.5 9.3 10.0 6.0 1.3 3.4 8.3 24.4 3.5 2.8 22.3 9.0 7.8 11.0 22.2 14.4 5.1 2.8 6.7 13.4 6.7 4.4 6.0 7.5 6.3 4.0 4.8 15.7 4.3 10.3 8.9 2.1 8.3 8.5 9.0 17.4 12.2 8.6 12.3 14.6 7.6 3.9 7.9 6.0 7.3 2.7 6.5 12.3 15.3 3.4 23.0 15.1 30.2 4.2 18.3 3.4 2.3 6.3 5.5 9.9 1.9 3.1 4.1 20.1 3.8 19.2 2.5 10.0 6.0 16.2 20.0 10.2 17.6 13.5 10.4 10.6 17.6 18.4 11.5 8.9 21.6 15.2 23.3 15.8 17.0 32.3 28.1 20.1 17.0 24.4 0.0 45.9 94.5 28.0 2.0 15.3 46.3 0.0 43.7 21.6 29.9 20.6 19.7 52.9 46.9 7.9 24.2 51.0 96.9 4.7 23.9 34.6 28.7 36.1 27.9 29.4 40.7 45.6 25.8 78.7 16.9 19.4 11.8 18.5 23.2 22.2 37.9 28.7 34.5 24.3 FAM47E "FLJ42946, LOC100129583" ENSG00000189157 "Family with sequence similarity 47 member E" Q6ZV65 4 76214040-76283780 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Ciliated cells: 75.0;Early spermatids: 25.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "naive B-cell: 3.1;plasmacytoid DC: 2.3" "Group enriched" "Detected in many" 5 "B-cells: 3.1;dendritic cells: 2.3" "Cell line enriched" "Detected in many" 5 "OE19: 24.0" HPA053331 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA053331: AB_2682115" "unprognostic (1.59e-1)" "unprognostic (1.76e-2)" "unprognostic (3.68e-2)" "unprognostic (3.90e-4)" "unprognostic (1.37e-2)" "unprognostic (1.66e-1)" "unprognostic (1.04e-1)" "unprognostic (5.63e-2)" "unprognostic (1.06e-1)" "unprognostic (2.21e-2)" "unprognostic (3.73e-2)" "unprognostic (1.31e-1)" "unprognostic (2.16e-8)" "unprognostic (1.01e-1)" "unprognostic (1.84e-2)" "unprognostic (3.04e-2)" "unprognostic (3.01e-2)" 5.5 6.8 12.5 0.8 8.5 1.2 8.9 2.4 14.8 3.7 3.2 9.2 4.4 4.3 2.4 15.5 1.6 23.5 5.1 3.2 10.1 13.7 9.1 11.2 4.8 0.9 10.7 15.5 1.2 9.7 9.9 10.3 10.0 12.1 5.2 3.8 2.7 5.4 4.0 9.5 2.0 4.2 3.0 13.3 1.8 6.0 9.2 6.2 0.0 13.2 1.5 0.9 2.6 1.1 3.1 2.3 0.1 0.4 0.1 0.5 0.1 0.4 2.0 1.8 0.5 1.4 0.2 0.4 0.2 1.3 0.3 0.4 2.3 1.7 0.1 0.5 0.7 4.1 0.6 0.8 0.4 0.7 1.8 0.1 0.1 1.1 3.3 0.8 0.4 0.3 0.8 0.5 0.5 0.5 0.7 0.2 0.2 0.2 1.1 0.6 2.8 0.1 0.2 0.4 24.0 0.9 0.3 0.5 0.3 2.5 1.6 3.1 2.2 0.8 1.0 0.3 0.5 1.0 0.2 0.5 0.4 0.4 1.1 0.3 4.4 1.0 0.1 1.3 0.2 0.6 0.0 0.4 0.1 0.2 0.0 0.5 0.2 0.2 0.1 0.2 3.1 0.4 0.1 0.1 0.1 0.4 2.3 0.0 0.1 12.5 8.5 2.4 14.8 10.1 13.7 10.7 15.5 12.1 6.2 8.9 1.6 0.5 2.2 0.6 11.4 6.2 5.1 75.0 7.9 0.0 11.8 2.2 8.3 5.8 25.0 1.5 5.4 0.0 6.9 0.9 1.5 4.2 0.0 3.0 0.7 1.6 7.5 2.5 0.0 3.1 0.6 0.0 1.7 0.0 4.9 4.3 5.1 2.9 0.4 7.8 6.9 0.0 1.2 10.9 3.9 0.3 2.9 0.0 2.7 1.6 FAM72A "LMPIP, MGC57827, RP11-312O7.1, UGENE" ENSG00000196550 "Family with sequence similarity 72 member A" Q5TYM5 1 206186179-206204414 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 14.9;Kupffer cells: 15.6;Late spermatids: 22.6;monocytes: 10.8;Spermatocytes: 13.5" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA043271, HPA067321" Uncertain Approved "Vesicles,Plasma membrane,Cytosol" NA Yes Vesicles "Plasma membrane, Cytosol" "HPA043271: AB_2678402, HPA067321: " "unprognostic (3.61e-2)" "unprognostic (1.58e-1)" "unprognostic (1.80e-1)" "unprognostic (5.20e-5)" "unprognostic (3.61e-1)" "unprognostic (1.19e-3)" "unprognostic (1.01e-5)" "unprognostic (7.70e-3)" "unprognostic (1.45e-2)" "unprognostic (5.58e-3)" "unprognostic (2.87e-2)" "unprognostic (1.03e-1)" "unprognostic (4.44e-16)" "unprognostic (1.82e-1)" "unprognostic (1.94e-2)" "unprognostic (4.83e-2)" "unprognostic (3.89e-1)" 3.4 2.5 1.9 4.7 1.6 6.3 3.2 8.0 1.3 0.8 1.5 2.4 0.6 0.0 2.5 1.8 2.2 0.9 2.4 1.8 1.0 1.3 2.4 8.9 2.6 0.8 0.7 2.3 0.4 2.8 0.5 1.7 0.7 0.2 0.2 5.0 2.2 1.3 3.1 6.3 0.8 6.3 0.5 6.2 1.1 1.2 2.1 5.6 1.2 9.2 0.6 3.6 2.4 9.7 8.0 8.4 3.6 1.2 1.5 10.1 7.0 3.0 8.1 6.1 4.7 14.6 25.1 6.0 1.8 9.1 11.7 9.7 3.8 9.7 13.8 8.0 11.3 7.3 6.3 0.8 19.5 12.8 2.1 0.7 7.2 12.8 2.4 5.0 21.9 22.5 17.3 5.0 5.7 12.1 17.5 15.3 6.9 10.7 13.5 14.6 18.9 4.6 1.5 8.4 4.9 5.0 4.6 4.1 10.0 9.7 10.6 2.6 6.5 7.5 8.4 11.5 14.0 20.5 22.5 5.3 16.1 8.9 0.0 7.5 0.0 0.9 9.2 0.2 2.1 1.8 1.8 5.6 0.8 0.2 0.4 1.2 0.6 5.4 2.3 3.6 2.4 0.0 1.0 0.9 0.1 1.5 0.0 0.4 0.0 1.4 1.2 0.0 0.0 0.4 0.0 0.8 14.9 5.2 0.9 0.0 0.7 2.8 2.4 0.4 0.0 0.0 7.8 0.0 0.0 6.7 15.6 22.6 0.0 6.0 3.3 10.8 0.4 0.5 0.3 0.0 0.0 0.1 0.1 0.0 1.7 13.5 4.5 0.9 0.6 0.9 0.4 0.5 FAM72B RP11-439A17.6 ENSG00000188610 "Family with sequence similarity 72 member B" Q86X60 1 121167646-121185539 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "bone marrow: 6.5;lymphoid tissue: 9.3" "Cell type enhanced" "Detected in some" 16 "Early spermatids: 4.7;Spermatocytes: 14.9" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "myeloid DC: 3.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA043271, HPA067321" Uncertain Approved "Vesicles,Plasma membrane,Cytosol" NA Yes Vesicles "Plasma membrane, Cytosol" "HPA043271: AB_2678402, HPA067321: " "unprognostic (8.53e-2)" "unprognostic (1.97e-2)" "unprognostic (1.63e-3)" "unprognostic (1.25e-3)" "unprognostic (4.36e-1)" "unprognostic (1.05e-1)" "unprognostic (1.26e-4)" "unprognostic (8.22e-5)" "unprognostic (1.30e-2)" "unprognostic (1.79e-2)" "unprognostic (1.36e-4)" "unprognostic (2.46e-2)" "unprognostic (0.00e+0)" "unprognostic (2.39e-2)" "unprognostic (1.71e-1)" "unprognostic (1.17e-2)" "unprognostic (5.30e-2)" 1.0 0.8 1.3 4.1 1.0 6.5 0.6 5.1 1.0 0.5 1.0 1.3 0.4 0.2 3.0 0.5 1.0 0.2 1.6 0.9 0.3 0.4 0.8 9.3 1.4 0.4 0.1 1.5 0.1 1.4 0.2 1.3 0.5 0.0 0.0 2.1 1.3 0.7 1.4 3.2 0.9 3.6 0.2 7.9 0.9 0.9 0.8 3.3 0.1 2.4 0.8 1.4 1.1 12.0 4.4 7.4 3.6 0.7 1.1 5.8 6.4 2.7 7.5 6.3 0.1 6.3 26.6 8.9 1.2 7.4 7.5 10.1 3.6 11.6 17.6 7.5 11.5 4.9 5.3 0.4 20.0 10.3 0.6 0.4 5.9 12.0 1.9 4.5 22.2 15.0 16.4 5.4 5.0 10.0 16.5 13.9 6.5 9.1 15.0 15.9 12.2 2.9 1.4 8.0 4.6 4.8 3.8 3.7 7.9 5.0 15.6 1.5 6.2 10.5 12.0 11.3 14.6 18.2 26.3 5.5 21.7 14.3 0.0 2.4 0.0 0.0 0.9 0.0 0.8 0.4 0.5 3.3 0.3 0.0 0.1 0.1 0.8 1.1 0.4 1.4 1.1 0.0 0.0 3.7 0.1 0.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 4.7 1.0 1.7 0.0 0.2 1.9 0.5 0.0 0.0 0.0 0.9 0.0 0.0 3.1 0.6 1.2 0.6 0.7 0.0 3.6 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.5 14.9 3.4 0.9 0.1 1.0 0.4 0.0 FAM72C RP5-998N21.9 ENSG00000263513 "Family with sequence similarity 72 member C" H0Y354 1 143955364-143971965 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "bone marrow: 3.6;lymphoid tissue: 6.4" "Cell type enhanced" "Detected in some" 16 "Extravillous trophoblasts: 3.6;Sertoli cells: 6.5;Spermatocytes: 10.0;Spermatogonia: 3.2" "Low cancer specificity" "Detected in single" "Cell type enhanced" "Detected in some" "T-reg: 2.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/84: 29.2" "HPA043271, HPA067321" Uncertain Approved "Vesicles,Plasma membrane,Cytosol" NA Yes Vesicles "Plasma membrane, Cytosol" "HPA043271: AB_2678402, HPA067321: " "unprognostic (2.18e-1)" "unprognostic (1.50e-1)" "unprognostic (6.45e-3)" "unprognostic (2.69e-2)" "unprognostic (2.21e-1)" "unprognostic (3.98e-3)" "unprognostic (9.46e-5)" "unprognostic (1.23e-3)" "unprognostic (4.36e-1)" "unprognostic (7.26e-2)" "unprognostic (1.04e-2)" "unprognostic (1.95e-1)" "unprognostic (0.00e+0)" "unprognostic (2.95e-1)" "unprognostic (4.70e-2)" "unprognostic (5.82e-2)" "unprognostic (1.47e-2)" 0.1 0.0 1.6 3.6 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 1.5 0.0 0.1 0.5 0.1 1.9 0.0 6.4 0.4 1.1 0.4 0.0 1.0 1.7 2.2 0.6 8.6 5.0 6.1 2.7 0.3 0.8 5.9 4.3 1.4 5.8 4.5 0.8 10.4 20.6 5.7 0.5 5.5 8.3 8.1 2.6 6.3 7.1 4.8 8.9 4.4 1.5 0.3 18.1 8.1 0.2 0.0 4.5 11.9 1.3 2.5 16.6 15.5 9.7 0.3 0.6 10.7 14.0 4.9 9.7 3.3 13.6 4.4 14.6 1.0 1.1 3.1 5.6 4.2 2.4 2.3 6.6 6.0 15.6 1.7 4.6 7.6 6.0 9.4 20.3 29.2 12.2 2.5 11.3 2.9 0.0 1.0 0.0 0.1 0.3 0.0 1.1 0.4 0.5 0.4 0.0 0.1 0.0 0.0 1.7 0.6 0.1 2.2 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.0 1.0 0.0 0.0 0.2 3.6 0.3 0.0 0.0 0.0 1.3 0.0 0.0 1.8 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 10.0 3.2 0.3 0.2 0.0 0.0 0.0 FAM72D ENSG00000215784 "Family with sequence similarity 72 member D" Q6L9T8 1 145096000-145112696 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 17.7" "Cell type enhanced" "Detected in some" 22 "Extravillous trophoblasts: 4.6;Spermatocytes: 17.9;Spermatogonia: 4.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA043271, HPA067321" Uncertain Approved "Vesicles,Plasma membrane,Cytosol" NA NA Vesicles "Plasma membrane, Cytosol" "HPA043271: AB_2678402, HPA067321: " "unprognostic (2.70e-2)" "unprognostic (1.64e-1)" "unprognostic (1.73e-1)" "unprognostic (4.03e-3)" "unprognostic (1.26e-1)" "unprognostic (7.10e-3)" "unprognostic (5.88e-5)" "unprognostic (7.65e-4)" "unprognostic (6.72e-2)" "unprognostic (2.36e-2)" "unprognostic (1.22e-2)" "unprognostic (1.46e-1)" "unprognostic (0.00e+0)" "unprognostic (6.63e-2)" "unprognostic (1.72e-1)" "unprognostic (9.74e-2)" "unprognostic (6.50e-2)" 1.1 0.7 0.8 7.2 0.8 5.5 0.7 4.0 0.9 0.6 1.1 0.6 0.4 1.4 0.8 0.4 4.4 0.2 0.5 0.4 1.0 0.7 0.5 0.4 1.3 7.6 1.0 0.4 0.4 0.4 0.3 0.4 1.5 0.8 0.4 1.6 0.4 0.6 0.4 0.4 2.9 2.0 0.5 1.1 3.3 0.8 6.7 0.4 17.7 0.4 2.7 7.4 1.1 2.5 0.1 0.7 0.1 1.7 0.0 1.0 0.5 8.4 5.1 6.0 2.4 0.2 0.5 6.6 4.8 1.4 6.1 3.8 3.4 7.6 13.8 4.9 0.7 5.5 8.9 7.3 1.4 7.2 11.0 7.3 6.9 2.5 5.0 0.1 12.2 7.7 0.3 0.5 4.8 9.3 1.0 2.7 16.7 13.6 19.2 4.0 6.3 8.3 11.9 11.5 10.5 7.1 7.3 7.6 16.2 2.1 1.1 5.9 5.0 3.7 3.3 2.2 7.9 9.3 7.9 1.2 4.5 5.0 3.8 8.6 14.6 22.8 21.4 0.0 9.8 5.1 0.0 1.2 0.0 0.0 1.7 0.0 0.1 0.2 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.6 0.0 1.0 0.5 0.8 0.8 4.0 0.9 1.0 0.7 1.0 0.4 0.8 0.4 0.0 0.0 0.0 0.0 0.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.7 0.5 0.0 0.0 0.0 4.6 1.0 0.1 0.0 0.0 1.2 0.0 0.0 0.6 1.2 0.0 0.0 1.2 1.7 1.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 17.9 4.1 0.9 0.2 0.5 0.1 0.0 FBLN7 "FLJ37440, TM14" ENSG00000144152 "Fibulin 7" Q53RD9 2 112138385-112188216 "Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" Heparin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Melanocytes: 16.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 25 "memory CD4 T-cell: 18.5;naive CD4 T-cell: 16.2;T-reg: 17.4" "Lineage enriched" "Detected in single" 36 "T-cells: 18.5" "Cell line enhanced" "Detected in some" "AF22: 17.5;BJ hTERT+: 12.5;hTERT-RPE1: 9.2;SCLC-21H: 11.3;SH-SY5Y: 9.0;U-2197: 18.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA034992 Approved "Plasma membrane,Cell Junctions" "Secreted to extracellular matrix" NA NA 27000 "Plasma membrane" "Cell Junctions" "HPA034992: AB_10601469" "unprognostic (1.72e-1)" "unprognostic (1.47e-1)" "unprognostic (5.88e-2)" "unprognostic (4.88e-3)" "unprognostic (1.24e-1)" "unprognostic (1.70e-3)" "unprognostic (4.34e-2)" "unprognostic (4.80e-2)" "unprognostic (5.77e-2)" "unprognostic (2.01e-1)" "unprognostic (7.91e-2)" "unprognostic (2.02e-2)" "unprognostic (2.35e-2)" "unprognostic (3.11e-2)" "unprognostic (8.10e-2)" "unprognostic (1.21e-2)" "unprognostic (9.33e-2)" 7.5 5.8 2.9 9.0 3.4 1.1 10.4 10.3 16.4 12.4 2.3 1.6 4.1 1.7 6.5 8.2 2.9 10.5 7.1 3.3 4.0 3.8 2.5 6.6 3.7 11.8 6.9 4.2 2.8 3.4 16.7 27.4 13.6 10.5 4.7 2.0 14.7 3.9 9.0 1.9 7.1 3.8 3.2 2.2 7.3 4.1 2.0 1.1 8.7 14.9 5.5 9.5 3.6 10.4 0.0 0.5 0.0 0.0 0.0 18.5 3.5 0.0 0.1 17.5 0.0 1.9 1.4 0.0 3.8 12.5 4.2 6.6 0.0 0.1 0.0 0.1 5.7 0.7 0.0 0.0 0.0 2.0 0.0 0.0 0.0 1.3 0.8 0.9 0.0 0.0 1.3 0.1 7.0 0.0 9.2 1.0 0.2 0.0 0.0 1.4 0.0 0.4 0.0 0.4 0.0 0.3 0.0 0.0 4.4 0.2 0.0 11.3 9.0 0.0 0.0 0.5 0.1 0.5 0.1 3.6 0.6 0.5 18.1 0.5 0.0 0.0 0.0 0.5 0.0 1.5 0.0 0.0 0.0 0.2 0.0 0.7 0.0 18.5 0.2 0.0 0.0 16.2 0.5 0.0 0.0 0.0 0.5 17.4 3.5 2.9 3.4 10.3 16.4 4.0 3.8 6.9 4.2 10.5 1.1 3.0 0.3 0.0 0.7 3.9 3.7 0.8 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.3 1.9 2.1 0.0 0.0 0.2 5.9 4.7 0.4 1.1 1.0 0.4 3.2 0.0 0.6 0.0 1.7 0.3 0.0 16.9 0.0 0.0 2.2 0.4 0.0 4.9 0.5 7.2 6.5 4.7 0.1 0.2 3.3 1.3 4.4 0.0 0.3 FBRSL1 KIAA1545 ENSG00000112787 "Fibrosin like 1" Q9HCM7 12 132489551-132585188 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 39.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NB-4: 34.7" "Low region specificity" "Detected in all" HPA049880 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA049880: AB_2680930" "unprognostic (2.02e-1)" "unprognostic (6.67e-2)" "unprognostic (1.88e-2)" "unprognostic (7.75e-2)" "unprognostic (3.21e-1)" "unprognostic (2.59e-2)" "unprognostic (1.29e-1)" "unprognostic (1.83e-1)" "unprognostic (2.25e-1)" "unprognostic (1.57e-1)" "unprognostic (2.77e-3)" "prognostic unfavorable (9.82e-4)" "prognostic favorable (1.17e-4)" "unprognostic (1.13e-1)" "unprognostic (3.39e-1)" "unprognostic (1.09e-2)" "prognostic favorable (7.21e-4)" 7.6 4.7 4.3 4.9 6.6 5.2 3.2 13.0 9.9 3.4 4.9 2.9 2.9 7.0 4.8 4.6 4.5 4.7 9.6 4.4 4.8 3.1 4.3 5.2 4.2 4.5 9.8 5.5 5.1 12.7 3.9 7.9 4.5 4.5 5.4 1.8 5.0 9.7 4.4 17.9 4.7 7.3 2.9 2.9 10.9 6.1 6.1 4.5 8.0 4.0 2.9 8.6 4.5 3.2 2.8 3.6 4.1 2.0 0.7 1.9 0.9 4.6 7.5 3.4 6.0 1.4 1.8 26.1 4.4 1.1 2.8 1.7 13.6 2.7 7.0 7.7 1.3 2.5 8.7 3.6 2.2 0.9 6.1 18.5 9.0 4.3 10.3 3.0 9.4 9.8 1.6 4.2 2.8 1.9 2.5 2.7 6.0 19.5 1.6 1.2 11.9 12.2 34.7 9.4 3.1 13.2 19.3 3.9 4.9 2.3 4.3 13.9 10.7 4.2 6.6 5.3 1.5 7.2 9.7 4.3 3.1 8.0 5.8 5.5 9.5 4.9 4.6 3.5 9.5 3.9 2.3 1.5 4.1 1.2 1.3 1.3 2.8 1.2 1.2 1.2 2.6 1.1 1.6 1.7 0.7 2.0 3.6 1.9 0.9 4.3 6.6 13.0 9.9 4.8 3.1 9.8 5.5 4.5 4.5 3.0 6.9 0.8 5.2 8.1 22.6 11.3 5.1 5.3 3.4 10.4 39.3 5.8 6.6 5.3 1.3 6.2 15.4 23.3 6.5 4.7 5.2 12.1 1.1 16.3 5.8 11.1 29.7 8.6 12.1 0.4 15.0 8.0 5.0 4.6 19.2 8.6 8.3 15.9 14.5 4.9 22.2 6.5 5.1 6.3 6.1 9.2 9.6 5.7 17.7 7.6 FBXO16 FBX16 ENSG00000214050 "F-box protein 16" Q8IX29 8 28348287-28490318 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 22.9;pituitary gland: 42.3" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 26.8;Cone photoreceptor cells: 33.4;Rod photoreceptor cells: 42.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "plasmacytoid DC: 11.5" "Lineage enriched" "Detected in many" 8 "dendritic cells: 11.5" "Cell line enhanced" "Detected in many" "AF22: 15.7;Karpas-707: 18.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058676, HPA076472" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Vesicles, Plasma membrane, Cytosol" "HPA058676: AB_2683795, HPA076472: " "unprognostic (3.44e-1)" "unprognostic (1.44e-1)" "unprognostic (3.37e-3)" "unprognostic (5.56e-3)" "unprognostic (1.87e-1)" "unprognostic (1.40e-2)" "unprognostic (2.55e-3)" "unprognostic (4.95e-3)" "unprognostic (6.49e-2)" "prognostic favorable (6.70e-5)" "unprognostic (3.41e-3)" "unprognostic (4.90e-2)" "unprognostic (7.15e-2)" "unprognostic (1.71e-2)" "unprognostic (4.85e-2)" "unprognostic (2.72e-2)" "unprognostic (2.07e-1)" 0.9 2.3 7.3 1.3 17.6 2.6 3.4 15.8 9.9 5.4 2.0 1.1 7.6 2.6 1.8 22.9 1.1 5.7 2.1 2.0 4.2 6.8 4.0 7.2 1.9 1.5 4.4 7.5 1.2 6.3 7.2 42.3 1.0 6.3 4.3 2.6 4.6 5.9 7.3 1.1 0.8 3.8 1.2 2.1 1.7 2.7 4.8 1.4 0.0 8.7 0.2 3.3 1.9 1.1 0.6 11.5 1.4 0.3 0.1 0.5 0.2 12.3 2.6 15.7 6.1 0.4 0.0 0.4 0.1 0.6 2.4 4.6 2.4 3.6 4.7 5.7 0.1 6.5 4.1 1.7 2.5 2.4 1.9 2.9 2.2 0.2 1.3 0.3 2.7 1.6 0.2 8.4 0.6 2.6 1.1 0.0 4.0 0.8 18.1 1.0 4.1 0.3 3.7 3.4 1.6 3.6 0.1 3.7 7.2 3.3 2.1 10.2 4.3 0.4 2.5 6.8 2.9 10.9 4.6 0.5 1.3 4.8 2.8 2.2 4.0 3.5 3.9 5.3 0.6 2.8 0.5 0.3 0.1 0.2 0.2 0.5 0.4 0.4 0.3 0.9 0.6 0.2 0.3 1.4 0.1 0.2 11.5 0.3 0.2 7.3 17.6 15.8 9.9 4.2 6.8 4.4 7.5 6.3 1.4 3.0 2.6 0.0 2.3 0.1 7.9 2.0 5.1 26.8 6.8 3.5 33.4 0.5 6.6 4.5 8.6 0.0 0.0 0.0 3.9 0.2 0.9 2.7 0.0 2.4 2.0 4.8 9.8 0.6 1.0 8.4 1.1 0.0 0.0 0.0 1.9 7.8 2.9 0.0 0.7 4.0 42.0 0.0 1.2 7.4 3.4 0.0 0.0 0.0 0.8 1.0 FBXO41 "Fbx41, KIAA1940" ENSG00000163013 "F-box protein 41" Q8TF61 2 73254682-73284431 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.3" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 10.8;Horizontal cells: 6.4;Intestinal endocrine cells: 11.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 2.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 27.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055246, HPA058386" Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA055246: AB_2682758, HPA058386: AB_2683701" "unprognostic (1.15e-3)" "unprognostic (9.36e-2)" "unprognostic (2.17e-2)" "prognostic unfavorable (5.76e-4)" "unprognostic (1.74e-2)" "unprognostic (5.85e-2)" "unprognostic (1.55e-3)" "unprognostic (1.58e-1)" "unprognostic (7.97e-3)" "unprognostic (7.55e-2)" "unprognostic (9.13e-3)" "unprognostic (4.35e-2)" "prognostic unfavorable (1.08e-5)" "unprognostic (3.08e-2)" "unprognostic (1.24e-1)" "unprognostic (1.97e-1)" "unprognostic (1.11e-2)" 1.5 3.6 21.9 5.9 19.3 4.2 2.1 21.7 33.3 1.2 2.1 1.7 0.9 2.2 1.9 3.6 1.6 2.0 2.7 1.1 18.8 10.6 0.8 1.1 2.2 9.4 5.9 17.8 2.5 4.1 9.8 7.3 1.1 6.8 3.0 2.4 0.8 3.7 3.3 0.6 3.4 2.7 2.1 2.1 7.5 2.5 2.4 3.5 2.1 1.5 0.0 9.0 2.8 0.8 0.5 0.9 0.0 2.6 1.1 0.7 0.4 3.6 1.8 0.6 0.0 0.1 0.1 0.8 0.7 0.6 1.2 1.5 4.1 2.1 27.0 0.1 0.1 2.7 3.0 3.8 2.4 1.2 11.2 0.3 8.2 4.1 1.7 0.9 12.4 6.3 1.5 0.9 0.0 0.9 3.3 0.2 7.4 1.6 4.4 1.2 0.9 4.3 11.6 2.7 1.3 1.6 15.2 7.0 13.1 0.8 1.3 9.4 3.5 4.6 2.0 2.9 0.2 2.6 5.2 0.2 4.2 3.7 3.8 0.7 5.3 2.2 12.8 1.1 13.7 1.7 0.0 0.5 0.0 0.6 2.6 0.7 0.5 0.4 0.0 0.9 0.2 0.4 0.4 0.0 1.1 0.1 0.7 0.2 0.4 21.9 19.3 21.7 33.3 18.8 10.6 5.9 17.8 6.8 3.5 0.0 1.1 1.7 0.3 0.2 10.8 1.7 2.5 1.4 0.0 1.8 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 2.2 0.1 0.6 0.7 2.3 0.0 1.7 6.4 11.5 1.3 2.6 0.9 0.3 0.9 1.7 1.8 0.0 0.6 1.0 0.0 0.7 0.0 2.2 0.0 0.5 0.5 1.7 0.3 0.0 1.3 0.4 0.1 FBXW11 "BTRC2, BTRCP2, Fbw11, Fbw1b, FBXW1B, Hos, KIAA0696" ENSG00000072803 "F-box and WD repeat domain containing 11" Q9UKB1 5 171861549-172006873 "Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Cell cycle, Host-virus interaction, Ubl conjugation pathway, Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072204 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" Nucleoplasm "HPA072204: AB_2686493" "unprognostic (4.04e-3)" "unprognostic (1.27e-1)" "unprognostic (2.69e-2)" "unprognostic (5.79e-2)" "unprognostic (1.39e-1)" "unprognostic (1.06e-1)" "unprognostic (1.90e-2)" "unprognostic (1.63e-1)" "unprognostic (6.87e-2)" "unprognostic (9.43e-2)" "unprognostic (1.53e-1)" "unprognostic (8.14e-3)" "unprognostic (2.38e-3)" "unprognostic (1.57e-1)" "unprognostic (1.54e-1)" "unprognostic (3.76e-3)" "unprognostic (1.76e-1)" 15.0 17.1 28.1 11.5 29.4 7.9 17.2 29.7 34.4 17.5 11.2 24.7 9.4 10.2 19.2 10.7 20.0 22.7 14.5 30.3 28.9 26.3 19.5 16.5 14.0 14.0 28.8 20.1 21.8 24.1 37.8 15.8 11.2 23.3 16.2 13.3 12.4 11.6 18.1 24.5 11.0 10.3 21.6 30.6 13.6 15.8 11.3 21.2 12.0 17.5 7.0 17.0 12.9 16.0 9.0 8.2 19.1 7.0 12.9 6.2 5.5 15.8 16.3 24.3 21.2 19.1 19.5 12.4 17.1 24.6 21.5 26.9 16.7 10.8 14.6 21.1 21.9 34.2 10.5 17.4 25.8 35.8 19.3 17.3 11.8 17.0 12.8 17.4 13.1 16.9 14.0 18.0 17.2 28.3 23.0 17.8 12.8 7.3 14.7 26.0 11.9 9.1 6.9 9.3 9.4 18.2 13.4 20.5 9.9 16.5 13.5 10.2 17.9 15.1 12.8 31.5 19.1 16.0 14.1 15.5 21.3 10.6 12.8 16.8 15.1 17.0 10.2 14.9 12.6 16.1 19.1 7.0 6.5 5.7 4.7 6.2 8.7 4.9 5.7 6.9 9.0 4.7 5.8 6.7 12.9 5.1 8.2 5.3 5.5 28.1 29.4 29.7 29.9 28.9 26.3 28.8 20.1 23.3 21.2 23.8 16.8 19.4 11.2 16.9 36.7 51.5 45.9 10.7 20.5 26.2 7.9 7.3 36.5 28.4 22.6 21.7 20.1 23.3 31.8 6.4 15.5 19.1 19.7 38.4 11.3 33.4 27.6 25.2 23.9 30.0 27.3 14.9 11.8 18.0 18.3 56.5 43.0 15.8 26.9 26.9 29.9 45.3 18.9 29.7 15.2 20.7 10.1 17.1 15.1 32.6 FCGBP FC(GAMMA)BP ENSG00000275395 "Fc fragment of IgG binding protein" 19 39863323-39934626 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "cervix, uterine: 13.9;gallbladder: 46.6;intestine: 43.3;stomach 1: 17.0;thyroid gland: 20.9" "Cell type enriched" "Detected in many" 10 "Mucus-secreting cells: 4433.7" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 9.8;JURKAT: 3.3;RH-30: 11.0;RPMI-8226: 3.8;U-266/70: 3.6" "Not detected" "Not detected" "HPA003517, HPA003564" Enhanced Approved "Golgi apparatus,Plasma membrane,Cytokinetic bridge" NA NA "Plasma membrane" "Golgi apparatus, Cytokinetic bridge" "HPA003517: AB_1078838, HPA003564: AB_2231648" "unprognostic (1.65e-2)" "unprognostic (1.92e-2)" "unprognostic (1.62e-3)" "unprognostic (1.77e-2)" "unprognostic (2.04e-2)" "prognostic favorable (1.28e-5)" "prognostic unfavorable (4.74e-5)" "unprognostic (1.36e-2)" "unprognostic (1.83e-1)" "prognostic unfavorable (9.70e-6)" "unprognostic (9.44e-2)" "unprognostic (3.03e-2)" "unprognostic (5.92e-3)" "unprognostic (8.60e-2)" "unprognostic (1.82e-1)" "prognostic unfavorable (4.27e-4)" "unprognostic (2.08e-1)" 1.7 0.6 1.7 5.9 1.8 0.0 2.7 0.2 1.6 13.9 43.3 0.8 0.7 15.2 0.2 0.4 0.2 0.0 46.6 0.7 0.6 0.6 0.2 0.6 0.2 0.9 0.6 0.6 0.2 0.0 1.2 1.5 1.1 0.4 16.7 0.3 1.3 1.2 0.2 2.8 16.9 0.2 2.1 0.2 17.0 0.4 0.9 0.5 20.9 0.2 0.5 0.2 0.2 0.6 2.3 0.0 0.9 1.3 3.2 0.6 0.0 9.8 0.0 0.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 3.1 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.9 0.3 0.1 0.3 1.0 0.2 0.0 0.0 0.0 0.0 3.3 0.1 0.4 0.0 0.4 2.8 1.2 0.3 3.2 0.7 0.2 11.0 3.8 0.2 1.3 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 3.6 0.4 0.2 0.0 0.0 0.0 0.0 0.2 0.0 1.6 0.9 0.3 0.0 0.7 1.4 2.3 0.6 0.9 3.2 0.0 1.3 0.5 0.0 0.2 0.6 3.0 3.2 2.7 0.7 3.3 1.2 3.1 114.7 5.3 21.6 24.4 0.0 0.6 0.0 3.5 6.2 0.7 445.8 0.0 0.8 0.2 1.1 18.9 16.1 0.8 33.7 0.0 77.9 0.6 21.7 7.1 0.9 10.0 8.5 0.0 4433.7 0.0 2.4 241.9 0.0 1.3 1.0 58.2 0.4 0.7 2.4 5.9 0.3 2.9 169.3 4.7 FGD1 "FGDY, ZFYVE3" ENSG00000102302 "FYVE, RhoGEF and PH domain containing 1" P98174 X 54445454-54496166 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Melanocytes: 6.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000911 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA000911: AB_1078853" "unprognostic (2.49e-1)" "unprognostic (1.56e-1)" "unprognostic (1.64e-2)" "prognostic unfavorable (2.10e-4)" "unprognostic (1.17e-1)" "unprognostic (1.02e-1)" "unprognostic (3.36e-2)" "unprognostic (8.74e-2)" "unprognostic (1.57e-2)" "unprognostic (2.94e-2)" "unprognostic (2.77e-3)" "unprognostic (1.49e-1)" "unprognostic (3.40e-3)" "unprognostic (1.70e-2)" "unprognostic (4.92e-2)" "unprognostic (3.41e-2)" "unprognostic (9.40e-3)" 5.9 7.7 15.6 5.9 10.9 1.6 7.1 16.3 15.6 12.3 7.2 3.7 3.4 4.5 12.4 4.4 9.3 7.6 7.8 9.2 9.6 7.1 5.1 1.9 4.6 4.0 4.8 11.2 13.7 6.9 6.9 5.4 9.4 5.7 6.5 3.8 6.8 7.7 7.9 3.3 11.8 5.5 11.9 3.7 5.8 5.2 4.6 4.8 0.0 5.6 7.3 4.3 7.6 7.8 1.6 0.6 0.5 2.6 1.2 3.2 1.1 13.6 5.8 11.2 14.6 5.2 9.3 5.4 8.1 8.2 6.9 5.6 1.7 1.2 0.8 6.7 12.6 8.7 5.3 9.4 5.8 3.8 1.4 8.2 0.4 4.5 2.0 5.6 0.7 0.5 7.5 3.7 10.5 5.0 8.7 6.2 3.3 2.2 0.5 5.4 2.9 1.6 1.5 11.0 1.6 9.2 7.8 6.4 0.5 5.9 0.8 10.5 9.8 8.9 0.8 13.4 18.6 9.8 1.2 6.0 8.6 7.7 18.9 7.5 1.0 2.0 1.5 9.6 1.6 4.7 0.0 0.6 0.5 2.0 1.3 2.0 1.5 1.6 2.2 0.6 1.6 3.2 1.8 0.0 1.2 2.6 0.2 1.4 1.1 15.6 10.9 16.3 15.6 9.6 7.1 4.8 11.2 5.7 4.8 0.0 0.0 0.0 1.1 2.6 2.5 3.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.2 0.4 3.5 0.0 0.0 0.9 1.0 4.7 0.7 0.0 0.0 0.3 1.6 1.2 3.1 0.0 0.0 2.6 0.0 6.8 0.0 0.8 2.3 0.6 0.0 3.9 1.4 3.3 0.0 2.1 0.2 1.5 3.6 0.2 0.0 2.6 0.8 FGR "c-fgr, p55c-fgr, SRC2" ENSG00000000938 "FGR proto-oncogene, Src family tyrosine kinase" P09769 1 27612064-27635277 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Immunity, Innate immunity" "Kinase, Transferase, Tyrosine-protein kinase" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adipose tissue: 20.8;blood: 68.0;bone marrow: 73.6;lung: 30.9;lymphoid tissue: 54.3" "Cell type enhanced" "Detected in many" 19 "Hofbauer cells: 58.9;Kupffer cells: 187.9;Macrophages: 86.1;T-cells: 45.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 4 "Daudi: 30.1;U-266/70: 55.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA002024 Enhanced Approved "Plasma membrane,Aggresome" NA NA "Plasma membrane" Aggresome "HPA002024: AB_1078503" "unprognostic (2.66e-2)" "unprognostic (1.51e-2)" "unprognostic (6.32e-2)" "unprognostic (9.74e-3)" "unprognostic (6.66e-3)" "unprognostic (6.71e-2)" "unprognostic (5.77e-2)" "unprognostic (1.25e-1)" "unprognostic (1.81e-2)" "unprognostic (7.45e-2)" "unprognostic (2.79e-2)" "unprognostic (1.10e-1)" "unprognostic (1.94e-2)" "unprognostic (6.26e-2)" "unprognostic (3.93e-2)" "unprognostic (2.30e-1)" "unprognostic (8.12e-3)" 20.8 2.6 2.2 23.6 4.5 73.6 5.6 1.1 4.2 2.9 2.8 1.5 4.2 1.6 4.0 2.3 2.2 6.3 5.3 8.5 2.6 2.3 3.0 4.2 30.9 34.1 6.6 1.7 1.9 2.4 0.4 1.2 3.3 4.2 2.5 1.8 2.1 2.9 2.6 4.4 1.7 3.7 6.4 4.8 54.3 2.5 2.6 4.1 1.9 2.9 2.5 7.8 5.1 6.1 13.3 28.9 40.8 68.0 36.3 29.6 55.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.5 10.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.3 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 55.9 0.7 2.3 0.0 6.8 0.0 3.1 52.4 32.3 29.6 68.0 1.7 7.7 2.6 13.6 28.9 13.3 1.3 12.8 40.8 36.3 55.6 1.3 0.1 55.0 2.2 4.5 1.1 4.2 2.6 2.3 6.6 1.7 4.2 4.1 6.0 30.7 12.5 0.5 2.5 0.0 1.6 2.5 2.7 10.3 1.8 0.0 0.4 0.0 0.0 0.2 11.5 0.0 0.0 0.2 0.5 1.4 0.3 12.7 0.9 58.9 0.0 0.0 4.3 187.9 0.4 0.3 86.1 1.7 7.2 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 1.0 0.2 0.5 1.0 0.8 45.8 0.0 0.9 FHIT "AP3Aase, FRA3B" ENSG00000189283 "Fragile histidine triad" P49789 3 59749310-61251459 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" Hydrolase "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Late spermatids: 138.8;Proximal tubular cells: 112.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "naive CD4 T-cell: 38.3" "Lineage enriched" "Detected in all" 14 "T-cells: 38.3" "Cell line enhanced" "Detected in many" "RPMI-8226: 12.1;U-266/70: 24.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002684, HPA018840, HPA018909" Enhanced Approved "Nucleoli fibrillar center,Plasma membrane" NA NA "Nucleoli fibrillar center, Plasma membrane" "CAB002684: , HPA018840: AB_1848538, HPA018909: AB_1848537" "unprognostic (2.36e-3)" "unprognostic (6.38e-2)" "unprognostic (1.59e-1)" "unprognostic (4.42e-2)" "unprognostic (1.10e-1)" "unprognostic (1.08e-2)" "unprognostic (1.18e-1)" "unprognostic (3.16e-2)" "unprognostic (2.77e-2)" "unprognostic (8.49e-2)" "unprognostic (2.36e-1)" "unprognostic (6.77e-2)" "prognostic favorable (1.36e-4)" "unprognostic (1.54e-1)" "unprognostic (5.96e-2)" "unprognostic (1.29e-2)" "unprognostic (1.80e-2)" 6.4 24.0 13.7 8.0 17.5 9.0 12.1 4.7 13.3 7.9 8.0 21.0 12.4 8.2 6.2 9.5 5.1 9.2 13.0 14.9 15.3 13.8 30.9 10.7 5.2 9.3 19.5 9.3 8.9 11.8 16.3 15.2 4.1 14.4 5.8 7.8 14.0 11.4 9.9 11.6 7.0 7.6 9.1 17.1 6.0 8.1 10.5 18.2 3.7 15.6 5.7 6.9 7.3 6.1 1.6 2.4 1.8 1.8 2.6 38.3 4.7 0.0 0.0 1.0 0.0 0.6 0.0 1.7 0.1 0.1 0.0 0.0 1.8 3.1 2.6 0.5 0.1 1.9 0.0 10.1 2.1 0.0 1.4 3.5 2.2 1.3 4.2 2.7 5.7 0.1 6.9 4.2 0.1 5.1 0.2 0.0 2.8 1.7 8.4 0.1 2.5 10.2 4.6 0.8 8.7 0.6 7.6 0.0 12.1 11.3 1.4 2.1 2.9 1.0 7.0 6.6 4.1 0.4 0.1 0.0 1.2 0.4 0.1 1.6 24.7 7.5 0.0 2.7 0.0 1.5 1.8 1.8 0.2 0.9 1.2 0.5 1.6 6.9 0.7 2.2 1.4 38.3 6.7 0.3 2.6 0.4 2.4 7.4 4.7 13.7 17.5 4.7 13.3 15.3 13.8 19.5 9.3 14.4 18.2 6.0 8.8 14.1 16.1 6.8 12.4 9.2 33.1 2.7 3.4 26.2 55.0 33.8 66.3 17.3 41.1 6.2 12.3 0.0 4.1 6.5 4.3 10.2 5.7 20.8 17.6 28.6 7.5 11.6 6.7 138.8 17.8 9.6 11.8 6.4 11.4 17.8 11.6 14.0 9.2 112.3 19.5 0.0 3.1 18.1 6.4 9.8 27.3 7.5 17.2 19.0 FHL1 "bA535K18.1, FHL1B, FLH1A, KYO-T, MGC111107, SLIM1, XMPMA" ENSG00000022267 "Four and a half LIM domains 1" Q13642 X 136146702-136211359 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Differentiation "Developmental protein" "Disease mutation, Emery-Dreifuss muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "skeletal muscle: 557.6;tongue: 239.4" "Cell type enhanced" "Detected in many" 14 "Cardiomyocytes: 1067.5;Early spermatids: 313.2;Late spermatids: 886.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 20.6" "Group enriched" "Detected in many" 4 "dendritic cells: 12.5;NK-cells: 20.6;T-cells: 11.4" "Cell line enhanced" "Detected in many" "BJ hTERT+: 58.7;fHDF/TERT166: 53.1" "Low region specificity" "Detected in all" "HPA001040, HPA001391, CAB020817" Enhanced Supported "Plasma membrane,Cytosol" NA NA 18000000 Cytosol "Plasma membrane" "CAB020817: , HPA001040: AB_1848541, HPA001391: AB_1848542" "unprognostic (2.16e-1)" "unprognostic (5.13e-2)" "unprognostic (1.33e-2)" "unprognostic (1.89e-1)" "unprognostic (1.61e-3)" "unprognostic (1.76e-2)" "unprognostic (2.51e-2)" "unprognostic (9.34e-2)" "unprognostic (7.12e-3)" "unprognostic (1.20e-1)" "unprognostic (2.21e-3)" "unprognostic (1.72e-1)" "unprognostic (6.17e-3)" "unprognostic (4.04e-2)" "unprognostic (7.52e-2)" "unprognostic (2.05e-3)" "prognostic unfavorable (2.11e-4)" 61.9 4.1 7.6 11.0 9.5 0.7 30.6 6.3 7.2 31.5 30.6 3.9 10.0 5.0 25.5 27.7 43.2 14.2 11.7 79.0 6.1 8.1 3.3 2.5 13.7 2.5 5.5 8.1 6.7 2.4 13.4 5.0 13.5 4.4 23.4 10.0 13.5 16.5 30.1 557.6 4.9 11.4 77.7 4.3 2.5 22.1 5.7 3.0 0.6 18.2 239.4 22.1 47.0 14.3 3.4 12.5 0.7 0.4 20.6 11.4 6.2 0.0 9.6 13.3 12.5 29.0 11.7 0.2 37.3 58.7 7.5 18.1 0.0 2.7 0.1 13.0 53.1 21.0 0.1 25.8 31.8 6.3 0.1 29.7 0.1 7.9 0.0 27.2 0.0 6.2 21.7 5.2 9.0 28.6 3.1 7.8 7.3 0.0 5.6 17.5 0.4 5.2 0.3 4.1 0.0 11.3 14.6 0.5 7.9 0.2 0.0 9.4 14.1 1.4 0.0 2.7 5.6 0.0 0.5 22.0 34.7 16.1 1.3 9.3 1.5 3.2 0.2 2.6 0.3 3.8 0.0 0.4 0.0 3.2 0.0 8.6 3.4 11.4 4.5 1.8 2.3 7.6 2.3 0.7 20.6 0.0 12.5 1.2 6.2 7.6 9.5 6.3 7.2 6.1 8.1 5.5 8.1 4.4 3.0 44.7 16.0 6.4 17.4 50.3 30.5 1067.5 0.0 5.3 7.9 10.4 7.9 0.7 1.7 3.3 313.2 63.3 0.0 0.0 0.2 1.0 98.8 2.5 15.1 4.7 3.8 93.8 13.2 131.3 5.9 886.8 114.8 9.8 30.4 10.8 0.5 182.0 0.6 0.2 143.2 4.8 16.9 103.5 304.9 6.0 79.0 39.1 2.3 13.4 0.6 1.8 FIGN ENSG00000182263 "Fidgetin, microtubule severing factor" Q5HY92 2 163593396-163736012 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Leydig cells: 48.1;Peritubular cells: 32.2;Sertoli cells: 71.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 54 "basophil: 5.4" "Lineage enriched" "Detected in single" 54 "granulocytes: 5.4" "Cell line enhanced" "Detected in many" "AF22: 17.2;SuSa: 10.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA034987, HPA057919" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "Vesicles, Cell Junctions" "HPA034987: AB_10669681, HPA057919: " "unprognostic (3.93e-2)" "unprognostic (8.30e-3)" "unprognostic (1.48e-1)" "unprognostic (7.68e-5)" "unprognostic (3.45e-2)" "unprognostic (8.98e-4)" "unprognostic (5.23e-3)" "unprognostic (7.65e-3)" "unprognostic (2.33e-1)" "unprognostic (1.64e-1)" "unprognostic (2.07e-2)" "unprognostic (3.24e-2)" "unprognostic (3.85e-3)" "unprognostic (3.22e-2)" "unprognostic (2.69e-1)" "unprognostic (4.10e-2)" "unprognostic (3.78e-2)" 8.5 7.6 9.6 2.9 13.7 2.8 5.2 5.1 11.9 6.8 5.9 5.5 3.7 2.1 3.3 5.0 2.9 4.5 4.4 10.1 8.8 4.3 7.2 7.9 4.3 2.5 8.7 4.7 14.3 7.2 1.8 12.1 4.4 7.7 4.8 3.4 4.3 8.4 9.9 3.6 3.2 3.6 5.6 9.1 8.7 4.5 4.4 10.5 0.0 3.1 3.0 1.6 4.1 6.3 0.0 0.0 5.4 0.0 0.0 0.0 0.0 5.6 2.0 17.2 0.0 0.0 0.0 6.3 2.2 1.5 1.6 3.0 0.0 2.0 0.0 6.2 2.4 3.2 0.8 5.7 2.4 1.3 0.0 4.2 0.0 3.9 4.1 1.4 0.0 0.0 0.8 2.1 3.1 8.4 2.5 3.7 0.0 0.0 0.0 4.7 1.4 0.0 0.0 7.3 0.4 2.7 0.0 5.8 0.0 4.0 1.9 2.7 2.3 0.0 1.6 1.5 10.1 1.8 0.0 0.3 7.1 6.5 0.0 4.6 1.0 0.0 0.0 2.1 0.0 3.9 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 13.7 5.1 11.9 8.8 4.3 8.7 4.7 7.7 10.5 6.0 5.3 1.4 0.1 1.6 15.3 16.8 10.2 6.7 3.4 12.2 0.0 18.1 1.7 2.5 2.7 0.7 0.0 0.0 1.3 5.9 6.3 0.9 0.0 11.3 1.2 6.4 0.0 7.4 0.0 4.2 48.1 0.2 16.9 0.0 0.0 6.5 1.7 0.0 32.2 6.3 1.9 71.1 13.9 0.2 0.6 0.4 14.1 0.0 0.0 0.0 FILIP1L "DOC-1, GIP130" ENSG00000168386 "Filamin A interacting protein 1 like" Q4L180 3 99830141-100114513 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 302.8;Sertoli cells: 252.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 5.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 27.3;HDLM-2: 25.5;TIME: 47.6" "Region enriched" "Detected in some" 7 "olfactory region: 22.1" "Low region specificity" "Detected in all" HPA043133 Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA043133: AB_10793991" "unprognostic (9.14e-2)" "unprognostic (2.16e-1)" "unprognostic (7.73e-2)" "unprognostic (5.25e-2)" "unprognostic (6.68e-2)" "unprognostic (1.06e-2)" "unprognostic (4.40e-2)" "unprognostic (1.29e-1)" "unprognostic (2.08e-2)" "unprognostic (2.18e-1)" "unprognostic (1.02e-1)" "unprognostic (3.32e-1)" "prognostic unfavorable (9.40e-4)" "unprognostic (2.46e-2)" "unprognostic (9.44e-2)" "unprognostic (5.30e-2)" "unprognostic (1.82e-3)" 29.0 7.5 11.7 22.1 2.4 0.0 15.2 1.3 7.4 36.2 28.3 0.9 27.2 6.9 52.5 50.0 25.3 17.8 24.3 23.8 4.0 2.1 12.5 6.7 15.9 10.9 2.9 6.5 65.6 10.3 7.7 3.1 14.6 9.4 36.7 7.7 5.5 6.1 36.8 44.8 9.5 19.2 86.3 2.2 27.1 25.1 19.9 1.3 2.5 11.7 53.4 5.8 49.8 16.2 1.5 4.4 0.5 5.9 1.0 0.4 0.5 18.7 0.0 7.4 0.0 12.2 10.4 0.6 9.6 19.3 16.8 19.1 5.7 0.0 0.0 1.7 27.3 4.4 2.3 0.0 4.7 20.0 25.5 0.2 1.5 0.0 7.5 6.1 0.4 0.0 8.2 1.7 1.9 0.0 10.8 7.5 0.0 1.2 0.1 2.5 0.1 1.6 0.3 0.4 1.0 0.0 0.0 8.7 0.2 11.3 0.3 0.6 1.2 0.1 0.1 0.0 4.1 0.0 3.4 47.6 2.9 0.0 0.6 5.0 1.4 0.0 0.1 2.2 0.1 0.0 0.3 1.0 0.2 0.3 2.2 0.1 1.4 0.4 0.3 4.4 1.5 0.2 0.2 0.5 1.0 5.9 0.8 0.3 0.5 11.7 2.4 1.3 7.4 4.0 2.1 2.9 6.5 9.4 1.3 14.9 17.2 0.0 37.5 24.6 4.0 115.5 33.1 2.7 2.3 5.2 7.9 0.6 1.7 158.4 302.8 69.7 2.9 0.0 97.5 0.6 90.1 2.5 33.5 0.5 3.0 100.1 2.9 44.2 29.2 157.4 76.8 76.0 16.9 28.9 3.0 1.0 44.0 0.0 97.9 0.3 5.9 252.2 159.4 7.1 1.9 19.8 2.6 0.5 0.3 3.7 FKBP2 "FKBP-13, PPIase" ENSG00000173486 "FK506 binding protein 2" P26885 11 64241003-64244132 "Enzymes, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 119.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025561, HPA049405" Enhanced Approved "Plasma membrane" "Intracellular and membrane" No No 400000 "Plasma membrane" "CAB025561: , HPA049405: AB_2680749" "unprognostic (4.94e-2)" "unprognostic (1.12e-1)" "unprognostic (5.77e-2)" "unprognostic (2.66e-3)" "unprognostic (7.40e-2)" "unprognostic (1.92e-2)" "unprognostic (8.64e-2)" "unprognostic (1.62e-1)" "unprognostic (3.23e-1)" "unprognostic (5.91e-3)" "unprognostic (5.86e-2)" "unprognostic (7.18e-2)" "unprognostic (1.70e-2)" "unprognostic (1.58e-1)" "unprognostic (5.23e-1)" "unprognostic (2.30e-1)" "unprognostic (3.57e-2)" 18.2 35.8 28.9 20.2 35.5 12.1 20.2 18.8 27.1 31.3 28.0 20.3 87.8 39.0 24.4 102.7 20.8 25.5 30.3 28.0 29.7 35.7 40.3 89.6 18.8 17.0 39.3 24.8 22.1 107.2 34.0 57.2 59.2 29.0 26.1 21.9 19.4 59.3 116.6 11.8 18.5 30.2 19.7 28.5 20.9 31.1 19.8 20.6 12.4 63.2 18.6 18.8 21.3 23.9 21.3 119.6 29.0 25.4 20.0 30.7 15.5 24.2 32.0 17.3 35.0 37.5 21.4 24.6 29.4 29.9 22.3 20.7 31.5 54.7 18.0 46.9 36.1 30.5 31.8 13.7 24.4 10.6 22.3 11.9 19.9 42.6 32.1 49.3 16.5 28.0 24.9 36.4 29.5 32.6 32.2 17.7 16.3 14.9 53.9 26.4 40.1 18.0 26.1 20.2 41.7 28.9 16.1 17.1 65.5 40.3 24.4 24.2 21.1 20.2 57.2 32.4 12.7 22.0 14.3 16.7 26.8 23.9 42.6 15.7 32.8 10.2 14.6 35.9 17.4 30.3 29.0 24.5 3.4 24.1 25.4 30.7 21.3 19.2 23.3 23.2 20.5 13.0 18.1 9.1 20.0 20.8 119.6 7.1 15.5 28.9 35.5 18.8 27.1 29.7 35.7 39.3 24.8 29.0 20.6 137.0 150.2 102.0 207.7 146.1 76.1 98.2 310.8 108.4 116.0 369.9 21.6 256.2 349.8 239.2 83.7 136.1 585.6 23.3 222.4 308.7 201.1 281.8 142.9 635.0 211.8 30.2 328.9 152.9 95.0 70.2 213.2 169.2 285.1 186.7 264.4 122.7 276.9 273.5 239.7 629.6 65.3 181.1 142.1 273.8 237.0 146.9 518.9 105.4 226.6 265.6 FLAD1 "FAD1, PP591" ENSG00000160688 "Flavin adenine dinucleotide synthetase 1" Q8NFF5 1 154983338-154993111 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028476, HPA028486, HPA028563" Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA028476: AB_10599974, HPA028486: AB_10600206, HPA028563: AB_10602286" "unprognostic (2.64e-1)" "unprognostic (2.60e-1)" "unprognostic (2.72e-1)" "unprognostic (3.84e-2)" "unprognostic (7.34e-2)" "unprognostic (1.45e-1)" "prognostic unfavorable (3.04e-4)" "unprognostic (1.31e-1)" "unprognostic (2.32e-1)" "unprognostic (8.08e-2)" "unprognostic (6.51e-2)" "unprognostic (9.74e-2)" "prognostic unfavorable (2.55e-6)" "unprognostic (1.67e-2)" "unprognostic (5.06e-2)" "unprognostic (5.50e-2)" "unprognostic (1.17e-2)" 16.5 16.5 20.3 15.5 18.9 12.1 17.4 15.9 20.8 14.1 16.4 19.3 14.7 19.6 15.9 21.2 19.8 16.7 11.8 16.1 18.2 10.4 19.0 36.5 13.5 20.0 20.8 15.6 14.5 19.0 13.6 12.0 18.5 15.9 18.7 19.0 16.1 16.2 16.3 26.3 23.3 23.9 17.6 12.4 22.9 16.1 19.1 18.9 15.7 20.8 18.4 22.0 15.5 15.4 25.1 24.5 15.2 24.1 14.9 26.4 22.7 13.0 20.9 13.3 22.7 11.6 8.6 25.4 9.9 8.2 14.4 12.4 18.6 16.1 15.2 20.0 9.1 7.5 17.1 25.6 20.5 9.4 15.8 19.2 12.3 16.6 13.1 15.9 17.8 16.1 12.3 26.9 16.4 17.6 7.0 16.7 16.3 19.8 12.4 12.2 28.1 12.2 12.5 29.1 28.4 21.7 20.7 6.6 34.9 13.7 18.2 22.5 30.9 15.5 35.1 19.5 27.0 30.0 27.1 10.5 9.1 12.5 11.6 15.5 19.4 24.0 26.2 10.9 14.5 14.5 15.2 23.0 14.8 24.0 20.9 26.4 25.1 22.1 22.7 24.1 20.5 20.5 20.2 5.2 14.9 24.1 24.5 23.3 22.7 20.3 18.9 15.9 20.8 18.2 10.4 20.8 15.6 15.9 18.9 8.9 8.8 15.9 13.2 23.6 15.2 34.3 20.4 16.0 11.4 24.4 5.9 36.7 26.6 22.3 20.5 11.2 23.6 23.3 24.5 35.2 12.7 16.8 8.1 24.5 24.6 14.3 11.5 9.8 14.6 61.7 9.5 14.0 13.5 41.5 18.3 19.0 20.5 17.5 9.2 27.4 14.7 6.5 13.3 20.0 17.9 24.1 30.1 16.0 19.9 17.0 FMN2 ENSG00000155816 "Formin 2" Q9NZ56 1 240014348-240475189 "Disease related genes, Predicted intracellular proteins" "DNA damage, Protein transport, Stress response, Transport" "Actin-binding, Developmental protein" "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 41.0;parathyroid gland: 26.6" "Cell type enhanced" "Detected in some" 25 "Bipolar cells: 28.2;Cone photoreceptor cells: 47.1;Horizontal cells: 117.6" "Group enriched" "Detected in some" 8 "glioma: 5.9;testis cancer: 3.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BJ: 27.0;BJ hTERT+: 14.3;fHDF/TERT166: 26.6;LHCN-M2: 29.3;U-138 MG: 19.4;WM-115: 30.2" "Low region specificity" "Detected in all" HPA050649 Approved "Plasma membrane,Actin filaments" NA NA "Plasma membrane, Actin filaments" "HPA050649: AB_2681202" "unprognostic (1.55e-2)" "unprognostic (8.21e-2)" "unprognostic (4.01e-2)" "unprognostic (8.06e-2)" "unprognostic (2.77e-1)" "unprognostic (1.76e-1)" "unprognostic (7.97e-3)" "unprognostic (2.11e-2)" "unprognostic (2.93e-1)" "unprognostic (3.92e-2)" "unprognostic (3.35e-3)" "unprognostic (4.08e-1)" "unprognostic (1.11e-2)" "unprognostic (8.03e-3)" "unprognostic (9.78e-2)" "unprognostic (3.10e-2)" "unprognostic (1.40e-3)" 1.2 7.3 17.1 1.3 14.5 0.9 1.3 17.2 41.0 1.1 3.2 9.4 0.0 1.4 2.5 2.1 2.1 3.7 2.0 0.9 16.2 11.8 2.9 0.9 1.4 0.9 9.9 15.5 3.9 2.1 26.6 5.6 1.2 12.2 2.9 3.0 1.4 1.3 3.6 0.9 1.0 1.3 2.7 12.3 1.2 1.2 3.4 12.3 0.0 1.3 0.0 1.0 1.2 0.4 0.5 0.4 0.6 0.3 0.4 2.3 0.0 0.0 0.8 2.9 0.0 7.4 5.6 0.0 27.0 14.3 10.7 5.8 0.0 0.0 0.0 0.0 26.6 0.5 0.0 0.4 0.0 10.5 0.0 2.2 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.0 3.5 0.7 6.8 0.0 0.0 0.0 0.0 29.3 0.0 0.0 0.0 0.9 0.0 0.9 0.0 0.1 0.0 0.0 0.0 4.5 4.0 0.0 0.1 0.1 0.1 1.1 0.0 0.1 19.4 0.1 7.3 7.0 0.0 0.0 0.0 3.8 0.0 30.2 0.6 0.3 0.1 0.3 0.2 0.2 0.1 0.9 0.1 0.1 0.5 2.3 1.4 0.5 0.4 0.1 0.4 0.3 0.0 17.1 14.5 17.2 19.3 16.2 11.8 9.9 15.5 12.2 12.3 0.0 0.0 0.0 0.0 0.1 28.2 1.2 0.0 0.0 0.0 1.8 47.1 0.0 0.0 0.0 9.1 0.3 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.1 117.6 11.6 0.6 1.2 2.4 0.3 0.2 1.7 0.0 0.2 1.8 0.0 0.0 0.0 0.0 2.4 0.0 0.3 1.6 4.4 0.0 0.5 0.0 0.0 0.0 FMNL2 "FHOD2, KIAA1902" ENSG00000157827 "Formin like 2" Q96PY5 2 152335237-152649834 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 74.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.7;non-classical monocyte: 4.2" "Lineage enriched" "Detected in single" 5 "monocytes: 4.2" "Cell line enhanced" "Detected in many" "BEWO: 57.7;hTERT-HME1: 37.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005464 Enhanced Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA Cytosol "Golgi apparatus, Plasma membrane" "HPA005464: AB_1848965" "unprognostic (1.19e-1)" "unprognostic (6.92e-2)" "unprognostic (8.75e-3)" "unprognostic (3.06e-2)" "unprognostic (7.40e-2)" "unprognostic (9.45e-2)" "prognostic unfavorable (9.04e-4)" "unprognostic (1.34e-2)" "unprognostic (1.98e-1)" "unprognostic (1.38e-1)" "unprognostic (2.54e-1)" "unprognostic (4.66e-2)" "unprognostic (5.68e-2)" "unprognostic (1.05e-1)" "unprognostic (2.58e-1)" "unprognostic (3.73e-2)" "unprognostic (1.58e-1)" 15.1 13.6 26.2 7.0 44.6 0.8 9.4 18.3 55.0 8.5 6.6 55.0 1.4 5.8 13.6 10.2 4.6 6.7 11.1 4.8 32.0 20.6 9.7 5.3 17.9 8.2 63.4 27.9 35.9 7.4 17.8 10.2 35.9 39.2 8.9 8.4 5.4 20.1 8.2 31.0 4.0 5.5 10.7 74.1 12.0 8.2 5.8 56.7 1.3 14.5 3.2 5.4 9.1 11.6 0.0 0.9 0.0 4.2 0.0 0.1 0.0 4.1 4.4 13.8 7.6 16.7 18.1 57.7 4.2 8.7 7.5 10.6 4.7 0.2 0.0 9.0 3.6 16.2 4.7 6.6 13.5 12.0 0.0 7.0 0.0 2.8 20.2 4.8 1.1 0.2 11.8 8.4 14.5 37.5 14.6 13.2 1.9 0.1 0.1 4.1 1.1 0.2 1.3 8.8 3.6 8.9 7.4 2.9 6.0 21.9 2.9 14.1 11.5 3.6 1.3 14.6 12.2 0.3 0.4 14.7 11.4 0.3 3.8 7.2 0.4 0.1 0.0 10.5 0.9 23.1 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.2 0.9 0.1 0.0 26.2 44.6 18.3 36.7 32.0 20.6 63.4 27.9 39.2 56.7 23.8 23.4 0.8 14.1 23.5 20.5 2.8 2.5 10.7 23.9 10.4 0.0 30.2 11.6 15.8 18.3 19.7 1.4 0.0 5.9 11.6 29.6 14.2 1.1 1.3 36.8 0.0 7.9 16.0 47.8 6.5 32.5 31.0 6.8 4.6 3.0 3.6 8.9 0.0 38.9 6.3 1.3 6.5 9.0 6.2 6.9 14.8 22.5 1.9 6.6 10.1 FOXN3 "C14orf116, CHES1" ENSG00000053254 "Forkhead box N3" O00409 14 89124871-89619149 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059209 Approved Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA059209: AB_2683949" "unprognostic (1.69e-1)" "unprognostic (6.13e-3)" "unprognostic (2.08e-1)" "unprognostic (1.84e-1)" "unprognostic (4.09e-2)" "unprognostic (2.03e-1)" "unprognostic (3.03e-1)" "unprognostic (1.34e-2)" "unprognostic (8.75e-2)" "unprognostic (1.09e-1)" "unprognostic (2.64e-1)" "unprognostic (1.19e-1)" "prognostic favorable (9.58e-5)" "unprognostic (2.22e-2)" "unprognostic (1.88e-1)" "unprognostic (5.53e-2)" "unprognostic (2.11e-1)" 26.8 14.5 12.6 23.2 11.3 33.9 35.2 46.9 10.7 17.2 28.4 15.3 12.2 18.2 19.3 11.2 21.0 17.4 11.9 20.2 12.8 7.8 7.5 15.4 14.1 20.1 11.3 7.4 28.8 15.1 35.0 10.1 11.3 13.2 15.7 11.1 17.8 13.4 12.6 44.3 29.5 31.1 25.1 14.0 13.2 15.9 12.6 13.2 34.0 8.8 18.4 19.9 25.7 31.7 9.6 19.3 21.4 14.2 17.3 24.3 15.2 0.1 2.7 7.3 4.3 29.7 9.6 5.0 5.5 5.9 5.1 8.5 2.6 2.1 8.6 2.9 8.8 3.6 1.9 12.5 8.1 7.6 37.2 2.4 2.8 5.4 9.0 9.6 5.6 5.1 22.5 4.7 0.4 3.6 6.3 10.9 12.1 3.3 24.6 8.6 3.3 11.1 5.6 7.6 5.0 4.9 17.5 24.8 8.0 0.6 8.9 3.8 13.0 8.1 8.1 2.3 24.7 4.5 16.2 19.2 8.9 11.9 8.6 8.3 22.0 37.3 15.5 3.0 10.0 5.2 21.4 13.0 18.8 24.3 14.2 19.5 7.8 16.4 20.8 19.3 9.6 21.5 20.5 5.4 17.3 8.7 4.3 19.2 15.2 12.6 11.3 46.9 10.7 12.8 7.8 11.3 7.4 13.2 13.2 29.8 33.4 42.2 20.1 79.3 120.0 94.3 45.9 13.4 46.6 8.7 0.0 28.4 18.3 8.5 51.6 50.4 42.4 23.3 18.2 16.8 35.5 24.5 12.7 73.7 37.8 74.7 57.0 52.2 76.4 26.5 89.2 69.9 30.4 26.2 40.3 32.4 15.4 24.6 80.2 10.5 9.3 38.8 52.6 2.3 10.0 129.0 24.7 76.1 43.5 22.0 FP565260.3 ENSG00000277117 21 5022493-5040666 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 9.2" "Cell type enriched" "Detected in single" 22 "monocytes: 8.2" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in some" "naive B-cell: 5.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 16.3;REH: 12.7;SiHa: 10.9" HPA029179 Approved "Plasma membrane,Cytoplasmic bodies" NA NA "Plasma membrane, Cytoplasmic bodies" "HPA029179: AB_2732445" "unprognostic (3.34e-2)" "unprognostic (1.52e-1)" "unprognostic (2.82e-1)" "unprognostic (3.58e-4)" "unprognostic (6.66e-4)" "unprognostic (1.24e-2)" "unprognostic (1.12e-1)" "unprognostic (3.36e-1)" "unprognostic (2.46e-1)" "unprognostic (6.63e-2)" "unprognostic (1.14e-1)" "unprognostic (7.43e-2)" "unprognostic (2.13e-1)" "unprognostic (3.17e-1)" "unprognostic (3.60e-2)" "unprognostic (1.12e-1)" "unprognostic (2.09e-1)" 1.5 0.2 0.6 3.4 4.5 2.4 1.9 0.4 7.0 2.6 2.0 9.2 0.6 4.3 0.8 1.7 1.4 2.1 2.6 2.9 2.2 2.5 2.3 1.2 4.5 4.2 3.1 0.2 1.8 0.0 0.0 1.9 4.3 1.3 1.6 0.1 1.3 1.0 0.7 3.1 2.8 0.7 2.6 2.3 4.1 0.5 3.6 0.0 1.0 1.9 5.7 1.6 1.2 5.3 0.9 0.0 3.0 0.0 1.1 0.8 0.2 0.6 0.0 1.1 0.3 0.7 16.3 1.3 1.0 0.2 0.0 3.9 0.7 8.7 2.6 0.0 2.1 3.1 1.0 1.2 0.2 0.2 0.8 0.0 0.5 2.1 0.2 6.7 6.4 0.1 1.7 0.9 0.8 0.0 0.9 0.0 1.0 0.3 0.1 2.2 0.0 4.0 0.6 10.8 5.3 12.7 0.4 8.9 0.4 5.5 0.7 0.0 10.9 9.6 0.1 0.6 2.9 9.0 0.3 0.0 2.5 0.0 0.2 6.0 6.1 5.7 6.9 3.8 1.5 0.0 0.6 0.0 0.0 3.0 0.3 2.9 0.5 0.2 0.7 5.3 0.1 0.5 0.0 0.0 0.6 0.9 1.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 FRMD3 "EPB41L4O, MGC20553" ENSG00000172159 "FERM domain containing 3" A2A2Y4 9 83242990-83538546 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 48.5;skeletal muscle: 42.1" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 102.0;Cardiomyocytes: 66.5;Cone photoreceptor cells: 74.6;Early spermatids: 112.3;Horizontal cells: 95.3;Late spermatids: 100.0;Sertoli cells: 71.1" "Cancer enhanced" "Detected in many" "thyroid cancer: 27.3" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "classical monocyte: 2.8;intermediate monocyte: 4.7;neutrophil: 3.8;non-classical monocyte: 2.1" "Group enriched" "Detected in many" 6 "granulocytes: 3.8;monocytes: 4.7" "Cell line enhanced" "Detected in some" "HEL: 11.2;OE19: 23.5;RPMI-8226: 37.7;SCLC-21H: 13.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017285 Approved Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Golgi apparatus, Plasma membrane" Nucleoplasm "HPA017285: AB_2669569" "unprognostic (4.45e-2)" "unprognostic (1.85e-1)" "unprognostic (1.93e-1)" "unprognostic (6.44e-2)" "unprognostic (2.66e-1)" "unprognostic (2.23e-1)" "unprognostic (8.13e-2)" "unprognostic (3.93e-1)" "unprognostic (3.94e-2)" "unprognostic (1.06e-1)" "unprognostic (2.23e-1)" "unprognostic (5.87e-2)" "prognostic favorable (7.24e-4)" "unprognostic (3.12e-1)" "unprognostic (1.88e-1)" "prognostic favorable (1.79e-4)" "unprognostic (1.68e-3)" 12.7 4.6 3.5 2.8 2.3 3.0 16.8 2.0 3.0 4.6 7.1 1.7 14.3 1.9 5.5 9.8 4.1 1.9 2.9 48.5 3.2 4.5 11.7 0.7 2.9 0.9 3.6 1.7 1.4 1.4 8.9 6.1 8.7 2.9 5.1 4.1 5.3 2.1 35.3 42.1 1.6 10.9 3.5 2.8 4.3 2.2 6.1 0.8 0.0 8.8 11.1 0.7 3.8 5.0 0.6 0.6 3.8 4.7 0.4 0.6 9.2 0.0 2.1 1.8 0.1 0.3 0.1 0.1 2.0 0.1 0.0 0.0 0.2 2.5 0.4 2.3 0.9 0.4 0.1 0.1 0.0 0.0 0.1 0.1 11.2 2.4 1.3 0.1 0.0 0.1 0.5 0.0 0.0 0.1 0.1 1.3 0.0 0.0 0.0 2.4 0.3 0.0 0.0 0.2 23.5 3.5 0.0 1.5 37.7 3.1 4.9 13.9 6.7 0.7 0.1 0.4 0.3 0.8 0.4 2.1 0.1 0.3 0.0 1.4 0.2 0.1 0.0 0.5 3.6 1.4 0.0 2.8 0.0 0.4 4.7 0.6 0.5 0.2 0.1 0.4 0.6 0.1 0.0 3.8 0.4 2.1 0.6 0.0 9.2 3.5 2.3 2.0 3.0 3.2 4.5 3.6 1.7 2.9 0.8 20.8 0.6 0.0 1.0 0.9 102.0 66.5 10.2 0.0 2.3 1.8 74.6 0.3 14.9 2.5 112.3 13.1 26.2 0.0 1.7 0.9 2.1 1.0 0.0 0.2 0.8 95.3 1.2 3.1 4.6 100.0 2.0 1.5 0.0 0.0 19.4 2.0 2.0 7.0 4.6 8.7 4.7 71.1 28.9 1.6 1.4 1.1 0.1 0.0 1.6 1.3 FRMD7 "FLJ43346, NYS, NYS1" ENSG00000165694 "FERM domain containing 7" Q6ZUT3 X 132076993-132128020 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" Neurogenesis "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "endometrium 1: 7.4;kidney: 6.6;smooth muscle: 5.5" "Cell type enriched" "Detected in single" 30 "Distal tubular cells: 8.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.1;HSkMC: 1.6;SuSa: 3.6;U-87 MG: 5.5" "Region enriched" "Detected in single" 29 "olfactory region: 80.8" "Region enriched" "Detected in single" 103 "olfactory region: 45.5" HPA000886 Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA000886: AB_1079269" "unprognostic (3.08e-2)" "unprognostic (1.27e-1)" "unprognostic (1.36e-1)" "unprognostic (3.07e-1)" "unprognostic (4.02e-2)" "unprognostic (1.64e-2)" "unprognostic (2.28e-1)" "unprognostic (2.18e-2)" "unprognostic (3.84e-1)" "unprognostic (3.54e-2)" "unprognostic (3.00e-1)" 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.0 0.0 7.4 1.1 0.0 1.1 0.0 0.1 0.0 0.1 6.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.1 0.0 0.5 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 3.6 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FTCD ENSG00000160282 "Formimidoyltransferase cyclodeaminase" O95954 21 46136262-46155567 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Histidine metabolism" "Lyase, Multifunctional enzyme, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "liver: 126.8" "Cell type enhanced" "Detected in many" 16 "Hepatocytes: 338.0;Late spermatids: 92.6;Proximal tubular cells: 322.0" "Cancer enriched" "Detected in some" 8 "liver cancer: 87.3" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "T-reg: 2.5" "Lineage enriched" "Detected in single" 25 "T-cells: 2.5" "Cell line enriched" "Detected in some" 29 "Hep G2: 45.4" "HPA020073, HPA030928, HPA030929, HPA036114" Enhanced Approved "Plasma membrane,Cytosol" No NA 580000 Cytosol "Plasma membrane" "HPA020073: AB_1849005, HPA030928: AB_2673664, HPA030929: AB_2673665, HPA036114: AB_2674947" "unprognostic (1.71e-1)" "unprognostic (2.27e-1)" "unprognostic (4.62e-5)" "unprognostic (2.90e-2)" "unprognostic (1.13e-1)" "unprognostic (2.96e-1)" "prognostic favorable (1.70e-4)" "unprognostic (1.85e-1)" "unprognostic (2.67e-1)" "unprognostic (1.99e-1)" "prognostic favorable (6.78e-5)" "unprognostic (1.80e-1)" "prognostic favorable (5.78e-4)" "unprognostic (3.80e-2)" "unprognostic (3.60e-1)" "unprognostic (9.37e-2)" "unprognostic (2.10e-1)" 0.2 0.0 0.6 0.2 1.6 0.0 0.2 0.2 0.7 0.2 0.3 0.2 0.2 0.3 0.2 2.0 0.2 0.0 0.2 0.2 0.5 0.4 25.9 126.8 0.2 0.2 0.4 0.2 0.2 1.0 0.0 0.2 0.2 0.2 0.3 0.0 0.2 0.2 0.2 0.2 0.0 0.4 0.2 0.2 0.2 0.1 1.5 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 2.5 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 45.4 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 2.5 0.1 0.6 1.6 0.2 0.7 0.5 0.4 0.4 0.2 0.2 0.2 0.0 0.0 24.9 0.0 0.1 1.0 1.0 68.8 0.0 0.0 8.7 0.0 0.0 39.7 0.0 75.4 0.6 0.0 0.0 0.0 0.0 0.8 0.5 0.0 338.0 0.1 3.2 0.0 22.7 22.3 92.6 2.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.5 322.0 0.4 0.0 0.1 10.7 12.2 0.4 0.0 6.9 0.0 0.0 FXYD3 "MAT-8, PLML" ENSG00000089356 "FXYD domain containing ion transport regulator 3" Q14802 19 35115879-35124324 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 160.2;salivary gland: 141.7" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 1850.8;Mucus-secreting cells: 1977.6;Paneth cells: 3546.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 3.2" "Lineage enriched" "Detected in single" 5 "dendritic cells: 3.2" "Cell line enhanced" "Detected in some" "HaCaT: 70.3;hTCEpi: 128.0;OE19: 239.6;RT4: 66.8;SK-BR-3: 65.8;WM-115: 47.1" HPA010856 Enhanced Approved "Nucleoplasm,Plasma membrane" "Intracellular and membrane" NA NA Nucleoplasm "Plasma membrane" "HPA010856: AB_1078915" "unprognostic (2.18e-3)" "unprognostic (2.78e-2)" "unprognostic (8.37e-3)" "unprognostic (3.31e-3)" "unprognostic (6.38e-2)" "unprognostic (3.02e-1)" "unprognostic (2.64e-3)" "unprognostic (1.60e-1)" "unprognostic (3.59e-1)" "unprognostic (1.03e-1)" "unprognostic (2.32e-2)" "unprognostic (3.88e-1)" "prognostic unfavorable (1.15e-6)" "unprognostic (4.17e-2)" "unprognostic (2.08e-1)" "unprognostic (5.06e-2)" "unprognostic (7.69e-3)" 0.4 0.1 1.6 29.5 2.3 0.0 20.4 1.7 2.1 30.0 133.2 1.1 2.3 8.6 3.9 2.9 82.1 9.0 56.6 0.8 1.4 0.3 2.1 0.5 35.8 0.3 2.1 0.8 1.9 28.9 0.0 3.7 41.9 2.2 58.4 160.2 15.8 141.7 3.5 0.5 64.2 36.4 7.5 1.8 0.4 50.6 0.7 1.0 2.5 0.5 93.2 49.8 48.7 42.5 0.3 3.2 0.6 0.1 0.0 0.2 0.5 12.6 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 0.4 18.5 0.0 0.0 0.0 0.1 70.3 0.0 26.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 128.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.2 0.0 0.1 0.0 239.6 0.1 0.0 0.0 0.0 0.0 66.8 15.7 0.1 0.0 65.8 4.8 0.1 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.1 0.2 0.6 0.0 0.0 3.2 0.0 0.5 1.6 2.3 1.7 2.1 1.4 0.3 2.1 0.8 2.2 1.0 708.7 211.8 0.0 720.0 512.4 2.3 1.3 239.5 860.6 417.5 127.4 0.0 696.6 1.7 18.8 0.1 3.8 1850.8 0.0 640.2 148.4 41.3 1079.2 23.0 0.6 70.8 1.6 937.0 0.0 0.0 0.0 0.0 12.2 391.4 2.8 1977.6 233.2 377.2 3546.9 0.0 0.6 8.5 0.0 25.8 0.2 0.2 756.6 1264.5 0.7 1253.7 1183.0 FYB1 "ADAP, FYB, FYB-120/130, SLAP-130" ENSG00000082074 "FYN binding protein 1" O15117 5 39105255-39274528 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 153.7;lymphoid tissue: 63.5" "Cell type enhanced" "Detected in some" 17 "Extravillous trophoblasts: 65.7;Hofbauer cells: 145.5;Macrophages: 50.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 153.7" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "HEL: 16.3;JURKAT: 58.0;MOLT-4: 55.5;REH: 16.2;U-937: 21.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025336, HPA026796, HPA067427" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA 6600000 "Plasma membrane" Nucleoplasm "CAB025336: , HPA026796: AB_10964126, HPA067427: " "unprognostic (5.65e-2)" "unprognostic (2.92e-2)" "unprognostic (1.56e-2)" "unprognostic (6.26e-2)" "unprognostic (4.08e-1)" "unprognostic (3.29e-2)" "unprognostic (2.60e-1)" "unprognostic (1.97e-1)" "unprognostic (1.24e-1)" "unprognostic (5.63e-2)" "unprognostic (5.35e-2)" "unprognostic (3.21e-1)" "prognostic unfavorable (2.24e-4)" "unprognostic (2.40e-1)" "unprognostic (4.14e-2)" "unprognostic (8.99e-2)" "unprognostic (1.51e-1)" 7.0 3.5 6.3 36.0 18.3 22.1 3.9 1.8 10.1 3.5 4.4 8.3 0.3 4.1 2.7 6.5 4.9 4.2 7.9 3.5 6.8 6.6 5.7 6.2 13.8 35.5 15.5 2.7 2.6 2.5 1.3 3.5 8.7 11.7 3.8 5.3 3.0 5.4 1.5 1.9 2.4 11.7 5.6 29.4 41.5 5.2 3.5 12.2 63.5 4.1 1.8 28.0 10.1 3.6 0.1 11.9 153.7 41.3 8.6 28.7 30.8 0.0 1.1 0.0 0.0 0.1 0.0 6.2 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 2.2 4.5 0.0 0.1 0.0 0.0 0.0 16.3 0.0 0.0 0.0 6.1 5.2 0.0 0.1 0.0 0.1 0.0 0.0 58.0 0.0 0.0 0.0 0.0 55.5 3.5 0.0 0.0 0.0 16.2 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.1 1.6 0.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 21.5 0.0 11.9 33.8 32.3 7.9 38.6 5.5 0.1 22.5 13.8 11.9 0.1 28.7 17.3 153.7 8.6 41.3 3.0 21.7 30.8 6.3 18.3 1.8 10.1 6.8 6.6 15.5 2.7 11.7 12.2 14.9 34.3 0.0 0.0 0.0 0.0 0.0 0.0 6.7 10.3 14.0 0.0 25.9 8.3 0.0 0.0 0.0 0.0 0.0 0.0 65.7 0.0 0.0 14.0 0.0 145.5 0.0 0.0 0.0 0.0 0.0 0.0 50.3 0.0 10.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 33.6 0.0 0.0 0.0 FZD4 "CD344, EVR1" ENSG00000174804 "Frizzled class receptor 4" Q9ULV1 11 86945679-86955391 "CD markers, Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 75.7" "Cell type enhanced" "Detected in many" 18 "Collecting duct cells: 34.9;Endothelial cells: 26.3;Ito cells: 108.6;Sertoli cells: 32.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 25.9;Hep G2: 32.6;HSkMC: 18.8;HUVEC TERT2: 36.8;TIME: 18.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA042328, HPA074833" Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA042328: AB_10962494, HPA074833: AB_2686716" "unprognostic (6.49e-2)" "unprognostic (1.49e-2)" "unprognostic (1.03e-1)" "unprognostic (1.03e-1)" "unprognostic (5.87e-2)" "unprognostic (5.51e-2)" "unprognostic (1.82e-1)" "unprognostic (6.97e-2)" "unprognostic (3.33e-2)" "unprognostic (3.79e-2)" "unprognostic (1.36e-2)" "unprognostic (2.22e-1)" "prognostic favorable (8.60e-5)" "unprognostic (1.05e-2)" "unprognostic (9.96e-2)" "unprognostic (9.22e-2)" "unprognostic (1.97e-1)" 75.7 5.3 3.4 6.0 4.8 0.5 57.8 1.5 4.3 11.5 9.0 1.4 32.6 2.0 13.1 13.5 6.3 9.6 8.7 12.5 3.1 2.2 17.0 8.9 19.0 4.7 2.9 3.2 12.8 6.0 4.4 10.1 7.3 5.5 9.3 4.3 20.0 7.1 56.0 17.9 3.7 5.4 8.6 2.8 8.6 8.2 5.5 1.6 0.5 11.4 11.1 3.0 8.3 20.7 0.4 0.2 0.8 0.4 1.4 0.3 0.0 0.5 0.4 1.1 2.0 25.9 6.8 1.5 3.2 2.9 1.2 1.3 2.7 0.3 0.0 0.7 1.0 1.7 1.1 1.2 0.5 1.0 0.1 0.8 1.0 0.8 32.6 7.7 0.0 0.0 18.8 0.2 1.1 0.2 3.0 36.8 0.0 1.4 0.1 0.8 0.8 0.0 0.0 1.5 2.8 7.4 0.0 1.9 0.0 3.6 5.3 0.2 0.3 1.3 0.4 0.5 2.3 4.7 0.0 18.0 3.1 2.1 3.6 0.6 0.1 0.5 0.0 0.4 0.0 0.8 0.7 0.3 0.1 0.3 0.2 0.1 0.2 0.3 0.2 0.1 0.4 0.2 0.3 0.8 1.4 0.4 0.2 0.0 0.0 3.4 4.8 1.5 4.3 3.1 2.2 2.9 3.2 5.5 1.6 0.0 2.2 1.9 0.4 1.3 0.7 7.8 7.6 1.4 1.2 34.9 9.8 0.1 3.3 0.6 0.4 26.3 0.8 0.0 1.4 0.1 4.3 0.8 0.0 10.4 0.2 0.0 0.0 108.6 11.2 1.7 8.6 0.9 0.0 0.0 1.1 0.3 1.0 0.0 6.3 6.9 0.1 32.3 5.1 0.2 3.0 0.5 0.2 0.0 0.6 0.1 GAB1 ENSG00000109458 "GRB2 associated binding protein 1" Q13480 4 143336762-143474568 "Predicted intracellular proteins, RAS pathway related proteins" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 64.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 7.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "REH: 38.0;U-266/70: 18.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034333, HPA066404" Approved Approved "Nucleoli fibrillar center,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "Nucleoli fibrillar center" "CAB034333: AB_2107855, HPA066404: " "unprognostic (1.14e-1)" "unprognostic (1.16e-1)" "unprognostic (1.32e-3)" "unprognostic (1.66e-1)" "unprognostic (4.71e-2)" "unprognostic (1.79e-2)" "unprognostic (4.17e-2)" "unprognostic (1.23e-1)" "unprognostic (1.35e-2)" "unprognostic (8.20e-2)" "unprognostic (2.10e-1)" "unprognostic (2.20e-1)" "prognostic favorable (3.91e-5)" "unprognostic (4.99e-2)" "unprognostic (2.70e-1)" "unprognostic (1.68e-1)" "unprognostic (1.91e-1)" 9.2 8.4 15.0 7.3 33.3 8.8 9.7 5.8 22.0 10.1 17.0 64.0 10.2 10.4 17.7 13.1 18.2 8.6 11.1 26.2 19.5 11.4 12.9 7.9 15.6 5.0 35.7 19.0 18.1 7.0 17.2 6.3 18.0 30.5 7.8 20.3 15.4 11.7 13.9 11.2 11.1 10.4 15.9 32.3 6.2 11.0 7.9 41.7 1.0 7.8 6.0 7.3 9.9 11.9 3.1 3.4 5.9 2.3 7.4 0.4 0.4 3.4 0.7 8.9 6.4 4.5 4.3 11.6 2.4 8.0 2.9 5.1 6.6 5.9 0.1 0.7 3.3 2.0 1.9 8.5 2.8 3.3 0.5 2.0 6.2 1.9 3.1 3.1 0.8 1.2 5.3 5.0 3.5 2.3 6.2 3.8 0.1 2.0 11.5 2.0 4.9 0.5 0.0 2.5 1.8 2.8 38.0 4.3 4.4 4.5 4.2 2.1 6.3 1.6 7.0 3.0 6.2 4.5 0.8 2.8 3.7 2.9 1.7 1.8 18.5 9.0 13.7 2.5 2.5 3.0 5.9 0.6 0.7 0.0 0.8 0.4 1.3 0.1 0.0 0.8 3.1 0.0 0.0 4.0 7.4 2.3 3.4 0.0 0.4 15.0 33.3 5.8 22.0 19.5 11.4 35.7 19.0 30.5 41.7 26.8 14.7 6.7 7.6 18.0 1.9 27.8 7.6 2.7 5.7 12.2 0.0 18.0 0.0 5.0 0.9 16.5 11.2 0.0 2.2 8.5 11.5 6.2 2.3 5.8 5.3 3.2 21.4 11.6 9.7 2.1 19.2 5.7 15.1 2.8 25.0 14.1 4.1 8.6 17.7 5.0 0.7 12.9 16.5 1.8 5.2 21.8 8.7 1.3 13.5 11.1 GABRA1 EJM5 ENSG00000022355 "Gamma-aminobutyric acid type A receptor alpha1 subunit" P14867 5 161847063-161899981 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 22 "brain: 58.6" "Cell type enriched" "Detected in some" 24 "Bipolar cells: 209.5" "Cancer enriched" "Detected in single" 5 "glioma: 1.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 3.7;SCLC-21H: 1.1;U-2 OS: 1.6;U-87 MG: 2.3;WM-115: 1.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022502, HPA029363, HPA055746" Enhanced Supported Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "CAB022502: , HPA029363: , HPA055746: AB_2682904" "unprognostic (2.58e-2)" "unprognostic (4.78e-3)" "unprognostic (1.84e-1)" "unprognostic (3.31e-1)" "unprognostic (2.43e-1)" 1.0 2.6 8.5 1.0 21.9 1.0 1.0 35.2 58.6 1.0 1.0 1.8 0.0 1.1 1.0 1.0 1.0 1.0 1.0 1.0 10.5 8.8 1.0 1.0 1.0 1.0 6.7 22.0 1.0 1.0 1.0 0.1 1.0 7.4 1.2 1.0 0.2 1.0 1.1 1.0 1.0 1.0 1.0 1.3 1.1 1.5 1.1 0.0 0.0 1.0 0.0 1.3 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 3.7 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.1 0.0 0.0 2.3 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 21.9 35.2 49.8 10.5 8.8 6.7 22.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 209.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GABRA5 ENSG00000186297 "Gamma-aminobutyric acid type A receptor alpha5 subunit" P31644 15 26866363-26949207 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "brain: 52.6" "Cell type enhanced" "Detected in single" 18 "Spermatogonia: 1.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "A549: 26.4;HAP1: 9.1;NTERA-2: 10.9;U-2 OS: 9.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA029363, HPA077031, CAB079022" Supported Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "CAB079022: , HPA029363: , HPA077031: AB_2686825" "unprognostic (6.33e-2)" "unprognostic (8.94e-3)" "unprognostic (1.04e-1)" "unprognostic (2.50e-1)" "unprognostic (1.81e-1)" "unprognostic (3.75e-1)" "unprognostic (9.50e-3)" "unprognostic (2.57e-1)" "unprognostic (7.63e-2)" "unprognostic (8.50e-2)" "unprognostic (1.44e-2)" 0.8 0.8 12.0 0.8 48.2 0.8 0.8 0.1 52.6 0.8 0.8 0.8 0.0 0.8 0.8 0.7 2.5 0.8 1.5 0.9 20.9 6.0 0.9 0.8 0.8 0.8 2.3 15.2 0.7 0.7 0.7 0.1 0.8 1.0 1.0 0.7 0.0 0.7 0.9 0.7 0.8 0.7 1.4 0.3 0.8 1.1 1.4 2.0 1.3 0.9 0.0 1.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.4 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 9.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 48.2 0.1 26.0 20.9 6.0 2.3 15.2 1.0 2.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 GAD1 GAD ENSG00000128683 "Glutamate decarboxylase 1" Q99259 2 170813213-170861151 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Neurotransmitter biosynthesis" "Decarboxylase, Lyase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 53.9" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 9.8;Distal tubular cells: 6.6" "Cancer enhanced" "Detected in many" "endometrial cancer: 4.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 10.8;HEL: 34.9" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "olfactory region: 888.9" "CAB004415, HPA048871, HPA058412, CAB078176" Enhanced Supported Approved "Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane, Cytosol" "CAB004415: AB_627650, CAB078176: AB_2665792, HPA048871: , HPA058412: AB_2683710" "unprognostic (1.28e-1)" "prognostic favorable (7.31e-4)" "unprognostic (1.87e-2)" "prognostic favorable (8.61e-4)" "unprognostic (1.12e-1)" "unprognostic (3.05e-1)" "unprognostic (4.97e-7)" "unprognostic (1.51e-1)" "unprognostic (7.72e-2)" "unprognostic (4.27e-4)" "unprognostic (6.75e-2)" "unprognostic (9.18e-3)" "unprognostic (6.90e-5)" "unprognostic (2.93e-2)" "unprognostic (6.57e-2)" "unprognostic (1.56e-2)" "unprognostic (3.08e-3)" 1.2 2.0 14.5 0.9 28.1 3.7 1.0 10.6 53.9 1.8 1.0 3.1 0.0 1.0 2.6 5.5 1.2 1.1 1.0 1.0 10.8 24.4 6.0 1.0 1.1 1.1 8.6 17.5 1.1 1.1 9.5 2.8 1.4 6.0 1.8 1.0 1.3 1.0 1.3 0.9 1.0 1.1 1.0 2.6 1.0 1.0 4.0 3.4 0.0 1.1 0.0 1.2 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.4 0.0 3.8 0.0 0.0 0.0 0.2 0.0 1.4 0.9 2.5 3.6 0.0 0.5 0.2 1.7 10.8 1.2 0.3 0.8 1.4 7.4 34.9 3.0 0.1 0.0 0.1 0.6 0.0 3.1 0.0 1.2 0.3 0.0 0.3 9.0 0.1 0.4 0.8 0.0 0.0 4.3 5.2 3.8 0.5 2.6 0.2 4.7 5.0 3.7 1.2 6.6 0.0 1.8 0.3 0.1 0.0 0.0 6.5 0.9 1.3 3.8 0.0 0.0 0.0 6.3 1.7 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.5 28.1 10.6 36.7 10.8 24.4 8.6 17.5 6.0 3.4 0.0 0.0 0.0 1.4 0.2 3.8 1.1 0.0 0.0 0.0 0.0 9.8 0.0 6.6 4.2 4.3 0.3 0.0 0.0 4.7 0.1 0.2 0.8 0.0 0.0 3.0 4.8 2.9 0.0 0.3 3.6 0.6 0.2 0.0 0.0 0.0 3.9 4.2 0.0 0.0 0.0 5.4 0.0 0.8 3.2 4.7 0.1 0.5 0.0 0.0 0.3 GADL1 ENSG00000144644 "Glutamate decarboxylase like 1" Q6ZQY3 3 30726200-30894765 "Enzymes, Predicted intracellular proteins" "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "skeletal muscle: 21.6" "Cell type enhanced" "Detected in some" 18 "Club cells: 2.3;Collecting duct cells: 1.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HAP1: 9.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA039160, HPA040229" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039160: AB_10796222, HPA040229: AB_10796118" "unprognostic (4.96e-2)" "unprognostic (1.30e-2)" "unprognostic (9.83e-2)" "unprognostic (1.39e-2)" "unprognostic (5.60e-2)" "unprognostic (7.32e-2)" "unprognostic (5.05e-3)" "unprognostic (8.37e-2)" "unprognostic (1.23e-2)" "unprognostic (2.02e-3)" "unprognostic (1.63e-1)" "unprognostic (1.98e-5)" "unprognostic (8.81e-2)" "unprognostic (4.54e-2)" "unprognostic (4.39e-1)" "unprognostic (1.06e-1)" 0.5 0.3 0.2 0.2 0.3 1.0 0.4 0.5 0.7 0.4 0.2 0.0 0.0 0.1 0.2 1.6 1.4 0.2 2.0 2.3 0.2 0.3 0.7 0.2 1.6 0.3 0.3 0.8 0.5 0.3 0.1 0.6 0.5 2.1 0.5 0.1 0.3 0.3 0.0 21.6 0.8 0.2 2.5 0.7 0.5 0.2 1.1 0.0 0.0 1.2 3.3 0.7 0.5 0.3 1.7 0.5 1.9 0.8 0.5 1.3 0.3 1.3 0.3 0.8 1.1 0.9 0.5 1.6 0.6 0.3 0.3 0.2 1.3 1.2 1.1 0.5 0.2 0.7 0.9 9.9 0.3 0.4 1.7 0.5 1.6 1.6 0.5 0.4 0.9 3.4 0.4 0.6 0.7 0.3 1.0 0.6 1.0 1.2 4.1 0.9 1.1 0.7 1.3 1.9 0.7 0.5 1.9 2.1 1.0 1.0 1.5 1.2 1.0 1.2 0.7 2.9 1.2 1.2 0.8 5.1 1.5 1.4 1.9 0.7 1.6 0.8 0.7 0.6 0.9 1.9 1.9 0.7 0.8 1.0 0.6 0.8 1.2 0.9 0.6 0.4 1.7 1.1 1.0 1.7 0.5 0.8 0.5 1.3 0.3 0.2 0.3 0.5 0.7 0.2 0.3 0.3 0.8 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 2.3 1.8 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 GAGE1 CT4.1 ENSG00000205777 "G antigen 1" Q13068 X 49589496-49608536 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 37 "testis: 36.8" "Cell type enriched" "Detected in some" 11 "Spermatogonia: 107.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "AN3-CA: 249.2" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.8 0.0 0.0 0.0 0.0 0.6 1.0 0.7 0.8 0.1 0.7 0.0 0.0 0.0 0.0 249.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 22.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.8 0.1 0.3 0.3 0.7 0.0 0.2 0.3 0.3 0.0 0.0 0.6 0.1 0.3 0.7 0.1 0.8 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 6.5 0.0 9.7 107.0 0.0 0.0 0.0 0.0 0.0 GAGE12C ENSG00000237671 "G antigen 12C" A1L429 X 49532211-49539538 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 57 "testis: 23.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "U-2 OS: 7.8;U-266/84: 27.7" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 1.5 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 7.8 0.0 0.0 0.0 27.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GAGE12D ENSG00000227488 "G antigen 12D" A1L429 X 49541767-49549094 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 57 "testis: 23.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "U-2 OS: 7.8;U-266/84: 27.7" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 1.5 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 7.8 0.0 0.0 0.0 27.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 GAGE12F ENSG00000236362 "G antigen 12F" "P0CL80, O76087, P0CL82" X 49551278-49568218 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "blood: 16.2;testis: 58.6" "Cell type enriched" "Detected in single" 5 "Spermatogonia: 1.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 4 "AN3-CA: 136.7;K-562: 133.6" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.9 58.6 0.0 0.0 0.0 0.0 7.0 8.5 3.1 9.1 9.6 14.7 16.2 1.1 0.0 0.0 136.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 133.6 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.8 0.0 0.5 6.9 0.9 0.0 0.1 0.0 7.9 0.0 0.0 0.0 17.0 0.9 9.1 3.1 3.9 7.5 2.5 7.0 10.3 7.2 0.0 6.2 8.5 7.5 0.9 9.6 6.3 8.5 14.7 16.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.3 0.0 0.0 0.0 0.0 0.0 GAGE12G ENSG00000215269 "G antigen 12G" "P0CL81, O76087, P0CL82" X 49570434-49577754 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 33 "blood: 7.4;stomach 1: 14.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 7.4" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 7 "AN3-CA: 149.0" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 0.0 2.6 1.4 1.3 2.5 0.4 7.4 6.2 0.0 0.0 0.0 149.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.9 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.4 2.5 1.3 0.8 2.2 1.3 1.5 3.6 0.5 0.0 2.6 0.6 3.2 0.0 0.4 1.8 1.4 7.4 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GAGE12H ENSG00000224902 "G antigen 12H" A6NDE8 X 49579983-49587301 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 223 "testis: 22.3" "Cell type enriched" "Detected in single" 12 "Spermatogonia: 4.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 52 "A-431: 19.6;U-266/84: 58.0" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 58.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 4.7 0.0 0.0 0.0 0.0 0.0 GAGE12J GAGE11 ENSG00000224659 "G antigen 12J" A6NER3 X 49322057-49329384 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 20.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "AN3-CA: 48.3;K-562: 48.4" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 20.2 0.0 0.0 0.0 0.0 0.8 0.6 0.4 0.7 0.8 1.6 0.0 0.0 0.0 0.0 48.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.8 9.9 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.5 0.2 0.4 0.8 0.7 0.9 0.0 0.7 1.6 0.4 0.4 0.8 0.5 0.6 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 GAGE13 GAGE12A ENSG00000274274 "G antigen 13" X 49331616-49338952 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 26.8" "Cell type enriched" "Detected in some" 10 "Spermatogonia: 13.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "AN3-CA: 129.9" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 129.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.6 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.8 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 13.9 0.0 0.0 0.0 0.0 0.0 GAGE2A "CT4.2, GAGE2" ENSG00000189064 "G antigen 2A" Q6NT46 X 49589529-49596827 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 34 "testis: 46.7" "Cell type enriched" "Detected in some" 13 "Spermatogonia: 363.5" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "Karpas-707: 19.6;T-47d: 67.6;WM-115: 74.4" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" "unprognostic (1.29e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.7 0.0 0.0 0.0 0.0 1.0 0.7 0.4 0.7 0.5 0.6 1.3 0.0 0.0 0.0 0.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 19.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 67.6 0.0 0.0 11.0 2.4 0.0 0.0 0.2 2.9 0.0 0.6 0.0 74.4 0.4 0.6 0.1 0.1 0.7 0.0 1.0 0.5 0.6 0.0 0.4 0.5 0.2 0.0 0.5 0.6 0.7 0.6 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 12.9 0.0 27.8 363.5 0.0 0.0 0.0 0.0 0.0 GAGE2E GAGE8 ENSG00000275113 "G antigen 2E" X 49341192-49345922 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 52 "blood: 5.8;stomach 1: 18.4;testis: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 5.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 144.6;K-562: 69.2;T-47d: 35.0" HPA043232 Approved Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 18.4 4.9 0.0 0.0 0.0 2.5 2.6 0.7 1.2 0.7 5.8 0.2 0.0 0.0 0.0 144.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.2 1.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 35.0 0.0 0.4 8.9 0.3 0.0 0.0 0.1 2.6 0.0 0.1 0.0 15.2 0.7 1.2 0.3 1.0 0.0 0.0 1.5 0.4 2.2 0.0 2.5 4.9 0.0 0.7 0.7 0.0 2.6 5.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GALNT10 GalNAc-T10 ENSG00000164574 "Polypeptide N-acetylgalactosaminyltransferase 10" Q86SR1 5 154190730-154420984 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 43.7" "Cell type enhanced" "Detected in many" 4 "Peritubular cells: 47.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 74.0;TIME: 40.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007525 Approved Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" "Intracellular and membrane" NA NA 830000 "Plasma membrane" "Nucleoplasm, Golgi apparatus" "HPA007525: AB_1849443" "unprognostic (6.99e-2)" "unprognostic (4.33e-2)" "unprognostic (9.85e-2)" "prognostic favorable (3.33e-6)" "unprognostic (1.63e-1)" "unprognostic (6.98e-2)" "unprognostic (6.95e-3)" "unprognostic (2.38e-1)" "unprognostic (3.34e-1)" "prognostic unfavorable (5.69e-4)" "unprognostic (2.88e-3)" "unprognostic (2.63e-1)" "unprognostic (1.54e-1)" "unprognostic (7.76e-3)" "unprognostic (1.22e-1)" "unprognostic (1.61e-2)" "unprognostic (3.08e-1)" 9.5 13.5 8.4 15.4 9.1 10.1 8.7 3.2 6.2 15.9 10.6 14.4 1.0 8.8 4.9 11.5 5.9 9.2 17.8 7.7 6.9 7.5 6.8 3.4 10.1 11.5 7.2 5.2 43.7 9.2 14.1 9.7 5.2 10.1 8.3 9.4 31.6 11.6 2.4 5.6 4.0 12.4 14.1 7.7 16.7 13.8 4.3 9.2 5.6 10.6 4.2 9.3 7.5 10.0 4.7 3.1 5.7 3.8 3.9 7.5 2.1 6.2 21.4 5.2 4.5 11.1 9.9 4.0 18.1 10.1 7.2 6.9 3.0 14.4 4.1 12.8 30.4 12.9 1.1 2.4 14.1 6.6 10.6 1.7 11.2 4.1 4.0 8.5 2.4 10.9 12.3 3.3 5.8 8.6 74.0 13.8 3.1 2.5 13.0 12.3 6.5 0.2 1.6 2.0 17.6 4.4 1.2 2.7 4.1 10.0 4.3 0.7 1.7 8.0 30.0 2.3 8.0 11.6 1.8 40.5 17.6 4.2 4.3 19.2 3.7 3.6 2.2 11.5 4.8 5.3 3.4 2.7 5.3 7.5 3.6 6.6 4.5 4.3 4.8 3.1 4.7 1.9 5.3 5.7 3.9 3.8 2.7 3.5 2.1 8.4 9.1 3.2 6.2 6.9 7.5 7.2 5.2 10.1 9.2 8.9 36.1 12.3 3.5 4.2 3.5 4.1 5.1 0.0 12.5 14.0 3.9 0.6 8.3 9.3 10.6 13.4 15.5 23.3 26.2 1.2 9.1 9.9 10.3 4.7 7.2 0.0 2.9 19.0 15.4 16.0 35.4 9.7 0.0 6.4 16.1 20.8 26.5 11.5 47.0 2.9 11.4 6.5 7.3 1.7 3.1 3.1 0.7 13.8 9.3 2.8 GALR1 "GALNR, GALNR1" ENSG00000166573 "Galanin receptor 1" P47211 18 77250549-77277896 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 5.3;brain: 3.5;pituitary gland: 4.9" "Group enriched" "Detected in some" 6 "Ciliated cells: 21.4;Early spermatids: 46.5;Intestinal endocrine cells: 16.9" "Cancer enriched" "Detected in single" 6 "glioma: 1.0" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in some" "Region enhanced" "Detected in some" "hypothalamus: 6.1" "Low region specificity" "Detected in many" HPA074584 Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA074584: " "unprognostic (1.65e-1)" "unprognostic (1.56e-2)" "unprognostic (2.85e-1)" "unprognostic (3.00e-1)" "unprognostic (2.11e-1)" "unprognostic (2.77e-3)" "unprognostic (1.31e-2)" "unprognostic (5.34e-3)" "unprognostic (7.33e-3)" "unprognostic (9.49e-2)" "unprognostic (2.18e-1)" 1.1 5.3 1.2 0.3 0.8 0.7 0.5 0.0 3.5 0.0 0.3 0.4 0.2 0.5 0.0 0.3 0.1 0.1 0.7 2.0 0.1 0.5 0.0 0.1 0.8 0.1 0.5 0.0 4.9 0.0 0.8 0.5 0.5 0.7 0.1 0.4 0.5 0.1 0.9 0.0 0.3 0.4 0.3 0.0 0.0 0.1 0.4 0.4 1.6 0.2 0.5 0.3 0.0 0.3 0.4 0.6 0.8 0.5 1.2 0.6 0.2 0.5 0.1 0.1 0.8 1.1 0.8 0.2 0.4 0.2 0.4 0.4 0.3 0.1 1.1 0.6 1.1 0.8 0.5 0.3 0.5 0.8 0.8 0.4 0.3 0.3 0.5 0.3 0.5 0.4 1.6 0.1 0.9 0.4 0.9 0.6 0.1 0.5 0.5 0.4 0.4 0.2 0.6 1.5 0.5 0.2 0.4 0.4 0.9 0.5 0.4 0.6 0.6 0.7 1.1 0.1 0.6 0.3 0.4 0.8 0.3 0.4 1.0 0.2 0.3 0.3 0.2 0.3 0.3 0.3 0.2 0.1 0.4 0.2 0.2 1.6 0.5 0.2 0.4 0.1 0.0 0.0 5.1 0.0 0.7 0.0 1.8 0.4 0.0 21.4 1.2 1.8 0.0 0.0 0.0 0.0 46.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.1 0.0 0.1 0.0 16.9 0.0 0.0 3.6 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.0 GAS2 ENSG00000148935 "Growth arrest specific 2" O43903 11 22625642-22813055 "Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell shape, Growth arrest" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 37.2;lymphoid tissue: 19.6;pancreas: 22.7" "Cell type enhanced" "Detected in some" 15 "Cardiomyocytes: 10.9;Cholangiocytes: 10.2;Ciliated cells: 6.7;Hepatocytes: 20.2" "Cancer enhanced" "Detected in many" "liver cancer: 4.0" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 9 "Hep G2: 19.9;JURKAT: 11.3;Karpas-707: 40.7;SCLC-21H: 11.9;U-266/84: 13.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058904 Enhanced Approved "Nucleoplasm,Nucleoli,Plasma membrane,Cytosol" Yes NA "Plasma membrane, Cytosol" "Nucleoplasm, Nucleoli" "HPA058904: AB_2683850" "unprognostic (5.48e-3)" "unprognostic (1.00e-1)" "unprognostic (6.85e-2)" "unprognostic (1.16e-2)" "unprognostic (7.87e-2)" "unprognostic (2.08e-2)" "unprognostic (1.08e-1)" "unprognostic (1.49e-1)" "unprognostic (1.23e-1)" "unprognostic (3.71e-2)" "unprognostic (1.70e-2)" "unprognostic (3.30e-5)" "prognostic favorable (6.13e-4)" "unprognostic (5.85e-2)" "unprognostic (4.22e-2)" "unprognostic (7.94e-2)" "unprognostic (3.58e-2)" 0.7 1.1 2.1 1.1 3.6 0.4 0.9 0.9 2.2 1.2 0.7 1.4 1.2 2.0 1.1 1.3 1.0 1.5 2.7 3.6 2.1 2.5 5.3 37.2 1.3 1.1 4.3 1.2 2.3 22.7 0.5 4.8 0.7 4.5 1.3 0.7 0.5 2.2 0.9 4.8 1.0 1.8 0.6 8.6 1.5 2.6 1.1 3.2 19.6 1.1 3.0 1.0 1.8 0.7 1.0 0.6 0.3 0.0 0.1 1.7 0.1 0.0 0.0 0.8 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.2 0.1 0.0 19.9 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 11.3 0.7 40.7 0.0 0.1 0.1 0.0 0.1 1.1 0.0 0.4 0.2 2.0 0.0 0.5 11.9 0.6 0.0 0.0 0.2 0.1 0.0 0.0 0.8 0.0 0.2 0.5 0.0 0.5 13.5 0.0 0.2 0.0 0.2 0.0 0.0 0.3 0.2 0.0 1.7 1.0 0.4 0.0 0.0 0.9 1.6 0.4 0.0 0.1 0.0 0.6 0.3 0.1 2.1 3.6 0.9 2.2 2.1 2.5 4.3 1.2 4.5 3.2 0.0 0.0 0.0 0.2 0.1 2.7 10.9 10.2 6.7 0.0 0.0 0.0 0.0 0.0 0.8 1.7 0.0 0.0 0.0 2.9 0.0 0.3 0.1 0.0 20.2 0.0 0.0 0.0 0.6 0.0 3.7 0.6 0.0 0.0 0.0 0.0 0.3 2.6 0.3 0.0 2.1 0.9 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.9 0.3 GAS2L1 GAR22 ENSG00000185340 "Growth arrest specific 2 like 1" Q99501 22 29306582-29312785 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ductus deferens: 40.5" "Cell type enhanced" "Detected in many" 6 "Ito cells: 77.3;Late spermatids: 73.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 2.0;eosinophil: 3.1" "Group enriched" "Detected in many" 10 "dendritic cells: 1.1;granulocytes: 3.1;monocytes: 2.0" "Cell line enhanced" "Detected in many" "U-138 MG: 33.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019858 Approved Approved "Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Cell Junctions" "HPA019858: AB_1849486" "unprognostic (3.66e-1)" "unprognostic (5.22e-2)" "unprognostic (1.38e-1)" "unprognostic (4.95e-3)" "unprognostic (1.77e-1)" "unprognostic (1.11e-1)" "unprognostic (1.84e-3)" "unprognostic (8.99e-2)" "unprognostic (1.28e-1)" "unprognostic (6.05e-2)" "unprognostic (1.90e-1)" "unprognostic (1.21e-1)" "prognostic favorable (8.44e-4)" "unprognostic (4.23e-2)" "unprognostic (9.04e-2)" "unprognostic (1.32e-1)" "unprognostic (1.19e-2)" 15.1 10.7 15.2 5.3 13.4 5.4 7.6 10.5 19.8 4.5 5.6 6.8 40.5 17.9 5.1 8.4 8.6 4.6 4.3 7.0 12.9 8.1 6.0 6.6 7.5 2.2 11.3 10.2 2.9 10.0 4.6 6.8 4.3 9.5 7.1 2.2 3.2 12.7 22.9 4.9 22.4 13.0 4.5 10.0 11.5 8.3 16.6 8.8 0.0 4.5 9.2 3.5 3.9 4.7 0.0 1.1 3.1 2.0 0.0 0.2 1.2 8.3 9.8 1.5 6.2 2.4 2.3 9.8 12.6 3.8 5.4 2.8 4.4 6.0 0.0 5.7 6.7 5.6 25.6 2.6 7.1 1.0 11.4 1.2 11.0 7.8 3.1 3.1 0.1 7.7 2.5 4.9 5.1 2.0 3.9 7.1 11.2 5.2 1.7 3.8 7.1 0.2 6.1 2.2 5.6 22.1 0.2 4.4 0.7 3.2 5.4 0.5 8.3 9.7 13.0 7.0 2.0 13.0 1.7 15.0 33.7 23.2 15.0 12.6 0.1 0.1 0.1 14.9 0.4 8.2 0.0 2.0 3.1 0.0 0.3 0.0 0.0 0.1 0.0 1.1 0.0 0.2 0.0 0.5 0.0 1.4 0.0 0.0 1.2 15.2 13.4 10.5 19.8 12.9 8.1 11.3 10.2 9.5 8.8 6.0 1.7 0.8 5.7 25.0 2.6 3.5 7.6 1.4 9.1 1.8 5.9 19.1 6.6 10.8 26.3 19.3 19.0 23.3 6.0 10.4 10.8 6.1 1.1 10.5 13.1 12.7 1.7 77.3 12.6 73.5 8.9 10.7 11.8 4.6 5.4 4.5 8.3 9.3 11.0 7.0 19.2 38.8 14.1 2.3 10.8 28.2 5.6 0.7 9.0 2.2 GAS7 "KIAA0394, MGC1348" ENSG00000007237 "Growth arrest specific 7" O60861 17 9910609-10198551 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 86.2" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 49.9;Kupffer cells: 62.0;Late spermatids: 52.5" "Cancer enhanced" "Detected in all" "melanoma: 54.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 17.6" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 9 "WM-115: 110.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004838, HPA064678" Enhanced Approved "Plasma membrane,Actin filaments,Focal adhesion sites" NA NA "Plasma membrane" "Actin filaments, Focal adhesion sites" "HPA004838: AB_2667263, HPA064678: AB_2685319" "unprognostic (1.68e-2)" "unprognostic (2.84e-3)" "unprognostic (1.80e-1)" "unprognostic (1.28e-3)" "unprognostic (1.15e-1)" "unprognostic (1.01e-2)" "unprognostic (7.32e-2)" "unprognostic (7.16e-2)" "unprognostic (2.88e-1)" "unprognostic (1.50e-2)" "unprognostic (2.48e-1)" "unprognostic (1.79e-1)" "unprognostic (1.94e-3)" "unprognostic (6.48e-2)" "unprognostic (8.78e-2)" "unprognostic (3.08e-2)" "prognostic unfavorable (6.89e-4)" 19.1 6.5 22.1 15.4 40.3 18.7 10.8 86.2 64.7 22.6 9.3 33.4 1.7 5.2 9.7 4.4 17.0 12.6 11.5 23.1 25.8 15.0 1.5 2.1 9.9 5.9 28.1 25.0 5.9 2.8 1.4 1.7 11.0 14.2 3.7 8.7 7.7 4.0 8.2 3.9 21.2 7.4 16.3 33.8 10.0 4.2 11.8 22.2 2.7 2.5 2.7 7.2 11.7 7.8 0.4 3.6 11.0 17.6 2.8 2.1 4.4 0.0 0.1 0.1 0.2 3.4 4.9 0.0 0.1 0.0 0.5 0.2 0.0 0.0 1.3 0.4 1.3 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.3 0.1 1.1 0.3 10.1 0.9 0.0 1.0 0.0 0.0 0.0 8.7 0.0 0.1 0.0 0.0 10.7 3.2 0.5 0.4 0.0 2.8 0.0 9.8 0.0 0.0 0.0 0.6 0.0 0.0 12.7 4.7 0.5 5.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 7.1 110.2 0.4 17.6 10.8 2.1 4.7 0.7 0.3 0.2 1.0 3.6 0.4 0.2 1.0 11.0 2.8 3.1 0.6 0.0 4.4 22.1 40.3 86.2 38.8 25.8 15.0 28.1 25.0 14.2 22.2 0.0 6.2 3.2 3.8 7.3 34.5 11.3 0.0 26.8 1.2 5.2 25.5 1.1 0.0 0.6 49.9 7.0 0.0 0.0 0.0 1.1 43.4 1.6 17.3 0.5 34.5 0.0 0.0 7.4 62.0 52.5 9.5 29.6 32.1 1.0 0.0 8.0 0.3 0.0 1.8 0.0 30.3 0.0 5.2 1.1 6.1 14.4 1.6 7.5 0.0 4.3 GAS8 "DRC4, GAS11" ENSG00000141013 "Growth arrest specific 8" O95995 16 90019629-90044975 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Ciliopathy, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Ciliated cells: 84.3;Early spermatids: 174.5;Late spermatids: 126.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 26.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041311, HPA048238" Approved Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA041311: AB_2677402, HPA048238: AB_2680324" "unprognostic (2.23e-3)" "unprognostic (1.26e-1)" "unprognostic (1.73e-1)" "prognostic favorable (3.01e-4)" "unprognostic (1.73e-1)" "unprognostic (3.91e-1)" "unprognostic (1.96e-1)" "unprognostic (1.82e-1)" "unprognostic (1.16e-1)" "unprognostic (4.47e-1)" "prognostic favorable (7.67e-4)" "unprognostic (3.06e-2)" "prognostic favorable (1.09e-7)" "unprognostic (1.98e-1)" "unprognostic (2.46e-1)" "unprognostic (2.03e-1)" "unprognostic (4.19e-2)" 7.1 11.1 8.5 6.5 13.2 2.3 7.6 13.5 12.2 11.7 6.8 10.0 10.8 4.1 12.7 16.2 7.8 26.5 11.6 21.0 8.7 9.8 12.4 6.3 9.9 4.0 8.9 8.9 12.8 12.9 23.2 22.0 3.5 10.1 8.9 4.6 11.0 16.2 12.6 18.8 4.2 4.2 8.4 7.5 4.2 7.6 16.1 6.4 1.7 15.5 5.5 5.2 6.6 5.1 2.5 4.8 4.3 5.0 0.0 3.7 2.3 10.8 8.8 1.1 5.5 5.1 4.0 9.4 2.2 5.5 8.9 2.6 8.8 8.3 0.6 6.0 4.5 5.4 10.8 3.6 6.4 2.0 0.0 6.5 2.3 5.6 10.0 5.8 1.3 1.8 5.2 3.7 6.7 3.1 3.8 5.3 3.8 8.7 1.2 3.8 26.1 1.5 5.5 7.3 6.9 4.6 0.4 10.2 0.6 11.2 5.3 9.3 6.7 11.5 6.2 13.1 1.0 11.7 5.1 3.7 5.5 6.4 3.0 5.1 2.0 3.3 0.0 14.0 1.7 9.6 4.3 3.1 3.7 1.8 5.0 1.8 1.2 2.8 3.7 4.4 2.5 2.3 2.0 4.0 0.0 3.1 4.8 3.5 2.3 8.5 13.2 13.5 12.2 8.7 9.8 8.9 8.9 10.1 6.4 20.8 9.9 0.5 4.2 1.0 8.8 6.4 28.1 84.3 15.9 21.0 19.6 2.6 11.6 14.7 174.5 4.5 4.3 0.0 9.6 3.0 3.3 6.4 2.3 3.6 3.3 25.4 5.8 4.9 0.0 126.7 13.0 3.3 5.0 1.8 5.4 11.4 10.1 3.5 7.1 23.0 25.1 6.5 3.7 18.9 13.6 2.3 1.4 0.0 5.0 4.8 GCA GCL ENSG00000115271 Grancalcin P28676 2 162318840-162371595 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "blood: 112.7;bone marrow: 116.0;brain: 30.2;lymphoid tissue: 51.8" "Cell type enhanced" "Detected in many" 6 "Kupffer cells: 188.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "eosinophil: 41.1;neutrophil: 112.7" "Lineage enriched" "Detected in many" 6 "granulocytes: 112.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035033, HPA035034" Enhanced Supported "Plasma membrane,Cytosol" NA NA 890000 Cytosol "Plasma membrane" "HPA035033: AB_10669854, HPA035034: AB_10669900" "unprognostic (9.62e-2)" "unprognostic (9.76e-2)" "unprognostic (3.33e-1)" "unprognostic (3.82e-2)" "unprognostic (2.60e-1)" "unprognostic (1.06e-1)" "unprognostic (2.33e-3)" "unprognostic (1.36e-1)" "unprognostic (8.87e-2)" "unprognostic (2.49e-2)" "unprognostic (1.20e-1)" "unprognostic (9.78e-2)" "unprognostic (6.56e-2)" "unprognostic (5.80e-2)" "unprognostic (3.07e-1)" "unprognostic (3.06e-2)" "unprognostic (1.32e-2)" 13.1 6.8 13.4 24.8 21.3 116.0 7.8 6.9 15.8 6.0 7.7 15.3 3.2 8.2 4.6 11.0 5.0 7.2 9.7 11.2 15.9 13.0 8.5 7.6 15.6 51.8 26.0 9.7 4.4 11.5 4.8 8.1 10.6 24.6 5.7 8.6 3.7 6.9 4.9 2.2 3.7 7.8 7.7 30.2 50.0 10.3 10.7 20.8 5.8 7.4 2.5 10.3 10.0 6.3 3.1 8.9 112.7 18.2 0.3 1.3 8.4 1.4 2.1 5.9 0.0 1.4 1.3 0.2 2.1 6.2 3.4 6.2 4.8 16.4 1.9 15.2 0.1 7.8 0.8 2.2 6.9 4.2 9.2 9.3 17.3 1.5 9.2 1.7 21.5 5.0 1.5 2.4 3.1 0.7 9.0 0.4 14.1 0.3 6.7 0.3 16.9 0.5 12.5 3.7 12.0 8.4 7.5 1.4 9.7 18.1 9.6 3.8 6.5 2.8 12.7 10.7 7.2 8.6 9.7 0.4 0.8 6.3 9.8 3.2 6.3 11.8 0.3 5.4 8.4 4.0 4.4 18.2 41.1 0.4 10.7 0.5 3.0 0.6 0.6 8.9 3.1 1.1 0.7 112.7 0.3 8.0 2.2 1.3 8.4 13.4 21.3 6.9 15.8 15.9 13.0 26.0 9.7 24.6 20.8 14.9 44.6 45.9 25.1 13.7 9.0 2.8 50.9 26.8 12.5 31.4 2.0 46.0 64.6 39.8 106.9 25.9 14.7 0.0 53.4 16.4 13.6 27.8 42.8 11.6 91.1 11.1 37.8 39.3 188.7 17.6 10.0 119.8 15.1 66.7 26.1 17.3 34.6 28.1 6.0 52.8 4.6 6.5 18.9 62.9 11.5 15.8 39.2 10.7 26.4 20.4 GCC1 "FLJ22035, GCC1P, GCC88, MGC20706" ENSG00000179562 "GRIP and coiled-coil domain containing 1" Q96CN9 7 127580618-127593611 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 9 "Early spermatids: 108.4;Late spermatids: 98.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019369, HPA021323" Enhanced Supported "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Golgi apparatus" "Plasma membrane, Cytosol" "HPA019369: AB_1849552, HPA021323: AB_1849554" "unprognostic (1.09e-1)" "unprognostic (4.96e-2)" "unprognostic (1.83e-1)" "unprognostic (9.51e-2)" "unprognostic (1.07e-1)" "unprognostic (7.20e-2)" "unprognostic (1.26e-1)" "unprognostic (2.54e-2)" "unprognostic (1.83e-1)" "unprognostic (5.08e-2)" "unprognostic (4.81e-2)" "unprognostic (4.50e-3)" "unprognostic (1.17e-3)" "unprognostic (4.17e-3)" "unprognostic (1.22e-1)" "unprognostic (8.65e-2)" "unprognostic (9.96e-2)" 11.5 14.1 13.4 11.0 13.7 17.7 14.2 13.9 12.8 11.6 10.2 12.8 8.6 9.6 13.2 10.3 14.1 10.7 12.2 9.0 10.2 7.9 9.8 17.8 10.4 12.3 19.8 7.6 13.6 12.7 14.8 14.5 13.6 13.0 11.5 9.6 8.4 13.8 11.0 12.5 14.5 12.9 8.4 12.1 15.5 12.7 20.7 17.9 15.7 11.8 9.5 14.4 10.3 29.2 8.4 7.9 15.6 9.1 10.2 11.6 8.8 8.4 11.4 5.0 10.8 11.3 7.8 7.0 7.4 8.6 7.4 9.4 9.5 5.8 7.8 4.5 6.8 16.8 9.3 7.3 8.1 8.0 10.8 6.6 5.7 6.2 4.9 16.8 9.8 9.5 7.3 22.3 7.9 15.7 7.0 7.0 7.8 9.3 8.9 8.3 8.4 9.5 8.5 10.5 9.3 8.9 6.8 5.4 8.8 6.4 6.5 8.0 11.6 7.9 37.8 14.7 9.5 6.4 7.1 9.0 11.0 3.5 9.5 8.4 24.5 10.7 5.0 10.9 10.1 11.2 5.8 8.1 15.0 9.1 8.2 11.6 8.4 8.2 8.9 7.9 8.0 6.8 6.7 15.6 10.2 9.1 4.6 7.6 8.8 13.4 13.7 13.9 12.8 10.2 7.9 19.8 7.6 13.0 17.9 11.9 7.7 0.9 5.0 9.4 3.7 3.7 5.1 0.0 3.4 3.5 3.9 5.4 5.0 4.5 108.4 5.6 6.6 0.0 5.5 3.9 4.3 5.3 1.1 6.8 4.5 11.1 6.9 4.9 7.9 98.5 4.9 5.4 11.8 5.4 7.5 4.4 5.5 5.5 3.5 3.3 5.3 6.5 6.1 5.6 4.5 9.2 8.7 5.7 4.5 5.1 GCLM GLCLR ENSG00000023909 "Glutamate-cysteine ligase modifier subunit" P48507 1 93885205-93909456 "Cancer-related genes, Predicted intracellular proteins" "Glutathione biosynthesis" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Erythroid cells: 210.2;Glandular cells: 272.8;Urothelial cells: 201.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009568, HPA023696, CAB040554" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 1000000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB009568: AB_2107835, CAB040554: , HPA023696: AB_1849560" "unprognostic (2.31e-1)" "unprognostic (7.92e-2)" "unprognostic (8.85e-3)" "unprognostic (1.56e-2)" "unprognostic (2.83e-2)" "unprognostic (4.64e-2)" "prognostic unfavorable (9.83e-6)" "unprognostic (2.37e-1)" "unprognostic (1.07e-1)" "unprognostic (3.53e-1)" "unprognostic (3.51e-2)" "unprognostic (3.89e-2)" "unprognostic (2.19e-2)" "unprognostic (1.09e-2)" "unprognostic (1.79e-1)" "unprognostic (2.43e-1)" "unprognostic (2.34e-3)" 10.3 17.5 7.0 6.0 7.7 11.3 23.9 5.7 8.9 4.5 22.8 4.2 11.5 16.6 3.5 6.5 8.8 12.8 12.5 7.7 6.8 8.9 17.8 41.7 8.4 10.4 9.2 5.7 4.6 6.9 6.3 5.1 10.3 8.7 5.3 5.2 6.4 6.7 6.4 19.2 3.4 20.0 3.4 7.7 6.9 6.1 3.2 2.8 5.6 15.0 23.0 8.6 8.9 8.0 3.2 1.9 3.3 0.7 4.6 6.7 1.2 13.1 20.9 2.3 4.5 7.8 4.9 8.9 15.8 9.8 12.0 9.0 3.5 7.8 5.0 31.6 10.2 39.2 13.3 3.4 6.4 9.7 13.5 4.6 34.9 14.2 15.0 14.6 12.8 5.6 6.0 2.4 24.4 3.9 4.8 13.1 5.7 13.8 7.4 8.6 2.5 9.2 3.0 7.9 12.6 10.0 4.3 7.0 7.3 8.5 15.4 5.4 2.2 14.8 11.7 5.5 27.5 2.6 8.0 13.7 12.6 7.4 23.6 23.6 6.7 8.5 5.2 10.4 7.2 4.4 3.3 0.7 1.3 5.3 0.4 3.1 2.6 5.0 6.7 0.6 3.2 3.2 3.2 2.9 4.6 0.5 1.9 1.3 1.2 7.0 7.7 5.7 8.9 6.8 8.9 9.2 5.7 8.7 2.8 38.7 18.4 13.3 119.7 10.2 23.7 13.5 53.5 49.5 19.4 27.9 5.9 60.1 21.6 24.6 3.0 14.5 25.6 210.2 10.7 16.4 25.0 272.8 19.6 71.6 16.8 31.8 50.4 41.7 17.7 1.9 19.8 15.4 8.5 10.8 9.3 19.3 22.5 7.0 11.7 45.8 12.6 0.0 44.3 22.8 40.4 8.2 37.6 34.6 13.2 201.0 GFOD1 "ADG-90, C6orf114, FLJ20330" ENSG00000145990 "Glucose-fructose oxidoreductase domain containing 1" Q9NXC2 6 13357830-13487662 "Predicted intracellular proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 87.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "eosinophil: 12.8;NK-cell: 11.4" "Group enriched" "Detected in many" 5 "granulocytes: 12.8;NK-cells: 11.4" "Cell line enhanced" "Detected in many" "HEL: 18.8;HMC-1: 29.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029096 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" "Secreted - unknown location" No No "Nucleoplasm, Cytosol" "Plasma membrane" "HPA029096: AB_10602320" "unprognostic (5.00e-2)" "unprognostic (1.34e-2)" "unprognostic (1.08e-1)" "prognostic unfavorable (2.29e-5)" "unprognostic (8.49e-2)" "unprognostic (1.95e-3)" "unprognostic (1.36e-2)" "unprognostic (2.81e-1)" "unprognostic (2.34e-2)" "unprognostic (3.11e-2)" "unprognostic (6.49e-2)" "unprognostic (1.15e-1)" "prognostic unfavorable (6.72e-5)" "unprognostic (9.79e-2)" "unprognostic (1.61e-1)" "unprognostic (3.56e-1)" "unprognostic (4.66e-3)" 15.7 3.8 9.4 4.6 11.5 17.5 8.7 28.5 22.3 5.4 5.0 4.0 0.5 3.5 4.0 2.6 12.1 4.3 11.8 18.5 11.9 7.1 2.1 6.6 8.2 6.6 6.3 14.2 1.7 2.3 3.9 3.3 6.8 6.6 4.4 5.2 1.5 3.4 3.0 15.5 4.7 5.6 8.3 4.2 12.0 8.2 1.5 4.1 1.9 3.9 4.5 6.9 4.7 7.6 2.3 0.2 12.8 0.8 11.4 1.4 0.8 7.4 0.7 0.6 1.3 1.1 1.1 0.8 0.6 0.3 0.4 0.2 0.2 0.5 10.2 10.6 0.7 0.6 6.6 2.0 3.2 0.4 0.7 3.8 18.8 3.9 3.9 1.5 5.4 29.1 0.6 2.5 1.0 2.8 1.6 5.7 2.7 0.6 0.9 0.8 2.4 1.2 3.3 1.0 2.5 2.2 4.1 1.4 5.2 0.3 1.4 3.5 0.6 2.5 0.4 2.4 1.4 0.6 0.5 7.7 0.9 2.0 2.2 3.3 8.5 4.8 12.2 0.8 3.2 0.2 0.1 0.4 12.8 1.4 0.7 0.2 2.3 0.2 0.6 0.2 1.9 0.1 0.5 0.3 11.4 0.8 0.0 0.1 0.8 9.4 11.5 28.5 18.7 11.9 7.1 6.3 14.2 6.6 4.1 0.0 2.6 12.7 4.9 18.0 38.9 87.7 12.7 12.0 0.0 0.0 0.0 0.4 0.0 4.3 0.0 36.2 13.5 46.7 2.7 27.6 5.8 2.3 4.6 16.8 2.4 1.6 8.1 33.2 15.8 0.0 2.3 10.4 11.8 0.0 11.8 2.0 18.1 31.7 1.1 0.5 3.0 12.9 20.8 0.0 1.7 19.6 0.6 34.8 3.3 4.7 GINM1 "C6orf72, dJ12G14.2" ENSG00000055211 "Glycoprotein integral membrane 1" Q9NU53 6 149566294-149591748 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 261.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017210, HPA041679" Approved Approved "Nucleoli fibrillar center,Plasma membrane" NA NA 8700 "Nucleoli fibrillar center, Plasma membrane" "HPA017210: AB_1845743, HPA041679: AB_2677611" "unprognostic (6.09e-3)" "unprognostic (2.19e-2)" "unprognostic (2.38e-1)" "unprognostic (2.48e-1)" "unprognostic (7.24e-2)" "unprognostic (1.32e-3)" "unprognostic (3.18e-2)" "unprognostic (1.27e-1)" "unprognostic (2.31e-1)" "unprognostic (8.23e-2)" "unprognostic (1.05e-1)" "unprognostic (2.10e-2)" "unprognostic (2.09e-2)" "unprognostic (2.88e-2)" "unprognostic (2.64e-2)" "unprognostic (4.87e-2)" "unprognostic (4.79e-3)" 32.1 26.3 21.3 17.8 34.7 20.0 51.5 26.1 27.6 28.8 25.7 22.4 29.0 14.2 29.3 36.9 21.5 24.1 24.3 48.2 20.3 18.3 51.3 29.6 28.4 32.9 43.6 21.4 31.7 28.3 27.1 17.5 34.0 23.0 23.6 19.8 21.7 20.7 40.1 29.2 20.9 17.3 36.7 31.3 18.6 22.8 31.0 30.2 11.5 41.5 21.6 13.1 28.6 22.6 16.8 12.6 23.7 16.0 8.0 8.1 7.7 7.9 5.7 9.3 12.5 50.2 30.1 15.2 27.2 31.9 20.7 26.0 7.4 10.7 5.9 15.0 25.7 19.1 16.4 6.0 13.6 27.1 9.8 13.4 5.6 5.5 8.8 19.2 11.0 5.4 33.4 11.8 17.5 12.1 22.7 22.2 8.1 7.2 9.8 19.4 10.2 6.9 8.3 3.2 11.7 6.1 7.4 16.7 4.4 29.4 7.0 5.9 5.7 27.1 16.1 5.6 10.7 10.1 11.2 15.5 11.2 11.8 28.5 17.9 9.7 11.2 7.3 20.8 9.9 10.3 11.9 13.7 17.1 6.8 13.2 7.9 16.8 8.1 7.4 10.0 11.7 7.9 6.4 23.7 8.0 16.0 12.6 7.5 7.7 21.3 34.7 26.1 27.6 20.3 18.3 43.6 21.4 23.0 30.2 74.5 47.2 33.3 50.3 41.6 20.9 44.8 30.6 33.5 43.3 62.8 27.5 69.7 33.2 80.6 144.2 73.7 38.6 0.0 70.5 63.5 82.2 48.5 27.8 35.6 40.9 15.9 25.7 88.4 45.9 261.3 120.0 45.3 40.5 82.0 22.0 80.5 55.4 29.4 106.1 117.9 21.9 97.0 65.6 141.4 88.4 41.0 102.6 28.7 25.1 50.0 GIPC1 "C19orf3, GIPC, GLUT1CBP, Hs.6454, NIP, RGS19IP1, SEMCAP, SYNECTIN, TIP-2" ENSG00000123159 "GIPC PDZ domain containing family member 1" O14908 19 14477760-14496149 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 262.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043958, HPA061786" Approved Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" Nucleoplasm "HPA043958: AB_10963436, HPA061786: AB_2756319" "unprognostic (2.80e-1)" "unprognostic (1.16e-1)" "unprognostic (8.21e-2)" "unprognostic (1.03e-1)" "unprognostic (2.82e-1)" "unprognostic (1.07e-1)" "unprognostic (1.18e-2)" "unprognostic (1.28e-1)" "unprognostic (1.19e-1)" "unprognostic (4.82e-2)" "unprognostic (3.53e-2)" "unprognostic (7.72e-2)" "unprognostic (1.04e-2)" "unprognostic (7.17e-3)" "unprognostic (1.70e-1)" "unprognostic (1.16e-1)" "unprognostic (8.82e-2)" 16.4 15.1 17.4 12.0 21.0 2.0 11.2 12.1 28.8 19.4 51.0 29.7 15.3 14.2 11.9 14.9 71.2 14.4 21.2 17.9 16.9 14.8 18.7 16.9 20.5 7.9 18.3 23.0 10.2 15.1 6.5 12.4 24.0 23.0 14.0 23.9 15.2 22.1 19.6 26.8 40.4 13.3 15.8 21.8 10.8 35.7 6.5 16.6 11.1 18.2 26.0 24.7 17.1 26.3 2.0 4.0 2.4 1.2 1.5 12.1 1.9 66.0 30.7 9.4 14.7 8.7 8.8 7.4 24.8 12.6 20.5 18.6 16.4 25.1 0.9 46.8 17.5 13.7 38.0 8.0 20.8 7.0 6.8 14.4 12.9 21.0 16.0 26.8 1.3 16.0 10.1 20.8 12.4 10.9 12.2 13.8 9.8 6.0 11.4 10.4 49.3 4.2 2.6 10.2 37.0 30.8 4.4 7.9 8.8 25.2 57.9 8.8 9.8 13.9 34.3 31.8 5.1 21.5 7.2 23.8 29.0 16.0 40.4 26.5 10.7 13.6 3.3 24.3 10.5 30.4 2.4 0.8 0.1 5.8 1.2 5.4 2.0 5.9 5.9 1.2 1.0 4.9 3.9 0.3 1.5 0.5 4.0 12.1 1.9 17.4 21.0 12.1 28.8 16.9 14.8 18.3 23.0 23.0 16.6 26.8 14.6 11.5 47.9 101.2 65.6 12.9 17.8 4.0 15.9 78.5 33.4 29.4 44.7 162.1 0.8 27.0 262.4 0.0 146.8 55.5 40.6 96.5 10.3 16.4 46.4 71.5 41.3 19.0 9.5 1.9 19.0 13.8 55.6 37.9 62.6 60.8 195.2 130.6 23.7 38.4 38.1 19.4 38.2 7.4 20.6 148.3 21.5 13.8 65.5 154.2 GJB7 "bA136M9.1, CX25" ENSG00000164411 "Gap junction protein beta 7" Q6PEY0 6 87282978-87329278 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "fallopian tube: 12.3;pituitary gland: 10.0;placenta: 4.5" "Cell type enhanced" "Detected in some" 28 "Ciliated cells: 29.4;Cytotrophoblasts: 7.7;Extravillous trophoblasts: 4.4;Syncytiotrophoblasts: 6.1" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 1.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 6.5;HDLM-2: 10.5;MCF7: 5.8;OE19: 6.7;RT4: 5.2;SuSa: 3.6" "Low region specificity" "Detected in many" HPA014392 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA014392: " "unprognostic (8.30e-2)" "unprognostic (2.45e-1)" "unprognostic (3.06e-1)" "unprognostic (4.20e-1)" "unprognostic (2.84e-1)" "unprognostic (4.07e-3)" "unprognostic (2.61e-1)" "unprognostic (5.13e-3)" "unprognostic (6.69e-3)" "unprognostic (1.59e-1)" "unprognostic (3.82e-2)" "unprognostic (4.15e-2)" "unprognostic (3.24e-1)" "unprognostic (5.64e-2)" "unprognostic (2.09e-2)" "unprognostic (3.10e-2)" 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 12.3 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 10.0 4.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 1.3 0.0 0.1 0.5 0.0 0.7 0.1 1.0 0.0 0.0 1.3 0.0 2.1 0.0 0.1 0.1 0.0 0.0 6.5 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.1 0.0 5.8 0.0 0.1 1.8 6.7 0.0 0.2 0.0 0.0 0.0 5.2 0.1 0.0 1.2 0.0 0.0 3.6 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.7 0.2 0.0 0.1 0.6 1.3 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.0 29.4 0.0 0.0 0.0 7.7 0.0 0.0 0.6 0.0 0.0 0.0 0.2 4.4 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.5 0.0 0.0 0.2 0.1 0.0 6.1 0.0 0.2 0.1 GLRX "GRX, GRX1" ENSG00000173221 Glutaredoxin P35754 5 95751319-95823005 "Plasma proteins, Predicted intracellular proteins" "Electron transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 94.4;skeletal muscle: 141.6" "Cell type enhanced" "Detected in many" 8 "Distal tubular cells: 613.5;Extravillous trophoblasts: 605.3;Proximal tubular cells: 870.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 85.0;RPTEC TERT1: 65.0;U-87 MG: 69.9" "Low region specificity" "Detected in all" "CAB008634, HPA046431, CAB069419" Approved Supported "Plasma membrane,Cytosol" NA NA 13000000 "Plasma membrane, Cytosol" "CAB008634: AB_1616672, CAB069419: AB_1616670, HPA046431: AB_2679663" "unprognostic (1.69e-1)" "unprognostic (1.32e-1)" "unprognostic (1.94e-2)" "unprognostic (4.81e-2)" "unprognostic (2.01e-2)" "unprognostic (2.22e-2)" "unprognostic (8.62e-3)" "unprognostic (9.31e-3)" "unprognostic (1.99e-2)" "unprognostic (1.65e-2)" "unprognostic (2.34e-1)" "unprognostic (1.82e-1)" "unprognostic (8.11e-2)" "unprognostic (2.18e-1)" "unprognostic (1.03e-1)" "unprognostic (2.61e-1)" "unprognostic (2.61e-1)" 17.7 20.7 6.2 15.0 6.6 30.6 10.5 15.5 15.5 5.4 22.6 3.1 4.0 40.2 2.9 4.6 3.1 3.7 9.5 25.2 12.1 7.8 45.9 46.9 23.1 21.5 7.8 5.9 3.5 2.6 9.5 6.4 63.9 7.6 5.7 8.8 2.4 17.9 5.5 141.6 7.3 42.5 4.5 7.3 15.2 8.2 2.2 4.0 14.4 6.3 6.4 14.3 11.6 5.8 16.0 52.2 94.4 81.6 11.2 48.9 71.1 3.3 15.0 1.1 2.4 32.4 46.6 0.2 50.1 85.0 5.4 9.1 3.7 1.5 13.0 7.1 15.0 12.2 1.3 1.9 23.8 15.1 11.3 3.7 9.4 9.9 34.4 61.7 10.0 27.9 29.1 2.9 34.3 3.3 12.0 10.3 26.7 1.2 7.8 34.0 1.1 17.2 17.7 3.3 0.4 17.1 27.9 10.2 16.1 65.0 2.4 3.4 1.8 13.1 6.5 5.7 3.1 1.8 9.9 11.9 14.2 16.0 11.3 2.1 5.6 28.7 10.4 69.9 25.1 3.0 3.8 81.6 94.4 26.2 51.0 35.7 16.0 24.1 19.5 52.2 10.7 24.1 22.1 85.7 11.2 40.5 18.0 48.9 71.1 6.2 6.6 15.5 15.5 12.1 7.8 7.8 5.9 7.6 4.0 20.8 27.9 60.2 35.5 15.2 1.5 153.4 79.0 53.5 27.3 89.0 0.0 19.8 613.5 47.8 0.2 38.0 373.9 23.3 81.2 605.3 54.7 75.6 30.1 177.3 241.8 0.0 30.4 44.2 275.4 0.9 17.5 243.9 65.8 117.2 64.0 5.5 118.2 157.8 13.1 870.9 3.3 19.4 70.2 0.5 1.1 18.1 238.6 103.6 64.3 137.4 GMIP ARHGAP46 ENSG00000089639 "GEM interacting protein" Q9P107 19 19629476-19643667 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 32.7;bone marrow: 31.0;lymphoid tissue: 40.0" "Cell type enhanced" "Detected in many" 8 "Hofbauer cells: 20.7;Kupffer cells: 34.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 43.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042484, HPA045481" Enhanced Enhanced "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA042484: AB_2678018, HPA045481: AB_2679343" "unprognostic (7.54e-2)" "unprognostic (5.35e-3)" "unprognostic (3.10e-3)" "unprognostic (4.54e-3)" "unprognostic (1.44e-1)" "unprognostic (1.24e-3)" "unprognostic (1.23e-2)" "unprognostic (4.29e-2)" "unprognostic (1.12e-1)" "unprognostic (2.30e-1)" "unprognostic (6.85e-2)" "unprognostic (6.75e-3)" "prognostic unfavorable (3.97e-5)" "prognostic favorable (3.03e-4)" "unprognostic (4.92e-2)" "unprognostic (2.54e-1)" "prognostic favorable (5.15e-4)" 6.1 2.8 3.5 20.3 4.9 31.0 4.0 0.9 4.1 2.9 6.9 4.3 2.7 7.0 2.7 3.2 6.2 4.4 7.9 3.3 4.3 3.4 4.2 3.9 11.7 28.0 4.2 2.5 2.4 4.6 10.6 3.0 3.9 3.4 4.1 4.6 2.7 6.0 4.5 1.5 4.9 15.3 2.9 4.9 40.0 11.1 2.2 3.1 26.8 6.2 2.7 23.2 6.1 4.5 6.6 6.7 32.7 13.9 4.2 6.4 4.6 4.4 2.1 2.8 3.0 3.1 1.6 11.2 2.8 2.5 1.7 1.6 1.7 6.1 11.0 5.8 2.0 2.2 5.4 1.8 3.1 1.1 3.8 2.8 3.5 3.3 1.8 0.9 9.8 43.8 2.0 2.1 1.8 1.0 2.0 3.8 9.9 2.3 4.0 1.8 6.6 6.1 16.2 1.6 5.8 3.8 10.6 1.2 6.3 3.2 10.7 2.4 7.2 3.9 4.1 1.6 2.2 3.8 14.1 7.0 3.2 1.8 3.6 2.1 2.0 0.8 9.1 2.0 12.9 2.1 2.9 8.3 21.5 6.4 10.6 5.9 5.9 4.0 5.7 6.7 6.6 4.5 4.6 32.7 4.2 13.9 6.1 4.5 4.6 3.5 4.9 0.9 4.1 4.3 3.4 4.2 2.5 3.4 3.1 0.0 15.1 15.6 1.1 1.0 0.0 0.6 2.5 1.4 2.3 0.0 0.0 0.5 0.0 3.8 0.1 1.4 13.3 0.0 4.2 4.6 0.9 1.6 6.9 0.9 20.7 0.0 0.0 2.5 34.3 0.0 0.6 16.5 1.7 17.2 6.3 0.2 9.4 12.2 0.7 0.6 0.0 0.0 0.9 0.1 1.5 1.0 0.7 15.9 5.8 2.6 GNAQ "G-ALPHA-q, GAQ" ENSG00000156052 "G protein subunit alpha q" P50148 9 77716087-78031458 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" Transducer "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 18.4" "Lineage enriched" "Detected in many" 5 "granulocytes: 18.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010036, HPA048886" Uncertain Approved "Nuclear speckles,Plasma membrane,Cytosol" NA NA 28000000 "Nuclear speckles" "Plasma membrane, Cytosol" "CAB010036: AB_631536, HPA048886: AB_2680544" "unprognostic (2.10e-1)" "unprognostic (8.53e-2)" "unprognostic (1.45e-1)" "unprognostic (4.37e-2)" "unprognostic (1.87e-1)" "unprognostic (6.83e-3)" "unprognostic (1.05e-1)" "unprognostic (3.84e-2)" "unprognostic (2.46e-1)" "unprognostic (2.16e-1)" "unprognostic (1.85e-1)" "unprognostic (1.44e-1)" "prognostic favorable (1.11e-7)" "unprognostic (1.90e-1)" "unprognostic (3.13e-1)" "unprognostic (1.05e-1)" "unprognostic (2.01e-1)" 12.7 12.6 24.3 9.9 20.8 21.8 11.6 12.5 29.6 13.1 16.6 17.1 9.1 7.9 13.7 11.2 13.1 10.0 11.6 5.6 24.2 18.3 12.1 12.3 23.1 11.8 19.1 14.6 13.5 8.5 12.7 7.6 12.1 14.3 13.0 16.0 10.4 9.8 15.9 5.9 5.1 9.0 18.2 23.9 5.8 15.5 6.0 14.8 18.6 13.3 4.0 4.8 14.5 13.1 0.8 2.8 18.4 3.5 3.3 2.0 1.2 12.0 13.7 12.2 13.4 15.5 15.9 17.6 16.4 12.4 7.2 8.7 4.2 9.9 0.0 13.3 15.0 10.1 19.8 9.1 9.9 9.0 0.4 5.3 33.0 12.0 8.4 14.0 20.1 12.4 10.8 12.2 13.9 14.2 15.0 17.7 29.8 5.8 0.1 12.6 15.3 23.2 12.8 9.9 19.4 1.9 8.6 15.0 0.1 16.4 25.8 13.7 20.9 11.8 10.0 12.3 12.0 9.1 7.5 22.1 12.7 0.8 17.2 9.5 0.1 0.0 0.1 8.8 11.9 13.1 18.4 2.2 4.6 0.8 1.9 1.6 0.8 1.8 1.0 2.4 0.8 2.0 1.6 7.7 3.3 3.5 2.8 1.9 1.2 24.3 20.8 12.5 24.0 24.2 18.3 19.1 14.6 14.3 14.8 163.8 71.4 6.4 33.6 42.0 29.9 5.9 43.3 42.8 35.2 73.3 15.7 39.3 6.6 28.1 13.1 85.4 69.5 46.7 34.7 42.2 42.9 51.3 49.7 51.3 47.8 77.9 88.6 107.4 139.4 6.8 36.5 92.7 45.5 72.1 90.6 37.0 44.3 48.9 49.1 35.4 4.2 25.8 40.1 4.7 6.6 18.9 24.3 21.8 67.3 50.3 GNB1 ENSG00000078369 "G protein subunit beta 1" P62873 1 1785285-1891117 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins, Transporters" Transducer "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "Rod photoreceptor cells: 1104.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040736 Supported Approved "Golgi apparatus,Plasma membrane" NA NA 60000000 "Plasma membrane" "Golgi apparatus" "HPA040736: AB_2677106" "unprognostic (9.49e-2)" "unprognostic (4.91e-3)" "unprognostic (1.24e-1)" "unprognostic (1.56e-1)" "unprognostic (3.34e-1)" "unprognostic (9.07e-3)" "prognostic unfavorable (3.61e-6)" "unprognostic (1.99e-2)" "unprognostic (3.60e-1)" "unprognostic (7.27e-2)" "unprognostic (8.47e-3)" "unprognostic (1.95e-1)" "unprognostic (9.76e-2)" "unprognostic (1.08e-1)" "unprognostic (4.62e-2)" "unprognostic (1.14e-1)" "unprognostic (7.90e-2)" 55.2 42.1 84.7 55.1 82.3 41.7 37.8 78.8 112.5 44.0 52.1 46.4 26.0 55.4 44.3 31.2 41.7 38.8 36.6 39.6 74.7 65.7 43.9 38.7 47.1 47.1 68.5 52.1 45.0 33.9 48.9 36.9 45.3 56.6 40.1 41.0 70.7 37.6 41.7 19.7 35.5 65.3 51.2 61.0 51.0 40.8 31.4 39.2 44.5 37.6 19.5 45.6 42.2 54.1 7.7 18.8 18.4 13.2 10.6 9.9 6.0 54.7 51.8 61.6 42.9 35.2 38.8 23.8 77.8 51.9 70.7 55.6 42.3 54.9 57.2 57.4 78.5 40.1 28.9 61.7 56.4 64.7 87.8 30.3 55.5 49.2 48.0 44.4 33.3 61.0 34.3 39.8 67.5 62.9 47.8 57.3 45.4 34.3 51.8 67.3 34.1 73.0 26.3 35.4 28.2 42.0 71.3 47.6 45.2 48.4 34.1 75.8 86.4 72.1 47.0 63.1 44.3 32.9 45.8 87.3 62.3 41.8 48.4 56.4 35.1 61.2 131.0 53.3 70.4 35.0 7.4 11.1 17.1 8.7 13.2 8.0 7.4 8.7 9.7 10.9 7.7 5.9 6.5 18.4 10.6 13.2 18.8 9.9 6.0 84.7 82.3 78.8 112.5 74.7 65.7 68.5 52.1 56.6 39.2 65.5 41.8 61.1 42.7 76.6 128.2 51.2 58.6 30.8 35.2 71.5 164.9 36.8 39.7 78.1 24.7 107.9 139.4 0.0 86.3 77.4 70.2 78.2 52.0 51.3 89.1 170.0 118.1 93.9 126.8 25.1 70.5 95.3 50.6 74.9 88.7 159.0 130.7 84.2 82.7 56.2 1104.1 77.6 76.5 56.5 67.9 89.0 30.4 48.0 64.7 70.1 GNB3 ENSG00000111664 "G protein subunit beta 3" P16520 12 6839954-6847393 "Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" Transducer "Congenital stationary night blindness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "pituitary gland: 27.0;retina: 79.9" "Group enriched" "Detected in some" 9 "Bipolar cells: 509.6;Cone photoreceptor cells: 877.7;Rod photoreceptor cells: 442.8" "Cancer enhanced" "Detected in some" "testis cancer: 3.1" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory B-cell: 1.5" "Lineage enriched" "Detected in single" 9 "B-cells: 1.5" "Cell line enhanced" "Detected in many" "Daudi: 8.5;NTERA-2: 10.3;U-698: 25.9" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "cerebellum: 10.4" HPA040736 Uncertain Approved "Golgi apparatus,Plasma membrane" NA NA "Plasma membrane" "Golgi apparatus" "HPA040736: AB_2677106" "unprognostic (3.86e-2)" "unprognostic (1.58e-1)" "unprognostic (4.96e-2)" "unprognostic (8.75e-2)" "unprognostic (2.53e-2)" "unprognostic (5.74e-3)" "unprognostic (5.98e-2)" "unprognostic (4.43e-3)" "unprognostic (1.19e-1)" "unprognostic (1.98e-1)" "unprognostic (2.25e-5)" "unprognostic (3.21e-2)" "unprognostic (4.77e-11)" "unprognostic (2.43e-1)" "unprognostic (6.48e-2)" "unprognostic (1.36e-1)" "unprognostic (1.07e-2)" 0.8 1.6 0.9 1.4 2.0 0.5 0.8 6.9 1.6 1.1 1.0 0.8 0.8 2.3 2.7 0.8 0.8 1.0 1.1 5.4 1.0 1.3 0.8 0.8 0.8 1.4 1.1 0.8 3.5 0.8 3.2 27.0 0.8 1.6 1.6 0.4 79.9 2.6 1.8 1.5 0.6 1.6 4.1 0.9 0.9 0.9 0.8 0.8 0.8 1.2 1.0 1.8 2.1 0.8 1.5 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.4 5.0 0.8 0.6 0.9 0.5 2.9 0.6 1.6 1.1 1.1 0.3 8.5 0.0 3.1 0.1 0.3 4.9 0.2 1.5 0.7 1.1 2.2 2.7 0.7 0.5 0.6 1.4 1.2 0.2 1.5 2.1 5.3 1.4 1.1 0.8 0.7 0.4 0.4 0.4 0.5 10.3 0.0 0.3 0.4 1.7 0.5 0.3 0.2 0.8 1.2 0.2 0.0 0.6 1.7 0.0 0.5 2.6 1.3 2.1 2.5 3.8 0.7 0.5 25.9 0.6 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 2.0 6.9 1.5 1.0 1.3 1.1 0.8 1.6 0.8 0.0 0.0 0.0 0.4 0.3 509.6 4.6 0.0 0.0 0.0 0.0 877.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.4 0.0 0.0 0.1 69.9 0.0 0.0 0.0 0.0 3.4 0.0 1.7 0.0 0.0 58.9 0.2 0.0 3.2 0.0 442.8 0.0 1.9 0.0 0.4 0.0 0.0 0.0 0.0 0.1 GNG2 ENSG00000186469 "G protein subunit gamma 2" P59768 14 51826195-51979342 "Predicted intracellular proteins, RAS pathway related proteins" Transducer "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 68.4;brain: 50.5;testis: 55.7" "Group enriched" "Detected in many" 4 "Early spermatids: 648.7;Late spermatids: 811.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 20.9;fHDF/TERT166: 36.9;MOLT-4: 28.7;SH-SY5Y: 24.3;WM-115: 66.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003534, CAB018380" Uncertain Supported Approved "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "CAB018380: AB_631547, HPA003534: AB_1079004" "unprognostic (6.11e-2)" "unprognostic (5.78e-3)" "unprognostic (2.06e-3)" "unprognostic (6.55e-2)" "unprognostic (1.33e-1)" "unprognostic (4.01e-2)" "unprognostic (1.18e-1)" "unprognostic (1.03e-1)" "unprognostic (5.72e-2)" "unprognostic (1.24e-1)" "prognostic favorable (1.64e-4)" "unprognostic (8.47e-2)" "prognostic unfavorable (3.90e-6)" "unprognostic (9.82e-2)" "unprognostic (1.29e-1)" "unprognostic (1.08e-1)" "unprognostic (3.59e-2)" 22.0 10.4 50.5 17.4 18.5 25.0 11.7 4.9 46.1 5.9 13.0 5.2 1.6 6.8 5.7 4.7 6.5 3.5 7.9 6.6 30.9 50.3 4.0 5.6 8.5 19.4 10.7 20.7 7.1 3.3 1.6 12.2 8.6 8.9 6.6 9.1 8.3 4.5 4.4 2.3 3.5 9.9 8.8 8.5 41.2 7.3 55.7 2.5 39.6 3.9 4.3 19.5 8.5 4.0 8.0 13.9 68.4 34.9 5.0 36.5 27.6 0.0 0.8 20.9 13.0 3.2 4.2 0.3 3.4 4.2 1.6 1.3 1.7 0.0 0.0 0.5 36.9 2.4 0.0 2.7 0.0 1.1 9.4 0.3 0.0 0.2 0.0 1.6 1.9 0.1 6.9 0.0 1.6 0.1 8.8 0.0 18.1 0.0 1.7 10.6 0.0 28.7 3.1 11.0 0.0 2.5 10.2 1.6 0.5 1.7 0.0 3.1 24.3 0.0 0.0 9.0 0.7 0.0 0.0 0.0 5.1 0.8 0.1 2.6 0.0 0.0 1.4 4.2 10.2 66.5 68.4 13.5 36.0 36.5 23.3 24.6 8.0 20.3 29.7 13.9 7.3 12.9 22.8 39.9 5.0 34.9 6.0 28.8 27.6 50.5 18.5 4.9 44.2 30.9 50.3 10.7 20.7 8.9 2.5 6.0 11.1 29.6 0.2 10.2 12.4 0.6 0.0 0.0 0.0 3.5 2.0 0.4 1.7 0.1 648.7 6.3 0.1 0.0 0.0 0.6 18.4 0.2 31.2 0.9 39.5 0.0 168.9 12.3 83.7 811.3 9.2 65.9 52.3 14.4 1.0 0.5 0.8 0.0 5.6 0.8 1.8 38.8 8.0 11.9 3.8 5.8 0.6 100.2 0.4 0.1 GP9 "CD42a, GPIX" ENSG00000169704 "Glycoprotein IX platelet" P14770 3 129060767-129062406 "CD markers, Disease related genes, Predicted membrane proteins" "Blood coagulation, Cell adhesion, Hemostasis" "Bernard Soulier syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 27.1;bone marrow: 10.0;lymphoid tissue: 24.5" "Group enriched" "Detected in some" 11 "Early spermatids: 14.0;Late spermatids: 13.3" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "basophil: 8.8;neutrophil: 7.5" "Lineage enriched" "Detected in many" 6 "granulocytes: 8.8" "Cell line enriched" "Detected in some" 14 "HEL: 43.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA063182 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 68000000 "Plasma membrane, Cytosol" Nucleoplasm "HPA063182: AB_2684956" "unprognostic (1.70e-1)" "unprognostic (3.97e-1)" "unprognostic (1.10e-1)" "unprognostic (3.80e-2)" "unprognostic (2.50e-2)" "unprognostic (3.24e-1)" "unprognostic (2.53e-2)" "unprognostic (8.47e-2)" "unprognostic (8.70e-2)" 0.2 0.1 0.1 0.1 0.1 10.0 0.1 0.0 0.6 0.4 0.5 0.0 0.0 0.1 0.1 0.0 0.1 0.3 0.1 5.0 0.8 0.1 0.1 0.4 4.8 0.0 0.8 0.2 0.5 0.1 0.0 0.3 1.5 0.4 0.1 0.4 0.2 0.0 0.6 0.2 0.0 0.1 0.0 0.1 24.5 0.3 2.2 0.0 0.0 0.6 0.6 0.0 0.6 3.0 0.1 1.5 8.8 0.6 0.0 0.2 27.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.6 0.1 0.1 0.3 0.1 0.0 0.0 0.2 0.3 0.1 0.0 0.0 7.5 0.0 0.0 1.5 0.0 27.1 0.1 0.1 0.0 0.6 0.8 0.1 0.8 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.3 13.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 GPBP1 "DKFZp761C169, vasculin" ENSG00000062194 "GC-rich promoter binding protein 1" Q86WP2 5 57173948-57264679 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037773 Approved Approved "Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Cytosol" "Plasma membrane" "HPA037773: AB_10671721" "unprognostic (1.53e-1)" "unprognostic (2.23e-2)" "unprognostic (1.57e-1)" "unprognostic (3.49e-1)" "unprognostic (8.30e-2)" "unprognostic (9.68e-3)" "unprognostic (1.24e-2)" "unprognostic (3.19e-2)" "unprognostic (6.85e-3)" "unprognostic (3.70e-1)" "unprognostic (5.93e-2)" "unprognostic (5.48e-2)" "unprognostic (3.75e-2)" "unprognostic (1.65e-1)" "unprognostic (4.89e-2)" "unprognostic (2.57e-1)" "prognostic favorable (4.15e-5)" 25.6 33.1 33.8 27.0 37.8 38.0 37.2 53.9 34.0 30.6 23.5 29.7 20.3 20.8 29.0 33.1 25.5 32.4 24.5 25.4 32.5 28.4 27.1 28.4 29.9 34.0 41.5 34.0 46.7 23.5 37.6 43.9 35.6 33.2 27.6 24.9 19.7 27.2 26.9 37.3 24.6 25.8 22.0 42.4 31.5 24.0 46.9 37.2 49.9 35.1 20.3 33.7 29.4 50.2 31.7 18.9 35.5 18.9 33.5 37.7 27.1 21.8 17.5 33.5 28.1 21.9 21.8 30.8 16.6 28.4 27.6 35.6 28.2 25.4 29.0 19.5 17.0 34.2 15.1 28.6 19.2 35.0 16.4 19.6 23.8 19.9 23.5 25.6 17.1 24.6 17.7 29.8 22.5 31.6 26.6 22.2 23.7 24.1 47.7 22.0 27.4 27.0 30.0 20.8 10.7 12.2 29.3 27.4 28.4 21.2 22.7 30.1 23.4 24.3 21.8 26.5 22.6 42.6 29.3 14.7 10.1 20.7 14.6 24.0 36.3 30.4 32.3 16.9 25.9 18.8 35.5 17.1 32.3 28.1 17.7 35.2 31.7 34.0 33.1 18.9 26.8 37.7 34.9 33.2 33.5 18.9 13.4 35.3 27.1 33.8 37.8 53.9 34.0 32.5 28.4 41.5 34.0 33.2 37.2 56.6 73.1 104.6 209.8 202.1 136.5 78.6 50.9 156.6 117.2 80.3 139.4 79.0 84.6 64.9 165.9 107.9 88.6 0.0 48.6 61.5 139.8 213.9 141.7 40.1 49.2 127.1 103.2 53.4 59.9 85.3 124.0 98.1 178.8 169.5 57.2 92.1 59.0 101.7 85.9 53.3 176.2 51.8 188.5 265.7 227.4 207.8 135.2 127.1 57.2 255.1 GPBP1L1 SP192 ENSG00000159592 "GC-rich promoter binding protein 1 like 1" Q9HC44 1 45627304-45688113 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028593 Approved Approved "Nucleoplasm,Plasma membrane,Focal adhesion sites,Cytosol" NA NA Nucleoplasm "Plasma membrane, Focal adhesion sites, Cytosol" "HPA028593: AB_10602906" "unprognostic (1.39e-1)" "unprognostic (8.41e-2)" "unprognostic (1.44e-3)" "unprognostic (6.60e-2)" "unprognostic (6.35e-2)" "unprognostic (1.97e-3)" "unprognostic (2.42e-3)" "unprognostic (9.79e-2)" "unprognostic (3.91e-2)" "unprognostic (1.94e-3)" "unprognostic (1.12e-2)" "unprognostic (4.11e-1)" "unprognostic (1.25e-2)" "unprognostic (6.63e-2)" "unprognostic (4.51e-1)" "unprognostic (7.56e-3)" "unprognostic (6.13e-2)" 29.9 20.5 16.9 21.2 23.7 24.9 25.2 24.4 18.6 27.4 36.9 33.3 29.7 31.6 26.3 23.8 34.8 22.5 19.7 23.9 17.3 17.0 30.2 38.9 28.3 29.1 33.2 12.4 24.7 46.9 24.4 36.6 25.7 22.1 26.4 37.2 29.8 33.5 35.3 29.6 31.0 58.0 25.7 28.2 30.6 26.2 33.2 27.2 40.5 37.7 30.3 35.4 32.5 27.5 13.5 17.8 29.8 22.1 20.0 20.0 15.4 15.8 9.8 17.1 18.1 20.2 19.7 23.4 12.6 21.0 18.3 23.1 9.8 17.8 22.0 16.5 17.3 19.3 16.6 18.7 19.0 23.3 25.1 13.3 28.5 11.4 15.2 27.8 28.4 26.5 14.3 41.6 14.3 41.0 24.7 23.1 28.3 24.3 19.6 20.8 8.5 25.2 25.6 24.3 21.4 11.2 16.6 22.2 16.1 21.0 15.7 21.1 14.1 20.8 30.8 32.1 34.8 14.0 33.6 19.6 13.2 13.9 14.2 19.1 19.2 17.8 16.2 13.9 23.8 13.8 16.4 16.6 29.8 17.8 21.2 18.9 13.5 17.6 17.4 17.8 11.5 19.4 18.9 17.7 20.0 22.1 10.2 20.0 15.4 16.9 23.7 24.4 18.6 17.3 17.0 33.2 12.4 22.1 27.2 56.6 19.5 31.8 35.2 57.7 23.3 41.7 45.9 16.0 29.6 57.6 33.4 23.0 43.1 29.6 10.8 38.3 66.9 46.7 33.6 29.3 24.3 50.8 58.8 72.6 22.6 35.0 36.8 31.9 45.9 13.4 19.0 33.1 21.9 23.4 66.9 16.0 42.8 46.0 20.1 45.1 32.3 19.4 35.3 70.7 75.4 59.2 38.0 35.1 54.0 53.8 GPC4 K-glypican ENSG00000076716 "Glypican 4" O75487 X 133300103-133415490 "Plasma proteins, Predicted membrane proteins" "Deafness, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 47.6;Extravillous trophoblasts: 33.8;Proximal tubular cells: 34.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 47.7;HAP1: 27.3;NTERA-2: 25.0;RPTEC TERT1: 63.0;SuSa: 57.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA030834, HPA030836" Approved Approved "Nucleoplasm,Plasma membrane" "Intracellular and membrane" NA NA 170000 "Plasma membrane" Nucleoplasm "HPA030834: , HPA030836: AB_10601327" "unprognostic (9.60e-2)" "unprognostic (8.67e-2)" "unprognostic (2.29e-1)" "unprognostic (8.21e-2)" "unprognostic (8.51e-3)" "unprognostic (5.90e-3)" "unprognostic (5.68e-2)" "prognostic favorable (3.51e-4)" "unprognostic (2.54e-2)" "unprognostic (1.26e-1)" "unprognostic (5.87e-3)" "unprognostic (1.30e-1)" "prognostic favorable (1.25e-5)" "unprognostic (1.97e-1)" "unprognostic (2.89e-1)" "unprognostic (2.75e-1)" "unprognostic (2.72e-1)" 39.7 9.9 16.3 10.7 5.3 0.3 6.8 3.7 4.9 14.6 21.6 8.2 3.4 10.0 11.7 16.3 18.6 11.2 23.7 9.6 9.5 5.0 39.6 2.4 25.6 7.1 5.1 6.6 12.4 12.5 9.4 20.4 26.9 9.5 10.3 10.7 9.3 12.2 11.6 20.3 4.3 11.3 16.9 7.9 6.5 19.8 7.2 6.4 5.2 12.4 11.6 2.0 17.1 11.7 0.9 0.6 0.1 0.7 0.0 0.0 0.2 0.0 0.0 47.7 1.8 2.0 0.3 5.9 0.3 0.0 0.0 0.0 0.0 0.1 0.0 16.4 0.2 0.0 0.0 27.3 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 25.0 0.0 0.7 0.1 4.3 0.0 63.0 1.8 0.0 0.3 0.2 0.0 0.0 57.9 0.7 0.7 0.0 4.9 5.8 0.0 3.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 16.3 5.3 3.7 4.9 9.5 5.0 5.1 6.6 9.5 6.4 47.6 20.3 0.0 3.3 1.3 0.0 3.4 5.1 9.4 9.1 22.7 0.0 0.3 3.3 6.4 0.4 0.6 2.9 0.0 10.9 33.8 6.9 1.1 0.0 0.0 2.5 0.0 2.4 0.0 0.8 0.9 2.0 2.4 1.7 1.8 9.3 0.8 12.6 3.5 0.4 34.9 0.0 0.0 14.4 1.2 21.2 0.4 2.6 0.0 10.2 0.6 GPR173 SREB3 ENSG00000184194 "G protein-coupled receptor 173" Q9NS66 X 53049091-53080615 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 23.2" "Cell type enhanced" "Detected in some" 8 "Bipolar cells: 6.4;Horizontal cells: 6.4;Intestinal endocrine cells: 3.4;Peritubular cells: 4.2" "Cancer enhanced" "Detected in many" "glioma: 8.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 5.7" "Group enriched" "Detected in many" 4 "granulocytes: 5.7;NK-cells: 1.8" "Cell line enhanced" "Detected in many" "HAP1: 10.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003905 Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA003905: AB_1078922" "unprognostic (2.68e-1)" "unprognostic (2.33e-1)" "unprognostic (4.95e-3)" "prognostic unfavorable (2.88e-6)" "unprognostic (3.87e-2)" "unprognostic (8.58e-2)" "unprognostic (2.73e-1)" "unprognostic (1.47e-1)" "unprognostic (1.92e-1)" "unprognostic (1.70e-2)" "prognostic favorable (2.33e-5)" "unprognostic (1.03e-1)" "prognostic unfavorable (2.47e-4)" "unprognostic (1.08e-4)" "unprognostic (2.83e-1)" "unprognostic (3.92e-2)" "unprognostic (6.95e-2)" 2.5 5.2 8.2 3.0 9.4 2.2 3.1 15.4 23.2 4.2 2.8 11.6 0.8 1.8 6.4 5.0 2.4 7.7 3.3 4.2 7.9 10.0 2.4 1.1 2.8 2.1 7.3 11.2 15.0 1.3 1.3 14.6 4.5 9.7 3.2 2.6 6.4 2.0 5.4 4.6 3.9 2.1 4.5 6.5 4.0 2.1 2.4 9.6 0.7 3.1 0.1 1.5 3.3 2.8 0.9 0.7 5.7 0.4 1.8 0.7 0.0 0.0 0.0 8.1 0.5 4.6 2.7 0.0 1.3 2.9 2.1 2.5 0.8 0.1 0.2 2.0 2.8 6.4 0.6 10.2 0.0 1.9 0.6 1.0 0.5 8.3 0.3 6.7 0.5 0.1 6.6 0.0 3.3 4.6 7.5 3.5 0.0 0.0 5.7 3.2 4.2 0.0 0.0 6.3 0.4 3.6 0.1 2.4 0.3 0.5 0.4 5.9 8.3 0.0 0.4 0.0 5.5 1.1 0.1 6.4 3.5 5.1 2.3 1.1 0.2 0.3 0.7 2.5 0.0 1.9 5.7 0.2 0.3 0.7 0.1 0.5 0.3 0.2 0.1 0.1 0.9 0.5 0.4 1.2 1.8 0.4 0.7 0.0 0.0 8.2 9.4 15.4 15.1 7.9 10.0 7.3 11.2 9.7 9.6 0.0 0.0 0.0 0.4 0.2 6.4 0.7 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.2 6.4 3.4 1.8 0.3 0.0 2.8 0.0 1.7 0.0 0.1 2.7 0.1 0.0 4.2 0.0 2.8 0.0 1.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 GPR27 SREB1 ENSG00000170837 "G protein-coupled receptor 27" Q9NS67 3 71754050-71756496 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 23.2;parathyroid gland: 29.6" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 11.0;Collecting duct cells: 12.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "eosinophil: 3.7;neutrophil: 10.5" "Lineage enriched" "Detected in single" 12 "granulocytes: 10.5" "Cell line enhanced" "Detected in some" "EFO-21: 13.0;HL-60: 12.5;MCF7: 10.8;NTERA-2: 21.5;RPTEC TERT1: 10.4;SH-SY5Y: 8.2;T-47d: 7.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029395 Approved Approved "Nucleoplasm,Plasma membrane,Actin filaments,Cytosol" NA NA Nucleoplasm "Plasma membrane, Actin filaments, Cytosol" "HPA029395: AB_10602907" "prognostic favorable (5.63e-4)" "unprognostic (2.99e-1)" "unprognostic (3.23e-2)" "unprognostic (3.22e-1)" "unprognostic (7.14e-3)" "unprognostic (1.50e-2)" "unprognostic (2.17e-2)" "unprognostic (1.18e-2)" "unprognostic (3.22e-1)" "prognostic favorable (1.21e-6)" "unprognostic (2.97e-3)" "unprognostic (4.97e-2)" "unprognostic (1.51e-2)" "unprognostic (1.21e-2)" "unprognostic (2.71e-2)" "unprognostic (1.45e-2)" "unprognostic (6.79e-2)" 1.7 4.5 14.9 1.7 23.2 14.5 4.3 4.4 15.4 3.4 1.0 5.8 1.7 0.6 5.5 3.3 2.7 7.7 1.2 3.5 12.8 12.4 3.2 0.9 2.4 5.5 10.6 8.8 5.0 2.6 29.6 5.1 2.0 5.9 5.7 0.7 3.3 1.7 5.1 1.8 1.9 0.7 3.3 16.8 3.7 2.4 4.2 3.6 0.0 6.8 1.2 0.5 2.1 2.8 0.0 0.2 10.5 0.8 0.0 0.4 0.1 0.0 0.8 1.5 1.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 13.0 0.0 0.6 0.0 3.2 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 12.5 0.7 0.0 2.2 0.0 0.9 0.0 0.0 2.7 0.0 0.0 0.0 10.8 0.9 0.2 21.5 0.0 0.0 0.0 0.0 0.0 10.4 5.8 2.3 8.2 2.8 0.0 0.0 2.9 7.5 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.8 3.7 0.1 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.4 0.1 10.5 0.0 0.1 0.0 0.0 0.1 14.9 23.2 4.4 9.9 12.8 12.4 10.6 8.8 5.9 3.6 0.0 1.4 0.0 4.0 1.6 11.0 2.8 5.1 2.7 2.3 12.2 3.9 1.1 1.7 0.4 0.1 0.0 0.0 0.0 0.0 1.1 0.9 4.5 0.0 0.0 1.0 0.0 1.2 0.0 5.1 0.0 0.9 0.5 0.0 0.0 0.0 0.5 0.4 0.0 1.1 0.0 0.3 0.0 0.4 0.2 0.9 1.5 0.2 0.0 0.0 1.8 GPR63 "PSP24(beta), PSP24B" ENSG00000112218 "G protein-coupled receptor 63" Q9BZJ6 6 96794126-96837463 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Early spermatids: 21.8;Late spermatids: 26.5;Spermatocytes: 22.8;Spermatogonia: 9.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 7.8;HHSteC: 12.8;Karpas-707: 19.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039103 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA039103: AB_10672841" "unprognostic (8.22e-2)" "unprognostic (2.77e-1)" "unprognostic (1.71e-2)" "unprognostic (1.02e-2)" "unprognostic (1.83e-1)" "unprognostic (1.33e-1)" "unprognostic (2.65e-2)" "unprognostic (1.15e-1)" "unprognostic (3.39e-1)" "unprognostic (2.53e-2)" "unprognostic (7.29e-3)" "unprognostic (3.00e-1)" "unprognostic (2.03e-3)" "unprognostic (1.67e-1)" "unprognostic (1.34e-1)" "unprognostic (2.34e-1)" "unprognostic (2.30e-2)" 1.8 3.4 3.8 3.1 11.0 0.8 1.6 7.5 10.7 3.3 3.9 1.6 1.0 5.1 1.9 1.5 2.0 2.8 2.7 1.9 3.2 2.2 1.4 0.5 1.4 0.9 2.2 6.4 4.0 5.0 3.9 4.3 2.5 10.1 3.3 6.2 2.5 1.7 2.2 1.0 1.7 3.6 3.6 1.4 1.3 4.1 8.0 5.2 2.5 2.3 0.0 0.9 2.2 4.8 0.8 0.9 2.6 0.6 1.4 1.1 0.1 0.0 0.1 1.5 0.3 2.2 0.8 0.4 0.9 0.0 0.0 0.2 0.2 1.1 0.0 0.0 0.1 1.2 1.1 4.9 2.3 0.0 7.8 3.8 4.7 0.4 0.0 12.8 2.9 0.5 2.4 0.4 0.0 3.5 0.3 0.0 7.0 3.4 19.2 0.4 0.4 2.2 0.0 5.0 0.0 0.7 0.0 1.8 3.8 0.3 0.2 2.3 1.4 0.3 3.1 0.5 1.7 1.2 0.6 0.0 1.3 2.0 0.2 1.8 1.5 0.8 0.1 0.8 1.8 1.0 0.8 0.6 0.2 0.6 0.2 0.3 0.7 1.1 0.6 0.1 0.8 1.0 0.9 2.6 1.4 0.2 0.9 0.3 0.1 3.8 11.0 7.5 10.7 3.2 2.2 2.2 6.4 10.1 5.2 0.0 0.0 0.0 0.8 1.6 1.1 0.5 0.0 0.0 0.0 1.8 0.0 0.2 0.0 0.4 21.8 0.1 0.0 0.0 0.8 0.6 0.9 1.0 0.0 0.0 0.2 0.0 2.9 1.8 0.0 26.5 3.1 0.0 1.7 0.0 0.4 0.3 0.5 0.0 4.6 0.0 0.2 0.0 1.1 22.8 9.3 0.3 0.1 0.0 0.5 0.3 GPRIN2 "KIAA0514, MGC15171" ENSG00000204175 "G protein regulated inducer of neurite outgrowth 2" O60269 10 46549044-46555530 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 8.9;lung: 10.5;skin 1: 13.8" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 17.9;Exocrine glandular cells: 18.0;Mucus-secreting cells: 22.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 9.8;A549: 28.4;SiHa: 5.3;SK-BR-3: 15.7" "Low region specificity" "Detected in many" "HPA038129, HPA070760" Approved Approved "Plasma membrane,Microtubules,Cytokinetic bridge,Mitotic spindle" NA NA "Plasma membrane, Microtubules" "Cytokinetic bridge, Mitotic spindle" "HPA038129: AB_2675846, HPA070760: " "unprognostic (1.00e-2)" "unprognostic (1.91e-1)" "unprognostic (1.77e-2)" "prognostic unfavorable (8.60e-8)" "unprognostic (5.77e-2)" "prognostic favorable (3.47e-4)" "unprognostic (2.23e-1)" "unprognostic (2.67e-2)" "unprognostic (2.54e-1)" "unprognostic (1.27e-1)" "unprognostic (1.52e-2)" "unprognostic (1.45e-1)" "unprognostic (8.97e-2)" "unprognostic (1.98e-2)" "unprognostic (2.37e-1)" "unprognostic (1.23e-1)" "unprognostic (5.67e-3)" 0.0 0.0 0.0 0.6 0.2 0.0 1.1 6.5 0.0 0.2 5.7 6.6 0.0 0.0 2.8 0.1 0.0 0.0 0.0 5.2 1.7 0.0 10.5 0.0 1.2 0.0 4.1 0.0 3.0 0.0 1.6 4.0 4.2 1.5 0.0 13.8 8.9 0.0 0.2 0.0 5.1 1.3 2.3 0.3 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 28.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.0 0.3 0.0 1.0 1.1 0.1 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 2.2 0.0 0.0 0.0 0.0 1.5 0.4 0.7 0.1 5.3 15.7 0.0 1.2 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.9 3.0 0.0 2.4 1.4 0.4 0.1 5.1 2.7 1.2 3.5 0.0 0.0 0.0 11.6 7.9 0.0 12.8 0.0 18.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 6.3 0.0 0.0 12.9 0.3 0.0 0.0 0.0 22.0 0.0 9.1 10.5 0.4 2.4 0.0 0.0 0.0 0.5 0.4 5.4 0.0 0.0 6.3 1.1 GPX8 "EPLA847, UNQ847" ENSG00000164294 "Glutathione peroxidase 8 (putative)" Q8TED1 5 55160118-55167071 "Enzymes, Predicted intracellular proteins" "Oxidoreductase, Peroxidase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 15 "Extravillous trophoblasts: 185.8;Fibroblasts: 64.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 52.6;fHDF/TERT166: 49.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036720 Enhanced Approved "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane, Cytosol" "Actin filaments" "HPA036720: AB_2675269" "unprognostic (4.85e-2)" "unprognostic (1.23e-2)" "unprognostic (6.53e-2)" "unprognostic (1.92e-2)" "unprognostic (2.31e-2)" "unprognostic (9.74e-3)" "unprognostic (1.78e-2)" "unprognostic (1.63e-3)" "unprognostic (2.07e-2)" "unprognostic (4.34e-2)" "unprognostic (4.31e-2)" "unprognostic (8.68e-2)" "prognostic unfavorable (5.13e-9)" "prognostic unfavorable (7.96e-4)" "unprognostic (8.11e-2)" "unprognostic (1.16e-2)" "unprognostic (2.63e-2)" 12.6 7.1 0.8 5.8 1.0 0.0 12.2 0.5 0.7 31.4 6.8 1.7 17.3 1.3 23.6 34.5 13.3 13.2 11.2 12.1 1.0 0.9 13.7 2.6 7.3 5.6 1.1 0.9 31.5 5.0 4.5 3.2 40.9 4.0 24.2 4.7 17.8 7.3 16.7 5.0 5.1 4.4 14.1 3.3 7.5 4.9 10.2 0.5 0.7 28.4 11.0 5.4 15.8 19.7 1.0 0.7 2.4 0.5 0.6 0.9 0.2 7.1 5.9 13.0 12.6 34.3 39.0 7.1 36.2 52.6 20.4 40.7 0.6 16.2 0.0 38.6 49.2 17.4 6.1 7.7 10.5 28.0 0.0 3.2 0.3 10.6 1.3 10.8 0.0 0.0 27.6 10.5 12.4 6.5 19.2 23.6 0.0 0.2 0.0 23.1 2.2 0.0 0.0 5.9 0.2 8.4 0.0 7.4 0.0 12.5 0.2 0.0 0.3 12.1 0.9 12.8 15.5 11.6 0.7 21.2 10.9 12.0 16.1 19.4 0.0 0.0 0.0 17.3 0.0 23.6 1.4 0.5 0.3 0.5 0.3 0.5 0.6 0.5 0.5 0.2 1.0 0.9 0.9 2.4 0.6 0.3 0.7 0.2 0.2 0.8 1.0 0.5 0.7 1.0 0.9 1.1 0.9 4.0 0.5 0.0 0.6 0.0 4.8 6.4 0.0 2.6 0.0 14.7 13.6 24.4 0.0 48.1 5.0 12.0 0.4 13.5 0.0 0.0 34.7 185.8 64.1 2.1 4.6 0.0 9.1 0.0 0.0 19.0 0.0 0.2 47.5 1.3 23.6 1.8 3.6 6.6 18.2 0.0 37.4 0.2 0.2 12.9 11.2 0.1 0.1 5.4 11.1 0.7 0.8 1.8 GRAP2 "GADS, GRBLG, GrbX, Grf40, Mona" ENSG00000100351 "GRB2-related adaptor protein 2" O75791 22 39901082-39973721 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 138.0" "Group enriched" "Detected in many" 4 "granulocytes: 142.1;T-cells: 44.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "gdT-cell: 19.5;MAIT T-cell: 14.4;memory CD4 T-cell: 14.4;memory CD8 T-cell: 21.1;naive CD4 T-cell: 12.2;naive CD8 T-cell: 22.5;T-reg: 12.0" "Lineage enriched" "Detected in many" 9 "T-cells: 22.5" "Cell line enhanced" "Detected in some" "HEL: 14.4;JURKAT: 57.1;K-562: 13.9;MOLT-4: 38.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA005788, CAB022073" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 260000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB022073: , HPA005788: AB_1079021" "unprognostic (1.96e-4)" "unprognostic (1.82e-4)" "unprognostic (4.19e-2)" "unprognostic (8.91e-4)" "unprognostic (2.92e-2)" "unprognostic (5.56e-5)" "unprognostic (1.27e-2)" "unprognostic (8.41e-3)" "unprognostic (4.69e-2)" "unprognostic (9.29e-2)" "unprognostic (5.17e-3)" "unprognostic (2.83e-2)" "unprognostic (1.75e-3)" "unprognostic (2.10e-1)" "unprognostic (2.20e-2)" "unprognostic (1.34e-1)" "unprognostic (8.06e-2)" 1.6 0.4 0.3 7.7 0.7 7.6 1.5 0.3 0.4 1.1 2.3 0.6 0.4 2.9 2.3 1.6 1.6 1.2 3.5 2.8 0.6 0.4 1.2 1.8 6.4 12.6 0.9 0.4 1.0 0.8 0.0 0.6 1.1 0.6 2.4 1.9 1.2 2.4 1.2 0.5 1.4 6.2 2.0 2.2 13.2 2.9 2.4 0.3 138.0 1.3 1.5 11.3 3.0 1.9 2.1 0.4 2.5 0.2 1.7 22.5 25.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 14.4 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.1 0.0 57.1 13.9 0.0 0.0 0.0 38.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 1.8 0.2 0.0 19.5 0.1 14.4 1.0 14.4 21.1 0.4 2.1 12.2 22.5 2.5 1.7 0.1 0.3 12.0 25.9 0.3 0.7 0.3 0.4 0.6 0.4 0.9 0.4 0.6 0.3 0.0 10.7 1.3 0.0 1.4 0.7 0.8 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.8 0.1 0.0 23.3 0.2 0.0 1.1 0.6 142.1 1.7 0.2 0.0 1.2 1.8 1.8 2.1 0.3 1.6 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 4.4 1.5 1.0 0.1 44.5 0.0 0.3 GRID2IP ENSG00000215045 "Grid2 interacting protein" A4D2P6 7 6497462-6551436 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 23.6" "Cell type enhanced" "Detected in single" 12 "Rod photoreceptor cells: 1.2" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "cerebellum: 23.6" "Cell type enhanced" "Detected in single" "NK-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "REH: 8.9" "Group enriched" "Detected in some" 5 "cerebellum: 25.2;thalamus: 7.9" "Group enriched" "Detected in all" 5 "cerebellum: 14.3;midbrain: 10.0;pons and medulla: 9.7;thalamus: 14.7" HPA045381 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA045381: AB_10962495" "unprognostic (1.77e-1)" "unprognostic (2.64e-1)" "unprognostic (3.39e-4)" "unprognostic (1.19e-3)" "unprognostic (5.52e-2)" "unprognostic (2.50e-2)" "unprognostic (2.82e-1)" "unprognostic (2.37e-2)" "unprognostic (1.92e-3)" "unprognostic (2.06e-3)" "unprognostic (1.64e-1)" "unprognostic (3.40e-2)" "unprognostic (3.38e-2)" "unprognostic (5.54e-2)" "unprognostic (8.08e-2)" "unprognostic (1.87e-1)" "unprognostic (3.17e-1)" 0.2 1.7 0.8 0.6 3.6 1.1 1.1 23.6 6.6 0.6 1.4 6.5 0.0 1.8 0.4 0.1 1.2 1.1 0.6 0.3 1.6 1.6 0.7 0.3 1.2 0.5 0.7 1.2 0.9 1.8 3.9 3.0 0.2 5.5 2.3 0.7 0.3 2.1 1.6 0.2 3.4 1.6 0.0 1.5 1.4 2.2 1.2 6.8 2.5 1.6 0.0 0.6 0.9 0.8 0.7 0.2 0.0 0.2 1.1 0.4 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.2 0.5 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.5 0.0 0.7 0.7 0.0 0.2 0.8 0.0 8.9 0.3 0.2 0.2 0.3 0.1 1.1 0.0 0.8 0.0 0.3 2.0 0.2 0.1 0.0 1.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.6 0.4 0.0 0.0 1.1 0.2 0.2 0.0 0.1 0.8 3.6 23.6 6.6 1.6 1.6 0.7 1.2 5.5 6.8 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.1 GRK3 "ADRBK2, BARK2" ENSG00000100077 "G protein-coupled receptor kinase 3" P35626 22 25564849-25729294 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 28.0" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 2: 44.1;Club cells: 30.7;Extravillous trophoblasts: 22.7;Hofbauer cells: 25.0;monocytes: 47.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "classical monocyte: 4.8;eosinophil: 5.6;intermediate monocyte: 8.0;memory B-cell: 4.9;myeloid DC: 3.7;naive B-cell: 6.2;non-classical monocyte: 7.4;plasmacytoid DC: 3.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 20.4;JURKAT: 33.6;SH-SY5Y: 18.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000804 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA000804: AB_1078281" "unprognostic (1.02e-1)" "unprognostic (4.38e-2)" "unprognostic (5.68e-3)" "unprognostic (4.33e-2)" "unprognostic (2.09e-1)" "unprognostic (3.67e-2)" "unprognostic (3.29e-1)" "unprognostic (1.78e-2)" "unprognostic (1.97e-1)" "unprognostic (3.54e-1)" "unprognostic (1.95e-3)" "unprognostic (5.79e-2)" "unprognostic (1.01e-3)" "unprognostic (1.74e-1)" "unprognostic (2.87e-3)" "unprognostic (1.89e-2)" "prognostic favorable (1.29e-4)" 28.0 6.0 11.9 12.4 10.8 7.0 11.3 7.9 18.9 4.7 4.0 3.1 0.7 3.0 5.7 3.1 2.7 9.1 5.0 4.6 15.7 8.3 3.0 3.4 9.4 14.1 9.7 9.8 4.1 8.4 4.4 8.2 4.5 9.6 8.2 4.3 4.8 3.7 1.9 1.4 4.1 6.1 6.2 4.9 23.2 4.0 14.8 2.7 11.6 4.5 1.3 15.2 6.7 2.5 6.2 3.7 5.6 8.0 0.0 0.4 1.6 0.0 1.9 5.8 1.9 4.1 0.5 8.5 0.6 1.8 1.8 3.2 3.0 3.3 10.6 0.1 0.1 5.2 0.1 5.8 4.3 5.5 20.4 3.8 4.9 0.6 6.7 0.1 15.8 8.3 1.0 3.0 1.3 2.3 0.3 0.3 33.6 0.5 0.0 2.1 2.6 11.3 1.1 4.1 5.7 0.0 5.1 9.3 1.8 0.0 3.1 13.7 18.5 1.0 0.0 4.4 5.6 1.6 6.3 0.1 0.0 12.0 0.1 2.3 1.2 4.2 8.3 7.8 5.6 1.8 0.6 4.8 5.6 0.0 8.0 0.3 4.9 0.0 0.3 3.7 6.2 0.1 0.2 0.3 0.0 7.4 3.2 0.4 1.6 11.9 10.8 7.9 18.9 15.7 8.3 9.7 9.8 9.6 2.7 14.9 44.1 0.0 0.0 0.0 0.0 0.0 0.0 12.0 30.7 0.0 0.0 1.5 1.7 7.0 0.0 0.0 0.0 0.0 1.6 22.7 0.0 0.0 17.4 0.0 25.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 47.7 0.0 0.0 3.4 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 GTSE1 "B99, GTSE-1" ENSG00000075218 "G2 and S-phase expressed 1" Q9NYZ3 22 46296741-46330810 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 20.0;testis: 22.3" "Cell type enhanced" "Detected in many" 18 "Erythroid cells: 93.5;Extravillous trophoblasts: 27.0;Spermatocytes: 47.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA029457 Approved "Plasma membrane,Centrosome" Yes Yes Centrosome "Plasma membrane" "HPA029457: " "unprognostic (1.97e-1)" "unprognostic (3.07e-2)" "unprognostic (1.71e-3)" "unprognostic (2.59e-1)" "unprognostic (7.16e-2)" "unprognostic (2.40e-2)" "prognostic unfavorable (1.90e-10)" "prognostic unfavorable (4.66e-4)" "unprognostic (1.09e-1)" "unprognostic (8.37e-2)" "prognostic unfavorable (1.29e-4)" "unprognostic (3.49e-3)" "unprognostic (0.00e+0)" "unprognostic (6.52e-3)" "unprognostic (3.25e-1)" "unprognostic (1.14e-1)" "unprognostic (4.85e-2)" 1.1 1.3 0.3 10.4 0.8 10.2 1.3 1.0 1.1 1.2 2.5 0.7 0.1 4.1 1.1 1.3 6.6 0.4 0.4 0.8 1.0 0.3 0.9 0.9 1.3 9.0 0.6 0.4 0.9 0.5 0.0 0.9 2.8 1.8 0.6 2.6 0.7 1.5 0.1 0.3 2.4 3.3 1.0 0.6 4.6 2.4 22.3 0.3 20.0 0.5 5.8 8.8 1.1 2.1 1.4 1.9 3.0 0.2 1.8 1.6 0.9 21.8 10.4 20.5 16.2 0.4 1.2 9.8 19.0 9.0 27.7 22.9 10.8 8.3 20.7 5.0 7.3 12.7 11.5 18.3 4.8 17.8 12.4 19.7 13.8 14.6 8.4 0.0 24.7 16.9 0.2 0.3 11.9 6.1 2.9 11.9 15.0 10.5 26.0 16.5 12.2 22.1 12.1 14.3 9.0 11.7 22.0 23.0 13.5 4.5 4.0 10.6 14.5 18.1 11.8 8.4 9.6 10.0 9.6 9.4 15.8 30.0 12.9 19.9 14.9 7.1 21.0 10.0 11.9 23.0 0.1 0.2 1.5 1.3 0.1 0.4 1.4 0.6 0.6 0.3 0.6 0.4 0.3 3.0 1.8 0.1 1.9 1.6 0.9 0.3 0.8 1.0 1.1 1.0 0.3 0.6 0.4 1.8 0.3 0.0 0.0 0.8 0.6 2.5 0.6 1.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.5 3.9 0.4 0.5 93.5 0.2 27.0 1.1 0.6 0.0 0.5 16.0 0.0 1.2 5.5 6.2 3.8 0.3 3.5 0.0 0.0 2.0 0.2 0.4 0.0 0.7 0.4 0.1 6.5 0.9 47.7 20.4 2.3 1.3 2.9 3.7 1.4 GUCA1A "C6orf131, COD3, CORD14, dJ139D8.6, GCAP, GCAP1, GUCA, GUCA1" ENSG00000048545 "Guanylate cyclase activator 1A" P43080 6 42155406-42180056 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "retina: 91.2;testis: 62.2" "Group enriched" "Detected in some" 5 "Cone photoreceptor cells: 628.3;Late spermatids: 331.5;Rod photoreceptor cells: 949.8" "Cancer enriched" "Detected in single" 9 "testis cancer: 3.5" "Region enhanced" "Detected in many" "basal ganglia: 10.0" "Cell type enriched" "Detected in single" 84 "plasmacytoid DC: 8.4" "Lineage enriched" "Detected in single" 84 "dendritic cells: 8.4" "Group enriched" "Detected in some" 8 "NTERA-2: 7.2;SH-SY5Y: 9.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA005561, HPA075056" Enhanced Approved "Plasma membrane" NA NA "Plasma membrane" "HPA005561: AB_2667361, HPA075056: " "unprognostic (1.91e-2)" "unprognostic (3.92e-3)" "unprognostic (2.49e-2)" "unprognostic (9.16e-2)" "unprognostic (1.04e-4)" "unprognostic (9.70e-2)" "unprognostic (6.71e-3)" "unprognostic (1.89e-1)" "unprognostic (1.59e-2)" "unprognostic (3.08e-3)" "unprognostic (2.79e-1)" "unprognostic (1.51e-1)" "unprognostic (1.54e-1)" "unprognostic (1.16e-1)" 0.2 0.2 2.7 0.3 10.0 0.2 0.2 0.1 1.6 0.2 0.2 0.1 0.1 0.1 0.1 0.4 0.2 0.1 0.2 0.1 1.5 5.4 0.1 0.1 0.2 0.3 1.1 0.1 0.1 0.1 0.1 0.1 0.2 0.3 0.2 0.2 91.2 0.2 0.1 0.1 0.2 0.2 0.3 0.2 0.1 0.1 62.2 0.1 0.1 0.1 0.1 0.5 0.3 0.1 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.1 0.0 0.7 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 2.7 10.0 0.1 0.8 1.5 5.4 1.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 118.0 0.3 0.0 0.0 0.0 0.0 628.3 0.4 0.0 0.0 108.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 62.0 0.0 0.0 0.0 331.5 1.7 0.0 0.0 9.0 0.0 125.6 0.0 0.0 1.8 0.0 949.8 0.0 0.0 2.8 1.9 0.0 0.2 0.0 0.0 0.0 HAPLN3 "EXLD1, HsT19883" ENSG00000140511 "Hyaluronan and proteoglycan link protein 3" Q96S86 15 88877288-88895626 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 25.4;lymphoid tissue: 23.6" "Cell type enriched" "Detected in many" 8 "Extravillous trophoblasts: 899.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 25.4" "Lineage enriched" "Detected in many" 5 "T-cells: 25.4" "Cell line enhanced" "Detected in many" "HDLM-2: 21.0;U-2 OS: 21.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039237 Approved Approved "Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA "Plasma membrane, Cytosol" "HPA039237: AB_10805357" "unprognostic (1.67e-2)" "unprognostic (1.04e-3)" "unprognostic (2.57e-1)" "unprognostic (2.53e-2)" "unprognostic (3.27e-1)" "unprognostic (2.24e-2)" "unprognostic (4.21e-1)" "unprognostic (3.82e-1)" "unprognostic (3.37e-3)" "unprognostic (7.37e-3)" "unprognostic (1.13e-3)" "unprognostic (4.30e-1)" "prognostic unfavorable (4.18e-13)" "unprognostic (1.95e-1)" "unprognostic (3.01e-2)" "unprognostic (6.12e-2)" "unprognostic (1.12e-1)" 9.9 1.3 1.1 20.6 2.7 4.4 8.7 1.0 2.3 5.3 2.6 1.1 0.3 1.4 4.4 4.9 5.7 6.0 4.7 9.8 3.2 1.0 3.0 0.8 8.7 23.6 3.1 0.9 5.2 2.3 0.9 2.2 2.7 3.6 5.2 1.1 3.2 6.4 1.6 4.2 6.0 4.1 4.7 6.2 6.9 3.6 1.9 1.8 5.7 7.2 7.6 10.9 6.0 5.6 0.8 1.1 0.7 0.6 4.8 25.4 3.2 1.2 4.4 0.9 9.8 2.8 3.0 3.1 2.7 0.6 1.0 1.3 2.8 4.1 0.0 7.8 3.4 1.6 1.0 9.3 1.2 0.0 21.0 8.2 3.0 0.2 0.0 0.4 0.0 0.1 1.1 0.5 2.0 0.1 0.1 4.6 0.4 0.0 6.0 0.4 0.1 0.0 0.0 7.3 0.0 0.1 0.0 0.4 7.3 1.8 0.1 0.1 2.7 0.5 0.5 3.7 1.2 0.0 0.4 0.8 7.1 21.0 5.3 0.4 0.9 0.0 0.0 2.5 0.0 6.1 0.7 0.6 0.0 0.6 0.3 3.0 0.1 10.0 4.1 1.1 0.8 10.2 4.5 0.1 4.8 0.1 0.4 25.4 3.2 1.1 2.7 1.0 2.3 3.2 1.0 3.1 0.9 3.6 1.8 0.0 4.3 0.9 6.0 28.4 2.6 7.7 0.0 1.4 5.7 1.8 9.8 5.6 0.0 5.7 0.0 18.6 0.0 0.0 1.8 899.6 9.3 3.9 1.1 0.0 17.6 0.0 0.0 3.1 0.0 0.0 0.9 2.9 16.9 16.2 0.2 2.4 8.7 0.0 0.7 0.1 108.4 12.9 38.9 0.5 1.7 21.1 17.0 3.2 0.2 6.8 HCFC2 HCF-2 ENSG00000111727 "Host cell factor C2" Q9Y5Z7 12 104064457-104106524 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 190.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006227 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA006227: AB_1079042" "unprognostic (4.22e-3)" "unprognostic (1.22e-1)" "unprognostic (1.08e-1)" "unprognostic (7.66e-2)" "unprognostic (3.15e-2)" "unprognostic (2.11e-2)" "unprognostic (1.46e-1)" "unprognostic (1.07e-2)" "unprognostic (1.59e-1)" "unprognostic (1.43e-2)" "unprognostic (2.71e-2)" "unprognostic (4.54e-2)" "unprognostic (4.23e-3)" "unprognostic (1.16e-2)" "unprognostic (2.24e-1)" "unprognostic (1.19e-2)" "unprognostic (7.23e-2)" 11.5 10.0 11.9 4.7 13.2 3.2 12.9 3.8 11.1 11.5 14.4 9.1 8.7 7.2 12.6 7.5 9.1 8.5 8.1 7.7 9.3 5.8 8.5 10.2 9.1 5.9 12.5 8.1 11.8 9.1 10.4 14.3 10.6 10.0 10.8 6.3 6.8 8.0 14.6 17.5 7.4 7.5 19.0 10.2 6.8 9.9 19.2 11.0 9.1 10.1 5.1 5.0 12.8 10.3 1.8 2.2 2.8 5.0 2.5 3.2 1.7 1.9 2.1 2.2 1.9 12.4 12.4 1.6 8.5 3.9 6.6 3.8 1.0 0.9 1.9 3.0 6.6 2.4 2.1 2.7 1.5 7.1 3.2 2.6 1.9 2.0 0.9 8.4 1.6 3.1 7.7 4.2 4.1 3.4 9.5 5.0 3.0 2.2 4.1 11.7 1.7 2.8 3.7 0.4 1.2 4.4 2.3 7.3 1.2 2.9 1.3 3.2 2.4 4.2 3.0 3.2 1.6 4.8 1.7 7.5 10.4 1.4 5.3 2.9 5.2 1.5 1.7 4.9 2.1 4.1 1.3 2.0 2.8 2.6 3.7 3.1 1.6 2.5 3.2 2.2 1.8 3.0 3.2 0.5 2.5 5.0 1.2 2.8 1.7 11.9 13.2 3.8 11.1 9.3 5.8 12.5 8.1 10.0 11.0 11.9 16.0 8.4 6.6 7.1 18.4 9.6 0.0 10.7 11.4 5.2 19.6 4.3 8.3 4.8 190.7 11.3 6.9 0.0 2.9 3.5 9.5 3.2 16.2 9.0 6.3 22.3 8.1 15.4 9.4 44.6 20.1 6.9 6.8 4.6 3.3 13.8 2.7 3.2 26.2 7.0 22.6 12.9 10.3 57.9 10.2 6.4 9.0 9.6 3.3 3.1 HEG1 "HEG, KIAA1237" ENSG00000173706 "Heart development protein with EGF like domains 1" Q9ULI3 3 124965710-125055958 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 1: 80.4;Cardiomyocytes: 80.5;Cone photoreceptor cells: 249.4;Ito cells: 95.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 42.0;HHSteC: 51.1;hTERT-RPE1: 77.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010952, HPA011559" Approved Approved "Vesicles,Plasma membrane" "Intracellular and membrane" NA NA 360000000 Vesicles "Plasma membrane" "HPA010952: AB_2668389, HPA011559: AB_1850580" "unprognostic (1.10e-1)" "unprognostic (2.21e-1)" "unprognostic (6.52e-2)" "unprognostic (2.23e-1)" "unprognostic (1.30e-1)" "unprognostic (5.40e-2)" "unprognostic (6.48e-2)" "unprognostic (2.89e-2)" "unprognostic (2.36e-1)" "unprognostic (9.80e-2)" "unprognostic (1.69e-1)" "unprognostic (8.33e-2)" "prognostic unfavorable (1.93e-5)" "unprognostic (1.11e-2)" "unprognostic (4.99e-2)" "unprognostic (6.20e-3)" "prognostic unfavorable (1.16e-4)" 23.6 8.2 5.8 12.1 8.4 0.7 16.4 2.6 8.9 12.2 9.6 14.7 8.0 3.9 12.0 7.3 9.0 11.4 29.6 36.3 6.9 5.5 8.9 5.5 42.4 7.7 9.7 4.7 8.1 16.6 14.2 4.0 17.4 11.6 7.2 6.5 26.2 7.1 7.4 6.2 4.3 7.9 14.4 11.9 11.5 7.5 11.3 6.5 3.0 29.1 10.8 8.7 13.0 15.6 1.0 0.9 1.2 3.9 7.3 4.0 1.1 1.8 1.9 13.4 1.1 16.6 14.7 5.0 15.7 20.6 17.5 19.3 13.7 0.2 0.5 10.7 42.0 12.8 3.3 2.0 7.7 21.1 1.4 1.0 0.3 10.2 1.6 51.1 0.3 20.4 18.0 2.2 22.8 5.4 77.1 17.0 1.2 0.0 0.2 5.3 0.2 0.8 0.0 2.3 0.0 1.2 1.2 10.2 0.0 3.0 0.3 0.2 1.2 34.9 2.4 1.3 12.4 5.7 0.8 26.4 9.9 11.0 35.4 6.7 1.4 4.3 0.0 18.6 1.5 19.2 1.2 0.3 0.0 4.0 3.6 2.7 0.9 1.6 3.6 0.7 1.0 2.4 1.5 0.0 7.3 3.9 0.9 0.5 1.1 5.8 8.4 2.6 8.9 6.9 5.5 9.7 4.7 11.6 6.5 80.4 7.2 4.9 7.1 4.4 3.0 80.5 5.1 0.0 4.5 26.2 249.4 0.8 0.0 31.8 5.1 76.0 0.0 0.0 5.8 53.1 23.5 2.8 26.5 2.5 5.7 1.6 0.0 95.2 15.8 7.6 4.6 4.8 6.8 2.8 0.6 4.1 6.9 0.0 13.1 1.2 62.4 0.0 21.2 0.2 0.2 3.9 2.7 14.6 0.1 0.9 HELZ "DHRC, HUMORF5, KIAA0054" ENSG00000198265 "Helicase with zinc finger" P42694 17 67070438-67245989 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028276 Approved Approved "Nucleoli,Nucleoli rim,Plasma membrane,Actin filaments" NA NA "Nucleoli, Nucleoli rim" "Plasma membrane, Actin filaments" "HPA028276: AB_10601814" "unprognostic (3.16e-1)" "unprognostic (2.10e-2)" "unprognostic (7.56e-3)" "unprognostic (1.29e-1)" "unprognostic (4.83e-2)" "unprognostic (4.71e-2)" "unprognostic (5.85e-2)" "unprognostic (5.31e-2)" "unprognostic (3.60e-2)" "unprognostic (1.16e-1)" "unprognostic (1.51e-1)" "unprognostic (4.98e-2)" "unprognostic (1.33e-3)" "unprognostic (1.42e-1)" "unprognostic (1.24e-1)" "unprognostic (1.59e-1)" "unprognostic (1.31e-1)" 17.9 12.9 11.2 14.3 14.3 17.7 12.6 24.3 17.7 14.4 14.0 11.6 12.9 7.9 17.0 13.0 9.1 11.1 11.5 11.1 12.0 9.7 11.8 17.3 14.8 14.6 10.7 6.2 20.5 13.9 34.1 33.5 19.2 16.5 11.9 10.9 12.2 12.4 10.9 18.9 9.0 15.6 12.2 13.5 17.3 11.7 16.4 12.7 34.1 15.3 8.8 13.9 15.3 11.9 4.8 4.4 4.3 4.9 4.0 11.0 3.2 7.6 7.6 9.3 9.6 11.8 6.6 14.3 6.8 6.7 8.9 9.7 11.1 6.0 15.7 5.6 9.0 5.7 8.0 17.8 8.6 14.3 6.0 5.5 20.1 8.4 9.1 5.7 16.6 12.3 7.8 8.2 8.8 11.1 6.9 13.7 11.7 13.9 10.0 7.4 9.7 21.3 5.7 5.7 6.9 7.3 14.4 16.9 6.9 7.2 10.8 9.4 8.6 10.7 8.9 11.7 13.5 10.6 10.3 12.3 11.5 13.2 6.2 6.0 8.3 9.6 11.9 5.7 10.3 11.9 3.6 4.9 4.3 8.8 4.5 11.0 2.9 5.4 5.3 4.4 4.8 3.3 4.5 3.7 4.0 2.9 3.6 4.8 3.2 11.2 14.3 24.3 17.7 12.0 9.7 10.7 6.2 16.5 12.7 17.9 29.6 17.6 21.6 28.5 49.3 24.4 22.9 21.4 29.6 26.2 88.4 26.8 6.6 15.0 3.7 24.5 22.3 0.0 12.2 34.0 24.9 25.4 33.4 40.0 27.1 63.5 36.8 63.8 75.2 7.2 35.9 25.6 13.5 10.8 29.0 24.5 16.1 21.0 40.3 12.1 51.1 12.9 22.6 36.7 24.8 17.7 15.3 76.1 22.6 32.3 HENMT1 "C1orf59, FLJ30525, HEN1" ENSG00000162639 "HEN methyltransferase 1" Q5T8I9 1 108648290-108661526 "Enzymes, Predicted intracellular proteins" "RNA-mediated gene silencing" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.8;testis: 45.2" "Group enriched" "Detected in many" 4 "Spermatocytes: 118.4;Spermatogonia: 74.4;T-cells: 38.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "JURKAT: 25.7;MOLT-4: 23.6;NB-4: 26.4;U-937: 34.8" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 15 "cerebellum: 18.1" "HPA028464, HPA028497" Uncertain Approved "Plasma membrane,Focal adhesion sites" NA NA "Plasma membrane, Focal adhesion sites" "HPA028464: AB_10600103, HPA028497: AB_10601552" "unprognostic (1.82e-1)" "prognostic favorable (2.56e-4)" "prognostic favorable (9.95e-4)" "unprognostic (2.92e-3)" "unprognostic (1.91e-1)" "unprognostic (3.88e-3)" "unprognostic (2.01e-2)" "unprognostic (1.49e-1)" "unprognostic (7.01e-2)" "unprognostic (1.25e-1)" "unprognostic (2.95e-1)" "unprognostic (1.19e-1)" "prognostic unfavorable (2.48e-5)" "unprognostic (2.53e-1)" "unprognostic (2.43e-1)" "unprognostic (2.18e-1)" "unprognostic (1.65e-1)" 3.5 2.2 6.7 5.1 10.2 7.7 5.5 3.6 11.6 6.1 4.4 4.2 1.4 3.4 2.8 3.4 1.9 1.8 4.5 3.1 9.5 10.1 1.8 1.4 4.9 9.8 8.2 5.6 3.8 1.5 0.6 3.9 3.8 10.7 2.7 6.6 1.3 2.4 2.6 2.0 2.6 5.2 2.5 6.9 8.0 3.2 45.2 2.5 10.3 1.7 1.2 7.3 5.5 1.6 5.4 10.6 18.2 12.0 22.9 28.8 15.9 5.8 3.0 0.2 0.0 0.2 0.2 0.0 1.4 0.5 3.5 0.5 8.8 9.3 0.0 3.2 2.6 0.0 0.0 0.0 0.0 2.2 1.9 0.0 15.0 11.3 0.0 3.0 8.8 13.4 2.9 0.1 0.7 0.0 0.0 0.7 25.7 0.0 6.7 0.1 14.9 23.6 26.4 8.7 4.7 1.3 10.3 0.0 0.5 0.0 6.4 14.7 0.0 12.6 3.5 0.0 0.9 0.0 19.8 0.1 0.0 11.7 6.4 0.0 4.1 5.1 0.0 0.0 34.8 0.1 16.0 8.8 18.2 28.8 10.1 26.0 5.4 14.2 26.0 10.6 2.9 11.8 21.7 8.6 22.9 12.0 8.5 13.1 15.9 6.7 10.2 3.6 11.6 9.5 10.1 8.2 5.6 10.7 2.5 0.0 0.6 0.0 1.4 1.4 3.8 1.5 17.8 1.4 1.2 5.2 0.0 10.4 3.3 2.8 8.7 2.6 3.9 0.0 1.2 16.4 3.1 0.6 6.9 0.4 14.0 0.0 4.7 6.7 11.7 17.0 4.6 8.5 1.7 7.2 2.5 2.0 1.9 6.8 2.8 0.7 2.6 6.5 2.8 118.4 74.4 1.4 4.3 38.3 5.6 2.5 HERC2 "D15F37S1, jdf2, p528" ENSG00000128731 "HECT and RLD domain containing E3 ubiquitin protein ligase 2" O95714 15 28111040-28322152 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 33.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017188, HPA048389, HPA074166" Approved Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "CAB017188: , HPA048389: AB_2680382, HPA074166: " "unprognostic (1.59e-1)" "unprognostic (1.44e-1)" "unprognostic (1.92e-1)" "unprognostic (6.64e-2)" "unprognostic (6.62e-2)" "unprognostic (5.74e-2)" "unprognostic (9.17e-2)" "unprognostic (2.08e-1)" "unprognostic (1.87e-1)" "unprognostic (4.11e-2)" "unprognostic (9.40e-3)" "unprognostic (3.60e-2)" "prognostic favorable (1.41e-7)" "unprognostic (7.66e-2)" "unprognostic (2.10e-1)" "unprognostic (2.34e-2)" "unprognostic (1.71e-1)" 2.5 3.3 3.2 2.2 4.5 3.9 3.1 7.0 5.7 3.2 4.6 2.7 4.4 1.7 2.8 4.1 2.1 4.6 3.5 3.6 3.3 1.6 2.5 2.1 3.8 8.5 3.6 9.2 3.5 2.7 3.0 3.0 2.3 3.3 8.2 3.1 3.1 4.1 4.1 2.3 3.4 3.2 5.6 2.4 3.3 2.3 1.0 1.1 0.5 0.4 0.2 1.1 0.4 5.2 10.3 7.2 3.0 6.0 4.5 2.0 3.8 4.5 4.9 4.7 5.3 0.7 5.2 4.6 6.4 7.4 5.3 7.6 3.7 3.6 3.2 4.9 33.3 12.0 1.7 2.3 7.8 2.7 3.7 2.9 5.8 7.3 3.1 6.4 4.4 12.8 2.2 4.6 2.4 1.7 2.6 2.1 4.0 4.5 6.2 10.3 0.4 1.7 11.3 7.9 4.6 9.1 2.6 3.0 3.9 3.0 9.2 9.6 9.1 5.9 3.5 5.6 1.4 2.0 4.9 4.2 3.7 4.8 0.0 0.4 0.5 1.1 0.1 0.6 0.5 0.2 0.5 1.1 1.0 0.9 0.5 0.0 0.2 0.3 0.9 0.4 0.4 20.8 19.7 23.1 13.0 14.5 100.9 54.0 28.1 17.4 25.0 61.1 139.4 22.6 1.7 24.7 11.1 39.4 24.9 0.0 26.5 13.6 21.3 18.7 3.5 30.6 16.6 116.0 27.0 36.8 21.8 10.6 52.0 17.3 65.8 26.2 29.8 46.8 29.3 31.6 49.1 16.6 140.1 64.7 24.7 57.9 59.4 18.3 14.9 30.2 30.9 10.1 HIP1R "FLJ14000, HIP12, HIP3, ILWEQ, KIAA0655" ENSG00000130787 "Huntingtin interacting protein 1 related" O75146 12 122834453-122862960 "Cancer-related genes, Predicted intracellular proteins" Endocytosis Actin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Collecting duct cells: 57.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 9.5;naive B-cell: 12.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017187, HPA038135, HPA038136" Enhanced Supported "Vesicles,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Vesicles "CAB017187: , HPA038135: AB_2675851, HPA038136: AB_2675852" "unprognostic (4.52e-1)" "unprognostic (6.39e-2)" "unprognostic (7.07e-2)" "unprognostic (6.55e-3)" "unprognostic (8.67e-2)" "unprognostic (1.00e-2)" "unprognostic (1.02e-2)" "unprognostic (8.11e-2)" "unprognostic (6.37e-2)" "unprognostic (1.76e-1)" "unprognostic (1.39e-2)" "unprognostic (6.72e-2)" "prognostic favorable (6.50e-7)" "unprognostic (2.18e-2)" "unprognostic (2.84e-1)" "unprognostic (2.54e-3)" "prognostic favorable (7.26e-4)" 9.8 14.5 24.6 13.2 26.5 11.6 8.0 11.5 31.6 4.6 11.6 40.5 19.7 29.2 4.0 9.1 7.0 4.0 7.8 10.8 29.5 21.7 16.2 9.0 6.3 15.3 31.4 20.6 3.2 27.7 7.4 15.6 5.2 18.0 8.6 5.4 2.9 52.0 24.1 5.7 26.5 21.3 3.0 27.4 11.1 30.4 4.0 30.6 8.1 8.1 5.9 12.6 7.4 6.5 12.3 0.0 2.7 0.0 0.6 3.2 1.6 17.5 5.1 3.8 15.8 1.1 3.0 18.9 2.8 4.5 2.8 2.2 7.8 5.3 16.7 9.3 2.0 4.3 15.2 4.6 10.1 0.2 2.6 6.7 0.4 5.8 8.2 3.5 1.3 11.9 1.9 7.2 3.8 6.5 3.9 19.5 7.9 4.3 0.9 1.6 25.2 7.9 4.1 3.5 15.2 6.1 4.1 4.9 5.8 9.5 21.3 3.9 8.7 3.3 8.6 4.5 2.2 17.6 0.7 15.4 1.8 13.6 5.6 2.6 12.0 6.4 9.9 2.9 2.8 1.5 0.0 0.0 2.7 2.9 0.0 1.7 9.5 1.8 2.2 0.0 12.3 3.2 2.0 0.2 0.6 0.0 0.0 0.4 1.6 24.6 26.5 11.5 19.8 29.5 21.7 31.4 20.6 18.0 30.6 0.0 12.0 32.0 12.8 11.7 8.4 4.1 50.9 8.1 7.9 57.6 27.5 3.0 0.0 34.4 2.3 11.7 36.4 0.0 24.6 10.4 2.1 17.0 5.7 20.8 0.6 17.5 7.5 18.4 1.2 2.2 1.4 0.4 10.1 0.0 24.4 12.3 20.4 22.6 1.1 12.5 17.4 0.0 1.9 4.7 9.8 18.3 1.6 6.7 18.0 25.8 HPS3 "BLOC2S1, SUTAL" ENSG00000163755 "HPS3, biogenesis of lysosomal organelles complex 2 subunit 1" Q969F9 3 149129584-149173732 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Albinism, Disease mutation, Hermansky-Pudlak syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "GAMG: 49.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046281, HPA052778" Approved Approved "Golgi apparatus,Plasma membrane" NA NA "Golgi apparatus, Plasma membrane" "HPA046281: AB_10961641, HPA052778: AB_2681943" "unprognostic (1.47e-2)" "unprognostic (7.83e-2)" "unprognostic (1.04e-1)" "unprognostic (1.11e-3)" "unprognostic (1.28e-1)" "unprognostic (1.50e-1)" "prognostic unfavorable (6.04e-4)" "unprognostic (1.33e-1)" "unprognostic (1.75e-1)" "unprognostic (1.08e-1)" "unprognostic (1.82e-2)" "unprognostic (1.08e-1)" "prognostic unfavorable (4.38e-4)" "unprognostic (2.00e-1)" "unprognostic (1.28e-1)" "unprognostic (3.03e-1)" "unprognostic (3.06e-2)" 14.4 17.6 10.5 16.1 11.5 6.3 18.8 8.1 11.8 13.0 11.7 12.8 6.2 13.7 17.1 10.3 10.2 12.4 11.5 8.9 9.9 8.7 15.3 10.1 12.1 25.1 11.5 10.4 18.7 13.8 10.1 11.8 13.3 11.9 13.4 11.8 13.9 13.4 11.5 5.9 8.9 16.3 13.4 17.1 19.8 12.5 8.5 12.6 23.8 13.7 4.5 19.9 16.3 17.9 16.3 19.9 16.1 15.4 9.3 16.0 10.7 19.8 11.0 6.6 6.8 9.3 12.0 5.0 8.2 16.1 10.8 14.0 3.7 13.2 5.1 10.5 9.8 49.5 6.8 7.3 5.6 14.0 12.4 5.8 2.3 5.3 4.1 8.3 6.3 3.9 7.8 5.7 10.4 4.3 22.2 11.0 8.4 2.6 12.4 13.7 12.3 4.5 8.9 15.9 10.8 8.9 5.4 4.3 13.6 5.9 10.0 2.0 5.3 7.0 7.5 15.2 15.0 8.1 8.4 5.5 10.8 1.9 10.9 11.8 10.2 4.0 12.6 16.1 12.4 2.6 16.1 12.8 11.9 13.4 15.4 16.0 16.3 12.2 13.8 19.9 13.3 9.5 12.5 5.8 9.3 10.1 11.3 10.5 10.7 10.5 11.5 8.1 11.8 9.9 8.7 11.5 10.4 11.9 12.6 11.9 15.0 15.9 4.2 3.3 6.4 2.0 5.1 24.1 30.7 7.0 2.0 20.2 5.0 9.2 2.4 7.7 8.4 0.0 15.5 11.9 8.0 7.2 15.0 6.7 18.3 3.2 8.6 20.3 25.2 2.6 10.6 17.8 13.5 3.6 8.6 26.3 10.6 3.5 28.3 18.9 5.0 0.0 5.1 2.6 9.3 4.5 11.8 20.0 6.0 4.4 HS6ST3 ENSG00000185352 "Heparan sulfate 6-O-sulfotransferase 3" Q8IZP7 13 96090839-96839562 "Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 18.7" "Cell type enhanced" "Detected in some" 13 "Horizontal cells: 3.2;Pancreatic endocrine cells: 1.0;Rod photoreceptor cells: 1.8;Spermatogonia: 1.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "RT4: 19.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA078257 Approved "Nucleoplasm,Nuclear membrane,Plasma membrane,Actin filaments" "Intracellular and membrane" NA NA 9800 "Nucleoplasm, Nuclear membrane" "Plasma membrane, Actin filaments" "HPA078257: AB_2732374" "unprognostic (2.34e-2)" "unprognostic (1.90e-2)" "unprognostic (2.82e-2)" "unprognostic (1.72e-2)" "unprognostic (4.88e-2)" "unprognostic (2.78e-2)" "unprognostic (1.55e-1)" "unprognostic (3.67e-3)" "unprognostic (8.11e-3)" "unprognostic (1.19e-1)" "prognostic favorable (6.12e-5)" "unprognostic (1.54e-4)" "unprognostic (2.24e-1)" "unprognostic (1.57e-3)" "unprognostic (9.89e-2)" 0.9 4.5 1.5 0.0 1.9 0.0 0.0 0.4 18.7 1.9 0.0 0.2 2.1 2.2 0.2 0.1 0.0 0.2 3.2 2.7 0.7 0.0 0.0 0.0 0.9 0.0 2.1 0.0 0.7 0.0 0.1 0.0 0.0 0.1 0.6 0.1 0.0 1.6 0.4 0.0 0.7 0.1 2.4 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.1 0.0 0.0 1.2 0.0 1.3 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 19.6 1.0 0.8 0.1 0.1 0.0 0.3 0.6 0.0 0.2 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.5 0.1 0.0 0.4 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.7 0.6 0.0 0.0 0.0 0.0 0.8 1.0 0.0 0.0 0.0 1.8 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 HSH2D "ALX, FLJ14886, HSH2" ENSG00000196684 "Hematopoietic SH2 domain containing" Q96JZ2 19 16134028-16158575 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 47.4;lymphoid tissue: 33.8" "Cell type enhanced" "Detected in many" 14 "B-cells: 71.7;T-cells: 40.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "basophil: 47.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 13.2;HL-60: 13.7;HMC-1: 18.9;NB-4: 44.6;RPMI-8226: 20.0;U-266/84: 12.9;U-937: 43.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA036616 Approved "Plasma membrane,Focal adhesion sites,Cytosol" NA NA "Plasma membrane" "Focal adhesion sites, Cytosol" "HPA036616: AB_10671962" "unprognostic (1.69e-1)" "unprognostic (2.97e-2)" "prognostic unfavorable (9.46e-6)" "unprognostic (1.06e-1)" "unprognostic (5.50e-3)" "unprognostic (5.21e-3)" "unprognostic (9.35e-2)" "unprognostic (4.78e-2)" "unprognostic (4.21e-3)" "unprognostic (9.96e-2)" "unprognostic (1.57e-2)" "unprognostic (2.22e-2)" "prognostic unfavorable (6.49e-6)" "unprognostic (9.17e-3)" "unprognostic (6.18e-2)" "unprognostic (3.21e-2)" "prognostic favorable (3.47e-5)" 1.2 1.1 1.2 31.5 1.1 19.2 1.2 1.1 1.1 1.4 8.9 0.0 5.2 5.5 1.1 6.2 2.0 1.5 10.3 1.2 1.1 1.1 1.3 1.5 6.0 16.7 1.0 0.0 1.1 4.8 0.9 3.7 2.3 0.3 2.2 4.0 1.0 8.8 5.2 1.1 1.1 12.1 0.7 1.1 21.8 5.4 1.1 0.0 8.5 1.7 2.4 33.8 4.7 1.1 14.5 6.0 47.4 8.4 19.0 4.3 3.6 4.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 7.0 13.2 0.2 0.0 0.2 0.2 0.0 0.1 0.0 0.7 0.0 0.2 0.1 0.8 0.0 13.7 18.9 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 12.4 0.0 2.8 0.0 44.6 0.0 1.7 0.0 0.9 0.0 20.0 0.1 1.8 0.0 0.0 0.0 0.4 0.1 0.0 0.1 5.1 0.0 0.0 0.0 0.0 0.0 1.9 12.9 7.3 0.0 43.8 0.0 47.4 3.7 23.0 4.3 5.0 3.9 14.5 1.9 2.8 6.0 8.6 1.8 2.3 43.7 19.0 8.4 1.8 2.9 3.6 1.2 1.1 1.1 1.1 1.1 1.1 1.0 0.0 0.3 0.0 3.0 9.9 71.7 0.7 0.2 0.0 0.6 2.5 4.0 4.5 5.2 0.0 2.1 0.0 5.3 0.0 0.0 13.5 0.0 4.4 3.1 0.4 4.3 5.8 0.0 1.1 0.0 8.1 1.8 1.5 0.0 0.0 2.5 10.1 2.8 14.1 0.0 6.8 10.5 0.0 0.3 0.0 0.0 0.3 0.0 0.5 0.1 2.9 40.6 7.7 3.2 HSPG2 "perlecan, PRCAN, SJS1" ENSG00000142798 "Heparan sulfate proteoglycan 2" P98160 1 21822245-21937297 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Angiogenesis "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 104.4" "Cell type enriched" "Detected in many" 7 "Ito cells: 621.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "plasmacytoid DC: 3.0" "Lineage enriched" "Detected in single" 12 "dendritic cells: 3.0" "Cell line enhanced" "Detected in many" "EFO-21: 46.8;HUVEC TERT2: 103.4;TIME: 82.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB009820, HPA018892, CAB020718, HPA072690" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA 1700000000 "Nucleoplasm, Plasma membrane, Cytosol" "CAB009820: AB_2119229, CAB020718: , HPA018892: AB_1850597, HPA072690: " "unprognostic (1.61e-1)" "unprognostic (1.57e-2)" "unprognostic (4.93e-2)" "unprognostic (9.60e-2)" "unprognostic (2.38e-2)" "unprognostic (8.56e-2)" "unprognostic (4.55e-1)" "unprognostic (1.90e-2)" "unprognostic (9.35e-2)" "unprognostic (2.19e-3)" "unprognostic (5.82e-2)" "unprognostic (2.83e-1)" "unprognostic (1.21e-3)" "unprognostic (1.17e-2)" "unprognostic (4.86e-2)" "unprognostic (1.46e-2)" "prognostic unfavorable (2.82e-4)" 54.8 12.8 1.1 22.9 1.5 0.2 19.8 0.8 1.5 37.3 32.3 2.4 37.2 6.2 62.8 37.6 32.7 20.6 60.0 30.2 1.2 1.2 15.7 8.9 12.5 7.8 2.5 1.2 19.8 9.4 4.6 3.4 24.6 3.8 32.0 2.5 24.6 15.5 22.3 20.8 12.2 13.7 104.4 1.8 16.4 18.9 11.4 0.7 3.4 16.9 20.1 8.5 66.2 28.2 0.2 3.0 0.0 0.0 0.0 0.2 0.0 7.0 6.5 2.2 7.7 22.6 17.2 8.6 10.7 2.7 3.1 2.8 7.9 14.5 0.5 46.8 16.5 0.1 4.4 0.5 5.2 0.7 0.1 0.7 2.4 7.0 5.7 4.7 0.0 0.6 10.4 1.6 3.2 0.9 4.7 103.4 0.0 3.1 0.9 4.2 1.9 0.0 3.2 1.9 3.2 2.9 1.0 9.2 0.9 6.0 0.9 0.2 0.6 8.1 3.4 4.7 2.0 1.3 1.2 82.5 6.1 8.0 4.7 0.3 0.0 1.0 0.4 1.6 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 3.0 0.0 0.0 1.1 1.5 0.8 1.5 1.2 1.2 2.5 1.2 3.8 0.7 65.5 28.7 5.2 10.9 23.5 0.7 4.5 40.8 1.4 12.5 87.2 0.0 9.4 0.0 63.1 1.0 75.0 34.2 0.0 21.9 85.1 58.4 6.6 22.0 2.8 6.1 3.2 2.4 621.2 31.6 2.2 69.6 3.5 57.3 2.8 12.8 1.4 55.1 20.7 65.0 0.5 0.5 32.3 38.8 0.4 4.1 15.6 7.8 6.4 13.9 8.3 HUNK ENSG00000142149 "Hormonally up-regulated Neu-associated kinase" P57058 21 31873315-32044633 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Cholangiocytes: 17.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 10.6;BEWO: 13.0;RH-30: 14.4;SCLC-21H: 11.7;SiHa: 10.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027295, HPA027372" Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA027295: AB_2672203, HPA027372: AB_2672239" "unprognostic (9.09e-3)" "unprognostic (7.29e-2)" "unprognostic (1.42e-1)" "unprognostic (5.95e-3)" "unprognostic (1.99e-1)" "unprognostic (2.12e-4)" "unprognostic (4.00e-2)" "unprognostic (6.90e-2)" "unprognostic (5.07e-1)" "unprognostic (2.27e-1)" "unprognostic (9.09e-2)" "unprognostic (1.13e-1)" "prognostic favorable (7.48e-5)" "unprognostic (8.84e-2)" "unprognostic (2.22e-1)" "unprognostic (1.39e-1)" "unprognostic (6.69e-2)" 1.7 1.9 2.7 2.9 3.5 0.5 2.1 3.2 6.4 1.1 5.9 0.2 12.6 2.4 9.0 3.4 1.1 3.3 1.0 1.7 3.7 3.2 6.0 1.3 1.7 0.7 1.2 2.1 1.8 15.7 0.2 4.7 7.6 1.4 4.0 6.5 9.1 1.5 11.1 0.6 5.0 4.4 4.1 0.9 0.4 2.1 1.8 0.2 0.4 1.1 2.2 1.0 3.8 7.7 1.0 0.7 1.7 0.5 0.5 0.5 0.1 0.0 3.0 10.6 0.1 0.0 0.0 13.0 1.0 0.0 0.2 0.0 4.2 0.1 0.0 0.4 4.9 0.2 0.1 6.2 0.0 0.0 0.0 3.2 0.0 2.8 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.9 0.2 0.9 8.0 0.0 0.1 0.1 14.4 0.0 1.1 0.0 11.7 7.8 10.3 0.8 0.4 7.7 4.3 1.1 0.0 0.0 7.5 0.0 0.0 0.1 0.0 1.4 0.0 0.0 5.0 0.8 0.5 0.5 0.5 0.3 0.3 0.5 0.5 0.3 0.2 1.0 0.5 0.5 1.7 0.5 0.3 0.7 0.4 0.1 2.7 3.5 3.2 6.4 3.7 3.2 1.2 2.1 1.4 0.2 6.0 7.8 0.0 1.8 4.5 4.3 3.2 17.8 1.4 4.5 7.0 2.0 8.1 0.0 3.8 0.0 0.9 2.7 0.0 2.9 11.6 10.6 1.6 0.0 0.9 2.3 3.2 4.7 0.0 0.0 0.0 0.3 0.0 3.3 0.0 3.9 11.4 2.6 2.9 0.0 1.5 1.2 0.0 1.4 0.9 0.7 5.1 5.1 0.0 9.0 0.8 HYDIN "CILD5, DKFZp434D0513, KIAA1864, PPP1R31" ENSG00000157423 "HYDIN, axonemal central pair apparatus protein" Q4G0P3 16 70807378-71230722 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.5;pituitary gland: 23.6;testis: 19.1" "Cell type enhanced" "Detected in many" 22 "Ciliated cells: 180.7;Cone photoreceptor cells: 49.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "GAMG: 3.5;RPTEC TERT1: 5.3;SiHa: 11.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA067155, HPA074129" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA067155: AB_2685792, HPA074129: AB_2686665" "unprognostic (8.90e-2)" "unprognostic (1.04e-2)" "unprognostic (8.65e-2)" "unprognostic (4.88e-4)" "unprognostic (4.25e-3)" "unprognostic (1.81e-1)" "unprognostic (3.87e-2)" "unprognostic (2.45e-1)" "unprognostic (3.95e-1)" "unprognostic (3.42e-1)" "unprognostic (4.90e-2)" "unprognostic (3.21e-1)" "unprognostic (2.52e-5)" "unprognostic (2.13e-3)" "unprognostic (1.02e-2)" "unprognostic (1.42e-1)" "unprognostic (3.97e-2)" 0.8 0.9 6.3 1.2 13.9 1.7 1.5 2.9 4.2 2.1 1.2 13.3 4.4 1.0 2.4 18.4 0.9 14.5 1.9 1.0 6.9 4.3 3.5 1.8 7.1 1.1 2.3 4.1 7.2 1.6 9.0 23.6 0.7 21.5 1.4 0.8 3.9 0.9 1.5 0.8 1.7 1.1 1.0 3.1 1.5 1.1 19.1 3.8 0.0 3.2 0.0 0.6 1.2 0.8 0.9 1.1 3.7 1.3 0.7 1.2 0.2 0.1 0.1 2.1 0.2 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.9 0.3 0.2 0.4 0.3 3.5 0.7 0.3 0.2 1.6 0.4 0.5 0.1 0.1 0.2 0.4 0.5 0.2 0.4 0.5 0.0 0.0 0.8 0.0 2.2 0.4 0.1 0.1 0.0 0.7 0.8 1.3 0.1 0.7 0.3 0.2 0.8 5.3 0.7 2.5 0.5 11.0 0.3 0.4 0.4 0.7 0.0 0.3 0.3 0.8 0.1 0.3 1.8 0.1 1.0 0.9 0.2 0.6 1.5 1.0 0.8 1.2 0.9 1.2 0.6 1.0 1.1 0.3 0.9 0.9 0.8 3.7 0.7 1.3 1.1 0.6 0.2 6.3 13.9 2.9 4.2 6.9 4.3 2.3 4.1 21.5 3.8 3.0 1.6 0.0 0.2 0.0 13.2 2.0 0.0 180.7 29.6 8.7 49.1 0.0 1.7 1.7 26.1 0.1 0.0 0.0 0.5 0.0 0.9 0.8 0.0 0.0 0.1 0.0 3.4 0.0 0.0 21.2 2.3 0.0 3.3 0.0 0.0 12.9 0.5 0.0 4.2 1.4 26.6 0.0 0.7 17.1 6.1 0.0 0.0 0.0 0.0 0.1 HYI HT036 ENSG00000178922 "Hydroxypyruvate isomerase (putative)" Q5T013 1 43451003-43453989 "Enzymes, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ductus deferens: 130.4;seminal vesicle: 80.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 21.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 39.2;WM-115: 33.2" "Low region specificity" "Detected in all" HPA040092 Approved Approved "Golgi apparatus,Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "Golgi apparatus" "HPA040092: AB_10795374" "prognostic favorable (9.18e-4)" "unprognostic (1.67e-1)" "prognostic unfavorable (4.96e-4)" "unprognostic (2.68e-2)" "unprognostic (3.86e-1)" "unprognostic (4.40e-2)" "prognostic unfavorable (5.55e-4)" "unprognostic (2.75e-2)" "unprognostic (1.42e-1)" "unprognostic (2.34e-2)" "unprognostic (1.10e-2)" "unprognostic (4.43e-2)" "prognostic unfavorable (2.75e-5)" "unprognostic (5.10e-2)" "unprognostic (7.93e-2)" "unprognostic (3.58e-2)" "prognostic favorable (2.72e-5)" 16.5 12.5 11.6 12.1 10.1 5.3 12.8 11.3 9.7 14.6 16.5 13.0 130.4 23.4 15.8 14.8 8.4 15.3 16.7 10.9 9.2 10.0 15.9 25.8 17.8 6.7 10.9 9.3 25.1 34.0 13.8 11.2 10.8 9.0 15.6 7.5 15.0 20.8 80.0 8.8 8.4 22.1 13.4 14.3 7.6 14.1 4.5 11.1 4.9 12.8 9.6 6.4 10.7 11.3 3.2 21.6 6.2 1.2 4.8 5.4 3.0 17.4 2.2 0.7 1.2 3.4 6.4 0.0 15.2 13.7 19.2 12.9 8.9 30.5 0.0 1.1 9.8 7.7 3.2 0.0 16.1 7.9 4.3 6.3 2.8 8.0 0.0 22.7 0.0 0.0 3.8 4.6 21.8 0.0 19.4 39.2 0.1 0.2 0.0 12.9 0.3 2.6 2.9 3.2 1.6 4.5 13.5 0.0 0.1 13.3 0.6 8.3 6.1 17.1 9.6 3.8 2.8 2.5 21.9 18.1 1.2 0.0 3.4 29.7 0.0 0.0 0.0 1.0 4.0 33.2 6.2 1.1 2.4 3.3 0.9 4.1 3.2 5.4 2.6 4.1 2.7 5.1 1.5 0.1 4.8 1.2 21.6 0.5 3.0 11.6 10.1 11.3 9.7 9.2 10.0 10.9 9.3 9.0 11.1 17.9 66.3 11.9 39.0 24.8 15.2 0.3 68.8 10.7 20.5 54.1 9.8 14.0 38.1 94.3 0.9 20.2 81.2 23.3 74.3 97.6 32.9 36.0 43.7 49.7 24.9 7.9 66.7 21.5 7.0 3.1 29.4 17.5 38.8 23.4 57.1 28.8 107.8 112.2 28.7 115.0 14.1 25.8 53.4 0.9 2.1 19.3 10.1 10.0 43.0 29.2 HYLS1 FLJ32915 ENSG00000198331 "HYLS1, centriolar and ciliogenesis associated" Q96M11 11 125883614-125900648 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 28.6" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 72.7;Late spermatids: 40.2;Spermatocytes: 98.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041210 Enhanced Supported "Plasma membrane,Cytosol" NA Yes "Plasma membrane, Cytosol" "HPA041210: AB_10794987" "unprognostic (2.46e-1)" "unprognostic (1.60e-1)" "unprognostic (1.49e-1)" "unprognostic (2.35e-1)" "unprognostic (3.53e-3)" "unprognostic (1.17e-2)" "prognostic unfavorable (1.92e-4)" "unprognostic (3.28e-1)" "unprognostic (1.04e-3)" "unprognostic (6.56e-3)" "unprognostic (7.63e-2)" "unprognostic (4.81e-3)" "unprognostic (3.00e-2)" "unprognostic (2.19e-1)" "unprognostic (2.49e-1)" "unprognostic (1.03e-1)" "unprognostic (4.56e-2)" 4.3 4.3 6.5 3.6 8.8 2.8 5.2 12.3 11.6 5.9 5.5 2.7 6.0 7.0 5.3 8.3 5.7 5.0 3.2 5.7 6.7 7.2 8.7 7.2 3.1 6.7 5.0 8.6 5.0 3.4 3.4 5.5 5.1 7.6 6.2 6.0 2.2 3.9 7.6 3.7 5.7 6.7 7.1 3.5 5.6 6.2 28.6 4.3 7.6 5.1 4.6 9.6 5.0 3.8 11.8 14.3 3.2 6.0 4.6 10.3 4.7 4.6 10.2 3.7 2.7 7.4 5.0 6.5 11.8 4.7 11.1 7.5 0.1 7.7 2.0 5.0 10.3 3.7 7.0 5.3 4.1 12.9 11.4 3.7 1.5 1.1 2.1 5.5 5.2 7.9 3.2 4.8 11.0 12.5 2.4 8.0 4.6 2.6 12.7 14.5 7.9 3.8 15.7 8.3 19.6 17.3 8.0 0.0 6.8 11.9 7.8 5.3 3.3 12.5 9.7 4.7 5.0 23.9 11.6 7.2 0.8 9.7 8.8 2.0 4.7 4.6 4.9 2.3 11.5 9.7 3.2 5.5 1.1 8.1 6.0 7.6 11.5 10.2 9.4 6.7 11.8 10.3 7.4 0.9 4.6 4.2 14.3 10.3 4.7 6.5 8.8 12.3 11.6 6.7 7.2 5.0 8.6 7.6 4.3 0.0 0.3 8.0 2.4 3.8 7.9 4.0 2.5 4.0 0.0 1.8 3.9 12.5 10.0 3.9 72.7 3.5 3.3 23.3 3.6 10.5 5.1 2.6 0.0 5.5 6.3 0.0 4.7 4.3 1.9 40.2 7.8 2.2 6.8 14.4 2.1 4.4 3.9 6.0 5.6 10.2 5.6 6.5 5.0 98.2 33.7 3.8 3.7 6.4 5.0 1.4 ICAM1 "BB2, CD54" ENSG00000090339 "Intercellular adhesion molecule 1" P05362 19 10270835-10286615 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 68.3;lung: 91.3" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 568.7;Alveolar cells type 2: 522.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 31.6;Karpas-707: 90.1;RPMI-8226: 28.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA002126, CAB002142, HPA004877" Enhanced Approved "Plasma membrane,Cytosol" NA NA 87900000 3100000000 "Plasma membrane, Cytosol" "CAB002142: AB_563596, HPA002126: AB_1078470, HPA004877: AB_1846317" "prognostic favorable (7.09e-4)" "unprognostic (1.88e-1)" "unprognostic (1.94e-1)" "unprognostic (2.63e-2)" "unprognostic (3.25e-3)" "unprognostic (3.05e-1)" "unprognostic (1.45e-2)" "unprognostic (3.48e-1)" "unprognostic (3.18e-2)" "unprognostic (1.09e-2)" "unprognostic (1.49e-2)" "unprognostic (1.79e-1)" "prognostic unfavorable (1.32e-6)" "unprognostic (2.77e-1)" "unprognostic (2.16e-2)" "unprognostic (2.25e-1)" "unprognostic (3.70e-3)" 26.1 8.6 4.0 41.0 4.1 36.5 15.0 1.0 4.5 5.6 10.0 2.7 1.6 6.1 8.5 7.7 7.9 10.7 19.8 16.3 2.6 2.1 10.9 68.3 91.3 32.8 5.4 1.7 12.4 7.2 2.5 4.0 9.3 6.8 10.4 6.6 10.6 7.2 3.6 13.9 6.9 7.9 8.0 7.8 42.2 7.3 6.5 3.6 8.3 11.6 13.7 13.4 14.8 17.1 2.2 13.3 22.2 14.2 7.9 5.6 8.9 8.4 0.1 1.5 0.0 0.4 0.9 2.1 1.7 18.8 4.2 12.7 2.8 9.5 7.7 26.2 0.7 19.3 1.7 0.3 0.0 8.9 23.1 0.0 0.7 0.2 11.5 31.6 0.2 4.5 11.1 0.7 2.6 4.1 0.4 2.1 0.9 2.9 90.1 0.3 0.6 0.1 6.5 0.5 0.1 4.8 0.2 0.0 28.6 7.2 0.0 0.0 0.2 11.6 0.6 18.4 0.7 1.4 0.5 6.5 4.3 0.4 2.4 0.1 27.5 28.3 4.8 7.0 4.9 6.3 2.2 13.9 2.6 3.0 14.2 5.6 2.2 2.4 3.6 13.3 0.9 1.0 2.2 22.2 7.9 7.9 7.5 3.4 8.9 4.0 4.1 1.0 4.5 2.6 2.1 5.4 1.7 6.8 3.6 568.7 522.3 12.0 22.9 75.8 0.0 0.8 20.4 80.3 159.3 3.5 0.0 1.0 0.0 152.6 1.9 139.3 0.5 0.0 84.4 2.5 171.6 19.1 133.1 12.9 75.0 0.0 2.4 56.4 41.3 1.1 4.4 160.6 72.6 168.7 0.3 2.3 107.4 0.0 1.4 9.4 0.3 6.5 95.4 0.5 1.7 60.6 1.0 12.7 0.5 10.0 ICAM2 CD102 ENSG00000108622 "Intercellular adhesion molecule 2" P13598 17 64002594-64020634 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 74.5;lymphoid tissue: 63.9" "Cell type enhanced" "Detected in many" 13 "B-cells: 46.1;Endothelial cells: 80.1;Ito cells: 147.3;Kupffer cells: 54.5;T-cells: 52.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 6 "HUVEC TERT2: 167.1;TIME: 42.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA071155 Approved "Plasma membrane,Cytosol" NA NA 1200000000 "Plasma membrane" Cytosol "HPA071155: " "unprognostic (9.43e-3)" "unprognostic (3.31e-2)" "unprognostic (5.15e-2)" "unprognostic (1.15e-1)" "unprognostic (8.97e-2)" "unprognostic (1.64e-3)" "unprognostic (1.34e-1)" "unprognostic (3.74e-1)" "unprognostic (8.28e-2)" "unprognostic (2.15e-1)" "unprognostic (4.18e-2)" "unprognostic (1.55e-2)" "unprognostic (9.07e-2)" "unprognostic (1.48e-1)" "unprognostic (3.93e-2)" "unprognostic (6.04e-2)" "unprognostic (2.29e-1)" 36.0 3.6 8.4 13.0 11.5 8.3 34.1 3.5 7.7 9.4 9.7 5.6 2.8 6.4 9.8 5.2 9.5 7.4 8.8 22.8 9.5 8.9 10.5 8.7 27.9 24.0 12.3 3.1 6.3 7.4 3.1 4.5 36.8 9.1 7.9 8.5 8.1 8.8 4.3 17.1 5.5 10.8 13.9 10.5 63.9 8.0 4.0 7.4 14.3 11.6 9.0 18.0 12.8 23.6 49.0 30.9 56.5 74.5 26.0 65.3 67.5 0.0 0.0 0.0 0.0 1.4 1.5 0.4 0.1 0.1 0.0 0.1 0.3 6.9 11.7 2.1 0.0 0.0 0.0 0.1 0.0 0.2 2.6 0.0 10.5 0.6 1.2 0.2 1.7 0.0 0.0 0.0 0.1 0.0 0.0 167.1 9.9 8.6 6.9 0.0 0.0 13.1 1.5 0.0 0.0 0.0 7.9 0.0 16.3 0.8 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 42.2 0.0 0.1 0.8 0.0 6.6 2.2 10.5 0.0 2.2 0.0 56.5 30.0 8.9 45.8 66.5 52.8 36.5 60.1 42.8 30.9 49.0 65.3 40.7 3.6 26.0 74.5 10.0 64.5 67.5 8.4 11.5 3.5 7.7 9.5 8.9 12.3 3.1 9.1 7.4 0.0 12.5 46.1 3.4 6.5 0.0 0.3 0.0 6.7 6.8 7.0 0.0 0.4 0.0 0.8 0.5 80.1 0.3 0.0 1.2 0.3 6.9 1.6 11.5 1.0 18.7 0.0 1.2 147.3 54.5 0.0 0.3 23.4 27.0 6.4 1.4 0.4 5.1 5.8 1.8 0.5 0.3 6.5 4.4 0.2 0.2 4.6 0.8 52.4 1.7 2.6 ICOS "AILIM, CD278" ENSG00000163600 "Inducible T cell costimulator" Q9Y6W8 2 203936748-203961577 "CD markers, Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 18.4;bone marrow: 13.8;lymphoid tissue: 51.8" "Cell type enriched" "Detected in some" 4 "T-cells: 23.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 18.4" "Lineage enriched" "Detected in single" 58 "T-cells: 18.4" "Group enriched" "Detected in some" 7 "HEL: 6.0;MOLT-4: 15.7" "Low region specificity" "Detected in single" "CAB032575, HPA034865" Approved Approved "Plasma membrane,Actin filaments" "Intracellular and membrane" NA NA "Plasma membrane" "Actin filaments" "CAB032575: AB_2122593, HPA034865: " "unprognostic (2.66e-2)" "unprognostic (2.13e-3)" "unprognostic (4.19e-4)" "unprognostic (2.35e-5)" "unprognostic (1.07e-1)" "prognostic favorable (1.80e-4)" "unprognostic (9.38e-2)" "unprognostic (2.89e-2)" "unprognostic (1.49e-2)" "unprognostic (3.51e-4)" "unprognostic (7.50e-2)" "unprognostic (2.12e-1)" "unprognostic (2.86e-5)" "unprognostic (7.05e-2)" "unprognostic (2.48e-2)" "unprognostic (1.93e-1)" "unprognostic (8.82e-3)" 1.5 0.3 0.2 15.6 0.2 13.8 0.7 0.2 0.2 0.8 1.2 0.0 0.2 0.5 1.2 0.5 1.1 1.2 1.6 0.5 0.2 0.2 1.0 0.8 4.0 19.4 0.3 0.0 0.6 0.3 0.0 0.4 0.1 0.1 0.7 1.1 0.7 2.9 0.0 0.2 0.6 6.2 0.3 0.4 6.1 1.0 0.6 0.0 51.8 1.4 2.4 28.9 3.0 0.9 0.0 0.0 0.0 0.0 0.3 18.4 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 2.9 0.0 10.5 4.6 0.0 0.0 11.0 5.0 0.0 0.3 0.0 0.0 18.4 3.0 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.0 0.1 0.0 0.0 2.2 0.0 0.0 2.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 5.8 0.0 0.1 0.0 0.0 0.6 0.3 0.0 0.0 0.6 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 1.6 0.1 23.5 0.0 0.0 ICOSLG "B7-H2, B7H2, B7RP-1, B7RP1, CD275, GL50, ICOS-L, ICOSL, KIAA0653" ENSG00000160223 "Inducible T cell costimulator ligand" O75144 21 44217014-44240966 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, B-cell activation, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 14.1" "Cell type enhanced" "Detected in many" 9 "B-cells: 17.5;monocytes: 34.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 6.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 14.1" "CAB026037, HPA029179" Uncertain Approved "Plasma membrane,Cytoplasmic bodies" NA NA 150000000 "Plasma membrane, Cytoplasmic bodies" "CAB026037: , HPA029179: AB_2732445" "unprognostic (3.03e-2)" "unprognostic (1.40e-4)" "unprognostic (3.52e-2)" "unprognostic (1.94e-2)" "unprognostic (6.74e-2)" "unprognostic (9.40e-2)" "unprognostic (6.94e-2)" "unprognostic (3.71e-1)" "unprognostic (1.40e-1)" "unprognostic (3.76e-2)" "unprognostic (1.40e-1)" "unprognostic (2.42e-1)" "unprognostic (3.00e-2)" "unprognostic (3.11e-1)" "unprognostic (1.36e-1)" "unprognostic (1.47e-1)" "unprognostic (1.84e-1)" 2.3 3.0 5.3 3.9 7.1 14.1 2.3 2.3 5.9 2.9 2.3 2.3 2.3 1.8 2.3 2.3 4.0 2.7 3.5 3.7 8.8 3.7 5.3 2.7 2.3 6.5 6.5 2.3 2.3 2.3 0.0 2.3 2.3 2.3 2.3 1.2 2.3 2.3 2.3 2.3 5.5 2.9 2.3 8.4 3.2 4.2 2.3 2.3 2.3 2.3 2.3 4.5 2.4 2.6 6.5 1.6 1.0 0.8 0.5 1.1 0.4 0.3 3.3 0.1 2.8 0.8 1.1 7.7 0.7 0.7 0.4 0.2 5.6 0.4 14.1 2.1 0.3 1.3 4.3 2.0 1.3 0.2 1.4 1.4 0.4 2.7 1.6 0.7 6.1 10.4 1.1 1.9 0.9 0.9 0.2 0.8 0.5 2.3 1.3 0.2 3.7 0.3 8.0 2.0 9.5 3.5 12.0 0.9 8.2 0.6 7.5 1.4 0.0 9.4 13.3 0.3 1.1 3.9 8.7 0.8 0.4 3.3 0.3 0.2 12.1 8.3 11.8 4.4 5.7 1.9 0.6 0.8 0.4 0.3 0.8 0.3 3.7 0.8 0.5 0.5 6.5 0.8 1.1 1.0 0.5 0.5 1.6 0.4 0.4 5.3 7.1 2.3 2.3 8.8 3.7 6.5 2.3 2.3 2.3 0.0 1.0 17.5 5.3 6.6 0.4 0.3 0.0 0.0 1.2 8.7 0.0 0.3 0.0 1.3 0.7 3.1 4.2 0.0 0.6 0.9 4.8 11.7 0.0 1.9 3.4 0.0 5.1 1.3 6.7 2.7 2.8 10.5 8.5 34.3 4.4 1.3 0.7 1.4 10.3 3.6 0.8 0.0 8.1 0.0 0.2 5.6 0.5 0.0 3.9 5.9 IFFO2 ENSG00000169991 "Intermediate filament family orphan 2" Q5TF58 1 18904281-18956686 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 76.8" "Cell type enhanced" "Detected in many" 10 "Basal glandular cells: 68.5;Basal keratinocytes: 107.4;Suprabasal keratinocytes: 87.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 11 "basophil: 10.6" "Lineage enriched" "Detected in many" 11 "granulocytes: 10.6" "Cell line enhanced" "Detected in many" "HDLM-2: 50.5" "HPA015987, HPA064603" Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA015987: AB_2121678, HPA064603: AB_2685296" "unprognostic (1.43e-1)" "unprognostic (1.06e-2)" "unprognostic (2.81e-2)" "unprognostic (1.18e-1)" "unprognostic (1.39e-1)" "unprognostic (2.08e-2)" "unprognostic (2.03e-2)" "unprognostic (1.78e-1)" "unprognostic (4.34e-2)" "unprognostic (2.27e-3)" "unprognostic (3.24e-3)" "unprognostic (7.42e-2)" "unprognostic (3.24e-2)" "unprognostic (5.24e-3)" "unprognostic (2.72e-1)" "unprognostic (4.71e-1)" "unprognostic (1.36e-1)" 3.5 5.1 3.8 5.0 7.8 5.7 8.9 22.3 6.4 6.7 4.6 6.2 4.9 1.4 4.7 2.2 28.7 3.6 4.8 2.7 4.4 4.0 4.9 8.9 5.0 5.3 6.8 3.6 2.4 14.5 13.0 4.0 4.7 9.3 6.6 2.0 3.4 7.9 6.5 4.3 76.8 2.5 13.5 8.9 3.9 2.9 1.4 4.6 3.2 4.3 33.2 11.3 6.3 8.8 0.8 0.6 10.6 0.3 0.3 1.0 0.1 8.4 13.8 3.7 10.3 2.4 1.9 6.0 6.4 4.2 3.5 2.4 18.9 9.9 0.1 8.2 4.8 4.0 21.2 2.8 13.5 2.8 50.5 2.5 0.1 2.6 7.4 1.7 1.4 16.2 1.2 13.8 4.7 6.0 5.8 7.4 0.4 0.6 1.7 2.3 1.7 1.4 1.3 1.6 8.7 3.3 4.7 2.3 3.6 2.0 5.4 11.9 0.6 4.8 6.8 4.7 4.0 1.8 0.7 20.2 4.7 6.6 2.7 18.3 3.6 3.9 0.2 3.2 2.1 5.5 10.6 0.3 0.0 0.6 0.3 0.8 0.8 0.5 0.7 0.1 0.3 0.5 1.0 0.1 0.3 0.0 0.6 0.5 0.1 3.8 7.8 22.3 6.4 4.4 4.0 6.8 3.6 9.3 4.6 3.0 4.8 0.9 68.5 107.4 5.7 5.5 15.3 12.0 4.5 1.8 0.0 4.1 1.7 12.7 1.2 7.1 1.0 0.0 15.2 5.8 3.6 12.6 3.5 3.9 2.0 23.8 2.4 6.2 0.8 2.2 1.1 4.0 13.5 2.8 0.6 5.1 13.4 2.9 2.8 8.1 1.6 0.0 8.5 0.7 0.5 87.7 3.3 2.9 1.0 39.7 IFRD1 "PC4, TIS7" ENSG00000006652 "Interferon related developmental regulator 1" O00458 7 112422968-112481017 "Predicted intracellular proteins, Predicted membrane proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 93.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 6 "eosinophil: 25.6;neutrophil: 44.2" "Lineage enriched" "Detected in all" 12 "granulocytes: 44.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024122, HPA072413" Enhanced Approved "Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "HPA024122: AB_1851452, HPA072413: " "unprognostic (2.29e-1)" "unprognostic (3.47e-1)" "unprognostic (1.10e-1)" "unprognostic (9.82e-3)" "unprognostic (1.36e-2)" "unprognostic (2.39e-1)" "unprognostic (5.73e-3)" "unprognostic (1.37e-1)" "unprognostic (2.48e-2)" "prognostic favorable (5.45e-4)" "unprognostic (6.41e-2)" "unprognostic (2.93e-3)" "unprognostic (1.50e-3)" "unprognostic (4.81e-2)" "unprognostic (1.98e-1)" "unprognostic (2.89e-1)" "unprognostic (4.70e-2)" 19.5 18.0 16.7 12.9 19.6 83.1 24.0 14.3 15.7 10.7 18.3 15.6 11.7 18.7 15.7 12.5 12.7 11.4 12.7 16.0 15.2 13.3 11.9 14.1 19.2 7.9 30.9 13.2 16.9 93.0 12.5 23.1 18.7 16.9 14.7 11.7 11.2 14.3 11.0 37.6 12.3 19.0 23.9 28.2 11.7 17.7 17.9 22.0 7.5 16.5 13.5 7.4 14.7 37.5 3.8 2.9 44.2 3.2 3.4 3.7 2.6 15.0 10.1 15.7 14.8 26.9 17.5 14.6 14.9 14.3 19.3 17.4 16.7 12.7 7.3 28.5 7.7 38.4 9.0 10.9 12.6 26.4 12.4 15.5 8.2 18.8 16.0 30.8 11.1 6.5 13.3 27.0 20.4 23.4 15.5 8.0 12.6 25.0 16.5 7.8 13.6 14.1 18.7 35.8 14.0 17.8 12.3 6.3 13.6 5.8 4.2 25.3 13.1 17.0 14.5 48.1 29.7 5.6 12.0 6.9 32.9 7.0 25.6 44.9 14.8 17.5 20.0 8.9 30.9 37.6 5.7 3.2 25.6 3.6 2.8 2.8 3.8 3.5 3.4 2.9 3.0 3.4 3.3 44.2 3.4 2.8 2.1 3.7 2.6 16.7 19.6 14.3 15.7 15.2 13.3 30.9 13.2 16.9 22.0 29.8 31.8 25.5 140.2 175.3 48.0 49.5 22.9 13.4 33.0 17.4 84.4 63.5 14.9 41.7 32.2 54.5 231.2 23.3 49.6 52.8 71.4 123.0 75.8 18.7 104.1 20.6 132.5 47.9 76.5 7.5 33.9 78.9 97.8 73.1 82.8 22.6 50.8 210.5 38.5 11.0 72.9 38.8 197.8 13.7 11.5 110.2 126.9 55.4 87.9 126.0 IGFL2 UNQ645 ENSG00000204866 "IGF like family member 2" Q6UWQ7 19 46143106-46161299 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "skin 1: 26.8;tongue: 24.8" "Cell type enhanced" "Detected in some" 8 "Early spermatids: 5.9;Late spermatids: 3.9;Spermatocytes: 8.0;Spermatogonia: 7.0;Suprabasal keratinocytes: 4.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 24 "memory CD4 T-cell: 2.4" "Lineage enriched" "Detected in single" 24 "T-cells: 2.4" "Group enriched" "Detected in some" 64 "CACO-2: 28.9;OE19: 58.1" HPA059137 Uncertain Approved "Nucleoplasm,Plasma membrane" "Secreted in other tissues" NA NA Nucleoplasm "Plasma membrane" "HPA059137: AB_2683920" "unprognostic (1.53e-1)" "unprognostic (7.87e-2)" "unprognostic (1.64e-1)" "unprognostic (1.69e-2)" "unprognostic (7.30e-2)" "unprognostic (9.74e-2)" "unprognostic (1.92e-1)" "unprognostic (1.81e-1)" "unprognostic (1.84e-1)" "unprognostic (1.68e-1)" "unprognostic (4.26e-3)" "unprognostic (9.63e-3)" "unprognostic (4.14e-9)" "unprognostic (1.27e-1)" "unprognostic (2.76e-2)" "unprognostic (8.73e-2)" "unprognostic (9.91e-3)" 1.5 0.0 0.4 0.1 0.1 0.0 1.8 0.1 0.4 0.3 0.3 0.1 0.1 0.0 0.1 0.5 1.0 0.0 0.1 1.1 0.1 0.1 0.1 0.1 0.8 1.2 0.4 0.1 0.1 0.1 3.4 0.1 1.6 0.9 0.1 0.7 0.1 0.5 0.1 0.1 26.8 0.1 0.1 0.3 0.1 0.0 2.4 0.1 0.4 0.1 24.8 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.6 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 28.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.4 0.1 0.1 0.4 0.1 0.9 0.1 0.0 0.0 0.0 0.0 1.9 1.9 0.4 0.0 0.0 1.2 0.0 0.0 3.2 0.0 0.0 5.9 0.0 0.5 0.0 0.2 0.1 1.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.9 0.0 0.0 1.7 0.0 0.2 0.4 0.0 0.0 0.0 0.0 1.9 0.0 0.4 8.0 7.0 4.1 2.2 0.0 1.3 0.0 IL12RB1 "CD212, IL12RB" ENSG00000096996 "Interleukin 12 receptor subunit beta 1" P42701 19 18058995-18098944 "CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.6;lymphoid tissue: 21.4" "Cell type enhanced" "Detected in some" 20 "B-cells: 9.0;Kupffer cells: 10.0;T-cells: 35.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 10.7;HDLM-2: 18.0;Karpas-707: 30.8;U-698: 9.0" "Low region specificity" "Detected in all" HPA074414 Approved "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "HPA074414: AB_2686687" "unprognostic (7.70e-3)" "prognostic favorable (3.41e-4)" "unprognostic (9.08e-3)" "unprognostic (1.18e-4)" "unprognostic (2.91e-1)" "unprognostic (1.33e-3)" "unprognostic (2.27e-1)" "unprognostic (8.99e-2)" "unprognostic (1.65e-2)" "unprognostic (1.35e-1)" "unprognostic (1.51e-1)" "unprognostic (2.94e-1)" "prognostic unfavorable (5.90e-5)" "unprognostic (1.49e-1)" "unprognostic (2.21e-2)" "unprognostic (4.34e-2)" "unprognostic (2.93e-2)" 1.9 1.5 1.3 17.5 2.1 5.6 1.2 0.5 1.0 0.9 3.4 2.4 1.1 2.9 1.0 2.4 1.3 1.5 2.5 1.4 1.3 1.2 1.8 1.8 5.0 16.0 2.0 0.2 1.1 1.3 1.2 1.1 2.4 1.4 1.7 2.0 1.1 6.6 0.2 0.9 1.0 8.0 1.0 2.4 21.4 2.3 0.7 2.2 10.1 1.3 0.7 16.9 3.8 1.0 4.9 5.9 6.2 14.0 16.2 28.6 9.0 0.2 0.1 0.1 0.2 0.0 0.1 0.5 0.1 0.1 0.2 0.6 0.2 1.0 10.7 0.1 0.1 0.3 0.2 0.1 0.0 0.0 18.0 0.2 1.2 0.3 0.2 0.4 0.7 1.7 0.0 0.0 0.3 0.1 0.1 0.0 2.4 0.2 30.8 0.0 0.1 5.1 0.2 0.1 0.0 0.1 3.6 0.1 0.5 0.0 0.0 0.3 0.1 0.2 0.2 0.2 0.1 0.2 5.8 0.2 0.3 0.3 0.1 0.1 3.7 5.5 9.0 0.4 6.2 0.7 3.3 5.1 3.6 22.8 14.0 28.6 4.9 15.5 18.3 5.9 3.7 8.7 15.2 6.2 16.2 13.2 3.5 20.5 9.0 1.3 2.1 0.5 1.0 1.3 1.2 2.0 0.2 1.4 2.2 0.0 4.8 9.0 0.6 0.2 0.0 0.8 2.5 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.4 0.4 0.4 4.6 0.0 5.9 0.0 0.0 0.6 10.0 0.0 0.0 5.8 0.0 6.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.6 0.1 35.2 0.0 1.0 IL12RB2 ENSG00000081985 "Interleukin 12 receptor subunit beta 2" Q99665 1 67307364-67396900 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 18.2;pancreas: 15.0" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 2: 2.9;Hofbauer cells: 2.9;Melanocytes: 1.7;T-cells: 6.4" "Cancer enhanced" "Detected in many" "melanoma: 5.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "NK-cell: 18.2" "Group enriched" "Detected in many" 42 "NK-cells: 18.2;T-cells: 6.1" "Cell line enhanced" "Detected in some" "HMC-1: 4.5;SCLC-21H: 8.9;SK-MEL-30: 22.4;THP-1: 13.0" "Region enhanced" "Detected in single" "olfactory region: 1.8" "Low region specificity" "Detected in all" HPA024168 Uncertain Approved "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "HPA024168: AB_1851629" "unprognostic (1.32e-1)" "unprognostic (1.54e-3)" "unprognostic (2.09e-1)" "unprognostic (2.68e-2)" "unprognostic (2.82e-2)" "unprognostic (1.09e-3)" "unprognostic (2.37e-2)" "unprognostic (3.90e-2)" "unprognostic (1.10e-1)" "unprognostic (2.38e-2)" "unprognostic (1.39e-1)" "unprognostic (3.60e-2)" "unprognostic (1.08e-3)" "unprognostic (1.82e-1)" "unprognostic (4.69e-2)" "unprognostic (7.11e-3)" "unprognostic (1.90e-1)" 3.8 1.0 1.8 3.1 3.6 1.5 3.7 0.6 7.7 2.4 1.0 0.0 0.0 0.7 0.8 1.1 3.2 0.9 1.1 5.2 9.6 1.1 1.5 1.4 1.8 4.3 1.0 6.0 0.8 15.0 0.9 0.8 14.1 1.6 1.2 0.9 1.3 7.2 1.7 11.4 2.1 1.4 1.0 1.0 2.5 1.0 2.3 0.0 1.1 1.1 3.2 1.6 1.4 1.2 0.0 0.0 0.2 0.0 18.2 6.1 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.1 2.1 1.3 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.1 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.4 0.0 0.0 22.4 0.0 0.0 13.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 2.7 0.0 1.5 1.0 0.0 0.0 0.0 0.0 0.2 18.2 0.0 0.0 3.9 1.0 1.8 3.6 0.6 7.7 9.6 1.1 1.0 6.0 1.6 0.0 0.0 2.9 0.0 0.2 0.5 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 2.9 0.0 0.0 0.0 0.6 0.2 0.0 0.0 1.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 6.4 0.0 0.1 IL13 "ALRH, BHR1, IL-13, MGC116786, MGC116788, MGC116789, P600" ENSG00000169194 "Interleukin 13" P35225 5 132656263-132661110 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 20.7" "Group enriched" "Detected in some" 7 "Early spermatids: 74.4;Late spermatids: 141.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 177 "HDLM-2: 30.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA042421 Approved "Plasma membrane,Cytosol" "Secreted to blood" NA NA 40000 "Plasma membrane, Cytosol" "HPA042421: AB_10795504" "unprognostic (2.17e-1)" "unprognostic (2.29e-2)" "unprognostic (7.48e-2)" "unprognostic (2.18e-2)" "unprognostic (1.92e-1)" "unprognostic (5.21e-3)" "unprognostic (1.79e-1)" "unprognostic (2.69e-1)" "unprognostic (5.20e-1)" "unprognostic (7.10e-2)" "unprognostic (3.61e-3)" "unprognostic (3.34e-1)" "unprognostic (5.97e-4)" "unprognostic (4.70e-2)" "unprognostic (2.05e-1)" "unprognostic (7.39e-2)" "unprognostic (1.38e-1)" 0.3 0.0 0.1 0.8 0.1 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.6 0.1 3.0 0.0 0.0 0.1 0.0 0.0 1.8 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.1 0.2 0.2 0.6 0.0 0.0 0.0 0.0 20.7 0.0 2.9 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 74.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 16.3 0.0 0.0 0.0 0.0 0.0 0.0 141.6 2.6 0.3 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 2.2 1.2 0.5 0.0 0.0 0.0 0.0 IL13RA2 "CD213a2, CT19, IL-13R, IL13BP" ENSG00000123496 "Interleukin 13 receptor subunit alpha 2" Q14627 X 115003975-115019977 "Cancer-related genes, CD markers, Predicted membrane proteins" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 16.1;testis: 31.5" "Cell type enhanced" "Detected in some" 28 "Early spermatids: 253.7;Ito cells: 63.3;Late spermatids: 36.6;Spermatocytes: 64.6" "Cancer enhanced" "Detected in many" "glioma: 17.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "PC-3: 27.0;U-2197: 86.8;U-251 MG: 58.3;U-87 MG: 34.6" "Region enhanced" "Detected in some" "olfactory region: 8.7" "Low region specificity" "Detected in many" "HPA045831, HPA067363" Approved "Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" "Nucleoplasm, Vesicles" "HPA045831: , HPA067363: " "unprognostic (1.97e-1)" "unprognostic (2.83e-1)" "unprognostic (6.62e-4)" "unprognostic (7.39e-2)" "unprognostic (8.45e-2)" "unprognostic (1.80e-1)" "prognostic favorable (3.55e-4)" "unprognostic (3.54e-1)" "unprognostic (2.85e-1)" "unprognostic (1.92e-2)" "unprognostic (2.20e-3)" "unprognostic (2.19e-2)" "unprognostic (1.53e-5)" "unprognostic (1.58e-1)" "unprognostic (1.63e-1)" "unprognostic (9.70e-3)" "unprognostic (1.20e-1)" 0.5 4.8 3.7 3.9 11.3 0.0 0.8 0.3 3.1 1.2 0.4 2.1 5.7 0.3 0.9 4.4 0.5 0.1 0.8 0.6 5.1 11.2 3.5 9.6 1.0 0.1 1.2 2.6 0.1 0.1 0.5 16.1 2.1 3.9 4.3 0.7 1.6 0.8 3.7 0.0 0.1 0.3 0.4 0.6 0.2 0.1 31.5 1.4 0.0 1.3 0.2 0.2 1.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.7 0.0 5.9 5.7 0.0 0.0 0.0 0.0 0.0 0.1 2.9 9.6 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.0 0.1 0.9 5.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 27.0 0.0 0.0 0.0 0.5 0.0 0.0 1.4 0.4 0.0 0.1 0.0 0.0 0.0 0.0 3.1 0.0 86.8 58.3 0.0 0.0 0.0 34.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 11.3 0.3 3.1 5.1 11.2 1.2 2.6 3.9 1.4 0.0 0.0 0.0 2.6 0.1 0.0 0.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 253.7 1.0 0.0 0.0 0.0 0.0 0.4 2.3 0.0 0.4 0.0 0.0 4.1 63.3 4.8 36.6 2.6 0.0 0.0 1.0 0.0 0.0 5.5 0.0 4.6 0.0 0.0 0.0 0.2 64.6 2.1 0.0 0.0 0.0 0.0 2.5 IL16 "FLJ16806, FLJ42735, HsT19289, IL-16, LCF, prIL-16" ENSG00000172349 "Interleukin 16" Q14005 15 81159575-81314058 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Chemotaxis, Host-virus interaction, Transcription, Transcription regulation" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 75.7;lymphoid tissue: 97.9" "Cell type enhanced" "Detected in many" 14 "B-cells: 169.7;Erythroid cells: 70.0;Kupffer cells: 59.0;T-cells: 92.0" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 40.1" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 12.4;HEL: 13.2;HMC-1: 23.8;RPMI-8226: 22.5;U-266/70: 28.3;U-698: 11.7;U-937: 15.8" "Group enriched" "Detected in some" 13 "cerebellum: 61.1;hippocampal formation: 29.7" "Region enriched" "Detected in single" 37 "cerebellum: 96.7" "CAB005247, HPA018467, HPA048861" Enhanced Supported "Nuclear speckles,Plasma membrane,Cytosol" "Secreted to blood" Yes NA 208000 14000 "Nuclear speckles" "Plasma membrane, Cytosol" "CAB005247: AB_2124730, HPA018467: AB_1851642, HPA048861: " "unprognostic (8.23e-3)" "unprognostic (2.70e-3)" "unprognostic (1.97e-2)" "unprognostic (9.61e-4)" "unprognostic (2.01e-1)" "unprognostic (5.26e-4)" "unprognostic (2.63e-2)" "unprognostic (6.72e-3)" "unprognostic (2.25e-1)" "unprognostic (3.91e-1)" "unprognostic (1.47e-1)" "unprognostic (6.21e-2)" "unprognostic (3.16e-3)" "unprognostic (1.21e-1)" "unprognostic (3.23e-2)" "unprognostic (5.26e-2)" "unprognostic (1.29e-1)" 8.8 2.4 4.1 48.0 5.8 19.5 7.8 40.1 4.3 4.7 4.8 4.6 0.9 3.8 5.4 2.9 3.4 9.7 5.6 5.1 4.9 2.1 2.5 3.9 14.7 58.0 5.8 2.3 3.7 1.7 0.7 1.4 3.0 6.7 3.5 5.9 3.4 13.5 1.5 1.8 6.1 19.2 3.3 7.8 38.2 5.0 2.2 5.5 97.9 3.7 2.4 54.8 8.7 5.4 43.3 37.1 75.7 35.0 49.3 60.5 66.5 0.0 0.0 0.0 0.0 8.4 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 13.2 0.0 0.0 0.4 9.3 23.8 0.4 0.0 0.0 0.2 0.0 0.2 1.6 1.4 5.0 0.0 0.0 0.7 9.9 0.0 0.0 0.0 0.0 0.0 22.5 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 2.1 0.1 0.1 0.1 0.4 0.0 28.3 2.4 11.7 0.8 15.8 0.7 52.7 27.4 75.7 43.1 35.0 48.6 43.3 45.1 47.1 37.1 39.9 60.5 48.6 69.1 49.3 33.7 28.0 47.0 66.5 4.1 5.8 40.1 4.3 4.9 2.1 5.8 2.3 6.7 5.5 3.0 10.0 169.7 0.1 7.2 0.0 1.2 10.2 8.1 3.4 1.8 0.0 0.2 0.0 0.1 1.3 4.9 0.0 70.0 0.2 0.2 6.6 0.1 25.5 2.4 16.6 0.0 0.0 36.2 59.0 0.7 10.0 30.8 27.0 0.0 0.3 0.4 0.0 0.3 17.0 0.3 0.6 6.5 3.7 2.1 4.7 3.1 0.3 92.0 0.0 0.0 IL1R1 "CD121A, D2S1473, IL1R, IL1RA" ENSG00000115594 "Interleukin 1 receptor type 1" P14778 2 102064544-102179874 "Cancer-related genes, CD markers, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Inflammatory response" "Hydrolase, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Club cells: 93.3;Ito cells: 139.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 95.6;ASC TERT1: 42.7;HHSteC: 30.0;HSkMC: 117.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA001237, HPA005823, CAB007779, HPA029560" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Secreted to blood" NA NA 1000000 "Nucleoplasm, Vesicles" "Plasma membrane, Cytosol" "CAB007779: AB_562073, HPA001237: , HPA005823: AB_2667445, HPA029560: AB_2673094" "unprognostic (6.16e-3)" "unprognostic (3.55e-2)" "unprognostic (3.33e-1)" "unprognostic (1.22e-1)" "unprognostic (4.26e-2)" "unprognostic (7.10e-2)" "unprognostic (2.01e-1)" "unprognostic (3.36e-2)" "unprognostic (1.44e-1)" "unprognostic (3.16e-1)" "unprognostic (4.26e-2)" "unprognostic (7.77e-2)" "prognostic unfavorable (6.92e-6)" "unprognostic (2.48e-2)" "unprognostic (6.95e-2)" "unprognostic (4.83e-2)" "unprognostic (7.73e-2)" 48.6 25.2 2.6 18.2 5.2 4.0 92.4 2.4 3.9 47.8 21.0 2.5 34.3 5.2 15.2 30.2 18.2 17.1 25.8 27.0 4.2 2.5 23.7 74.8 40.5 28.0 5.6 1.1 25.1 17.1 16.9 7.3 66.2 10.9 26.0 8.4 8.6 12.7 36.4 15.5 13.5 13.0 15.1 10.0 19.2 15.6 13.4 2.8 3.5 33.6 9.0 9.6 32.0 36.4 0.1 0.1 4.0 0.5 0.8 1.8 0.2 0.2 1.8 0.0 1.5 95.6 42.7 0.6 4.0 18.2 2.8 4.3 0.8 0.5 0.0 2.9 8.0 5.0 0.8 0.0 0.3 2.4 7.9 0.0 0.1 0.4 4.4 30.0 0.0 0.0 117.7 0.3 3.2 0.7 1.2 1.2 0.0 0.5 0.1 4.1 0.8 0.0 0.1 0.1 0.8 0.1 0.0 0.3 0.0 2.7 1.9 0.0 0.0 1.8 1.1 0.0 0.5 1.6 0.1 0.0 8.2 0.5 13.7 0.3 0.0 0.0 0.0 3.2 0.0 0.5 0.6 0.5 0.1 0.0 0.0 0.7 0.1 1.1 0.0 0.1 0.1 0.0 0.1 4.0 0.8 0.0 0.1 1.8 0.2 2.6 5.2 2.4 3.9 4.2 2.5 5.6 1.1 10.9 2.8 23.8 55.6 3.7 27.6 27.6 0.0 3.9 28.1 40.2 93.3 5.2 0.0 5.3 3.3 21.6 6.4 58.3 0.0 0.0 18.7 76.6 77.2 84.5 1.1 43.2 5.1 0.0 1.2 139.3 12.4 9.4 25.9 21.6 18.6 9.0 0.7 7.3 15.4 0.0 1.4 6.2 1.0 6.5 23.1 0.7 0.9 33.8 20.0 2.6 0.9 19.6 ILDR2 C1orf32 ENSG00000143195 "Immunoglobulin like domain containing receptor 2" Q71H61 1 166895711-166975482 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.6;testis: 18.0" "Cell type enriched" "Detected in some" 8 "Muller glia cells: 116.0" "Cancer enhanced" "Detected in some" "glioma: 4.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 9.7;JURKAT: 7.4;MOLT-4: 5.1;U-2 OS: 12.5;U-251 MG: 6.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA012545, HPA012815" Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA012545: AB_2126894, HPA012815: " "unprognostic (9.14e-2)" "unprognostic (5.05e-2)" "unprognostic (8.27e-2)" "unprognostic (2.16e-1)" "unprognostic (5.89e-2)" "unprognostic (5.33e-2)" "unprognostic (2.89e-5)" "unprognostic (2.09e-1)" "unprognostic (8.55e-2)" "unprognostic (4.51e-2)" "unprognostic (1.52e-1)" "unprognostic (2.58e-1)" "unprognostic (9.17e-2)" "unprognostic (5.87e-3)" "unprognostic (4.92e-2)" "unprognostic (1.64e-1)" "unprognostic (1.36e-1)" 0.8 1.1 9.8 0.9 6.4 1.4 0.5 2.1 14.6 0.7 2.9 3.6 0.1 0.7 0.9 1.4 0.9 0.8 1.3 3.1 7.2 7.7 6.3 1.3 1.4 1.0 2.7 8.0 0.8 0.7 0.5 3.3 0.8 3.1 2.3 1.2 2.8 0.8 2.8 0.8 0.7 0.8 2.0 2.3 0.7 0.7 18.0 3.1 1.9 0.9 0.0 1.1 0.9 0.3 0.0 0.4 0.3 0.0 0.0 0.3 0.5 0.0 0.0 9.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.2 1.0 1.8 0.3 0.0 0.4 0.0 0.0 0.0 0.0 2.2 1.9 0.0 0.0 0.2 0.0 3.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.1 0.2 0.0 5.1 0.0 3.3 0.1 0.0 0.0 0.3 0.7 0.7 0.2 1.3 0.0 0.0 0.0 0.0 1.0 0.0 0.9 0.0 0.0 12.5 0.0 6.6 2.3 0.0 0.5 1.4 1.3 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.3 0.0 0.3 0.0 0.0 0.1 0.0 0.5 9.8 6.4 2.1 11.4 7.2 7.7 2.7 8.0 3.1 3.1 0.0 0.0 0.0 0.0 0.0 3.9 3.2 0.0 0.0 1.2 0.0 5.9 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.1 0.1 1.6 1.2 0.0 0.0 13.8 0.6 0.0 0.0 1.0 0.0 116.0 0.1 0.0 0.0 4.6 6.5 0.0 0.1 3.3 1.3 0.0 0.2 0.0 0.2 0.0 INPP5A 5PTASE ENSG00000068383 "Inositol polyphosphate-5-phosphatase A" Q14642 10 132537820-132783480 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "basophil: 8.4" "Lineage enriched" "Detected in single" 21 "granulocytes: 8.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012285 Enhanced Approved "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA Cytosol "Plasma membrane" "HPA012285: AB_1851802" "prognostic unfavorable (7.47e-4)" "unprognostic (2.38e-1)" "unprognostic (2.54e-1)" "unprognostic (1.68e-3)" "unprognostic (1.43e-1)" "unprognostic (3.25e-2)" "unprognostic (2.08e-1)" "unprognostic (1.16e-1)" "unprognostic (5.65e-2)" "unprognostic (4.35e-1)" "unprognostic (4.70e-2)" "unprognostic (1.70e-2)" "prognostic favorable (3.15e-4)" "unprognostic (2.14e-1)" "unprognostic (1.44e-1)" "unprognostic (8.91e-3)" "unprognostic (8.66e-2)" 13.6 11.8 10.3 11.3 49.8 5.8 10.3 40.7 20.8 17.4 24.0 10.1 11.5 12.9 25.8 13.9 20.3 15.2 13.6 48.8 9.5 8.5 9.4 7.2 13.8 6.0 9.2 10.4 13.1 11.6 8.9 9.4 19.0 9.1 17.1 11.7 17.1 8.5 16.9 43.7 11.5 14.8 27.9 10.6 8.9 14.8 14.9 16.6 4.2 9.5 12.1 7.8 19.4 22.4 0.3 0.1 8.4 0.2 0.0 0.3 0.6 18.7 7.5 12.6 12.1 19.3 13.6 10.3 19.9 15.3 13.0 8.7 17.7 7.7 1.7 7.7 21.1 8.5 10.7 13.6 8.3 15.7 5.7 7.9 2.7 9.4 24.0 14.0 6.8 6.6 9.2 8.3 8.3 15.9 10.5 9.0 3.6 3.9 10.1 6.9 15.2 1.9 21.9 5.7 11.3 13.4 4.0 8.3 3.0 10.8 10.7 3.0 10.3 9.9 14.7 12.0 12.0 9.5 16.5 7.5 8.4 9.7 11.2 11.6 2.0 9.3 5.8 8.1 4.7 3.6 8.4 0.2 1.1 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.2 0.0 0.0 1.5 0.0 0.2 0.0 0.3 0.6 10.3 49.8 40.7 20.8 9.5 8.5 9.2 10.4 9.1 16.6 8.9 22.4 1.4 3.6 4.7 10.7 9.0 5.1 2.7 9.1 7.0 0.0 3.3 0.0 5.7 9.4 6.4 18.4 0.0 7.9 3.3 6.2 6.4 8.1 16.0 2.6 7.9 5.8 19.0 6.3 11.2 6.6 3.1 1.7 0.0 9.3 7.8 9.9 11.5 11.0 3.8 4.9 6.5 20.0 5.5 6.6 5.1 2.1 1.9 10.9 5.0 IPCEF1 "KIAA0403, PIP3-E" ENSG00000074706 "Interaction protein for cytohesin exchange factors 1" Q8WWN9 6 154154496-154356792 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "blood: 30.1;bone marrow: 15.2;brain: 26.4;lymphoid tissue: 12.4;thyroid gland: 36.9" "Cell type enhanced" "Detected in many" 17 "Kupffer cells: 14.6;Macrophages: 9.5;T-cells: 30.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "HMC-1: 19.7;THP-1: 10.0;U-937: 10.5" "HPA028708, HPA028710" Enhanced Approved "Nucleoli,Nuclear speckles,Plasma membrane,Cytoplasmic bodies" NA NA "Nuclear speckles, Plasma membrane" "Nucleoli, Cytoplasmic bodies" "HPA028708: AB_10601916, HPA028710: AB_2732442" "unprognostic (1.23e-2)" "unprognostic (8.93e-3)" "unprognostic (4.18e-2)" "unprognostic (5.63e-3)" "unprognostic (2.05e-1)" "unprognostic (6.55e-3)" "unprognostic (1.30e-3)" "unprognostic (2.57e-2)" "unprognostic (3.87e-1)" "unprognostic (5.84e-2)" "unprognostic (3.27e-2)" "unprognostic (4.87e-2)" "unprognostic (5.01e-2)" "unprognostic (8.64e-2)" "unprognostic (5.45e-2)" "unprognostic (1.42e-2)" "unprognostic (1.51e-4)" 1.3 0.7 5.3 6.9 12.9 15.2 1.9 20.0 26.4 3.4 1.6 5.5 0.0 1.1 1.7 1.8 1.9 2.5 3.2 1.0 3.8 4.6 3.4 2.4 2.0 12.4 3.9 14.1 1.3 1.4 0.4 1.3 2.0 5.5 1.3 1.6 0.0 1.4 0.8 0.7 1.2 2.9 1.3 4.2 6.4 2.6 1.5 4.9 10.0 36.9 0.0 11.7 2.4 1.1 0.0 7.1 30.1 6.3 6.0 13.5 5.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.1 19.7 0.1 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 2.8 1.1 1.0 0.0 0.5 0.2 0.2 0.5 1.0 2.1 0.3 0.4 0.0 0.1 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 10.5 0.0 1.4 6.3 30.1 6.1 2.8 13.1 0.0 7.7 5.8 7.1 0.0 13.5 7.9 19.3 6.0 3.4 0.2 9.9 5.3 5.3 12.9 20.0 26.4 3.8 4.6 3.9 14.1 5.5 4.9 0.0 1.7 0.5 0.4 0.6 0.0 0.9 0.0 1.4 2.3 1.8 0.0 1.4 6.6 0.9 0.7 1.4 0.0 0.0 0.0 0.1 0.8 0.4 0.0 0.8 2.2 3.2 0.0 2.5 14.6 0.0 0.3 9.5 0.0 0.0 0.3 0.3 0.0 0.0 0.4 1.2 0.1 0.0 0.4 0.2 0.1 0.5 2.3 30.5 0.2 1.2 IQGAP2 ENSG00000145703 "IQ motif containing GTPase activating protein 2" Q13576 5 76403249-76708132 "Plasma proteins, Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 66.1" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 913.2;Late spermatids: 268.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 22.0;Hep G2: 18.2;HMC-1: 65.2;RPMI-8226: 23.8;U-937: 17.0" "Region enhanced" "Detected in many" "hippocampal formation: 34.4" "Low region specificity" "Detected in all" "CAB004241, HPA037403, HPA037404" Uncertain Approved "Vesicles,Plasma membrane" NA NA 8400000 "Vesicles, Plasma membrane" "CAB004241: AB_2125909, HPA037403: AB_2675459, HPA037404: AB_2675460" "unprognostic (9.46e-2)" "unprognostic (1.27e-1)" "unprognostic (1.35e-1)" "unprognostic (1.48e-1)" "unprognostic (9.03e-3)" "unprognostic (8.85e-2)" "prognostic favorable (5.65e-4)" "unprognostic (5.96e-2)" "unprognostic (1.14e-1)" "unprognostic (2.34e-1)" "unprognostic (2.14e-1)" "unprognostic (1.41e-1)" "prognostic favorable (9.44e-12)" "unprognostic (3.29e-2)" "unprognostic (9.89e-2)" "unprognostic (1.52e-2)" "unprognostic (1.27e-2)" 11.1 11.3 1.4 14.7 1.7 6.3 8.0 1.1 1.2 6.1 21.6 0.6 36.2 16.8 2.6 14.7 3.3 2.7 21.7 4.2 1.6 1.6 13.2 66.1 7.8 13.0 1.3 0.7 4.2 14.8 25.5 2.3 42.5 2.1 9.1 6.8 15.2 18.9 34.3 1.4 3.7 35.7 3.4 2.0 16.5 12.4 30.7 0.4 7.7 12.8 2.8 7.7 4.3 4.2 0.6 7.8 14.9 3.2 4.1 5.9 1.3 0.0 2.8 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.0 0.0 0.2 0.8 0.0 0.8 0.0 3.6 0.0 0.0 2.5 3.6 8.1 2.1 18.2 0.0 4.5 65.2 0.0 0.0 0.0 0.0 0.0 0.3 4.5 7.1 6.5 0.0 0.0 3.9 12.3 4.5 7.5 0.1 1.4 0.0 23.8 0.0 0.0 0.1 1.0 5.1 0.3 0.0 10.1 0.0 2.7 0.1 0.0 0.1 0.0 0.0 6.1 0.0 5.6 0.0 17.0 0.9 14.9 3.2 1.8 4.8 2.4 4.0 0.6 5.0 4.1 2.9 0.2 2.0 3.6 6.3 4.1 3.1 7.8 5.9 1.3 1.4 1.7 1.1 1.2 1.6 1.6 1.3 0.7 2.1 0.4 11.9 16.4 11.2 18.7 4.1 5.9 2.4 101.9 20.1 13.6 33.2 102.1 11.9 6.6 28.5 913.2 3.6 83.5 23.3 58.0 0.6 7.5 28.7 91.4 219.4 58.8 1.6 8.7 20.3 125.0 268.6 6.9 72.8 15.1 19.0 45.0 11.3 23.8 38.6 4.9 53.7 118.4 0.0 2.3 14.9 4.4 3.3 6.1 66.1 31.5 5.5 ISLR HsT17563 ENSG00000129009 "Immunoglobulin superfamily containing leucine rich repeat" O14498 15 74173671-74176872 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Fibroblasts: 63.6;Leydig cells: 199.0;Peritubular cells: 150.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 33.9;ASC TERT1: 18.2;fHDF/TERT166: 76.1;HSkMC: 13.8;RPMI-8226: 23.3" "Region enriched" "Detected in all" 5 "olfactory region: 145.0" "Low region specificity" "Detected in many" "HPA040326, HPA050811" Approved Approved "Golgi apparatus,Plasma membrane" "Secreted - unknown location" NA NA 110000000 "Plasma membrane" "Golgi apparatus" "HPA040326: AB_2676928, HPA050811: AB_2681243" "unprognostic (2.58e-1)" "unprognostic (1.36e-2)" "unprognostic (3.54e-2)" "unprognostic (3.06e-2)" "unprognostic (1.30e-1)" "unprognostic (1.76e-2)" "unprognostic (1.51e-1)" "unprognostic (1.21e-1)" "unprognostic (6.76e-3)" "unprognostic (1.16e-2)" "unprognostic (6.81e-2)" "unprognostic (8.93e-3)" "prognostic unfavorable (4.89e-8)" "unprognostic (1.64e-2)" "unprognostic (3.42e-2)" "unprognostic (2.28e-1)" "unprognostic (9.86e-3)" 24.6 6.8 3.3 10.4 4.6 0.1 21.4 2.0 12.1 72.8 19.7 2.9 13.2 4.1 67.3 36.3 23.0 22.1 29.6 17.7 1.7 1.7 8.0 2.5 10.2 5.8 3.3 7.2 80.2 3.4 1.2 13.8 31.5 3.9 32.2 4.0 36.4 10.0 17.9 12.5 13.6 8.8 27.5 9.0 9.8 10.3 16.3 0.6 1.3 18.9 17.0 9.9 27.9 35.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 33.9 18.2 0.1 5.2 0.0 0.0 0.0 0.0 2.1 0.0 0.3 76.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 23.3 0.0 0.0 0.2 3.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.2 4.0 0.0 0.1 0.5 0.0 0.2 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 4.6 2.0 12.1 1.7 1.7 3.3 7.2 3.9 0.6 0.0 2.2 0.0 0.1 10.4 0.0 3.1 0.0 2.7 1.2 0.0 0.0 1.1 0.0 0.2 1.7 8.7 0.0 0.0 0.2 1.6 63.6 0.1 0.0 0.0 3.5 0.0 0.0 7.4 0.0 3.2 199.0 0.8 11.8 0.0 0.0 0.1 1.3 0.0 150.3 0.0 0.3 25.8 21.7 0.9 0.5 7.8 0.8 0.0 0.0 0.2 ITGA2B "CD41, CD41B, GP2B, PPP1R93" ENSG00000005961 "Integrin subunit alpha 2b" P08514 17 44372180-44389505 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.5;epididymis: 25.2;lymphoid tissue: 22.8" "Cell type enhanced" "Detected in some" 11 "Cone photoreceptor cells: 7.9;Early spermatids: 14.4;granulocytes: 18.4;Late spermatids: 20.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 10 "basophil: 28.5" "Lineage enriched" "Detected in single" 54 "granulocytes: 28.5" "Group enriched" "Detected in some" 13 "HEL: 71.0;HMC-1: 121.4" "Low region specificity" "Detected in single" "CAB018611, HPA031168, HPA031169, HPA031170, HPA031171" Enhanced Approved "Plasma membrane" NA NA 1100000000 "Plasma membrane" "CAB018611: AB_2265153, HPA031168: AB_10664706, HPA031169: AB_10669671, HPA031170: AB_10696214, HPA031171: AB_10669773" "unprognostic (6.11e-2)" "unprognostic (3.23e-2)" "unprognostic (1.23e-1)" "unprognostic (4.85e-2)" "unprognostic (1.59e-2)" "unprognostic (3.98e-3)" "unprognostic (4.23e-5)" "unprognostic (1.25e-1)" "unprognostic (1.33e-2)" "unprognostic (7.22e-2)" "unprognostic (2.97e-3)" "unprognostic (1.30e-1)" "unprognostic (8.83e-9)" "unprognostic (7.82e-2)" "unprognostic (1.85e-1)" "unprognostic (1.95e-1)" "unprognostic (2.25e-1)" 0.7 0.2 1.4 0.4 1.0 15.2 0.6 3.8 2.4 1.2 0.9 0.4 0.4 0.1 1.1 25.2 0.7 1.9 1.4 10.6 0.9 1.6 1.0 0.4 6.5 0.5 0.7 0.8 2.1 2.5 0.1 2.5 1.9 1.1 0.6 0.3 0.6 0.4 1.6 0.8 0.1 0.6 0.4 0.8 22.8 0.2 3.0 0.4 0.4 5.2 1.0 0.6 0.7 1.9 0.0 0.5 28.5 0.2 0.0 0.2 11.1 0.0 0.1 0.7 0.0 0.0 0.0 2.9 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.4 71.0 0.1 0.7 0.0 0.0 121.4 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.3 0.0 7.3 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.7 0.6 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 28.5 0.2 2.1 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.8 0.0 0.0 0.5 0.0 11.1 1.4 1.0 3.8 2.4 0.9 1.6 0.7 0.8 1.1 0.4 0.0 1.0 0.0 0.5 0.2 4.5 1.2 0.0 0.0 2.3 5.2 7.9 0.5 0.0 0.0 14.4 0.6 0.0 0.0 0.0 1.1 0.8 0.3 18.4 0.0 0.2 3.2 0.0 0.6 0.3 20.0 1.7 0.0 0.0 0.0 0.0 1.9 0.1 0.0 1.8 0.0 3.1 0.0 0.0 0.7 3.4 0.0 0.6 0.0 0.0 0.1 ITGA4 CD49d ENSG00000115232 "Integrin subunit alpha 4" P13612 2 181457202-181536187 "Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 38.4;lymphoid tissue: 101.6" "Cell type enhanced" "Detected in many" 11 "B-cells: 42.0;Erythroid cells: 70.0;monocytes: 36.1;T-cells: 59.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 39.1;HEL: 62.0;JURKAT: 32.6;MOLT-4: 72.3" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 7 "cerebellum: 26.0" HPA074961 Approved "Plasma membrane" "Intracellular and membrane" NA NA 100000 "Plasma membrane" "HPA074961: AB_2732273" "unprognostic (5.31e-2)" "unprognostic (1.54e-1)" "unprognostic (1.99e-2)" "unprognostic (3.94e-2)" "unprognostic (3.76e-1)" "prognostic favorable (8.29e-4)" "unprognostic (1.27e-1)" "unprognostic (1.11e-2)" "unprognostic (1.76e-1)" "unprognostic (2.67e-2)" "unprognostic (1.85e-1)" "unprognostic (1.94e-1)" "prognostic unfavorable (3.08e-5)" "unprognostic (2.26e-2)" "unprognostic (8.64e-3)" "unprognostic (2.49e-1)" "unprognostic (2.57e-2)" 3.8 1.7 1.3 39.7 1.1 19.2 3.2 2.4 1.9 6.7 4.8 0.5 1.1 3.8 3.0 3.1 2.9 2.1 6.9 1.7 2.9 1.3 3.0 2.5 13.6 33.7 1.2 0.5 1.8 1.6 0.0 1.3 7.1 0.9 3.8 4.9 2.9 7.5 2.0 1.0 1.5 11.6 2.4 1.6 36.0 4.4 1.2 0.2 101.6 2.6 1.5 14.3 6.0 4.1 11.0 19.1 38.4 38.3 8.8 15.9 16.2 0.0 0.2 1.0 0.0 9.2 13.9 0.0 9.0 11.3 4.8 10.2 0.0 0.0 7.2 0.0 39.1 4.2 5.3 3.2 0.1 5.8 0.0 0.7 62.0 0.2 0.0 0.9 27.4 1.5 9.9 0.0 0.3 0.0 4.7 0.5 32.6 0.0 10.5 3.0 0.0 72.3 19.2 0.8 0.0 0.0 15.9 4.5 1.0 0.0 0.0 1.6 0.6 0.0 0.0 0.3 0.4 0.0 18.1 4.9 1.5 0.9 0.1 1.8 20.5 15.2 4.1 0.8 13.6 20.8 6.7 16.2 38.4 12.9 38.3 9.7 11.0 14.6 15.9 19.1 10.0 8.5 10.4 2.1 8.8 37.5 5.0 3.7 16.2 1.3 1.1 2.4 1.9 2.9 1.3 1.2 0.5 0.9 0.2 0.0 7.9 42.0 0.2 0.2 2.4 0.8 5.1 1.4 3.4 0.0 5.9 0.1 0.0 0.0 0.0 0.0 0.0 70.0 0.0 0.2 2.9 0.3 17.4 0.0 5.8 0.0 0.0 1.8 21.0 0.0 0.6 22.7 0.0 36.1 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 1.6 0.4 0.9 0.5 0.3 59.7 0.0 0.2 ITGA7 ENSG00000135424 "Integrin subunit alpha 7" Q13683 12 55684568-55716043 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Cell shape" "Integrin, Receptor" "Congenital muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 66.4;skeletal muscle: 81.3" "Group enriched" "Detected in many" 17 "Cardiomyocytes: 123.1;Sertoli cells: 161.7;Smooth muscle cells: 105.1" "Cancer enhanced" "Detected in all" "glioma: 35.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 5 "hTERT-RPE1: 85.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008427 Uncertain Approved "Nuclear speckles,Vesicles,Plasma membrane" NA NA 770000 "Plasma membrane" "Nuclear speckles, Vesicles" "HPA008427: AB_1851823" "unprognostic (4.71e-2)" "unprognostic (1.55e-1)" "unprognostic (2.00e-3)" "unprognostic (3.02e-3)" "unprognostic (2.50e-1)" "unprognostic (2.36e-1)" "unprognostic (1.66e-2)" "unprognostic (2.20e-1)" "unprognostic (2.20e-2)" "unprognostic (3.57e-1)" "prognostic favorable (1.75e-4)" "unprognostic (2.85e-2)" "unprognostic (5.89e-2)" "unprognostic (1.79e-1)" "unprognostic (5.10e-1)" "unprognostic (2.98e-2)" "prognostic unfavorable (9.59e-5)" 46.2 3.4 6.1 7.2 6.8 0.9 20.6 3.6 7.6 6.3 22.4 5.7 5.9 6.6 15.1 13.5 11.6 12.9 14.8 66.4 7.8 2.6 3.1 4.1 3.4 2.9 3.9 7.6 5.1 1.9 3.4 3.1 1.0 5.7 8.9 3.7 5.6 3.3 14.6 81.3 3.6 7.2 33.3 4.5 2.4 10.3 2.9 5.3 0.2 6.5 10.6 2.2 13.6 14.1 0.5 1.7 0.0 1.0 0.0 0.8 0.3 0.0 1.0 1.9 3.2 18.2 3.6 0.2 1.3 2.3 3.1 3.2 2.1 1.7 0.6 1.9 0.8 0.2 0.2 1.3 0.0 2.7 0.0 1.0 0.2 0.6 0.8 0.1 0.0 0.7 5.1 0.0 17.2 0.1 85.4 0.0 0.5 0.2 0.4 10.4 1.3 0.0 0.7 5.6 0.4 0.1 0.0 7.5 0.1 0.0 0.0 0.2 0.7 0.1 0.0 12.6 1.1 0.2 3.5 0.0 0.3 3.4 0.2 2.1 0.8 0.5 0.2 15.6 2.1 0.1 0.0 0.7 0.0 0.4 1.0 0.0 0.1 0.0 0.8 1.7 0.5 0.3 0.4 0.0 0.0 1.0 0.6 0.0 0.3 6.1 6.8 3.6 7.6 7.8 2.6 3.9 7.6 5.7 5.3 0.0 0.0 0.0 0.5 1.6 1.0 123.1 5.1 0.0 0.0 1.8 3.9 0.0 0.0 0.2 0.1 5.1 1.1 0.0 0.0 0.1 1.1 0.6 0.0 0.9 0.5 0.0 7.5 1.3 1.8 0.0 6.1 1.2 3.3 0.0 1.1 4.4 0.4 0.0 6.0 0.6 0.2 161.7 105.1 3.7 2.2 1.9 0.1 0.0 0.8 0.3 ITGA8 ENSG00000077943 "Integrin subunit alpha 8" P53708 10 15513949-15720125 "Disease related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion, Differentiation, Neurogenesis" "Developmental protein, Integrin, Receptor" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 7 "Muller glia cells: 17.3;Sertoli cells: 51.8;Smooth muscle cells: 54.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 7.9;HMC-1: 19.0;HSkMC: 8.4;U-266/70: 3.6;U-266/84: 8.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA003432 Approved Approved "Plasma membrane" NA NA 110000 "Plasma membrane" "HPA003432: AB_1851825" "unprognostic (2.15e-1)" "unprognostic (1.22e-3)" "unprognostic (1.05e-2)" "unprognostic (2.03e-1)" "unprognostic (1.25e-2)" "unprognostic (8.44e-4)" "unprognostic (2.23e-1)" "unprognostic (6.13e-3)" "unprognostic (6.82e-2)" "unprognostic (3.80e-1)" "unprognostic (2.54e-2)" "unprognostic (1.27e-1)" "unprognostic (4.10e-3)" "unprognostic (1.39e-1)" "unprognostic (1.71e-1)" "unprognostic (2.26e-1)" "unprognostic (6.03e-2)" 7.1 7.8 2.3 2.4 1.9 0.1 3.1 1.4 3.7 36.1 5.5 1.5 4.1 4.8 17.9 22.8 12.4 7.1 10.7 10.3 3.0 1.6 7.4 0.8 22.1 3.7 1.7 2.6 17.0 0.8 0.7 3.3 0.2 2.9 28.3 4.6 18.8 3.0 22.9 3.3 3.1 4.9 21.2 1.5 17.0 19.4 12.1 1.2 0.0 5.3 5.5 4.3 21.3 10.8 0.2 0.2 0.6 0.4 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.5 1.5 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.1 0.0 0.0 0.0 0.0 0.0 7.9 2.3 0.0 0.0 0.0 0.0 19.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 8.6 0.0 0.0 0.1 1.6 0.6 0.0 0.2 0.2 0.4 0.2 0.2 0.3 0.3 0.0 0.2 0.5 0.5 0.5 0.2 0.4 0.2 0.8 0.0 2.3 1.9 1.4 3.7 3.0 1.6 1.7 2.6 2.9 1.2 0.0 2.2 0.0 1.9 0.9 2.7 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.8 0.0 0.0 0.0 0.0 2.4 1.2 0.0 0.0 0.1 0.0 0.0 4.3 0.0 0.0 0.9 1.0 1.7 0.0 0.0 17.3 0.0 0.0 0.0 0.0 0.2 51.8 54.5 0.0 0.2 1.0 0.0 0.0 0.0 1.4 ITGA9 "ALPHA-RLC, ITGA4L, RLC" ENSG00000144668 "Integrin subunit alpha 9" Q13797 3 37452115-37823514 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Ito cells: 62.0;Kupffer cells: 24.9;Leydig cells: 38.3;Peritubular cells: 70.4" "Cancer enhanced" "Detected in all" "thyroid cancer: 23.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 2.1" "Lineage enhanced" "Detected in single" "granulocytes: 2.1" "Cell line enhanced" "Detected in some" "CACO-2: 9.4;HEL: 7.5;SH-SY5Y: 11.2;SuSa: 17.0;WM-115: 5.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA030609 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions" "Intracellular and membrane" NA NA 250000 Vesicles "Nucleoplasm, Plasma membrane, Cell Junctions" "HPA030609: AB_10600815" "unprognostic (2.35e-2)" "unprognostic (3.36e-2)" "unprognostic (5.58e-2)" "unprognostic (3.94e-2)" "unprognostic (4.48e-2)" "unprognostic (2.85e-2)" "unprognostic (3.10e-1)" "unprognostic (8.87e-3)" "unprognostic (3.23e-1)" "unprognostic (2.31e-1)" "unprognostic (2.04e-1)" "unprognostic (1.51e-1)" "unprognostic (1.78e-2)" "unprognostic (1.50e-2)" "unprognostic (1.07e-1)" "unprognostic (1.72e-2)" "unprognostic (3.16e-2)" 8.5 15.5 3.1 5.3 3.7 5.8 9.6 1.6 5.7 17.9 11.1 2.9 5.8 4.6 17.3 7.5 12.3 6.9 17.8 25.0 4.5 2.0 4.6 13.6 8.3 16.8 3.4 2.7 7.5 2.1 2.4 3.0 7.3 2.6 10.0 5.3 8.4 4.7 8.7 3.7 3.5 8.7 16.2 4.0 30.5 10.9 10.2 2.7 1.0 35.4 7.2 3.6 7.4 8.4 0.0 0.7 2.1 0.2 0.0 0.0 0.4 0.2 0.0 4.1 0.3 0.0 0.2 0.1 0.1 0.0 0.0 0.0 9.4 0.0 3.0 1.3 0.0 0.1 0.2 3.6 0.0 0.0 0.0 0.6 7.5 0.1 0.2 0.2 0.0 4.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.2 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.4 0.2 0.0 0.2 0.5 11.2 0.1 0.5 0.6 17.0 0.0 2.9 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.1 0.2 5.8 2.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 3.1 3.7 1.6 5.7 4.5 2.0 3.4 2.7 2.6 2.7 0.0 14.3 0.0 1.0 2.3 0.8 13.2 2.5 0.0 5.7 1.8 0.0 0.2 0.0 0.1 0.9 18.0 0.0 0.0 0.0 0.2 3.2 0.2 5.8 0.2 2.2 0.0 0.0 62.0 24.9 3.1 38.3 1.3 3.3 0.0 0.0 0.5 0.0 0.0 70.4 0.0 0.0 0.0 3.3 0.5 0.9 1.5 0.2 0.0 0.0 0.3 ITGB5 ENSG00000082781 "Integrin subunit beta 5" P18084 3 124761948-124901418 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Integrin, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 71.2;hTERT-RPE1: 81.6;WM-115: 74.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001820, CAB022050" Approved Approved "Plasma membrane,Mitochondria" NA NA 95000 "Plasma membrane, Mitochondria" "CAB022050: , HPA001820: AB_1079142" "unprognostic (2.63e-1)" "unprognostic (1.04e-1)" "unprognostic (3.57e-1)" "unprognostic (4.44e-2)" "unprognostic (1.37e-2)" "unprognostic (6.07e-2)" "unprognostic (3.49e-3)" "unprognostic (3.16e-3)" "unprognostic (1.68e-1)" "unprognostic (1.53e-2)" "prognostic unfavorable (1.40e-4)" "unprognostic (1.16e-1)" "unprognostic (2.16e-3)" "unprognostic (2.49e-3)" "unprognostic (1.12e-1)" "unprognostic (1.01e-1)" "unprognostic (4.38e-3)" 72.5 13.8 9.7 9.7 10.0 0.8 50.1 5.7 8.2 34.2 18.8 14.8 28.0 12.9 31.7 17.2 25.6 13.9 29.1 32.9 9.4 5.1 19.6 22.1 20.4 3.5 12.0 6.2 17.4 12.1 8.9 8.4 36.4 13.0 23.0 10.1 27.1 18.6 23.1 15.9 33.3 16.1 25.1 9.0 18.7 12.4 17.0 8.7 2.8 18.8 16.2 10.9 24.4 27.1 0.1 1.1 0.4 0.6 0.9 2.1 5.8 28.5 71.2 5.1 12.9 48.3 14.1 26.4 30.6 19.0 5.7 9.2 14.2 37.3 0.1 14.9 51.9 28.1 22.9 4.6 15.9 5.0 0.3 3.1 10.1 11.0 14.9 8.4 0.0 18.5 8.4 3.7 14.3 7.5 81.6 19.1 0.0 9.0 15.3 19.5 29.0 0.1 0.1 22.9 16.0 7.9 0.0 8.2 10.7 16.1 6.3 0.1 10.7 22.7 33.8 25.8 9.4 19.1 0.6 49.1 21.5 32.5 18.6 15.8 2.6 2.7 0.1 22.5 0.1 74.2 0.4 0.6 0.2 2.1 0.2 0.0 0.0 0.2 0.0 1.1 0.1 0.3 0.4 0.4 0.9 0.4 0.1 0.0 5.8 9.7 10.0 5.7 8.2 9.4 5.1 12.0 6.2 13.0 8.7 6.0 7.9 2.2 18.8 15.2 6.2 26.4 43.3 5.3 10.3 27.9 3.9 56.6 10.0 34.5 7.5 22.6 19.6 0.0 16.3 4.7 30.7 22.0 0.0 32.1 60.3 33.4 3.4 41.1 27.6 2.3 18.7 16.7 10.1 0.0 13.3 47.4 43.9 27.4 15.6 10.2 15.2 38.8 35.3 1.4 6.4 19.4 46.1 0.0 15.0 12.0 ITGB7 ENSG00000139626 "Integrin subunit beta 7" P26010 12 53191318-53207307 "Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Host cell receptor for virus entry, Integrin, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 31.3;lymphoid tissue: 37.6" "Cell type enhanced" "Detected in many" 10 "B-cells: 35.7;granulocytes: 29.9;T-cells: 27.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 99 "Karpas-707: 295.2;RPMI-8226: 230.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA042277 Approved "Nucleoplasm,Nuclear membrane,Vesicles,Plasma membrane,Cytosol" NA NA 42000 "Plasma membrane, Cytosol" "Nucleoplasm, Nuclear membrane, Vesicles" "HPA042277: AB_10793877" "unprognostic (5.34e-2)" "unprognostic (4.47e-2)" "unprognostic (2.80e-3)" "unprognostic (1.40e-2)" "unprognostic (6.57e-4)" "unprognostic (3.51e-5)" "unprognostic (3.11e-3)" "unprognostic (1.37e-2)" "unprognostic (3.58e-1)" "unprognostic (2.18e-1)" "unprognostic (9.63e-3)" "unprognostic (3.36e-1)" "unprognostic (1.02e-2)" "unprognostic (2.16e-1)" "unprognostic (6.95e-2)" "unprognostic (9.34e-2)" "unprognostic (2.47e-4)" 1.8 1.4 1.4 29.1 1.8 7.5 1.5 0.6 1.2 1.8 8.7 2.9 0.8 6.7 2.3 2.8 6.6 2.0 5.6 1.4 1.5 1.0 5.4 5.1 4.9 26.4 1.9 1.0 1.1 1.3 0.7 1.7 1.8 2.4 2.7 5.6 2.1 10.7 2.2 1.0 6.4 15.1 1.5 2.0 26.7 4.3 0.9 2.0 7.8 3.6 4.4 37.6 4.6 3.0 10.1 15.4 31.3 1.9 7.5 23.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 295.2 0.0 0.0 0.0 0.4 0.0 2.4 0.0 0.1 0.0 230.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 1.0 0.2 0.2 0.1 0.1 22.6 1.9 31.3 19.3 0.5 14.3 10.1 19.4 23.0 15.4 8.3 16.3 17.1 0.5 7.5 0.1 4.2 22.7 5.2 1.4 1.8 0.6 1.2 1.5 1.0 1.9 1.0 2.4 2.0 3.0 8.5 35.7 0.3 1.9 0.0 0.4 2.5 0.0 0.0 7.0 3.9 0.1 6.6 0.2 0.0 0.1 0.0 0.0 0.5 0.1 1.0 0.1 29.9 1.6 13.8 0.0 0.0 0.6 3.0 0.0 0.0 7.0 6.8 7.2 0.3 6.6 0.6 0.0 0.0 4.4 0.7 0.0 0.4 0.2 1.1 3.1 0.1 27.7 0.9 1.3 ITGB8 ENSG00000105855 "Integrin subunit beta 8" P26012 7 20330702-20415754 "Cancer-related genes, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 99.3;Ciliated cells: 78.9;Glandular cells: 109.9;Urothelial cells: 146.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 105 "basophil: 13.8" "Lineage enriched" "Detected in single" 105 "granulocytes: 13.8" "Cell line enhanced" "Detected in many" "AF22: 16.6;EFO-21: 21.4;RPTEC TERT1: 33.2;WM-115: 47.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027796, HPA027797" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA027796: AB_10600299, HPA027797: AB_10600879" "unprognostic (8.32e-3)" "unprognostic (1.42e-1)" "unprognostic (1.03e-1)" "unprognostic (3.37e-3)" "unprognostic (5.63e-2)" "unprognostic (3.53e-1)" "unprognostic (1.75e-1)" "unprognostic (1.46e-1)" "unprognostic (4.36e-2)" "unprognostic (1.75e-2)" "unprognostic (2.49e-3)" "unprognostic (8.47e-2)" "prognostic favorable (1.77e-4)" "unprognostic (2.90e-1)" "unprognostic (1.56e-1)" "unprognostic (4.63e-2)" "unprognostic (6.92e-3)" 4.7 4.1 18.0 5.8 20.0 1.2 12.7 7.8 24.3 22.1 4.6 19.4 9.0 4.6 10.5 19.0 8.8 10.4 11.7 3.9 19.4 12.5 28.1 1.7 3.7 1.3 29.3 14.5 7.1 17.5 8.1 7.7 10.7 22.8 9.6 4.4 37.5 16.6 13.1 0.9 8.5 6.0 7.0 23.1 0.8 6.2 8.7 24.0 0.0 3.4 1.3 9.0 6.8 9.9 0.0 0.0 13.8 0.1 0.0 0.1 0.0 10.2 0.4 16.6 2.1 1.4 5.9 0.0 0.0 0.1 0.1 0.6 0.1 2.6 0.0 21.4 0.7 0.6 11.4 0.7 1.6 0.2 0.0 0.2 0.0 8.0 0.0 0.7 0.0 0.0 0.7 4.7 0.2 0.9 10.2 0.8 0.0 0.0 3.1 0.3 0.0 0.0 0.0 1.2 0.1 1.8 0.0 1.4 0.0 33.2 0.9 0.2 0.7 3.2 0.0 8.3 0.3 0.2 0.0 1.1 4.3 2.8 1.2 2.1 3.9 0.0 0.0 1.0 0.0 47.5 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 18.0 20.0 7.8 14.2 19.4 12.5 29.3 14.5 22.8 24.0 11.9 3.7 0.8 99.3 29.5 5.2 3.1 43.3 78.9 30.7 36.6 0.0 12.5 6.6 22.1 2.3 1.9 4.6 0.0 15.3 0.9 3.2 109.9 1.1 0.0 3.1 1.6 32.6 1.3 1.5 3.5 40.9 12.4 3.3 55.1 6.8 26.0 24.5 6.2 42.1 44.6 1.2 0.0 1.4 0.5 0.7 10.8 4.1 0.5 7.3 146.8 ITM2A "BRICD2A, E25A" ENSG00000078596 "Integral membrane protein 2A" O43736 X 79360384-79367667 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 100.7" "Cell type enhanced" "Detected in many" 9 "Endothelial cells: 252.4;granulocytes: 190.5;Leydig cells: 310.7;Muller glia cells: 153.0;T-cells: 187.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 26.5;eosinophil: 16.8;gdT-cell: 23.2;MAIT T-cell: 17.0;memory CD4 T-cell: 44.6;memory CD8 T-cell: 36.5;naive CD4 T-cell: 48.0;naive CD8 T-cell: 22.6;NK-cell: 25.2;T-reg: 32.4" "Group enriched" "Detected in many" 7 "granulocytes: 26.5;NK-cells: 25.2;T-cells: 48.0" "Cell line enriched" "Detected in some" 5 "MOLT-4: 191.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000296 Approved "Golgi apparatus,Vesicles,Plasma membrane" NA NA Vesicles "Golgi apparatus, Plasma membrane" "HPA000296: " "unprognostic (1.05e-2)" "unprognostic (5.22e-3)" "unprognostic (2.77e-3)" "unprognostic (5.65e-2)" "unprognostic (1.73e-2)" "unprognostic (1.06e-3)" "prognostic favorable (3.66e-6)" "unprognostic (1.57e-1)" "unprognostic (4.94e-2)" "unprognostic (9.85e-2)" "unprognostic (1.33e-2)" "unprognostic (2.57e-1)" "unprognostic (1.04e-2)" "unprognostic (1.56e-1)" "unprognostic (3.31e-1)" "unprognostic (2.18e-1)" "unprognostic (4.30e-1)" 27.2 4.1 27.0 9.1 37.8 13.6 27.4 7.8 25.8 21.8 11.0 16.1 6.5 5.4 16.4 19.4 14.8 15.3 10.6 42.1 33.6 22.5 7.7 2.2 19.0 28.5 34.8 19.5 69.6 6.3 2.7 9.3 10.6 25.8 16.7 11.9 16.2 28.2 8.8 13.2 10.3 8.8 20.9 33.9 8.4 9.6 8.0 12.5 100.7 31.1 14.1 16.5 14.7 16.6 4.7 1.1 26.5 0.2 25.2 48.0 22.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.7 0.3 0.0 0.5 0.0 7.8 0.0 0.0 0.0 12.4 14.4 2.3 0.0 0.0 0.0 0.0 0.0 37.7 8.8 0.0 0.0 0.0 191.0 8.6 2.8 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 2.2 0.0 0.1 0.0 2.1 0.2 0.2 0.3 0.0 0.2 0.0 0.1 24.1 0.0 0.0 0.0 0.0 0.9 26.5 0.1 16.8 23.2 0.2 17.0 4.6 44.6 36.5 0.1 4.7 48.0 22.6 0.8 25.2 0.2 1.1 32.4 22.6 27.0 37.8 7.8 25.8 33.6 22.5 34.8 19.5 25.8 12.5 3.0 20.8 15.9 13.6 59.9 2.3 25.4 5.1 1.4 7.9 1.8 0.0 0.4 5.0 0.2 2.4 252.4 0.0 0.0 46.7 0.1 64.7 9.2 190.5 0.8 1.0 1.6 2.4 119.7 10.6 4.7 310.7 4.2 59.1 1.0 66.9 153.0 0.9 0.0 110.7 1.1 5.8 0.0 20.2 0.4 1.1 41.0 0.2 187.1 2.3 2.3 ITPKA "IP3-3KA, IP3KA" ENSG00000137825 "Inositol-trisphosphate 3-kinase A" P23677 15 41493393-41503551 "Enzymes, Predicted intracellular proteins" "Calmodulin-binding, Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 28.8;intestine: 19.8;stomach 1: 10.7" "Cell type enhanced" "Detected in some" 23 "Early spermatids: 36.6;Enterocytes: 34.8;Late spermatids: 119.2" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 5 "amygdala: 12.3;basal ganglia: 21.2;cerebral cortex: 28.8;hippocampal formation: 10.4;olfactory region: 8.2" "Cell type enriched" "Detected in single" 8 "MAIT T-cell: 4.7" "Lineage enriched" "Detected in single" 13 "T-cells: 4.7" "Cell line enhanced" "Detected in many" "Hep G2: 22.7;OE19: 12.5" "Group enriched" "Detected in many" 13 "amygdala: 120.1;basal ganglia: 97.6;cerebellum: 62.9;cerebral cortex: 164.4;hippocampal formation: 162.9" "Group enriched" "Detected in many" 7 "amygdala: 12.1;basal ganglia: 40.8;cerebral cortex: 32.2;hippocampal formation: 28.6" HPA040454 Enhanced Approved Approved "Vesicles,Plasma membrane" No No Vesicles "Plasma membrane" "HPA040454: AB_10672897" "unprognostic (5.91e-2)" "unprognostic (2.16e-3)" "unprognostic (4.19e-1)" "unprognostic (3.57e-3)" "prognostic unfavorable (6.77e-4)" "unprognostic (2.25e-2)" "unprognostic (2.69e-2)" "unprognostic (1.01e-1)" "unprognostic (3.58e-1)" "unprognostic (1.28e-1)" "unprognostic (1.21e-1)" "unprognostic (2.06e-1)" "prognostic unfavorable (3.76e-9)" "unprognostic (2.15e-1)" "unprognostic (2.87e-1)" "unprognostic (1.12e-3)" "unprognostic (2.10e-2)" 0.4 3.0 12.3 1.1 21.2 0.8 0.4 3.0 28.8 0.6 8.5 0.3 0.0 19.8 0.6 0.5 0.4 0.6 0.6 0.7 10.4 0.9 0.4 0.8 0.4 0.4 1.6 8.2 0.6 2.5 1.7 0.0 0.7 0.3 0.8 3.4 0.0 2.1 0.8 1.4 0.4 19.7 0.7 0.2 0.4 10.7 3.5 0.6 0.0 0.4 0.0 0.4 0.4 0.2 0.0 0.0 0.0 0.0 0.3 4.7 0.0 4.7 1.3 0.2 5.6 0.0 1.8 10.2 3.0 2.4 2.0 2.1 11.2 0.2 0.0 2.5 0.2 4.5 0.5 2.4 0.2 0.1 4.5 3.0 6.8 3.0 22.7 9.2 2.3 0.3 0.1 0.1 1.9 0.6 1.1 0.1 0.9 8.6 1.3 0.7 3.1 0.2 4.4 0.6 12.5 4.0 1.1 1.0 0.4 0.2 0.3 0.5 1.1 2.2 0.0 0.2 0.0 0.6 3.4 0.2 4.9 5.1 5.4 8.1 0.7 7.1 0.0 9.1 9.0 1.6 0.0 0.0 0.0 0.3 0.0 4.7 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 12.3 21.2 3.0 28.8 10.4 0.9 1.6 8.2 0.3 0.6 0.0 0.0 0.0 0.4 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 36.6 0.0 34.8 0.0 0.6 0.4 0.2 0.2 0.0 0.0 0.2 0.0 0.0 0.6 0.0 119.2 2.3 0.0 0.0 0.0 12.0 7.3 0.4 19.3 1.4 0.0 0.1 6.5 0.7 1.9 3.0 0.0 0.1 0.0 14.4 0.1 JAG1 "AGS, AHD, AWS, CD339, HJ1, JAGL1" ENSG00000101384 "Jagged 1" P78504 20 10637684-10673999 "CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Notch signaling pathway" "Developmental protein" "Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Smooth muscle cells: 154.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 2.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 56.7;hTERT-HME1: 35.0;U-251 MG: 47.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB010343, HPA021555" Supported Approved "Golgi apparatus,Plasma membrane" NA NA 14000000 "Golgi apparatus, Plasma membrane" "CAB010343: AB_649685, HPA021555: AB_1851969" "unprognostic (2.23e-1)" "unprognostic (2.04e-2)" "unprognostic (1.78e-1)" "unprognostic (4.15e-2)" "unprognostic (1.21e-1)" "unprognostic (6.42e-2)" "unprognostic (4.21e-2)" "unprognostic (8.94e-3)" "unprognostic (6.07e-2)" "unprognostic (5.20e-2)" "prognostic unfavorable (4.10e-6)" "unprognostic (5.48e-2)" "unprognostic (1.71e-3)" "unprognostic (2.22e-1)" "unprognostic (1.66e-1)" "unprognostic (3.10e-1)" "unprognostic (1.41e-3)" 27.7 5.6 6.8 14.5 5.4 9.7 56.5 2.9 6.7 34.2 20.1 4.3 17.4 7.2 26.1 22.8 33.9 16.7 23.1 18.8 5.4 5.1 12.9 3.8 22.0 12.4 5.4 4.0 14.7 22.2 21.7 6.0 36.3 6.0 19.2 12.7 21.4 11.2 23.4 16.8 34.8 11.7 21.4 13.0 14.2 13.4 9.1 3.8 1.5 14.5 24.6 16.1 18.7 31.4 0.0 0.9 2.4 2.0 0.4 0.1 0.4 1.0 5.3 16.6 20.4 3.2 3.1 0.6 0.6 3.1 0.9 0.4 4.7 2.9 0.1 15.7 0.6 4.7 22.2 2.4 56.7 0.7 0.0 1.1 1.7 0.5 22.2 1.5 7.1 0.1 1.2 16.8 2.8 35.0 3.3 5.5 0.0 0.0 2.3 1.5 0.0 0.0 5.1 4.8 17.5 5.3 1.3 1.0 3.3 8.0 6.5 0.7 0.5 1.6 1.1 6.7 13.8 0.1 0.8 20.7 3.8 2.6 3.1 47.7 0.9 0.1 0.2 2.4 2.6 2.9 0.0 2.0 2.4 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 1.6 0.4 0.3 0.9 0.0 0.4 6.8 5.4 2.9 6.7 5.4 5.1 5.4 4.0 6.0 3.8 38.7 12.5 0.0 46.4 93.0 10.0 12.5 35.7 20.1 22.7 15.7 41.2 12.0 1.7 26.8 3.9 70.8 26.0 0.0 27.0 0.9 33.7 18.4 6.9 1.5 3.7 20.6 5.1 38.1 3.7 6.3 19.8 7.7 13.5 1.8 10.2 9.3 60.7 22.4 31.8 2.1 72.6 84.1 154.6 0.7 2.8 93.3 1.8 0.0 22.9 32.5 JAK2 JTK10 ENSG00000096968 "Janus kinase 2" O60674 9 4984390-5128183 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Immunity, Innate immunity" "Chromatin regulator, Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Kupffer cells: 36.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 40.8" "Lineage enriched" "Detected in all" 4 "granulocytes: 40.8" "Group enriched" "Detected in many" 5 "ASC diff: 19.4;HDLM-2: 27.4;HEL: 56.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013089, HPA040820, HPA043870" Approved Supported "Nucleoplasm,Plasma membrane,Focal adhesion sites" No No Nucleoplasm "Plasma membrane, Focal adhesion sites" "CAB013089: AB_2533647, HPA040820: AB_2677151, HPA043870: AB_2678708" "unprognostic (2.24e-3)" "unprognostic (2.76e-2)" "unprognostic (1.50e-2)" "unprognostic (7.67e-2)" "unprognostic (5.50e-2)" "unprognostic (3.09e-2)" "unprognostic (1.48e-1)" "unprognostic (7.36e-2)" "unprognostic (1.09e-1)" "unprognostic (5.49e-3)" "unprognostic (1.58e-1)" "unprognostic (1.72e-2)" "unprognostic (3.85e-1)" "unprognostic (4.53e-2)" "unprognostic (3.43e-2)" "unprognostic (1.96e-1)" "unprognostic (7.37e-3)" 19.8 8.8 11.5 19.0 10.5 19.0 17.7 14.7 14.4 17.8 10.6 7.0 10.3 7.2 14.8 13.6 12.4 13.4 14.6 27.6 10.3 6.7 7.7 5.6 16.1 19.4 7.0 10.5 15.9 6.7 10.1 7.5 12.0 10.0 12.0 7.4 9.4 7.2 7.4 14.4 19.0 12.3 10.4 11.7 21.5 14.1 10.1 9.0 13.6 8.6 6.5 13.5 13.9 15.6 2.1 9.6 40.8 7.5 3.4 2.1 2.5 2.5 1.5 1.5 2.5 19.4 5.0 0.4 3.5 3.0 2.7 1.8 0.1 0.8 0.1 0.8 2.1 2.2 0.9 1.6 2.1 2.0 27.4 0.5 56.1 3.0 0.7 4.0 3.8 2.9 4.1 0.9 1.1 1.8 3.3 2.5 2.0 4.0 6.5 4.8 0.9 0.9 5.4 1.3 1.3 1.7 1.9 2.8 0.8 2.0 1.3 1.7 0.9 1.0 1.5 1.1 1.6 0.8 6.7 5.1 4.1 1.4 4.2 2.4 1.2 2.3 0.5 5.3 1.9 2.0 40.8 7.5 13.4 2.1 7.3 1.7 2.1 1.6 1.2 9.6 1.9 0.9 1.1 7.1 3.4 5.8 3.6 1.6 2.5 11.5 10.5 14.7 14.4 10.3 6.7 7.0 10.5 10.0 9.0 14.9 6.4 6.9 2.8 8.7 7.4 22.0 0.0 5.3 7.9 7.0 7.9 1.8 1.7 3.0 7.4 8.7 3.9 23.3 3.4 0.8 7.0 1.7 13.9 1.6 11.9 7.9 2.9 4.9 36.0 5.3 21.9 27.7 5.0 16.2 4.2 12.2 5.4 14.4 31.5 2.5 11.1 0.0 5.0 14.9 5.7 7.3 2.9 5.0 3.3 4.1 JAK3 "JAK-3, JAK3_HUMAN, JAKL, L-JAK, LJAK" ENSG00000105639 "Janus kinase 3" P52333 19 17824780-17848071 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Adaptive immunity, Immunity, Innate immunity" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 68.3" "Cell type enhanced" "Detected in many" 7 "B-cells: 18.2;Ito cells: 14.1;Peritubular cells: 13.8;T-cells: 24.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 20.6;HEL: 9.2;HMC-1: 9.4;Karpas-707: 24.0;U-266/70: 9.3;U-266/84: 13.8;U-937: 14.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA070314 Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA070314: AB_2686251" "unprognostic (5.59e-3)" "prognostic favorable (6.42e-5)" "unprognostic (5.71e-2)" "unprognostic (2.34e-1)" "unprognostic (6.13e-3)" "unprognostic (1.11e-3)" "unprognostic (4.21e-2)" "unprognostic (2.60e-1)" "unprognostic (2.38e-2)" "unprognostic (2.36e-1)" "unprognostic (3.58e-2)" "unprognostic (1.94e-1)" "prognostic unfavorable (2.89e-14)" "unprognostic (2.28e-1)" "unprognostic (2.21e-2)" "unprognostic (4.43e-2)" "unprognostic (7.61e-2)" 6.8 1.7 4.0 24.5 8.5 12.0 2.7 2.4 3.1 1.9 2.3 1.0 0.0 2.2 1.7 2.0 2.5 3.5 3.6 4.3 2.7 2.8 3.8 2.0 8.4 68.3 7.5 0.0 11.0 2.0 0.4 2.3 4.1 5.3 3.0 2.4 1.6 6.1 1.5 0.7 1.3 9.5 2.5 8.4 36.1 3.2 1.8 5.8 20.9 3.4 1.7 28.8 5.3 2.4 7.4 4.5 16.9 9.6 8.4 15.0 6.8 0.1 0.3 0.3 1.1 0.4 1.5 0.2 0.5 0.0 0.0 0.1 0.0 0.9 0.4 2.0 0.4 0.3 0.1 0.0 0.2 0.0 20.6 0.0 9.2 0.0 0.8 0.7 0.0 9.4 5.1 0.2 0.0 0.0 0.0 0.2 2.1 0.0 24.0 0.0 0.4 3.6 0.0 0.2 0.5 0.7 4.7 0.0 0.4 0.5 0.0 0.0 0.3 0.1 0.2 0.0 0.1 2.0 1.4 0.4 0.0 0.4 0.0 0.0 9.3 13.8 2.5 0.1 14.0 0.2 1.2 4.9 0.2 12.6 9.6 14.5 6.5 15.0 13.1 4.5 7.4 14.9 13.0 16.9 8.4 8.8 3.7 11.8 6.8 4.0 8.5 2.4 3.1 2.7 2.8 7.5 0.0 5.3 5.8 0.0 5.8 18.2 0.5 0.7 0.3 1.4 0.0 0.0 1.2 1.8 0.0 0.9 0.0 0.6 1.0 5.8 0.0 0.0 0.3 0.7 2.3 0.2 4.7 0.0 11.5 0.0 0.0 14.1 10.8 0.9 11.5 3.5 3.3 12.6 0.0 0.8 0.4 0.0 13.8 0.1 0.5 6.5 2.1 0.3 0.7 0.9 1.1 24.5 0.0 0.5 KANK3 "ANKRD47, FLJ46061" ENSG00000186994 "KN motif and ankyrin repeat domains 3" Q6NY19 19 8322584-8343262 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Endothelial cells: 58.3;Ito cells: 34.4;Sertoli cells: 19.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "granulocytes: 1.0;NK-cells: 3.6;T-cells: 3.5" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 9.3;TIME: 16.8;U-266/70: 6.9" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 5 "olfactory region: 34.0" HPA051153 Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA051153: AB_2681365" "unprognostic (1.56e-1)" "unprognostic (1.63e-4)" "unprognostic (1.54e-2)" "unprognostic (8.95e-3)" "unprognostic (1.07e-1)" "unprognostic (2.84e-3)" "unprognostic (1.82e-3)" "unprognostic (3.26e-2)" "unprognostic (1.19e-1)" "unprognostic (1.39e-2)" "unprognostic (1.34e-2)" "unprognostic (4.77e-1)" "prognostic favorable (1.69e-5)" "unprognostic (5.03e-2)" "unprognostic (1.67e-1)" "unprognostic (2.86e-1)" "unprognostic (3.24e-1)" 23.3 3.6 5.2 3.8 4.8 1.2 13.2 2.7 6.5 3.8 5.6 1.6 2.9 4.0 5.4 6.2 4.7 5.2 3.4 9.6 6.2 2.9 7.7 2.3 19.0 6.3 4.4 1.6 3.1 3.1 1.6 3.5 18.3 4.8 3.3 1.2 6.4 3.4 2.8 15.5 3.5 4.0 3.5 2.8 21.0 3.1 2.5 5.0 0.3 7.9 3.0 1.6 2.5 6.7 0.5 0.3 1.0 0.3 3.6 3.5 0.7 0.1 0.7 0.3 0.6 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.8 0.2 0.0 2.7 0.0 0.1 0.1 0.6 2.9 0.0 0.8 1.6 0.4 0.4 0.5 0.1 0.2 1.5 0.0 0.9 0.0 0.0 0.0 9.3 0.7 0.0 0.4 0.0 0.5 0.0 0.5 0.6 0.6 0.3 1.5 0.0 0.8 0.1 0.2 0.0 0.1 0.0 0.8 0.1 0.0 0.6 0.0 16.8 0.1 1.6 0.4 0.1 6.9 0.2 0.3 0.2 0.1 0.2 0.8 0.3 0.1 3.5 0.1 1.6 0.3 1.9 0.6 0.1 0.5 0.8 1.3 1.0 3.6 0.1 0.3 1.3 0.7 5.2 4.8 2.7 6.5 6.2 2.9 4.4 1.6 4.8 5.0 6.0 5.6 0.0 0.2 2.3 0.2 0.8 0.0 0.0 0.0 0.0 3.9 0.3 5.0 0.2 4.0 58.3 0.0 0.0 1.6 0.2 1.7 0.8 0.0 0.8 0.4 0.0 0.0 34.4 1.6 4.1 0.6 0.7 5.0 0.0 0.0 0.2 0.4 0.0 0.4 0.3 0.7 19.4 2.5 1.1 3.1 1.1 0.2 2.5 0.0 0.5 KATNB1 ENSG00000140854 "Katanin regulatory subunit B1" Q9BVA0 16 57735730-57757250 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Disease mutation, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 86.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041165, HPA041839" Enhanced Supported "Plasma membrane,Microtubules,Cytosol" NA NA "Plasma membrane, Cytosol" Microtubules "HPA041165: AB_10795584, HPA041839: AB_10795598" "unprognostic (1.37e-1)" "unprognostic (2.76e-2)" "unprognostic (1.56e-1)" "prognostic favorable (9.24e-4)" "unprognostic (2.54e-1)" "unprognostic (2.51e-1)" "prognostic unfavorable (3.93e-4)" "unprognostic (1.42e-1)" "unprognostic (2.92e-1)" "unprognostic (1.75e-1)" "prognostic favorable (8.44e-4)" "unprognostic (2.89e-2)" "unprognostic (1.03e-3)" "unprognostic (2.20e-1)" "unprognostic (1.29e-1)" "unprognostic (6.88e-2)" "unprognostic (1.54e-1)" 6.9 9.1 15.3 9.3 21.4 18.7 6.3 13.2 29.0 7.0 7.4 8.8 6.7 9.4 6.6 5.8 11.0 18.7 5.9 8.5 16.0 14.5 5.8 10.3 8.0 8.8 9.3 14.1 7.0 9.4 9.5 8.0 7.9 10.6 6.3 5.2 6.2 11.9 8.0 7.1 21.4 8.5 6.0 6.9 8.0 9.1 32.7 8.1 10.8 7.2 10.3 8.6 7.4 6.4 5.8 9.8 24.6 11.6 8.4 12.4 10.5 7.4 13.7 7.5 9.7 4.2 3.7 13.3 5.3 7.0 13.9 7.7 11.4 6.7 6.1 10.6 3.4 5.1 10.1 10.1 10.6 6.3 4.1 28.7 8.0 7.6 15.6 4.4 17.3 29.9 3.8 6.5 10.9 6.4 5.8 8.2 22.3 15.6 3.0 5.5 8.0 25.0 22.5 13.2 5.4 23.8 20.1 9.4 22.0 4.2 3.7 38.1 11.4 8.6 10.4 6.2 3.1 3.9 8.9 5.8 9.8 8.6 8.5 11.4 7.0 5.5 7.4 13.6 13.4 6.0 24.1 10.1 24.6 12.4 11.2 12.4 5.6 10.5 9.9 9.8 5.8 10.1 10.0 15.5 8.4 11.6 7.4 10.9 10.5 15.3 21.4 13.2 29.0 16.0 14.5 9.3 14.1 10.6 8.1 3.0 5.6 3.7 6.3 8.0 8.0 1.7 5.1 14.7 4.5 5.2 5.9 14.7 10.0 10.8 86.6 5.3 9.2 0.0 11.9 10.0 8.5 6.7 4.7 3.8 8.6 17.5 4.6 5.5 5.3 24.3 7.2 5.3 6.8 6.4 8.3 8.7 7.8 3.5 4.6 5.9 9.4 6.5 5.0 25.9 8.3 12.0 6.4 11.7 11.9 8.2 KCNB2 Kv2.2 ENSG00000182674 "Potassium voltage-gated channel subfamily B member 2" Q92953 8 72537391-72938349 "FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.7;lymphoid tissue: 8.6;pituitary gland: 9.2" "Cell type enriched" "Detected in some" 15 "Cone photoreceptor cells: 249.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HaCaT: 3.2;HDLM-2: 3.1;HEK 293: 7.6;SCLC-21H: 6.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA065970 Approved "Nucleoli,Plasma membrane,Midbody" Yes NA "Plasma membrane" "Nucleoli, Midbody" "HPA065970: AB_2685591" "unprognostic (9.87e-3)" "unprognostic (1.71e-1)" "unprognostic (7.57e-2)" "unprognostic (1.10e-3)" "unprognostic (1.22e-1)" "unprognostic (1.34e-1)" "unprognostic (1.44e-2)" "unprognostic (2.72e-1)" "unprognostic (6.93e-5)" "unprognostic (5.53e-3)" "unprognostic (3.30e-2)" "unprognostic (1.62e-1)" "unprognostic (3.35e-2)" "unprognostic (3.26e-1)" 0.8 1.9 3.8 0.6 5.3 0.4 0.7 0.3 9.7 0.5 0.7 0.0 0.0 1.2 0.4 0.4 1.1 2.1 0.5 0.4 7.1 3.1 0.5 0.4 0.6 0.5 0.9 7.8 0.4 2.4 0.4 9.2 0.5 3.2 0.7 0.7 4.2 0.5 0.5 0.4 0.4 1.6 0.5 1.6 8.6 2.4 1.7 0.4 0.9 0.4 0.0 0.9 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 3.1 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 5.3 0.3 9.7 7.1 3.1 0.9 7.8 3.2 0.4 0.0 0.0 0.0 0.0 0.0 12.9 0.2 0.0 0.0 0.0 1.8 249.4 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 17.1 0.0 0.0 5.0 1.1 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.4 0.0 2.4 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 KCNJ15 "IRKK, Kir1.3, Kir4.2" ENSG00000157551 "Potassium voltage-gated channel subfamily J member 15" Q99712 21 38155549-38307357 "Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 74.8;kidney: 99.7" "Cell type enhanced" "Detected in many" 16 "Alveolar cells type 1: 56.6;Alveolar cells type 2: 153.4;Cholangiocytes: 63.7;Proximal tubular cells: 211.6" "Cancer enhanced" "Detected in many" "thyroid cancer: 29.6" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 21 "neutrophil: 74.8" "Lineage enriched" "Detected in many" 21 "granulocytes: 74.8" "Cell line enhanced" "Detected in some" "ASC TERT1: 26.1;GAMG: 37.4;HBEC3-KT: 25.1;RPTEC TERT1: 25.0;RT4: 29.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA016702 Approved Approved "Vesicles,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Vesicles, Cytosol" "HPA016702: AB_1855560" "unprognostic (6.34e-2)" "unprognostic (5.04e-2)" "unprognostic (7.92e-2)" "unprognostic (2.07e-3)" "unprognostic (1.21e-1)" "unprognostic (3.54e-3)" "unprognostic (2.72e-3)" "unprognostic (3.03e-2)" "unprognostic (6.79e-2)" "unprognostic (2.89e-3)" "unprognostic (3.77e-2)" "unprognostic (1.95e-2)" "prognostic favorable (4.09e-10)" "unprognostic (9.46e-3)" "unprognostic (1.82e-1)" "unprognostic (5.27e-2)" "prognostic favorable (1.95e-4)" 6.0 0.3 0.4 5.3 0.3 3.2 1.4 0.2 0.3 3.5 0.4 0.2 27.1 0.2 0.5 12.8 6.0 0.8 17.7 1.0 0.2 0.1 99.7 1.5 34.1 0.8 0.5 0.2 0.6 16.7 0.0 0.3 1.0 0.6 4.0 0.0 0.2 14.4 26.8 1.0 1.7 0.2 0.9 0.4 6.8 10.7 1.1 0.2 0.4 36.8 3.2 1.9 11.3 4.3 0.0 0.2 74.8 3.5 0.0 0.0 0.7 0.6 0.0 0.1 0.2 5.1 26.1 0.2 0.3 1.7 0.0 0.0 0.0 0.2 0.1 0.0 2.7 37.4 8.8 0.0 25.1 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 7.7 2.5 6.5 1.4 0.5 1.2 0.0 0.0 0.2 11.5 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.1 0.2 25.0 29.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.1 1.3 0.0 0.6 0.1 0.0 2.1 1.5 0.1 0.0 3.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 74.8 0.0 0.0 0.0 0.0 0.7 0.4 0.3 0.2 0.3 0.2 0.1 0.5 0.2 0.6 0.2 56.6 153.4 0.8 8.5 2.5 0.0 1.2 63.7 9.4 52.4 29.6 0.0 0.1 14.9 23.3 1.4 1.4 0.0 0.0 7.8 0.4 0.8 0.4 5.8 0.0 0.3 0.0 0.0 1.3 5.1 1.9 0.6 2.6 1.7 0.0 0.0 0.0 26.3 0.0 0.0 211.6 0.0 0.0 1.0 0.9 1.0 1.4 0.1 0.0 0.0 4.1 KCNK6 "K2p6.1, TWIK-2" ENSG00000099337 "Potassium two pore domain channel subfamily K member 6" Q9Y257 19 38319844-38332076 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Ito cells: 179.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 16.2" "Group enriched" "Detected in many" 5 "dendritic cells: 8.9;granulocytes: 16.2;monocytes: 5.4" "Cell line enhanced" "Detected in many" "HEL: 21.9;HMC-1: 24.6;T-47d: 13.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB022637, HPA040184" Uncertain Approved "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane, Cytosol" "Actin filaments" "CAB022637: , HPA040184: AB_2676876" "unprognostic (7.98e-2)" "unprognostic (2.57e-1)" "unprognostic (1.29e-1)" "prognostic favorable (1.45e-6)" "unprognostic (3.76e-1)" "unprognostic (6.88e-2)" "unprognostic (1.87e-1)" "unprognostic (3.08e-2)" "unprognostic (4.31e-1)" "unprognostic (4.91e-1)" "unprognostic (4.10e-3)" "unprognostic (3.15e-1)" "prognostic unfavorable (1.04e-5)" "unprognostic (1.07e-2)" "unprognostic (3.46e-1)" "unprognostic (5.88e-2)" "unprognostic (4.59e-3)" 3.0 2.0 2.1 7.4 2.5 2.8 4.9 0.8 2.0 25.3 9.2 1.7 10.6 3.8 20.1 5.2 21.7 8.6 13.1 4.3 2.1 1.0 2.8 2.7 7.1 8.9 2.0 1.3 8.0 21.3 0.2 1.7 11.6 2.3 7.3 8.3 2.3 29.0 13.5 0.9 15.1 10.1 13.4 3.7 12.7 7.0 2.0 2.2 4.2 1.7 17.5 18.8 14.3 12.5 1.2 8.9 16.2 5.4 0.6 1.9 1.5 5.3 2.0 0.3 0.3 3.2 2.1 0.4 4.6 2.3 1.2 1.6 1.5 5.9 0.4 2.2 6.6 1.3 7.0 2.5 10.5 0.8 0.2 0.2 21.9 1.0 0.2 2.9 1.6 24.6 0.5 9.5 1.5 2.9 6.4 3.2 3.6 0.3 1.7 3.4 11.7 1.5 1.4 0.3 11.3 1.3 2.3 0.4 1.6 4.3 0.5 0.3 0.5 0.5 0.5 0.2 1.1 13.8 6.2 3.5 0.4 2.8 2.5 0.2 0.6 0.1 0.6 0.4 7.9 0.2 16.2 5.4 11.7 1.3 4.8 1.1 1.2 1.7 1.6 8.9 1.1 1.5 1.1 4.2 0.6 5.1 2.5 1.9 1.5 2.1 2.5 0.8 2.0 2.1 1.0 2.0 1.3 2.3 2.2 0.0 14.6 13.7 23.5 38.2 2.8 10.2 22.9 6.7 9.1 7.0 5.9 1.3 0.0 19.0 1.1 17.5 33.5 70.0 41.6 3.3 11.7 39.3 21.9 1.0 34.5 0.0 12.1 179.2 66.5 0.5 23.9 52.6 5.0 14.4 56.7 0.9 47.3 39.3 19.1 0.3 5.0 25.8 6.9 9.3 2.7 58.7 2.1 10.1 24.1 88.8 KCNK7 K2p7.1 ENSG00000173338 "Potassium two pore domain channel subfamily K member 7" Q9Y2U2 11 65592855-65595996 "Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "skin 1: 35.0;tongue: 20.7" "Cell type enriched" "Detected in some" 5 "Suprabasal keratinocytes: 90.7" "Cancer enhanced" "Detected in many" "head and neck cancer: 4.4" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 12 "basophil: 4.8;naive B-cell: 2.9;neutrophil: 3.6" "Group enriched" "Detected in many" 12 "B-cells: 2.9;granulocytes: 4.8" "Cell line enhanced" "Detected in many" "SCLC-21H: 12.4" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA077577 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA077577: AB_2686845" "unprognostic (1.12e-2)" "unprognostic (1.21e-1)" "unprognostic (6.08e-2)" "unprognostic (5.71e-2)" "unprognostic (8.59e-2)" "unprognostic (1.34e-1)" "unprognostic (1.68e-3)" "unprognostic (8.53e-2)" "unprognostic (1.69e-1)" "unprognostic (2.87e-1)" "unprognostic (6.90e-2)" "unprognostic (4.88e-2)" "unprognostic (1.49e-2)" "unprognostic (2.65e-1)" "unprognostic (3.57e-1)" "unprognostic (1.16e-1)" "unprognostic (8.11e-2)" 0.6 0.6 0.8 0.3 0.7 3.9 2.6 1.6 2.1 1.4 0.5 0.8 0.3 0.4 0.4 0.3 10.8 0.6 0.3 0.5 0.8 0.4 0.3 0.3 0.3 0.3 0.6 1.1 0.6 0.3 0.1 0.3 0.5 0.4 0.3 0.1 0.3 0.8 0.4 1.8 35.0 0.5 0.3 0.7 0.5 0.3 0.3 0.5 0.7 0.3 20.7 5.7 0.3 3.4 2.9 0.0 4.8 0.2 0.2 0.3 0.1 0.5 2.3 0.1 0.7 0.0 0.0 0.2 0.3 0.0 0.5 0.1 0.3 1.7 0.8 0.7 0.2 0.4 3.8 0.0 0.0 0.0 0.8 2.6 0.8 1.2 1.0 0.0 0.0 0.6 0.1 0.0 0.2 0.0 0.4 0.0 1.6 1.4 2.2 0.7 1.7 0.9 0.7 1.0 1.0 2.2 1.6 0.0 0.4 1.0 0.2 12.4 2.8 0.5 0.7 1.2 0.1 0.7 2.2 0.0 0.6 1.9 1.9 0.1 2.0 1.3 0.5 1.4 1.1 1.0 4.8 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 2.9 0.1 0.0 3.6 0.2 0.2 0.0 0.0 0.1 0.8 0.7 1.6 2.1 0.8 0.4 0.6 1.1 0.4 0.5 0.0 0.3 0.0 0.4 16.9 2.3 0.1 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.5 0.3 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.4 0.0 1.2 0.0 1.5 1.3 0.6 0.0 3.3 0.0 0.3 0.2 0.1 2.8 0.0 0.0 0.8 6.5 1.9 0.1 0.5 90.7 0.0 0.0 0.5 1.0 KCNK9 "K2p9.1, TASK-3, TASK3" ENSG00000169427 "Potassium two pore domain channel subfamily K member 9" Q9NPC2 8 139600838-139703056 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Disease mutation, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "adrenal gland: 9.4;brain: 15.4" "Cell type enhanced" "Detected in some" 18 "Collecting duct cells: 1.8;Distal tubular cells: 1.7;Exocrine glandular cells: 2.2;Late spermatids: 4.6" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "cerebellum: 15.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "PC-3: 6.6;SCLC-21H: 2.9;SH-SY5Y: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075842 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA075842: " "unprognostic (1.84e-2)" "unprognostic (2.57e-1)" "unprognostic (1.58e-1)" "unprognostic (8.96e-8)" "unprognostic (1.91e-1)" "unprognostic (8.17e-3)" "unprognostic (2.19e-3)" "unprognostic (1.65e-1)" "unprognostic (3.87e-1)" "unprognostic (1.69e-1)" "unprognostic (1.00e-2)" "unprognostic (3.21e-1)" "unprognostic (5.12e-6)" "unprognostic (2.94e-2)" "unprognostic (1.64e-1)" "unprognostic (9.99e-3)" "unprognostic (1.76e-1)" 0.2 9.4 0.5 0.5 1.0 0.1 0.1 15.4 7.7 1.3 0.5 0.0 0.0 0.1 0.3 0.1 0.2 0.3 0.1 0.2 1.6 1.4 0.1 0.1 0.1 0.1 0.7 1.7 0.1 0.1 0.1 1.1 0.2 6.6 0.1 0.2 0.2 0.1 0.1 1.4 0.1 0.1 0.6 0.6 0.1 0.3 0.5 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 6.6 0.0 0.0 0.0 0.0 0.0 2.9 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 1.0 15.4 3.7 1.6 1.4 0.7 1.7 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 1.8 0.0 0.0 1.7 0.2 1.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 KIAA0556 "JBTS26, KATNIP" ENSG00000047578 KIAA0556 O60303 16 27550133-27780369 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Joubert syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 33.6;Ciliated cells: 36.1;Cone photoreceptor cells: 64.8;Rod photoreceptor cells: 54.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 11.0" "Group enriched" "Detected in all" 4 "granulocytes: 11.0;NK-cells: 5.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035089, HPA035090" Enhanced Approved "Nuclear speckles,Plasma membrane" NA NA "Nuclear speckles" "Plasma membrane" "HPA035089: AB_10671509, HPA035090: AB_10601129" "unprognostic (1.81e-1)" "unprognostic (1.13e-1)" "unprognostic (1.55e-1)" "unprognostic (3.65e-3)" "unprognostic (7.76e-2)" "prognostic favorable (3.00e-4)" "unprognostic (2.72e-2)" "unprognostic (3.58e-2)" "unprognostic (2.02e-1)" "unprognostic (1.22e-1)" "unprognostic (2.94e-1)" "unprognostic (2.12e-1)" "unprognostic (1.47e-3)" "unprognostic (2.98e-1)" "unprognostic (2.11e-1)" "unprognostic (1.50e-3)" "unprognostic (1.45e-1)" 6.1 6.2 7.1 8.7 10.9 7.9 6.8 6.3 10.8 8.4 8.2 12.0 13.2 6.5 15.1 13.1 11.2 38.6 7.5 7.0 7.1 6.7 9.7 5.0 8.2 5.6 6.5 7.3 8.2 11.7 14.9 19.0 6.8 8.6 11.9 9.8 11.8 9.8 9.7 4.1 11.0 7.9 8.4 9.3 7.9 12.1 22.8 8.4 8.7 20.9 5.0 11.1 7.6 9.0 1.4 1.5 11.0 2.0 5.5 1.8 0.4 5.4 11.2 6.3 5.9 9.6 8.8 10.5 7.4 8.0 6.6 9.0 9.8 9.1 4.6 10.6 10.5 12.8 9.1 8.0 9.5 13.2 21.4 5.6 3.6 11.3 5.7 5.7 4.9 9.3 9.3 8.4 14.4 15.6 8.5 12.9 5.3 5.8 3.9 9.3 12.5 5.4 6.0 3.8 7.0 4.6 7.7 7.7 5.0 12.1 7.6 8.1 5.2 7.4 6.7 4.1 9.2 14.9 4.3 11.1 8.4 5.4 6.5 6.4 5.3 4.5 5.0 9.7 4.8 7.5 9.5 2.0 3.8 0.8 1.3 0.8 0.9 0.4 1.4 1.3 1.4 1.8 0.3 11.0 5.5 0.5 1.5 1.5 0.4 7.1 10.9 6.3 10.8 7.1 6.7 6.5 7.3 8.6 8.4 6.0 1.9 2.9 4.8 1.3 33.6 4.5 0.0 36.1 9.1 1.8 64.8 2.5 0.0 3.0 11.2 3.5 5.9 0.0 3.2 2.2 2.7 6.5 0.0 0.8 2.3 3.2 11.6 3.1 1.8 12.0 2.3 3.2 5.0 2.8 3.3 6.5 3.6 3.5 1.1 1.7 54.4 0.0 2.0 9.9 4.9 1.3 1.8 3.3 3.3 4.4 KIAA0895 ENSG00000164542 KIAA0895 Q8NCT3 7 36324221-36390125 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 69.3;Late spermatids: 54.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SCLC-21H: 28.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021036, HPA061066" Uncertain Approved "Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cell Junctions, Cytosol" "HPA021036: AB_2670571, HPA061066: AB_2684423" "unprognostic (4.94e-2)" "unprognostic (9.59e-2)" "unprognostic (2.93e-1)" "unprognostic (1.39e-1)" "unprognostic (8.85e-2)" "unprognostic (1.15e-3)" "unprognostic (3.79e-3)" "unprognostic (3.43e-1)" "unprognostic (3.74e-1)" "unprognostic (4.71e-3)" "unprognostic (1.46e-1)" "unprognostic (3.49e-1)" "unprognostic (4.51e-2)" "unprognostic (6.68e-2)" "unprognostic (3.06e-2)" "unprognostic (2.35e-2)" "unprognostic (5.24e-2)" 1.5 9.9 8.1 1.3 11.0 2.8 5.2 28.9 13.5 3.7 3.0 5.8 6.0 3.0 4.6 9.1 3.6 8.6 4.6 2.6 6.2 8.1 13.1 10.4 4.2 0.7 4.2 8.2 12.7 12.4 18.6 14.7 2.0 8.0 4.6 2.1 6.6 4.1 4.7 2.1 7.8 1.7 4.4 4.7 1.2 14.3 27.1 4.9 2.1 5.5 1.5 0.9 2.3 2.7 0.6 0.5 1.3 0.1 0.5 1.5 0.4 7.3 4.5 9.3 9.1 0.2 0.2 2.1 2.0 2.3 4.4 5.4 1.9 3.8 0.0 2.0 0.4 7.7 4.2 12.0 3.9 3.9 0.6 7.6 0.1 7.0 1.7 1.6 1.2 0.2 1.0 7.1 3.9 5.0 5.4 0.1 4.0 2.9 0.1 0.5 2.4 3.6 2.6 0.4 1.9 1.1 1.4 0.4 0.0 10.1 0.8 28.4 9.9 3.6 8.6 2.6 6.6 8.6 1.3 0.0 0.6 2.2 1.3 2.9 4.2 9.4 0.0 1.8 0.3 2.1 0.8 0.1 0.3 0.1 0.1 1.3 0.3 0.9 0.2 0.1 0.6 1.4 0.6 1.3 0.5 0.1 0.5 1.5 0.4 8.1 11.0 28.9 13.5 6.2 8.1 4.2 8.2 8.0 4.9 6.0 2.4 0.0 4.2 8.7 17.4 2.6 5.1 16.0 3.4 3.5 25.5 1.9 5.0 4.7 69.3 1.1 0.4 0.0 2.5 1.3 0.9 3.6 1.1 5.0 0.4 11.1 8.1 0.0 0.0 54.0 2.6 0.2 3.3 0.0 1.0 5.0 3.7 1.4 0.4 9.4 15.7 6.5 1.0 21.6 12.4 7.5 0.6 0.0 1.0 1.4 KIAA1958 FLJ39294 ENSG00000165185 KIAA1958 Q8N8K9 9 112486847-112669397 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Bipolar cells: 19.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020625 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA020625: AB_1852451" "unprognostic (3.09e-3)" "unprognostic (1.04e-1)" "unprognostic (1.61e-2)" "unprognostic (1.33e-1)" "unprognostic (7.48e-2)" "unprognostic (2.08e-2)" "unprognostic (2.01e-1)" "unprognostic (4.95e-2)" "unprognostic (1.14e-1)" "unprognostic (1.65e-2)" "unprognostic (2.73e-2)" "unprognostic (7.67e-2)" "unprognostic (5.48e-3)" "unprognostic (3.14e-2)" "unprognostic (1.82e-1)" "unprognostic (2.10e-2)" "unprognostic (2.58e-1)" 2.6 14.7 8.6 2.8 14.4 8.7 6.3 21.2 11.7 10.4 3.0 10.8 5.6 3.7 7.0 3.1 3.6 6.3 3.1 2.8 7.8 5.2 11.7 6.9 7.8 2.9 14.0 6.2 19.9 10.8 4.1 8.0 1.9 11.3 3.5 3.4 5.5 5.5 8.0 2.7 4.0 3.9 6.5 10.6 3.2 8.8 11.0 16.5 4.7 5.0 0.4 2.9 3.8 4.8 2.1 2.4 2.6 2.8 2.4 2.7 1.5 2.9 4.2 17.3 5.0 1.2 0.3 8.3 2.2 0.7 2.7 3.0 7.7 2.0 9.5 2.6 7.2 1.8 2.6 12.7 1.2 3.8 2.9 5.1 3.7 5.7 5.4 0.7 5.6 4.7 0.5 1.0 3.5 1.7 2.4 2.1 9.0 8.6 2.4 0.8 3.4 8.7 3.2 9.5 6.9 2.0 7.1 9.9 2.7 3.6 4.1 8.9 9.4 3.7 3.9 2.2 10.0 3.5 5.7 0.4 0.9 5.2 0.6 2.7 4.5 8.1 5.7 1.2 3.9 0.7 1.4 2.8 0.2 2.1 0.9 0.9 0.3 0.8 1.6 0.9 2.1 2.0 2.7 2.6 2.4 0.8 2.4 0.4 1.5 8.6 14.4 21.2 11.7 7.8 5.2 14.0 6.2 11.3 16.5 3.0 13.4 0.0 3.6 4.1 19.3 3.6 2.5 2.7 9.1 1.8 13.7 1.0 6.6 2.5 3.4 0.8 3.6 0.0 5.9 0.9 1.7 5.6 0.0 6.8 0.8 6.4 4.6 0.6 3.5 1.5 6.1 4.1 1.7 0.0 4.4 11.6 3.3 4.3 4.9 9.8 11.0 6.5 2.1 1.1 4.7 4.1 0.7 1.0 5.2 3.5 KIF17 "KIAA1405, KIF17B, KIF3X, KLP-2, OSM-3" ENSG00000117245 "Kinesin family member 17" Q9P2E2 1 20664014-20718017 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.2;testis: 19.4" "Cell type enhanced" "Detected in many" 17 "Early spermatids: 35.8;Ito cells: 16.5;Late spermatids: 60.3;Sertoli cells: 19.4" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 4 "amygdala: 2.4;basal ganglia: 5.2;cerebral cortex: 3.6;hippocampal formation: 1.8;hypothalamus: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 3.8;hTERT-HME1: 8.4;U-2 OS: 5.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA032085 Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA032085: AB_10669917" "unprognostic (4.15e-3)" "unprognostic (8.60e-3)" "unprognostic (6.43e-2)" "unprognostic (1.12e-2)" "unprognostic (7.68e-2)" "unprognostic (3.70e-1)" "unprognostic (1.07e-2)" "unprognostic (1.04e-1)" "unprognostic (7.11e-2)" "unprognostic (1.08e-1)" "unprognostic (7.34e-3)" "unprognostic (8.73e-2)" "unprognostic (3.63e-3)" "unprognostic (1.08e-2)" "unprognostic (2.26e-1)" "unprognostic (1.22e-1)" "unprognostic (1.20e-2)" 0.1 0.4 2.4 0.2 5.2 0.1 0.1 0.0 3.9 0.4 0.2 0.4 0.0 0.3 0.4 0.8 0.1 3.1 0.2 0.2 1.8 3.5 0.2 0.1 0.4 0.1 0.4 0.7 0.6 0.1 0.2 1.5 0.7 0.5 0.4 0.1 0.0 0.1 0.8 0.1 0.1 0.2 0.9 0.3 0.1 0.1 19.4 0.0 0.0 0.9 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.5 0.9 0.0 0.0 0.1 0.2 2.7 3.8 1.5 0.9 0.4 1.0 0.0 1.2 2.0 0.7 0.0 1.3 0.9 1.1 0.0 0.3 0.0 0.0 0.4 1.6 0.0 0.0 0.3 0.8 1.0 8.4 1.0 0.0 0.1 0.6 0.0 1.8 0.1 0.0 0.0 2.5 0.1 1.8 0.0 0.1 0.0 0.6 0.0 0.7 1.5 0.5 0.0 0.3 1.6 0.0 0.0 0.0 0.6 5.1 0.5 0.4 0.1 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 5.2 0.0 3.6 1.8 3.5 0.4 0.7 0.5 0.0 0.0 0.0 0.0 0.0 1.4 0.0 1.6 0.0 2.7 0.0 1.8 3.9 0.1 0.0 0.0 35.8 12.6 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.4 4.0 0.0 0.0 16.5 1.5 60.3 1.1 3.3 1.7 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.3 19.4 1.4 1.5 4.2 1.1 1.4 0.0 0.0 0.1 KIF19 "FLJ37300, KIF19A" ENSG00000196169 "Kinesin family member 19" Q2TAC6 17 74326210-74355820 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.9;fallopian tube: 25.2" "Cell type enhanced" "Detected in some" 15 "Ciliated cells: 34.8;Intestinal endocrine cells: 22.8;Ito cells: 19.6;Mucus-secreting cells: 10.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 5.5" "Lineage enriched" "Detected in single" 55 "T-cells: 5.5" "Cell line enriched" "Detected in single" 11 "SCLC-21H: 10.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043638, HPA073303" Enhanced Approved "Plasma membrane,Actin filaments,Centrosome" NA NA "Plasma membrane" "Actin filaments, Centrosome" "HPA043638: AB_10962579, HPA073303: AB_2686593" "unprognostic (1.59e-3)" "unprognostic (1.05e-1)" "unprognostic (1.00e-1)" "unprognostic (5.37e-3)" "unprognostic (9.64e-2)" "unprognostic (1.64e-1)" "unprognostic (2.70e-2)" "unprognostic (2.81e-1)" "unprognostic (1.03e-1)" "unprognostic (9.83e-3)" "unprognostic (1.05e-3)" "unprognostic (1.14e-1)" "unprognostic (1.59e-9)" "unprognostic (5.16e-5)" "unprognostic (2.72e-1)" "unprognostic (1.67e-2)" "unprognostic (1.53e-1)" 1.6 0.9 9.3 1.6 29.5 1.1 1.1 25.8 14.1 2.1 3.1 17.4 0.0 6.6 1.1 1.1 1.1 25.2 1.6 1.1 11.9 6.6 0.9 1.6 3.1 1.0 25.0 4.2 1.1 3.0 0.9 0.3 0.8 6.5 0.9 2.1 0.8 2.5 1.3 1.0 0.8 5.2 1.6 6.2 11.6 2.2 1.2 29.9 0.0 2.3 0.0 1.0 1.3 1.3 0.0 0.0 0.0 0.0 0.0 5.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 10.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.6 0.0 0.9 1.6 0.0 0.0 0.7 2.4 0.0 0.0 0.0 0.0 0.0 0.7 9.3 29.5 25.8 14.1 11.9 6.6 25.0 4.2 6.5 29.9 0.0 0.0 0.0 0.3 0.0 0.9 1.1 0.0 34.8 7.9 0.0 0.0 0.0 0.0 0.0 0.4 1.9 0.2 0.0 0.0 2.5 0.2 0.2 0.0 0.0 0.1 0.0 22.8 19.6 1.2 0.0 0.0 0.0 3.3 0.0 10.6 7.5 0.0 0.0 0.0 0.0 0.2 0.0 1.4 0.2 1.4 0.1 0.0 0.0 1.3 0.1 KIF21B "DKFZP434J212, KIAA0449" ENSG00000116852 "Kinesin family member 21B" O75037 1 200969390-201023700 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 34.3;brain: 20.4" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 21.3;Cone photoreceptor cells: 55.0;Late spermatids: 57.7;Muller glia cells: 22.6;Rod photoreceptor cells: 23.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 8.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 15.7;HMC-1: 16.8;JURKAT: 31.6;Karpas-707: 19.8;RPMI-8226: 16.8;U-266/70: 36.2;U-266/84: 16.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027249, HPA027274" Approved Approved "Plasma membrane,Mitotic spindle,Cytosol" Yes No "Plasma membrane" "Mitotic spindle, Cytosol" "HPA027249: AB_10602241, HPA027274: AB_1852483" "unprognostic (3.49e-2)" "unprognostic (1.82e-1)" "unprognostic (4.70e-2)" "unprognostic (2.15e-1)" "unprognostic (2.28e-1)" "unprognostic (3.92e-3)" "unprognostic (1.32e-2)" "unprognostic (1.80e-1)" "unprognostic (2.18e-1)" "unprognostic (3.03e-1)" "unprognostic (1.54e-3)" "unprognostic (7.14e-2)" "unprognostic (1.41e-4)" "unprognostic (5.98e-3)" "unprognostic (2.64e-1)" "unprognostic (6.81e-2)" "unprognostic (5.81e-4)" 2.2 1.6 19.8 10.0 12.9 34.3 1.5 3.7 20.4 1.5 2.8 6.0 1.0 2.7 1.4 1.0 1.5 1.4 2.9 1.5 15.1 12.5 1.4 1.7 4.3 15.7 8.3 12.7 1.4 1.5 11.3 0.9 1.6 7.1 1.2 2.6 8.6 2.1 1.7 0.9 1.3 6.1 1.5 4.3 11.5 3.2 11.1 4.9 10.8 1.2 0.0 9.1 3.7 1.1 0.9 0.2 8.0 0.5 2.4 1.7 0.6 0.5 0.5 4.7 0.2 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.3 0.1 15.7 0.2 0.0 1.4 0.1 0.4 0.1 0.1 0.7 0.1 3.7 0.1 0.0 0.4 11.4 16.8 0.3 1.6 0.1 0.3 0.0 0.6 31.6 1.7 19.8 0.0 0.0 9.1 4.1 2.0 1.5 0.0 3.2 0.0 16.8 0.1 0.0 3.2 0.4 0.2 0.2 0.2 0.8 0.0 3.4 1.1 0.0 1.4 0.0 0.1 36.2 16.7 7.8 1.6 4.9 0.1 8.0 0.1 1.0 1.6 0.4 1.7 0.9 1.2 1.7 0.1 0.7 1.0 1.1 2.0 2.4 0.5 0.2 1.0 0.6 19.8 12.9 3.7 20.0 15.1 12.5 8.3 12.7 7.1 4.9 0.0 6.7 6.1 0.2 0.9 21.3 1.2 0.0 0.0 0.0 1.8 55.0 0.0 0.0 0.6 20.0 1.8 0.0 0.0 1.4 0.1 0.9 0.3 5.8 0.0 1.4 1.6 0.0 0.6 3.8 57.7 0.9 2.5 0.0 2.8 1.1 22.6 1.7 0.0 0.0 0.0 23.6 6.5 1.2 1.4 2.5 0.9 0.0 11.7 0.7 1.8 KIF26A "DKFZP434N178, KIAA1236" ENSG00000066735 "Kinesin family member 26A" Q9ULI4 14 104138723-104180894 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 12 "Horizontal cells: 17.5;Intestinal endocrine cells: 7.5;Ito cells: 11.1;Spermatogonia: 7.5" "Group enriched" "Detected in many" 5 "stomach cancer: 3.8;testis cancer: 14.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 17.2;MCF7: 14.6;NTERA-2: 12.8;REH: 11.1;SCLC-21H: 11.9;SH-SY5Y: 24.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA046882, HPA060346" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA046882: AB_2679856, HPA060346: AB_2684259" "unprognostic (3.01e-1)" "unprognostic (3.20e-1)" "unprognostic (3.95e-1)" "unprognostic (1.77e-2)" "unprognostic (2.79e-1)" "unprognostic (1.12e-1)" "unprognostic (5.49e-3)" "unprognostic (1.69e-1)" "unprognostic (1.21e-2)" "unprognostic (3.31e-3)" "unprognostic (5.24e-3)" "unprognostic (7.01e-2)" "prognostic unfavorable (7.78e-4)" "unprognostic (7.96e-2)" "unprognostic (1.72e-1)" "unprognostic (9.12e-2)" "unprognostic (4.68e-3)" 12.0 6.8 1.8 4.9 2.1 5.0 15.9 1.3 3.9 8.9 3.3 1.5 4.9 1.7 5.9 3.9 2.1 3.7 4.9 10.1 1.6 2.6 3.4 2.5 8.5 2.5 1.9 2.8 23.5 9.4 1.6 4.4 6.8 2.0 2.5 1.6 6.9 2.5 4.0 9.1 3.9 2.5 2.3 1.0 9.3 2.5 4.1 0.9 1.9 2.3 5.6 0.9 2.6 8.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.6 2.4 0.0 0.0 4.1 0.2 0.0 0.0 0.0 1.9 0.0 0.0 3.3 0.0 0.4 1.5 1.9 0.0 0.0 0.0 3.0 0.0 17.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 4.1 0.0 0.0 0.0 14.6 0.0 0.0 12.8 0.1 1.2 11.1 4.9 1.2 0.0 0.0 11.9 24.3 2.6 0.4 0.0 1.6 0.2 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 2.1 1.3 3.5 1.6 2.6 1.9 2.8 2.0 0.9 0.0 0.0 0.0 0.0 1.0 1.2 2.2 0.0 0.0 0.0 1.8 0.0 0.8 1.7 0.8 0.2 5.4 0.0 0.0 0.2 0.8 3.1 0.1 0.0 0.0 1.9 17.5 7.5 11.1 0.0 0.0 0.0 0.0 1.7 0.0 1.0 0.3 0.2 0.0 0.7 0.0 0.0 0.0 0.2 0.1 7.5 1.5 0.3 0.0 3.3 0.0 KIF26B FLJ10157 ENSG00000162849 "Kinesin family member 26B" Q2KJY2 1 245154985-245709431 "Predicted intracellular proteins" "Developmental protein, Motor protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 7 "Collecting duct cells: 7.0;Cone photoreceptor cells: 3.9;Exocrine glandular cells: 4.4;Pancreatic endocrine cells: 5.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 58 "plasmacytoid DC: 6.3" "Lineage enriched" "Detected in single" 58 "dendritic cells: 6.3" "Cell line enhanced" "Detected in some" "HSkMC: 10.6;REH: 18.9;SH-SY5Y: 10.3;U-937: 9.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027709, HPA028478, HPA028561, HPA028562" Enhanced Approved "Plasma membrane,Microtubules" NA NA "Plasma membrane, Microtubules" "HPA027709: AB_10600215, HPA028478: AB_10601231, HPA028561: AB_10601960, HPA028562: AB_10602417" "unprognostic (3.66e-1)" "unprognostic (5.67e-2)" "unprognostic (7.90e-3)" "unprognostic (4.50e-3)" "unprognostic (3.23e-2)" "unprognostic (1.49e-1)" "unprognostic (4.17e-2)" "unprognostic (1.61e-1)" "unprognostic (9.63e-2)" "prognostic unfavorable (1.24e-4)" "unprognostic (8.30e-3)" "unprognostic (3.63e-1)" "unprognostic (1.38e-1)" "unprognostic (1.13e-2)" "unprognostic (5.77e-2)" "unprognostic (1.17e-4)" "unprognostic (7.22e-3)" 0.7 3.9 7.1 3.0 6.3 0.7 2.1 10.2 9.7 5.2 1.7 8.7 6.0 1.2 3.7 2.9 1.3 2.1 4.2 1.3 5.6 7.2 3.2 1.1 2.7 1.7 7.8 4.6 1.2 1.8 1.4 1.4 7.6 9.6 3.7 0.8 1.1 1.2 7.7 0.9 2.7 1.1 2.3 4.9 1.1 2.9 2.9 3.7 1.3 3.4 1.2 1.4 4.0 0.8 0.0 6.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 2.6 0.5 0.8 1.9 2.1 1.5 0.1 0.1 3.2 0.0 0.0 3.5 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 1.5 0.3 0.3 10.6 0.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 18.9 0.1 0.0 1.9 0.0 2.6 10.3 0.0 0.0 0.0 1.8 0.0 1.0 0.3 2.0 0.1 0.0 0.8 0.0 0.0 0.1 0.3 9.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.3 0.0 0.0 7.1 6.3 10.2 9.7 5.6 7.2 7.8 4.6 9.6 3.7 0.0 0.3 0.0 0.1 0.8 0.8 2.2 0.0 2.7 0.0 7.0 3.9 1.8 0.0 1.8 1.7 0.0 0.0 0.0 4.4 2.0 0.9 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 2.4 0.6 0.4 3.3 1.0 0.0 0.3 5.5 0.0 0.0 0.0 0.1 0.0 0.4 0.5 1.0 1.1 2.1 0.0 0.0 0.0 KLHDC7B MGC16635 ENSG00000130487 "Kelch domain containing 7B" Q96G42 22 50548033-50551022 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 8.4;parathyroid gland: 12.5" "Cell type enriched" "Detected in some" 5 "monocytes: 30.7" "Cancer enhanced" "Detected in many" "cervical cancer: 42.3;urothelial cancer: 40.7" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 4 "HMC-1: 47.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA000518, HPA076540" Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA000518: AB_1079213, HPA076540: " "prognostic favorable (1.30e-4)" "unprognostic (3.18e-2)" "unprognostic (2.74e-2)" "unprognostic (2.21e-1)" "unprognostic (3.96e-2)" "unprognostic (6.04e-3)" "unprognostic (3.91e-1)" "unprognostic (1.07e-1)" "unprognostic (1.07e-2)" "unprognostic (7.13e-2)" "unprognostic (3.33e-3)" "unprognostic (2.48e-1)" "unprognostic (2.09e-3)" "unprognostic (2.89e-1)" "unprognostic (4.69e-2)" "unprognostic (3.49e-1)" "unprognostic (1.02e-1)" 0.4 0.4 0.3 3.9 1.2 1.2 0.7 0.3 1.5 1.3 0.3 0.3 0.3 0.3 0.3 0.3 0.7 0.2 0.3 0.3 0.3 0.1 8.4 1.1 1.1 4.0 0.3 0.3 0.8 0.3 12.5 2.2 0.3 0.9 0.7 0.0 0.8 3.0 0.3 0.3 0.3 2.0 0.3 0.3 5.4 0.5 0.3 0.3 6.5 2.9 0.3 1.7 3.0 0.3 3.8 2.0 2.4 4.0 1.4 5.7 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.1 47.5 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 2.4 2.2 0.2 4.5 4.0 3.3 3.8 4.7 5.7 2.0 3.1 5.2 4.3 0.4 1.4 2.8 0.7 4.1 2.5 0.3 1.2 0.3 1.5 0.3 0.1 0.3 0.3 0.9 0.3 0.0 1.1 3.7 0.0 0.1 0.0 0.5 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.1 5.7 0.0 1.6 0.0 0.0 0.0 4.7 0.0 0.0 1.7 0.0 30.7 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 4.4 0.0 0.1 KLHL6 FLJ00029 ENSG00000172578 "Kelch like family member 6" Q8WZ60 3 183487531-183555689 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 43.2" "Cell type enhanced" "Detected in many" 12 "B-cells: 16.2;Ciliated cells: 18.7;granulocytes: 47.6;Hofbauer cells: 22.0;Kupffer cells: 16.7;Macrophages: 17.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 15.4;HEL: 9.8;HMC-1: 10.3;U-266/70: 31.6;U-266/84: 16.4;U-698: 46.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024512 Uncertain Approved "Plasma membrane,Microtubules,Mitotic spindle,Centriolar satellite" Yes NA "Centriolar satellite" "Plasma membrane, Microtubules, Mitotic spindle" "HPA024512: AB_2131015" "unprognostic (8.46e-2)" "unprognostic (3.67e-4)" "unprognostic (1.48e-2)" "unprognostic (6.03e-4)" "unprognostic (5.15e-2)" "unprognostic (1.30e-3)" "unprognostic (1.39e-1)" "unprognostic (5.05e-2)" "unprognostic (7.43e-2)" "unprognostic (9.62e-2)" "unprognostic (8.24e-2)" "unprognostic (2.68e-1)" "prognostic unfavorable (3.53e-4)" "unprognostic (1.81e-1)" "unprognostic (3.68e-2)" "unprognostic (2.42e-1)" "unprognostic (5.73e-2)" 4.4 1.2 1.4 43.2 3.3 2.9 2.2 0.5 1.8 1.7 4.1 2.4 0.5 2.3 1.1 0.3 1.7 4.2 2.3 1.9 1.8 1.3 1.4 1.4 8.0 23.8 4.4 0.0 0.7 0.8 0.2 1.0 1.8 2.8 1.4 2.2 0.8 4.6 0.6 0.7 0.8 9.9 0.7 8.8 15.1 3.5 0.7 2.3 21.4 1.6 0.5 34.5 2.8 2.7 4.4 5.2 13.3 3.3 2.8 4.8 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 9.8 0.0 0.0 0.0 2.6 10.3 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.1 7.0 0.0 0.0 3.2 1.5 0.0 0.0 0.0 5.4 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.9 0.0 0.0 0.0 0.0 31.6 16.4 46.4 0.0 2.9 0.0 7.1 3.3 13.3 0.8 2.7 0.9 4.4 3.0 1.3 2.3 3.3 3.6 2.2 3.1 2.8 3.0 5.2 4.8 2.7 1.4 3.3 0.5 1.8 1.8 1.3 4.4 0.0 2.8 2.3 6.0 9.2 16.2 1.5 1.0 0.6 3.2 0.0 18.7 9.1 0.0 2.0 0.2 0.0 0.0 1.5 2.9 0.0 0.0 0.0 0.2 1.1 1.1 47.6 0.0 22.0 0.0 0.0 1.8 16.7 0.0 0.3 17.0 8.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.4 0.5 0.5 10.8 0.0 1.0 KLHL7 "KLHL6, RP42, SBBI26" ENSG00000122550 "Kelch like family member 7" Q8IXQ5 7 23105758-23177914 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 15 "Early spermatids: 452.0;Late spermatids: 236.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029491, HPA029492" Uncertain Enhanced "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA029491: AB_10599605, HPA029492: AB_10600881" "unprognostic (1.24e-2)" "unprognostic (4.45e-1)" "unprognostic (1.77e-1)" "unprognostic (4.55e-2)" "unprognostic (1.29e-2)" "unprognostic (1.65e-2)" "prognostic unfavorable (7.96e-4)" "unprognostic (3.78e-1)" "unprognostic (6.10e-2)" "unprognostic (6.41e-3)" "unprognostic (1.30e-1)" "unprognostic (1.51e-1)" "prognostic favorable (8.98e-5)" "unprognostic (2.46e-2)" "unprognostic (3.55e-3)" "unprognostic (3.23e-2)" "unprognostic (2.27e-2)" 7.5 14.6 9.2 5.6 13.0 8.2 10.3 12.6 15.1 8.8 5.7 7.9 4.7 5.9 9.1 9.9 7.7 7.4 7.6 37.1 8.1 8.7 9.2 7.7 6.4 5.8 8.3 9.7 9.6 5.9 7.1 6.1 6.5 15.9 8.1 6.3 8.6 7.2 6.8 7.4 8.6 5.8 8.1 10.6 5.8 5.2 40.7 6.2 9.6 7.2 5.1 6.7 6.9 7.1 5.5 5.5 32.0 8.7 4.2 8.0 6.0 10.9 9.4 25.9 30.6 12.7 11.1 9.5 9.7 14.4 14.3 16.7 11.4 8.0 10.8 7.9 11.8 23.7 11.9 9.9 6.8 12.1 2.8 7.1 7.1 8.1 14.6 9.5 14.3 5.6 9.8 8.9 16.4 13.5 11.4 18.2 13.4 12.4 11.8 23.3 12.6 11.9 22.8 35.7 7.5 11.2 10.6 14.5 9.8 13.4 9.5 15.6 15.3 21.1 10.5 9.9 16.6 8.7 7.5 7.7 12.1 12.6 26.5 11.5 18.6 15.2 25.7 8.0 15.2 14.4 18.7 7.8 32.0 6.8 8.7 7.1 4.5 7.3 6.4 5.5 5.5 5.5 5.4 7.4 4.2 7.5 4.0 8.0 6.0 9.2 13.0 12.6 15.1 8.1 8.7 8.3 9.7 15.9 6.2 20.8 5.6 13.3 15.2 20.9 19.9 85.8 5.1 16.0 9.1 8.7 27.5 18.6 10.0 15.7 452.0 14.1 4.9 0.0 15.3 24.1 17.0 11.5 20.8 5.9 16.7 35.0 10.4 14.1 15.3 236.4 15.5 14.1 11.8 12.6 7.6 23.5 14.7 0.0 19.4 9.8 15.0 6.5 19.1 94.0 10.6 29.5 19.8 15.2 6.4 22.7 KLRC1 "CD159a, NKG2, NKG2-A, NKG2-B" ENSG00000134545 "Killer cell lectin like receptor C1" P26715 12 10442264-10454685 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "blood: 64.3;lymphoid tissue: 22.1" "Cell type enriched" "Detected in some" 22 "T-cells: 112.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 7 "gdT-cell: 45.7;NK-cell: 64.3" "Group enriched" "Detected in many" 42 "NK-cells: 64.3;T-cells: 45.7" "Cell line enhanced" "Detected in some" "HeLa: 9.3;Karpas-707: 3.8;SuSa: 3.7" HPA058052 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA058052: AB_2683589" "unprognostic (8.17e-3)" "unprognostic (2.13e-2)" "unprognostic (1.48e-2)" "unprognostic (4.58e-7)" "unprognostic (3.57e-1)" "unprognostic (1.17e-2)" "unprognostic (1.05e-1)" "unprognostic (3.68e-2)" "unprognostic (3.73e-4)" "unprognostic (4.13e-2)" "unprognostic (6.49e-2)" "unprognostic (2.54e-1)" "unprognostic (1.18e-4)" "unprognostic (1.88e-1)" "unprognostic (3.23e-1)" "unprognostic (2.45e-1)" "unprognostic (1.92e-3)" 2.4 0.5 1.2 5.8 1.4 5.6 2.3 1.0 2.7 1.7 3.3 0.7 1.2 1.5 5.5 3.9 1.7 2.5 2.4 2.6 1.6 1.3 1.9 2.0 5.9 10.3 2.3 0.6 1.2 1.4 0.3 1.3 3.6 1.5 1.9 2.5 2.0 3.1 0.3 0.5 1.0 5.0 2.1 2.6 22.1 5.2 1.4 0.5 3.5 1.9 3.0 2.9 2.9 1.8 0.1 0.0 1.2 0.1 64.3 45.7 5.1 0.4 1.6 0.1 0.1 0.5 0.4 0.8 0.0 0.0 0.8 1.7 0.0 1.3 0.2 0.1 0.4 3.3 0.3 0.6 2.8 1.1 0.9 0.4 2.1 9.3 0.0 0.1 0.6 0.4 1.0 0.0 0.3 0.0 0.0 0.8 0.7 1.3 3.8 0.8 0.0 0.2 2.8 0.0 0.1 0.0 0.9 0.2 0.3 0.2 0.0 0.5 0.1 0.8 0.0 0.3 3.7 0.3 0.0 2.6 0.4 0.0 0.0 0.3 0.0 0.0 0.7 2.1 0.8 0.0 0.2 0.0 0.0 45.7 0.0 5.8 0.1 0.0 7.9 0.0 0.0 0.0 6.9 1.2 64.3 0.1 0.0 0.0 5.1 1.2 1.4 1.0 0.9 1.6 1.3 2.3 0.6 1.5 0.5 0.0 1.1 0.0 0.2 0.1 0.0 0.4 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.8 0.1 1.6 1.7 1.3 3.2 0.0 0.6 0.0 5.0 0.0 1.9 0.0 0.0 0.3 1.1 0.6 1.5 0.0 0.3 0.5 0.2 0.1 0.1 112.3 0.0 0.4 KLRC2 "CD159c, NKG2-C" ENSG00000205809 "Killer cell lectin like receptor C2" P26717 12 10426854-10442300 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 32.8;brain: 16.2" "Group enriched" "Detected in some" 20 "Intestinal endocrine cells: 9.2;T-cells: 36.2" "Cancer enriched" "Detected in single" 8 "glioma: 3.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "gdT-cell: 10.7;NK-cell: 32.8" "Group enriched" "Detected in many" 92 "NK-cells: 32.8;T-cells: 10.7" "Cell line enhanced" "Detected in some" "GAMG: 17.9;HEL: 5.3;HeLa: 16.4;HSkMC: 4.0" HPA058052 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA058052: AB_2683589" "unprognostic (9.05e-4)" "unprognostic (2.54e-2)" "unprognostic (3.77e-2)" "unprognostic (2.51e-3)" "unprognostic (2.83e-1)" "unprognostic (9.49e-4)" "unprognostic (1.27e-1)" "unprognostic (8.74e-2)" "unprognostic (2.88e-1)" "unprognostic (4.00e-3)" "unprognostic (2.88e-2)" "unprognostic (9.16e-3)" "unprognostic (1.55e-9)" "unprognostic (8.10e-2)" "unprognostic (2.34e-1)" "unprognostic (8.93e-2)" "unprognostic (5.31e-3)" 0.5 0.2 8.2 0.6 4.6 2.8 1.1 1.2 16.2 0.4 1.9 2.3 0.1 1.0 1.4 1.0 0.8 0.6 1.7 0.2 6.1 5.4 0.1 1.1 1.4 1.5 6.2 2.6 1.5 0.1 0.0 0.1 0.6 3.7 0.3 1.3 0.1 0.5 0.3 0.1 0.2 1.8 0.1 4.1 8.1 3.2 0.5 1.7 2.2 0.2 0.1 2.0 1.2 0.1 0.0 0.0 0.2 0.0 32.8 10.7 1.7 0.0 0.8 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 17.9 0.0 0.0 2.0 0.0 0.0 0.0 5.3 16.4 0.3 0.0 0.5 0.0 4.0 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.5 0.0 0.1 1.1 0.1 0.4 0.0 0.0 0.0 0.0 0.5 2.7 0.1 0.1 0.0 0.0 0.0 10.7 0.0 0.2 0.0 0.0 4.7 0.0 0.0 0.0 3.7 0.2 32.8 0.0 0.0 0.0 1.7 8.2 4.6 1.2 3.6 6.1 5.4 6.2 2.6 3.7 1.7 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.2 0.0 0.0 KLRF1 "CLEC5C, NKp80" ENSG00000150045 "Killer cell lectin like receptor F1" Q9NZS2 12 9827481-9845007 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 95.2;lymphoid tissue: 24.7" "Cell type enriched" "Detected in many" 10 "T-cells: 119.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 6 "NK-cell: 95.2" "Lineage enriched" "Detected in many" 6 "NK-cells: 95.2" "Cell line enhanced" "Detected in some" "BJ hTERT+: 3.3;CAPAN-2: 1.9;HAP1: 3.0;U-937: 9.5" "Low region specificity" "Detected in some" HPA054038 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA054038: " "unprognostic (2.96e-1)" "unprognostic (8.59e-2)" "unprognostic (3.18e-2)" "unprognostic (2.95e-1)" "unprognostic (3.26e-1)" "unprognostic (1.69e-4)" "unprognostic (6.06e-2)" "unprognostic (3.68e-2)" "unprognostic (9.95e-3)" "unprognostic (3.00e-1)" "unprognostic (2.90e-1)" "unprognostic (4.43e-2)" "unprognostic (6.53e-2)" "unprognostic (4.64e-2)" "unprognostic (1.12e-1)" "unprognostic (2.15e-1)" "unprognostic (8.89e-3)" 3.3 0.7 0.9 3.0 1.2 8.8 1.4 0.6 0.8 1.0 0.6 0.3 0.1 0.0 0.7 3.3 0.8 1.1 0.9 1.0 1.0 0.8 0.8 5.8 10.0 4.0 0.9 0.7 0.7 1.1 0.0 0.9 1.7 0.4 1.5 0.5 0.9 1.5 0.8 1.3 0.8 1.0 0.5 1.0 24.7 0.7 1.0 0.4 2.0 0.8 0.5 2.8 1.0 0.7 0.4 0.3 0.9 0.2 95.2 14.9 11.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 3.3 0.0 0.2 0.0 1.9 0.0 0.3 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.4 0.3 0.1 0.0 0.0 0.0 0.0 1.1 0.1 1.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 9.5 1.4 0.0 0.1 0.1 11.6 0.2 14.9 0.4 0.6 5.5 0.2 0.1 0.2 5.8 0.9 95.2 0.1 0.3 0.1 11.1 0.9 1.2 0.6 0.8 1.0 0.8 0.9 0.7 0.4 0.4 0.0 2.1 0.0 1.1 1.3 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.8 8.3 0.2 0.4 1.2 0.0 0.0 0.2 0.5 0.7 0.6 1.1 0.9 1.2 0.0 0.0 8.0 10.1 0.9 0.0 1.4 11.8 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.1 0.1 1.5 1.0 0.5 119.3 0.2 2.1 KMT2D "ALR, CAGL114, MLL2, MLL4, TNRC21" ENSG00000167548 "Lysine methyltransferase 2D" O14686 12 49018975-49059774 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Transferase" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 49.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 5.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035977 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" Yes No "Plasma membrane, Cytosol" Nucleoplasm "HPA035977: AB_10670673" "unprognostic (8.33e-2)" "unprognostic (1.49e-1)" "unprognostic (9.14e-2)" "unprognostic (2.52e-1)" "unprognostic (8.07e-2)" "unprognostic (6.91e-3)" "unprognostic (7.35e-2)" "unprognostic (2.29e-1)" "unprognostic (3.57e-1)" "unprognostic (5.14e-2)" "unprognostic (7.23e-2)" "unprognostic (3.07e-1)" "unprognostic (1.68e-2)" "unprognostic (7.10e-2)" "unprognostic (1.87e-1)" "unprognostic (3.20e-2)" "unprognostic (7.60e-2)" 12.1 7.6 4.9 6.7 10.8 26.1 6.8 11.7 10.5 9.5 6.5 5.8 13.0 5.5 15.7 7.4 8.8 8.9 5.8 9.1 6.1 3.5 6.2 6.5 22.9 9.6 6.7 3.3 9.7 11.6 13.3 9.2 12.9 13.7 6.7 6.6 9.8 7.6 8.0 16.1 13.6 9.4 7.1 9.1 13.6 8.3 7.3 5.7 6.2 11.0 6.1 7.6 7.0 6.3 2.0 2.2 5.9 0.5 1.5 0.8 0.6 17.1 16.3 16.5 13.3 17.1 11.5 17.7 9.1 9.5 11.8 6.3 28.6 7.3 17.8 11.8 12.7 8.5 11.6 21.7 10.0 9.8 10.4 17.4 22.6 17.1 15.3 11.7 26.8 22.7 9.7 14.4 16.5 17.1 14.1 17.5 18.5 28.3 9.9 13.3 18.9 13.3 25.0 15.6 23.7 14.1 20.0 10.2 6.4 9.9 19.0 13.8 11.7 14.0 13.8 9.5 15.0 13.7 23.5 23.3 9.3 16.6 8.1 15.2 14.1 9.1 17.3 10.7 13.9 6.9 0.6 0.5 3.0 0.8 0.2 0.4 0.3 0.3 0.5 0.3 2.0 0.3 0.8 5.9 1.5 0.1 2.2 0.0 0.6 4.9 10.8 11.7 10.5 6.1 3.5 6.7 3.3 13.7 5.7 8.9 18.4 11.1 6.5 12.5 25.2 4.7 12.7 5.3 9.1 17.4 49.1 6.6 1.7 5.8 2.5 12.6 11.1 0.0 5.2 4.6 8.5 8.3 8.1 12.3 8.3 20.6 12.6 17.2 19.7 1.1 8.9 9.6 10.1 4.6 10.5 5.2 7.2 8.6 10.3 4.3 38.9 6.5 3.3 3.7 3.2 15.4 9.5 10.4 10.1 8.4 KNDC1 "bB439H18.3, C10orf23, FLJ25027, KIAA1768, RASGEF2, v-KIND, Very-KIND" ENSG00000171798 "Kinase non-catalytic C-lobe domain containing 1" Q76NI1 10 133160447-133226412 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.2" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 2: 7.0;Ciliated cells: 22.7;Club cells: 6.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "intermediate monocyte: 1.4;non-classical monocyte: 3.1" "Lineage enriched" "Detected in single" 10 "monocytes: 3.1" "Cell line enhanced" "Detected in some" "AN3-CA: 4.0;EFO-21: 2.9;MCF7: 2.6;NTERA-2: 3.6;RPMI-8226: 5.0;SuSa: 4.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039624, HPA056143" Uncertain Approved "Vesicles,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane, Cytosol" Vesicles "HPA039624: AB_10671045, HPA056143: " "unprognostic (2.32e-1)" "unprognostic (1.11e-1)" "unprognostic (6.35e-4)" "unprognostic (1.59e-3)" "unprognostic (1.96e-2)" "unprognostic (2.76e-1)" "unprognostic (5.61e-2)" "unprognostic (2.75e-2)" "unprognostic (6.77e-2)" "unprognostic (1.15e-1)" "unprognostic (6.80e-3)" "unprognostic (2.46e-3)" "unprognostic (1.18e-1)" "unprognostic (1.25e-1)" "unprognostic (2.53e-1)" "unprognostic (1.94e-1)" "unprognostic (9.41e-2)" 1.1 11.4 14.7 1.2 13.2 1.0 1.2 23.9 26.2 2.1 1.1 5.4 0.0 1.1 3.9 2.7 1.0 14.6 1.5 1.2 11.3 12.1 1.5 5.5 4.2 1.1 8.3 13.2 10.9 2.1 1.0 13.2 1.9 8.5 2.0 1.1 0.7 2.5 3.2 1.2 1.2 1.2 1.9 3.2 1.7 1.4 2.8 3.5 0.0 2.4 0.0 1.1 1.1 0.3 0.3 0.0 0.0 3.1 0.0 0.0 0.1 0.6 0.9 0.5 4.0 0.0 0.1 0.0 0.5 0.3 0.0 0.0 1.5 0.6 0.0 2.9 0.3 1.4 0.6 0.1 0.0 0.0 0.9 0.5 0.0 0.0 0.0 0.5 0.0 1.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.3 3.6 0.1 0.0 0.0 0.1 5.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 4.9 0.4 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.1 14.7 13.2 23.9 25.2 11.3 12.1 8.3 13.2 8.5 3.5 0.0 7.0 0.0 0.0 0.0 0.8 2.0 2.5 22.7 6.8 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 4.3 0.2 1.6 2.9 0.0 1.0 0.8 3.4 0.4 0.0 0.0 0.0 4.0 0.0 0.0 1.1 0.0 1.1 0.0 0.0 0.0 0.9 0.3 0.1 0.0 0.0 0.0 KNSTRN "C15orf23, FLJ14502, kinastrin, SKAP, TRAF4AF1" ENSG00000128944 "Kinetochore localized astrin/SPAG5 binding protein" Q9Y448 15 40382721-40394246 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "blood: 26.2;lymphoid tissue: 18.4;testis: 40.1;thyroid gland: 59.8" "Group enriched" "Detected in many" 4 "Early spermatids: 321.9;Late spermatids: 423.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA042027 Enhanced Enhanced "Plasma membrane,Mitotic spindle,Centriolar satellite" Yes Yes "Mitotic spindle, Centriolar satellite" "Plasma membrane" "HPA042027: AB_10797378" "unprognostic (2.35e-3)" "unprognostic (6.83e-2)" "unprognostic (3.01e-1)" "unprognostic (5.23e-3)" "unprognostic (6.19e-2)" "unprognostic (2.28e-2)" "unprognostic (1.54e-3)" "unprognostic (2.47e-3)" "unprognostic (1.23e-1)" "unprognostic (2.55e-1)" "prognostic unfavorable (3.43e-5)" "unprognostic (6.31e-2)" "prognostic unfavorable (7.88e-9)" "unprognostic (1.70e-1)" "unprognostic (1.58e-1)" "unprognostic (2.67e-1)" "unprognostic (1.52e-2)" 5.5 4.4 6.7 5.5 6.3 7.3 9.0 8.1 7.0 3.3 4.5 4.0 8.0 5.3 3.9 7.8 6.2 3.4 2.5 4.1 6.0 5.3 4.2 7.0 4.1 8.0 4.6 7.1 3.4 3.5 6.0 4.2 7.4 6.8 4.4 6.3 2.5 6.4 5.0 7.5 4.2 4.1 5.9 4.3 4.8 6.2 40.1 4.5 18.4 59.8 6.0 9.1 3.8 3.7 5.9 11.0 10.0 26.2 5.5 5.5 4.0 31.2 14.7 29.4 19.2 6.5 10.1 15.3 21.7 16.9 44.9 39.7 31.5 13.8 12.1 11.1 14.6 35.8 36.2 31.3 20.1 40.7 21.5 15.3 35.9 33.0 19.8 6.1 19.2 18.8 5.2 11.6 22.6 22.7 11.0 25.1 30.5 25.8 21.0 37.7 15.8 16.6 15.5 18.5 26.8 22.4 17.1 22.1 14.0 15.6 13.0 28.7 19.9 18.1 20.0 4.8 18.6 20.9 13.8 12.9 21.7 22.2 22.1 30.0 18.0 29.1 21.8 13.4 25.8 17.7 4.8 10.3 10.0 4.8 14.5 4.4 5.9 3.6 4.4 11.0 5.4 3.5 3.6 5.9 5.5 26.2 7.5 5.5 4.0 6.7 6.3 8.1 7.0 6.0 5.3 4.6 7.1 6.8 4.5 8.9 0.6 0.8 3.1 1.9 7.8 4.7 2.5 9.4 5.7 0.0 7.9 14.3 3.3 9.5 321.9 1.7 1.6 46.7 8.1 35.4 6.2 3.8 1.1 5.7 18.4 4.8 2.4 3.1 7.5 423.6 8.3 7.6 3.3 8.2 3.6 7.0 8.7 0.0 6.7 4.4 7.4 0.0 2.7 83.7 18.1 1.3 17.6 3.2 3.0 2.8 KNTC1 "KIAA0166, ROD" ENSG00000184445 "Kinetochore associated 1" P50748 12 122527246-122626396 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 39.6" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 23.5;Erythroid cells: 23.3;Spermatocytes: 24.6;Spermatogonia: 35.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA025241 Approved Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA025241: AB_1852629" "unprognostic (1.17e-1)" "unprognostic (2.12e-3)" "unprognostic (2.51e-1)" "unprognostic (1.53e-2)" "unprognostic (9.34e-2)" "prognostic favorable (8.69e-4)" "prognostic unfavorable (4.79e-6)" "unprognostic (4.04e-2)" "unprognostic (7.20e-3)" "unprognostic (1.59e-2)" "unprognostic (4.78e-2)" "unprognostic (1.92e-2)" "prognostic unfavorable (7.89e-8)" "unprognostic (2.17e-2)" "unprognostic (3.08e-1)" "unprognostic (8.04e-2)" "unprognostic (1.74e-1)" 5.6 5.6 4.5 15.3 5.4 28.9 5.8 7.5 5.6 5.2 6.4 2.7 3.9 7.0 5.4 5.5 9.6 4.9 2.9 2.9 4.6 1.8 4.9 4.5 5.8 11.8 4.0 3.8 6.7 4.9 3.5 5.9 8.1 3.6 5.3 9.7 3.9 6.1 2.8 1.6 11.7 10.9 7.7 3.1 14.1 5.5 23.2 2.8 39.6 4.0 7.0 15.6 4.4 6.6 4.8 2.1 5.0 2.6 2.2 3.6 0.8 13.1 11.0 31.7 7.3 2.5 4.5 14.3 12.2 7.9 12.1 11.5 10.4 11.1 15.8 6.4 5.9 8.0 18.2 13.7 7.6 16.1 11.2 9.5 19.4 20.5 10.6 0.8 19.0 13.4 2.4 1.7 12.5 8.3 6.3 8.2 20.2 19.3 11.9 9.1 9.7 15.7 44.1 16.0 6.4 13.9 21.6 15.4 17.5 7.2 14.1 9.8 12.7 22.2 4.7 6.5 19.7 17.9 11.0 6.0 13.9 13.3 13.5 14.2 16.1 16.1 24.3 8.3 12.4 15.8 5.0 1.4 4.6 2.0 1.9 1.8 4.8 3.3 3.6 1.3 3.0 2.5 2.9 4.4 2.2 2.6 2.1 1.4 0.8 4.5 5.4 7.5 5.6 4.6 1.8 4.0 3.8 3.6 2.8 0.0 1.6 6.0 1.2 3.8 2.5 1.2 0.0 6.7 2.3 5.2 3.9 5.0 0.0 1.2 23.5 2.1 1.0 23.3 0.3 5.0 2.1 0.8 1.1 0.9 4.0 0.0 0.0 1.3 2.4 13.7 4.4 3.1 1.7 1.8 1.2 0.9 0.7 0.0 2.8 0.3 3.6 6.5 1.4 24.6 35.8 1.9 2.4 3.3 5.2 0.6 KPTN 2E4 ENSG00000118162 "Kaptin, actin binding protein" Q9Y664 19 47475144-47484268 "Disease related genes, Predicted intracellular proteins" Actin-binding "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "plasmacytoid DC: 18.5" "Lineage enriched" "Detected in many" 5 "dendritic cells: 18.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041710, HPA041796" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Vesicles" "HPA041710: AB_10961904, HPA041796: AB_10962832" "unprognostic (4.80e-3)" "unprognostic (2.22e-1)" "unprognostic (7.24e-2)" "unprognostic (1.53e-1)" "unprognostic (5.54e-2)" "unprognostic (3.47e-2)" "prognostic unfavorable (7.91e-6)" "unprognostic (9.30e-2)" "unprognostic (2.24e-1)" "unprognostic (2.21e-2)" "unprognostic (5.51e-2)" "unprognostic (2.59e-2)" "prognostic unfavorable (7.82e-4)" "unprognostic (1.40e-1)" "unprognostic (8.72e-2)" "unprognostic (2.04e-1)" "unprognostic (2.34e-1)" 6.0 5.8 7.1 5.3 15.6 8.9 6.2 17.2 11.0 4.6 5.4 5.7 3.4 6.0 4.5 3.0 7.3 3.6 4.4 6.5 9.5 7.1 5.8 6.8 4.5 5.5 13.0 6.3 2.7 5.5 9.2 8.9 6.3 8.9 6.5 4.2 3.7 17.6 3.9 8.7 5.4 5.1 4.8 8.5 5.0 3.9 3.9 9.6 12.5 4.8 6.2 3.9 5.1 4.7 1.4 18.5 2.6 3.8 0.9 1.3 1.7 6.3 11.1 8.7 5.4 9.0 7.1 6.1 3.5 6.7 19.4 12.2 8.0 7.6 7.6 2.7 6.3 7.0 7.3 7.4 12.8 5.4 7.1 11.5 3.2 7.5 7.1 8.1 6.4 9.3 8.1 8.3 6.4 6.0 4.9 7.4 10.3 6.4 7.4 5.6 4.9 11.4 27.5 7.8 6.9 6.8 8.3 4.4 3.2 6.0 9.5 18.7 14.4 5.9 6.8 4.4 4.5 5.6 9.4 4.2 4.6 5.3 2.5 7.9 1.9 2.9 3.3 4.2 4.2 6.9 0.0 3.0 1.2 1.2 2.5 0.4 1.3 0.8 1.0 3.6 1.4 1.1 0.9 2.6 0.9 3.8 18.5 1.3 1.7 7.1 15.6 17.2 11.0 9.5 7.1 13.0 6.3 8.9 9.6 3.0 2.4 5.6 6.1 2.5 5.6 2.8 7.6 0.0 5.7 5.2 5.9 12.8 8.3 8.7 0.6 2.3 3.5 0.0 3.5 10.6 4.1 5.5 2.3 5.5 7.5 9.5 2.9 3.7 5.1 1.9 1.1 5.3 1.7 1.8 1.5 6.5 5.3 1.9 0.7 5.8 4.1 0.0 2.1 3.2 18.5 2.8 12.8 2.5 2.8 5.8 KRT75 K6HF ENSG00000170454 "Keratin 75" O95678 12 52424070-52434525 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "skin 1: 22.9;tongue: 18.8" "Cell type enhanced" "Detected in some" 14 "Basal keratinocytes: 2.5;Ductal cells: 1.2;Early spermatids: 2.0;Late spermatids: 1.9" "Cancer enhanced" "Detected in many" "head and neck cancer: 36.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "PC-3: 22.2;U-2 OS: 29.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA019367, HPA076201" Enhanced Approved "Plasma membrane,Cytosol" NA NA 2200000000 Cytosol "Plasma membrane" "HPA019367: AB_1852239, HPA076201: AB_2686786" "unprognostic (2.83e-2)" "unprognostic (2.81e-2)" "unprognostic (1.65e-2)" "unprognostic (5.79e-2)" "unprognostic (8.85e-3)" "unprognostic (2.67e-1)" "unprognostic (2.17e-2)" "unprognostic (1.72e-1)" "unprognostic (6.60e-2)" "unprognostic (9.20e-2)" "unprognostic (5.19e-2)" "unprognostic (2.45e-1)" "unprognostic (8.98e-2)" "unprognostic (1.94e-1)" 0.4 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 22.9 0.0 0.0 0.0 0.1 0.0 0.4 0.0 3.5 0.0 18.8 3.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.8 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 KRT77 KRT1B ENSG00000189182 "Keratin 77" Q7Z794 12 52689626-52703463 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "skin 1: 77.7" "Cell type enriched" "Detected in some" 9 "Suprabasal keratinocytes: 17.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 36 "HaCaT: 9.1" "Group enriched" "Detected in many" 5 "amygdala: 9.3;basal ganglia: 6.7;cerebral cortex: 4.7;hippocampal formation: 8.3;hypothalamus: 6.3" "Not detected" "Not detected" HPA045934 Enhanced Approved "Nuclear membrane,Plasma membrane" NA NA 2100000000 "Nuclear membrane, Plasma membrane" "HPA045934: AB_10960065" "unprognostic (3.52e-2)" "unprognostic (1.54e-1)" "unprognostic (1.41e-1)" "unprognostic (3.79e-1)" "unprognostic (2.61e-1)" "unprognostic (2.11e-1)" "unprognostic (2.06e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 6.4 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 1.2 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 77.7 0.1 0.1 0.1 0.1 0.0 0.1 0.1 4.6 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 17.7 0.0 0.0 0.0 0.0 KRTAP25-1 KAP25.1 ENSG00000232263 "Keratin associated protein 25-1" Q3LHN0 21 30289145-30289514 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA031438 Uncertain Approved "Nuclear membrane,Plasma membrane,Cytosol" NA NA "Nuclear membrane" "Plasma membrane, Cytosol" "HPA031438: AB_10610000" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 L3MBTL1 "dJ138B7.3, DKFZp586P1522, KIAA0681, L3MBTL, ZC2HC3" ENSG00000185513 "L3MBTL1, histone methyl-lysine binding protein" Q9Y468 20 43507680-43550950 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 16.2;Cone photoreceptor cells: 13.7;Spermatocytes: 15.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 10.7;SuSa: 11.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA068051 Supported "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA068051: AB_2732778" "unprognostic (2.32e-1)" "unprognostic (2.77e-1)" "unprognostic (5.66e-2)" "unprognostic (7.19e-3)" "unprognostic (1.28e-1)" "unprognostic (1.50e-2)" "unprognostic (7.65e-4)" "unprognostic (6.02e-2)" "unprognostic (6.00e-2)" "unprognostic (2.23e-2)" "unprognostic (1.15e-3)" "unprognostic (1.20e-2)" "unprognostic (1.44e-3)" "unprognostic (2.01e-1)" "unprognostic (1.65e-1)" "unprognostic (2.89e-1)" "unprognostic (1.56e-4)" 3.3 5.7 12.6 4.3 11.7 6.4 5.2 25.0 14.3 5.6 4.9 10.5 8.3 4.3 8.2 10.7 4.0 10.4 3.9 5.7 13.8 16.4 4.5 1.8 4.2 4.7 16.3 9.6 11.2 3.3 7.1 14.6 5.1 10.1 6.6 4.4 7.5 8.1 8.0 9.0 9.7 4.7 6.0 7.4 5.6 4.2 13.3 14.5 4.6 7.2 0.7 5.5 4.3 5.4 0.5 1.3 1.5 0.2 2.5 1.8 1.4 0.2 2.0 5.5 3.7 0.1 0.0 10.7 1.2 1.5 1.8 3.1 0.5 5.7 3.1 2.0 2.0 2.4 4.8 0.0 1.1 1.5 0.0 4.9 2.5 4.9 3.8 1.4 0.0 2.9 2.2 2.5 1.2 0.0 5.1 1.1 4.3 2.9 2.1 1.0 0.6 1.3 3.2 2.7 2.0 2.9 2.4 1.3 0.8 4.1 1.3 2.0 6.2 2.0 1.3 0.3 11.1 2.7 3.2 2.0 1.0 3.7 0.0 0.9 4.0 1.0 1.1 3.9 3.9 1.1 0.0 0.2 0.6 0.8 0.2 1.3 0.5 1.0 1.0 0.9 0.4 1.8 0.6 1.5 2.5 0.1 1.3 0.3 1.4 12.6 11.7 25.0 14.3 13.8 16.4 16.3 9.6 10.1 14.5 3.0 2.7 0.0 1.9 0.8 16.2 1.6 0.0 6.7 5.7 5.2 13.7 1.9 1.7 1.1 1.6 1.0 1.1 0.0 0.2 2.8 1.1 2.0 4.7 0.8 1.1 6.4 1.2 1.3 1.9 2.1 4.6 2.4 3.3 0.0 1.1 6.4 0.6 1.9 5.6 0.3 11.7 0.0 1.4 15.1 10.2 1.0 1.6 1.5 1.7 1.4 LAMA4 LAMA3 ENSG00000112769 "Laminin subunit alpha 4" Q16363 6 112108760-112254939 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 76.6;Fibroblasts: 77.1;Leydig cells: 154.2;Peritubular cells: 76.4;Smooth muscle cells: 100.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 51.9;ASC TERT1: 79.0;HSkMC: 61.5;hTERT-RPE1: 38.0;HUVEC TERT2: 64.8;TIME: 59.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA015693, CAB078156" Enhanced Approved "Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA 350000 "Plasma membrane, Cytosol" "CAB078156: AB_2665814, HPA015693: AB_1852687" "unprognostic (1.87e-2)" "unprognostic (6.48e-2)" "unprognostic (8.37e-2)" "unprognostic (2.39e-2)" "unprognostic (1.04e-1)" "unprognostic (1.15e-1)" "unprognostic (2.52e-2)" "unprognostic (5.07e-2)" "unprognostic (4.59e-2)" "unprognostic (2.93e-2)" "unprognostic (9.06e-2)" "unprognostic (1.78e-1)" "prognostic unfavorable (2.00e-4)" "unprognostic (4.40e-3)" "unprognostic (1.85e-1)" "unprognostic (2.80e-2)" "unprognostic (1.15e-2)" 42.3 3.6 5.8 20.7 5.4 0.0 21.7 3.7 4.6 28.7 28.6 4.7 12.9 6.3 41.0 24.8 29.7 29.6 23.3 13.8 5.1 4.1 4.6 1.8 27.9 8.8 5.5 2.1 19.9 1.6 3.6 5.6 25.4 5.0 21.3 13.2 18.4 22.9 15.7 5.7 6.8 13.1 53.6 3.6 0.4 15.6 9.4 2.5 1.1 9.1 15.2 6.6 35.6 19.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 51.9 79.0 0.0 13.0 7.8 1.3 0.2 0.0 4.9 0.0 8.6 22.4 3.0 0.0 0.5 0.0 0.2 0.0 6.7 0.0 6.5 0.0 10.6 0.0 0.0 61.5 0.0 9.4 0.0 38.0 64.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.0 21.2 0.3 0.0 0.3 2.0 0.0 10.0 0.2 0.0 0.0 59.2 21.4 1.1 23.8 4.3 0.0 0.0 0.0 5.3 0.0 28.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 5.4 3.7 4.6 5.1 4.1 5.5 2.1 5.0 2.5 3.0 5.0 0.0 1.2 20.1 1.0 47.4 0.0 0.0 3.4 3.5 0.0 0.9 3.3 0.4 76.6 56.3 0.0 0.0 0.6 71.2 77.1 1.1 1.1 28.2 2.7 0.0 0.0 19.6 2.2 34.0 154.2 1.7 54.0 1.0 0.0 0.0 0.6 0.0 76.4 0.0 0.2 64.7 100.7 0.7 0.5 16.3 2.5 0.0 0.0 5.2 LAMC1 LAMB2 ENSG00000135862 "Laminin subunit gamma 1" P11047 1 183023460-183145592 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Leydig cells: 111.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 13 "memory B-cell: 1.1;naive B-cell: 3.2;plasmacytoid DC: 1.3" "Group enriched" "Detected in many" 15 "B-cells: 3.2;dendritic cells: 1.3" "Cell line enhanced" "Detected in many" "ASC diff: 170.5;ASC TERT1: 93.8;HSkMC: 105.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001908, HPA001909, CAB004486, CAB078163" Enhanced Approved "Endoplasmic reticulum,Plasma membrane" "Secreted to extracellular matrix" NA NA 90000000 "Endoplasmic reticulum, Plasma membrane" "CAB004486: AB_627870, CAB078163: AB_2665817, HPA001908: AB_1079229, HPA001909: AB_1079230" "unprognostic (1.46e-1)" "unprognostic (1.05e-2)" "unprognostic (8.30e-2)" "unprognostic (8.84e-3)" "unprognostic (3.75e-2)" "unprognostic (1.02e-1)" "unprognostic (1.55e-2)" "unprognostic (1.54e-2)" "unprognostic (1.38e-2)" "unprognostic (2.71e-2)" "unprognostic (1.10e-1)" "unprognostic (1.80e-1)" "unprognostic (1.88e-3)" "unprognostic (1.10e-3)" "unprognostic (1.53e-1)" "unprognostic (1.54e-1)" "prognostic unfavorable (8.85e-5)" 49.0 6.8 2.9 11.3 4.0 0.2 51.5 5.9 3.4 30.4 27.7 2.8 12.8 4.9 30.5 28.7 31.5 21.5 25.9 39.5 3.4 2.0 10.0 6.8 22.5 10.6 3.9 2.7 22.7 9.8 7.4 4.1 73.1 3.5 23.9 11.4 11.7 11.6 17.3 32.2 15.6 17.6 41.3 3.0 4.7 22.3 16.1 2.7 3.5 21.7 16.4 7.3 40.2 37.6 3.2 1.3 0.0 0.1 0.0 0.0 0.2 5.2 8.5 28.2 8.0 170.5 93.8 42.7 38.6 38.8 15.6 9.2 25.3 6.0 1.9 17.8 18.5 9.2 13.1 5.3 10.2 11.9 0.0 5.4 0.0 7.7 9.2 26.8 1.6 0.9 105.6 5.5 18.6 14.7 27.9 27.1 0.0 0.0 5.7 18.9 2.3 0.0 1.7 11.4 9.7 1.6 1.3 23.8 0.9 25.2 14.0 1.8 5.3 10.1 0.0 9.9 50.7 2.2 4.4 50.0 19.1 7.5 17.6 9.6 2.2 0.0 1.2 15.8 1.2 18.4 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.2 2.9 4.0 5.9 3.4 3.4 2.0 3.9 2.7 3.5 2.7 32.8 16.3 4.5 38.6 27.8 1.9 48.8 25.5 10.7 17.0 34.9 3.9 80.1 1.7 50.0 5.4 59.4 0.7 0.0 19.8 53.9 99.3 48.3 2.3 17.8 16.1 1.6 1.2 26.4 10.8 3.8 111.9 5.3 32.1 10.0 1.7 2.0 39.3 3.5 58.7 10.2 0.6 71.1 83.0 7.0 39.9 14.8 60.3 0.5 2.6 21.6 LAPTM4A "HUMORF13, KIAA0108, LAPTM4, MBNT, Mtrp" ENSG00000068697 "Lysosomal protein transmembrane 4 alpha" Q15012 2 20032650-20052028 "Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 133.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031402, HPA031404, HPA068554" Approved Approved "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Golgi apparatus, Vesicles" "Plasma membrane" "HPA031402: AB_10669882, HPA031404: AB_10670293, HPA068554: AB_2686003" "unprognostic (2.01e-1)" "unprognostic (1.98e-2)" "unprognostic (1.44e-1)" "unprognostic (5.73e-1)" "unprognostic (6.04e-2)" "unprognostic (3.00e-2)" "unprognostic (1.53e-3)" "unprognostic (5.37e-2)" "unprognostic (1.27e-1)" "unprognostic (3.65e-2)" "prognostic unfavorable (4.37e-4)" "unprognostic (8.70e-2)" "unprognostic (1.05e-2)" "unprognostic (7.78e-3)" "unprognostic (2.18e-2)" "unprognostic (7.98e-3)" "unprognostic (2.36e-1)" 59.2 63.8 23.4 20.1 22.8 19.8 53.6 15.9 23.4 85.7 44.0 25.9 181.0 26.0 80.3 57.4 50.4 53.0 49.9 50.1 22.3 19.0 95.9 83.0 48.7 24.3 22.0 17.3 72.7 63.6 28.9 46.5 137.6 24.9 64.9 28.4 56.8 49.9 175.6 33.6 41.2 44.9 56.4 21.6 34.8 40.7 83.3 18.6 13.7 75.3 37.9 37.7 65.3 57.8 27.2 37.4 82.4 53.4 16.5 19.4 48.0 37.5 20.8 12.8 26.5 133.1 99.0 47.9 47.7 59.9 32.7 37.2 16.3 37.0 6.6 11.0 57.9 34.0 37.4 10.6 22.9 29.9 16.2 16.9 10.1 24.6 46.3 51.4 7.8 28.1 66.1 46.6 31.7 36.5 45.7 33.7 5.7 7.6 12.7 48.4 21.6 4.6 10.2 28.2 32.2 19.1 8.1 37.5 12.5 80.0 31.5 20.3 19.6 44.3 36.7 30.0 48.7 15.8 6.4 42.9 55.0 19.7 47.2 30.6 21.2 30.4 10.7 43.5 15.6 21.8 82.4 53.4 38.5 14.2 44.2 17.1 27.2 17.0 15.7 37.4 26.2 19.4 17.3 28.1 16.5 50.3 31.3 15.9 48.0 23.4 22.8 15.9 23.4 22.3 19.0 22.0 17.3 24.9 18.6 181.7 179.3 127.9 498.3 585.3 19.7 191.2 331.2 204.8 200.2 525.1 11.8 156.0 137.6 412.4 1117.0 311.4 159.7 46.7 306.5 887.8 890.1 264.1 506.1 427.2 285.9 19.1 132.5 307.6 307.4 952.2 773.5 352.6 558.5 334.6 176.2 293.0 282.2 210.1 564.6 774.3 23.0 523.9 560.6 321.9 146.0 620.4 253.3 94.8 178.7 415.2 LCP1 "CP64, L-PLASTIN, LC64P, PLS2" ENSG00000136167 "Lymphocyte cytosolic protein 1" P13796 13 46125920-46211871 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 188.6;lymphoid tissue: 118.2" "Group enriched" "Detected in many" 4 "Alveolar cells type 2: 106.9;B-cells: 102.2;Early spermatids: 108.1;granulocytes: 292.1;Hofbauer cells: 246.0;Kupffer cells: 369.7;Late spermatids: 220.3;Macrophages: 303.2;monocytes: 275.9;T-cells: 260.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 82.8;HDLM-2: 75.7;HL-60: 80.4;HMC-1: 85.3;JURKAT: 76.6;THP-1: 75.0;U-698: 106.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019493, CAB020673" Enhanced Approved "Plasma membrane,Actin filaments,Cytosol" NA NA 2200000000 "Plasma membrane, Cytosol" "Actin filaments" "CAB020673: , HPA019493: AB_1855457" "unprognostic (2.79e-2)" "unprognostic (8.20e-3)" "unprognostic (1.19e-2)" "unprognostic (3.95e-3)" "unprognostic (1.19e-1)" "unprognostic (2.84e-2)" "unprognostic (2.70e-1)" "unprognostic (4.99e-2)" "unprognostic (6.70e-3)" "unprognostic (2.54e-1)" "unprognostic (5.47e-2)" "unprognostic (3.63e-1)" "unprognostic (3.32e-3)" "unprognostic (2.51e-1)" "unprognostic (1.02e-1)" "unprognostic (7.50e-2)" "unprognostic (2.92e-1)" 57.1 10.0 5.6 44.3 9.4 71.2 8.7 3.9 4.6 3.6 6.2 4.5 5.0 4.5 5.3 43.1 6.2 8.3 8.9 5.5 4.3 3.8 7.2 12.2 33.7 59.1 12.0 1.0 5.7 3.9 0.1 2.8 24.7 7.7 21.5 8.1 5.5 9.5 2.5 3.5 6.8 21.7 6.5 11.9 112.9 6.1 8.2 9.2 118.2 4.5 4.1 68.7 14.0 7.1 25.4 79.3 133.5 127.6 43.2 67.2 188.6 3.3 0.0 0.1 0.0 0.0 0.0 40.2 0.0 0.1 0.3 0.2 22.2 0.1 82.8 17.6 0.0 24.6 0.1 0.0 0.0 0.3 75.7 19.7 17.9 0.0 0.0 0.0 80.4 85.3 0.2 0.0 0.1 0.1 0.0 0.0 76.6 9.3 55.1 0.0 0.1 56.9 55.7 0.0 0.0 0.8 42.4 0.1 59.2 0.0 22.9 0.1 0.7 0.1 8.8 0.6 2.5 0.4 75.0 0.2 2.1 1.3 0.1 2.4 13.2 27.4 106.5 1.6 49.0 0.3 57.1 96.6 54.3 67.2 127.6 60.8 25.4 40.4 55.5 79.3 18.3 25.2 42.3 133.5 43.2 118.1 20.8 40.5 188.6 5.6 9.4 3.9 4.6 4.3 3.8 12.0 1.0 7.7 9.2 29.8 106.9 102.2 0.8 10.6 0.4 3.1 2.5 25.4 33.0 3.5 0.0 8.6 0.0 19.4 108.1 6.6 0.0 23.3 14.4 53.7 6.6 52.4 292.1 26.8 246.0 0.0 1.2 14.1 369.7 220.3 1.1 303.2 21.9 275.9 0.0 19.2 4.7 0.6 1.8 1.4 0.9 0.0 7.9 1.8 1.7 10.3 11.3 260.3 0.1 2.2 LCTL "FLJ33279, KLG, KLPH" ENSG00000188501 "Lactase like" Q6UWM7 15 66547179-66565979 "Cancer-related genes, Predicted membrane proteins" "Sensory transduction, Vision" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.4" "Group enriched" "Detected in some" 4 "Early spermatids: 5.0;Late spermatids: 7.5;Spermatogonia: 2.7" "Group enriched" "Detected in some" 5 "glioma: 1.5;melanoma: 0.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 3.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 6.3;hTERT-RPE1: 7.5;NTERA-2: 5.8;SuSa: 7.0;U-2 OS: 16.2;U-251 MG: 6.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA071640 Approved "Endoplasmic reticulum,Plasma membrane" NA NA "Plasma membrane" "Endoplasmic reticulum" "HPA071640: AB_2686428" "unprognostic (4.60e-2)" "unprognostic (5.46e-2)" "unprognostic (8.70e-2)" "unprognostic (1.56e-2)" "unprognostic (3.22e-3)" "unprognostic (3.53e-2)" "unprognostic (6.67e-2)" "unprognostic (1.06e-2)" "unprognostic (2.59e-2)" "unprognostic (1.04e-1)" "unprognostic (3.47e-1)" "unprognostic (4.51e-3)" "unprognostic (4.44e-16)" "unprognostic (6.06e-2)" "unprognostic (3.39e-1)" "unprognostic (5.48e-2)" "unprognostic (1.39e-1)" 0.4 0.7 6.0 0.9 4.3 3.1 0.4 0.7 3.1 0.4 0.5 3.1 0.0 1.4 0.8 0.9 0.7 0.3 1.0 0.4 3.3 1.2 0.4 0.4 0.4 1.0 5.3 3.1 0.6 0.7 0.2 0.4 0.3 4.9 0.4 0.3 1.1 0.6 0.3 3.0 2.6 0.7 0.4 10.4 0.8 0.7 1.5 2.3 0.0 0.5 0.0 0.2 0.3 0.3 0.9 0.6 3.9 0.7 1.0 0.5 0.2 0.3 0.3 3.2 0.3 0.1 0.1 0.8 0.8 0.0 0.0 0.3 0.4 0.4 0.4 6.3 0.2 0.6 0.6 0.0 0.0 0.2 0.2 0.2 0.7 1.0 1.5 0.0 0.2 0.4 0.4 0.0 0.3 0.0 7.5 0.0 0.2 0.4 0.4 0.2 0.1 0.2 0.4 5.8 0.4 0.1 0.2 3.4 0.3 0.0 0.4 0.4 0.3 0.1 0.3 1.8 7.0 0.4 0.5 0.4 1.6 16.2 0.6 6.9 0.2 0.2 0.2 2.1 0.7 2.9 1.6 0.7 0.5 0.5 0.4 0.3 0.4 0.5 0.3 0.2 0.9 0.5 0.4 3.9 1.0 0.4 0.6 0.5 0.2 6.0 4.3 0.7 2.7 3.3 1.2 5.3 3.1 4.9 2.3 0.0 0.0 0.0 0.5 0.3 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.0 0.1 0.0 0.0 0.0 0.3 0.1 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.3 7.5 0.6 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 1.1 0.0 0.4 1.2 2.7 0.3 0.2 0.0 0.0 0.3 LENG1 ENSG00000105617 "Leukocyte receptor cluster member 1" Q96BZ8 19 54155161-54159882 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "AF22: 5.7;HaCaT: 8.3;HDLM-2: 5.1;HSkMC: 3.9;LHCN-M2: 4.8;U-87 MG: 5.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043541 Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA043541: AB_10961190" "unprognostic (8.75e-2)" "unprognostic (4.36e-2)" "unprognostic (2.72e-2)" "unprognostic (2.30e-1)" "unprognostic (5.69e-2)" "unprognostic (1.91e-1)" "unprognostic (1.10e-1)" "unprognostic (8.73e-2)" "unprognostic (6.42e-2)" "unprognostic (5.22e-2)" "prognostic favorable (8.12e-4)" "unprognostic (7.51e-2)" "prognostic favorable (3.72e-4)" "unprognostic (2.21e-1)" "unprognostic (2.84e-1)" "unprognostic (4.82e-2)" "unprognostic (1.14e-2)" 9.6 8.0 8.2 8.0 11.1 6.1 7.3 10.1 9.5 7.5 10.8 11.5 10.8 7.6 13.4 8.7 6.1 11.9 9.6 12.7 8.2 7.9 7.6 7.2 8.9 6.3 11.2 7.6 10.3 9.7 7.3 8.5 7.3 10.3 9.3 10.7 6.6 21.6 10.4 13.1 9.9 14.8 7.5 10.8 21.8 8.8 12.3 13.1 10.1 10.8 7.6 6.8 8.2 15.8 3.8 3.2 4.1 3.3 2.8 3.8 0.8 0.1 0.4 5.7 0.2 0.6 0.2 0.4 0.8 0.1 0.6 0.3 0.2 0.0 0.0 0.2 0.0 0.5 8.3 0.3 0.2 0.2 5.1 1.3 0.0 0.5 0.1 0.0 0.0 0.5 3.9 0.7 0.2 0.5 0.2 0.1 0.5 0.1 0.0 4.8 0.6 0.4 0.5 0.0 0.2 0.6 0.0 0.1 0.8 0.5 0.5 0.2 0.2 0.3 0.0 0.3 0.0 0.2 0.1 0.7 0.4 0.4 0.2 0.4 0.1 0.2 0.0 5.6 0.1 2.7 1.0 2.7 4.1 2.5 3.3 2.8 1.6 3.7 3.8 2.2 3.8 3.7 2.9 3.7 2.8 1.6 3.2 2.7 0.8 8.2 11.1 10.1 9.5 8.2 7.9 11.2 7.6 10.3 13.1 17.9 9.1 29.1 20.5 18.3 10.2 6.4 15.3 18.7 6.8 17.4 0.0 24.4 19.9 18.7 76.0 20.3 33.5 0.0 24.7 12.4 18.9 14.1 54.2 15.5 26.7 6.4 25.9 25.8 16.2 6.4 20.8 26.0 20.3 26.2 20.4 14.5 21.8 17.8 14.2 21.2 13.9 38.8 26.8 23.1 29.4 18.7 35.8 35.5 16.6 14.7 LGALS3 "GALIG, LGALS2, MAC-2" ENSG00000131981 "Galectin 3" P17931 14 55124110-55145413 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Immunity, Innate immunity, mRNA processing, mRNA splicing" "IgE-binding protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 3145.4;Paneth cells: 2942.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 67.4;intermediate monocyte: 55.4;myeloid DC: 41.7;non-classical monocyte: 44.2;T-reg: 25.9" "Group enriched" "Detected in all" 12 "dendritic cells: 41.7;monocytes: 67.4;T-cells: 25.9" "Cell line enhanced" "Detected in many" "ASC TERT1: 90.9;CAPAN-2: 72.2;OE19: 119.2;SK-MEL-30: 169.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA003162, CAB005191" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to blood" NA NA 2300000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB005191: AB_2136784, HPA003162: AB_1078937" "unprognostic (1.42e-1)" "unprognostic (9.79e-2)" "unprognostic (1.14e-1)" "unprognostic (3.15e-1)" "unprognostic (2.46e-2)" "unprognostic (3.34e-2)" "unprognostic (1.73e-3)" "unprognostic (1.00e-1)" "unprognostic (2.13e-2)" "unprognostic (1.28e-1)" "unprognostic (1.08e-3)" "unprognostic (5.97e-2)" "unprognostic (8.52e-2)" "unprognostic (1.44e-1)" "unprognostic (2.96e-2)" "unprognostic (2.65e-3)" "unprognostic (7.60e-3)" 95.7 11.0 10.4 50.9 13.6 29.8 53.2 6.5 11.7 54.1 127.1 6.1 42.4 75.7 50.3 30.7 76.1 26.1 83.9 42.3 8.4 5.7 19.9 3.9 65.5 16.6 8.5 9.4 58.9 24.2 0.5 11.0 78.7 5.5 51.7 93.7 25.7 78.3 51.7 31.3 76.1 182.4 48.2 8.7 11.1 36.9 20.4 5.7 5.5 18.0 65.7 41.7 41.1 44.4 1.3 41.7 3.6 67.4 2.5 25.9 37.2 21.7 6.9 0.2 0.1 45.3 90.9 26.5 17.4 36.7 4.8 8.6 15.0 72.2 0.0 9.2 20.3 8.8 21.8 0.4 18.2 2.7 25.7 0.3 0.0 7.7 6.9 34.4 0.0 0.0 28.3 27.8 5.6 11.7 11.0 7.5 0.0 0.0 21.0 10.9 14.7 0.0 5.3 0.3 119.2 19.6 0.0 0.9 1.5 45.3 29.1 0.6 1.7 40.7 0.0 169.5 1.2 17.9 2.4 13.7 23.0 3.2 8.5 0.3 11.7 37.1 0.1 33.0 1.4 2.4 1.7 67.4 3.4 1.8 55.4 11.4 1.3 6.8 5.1 41.7 0.4 0.3 1.0 3.6 2.5 44.2 1.1 25.9 37.2 10.4 13.6 6.5 11.7 8.4 5.7 8.5 9.4 5.5 5.7 670.0 300.6 39.7 543.1 560.7 2.0 183.5 254.8 1263.4 586.9 113.4 0.0 565.8 570.3 541.1 17.4 423.0 3145.4 116.8 951.7 754.6 506.8 590.1 552.4 0.9 1164.5 1.6 166.8 50.3 236.1 23.5 514.6 722.3 804.8 642.0 1587.7 215.8 859.9 2942.3 361.0 42.5 11.3 142.3 241.1 7.7 3.6 697.2 404.6 52.2 1480.8 936.7 LGALS8 PCTA-1 ENSG00000116977 "Galectin 8" O00214 1 236518000-236552981 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 244.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 38.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012734, HPA030491" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA012734: AB_2668720, HPA030491: AB_10602345" "unprognostic (2.03e-2)" "unprognostic (1.54e-1)" "unprognostic (2.38e-2)" "unprognostic (3.80e-3)" "unprognostic (2.02e-3)" "unprognostic (4.71e-3)" "unprognostic (3.93e-2)" "prognostic favorable (9.40e-4)" "unprognostic (9.96e-2)" "unprognostic (1.41e-1)" "unprognostic (2.12e-1)" "unprognostic (1.78e-3)" "prognostic unfavorable (4.93e-7)" "unprognostic (1.41e-1)" "unprognostic (1.57e-1)" "unprognostic (3.15e-2)" "unprognostic (8.21e-2)" 27.8 14.0 15.0 17.0 30.5 28.9 18.6 21.7 22.6 14.1 14.8 9.5 10.7 15.5 13.6 19.2 18.5 12.4 17.2 36.0 16.2 14.8 18.5 34.1 21.0 28.2 13.7 17.0 18.3 18.8 22.5 22.7 43.1 25.2 19.8 14.9 10.0 22.4 17.5 7.7 25.3 18.1 15.3 18.1 41.3 13.6 39.9 14.6 19.9 16.8 13.0 16.4 20.7 14.6 4.4 12.7 38.5 14.2 5.3 8.9 9.3 17.7 9.3 1.3 7.0 16.6 14.1 20.6 13.2 15.1 16.5 19.2 12.6 21.7 0.5 12.9 10.9 9.7 19.9 3.7 18.9 15.5 10.3 2.8 12.0 8.1 22.4 20.9 15.9 28.4 13.0 15.1 14.8 5.0 15.9 18.2 9.2 14.2 9.0 11.9 10.9 7.5 3.1 4.8 1.5 7.0 9.1 0.3 1.1 11.7 28.9 4.5 9.3 8.5 28.0 4.7 0.8 20.8 12.6 13.3 0.3 8.2 9.9 16.5 3.4 2.6 0.4 17.1 22.3 10.5 38.5 14.2 7.2 5.4 12.9 7.4 4.4 7.8 5.8 12.7 2.9 5.2 5.4 6.7 5.3 8.7 5.8 8.9 9.3 15.0 30.5 21.7 22.6 16.2 14.8 13.7 17.0 25.2 14.6 71.5 57.4 15.2 26.4 28.8 24.1 47.0 28.1 68.3 67.1 14.0 23.6 53.8 5.0 47.7 244.5 34.9 23.1 0.0 34.4 48.3 22.6 20.5 104.2 22.4 48.8 36.5 17.4 38.6 85.5 157.7 21.9 34.0 6.8 4.6 17.8 6.5 38.3 26.2 13.1 10.3 18.2 25.8 20.0 24.6 8.7 32.4 147.4 34.6 14.5 18.7 LGR6 FLJ14471 ENSG00000133067 "Leucine rich repeat containing G protein-coupled receptor 6" Q9HBX8 1 202193901-202319781 "G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Wnt signaling pathway" "G-protein coupled receptor, Receptor, Transducer" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 49.6" "Cell type enhanced" "Detected in some" 12 "Basal glandular cells: 2.8;Cardiomyocytes: 8.3;Late spermatids: 3.2;Spermatocytes: 6.0;Spermatogonia: 3.3" "Cancer enhanced" "Detected in many" "ovarian cancer: 17.8" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "gdT-cell: 14.3;memory CD8 T-cell: 8.3;naive CD8 T-cell: 4.7" "Lineage enriched" "Detected in single" 41 "T-cells: 14.3" "Cell line enhanced" "Detected in some" "A549: 16.6;CAPAN-2: 14.8;HaCaT: 8.0;HeLa: 4.0" "Region enriched" "Detected in some" 9 "olfactory region: 30.0" HPA008556 Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA008556: " "unprognostic (4.72e-3)" "unprognostic (5.29e-2)" "unprognostic (1.21e-1)" "unprognostic (2.89e-2)" "prognostic unfavorable (4.35e-4)" "unprognostic (1.08e-1)" "unprognostic (5.13e-2)" "unprognostic (9.23e-2)" "unprognostic (1.12e-1)" "unprognostic (2.54e-2)" "unprognostic (4.01e-2)" "unprognostic (7.89e-2)" "unprognostic (1.00e-2)" "unprognostic (1.17e-3)" "unprognostic (2.08e-1)" "unprognostic (1.70e-1)" "unprognostic (7.83e-2)" 1.1 0.1 0.9 0.8 3.2 1.8 7.9 6.0 2.4 2.6 2.2 1.5 0.5 0.2 1.6 7.3 4.4 13.8 49.6 12.3 0.7 3.3 0.9 1.4 6.9 1.1 6.8 0.2 2.2 0.5 0.1 15.9 0.9 9.3 6.7 1.1 0.8 8.5 2.5 0.3 3.2 1.6 2.6 1.6 5.3 0.7 4.9 3.9 0.2 4.1 2.6 3.4 3.2 2.9 0.0 0.0 0.0 0.0 0.3 14.3 2.5 0.0 16.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.0 1.7 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.9 0.0 1.7 8.3 0.0 0.0 0.7 4.7 0.0 0.3 0.0 0.0 0.4 2.5 0.9 3.2 6.0 2.4 0.7 3.3 6.8 0.2 9.3 3.9 0.0 0.0 0.0 2.8 1.1 0.0 8.3 0.0 0.0 1.2 0.0 0.0 0.5 0.0 0.0 2.4 0.0 0.2 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.6 0.0 3.2 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 6.0 3.3 0.1 0.7 0.5 1.7 0.3 LHFPL2 KIAA0206 ENSG00000145685 "LHFPL tetraspan subfamily member 2" Q6ZUX7 5 78485215-78770021 "Predicted membrane proteins" Fertilization "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Hofbauer cells: 56.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 8.0;plasmacytoid DC: 7.9" "Group enriched" "Detected in many" 7 "dendritic cells: 7.9;granulocytes: 8.0;monocytes: 4.7" "Cell line enhanced" "Detected in many" "GAMG: 41.5;hTERT-HME1: 31.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042402, HPA076743" Uncertain Approved "Nuclear bodies,Vesicles,Plasma membrane" NA NA 110000 "Plasma membrane" "Nuclear bodies, Vesicles" "HPA042402: AB_10794276, HPA076743: " "unprognostic (2.19e-2)" "unprognostic (3.86e-2)" "unprognostic (2.00e-2)" "unprognostic (1.09e-1)" "unprognostic (2.40e-1)" "unprognostic (4.45e-2)" "prognostic unfavorable (2.73e-4)" "unprognostic (3.44e-3)" "unprognostic (2.32e-1)" "unprognostic (8.43e-2)" "unprognostic (3.62e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (3.45e-7)" "unprognostic (3.40e-2)" "unprognostic (3.88e-2)" "unprognostic (1.34e-2)" "unprognostic (7.85e-2)" 17.1 18.2 10.3 16.1 11.7 11.5 34.7 3.5 9.1 15.8 15.4 12.0 14.1 17.6 14.6 15.0 7.6 10.7 17.6 14.1 11.7 7.6 3.8 4.7 17.2 10.3 15.2 7.2 18.7 18.0 9.2 7.3 11.3 12.9 13.3 13.5 18.2 21.4 20.5 4.6 6.7 27.1 16.6 18.0 4.7 10.8 10.9 13.1 5.7 10.3 4.9 10.4 15.4 18.2 0.9 7.9 8.0 4.7 0.0 0.1 1.5 3.2 12.3 3.7 4.9 22.8 6.6 11.6 3.8 9.7 6.6 11.6 4.3 9.9 8.3 1.7 7.4 41.5 5.8 3.5 4.1 11.0 0.0 3.2 8.2 2.5 7.3 16.9 0.0 0.0 7.5 16.5 20.3 31.7 10.5 15.6 0.3 0.0 6.2 15.0 1.7 0.0 0.4 4.1 2.7 3.6 1.6 5.3 2.3 2.5 14.7 0.7 5.1 6.2 2.3 21.1 8.2 1.3 1.0 10.2 7.7 4.2 21.2 11.3 0.2 0.0 11.9 20.6 0.0 13.8 8.0 4.7 4.8 0.0 1.8 0.1 0.9 0.0 0.0 1.1 0.9 0.0 0.0 1.0 0.0 0.6 7.9 0.1 1.5 10.3 11.7 3.5 9.1 11.7 7.6 15.2 7.2 12.9 13.1 3.0 4.3 4.2 6.0 7.7 6.1 3.4 2.5 2.7 7.9 7.0 0.0 3.2 0.0 6.9 1.1 22.2 23.7 23.3 11.2 2.0 20.9 10.4 0.0 0.5 56.6 3.2 2.4 33.7 28.3 0.5 17.8 20.5 10.1 1.0 10.7 5.0 15.0 8.6 31.5 0.3 2.1 6.5 8.2 0.5 0.9 4.3 6.1 0.0 8.6 11.1 LIPJ "bA425M17.2, LIPL1" ENSG00000204022 "Lipase family member J" Q5W064 10 88586753-88606976 "Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "testis: 11.5" "Cell type enriched" "Detected in some" 6 "Early spermatids: 32.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "eosinophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Karpas-707: 2.7;NB-4: 1.0;SK-MEL-30: 2.4;U-2197: 1.0" HPA048594 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA048594: AB_2680456" "unprognostic (4.79e-3)" "unprognostic (6.77e-2)" "unprognostic (4.80e-2)" "unprognostic (2.36e-1)" "unprognostic (2.70e-2)" "unprognostic (9.33e-2)" "unprognostic (2.90e-3)" "unprognostic (7.50e-2)" "unprognostic (1.65e-1)" "unprognostic (1.09e-1)" "unprognostic (4.73e-2)" "unprognostic (1.73e-2)" "unprognostic (6.21e-4)" "unprognostic (9.87e-2)" "unprognostic (9.57e-2)" "unprognostic (1.85e-1)" "unprognostic (1.88e-1)" 0.2 0.0 0.3 0.0 0.3 0.0 0.2 1.0 0.3 0.1 0.0 0.4 0.2 1.6 0.0 1.1 0.1 0.1 0.4 0.5 0.2 0.7 0.0 0.3 0.0 0.1 0.6 0.0 0.1 0.0 0.3 0.2 0.6 0.0 0.4 0.1 0.1 0.3 0.1 0.1 0.3 11.5 0.9 0.4 0.5 0.1 0.7 0.0 1.0 0.1 0.5 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.7 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.4 0.0 0.0 0.8 0.0 0.1 0.7 1.0 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 1.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 32.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 LMCD1 ENSG00000071282 "LIM and cysteine rich domains 1" Q9NZU5 3 8501707-8574673 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 189.9" "Cell type enhanced" "Detected in many" 8 "Ductal cells: 99.6;Horizontal cells: 92.2;Smooth muscle cells: 171.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "T-reg: 17.0" "Lineage enriched" "Detected in many" 6 "T-cells: 17.0" "Cell line enhanced" "Detected in many" "HHSteC: 30.4;HSkMC: 42.6;hTEC/SVTERT24-B: 31.3;U-2197: 27.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA024059 Enhanced Supported "Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol" No No "Nucleoplasm, Cytosol" "Plasma membrane, Cell Junctions" "HPA024059: AB_1852950" "unprognostic (2.46e-1)" "unprognostic (1.79e-1)" "unprognostic (5.13e-3)" "unprognostic (1.30e-1)" "unprognostic (2.28e-2)" "unprognostic (2.10e-1)" "unprognostic (1.56e-1)" "unprognostic (1.38e-1)" "unprognostic (2.96e-1)" "unprognostic (8.21e-3)" "unprognostic (4.29e-1)" "unprognostic (2.54e-2)" "prognostic unfavorable (8.66e-5)" "unprognostic (3.80e-2)" "unprognostic (1.33e-1)" "unprognostic (1.01e-3)" "unprognostic (3.68e-3)" 38.6 3.3 1.6 10.1 1.8 0.0 36.4 3.9 1.9 11.7 4.4 3.8 5.2 1.9 22.3 20.8 8.3 11.9 15.4 15.9 2.3 1.7 5.5 2.2 25.9 3.8 2.4 1.7 17.9 8.5 5.8 2.0 14.1 4.5 16.1 1.6 4.6 19.2 7.0 189.9 5.7 3.3 72.9 3.7 14.3 10.6 9.3 1.3 0.8 4.6 34.3 7.1 29.4 15.7 1.8 2.7 0.0 0.3 0.0 17.0 0.2 2.9 16.9 2.8 2.1 21.1 11.9 2.9 12.4 6.4 6.8 16.9 12.5 3.8 0.0 1.4 14.3 2.9 0.2 1.6 3.2 2.8 5.1 1.1 3.7 1.1 2.4 30.4 0.0 0.3 42.6 0.0 31.3 0.2 4.0 3.3 0.0 0.0 0.0 8.8 2.1 0.0 0.0 5.5 3.8 0.7 0.0 9.4 0.0 6.3 1.1 0.1 7.1 2.0 10.3 6.4 8.4 13.4 0.0 1.6 6.9 13.8 27.6 8.3 1.7 1.9 0.8 1.4 0.9 8.8 0.0 0.0 0.0 0.0 0.3 0.1 1.8 2.6 0.5 2.7 0.3 0.0 0.0 0.0 0.0 0.0 0.9 17.0 0.2 1.6 1.8 3.9 1.9 2.3 1.7 2.4 1.7 4.5 1.3 8.9 15.4 0.0 47.6 28.0 13.3 13.7 20.4 20.1 15.9 5.2 9.8 2.6 3.3 99.6 0.9 70.2 0.5 0.0 42.3 3.5 58.2 6.1 10.3 11.3 3.1 92.2 11.6 36.2 0.6 1.5 10.6 4.0 50.6 15.4 2.2 34.8 83.3 0.0 30.4 29.2 7.9 0.0 171.0 5.0 7.0 23.7 3.7 2.2 3.3 5.2 LMTK2 "AATYK2, BREK, cprk, KIAA1079, KPI-2, KPI2, LMR2, PPP1R100" ENSG00000164715 "Lemur tyrosine kinase 2" Q8IWU2 7 98106885-98209633 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010657, HPA041836" Uncertain Approved "Nuclear speckles,Plasma membrane,Centriolar satellite,Cytosol" NA NA "Nuclear speckles, Centriolar satellite" "Plasma membrane, Cytosol" "HPA010657: AB_1079259, HPA041836: AB_2677698" "unprognostic (7.36e-2)" "unprognostic (3.16e-1)" "unprognostic (1.59e-1)" "unprognostic (2.60e-3)" "unprognostic (2.47e-2)" "unprognostic (2.45e-1)" "unprognostic (2.35e-2)" "unprognostic (1.23e-1)" "unprognostic (4.96e-1)" "prognostic unfavorable (8.03e-4)" "unprognostic (1.23e-1)" "unprognostic (4.65e-1)" "prognostic favorable (1.12e-7)" "unprognostic (1.88e-1)" "unprognostic (3.92e-1)" "unprognostic (2.16e-2)" "unprognostic (6.38e-3)" 5.1 10.3 13.7 5.6 21.3 17.3 5.6 16.6 34.3 7.3 13.8 6.1 5.6 12.6 6.1 6.3 12.7 6.4 7.9 16.9 11.0 10.1 10.1 8.5 10.0 5.1 7.5 18.9 8.0 21.0 22.2 10.0 4.8 13.2 7.9 11.8 5.4 10.5 6.5 17.5 11.5 13.8 5.7 5.5 6.8 9.4 8.0 6.9 7.2 8.7 5.7 7.4 8.3 8.1 0.6 0.7 4.8 0.9 0.3 1.6 0.5 9.8 11.6 9.0 9.2 4.8 3.9 8.4 4.1 4.5 4.0 4.9 9.1 9.0 5.2 11.8 5.2 15.3 10.8 10.4 6.3 6.3 7.4 7.3 3.5 10.4 9.1 5.9 6.2 6.3 2.6 8.7 8.3 11.3 4.1 6.0 6.0 9.1 10.9 3.6 13.3 6.6 3.7 11.0 13.5 5.7 7.2 6.1 10.2 6.7 17.3 6.5 12.9 8.2 15.0 6.0 9.5 4.1 2.5 7.3 8.4 13.8 16.8 9.3 4.9 8.5 10.3 5.7 4.9 10.0 1.2 0.6 0.5 0.8 0.3 0.5 0.6 0.9 0.9 0.3 0.6 1.1 1.6 4.8 0.3 0.9 0.7 0.8 0.5 13.7 21.3 16.6 34.3 11.0 10.1 7.5 18.9 13.2 6.9 26.8 10.5 0.0 4.2 8.7 14.0 18.7 17.8 10.7 9.1 1.8 13.7 2.3 1.7 5.0 0.8 3.1 26.2 0.0 7.9 1.6 3.5 6.2 2.3 6.8 1.8 6.4 11.5 3.1 2.6 2.1 1.7 2.3 1.7 0.0 13.5 5.8 8.6 13.1 4.2 2.4 9.9 0.0 3.8 6.3 4.7 9.5 2.5 2.9 12.6 13.2 LNX2 "MGC46315, PDZRN1" ENSG00000139517 "Ligand of numb-protein X 2" Q8N448 13 27545911-27620404 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 45.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040698 Approved Approved "Vesicles,Plasma membrane,Cytosol" NA NA Vesicles "Plasma membrane, Cytosol" "HPA040698: AB_10673138" "unprognostic (4.97e-2)" "unprognostic (1.97e-2)" "unprognostic (3.29e-2)" "unprognostic (1.47e-1)" "unprognostic (1.15e-1)" "unprognostic (2.65e-2)" "unprognostic (1.12e-1)" "unprognostic (8.38e-2)" "unprognostic (1.16e-1)" "unprognostic (9.27e-3)" "unprognostic (4.21e-2)" "unprognostic (8.79e-2)" "prognostic favorable (7.09e-13)" "unprognostic (4.18e-3)" "unprognostic (1.67e-1)" "unprognostic (2.21e-1)" "unprognostic (2.84e-2)" 4.6 10.3 2.5 6.7 4.2 2.7 9.8 7.6 4.1 6.0 13.2 2.3 8.3 12.2 4.4 4.3 12.4 4.1 9.7 8.8 2.8 2.9 9.2 24.5 22.1 4.9 3.4 3.1 6.3 24.7 7.6 9.6 10.8 3.7 7.0 9.3 10.2 12.1 9.9 8.0 7.6 19.6 6.5 3.3 4.6 9.0 10.3 2.6 13.4 9.9 4.2 10.0 6.2 8.5 1.6 0.8 5.3 0.9 3.3 2.8 0.6 4.8 2.6 5.1 5.6 5.3 2.4 5.3 4.3 3.7 4.2 3.8 9.5 9.6 7.3 3.7 3.8 7.7 9.1 9.0 11.4 5.6 4.4 3.8 9.2 5.6 6.9 8.4 4.9 5.9 2.0 17.8 2.9 11.6 12.0 7.6 7.6 2.8 2.8 6.1 5.8 7.3 3.2 5.6 21.7 3.0 6.8 9.9 3.7 9.2 8.4 13.0 2.7 5.9 11.8 7.5 6.6 8.3 3.8 9.6 2.4 3.4 2.4 3.5 2.7 4.6 7.6 1.6 4.7 3.4 5.3 0.9 2.4 1.7 0.3 2.3 1.6 1.8 2.1 0.8 1.3 1.9 1.8 1.1 3.3 0.7 0.4 2.8 0.6 2.5 4.2 7.6 4.1 2.8 2.9 3.4 3.1 3.7 2.6 29.8 22.2 3.7 22.5 22.6 3.8 9.2 25.5 16.0 6.8 19.2 2.0 1.2 3.3 8.1 10.5 5.9 18.6 0.0 12.1 6.8 3.1 19.8 1.1 45.5 1.9 4.8 9.8 10.4 5.2 5.3 2.6 5.2 10.1 1.0 14.5 4.5 10.7 23.0 3.2 6.7 16.7 0.0 3.1 16.1 15.8 19.3 2.5 5.2 10.7 16.5 LONRF1 "FLJ23749, RNF191" ENSG00000154359 "LON peptidase N-terminal domain and ring finger 1" Q17RB8 8 12721894-12756073 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Suprabasal keratinocytes: 64.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 32.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023584, HPA024814" Uncertain Approved "Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane, Cytosol" Centrosome "HPA023584: AB_1853233, HPA024814: AB_1853235" "unprognostic (2.59e-1)" "unprognostic (2.17e-3)" "unprognostic (1.35e-2)" "unprognostic (3.56e-1)" "unprognostic (9.09e-2)" "unprognostic (3.96e-3)" "unprognostic (3.13e-1)" "unprognostic (5.78e-2)" "unprognostic (2.74e-3)" "unprognostic (1.18e-1)" "unprognostic (5.83e-2)" "unprognostic (3.39e-1)" "unprognostic (5.46e-3)" "unprognostic (8.97e-2)" "unprognostic (8.90e-2)" "unprognostic (3.08e-3)" "unprognostic (1.15e-1)" 16.5 7.6 7.6 4.9 9.9 4.9 10.4 9.9 8.4 14.0 8.1 6.3 8.8 2.2 11.1 13.0 12.9 11.2 9.4 6.5 8.9 5.3 6.3 9.3 8.1 8.7 6.9 6.9 20.4 10.3 12.6 4.9 9.6 5.5 12.8 4.2 13.9 7.9 10.9 18.4 29.7 5.3 10.0 6.1 9.2 6.9 16.1 4.5 6.2 8.6 7.3 7.3 10.6 19.0 1.1 0.9 2.4 2.1 0.1 1.6 0.2 0.6 1.6 8.6 2.6 9.1 4.4 5.7 2.1 3.6 2.3 3.3 0.5 2.2 13.2 0.5 3.7 7.5 1.0 6.8 2.6 2.6 2.0 3.8 4.3 0.3 3.5 8.5 1.1 1.7 4.1 4.7 1.5 5.2 2.2 3.6 5.4 0.6 32.4 1.5 2.4 5.6 3.8 8.8 2.7 0.5 3.1 5.9 2.4 2.1 5.7 18.0 2.1 1.2 2.9 16.8 6.4 0.6 5.8 1.6 1.3 2.2 5.1 1.6 2.4 11.0 6.9 6.9 4.0 3.9 0.0 0.5 2.4 0.5 1.8 1.6 1.0 1.0 0.6 0.4 1.1 0.0 0.0 1.9 0.1 2.1 0.9 0.0 0.2 7.6 9.9 9.9 8.4 8.9 5.3 6.9 6.9 5.5 4.5 8.9 18.9 3.9 28.3 54.0 22.8 8.7 7.6 13.4 15.9 10.4 15.7 2.8 6.6 5.4 50.1 13.5 3.2 0.0 3.5 6.8 12.7 23.1 5.8 11.9 4.9 7.9 2.4 6.7 7.3 44.0 27.0 10.1 42.2 1.8 5.4 9.2 4.5 5.8 18.7 5.7 12.9 19.4 29.5 7.7 17.7 64.4 6.1 5.0 4.7 22.2 LONRF3 "FLJ22612, RNF127" ENSG00000175556 "LON peptidase N-terminal domain and ring finger 3" Q496Y0 X 118974614-119018355 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 2: 14.9;Basal glandular cells: 13.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 7.4" "Lineage enriched" "Detected in single" 8 "T-cells: 7.4" "Cell line enhanced" "Detected in many" "GAMG: 9.9;K-562: 10.6;OE19: 12.0;PC-3: 12.1;SiHa: 11.0;SK-MEL-30: 9.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050422, HPA061162" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA050422: AB_2681122, HPA061162: AB_2732658" "unprognostic (1.80e-2)" "unprognostic (1.48e-1)" "unprognostic (1.24e-1)" "unprognostic (1.92e-1)" "unprognostic (4.24e-2)" "unprognostic (1.64e-1)" "unprognostic (6.06e-3)" "unprognostic (1.29e-2)" "unprognostic (3.21e-1)" "unprognostic (8.01e-2)" "prognostic unfavorable (4.32e-4)" "unprognostic (4.29e-2)" "unprognostic (2.31e-3)" "unprognostic (6.34e-2)" "unprognostic (6.16e-2)" "unprognostic (1.70e-1)" "unprognostic (1.27e-3)" 3.8 3.9 4.2 2.1 3.4 4.6 10.8 15.8 6.1 1.9 4.1 2.0 1.6 2.9 2.4 3.1 1.7 2.5 3.9 3.9 5.0 1.9 3.6 15.4 11.8 0.8 1.7 3.7 2.0 8.1 0.4 3.5 0.9 4.4 3.0 5.5 4.1 8.1 3.0 13.8 1.4 2.3 10.8 2.7 1.1 4.5 2.7 2.5 0.0 9.9 1.9 1.1 4.7 6.6 0.0 0.1 0.8 0.8 0.0 7.4 0.7 3.7 5.5 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 4.6 0.0 2.7 0.0 9.9 0.0 1.1 0.0 0.0 0.1 3.1 4.7 9.0 5.3 3.1 4.0 0.6 0.0 0.0 0.0 0.0 1.7 1.4 0.4 10.6 0.0 0.8 4.5 0.0 1.8 0.0 12.0 12.1 0.0 2.5 0.0 3.3 1.5 0.2 0.0 11.0 0.3 9.6 0.1 0.0 3.5 0.2 0.1 0.2 0.0 5.8 1.2 4.7 0.0 2.6 4.1 2.4 0.0 0.8 0.0 4.5 0.0 7.4 0.0 2.0 1.5 0.1 0.0 1.1 1.6 0.8 0.0 0.0 0.0 0.7 0.7 4.2 3.4 15.8 6.1 5.0 1.9 1.7 3.7 4.4 2.5 6.0 14.9 0.0 13.8 1.3 3.6 3.2 0.0 0.0 10.3 1.8 0.0 0.5 1.7 2.4 1.3 1.9 5.8 0.0 3.8 0.0 2.8 4.7 5.8 4.0 2.9 1.6 1.2 3.1 3.7 0.4 0.9 3.8 3.3 0.0 2.3 6.1 4.6 3.1 1.4 0.7 0.2 0.0 3.1 1.7 4.1 0.1 0.3 1.3 2.5 9.8 LOXHD1 "DFNB77, FLJ32670, LH2D1" ENSG00000167210 "Lipoxygenase homology domains 1" Q8IVV2 18 46476972-46657220 "Disease related genes, Predicted intracellular proteins" Hearing "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "ductus deferens: 15.5;epididymis: 9.7;testis: 22.0" "Group enriched" "Detected in some" 84 "Early spermatids: 168.6;Late spermatids: 330.2" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Group enriched" "Detected in some" 5 "basal ganglia: 2.4;cerebral cortex: 1.9;thalamus: 1.1" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "THP-1: 3.5;WM-115: 1.4" "Low region specificity" "Detected in single" "Region enriched" "Detected in single" 5 "olfactory region: 1.0" HPA077128 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA077128: " "unprognostic (6.95e-2)" "unprognostic (1.88e-2)" "unprognostic (4.81e-3)" "unprognostic (2.65e-1)" "unprognostic (1.30e-2)" "unprognostic (7.75e-4)" "unprognostic (9.53e-2)" "unprognostic (7.91e-2)" "unprognostic (7.61e-2)" "unprognostic (9.44e-2)" "unprognostic (1.26e-2)" "unprognostic (1.93e-2)" "unprognostic (7.43e-3)" "unprognostic (6.48e-5)" "unprognostic (2.30e-1)" "unprognostic (8.10e-3)" "unprognostic (1.66e-3)" 1.7 0.0 0.4 0.0 2.4 2.7 0.4 0.1 1.9 0.0 0.1 0.2 15.5 0.0 0.0 9.7 0.1 1.7 0.1 0.5 0.2 0.1 0.5 0.0 0.8 0.0 0.0 0.0 0.1 0.1 0.4 4.0 0.6 0.0 0.0 0.0 0.0 0.1 0.2 0.6 0.2 0.1 0.0 0.0 0.7 0.1 22.0 1.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.9 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.4 2.4 0.1 1.9 0.2 0.1 0.0 0.0 0.0 1.1 3.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 2.7 0.0 0.0 0.0 0.0 1.7 0.0 168.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 330.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 2.8 1.5 0.0 0.0 0.0 0.0 0.0 LPIN1 KIAA0188 ENSG00000134324 "Lipin 1" Q14693 2 11677595-11827409 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism, Transcription, Transcription regulation" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 88.4" "Cell type enriched" "Detected in many" 4 "Late spermatids: 1310.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 38.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024591, HPA038021" Approved Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA024591: , HPA038021: AB_10669514" "unprognostic (1.97e-1)" "unprognostic (2.47e-1)" "unprognostic (1.32e-1)" "unprognostic (1.87e-2)" "unprognostic (9.17e-2)" "unprognostic (2.69e-2)" "unprognostic (8.20e-2)" "unprognostic (5.28e-3)" "unprognostic (1.09e-1)" "unprognostic (1.07e-2)" "unprognostic (2.45e-3)" "unprognostic (2.55e-2)" "unprognostic (1.06e-1)" "unprognostic (5.58e-3)" "unprognostic (1.25e-1)" "unprognostic (9.60e-2)" "unprognostic (4.02e-1)" 18.1 10.1 13.0 10.7 18.3 6.0 22.1 20.0 16.4 10.5 8.6 10.9 7.3 8.9 11.0 15.0 20.0 7.0 10.4 12.8 11.6 11.9 7.6 13.2 8.0 15.4 13.2 11.2 19.3 7.5 17.2 32.0 9.0 17.9 9.6 7.1 9.0 14.4 11.6 88.4 6.5 9.2 11.0 10.3 8.4 7.6 39.0 13.2 8.3 8.1 14.0 19.2 10.4 21.7 6.5 9.6 11.6 2.8 8.0 11.1 3.2 5.5 6.6 5.5 12.3 25.5 28.4 2.8 7.8 13.4 5.0 8.7 2.4 5.5 2.7 1.0 6.6 14.8 6.0 6.2 17.0 4.6 11.4 3.4 6.8 3.7 3.5 9.0 4.7 32.1 25.6 7.7 20.8 7.9 14.7 9.7 6.7 9.4 24.7 3.7 2.1 4.4 4.1 5.7 1.8 6.7 6.1 10.1 17.3 12.7 3.6 15.3 12.1 2.8 6.8 17.5 5.5 1.7 2.6 6.8 8.0 7.2 5.1 6.7 38.8 30.0 5.2 11.3 8.4 5.9 9.5 2.8 11.6 10.3 2.1 11.1 6.5 9.6 9.7 2.5 5.0 8.4 7.1 1.1 8.0 2.1 9.6 10.5 3.2 13.0 18.3 20.0 14.4 11.6 11.9 13.2 11.2 17.9 13.2 20.8 49.1 22.9 38.9 16.9 40.6 49.5 25.5 61.6 63.7 10.4 80.5 7.3 6.6 18.7 314.7 24.6 9.7 0.0 24.2 5.3 24.6 29.2 33.6 21.9 8.1 46.1 34.7 15.4 15.7 1310.7 110.1 27.2 16.9 7.2 23.9 16.4 25.5 11.6 169.0 3.4 47.2 32.3 20.6 18.4 17.8 10.5 10.3 57.5 13.6 26.8 LPIN2 KIAA0249 ENSG00000101577 "Lipin 2" Q92539 18 2916994-3013315 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism, Transcription, Transcription regulation" Hydrolase "Congenital dyserythropoietic anemia, Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 83.9" "Cell type enhanced" "Detected in all" 5 "Cholangiocytes: 140.1;Hepatocytes: 111.5;Horizontal cells: 109.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 6 "granulocytes: 20.8;NK-cells: 10.1;T-cells: 9.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015223, HPA017857, HPA030550" Enhanced Approved "Plasma membrane,Actin filaments,Cytosol" Yes No Cytosol "Plasma membrane, Actin filaments" "CAB015223: , HPA017857: AB_1852904, HPA030550: AB_2673519" "unprognostic (7.03e-2)" "unprognostic (1.05e-1)" "unprognostic (2.88e-1)" "unprognostic (1.51e-3)" "unprognostic (1.20e-1)" "prognostic favorable (8.01e-4)" "unprognostic (9.85e-3)" "unprognostic (1.89e-2)" "unprognostic (1.03e-2)" "unprognostic (3.44e-3)" "unprognostic (3.19e-1)" "unprognostic (1.94e-1)" "unprognostic (3.15e-3)" "unprognostic (4.66e-2)" "unprognostic (2.21e-1)" "unprognostic (2.49e-1)" "unprognostic (7.11e-2)" 6.8 5.6 13.0 10.5 18.4 9.2 7.7 11.9 16.5 6.6 25.2 10.4 2.4 31.6 6.7 3.9 5.9 6.3 14.3 5.1 11.0 14.5 20.7 83.9 11.8 11.8 11.2 9.8 8.8 9.0 9.7 8.2 16.3 15.3 5.8 7.4 6.8 4.4 5.3 2.2 2.7 43.3 6.1 9.6 10.7 15.6 13.5 9.6 6.3 7.5 1.5 10.0 6.8 6.7 1.2 1.1 20.8 2.0 10.1 9.5 2.1 4.9 6.7 10.6 3.7 18.4 17.1 6.3 12.0 14.6 11.9 11.6 8.7 4.2 3.6 7.3 18.3 18.6 0.2 8.7 3.7 9.4 7.0 1.8 9.2 5.2 9.9 17.2 7.3 10.2 17.2 2.5 11.8 10.3 17.3 14.8 8.8 8.3 1.9 16.7 3.7 9.1 6.3 3.4 7.4 9.6 16.1 9.2 13.4 9.5 11.1 9.0 6.2 11.2 5.3 3.8 6.4 0.0 10.1 20.8 15.4 18.7 19.7 8.8 3.5 5.3 7.8 13.6 7.5 5.4 6.5 2.0 6.1 9.3 1.3 9.5 0.9 7.1 5.3 0.8 1.2 7.3 4.7 20.8 10.1 0.6 1.1 6.3 2.1 13.0 18.4 11.9 16.5 11.0 14.5 11.2 9.8 15.3 9.6 62.5 38.2 16.9 8.2 4.9 31.9 10.4 140.1 21.4 35.2 36.6 13.7 17.4 14.9 9.7 2.1 17.5 52.0 46.7 16.6 9.6 15.9 14.5 11.6 111.5 19.6 109.7 14.3 20.3 21.0 6.9 21.0 19.9 8.5 24.4 30.3 16.0 18.6 10.5 29.4 40.8 14.8 6.5 9.9 28.8 59.6 1.8 41.4 39.9 11.9 3.4 LRCH2 KIAA1495 ENSG00000130224 "Leucine rich repeats and calponin homology domain containing 2" Q5VUJ6 X 115110616-115234072 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 2: 10.5;Sertoli cells: 25.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HAP1: 17.8;hTERT-RPE1: 9.1;U-266/70: 11.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003233 Approved Approved "Nucleoli,Plasma membrane" NA NA Nucleoli "Plasma membrane" "HPA003233: AB_2265929" "unprognostic (9.74e-2)" "unprognostic (9.48e-2)" "unprognostic (1.14e-2)" "unprognostic (4.22e-5)" "unprognostic (2.88e-2)" "unprognostic (1.17e-1)" "unprognostic (1.42e-1)" "unprognostic (9.39e-2)" "unprognostic (1.34e-1)" "unprognostic (1.43e-1)" "unprognostic (1.01e-2)" "unprognostic (1.84e-1)" "unprognostic (4.29e-5)" "unprognostic (1.09e-3)" "unprognostic (1.34e-1)" "unprognostic (7.75e-2)" "unprognostic (1.16e-2)" 5.1 8.7 11.6 3.4 10.2 0.7 3.3 11.2 10.6 11.2 11.6 5.5 4.0 1.6 9.9 4.5 3.6 4.6 5.3 4.7 7.9 8.9 2.6 1.0 5.7 1.8 5.7 4.6 13.8 1.6 1.3 20.9 13.7 7.6 16.4 4.2 2.5 1.3 14.5 1.2 1.1 3.2 13.7 6.4 3.7 3.6 4.3 7.9 0.0 4.8 0.4 1.1 11.6 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 3.9 5.5 4.6 0.0 3.5 7.6 3.4 7.9 0.0 0.0 0.1 0.0 4.6 2.7 0.3 17.8 0.0 5.2 0.0 4.8 0.0 0.0 0.0 4.4 0.0 0.1 2.7 0.0 1.4 0.2 9.1 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 5.2 0.0 3.8 0.0 4.3 0.5 0.0 6.8 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 2.1 0.0 4.9 11.8 2.0 0.0 1.5 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 10.2 11.2 8.4 7.9 8.9 5.7 4.6 7.6 7.9 3.0 10.5 0.0 0.0 0.6 6.7 5.5 0.0 0.0 0.0 1.8 0.0 0.1 1.7 0.0 5.7 4.5 0.0 0.0 0.0 0.1 5.4 1.2 0.0 0.0 0.5 1.6 0.0 1.8 0.0 1.5 8.1 0.0 1.7 0.0 0.0 6.6 0.0 0.0 6.0 0.0 2.4 25.8 7.1 3.6 3.0 0.1 0.2 0.0 0.0 0.0 LRP11 "bA350J20.3, MANSC3" ENSG00000120256 "LDL receptor related protein 11" Q86VZ4 6 149818798-149864026 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 3.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017267 Approved "Vesicles,Plasma membrane" NA NA 640000 "Plasma membrane" Vesicles "HPA017267: " "prognostic unfavorable (2.31e-8)" "unprognostic (3.85e-3)" "unprognostic (1.68e-1)" "unprognostic (1.30e-2)" "unprognostic (5.17e-2)" "unprognostic (4.25e-3)" "prognostic unfavorable (2.01e-5)" "unprognostic (5.05e-2)" "unprognostic (1.47e-1)" "unprognostic (2.49e-1)" "unprognostic (3.29e-1)" "unprognostic (2.63e-1)" "unprognostic (4.76e-2)" "unprognostic (2.47e-1)" "unprognostic (6.75e-2)" "unprognostic (1.34e-2)" "unprognostic (4.23e-2)" 12.0 16.5 17.8 4.4 26.9 1.6 11.2 17.9 25.6 14.0 11.5 15.1 9.4 10.5 10.6 14.8 20.2 20.2 10.5 8.0 19.7 19.3 18.2 9.0 12.1 2.2 15.0 16.9 15.3 17.2 46.2 15.2 14.7 20.6 23.3 11.4 10.8 14.2 12.3 8.1 20.2 8.7 10.9 13.3 3.6 14.4 7.2 15.6 0.8 20.8 13.8 6.4 17.3 14.2 3.5 1.0 0.0 1.7 0.0 0.7 0.1 9.5 8.4 6.4 5.6 14.3 26.2 1.2 10.0 19.6 7.0 8.5 2.5 20.0 0.1 13.7 15.7 30.9 25.6 7.2 18.2 5.0 15.4 7.2 4.5 30.9 11.0 8.8 4.6 0.1 16.3 35.5 9.0 17.8 19.9 10.8 4.4 9.3 4.3 8.3 16.5 0.1 0.1 3.8 19.0 8.4 5.0 9.6 2.2 12.6 19.6 8.5 5.7 31.6 17.7 6.0 3.3 14.5 9.6 8.4 8.8 2.0 18.3 7.6 0.0 3.0 2.2 15.9 4.7 5.1 0.0 0.1 0.0 0.2 0.4 0.0 3.5 0.7 0.6 1.0 0.6 0.2 0.3 0.0 0.0 1.7 0.0 0.0 0.1 17.8 26.9 17.9 25.6 19.7 19.3 15.0 16.9 20.6 15.6 6.0 3.2 0.8 10.9 10.1 10.5 7.6 20.4 24.1 5.7 19.2 2.0 1.4 5.0 5.6 26.8 6.8 3.9 0.0 19.4 2.2 12.9 21.0 0.0 8.3 2.9 7.9 28.3 11.1 1.8 24.2 15.3 1.1 13.5 0.0 3.7 6.3 16.2 2.9 13.8 5.4 5.4 0.0 5.6 6.1 5.9 12.5 4.7 0.0 11.3 20.6 LRP12 "FLJ12929, ST7" ENSG00000147650 "LDL receptor related protein 12" Q9Y561 8 104489231-104589024 "Predicted membrane proteins" Endocytosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 27.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "basophil: 22.6" "Lineage enriched" "Detected in many" 22 "granulocytes: 22.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017245 Uncertain Approved "Nucleoli fibrillar center,Plasma membrane,Mitochondria" NA NA "Nucleoli fibrillar center, Plasma membrane, Mitochondria" "HPA017245: AB_1857532" "unprognostic (2.17e-1)" "unprognostic (6.80e-2)" "unprognostic (2.20e-1)" "prognostic unfavorable (2.67e-4)" "unprognostic (2.07e-1)" "unprognostic (2.15e-3)" "unprognostic (4.87e-4)" "unprognostic (2.96e-2)" "unprognostic (3.96e-1)" "unprognostic (4.59e-2)" "unprognostic (1.32e-1)" "unprognostic (3.39e-2)" "unprognostic (9.89e-2)" "unprognostic (7.56e-3)" "unprognostic (4.88e-2)" "unprognostic (1.45e-1)" "unprognostic (4.05e-3)" 6.1 5.3 10.7 4.0 23.4 2.1 4.7 11.3 16.3 7.4 5.1 4.3 5.1 3.3 18.2 4.5 4.6 6.9 8.1 14.2 8.7 6.5 7.2 1.6 4.8 1.6 4.6 9.5 6.9 5.4 13.0 11.0 5.6 7.1 7.4 5.3 3.3 5.0 6.8 11.8 5.1 3.1 20.2 4.1 3.8 3.8 5.0 5.2 18.0 7.4 3.4 2.4 6.2 5.4 0.0 0.3 22.6 0.4 0.4 1.0 0.2 7.3 4.3 8.8 15.4 10.0 8.0 1.9 21.1 21.2 7.4 10.4 0.9 7.3 0.0 8.5 19.9 8.9 3.3 3.6 9.0 15.9 13.7 3.4 11.5 2.0 0.3 6.2 0.1 9.3 10.6 6.4 12.3 10.1 26.8 3.8 9.0 2.4 0.0 26.4 1.2 10.5 0.2 2.2 0.6 7.5 0.8 8.6 1.6 5.9 0.3 11.3 6.9 6.7 0.3 18.0 6.9 2.0 2.2 10.5 20.4 13.2 6.5 13.6 10.0 7.8 0.0 11.0 0.0 22.3 22.6 0.2 3.5 0.1 0.4 1.0 0.0 0.7 0.0 0.1 0.0 0.2 0.1 0.1 0.4 0.3 0.3 0.0 0.2 10.7 23.4 11.3 16.3 8.7 6.5 4.6 9.5 7.1 5.2 14.9 2.1 0.0 5.3 10.2 16.6 9.8 7.6 4.0 3.4 14.0 5.9 0.2 0.0 3.9 3.3 6.7 0.8 0.0 3.9 0.3 9.4 5.6 8.1 0.5 5.1 27.0 13.8 3.7 7.3 1.6 8.1 4.8 6.8 8.2 2.3 4.8 4.4 0.0 8.5 2.9 7.4 6.5 9.0 7.2 11.0 9.5 0.2 4.9 1.7 4.3 LRRC15 LIB ENSG00000172061 "Leucine rich repeat containing 15" Q8TF66 3 194355247-194369743 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "placenta: 48.1" "Cell type enhanced" "Detected in some" 17 "Basal keratinocytes: 1.6;Suprabasal keratinocytes: 1.3" "Cancer enhanced" "Detected in many" "breast cancer: 25.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 48.9;U-138 MG: 9.5;U-87 MG: 26.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA035503 Uncertain Approved "Vesicles,Plasma membrane" NA NA 1800000 Vesicles "Plasma membrane" "HPA035503: AB_10961253" "unprognostic (3.20e-2)" "unprognostic (1.45e-2)" "unprognostic (3.11e-1)" "unprognostic (6.30e-2)" "unprognostic (1.19e-2)" "unprognostic (2.04e-1)" "unprognostic (7.11e-2)" "unprognostic (2.95e-2)" "unprognostic (1.84e-1)" "unprognostic (3.53e-2)" "unprognostic (3.97e-2)" "unprognostic (1.88e-3)" "unprognostic (1.22e-8)" "unprognostic (5.81e-2)" "unprognostic (1.11e-1)" "unprognostic (5.62e-3)" "unprognostic (7.54e-3)" 3.3 0.5 0.5 3.1 0.6 0.0 5.3 0.5 0.5 4.6 2.1 0.2 0.0 0.4 3.5 0.3 1.0 1.3 2.0 1.8 0.5 0.5 0.5 0.5 2.5 0.8 0.5 0.0 3.1 0.8 0.0 0.5 48.1 0.3 0.6 4.2 0.7 1.6 0.0 1.0 9.1 0.8 0.7 0.5 1.3 1.9 0.9 0.0 1.1 1.8 7.7 7.7 2.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.7 0.0 0.0 0.1 0.0 0.0 0.4 48.9 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 9.5 1.6 1.2 0.0 0.0 0.0 0.0 26.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.5 0.5 0.5 0.5 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.3 0.0 0.0 0.0 0.0 LRRC45 MGC20806 ENSG00000169683 "Leucine rich repeat containing 45" Q96CN5 17 82023302-82031151 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Extravillous trophoblasts: 22.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023372, HPA023382, HPA024768" Enhanced Supported "Nucleoplasm,Plasma membrane,Centrosome,Cytosol" NA NA "Centrosome, Cytosol" "Nucleoplasm, Plasma membrane" "HPA023372: AB_1853317, HPA023382: AB_1853318, HPA024768: AB_10602348" "unprognostic (6.69e-2)" "unprognostic (6.10e-2)" "unprognostic (6.86e-2)" "unprognostic (1.38e-2)" "unprognostic (6.92e-2)" "unprognostic (4.41e-3)" "unprognostic (4.70e-3)" "unprognostic (1.23e-1)" "unprognostic (6.10e-2)" "unprognostic (1.78e-3)" "unprognostic (6.17e-3)" "unprognostic (7.46e-2)" "prognostic unfavorable (1.54e-4)" "unprognostic (1.22e-3)" "unprognostic (1.24e-1)" "unprognostic (4.79e-2)" "unprognostic (3.58e-1)" 5.1 4.9 7.1 7.0 9.3 12.0 4.5 20.3 10.8 4.6 7.0 5.7 9.5 11.1 4.4 5.0 8.0 10.5 5.8 3.1 7.7 3.9 5.9 12.9 5.6 6.5 8.3 4.7 3.7 15.5 4.5 4.8 4.9 6.5 6.6 3.6 4.9 13.6 5.0 4.3 10.2 9.4 5.2 3.3 7.6 10.4 3.1 9.9 7.1 9.8 6.8 6.5 5.0 5.1 2.3 3.3 5.0 3.2 2.8 4.6 3.1 9.8 11.2 3.4 7.0 1.4 1.9 13.4 6.9 2.9 4.2 3.5 10.0 6.8 7.4 6.2 1.4 4.3 11.6 3.3 4.1 0.9 4.5 21.3 4.7 20.5 13.5 1.2 5.5 11.8 1.9 1.7 2.5 0.6 1.7 6.1 7.2 3.3 3.3 1.1 16.7 12.3 18.4 3.5 8.0 15.1 10.1 6.7 4.1 2.7 9.2 10.6 10.4 3.1 16.5 5.8 1.8 13.5 6.4 3.5 7.3 9.3 11.6 11.7 6.4 1.6 1.1 3.9 4.8 7.6 5.0 3.2 3.6 3.9 2.4 4.0 1.5 4.5 4.6 2.2 2.3 2.4 3.1 0.2 2.8 1.0 3.3 3.8 3.1 7.1 9.3 20.3 10.8 7.7 3.9 8.3 4.7 6.5 9.9 6.0 2.1 1.9 4.2 3.9 4.5 2.4 10.2 14.7 7.9 3.5 0.0 8.9 5.0 6.8 1.1 3.1 9.1 0.0 4.2 22.5 4.0 3.5 4.6 11.1 7.4 4.8 4.6 8.6 5.9 1.1 6.6 2.5 8.5 2.8 9.8 5.0 5.0 8.6 6.0 6.5 4.0 0.0 3.8 1.4 11.0 2.0 2.5 5.3 10.3 2.0 LRRC69 ENSG00000214954 "Leucine rich repeat containing 69" Q6ZNQ3 8 91101832-91219236 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 6.6" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 38.9;Late spermatids: 11.9" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEK 293: 6.8;SuSa: 6.1;U-266/70: 17.7;U-266/84: 9.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA046337 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA046337: AB_2679626" "unprognostic (1.63e-2)" "unprognostic (1.02e-1)" "unprognostic (4.69e-1)" "unprognostic (3.28e-1)" "unprognostic (2.78e-1)" "unprognostic (3.17e-1)" "unprognostic (3.51e-2)" "unprognostic (3.50e-2)" "unprognostic (2.49e-2)" "unprognostic (1.47e-1)" "unprognostic (9.18e-2)" "unprognostic (1.88e-1)" "unprognostic (3.09e-6)" "unprognostic (6.91e-2)" "unprognostic (1.60e-1)" "unprognostic (1.43e-1)" "unprognostic (8.68e-5)" 0.8 0.9 0.2 1.5 0.2 0.0 1.0 0.0 0.1 0.7 0.5 0.1 0.5 1.9 0.7 0.4 0.5 1.1 0.1 0.1 0.9 0.7 0.7 1.9 0.3 0.4 0.7 0.3 0.6 0.5 1.0 1.5 1.1 0.3 0.6 3.5 0.6 1.4 0.3 1.2 0.6 6.6 1.3 1.1 1.0 0.8 1.9 2.0 1.5 1.1 0.4 2.3 0.1 0.6 0.7 0.2 0.5 0.7 1.5 1.2 0.4 0.1 0.3 0.3 1.1 0.9 1.0 0.5 0.2 0.1 0.6 0.7 1.2 0.3 0.3 6.8 1.5 1.8 0.5 0.2 0.5 1.1 0.4 1.1 0.4 0.8 0.4 0.1 1.2 1.1 0.6 0.4 0.2 0.3 0.5 0.7 1.1 0.4 0.8 0.0 0.7 0.2 0.7 0.0 0.2 0.0 0.4 1.0 6.1 1.6 1.2 0.2 0.3 0.7 0.2 0.9 17.7 9.8 4.0 0.1 2.2 0.9 1.3 0.6 1.5 1.5 1.1 1.5 1.2 1.6 0.6 0.1 1.9 2.3 1.2 0.1 0.4 0.6 2.0 2.1 0.1 0.0 0.6 0.8 2.4 4.1 1.8 2.4 0.0 6.7 1.2 3.5 3.9 1.9 3.3 1.3 38.9 2.1 0.5 0.0 1.0 1.5 2.2 3.1 0.0 0.8 0.8 0.0 2.4 3.7 2.1 11.9 2.6 1.7 6.8 4.6 1.4 1.1 1.5 0.9 1.1 0.2 3.2 0.0 2.1 2.3 2.5 4.5 0.8 0.0 1.4 2.0 LRRC7 "densin-180, KIAA1365" ENSG00000033122 "Leucine rich repeat containing 7" Q96NW7 1 69568398-70151945 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 29.1" "Cell type enhanced" "Detected in many" 14 "Bipolar cells: 37.9;Early spermatids: 20.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "eosinophil: 1.4;naive CD4 T-cell: 1.7;naive CD8 T-cell: 1.3" "Group enriched" "Detected in many" 14 "granulocytes: 1.4;T-cells: 1.7" "Group enriched" "Detected in some" 6 "HaCaT: 10.5;HEL: 31.3" "Low region specificity" "Detected in many" HPA005625 Supported "Nucleoplasm,Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane, Cytosol" "Nucleoplasm, Centrosome" "HPA005625: AB_1853340" "unprognostic (2.81e-2)" "unprognostic (1.62e-2)" "unprognostic (1.51e-1)" "unprognostic (2.98e-3)" "unprognostic (2.47e-1)" "unprognostic (1.73e-1)" "unprognostic (1.04e-1)" "unprognostic (3.50e-2)" "unprognostic (4.84e-3)" "unprognostic (2.92e-2)" "unprognostic (1.06e-3)" "unprognostic (1.46e-1)" "unprognostic (5.64e-6)" "unprognostic (1.31e-2)" "unprognostic (1.74e-2)" "unprognostic (5.13e-3)" "unprognostic (2.08e-3)" 1.0 1.3 20.2 1.0 29.1 1.0 0.8 0.5 21.9 1.2 1.9 5.0 0.0 1.0 1.2 1.0 1.3 0.8 3.2 2.8 15.4 5.8 2.8 1.2 0.8 0.9 4.4 17.6 1.0 2.7 0.7 0.4 1.2 2.4 1.5 2.4 0.2 0.9 1.1 2.8 1.1 1.3 1.2 2.5 0.8 0.8 5.8 7.6 0.0 6.7 0.0 0.8 0.9 0.5 0.0 0.1 1.4 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 3.3 0.0 0.0 10.5 0.2 0.0 0.0 0.0 0.5 31.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 3.6 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 1.7 1.3 0.0 0.0 0.0 0.0 0.0 0.1 20.2 29.1 0.5 19.2 15.4 5.8 4.4 17.6 2.4 7.6 0.0 0.0 5.1 0.5 0.7 37.9 5.8 2.5 0.0 0.0 0.0 2.0 0.4 0.0 0.0 20.2 1.4 0.0 0.0 0.0 0.4 2.1 0.7 0.0 5.5 0.3 6.4 0.0 1.8 1.5 4.6 0.6 0.7 5.0 0.0 0.0 0.5 0.0 0.0 2.8 1.3 7.9 0.0 1.4 7.4 2.7 1.1 0.1 2.5 0.0 0.1 LRRC9 FLJ46156 ENSG00000131951 "Leucine rich repeat containing 9" Q6ZRR7 14 59919713-60063559 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 16.4;pituitary gland: 13.9;testis: 14.3" "Group enriched" "Detected in some" 9 "Early spermatids: 98.5;Late spermatids: 64.1" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "basal ganglia: 7.3;pons and medulla: 16.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.3;CACO-2: 2.0;GAMG: 1.1;NTERA-2: 4.2;SCLC-21H: 1.9;SH-SY5Y: 1.3;SuSa: 1.7;U-2 OS: 1.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA040965, HPA041381, HPA077675" Uncertain Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" "Nucleoplasm, Nuclear bodies" "HPA040965: AB_2677225, HPA041381: AB_2677444, HPA077675: " "unprognostic (1.01e-2)" "unprognostic (2.00e-1)" "unprognostic (4.45e-2)" "unprognostic (2.12e-3)" "unprognostic (2.80e-1)" "unprognostic (2.95e-3)" "unprognostic (1.93e-1)" "unprognostic (3.11e-2)" "unprognostic (1.91e-2)" "unprognostic (4.82e-2)" "unprognostic (3.45e-3)" "unprognostic (6.06e-2)" "unprognostic (2.62e-3)" "unprognostic (8.54e-3)" "unprognostic (8.30e-2)" "unprognostic (1.67e-2)" "unprognostic (2.29e-2)" 0.6 0.4 0.6 0.1 7.3 0.2 0.1 0.2 1.1 0.3 0.1 3.2 0.0 0.1 0.2 1.4 0.1 3.4 0.1 0.1 1.4 1.2 0.2 0.2 0.1 0.1 0.5 1.3 1.0 0.2 4.8 13.9 0.1 16.4 1.3 0.1 0.0 0.1 0.2 0.1 0.1 0.7 0.1 0.9 0.1 0.2 14.3 2.2 0.0 0.1 0.0 0.1 0.2 0.1 0.6 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 4.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 7.3 0.2 1.1 1.4 1.2 0.5 1.3 16.4 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 98.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.6 0.0 0.0 0.0 64.1 0.9 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.7 0.0 0.1 0.0 0.0 8.8 0.9 0.0 0.1 0.0 0.0 0.0 LRRFIP2 HUFI-2 ENSG00000093167 "LRR binding FLII interacting protein 2" Q9Y608 3 37052656-37183689 "Predicted intracellular proteins, Transcription factors" "Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Early spermatids: 388.9;Urothelial cells: 309.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035956, HPA042023" Uncertain Approved "Plasma membrane,Actin filaments" NA NA 1000000 "Plasma membrane, Actin filaments" "HPA035956: AB_10671238, HPA042023: AB_2677802" "unprognostic (2.03e-3)" "prognostic favorable (6.31e-4)" "unprognostic (1.16e-2)" "unprognostic (7.90e-2)" "unprognostic (2.48e-1)" "unprognostic (2.97e-1)" "unprognostic (5.41e-2)" "unprognostic (1.82e-1)" "unprognostic (3.09e-2)" "unprognostic (2.56e-2)" "unprognostic (4.99e-3)" "unprognostic (1.98e-1)" "unprognostic (4.13e-3)" "unprognostic (2.62e-1)" "unprognostic (1.37e-1)" "unprognostic (4.84e-3)" "unprognostic (3.76e-2)" 15.4 17.3 23.0 17.5 22.0 27.5 21.9 30.0 22.8 35.7 35.8 26.5 17.7 24.7 28.2 20.0 33.0 15.7 22.8 47.4 23.8 25.3 19.8 33.9 18.7 19.3 24.2 19.4 20.6 16.9 33.9 18.3 16.9 24.4 30.3 24.8 19.6 19.3 19.5 58.5 23.2 37.1 27.3 31.2 29.7 17.0 47.2 24.8 11.6 20.6 33.6 21.6 23.7 25.1 7.1 9.8 22.7 17.2 11.9 8.8 7.5 15.6 8.7 10.1 7.9 13.5 20.8 8.8 42.7 42.6 24.1 27.8 8.1 7.2 6.2 7.0 41.1 11.9 8.2 7.4 21.1 39.5 13.8 5.8 11.1 12.5 7.9 19.3 8.7 6.8 9.2 15.2 31.3 32.5 13.4 16.7 9.7 8.8 10.9 20.0 4.0 7.4 4.7 6.6 6.4 11.2 3.6 28.9 6.3 16.9 6.1 3.6 5.8 16.5 15.3 13.8 8.5 8.8 9.1 16.0 18.5 12.5 27.1 20.0 8.5 15.2 9.5 10.9 7.9 26.2 12.2 15.0 22.7 6.6 10.4 8.5 7.1 7.0 7.0 9.8 5.4 5.2 6.2 14.0 11.9 17.2 5.5 8.8 7.5 23.0 22.0 30.0 22.8 23.8 25.3 24.2 19.4 24.4 24.8 26.8 32.2 18.0 127.0 120.9 34.6 89.3 25.5 36.1 66.0 22.7 27.5 25.5 54.7 70.3 388.9 46.3 105.3 23.3 82.3 35.6 59.0 267.5 50.8 52.9 22.7 116.0 51.9 60.8 39.4 269.5 39.1 42.2 70.9 77.5 39.2 48.7 85.8 59.6 54.1 33.1 51.1 38.8 54.0 116.1 61.4 149.1 32.8 24.5 60.8 309.6 LRRIQ3 "LRRC44, MGC22773" ENSG00000162620 "Leucine rich repeats and IQ motif containing 3" A6PVS8 1 74026015-74198187 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 34.1" "Cell type enhanced" "Detected in many" 17 "Early spermatids: 144.3;Late spermatids: 74.3;Spermatocytes: 156.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "GAMG: 12.2;JURKAT: 7.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA030799 Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA030799: AB_10601337" "unprognostic (5.94e-3)" "unprognostic (6.00e-2)" "unprognostic (6.49e-3)" "unprognostic (1.63e-1)" "unprognostic (6.62e-2)" "unprognostic (2.78e-1)" "unprognostic (2.27e-2)" "unprognostic (2.27e-1)" "unprognostic (8.17e-2)" "unprognostic (2.44e-1)" "unprognostic (1.12e-3)" "unprognostic (1.71e-1)" "unprognostic (1.41e-1)" "unprognostic (1.05e-1)" "unprognostic (1.13e-1)" "unprognostic (1.88e-2)" "unprognostic (4.65e-2)" 1.8 1.3 0.9 0.9 2.7 0.2 0.9 0.3 1.5 0.8 0.4 1.1 0.1 0.3 0.4 1.2 0.6 2.8 0.6 0.6 1.0 1.1 3.5 1.7 1.6 0.9 2.5 1.4 2.5 0.6 2.1 7.2 0.3 2.4 0.6 0.3 0.6 0.8 0.6 0.4 0.3 0.4 0.2 1.3 1.6 0.5 34.1 1.0 1.4 1.9 0.0 0.8 0.5 0.4 3.9 1.1 1.9 1.1 1.1 4.0 0.9 0.3 1.5 0.2 0.6 1.6 0.6 1.0 0.9 0.6 1.3 1.4 0.2 2.1 2.1 1.9 0.2 12.2 0.2 3.3 3.0 1.6 5.2 0.0 1.9 0.5 1.0 0.2 3.4 1.1 1.1 1.6 2.2 0.8 0.5 0.6 7.3 1.6 3.0 2.1 0.0 1.3 0.5 1.7 3.7 1.0 1.6 1.2 2.1 1.9 0.2 1.6 1.1 0.2 0.2 4.6 0.3 1.3 1.9 0.2 0.2 1.1 0.8 1.8 3.1 1.1 1.7 2.3 0.3 1.6 0.0 0.2 1.9 2.3 1.1 2.9 3.9 2.6 2.9 0.3 2.0 2.5 3.5 0.0 1.1 0.3 1.1 4.0 0.9 0.9 2.7 0.3 1.5 1.0 1.1 2.5 1.4 2.4 1.0 0.0 1.0 0.0 1.0 1.0 0.8 0.4 0.0 36.1 1.2 0.0 3.9 1.4 11.6 1.4 144.3 0.1 0.0 0.0 1.6 1.5 0.2 1.2 0.0 1.0 1.1 0.0 2.9 0.0 0.6 74.3 1.7 0.4 0.0 1.0 0.9 1.1 0.7 0.0 1.4 4.2 0.6 0.0 0.4 156.8 22.6 0.1 0.2 0.7 0.6 0.7 LSMEM2 "C3orf45, FLJ38608" ENSG00000179564 "Leucine rich single-pass membrane protein 2" Q8N112 3 50279027-50288114 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "heart muscle: 26.6;skeletal muscle: 16.3;tongue: 7.2" "Cell type enriched" "Detected in some" 5 "Late spermatids: 197.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.2" "Lineage enriched" "Detected in single" 13 "T-cells: 1.2" "Cell line enhanced" "Detected in some" "HeLa: 3.7;WM-115: 3.5" "Low region specificity" "Detected in many" HPA079523 Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA079523: " "unprognostic (2.84e-3)" "unprognostic (6.54e-2)" "unprognostic (2.36e-2)" "unprognostic (1.09e-1)" "unprognostic (1.03e-1)" "unprognostic (2.30e-1)" "unprognostic (8.96e-2)" "unprognostic (1.02e-1)" "unprognostic (1.55e-2)" "unprognostic (2.65e-1)" "unprognostic (3.17e-2)" "unprognostic (2.82e-1)" "unprognostic (1.82e-1)" "unprognostic (2.46e-2)" "unprognostic (2.48e-1)" "unprognostic (6.49e-3)" "unprognostic (1.71e-1)" 0.6 0.3 1.2 0.2 2.1 0.4 0.2 0.7 1.9 1.1 0.3 2.1 0.1 0.4 1.4 0.4 0.7 0.8 0.4 26.6 1.4 0.7 0.3 0.1 0.3 0.1 1.3 0.6 0.9 0.3 0.1 0.1 0.2 1.3 0.4 0.3 1.6 1.4 0.5 16.3 0.1 0.5 0.5 1.6 0.2 0.2 3.0 0.9 0.1 0.2 7.2 0.2 0.3 0.7 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.3 0.2 0.3 0.0 0.0 0.4 0.4 0.4 0.4 0.2 0.3 0.5 0.1 0.1 0.0 0.5 0.1 0.1 1.1 0.1 0.0 0.5 0.2 3.7 0.2 0.0 0.3 0.2 0.2 0.0 0.1 0.2 0.5 0.0 1.1 0.0 1.0 0.0 0.2 0.1 0.7 0.5 0.4 0.0 0.0 0.3 0.0 0.3 0.3 0.1 0.5 0.0 0.8 1.0 0.4 0.0 0.0 0.0 0.2 1.3 0.4 0.4 0.9 0.6 0.6 0.1 0.9 3.5 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.3 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 2.1 0.7 1.9 1.4 0.7 1.3 0.6 1.3 0.9 0.0 1.1 0.0 0.1 0.9 0.1 3.0 0.0 0.0 1.2 1.8 0.0 0.0 0.0 0.1 41.7 0.0 0.9 0.0 0.2 0.1 0.3 0.3 4.7 0.0 0.1 0.0 0.0 0.0 0.0 197.4 1.1 0.0 1.7 0.0 0.4 0.5 0.1 0.0 0.7 0.0 0.2 0.0 0.7 1.6 1.0 1.1 0.1 0.0 0.6 0.1 LUZP2 ENSG00000187398 "Leucine zipper protein 2" Q86TE4 11 24496970-25082631 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 11.1;brain: 32.7" "Group enriched" "Detected in some" 4 "Early spermatids: 18.8;Paneth cells: 21.8" "Group enriched" "Detected in some" 7 "glioma: 3.5;prostate cancer: 4.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HaCaT: 14.2;HAP1: 7.1;HeLa: 2.5;hTERT-RPE1: 6.1" "Low region specificity" "Detected in all" "HPA039007, HPA046161" Enhanced Supported Approved "Nucleoplasm,Plasma membrane,Cytosol" "Secreted in brain" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA039007: AB_2676307, HPA046161: AB_2679564" "unprognostic (4.49e-2)" "unprognostic (2.74e-2)" "unprognostic (8.63e-2)" "unprognostic (3.50e-1)" "unprognostic (5.22e-3)" "unprognostic (3.38e-1)" "unprognostic (4.88e-2)" "unprognostic (5.67e-4)" "unprognostic (2.40e-1)" "unprognostic (5.66e-2)" "unprognostic (6.16e-3)" "unprognostic (4.09e-2)" "unprognostic (5.18e-3)" "unprognostic (9.41e-3)" "unprognostic (4.18e-2)" "unprognostic (2.17e-1)" "unprognostic (9.64e-2)" 1.2 11.1 14.5 0.9 10.8 0.9 1.6 2.6 32.7 0.9 2.1 5.9 0.0 0.9 1.0 0.8 0.9 0.8 1.0 1.0 10.3 13.8 1.0 2.3 1.1 0.8 13.7 5.6 0.8 0.8 0.7 1.9 0.8 26.7 4.5 1.7 0.0 1.0 0.9 0.8 0.9 1.1 1.2 30.0 0.9 0.9 1.6 14.5 0.0 0.8 0.9 0.8 1.6 0.3 0.5 0.4 1.9 0.3 0.3 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 14.2 7.1 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 6.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.6 0.0 0.3 0.0 0.2 0.2 0.0 1.5 0.1 1.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 1.5 0.3 0.4 0.2 0.1 0.2 0.2 0.1 0.3 0.1 0.5 0.3 0.2 1.9 0.3 0.2 0.4 0.1 0.0 14.5 10.8 2.6 9.3 10.3 13.8 13.7 5.6 26.7 14.5 0.0 0.0 0.0 0.1 0.6 2.3 0.4 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.6 4.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.0 0.9 0.0 0.0 0.0 1.8 0.2 0.1 21.8 0.0 0.6 0.6 0.0 0.0 0.2 0.2 0.3 0.1 0.0 0.9 0.7 LY6K "CT97, FLJ35226, HSJ001348" ENSG00000160886 "Lymphocyte antigen 6 family member K" Q17RY6 8 142700111-142705127 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 39.3" "Cell type enhanced" "Detected in many" 18 "Extravillous trophoblasts: 132.9;Glandular cells: 88.0;Spermatocytes: 359.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 10 "neutrophil: 5.3" "Lineage enriched" "Detected in single" 11 "granulocytes: 5.3" "Cell line enhanced" "Detected in many" "A-431: 28.8;BJ: 31.3;HeLa: 34.1;SiHa: 49.0;U-2197: 66.2" "HPA017770, CAB075742, CAB075743" Enhanced Approved "Nucleoplasm,Plasma membrane" "Secreted in male reproductive system" NA NA "Plasma membrane" Nucleoplasm "CAB075742: AB_2665748, CAB075743: AB_2665749, HPA017770: AB_1853414" "unprognostic (1.25e-1)" "unprognostic (1.95e-2)" "unprognostic (1.48e-1)" "unprognostic (7.23e-3)" "unprognostic (3.47e-2)" "unprognostic (2.39e-1)" "unprognostic (2.23e-1)" "prognostic unfavorable (9.17e-5)" "unprognostic (4.18e-2)" "unprognostic (6.89e-2)" "unprognostic (9.75e-2)" "unprognostic (1.40e-1)" "unprognostic (5.27e-5)" "unprognostic (1.71e-1)" "unprognostic (1.46e-1)" "unprognostic (2.03e-1)" "unprognostic (4.61e-2)" 6.6 0.4 1.4 0.3 1.8 0.4 7.6 0.9 3.8 1.8 1.6 0.1 9.8 0.5 0.7 0.8 10.9 0.8 1.2 1.2 1.5 1.9 2.0 0.2 0.6 1.9 1.7 0.0 0.7 0.4 0.0 0.3 6.3 1.0 1.1 0.1 0.1 1.4 7.0 6.3 4.3 0.2 0.6 1.1 0.3 0.4 39.3 0.2 0.2 1.1 4.5 6.8 1.0 3.2 0.1 0.1 5.3 0.2 0.4 0.2 0.0 28.8 0.5 0.0 1.5 0.6 1.9 0.3 31.3 3.7 9.7 5.9 0.0 0.2 0.0 2.6 3.5 3.4 2.6 0.0 1.7 8.2 0.3 0.0 0.0 34.1 0.0 0.4 0.0 0.0 2.9 5.1 7.2 9.3 0.0 0.8 0.0 0.0 0.1 18.2 0.2 0.0 0.0 1.0 0.9 0.5 0.0 0.1 0.0 1.6 0.4 0.9 0.1 49.0 0.6 9.5 1.7 0.1 0.0 1.2 0.4 2.8 66.2 0.0 0.0 0.0 0.0 0.1 0.0 3.2 0.5 0.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 5.3 0.4 0.1 0.1 0.0 0.0 1.4 1.8 0.9 1.7 1.5 1.9 1.7 0.0 1.0 0.2 3.0 0.3 0.0 65.7 34.6 0.3 0.1 10.2 1.4 7.9 24.4 0.0 11.3 0.0 0.5 5.0 3.3 0.0 0.0 0.0 132.9 2.9 88.0 0.0 0.0 5.3 0.0 0.0 1.3 0.0 10.1 3.7 2.8 11.8 0.0 0.0 0.5 3.9 0.0 2.8 0.0 0.7 0.0 13.3 359.5 76.0 39.3 21.2 0.0 0.0 76.5 LYPD1 "LYPDC1, MGC29643" ENSG00000150551 "LY6/PLAUR domain containing 1" Q8N2G4 2 132644853-132671579 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.8;fallopian tube: 74.6" "Group enriched" "Detected in many" 5 "Ductal cells: 49.4;Exocrine glandular cells: 65.7;monocytes: 108.2;Pancreatic endocrine cells: 67.6" "Cancer enhanced" "Detected in many" "ovarian cancer: 57.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "eosinophil: 10.9" "Lineage enriched" "Detected in single" 36 "granulocytes: 10.9" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 17.4;HUVEC TERT2: 14.8;SK-MEL-30: 15.2;SuSa: 13.7;U-251 MG: 31.7;WM-115: 63.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA068333 Approved "Nucleoplasm,Vesicles,Plasma membrane" "Intracellular and membrane" NA NA Nucleoplasm "Vesicles, Plasma membrane" "HPA068333: " "unprognostic (9.25e-2)" "unprognostic (7.45e-2)" "unprognostic (1.03e-1)" "unprognostic (1.44e-2)" "unprognostic (1.15e-1)" "unprognostic (2.07e-2)" "unprognostic (6.40e-3)" "unprognostic (5.60e-2)" "unprognostic (8.36e-3)" "unprognostic (1.05e-2)" "unprognostic (6.70e-2)" "unprognostic (2.86e-2)" "unprognostic (1.51e-2)" "unprognostic (1.43e-2)" "unprognostic (1.55e-1)" "unprognostic (1.03e-1)" "unprognostic (6.78e-2)" 1.5 2.5 16.4 1.7 27.8 1.2 1.4 3.8 16.8 1.3 2.5 4.6 0.0 1.4 2.5 1.8 1.4 74.6 3.6 1.8 18.9 19.0 3.2 1.6 1.4 3.5 16.9 5.4 8.4 3.5 2.0 12.4 1.2 11.8 1.4 1.4 5.4 21.7 1.4 1.2 1.5 1.4 1.8 7.0 1.3 1.4 1.5 3.4 1.2 1.3 1.1 2.5 1.4 0.0 0.3 0.0 10.9 0.0 0.0 0.0 0.0 0.2 4.8 5.4 0.0 0.0 0.0 0.0 1.1 0.6 2.4 0.5 0.4 0.6 0.0 10.1 2.0 1.6 5.2 0.0 0.0 1.2 0.0 1.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 17.4 0.0 1.0 14.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 5.3 0.1 2.1 0.0 0.0 0.0 7.1 0.1 0.7 1.3 0.6 0.0 15.2 13.7 0.0 0.1 0.7 0.3 7.6 3.2 31.7 0.0 0.0 0.0 6.2 0.0 63.9 1.3 0.0 10.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.4 27.8 3.8 11.0 18.9 19.0 16.9 5.4 11.8 3.4 0.0 0.0 0.0 0.0 0.1 0.8 0.2 5.1 0.0 0.0 5.2 0.0 0.0 1.7 49.4 4.4 0.0 0.0 0.0 65.7 0.0 0.1 0.1 0.0 0.0 0.1 14.3 1.7 0.6 0.3 6.3 3.7 0.0 0.0 108.2 0.0 1.5 67.6 0.0 0.0 2.2 0.8 0.0 5.3 1.1 1.8 0.0 0.0 0.0 0.0 0.0 LYST "CHS, CHS1" ENSG00000143669 "Lysosomal trafficking regulator" Q99698 1 235661041-235883640 "Disease related genes, Predicted intracellular proteins" "Phagocytosis, Protein transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 38.8" "Cell type enhanced" "Detected in many" 6 "monocytes: 236.3;Rod photoreceptor cells: 167.4" "Cancer enhanced" "Detected in all" "melanoma: 11.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 13.0" "Group enriched" "Detected in all" 5 "granulocytes: 13.0;monocytes: 5.9" "Cell line enhanced" "Detected in many" "HDLM-2: 13.7;SK-MEL-30: 12.7;THP-1: 44.9;U-937: 17.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053366, HPA055725" Supported "Nucleoplasm,Plasma membrane,Centriolar satellite" Yes No Nucleoplasm "Plasma membrane, Centriolar satellite" "HPA053366: AB_2682129, HPA055725: AB_2682898" "unprognostic (1.56e-2)" "unprognostic (1.54e-1)" "unprognostic (9.92e-2)" "unprognostic (8.85e-2)" "unprognostic (1.96e-2)" "unprognostic (4.32e-2)" "unprognostic (4.11e-2)" "unprognostic (7.79e-2)" "unprognostic (4.08e-2)" "unprognostic (1.95e-1)" "unprognostic (1.55e-1)" "unprognostic (9.31e-2)" "prognostic unfavorable (5.27e-5)" "unprognostic (1.59e-1)" "unprognostic (1.54e-1)" "unprognostic (6.29e-2)" "unprognostic (1.99e-1)" 10.3 5.2 6.4 9.0 8.8 31.3 10.6 10.5 7.1 8.8 5.3 3.8 3.4 3.4 6.8 4.3 6.6 5.6 5.8 4.7 4.3 2.4 5.0 6.1 10.9 7.8 4.2 6.0 6.2 5.0 9.1 12.6 5.5 5.3 6.0 5.0 9.6 8.2 4.8 3.9 11.7 6.3 9.8 9.2 11.3 8.4 6.4 6.3 38.8 8.5 4.0 7.6 9.3 10.6 1.6 1.7 13.0 5.9 1.7 1.0 0.7 3.8 0.9 0.4 0.9 6.0 6.9 0.6 1.4 5.7 1.5 1.4 0.0 1.0 0.5 0.6 3.1 3.6 1.8 0.5 0.7 1.3 13.7 1.2 1.2 0.8 0.3 1.1 1.8 1.7 2.3 3.6 1.9 4.7 2.2 1.2 0.6 0.1 0.8 1.2 0.2 2.3 3.9 0.1 0.7 0.4 0.1 0.5 0.0 4.4 4.2 2.5 0.5 1.5 0.0 12.7 0.5 0.5 44.9 2.6 1.1 0.5 1.3 1.2 0.9 0.0 0.0 1.9 17.2 3.2 0.4 3.1 5.7 0.6 3.5 1.0 1.1 0.3 0.7 1.7 1.6 0.2 0.5 13.0 1.7 5.9 0.2 0.2 0.7 6.4 8.8 10.5 7.1 4.3 2.4 4.2 6.0 5.3 6.3 17.9 50.4 48.0 71.9 63.1 61.8 9.2 10.2 24.1 39.8 10.4 88.4 5.4 10.0 5.6 9.9 41.7 11.5 0.0 10.7 4.0 23.9 49.0 106.6 14.5 28.2 49.3 9.2 15.4 73.1 13.4 25.9 70.4 114.7 236.3 11.3 23.7 24.4 14.2 20.5 9.0 167.4 12.9 28.6 79.6 22.6 57.0 7.3 65.4 6.3 82.9 LZTS1 FEZ1 ENSG00000061337 "Leucine zipper tumor suppressor 1" Q9Y250 8 20246165-20303963 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 19.0;parathyroid gland: 64.9" "Cell type enhanced" "Detected in some" 21 "Horizontal cells: 19.1;Melanocytes: 18.6;Rod photoreceptor cells: 17.9;Sertoli cells: 64.7" "Cancer enhanced" "Detected in all" "melanoma: 59.2" "Group enriched" "Detected in many" 5 "amygdala: 13.3;basal ganglia: 19.0;cerebral cortex: 19.0;hippocampal formation: 8.9;olfactory region: 8.8" "Cell type enhanced" "Detected in single" "gdT-cell: 2.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "SK-MEL-30: 36.7;U-698: 11.2;WM-115: 24.8" "Group enriched" "Detected in many" 5 "amygdala: 47.8;basal ganglia: 76.8;cerebral cortex: 46.2;hippocampal formation: 41.3;olfactory region: 26.1" "Group enriched" "Detected in many" 9 "amygdala: 28.4;basal ganglia: 66.4;cerebral cortex: 45.3;hippocampal formation: 38.6;olfactory region: 47.4" "HPA006294, HPA022046" Approved Approved "Nucleoli,Plasma membrane" NA NA "Plasma membrane" Nucleoli "HPA006294: AB_1079288, HPA022046: AB_1853455" "unprognostic (7.76e-2)" "unprognostic (1.02e-1)" "unprognostic (3.49e-3)" "prognostic unfavorable (3.03e-4)" "unprognostic (6.27e-2)" "unprognostic (1.96e-1)" "unprognostic (7.29e-2)" "unprognostic (5.76e-2)" "unprognostic (1.41e-2)" "unprognostic (9.06e-3)" "unprognostic (6.81e-2)" "unprognostic (3.63e-2)" "prognostic unfavorable (9.28e-6)" "unprognostic (3.35e-2)" "unprognostic (2.71e-1)" "unprognostic (1.11e-1)" "unprognostic (6.82e-3)" 2.4 2.1 13.3 1.8 19.0 0.8 1.9 0.6 19.0 1.6 1.1 2.2 0.4 1.1 2.2 1.5 3.5 1.4 3.5 2.3 8.9 2.6 1.9 1.1 4.0 1.5 2.5 8.8 1.7 1.6 64.9 1.4 5.8 1.9 1.7 1.1 10.3 1.3 1.7 1.6 4.2 1.2 2.7 0.8 1.1 1.3 6.6 1.5 0.3 2.0 0.9 1.1 1.9 1.0 0.2 0.1 0.7 0.1 0.1 2.2 0.5 0.0 0.0 4.8 4.0 0.0 0.0 0.6 2.4 0.0 2.1 1.8 0.1 0.0 5.3 1.7 1.5 0.8 0.1 0.2 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.5 0.0 0.8 0.0 0.3 0.0 5.7 0.0 0.0 7.0 0.0 9.2 0.0 6.0 0.0 0.0 0.0 7.7 0.0 1.3 0.2 7.4 6.4 0.0 0.0 36.7 4.2 0.0 0.2 0.0 2.5 1.7 0.0 0.7 0.0 0.0 11.2 0.0 0.5 24.8 0.2 0.1 0.0 2.2 0.0 0.8 0.0 0.7 0.4 0.0 0.2 0.2 0.3 0.7 0.1 0.0 0.1 0.0 0.5 13.3 19.0 0.6 19.0 8.9 2.6 2.5 8.8 1.9 1.5 0.0 0.0 0.0 0.6 1.1 1.5 1.0 0.0 0.0 0.0 0.0 3.9 6.1 1.7 0.0 0.4 0.7 0.0 0.0 0.0 1.6 1.0 0.1 0.0 0.0 0.8 19.1 0.0 0.0 0.0 0.4 1.1 0.0 18.6 0.0 0.0 0.9 0.0 0.0 0.4 0.2 17.9 64.7 10.5 0.2 1.1 0.1 0.7 0.0 0.0 0.0 MADD "DENN, KIAA0358, RAB3GEP" ENSG00000110514 "MAP kinase activating death domain" Q8WXG6 11 47269161-47330031 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.3" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 72.8;Cone photoreceptor cells: 117.8;Horizontal cells: 125.5;Rod photoreceptor cells: 106.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 20.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038568 Uncertain Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA038568: AB_10795030" "unprognostic (3.16e-1)" "unprognostic (1.81e-1)" "unprognostic (8.51e-3)" "prognostic favorable (6.62e-5)" "unprognostic (1.27e-1)" "unprognostic (6.36e-3)" "unprognostic (4.82e-3)" "unprognostic (1.16e-1)" "unprognostic (1.91e-1)" "unprognostic (3.78e-2)" "prognostic favorable (5.69e-5)" "unprognostic (1.53e-1)" "unprognostic (3.55e-1)" "unprognostic (8.07e-2)" "unprognostic (1.06e-1)" "unprognostic (2.76e-1)" "prognostic favorable (8.25e-4)" 7.7 18.2 18.3 11.5 27.6 16.9 8.7 66.3 46.5 9.2 10.8 15.5 13.1 8.6 9.4 8.9 6.9 9.4 8.6 13.8 20.2 18.4 9.8 7.7 11.0 13.2 15.5 19.8 14.0 12.2 18.8 26.7 11.2 20.7 12.5 12.0 16.0 10.2 14.0 16.1 14.0 9.8 10.5 11.3 12.3 13.2 19.4 11.0 14.6 8.4 6.0 12.2 11.0 7.8 3.5 4.1 20.8 5.8 4.5 5.7 4.4 6.5 13.6 14.9 13.3 10.2 7.1 3.3 9.2 12.3 11.7 12.7 9.9 6.2 13.8 2.9 10.0 15.2 12.9 12.0 6.4 10.2 15.3 12.3 24.5 25.2 8.4 7.4 16.6 33.8 6.9 6.9 6.2 7.8 8.0 10.7 8.9 15.7 10.2 10.3 9.1 7.8 17.9 8.9 15.3 9.4 10.8 24.0 9.1 6.1 31.1 23.6 15.3 11.8 14.0 8.1 9.2 11.0 12.7 9.1 11.0 7.0 15.6 6.1 12.1 12.5 7.9 10.2 11.8 10.3 20.8 2.6 4.8 4.8 4.6 4.2 3.5 3.4 4.0 4.1 3.3 4.0 3.1 0.7 4.5 5.8 2.2 5.7 4.4 18.3 27.6 66.3 44.6 20.2 18.4 15.5 19.8 20.7 11.0 11.9 8.6 9.0 3.5 9.5 72.8 22.6 10.2 1.4 3.4 7.0 117.8 3.9 0.0 7.0 11.4 9.5 12.1 0.0 4.2 1.9 6.1 7.5 26.5 5.0 10.1 125.5 15.6 17.8 18.3 4.0 6.6 10.6 10.1 9.0 17.0 13.7 8.8 10.5 12.0 4.2 106.1 6.5 6.2 14.6 21.5 7.2 3.7 6.9 11.2 4.8 MAMDC2 MGC21981 ENSG00000165072 "MAM domain containing 2" Q7Z304 9 70043581-70226970 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 37.9;Leydig cells: 89.5;Peritubular cells: 77.1;Sertoli cells: 38.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 4 "NK-cell: 2.6" "Lineage enriched" "Detected in single" 4 "NK-cells: 2.6" "Cell line enhanced" "Detected in some" "ASC diff: 23.0;HHSteC: 24.0;LHCN-M2: 29.9;TIME: 28.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA021814, HPA022249" Uncertain Approved "Nuclear speckles,Plasma membrane" "Secreted in other tissues" NA NA "Nuclear speckles, Plasma membrane" "HPA021814: AB_1853508, HPA022249: AB_2139157" "unprognostic (1.88e-1)" "unprognostic (3.16e-3)" "unprognostic (2.21e-3)" "unprognostic (2.71e-2)" "unprognostic (4.30e-2)" "unprognostic (8.49e-2)" "unprognostic (1.27e-2)" "unprognostic (8.25e-2)" "unprognostic (5.91e-2)" "unprognostic (3.65e-2)" "unprognostic (1.92e-1)" "unprognostic (3.67e-1)" "unprognostic (3.03e-2)" "unprognostic (4.23e-3)" "unprognostic (2.35e-1)" "prognostic unfavorable (7.78e-4)" "unprognostic (2.79e-3)" 9.0 4.3 0.6 11.1 0.5 0.0 14.7 0.6 0.8 32.3 27.7 0.3 9.1 4.3 40.7 33.7 31.6 28.7 44.9 13.5 0.6 0.6 2.0 1.0 42.4 2.3 0.7 0.8 35.5 2.4 1.0 0.8 2.6 1.3 13.9 6.6 16.1 5.4 10.8 15.5 5.0 14.2 46.3 2.6 12.0 10.7 20.0 0.0 0.3 6.8 24.6 6.1 36.4 27.5 0.0 0.3 0.0 0.0 2.6 0.6 0.0 0.1 0.0 0.2 0.0 23.0 7.8 0.7 4.5 2.0 1.0 1.9 0.0 0.5 0.0 0.3 0.8 0.6 3.6 0.0 0.3 0.9 0.0 0.0 0.0 7.4 0.0 24.0 0.0 0.0 1.4 0.2 0.6 0.4 8.2 1.9 0.0 0.0 0.2 29.9 0.0 0.0 0.0 3.2 0.0 0.0 0.0 3.6 2.8 10.1 0.0 0.3 0.0 0.0 0.0 0.0 8.9 0.0 0.0 28.7 0.0 0.9 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.3 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.6 0.5 0.6 0.8 0.6 0.6 0.7 0.8 1.3 0.0 0.0 1.0 0.0 0.4 5.5 0.4 3.1 0.0 0.0 0.0 3.5 3.9 0.1 0.0 0.0 37.9 2.9 0.0 0.0 0.2 5.7 21.0 0.1 1.1 0.0 2.6 0.0 0.0 0.0 0.0 9.1 89.5 0.7 10.1 0.0 0.0 15.4 0.3 0.0 77.1 0.3 0.2 38.8 25.0 0.3 0.4 4.3 0.2 0.0 0.0 0.0 MAP2 "MAP2A, MAP2B, MAP2C" ENSG00000078018 "Microtubule associated protein 2" P11137 2 209424058-209734118 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Calmodulin-binding "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 122.3" "Group enriched" "Detected in many" 5 "Cone photoreceptor cells: 824.7;Rod photoreceptor cells: 453.2" "Cancer enhanced" "Detected in many" "glioma: 30.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 13 "memory B-cell: 2.6;naive B-cell: 3.4" "Lineage enriched" "Detected in single" 15 "B-cells: 3.4" "Cell line enhanced" "Detected in some" "AF22: 76.3;NTERA-2: 27.3;SCLC-21H: 38.4;SH-SY5Y: 21.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001984, HPA008273, HPA012558, HPA012828" Enhanced Supported Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB001984: , HPA008273: AB_1853945, HPA012558: , HPA012828: AB_1853946" "unprognostic (2.47e-2)" "unprognostic (2.81e-1)" "unprognostic (2.58e-2)" "prognostic unfavorable (1.98e-6)" "unprognostic (2.29e-2)" "unprognostic (1.79e-1)" "unprognostic (1.13e-2)" "unprognostic (6.06e-2)" "unprognostic (1.31e-1)" "unprognostic (9.84e-2)" "unprognostic (1.09e-2)" "unprognostic (1.60e-1)" "unprognostic (1.23e-1)" "unprognostic (2.69e-3)" "unprognostic (2.54e-1)" "unprognostic (7.28e-2)" "unprognostic (4.10e-5)" 4.6 9.2 62.1 2.1 63.1 1.5 4.9 24.7 122.3 4.4 2.5 3.8 0.0 2.0 2.9 4.0 5.6 2.8 6.3 6.2 73.6 53.8 3.9 3.7 9.3 2.4 31.0 48.8 6.4 8.2 12.5 14.7 1.9 35.4 6.5 2.5 7.6 4.9 4.7 2.2 12.1 2.0 3.2 19.9 2.4 2.6 5.4 11.4 0.0 12.2 0.4 2.9 2.8 1.5 3.4 0.1 0.0 0.0 0.0 0.2 0.3 0.6 0.1 76.3 0.0 1.0 0.5 0.0 0.4 0.5 0.1 0.5 0.0 4.0 0.0 0.4 0.9 3.6 1.0 5.9 0.4 0.2 0.0 0.3 0.2 2.4 0.0 9.7 0.0 0.0 0.8 2.4 0.0 1.5 4.4 2.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 27.3 0.1 0.1 0.0 0.1 0.0 1.0 0.0 38.4 21.5 1.6 0.2 0.9 9.4 2.1 0.0 0.0 0.0 0.4 0.0 1.0 0.5 0.0 0.0 4.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.0 3.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 62.1 63.1 24.7 79.6 73.6 53.8 31.0 48.8 35.4 11.4 89.3 2.7 0.0 3.1 5.3 111.0 3.6 30.6 1.4 4.5 5.2 824.7 0.3 3.3 19.1 16.8 7.1 0.0 0.0 9.4 0.0 1.9 10.4 1.1 0.0 0.5 31.8 31.2 16.0 3.0 7.5 26.4 0.8 18.6 0.0 0.0 125.4 13.7 0.0 14.5 0.4 453.2 32.3 17.6 3.3 19.9 5.6 0.2 0.0 0.0 0.6 MAP2K7 "Jnkk2, MKK7, PRKMK7" ENSG00000076984 "Mitogen-activated protein kinase kinase 7" O14733 19 7903843-7914478 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Stress response" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001633, CAB004262, HPA064711" Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "Golgi apparatus" "CAB004262: AB_627925, HPA001633: AB_1079516, HPA064711: AB_2685331" "unprognostic (1.77e-1)" "unprognostic (5.04e-2)" "unprognostic (1.06e-2)" "unprognostic (2.16e-1)" "unprognostic (4.24e-2)" "prognostic favorable (8.54e-5)" "unprognostic (1.80e-3)" "unprognostic (2.55e-1)" "unprognostic (2.69e-2)" "unprognostic (1.69e-2)" "unprognostic (1.27e-3)" "unprognostic (1.56e-1)" "unprognostic (3.54e-2)" "unprognostic (3.71e-2)" "unprognostic (6.05e-2)" "unprognostic (1.73e-2)" "prognostic favorable (1.56e-4)" 16.3 14.9 13.5 16.4 16.4 23.8 13.6 28.7 21.5 14.3 15.6 23.2 15.1 19.3 19.1 9.9 13.6 13.1 14.3 15.8 14.6 11.9 12.8 15.9 12.5 15.9 17.2 13.9 18.4 22.3 13.9 17.0 16.4 16.2 14.4 7.9 14.2 23.0 13.4 61.6 21.3 18.7 14.1 12.5 19.4 14.8 21.5 16.5 9.8 13.7 17.3 12.8 15.4 15.2 3.0 2.6 4.8 2.7 3.3 2.5 1.0 12.9 7.4 6.4 10.6 5.2 5.0 12.1 8.5 4.2 5.8 6.0 10.7 7.9 15.4 13.8 4.5 5.7 11.9 5.6 6.5 2.3 12.2 27.8 10.8 9.8 7.9 6.7 10.1 13.8 5.8 8.5 4.6 5.2 7.7 5.2 11.3 15.8 20.3 3.3 6.8 14.3 24.5 11.4 6.9 16.7 14.3 7.0 15.6 5.2 10.8 11.9 11.9 5.8 10.2 11.8 4.0 11.0 11.5 7.8 17.7 10.1 12.4 11.5 29.4 13.6 14.5 8.9 14.9 7.1 0.0 2.7 1.9 2.3 2.5 1.5 2.1 1.9 2.0 1.3 3.0 1.7 2.5 4.8 3.3 1.5 2.6 0.7 1.0 13.5 16.4 28.7 21.5 14.6 11.9 17.2 13.9 16.2 16.5 23.8 21.5 21.9 31.0 34.3 50.6 12.6 22.9 9.4 5.7 19.2 72.6 23.2 11.6 19.1 3.8 18.7 26.2 0.0 16.4 25.3 18.1 32.9 10.4 17.4 16.3 54.0 35.1 19.0 12.4 8.6 26.7 15.7 30.4 16.2 23.6 25.8 19.2 21.0 11.7 14.7 70.3 32.3 26.9 14.2 26.4 37.3 41.2 28.0 24.2 25.2 MAP3K12 "DLK, MEKK12, MUK, ZPK, ZPKP1" ENSG00000139625 "Mitogen-activated protein kinase kinase kinase 12" Q12852 12 53479669-53500063 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 40.3" "Cell type enhanced" "Detected in many" 10 "Cone photoreceptor cells: 35.3;Rod photoreceptor cells: 81.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "granulocytes: 3.4;monocytes: 1.7;T-cells: 2.8" "Cell line enhanced" "Detected in many" "ASC diff: 26.4;HHSteC: 25.2;HSkMC: 25.1;hTERT-RPE1: 33.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039936, HPA071996" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA039936: AB_10795239, HPA071996: AB_2686481" "unprognostic (4.01e-1)" "unprognostic (3.30e-1)" "unprognostic (8.89e-3)" "unprognostic (6.40e-3)" "unprognostic (1.10e-1)" "unprognostic (2.22e-1)" "unprognostic (6.97e-2)" "unprognostic (3.61e-2)" "unprognostic (2.39e-1)" "unprognostic (2.70e-1)" "prognostic favorable (1.51e-4)" "unprognostic (8.50e-3)" "prognostic unfavorable (5.43e-10)" "unprognostic (1.65e-2)" "unprognostic (2.44e-1)" "unprognostic (1.32e-1)" "unprognostic (1.18e-1)" 8.0 8.7 12.3 5.8 16.0 3.0 5.1 40.3 20.6 14.1 6.1 7.0 7.8 3.6 15.1 5.8 4.6 11.5 16.1 4.2 9.4 7.7 4.5 1.4 8.8 4.5 6.4 14.7 13.7 1.8 3.0 12.7 7.3 10.8 5.9 4.6 9.5 2.4 13.5 1.2 4.5 4.1 16.9 5.3 5.3 3.9 6.5 7.4 2.7 4.3 1.4 3.2 11.3 6.4 0.3 0.6 3.4 1.7 0.6 2.8 0.5 0.2 7.0 4.4 6.8 26.4 14.1 0.5 4.7 8.9 5.2 5.3 0.1 0.8 1.5 2.7 5.1 4.2 0.0 2.0 3.1 2.1 2.3 2.4 1.7 3.6 0.0 25.2 0.0 1.7 25.1 2.3 7.1 3.7 33.3 8.1 3.5 0.0 7.5 4.9 3.0 1.7 0.3 1.5 0.0 2.6 2.4 2.9 0.4 2.6 0.0 4.4 6.0 2.5 3.2 6.7 1.0 2.2 4.4 5.9 5.0 5.4 2.3 1.2 3.0 3.4 0.0 8.1 3.0 4.9 0.0 1.7 0.0 1.5 1.3 2.8 0.3 2.1 2.3 0.6 0.0 0.9 1.2 3.4 0.6 0.4 0.3 0.4 0.5 12.3 16.0 40.3 20.6 9.4 7.7 6.4 14.7 10.8 7.4 6.0 13.4 5.6 1.9 0.7 26.7 0.7 10.2 8.1 11.4 1.8 35.3 1.6 8.3 5.4 1.2 3.7 4.6 0.0 1.6 1.8 3.8 2.7 12.7 7.7 3.6 28.6 3.4 7.4 12.7 1.4 7.5 5.9 0.0 7.2 2.5 17.4 4.5 2.6 7.8 7.0 81.9 6.5 4.9 2.3 1.9 0.9 1.8 7.5 3.5 2.0 MAP3K21 "KIAA1804, MLK4" ENSG00000143674 "Mitogen-activated protein kinase kinase kinase 21" Q5TCX8 1 233327768-233385148 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 28.9" "Cell type enhanced" "Detected in some" 18 "Alveolar cells type 1: 32.8;Alveolar cells type 2: 7.7;Collecting duct cells: 14.0;Ductal cells: 9.7;Exocrine glandular cells: 8.4;Pancreatic endocrine cells: 7.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 6 "NK-cell: 5.0" "Lineage enriched" "Detected in single" 6 "NK-cells: 5.0" "Cell line enhanced" "Detected in many" "HEK 293: 18.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA007636 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA007636: AB_1079392" "unprognostic (3.29e-2)" "unprognostic (5.10e-2)" "unprognostic (2.00e-1)" "unprognostic (2.42e-3)" "unprognostic (4.30e-2)" "unprognostic (1.23e-1)" "unprognostic (1.82e-2)" "unprognostic (1.84e-1)" "unprognostic (1.51e-1)" "unprognostic (1.25e-1)" "unprognostic (2.09e-1)" "unprognostic (8.21e-2)" "unprognostic (3.76e-2)" "unprognostic (2.23e-1)" "unprognostic (1.71e-1)" "unprognostic (9.22e-2)" "unprognostic (4.84e-2)" 0.6 3.2 2.0 3.4 2.2 1.3 2.2 10.0 3.3 1.5 11.4 0.6 9.1 9.9 0.8 5.2 2.4 3.9 3.9 0.7 1.3 2.1 12.5 13.3 5.6 0.5 0.9 1.7 0.8 28.9 4.4 2.6 1.0 1.2 1.3 6.0 1.0 3.7 2.5 0.4 2.7 17.2 0.3 0.9 0.7 10.1 12.4 0.6 0.5 2.4 0.8 1.3 1.1 1.6 0.5 0.8 0.1 0.3 5.0 0.2 0.1 7.4 12.7 0.2 0.0 0.0 0.0 6.4 0.2 0.0 0.3 0.5 7.0 6.5 0.7 5.2 0.1 2.4 4.0 9.5 3.9 0.8 13.8 18.3 0.1 7.1 0.0 0.5 12.1 2.9 0.1 5.2 0.2 7.4 1.4 0.4 5.8 0.1 2.4 0.0 1.6 3.8 4.3 9.1 8.7 5.6 0.0 0.0 13.3 8.8 3.1 9.4 2.5 4.3 0.2 0.0 1.0 3.7 3.9 0.0 0.0 1.2 0.0 7.4 2.3 2.9 0.0 1.2 3.3 0.3 0.0 0.3 0.0 0.0 0.1 0.0 0.3 0.2 0.1 0.8 0.5 0.0 0.0 0.1 5.0 0.0 0.2 0.2 0.1 2.0 2.2 10.0 3.3 1.3 2.1 0.9 1.7 1.2 0.6 32.8 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 14.0 0.0 0.0 3.3 9.7 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.8 0.0 0.0 7.8 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 MAP3K6 "ASK2, MAPKKK6, MEKK6" ENSG00000142733 "Mitogen-activated protein kinase kinase kinase 6" O95382 1 27355184-27366892 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 63.9" "Cell type enhanced" "Detected in many" 4 "Ito cells: 28.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA051192 Approved Approved "Nucleoplasm,Plasma membrane,Actin filaments,Cytosol" NA NA Nucleoplasm "Plasma membrane, Actin filaments, Cytosol" "HPA051192: AB_2681380" "unprognostic (1.19e-2)" "unprognostic (2.77e-3)" "unprognostic (2.62e-2)" "unprognostic (1.97e-2)" "prognostic unfavorable (2.13e-4)" "prognostic favorable (7.26e-4)" "prognostic unfavorable (8.76e-4)" "unprognostic (9.10e-2)" "unprognostic (2.79e-1)" "unprognostic (6.91e-2)" "unprognostic (6.56e-2)" "unprognostic (1.25e-1)" "unprognostic (4.65e-3)" "unprognostic (4.95e-2)" "unprognostic (2.79e-1)" "unprognostic (7.07e-3)" "unprognostic (1.50e-1)" 37.5 6.3 7.4 6.9 8.6 1.3 22.1 12.6 8.3 19.9 9.0 2.7 8.9 3.3 13.1 10.3 25.7 12.8 12.4 14.9 6.2 2.6 13.6 5.0 21.7 5.5 11.4 1.9 11.7 8.3 8.2 15.8 7.3 9.8 13.9 5.9 15.7 11.5 9.7 6.3 63.9 6.2 16.0 11.7 8.7 9.0 6.7 7.0 0.6 12.0 16.1 14.3 14.3 18.3 2.7 3.3 5.1 6.9 1.1 7.6 2.4 7.5 7.0 6.3 7.0 8.8 15.4 1.6 9.4 5.4 7.1 5.4 2.1 10.2 0.1 8.4 14.2 2.8 11.9 2.1 6.5 3.6 6.2 5.2 0.5 16.2 3.1 2.7 0.5 0.6 12.4 16.1 7.4 2.6 7.9 4.8 0.5 2.3 4.1 11.3 18.7 0.3 8.6 2.0 7.5 5.8 2.7 4.2 1.7 10.6 7.9 2.3 3.5 9.9 8.7 7.4 2.7 4.6 6.4 9.9 17.9 7.5 19.9 4.9 3.4 4.2 0.1 15.8 6.1 5.2 1.8 1.5 5.1 5.3 3.3 7.6 2.7 5.5 5.9 3.3 2.3 4.4 3.6 2.4 1.1 6.9 0.0 5.6 2.4 7.4 8.6 12.6 8.3 6.2 2.6 11.4 1.9 9.8 7.0 17.9 16.2 4.7 10.4 11.1 0.5 8.9 10.2 1.4 11.4 3.5 0.0 0.9 3.3 2.3 0.4 15.8 1.7 0.0 3.8 1.7 7.7 7.3 2.3 0.8 2.5 4.8 0.0 28.8 12.5 1.1 15.0 5.1 5.0 13.6 4.9 5.2 8.9 0.0 14.2 1.5 0.4 6.5 10.5 8.7 2.1 12.9 0.1 10.2 4.3 14.4 MAP4K1 HPK1 ENSG00000104814 "Mitogen-activated protein kinase kinase kinase kinase 1" Q92918 19 38587641-38618882 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 16.2;intestine: 16.9;lymphoid tissue: 39.2" "Cell type enhanced" "Detected in many" 14 "B-cells: 29.0;Rod photoreceptor cells: 58.2;T-cells: 33.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 20.8;HDLM-2: 20.6;Karpas-707: 21.4;REH: 11.4;RPMI-8226: 12.9;U-266/70: 16.9;U-266/84: 16.6;U-698: 26.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA007419, CAB007754" Enhanced Approved "Plasma membrane" NA NA "Plasma membrane" "CAB007754: AB_562299, HPA007419: AB_1853778" "unprognostic (1.99e-3)" "prognostic favorable (6.17e-5)" "unprognostic (9.50e-3)" "unprognostic (3.27e-1)" "unprognostic (6.03e-2)" "prognostic favorable (3.26e-4)" "unprognostic (4.88e-3)" "unprognostic (5.32e-3)" "unprognostic (2.79e-1)" "unprognostic (2.51e-1)" "unprognostic (3.92e-2)" "unprognostic (2.55e-1)" "prognostic unfavorable (7.99e-10)" "unprognostic (1.72e-1)" "unprognostic (1.83e-1)" "unprognostic (3.18e-2)" "unprognostic (1.50e-2)" 1.6 0.9 1.2 31.4 2.3 6.3 1.1 1.0 1.2 1.0 3.1 1.7 0.1 2.1 0.9 1.4 2.6 1.2 2.9 0.9 1.1 1.4 2.2 1.6 3.9 23.0 2.3 0.7 0.8 1.2 0.2 1.2 1.4 2.1 1.6 1.9 2.0 4.4 0.8 0.5 1.2 16.9 0.7 3.4 34.4 2.3 0.9 1.3 19.1 1.9 1.4 39.2 3.1 1.3 16.2 15.9 1.3 6.2 3.7 14.6 7.3 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 20.6 0.1 4.4 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.1 21.4 0.0 0.1 4.9 5.2 0.6 0.1 0.0 11.4 0.0 12.9 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.1 4.7 0.0 0.0 0.1 0.0 0.0 16.9 16.6 26.2 0.0 5.9 0.0 1.3 3.2 1.2 13.4 6.2 12.4 16.2 11.2 14.0 15.9 10.7 6.2 8.7 0.3 3.7 3.4 14.0 14.6 7.3 1.2 2.3 1.0 1.2 1.1 1.4 2.3 0.7 2.1 1.3 3.0 8.2 29.0 0.1 2.1 6.1 0.6 0.0 0.0 1.2 0.0 11.8 0.2 0.0 0.0 0.0 1.4 0.0 0.0 0.2 0.2 1.0 0.3 15.1 0.0 2.5 1.6 0.0 1.3 7.1 0.0 0.0 11.7 3.3 2.8 0.0 6.7 0.0 0.0 0.0 0.2 58.2 0.0 0.4 0.6 4.3 0.9 0.1 33.2 0.2 0.1 MAP4K5 "GCKR, KHS, KHS1" ENSG00000012983 "Mitogen-activated protein kinase kinase kinase kinase 5" 14 50418501-50561126 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 26.1" "Lineage enriched" "Detected in all" 5 "granulocytes: 26.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036696, HPA078030" Uncertain Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA036696: AB_10672362, HPA078030: " "unprognostic (1.39e-1)" "unprognostic (1.00e-1)" "unprognostic (3.80e-1)" "unprognostic (1.66e-1)" "unprognostic (4.41e-2)" "unprognostic (1.43e-1)" "unprognostic (8.58e-3)" "unprognostic (4.13e-2)" "unprognostic (6.31e-2)" "unprognostic (2.24e-2)" "unprognostic (1.53e-3)" "unprognostic (7.34e-2)" "unprognostic (1.78e-2)" "unprognostic (3.71e-2)" "unprognostic (1.40e-1)" "unprognostic (9.58e-3)" "unprognostic (2.02e-2)" 17.4 11.8 23.4 12.1 44.4 16.5 19.7 24.6 32.3 25.8 17.1 43.5 13.4 11.3 29.9 12.1 18.7 17.4 19.3 10.3 24.4 14.0 10.9 8.7 15.2 9.9 48.8 17.1 29.9 13.3 16.7 17.5 17.3 26.0 16.6 15.1 9.1 16.9 19.9 10.7 24.8 12.7 22.3 30.7 13.0 14.4 6.8 51.1 8.4 15.3 8.7 11.2 19.3 21.2 5.0 2.7 26.1 1.8 5.4 3.9 1.0 22.9 6.9 17.0 14.6 15.7 16.6 16.6 27.1 24.5 18.5 16.5 8.7 16.1 15.9 16.2 24.8 9.8 16.5 15.8 14.6 28.2 13.1 11.5 9.7 12.2 7.8 13.3 8.7 15.4 12.0 12.0 16.2 17.0 29.6 24.2 14.5 9.2 10.4 27.0 8.7 11.7 8.3 8.3 7.4 13.6 14.2 25.8 6.0 18.3 17.9 5.5 12.5 15.3 10.7 10.5 14.3 11.9 6.6 24.6 24.1 16.8 16.4 12.7 7.6 7.7 10.6 9.0 6.1 17.1 26.1 1.5 13.5 3.9 1.8 2.2 3.2 2.4 3.3 1.6 5.0 2.6 2.7 0.6 5.4 1.1 2.7 0.5 1.0 23.4 44.4 24.6 32.3 24.4 14.0 48.8 17.1 26.0 51.1 38.7 17.3 14.6 29.9 62.2 51.9 7.3 20.4 26.8 27.3 26.2 45.2 9.4 16.6 24.0 2.8 33.1 15.9 23.3 18.3 16.7 46.1 53.8 28.9 7.8 7.5 31.8 22.5 35.6 13.9 2.2 39.4 20.9 21.9 17.2 14.2 18.2 23.1 15.0 48.1 9.9 33.6 12.9 40.4 11.2 13.6 75.3 5.5 21.8 16.2 55.0 MARCH10 "FLJ35757, MARCH-X, RNF190" ENSG00000173838 "Membrane associated ring-CH-type finger 10" Q8NA82 17 62701314-62808344 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 80.2" "Group enriched" "Detected in some" 7 "Early spermatids: 371.3;Late spermatids: 1043.9" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 3.4" "Lineage enriched" "Detected in single" 5 "T-cells: 3.4" "Cell line enhanced" "Detected in some" "BEWO: 3.9;EFO-21: 7.3;HSkMC: 3.2;SCLC-21H: 12.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA023322 Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA023322: AB_1856351" "unprognostic (2.79e-2)" "unprognostic (2.32e-1)" "unprognostic (9.60e-3)" "unprognostic (6.95e-2)" "unprognostic (1.21e-1)" "unprognostic (1.21e-1)" "unprognostic (1.03e-2)" "unprognostic (1.67e-1)" "unprognostic (1.39e-1)" "unprognostic (7.99e-4)" "unprognostic (3.16e-1)" "unprognostic (2.85e-3)" "unprognostic (1.38e-1)" "unprognostic (4.83e-2)" "unprognostic (9.37e-3)" "unprognostic (2.66e-1)" 0.2 0.1 0.7 0.2 1.6 0.0 0.1 0.1 0.3 0.5 0.1 1.9 0.6 0.0 0.3 4.8 0.1 7.9 0.1 0.1 1.0 1.0 0.6 0.1 1.4 0.1 0.2 0.5 1.0 0.1 0.3 4.5 0.1 1.8 0.1 0.0 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 80.2 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.7 0.0 0.0 0.6 3.4 0.3 0.1 0.0 0.2 0.0 0.0 0.2 3.9 1.7 0.2 1.2 0.3 0.0 0.1 0.0 7.3 0.5 0.1 0.0 0.0 0.4 1.4 0.0 0.0 1.3 0.7 0.0 1.5 0.0 0.0 3.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.9 1.5 0.1 0.1 0.3 0.0 0.2 0.0 0.0 0.2 1.1 0.0 12.7 0.0 0.0 0.7 0.1 0.5 0.2 0.0 0.0 0.0 0.7 0.1 1.4 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 3.4 0.0 1.5 0.0 0.7 0.3 0.7 0.1 0.6 1.8 0.0 0.6 0.0 0.0 0.7 0.3 0.7 1.6 0.1 0.3 1.0 1.0 0.2 0.5 1.8 0.3 3.0 1.0 0.0 0.0 0.1 0.0 0.3 0.0 105.7 15.9 3.5 0.0 0.1 44.7 0.0 371.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.6 0.0 1043.9 4.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 6.5 0.0 42.4 10.6 0.0 0.1 0.5 0.0 0.0 MAS1L "dJ994E9.2, MAS-L, MRG" ENSG00000204687 "MAS1 proto-oncogene like, G protein-coupled receptor" P35410 6 29486697-29487956 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "cervix, uterine: 7.5;epididymis: 4.0" "Cell type enriched" "Detected in single" 58 "granulocytes: 5.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 40 "HEL: 3.9" HPA017983 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA017983: AB_1849332" "unprognostic (3.66e-2)" "unprognostic (2.51e-1)" "unprognostic (2.30e-2)" "unprognostic (5.22e-2)" "unprognostic (1.65e-1)" 2.1 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 7.5 1.3 0.4 1.2 4.0 2.1 0.2 1.2 0.4 0.0 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.8 1.1 1.5 0.3 0.2 1.7 1.5 1.1 0.0 0.0 0.5 0.3 0.0 0.5 0.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAT2B "MATIIbeta, SDR23E1" ENSG00000038274 "Methionine adenosyltransferase 2B" Q9NZL9 5 163503114-163519336 "Predicted intracellular proteins" "One-carbon metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037721, HPA037722" Uncertain Approved "Plasma membrane" NA NA 1000000 "Plasma membrane" "HPA037721: AB_10672389, HPA037722: AB_10671718" "unprognostic (1.22e-2)" "unprognostic (2.80e-2)" "unprognostic (1.80e-3)" "unprognostic (1.64e-1)" "unprognostic (5.06e-1)" "unprognostic (2.12e-1)" "unprognostic (1.20e-1)" "unprognostic (1.77e-1)" "unprognostic (9.72e-2)" "unprognostic (1.68e-1)" "unprognostic (5.19e-3)" "unprognostic (3.57e-2)" "prognostic favorable (4.51e-7)" "unprognostic (1.06e-1)" "unprognostic (1.09e-2)" "unprognostic (2.16e-2)" "unprognostic (1.37e-3)" 25.1 32.5 25.2 29.1 28.6 12.1 23.9 37.1 39.6 25.3 41.6 20.1 25.1 38.9 28.0 29.0 27.9 31.9 20.4 41.8 24.2 28.6 48.4 37.2 26.6 41.7 24.7 24.9 35.9 16.4 25.7 17.1 23.9 27.6 30.7 31.4 24.3 28.6 26.8 28.7 20.9 57.2 21.3 21.4 45.5 24.9 18.1 17.7 50.8 53.3 20.1 41.0 32.5 32.9 60.4 34.5 82.4 46.0 62.4 86.8 98.8 19.5 17.0 29.9 16.2 22.2 22.1 17.9 17.5 19.9 20.1 29.5 11.9 37.2 20.9 36.8 19.0 29.5 16.1 24.8 36.3 26.7 68.8 20.5 19.0 19.9 17.7 29.2 19.9 12.9 18.3 30.0 25.6 19.9 24.4 43.5 22.2 15.1 26.4 24.6 11.5 27.4 24.0 11.3 12.4 11.6 31.6 14.5 34.4 32.9 21.3 11.8 17.2 23.3 15.7 25.3 13.7 21.9 26.9 35.0 22.0 14.3 14.6 30.2 22.5 21.7 19.1 16.0 36.5 14.8 82.4 38.3 75.6 58.7 44.6 64.3 60.4 64.8 63.2 34.5 56.6 66.2 63.6 58.8 62.4 46.0 27.8 86.8 98.8 25.2 28.6 37.1 39.6 24.2 28.6 24.7 24.9 27.6 17.7 44.7 37.1 50.2 31.8 37.9 20.3 51.5 35.7 54.9 26.1 41.8 7.9 48.4 53.0 29.8 30.6 40.9 34.6 93.5 23.0 24.4 26.9 37.0 26.7 47.9 41.2 17.5 14.5 33.7 74.1 10.9 31.9 43.7 40.5 50.5 44.3 33.3 25.6 24.6 29.4 77.8 15.0 45.3 29.9 21.6 29.8 31.7 31.5 64.2 48.1 35.5 MBP ENSG00000197971 "Myelin basic protein" P02686 18 76978827-77133683 "Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Autoimmune encephalomyelitis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 43 "brain: 1297.7" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 9 "glioma: 47.5;melanoma: 20.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HL-60: 29.0;SK-MEL-30: 60.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002300, HPA049222, HPA064368" Enhanced Supported Approved "Plasma membrane" NA NA "Plasma membrane" "CAB002300: AB_563893, HPA049222: AB_2680679, HPA064368: AB_2685247" "unprognostic (9.36e-2)" "unprognostic (7.60e-2)" "unprognostic (1.28e-2)" "unprognostic (1.22e-1)" "unprognostic (6.93e-2)" "unprognostic (2.81e-1)" "unprognostic (1.14e-1)" "unprognostic (3.31e-1)" "unprognostic (9.87e-2)" "unprognostic (2.90e-2)" "unprognostic (5.25e-2)" "unprognostic (1.95e-1)" "prognostic favorable (4.48e-12)" "unprognostic (2.90e-1)" "unprognostic (5.99e-2)" "unprognostic (1.33e-1)" "unprognostic (6.03e-2)" 4.0 3.4 271.6 6.1 244.9 10.1 4.5 28.7 418.9 5.6 5.5 487.7 0.0 5.9 4.4 3.6 6.4 9.0 5.7 6.8 355.0 247.6 6.2 5.9 6.2 7.1 645.5 43.4 3.7 6.8 16.4 0.7 2.7 242.9 4.5 5.6 0.4 5.0 4.9 29.9 7.9 6.2 3.8 1297.7 7.6 5.1 2.9 224.3 0.0 6.8 0.0 7.7 6.0 0.6 3.4 6.8 23.7 4.7 15.4 17.1 5.6 7.5 6.6 0.0 0.2 11.2 16.7 2.6 0.2 0.2 0.2 0.1 0.9 11.8 4.7 1.3 0.5 0.0 15.0 1.1 6.6 0.2 18.2 1.6 3.0 1.1 1.5 7.0 29.0 20.2 2.4 5.6 6.0 9.3 5.0 1.9 11.4 0.0 1.0 0.0 0.9 1.1 14.9 0.6 4.5 5.3 0.4 0.1 10.5 10.6 10.3 0.5 0.1 0.9 0.0 60.4 1.9 0.2 17.8 0.0 0.0 0.1 0.0 0.8 0.0 0.1 5.0 1.8 18.3 0.7 11.0 4.7 17.8 13.2 4.6 8.0 3.4 9.4 17.1 5.3 3.3 5.7 10.5 23.7 15.4 4.4 6.8 7.9 5.6 271.6 244.9 28.7 127.7 355.0 247.6 645.5 43.4 242.9 224.3 44.7 33.2 33.8 46.5 105.6 50.2 38.2 38.2 56.2 44.3 97.7 2.0 0.6 34.9 38.1 4.8 9.9 40.8 46.7 31.6 0.6 21.8 82.0 69.4 25.5 41.0 1.6 47.8 11.1 60.5 4.5 26.2 83.3 87.7 24.4 45.4 26.0 43.3 23.0 13.4 28.1 6.2 0.0 6.6 4.8 0.7 135.3 0.6 123.7 33.3 87.7 MCAM "CD146, MUC18" ENSG00000076706 "Melanoma cell adhesion molecule" P43121 11 119308529-119321521 "CD markers, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 16 "Endothelial cells: 83.4;Muller glia cells: 87.4;Sertoli cells: 316.9;Smooth muscle cells: 214.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.2" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in many" 4 "HUVEC TERT2: 128.2;TIME: 125.2;WM-115: 99.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002147, HPA008848" Enhanced Approved "Plasma membrane" NA NA 2600000000 "Plasma membrane" "CAB002147: AB_563499, HPA008848: AB_1078445" "unprognostic (6.45e-2)" "prognostic unfavorable (7.61e-4)" "unprognostic (7.03e-2)" "unprognostic (1.22e-2)" "unprognostic (6.67e-2)" "unprognostic (2.34e-1)" "unprognostic (2.23e-2)" "unprognostic (8.42e-2)" "unprognostic (2.09e-2)" "unprognostic (1.45e-1)" "unprognostic (1.58e-1)" "unprognostic (9.39e-2)" "prognostic unfavorable (5.14e-4)" "unprognostic (8.75e-3)" "unprognostic (7.84e-2)" "unprognostic (2.31e-1)" "unprognostic (2.79e-3)" 88.2 8.9 6.4 18.5 10.3 0.4 86.1 17.7 13.4 22.3 33.2 13.3 11.7 8.3 40.1 32.5 27.6 29.3 50.9 32.0 7.1 8.2 7.5 3.8 23.8 13.0 7.4 8.1 23.6 6.2 54.5 3.9 47.4 11.1 22.9 9.7 25.0 9.4 44.9 21.1 10.5 15.6 67.1 6.5 9.6 25.0 18.4 5.4 2.2 13.1 15.7 4.8 55.0 24.3 0.8 0.0 0.3 0.0 0.0 2.2 0.0 0.0 0.5 0.5 0.0 2.5 0.0 2.6 0.3 0.0 3.4 1.5 1.9 0.1 0.1 10.9 1.2 5.2 0.3 4.4 0.9 1.7 6.2 1.5 0.1 12.3 2.2 6.0 0.0 0.0 1.8 0.0 4.7 2.2 0.1 128.2 0.8 4.1 0.1 0.7 0.0 0.1 1.0 2.2 0.0 0.5 0.1 17.1 3.6 3.1 0.0 1.4 0.4 9.8 0.2 28.2 5.6 0.5 0.1 125.2 0.3 18.4 0.0 9.9 0.2 0.2 0.0 5.0 0.0 99.5 0.0 0.0 0.0 0.0 0.0 2.2 0.8 0.6 1.1 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 1.3 0.0 6.4 10.3 17.7 13.4 7.1 8.2 7.4 8.1 11.1 5.4 0.0 2.9 0.8 0.5 4.1 1.3 57.3 12.7 1.4 1.2 0.0 21.6 0.3 0.0 14.3 1.6 83.4 0.0 0.0 0.3 34.2 4.4 1.1 0.0 0.0 0.7 0.0 0.0 74.9 1.6 0.6 0.9 2.7 20.3 1.0 0.0 87.4 2.5 0.0 23.7 0.0 2.1 316.9 214.2 2.2 1.2 2.9 0.3 0.7 0.0 0.7 MCF2L2 "ARHGEF22, KIAA0861" ENSG00000053524 "MCF.2 cell line derived transforming sequence-like 2" Q86YR7 3 183178043-183428778 "Disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Diabetes mellitus" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 16.4;brain: 23.7" "Group enriched" "Detected in many" 11 "Bipolar cells: 64.6;Cone photoreceptor cells: 208.1;Early spermatids: 86.7;Rod photoreceptor cells: 135.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "T-reg: 4.6" "Lineage enriched" "Detected in single" 8 "T-cells: 4.6" "Cell line enhanced" "Detected in many" "HDLM-2: 9.4;Karpas-707: 8.2;REH: 5.4" "Low region specificity" "Detected in all" "HPA038946, HPA038947" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA038946: AB_10670914, HPA038947: AB_10672655" "unprognostic (2.17e-2)" "unprognostic (4.42e-1)" "unprognostic (3.08e-1)" "unprognostic (1.95e-3)" "unprognostic (1.98e-1)" "unprognostic (2.87e-2)" "unprognostic (3.70e-2)" "unprognostic (1.54e-1)" "unprognostic (1.46e-1)" "unprognostic (5.08e-2)" "unprognostic (4.80e-4)" "unprognostic (1.32e-1)" "unprognostic (8.75e-6)" "unprognostic (1.09e-1)" "unprognostic (5.47e-2)" "unprognostic (2.95e-1)" "unprognostic (1.78e-1)" 0.9 16.4 12.8 1.4 14.9 1.1 1.1 11.3 23.7 1.3 1.4 3.6 0.0 0.9 1.3 1.3 1.3 1.0 1.5 1.1 12.2 7.6 1.4 0.8 1.2 1.7 5.6 13.0 1.2 1.2 10.5 8.9 0.8 7.3 2.1 1.4 7.5 0.8 1.6 1.4 1.0 1.2 1.4 4.5 5.3 1.2 5.5 4.3 0.0 0.9 0.0 2.1 1.6 0.4 0.1 0.0 0.6 0.0 0.1 4.6 0.2 0.1 0.6 0.2 1.8 0.1 0.2 0.4 0.0 0.1 0.3 0.0 1.2 0.2 1.5 0.2 0.1 1.9 0.0 0.3 0.2 0.1 9.4 1.4 4.0 0.3 0.0 0.3 1.2 0.8 0.3 0.0 0.0 0.7 0.0 0.7 2.5 1.2 8.2 0.5 1.2 1.2 0.9 1.3 0.0 1.6 5.4 0.0 1.5 0.4 0.2 2.6 0.9 1.0 0.0 2.1 0.6 0.5 0.9 0.6 0.0 0.9 0.1 0.1 3.3 3.5 1.7 0.8 1.4 0.1 0.1 0.0 0.1 0.4 0.0 1.0 0.0 1.0 0.6 0.0 0.1 0.0 0.9 0.6 0.1 0.0 0.0 4.6 0.2 12.8 14.9 11.3 23.7 12.2 7.6 5.6 13.0 7.3 4.3 0.0 2.1 0.0 0.4 0.3 64.6 1.2 0.0 4.0 0.0 5.2 208.1 0.2 0.0 0.1 86.7 0.7 0.3 0.0 0.2 0.1 0.7 0.2 1.1 0.0 0.4 7.9 0.0 3.1 0.6 11.7 0.9 1.0 1.7 2.8 0.0 3.0 0.2 0.0 0.4 0.0 135.4 0.0 0.4 0.7 3.4 0.4 1.1 2.1 0.0 0.6 MERTK "c-Eyk, mer, RP38, Tyro12" ENSG00000153208 "MER proto-oncogene, tyrosine kinase" Q12866 2 111898479-112029561 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Disease mutation, Proto-oncogene, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 15 "Ito cells: 36.8;Kupffer cells: 92.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "intermediate monocyte: 10.3;non-classical monocyte: 6.4" "Lineage enriched" "Detected in single" 48 "monocytes: 10.3" "Cell line enhanced" "Detected in many" "CACO-2: 21.3;Hep G2: 22.1;HUVEC TERT2: 22.0;RT4: 13.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036196, HPA075622" Enhanced Approved "Endoplasmic reticulum,Plasma membrane,Midbody,Cytosol" NA NA 29000000 "Plasma membrane" "Endoplasmic reticulum, Midbody, Cytosol" "HPA036196: AB_10670676, HPA075622: AB_2686759" "unprognostic (2.17e-2)" "unprognostic (8.10e-2)" "unprognostic (4.85e-2)" "unprognostic (2.68e-1)" "unprognostic (2.44e-1)" "unprognostic (1.77e-1)" "unprognostic (1.07e-1)" "prognostic favorable (4.74e-4)" "unprognostic (6.84e-2)" "unprognostic (1.25e-1)" "unprognostic (6.22e-2)" "unprognostic (3.72e-1)" "prognostic favorable (4.43e-5)" "unprognostic (5.13e-2)" "unprognostic (2.11e-1)" "unprognostic (5.86e-2)" "unprognostic (2.05e-2)" 20.1 55.1 13.1 12.5 17.8 1.9 31.8 6.2 13.8 10.8 13.8 6.8 27.7 11.5 11.3 25.4 8.4 12.8 11.7 7.1 16.5 6.3 14.2 18.9 12.7 30.3 8.1 10.1 12.9 9.0 23.9 14.3 18.4 18.6 14.1 7.9 20.4 6.8 24.9 6.4 6.4 12.8 13.6 12.2 38.4 12.3 17.3 9.8 1.7 9.9 2.0 8.4 14.1 26.6 0.0 0.2 0.1 10.3 0.0 0.0 0.3 0.5 0.9 4.4 10.0 0.2 0.1 7.1 0.0 0.1 0.5 1.0 21.3 1.3 0.1 4.7 0.0 4.6 0.1 5.8 0.0 0.8 0.8 3.1 3.8 0.0 22.1 0.1 0.1 0.9 0.2 0.0 5.1 0.3 2.3 22.0 0.8 1.2 2.0 1.7 1.0 0.0 5.0 2.7 0.6 3.4 1.4 1.2 1.7 11.2 13.1 0.1 4.2 0.1 0.3 1.7 1.6 0.0 0.2 3.3 0.6 2.0 0.0 0.0 1.7 2.5 0.0 0.0 0.8 0.0 0.0 0.8 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 6.4 0.1 0.0 0.3 13.1 17.8 6.2 13.8 16.5 6.3 8.1 10.1 18.6 9.8 3.0 20.1 0.8 2.9 1.4 0.6 2.1 5.1 1.4 11.4 0.0 2.0 2.6 1.7 0.8 1.6 7.1 1.6 0.0 0.8 1.0 4.1 2.0 0.0 8.9 23.6 0.0 0.0 36.8 92.6 1.5 4.6 11.0 0.0 0.0 2.3 8.6 1.7 1.9 6.3 1.9 9.2 6.5 11.3 0.5 1.5 1.1 15.8 0.8 1.8 1.4 MET "DFNB97, HGFR, RCCP2" ENSG00000105976 "MET proto-oncogene, receptor tyrosine kinase" P08581 7 116672390-116798386 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Deafness, Disease mutation, FDA approved drug targets, Non-syndromic deafness, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 2: 78.1;Club cells: 116.0;Urothelial cells: 88.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "A-431: 45.3;CAPAN-2: 49.5" "Group enriched" "Detected in many" 5 "amygdala: 3.5;basal ganglia: 9.9;cerebral cortex: 7.6;hippocampal formation: 8.0;olfactory region: 9.1" "Low region specificity" "Detected in many" "CAB005282, CAB018577, HPA055607" Approved Approved "Plasma membrane,Cytosol" "Secreted to blood" NA NA 179000000 70000000 "Plasma membrane, Cytosol" "CAB005282: AB_631940, CAB018577: AB_649068, HPA055607: AB_2682860" "unprognostic (1.60e-2)" "unprognostic (7.71e-2)" "unprognostic (2.53e-2)" "unprognostic (1.58e-1)" "unprognostic (3.57e-3)" "prognostic unfavorable (6.75e-4)" "unprognostic (1.68e-1)" "unprognostic (3.22e-2)" "unprognostic (3.81e-2)" "unprognostic (2.52e-2)" "prognostic unfavorable (1.21e-7)" "unprognostic (1.86e-1)" "unprognostic (1.25e-1)" "unprognostic (5.53e-2)" "unprognostic (8.88e-2)" "unprognostic (2.01e-2)" "unprognostic (2.20e-1)" 16.2 1.1 1.8 4.5 2.3 4.3 11.2 0.9 15.2 9.9 6.5 2.4 2.4 4.4 7.5 5.2 5.1 4.6 12.3 5.4 5.7 1.8 20.1 30.2 15.6 1.4 3.6 2.1 2.0 9.3 0.7 8.1 24.4 2.6 8.0 6.6 34.1 12.2 8.4 12.8 7.2 8.6 4.0 2.3 5.7 10.6 2.7 2.4 0.5 21.4 7.0 2.1 10.1 15.0 0.2 0.3 1.2 0.2 0.3 0.4 0.0 45.3 26.1 0.0 0.1 2.0 2.0 1.8 25.9 10.5 14.0 11.8 5.4 49.5 2.0 43.2 16.2 37.7 12.0 4.4 24.7 28.6 0.1 5.6 0.0 27.1 4.7 0.3 0.0 0.0 2.6 9.8 9.1 30.0 25.3 9.6 0.0 0.9 0.2 25.9 1.0 0.0 0.0 3.9 7.2 26.6 0.0 22.0 0.0 24.5 5.2 3.8 0.0 10.6 3.4 10.1 4.7 0.0 0.2 17.6 20.9 7.4 11.0 20.0 0.5 4.0 0.2 22.9 0.0 2.9 1.1 0.2 0.4 0.4 0.1 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 1.2 0.3 0.1 0.3 0.1 0.0 1.8 2.3 0.9 15.2 5.7 1.8 3.6 2.1 2.6 2.4 26.8 78.1 2.4 56.1 34.7 0.9 10.0 15.3 22.7 116.0 29.6 0.0 57.9 0.0 28.0 0.0 11.7 11.2 0.0 39.8 5.0 4.0 55.8 0.0 26.0 6.1 0.0 6.9 1.3 1.0 0.0 0.6 2.0 3.3 1.8 19.7 7.4 69.4 7.0 0.0 13.5 0.3 0.0 2.3 0.0 0.6 15.6 18.2 0.0 12.7 88.5 METAP1 "KIAA0094, MAP1A, MetAP1A" ENSG00000164024 "Methionyl aminopeptidase 1" P53582 4 98995620-99062813 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 14 "Early spermatids: 345.0;Late spermatids: 1171.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025485, HPA037997, HPA037998" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 11000 Cytosol "Nucleoplasm, Plasma membrane" "CAB025485: , HPA037997: AB_2675777, HPA037998: AB_2675778" "unprognostic (1.79e-1)" "unprognostic (3.39e-1)" "prognostic favorable (7.22e-4)" "unprognostic (1.58e-2)" "unprognostic (6.53e-2)" "unprognostic (2.15e-1)" "prognostic unfavorable (3.08e-5)" "unprognostic (1.09e-1)" "unprognostic (1.51e-3)" "unprognostic (2.05e-1)" "prognostic unfavorable (2.28e-5)" "unprognostic (2.00e-1)" "prognostic favorable (1.72e-4)" "unprognostic (5.50e-2)" "unprognostic (8.51e-2)" "unprognostic (1.15e-3)" "prognostic favorable (9.31e-4)" 12.1 8.3 10.0 16.0 10.1 11.8 18.6 9.2 13.8 16.0 17.9 7.0 22.9 13.4 24.1 25.9 37.2 14.0 12.3 27.9 9.5 7.1 14.3 13.7 10.7 12.6 7.9 9.8 11.3 13.0 7.8 14.4 9.2 9.9 19.1 19.3 7.5 19.0 21.5 27.2 16.4 15.2 27.8 10.1 13.9 11.6 46.8 8.1 27.0 10.8 21.8 19.1 36.6 22.6 12.7 11.7 10.4 11.1 12.5 19.2 10.8 21.7 21.5 18.9 20.3 15.0 24.1 21.0 31.2 20.1 26.7 25.5 24.1 32.5 32.3 12.5 25.2 16.0 21.9 33.1 31.2 37.1 22.5 15.8 28.8 15.7 25.9 16.3 38.9 24.2 17.3 22.8 22.7 24.1 20.8 21.9 18.3 22.5 19.5 28.5 16.6 34.1 18.6 23.2 37.1 17.5 22.4 29.5 17.2 42.9 28.2 25.9 15.3 10.4 32.4 12.3 22.1 12.4 14.9 17.8 21.6 27.5 19.8 27.2 14.2 19.9 25.5 18.6 20.0 21.4 10.4 9.4 4.2 14.9 11.1 19.2 12.7 15.4 14.5 11.7 10.1 15.1 13.5 2.3 12.5 10.7 5.8 13.4 10.8 10.0 10.1 9.2 13.8 9.5 7.1 7.9 9.8 9.9 8.1 38.7 10.5 13.7 44.1 37.7 4.6 49.8 20.4 18.7 17.0 14.0 2.0 22.0 11.6 26.9 345.0 13.5 29.0 0.0 25.4 55.9 12.3 21.8 3.5 16.4 15.6 3.2 7.5 16.5 19.6 1171.9 17.8 14.6 15.1 6.4 25.2 8.3 22.3 34.2 21.2 22.9 3.5 25.8 22.1 15.1 46.4 33.9 6.4 15.2 32.6 39.6 METAP2 "MAP2, MNPEP, p67" ENSG00000111142 "Methionyl aminopeptidase 2" P50579 12 95473520-95515839 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013025, HPA019095" Enhanced Supported "Plasma membrane,Cytosol" NA NA 22000 "Plasma membrane, Cytosol" "CAB013025: AB_2533993, HPA019095: AB_1853823" "unprognostic (1.91e-1)" "unprognostic (1.02e-1)" "unprognostic (5.92e-2)" "unprognostic (2.44e-1)" "unprognostic (3.27e-2)" "unprognostic (2.57e-2)" "prognostic unfavorable (4.51e-6)" "unprognostic (1.25e-1)" "unprognostic (2.28e-2)" "unprognostic (1.40e-2)" "unprognostic (8.53e-2)" "unprognostic (1.66e-1)" "unprognostic (1.49e-1)" "unprognostic (2.51e-1)" "unprognostic (1.07e-1)" "unprognostic (2.95e-2)" "unprognostic (1.03e-1)" 24.2 36.4 25.8 49.9 33.7 39.1 25.1 25.9 32.3 23.9 26.2 16.3 102.5 16.6 28.7 25.4 30.1 22.5 21.7 30.7 29.6 24.0 26.0 46.8 22.1 32.6 29.1 23.4 29.4 31.9 21.0 36.1 25.1 42.9 24.2 24.0 10.1 22.1 140.7 94.4 28.7 19.7 26.1 48.2 25.2 22.2 26.3 27.7 32.1 24.1 29.0 55.2 33.4 37.3 39.4 31.8 21.3 27.1 25.7 32.0 16.2 33.9 28.6 30.6 23.8 18.7 30.0 23.6 33.5 23.4 33.0 23.5 41.5 16.3 98.8 21.1 23.9 19.2 21.9 34.4 25.6 38.0 23.5 29.7 44.2 21.8 29.2 19.9 54.7 21.7 25.9 27.4 31.2 30.6 39.6 35.1 34.1 57.2 11.2 24.4 22.3 40.5 37.4 37.5 19.6 42.8 31.9 26.5 32.4 22.6 36.0 23.8 31.3 29.7 24.3 29.3 27.6 29.3 26.0 30.1 19.0 18.4 21.2 35.3 16.2 42.1 105.9 10.8 30.9 23.8 21.3 27.1 11.1 23.8 19.1 29.2 39.4 26.7 26.6 24.4 37.6 32.0 29.7 1.2 25.7 22.3 31.8 25.3 16.2 25.8 33.7 25.9 32.3 29.6 24.0 29.1 23.4 42.9 27.7 262.0 228.6 96.8 102.9 207.2 62.7 117.4 91.7 104.4 160.3 275.7 62.8 125.5 139.3 94.7 135.8 104.6 80.2 256.9 126.2 136.4 102.7 68.6 119.0 278.9 86.9 71.5 88.0 102.5 122.4 83.3 92.9 93.2 87.7 80.2 109.6 67.6 105.7 83.4 100.4 81.6 68.7 97.0 97.6 340.7 217.0 187.9 143.8 93.5 118.5 90.7 METTL15 "FLJ33979, METT5D1" ENSG00000169519 "Methyltransferase like 15" A6NJ78 11 28108248-28527041 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039885 Approved "Golgi apparatus,Plasma membrane,Actin filaments" NA NA "Golgi apparatus, Plasma membrane" "Actin filaments" "HPA039885: AB_2676725" "unprognostic (2.57e-1)" "unprognostic (2.64e-1)" "unprognostic (1.00e-2)" "unprognostic (3.21e-2)" "unprognostic (2.66e-2)" "unprognostic (1.83e-1)" "unprognostic (4.17e-2)" "unprognostic (1.95e-1)" "unprognostic (2.94e-2)" "unprognostic (7.93e-2)" "unprognostic (6.31e-3)" "unprognostic (2.28e-1)" "prognostic favorable (7.95e-5)" "unprognostic (7.77e-2)" "unprognostic (1.38e-1)" "unprognostic (6.58e-2)" "unprognostic (6.84e-3)" 10.3 17.5 11.2 13.4 11.2 4.3 12.4 16.0 13.4 13.6 13.4 12.2 15.0 9.9 21.0 14.8 10.8 11.8 12.3 14.7 11.3 12.0 15.4 17.9 9.6 9.5 10.5 10.1 12.3 11.4 18.8 32.6 11.1 13.6 12.9 13.8 15.5 12.4 13.7 16.9 10.0 9.8 13.3 12.7 9.8 10.3 11.8 11.2 16.5 15.3 11.0 14.3 10.6 9.8 6.4 3.3 6.0 2.7 7.6 6.8 2.9 7.3 7.9 8.0 6.1 10.0 16.1 5.6 9.1 7.0 9.2 9.5 5.3 5.0 16.9 5.4 7.4 5.8 6.2 10.5 9.3 17.8 10.4 9.2 5.3 5.9 6.1 11.2 9.9 4.8 9.1 13.9 5.1 13.3 10.0 8.8 5.6 11.2 7.7 10.8 5.0 6.9 6.2 6.2 7.7 5.9 3.7 17.5 6.2 13.7 4.2 7.1 5.9 7.4 6.7 10.6 8.1 13.3 6.1 6.6 8.4 6.5 10.7 7.9 5.2 6.1 9.9 11.9 10.1 9.1 3.1 2.7 6.0 4.2 1.7 5.3 6.4 5.2 5.5 3.0 3.3 5.6 6.8 1.3 7.6 2.2 3.3 5.5 2.9 11.2 11.2 16.0 13.4 11.3 12.0 10.5 10.1 13.6 11.2 11.9 25.3 12.7 27.9 39.0 12.6 12.6 7.6 14.7 15.9 10.4 17.7 9.6 10.0 9.4 22.3 10.0 13.9 0.0 10.3 11.4 16.4 28.7 4.7 12.5 9.3 12.7 9.2 14.7 8.8 10.2 10.0 10.2 13.5 3.6 17.1 7.0 7.7 10.5 7.8 12.9 16.4 6.5 26.8 16.5 8.2 31.1 7.1 25.4 16.0 46.3 MFSD1 "FLJ14153, UG0581B09" ENSG00000118855 "Major facilitator superfamily domain containing 1" Q9H3U5 3 158732198-158829719 "Predicted intracellular proteins, Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Hofbauer cells: 192.2;Kupffer cells: 259.8;Macrophages: 135.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 45.3;granulocytes: 42.6;monocytes: 49.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065858 Approved Approved "Plasma membrane,Cytosol" NA NA 14000 "Plasma membrane" Cytosol "HPA065858: AB_2685569" "unprognostic (9.94e-2)" "unprognostic (3.12e-3)" "unprognostic (3.54e-2)" "unprognostic (1.00e-1)" "unprognostic (2.16e-2)" "unprognostic (7.37e-2)" "unprognostic (1.28e-2)" "unprognostic (2.61e-2)" "unprognostic (2.52e-1)" "unprognostic (1.15e-1)" "unprognostic (6.48e-2)" "unprognostic (2.92e-1)" "prognostic favorable (5.60e-5)" "unprognostic (1.62e-1)" "unprognostic (6.33e-3)" "unprognostic (4.66e-2)" "unprognostic (2.57e-1)" 26.2 29.5 11.4 22.0 11.8 17.2 24.2 9.1 14.0 18.7 15.7 13.4 18.9 13.2 18.3 20.6 37.0 18.4 17.5 17.7 10.8 10.3 20.7 24.8 24.9 39.8 15.7 11.7 15.3 16.8 16.5 16.8 18.3 13.6 14.7 11.5 14.5 34.5 17.9 9.2 18.6 16.8 15.0 14.5 29.1 19.9 15.0 14.3 11.3 18.7 16.3 16.7 23.8 24.1 10.5 45.3 42.6 49.6 5.4 7.3 35.3 14.9 6.4 1.6 5.0 8.7 8.2 10.3 23.4 10.5 8.3 8.2 2.6 14.8 4.2 17.2 14.9 5.0 7.8 4.0 5.1 7.8 16.6 10.9 11.2 4.9 1.1 9.4 41.3 28.1 12.2 6.7 7.5 2.1 3.3 6.5 2.8 8.7 8.6 14.7 3.4 2.5 12.2 1.6 6.3 16.4 5.6 2.4 36.6 3.0 3.9 4.8 7.2 17.2 13.3 4.1 2.0 10.5 16.2 21.3 11.9 4.6 17.6 11.5 27.4 19.2 2.3 15.0 30.0 8.3 14.0 49.6 42.6 7.3 38.5 6.6 10.5 5.8 6.5 45.3 8.5 6.4 7.0 17.6 5.4 31.6 14.7 6.8 35.3 11.4 11.8 9.1 14.0 10.8 10.3 15.7 11.7 13.6 14.3 17.9 31.3 39.5 33.3 19.1 11.9 17.1 12.7 40.2 29.6 21.0 5.9 23.7 16.6 28.2 3.5 25.1 25.5 23.3 24.8 27.2 23.6 39.9 47.4 30.1 192.2 17.5 21.9 39.3 259.8 5.3 11.2 135.3 30.4 15.4 26.6 23.4 26.7 20.1 10.6 25.9 10.0 12.9 15.5 8.8 7.0 22.7 46.8 15.4 24.0 47.5 MGAT4C HGNT-IV-H ENSG00000182050 "MGAT4 family member C" Q9UBM8 12 85955666-86838904 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "brain: 12.8;epididymis: 10.9;pituitary gland: 25.9;testis: 7.8;thyroid gland: 18.0" "Group enriched" "Detected in some" 6 "Early spermatids: 99.1;Late spermatids: 74.0" "Cancer enriched" "Detected in single" 19 "thyroid cancer: 2.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "NTERA-2: 11.0;SCLC-21H: 4.8;SuSa: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA016418 Approved Approved "Vesicles,Plasma membrane,Centriolar satellite" NA NA "Vesicles, Plasma membrane" "Centriolar satellite" "HPA016418: AB_2732416" "unprognostic (5.23e-2)" "unprognostic (2.33e-1)" "unprognostic (1.84e-1)" "unprognostic (3.32e-4)" "unprognostic (1.07e-1)" "unprognostic (9.64e-2)" "unprognostic (5.94e-3)" "unprognostic (1.88e-1)" "unprognostic (8.05e-2)" "unprognostic (1.89e-1)" "unprognostic (6.32e-3)" "unprognostic (3.51e-2)" "unprognostic (6.85e-10)" "unprognostic (3.15e-2)" "unprognostic (1.77e-1)" "unprognostic (1.97e-1)" "unprognostic (4.74e-3)" 1.0 3.0 5.5 1.0 12.3 1.1 0.9 4.9 12.8 1.3 1.2 2.5 0.4 0.9 1.0 10.9 1.1 1.1 1.2 3.6 9.4 3.9 1.0 0.9 1.0 0.9 3.0 9.3 0.9 0.9 0.9 25.9 0.8 10.6 1.1 1.2 0.0 0.9 2.4 0.8 1.0 1.0 1.0 4.3 0.9 1.0 7.8 5.1 0.0 18.0 0.0 0.8 0.9 0.6 0.5 0.3 0.8 0.2 0.2 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.5 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.1 0.1 0.2 0.0 0.2 0.1 0.0 0.3 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.2 0.1 0.1 0.0 11.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 3.8 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.8 0.2 0.1 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.5 0.2 0.1 0.8 0.2 0.1 0.3 0.2 0.0 5.5 12.3 4.9 12.8 9.4 3.9 3.0 9.3 10.6 5.1 6.0 0.6 0.0 0.1 0.1 9.7 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 99.1 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 74.0 15.0 0.0 0.0 0.0 0.0 0.5 0.7 0.0 3.9 0.0 1.6 0.0 0.0 1.7 0.6 0.1 0.0 0.0 0.0 0.3 MICB PERB11.2 ENSG00000204516 "MHC class I polypeptide-related sequence B" Q29980 6 31494881-31511124 "Disease related genes, Predicted membrane proteins" "Adaptive immunity, Cytolysis, Host-virus interaction, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "vagina: 26.5" "Cell type enhanced" "Detected in many" 10 "Erythroid cells: 23.3;Hofbauer cells: 9.9;Kupffer cells: 12.9;monocytes: 10.0;T-cells: 10.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 11.6;U-266/84: 26.5" HPA064618 Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Golgi apparatus, Plasma membrane" Nucleoplasm "HPA064618: AB_2685301" "unprognostic (3.63e-3)" "unprognostic (8.81e-2)" "unprognostic (3.19e-1)" "unprognostic (1.51e-2)" "unprognostic (8.44e-2)" "unprognostic (5.94e-2)" "prognostic unfavorable (7.04e-5)" "unprognostic (2.05e-1)" "unprognostic (2.61e-1)" "unprognostic (1.67e-3)" "unprognostic (2.28e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (4.94e-9)" "unprognostic (1.91e-3)" "unprognostic (2.80e-2)" "unprognostic (9.72e-2)" "unprognostic (1.21e-2)" 3.3 1.2 0.8 9.1 0.8 6.1 3.5 3.0 1.0 1.8 1.6 0.9 0.0 1.0 2.1 1.3 2.1 1.1 1.7 2.2 1.0 0.6 2.9 1.3 6.9 7.8 1.2 0.8 1.3 2.9 0.2 0.6 0.8 1.2 1.1 1.9 1.1 1.9 0.7 0.8 1.0 5.0 1.7 1.5 11.7 1.4 2.3 1.1 8.1 2.4 0.7 8.1 3.2 26.5 2.2 2.1 4.1 4.8 1.9 4.4 1.9 2.4 0.8 0.0 0.0 1.5 2.5 0.0 1.7 1.7 2.2 2.9 0.0 0.3 2.8 6.2 3.2 7.1 0.6 0.7 2.9 0.8 2.4 2.6 3.2 0.5 1.1 0.5 1.0 2.7 3.1 0.6 3.8 2.2 2.3 1.4 4.4 3.3 5.9 2.6 0.0 0.9 4.2 0.3 0.0 0.4 3.4 0.0 5.9 2.6 0.1 0.0 0.0 1.1 0.0 0.5 0.9 1.5 1.2 1.4 1.7 0.0 1.5 0.0 11.6 26.5 6.2 0.4 8.7 3.7 4.1 3.1 4.0 2.9 3.6 3.6 2.2 2.9 3.9 2.1 2.0 1.6 3.1 3.1 1.9 4.8 1.3 4.4 1.9 0.8 0.8 3.0 1.0 1.0 0.6 1.2 0.8 1.2 1.1 3.0 1.0 5.1 0.6 2.6 0.0 0.3 2.5 0.0 1.2 0.0 0.0 0.1 1.7 1.2 0.0 1.9 0.3 23.3 0.6 0.2 3.3 1.7 0.0 0.0 9.9 0.0 0.0 3.1 12.9 0.0 0.3 8.1 1.7 10.0 0.7 0.0 1.5 2.0 0.4 0.3 0.0 0.0 3.9 0.7 1.5 1.0 0.1 10.0 1.7 1.1 MKLN1 TWA2 ENSG00000128585 "Muskelin 1" Q9UL63 7 131110096-131496636 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "neutrophil: 12.4" "Lineage enriched" "Detected in many" 5 "granulocytes: 12.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022817, HPA041810" Approved Approved "Vesicles,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Vesicles "HPA022817: AB_1853974, HPA041810: AB_2677686" "unprognostic (1.97e-1)" "unprognostic (2.83e-2)" "unprognostic (1.23e-1)" "unprognostic (3.92e-3)" "unprognostic (1.03e-1)" "unprognostic (4.20e-2)" "unprognostic (1.44e-3)" "unprognostic (4.58e-2)" "unprognostic (1.94e-2)" "unprognostic (1.97e-1)" "unprognostic (2.43e-3)" "unprognostic (1.55e-1)" "unprognostic (9.18e-3)" "unprognostic (1.70e-1)" "unprognostic (4.13e-1)" "unprognostic (1.13e-2)" "unprognostic (2.32e-1)" 22.7 21.1 22.1 15.7 27.6 12.8 34.4 27.5 25.8 18.8 15.0 11.7 26.6 14.2 19.3 19.8 11.8 19.6 11.6 16.7 21.9 14.4 23.0 22.8 19.3 18.7 26.6 17.5 23.2 12.6 20.9 28.8 18.2 25.0 26.4 12.2 10.0 18.1 28.9 28.6 15.4 13.5 20.8 30.3 13.1 14.4 16.9 24.0 14.7 18.0 9.9 12.0 17.8 21.5 2.3 1.6 12.4 1.6 0.9 2.3 0.5 8.3 9.7 8.4 8.5 20.9 18.8 5.1 8.1 18.9 9.3 11.9 4.4 7.2 8.7 5.5 10.1 18.3 5.8 8.8 7.7 15.2 8.4 4.3 3.7 7.5 5.1 10.0 6.1 5.4 11.3 5.5 12.5 6.3 10.0 8.4 5.4 13.6 6.3 11.4 3.1 7.2 6.6 9.6 6.8 5.1 4.5 10.0 6.0 10.3 4.9 4.4 9.4 15.9 15.9 7.3 9.2 3.1 7.7 8.6 7.3 4.1 13.1 6.6 15.4 5.7 14.9 25.0 7.4 10.6 1.2 1.0 1.7 1.6 1.1 1.2 1.2 1.5 1.3 1.0 2.3 2.3 1.9 12.4 0.9 1.6 1.6 0.9 0.5 22.1 27.6 27.5 25.8 21.9 14.4 26.6 17.5 25.0 24.0 47.6 36.6 23.7 26.7 39.2 45.2 21.2 38.2 10.7 22.7 43.6 66.8 14.7 6.6 17.8 2.6 48.1 26.9 0.0 20.5 13.9 40.1 45.0 33.5 67.6 18.7 50.9 35.6 60.2 36.9 3.6 63.0 28.4 33.7 24.4 27.8 54.4 22.4 31.9 79.2 25.0 67.1 84.1 41.9 34.6 26.5 40.1 12.4 26.1 25.0 33.3 MKRN3 "D15S9, MGC88288, RNF63, ZFP127, ZNF127" ENSG00000179455 "Makorin ring finger protein 3" Q13064 15 23565678-23630075 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.4" "Cell type enhanced" "Detected in some" 19 "Bipolar cells: 12.6;Cone photoreceptor cells: 23.6;Horizontal cells: 6.4;Rod photoreceptor cells: 6.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD8 T-cell: 5.7" "Lineage enriched" "Detected in many" 4 "T-cells: 5.7" "Cell line enhanced" "Detected in many" "JURKAT: 16.0;K-562: 17.1" "Low region specificity" "Detected in many" HPA029494 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA029494: AB_10603873" "unprognostic (3.18e-1)" "unprognostic (1.26e-1)" "unprognostic (4.26e-1)" "unprognostic (1.86e-3)" "unprognostic (1.04e-3)" "unprognostic (1.15e-2)" "unprognostic (6.27e-4)" "unprognostic (1.51e-1)" "unprognostic (8.52e-2)" "unprognostic (7.05e-2)" "unprognostic (4.97e-3)" "unprognostic (2.86e-1)" "unprognostic (1.05e-4)" "unprognostic (5.37e-2)" "unprognostic (1.52e-1)" "unprognostic (8.91e-2)" "unprognostic (9.78e-2)" 1.0 0.7 5.1 1.2 10.4 4.0 1.2 1.0 11.1 0.5 1.1 8.4 0.0 1.3 1.3 3.2 5.6 0.9 0.8 0.8 6.4 3.4 1.1 0.7 1.0 1.9 14.4 3.0 1.2 1.7 0.5 3.8 8.5 5.1 1.2 0.8 3.1 5.2 1.0 1.4 1.2 1.9 0.8 8.2 1.5 0.9 5.7 13.3 5.0 0.9 1.1 1.7 0.7 0.6 1.0 0.9 1.3 0.5 0.4 5.7 0.7 4.6 3.3 3.0 3.1 0.0 0.0 7.0 0.3 0.0 2.8 1.9 8.3 0.0 0.2 0.1 0.0 6.2 8.0 1.3 0.0 0.7 0.0 0.3 6.7 8.9 0.3 0.1 7.8 6.0 0.1 0.0 5.8 0.0 1.2 0.0 16.0 17.1 7.3 0.8 0.0 8.2 3.4 0.0 4.4 10.1 5.9 1.1 4.1 0.0 0.1 0.7 2.4 0.0 3.4 0.0 0.2 2.6 2.3 0.0 7.8 6.6 0.4 5.5 9.2 11.3 5.5 4.5 0.1 0.1 1.3 0.5 0.4 1.8 0.2 1.0 1.0 0.6 1.4 0.2 0.9 2.0 5.7 1.3 0.4 0.3 0.9 0.4 0.7 5.1 10.4 1.0 6.8 6.4 3.4 14.4 3.0 5.1 13.3 0.0 0.0 0.0 1.1 0.5 12.6 0.4 0.0 0.0 0.0 0.0 23.6 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.9 0.3 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.0 0.0 3.4 0.0 0.0 0.4 0.0 6.4 0.0 1.2 2.4 1.0 0.0 0.5 0.0 0.0 0.4 MLF2 NTN4 ENSG00000089693 "Myeloid leukemia factor 2" Q15773 12 6747996-6767475 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010811, HPA010859" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA010811: AB_1079389, HPA010859: AB_1079388" "unprognostic (1.65e-1)" "unprognostic (6.55e-2)" "unprognostic (4.42e-1)" "unprognostic (9.88e-3)" "unprognostic (1.76e-1)" "unprognostic (4.19e-2)" "unprognostic (1.52e-1)" "unprognostic (4.15e-2)" "unprognostic (1.31e-1)" "unprognostic (9.11e-2)" "unprognostic (3.37e-1)" "unprognostic (6.23e-2)" "unprognostic (1.38e-1)" "unprognostic (5.83e-2)" "unprognostic (4.72e-1)" "unprognostic (8.44e-2)" "unprognostic (3.63e-1)" 31.4 45.6 55.8 23.3 65.4 36.9 24.9 50.5 100.5 28.6 30.9 44.0 23.9 36.5 32.1 30.5 39.3 31.7 28.6 44.1 54.4 47.2 37.9 77.4 24.8 21.5 40.2 42.5 28.3 33.4 43.3 31.1 32.5 44.8 38.4 27.6 28.2 43.1 36.7 45.3 33.6 35.1 35.9 33.7 21.8 27.7 21.0 30.7 26.0 36.3 28.9 29.4 29.3 23.6 17.0 38.9 86.7 20.1 11.8 14.8 16.9 39.1 64.9 33.4 58.7 31.3 31.9 51.3 38.6 46.4 66.4 58.3 62.7 38.9 28.3 10.2 50.2 43.4 32.9 41.0 55.8 41.3 44.5 38.0 20.0 34.4 35.9 34.6 21.2 27.6 29.8 45.6 51.3 39.3 48.8 27.0 27.0 25.1 11.8 46.2 55.6 29.1 32.8 107.8 42.5 22.4 18.6 30.7 25.1 55.4 49.5 21.3 42.2 34.8 61.6 37.3 73.7 17.9 35.1 26.6 39.6 52.8 41.8 56.3 14.4 16.3 37.6 52.9 18.5 46.6 35.4 20.1 73.9 14.8 18.0 14.3 15.3 11.5 13.9 22.6 17.0 12.2 13.5 86.7 11.8 19.5 38.9 11.2 16.9 55.8 65.4 50.5 100.5 54.4 47.2 40.2 42.5 44.8 30.7 35.7 25.7 57.9 127.1 121.2 102.4 55.8 104.4 45.5 36.4 104.7 39.3 229.6 237.1 156.1 7.9 68.0 134.5 0.0 110.6 175.2 95.0 155.3 83.1 146.5 129.4 76.3 96.6 62.0 41.9 7.0 105.6 62.0 97.8 201.0 116.3 120.9 125.1 111.0 100.8 262.4 48.7 51.8 117.9 51.9 90.7 109.8 357.4 59.8 120.9 152.3 MMACHC "cblC, DKFZP564I122" ENSG00000132763 "Methylmalonic aciduria (cobalamin deficiency) cblC type, with homocystinuria" Q9Y4U1 1 45500053-45513382 "Disease related genes, Predicted intracellular proteins" "Oxidoreductase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 30.1" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 21.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027394, HPA027399, HPA027402" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA027394: AB_10601669, HPA027399: AB_10601987, HPA027402: AB_2672255" "unprognostic (3.34e-1)" "unprognostic (1.63e-1)" "unprognostic (7.03e-3)" "unprognostic (3.14e-2)" "unprognostic (4.05e-1)" "unprognostic (1.16e-2)" "unprognostic (9.04e-2)" "unprognostic (1.03e-2)" "unprognostic (1.90e-1)" "unprognostic (1.05e-2)" "unprognostic (3.88e-2)" "unprognostic (6.81e-2)" "unprognostic (2.61e-3)" "unprognostic (2.08e-3)" "unprognostic (8.83e-2)" "unprognostic (2.50e-2)" "unprognostic (2.58e-2)" 3.5 7.4 5.8 3.3 10.2 2.2 6.1 3.6 12.2 5.4 6.3 11.8 3.2 5.6 4.1 5.6 4.0 6.2 2.9 11.1 6.2 5.1 7.6 30.1 2.7 3.1 7.3 6.9 6.4 9.8 9.5 5.4 2.9 8.5 3.9 7.6 4.0 11.9 7.5 14.7 3.8 4.1 4.2 6.7 3.6 4.5 7.3 5.7 4.1 4.4 3.7 3.6 3.9 3.1 2.1 3.6 5.0 6.1 2.6 3.9 1.1 6.8 3.5 6.1 9.2 5.8 3.5 7.6 5.3 3.5 9.7 8.8 7.3 4.2 10.7 6.9 4.4 1.8 5.7 11.2 12.7 8.9 2.9 10.2 8.3 5.9 8.2 5.5 11.8 3.0 5.0 7.2 10.7 11.8 3.5 4.6 11.3 9.4 6.1 7.4 7.3 7.9 3.8 10.0 7.8 8.3 9.8 2.5 11.9 5.6 5.4 9.8 5.0 8.0 13.3 17.3 4.8 7.6 4.3 2.1 6.8 9.3 7.6 2.8 9.2 7.4 6.2 4.9 5.7 6.3 5.0 1.6 1.6 1.7 2.4 2.8 2.0 2.0 1.4 1.7 2.1 3.9 2.0 3.5 2.6 6.1 3.6 1.4 1.1 5.8 10.2 3.6 12.2 6.2 5.1 7.3 6.9 8.5 5.7 3.0 5.6 1.5 1.7 0.1 0.9 8.7 2.5 1.4 3.4 1.8 0.0 3.1 5.0 1.1 0.6 0.7 1.6 0.0 1.2 3.7 1.8 1.3 2.3 21.9 2.9 3.2 4.1 2.5 3.1 0.0 1.7 0.9 0.0 0.0 2.6 1.0 1.8 0.0 1.4 3.2 4.4 0.0 1.7 8.1 2.0 0.1 2.3 1.3 6.0 1.6 MMP10 STMY2 ENSG00000166670 "Matrix metallopeptidase 10" P09238 11 102770503-102780628 "Cancer-related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "endometrium 1: 89.4" "Cell type enhanced" "Detected in some" 14 "Basal glandular cells: 38.9;Club cells: 70.5;Collecting duct cells: 27.9;Pancreatic endocrine cells: 62.0" "Cancer enhanced" "Detected in many" "head and neck cancer: 102.2" "Region enriched" "Detected in single" 9 "pons and medulla: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 12.6;HUVEC TERT2: 16.2;SCLC-21H: 5.2" "Not detected" "Not detected" CAB002159 Uncertain Approved "Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA 765000 Cytosol "Plasma membrane" "CAB002159: AB_564103" "unprognostic (8.76e-2)" "unprognostic (3.38e-1)" "unprognostic (1.98e-3)" "unprognostic (2.72e-3)" "unprognostic (7.17e-3)" "unprognostic (1.52e-2)" "unprognostic (5.67e-8)" "unprognostic (2.08e-3)" "unprognostic (2.20e-1)" "unprognostic (1.75e-1)" "unprognostic (1.67e-2)" "unprognostic (2.67e-1)" "unprognostic (6.99e-5)" "unprognostic (2.66e-2)" "unprognostic (7.98e-2)" "unprognostic (5.46e-2)" "prognostic favorable (7.12e-4)" 0.1 0.1 0.0 2.6 0.2 0.1 0.1 0.0 0.3 1.7 0.5 0.0 0.0 0.4 89.4 0.1 0.2 0.1 0.5 0.1 0.0 0.1 0.1 3.6 11.0 0.1 0.0 0.0 0.5 0.3 0.1 0.9 19.8 2.8 3.2 0.2 0.0 2.9 0.1 0.1 0.1 0.7 0.1 0.0 0.2 3.3 0.5 0.0 1.2 0.1 0.0 1.9 0.6 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.2 0.0 0.0 0.2 12.6 0.7 0.1 0.1 0.3 0.0 0.0 3.7 1.9 0.2 2.9 0.0 1.4 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.6 0.0 16.2 0.0 0.7 0.0 0.0 0.0 0.0 0.3 3.0 0.5 1.7 0.0 0.0 0.0 0.0 0.7 5.2 0.0 2.5 0.0 0.0 0.9 0.0 0.0 2.0 3.9 1.3 0.4 0.5 0.0 0.0 0.0 0.6 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 38.9 0.7 0.0 0.0 0.0 5.3 70.5 27.9 0.0 0.0 0.0 9.8 5.0 0.0 0.0 0.0 12.9 0.0 0.2 5.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.2 0.0 2.8 0.0 0.0 62.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.0 0.0 7.4 MMP15 "MT2-MMP, MTMMP2, SMCP-2" ENSG00000102996 "Matrix metallopeptidase 15" P51511 16 58025566-58046901 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 43.2" "Cell type enhanced" "Detected in many" 7 "Cholangiocytes: 56.0;Enterocytes: 81.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 30 "plasmacytoid DC: 2.9" "Lineage enriched" "Detected in single" 30 "dendritic cells: 2.9" "Cell line enhanced" "Detected in many" "BEWO: 37.1;Hep G2: 19.3;SK-BR-3: 18.6;WM-115: 30.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002611, HPA040390" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "CAB002611: , HPA040390: AB_2676956" "unprognostic (1.76e-2)" "unprognostic (7.32e-2)" "unprognostic (2.69e-1)" "unprognostic (6.85e-2)" "unprognostic (3.09e-1)" "unprognostic (1.68e-1)" "unprognostic (6.88e-3)" "unprognostic (1.40e-1)" "unprognostic (3.02e-2)" "unprognostic (1.24e-2)" "unprognostic (4.81e-2)" "unprognostic (1.81e-1)" "prognostic favorable (8.54e-8)" "unprognostic (3.63e-2)" "unprognostic (1.36e-1)" "unprognostic (1.28e-1)" "prognostic favorable (3.08e-4)" 5.9 2.3 2.0 5.5 3.0 0.1 7.7 3.7 7.2 3.3 19.5 4.2 16.3 22.6 2.9 1.7 2.5 3.6 15.9 17.6 2.3 3.7 8.4 26.4 6.1 2.0 2.5 2.2 2.1 10.3 7.3 5.2 28.5 10.4 3.6 8.2 9.5 4.7 14.7 3.4 2.3 43.2 3.4 3.4 5.2 14.7 28.0 2.1 1.1 26.8 2.5 2.2 3.3 4.2 0.0 2.9 0.0 0.0 0.0 0.0 0.0 5.7 4.4 2.3 11.9 2.4 0.1 37.1 0.5 0.3 2.1 0.5 3.5 14.9 0.0 7.0 0.6 1.6 8.1 2.0 1.7 0.6 0.0 3.9 0.0 1.9 19.3 3.1 0.1 7.7 1.2 3.1 0.3 0.9 3.3 1.4 3.3 4.8 0.0 0.7 2.9 0.2 0.9 6.8 17.0 1.2 2.9 0.3 3.1 6.5 2.1 0.6 4.1 7.7 18.6 3.5 5.5 2.0 3.1 1.3 0.1 3.7 1.4 0.5 0.0 0.0 0.1 0.7 0.9 30.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 2.0 3.0 3.7 7.2 2.3 3.7 2.5 2.2 10.4 2.1 17.9 11.8 0.9 1.0 2.3 1.9 19.3 56.0 5.3 9.1 17.4 15.7 33.4 1.7 33.5 2.2 6.0 81.1 0.0 10.5 19.6 2.8 1.6 0.0 29.0 10.2 1.6 10.9 19.6 3.5 4.8 0.9 0.1 1.7 0.0 31.8 1.7 13.5 40.7 3.2 5.4 1.4 0.0 0.8 0.9 4.9 1.9 40.5 1.5 28.3 1.4 MMP24 MT5-MMP ENSG00000125966 "Matrix metallopeptidase 24" Q9Y5R2 20 35226654-35277000 "Enzymes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Hydrolase, Metalloprotease, Protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 38.5" "Cell type enhanced" "Detected in some" 10 "Alveolar cells type 1: 14.9;Cholangiocytes: 12.7;Ductal cells: 7.5;Horizontal cells: 14.3;Proximal tubular cells: 7.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 5 "cerebellum: 38.5" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 20.1;CACO-2: 30.6;EFO-21: 9.0;RPTEC TERT1: 13.8;U-2 OS: 10.4" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 91.3" "HPA049280, HPA078816" Approved Approved "Nucleoli,Plasma membrane" "Secreted to extracellular matrix" Yes No "Nucleoli, Plasma membrane" "HPA049280: , HPA078816: " "unprognostic (1.52e-3)" "unprognostic (1.36e-1)" "unprognostic (1.18e-1)" "unprognostic (4.51e-4)" "unprognostic (2.47e-2)" "unprognostic (7.61e-3)" "unprognostic (1.22e-1)" "unprognostic (4.59e-2)" "unprognostic (2.32e-2)" "unprognostic (8.82e-2)" "unprognostic (9.20e-3)" "unprognostic (7.12e-2)" "prognostic favorable (8.17e-11)" "unprognostic (3.32e-2)" "unprognostic (5.63e-2)" "unprognostic (1.69e-2)" "unprognostic (9.90e-4)" 1.6 1.3 4.0 0.4 7.8 0.6 0.4 38.5 8.9 0.7 0.3 1.3 0.2 2.8 1.6 0.9 0.2 2.8 0.6 1.0 2.7 3.2 8.6 0.9 6.1 0.3 1.8 1.5 0.9 8.0 0.0 3.8 0.6 1.7 2.2 0.1 0.5 0.4 6.0 0.2 1.5 1.7 2.5 0.9 0.6 0.7 0.4 1.4 0.2 0.8 0.2 0.2 0.5 0.2 0.8 0.4 2.2 0.8 0.6 1.2 0.3 0.3 20.1 0.0 0.1 0.1 0.0 0.6 1.1 1.3 2.1 1.1 30.6 5.4 0.0 9.0 1.4 0.7 0.3 4.7 0.0 0.9 0.1 0.2 1.1 0.6 0.3 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.6 0.0 0.1 0.0 0.3 0.2 0.2 0.1 0.1 7.7 0.0 1.4 0.0 0.1 0.0 13.8 0.1 8.0 5.5 1.4 0.5 0.2 1.8 0.3 0.1 0.3 4.3 10.4 1.0 0.4 0.1 0.1 0.0 0.9 0.1 0.6 1.0 0.6 0.1 1.0 0.7 1.2 0.6 0.7 0.8 0.4 0.8 0.6 0.6 2.2 0.6 0.8 0.2 0.0 0.3 4.0 7.8 38.5 5.3 2.7 3.2 1.8 1.5 1.7 1.4 14.9 1.0 0.0 0.1 0.1 3.6 0.6 12.7 0.0 2.3 1.8 0.0 0.0 5.0 7.5 0.6 0.7 0.3 0.0 0.8 0.1 0.2 0.4 0.0 0.2 0.0 14.3 0.0 0.0 0.3 0.0 0.3 0.0 1.7 0.0 0.0 0.2 2.1 0.0 0.0 7.3 0.3 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 MPI ENSG00000178802 "Mannose phosphate isomerase" P34949 15 74890005-74902219 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Isomerase "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007200 Approved Approved "Plasma membrane,Cytosol" NA NA 170000 Cytosol "Plasma membrane" "HPA007200: AB_1854079" "unprognostic (1.38e-1)" "unprognostic (7.18e-2)" "unprognostic (1.63e-1)" "unprognostic (1.65e-3)" "unprognostic (7.34e-2)" "prognostic unfavorable (2.39e-4)" "unprognostic (1.79e-1)" "unprognostic (2.76e-1)" "unprognostic (3.20e-1)" "unprognostic (2.93e-2)" "unprognostic (1.47e-1)" "unprognostic (1.27e-1)" "unprognostic (3.34e-2)" "unprognostic (2.11e-1)" "unprognostic (1.15e-1)" "unprognostic (2.09e-1)" "unprognostic (6.58e-2)" 13.6 33.3 24.2 11.2 26.2 7.4 14.7 19.2 33.7 16.7 22.6 26.1 15.3 32.6 15.7 26.8 17.1 20.7 13.4 28.8 22.7 22.2 22.5 30.2 10.6 16.2 28.1 28.3 23.2 34.2 24.7 15.0 11.4 37.4 20.6 23.1 18.3 18.6 17.9 33.3 11.7 27.4 16.4 21.7 14.7 14.3 23.5 17.7 16.4 17.1 15.0 16.6 15.6 11.7 12.8 10.2 2.4 7.4 17.7 27.1 12.9 10.6 14.7 12.2 13.8 28.0 13.6 10.7 9.2 15.0 15.8 22.1 14.5 14.1 15.1 20.0 13.4 12.6 26.6 24.2 26.7 15.0 11.5 30.3 27.1 14.0 15.6 19.9 12.5 8.0 18.1 6.9 14.8 26.7 24.0 21.4 18.2 9.0 12.4 20.3 9.1 13.3 5.5 6.7 16.1 12.6 13.7 11.5 37.0 18.5 12.1 22.9 10.0 10.7 19.4 11.5 18.7 26.5 8.6 9.6 9.5 8.1 7.0 8.9 30.8 18.2 9.9 19.8 18.1 6.9 0.7 7.2 2.4 13.5 7.4 17.5 12.8 18.3 15.4 10.2 12.5 27.1 19.7 1.1 17.7 6.3 8.5 22.7 12.9 24.2 26.2 19.2 33.7 22.7 22.2 28.1 28.3 37.4 17.7 6.0 15.9 13.7 6.7 1.6 21.7 47.5 10.2 5.3 7.9 14.0 3.9 26.1 13.3 15.5 13.7 8.7 34.2 0.0 7.5 9.1 12.2 5.4 15.0 15.8 20.6 33.4 10.4 6.2 5.3 24.3 10.3 5.6 3.3 11.8 18.1 18.3 14.3 17.3 8.1 25.8 16.8 6.5 6.6 23.8 10.1 2.4 13.6 6.9 11.8 4.7 MPP5 "FLJ12615, PALS1" ENSG00000072415 "Membrane palmitoylated protein 5" Q8N3R9 14 67241109-67335819 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A-431: 54.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000993, HPA063890" Enhanced Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA000993: AB_1079407, HPA063890: AB_2732707" "unprognostic (3.65e-1)" "unprognostic (3.82e-3)" "unprognostic (4.56e-2)" "unprognostic (9.20e-2)" "unprognostic (9.86e-2)" "unprognostic (1.36e-1)" "prognostic unfavorable (5.62e-4)" "unprognostic (1.48e-1)" "unprognostic (1.02e-1)" "unprognostic (1.37e-1)" "unprognostic (1.93e-3)" "unprognostic (9.89e-3)" "prognostic favorable (1.71e-12)" "unprognostic (2.28e-1)" "unprognostic (1.82e-1)" "unprognostic (6.90e-2)" "unprognostic (6.87e-2)" 7.1 9.2 14.8 6.8 29.2 7.0 10.1 9.4 18.0 9.0 12.5 15.9 13.7 18.5 6.9 20.8 14.4 7.2 9.0 7.3 16.4 17.0 28.8 17.2 11.5 4.5 30.6 10.2 6.4 8.6 22.9 11.4 27.9 20.5 15.8 11.6 7.6 15.9 18.6 14.6 8.6 18.7 11.9 23.3 6.2 9.7 8.2 25.4 6.8 24.1 6.9 5.8 9.1 9.1 3.6 2.4 3.7 2.8 6.7 4.4 1.2 54.9 8.8 8.9 7.2 5.2 4.7 7.9 16.8 8.8 12.3 8.3 8.7 16.9 4.7 8.0 13.6 4.3 11.5 5.1 9.7 18.9 2.2 3.5 4.3 9.3 6.0 6.0 1.6 3.3 5.0 3.7 7.1 9.1 8.9 6.8 5.4 4.5 2.1 19.6 7.4 5.2 2.0 3.0 8.0 6.0 4.7 14.2 5.6 11.2 13.7 5.0 3.6 10.4 10.2 5.8 8.2 10.5 3.3 10.6 15.7 33.4 5.5 7.3 3.2 2.9 7.2 10.5 3.7 5.4 0.4 2.2 3.7 1.7 2.8 1.4 3.6 2.0 1.9 2.4 1.9 4.4 2.4 0.8 6.7 2.3 2.4 1.1 1.2 14.8 29.2 9.4 18.0 16.4 17.0 30.6 10.2 20.5 25.4 59.6 21.6 6.0 21.7 18.7 9.4 22.4 12.7 9.4 17.0 21.0 41.2 18.5 11.6 19.2 4.4 14.3 41.0 0.0 23.5 8.9 16.6 25.6 4.7 16.8 14.2 3.2 5.2 16.5 9.6 3.9 7.5 7.2 3.3 7.2 18.4 24.1 20.2 31.6 10.6 28.4 34.5 6.5 19.6 8.3 33.8 15.2 14.6 4.4 19.5 31.5 MRNIP "C5orf45, DKFZp686L2452, LOC51149, MGC65027, MGC78537" ENSG00000161010 "MRN complex interacting protein" Q6NTE8 5 179835133-179862173 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Ciliated cells: 54.9;Club cells: 21.6;Distal tubular cells: 39.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043975 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA043975: AB_2678754" "unprognostic (4.97e-2)" "unprognostic (2.79e-1)" "unprognostic (7.98e-2)" "unprognostic (1.08e-1)" "unprognostic (1.63e-1)" "unprognostic (5.15e-3)" "unprognostic (1.68e-3)" "unprognostic (2.51e-2)" "unprognostic (1.10e-1)" "unprognostic (6.11e-2)" "unprognostic (3.63e-3)" "unprognostic (2.05e-2)" "prognostic unfavorable (2.64e-5)" "unprognostic (1.18e-1)" "unprognostic (3.73e-1)" "unprognostic (7.00e-2)" "unprognostic (1.43e-3)" 6.6 6.3 11.8 10.7 12.2 4.6 10.8 30.0 16.1 14.8 8.5 14.2 14.3 7.8 13.7 16.1 4.8 23.5 7.7 7.8 12.6 11.8 8.8 6.0 8.8 14.1 16.0 13.4 21.1 9.7 11.2 22.7 5.0 12.1 11.1 8.4 12.9 9.1 19.8 5.8 12.0 11.0 11.7 10.1 13.3 7.1 8.0 14.7 2.7 11.6 3.5 14.0 8.6 10.5 10.7 5.5 2.9 1.0 4.0 8.1 2.8 1.3 2.8 4.5 10.9 9.1 8.2 5.4 3.2 2.8 4.0 5.8 4.6 4.2 5.2 3.8 1.5 1.9 3.5 5.0 10.3 3.1 4.9 5.0 1.7 4.9 3.2 5.6 2.2 2.1 6.1 8.3 4.6 3.6 3.2 4.4 5.4 2.5 2.5 4.1 5.3 3.4 2.2 2.2 1.6 2.5 4.1 1.7 3.8 7.1 1.0 8.5 2.7 1.5 4.4 3.7 3.7 5.5 1.8 1.0 2.5 2.0 1.9 2.2 3.0 1.8 3.6 2.4 3.6 1.7 1.3 0.7 2.9 3.4 0.7 4.5 10.7 5.1 4.2 0.9 10.3 8.1 5.9 1.1 4.0 1.0 5.5 2.9 2.8 11.8 12.2 30.0 16.1 12.6 11.8 16.0 13.4 12.1 14.7 14.9 14.1 0.0 0.0 0.0 0.0 0.0 0.0 54.9 21.6 17.4 0.0 8.6 39.7 3.6 0.0 0.0 0.0 0.0 2.0 5.9 0.0 0.0 10.5 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 3.0 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 MRPL42 "HSPC204, MRP-L31, MRPL31, MRPS32, PTD007, RPML31" ENSG00000198015 "Mitochondrial ribosomal protein L42" Q9Y6G3 12 93467488-93516213 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 276.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039398 Approved Supported "Plasma membrane,Mitochondria" NA NA "Plasma membrane, Mitochondria" "HPA039398: AB_10673529" "unprognostic (9.32e-2)" "unprognostic (4.18e-2)" "unprognostic (4.50e-2)" "unprognostic (3.89e-2)" "unprognostic (1.27e-2)" "unprognostic (1.75e-1)" "prognostic unfavorable (7.49e-4)" "unprognostic (6.13e-2)" "unprognostic (3.66e-2)" "unprognostic (1.95e-1)" "unprognostic (2.18e-2)" "unprognostic (1.90e-1)" "unprognostic (1.51e-1)" "unprognostic (2.45e-2)" "unprognostic (4.92e-1)" "unprognostic (1.62e-1)" "prognostic favorable (8.12e-4)" 18.4 35.6 16.7 13.9 23.6 14.6 22.5 23.2 24.4 22.0 21.5 16.6 16.3 17.0 18.7 16.5 26.7 20.5 15.1 24.2 16.8 16.4 31.0 28.9 16.0 15.3 21.4 16.7 18.4 16.3 26.1 35.8 18.5 26.2 19.3 26.4 13.7 17.8 19.0 15.1 15.8 18.4 19.8 20.4 18.8 18.1 34.5 17.1 25.7 19.5 14.9 21.5 19.1 21.0 29.9 18.8 23.3 23.1 29.3 32.0 21.0 17.3 18.7 30.1 24.4 18.0 27.1 25.4 21.5 21.8 32.9 26.6 25.1 13.9 24.5 9.4 19.6 15.6 15.7 38.7 29.0 50.4 28.7 29.9 28.2 12.8 31.1 24.6 32.6 14.2 20.0 31.8 28.5 42.3 24.9 31.8 27.6 37.2 13.4 37.4 18.5 36.5 25.5 45.0 27.7 34.4 30.3 15.2 29.9 36.3 35.7 36.9 20.1 18.4 30.8 23.1 25.6 30.5 18.0 15.7 24.2 13.8 15.3 28.8 16.0 23.2 27.0 9.5 25.7 36.2 18.0 17.7 23.3 19.0 23.1 24.4 29.9 24.9 20.9 18.8 23.9 26.1 26.8 7.4 29.3 21.5 13.3 32.0 21.0 16.7 23.6 23.2 24.4 16.8 16.4 21.4 16.7 26.2 17.1 26.8 28.6 54.8 70.8 59.8 33.3 73.5 40.8 62.9 31.8 43.6 56.9 85.2 180.8 81.9 276.9 50.6 37.0 0.0 67.3 120.5 56.8 91.3 58.7 45.9 48.2 44.5 89.3 28.3 38.6 81.3 47.8 37.0 57.3 27.9 49.8 19.9 75.9 42.1 52.6 106.7 35.0 51.8 64.3 114.9 71.6 65.6 79.9 55.1 63.5 104.3 MS4A12 "FLJ20217, Ms4a10" ENSG00000071203 "Membrane spanning 4-domains A12" Q9NXJ0 11 60492778-60507430 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 41 "intestine: 64.7;lymphoid tissue: 28.6" "Group enriched" "Detected in some" 6 "Enterocytes: 108.9;Paneth cells: 59.6" "Cancer enriched" "Detected in some" 8 "colorectal cancer: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 1.6;LHCN-M2: 2.2;NTERA-2: 3.1;RH-30: 4.3;U-2 OS: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA048616, HPA057657" Enhanced Approved "Nucleoli,Endoplasmic reticulum,Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "Nucleoli, Endoplasmic reticulum, Golgi apparatus" "HPA048616: , HPA057657: AB_2683491" "unprognostic (2.64e-2)" "unprognostic (2.33e-1)" "unprognostic (1.49e-1)" "unprognostic (3.26e-1)" "unprognostic (2.83e-1)" "unprognostic (9.20e-3)" 0.1 0.0 0.1 28.6 0.1 0.0 0.1 0.1 0.1 0.1 57.7 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 64.7 0.1 0.1 0.1 0.1 0.0 0.2 1.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 3.1 0.0 0.0 0.2 4.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.0 1.8 0.0 0.3 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 108.9 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.0 59.6 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 13.2 0.0 MS4A14 "DKFZp434H092, FLJ32856, MS4A16, NYD-SP21" ENSG00000166928 "Membrane spanning 4-domains A14" Q96JA4 11 60378530-60417756 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 79.3;testis: 53.6" "Group enriched" "Detected in some" 41 "Early spermatids: 207.0;Late spermatids: 514.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "intermediate monocyte: 6.8;non-classical monocyte: 9.2" "Lineage enriched" "Detected in many" 5 "monocytes: 9.2" "Cell line enriched" "Detected in single" 24 "THP-1: 14.6" HPA058973 Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA058973: " "unprognostic (1.78e-1)" "unprognostic (1.76e-1)" "unprognostic (5.75e-2)" "unprognostic (1.77e-1)" "unprognostic (1.27e-1)" "unprognostic (1.79e-2)" "unprognostic (1.24e-1)" "unprognostic (3.45e-2)" "unprognostic (4.00e-2)" "unprognostic (1.05e-1)" "unprognostic (1.77e-1)" "unprognostic (2.14e-1)" "unprognostic (4.50e-6)" "unprognostic (3.73e-2)" "unprognostic (7.16e-3)" "unprognostic (8.40e-2)" "unprognostic (7.11e-2)" 14.5 4.4 2.0 4.6 2.3 1.5 5.4 0.8 1.5 2.4 3.9 1.9 1.1 1.5 1.9 6.4 1.8 1.3 2.3 6.4 2.5 2.3 3.5 13.3 18.0 11.3 2.4 0.1 1.3 1.5 1.2 3.2 6.0 2.4 3.0 2.2 4.5 2.1 1.6 1.3 1.3 4.0 2.4 5.5 79.3 1.5 53.6 1.5 3.7 1.7 0.7 3.0 2.4 1.7 0.5 1.8 0.1 9.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 14.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 4.3 0.0 0.0 6.8 0.0 0.0 0.0 0.0 1.8 0.5 0.0 0.0 0.1 0.0 9.2 0.0 0.0 0.9 2.0 2.3 0.8 1.5 2.5 2.3 2.4 0.1 2.4 1.5 0.0 0.6 0.0 0.0 0.1 0.0 0.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 207.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 7.5 514.6 3.7 8.8 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 6.5 0.0 5.7 2.4 0.3 0.1 0.0 0.0 0.0 MS4A15 ENSG00000166961 "Membrane spanning 4-domains A15" Q8N5U1 11 60756953-60776732 "Predicted membrane proteins" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 9 "blood: 9.9;lung: 32.4" "Cell type enriched" "Detected in some" 8 "Alveolar cells type 1: 89.3" "Cancer enhanced" "Detected in many" "lung cancer: 6.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 9.9" "Lineage enriched" "Detected in single" 15 "T-cells: 9.9" "Cell line enhanced" "Detected in some" "HEL: 9.2;JURKAT: 3.4;Karpas-707: 3.8;MOLT-4: 4.1;U-266/70: 13.5;U-266/84: 5.7" "Region enriched" "Detected in single" 28 "olfactory region: 205.0" "Region enriched" "Detected in single" 30 "olfactory region: 39.1" HPA054563 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA054563: " "unprognostic (1.85e-1)" "unprognostic (4.31e-3)" "unprognostic (8.59e-2)" "unprognostic (5.89e-4)" "unprognostic (4.49e-1)" "unprognostic (1.09e-3)" "unprognostic (3.92e-3)" "unprognostic (5.43e-3)" "unprognostic (1.20e-1)" "unprognostic (7.30e-2)" "unprognostic (3.14e-1)" "unprognostic (1.04e-9)" "unprognostic (7.02e-2)" "unprognostic (8.63e-2)" "unprognostic (2.75e-1)" "unprognostic (1.47e-1)" 0.3 0.2 0.3 0.3 0.3 0.0 1.3 0.3 0.3 0.3 0.3 0.3 0.3 0.6 1.8 0.3 0.4 1.0 0.3 0.3 0.3 0.2 0.3 0.3 32.4 0.3 0.3 0.3 2.4 0.3 0.0 0.3 1.1 0.3 0.3 0.5 0.3 0.3 1.9 0.3 0.2 1.4 1.7 0.3 0.3 0.2 0.6 0.3 0.3 0.3 0.3 1.0 0.7 0.3 0.2 0.0 0.0 0.0 0.6 9.9 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 9.2 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 3.4 1.6 3.8 0.0 0.0 4.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 1.1 0.0 0.0 0.0 0.5 0.0 0.0 13.5 5.7 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 2.9 0.5 0.0 0.0 1.8 0.7 0.0 0.6 0.0 0.0 9.9 0.7 0.3 0.3 0.3 0.3 0.3 0.2 0.3 0.3 0.3 0.3 89.3 4.8 0.0 0.0 0.0 0.0 0.2 0.0 2.7 11.4 0.0 0.0 0.7 0.0 0.0 4.7 0.0 0.0 0.0 0.0 2.2 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.9 0.0 1.7 0.0 0.0 0.0 MTCP1 "P13MTCP1, p8MTCP1" ENSG00000214827 "Mature T cell proliferation 1" P56278 X 155061622-155147937 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 9 "Ciliated cells: 4.0;Club cells: 2.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HeLa: 14.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA032040 Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA032040: AB_2674122" "unprognostic (2.42e-2)" "unprognostic (2.07e-2)" "unprognostic (1.14e-1)" "unprognostic (6.29e-3)" "unprognostic (8.30e-2)" "unprognostic (4.10e-1)" "unprognostic (2.40e-5)" "unprognostic (9.30e-2)" "unprognostic (1.17e-1)" "unprognostic (4.94e-2)" "unprognostic (5.72e-2)" "unprognostic (1.15e-2)" "prognostic unfavorable (4.52e-8)" "unprognostic (1.55e-3)" "unprognostic (1.06e-2)" "unprognostic (1.39e-2)" "unprognostic (1.75e-2)" 6.4 7.1 4.1 5.3 5.3 7.2 15.8 4.4 4.8 6.0 6.2 3.4 7.7 5.7 6.0 8.2 7.0 6.1 4.4 30.1 4.7 2.9 6.7 12.8 8.5 15.5 4.5 2.7 9.1 20.7 3.9 6.5 3.5 6.4 5.8 6.1 3.9 7.3 7.0 11.4 12.0 6.7 8.7 7.2 6.7 6.2 16.1 3.8 2.5 8.2 5.4 7.2 6.9 4.0 0.2 0.0 0.8 0.7 0.5 2.0 0.1 1.4 4.9 2.4 3.9 1.6 1.3 2.7 3.0 1.5 1.9 4.8 4.3 7.5 2.7 3.1 0.6 3.0 4.8 3.2 3.5 2.4 1.8 3.2 1.2 14.3 2.3 1.4 2.9 3.3 2.4 1.7 3.2 3.0 2.3 1.8 4.7 1.1 4.9 1.3 2.0 3.7 6.1 1.1 1.8 0.8 4.0 2.6 6.1 2.4 2.1 1.2 1.8 2.2 1.2 2.1 1.7 2.2 1.3 1.8 2.2 3.9 2.1 2.2 10.7 4.6 5.2 4.3 3.5 3.1 0.0 0.6 0.8 1.1 0.0 2.0 0.2 1.2 0.4 0.0 0.1 0.2 1.4 0.0 0.5 0.7 0.0 0.0 0.1 4.1 5.3 4.4 4.8 4.7 2.9 4.5 2.7 6.4 3.8 0.0 1.0 0.0 0.2 0.2 0.0 0.6 0.0 4.0 2.3 0.0 0.0 0.1 0.0 0.5 0.0 0.3 0.0 0.0 1.1 0.2 0.3 0.3 0.0 1.0 0.4 0.0 1.7 0.0 1.0 0.2 1.1 0.5 1.7 1.0 0.0 0.0 1.1 0.0 0.4 0.2 0.0 0.0 0.3 0.5 0.2 0.6 0.2 0.0 0.5 0.0 MTPN "GCDP, MYOTROPHIN, V-1" ENSG00000105887 Myotrophin P58546 7 135926761-135977353 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019735 Approved Approved "Plasma membrane,Cytosol" NA NA 48000000 "Plasma membrane, Cytosol" "HPA019735: AB_1858710" "unprognostic (5.97e-2)" "unprognostic (2.53e-2)" "unprognostic (8.52e-2)" "unprognostic (3.62e-3)" "unprognostic (2.20e-2)" "unprognostic (1.95e-1)" "prognostic unfavorable (1.19e-4)" "unprognostic (2.06e-3)" "unprognostic (3.30e-2)" "unprognostic (8.11e-2)" "prognostic unfavorable (3.05e-4)" "unprognostic (4.50e-2)" "unprognostic (1.83e-2)" "unprognostic (2.60e-2)" "unprognostic (2.43e-1)" "unprognostic (9.00e-3)" "unprognostic (4.86e-3)" 31.0 22.1 40.2 28.5 53.2 55.1 39.6 34.4 50.0 30.9 21.4 20.4 16.0 17.2 29.5 21.9 62.1 27.0 23.7 31.6 38.0 31.6 25.1 20.5 31.6 49.3 24.2 32.4 22.0 10.7 29.2 22.5 26.3 22.9 23.4 23.6 21.5 22.2 24.0 27.4 19.1 23.1 27.9 23.3 42.4 17.6 23.4 19.9 36.4 36.9 24.9 42.8 26.1 30.5 37.9 24.6 50.6 43.5 12.8 16.7 17.0 27.7 22.0 24.3 36.3 34.9 41.5 12.7 44.0 44.7 28.2 30.9 25.0 30.0 49.0 32.6 54.0 43.2 17.7 22.7 34.5 52.4 36.2 22.4 33.4 23.8 16.3 28.7 44.8 48.2 30.3 34.2 33.5 31.5 39.1 43.9 39.3 39.6 29.6 53.1 21.2 45.1 33.2 34.4 25.6 31.3 26.3 18.6 39.8 30.6 23.0 31.3 57.2 35.8 22.3 33.8 23.0 16.4 27.4 47.0 42.7 19.6 42.4 41.4 24.7 36.3 72.3 68.3 39.4 90.8 25.4 21.4 22.6 16.7 28.9 14.3 30.9 10.4 12.5 24.6 37.9 6.9 9.9 50.6 12.8 43.5 24.2 9.0 17.0 40.2 53.2 34.4 50.0 38.0 31.6 24.2 32.4 22.9 19.9 44.7 37.6 120.5 45.1 105.9 0.0 68.2 66.2 34.8 50.0 66.3 0.0 53.8 76.3 60.3 68.1 93.1 49.6 70.0 44.7 56.8 87.2 72.5 93.8 50.8 91.4 0.0 31.8 97.0 229.9 24.5 80.0 156.1 96.2 119.0 41.0 0.0 73.4 59.1 116.3 67.4 0.0 90.5 53.6 60.7 100.9 130.2 57.6 66.6 47.3 89.4 MTSS1 "KIAA0429, MIM, MIMA, MIMB" ENSG00000170873 "MTSS1, I-BAR domain containing" O43312 8 124550790-124728429 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 152.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 44.8" "Group enriched" "Detected in many" 4 "B-cells: 16.1;monocytes: 44.8" "Cell line enhanced" "Detected in many" "ASC diff: 21.1;HDLM-2: 24.2;HEL: 83.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019613, HPA064003, HPA075540" Approved Supported Approved "Plasma membrane,Cytosol" NA NA 10000 "Plasma membrane, Cytosol" "HPA019613: , HPA064003: , HPA075540: AB_2686756" "unprognostic (1.70e-1)" "unprognostic (4.13e-2)" "unprognostic (9.50e-2)" "unprognostic (1.38e-1)" "unprognostic (3.87e-2)" "unprognostic (7.02e-2)" "unprognostic (4.24e-2)" "unprognostic (1.26e-2)" "unprognostic (2.18e-1)" "unprognostic (2.50e-1)" "unprognostic (8.12e-2)" "unprognostic (1.48e-1)" "prognostic favorable (2.11e-7)" "unprognostic (6.74e-2)" "unprognostic (1.04e-1)" "unprognostic (2.41e-1)" "unprognostic (8.92e-3)" 18.7 27.3 14.0 9.2 16.3 8.5 12.4 36.0 19.1 8.1 8.2 32.1 1.7 5.0 5.6 15.8 32.4 8.9 7.0 13.4 13.5 13.6 18.2 51.5 12.0 12.1 18.1 10.3 8.2 21.0 2.6 10.5 25.3 16.9 7.9 7.0 19.8 10.2 5.3 16.5 21.3 5.0 7.2 20.9 23.9 9.0 15.8 20.0 8.2 4.1 12.1 12.2 9.7 13.7 16.1 3.3 0.6 44.8 0.6 6.9 6.8 0.9 0.2 13.2 0.3 21.1 10.9 0.0 0.5 3.5 0.2 0.1 1.2 0.1 0.4 1.3 0.0 0.1 0.2 0.1 7.3 0.2 24.2 0.4 83.0 0.2 6.6 4.8 0.0 8.9 17.3 16.8 4.0 10.5 0.5 7.9 0.1 0.1 0.1 1.4 0.7 0.2 1.0 0.5 13.5 0.1 0.1 0.0 0.1 2.9 2.8 9.5 0.8 2.0 2.0 6.7 0.7 0.3 0.2 4.1 0.7 0.4 0.0 0.2 0.2 0.2 1.4 7.6 0.2 2.7 0.6 3.9 0.0 6.9 25.6 0.8 13.2 1.5 2.6 3.3 16.1 0.7 2.1 0.6 0.6 44.8 0.0 0.1 6.8 14.0 16.3 36.0 16.7 13.5 13.6 18.1 10.3 16.9 20.0 0.0 21.1 45.6 48.9 31.8 0.0 27.4 30.6 33.5 18.2 62.8 0.0 25.3 18.3 13.8 44.0 23.2 2.5 0.0 4.6 1.9 16.6 37.6 45.1 69.1 57.6 0.0 42.4 74.3 152.0 42.3 3.4 94.8 25.3 120.0 19.1 0.0 21.1 14.0 4.2 16.2 0.0 38.8 12.2 2.8 11.5 55.5 78.9 13.4 15.0 51.5 MUC20 "FLJ14408, KIAA1359" ENSG00000176945 "Mucin 20, cell surface associated" Q8N307 3 195720882-195741123 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 50.6" "Cell type enhanced" "Detected in many" 9 "Ciliated cells: 60.2;Urothelial cells: 102.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.2" "Lineage enhanced" "Detected in single" "T-cells: 1.2" "Cell line enriched" "Detected in some" 7 "SK-BR-3: 25.3" HPA042249 Approved "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA 11000 "Nucleoplasm, Cytosol" "Plasma membrane" "HPA042249: " "unprognostic (1.85e-1)" "unprognostic (4.64e-2)" "unprognostic (1.05e-2)" "unprognostic (1.83e-3)" "unprognostic (2.12e-1)" "unprognostic (1.59e-2)" "unprognostic (2.06e-1)" "unprognostic (2.41e-1)" "unprognostic (3.99e-4)" "unprognostic (7.66e-2)" "unprognostic (2.84e-2)" "unprognostic (1.14e-1)" "prognostic favorable (1.57e-4)" "unprognostic (2.05e-1)" "unprognostic (2.56e-1)" "unprognostic (3.98e-3)" "unprognostic (1.17e-1)" 1.7 1.2 1.1 3.4 2.1 1.2 1.8 2.5 1.2 6.3 15.2 1.1 4.7 3.2 1.5 5.2 15.9 5.7 8.7 1.1 1.1 0.7 50.6 4.8 6.4 1.1 1.1 1.1 4.6 7.6 1.0 4.6 13.3 1.1 4.9 7.6 1.2 10.6 1.8 2.5 2.1 4.1 2.0 1.1 1.6 2.3 1.8 1.1 3.0 3.9 1.9 14.9 10.6 26.6 0.4 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.2 0.6 0.2 0.0 0.6 0.0 0.1 0.0 0.0 0.0 3.0 0.1 0.5 0.0 0.2 1.3 0.1 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.4 0.0 0.5 3.4 0.1 0.8 0.1 0.8 0.0 1.9 1.0 0.3 0.0 25.3 0.2 0.4 0.1 0.0 0.0 0.2 0.7 0.9 0.1 1.1 1.3 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.2 0.0 0.0 0.4 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.1 2.5 1.2 1.1 0.7 1.1 1.1 1.1 1.1 32.8 14.7 0.0 8.8 1.5 20.2 0.5 10.2 60.2 37.5 21.0 33.4 0.0 1.7 32.3 0.0 1.3 15.6 0.0 8.7 0.1 1.5 12.8 1.1 6.4 0.4 11.1 13.3 1.8 0.6 0.0 4.9 0.9 3.3 0.0 7.2 5.6 13.7 18.6 6.0 1.4 22.0 0.0 1.6 1.1 0.7 1.6 0.0 0.5 13.5 102.7 MYL4 "ALC1, AMLC, GT1, PRO1957" ENSG00000198336 "Myosin light chain 4" P12829 17 47200446-47223679 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Atrial fibrillation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 68 "heart muscle: 712.3" "Cell type enriched" "Detected in many" 5 "Cardiomyocytes: 2384.1" "Group enriched" "Detected in some" 7 "testis cancer: 2.4;thyroid cancer: 11.7" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 11 "plasmacytoid DC: 5.2" "Lineage enriched" "Detected in single" 11 "dendritic cells: 5.2" "Cell line enriched" "Detected in some" 4 "HEL: 109.9" "Group enriched" "Detected in many" 6 "amygdala: 25.9;cerebral cortex: 83.3;hippocampal formation: 27.8" "Not detected" "Not detected" "HPA046859, HPA051884, HPA063034" Enhanced Approved "Plasma membrane" NA NA 140000 "Plasma membrane" "HPA046859: AB_2679842, HPA051884: AB_2681651, HPA063034: AB_2684927" "unprognostic (2.43e-2)" "unprognostic (9.57e-2)" "unprognostic (2.25e-1)" "unprognostic (5.51e-2)" "unprognostic (2.33e-1)" "unprognostic (4.12e-3)" "unprognostic (5.06e-3)" "unprognostic (1.34e-1)" "unprognostic (1.13e-1)" "unprognostic (6.52e-2)" "unprognostic (2.10e-2)" "unprognostic (7.37e-2)" "unprognostic (1.00e-6)" "unprognostic (1.92e-4)" "unprognostic (2.54e-1)" "unprognostic (6.51e-3)" "unprognostic (1.50e-1)" 0.1 0.0 0.0 0.1 0.0 10.4 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 712.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.7 0.0 0.0 0.7 0.1 0.0 0.0 0.8 3.3 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.2 0.7 0.0 0.1 0.6 4.6 0.1 0.1 0.2 0.2 5.2 0.0 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 109.9 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.2 0.3 26.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.1 5.2 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 3.0 0.0 0.0 0.0 0.7 4.5 2384.1 0.0 0.0 0.0 0.0 60.9 0.4 0.0 0.0 16.3 3.0 0.3 443.9 0.0 2.6 2.1 0.0 0.0 0.0 1.8 1.6 0.0 1.3 0.0 42.1 3.1 0.0 11.8 0.0 0.0 4.9 0.1 0.0 1.4 0.0 17.0 0.0 2.0 1.5 0.4 0.6 1.1 0.0 0.0 0.0 MYO1E "HuncM-IC, MGC104638, MYO1C" ENSG00000157483 "Myosin IE" Q12965 15 59132434-59372900 "Disease related genes, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 16.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 51.5;HaCaT: 47.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003003, HPA023886" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane" Cytosol "HPA003003: , HPA023886: AB_1854253" "unprognostic (7.90e-2)" "unprognostic (1.35e-1)" "unprognostic (1.52e-1)" "prognostic favorable (4.19e-4)" "unprognostic (1.49e-1)" "unprognostic (3.59e-1)" "unprognostic (1.16e-2)" "prognostic unfavorable (1.57e-6)" "unprognostic (1.89e-1)" "unprognostic (5.38e-3)" "prognostic unfavorable (7.99e-4)" "unprognostic (2.41e-1)" "unprognostic (7.92e-2)" "unprognostic (7.31e-2)" "unprognostic (9.71e-2)" "unprognostic (1.15e-1)" "unprognostic (5.62e-2)" 25.9 4.6 7.9 18.4 19.0 0.7 13.3 2.3 12.6 13.6 28.5 40.6 26.5 13.6 18.1 17.0 22.1 10.0 21.5 6.8 12.6 7.6 22.4 33.4 11.6 18.9 27.2 7.6 6.8 8.8 23.7 6.6 18.7 17.2 15.6 19.4 13.0 12.4 43.5 7.2 28.8 25.9 12.3 25.5 11.4 17.1 4.7 22.4 2.6 9.9 10.6 21.7 15.6 16.2 7.0 16.9 0.4 3.4 2.5 0.4 1.6 29.6 51.5 2.8 1.9 22.1 18.1 14.6 12.1 5.9 6.7 7.9 12.7 11.6 11.8 8.7 9.4 27.7 47.8 4.3 18.7 9.0 5.4 2.4 0.1 43.0 11.2 20.5 0.0 1.6 24.7 11.5 8.6 25.4 21.4 11.0 0.2 0.0 0.1 11.4 2.7 0.1 0.2 6.8 4.8 11.5 0.0 12.5 7.2 36.4 14.0 1.5 5.1 26.9 5.6 10.4 8.9 3.7 1.3 13.3 13.6 3.9 41.3 11.8 0.0 0.7 0.2 24.9 0.1 12.2 0.0 3.1 0.0 0.1 3.4 0.0 6.6 0.0 0.0 11.0 7.0 0.0 0.0 0.4 2.5 1.2 16.9 0.4 1.6 7.9 19.0 2.3 12.6 12.6 7.6 27.2 7.6 17.2 22.4 6.0 7.7 0.0 21.2 22.0 0.0 3.2 20.4 34.8 6.8 24.4 0.0 3.3 3.3 39.7 3.4 16.1 46.1 0.0 15.8 17.7 9.9 27.4 4.6 9.4 29.8 0.0 18.9 4.3 3.3 5.2 8.6 16.2 18.6 7.2 21.7 11.7 42.3 31.6 11.3 3.0 0.9 12.9 23.0 1.0 3.8 21.0 10.8 1.0 19.6 34.4 MYO3A DFNB30 ENSG00000095777 "Myosin IIIA" Q8NEV4 10 25934071-26212536 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hearing, Sensory transduction, Vision" "Actin-binding, Kinase, Motor protein, Myosin, Serine/threonine-protein kinase, Transferase" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 8.1;testis: 12.5" "Cell type enhanced" "Detected in some" 23 "Early spermatids: 127.9;Late spermatids: 34.5;Muller glia cells: 68.5" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basal ganglia: 5.0;cerebral cortex: 1.9;hypothalamus: 1.3;pons and medulla: 5.4" "Cell type enriched" "Detected in single" 12 "naive B-cell: 1.1" "Lineage enriched" "Detected in single" 12 "B-cells: 1.1" "Cell line enhanced" "Detected in some" "AF22: 2.3;CAPAN-2: 2.2;HEK 293: 2.7;SCLC-21H: 2.5;U-2 OS: 4.4;U-698: 11.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA051893, HPA075413" Enhanced Supported "Plasma membrane,Actin filaments,Cytoplasmic bodies" No No "Actin filaments, Cytoplasmic bodies" "Plasma membrane" "HPA051893: , HPA075413: " "unprognostic (5.00e-3)" "unprognostic (3.36e-2)" "unprognostic (1.53e-1)" "unprognostic (3.20e-3)" "unprognostic (2.96e-1)" "unprognostic (4.37e-2)" "unprognostic (5.29e-2)" "unprognostic (2.74e-1)" "unprognostic (4.31e-2)" "unprognostic (1.03e-1)" "unprognostic (5.66e-3)" "unprognostic (7.96e-3)" "unprognostic (6.34e-2)" "unprognostic (1.46e-2)" "unprognostic (6.62e-2)" "unprognostic (9.69e-2)" 0.8 0.7 0.4 0.3 5.0 0.5 1.5 0.3 1.9 2.1 0.6 0.1 0.7 0.4 0.3 3.2 0.9 1.1 0.3 0.3 0.5 1.3 0.9 0.2 1.0 0.3 0.2 0.0 0.5 2.1 0.2 8.1 0.2 5.4 0.5 1.1 3.8 0.2 0.6 0.3 2.2 0.6 1.0 0.4 0.3 0.9 12.5 0.8 0.0 1.3 1.4 0.9 0.5 0.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.6 1.5 0.0 0.0 1.2 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 5.0 0.3 1.9 0.5 1.3 0.2 0.0 5.4 0.8 0.0 0.3 0.0 0.3 1.5 0.9 0.6 0.0 0.0 4.5 0.0 0.0 0.0 1.7 0.5 127.9 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.1 0.0 1.7 0.0 0.0 34.5 1.1 0.0 0.0 0.0 0.2 68.5 0.3 0.0 1.1 1.4 3.4 0.0 0.0 20.0 5.8 0.9 0.0 0.0 0.0 0.1 MYO5B KIAA1119 ENSG00000167306 "Myosin VB" Q9ULV0 18 49822813-50195093 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "intestine: 92.2" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 114.3;Pancreatic endocrine cells: 76.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "NK-cell: 2.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 21.0;HaCaT: 33.2;RH-30: 51.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA040593, HPA040902, HPA069773" Enhanced Approved "Plasma membrane" NA NA "Plasma membrane" "HPA040593: AB_10795525, HPA040902: AB_10796230, HPA069773: AB_2686194" "unprognostic (2.51e-1)" "unprognostic (2.15e-2)" "unprognostic (2.12e-2)" "unprognostic (6.17e-3)" "unprognostic (2.14e-1)" "unprognostic (8.84e-3)" "unprognostic (1.32e-1)" "unprognostic (2.59e-1)" "unprognostic (4.13e-2)" "unprognostic (3.46e-1)" "prognostic unfavorable (2.26e-5)" "unprognostic (4.48e-2)" "prognostic favorable (1.45e-11)" "unprognostic (2.17e-3)" "unprognostic (1.50e-1)" "unprognostic (6.56e-2)" "unprognostic (3.28e-1)" 2.0 1.2 1.1 12.7 1.3 0.0 5.2 0.4 2.5 7.5 56.9 1.0 13.7 23.5 1.8 10.4 20.3 4.6 20.6 2.0 1.8 1.2 19.1 13.9 9.4 0.6 0.7 1.5 1.7 16.4 9.3 10.5 13.5 2.1 6.0 17.5 8.4 21.6 8.7 0.6 14.5 92.2 0.8 0.7 0.9 13.1 5.5 0.3 2.4 16.3 14.9 17.4 4.0 11.8 1.0 0.1 0.0 0.0 2.4 0.6 0.0 21.0 5.7 0.1 0.1 0.0 0.0 11.5 0.1 0.8 0.4 0.0 14.9 9.0 0.0 5.3 0.0 1.7 33.2 7.5 9.0 0.4 0.0 2.3 0.0 2.5 10.5 0.0 0.0 0.1 0.0 7.9 0.2 5.5 1.7 0.7 0.1 0.1 8.3 0.9 8.1 0.0 0.0 1.5 12.3 2.3 0.0 51.4 3.5 19.0 4.3 11.4 0.2 8.0 9.5 0.0 3.0 5.6 0.0 0.5 0.0 11.6 0.1 2.2 5.6 3.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.6 1.0 0.4 0.1 0.0 0.0 0.2 0.4 0.0 2.4 0.0 0.1 0.1 0.0 1.1 1.3 0.4 2.5 1.8 1.2 0.7 1.5 2.1 0.3 50.6 12.0 0.8 8.3 0.3 8.2 1.9 15.3 24.1 19.4 7.0 9.8 3.2 5.0 40.6 14.7 0.6 114.3 0.0 41.1 1.1 0.5 42.9 0.0 15.3 0.7 0.0 6.4 0.0 0.3 1.5 0.9 0.9 3.3 3.6 33.5 29.9 76.1 53.7 0.7 13.0 29.0 0.0 0.2 9.5 3.8 5.6 3.9 0.0 38.0 58.3 MYO9A "FLJ11061, FLJ13244, MGC71859" ENSG00000066933 "Myosin IXA" B2RTY4 15 71822289-72118577 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, GTPase activation, Motor protein, Myosin" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Rod photoreceptor cells: 446.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Daudi: 28.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039812, HPA040071" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA039812: AB_10961421, HPA040071: AB_10961117" "unprognostic (7.53e-2)" "unprognostic (2.40e-1)" "unprognostic (1.96e-1)" "unprognostic (2.42e-3)" "unprognostic (1.63e-1)" "unprognostic (8.69e-3)" "unprognostic (3.77e-2)" "unprognostic (3.56e-2)" "unprognostic (1.26e-1)" "unprognostic (5.50e-2)" "unprognostic (1.32e-1)" "unprognostic (1.34e-1)" "prognostic favorable (2.14e-4)" "unprognostic (3.44e-1)" "unprognostic (4.41e-1)" "unprognostic (1.25e-1)" "unprognostic (4.23e-2)" 10.5 6.0 13.8 9.6 17.9 6.1 14.8 18.3 16.4 13.3 11.1 7.5 10.6 3.4 15.0 11.0 11.2 10.8 7.5 9.3 9.5 9.3 19.6 5.5 12.2 8.4 9.1 12.0 17.5 5.0 15.9 14.7 10.5 14.6 11.9 9.2 9.1 8.3 11.3 12.9 12.0 8.0 14.4 9.0 10.0 9.7 35.6 11.2 9.1 18.4 6.6 8.8 11.9 13.9 6.1 9.3 5.2 3.4 3.7 7.6 1.3 6.4 9.9 6.5 4.6 10.1 11.9 3.9 6.1 6.7 6.2 6.4 4.8 4.4 28.9 3.6 12.1 8.2 6.1 13.1 7.0 8.3 6.3 7.6 7.3 5.6 2.1 6.4 7.3 5.9 6.7 7.1 7.4 10.6 5.2 7.9 5.2 4.7 6.9 8.4 4.0 4.1 3.0 3.5 2.4 4.0 2.9 12.6 2.8 7.6 9.6 3.7 4.1 7.9 6.9 6.4 8.3 5.4 3.5 10.5 12.5 6.1 20.1 6.9 4.4 10.9 7.8 7.4 6.1 5.5 2.2 2.2 5.2 5.6 2.0 7.6 4.7 5.4 4.6 2.2 6.1 5.7 5.3 0.3 3.7 3.4 9.3 4.5 1.3 13.8 17.9 18.3 16.4 9.5 9.3 9.1 12.0 14.6 11.2 107.2 59.0 9.1 19.4 18.5 49.1 28.5 0.0 33.5 31.8 27.9 51.1 9.2 14.9 5.8 102.4 24.2 12.5 23.3 7.0 9.5 20.2 21.2 9.3 4.5 8.0 50.9 12.1 20.9 36.4 117.2 35.9 10.6 21.9 11.8 10.2 22.7 9.6 14.4 40.3 11.0 446.4 19.4 27.4 104.1 36.6 20.8 10.1 7.7 10.6 14.8 N4BP2 B3BP ENSG00000078177 "NEDD4 binding protein 2" Q86UW6 4 40056826-40158252 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 35.6" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 68.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 20.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036770, HPA042607, HPA072549" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA036770: AB_10672477, HPA042607: AB_2678074, HPA072549: " "unprognostic (5.03e-2)" "unprognostic (3.42e-1)" "unprognostic (7.94e-3)" "unprognostic (1.15e-1)" "unprognostic (1.50e-1)" "unprognostic (3.99e-3)" "unprognostic (2.88e-1)" "unprognostic (1.01e-1)" "unprognostic (3.66e-2)" "unprognostic (2.65e-2)" "unprognostic (9.55e-3)" "unprognostic (4.49e-2)" "unprognostic (2.14e-2)" "unprognostic (1.24e-1)" "unprognostic (9.31e-2)" "unprognostic (6.85e-3)" "unprognostic (1.45e-1)" 3.5 3.1 3.4 7.4 5.1 7.0 5.8 6.1 3.2 5.5 4.3 1.2 7.1 4.7 7.0 6.6 5.2 4.8 3.8 3.5 2.5 3.6 3.2 11.3 7.5 9.2 1.9 1.6 7.0 13.1 2.5 14.3 11.9 2.8 4.9 4.5 4.3 10.7 11.0 2.9 5.4 5.3 3.2 3.1 4.3 3.8 3.5 2.1 35.6 7.2 3.5 7.8 5.6 5.2 2.4 8.1 5.7 1.2 10.6 4.5 1.2 1.5 1.6 9.4 1.5 0.6 3.1 7.7 1.8 1.9 1.0 2.2 3.0 3.1 8.3 3.5 1.7 1.7 1.2 6.0 1.9 2.5 2.6 1.9 3.7 1.4 1.4 1.6 10.0 8.9 3.5 2.7 1.7 3.7 0.3 2.7 7.9 8.2 3.6 2.0 1.5 20.2 4.3 4.7 1.2 1.3 11.8 11.1 1.9 0.8 3.7 3.8 6.7 1.6 1.3 1.5 6.3 1.1 2.7 3.7 1.1 5.9 0.7 1.3 5.9 6.0 5.7 1.2 3.6 2.3 5.7 1.1 0.5 2.3 1.2 2.4 1.7 3.0 1.7 1.7 2.4 4.5 2.5 0.3 10.6 1.0 8.1 1.3 1.2 3.4 5.1 6.1 3.2 2.5 3.6 1.9 1.6 2.8 2.1 20.8 19.5 2.9 12.0 10.6 30.6 12.3 12.7 6.7 18.2 21.0 25.5 34.4 0.0 5.4 2.6 6.6 6.0 23.3 10.7 11.4 12.3 12.2 4.7 15.5 10.4 68.3 18.6 4.9 16.3 2.7 9.2 17.8 6.8 9.0 15.0 11.8 9.7 8.6 3.5 3.1 20.2 12.9 5.7 13.6 27.0 11.4 22.5 13.8 8.0 8.4 NAB1 ENSG00000138386 "NGFI-A binding protein 1" Q13506 2 190646746-190692766 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 90.6;Suprabasal keratinocytes: 121.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002738 Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "Golgi apparatus" "HPA002738: AB_1079447" "unprognostic (1.44e-1)" "unprognostic (2.65e-2)" "unprognostic (6.02e-3)" "unprognostic (4.04e-3)" "unprognostic (9.05e-2)" "unprognostic (9.45e-2)" "unprognostic (7.12e-3)" "unprognostic (6.41e-2)" "unprognostic (2.13e-2)" "unprognostic (1.79e-2)" "prognostic unfavorable (1.01e-4)" "unprognostic (3.52e-1)" "unprognostic (7.23e-3)" "unprognostic (1.71e-1)" "unprognostic (1.90e-1)" "unprognostic (1.13e-1)" "unprognostic (3.85e-2)" 19.1 10.3 12.1 12.5 13.7 7.6 28.3 28.2 15.7 18.5 19.9 10.4 7.2 7.4 16.2 26.4 32.3 14.1 13.9 21.2 12.1 9.7 10.6 18.6 12.5 13.8 14.5 12.0 15.7 9.3 16.4 20.2 12.8 12.4 16.3 12.9 19.8 15.9 17.5 6.9 33.2 10.9 13.3 14.3 9.3 18.4 12.3 12.4 13.6 19.0 15.7 13.0 13.0 25.8 1.4 1.7 5.4 6.1 4.6 6.0 1.4 12.2 9.1 23.2 8.1 9.1 15.8 40.2 12.5 19.7 9.4 10.8 22.1 13.6 13.7 14.7 9.8 17.6 31.4 13.2 16.1 18.8 43.7 11.2 16.1 32.5 10.5 5.9 6.7 8.1 9.1 25.8 20.0 6.2 13.5 14.6 8.4 15.7 11.8 14.5 6.0 9.7 7.0 8.2 13.2 12.6 12.0 16.7 5.4 7.2 12.0 21.0 17.0 14.7 5.0 13.1 31.0 4.0 10.6 10.1 19.9 15.8 11.2 7.4 9.4 10.1 10.2 21.0 6.2 15.5 0.0 2.6 1.1 2.7 2.0 4.0 1.4 2.8 3.5 1.7 0.9 2.9 3.1 5.4 4.6 6.1 1.6 6.0 1.4 12.1 13.7 28.2 15.7 12.1 9.7 14.5 12.0 12.4 12.4 6.0 23.4 2.2 21.8 90.6 15.9 15.7 17.8 21.4 31.8 12.2 11.8 3.8 3.3 8.7 1.1 28.6 7.3 0.0 6.9 8.3 21.6 24.1 19.7 23.7 6.0 6.4 13.8 35.0 19.5 3.2 12.4 18.1 37.1 6.4 15.0 11.5 7.4 28.8 13.8 3.6 14.1 45.3 59.7 1.4 36.3 121.5 1.0 12.8 13.6 26.5 NAIF1 "bA379C10.2, C9orf90, DKFZp762G199" ENSG00000171169 "Nuclear apoptosis inducing factor 1" Q69YI7 9 128061233-128068206 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054898, HPA064931" Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA054898: AB_2682633, HPA064931: AB_2732725" "unprognostic (7.09e-2)" "unprognostic (5.92e-2)" "unprognostic (1.20e-2)" "unprognostic (5.56e-3)" "unprognostic (1.58e-1)" "unprognostic (2.17e-1)" "prognostic unfavorable (1.61e-4)" "unprognostic (1.60e-1)" "unprognostic (6.15e-2)" "unprognostic (9.41e-2)" "prognostic favorable (1.02e-5)" "unprognostic (3.08e-1)" "prognostic favorable (8.30e-5)" "unprognostic (8.48e-2)" "unprognostic (2.47e-1)" "unprognostic (6.67e-2)" "unprognostic (3.92e-2)" 7.1 7.2 4.5 5.1 4.5 11.3 10.3 5.6 5.5 6.0 4.5 2.4 10.9 6.0 6.3 5.1 7.1 5.4 6.6 7.4 5.5 3.4 5.2 8.3 9.3 8.3 3.8 4.2 5.4 7.3 3.4 4.5 7.3 5.3 6.0 3.7 5.5 6.5 9.5 7.1 5.5 6.2 5.2 4.8 9.0 5.5 15.6 2.9 12.5 6.2 6.1 7.8 5.5 16.3 3.4 2.2 4.5 3.0 1.6 3.4 1.5 4.8 4.2 2.7 6.9 2.5 2.3 6.1 3.7 2.2 3.2 2.6 3.3 3.9 5.9 3.3 2.3 4.5 3.6 2.8 2.8 2.6 18.0 3.7 4.4 5.0 1.9 4.2 6.0 12.4 2.1 3.4 2.4 4.0 2.5 2.9 6.7 10.3 3.8 2.9 5.6 5.8 7.3 2.9 6.6 7.2 5.6 4.3 5.3 2.4 3.0 3.9 4.5 3.6 5.1 3.8 2.0 3.9 6.0 1.9 3.8 11.9 3.1 4.2 6.2 12.9 3.9 3.6 3.9 5.0 0.0 2.2 3.3 1.7 2.0 1.4 1.1 3.4 2.5 2.2 3.4 2.6 2.2 4.5 1.6 3.0 1.7 0.9 1.5 4.5 4.5 5.6 5.5 5.5 3.4 3.8 4.2 5.3 2.9 0.0 4.0 8.8 4.0 4.2 3.3 3.9 5.1 0.0 2.3 5.2 0.0 5.0 3.3 3.1 5.9 4.7 5.1 0.0 5.8 5.0 3.3 3.0 8.1 2.4 4.8 9.5 5.2 5.5 4.7 9.2 5.8 4.4 0.0 4.6 2.5 4.1 3.4 4.0 2.8 3.4 5.0 0.0 3.3 10.8 7.6 3.3 3.9 7.2 3.1 2.0 NAPG ENSG00000134265 "NSF attachment protein gamma" Q99747 18 10525905-10552761 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 54.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008208, HPA011389" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA008208: AB_1854305, HPA011389: AB_1854306" "unprognostic (1.23e-1)" "unprognostic (7.64e-3)" "unprognostic (6.96e-2)" "unprognostic (1.53e-1)" "unprognostic (9.83e-2)" "unprognostic (2.28e-1)" "unprognostic (1.28e-1)" "unprognostic (4.59e-2)" "unprognostic (1.55e-2)" "unprognostic (2.77e-3)" "unprognostic (1.46e-3)" "unprognostic (5.85e-2)" "prognostic favorable (8.14e-4)" "unprognostic (3.81e-2)" "unprognostic (2.87e-1)" "unprognostic (4.97e-2)" "unprognostic (6.96e-2)" 11.0 14.0 20.5 9.1 31.2 6.1 12.1 24.0 40.2 11.6 11.6 17.8 4.9 9.3 11.0 12.7 12.3 11.3 13.5 19.3 26.3 20.8 16.9 13.3 9.6 8.7 24.1 21.4 7.6 12.4 12.8 10.5 13.7 54.1 14.3 14.1 10.1 10.7 11.6 9.0 8.8 10.3 12.5 25.2 8.5 13.4 7.1 11.9 6.9 14.8 8.2 10.6 12.6 8.7 8.4 4.7 15.2 7.1 6.6 7.1 3.6 5.0 3.0 5.3 4.6 15.2 10.5 7.7 10.7 15.4 10.5 13.4 6.6 7.6 6.7 8.6 14.6 9.6 4.9 7.0 9.7 15.1 5.7 4.3 4.9 5.3 6.8 14.6 13.5 9.2 11.0 11.2 12.0 9.0 6.9 9.8 8.7 7.9 16.0 15.3 7.0 10.4 5.8 4.1 38.5 4.5 4.6 8.8 11.2 12.3 11.9 21.2 5.6 8.7 9.3 12.3 9.0 4.2 9.0 11.0 16.6 8.0 15.2 11.3 10.3 10.5 7.4 11.1 9.5 7.6 11.3 5.7 15.2 6.5 7.1 5.8 8.4 5.2 6.3 4.2 4.1 7.1 6.1 9.7 6.6 6.9 4.7 5.1 3.6 20.5 31.2 24.0 40.2 26.3 20.8 24.1 21.4 54.1 11.9 26.8 26.7 24.1 23.8 21.6 62.1 30.5 22.9 17.4 22.7 26.2 11.8 20.2 34.9 43.8 12.0 21.5 22.5 0.0 37.3 25.1 18.2 29.7 43.9 18.8 22.3 42.9 22.5 17.2 23.1 2.1 7.2 19.7 25.3 19.8 17.1 28.2 53.8 34.5 19.8 31.9 31.3 25.8 21.7 12.7 37.9 18.4 37.8 20.1 14.3 46.1 NARFL "FLJ21988, HPRN, IOP1, NAR1, PRN" ENSG00000103245 "Nuclear prelamin A recognition factor like" Q9H6Q4 16 729753-741329 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "REH: 56.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040851 Approved Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA040851: AB_10794427" "unprognostic (6.31e-2)" "prognostic favorable (1.32e-5)" "unprognostic (7.61e-2)" "unprognostic (8.25e-2)" "unprognostic (1.01e-1)" "unprognostic (1.27e-3)" "unprognostic (8.85e-2)" "unprognostic (3.76e-2)" "unprognostic (2.23e-1)" "unprognostic (8.39e-2)" "unprognostic (4.45e-3)" "unprognostic (3.02e-1)" "prognostic favorable (9.83e-5)" "unprognostic (2.49e-2)" "unprognostic (8.15e-2)" "unprognostic (2.62e-1)" "unprognostic (8.33e-3)" 10.2 11.9 16.4 15.3 19.7 15.0 10.3 21.8 28.8 10.0 12.6 21.6 21.1 20.9 11.1 19.2 15.2 13.7 10.6 20.9 18.1 14.2 16.1 17.6 9.1 16.2 15.1 9.8 11.3 18.4 18.5 13.1 11.1 16.7 15.7 8.1 14.3 25.4 17.5 24.1 14.9 15.5 8.7 14.1 15.0 14.5 8.7 13.1 18.4 12.6 13.7 18.9 11.7 11.3 16.0 11.8 8.3 10.9 13.9 12.9 9.4 3.5 10.5 4.2 6.0 4.4 3.1 10.1 5.1 3.8 7.2 6.2 7.4 8.9 5.1 7.9 3.2 5.2 8.1 4.1 6.2 2.6 9.4 9.3 4.3 6.0 6.0 5.6 7.6 6.2 3.8 7.8 4.2 3.5 4.7 5.2 20.5 7.9 4.9 3.5 13.2 6.8 3.5 3.4 7.3 6.7 56.0 6.3 9.2 4.3 3.6 4.8 6.6 6.1 14.7 5.2 2.6 13.4 7.7 5.6 6.0 5.6 6.6 4.5 6.4 4.5 14.1 4.1 4.3 7.7 2.7 10.9 8.3 11.5 9.9 8.9 16.0 11.7 9.5 11.8 10.5 9.5 12.9 2.3 13.9 10.6 9.5 11.1 9.4 16.4 19.7 21.8 28.8 18.1 14.2 15.1 9.8 16.7 13.1 6.0 6.4 14.5 7.7 4.9 20.9 9.7 7.6 5.3 5.7 14.0 13.7 17.8 6.6 15.0 1.0 7.2 23.1 0.0 13.6 10.0 4.7 8.1 15.0 5.9 13.5 36.5 7.5 4.9 9.5 1.9 9.5 7.2 10.1 29.7 16.3 14.6 10.4 15.0 9.9 11.3 16.3 12.9 4.7 11.3 8.9 5.3 11.9 8.7 15.0 7.0 NCKAP5 "ERIH1, ERIH2, NAP5" ENSG00000176771 "NCK associated protein 5" O14513 2 132671799-133568463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 18.3;lung: 19.2" "Cell type enhanced" "Detected in many" 17 "Alveolar cells type 1: 244.2;Bipolar cells: 119.6;Muller glia cells: 83.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "basophil: 3.1" "Lineage enriched" "Detected in single" 8 "granulocytes: 3.1" "Cell line enriched" "Detected in some" 6 "AF22: 32.3" "Low region specificity" "Detected in all" "HPA034639, HPA044859" Uncertain Approved "Nucleoli,Golgi apparatus,Plasma membrane,Cytosol" NA NA Nucleoli "Golgi apparatus, Plasma membrane, Cytosol" "HPA034639: AB_10669678, HPA044859: AB_2679114" "unprognostic (2.54e-1)" "unprognostic (1.95e-2)" "unprognostic (2.30e-2)" "unprognostic (2.58e-2)" "unprognostic (2.49e-2)" "unprognostic (3.13e-1)" "unprognostic (7.07e-2)" "unprognostic (1.90e-1)" "unprognostic (1.96e-2)" "unprognostic (1.82e-2)" "unprognostic (1.46e-1)" "unprognostic (2.93e-1)" "unprognostic (1.06e-11)" "unprognostic (4.56e-2)" "unprognostic (1.17e-1)" "unprognostic (8.95e-2)" "unprognostic (1.03e-1)" 3.6 2.0 6.6 1.5 6.3 0.2 5.4 5.2 5.6 3.1 5.8 6.2 0.9 3.8 3.6 6.2 6.9 1.0 1.5 4.6 6.0 3.9 16.3 6.7 19.2 2.2 6.6 4.7 4.5 1.8 2.2 1.3 4.6 4.2 1.6 1.9 7.5 7.8 1.0 1.1 3.7 18.3 1.0 6.3 2.9 3.0 2.1 6.6 0.3 2.1 5.4 2.3 1.3 3.1 0.0 0.3 3.1 0.0 0.0 0.0 0.0 0.0 1.5 32.3 0.0 0.0 0.3 0.1 0.5 5.7 0.5 0.6 0.0 0.0 2.4 0.0 0.3 0.3 0.1 0.2 0.4 1.8 0.0 0.2 0.0 4.8 0.0 0.0 0.0 0.0 0.3 2.7 3.1 0.4 5.3 0.5 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.7 0.2 1.0 0.3 0.0 1.3 0.7 0.7 0.1 1.0 0.0 1.2 1.6 0.3 0.5 0.0 1.6 0.2 0.2 4.7 0.0 0.1 0.0 0.9 0.3 0.0 0.4 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 6.3 5.2 5.6 6.0 3.9 6.6 4.7 4.2 6.6 244.2 14.1 0.0 0.4 7.9 119.6 16.1 0.0 1.4 51.2 1.8 39.3 0.0 3.3 0.4 5.4 0.8 11.0 0.0 0.2 0.1 5.2 0.9 1.1 5.3 0.5 31.8 3.5 0.6 5.1 2.7 24.5 6.8 1.7 6.4 3.3 83.1 0.9 4.9 7.1 9.0 5.6 6.5 8.1 0.1 0.7 2.5 0.0 0.0 0.9 1.6 NDC1 "FLJ10407, NET3, TMEM48" ENSG00000058804 "NDC1 transmembrane nucleoporin" Q9BTX1 1 53765460-53838860 "Predicted membrane proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA069751, HPA070882" Approved Supported "Nuclear membrane,Plasma membrane,Actin filaments" NA NA "Nuclear membrane" "Plasma membrane, Actin filaments" "HPA069751: AB_2686189, HPA070882: AB_2686320" "unprognostic (2.51e-1)" "unprognostic (1.93e-1)" "prognostic favorable (4.48e-5)" "unprognostic (6.96e-3)" "unprognostic (1.31e-1)" "unprognostic (1.36e-3)" "prognostic unfavorable (7.52e-7)" "unprognostic (3.46e-3)" "unprognostic (1.53e-2)" "unprognostic (2.01e-1)" "prognostic unfavorable (3.58e-4)" "unprognostic (9.27e-2)" "unprognostic (6.22e-3)" "unprognostic (3.00e-3)" "unprognostic (4.38e-2)" "unprognostic (9.24e-2)" "unprognostic (6.07e-2)" 8.8 6.7 3.3 8.6 5.7 4.9 12.9 10.9 7.7 4.8 8.4 5.1 1.9 6.2 6.0 5.4 11.0 5.3 2.9 5.5 4.3 2.8 4.9 11.7 4.4 10.6 8.0 1.5 4.6 6.0 7.6 5.5 5.5 6.6 4.0 10.7 5.5 6.4 3.7 7.1 6.8 6.5 5.0 7.5 7.1 5.8 17.4 7.5 9.1 5.8 6.7 13.0 6.4 5.8 5.5 3.8 2.0 7.2 4.0 8.2 3.4 20.0 10.6 14.4 14.7 5.3 5.4 17.0 13.8 10.3 21.6 17.5 15.6 13.5 39.6 9.0 6.1 17.5 24.2 24.3 14.3 30.6 9.8 17.5 19.3 15.5 13.2 5.0 30.9 11.0 3.2 5.7 21.3 12.7 6.3 13.0 14.8 22.0 5.7 11.8 7.2 15.1 12.3 34.3 17.0 16.9 17.1 23.3 21.6 10.1 13.8 8.7 11.1 12.3 24.0 11.8 16.0 18.6 16.4 7.6 11.3 11.3 15.5 24.7 6.3 15.6 28.2 9.4 23.5 14.1 0.0 3.2 2.0 4.5 7.2 6.9 5.5 4.3 4.0 3.8 4.1 8.2 6.3 0.2 4.0 4.5 3.3 4.7 3.4 3.3 5.7 10.9 7.7 4.3 2.8 8.0 1.5 6.6 7.5 6.0 4.6 3.7 6.1 9.0 4.1 7.6 2.5 2.7 2.3 5.2 2.0 8.2 0.0 5.9 1.7 4.8 3.3 0.0 7.7 16.4 5.9 5.0 7.0 5.9 10.3 3.2 0.0 4.3 9.1 1.7 2.6 6.7 6.8 2.8 8.4 4.1 6.1 2.9 3.2 4.5 3.2 6.5 4.7 9.3 13.1 7.4 5.7 4.1 15.1 5.4 NEDD1 "GCP-WD, TUBGCP7" ENSG00000139350 "Neural precursor cell expressed, developmentally down-regulated 1" Q8NHV4 12 96907223-96953777 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 165.2;Late spermatids: 65.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ: 47.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038591 Approved Approved "Nucleoplasm,Plasma membrane,Centrosome" NA NA "Nucleoplasm, Centrosome" "Plasma membrane" "HPA038591: AB_10674688" "unprognostic (7.93e-2)" "unprognostic (3.18e-1)" "unprognostic (7.00e-2)" "unprognostic (1.19e-2)" "unprognostic (2.21e-1)" "unprognostic (5.92e-2)" "prognostic unfavorable (1.94e-4)" "prognostic unfavorable (3.70e-4)" "unprognostic (1.81e-2)" "unprognostic (9.29e-2)" "unprognostic (1.83e-2)" "unprognostic (1.56e-1)" "unprognostic (2.46e-3)" "unprognostic (7.29e-2)" "unprognostic (2.28e-1)" "unprognostic (1.34e-1)" "unprognostic (5.59e-2)" 10.7 6.2 5.7 10.0 6.6 9.8 9.8 2.5 7.1 10.8 9.3 7.1 1.7 4.9 13.5 8.3 11.6 10.0 5.5 8.3 6.0 4.4 12.6 5.4 9.4 10.3 7.0 3.7 13.3 7.7 14.9 13.5 7.9 6.5 11.9 7.2 6.3 8.5 6.3 25.5 7.8 10.3 15.4 8.4 14.5 7.2 17.8 8.3 30.6 11.9 24.3 10.7 15.1 9.6 9.4 5.9 19.9 11.1 15.6 14.0 7.3 13.7 9.1 15.8 9.6 7.8 7.1 11.2 47.8 17.0 22.1 19.1 6.0 5.1 8.5 4.6 38.2 10.3 12.4 10.6 11.0 29.8 16.3 9.1 10.6 6.0 5.3 6.5 14.4 9.6 5.2 9.1 13.4 10.4 14.6 10.8 14.7 6.1 6.3 15.8 5.6 26.2 6.6 8.7 7.2 29.2 13.9 16.0 8.4 9.0 9.0 4.9 8.7 13.4 7.6 8.3 12.9 10.2 5.1 7.7 13.9 10.7 9.9 11.2 6.2 7.5 11.4 4.3 7.3 16.8 10.0 6.9 19.9 12.1 11.1 13.7 9.4 13.4 12.9 5.9 8.1 14.0 10.9 5.4 15.6 7.8 4.6 14.0 7.3 5.7 6.6 2.5 7.1 6.0 4.4 7.0 3.7 6.5 8.3 8.9 8.6 11.3 24.7 17.2 8.1 8.9 7.6 25.4 15.9 15.7 0.0 7.5 8.3 8.1 165.2 9.1 5.3 0.0 7.0 11.4 8.4 20.9 16.1 4.9 7.5 17.5 5.8 12.3 4.3 65.3 11.5 9.3 6.8 3.6 7.0 12.9 6.8 7.0 9.6 10.5 8.4 19.4 8.2 26.7 24.6 12.3 3.3 18.1 6.6 16.3 NEDD9 "CAS-L, CASS2, HEF1" ENSG00000111859 "Neural precursor cell expressed, developmentally down-regulated 9" Q14511 6 11183298-11382348 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion, Cell cycle, Cell division, Growth regulation, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 72.8" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 437.7;Basal glandular cells: 247.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 49.8;HSkMC: 24.9" "Low region specificity" "Detected in all" "HPA009689, CAB009720, HPA038768, HPA039270, HPA072955" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "CAB009720: , HPA009689: , HPA038768: AB_2676196, HPA039270: AB_2676422, HPA072955: " "unprognostic (2.83e-3)" "unprognostic (2.33e-2)" "unprognostic (1.08e-2)" "unprognostic (6.93e-2)" "unprognostic (2.12e-1)" "unprognostic (1.16e-1)" "unprognostic (1.62e-1)" "unprognostic (9.54e-2)" "unprognostic (3.05e-2)" "unprognostic (2.09e-1)" "unprognostic (2.90e-1)" "unprognostic (1.64e-1)" "unprognostic (5.59e-3)" "unprognostic (2.25e-2)" "unprognostic (2.37e-1)" "unprognostic (2.41e-1)" "unprognostic (1.05e-1)" 72.8 4.7 4.5 14.9 5.6 3.3 35.7 2.2 5.9 14.0 16.6 5.1 14.2 7.1 17.3 21.7 10.3 11.5 15.3 17.3 4.6 4.1 34.6 9.5 58.4 15.0 4.9 3.9 11.1 7.9 4.2 6.1 32.6 6.6 13.4 14.7 12.8 15.4 15.4 22.4 12.3 17.9 12.4 5.3 25.7 10.9 12.2 4.3 18.8 15.8 6.8 18.6 17.6 9.9 5.8 6.0 34.8 19.8 5.1 8.3 6.3 1.5 10.2 9.5 0.1 6.5 0.8 10.0 2.3 2.9 4.4 8.1 3.2 0.6 3.2 49.8 5.1 0.5 4.4 12.7 4.7 5.7 1.4 0.3 0.3 1.5 21.4 3.0 3.4 0.2 24.9 1.4 2.8 0.5 1.6 7.4 0.2 0.0 2.7 9.8 0.4 1.9 1.3 1.4 11.9 1.0 0.5 0.2 1.8 2.2 13.9 0.2 1.7 0.4 11.2 19.3 11.0 0.8 2.6 18.8 3.0 5.3 0.3 5.7 2.8 11.5 3.9 0.0 2.7 12.9 9.1 5.5 15.4 8.3 12.2 6.8 5.0 5.6 8.0 6.0 5.8 3.0 4.7 34.8 5.1 19.8 3.7 5.0 6.3 4.5 5.6 2.2 5.9 4.6 4.1 4.9 3.9 6.6 4.3 437.7 110.8 20.8 247.6 53.8 4.8 7.3 53.5 97.7 139.9 41.8 23.6 41.8 8.3 54.6 6.0 101.8 77.5 0.0 17.3 34.2 31.7 54.5 61.4 16.3 13.3 9.5 103.9 91.4 24.8 2.9 6.9 22.9 23.6 1.8 90.0 104.5 46.5 35.1 27.3 20.3 12.2 25.8 25.0 1.1 0.5 18.1 35.8 41.5 37.6 69.7 NEXN "NELIN, nexilin" ENSG00000162614 "Nexilin F-actin binding protein" Q0ZGT2 1 77888513-77943895 "Disease related genes, Predicted intracellular proteins" Actin-binding "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 110.8;skeletal muscle: 198.5" "Cell type enriched" "Detected in many" 6 "Cardiomyocytes: 2090.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 43.5;LHCN-M2: 40.0;RH-30: 31.7" "Low region specificity" "Detected in many" "HPA011185, HPA011904" Approved Supported "Plasma membrane,Actin filaments" NA NA 12000000 "Plasma membrane, Actin filaments" "HPA011185: AB_1854409, HPA011904: " "unprognostic (9.73e-2)" "unprognostic (6.72e-2)" "prognostic unfavorable (5.60e-4)" "unprognostic (1.72e-2)" "unprognostic (1.11e-1)" "unprognostic (1.42e-2)" "unprognostic (1.62e-2)" "unprognostic (1.09e-1)" "unprognostic (3.03e-2)" "unprognostic (2.22e-1)" "unprognostic (1.46e-1)" "unprognostic (3.25e-1)" "unprognostic (5.41e-2)" "unprognostic (5.60e-2)" "unprognostic (2.48e-1)" "unprognostic (9.65e-3)" "unprognostic (3.68e-2)" 8.9 4.3 0.4 10.4 0.8 0.0 5.0 0.5 0.4 14.1 17.0 0.2 12.5 1.9 16.6 12.5 24.1 9.9 8.7 110.8 0.4 0.5 4.0 1.2 6.2 3.8 0.6 0.5 8.2 2.0 0.3 0.5 2.6 0.7 13.1 3.2 0.9 4.1 14.8 198.5 1.4 5.5 45.8 0.8 3.9 10.6 4.2 1.2 0.0 5.1 40.1 1.0 29.7 10.3 1.4 1.7 2.9 3.4 0.6 0.6 7.0 7.1 0.4 1.3 0.0 23.5 22.8 3.5 43.5 19.3 8.9 6.0 1.2 0.0 0.0 2.5 15.8 10.1 0.9 0.9 4.1 16.0 0.2 0.9 1.7 2.2 0.4 17.6 0.3 0.0 17.0 0.9 12.3 6.9 19.0 6.7 1.7 0.0 0.0 40.0 0.0 8.1 0.5 6.9 0.0 5.3 6.8 31.7 0.0 10.4 0.3 0.0 0.3 3.8 0.0 0.2 9.1 0.0 0.9 6.8 21.3 15.6 9.0 21.6 0.0 0.0 0.0 1.2 0.8 0.0 0.0 3.4 0.0 0.4 2.0 0.1 1.4 0.3 0.4 1.7 1.1 0.6 0.2 2.9 0.6 1.4 1.2 0.0 7.0 0.4 0.8 0.5 0.4 0.4 0.5 0.6 0.5 0.7 1.2 98.3 8.2 0.0 0.8 1.5 2.8 2090.8 0.0 0.0 9.1 0.0 3.9 0.3 1.7 15.9 15.1 11.3 0.9 0.0 27.4 2.8 19.0 0.9 1.1 0.8 1.1 1.6 0.0 53.4 2.6 5.4 67.9 5.3 0.0 0.0 0.0 0.2 23.5 0.0 325.3 0.5 2.6 213.4 98.6 0.7 2.1 0.6 0.2 2.2 0.3 0.2 NGEF ARHGEF27 ENSG00000066248 "Neuronal guanine nucleotide exchange factor" Q8N5V2 2 232878686-233013272 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 29.1;brain: 55.6;intestine: 23.2" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 44.3;Hepatocytes: 17.7;Paneth cells: 20.1;Undifferentiated cells: 17.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 25.6;HDLM-2: 21.6;HeLa: 10.4;PC-3: 28.1;T-47d: 15.9" "Group enriched" "Detected in many" 4 "amygdala: 177.2;basal ganglia: 332.1;cerebral cortex: 231.3;hippocampal formation: 147.2" "Low region specificity" "Detected in many" HPA008160 Approved Approved "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane, Cytosol" "HPA008160: AB_1854450" "unprognostic (3.92e-1)" "unprognostic (1.78e-1)" "unprognostic (4.12e-3)" "unprognostic (1.66e-1)" "unprognostic (5.25e-2)" "unprognostic (5.46e-2)" "unprognostic (1.15e-1)" "unprognostic (2.39e-3)" "unprognostic (5.41e-3)" "unprognostic (2.58e-1)" "unprognostic (6.94e-3)" "unprognostic (1.24e-1)" "unprognostic (6.16e-2)" "unprognostic (2.31e-1)" "unprognostic (1.10e-1)" "unprognostic (2.80e-2)" "unprognostic (2.74e-1)" 0.8 29.1 15.8 1.4 55.6 0.3 1.4 0.8 53.8 1.4 7.9 1.6 0.0 23.2 2.8 2.6 5.3 3.1 2.0 0.9 7.0 5.1 4.2 9.7 0.6 0.3 3.2 26.7 1.5 1.8 7.9 0.9 0.4 5.4 1.3 6.1 0.0 0.8 0.7 0.7 16.5 16.6 4.0 1.4 0.5 6.2 2.3 12.0 0.0 0.8 1.0 0.4 0.9 1.6 0.0 0.5 0.5 0.3 0.0 0.0 0.0 25.6 7.5 0.3 0.1 0.1 4.2 0.4 0.4 0.0 0.2 0.0 0.3 2.5 0.0 7.6 5.3 2.7 3.3 5.7 1.4 0.2 21.6 1.8 0.0 10.4 8.0 0.1 0.0 0.1 0.0 0.1 1.7 0.3 0.1 0.9 0.1 0.1 0.1 0.2 1.9 0.0 0.0 0.6 0.1 28.1 0.0 0.0 0.0 0.5 0.7 0.9 0.2 3.2 1.6 0.0 1.0 15.9 0.2 0.0 0.2 2.3 0.1 0.5 0.2 0.1 0.0 1.9 0.0 1.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 15.8 55.6 0.8 53.8 7.0 5.1 3.2 26.7 5.4 12.0 0.0 0.0 0.0 1.0 8.9 0.2 2.0 2.5 0.0 0.0 0.0 0.0 0.1 0.0 3.1 0.6 0.4 44.3 0.0 9.2 0.2 0.3 0.6 0.0 17.7 0.1 1.6 4.7 0.0 0.3 1.3 0.0 0.2 1.7 0.0 13.6 5.2 7.7 20.1 1.1 6.3 0.0 0.0 0.7 1.1 0.4 6.6 0.0 0.0 17.8 0.3 NHSL2 ENSG00000204131 "NHS like 2" Q5HYW2 X 71910818-72161750 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.1" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 52.1;Glandular cells: 82.4;Ito cells: 55.3;Kupffer cells: 52.6;Urothelial cells: 89.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 13.5" "Group enriched" "Detected in many" 4 "dendritic cells: 3.5;granulocytes: 13.5;monocytes: 5.7" "Cell line enhanced" "Detected in some" "AF22: 16.8;EFO-21: 19.9;HUVEC TERT2: 18.3;TIME: 10.6;U-937: 13.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049771 Uncertain Approved "Plasma membrane,Cell Junctions" NA NA "Cell Junctions" "Plasma membrane" "HPA049771: AB_2680872" "unprognostic (9.71e-3)" "unprognostic (1.96e-1)" "unprognostic (1.92e-1)" "unprognostic (4.56e-2)" "unprognostic (1.40e-1)" "unprognostic (5.50e-2)" "unprognostic (2.88e-2)" "unprognostic (5.72e-4)" "unprognostic (5.46e-2)" "unprognostic (3.36e-2)" "unprognostic (1.50e-2)" "unprognostic (1.91e-1)" "unprognostic (1.61e-2)" "unprognostic (4.27e-3)" "unprognostic (9.99e-2)" "unprognostic (7.76e-2)" "unprognostic (4.37e-4)" 7.8 2.3 11.0 4.8 22.5 3.4 5.2 27.1 9.4 6.6 5.5 1.5 0.9 1.3 8.7 2.7 5.5 3.8 7.4 3.6 4.9 3.2 2.0 1.6 5.5 1.3 2.2 4.9 3.1 1.6 3.1 6.1 3.7 4.3 6.4 3.3 6.2 2.6 8.7 2.8 2.3 2.6 11.7 2.4 4.5 3.4 9.6 2.7 0.3 5.3 4.6 1.6 6.3 4.4 0.0 3.5 13.5 5.7 0.9 1.8 1.7 0.2 0.4 16.8 0.1 0.2 0.7 0.1 0.5 3.1 0.1 0.2 0.1 0.0 0.1 19.9 1.7 0.0 0.0 1.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.9 0.3 0.0 0.6 0.0 0.0 18.3 0.0 0.0 2.7 0.1 0.1 0.1 1.3 3.2 0.0 0.0 0.0 1.0 0.0 0.1 1.9 0.4 3.8 0.0 0.0 0.0 4.9 0.0 1.1 10.6 0.0 1.1 1.3 0.0 0.0 0.0 0.1 0.8 13.3 0.0 4.1 5.7 11.8 1.8 3.9 1.7 0.0 1.0 1.6 3.5 0.0 0.1 0.2 13.5 0.9 3.0 0.0 0.1 1.7 11.0 22.5 27.1 9.4 4.9 3.2 2.2 4.9 4.3 2.7 0.0 3.4 0.0 52.1 0.5 0.6 16.3 10.2 0.0 0.0 1.8 0.0 15.3 0.0 0.2 3.0 21.8 2.4 23.3 0.6 18.6 11.2 82.4 7.0 14.3 16.2 0.0 1.2 55.3 52.6 4.9 29.4 3.4 1.7 0.0 4.5 1.2 0.3 0.0 20.1 1.4 0.3 25.8 2.2 2.5 1.7 0.3 20.8 27.7 4.9 89.4 NKX2-8 "Nkx2-9, NKX2.8, NKX2H" ENSG00000136327 "NK2 homeobox 8" O15522 14 36580579-36582607 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 9.6;lung: 7.7;testis: 22.9" "Cell type enhanced" "Detected in single" 18 "Basal glandular cells: 2.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 2.0;HaCaT: 10.0;HEK 293: 2.4;PC-3: 5.8;SiHa: 2.3" "Region enhanced" "Detected in single" "pons and medulla: 2.3" "Low region specificity" "Detected in many" HPA062879 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA062879: AB_2684892" "unprognostic (6.03e-2)" "unprognostic (1.75e-1)" "unprognostic (1.37e-3)" "unprognostic (2.27e-1)" "unprognostic (3.45e-4)" "unprognostic (2.36e-1)" "unprognostic (8.34e-2)" "unprognostic (7.80e-2)" "unprognostic (3.66e-1)" "unprognostic (3.11e-1)" "unprognostic (8.39e-3)" "unprognostic (4.60e-2)" "unprognostic (2.70e-1)" "unprognostic (6.13e-2)" 0.3 0.3 0.2 0.4 0.7 0.3 0.3 0.0 1.2 0.3 0.3 2.0 0.0 0.3 0.3 0.3 5.3 0.3 0.3 0.3 0.3 2.0 0.3 0.3 7.7 0.3 2.0 0.0 0.3 0.3 1.5 2.1 0.3 5.7 0.4 0.3 0.0 2.0 0.3 0.3 1.1 0.3 0.3 9.6 0.3 0.3 22.9 0.5 0.0 4.2 1.6 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.0 0.0 0.5 10.0 0.0 0.5 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.5 1.4 0.0 2.3 0.4 0.2 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 1.2 0.3 2.0 2.0 0.0 5.7 0.5 0.0 0.0 0.0 2.3 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.0 0.0 0.3 NLRX1 "CLR11.3, NOD9" ENSG00000160703 "NLR family member X1" Q86UT6 11 119166568-119184016 "Predicted intracellular proteins" "Host-virus interaction, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 34.9;lymphoid tissue: 37.5;tongue: 38.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 14.3" "Lineage enriched" "Detected in many" 4 "granulocytes: 14.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061516 Supported Supported "Plasma membrane,Cell Junctions,Mitochondria" NA NA 35000 Mitochondria "Plasma membrane, Cell Junctions" "HPA061516: AB_2684548" "unprognostic (7.58e-2)" "unprognostic (3.71e-1)" "unprognostic (6.36e-2)" "prognostic favorable (2.47e-5)" "unprognostic (5.60e-3)" "unprognostic (2.59e-2)" "unprognostic (2.06e-1)" "unprognostic (2.43e-2)" "unprognostic (8.80e-2)" "unprognostic (1.17e-1)" "unprognostic (3.49e-1)" "unprognostic (3.29e-1)" "prognostic favorable (2.59e-6)" "unprognostic (3.06e-2)" "unprognostic (1.70e-1)" "unprognostic (2.83e-2)" "unprognostic (4.22e-2)" 4.8 6.1 1.9 3.3 3.7 3.6 3.6 2.5 4.9 8.9 5.1 2.9 8.0 2.9 5.6 5.3 34.9 6.7 4.9 8.7 2.9 1.6 4.3 4.4 3.4 3.4 1.8 2.7 2.9 6.2 5.6 2.5 3.3 3.0 4.4 2.0 5.4 5.6 4.8 14.3 11.6 3.2 4.6 2.4 4.5 4.0 3.2 1.3 3.8 4.3 38.9 37.5 5.3 8.5 0.6 2.0 14.3 3.3 1.3 1.3 1.9 4.1 12.2 1.3 9.7 4.2 4.8 1.9 5.5 6.4 2.8 4.8 0.7 10.2 7.4 16.9 7.0 4.1 10.3 3.7 3.1 0.9 9.5 4.0 9.7 4.2 6.6 6.4 3.4 5.7 5.4 13.2 3.6 7.0 5.6 5.6 9.9 0.1 4.9 2.8 10.9 5.7 8.2 6.0 5.3 6.8 11.2 1.7 2.4 6.6 5.3 1.8 6.4 8.1 4.3 3.5 2.0 14.0 10.1 6.5 5.5 4.9 4.9 2.8 1.8 1.9 2.5 0.8 10.4 3.9 2.8 3.3 14.3 0.9 1.5 1.0 0.6 0.8 1.3 2.0 0.4 1.0 1.1 8.1 1.3 1.3 0.9 1.3 1.9 1.9 3.7 2.5 4.9 2.9 1.6 1.8 2.7 3.0 1.3 0.0 6.4 1.7 1.6 2.3 1.2 10.8 5.1 6.7 2.3 7.0 2.0 3.0 1.7 6.0 1.5 3.0 4.2 0.0 3.4 1.7 2.5 1.8 0.0 9.6 5.7 0.0 2.4 4.3 5.3 2.7 1.1 1.9 1.7 5.4 4.1 5.6 5.1 7.0 1.1 4.3 3.2 0.0 2.1 1.9 1.9 4.1 0.5 0.5 4.5 0.9 NMB "MGC17211, MGC2277, MGC3936" ENSG00000197696 "Neuromedin B" P08949 15 84655129-84658563 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "adipose tissue: 37.2;brain: 28.5;breast: 59.9" "Cell type enhanced" "Detected in many" 6 "Ductal cells: 91.4" "Cancer enhanced" "Detected in all" "glioma: 93.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 28.0" "Region enriched" "Detected in many" 16 "olfactory region: 206.6" "Group enriched" "Detected in many" 6 "olfactory region: 80.6;pons and medulla: 17.5" CAB019302 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" "Secreted to blood" NA NA "Nucleoplasm, Vesicles" "Plasma membrane" "CAB019302: " "unprognostic (2.44e-2)" "unprognostic (1.10e-1)" "unprognostic (2.34e-3)" "unprognostic (3.79e-1)" "prognostic favorable (3.43e-4)" "unprognostic (3.81e-1)" "unprognostic (6.45e-2)" "unprognostic (1.45e-2)" "unprognostic (2.17e-1)" "unprognostic (4.36e-1)" "unprognostic (7.24e-2)" "unprognostic (2.10e-1)" "prognostic unfavorable (2.25e-4)" "unprognostic (7.92e-3)" "unprognostic (1.45e-1)" "unprognostic (1.71e-2)" "unprognostic (1.00e-1)" 37.2 8.0 4.6 2.8 7.5 3.3 59.9 2.4 28.5 4.0 6.5 13.7 1.0 2.3 3.1 3.2 2.5 5.0 4.5 7.0 7.0 12.2 4.4 1.9 3.8 3.6 6.6 3.5 3.4 3.3 2.7 4.2 1.4 5.6 1.9 2.1 2.6 4.6 1.8 2.0 1.8 1.4 2.9 9.9 2.0 2.5 6.4 4.8 2.2 8.9 4.9 1.9 4.7 8.5 7.0 10.4 5.9 0.8 1.3 6.4 2.6 28.0 10.7 2.0 0.4 5.5 2.5 0.2 1.7 3.3 3.8 5.2 3.7 7.7 1.2 4.5 4.4 0.0 5.0 10.7 2.2 2.2 10.5 13.5 4.3 4.2 17.4 1.4 2.9 4.7 2.5 0.9 5.9 2.3 2.5 5.5 7.7 0.0 0.4 2.1 16.4 2.7 9.5 7.9 5.9 3.1 8.4 0.0 12.4 3.6 2.2 1.1 12.2 2.8 1.6 12.7 2.1 1.9 11.2 1.4 0.7 3.7 3.5 2.7 0.2 3.0 2.6 8.7 16.2 4.5 0.0 0.8 5.9 6.3 0.6 2.3 4.9 5.0 6.4 3.5 7.0 4.8 3.6 1.2 1.3 0.3 10.4 5.6 2.6 4.6 7.5 2.4 8.5 7.0 12.2 6.6 3.5 5.6 4.8 3.0 2.4 14.3 22.9 13.9 1.6 2.2 7.6 10.7 7.9 29.6 0.0 1.7 11.6 91.4 24.0 11.3 1.7 0.0 50.2 7.5 17.3 30.7 5.7 2.9 30.9 4.8 17.9 4.9 4.8 7.5 4.0 28.4 32.1 29.7 4.9 7.0 39.2 7.0 3.5 22.5 2.3 12.9 29.9 11.1 21.2 11.2 2.6 11.4 8.0 39.6 NME1 "NDPKA, NM23, NM23-H1" ENSG00000239672 "NME/NM23 nucleoside diphosphate kinase 1" P15531 17 51153536-51162428 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Endocytosis, Neurogenesis, Nucleotide metabolism" "Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008467, CAB040571, HPA041113" Supported Supported "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 28000000 Cytosol "Nucleoplasm, Plasma membrane" "CAB040571: , HPA008467: AB_1079492, HPA041113: AB_2677305" "unprognostic (2.24e-1)" "unprognostic (2.01e-1)" "unprognostic (3.48e-3)" "unprognostic (5.96e-2)" "unprognostic (9.71e-2)" "unprognostic (2.33e-3)" "prognostic unfavorable (2.60e-5)" "unprognostic (4.54e-2)" "unprognostic (3.35e-1)" "unprognostic (2.33e-3)" "unprognostic (2.90e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (2.07e-9)" "unprognostic (9.01e-2)" "unprognostic (1.51e-1)" "unprognostic (1.83e-1)" "unprognostic (9.46e-2)" 25.0 29.5 38.0 28.1 30.1 27.9 29.0 19.6 41.9 16.4 25.4 13.1 10.1 15.1 17.3 22.5 30.1 22.2 13.4 14.1 41.7 39.4 19.6 56.0 14.2 28.5 34.2 34.2 15.6 43.6 13.7 17.3 16.9 38.9 14.5 36.8 14.9 34.3 14.7 14.8 22.4 12.4 29.6 20.5 22.4 13.4 11.6 11.3 19.0 18.8 32.7 41.4 22.8 15.2 24.9 36.2 0.6 19.5 17.2 20.3 18.4 46.6 93.2 32.2 44.9 13.5 21.6 54.1 36.4 25.3 75.5 57.3 73.3 28.3 82.1 38.0 33.6 30.0 25.1 61.5 61.9 64.6 39.8 82.8 53.8 72.4 101.8 27.4 59.0 24.7 20.5 39.0 56.8 53.2 13.3 45.5 26.4 79.4 27.3 44.7 79.0 70.1 67.8 38.6 103.3 85.0 43.0 63.6 75.6 57.9 32.6 44.7 51.5 19.1 52.3 33.9 28.8 54.4 39.9 28.6 48.7 44.2 30.3 74.7 35.2 81.2 96.7 29.5 50.1 37.0 0.2 15.2 0.6 13.4 19.5 20.3 24.9 14.4 14.6 36.2 17.3 16.4 17.8 0.4 17.2 11.5 20.7 12.1 18.4 38.0 30.1 19.6 41.9 41.7 39.4 34.2 34.2 38.9 11.3 29.8 22.5 33.5 67.6 117.7 287.4 27.7 63.7 36.1 59.1 68.0 269.0 166.3 127.6 180.3 23.8 58.6 14.6 46.7 172.7 210.0 82.7 60.4 46.0 102.6 183.6 38.1 86.1 27.0 26.9 65.0 56.7 62.9 123.2 55.9 70.8 61.6 165.1 38.6 55.2 140.8 268.7 12.9 66.0 19.8 83.3 116.3 74.0 40.6 110.8 81.0 NMT1 NMT ENSG00000136448 "N-myristoyltransferase 1" P30419 17 45051610-45109016 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Hepatocytes: 304.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022949, HPA022963" Supported Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA022949: AB_1854534, HPA022963: AB_1854535" "unprognostic (1.40e-1)" "unprognostic (2.87e-1)" "unprognostic (1.30e-2)" "unprognostic (6.14e-2)" "unprognostic (1.65e-1)" "unprognostic (1.64e-1)" "prognostic unfavorable (4.94e-4)" "unprognostic (4.96e-3)" "unprognostic (3.86e-1)" "unprognostic (3.04e-2)" "unprognostic (2.19e-1)" "unprognostic (1.98e-1)" "unprognostic (3.77e-3)" "unprognostic (1.01e-2)" "unprognostic (4.89e-2)" "unprognostic (4.17e-3)" "unprognostic (9.45e-2)" 28.8 32.6 44.9 28.2 37.3 12.0 26.1 34.5 64.3 23.7 24.4 17.2 22.9 23.4 27.3 29.3 26.6 30.9 17.3 26.8 37.7 29.6 28.8 36.6 26.7 27.2 27.7 43.6 29.3 21.8 41.6 23.7 32.7 38.1 23.7 23.1 18.1 34.9 30.1 75.5 28.8 24.8 30.1 36.6 28.2 23.4 26.1 34.0 20.7 29.4 18.6 30.9 25.1 43.3 10.2 18.2 7.6 9.3 7.4 10.0 3.3 17.0 22.6 19.5 17.2 35.3 22.8 20.5 19.0 25.2 37.1 30.6 25.2 14.7 20.5 27.6 26.1 26.6 16.1 33.5 26.6 34.4 52.1 23.4 20.4 15.1 24.8 23.2 26.3 24.6 28.7 24.2 27.5 21.9 19.9 24.8 21.0 32.3 10.4 20.6 14.6 31.9 17.9 18.2 31.4 23.6 21.9 29.1 15.6 29.3 15.8 16.3 14.7 12.0 11.0 17.2 34.8 23.7 20.9 19.9 22.7 17.4 18.2 25.3 16.2 23.0 20.5 24.3 14.8 23.9 6.5 8.1 7.6 7.9 9.3 7.2 10.2 7.8 9.3 6.6 7.6 10.0 7.6 5.3 7.4 6.9 18.2 7.5 3.3 44.9 37.3 34.5 64.3 37.7 29.6 27.7 43.6 38.1 34.0 35.7 35.1 55.6 14.2 12.4 85.1 38.9 94.3 16.0 27.3 66.3 110.0 63.6 66.3 62.0 17.1 41.3 50.2 116.8 61.6 49.6 39.9 11.1 22.0 304.8 40.7 122.3 48.9 77.3 77.9 6.8 50.9 41.1 10.1 108.2 32.8 38.5 58.3 45.6 48.1 45.3 119.2 58.2 14.4 60.6 32.8 12.3 68.4 41.5 52.5 15.0 NPL "C1orf13, DHDPS1, NPL1" ENSG00000135838 "N-acetylneuraminate pyruvate lyase" Q9BXD5 1 182789293-182830384 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 76.0" "Cell type enhanced" "Detected in many" 18 "Cytotrophoblasts: 103.5;Hofbauer cells: 387.9;Ito cells: 109.2;Kupffer cells: 121.2;Syncytiotrophoblasts: 89.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 76.0" "Group enriched" "Detected in many" 36 "granulocytes: 76.0;monocytes: 23.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA028345, HPA075808" Enhanced Approved "Vesicles,Plasma membrane" NA NA 190000 Vesicles "Plasma membrane" "HPA028345: AB_10610145, HPA075808: " "unprognostic (2.43e-2)" "unprognostic (5.71e-3)" "unprognostic (1.72e-2)" "unprognostic (1.06e-1)" "unprognostic (1.57e-1)" "unprognostic (3.06e-1)" "prognostic unfavorable (8.05e-4)" "unprognostic (4.41e-2)" "unprognostic (6.54e-3)" "unprognostic (1.45e-1)" "unprognostic (1.49e-1)" "unprognostic (6.18e-2)" "prognostic unfavorable (6.63e-4)" "unprognostic (2.11e-1)" "unprognostic (2.93e-2)" "unprognostic (2.35e-2)" "unprognostic (7.44e-2)" 14.9 6.8 10.9 14.2 12.3 12.4 5.3 3.5 10.2 3.9 5.3 15.0 11.4 2.4 2.5 23.7 8.0 4.1 10.1 4.7 9.2 8.7 37.4 15.4 14.3 20.4 16.0 8.6 2.8 3.2 2.5 2.5 32.9 15.4 4.4 7.4 3.9 5.7 5.8 2.4 6.5 4.8 5.8 15.3 32.1 4.0 4.0 14.4 3.1 3.4 1.3 10.9 11.8 5.5 0.7 1.3 76.0 23.6 0.0 1.3 10.3 2.7 0.5 0.8 0.0 2.4 2.4 0.7 0.9 1.8 1.0 0.5 0.0 1.2 7.3 1.3 0.0 0.0 1.1 1.6 2.0 0.2 0.0 1.2 11.6 0.3 0.1 1.3 4.4 7.0 1.9 7.8 0.2 0.0 0.1 0.1 8.5 8.7 11.7 1.8 0.9 0.2 2.9 9.3 5.7 0.9 1.1 0.6 8.9 0.2 6.1 2.6 3.9 4.2 0.2 3.7 0.9 2.4 7.1 0.2 1.0 2.0 0.6 0.1 8.4 10.1 7.4 2.1 7.8 3.0 3.6 23.6 18.0 1.0 20.8 0.9 0.3 0.8 0.9 1.3 0.7 0.7 0.9 76.0 0.0 16.0 0.2 1.3 10.3 10.9 12.3 3.5 10.2 9.2 8.7 16.0 8.6 15.4 14.4 0.0 5.6 9.1 4.0 5.5 5.1 2.5 2.5 0.0 1.2 7.0 2.0 103.5 16.6 1.0 14.0 2.1 1.3 23.3 2.1 6.6 3.3 1.2 5.7 2.4 387.9 6.4 1.7 109.2 121.2 20.9 0.9 25.3 10.1 21.6 1.1 2.4 1.4 0.0 0.4 55.2 2.4 0.0 2.9 8.6 8.3 6.1 89.7 3.5 0.8 3.9 NPR1 "ANPa, ANPRA, GUCY2A, NPRA" ENSG00000169418 "Natriuretic peptide receptor 1" P16066 1 153678637-153693992 "Enzymes, FDA approved drug targets, Predicted membrane proteins" "cGMP biosynthesis" "Lyase, Receptor, Vasoactive" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 98.4" "Cell type enriched" "Detected in many" 10 "Ito cells: 136.2" "Cancer enhanced" "Detected in all" "ovarian cancer: 39.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "ASC diff: 60.5" "Region enriched" "Detected in many" 5 "olfactory region: 23.0" "Region enhanced" "Detected in single" "olfactory region: 11.1" HPA031087 Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA Nucleoli "Nucleoplasm, Plasma membrane" "HPA031087: AB_10601975" "unprognostic (2.54e-1)" "unprognostic (3.03e-3)" "unprognostic (6.31e-2)" "prognostic unfavorable (3.97e-4)" "unprognostic (1.55e-1)" "unprognostic (6.60e-2)" "unprognostic (1.54e-2)" "unprognostic (2.03e-1)" "unprognostic (2.46e-1)" "unprognostic (3.27e-2)" "prognostic favorable (2.49e-4)" "unprognostic (1.27e-1)" "unprognostic (6.69e-2)" "unprognostic (1.16e-2)" "unprognostic (1.09e-1)" "unprognostic (4.06e-1)" "unprognostic (1.74e-2)" 41.1 4.3 0.5 5.9 0.9 0.1 98.4 0.5 0.8 8.1 8.2 0.3 7.3 1.2 16.8 11.1 8.7 25.0 9.3 19.6 0.9 0.5 28.7 3.7 34.8 8.6 0.7 0.0 19.5 4.2 7.8 4.5 11.8 2.5 4.9 1.5 2.0 2.0 9.0 6.9 3.4 4.6 15.6 2.2 1.2 5.0 6.4 0.2 0.8 7.6 5.1 1.1 11.6 26.5 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 60.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 10.0 0.0 7.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 5.7 0.0 0.0 0.8 0.0 0.0 0.0 0.6 0.0 2.0 0.4 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.5 0.8 0.9 0.5 0.7 0.0 2.5 0.2 0.0 5.8 0.0 0.4 1.3 0.0 4.8 5.1 0.0 0.0 14.0 0.0 0.1 0.0 0.6 8.0 14.2 0.0 0.0 0.0 0.9 3.9 0.4 0.0 1.5 0.2 0.0 0.0 136.2 6.0 7.9 9.5 0.0 0.0 9.0 0.0 0.0 0.7 0.0 3.9 2.8 0.0 0.0 0.9 0.2 0.1 0.9 0.6 0.0 0.0 0.0 NPTN "GP55, GP65, np55, np65, SDFR1, SDR1" ENSG00000156642 Neuroplastin Q9Y639 15 73560014-73634134 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell adhesion, Neurogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051497, HPA072453" Approved Approved "Plasma membrane" NA No 21000 "Plasma membrane" "HPA051497: AB_2681507, HPA072453: AB_2686523" "unprognostic (9.30e-3)" "unprognostic (1.70e-1)" "unprognostic (5.01e-2)" "unprognostic (4.14e-1)" "unprognostic (3.11e-2)" "unprognostic (7.42e-3)" "unprognostic (9.74e-2)" "unprognostic (9.67e-2)" "unprognostic (3.63e-2)" "unprognostic (1.68e-1)" "unprognostic (3.57e-2)" "unprognostic (1.93e-1)" "unprognostic (1.60e-3)" "unprognostic (5.55e-2)" "unprognostic (7.41e-2)" "unprognostic (1.70e-1)" "unprognostic (1.17e-1)" 20.8 24.9 49.0 17.8 72.9 6.9 22.5 55.3 84.5 30.3 36.2 11.9 28.1 33.2 52.3 39.9 34.2 35.2 30.5 48.4 43.6 38.3 32.7 18.2 27.2 15.9 30.3 47.8 21.0 23.8 35.9 18.3 30.3 40.0 45.3 36.6 22.7 25.9 54.9 12.1 19.5 39.8 75.3 16.8 16.7 27.1 18.8 20.4 6.3 28.7 18.5 16.6 32.7 25.9 3.0 3.9 19.7 13.3 2.5 4.9 7.3 17.5 31.5 18.2 13.3 37.2 33.6 25.5 40.5 66.5 46.8 41.7 21.4 56.4 10.2 24.2 58.1 58.0 72.9 29.2 33.7 27.0 18.2 19.4 8.1 16.1 19.0 26.4 12.4 22.6 27.4 29.9 30.2 18.3 46.4 24.8 9.2 4.5 11.7 33.4 14.0 5.5 7.6 16.7 22.2 11.3 8.9 20.8 8.6 63.7 26.0 11.1 3.4 39.2 21.9 26.0 47.4 19.8 16.9 27.9 36.4 24.5 20.8 23.5 10.2 19.0 8.8 33.8 19.3 24.8 3.6 10.0 9.5 4.9 13.3 4.0 3.0 2.8 4.4 3.7 2.3 2.9 3.3 19.7 2.5 9.6 3.9 3.0 7.3 49.0 72.9 55.3 84.5 43.6 38.3 30.3 47.8 40.0 20.4 71.5 54.8 7.7 22.7 57.8 76.4 87.0 58.6 87.0 66.0 78.5 47.1 5.7 1.7 17.0 2.8 30.7 78.3 0.0 20.5 7.9 45.4 26.3 26.7 38.2 22.1 36.5 98.8 47.9 71.6 6.6 14.1 37.1 40.5 12.6 77.6 35.4 30.5 49.9 36.0 16.8 47.1 19.4 36.0 8.2 10.4 47.7 5.7 12.5 39.9 25.1 NPTXR ENSG00000221890 "Neuronal pentraxin receptor" O95502 22 38818452-38843982 "Plasma proteins, Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 73.6" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 14.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "GAMG: 11.4;SCLC-21H: 15.0;SiHa: 11.2;U-87 MG: 43.1" "Low region specificity" "Detected in all" HPA001079 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 280000 "Plasma membrane, Cytosol" Nucleoplasm "HPA001079: AB_1078414" "unprognostic (6.29e-2)" "prognostic favorable (3.93e-4)" "unprognostic (6.82e-3)" "prognostic unfavorable (2.85e-4)" "unprognostic (9.55e-2)" "unprognostic (6.93e-2)" "unprognostic (1.05e-1)" "unprognostic (1.51e-1)" "unprognostic (1.65e-2)" "unprognostic (1.71e-1)" "unprognostic (1.52e-3)" "unprognostic (1.37e-1)" "unprognostic (1.27e-1)" "unprognostic (1.49e-2)" "unprognostic (9.22e-2)" "unprognostic (8.65e-2)" "unprognostic (2.77e-2)" 2.3 3.8 39.1 1.8 17.5 0.8 1.9 16.2 73.6 5.8 2.6 4.3 0.5 1.5 5.6 3.3 2.7 6.1 2.0 10.5 57.4 15.2 1.3 0.8 1.7 1.6 5.6 20.7 6.2 3.6 5.9 2.0 0.9 4.5 6.2 1.7 1.0 3.2 5.6 0.9 1.2 1.4 5.7 3.3 2.1 2.0 1.6 4.0 0.0 2.5 0.0 1.6 2.5 1.9 0.3 0.2 0.6 0.2 0.6 2.3 0.4 0.4 2.9 0.1 0.8 6.0 0.6 0.0 1.9 0.4 3.8 1.3 2.9 0.6 0.0 3.5 0.5 11.4 0.4 0.8 0.1 1.3 0.2 1.0 0.0 0.1 4.5 0.6 0.0 0.1 1.9 0.1 3.5 0.0 5.6 0.1 0.0 3.6 0.1 0.1 4.5 0.0 0.2 3.5 1.4 1.0 0.7 0.0 7.0 1.0 8.1 15.0 0.9 11.2 0.0 0.3 0.8 4.8 1.1 0.2 6.9 4.2 0.0 0.3 1.0 0.0 0.0 43.1 8.7 3.5 0.5 0.2 0.1 1.8 0.0 1.3 0.1 1.0 2.3 0.0 0.3 1.5 1.2 0.6 0.6 0.1 0.2 0.0 0.4 39.1 17.5 16.2 49.0 57.4 15.2 5.6 20.7 4.5 4.0 0.0 0.0 0.0 1.9 1.0 5.4 14.2 5.1 2.7 3.4 3.5 2.0 0.0 0.0 5.7 1.6 4.2 0.0 0.0 3.3 0.0 0.8 4.6 0.0 0.2 0.2 0.0 1.7 5.5 0.3 0.4 1.7 0.3 1.7 0.0 0.0 6.5 3.1 0.0 2.1 0.5 3.1 0.0 2.6 0.0 0.8 0.9 0.0 0.0 0.0 3.3 NRCAM "Bravo, KIAA0343" ENSG00000091129 "Neuronal cell adhesion molecule" Q92823 7 108147623-108456717 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 82.0" "Cell type enhanced" "Detected in many" 15 "Bipolar cells: 66.8;Cone photoreceptor cells: 96.2;Muller glia cells: 46.7" "Cancer enriched" "Detected in all" 7 "glioma: 57.2" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "naive CD8 T-cell: 5.5" "Lineage enriched" "Detected in single" 15 "T-cells: 5.5" "Cell line enhanced" "Detected in some" "A549: 26.4;AF22: 25.7;EFO-21: 47.9;HMC-1: 51.2;SH-SY5Y: 31.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012606 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" "Intracellular and membrane" NA NA 70000000 Nucleoplasm "Vesicles, Plasma membrane" "HPA012606: AB_1854636" "unprognostic (2.66e-1)" "unprognostic (2.65e-1)" "unprognostic (2.52e-3)" "unprognostic (2.18e-2)" "unprognostic (4.08e-3)" "unprognostic (1.01e-2)" "unprognostic (4.47e-3)" "unprognostic (1.66e-1)" "unprognostic (1.73e-1)" "unprognostic (4.81e-2)" "unprognostic (9.10e-3)" "unprognostic (4.33e-2)" "unprognostic (2.22e-2)" "unprognostic (9.70e-3)" "unprognostic (6.42e-2)" "unprognostic (6.51e-3)" "unprognostic (3.28e-2)" 2.5 28.7 24.5 2.3 23.7 1.2 1.6 16.6 82.0 5.0 1.6 10.5 9.5 1.5 2.6 26.6 1.5 3.7 6.3 1.1 19.1 15.9 5.8 1.3 2.7 1.6 11.8 21.2 2.1 21.5 1.2 14.6 6.4 21.7 1.6 1.6 0.7 2.4 12.1 1.0 1.6 1.5 1.6 10.8 4.2 2.3 2.2 9.9 0.0 4.0 0.0 2.9 1.5 0.8 0.1 0.0 0.3 0.0 0.0 5.5 0.6 0.0 26.4 25.7 0.0 3.1 0.6 0.5 0.1 0.1 0.2 0.4 10.6 0.0 0.0 47.9 0.2 0.4 0.1 0.6 0.4 0.2 0.0 3.4 0.0 0.2 0.2 0.0 0.2 51.2 4.3 0.0 0.0 0.1 0.0 16.5 0.0 0.0 0.2 0.4 9.9 0.1 0.0 3.5 15.7 0.0 0.0 7.5 8.6 5.9 0.0 5.0 31.5 0.3 0.0 0.5 0.9 0.0 0.0 17.5 1.1 0.2 0.0 4.3 0.0 0.1 0.2 0.2 0.0 14.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 5.5 0.0 0.0 0.0 0.0 0.0 0.6 24.5 23.7 16.6 34.7 19.1 15.9 11.8 21.2 21.7 9.9 0.0 0.0 0.0 0.0 0.3 66.8 0.5 2.5 0.0 0.0 5.2 96.2 2.1 3.3 1.3 25.4 0.9 0.0 0.0 10.2 0.2 0.9 0.7 22.0 0.0 0.7 12.7 0.0 2.5 1.5 4.7 0.9 0.0 3.3 1.0 0.0 46.7 5.7 0.0 0.4 2.1 7.9 0.0 0.9 1.0 1.1 0.1 3.7 0.0 0.0 0.0 NRP2 VEGF165R2 ENSG00000118257 "Neuropilin 2" O60462 2 205681990-205798133 "Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Differentiation, Host-virus interaction, Neurogenesis" "Developmental protein, Heparin-binding, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 14 "Ito cells: 162.7;monocytes: 389.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 1.8;naive B-cell: 1.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 34.5;HUVEC TERT2: 30.2;TIME: 28.8;U-251 MG: 58.9;U-87 MG: 27.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA039980, HPA054974" Enhanced Approved "Nucleoplasm,Vesicles,Plasma membrane" "Secreted in other tissues" NA NA 15000000 "Vesicles, Plasma membrane" Nucleoplasm "HPA039980: AB_10795517, HPA054974: AB_2682657" "unprognostic (4.28e-2)" "unprognostic (1.17e-1)" "unprognostic (8.12e-3)" "unprognostic (3.38e-1)" "unprognostic (1.62e-1)" "unprognostic (1.57e-2)" "unprognostic (9.36e-2)" "unprognostic (3.70e-1)" "unprognostic (2.15e-3)" "unprognostic (2.90e-2)" "unprognostic (2.56e-3)" "unprognostic (4.17e-1)" "prognostic unfavorable (7.68e-7)" "unprognostic (2.22e-3)" "unprognostic (5.45e-2)" "unprognostic (6.41e-3)" "prognostic unfavorable (7.80e-5)" 24.3 14.5 8.7 11.4 7.4 2.6 7.8 1.2 7.0 34.4 35.4 3.9 8.4 3.5 33.7 4.6 24.8 13.1 25.8 4.4 11.5 8.3 3.4 6.2 15.8 4.9 8.9 3.9 33.0 1.4 2.5 6.6 29.9 9.0 18.6 7.0 27.7 2.6 21.0 2.5 3.3 8.2 44.7 8.6 4.7 17.1 3.4 5.2 2.6 7.3 6.0 3.0 39.3 24.6 1.4 0.5 0.0 1.8 0.0 0.0 0.5 0.7 14.2 9.1 0.0 8.2 2.6 2.7 2.2 4.3 2.8 2.7 13.4 34.5 0.0 3.4 7.1 5.6 5.5 0.4 4.4 4.7 0.0 1.9 0.1 0.6 0.1 22.4 0.0 0.5 19.7 3.4 3.9 3.5 17.4 30.2 0.0 0.0 0.0 1.9 0.0 0.0 0.0 11.4 0.0 2.5 0.0 0.5 3.1 5.7 0.0 8.2 0.3 0.3 0.0 20.3 24.3 0.0 0.1 28.8 12.5 0.1 3.2 58.9 0.0 0.0 0.8 27.8 0.0 26.1 0.0 1.8 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.5 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 8.7 7.4 1.2 3.8 11.5 8.3 8.9 3.9 9.0 5.2 83.4 48.1 3.9 13.9 17.2 25.2 4.8 7.6 64.3 72.8 1.8 0.0 68.2 0.0 2.1 5.6 84.5 0.0 0.0 3.3 4.0 46.3 4.7 3.5 0.9 113.5 0.0 1.2 162.7 27.7 10.2 2.6 22.5 18.6 389.5 0.1 4.3 31.6 0.0 4.6 0.6 2.4 0.0 10.3 1.7 0.7 11.0 21.5 0.7 0.0 44.5 NRSN1 "p24, VMP" ENSG00000152954 "Neurensin 1" Q8IZ57 6 24126122-24154900 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 67.2" "Cell type enriched" "Detected in some" 5 "Horizontal cells: 114.4" "Cancer enriched" "Detected in single" 17 "glioma: 3.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "SCLC-21H: 14.6;SH-SY5Y: 11.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019681, HPA061006" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA019681: , HPA061006: AB_2684413" "unprognostic (1.22e-1)" "unprognostic (4.26e-2)" "unprognostic (8.00e-3)" "unprognostic (8.01e-3)" "unprognostic (1.70e-1)" "unprognostic (4.53e-3)" "unprognostic (7.29e-2)" "unprognostic (1.36e-3)" "unprognostic (2.40e-3)" "unprognostic (1.45e-1)" "unprognostic (1.57e-1)" 1.3 6.9 21.5 1.7 27.7 1.7 1.3 5.3 67.2 1.3 1.7 2.1 0.0 1.7 1.5 1.4 1.4 1.3 1.5 1.4 15.3 25.0 1.5 1.4 1.4 1.5 12.4 25.4 1.3 2.6 1.4 12.9 1.3 27.4 1.4 1.7 0.3 1.5 1.3 3.3 1.5 1.6 1.6 6.7 1.5 1.9 1.6 5.0 0.0 1.4 0.0 1.3 1.3 0.1 0.5 0.2 1.8 0.2 0.1 0.3 0.0 0.7 0.0 0.3 0.7 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.2 0.7 0.1 1.7 0.0 0.0 0.3 0.1 0.0 0.1 1.7 0.6 0.0 0.1 0.2 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.3 2.0 1.3 0.1 0.2 0.3 0.9 0.7 0.2 2.5 0.5 0.2 0.5 0.0 0.0 14.6 11.7 0.0 0.1 0.9 0.2 1.7 3.5 0.2 0.5 0.6 0.1 0.4 0.8 2.3 0.9 0.7 0.0 1.3 1.8 0.1 0.3 0.2 0.2 0.1 0.2 0.1 0.1 0.0 0.5 0.1 0.3 1.0 0.1 0.2 0.2 0.0 0.0 21.5 27.7 5.3 34.1 15.3 25.0 12.4 25.4 27.4 5.0 0.0 0.0 0.0 0.0 0.0 24.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 114.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.6 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NUDCD3 "KIAA1068, NudCL" ENSG00000015676 "NudC domain containing 3" Q8IVD9 7 44379121-44490880 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019136, HPA019528, HPA019529" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA019136: AB_1852370, HPA019528: AB_1852372, HPA019529: AB_1852374" "unprognostic (3.72e-2)" "unprognostic (9.28e-3)" "unprognostic (2.33e-2)" "unprognostic (2.05e-3)" "unprognostic (2.18e-3)" "unprognostic (2.05e-2)" "unprognostic (4.73e-2)" "unprognostic (2.30e-2)" "unprognostic (2.18e-1)" "unprognostic (3.96e-2)" "unprognostic (2.28e-1)" "unprognostic (5.62e-2)" "prognostic favorable (9.16e-4)" "unprognostic (3.51e-2)" "unprognostic (1.58e-2)" "unprognostic (1.45e-1)" "unprognostic (6.50e-2)" 8.3 6.3 15.3 5.4 20.8 7.3 7.2 10.9 26.0 7.8 5.8 7.7 6.4 4.0 6.9 7.3 8.0 10.3 6.7 19.5 15.2 13.0 6.0 5.8 7.2 6.2 12.5 16.8 9.3 6.8 12.8 4.7 5.3 10.1 8.4 5.7 6.1 7.1 9.9 18.3 7.0 5.0 8.8 10.1 5.8 5.9 9.9 7.1 4.1 8.1 4.8 6.6 6.3 5.3 4.7 2.8 3.2 3.1 2.5 4.7 3.5 3.1 5.9 4.3 7.8 5.4 4.5 1.7 5.2 5.0 6.0 6.3 4.0 2.2 10.1 3.9 6.7 8.4 3.7 5.9 6.8 3.5 5.8 6.3 2.9 3.6 2.9 5.0 4.8 1.8 4.0 4.6 4.5 5.2 3.6 7.3 3.4 7.2 3.3 4.4 2.8 2.1 4.5 5.5 3.1 7.9 3.3 4.7 3.7 3.4 4.9 4.7 13.5 3.0 5.6 2.3 4.5 4.3 6.9 7.1 4.3 4.4 2.7 4.1 9.2 9.6 5.1 4.5 5.8 7.4 2.0 2.8 3.2 4.6 2.7 4.7 3.5 4.4 3.8 2.6 4.7 4.6 4.0 1.8 2.5 3.1 2.8 4.4 3.5 15.3 20.8 10.9 26.0 15.2 13.0 12.5 16.8 10.1 7.1 11.9 19.2 17.2 11.6 10.1 37.9 38.9 12.7 21.4 13.6 36.6 51.1 17.0 19.9 27.0 56.9 21.1 21.5 0.0 18.7 15.8 15.0 14.2 9.2 28.8 15.6 46.1 16.7 21.5 19.8 67.6 28.1 11.6 15.1 19.8 21.4 25.5 23.6 21.2 26.5 21.3 40.2 32.3 15.5 52.1 13.7 14.2 12.0 15.8 25.0 10.8 NUDT16L1 SDOS ENSG00000168101 "Nudix hydrolase 16 like 1" Q9BRJ7 16 4693694-4695859 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044186, HPA063605" Approved Approved "Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "HPA044186: AB_10968571, HPA063605: AB_2685058" "unprognostic (1.35e-2)" "unprognostic (1.70e-1)" "unprognostic (6.65e-2)" "unprognostic (2.17e-2)" "unprognostic (1.02e-1)" "unprognostic (2.34e-2)" "unprognostic (3.14e-1)" "prognostic favorable (2.79e-4)" "unprognostic (2.51e-1)" "unprognostic (1.89e-1)" "unprognostic (6.12e-3)" "unprognostic (6.81e-2)" "prognostic favorable (1.02e-6)" "unprognostic (2.78e-1)" "unprognostic (1.47e-1)" "unprognostic (4.08e-2)" "unprognostic (6.81e-3)" 11.2 21.7 19.3 13.2 22.1 19.3 11.0 25.3 33.1 13.6 20.6 15.9 25.5 21.7 10.4 17.1 14.0 16.5 16.8 31.8 19.7 17.5 20.1 27.2 15.2 18.5 18.3 15.8 13.9 14.8 15.7 19.6 10.5 13.4 19.7 12.2 16.3 16.8 16.3 22.4 10.9 18.6 8.9 16.2 15.9 15.3 13.0 15.9 18.2 21.6 14.2 15.9 10.5 9.8 30.1 40.4 44.9 27.0 28.5 39.6 42.7 7.4 12.3 11.3 15.1 8.5 6.6 10.3 8.9 6.8 10.9 6.9 13.8 6.0 7.8 13.0 10.7 5.5 8.7 12.1 12.2 5.1 11.4 20.4 8.6 10.6 16.6 9.3 12.3 10.2 10.2 11.3 9.1 5.7 7.4 8.0 11.8 15.6 9.8 10.5 29.0 18.4 18.2 17.8 12.5 14.2 25.9 11.9 12.2 13.0 9.3 22.3 16.7 13.0 13.7 5.9 9.2 20.2 28.9 10.3 9.0 13.5 21.1 8.1 17.1 10.1 13.1 5.6 16.5 18.2 23.1 27.0 44.9 27.2 22.5 32.6 28.8 33.3 32.4 24.5 30.1 39.6 33.6 33.3 28.5 24.0 40.4 36.7 42.7 19.3 22.1 25.3 33.1 19.7 17.5 18.3 15.8 13.4 15.9 14.9 19.0 34.7 19.4 12.5 52.0 47.7 12.7 17.4 12.5 40.1 9.8 43.2 92.9 25.8 3.1 23.2 52.5 0.0 27.2 25.3 19.0 19.1 27.6 35.5 35.0 44.5 41.3 15.4 17.0 5.5 29.1 17.5 28.7 51.3 44.4 75.6 24.1 42.1 47.0 80.4 54.6 45.3 22.1 10.9 35.7 14.4 41.1 37.4 46.0 14.6 NUP35 MP44 ENSG00000163002 "Nucleoporin 35" Q8NFH5 2 183117513-183161680 "Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 6 "Early spermatids: 131.7;Late spermatids: 308.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018401, HPA018410, HPA018441" Enhanced Supported "Nucleoplasm,Nuclear membrane,Plasma membrane" No No "Nucleoplasm, Nuclear membrane" "Plasma membrane" "HPA018401: AB_1854719, HPA018410: AB_1854721, HPA018441: AB_1854720" "unprognostic (6.18e-3)" "unprognostic (3.15e-1)" "unprognostic (1.83e-1)" "unprognostic (3.58e-3)" "unprognostic (1.37e-1)" "unprognostic (9.91e-2)" "prognostic unfavorable (5.02e-4)" "unprognostic (3.95e-1)" "unprognostic (6.21e-3)" "prognostic favorable (3.45e-4)" "unprognostic (2.32e-2)" "unprognostic (1.61e-3)" "unprognostic (1.78e-3)" "unprognostic (6.78e-2)" "unprognostic (3.47e-2)" "unprognostic (1.24e-1)" "unprognostic (3.96e-2)" 8.8 10.9 9.1 13.7 21.4 4.1 15.3 18.9 12.6 9.2 8.6 5.6 5.8 7.3 9.6 9.0 11.7 10.6 9.1 7.9 11.1 6.8 11.9 16.4 9.5 9.3 11.5 5.1 13.1 17.2 8.9 13.1 9.0 8.8 9.3 10.7 7.3 9.7 9.6 9.1 10.9 7.1 10.5 7.6 7.8 9.3 25.8 9.7 19.1 10.3 12.6 12.7 8.0 10.2 8.9 3.8 1.7 6.8 5.9 10.5 5.0 10.0 10.8 16.8 9.9 6.1 5.9 12.2 12.1 9.8 18.3 17.6 19.8 12.2 17.1 11.4 6.4 21.7 8.7 23.1 13.4 29.7 15.3 15.3 16.1 9.0 21.0 4.6 11.6 10.9 4.3 7.1 15.6 14.9 4.1 10.7 10.3 14.5 12.7 13.9 11.7 13.4 13.9 28.6 15.8 33.4 16.5 13.3 12.1 16.9 12.3 14.9 10.4 11.2 13.1 12.7 13.0 8.5 8.1 5.7 14.4 10.2 11.6 13.5 8.5 18.4 18.2 9.8 8.5 19.3 0.0 4.8 1.7 6.1 6.3 10.5 8.9 7.8 7.5 3.8 7.9 9.6 8.4 0.1 5.9 6.8 3.6 7.7 5.0 9.1 21.4 18.9 12.6 11.1 6.8 11.5 5.1 8.8 9.7 8.9 5.0 11.1 14.4 23.1 10.8 4.1 10.2 8.1 14.8 15.7 17.7 18.4 10.0 10.8 131.7 9.3 3.1 23.3 11.1 17.4 12.4 7.0 8.1 11.9 7.4 6.4 3.5 11.6 6.2 308.3 8.9 3.7 20.3 4.6 6.6 10.8 9.6 7.0 7.8 10.1 17.1 12.9 13.2 34.7 19.4 24.0 7.9 8.9 7.4 9.7 NUS1 "C6orf68, MGC7199, NgBR, TANGO14" ENSG00000153989 "NUS1 dehydrodolichyl diphosphate synthase subunit" Q96E22 6 117675502-117710640 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Angiogenesis, Differentiation, Lipid metabolism" "Developmental protein, Receptor, Transferase" "Congenital disorder of glycosylation, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027504 Supported Approved "Vesicles,Plasma membrane" NA NA Vesicles "Plasma membrane" "HPA027504: AB_10603124" "unprognostic (1.21e-2)" "prognostic unfavorable (6.99e-4)" "unprognostic (1.09e-2)" "unprognostic (2.31e-1)" "unprognostic (1.21e-1)" "unprognostic (8.26e-3)" "unprognostic (1.42e-3)" "unprognostic (2.42e-2)" "unprognostic (8.62e-2)" "unprognostic (2.99e-1)" "unprognostic (2.62e-1)" "unprognostic (8.35e-2)" "unprognostic (1.00e-1)" "unprognostic (2.27e-1)" "unprognostic (3.22e-2)" "unprognostic (1.56e-1)" "unprognostic (7.97e-2)" 8.4 10.2 14.7 9.3 14.7 7.0 10.0 8.8 13.4 29.6 9.2 6.8 2.0 7.1 9.6 13.5 9.5 8.8 7.1 8.2 12.7 9.9 13.1 17.4 9.5 8.4 16.4 15.7 8.8 28.9 15.0 20.0 10.6 16.2 9.6 9.3 7.1 13.8 14.9 7.9 6.1 14.4 8.5 7.3 9.1 10.6 5.6 12.2 7.2 16.5 3.1 8.7 9.1 18.0 2.4 8.1 3.3 4.9 4.1 4.5 2.3 10.3 7.6 16.4 18.3 16.6 21.8 40.4 18.9 19.7 15.8 18.2 17.2 11.6 24.4 20.6 17.4 20.1 9.4 24.4 18.5 29.5 18.2 22.5 27.9 12.8 30.7 25.6 35.1 16.5 19.0 21.0 17.3 35.4 16.2 16.2 18.3 33.3 21.8 23.6 11.6 16.5 22.4 19.1 14.2 13.9 15.9 11.8 17.5 31.4 10.3 19.5 15.4 11.4 14.8 13.8 19.1 9.4 36.9 14.2 9.8 12.1 15.6 27.1 30.3 22.6 26.0 23.2 27.1 19.5 3.3 3.0 1.8 3.1 3.0 4.5 2.4 3.7 4.1 3.2 2.1 3.1 4.0 0.2 4.1 4.9 8.1 3.4 2.3 14.7 14.7 8.8 13.4 12.7 9.9 16.4 15.7 16.2 12.2 0.0 21.1 21.6 29.1 53.8 14.3 6.1 15.3 10.7 14.8 24.4 9.8 21.6 23.2 19.8 11.9 17.5 19.7 0.0 26.2 41.6 19.7 52.1 31.1 35.9 32.9 14.3 12.6 27.0 29.1 11.8 16.7 32.9 30.4 22.6 26.8 7.5 29.9 21.0 19.1 29.2 8.2 6.5 37.6 21.8 28.8 49.1 48.4 14.1 21.0 80.5 OAS3 ENSG00000111331 "2'-5'-oligoadenylate synthetase 3" Q9Y6K5 12 112938352-112973249 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" "Nucleotidyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Urothelial cells: 25.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 64.2;BJ hTERT+ SV40 Large T+ RasG12V: 70.2;GAMG: 31.4" "Not detected" "Not detected" "HPA041253, HPA041372" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" Yes No 21000 "Nucleoplasm, Cytosol" "Plasma membrane" "HPA041253: AB_10794990, HPA041372: AB_10795590" "unprognostic (8.47e-2)" "unprognostic (9.13e-2)" "unprognostic (1.27e-2)" "unprognostic (4.39e-3)" "unprognostic (2.59e-2)" "unprognostic (1.45e-1)" "unprognostic (4.14e-3)" "unprognostic (8.06e-3)" "unprognostic (3.19e-1)" "unprognostic (1.73e-2)" "unprognostic (2.29e-3)" "unprognostic (2.48e-1)" "prognostic unfavorable (2.23e-5)" "unprognostic (4.25e-2)" "unprognostic (1.37e-2)" "unprognostic (3.29e-2)" "unprognostic (2.93e-2)" 36.9 4.9 5.1 11.2 5.4 18.3 7.0 2.9 5.5 10.5 6.8 5.5 3.2 7.3 10.0 11.8 17.9 4.2 9.4 6.7 4.5 5.3 10.3 7.1 19.9 13.3 5.1 5.1 6.1 3.2 3.3 4.6 19.3 8.7 5.6 6.9 8.9 24.7 3.4 3.3 6.0 9.3 8.3 6.2 22.0 9.5 3.0 3.3 21.3 9.9 6.7 13.5 9.9 8.2 2.6 4.8 10.1 14.7 5.0 3.8 3.9 6.3 9.5 0.0 1.5 0.3 1.4 0.8 1.2 8.3 64.2 70.2 7.2 5.8 0.4 2.3 2.9 31.4 5.5 1.2 7.8 5.4 4.7 0.3 4.9 4.4 2.3 1.2 1.7 2.7 0.5 2.5 9.1 0.5 1.1 3.3 1.3 0.1 1.0 0.8 4.1 2.7 0.9 0.5 11.7 5.6 3.9 3.4 0.1 3.0 17.6 0.2 0.0 5.8 2.2 5.7 0.0 7.6 0.5 2.2 1.7 1.2 1.5 2.6 0.5 19.2 0.1 1.4 4.8 5.2 0.9 7.9 1.6 2.0 8.6 2.5 2.6 3.0 3.0 4.8 1.3 2.2 2.6 10.1 5.0 14.7 0.2 3.8 3.9 5.1 5.4 2.9 5.5 4.5 5.3 5.1 5.1 8.7 3.3 3.0 4.6 2.4 4.8 3.1 0.4 1.7 0.0 0.0 2.3 3.5 0.0 4.0 3.3 10.8 6.1 13.4 4.1 0.0 8.6 15.8 5.4 6.5 1.1 1.5 16.5 0.0 1.7 9.2 4.7 5.9 9.5 6.6 1.7 6.4 6.3 4.4 14.5 4.0 14.2 2.1 0.2 0.0 3.1 0.5 0.2 4.1 1.6 4.6 3.7 25.3 OBSCN "ARHGEF30, KIAA1556, KIAA1639, UNC89" ENSG00000154358 "Obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF" Q5VST9 1 228208130-228378874 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Differentiation "Calmodulin-binding, Developmental protein, Kinase, Muscle protein, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "skeletal muscle: 180.2;tongue: 48.4" "Cell type enriched" "Detected in many" 14 "Cardiomyocytes: 136.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 3.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 16.0" "Low region specificity" "Detected in single" "HPA021186, HPA065801" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA021186: AB_1854761, HPA065801: " "unprognostic (8.47e-3)" "unprognostic (1.56e-1)" "unprognostic (9.99e-2)" "prognostic unfavorable (1.64e-4)" "unprognostic (5.30e-3)" "unprognostic (6.36e-2)" "unprognostic (4.54e-3)" "unprognostic (1.82e-1)" "unprognostic (8.81e-2)" "unprognostic (1.93e-2)" "unprognostic (3.38e-1)" "unprognostic (1.45e-1)" "unprognostic (1.57e-3)" "unprognostic (1.34e-1)" "unprognostic (1.77e-1)" "unprognostic (3.53e-1)" "unprognostic (1.16e-2)" 2.5 0.9 0.5 0.9 4.4 0.6 0.7 3.1 0.6 0.6 0.8 0.5 0.5 0.6 0.8 4.4 2.4 1.0 0.6 21.2 0.5 0.7 1.6 0.5 1.0 1.0 0.5 0.5 1.7 1.4 0.4 2.4 0.5 0.9 1.7 0.3 5.2 2.6 1.1 180.2 1.1 0.8 0.5 0.6 1.4 0.5 0.7 0.6 0.5 2.2 48.4 3.5 0.6 0.7 1.0 1.1 0.1 0.4 0.6 3.2 0.7 2.9 2.8 8.0 4.5 0.2 0.1 5.6 1.5 0.5 1.0 0.9 2.0 2.1 5.7 8.1 0.5 0.6 1.0 0.4 1.1 0.2 2.2 5.1 1.9 16.0 0.0 2.0 1.3 6.1 3.0 1.0 0.4 0.2 5.4 0.4 9.4 5.3 1.3 0.3 5.0 2.1 1.6 8.8 0.8 1.8 8.1 0.1 1.3 4.6 1.5 3.0 9.0 0.2 2.9 1.1 2.4 8.0 3.7 0.7 0.0 9.3 0.2 0.1 4.7 0.9 1.4 0.0 0.8 2.1 0.1 0.4 0.0 0.9 0.1 0.9 0.5 0.9 0.7 0.9 1.0 3.2 0.5 0.1 0.6 0.1 1.1 0.8 0.7 0.5 4.4 3.1 0.6 0.5 0.7 0.5 0.5 0.9 0.6 0.0 5.6 0.0 5.9 1.9 3.2 136.5 2.5 1.4 4.5 5.2 9.8 0.1 10.0 2.9 3.8 1.6 0.4 0.0 0.4 0.4 1.5 1.9 6.9 0.5 0.1 0.0 0.0 1.3 0.0 4.0 2.8 0.3 1.7 0.0 1.7 9.7 1.0 0.0 4.2 4.2 2.8 0.0 1.2 0.1 2.5 1.5 1.0 1.8 1.1 3.4 OCA2 "BEY, BEY1, BEY2, D15S12, EYCL, EYCL2, EYCL3, P" ENSG00000104044 "OCA2 melanosomal transmembrane protein" Q04671 15 27754875-28099358 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Albinism, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 37.9;skin 1: 12.3" "Cell type enhanced" "Detected in some" 24 "Leydig cells: 8.6;Melanocytes: 40.5;Peritubular cells: 13.8" "Cancer enriched" "Detected in many" 17 "melanoma: 19.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "SH-SY5Y: 5.9;SK-MEL-30: 22.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA036402 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA036402: " "unprognostic (6.07e-3)" "unprognostic (1.97e-2)" "unprognostic (3.25e-1)" "unprognostic (2.82e-2)" "unprognostic (4.60e-4)" "unprognostic (7.11e-2)" "unprognostic (1.10e-1)" "unprognostic (4.12e-2)" "unprognostic (3.47e-2)" "unprognostic (4.95e-2)" "unprognostic (1.96e-2)" "unprognostic (1.60e-2)" "unprognostic (2.20e-6)" "unprognostic (2.61e-1)" "unprognostic (4.21e-1)" "unprognostic (3.28e-2)" "unprognostic (2.28e-2)" 0.4 0.1 0.9 1.3 4.8 0.0 0.3 0.2 2.9 2.4 0.3 3.6 0.2 0.0 0.4 1.7 2.9 1.6 0.5 0.2 1.3 3.6 0.4 0.4 1.2 3.1 0.3 0.4 0.4 0.2 0.0 1.0 2.9 9.5 0.9 0.2 37.9 1.9 2.7 0.4 12.3 0.2 0.2 0.2 2.0 0.1 2.6 0.2 0.3 7.0 0.5 1.5 0.8 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.3 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.1 5.9 0.0 0.0 22.7 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 4.8 0.2 2.9 1.3 3.6 0.3 0.4 9.5 0.2 0.0 0.0 0.0 0.1 1.8 0.0 0.3 0.0 2.7 1.2 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 8.6 0.0 40.5 0.0 0.0 0.0 0.0 0.0 13.8 0.0 0.0 0.0 1.7 2.9 3.9 0.6 0.1 0.0 0.0 0.1 OCM OCM1 ENSG00000122543 Oncomodulin P0CE72 7 5879827-5886362 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 5.7;brain: 9.5;lymphoid tissue: 5.5" "Cell type enhanced" "Detected in some" 13 "Early spermatids: 1.7;Late spermatids: 1.8;Spermatogonia: 1.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 5.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "MCF7: 2.1;PC-3: 1.9;THP-1: 1.5;U-937: 2.2" "HPA046422, HPA052483" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA046422: AB_2679659, HPA052483: " "unprognostic (1.79e-2)" "unprognostic (2.55e-2)" "unprognostic (3.97e-1)" "unprognostic (1.50e-1)" "unprognostic (5.39e-2)" "unprognostic (1.31e-2)" "unprognostic (2.30e-2)" "unprognostic (7.62e-3)" "unprognostic (2.47e-1)" "unprognostic (1.52e-1)" "unprognostic (1.92e-3)" "unprognostic (6.13e-2)" "unprognostic (2.22e-3)" "unprognostic (1.21e-1)" "unprognostic (1.02e-1)" "unprognostic (3.23e-1)" "unprognostic (3.90e-4)" 0.1 0.5 9.5 0.7 1.7 1.8 1.6 3.1 1.4 0.2 0.5 0.0 0.2 2.7 0.3 0.3 0.5 0.0 2.0 1.8 0.3 0.1 0.1 5.5 0.9 0.5 0.3 0.0 0.2 0.0 0.2 0.6 0.9 0.8 0.0 2.0 0.7 0.2 0.8 1.4 0.1 2.3 0.6 2.3 0.3 0.1 2.1 0.1 2.0 0.8 0.0 5.7 1.3 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.1 0.0 0.8 0.4 0.6 1.9 0.0 0.0 0.6 0.0 0.0 0.0 0.7 0.0 0.5 0.1 0.0 0.0 1.5 0.0 0.0 0.2 0.5 0.4 0.3 0.3 0.1 0.0 2.2 0.0 0.0 0.8 2.0 1.1 0.5 0.4 0.9 2.8 0.8 0.1 2.1 3.7 1.0 1.6 0.0 0.4 0.0 5.7 1.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.6 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 OCM2 ENSG00000135175 "Oncomodulin 2" P0CE71 7 97984684-97991169 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 17 "WM-115: 1.7" "HPA046422, HPA052483" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA046422: AB_2679659, HPA052483: " 0.0 0.0 0.4 0.0 0.1 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ODC1 ODC ENSG00000115758 "Ornithine decarboxylase 1" P11926 2 10439968-10448504 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Polyamine biosynthesis" "Decarboxylase, Lyase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 459.5;Late spermatids: 626.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001536, CAB035996" Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB035996: , HPA001536: AB_1079521" "unprognostic (2.33e-1)" "unprognostic (3.41e-1)" "unprognostic (7.25e-3)" "unprognostic (5.21e-3)" "unprognostic (4.22e-2)" "unprognostic (2.70e-1)" "prognostic unfavorable (3.07e-5)" "unprognostic (3.06e-2)" "unprognostic (4.18e-2)" "unprognostic (6.27e-2)" "unprognostic (3.04e-1)" "unprognostic (6.65e-2)" "unprognostic (1.67e-3)" "unprognostic (1.18e-1)" "unprognostic (1.05e-1)" "unprognostic (2.26e-2)" "unprognostic (5.86e-2)" 13.2 8.2 11.6 33.5 11.1 41.8 9.1 7.2 11.8 11.7 17.4 11.5 33.8 8.6 22.9 21.6 16.5 16.5 30.0 33.8 9.7 10.6 31.5 48.7 14.2 42.3 11.3 6.5 29.2 48.7 13.4 35.4 6.9 11.2 26.3 20.7 18.2 11.0 27.2 64.2 9.6 14.9 26.2 10.2 20.4 19.2 54.6 6.3 31.0 16.4 19.8 39.6 16.1 14.6 13.4 10.8 2.4 2.4 1.2 4.4 3.0 19.0 15.3 21.3 25.2 3.8 11.4 49.4 27.6 13.6 26.1 12.1 81.2 8.9 100.7 13.8 16.8 25.2 3.5 65.2 31.3 31.8 38.3 27.2 46.0 26.3 49.5 30.9 77.6 11.0 7.6 8.5 59.0 74.1 13.5 20.9 28.1 76.4 32.8 14.4 12.5 76.8 30.6 38.8 26.5 49.9 54.9 66.9 67.9 15.8 14.0 29.8 25.3 34.6 10.6 13.9 17.1 7.1 34.8 14.6 21.2 43.7 27.3 59.1 15.3 46.3 91.6 19.0 51.5 13.0 0.0 1.3 2.4 2.7 2.4 3.2 13.4 3.8 4.4 3.0 11.0 2.7 4.3 0.5 1.2 1.5 10.8 3.8 3.0 11.6 11.1 7.2 11.8 9.7 10.6 11.3 6.5 11.2 6.3 41.7 217.2 112.6 112.8 51.5 34.5 48.8 71.4 25.4 36.4 38.4 29.5 1.0 61.3 55.5 459.5 35.3 38.6 0.0 23.5 53.1 21.2 276.8 57.7 46.1 43.4 6.4 260.2 11.6 30.9 626.4 14.4 29.0 21.9 12.6 143.2 85.1 24.6 48.9 10.6 101.8 62.6 0.0 40.8 91.4 74.0 76.5 2.9 37.6 120.9 94.9 ODR4 "C1orf27, FLJ20505, odr-4, TTG1" ENSG00000157181 "Odr-4 GPCR localization factor homolog" Q5SWX8 1 186375838-186421378 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 28.6;Ciliated cells: 28.1;Club cells: 54.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015988, HPA031352" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA015988: AB_1845644, HPA031352: AB_2673838" "unprognostic (1.19e-2)" "unprognostic (4.23e-2)" "unprognostic (1.12e-2)" "unprognostic (3.07e-2)" "unprognostic (1.08e-1)" "unprognostic (1.30e-2)" "unprognostic (2.11e-1)" "unprognostic (8.57e-2)" "unprognostic (8.11e-3)" "prognostic favorable (9.92e-4)" "unprognostic (1.15e-2)" "unprognostic (9.85e-2)" "unprognostic (2.18e-2)" "unprognostic (1.34e-1)" "unprognostic (3.50e-2)" "unprognostic (1.03e-2)" "unprognostic (4.20e-2)" 11.9 15.9 18.2 7.0 22.9 12.2 13.7 27.7 18.7 13.9 10.3 11.4 16.2 12.5 9.6 16.6 9.5 9.1 10.3 11.8 14.3 11.3 16.1 20.0 10.4 6.1 21.9 14.0 12.1 26.5 44.8 26.5 13.4 16.0 16.1 12.8 9.7 18.3 15.3 10.3 9.5 14.8 9.0 21.3 10.1 12.8 8.1 19.1 9.0 19.0 10.1 6.9 10.4 9.7 4.1 8.6 4.4 11.8 10.6 6.2 4.6 7.5 8.5 9.5 7.5 11.6 11.1 18.0 12.4 7.9 8.1 8.0 16.7 17.5 5.4 14.8 6.1 7.3 19.5 6.9 6.6 7.8 4.7 7.1 5.0 10.9 9.5 10.7 8.3 6.3 8.4 13.5 9.4 15.2 8.5 8.6 5.6 18.9 11.0 9.8 8.0 5.9 8.2 13.1 29.4 2.9 6.7 6.4 14.8 16.0 7.7 6.8 10.6 9.4 20.3 14.4 17.5 17.7 7.2 7.9 11.3 7.1 7.8 11.5 13.4 8.1 8.4 6.3 4.5 10.2 1.5 10.5 2.7 3.8 10.0 5.5 4.1 4.8 5.0 8.6 3.1 6.0 4.6 4.4 10.6 11.8 5.4 6.2 4.6 18.2 22.9 27.7 18.7 14.3 11.3 21.9 14.0 16.0 19.1 26.8 28.6 0.0 0.0 0.0 0.0 0.0 0.0 28.1 54.6 24.4 0.0 20.7 8.3 18.4 0.0 0.0 0.0 0.0 22.2 19.9 0.0 0.0 11.6 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 11.8 0.0 0.0 21.7 0.0 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 23.5 0.0 0.0 0.0 OPHN1 "ARHGAP41, MRX60, OPN1" ENSG00000079482 "Oligophrenin 1" O60890 X 68042344-68433913 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Endocytosis, Neurogenesis" "GTPase activation" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Syncytiotrophoblasts: 56.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002919 Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA002919: AB_1079526" "unprognostic (1.21e-1)" "unprognostic (3.21e-2)" "unprognostic (1.96e-1)" "unprognostic (7.31e-2)" "unprognostic (3.85e-3)" "unprognostic (4.32e-2)" "unprognostic (3.52e-2)" "unprognostic (3.09e-3)" "unprognostic (2.22e-1)" "unprognostic (6.62e-2)" "unprognostic (4.37e-2)" "unprognostic (2.30e-1)" "unprognostic (2.21e-4)" "unprognostic (1.98e-1)" "unprognostic (1.29e-2)" "unprognostic (2.08e-3)" "unprognostic (2.64e-3)" 5.8 8.2 21.9 2.4 22.6 3.6 7.1 12.3 21.6 9.9 4.9 10.7 3.2 3.5 9.7 4.8 6.1 5.3 4.5 4.1 19.5 9.7 7.0 1.7 6.6 2.0 9.6 12.2 7.1 4.0 6.6 4.8 20.7 9.1 16.2 5.1 7.9 7.2 8.0 7.8 8.6 4.1 6.3 6.2 2.9 5.9 2.9 12.4 0.1 7.2 2.0 2.3 3.9 6.2 2.7 3.3 4.1 1.7 1.7 1.2 0.3 15.1 3.8 2.4 5.9 5.5 5.7 3.9 2.8 3.9 5.3 6.4 2.4 3.1 0.7 10.8 3.4 2.4 4.1 2.1 1.2 8.2 0.4 1.5 3.2 4.3 2.4 1.8 0.8 3.8 3.3 3.9 4.9 4.8 8.9 4.3 0.6 2.1 1.4 3.1 7.8 0.5 0.8 4.6 7.6 3.2 0.4 4.8 0.7 6.9 5.9 0.9 2.3 5.5 7.0 12.4 5.9 4.7 1.3 4.7 3.6 5.8 12.7 3.6 2.1 2.5 0.5 2.8 1.9 2.6 1.1 1.7 0.6 1.2 0.9 1.0 1.3 1.0 0.8 0.7 2.7 1.1 1.2 4.1 1.7 1.2 3.3 0.7 0.3 21.9 22.6 12.3 18.6 19.5 9.7 9.6 12.2 9.1 12.4 14.9 13.4 0.0 4.9 2.9 5.3 3.1 2.5 17.4 7.9 17.4 5.9 18.1 0.0 0.9 1.6 4.5 3.4 0.0 0.7 9.5 11.0 11.1 8.1 0.0 3.9 0.0 4.1 3.7 1.9 0.2 19.5 6.3 8.5 0.0 2.8 18.4 1.0 3.2 11.3 1.6 5.2 0.0 5.1 0.2 1.3 4.4 56.0 0.0 3.4 3.1 OR2C3 "OR2C4, OR2C5P, OST742" ENSG00000196242 "Olfactory receptor family 2 subfamily C member 3" Q8N628 1 247524677-247536440 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 4.2;testis: 4.6" "Group enriched" "Detected in some" 6 "Early spermatids: 1.6;granulocytes: 1.1;Late spermatids: 2.1;Spermatocytes: 2.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "basophil: 4.2;plasmacytoid DC: 1.3" "Group enriched" "Detected in many" 18 "dendritic cells: 1.3;granulocytes: 4.2" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.8" HPA058578 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA058578: AB_2683761" "unprognostic (1.96e-1)" "unprognostic (7.29e-2)" "unprognostic (3.45e-2)" "unprognostic (1.03e-1)" 0.2 0.4 0.1 0.0 0.1 0.1 0.2 0.4 0.1 0.9 0.1 0.0 0.2 0.9 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.2 1.3 0.1 0.4 0.7 0.0 0.1 0.0 0.5 0.1 0.1 0.4 0.1 0.1 0.1 4.6 0.1 0.0 0.2 0.1 0.0 1.3 4.2 0.0 0.1 0.1 0.0 0.5 0.3 0.6 0.2 0.0 0.2 0.3 0.4 0.0 0.0 0.0 0.3 1.8 0.6 0.2 0.0 1.1 0.3 0.0 0.1 0.0 0.7 0.5 0.1 0.2 0.1 0.1 0.2 0.5 0.5 0.0 0.1 0.0 0.4 0.1 0.5 1.2 0.7 0.1 0.0 0.4 0.2 0.2 0.0 0.3 0.0 0.3 0.0 0.0 0.4 0.8 0.3 0.0 0.3 0.5 0.6 0.6 0.3 0.7 0.4 1.2 0.1 0.1 0.0 0.2 0.3 0.5 0.1 0.5 4.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.2 0.0 0.0 0.0 0.0 0.0 OR6B2 OR6B2P ENSG00000182083 "Olfactory receptor family 6 subfamily B member 2" Q6IFH4 2 240028965-240030456 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 6 "testis: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "MCF7: 1.5" HPA047529 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA047529: AB_2680077" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.4 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6B3 "OR6B3P, OR6B3Q" ENSG00000178586 "Olfactory receptor family 6 subfamily B member 3" Q8NGW1 2 240045077-240047027 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 6 "brain: 1.6;epididymis: 6.5;testis: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HaCaT: 1.2" HPA047529 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA047529: AB_2680077" 0.1 0.0 0.8 0.0 0.5 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 2.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OSBPL10 ENSG00000144645 "Oxysterol binding protein like 10" Q9BXB5 3 31657890-32077580 "Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "smooth muscle: 39.6" "Group enriched" "Detected in many" 13 "Early spermatids: 436.6;Late spermatids: 951.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 17 "memory B-cell: 11.5;naive B-cell: 6.6" "Lineage enriched" "Detected in single" 22 "B-cells: 11.5" "Cell line enhanced" "Detected in many" "hTERT-HME1: 31.5;RPTEC TERT1: 33.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003636 Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Golgi apparatus, Plasma membrane, Cytosol" "HPA003636: AB_1079529" "unprognostic (5.28e-3)" "unprognostic (2.06e-2)" "unprognostic (4.21e-2)" "unprognostic (1.44e-2)" "unprognostic (1.98e-1)" "unprognostic (2.79e-1)" "unprognostic (3.29e-2)" "unprognostic (3.63e-2)" "unprognostic (8.55e-2)" "unprognostic (1.43e-1)" "prognostic unfavorable (3.14e-4)" "unprognostic (2.15e-1)" "prognostic favorable (1.51e-4)" "unprognostic (5.86e-2)" "unprognostic (7.64e-2)" "unprognostic (2.23e-2)" "prognostic unfavorable (4.85e-4)" 11.7 3.5 3.8 8.7 4.3 1.0 6.7 1.4 7.6 8.6 5.6 0.4 5.9 2.5 11.8 6.7 10.0 5.5 16.7 2.9 2.6 2.6 14.5 1.6 4.6 8.2 3.1 3.6 4.1 2.5 1.3 12.0 16.5 2.5 12.8 6.0 8.5 7.3 16.6 2.0 5.5 7.3 39.6 1.2 9.5 4.4 24.0 1.2 0.4 4.3 4.3 15.1 25.2 11.8 11.5 0.1 0.5 0.0 0.0 0.0 0.2 6.2 3.5 0.6 12.5 1.1 2.3 20.9 1.7 1.9 1.6 2.3 8.7 4.5 14.7 16.8 0.4 5.7 3.7 2.7 14.7 1.9 0.1 2.7 0.0 8.7 5.5 0.9 0.0 0.1 2.4 12.4 2.5 31.5 6.1 7.2 0.0 0.0 0.0 6.8 5.1 0.0 0.0 7.9 20.0 9.0 0.1 0.2 0.2 33.2 2.5 0.9 0.1 3.1 5.4 1.7 12.3 3.6 0.0 5.1 2.0 21.5 0.2 8.2 1.4 1.0 14.0 2.9 0.0 12.7 0.2 0.0 0.1 0.0 0.0 0.0 11.5 0.0 0.0 0.0 6.6 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.2 3.8 4.3 1.4 7.6 2.6 2.6 3.1 3.6 2.5 1.2 8.9 3.8 36.5 6.8 9.6 4.8 2.0 5.1 6.7 4.5 7.0 0.0 12.6 8.3 1.9 436.6 17.1 5.7 0.0 4.4 21.8 5.4 16.4 0.0 0.0 2.2 0.0 14.5 20.9 1.2 951.1 10.3 0.9 8.5 1.8 3.5 52.0 10.6 4.5 3.9 20.7 1.7 19.4 9.4 6.5 4.1 10.8 25.3 2.9 7.4 8.6 OSBPL6 ORP6 ENSG00000079156 "Oxysterol binding protein like 6" Q9BZF3 2 178194481-178402891 "Plasma proteins, Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 33.4" "Group enriched" "Detected in many" 4 "Bipolar cells: 59.0;Ciliated cells: 133.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.2" "Group enriched" "Detected in many" 8 "granulocytes: 2.2;T-cells: 1.4" "Cell line enhanced" "Detected in many" "HEL: 25.0;hTERT-HME1: 27.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA032131 Enhanced Approved "Plasma membrane" NA NA "Plasma membrane" "HPA032131: AB_10670963" "unprognostic (6.22e-2)" "unprognostic (1.53e-1)" "unprognostic (2.47e-1)" "unprognostic (5.95e-3)" "unprognostic (5.26e-2)" "unprognostic (1.40e-2)" "unprognostic (7.55e-2)" "unprognostic (4.81e-2)" "unprognostic (3.32e-1)" "unprognostic (1.03e-1)" "unprognostic (3.03e-3)" "unprognostic (3.49e-2)" "unprognostic (1.15e-5)" "unprognostic (1.11e-2)" "unprognostic (1.30e-1)" "unprognostic (3.73e-4)" "unprognostic (4.44e-6)" 2.4 2.8 9.2 1.9 10.5 0.8 3.2 10.2 18.4 1.9 1.7 3.2 0.2 1.6 1.8 1.7 4.1 2.1 2.2 5.9 7.5 6.3 4.5 8.7 6.3 2.0 4.9 8.0 2.8 2.3 1.2 15.1 1.4 11.3 5.3 2.1 2.5 2.9 2.9 33.4 11.6 5.6 2.6 4.3 2.0 1.7 2.4 4.3 0.0 4.1 6.3 1.7 1.5 2.3 0.2 0.1 2.2 0.0 0.2 1.4 0.6 0.0 0.5 4.4 8.9 3.7 4.1 3.4 7.2 3.8 6.4 7.9 0.7 0.1 0.0 0.3 6.6 3.5 0.1 10.3 5.9 10.9 0.1 5.3 25.0 1.6 0.0 2.4 4.0 0.1 2.7 9.4 14.1 27.4 2.3 3.0 3.2 0.4 3.1 8.4 3.5 0.0 0.0 5.3 0.0 5.3 0.0 9.0 1.6 0.4 0.0 3.4 2.0 3.2 0.9 7.1 5.1 1.2 0.0 5.9 7.4 4.6 4.9 8.4 17.0 6.6 0.0 8.8 0.0 3.4 0.5 0.0 0.0 0.0 0.0 1.2 0.0 0.6 0.8 0.0 0.2 1.4 0.1 2.2 0.2 0.0 0.1 0.0 0.6 9.2 10.5 10.2 18.4 7.5 6.3 4.9 8.0 11.3 4.3 0.0 4.5 0.0 2.3 11.7 59.0 12.9 7.6 133.8 11.4 0.0 23.6 0.2 1.7 0.6 0.7 1.8 0.3 0.0 0.7 2.5 1.1 1.8 6.9 4.3 2.9 1.6 1.7 0.0 2.2 0.9 0.0 0.9 5.0 0.0 3.8 11.5 0.3 0.0 1.4 5.3 6.6 0.0 5.3 0.0 0.1 18.2 0.1 0.0 0.1 0.5 OSCAR ENSG00000170909 "Osteoclast associated, immunoglobulin-like receptor" Q8IYS5 19 54094668-54102692 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 20.6;bone marrow: 18.9;lung: 40.4;lymphoid tissue: 20.2" "Group enriched" "Detected in some" 5 "Hofbauer cells: 36.7;Kupffer cells: 33.7;Macrophages: 28.2;monocytes: 39.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 34 "classical monocyte: 20.6;eosinophil: 11.7;intermediate monocyte: 12.8;myeloid DC: 9.4;neutrophil: 18.3;non-classical monocyte: 11.2" "Group enriched" "Detected in many" 75 "dendritic cells: 9.4;granulocytes: 18.3;monocytes: 20.6" "Cell line enhanced" "Detected in some" "EFO-21: 13.6;HHSteC: 9.3;hTERT-HME1: 4.9;NB-4: 5.4;U-937: 16.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA073996 Approved "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 72000000 "Nucleoplasm, Plasma membrane, Cytosol" "HPA073996: " "unprognostic (9.09e-2)" "unprognostic (6.79e-3)" "unprognostic (8.47e-3)" "unprognostic (2.14e-1)" "unprognostic (2.12e-2)" "unprognostic (9.04e-2)" "unprognostic (1.39e-1)" "unprognostic (3.86e-1)" "unprognostic (8.57e-2)" "unprognostic (1.15e-1)" "unprognostic (2.05e-2)" "unprognostic (3.01e-1)" "prognostic unfavorable (2.71e-5)" "unprognostic (1.84e-1)" "unprognostic (2.88e-2)" "unprognostic (9.69e-2)" "unprognostic (4.28e-2)" 4.5 1.0 1.4 3.8 2.8 18.9 1.4 0.4 1.5 1.3 0.9 3.5 0.0 0.4 0.7 1.3 1.2 2.2 2.3 1.1 3.8 1.9 1.0 1.7 40.4 4.7 3.5 0.4 1.2 0.7 0.3 0.5 2.2 4.0 0.8 0.7 1.0 1.3 0.8 0.7 1.9 1.0 2.8 5.6 20.2 1.3 0.6 2.4 1.7 1.0 0.0 1.2 1.7 3.1 0.0 9.4 18.3 20.6 0.0 0.2 7.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.1 0.4 0.0 13.6 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 9.3 0.7 0.0 0.0 0.2 0.6 4.9 0.8 0.0 0.1 0.0 0.4 0.1 0.1 0.0 5.4 0.3 0.2 1.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 3.9 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.6 0.5 16.8 0.0 0.0 20.6 11.7 0.1 12.8 0.0 0.0 0.1 0.2 9.4 0.0 0.0 0.0 18.3 0.0 11.2 0.4 0.1 7.0 1.4 2.8 0.4 1.4 3.8 1.9 3.5 0.4 4.0 2.4 3.0 5.1 0.0 0.5 0.7 0.0 0.3 2.5 6.7 3.4 0.0 0.0 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.3 0.8 0.2 1.1 0.0 36.7 0.0 0.0 0.0 33.7 0.0 0.0 28.2 0.0 39.7 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.6 0.1 0.2 0.0 0.0 0.3 OSCP1 "C1orf102, NOR1" ENSG00000116885 "Organic solute carrier partner 1" Q8WVF1 1 36415827-36450451 "Predicted intracellular proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 35.8;testis: 49.9" "Group enriched" "Detected in many" 5 "Ciliated cells: 144.6;Early spermatids: 336.5;Spermatocytes: 91.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028436, HPA052655" Approved Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Nucleoplasm, Nucleoli" "Plasma membrane" "HPA028436: AB_10600885, HPA052655: " "unprognostic (3.46e-3)" "unprognostic (7.57e-2)" "unprognostic (4.67e-2)" "prognostic favorable (6.88e-4)" "unprognostic (1.28e-2)" "unprognostic (4.81e-2)" "unprognostic (3.38e-2)" "unprognostic (4.52e-2)" "unprognostic (5.52e-2)" "unprognostic (8.80e-2)" "unprognostic (2.21e-2)" "unprognostic (3.87e-2)" "prognostic favorable (2.18e-6)" "unprognostic (1.20e-1)" "unprognostic (2.04e-2)" "unprognostic (1.02e-2)" "unprognostic (4.20e-2)" 3.9 5.3 6.2 1.5 14.0 1.2 6.0 3.6 12.7 6.2 3.6 6.5 7.5 1.8 6.3 14.1 3.2 35.8 5.5 4.7 6.5 8.9 11.9 1.8 6.7 1.3 4.9 5.3 5.9 6.2 15.7 15.7 8.9 7.8 6.4 2.5 6.7 5.3 6.8 2.4 3.4 1.3 5.0 3.2 0.9 3.5 49.9 3.2 1.3 11.1 3.5 2.4 3.2 2.6 0.8 3.8 0.3 1.7 0.3 3.1 0.8 5.2 5.0 6.2 7.1 7.4 7.2 1.1 3.2 7.8 7.9 5.4 0.1 4.6 1.1 6.0 5.7 5.8 4.1 0.2 6.0 5.1 0.9 4.7 0.0 3.3 0.5 9.1 0.6 0.9 8.1 9.8 11.1 4.9 11.5 5.4 5.0 0.1 1.3 6.2 3.7 2.7 1.9 6.3 2.0 2.1 2.9 2.5 0.9 12.9 1.8 16.6 7.3 5.9 2.8 4.1 6.1 6.1 0.9 4.6 5.7 2.1 10.3 5.3 2.3 2.3 0.5 11.0 0.1 3.8 0.0 0.7 0.0 0.9 1.7 0.0 0.4 0.9 0.7 1.8 0.8 2.2 3.1 0.3 0.3 0.2 3.8 2.2 0.8 6.2 14.0 3.6 12.7 6.5 8.9 4.9 5.3 7.8 3.2 8.9 7.5 0.5 6.7 1.3 5.3 4.7 5.1 144.6 19.4 12.2 15.7 9.8 19.9 11.2 336.5 2.4 0.7 0.0 8.1 2.6 4.1 4.3 0.0 1.9 3.8 4.8 4.7 2.5 0.6 35.1 11.5 1.2 3.3 0.0 2.6 12.3 7.9 4.0 8.5 18.1 18.9 0.0 3.3 91.2 18.9 2.8 16.8 0.7 2.6 3.3 OSGEP "GCPL1, KAE1, OSGEP1, PRSMG1, TCS3" ENSG00000092094 "O-sialoglycoprotein endopeptidase" Q9NPF4 14 20446411-20455105 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "tRNA processing" "Acyltransferase, Transferase" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039751 Uncertain Supported "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA039751: AB_10794754" "prognostic favorable (1.48e-4)" "unprognostic (4.15e-3)" "unprognostic (1.29e-1)" "unprognostic (4.33e-3)" "unprognostic (1.54e-2)" "unprognostic (3.95e-2)" "unprognostic (5.54e-3)" "unprognostic (2.80e-3)" "unprognostic (2.98e-1)" "unprognostic (1.05e-1)" "unprognostic (3.35e-3)" "unprognostic (1.22e-1)" "prognostic unfavorable (4.64e-6)" "unprognostic (4.83e-2)" "unprognostic (1.86e-2)" "unprognostic (2.53e-2)" "unprognostic (9.91e-2)" 11.2 14.2 13.2 13.1 14.5 10.7 14.4 21.3 18.3 14.3 15.6 18.6 11.6 8.8 16.0 19.2 12.9 13.1 13.6 15.8 13.4 10.2 12.3 22.2 12.4 16.9 13.4 12.5 12.4 12.4 10.6 20.8 13.6 15.5 10.8 14.0 14.5 12.4 18.6 19.6 9.9 12.4 16.8 12.3 18.8 13.6 5.7 15.2 16.2 15.7 9.6 18.7 16.6 11.0 24.5 28.8 23.4 19.1 13.0 14.2 15.7 6.3 10.2 3.3 10.0 5.9 4.0 10.4 5.0 6.5 12.7 12.3 14.0 7.5 13.2 6.5 6.3 5.5 5.5 10.2 10.0 8.0 10.4 13.0 8.3 8.6 18.0 4.3 14.3 11.9 3.1 3.0 15.2 8.1 2.7 8.3 12.0 8.0 7.6 9.9 11.8 14.0 6.2 5.1 18.3 20.3 22.3 6.3 7.4 7.2 7.2 13.2 2.6 8.8 9.3 6.7 2.0 6.2 13.6 3.8 5.3 13.0 6.7 5.9 2.3 12.3 18.0 3.3 22.3 6.4 5.1 19.1 23.4 13.7 17.6 11.9 20.5 14.2 12.0 28.8 24.5 11.3 12.9 8.7 13.0 13.6 12.4 12.9 15.7 13.2 14.5 21.3 18.3 13.4 10.2 13.4 12.5 15.5 15.2 32.8 30.4 31.8 18.6 10.2 35.1 14.5 17.8 25.4 31.8 22.7 35.3 58.5 29.9 21.8 2.7 18.3 27.1 0.0 25.9 38.4 17.9 13.7 24.4 16.6 56.2 9.5 25.8 22.7 27.5 2.5 17.8 30.6 20.3 17.2 21.1 28.4 19.2 31.5 20.1 30.7 52.1 12.9 23.0 5.1 15.6 10.0 38.6 22.5 29.5 13.6 OSR2 FLJ90037 ENSG00000164920 "Odd-skipped related transciption factor 2" Q8N2R0 8 98944403-98952104 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 47.9" "Group enriched" "Detected in many" 7 "Leydig cells: 726.0;Peritubular cells: 712.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "eosinophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 17 "ASC diff: 113.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA052425, HPA063486" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA052425: AB_2681826, HPA063486: AB_2685022" "unprognostic (1.72e-1)" "unprognostic (1.92e-3)" "unprognostic (1.03e-1)" "unprognostic (5.94e-2)" "unprognostic (1.57e-1)" "prognostic favorable (2.44e-5)" "unprognostic (1.70e-2)" "unprognostic (1.15e-2)" "unprognostic (1.89e-2)" "unprognostic (3.73e-3)" "unprognostic (3.01e-2)" "unprognostic (6.19e-2)" "unprognostic (1.57e-7)" "unprognostic (1.37e-2)" "unprognostic (2.39e-1)" "unprognostic (2.56e-4)" "unprognostic (8.54e-3)" 10.6 2.4 0.5 4.2 0.7 0.0 10.9 0.6 0.5 41.7 3.1 0.5 10.2 0.0 47.9 18.9 4.6 37.6 7.3 1.9 0.5 0.0 1.3 0.5 1.3 2.0 0.8 0.5 36.3 1.4 0.6 1.0 7.7 0.7 20.9 0.8 0.5 1.4 23.7 3.5 6.7 7.4 15.3 0.8 0.5 1.3 27.0 0.6 0.8 1.8 1.8 3.0 6.7 24.1 0.0 0.0 1.0 0.0 0.0 0.6 0.6 6.3 0.9 0.0 0.8 113.9 3.6 0.9 3.5 6.7 2.8 2.8 0.6 0.8 0.0 0.6 5.3 0.1 2.5 0.5 0.9 1.4 0.3 2.6 0.1 0.6 0.3 1.8 0.1 0.1 3.5 2.0 0.4 0.3 0.1 0.0 0.9 0.7 0.0 0.1 2.8 0.5 1.1 0.0 0.5 0.5 2.7 0.3 0.2 0.2 0.5 0.2 0.0 0.3 1.5 0.0 0.0 0.8 1.4 0.0 0.4 0.0 2.8 0.2 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.7 0.6 0.5 0.5 0.0 0.8 0.5 0.7 0.6 0.0 0.0 0.0 4.2 12.6 0.0 0.6 0.0 0.0 2.3 0.0 0.0 11.1 0.0 0.0 5.0 0.6 1.3 0.0 0.0 96.9 87.0 2.9 0.0 0.0 8.4 0.0 0.0 0.0 0.8 6.4 726.0 1.5 15.1 0.0 1.7 0.0 0.0 0.0 712.8 0.0 0.0 32.3 19.6 3.4 4.7 8.0 20.3 0.0 1.2 0.9 OTOP2 ENSG00000183034 "Otopetrin 2" Q7RTS6 17 74924275-74933912 "Predicted membrane proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 20.4;testis: 5.1" "Cell type enriched" "Detected in some" 48 "Paneth cells: 508.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "myeloid DC: 1.4" "Lineage enhanced" "Detected in single" "dendritic cells: 1.4" "Cell line enriched" "Detected in single" 47 "HDLM-2: 15.2" "Region enriched" "Detected in single" 13 "olfactory region: 15.6" "Low region specificity" "Detected in all" "HPA024524, HPA053090" Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA024524: AB_2671592, HPA053090: AB_2682041" "unprognostic (1.62e-2)" "unprognostic (1.45e-1)" "unprognostic (7.25e-2)" "unprognostic (3.21e-2)" "unprognostic (3.62e-1)" "unprognostic (1.30e-1)" "unprognostic (2.85e-2)" "unprognostic (3.81e-1)" "unprognostic (9.04e-2)" "unprognostic (2.04e-2)" 0.1 0.0 0.1 2.9 0.1 0.0 0.1 0.1 0.1 0.1 20.4 0.1 0.1 0.2 0.5 0.1 1.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 10.9 0.1 0.1 0.1 0.1 0.2 11.3 0.2 0.1 0.1 0.0 5.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 1.4 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 15.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 10.6 0.0 0.0 0.0 0.0 2.7 0.0 0.0 508.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.5 0.0 P3H3 "GRCB, HSU47926, LEPREL2" ENSG00000110811 "Prolyl 3-hydroxylase 3" Q8IVL6 12 6828410-6839851 "Enzymes, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Bipolar cells: 28.3;Cone photoreceptor cells: 94.2;Horizontal cells: 41.3;Leydig cells: 46.1;Peritubular cells: 36.0;Rod photoreceptor cells: 26.9" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.1;naive CD4 T-cell: 1.7" "Lineage enriched" "Detected in single" 21 "T-cells: 2.1" "Cell line enhanced" "Detected in many" "BJ: 22.1;hTERT-RPE1: 15.7;NTERA-2: 15.7;U-251 MG: 15.3" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 17.6" HPA043695 Approved Approved "Nucleoli,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane, Cytosol" Nucleoli "HPA043695: AB_10797146" "unprognostic (2.54e-1)" "unprognostic (6.66e-2)" "unprognostic (1.14e-1)" "unprognostic (3.34e-2)" "unprognostic (5.76e-2)" "unprognostic (6.55e-2)" "unprognostic (2.66e-1)" "unprognostic (2.92e-1)" "unprognostic (6.90e-2)" "unprognostic (1.44e-1)" "prognostic favorable (4.91e-4)" "unprognostic (1.29e-1)" "prognostic unfavorable (1.64e-4)" "unprognostic (2.58e-2)" "unprognostic (9.67e-2)" "unprognostic (2.27e-1)" "unprognostic (7.77e-3)" 3.7 3.1 1.2 2.2 2.6 0.3 3.0 10.7 2.5 12.1 2.7 0.0 7.6 1.1 11.0 8.5 2.5 2.1 5.6 4.4 1.2 1.1 0.4 1.6 1.9 0.0 2.2 9.3 3.6 12.1 7.4 2.5 0.8 5.6 0.5 8.1 5.9 6.5 0.5 1.8 1.7 8.8 0.5 1.0 2.8 2.1 0.1 0.0 3.5 1.2 1.4 5.9 4.7 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.8 4.2 7.9 4.9 6.0 0.1 22.1 12.7 7.0 7.7 0.3 0.0 0.0 0.3 8.3 0.2 0.0 2.5 0.2 1.6 0.0 10.6 0.5 2.3 1.0 3.4 0.5 0.0 6.5 0.2 3.4 1.9 15.7 7.4 0.7 2.0 0.0 3.3 0.0 0.0 0.2 15.7 0.0 0.6 0.0 3.9 0.1 0.3 0.0 1.6 6.0 0.0 0.0 2.4 2.1 0.1 0.1 12.9 6.9 10.3 10.6 15.3 0.0 0.1 0.2 5.9 0.0 2.7 0.0 0.0 0.0 0.3 0.0 2.1 0.0 0.0 0.9 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.8 0.0 28.3 9.0 2.5 2.7 3.4 5.2 94.2 0.3 1.7 1.6 0.7 2.3 0.0 0.0 2.3 0.4 7.4 4.6 0.0 0.0 1.2 41.3 1.2 3.7 0.0 1.3 46.1 0.0 0.0 1.8 2.5 4.8 1.9 0.0 36.0 0.3 26.9 6.5 9.2 0.7 0.9 0.0 0.8 0.0 0.4 1.4 PALLD "CGI-151, KIAA0992, SIH002" ENSG00000129116 "Palladin, cytoskeletal associated protein" Q8WX93 4 168497066-168928457 "Disease related genes, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 203.3" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 352.0;Cardiomyocytes: 495.5;Peritubular cells: 375.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 13.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "LHCN-M2: 64.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035905, CAB070159" Enhanced Supported "Plasma membrane,Actin filaments,Cytosol" No No "Plasma membrane, Actin filaments" Cytosol "CAB070159: AB_1726016, HPA035905: AB_2674854" "unprognostic (3.59e-2)" "unprognostic (3.99e-1)" "unprognostic (2.55e-2)" "unprognostic (5.03e-3)" "unprognostic (2.51e-1)" "unprognostic (7.03e-2)" "unprognostic (2.60e-1)" "unprognostic (2.40e-2)" "unprognostic (3.57e-2)" "unprognostic (4.21e-2)" "unprognostic (2.38e-1)" "unprognostic (3.86e-1)" "unprognostic (8.54e-2)" "unprognostic (1.39e-2)" "unprognostic (1.36e-1)" "unprognostic (1.50e-1)" "prognostic unfavorable (3.28e-4)" 17.3 8.9 8.5 19.6 7.5 0.1 28.1 2.1 6.7 58.4 71.9 5.7 46.4 6.7 82.2 25.6 84.3 31.3 30.8 95.0 9.2 3.2 12.7 3.6 24.9 17.0 4.6 4.7 28.0 3.0 25.6 3.9 14.0 6.0 71.4 17.9 9.2 11.4 50.9 30.5 8.9 16.8 203.3 6.7 25.8 31.4 14.1 6.9 2.2 12.7 17.2 5.8 140.3 82.7 0.2 2.2 13.6 3.2 0.6 5.1 1.5 17.7 8.7 19.5 12.0 17.9 19.6 27.3 12.1 30.5 10.7 15.2 0.2 1.0 7.7 3.1 5.2 6.5 3.7 11.8 30.8 13.7 16.0 3.6 0.1 25.2 2.2 31.4 0.0 0.2 29.7 19.3 19.1 28.7 25.8 4.5 4.4 0.0 0.1 64.5 0.8 5.1 0.3 5.6 4.5 5.2 1.7 18.0 0.1 1.2 3.5 2.0 10.5 22.8 1.7 1.6 35.4 10.8 0.1 14.5 11.2 42.5 4.7 19.7 10.9 0.1 0.3 9.4 0.2 3.1 13.6 3.2 0.0 5.1 1.9 0.2 0.1 0.6 2.7 2.2 0.2 0.6 2.0 0.8 0.6 1.2 0.2 0.5 1.5 8.5 7.5 2.1 6.7 9.2 3.2 4.6 4.7 6.0 6.9 29.8 10.3 2.4 352.0 83.1 5.7 495.5 28.1 104.4 76.2 41.8 17.7 42.5 1.7 24.0 99.1 28.5 10.3 0.0 44.7 98.6 137.0 124.3 50.8 12.3 21.9 25.4 42.9 68.7 21.6 111.6 120.6 22.6 21.9 88.4 27.7 54.5 57.6 17.3 375.5 14.4 3.4 174.6 188.1 18.6 3.9 43.2 18.7 4.5 24.8 88.9 PALM2 ENSG00000243444 "Paralemmin 2" Q8IXS6 9 109640788-109946703 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.9;liver: 19.7" "Cell type enhanced" "Detected in some" 14 "Cardiomyocytes: 5.9;Fibroblasts: 5.4;Hepatocytes: 14.7;Intestinal endocrine cells: 7.9;Smooth muscle cells: 6.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 5.9;RH-30: 20.8" "Low region specificity" "Detected in many" "HPA074153, HPA076866" Approved "Plasma membrane" NA NA "Plasma membrane" "HPA074153: AB_2686669, HPA076866: " "unprognostic (7.68e-2)" "unprognostic (1.21e-1)" "unprognostic (1.44e-2)" "unprognostic (1.17e-3)" "unprognostic (3.14e-3)" "unprognostic (1.11e-1)" "unprognostic (2.51e-2)" "unprognostic (2.77e-2)" "unprognostic (2.36e-2)" "unprognostic (3.35e-1)" "unprognostic (7.62e-2)" "unprognostic (1.09e-1)" "unprognostic (5.59e-2)" "unprognostic (2.50e-2)" "unprognostic (2.02e-1)" "unprognostic (1.74e-6)" "unprognostic (8.39e-2)" 14.8 6.1 8.1 2.0 11.1 1.2 6.7 1.7 17.9 4.3 2.4 9.1 0.0 1.8 4.9 1.7 2.4 3.8 3.0 7.6 6.3 1.8 2.7 19.7 4.8 1.5 5.0 9.7 2.3 2.2 1.4 1.6 3.1 8.4 2.4 2.4 0.0 3.2 1.4 2.5 3.1 2.0 2.2 4.9 1.5 2.2 2.7 8.7 0.0 4.3 0.0 1.4 2.8 2.6 0.5 0.1 1.1 0.2 0.3 0.1 0.0 0.1 0.6 0.5 0.0 0.4 0.9 0.2 0.4 1.2 0.7 1.7 0.3 0.7 0.1 0.1 1.9 4.2 1.8 0.0 0.6 1.3 0.1 1.0 0.0 2.5 0.2 0.0 0.0 0.1 2.0 0.8 5.9 0.9 0.6 0.0 0.0 0.0 0.0 2.5 0.5 0.0 0.0 3.4 0.2 1.3 0.0 20.8 0.4 2.9 0.4 3.9 0.0 5.1 0.2 1.6 0.9 2.0 0.4 0.2 2.1 3.0 0.1 1.7 0.1 0.7 0.1 1.6 0.0 2.4 0.3 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.5 0.1 0.0 1.1 0.3 0.1 0.1 0.0 0.0 8.1 11.1 1.7 12.7 6.3 1.8 5.0 9.7 8.4 8.7 0.0 0.3 0.0 0.5 1.1 0.0 5.9 0.0 2.7 0.0 0.0 0.0 0.2 0.0 0.3 0.4 0.3 0.0 0.0 0.2 1.5 5.4 0.4 0.0 14.7 0.1 0.0 7.9 1.3 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.7 0.0 0.0 0.0 6.6 0.2 1.0 2.0 0.2 0.0 0.4 0.1 PALM2-AKAP2 ENSG00000157654 "PALM2-AKAP2 readthrough" 9 109780309-110172512 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 41.0;heart muscle: 26.8" "Group enriched" "Detected in some" 14 "Alveolar cells type 1: 125.0;granulocytes: 32.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 15.7;hTEC/SVTERT24-B: 15.1;RH-30: 29.7;U-251 MG: 13.2;WM-115: 17.3" "HPA058905, HPA074153, HPA076866" Uncertain Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Nuclear bodies" "HPA058905: AB_2683851, HPA074153: AB_2686669, HPA076866: " "unprognostic (7.12e-2)" "unprognostic (1.64e-6)" "unprognostic (7.90e-2)" "unprognostic (3.67e-2)" "unprognostic (2.45e-1)" "unprognostic (3.19e-1)" "unprognostic (9.91e-2)" "unprognostic (1.37e-1)" "unprognostic (1.75e-1)" "unprognostic (8.37e-3)" "unprognostic (2.40e-2)" "unprognostic (2.77e-1)" "unprognostic (1.19e-1)" "unprognostic (2.05e-3)" "unprognostic (7.77e-2)" "unprognostic (1.98e-4)" "unprognostic (3.36e-5)" 41.0 2.8 1.6 3.3 1.6 0.1 19.6 0.7 4.7 4.8 2.3 1.5 2.1 1.1 15.2 4.7 2.1 2.5 5.0 26.8 1.8 2.4 2.4 24.8 9.7 1.2 1.9 0.5 5.9 1.1 1.6 1.1 9.2 3.0 3.2 0.6 1.1 2.0 3.6 4.5 1.8 1.0 7.8 1.4 0.5 1.1 1.4 0.9 0.0 3.8 2.5 0.3 5.2 8.9 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.0 0.0 3.3 0.0 15.7 5.6 1.3 5.5 5.4 1.6 3.7 0.0 0.1 0.0 0.5 5.7 6.5 2.0 0.0 1.3 4.6 0.2 1.6 0.0 5.1 0.1 0.1 0.0 0.0 7.1 0.1 15.1 2.4 4.8 0.1 0.0 0.0 0.0 5.8 0.0 0.0 0.0 4.4 0.0 1.4 0.0 29.7 0.0 4.1 0.0 1.8 0.0 2.1 0.2 7.5 4.6 0.6 0.0 0.1 3.4 8.6 0.3 13.2 0.0 0.2 0.0 4.3 0.0 17.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 1.6 1.6 0.7 3.0 1.8 2.4 1.9 0.5 3.0 0.9 125.0 5.8 0.0 0.0 0.0 0.0 1.1 0.0 1.4 2.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 32.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 PALM3 ENSG00000187867 "Paralemmin 3" A6NDB9 19 14053365-14059159 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 26.5;testis: 19.7" "Group enriched" "Detected in many" 5 "Alveolar cells type 1: 53.6;Alveolar cells type 2: 36.3;Cholangiocytes: 17.8;Club cells: 18.2;Collecting duct cells: 36.6;Exocrine glandular cells: 24.3;Hepatocytes: 31.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AN3-CA: 22.1;CACO-2: 23.7;HAP1: 19.8;NTERA-2: 14.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA052794, HPA056119" Enhanced Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" NA NA "Nucleoplasm, Nuclear bodies" "Plasma membrane" "HPA052794: AB_2681952, HPA056119: AB_2683042" "unprognostic (3.67e-2)" "unprognostic (9.08e-2)" "unprognostic (4.72e-2)" "prognostic unfavorable (7.87e-4)" "unprognostic (2.14e-2)" "unprognostic (1.47e-1)" "unprognostic (4.66e-2)" "unprognostic (7.62e-2)" "unprognostic (1.97e-1)" "unprognostic (3.91e-1)" "unprognostic (3.93e-2)" "unprognostic (3.88e-2)" "unprognostic (2.09e-2)" "unprognostic (1.06e-1)" "unprognostic (5.68e-2)" "unprognostic (1.10e-2)" "unprognostic (1.72e-3)" 0.2 0.2 4.3 0.9 1.9 0.0 2.1 3.7 3.6 2.9 0.5 3.2 0.2 2.7 0.4 11.1 0.2 1.5 1.6 0.2 4.2 2.8 12.9 26.5 2.4 0.2 1.7 4.3 0.4 11.7 1.8 0.2 0.7 10.1 1.8 0.2 1.1 6.9 8.0 0.2 0.2 0.8 0.9 2.7 0.2 13.0 19.7 4.9 0.2 6.8 0.2 1.0 3.9 1.9 0.9 0.2 0.0 0.3 0.0 1.8 0.0 1.6 1.5 3.7 22.1 0.3 0.1 4.5 0.4 0.1 1.3 0.6 23.7 0.5 0.0 0.2 0.4 7.0 0.1 19.8 0.0 0.3 0.0 1.3 0.1 0.5 2.6 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.6 0.1 0.0 4.6 0.0 0.0 3.7 0.2 0.1 14.2 1.8 1.3 0.0 0.0 0.0 0.0 1.9 2.7 3.6 0.1 0.0 0.0 4.0 1.4 0.0 0.2 0.0 4.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.5 0.1 0.9 0.8 0.3 0.0 0.1 0.9 1.8 1.8 0.0 0.0 0.1 0.2 0.5 0.0 4.3 1.9 3.7 3.6 4.2 2.8 1.7 4.3 10.1 4.9 53.6 36.3 0.0 0.6 0.0 0.8 0.3 17.8 2.7 18.2 36.6 0.0 0.2 1.7 6.7 0.0 0.0 0.9 0.0 24.3 2.0 1.0 1.4 1.1 31.8 0.1 0.0 1.2 1.3 1.3 0.0 0.9 0.1 1.7 1.8 1.9 0.4 3.8 0.6 2.5 6.8 0.5 0.0 0.0 0.0 6.8 0.0 1.8 0.0 0.6 0.2 PALMD "C1orf11, FLJ20271, PALML" ENSG00000099260 Palmdelphin Q9NP74 1 99645943-99694541 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 84.9;skeletal muscle: 106.9" "Cell type enhanced" "Detected in many" 9 "Cardiomyocytes: 153.8;Ciliated cells: 174.0;Endothelial cells: 169.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 43.5;LHCN-M2: 14.0;TIME: 60.9;U-87 MG: 26.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017959, HPA030549" Supported Supported "Plasma membrane,Actin filaments,Focal adhesion sites" NA NA "Actin filaments" "Plasma membrane, Focal adhesion sites" "HPA017959: AB_1854949, HPA030549: AB_2673518" "unprognostic (1.48e-2)" "unprognostic (1.15e-2)" "unprognostic (2.05e-2)" "prognostic favorable (9.42e-4)" "unprognostic (7.67e-2)" "prognostic favorable (5.90e-5)" "unprognostic (1.54e-2)" "unprognostic (2.10e-1)" "unprognostic (3.93e-2)" "unprognostic (1.64e-1)" "unprognostic (8.32e-2)" "unprognostic (6.18e-2)" "unprognostic (5.19e-2)" "unprognostic (1.63e-2)" "unprognostic (1.88e-1)" "unprognostic (2.70e-1)" "unprognostic (8.08e-2)" 84.9 18.6 8.3 6.2 4.3 0.0 46.4 1.1 3.7 17.1 6.5 3.9 4.0 1.3 18.6 10.1 16.2 8.7 5.3 59.0 5.6 3.4 5.1 20.9 10.6 3.4 3.9 3.8 17.4 2.2 4.4 4.7 16.8 19.0 8.1 2.6 7.9 34.0 4.4 106.9 18.0 3.5 12.2 4.1 2.3 2.8 7.5 2.2 2.1 3.4 48.2 6.2 6.9 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.7 0.1 3.0 0.0 0.1 0.0 0.0 0.0 0.0 5.7 7.3 0.0 0.0 0.0 1.1 0.5 0.0 0.0 1.2 43.5 0.0 6.1 0.0 14.0 0.1 0.0 0.0 0.0 0.4 1.9 0.0 10.9 0.0 0.0 2.2 0.2 0.1 0.0 2.8 0.0 0.3 0.6 0.0 60.9 0.0 0.1 4.7 0.0 0.0 0.0 0.0 26.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 4.3 1.1 3.7 5.6 3.4 3.9 3.8 19.0 2.2 6.0 9.3 0.0 9.8 34.2 0.2 153.8 35.7 174.0 45.5 3.5 0.0 0.2 5.0 7.1 73.5 169.5 0.0 0.0 0.2 0.4 4.8 4.7 1.1 55.2 0.5 3.2 1.7 58.9 1.3 7.9 8.6 1.7 23.6 0.0 0.0 54.8 2.5 0.0 22.6 0.0 2.1 0.0 6.1 0.5 0.2 40.7 0.2 0.0 0.0 0.7 PARD6G "PAR-6G, PAR6gamma" ENSG00000178184 "Par-6 family cell polarity regulator gamma" Q9BYG4 18 80157232-80247546 "Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 37.0" "Cell type enhanced" "Detected in many" 13 "Basal keratinocytes: 35.1;Sertoli cells: 19.4;Suprabasal keratinocytes: 55.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 21.6;hTCEpi: 20.1;RT4: 16.1;U-2 OS: 17.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA047017 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA047017: AB_2679904" "unprognostic (1.11e-1)" "unprognostic (4.39e-2)" "unprognostic (9.88e-2)" "unprognostic (4.40e-2)" "unprognostic (2.97e-1)" "unprognostic (5.48e-3)" "prognostic unfavorable (3.19e-4)" "unprognostic (1.80e-1)" "unprognostic (9.96e-2)" "unprognostic (4.27e-2)" "unprognostic (1.17e-1)" "unprognostic (4.09e-2)" "unprognostic (6.86e-3)" "unprognostic (9.65e-2)" "unprognostic (1.01e-1)" "unprognostic (4.85e-1)" "unprognostic (2.72e-1)" 2.9 2.2 3.1 4.0 3.1 0.8 8.8 2.0 4.3 15.1 5.0 3.1 8.2 2.1 9.5 6.1 17.3 6.7 4.5 3.0 4.3 4.1 5.5 3.5 2.6 10.4 2.8 2.4 8.9 3.1 2.1 3.7 5.7 3.7 8.8 2.5 4.0 7.0 6.6 2.0 37.0 2.9 8.2 2.6 2.4 2.5 2.4 1.8 6.9 20.7 14.1 11.2 8.4 10.7 0.5 0.5 2.5 0.4 0.6 1.0 0.1 1.7 2.5 10.5 7.8 0.3 0.4 7.6 1.9 0.4 1.7 0.2 0.7 0.7 0.0 0.8 0.8 3.0 7.7 3.7 11.1 1.7 0.3 3.3 0.1 2.0 5.9 0.5 2.2 21.6 3.4 20.1 0.2 1.1 1.3 0.8 2.4 0.7 0.5 2.5 2.8 2.0 0.2 3.1 0.8 3.0 0.0 6.9 0.8 0.3 16.1 4.4 4.5 2.3 1.3 11.0 5.4 1.5 2.0 0.6 3.5 17.4 1.3 0.9 0.5 0.7 0.1 1.1 0.5 6.4 2.5 0.2 0.4 0.3 0.2 0.2 0.3 0.3 1.0 0.2 0.5 0.4 0.5 1.2 0.6 0.4 0.5 0.1 0.1 3.1 3.1 2.0 4.3 4.3 4.1 2.8 2.4 3.7 1.8 3.0 1.1 0.0 12.6 35.1 1.6 2.2 2.5 1.4 1.2 3.5 0.0 0.5 0.0 0.3 0.4 3.1 0.0 0.0 0.2 4.2 5.6 5.4 0.0 1.6 0.7 0.0 0.0 8.0 1.9 0.4 1.7 1.1 11.8 0.0 0.0 2.0 0.9 0.0 1.8 6.3 2.2 19.4 5.8 0.9 4.1 55.8 0.3 2.2 0.5 10.1 PARP6 pART17 ENSG00000137817 "Poly(ADP-ribose) polymerase family member 6" Q2NL67 15 72241181-72272999 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Late spermatids: 137.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026991 Approved Approved "Plasma membrane" Yes No "Plasma membrane" "HPA026991: AB_1854989" "unprognostic (3.88e-2)" "prognostic favorable (3.17e-5)" "prognostic unfavorable (3.37e-4)" "unprognostic (3.36e-1)" "unprognostic (7.13e-2)" "unprognostic (3.05e-1)" "unprognostic (2.37e-2)" "unprognostic (1.33e-1)" "unprognostic (2.00e-1)" "unprognostic (2.64e-1)" "unprognostic (8.55e-2)" "unprognostic (6.92e-2)" "prognostic unfavorable (8.02e-8)" "unprognostic (6.81e-2)" "unprognostic (1.14e-1)" "unprognostic (1.45e-1)" "unprognostic (4.42e-2)" 13.7 16.6 28.0 12.8 32.4 25.1 26.5 46.6 41.2 15.5 16.2 16.9 18.2 14.1 23.3 23.8 14.0 17.0 20.2 18.4 26.1 22.4 14.3 9.0 15.7 16.8 19.9 21.8 26.3 20.9 20.6 30.8 17.0 19.4 19.3 14.3 14.5 21.3 18.8 23.9 20.3 14.4 19.6 14.2 18.2 18.2 25.1 15.8 9.6 21.7 12.5 15.8 16.3 15.8 4.1 4.0 12.1 5.3 4.3 4.3 2.9 7.3 13.2 13.9 18.1 15.0 12.5 11.3 6.3 9.5 10.4 15.4 8.7 13.3 10.0 3.9 9.5 15.3 9.6 15.3 8.5 6.0 11.9 13.8 14.6 23.1 0.1 12.5 7.5 14.0 16.0 21.0 9.7 26.8 16.4 6.9 16.8 7.4 11.6 8.3 13.3 6.4 13.2 6.4 6.1 0.0 11.9 9.9 7.9 9.6 14.5 39.4 20.9 10.5 8.6 17.1 19.3 10.9 8.7 6.5 13.1 12.0 17.0 9.5 13.1 12.0 10.9 9.4 14.7 9.0 1.7 5.3 12.1 3.8 4.4 2.7 3.3 2.7 4.0 4.0 4.1 4.3 3.2 5.7 4.3 4.9 3.1 4.2 2.9 28.0 32.4 46.6 41.2 26.1 22.4 19.9 21.8 19.4 15.8 20.8 20.5 4.7 8.4 12.8 14.0 14.6 0.0 2.7 15.9 8.7 19.6 5.9 6.6 7.3 49.1 9.8 9.2 0.0 11.2 4.3 9.3 7.6 15.1 4.2 8.1 17.5 16.7 7.4 12.4 137.7 11.5 8.2 15.1 6.4 5.3 7.4 8.1 5.8 9.2 10.3 15.1 6.5 9.5 39.0 8.3 13.8 5.4 7.5 5.6 8.3 PAWR "par-4, PAR4" ENSG00000177425 "Pro-apoptotic WT1 regulator" Q96IZ0 12 79574979-79691097 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "memory B-cell: 5.0;naive B-cell: 6.2;NK-cell: 2.9" "Group enriched" "Detected in many" 8 "B-cells: 6.2;NK-cells: 2.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA012640, CAB020779" Approved Approved "Plasma membrane,Actin filaments" NA NA "Plasma membrane" "Actin filaments" "CAB020779: , HPA012640: AB_1855748" "unprognostic (2.42e-1)" "unprognostic (5.58e-2)" "unprognostic (9.77e-3)" "unprognostic (5.39e-2)" "unprognostic (9.44e-3)" "unprognostic (4.21e-3)" "unprognostic (9.21e-2)" "unprognostic (1.37e-1)" "unprognostic (4.78e-1)" "unprognostic (3.03e-1)" "unprognostic (2.42e-3)" "unprognostic (4.97e-3)" "unprognostic (2.22e-2)" "unprognostic (2.58e-2)" "unprognostic (4.64e-1)" "unprognostic (2.22e-1)" "unprognostic (4.23e-2)" 10.3 6.1 3.4 16.1 8.9 2.1 16.4 6.2 3.3 27.4 16.6 3.8 20.1 9.4 35.0 19.3 20.8 20.4 20.2 5.6 5.5 3.3 14.4 15.5 14.6 5.0 5.7 2.6 22.1 15.1 14.6 19.0 24.8 5.3 21.8 12.6 7.9 14.3 21.1 2.7 14.5 15.0 31.5 3.6 6.1 10.8 15.4 4.9 6.7 24.5 8.4 8.6 27.5 26.2 6.2 0.3 0.5 0.0 2.9 0.4 0.1 19.8 18.5 3.3 0.1 1.7 0.7 22.2 12.7 3.7 6.4 3.9 22.8 7.6 13.2 23.6 7.0 4.6 22.1 11.6 9.5 9.3 5.4 15.6 0.0 10.6 9.8 9.2 0.2 0.3 1.6 20.3 5.1 29.1 24.1 10.7 5.5 0.7 1.8 7.0 15.1 3.1 0.0 16.1 5.7 10.2 0.0 7.6 8.5 12.3 15.0 9.7 0.0 22.7 12.1 2.0 11.7 10.8 0.1 15.7 9.8 8.8 0.3 8.4 5.9 7.5 9.7 1.6 0.0 4.2 0.5 0.0 0.1 0.1 0.0 0.0 5.0 0.3 0.2 0.3 6.2 0.4 0.4 0.5 2.9 0.0 0.2 0.0 0.1 3.4 8.9 6.2 3.3 5.5 3.3 5.7 2.6 5.3 4.9 74.5 31.8 17.5 137.7 177.7 5.8 14.9 58.6 45.5 73.9 62.8 0.0 46.7 14.9 39.3 50.0 23.5 79.7 0.0 33.3 69.4 22.7 157.7 1.1 50.5 5.6 15.9 66.0 17.8 0.6 75.0 78.6 4.6 16.9 0.0 95.3 2.4 61.3 69.1 85.6 39.3 0.9 84.1 81.4 80.9 61.3 157.1 64.3 7.2 83.0 127.7 PCBD2 "DCOH2, DCOHM" ENSG00000132570 "Pterin-4 alpha-carbinolamine dehydratase 2" Q9H0N5 5 134904906-135007959 "Enzymes, Predicted intracellular proteins" "Tetrahydrobiopterin biosynthesis" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 47.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036428 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA036428: AB_10670103" "unprognostic (3.70e-2)" "unprognostic (3.53e-2)" "unprognostic (3.54e-3)" "unprognostic (1.36e-2)" "unprognostic (2.92e-1)" "unprognostic (1.98e-1)" "unprognostic (4.22e-1)" "unprognostic (6.43e-2)" "unprognostic (4.49e-1)" "unprognostic (1.01e-1)" "unprognostic (1.22e-1)" "unprognostic (5.18e-2)" "unprognostic (1.87e-3)" "unprognostic (4.57e-2)" "unprognostic (6.34e-2)" "unprognostic (9.32e-3)" "unprognostic (1.50e-1)" 4.9 8.1 5.4 7.0 6.6 6.6 5.3 3.0 4.4 3.9 8.7 6.5 9.4 8.0 6.5 8.4 9.3 4.9 6.9 13.8 5.0 5.3 9.2 9.8 6.5 5.0 5.6 5.2 5.1 12.9 9.6 6.1 4.8 6.8 4.7 6.4 9.6 14.2 7.9 47.0 6.7 12.7 7.6 7.0 5.5 7.1 5.5 5.8 5.3 8.3 13.5 8.1 5.6 5.5 8.2 11.5 7.2 10.1 6.3 6.6 4.3 7.8 7.6 8.1 6.1 5.6 4.8 6.0 6.3 4.9 3.6 3.6 14.2 20.1 9.4 10.6 4.2 7.1 5.3 5.5 6.0 3.3 13.1 3.7 5.3 8.1 8.5 5.4 6.1 3.8 2.6 5.9 3.7 8.7 4.2 4.2 7.3 7.7 14.1 6.3 16.1 6.4 10.4 4.5 10.8 7.4 10.2 7.6 8.3 6.6 6.7 6.1 8.0 9.4 4.9 7.8 7.1 13.7 8.1 4.6 6.9 5.2 6.1 8.0 11.0 15.0 6.4 6.2 7.5 4.5 2.7 10.1 7.2 5.1 6.3 5.0 8.2 6.3 5.3 8.6 8.2 5.4 5.3 3.3 6.3 6.1 11.5 6.6 4.3 5.4 6.6 3.0 4.1 5.0 5.3 5.6 5.2 6.8 5.8 8.9 6.4 4.5 5.6 3.2 12.0 29.7 17.8 10.7 3.4 15.7 11.8 10.5 18.3 14.5 5.4 8.4 17.2 46.7 15.8 21.0 4.9 6.2 5.8 21.7 21.4 22.3 4.1 6.7 5.9 2.5 6.6 9.5 5.0 31.5 8.4 13.5 15.4 3.5 2.1 21.4 46.7 0.0 5.3 5.6 10.4 5.3 8.5 7.5 15.8 7.2 PCDH17 "PCDH68, PCH68" ENSG00000118946 "Protocadherin 17" O14917 13 57631810-57729311 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.2;lymphoid tissue: 32.7" "Cell type enhanced" "Detected in many" 15 "Early spermatids: 31.0;Endothelial cells: 49.1;Ito cells: 86.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "eosinophil: 1.2" "Lineage enriched" "Detected in single" 13 "granulocytes: 1.2" "Cell line enhanced" "Detected in some" "AF22: 16.2;HEK 293: 10.1;U-87 MG: 6.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA026817 Uncertain Approved "Vesicles,Plasma membrane,Cytosol" NA NA 31000 Cytosol "Vesicles, Plasma membrane" "HPA026817: AB_1855044" "unprognostic (1.02e-2)" "unprognostic (2.39e-1)" "unprognostic (1.19e-1)" "unprognostic (6.52e-2)" "unprognostic (6.98e-3)" "unprognostic (1.95e-2)" "unprognostic (8.26e-4)" "unprognostic (3.56e-1)" "unprognostic (2.38e-2)" "unprognostic (2.82e-1)" "unprognostic (5.40e-2)" "unprognostic (1.03e-1)" "prognostic unfavorable (3.31e-5)" "unprognostic (1.07e-2)" "unprognostic (1.80e-1)" "unprognostic (2.35e-1)" "unprognostic (3.40e-2)" 2.0 2.4 8.0 2.1 11.2 0.3 0.9 4.6 18.2 2.9 1.2 6.2 0.3 1.1 2.6 1.3 1.7 2.5 3.6 2.3 6.5 12.1 1.6 1.4 13.5 0.9 7.4 4.8 0.8 6.2 2.0 1.0 4.7 4.4 1.2 1.2 1.1 1.0 1.1 1.8 0.6 0.7 2.6 4.4 32.7 1.8 8.9 7.7 0.0 3.4 0.4 0.8 3.4 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 16.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 2.8 0.0 0.0 0.0 1.8 0.0 0.0 0.0 10.1 0.4 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.4 0.0 2.5 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.6 1.4 0.0 1.0 0.0 0.0 0.0 6.1 0.0 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 11.2 4.6 7.8 6.5 12.1 7.4 4.8 4.4 7.7 0.0 7.0 0.0 0.0 2.4 3.5 4.2 0.0 9.4 15.9 1.8 0.0 0.2 0.0 6.9 31.0 49.1 0.0 0.0 7.0 0.1 1.8 0.3 0.0 0.0 0.5 0.0 0.0 86.5 2.8 11.9 1.7 0.8 10.1 2.8 0.0 2.1 2.1 0.0 1.1 0.0 0.0 6.5 7.6 15.8 10.1 0.9 0.0 0.0 0.0 0.1 PCDHA1 ENSG00000204970 "Protocadherin alpha 1" Q9Y5I3 5 140786136-141012347 "Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 7.1;testis: 3.1" "Cell type enhanced" "Detected in some" 24 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 2.1;Ito cells: 1.3;Sertoli cells: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "T-47d: 14.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035969 Enhanced Approved "Plasma membrane" "Secreted - unknown location" NA NA "Plasma membrane" "HPA035969: AB_10673492" "unprognostic (2.76e-5)" "unprognostic (1.19e-1)" "unprognostic (3.74e-2)" "unprognostic (1.09e-4)" "unprognostic (7.38e-2)" "unprognostic (2.86e-2)" "unprognostic (2.26e-3)" "unprognostic (1.25e-2)" "unprognostic (1.91e-2)" "unprognostic (1.81e-1)" "unprognostic (9.01e-5)" "unprognostic (2.46e-2)" "unprognostic (1.91e-1)" "unprognostic (7.57e-2)" "unprognostic (1.11e-1)" "unprognostic (1.77e-3)" "unprognostic (1.29e-1)" 0.2 1.5 4.6 0.2 4.4 0.1 0.2 3.3 7.1 0.2 0.3 0.7 0.5 0.1 0.2 0.2 0.4 0.1 5.0 3.7 0.6 0.1 0.2 0.3 3.4 0.2 0.2 1.0 1.4 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.6 0.2 3.4 0.2 0.3 3.1 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.4 1.0 0.0 0.2 1.8 0.3 14.4 0.5 0.0 1.6 1.0 0.7 0.1 0.0 0.1 0.0 0.4 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 PCDHA12 PCDH-ALPHA12 ENSG00000251664 "Protocadherin alpha 12" Q9UN75 5 140875302-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.6" "Cell type enhanced" "Detected in some" 19 "Alveolar cells type 1: 26.8;Bipolar cells: 11.2;Cone photoreceptor cells: 5.9" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 14.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 10.2;AN3-CA: 4.1;hTCEpi: 6.4;PC-3: 7.8;RT4: 7.7;SH-SY5Y: 4.4" HPA035812 Approved Approved "Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "HPA035812: AB_2674796" "unprognostic (3.95e-2)" "unprognostic (7.74e-2)" "unprognostic (7.55e-2)" "unprognostic (3.87e-2)" "unprognostic (2.74e-2)" "unprognostic (2.24e-2)" "unprognostic (2.08e-2)" "unprognostic (4.29e-2)" "unprognostic (1.07e-2)" "unprognostic (1.98e-4)" "unprognostic (3.18e-4)" "unprognostic (1.11e-1)" "unprognostic (3.21e-3)" "unprognostic (6.97e-2)" 1.0 1.7 0.9 0.3 1.2 0.0 0.9 14.6 3.7 3.5 0.4 1.1 0.0 0.1 1.0 0.5 0.2 1.9 4.3 0.3 1.0 0.7 3.8 1.7 5.7 0.2 0.5 0.8 0.3 2.4 0.9 4.6 0.0 2.3 0.4 0.1 1.5 5.7 0.3 0.1 0.2 0.2 0.6 0.8 0.2 0.3 2.1 0.2 0.0 3.4 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 2.5 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 6.4 0.0 0.2 0.2 0.0 0.4 0.0 0.0 0.0 1.4 0.0 0.0 2.4 2.6 7.8 0.0 0.0 0.0 0.3 7.7 0.3 4.4 0.0 0.9 0.1 0.5 1.6 0.0 0.0 0.2 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.2 14.6 3.7 1.0 0.7 0.5 0.8 2.3 0.2 26.8 3.2 0.0 0.0 0.0 11.2 0.4 5.1 0.0 0.0 1.8 5.9 0.0 0.0 0.9 1.1 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 4.8 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 1.3 0.0 0.4 0.2 2.9 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.1 PCDHA5 "CNR6, CNRN6, CNRS6, CRNR6, PCDH-ALPHA5" ENSG00000204965 "Protocadherin alpha 5" Q9Y5H7 5 140821604-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 13.6" "Group enriched" "Detected in some" 5 "Alveolar cells type 2: 2.2;Horizontal cells: 6.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 2.6;EFO-21: 7.5;T-47d: 7.7;WM-115: 2.8" "Low region specificity" "Detected in many" HPA044557 Approved Approved "Nuclear speckles,Plasma membrane,Mitochondria" NA NA "Plasma membrane" "Nuclear speckles, Mitochondria" "HPA044557: AB_10970597" "unprognostic (4.95e-2)" "unprognostic (6.23e-2)" "unprognostic (2.06e-1)" "unprognostic (8.81e-4)" "unprognostic (5.10e-2)" "unprognostic (6.25e-3)" "unprognostic (6.74e-2)" "unprognostic (9.79e-2)" "unprognostic (2.46e-2)" "unprognostic (4.49e-2)" "unprognostic (1.44e-2)" "unprognostic (1.10e-4)" "unprognostic (9.30e-4)" "unprognostic (1.07e-1)" "unprognostic (1.39e-1)" "unprognostic (8.17e-5)" "unprognostic (2.11e-1)" 0.9 1.2 3.4 0.5 3.6 0.6 0.6 13.6 10.2 0.6 0.6 0.4 0.0 0.5 1.2 0.5 0.4 0.5 1.1 0.3 1.6 2.0 1.1 0.4 0.7 0.4 1.3 5.1 0.6 1.2 0.4 2.5 0.4 2.3 0.6 0.5 0.0 0.4 0.4 0.4 0.5 0.5 0.7 1.1 0.4 0.7 0.9 0.1 0.0 0.5 0.0 0.3 0.5 0.2 0.6 0.6 1.6 0.5 0.3 0.3 0.2 0.0 2.6 0.9 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 7.5 0.1 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.6 1.6 1.5 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.3 0.0 0.1 7.7 0.1 0.1 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.8 1.5 0.5 0.5 0.3 0.3 0.2 0.4 0.3 0.2 0.1 0.6 0.3 0.3 1.6 0.3 0.4 0.6 0.2 0.2 3.4 3.6 13.6 7.2 1.6 2.0 1.3 5.1 2.3 0.1 0.0 2.2 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHB1 PCDH-BETA1 ENSG00000171815 "Protocadherin beta 1" Q9Y5F3 5 141051135-141059344 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "skeletal muscle: 4.9" "Cell type enhanced" "Detected in some" 18 "Alveolar cells type 2: 1.4;Basal glandular cells: 1.1;Cardiomyocytes: 2.2;Ciliated cells: 4.0;Club cells: 1.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA053921 Uncertain Uncertain "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA053921: AB_2682310" "unprognostic (5.54e-2)" "unprognostic (1.60e-2)" "unprognostic (9.01e-4)" "unprognostic (8.65e-2)" "unprognostic (8.00e-2)" "unprognostic (7.82e-2)" "unprognostic (2.63e-2)" "unprognostic (1.40e-1)" "unprognostic (8.17e-5)" "unprognostic (3.38e-2)" "unprognostic (9.40e-2)" "unprognostic (1.23e-1)" "unprognostic (5.77e-4)" 0.1 0.3 0.3 0.1 0.5 1.0 0.1 0.1 0.2 0.5 0.5 0.4 0.1 0.6 0.1 1.8 0.0 0.1 0.4 0.4 0.7 0.1 0.2 0.4 0.2 0.1 1.1 0.7 1.9 0.0 0.1 0.0 0.5 0.0 4.9 0.8 0.5 0.0 0.3 0.3 0.8 1.8 0.3 0.0 0.1 0.1 1.3 0.7 2.5 0.6 1.0 0.6 0.2 0.8 0.4 0.8 1.1 0.2 0.2 1.1 1.1 0.2 0.1 0.1 1.6 1.4 1.1 1.6 0.3 1.1 1.5 0.0 0.1 0.2 0.9 1.2 1.2 1.9 0.7 0.1 1.4 1.2 0.2 0.3 0.2 0.2 1.7 0.2 1.0 0.8 2.6 0.2 1.4 0.7 0.9 1.2 1.2 0.4 1.2 1.0 0.9 0.1 1.0 2.2 0.8 0.1 1.8 1.3 1.2 0.6 0.5 1.2 1.0 0.7 0.8 0.6 1.5 0.6 1.0 1.1 1.1 1.2 2.3 0.6 0.7 0.5 0.4 0.5 0.7 0.5 0.4 0.2 1.3 0.6 0.5 2.5 1.0 0.4 0.7 0.3 0.2 0.0 1.4 0.0 1.1 0.0 0.2 2.2 0.0 4.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.6 PCDHB11 "ME2, PCDH-BETA11" ENSG00000197479 "Protocadherin beta 11" Q9Y5F2 5 141199582-141203779 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 1: 3.0;Bipolar cells: 2.7;Peritubular cells: 3.2;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 8.2;EFO-21: 11.8;U-2 OS: 4.3" HPA045042 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA045042: AB_2679194" "unprognostic (1.32e-1)" "unprognostic (3.47e-2)" "unprognostic (7.21e-2)" "unprognostic (1.76e-1)" "unprognostic (1.18e-1)" "unprognostic (1.56e-1)" "unprognostic (2.82e-2)" "unprognostic (1.42e-1)" "unprognostic (6.78e-2)" "unprognostic (1.29e-2)" "unprognostic (1.07e-1)" "unprognostic (2.89e-1)" "unprognostic (3.87e-3)" "unprognostic (4.96e-2)" "unprognostic (1.37e-2)" "unprognostic (9.79e-2)" "unprognostic (6.47e-3)" 13.6 2.4 2.8 2.0 4.1 1.1 3.4 8.8 5.0 8.6 3.1 1.4 0.0 1.4 4.9 3.4 4.1 3.1 3.1 3.0 1.4 1.8 5.0 1.3 2.9 1.0 1.5 3.7 11.0 12.0 15.8 3.6 2.2 3.0 4.5 1.7 6.8 3.3 3.6 2.0 2.9 1.8 5.1 1.6 2.2 2.9 2.6 1.3 0.0 2.8 2.3 1.1 5.5 4.2 1.2 1.0 2.8 0.9 1.4 0.8 0.1 0.0 0.2 2.5 8.2 0.1 0.3 1.8 0.2 0.8 0.0 0.0 0.0 0.2 0.0 11.8 0.7 0.7 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.2 0.2 0.3 0.3 0.0 0.0 1.0 0.1 0.1 0.1 2.0 0.4 0.2 0.0 0.2 0.3 0.0 0.4 0.0 3.2 0.0 0.1 0.3 3.4 0.5 1.8 0.2 1.1 0.4 1.9 0.0 0.5 0.2 4.3 3.3 0.1 0.1 0.1 0.1 2.2 0.2 2.1 2.2 0.9 0.8 0.8 0.5 0.5 0.6 0.6 0.5 0.3 1.2 0.5 0.7 2.8 1.4 0.4 1.0 0.4 0.1 2.8 4.1 8.8 5.0 1.4 1.8 1.5 3.7 3.0 1.3 3.0 0.3 0.0 0.7 0.0 2.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.9 0.0 0.0 1.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 2.0 0.0 1.7 0.0 0.0 1.7 1.1 0.0 3.2 0.5 0.2 6.5 0.5 0.1 0.0 0.3 0.0 0.0 0.0 0.6 PCDHB12 PCDH-BETA12 ENSG00000120328 "Protocadherin beta 12" Q9Y5F1 5 141208697-141212571 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 8 "Bipolar cells: 3.2;Intestinal endocrine cells: 1.7;Melanocytes: 3.3;Peritubular cells: 2.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 4.8;ASC diff: 4.7;EFO-21: 5.4;RH-30: 5.8;U-2 OS: 4.4;U-2197: 4.4" HPA045042 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA045042: AB_2679194" "unprognostic (1.43e-2)" "unprognostic (3.22e-3)" "unprognostic (4.18e-3)" "unprognostic (8.43e-2)" "unprognostic (3.95e-3)" "unprognostic (7.87e-3)" "unprognostic (1.46e-1)" "unprognostic (2.95e-2)" "unprognostic (3.63e-1)" "unprognostic (9.13e-3)" "unprognostic (4.86e-2)" "unprognostic (2.94e-2)" "unprognostic (4.37e-3)" "unprognostic (3.22e-3)" "unprognostic (4.97e-3)" "unprognostic (3.83e-2)" "unprognostic (6.41e-3)" 4.2 2.5 4.4 1.9 5.0 0.4 3.4 9.1 7.5 5.8 3.3 2.5 1.5 1.3 8.0 3.5 1.8 4.9 3.9 3.9 3.1 2.2 2.6 1.5 3.6 0.9 3.0 6.4 8.3 4.0 3.6 13.9 2.0 3.7 4.5 1.8 3.2 1.9 3.9 1.8 1.6 1.7 6.8 3.9 2.6 2.1 3.1 2.7 0.0 1.9 1.2 0.9 3.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 4.8 4.7 2.7 0.7 0.1 3.4 0.3 0.4 0.0 0.0 0.0 5.4 0.5 2.5 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.1 1.2 0.0 0.0 1.3 0.4 0.0 0.0 1.2 1.2 0.3 0.0 0.0 0.1 0.0 1.0 0.9 5.8 0.0 0.0 0.0 2.8 1.6 0.0 0.0 1.0 0.4 3.7 0.8 0.3 0.7 4.4 4.4 0.1 0.0 0.0 0.0 2.8 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 5.0 9.1 7.5 3.1 2.2 3.0 6.4 3.7 2.7 0.0 0.6 0.0 0.0 0.3 3.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.6 0.3 0.0 0.0 0.8 0.0 0.8 0.0 0.0 0.0 0.1 0.0 1.7 0.6 0.0 0.0 1.1 0.0 3.3 0.0 0.0 1.4 0.4 0.0 2.5 0.0 0.3 0.0 0.5 0.9 0.0 0.1 0.0 0.0 0.0 0.0 PCDHB16 "KIAA1621, ME1, PCDH-BETA16, PCDH3X, PCDHB8a" ENSG00000272674 "Protocadherin beta 16" Q9NRJ7 5 141181399-141186399 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 17.5" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 13.4;Horizontal cells: 7.9;Muller glia cells: 6.3" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 12.2;LHCN-M2: 6.5;T-47d: 6.8;U-138 MG: 26.9;U-2197: 7.2;U-87 MG: 6.4" HPA014668 Approved "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA014668: AB_1855055" "unprognostic (3.44e-3)" "unprognostic (4.03e-2)" "unprognostic (8.14e-2)" "unprognostic (8.60e-2)" "unprognostic (2.78e-2)" "unprognostic (1.36e-2)" "unprognostic (1.17e-1)" "unprognostic (4.03e-2)" "unprognostic (3.13e-2)" "unprognostic (7.55e-3)" "unprognostic (3.49e-2)" "unprognostic (9.57e-2)" "unprognostic (3.55e-2)" "unprognostic (7.49e-3)" "unprognostic (2.00e-2)" "unprognostic (7.92e-3)" "unprognostic (2.83e-3)" 3.7 2.6 2.1 1.4 2.7 0.2 2.5 9.7 3.1 8.4 1.1 5.3 0.0 0.4 6.4 6.2 3.3 2.8 2.5 4.5 1.8 2.5 1.0 3.2 0.5 1.7 0.4 9.8 2.6 10.9 17.5 1.5 3.4 6.2 1.1 7.1 2.2 1.1 3.6 1.5 1.1 3.5 2.5 1.1 0.5 2.3 5.0 0.0 3.1 0.0 0.3 6.5 3.3 0.9 1.0 1.4 0.6 0.9 0.8 0.1 0.0 0.0 0.6 12.2 5.5 3.9 0.3 0.5 2.8 0.0 0.2 0.1 0.2 0.0 4.5 0.6 1.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.0 2.0 0.1 0.1 0.0 1.1 6.5 0.3 0.0 0.0 0.9 0.0 0.1 0.0 2.3 0.0 0.3 0.1 0.4 1.7 0.2 0.4 2.1 0.3 6.8 0.0 0.3 26.9 1.3 7.2 1.3 0.0 0.0 0.0 6.4 0.0 3.4 0.7 0.5 0.4 0.6 0.5 0.3 0.6 0.5 0.6 0.3 0.9 0.8 0.6 1.4 0.9 0.6 1.0 0.5 0.1 3.0 1.0 0.0 0.0 0.7 13.4 1.2 2.5 0.0 0.0 1.8 0.0 0.0 1.7 0.7 1.0 2.7 0.0 0.0 4.1 0.0 3.8 0.1 0.0 0.0 0.1 7.9 1.7 1.3 0.3 1.1 4.4 0.0 0.0 0.0 0.0 6.3 1.7 0.0 5.3 0.6 1.1 0.0 3.5 4.1 0.0 1.3 0.0 0.0 0.0 0.0 PCDHB5 "DKFZp586B0217, PCDH-BETA5" ENSG00000113209 "Protocadherin beta 5" Q9Y5E4 5 141135218-141138625 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 9 "Early spermatids: 4.5;Spermatocytes: 10.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 12.0;GAMG: 8.9;NTERA-2: 11.3;RH-30: 9.0;SCLC-21H: 10.6;SuSa: 14.6;T-47d: 11.2;U-138 MG: 21.0;U-2 OS: 9.4;WM-115: 9.3" "Low region specificity" "Detected in all" "HPA013191, HPA067473" Approved Approved "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA013191: AB_1855059, HPA067473: " "unprognostic (2.21e-1)" "unprognostic (4.71e-2)" "unprognostic (4.05e-3)" "unprognostic (1.81e-1)" "unprognostic (2.84e-2)" "unprognostic (5.23e-2)" "unprognostic (2.27e-2)" "unprognostic (1.76e-1)" "unprognostic (9.41e-2)" "unprognostic (1.25e-1)" "unprognostic (1.32e-2)" "unprognostic (3.16e-1)" "unprognostic (1.32e-1)" "unprognostic (1.06e-3)" "unprognostic (6.65e-2)" "unprognostic (3.14e-2)" "unprognostic (1.55e-3)" 3.8 4.6 8.1 1.6 10.7 0.7 3.6 7.7 11.0 9.0 2.9 7.9 3.6 1.2 10.4 9.2 2.5 7.5 4.9 4.9 7.9 4.1 6.6 2.3 4.0 1.1 3.6 7.1 14.9 11.2 6.3 7.6 1.6 6.4 7.6 1.4 6.9 5.6 5.9 3.0 1.9 1.5 5.7 5.2 2.2 2.4 6.1 5.9 0.0 6.6 0.7 1.0 4.4 3.2 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.6 12.0 0.2 0.9 0.5 0.1 0.2 0.0 0.2 0.2 0.0 0.0 0.0 6.2 0.0 8.9 0.0 6.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.6 0.5 0.0 0.0 0.0 2.4 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 9.0 0.0 0.0 0.0 10.6 0.3 0.0 0.1 3.6 14.6 11.2 2.6 0.0 21.0 9.4 3.4 0.0 0.0 0.0 0.0 1.1 0.0 9.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 8.1 10.7 7.7 10.5 7.9 4.1 3.6 7.1 6.4 5.9 0.0 0.0 0.0 1.5 0.0 3.7 0.6 2.5 0.0 0.0 1.8 0.0 0.0 0.0 2.4 4.5 0.1 0.0 0.0 3.1 0.0 1.0 0.9 0.0 0.2 0.0 3.2 0.0 0.6 0.0 2.7 2.8 0.0 0.0 0.0 0.0 4.3 3.1 0.0 4.2 0.2 0.7 0.0 1.5 10.3 0.0 0.1 0.0 0.0 0.0 0.6 PCDHGA1 PCDH-GAMMA-A1 ENSG00000204956 "Protocadherin gamma subfamily A, 1" Q9Y5H4 5 141330571-141512981 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 11.7" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 3.0;Bipolar cells: 1.6;Cardiomyocytes: 1.7;Horizontal cells: 3.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "LHCN-M2: 7.0;T-47d: 11.5;WM-115: 5.2" "Low region specificity" "Detected in many" "HPA008755, HPA010580, HPA036547" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA036547: AB_10669798" "unprognostic (9.50e-4)" "unprognostic (2.39e-2)" "unprognostic (9.88e-2)" "unprognostic (4.42e-3)" "unprognostic (3.39e-1)" "unprognostic (3.97e-2)" "unprognostic (2.42e-1)" "unprognostic (5.61e-3)" "unprognostic (1.70e-2)" "unprognostic (6.89e-2)" "unprognostic (2.86e-1)" "unprognostic (1.03e-1)" "unprognostic (1.07e-3)" "unprognostic (4.76e-2)" "unprognostic (1.38e-1)" "unprognostic (2.73e-2)" "unprognostic (1.45e-3)" 1.4 1.3 2.7 0.9 11.7 1.0 1.1 6.8 7.9 1.4 1.2 2.7 0.5 1.0 2.8 3.9 1.3 1.1 0.8 3.9 3.5 2.8 1.2 0.5 1.2 1.0 2.5 2.5 2.9 2.5 2.8 6.1 2.3 5.4 1.5 0.9 2.4 1.1 1.0 1.7 1.5 0.6 1.8 2.4 1.1 0.8 2.7 1.1 0.0 1.3 0.6 0.7 1.2 0.9 1.2 0.9 2.7 0.5 0.8 1.0 0.2 0.1 0.4 0.5 1.9 1.2 2.1 0.3 1.7 1.1 0.5 1.0 0.5 0.2 0.5 2.8 1.1 0.9 0.2 0.2 0.3 1.1 0.3 0.3 0.2 0.4 0.3 0.3 0.1 0.2 1.8 0.5 0.0 0.7 3.4 0.1 0.3 0.2 0.8 7.0 0.1 0.2 0.8 0.3 0.1 0.3 3.1 2.7 0.3 0.3 0.3 1.8 2.1 0.3 0.9 1.7 0.5 11.5 0.4 0.8 3.3 0.7 1.6 0.4 0.3 1.0 0.2 3.9 0.2 5.2 2.7 0.5 0.5 0.7 0.4 0.4 0.7 0.7 0.5 0.2 1.2 1.0 0.8 1.1 0.8 0.5 0.9 0.6 0.2 2.7 11.7 6.8 6.1 3.5 2.8 2.5 2.5 5.4 1.1 3.0 0.0 0.0 0.0 0.0 1.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 PCDHGA12 "CDH21, FIB3, KIAA0588, PCDH-GAMMA-A12" ENSG00000253159 "Protocadherin gamma subfamily A, 12" O60330 5 141430589-141512979 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.9" "Cell type enhanced" "Detected in some" 16 "Bipolar cells: 3.5;Cardiomyocytes: 1.8;Ito cells: 1.3" "Cancer enhanced" "Detected in many" "melanoma: 5.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 3.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ: 7.7;BJ hTERT+: 12.9;fHDF/TERT166: 19.1;HHSteC: 6.3;HSkMC: 14.3;TIME: 6.1" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (3.17e-3)" "unprognostic (2.71e-2)" "unprognostic (1.04e-2)" "unprognostic (2.67e-1)" "unprognostic (2.74e-1)" "unprognostic (5.06e-2)" "unprognostic (1.99e-1)" "unprognostic (9.01e-3)" "unprognostic (1.19e-1)" "unprognostic (4.65e-4)" "unprognostic (2.98e-1)" "unprognostic (3.02e-1)" "unprognostic (1.28e-4)" "unprognostic (8.30e-3)" "unprognostic (1.57e-1)" "unprognostic (2.42e-1)" "unprognostic (6.85e-3)" 5.1 12.7 14.8 2.8 18.9 0.7 2.4 4.7 13.8 4.9 1.8 8.6 0.6 1.4 5.4 2.3 3.5 2.7 11.3 6.5 15.7 5.6 3.1 2.8 6.5 1.6 4.7 7.3 6.2 3.6 2.0 2.7 6.5 8.4 3.5 1.7 3.4 1.7 4.9 1.9 5.1 1.5 5.3 8.4 3.7 2.2 1.6 12.4 0.4 3.0 0.6 1.7 4.5 3.6 3.7 0.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.6 1.2 0.1 7.7 12.9 0.0 0.0 0.0 0.0 0.4 0.0 19.1 0.0 2.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.3 0.0 0.0 14.3 0.0 3.8 0.0 0.0 4.5 0.0 0.0 0.0 2.7 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 6.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 14.8 18.9 4.7 10.4 15.7 5.6 4.7 7.3 8.4 12.4 0.0 0.0 0.0 0.2 0.0 3.5 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.3 0.3 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.3 0.1 0.0 0.4 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHGA2 PCDH-GAMMA-A2 ENSG00000081853 "Protocadherin gamma subfamily A, 2" Q9Y5H1 5 141338760-141512979 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 2.7;Cardiomyocytes: 1.6;Leydig cells: 1.1;Peritubular cells: 2.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 9.8;BJ: 5.4;fHDF/TERT166: 6.3;HSkMC: 5.0;hTERT-RPE1: 5.8" "Low region specificity" "Detected in all" "HPA008755, HPA010580, HPA038625" Approved Approved "Nucleoplasm,Nucleoli,Vesicles,Plasma membrane,Focal adhesion sites,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Nucleoli, Focal adhesion sites, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA038625: AB_2732480" "unprognostic (2.43e-3)" "unprognostic (2.10e-2)" "unprognostic (1.32e-2)" "unprognostic (4.54e-1)" "unprognostic (2.92e-1)" "unprognostic (1.14e-1)" "unprognostic (3.01e-1)" "unprognostic (2.82e-1)" "unprognostic (1.56e-1)" "unprognostic (1.18e-1)" "unprognostic (9.01e-2)" "unprognostic (4.32e-2)" "unprognostic (8.45e-3)" "unprognostic (9.68e-3)" "unprognostic (1.04e-2)" "unprognostic (1.18e-2)" "unprognostic (2.23e-4)" 5.1 4.3 6.7 2.1 8.0 0.6 4.2 5.2 12.6 6.6 2.6 4.6 1.0 0.9 6.5 5.7 2.4 5.5 5.5 11.1 6.5 4.6 3.3 2.4 4.6 1.1 6.0 2.3 15.3 8.4 9.2 10.6 2.2 7.8 5.3 1.4 13.8 3.3 5.8 2.6 2.9 1.4 5.2 5.6 1.9 2.1 10.4 3.5 0.0 4.3 1.2 1.1 3.2 5.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.5 0.3 3.9 9.8 0.1 5.4 2.1 0.5 0.9 0.1 0.1 0.1 0.7 6.3 0.8 0.2 0.0 0.4 1.3 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 5.0 0.2 0.1 0.3 5.8 2.0 0.0 0.0 0.1 0.9 0.0 0.0 0.1 0.0 0.0 0.1 1.4 0.3 0.2 0.8 0.0 0.3 0.7 0.0 3.6 0.1 0.5 0.7 0.0 3.3 0.9 0.5 0.3 0.1 0.0 0.4 0.0 2.3 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 8.0 5.2 7.2 6.5 4.6 6.0 2.3 7.8 3.5 0.0 0.0 0.0 0.1 0.0 2.7 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.5 0.3 0.3 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 PCDHGA3 PCDH-GAMMA-A3 ENSG00000254245 "Protocadherin gamma subfamily A, 3" Q9Y5H0 5 141343829-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 20 "Bipolar cells: 2.4;Cardiomyocytes: 1.1;Horizontal cells: 3.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AF22: 11.2;BJ: 3.7;EFO-21: 9.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (6.47e-2)" "unprognostic (4.79e-2)" "unprognostic (1.48e-2)" "unprognostic (1.64e-1)" "unprognostic (4.53e-2)" "unprognostic (1.03e-1)" "unprognostic (2.35e-1)" "unprognostic (1.85e-1)" "unprognostic (7.44e-2)" "unprognostic (1.08e-1)" "unprognostic (1.28e-1)" "unprognostic (3.17e-2)" "unprognostic (2.43e-1)" "unprognostic (2.32e-3)" "unprognostic (7.12e-3)" "unprognostic (3.31e-2)" "unprognostic (2.52e-4)" 4.0 4.5 11.7 1.4 10.5 0.7 2.5 6.9 13.7 4.7 1.3 7.9 0.0 0.7 4.5 3.5 1.5 2.9 3.5 12.2 8.5 5.8 2.5 2.5 2.6 1.0 6.6 7.7 8.6 3.6 1.8 6.3 5.7 8.7 3.0 1.3 4.6 2.9 3.2 1.5 1.9 1.1 3.6 6.0 1.5 1.2 5.2 3.8 0.0 3.3 1.3 1.0 1.7 2.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.1 0.2 1.5 0.0 3.7 0.3 0.0 0.1 0.0 0.0 0.1 9.2 0.8 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.9 0.0 0.0 0.0 0.3 1.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.4 0.1 0.5 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 10.5 6.9 13.7 8.5 5.8 6.6 7.7 8.7 3.8 0.0 0.0 0.0 0.1 0.0 2.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 PCDHGA4 PCDH-GAMMA-A4 ENSG00000262576 "Protocadherin gamma subfamily A, 4" Q9Y5G9 5 141355025-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "MAIT T-cell: 1.9" "Lineage enriched" "Detected in single" 7 "T-cells: 1.9" "Cell line enhanced" "Detected in many" "ASC TERT1: 10.3;BJ: 5.7;HSkMC: 6.0;HUVEC TERT2: 5.7;U-87 MG: 8.2" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (1.27e-2)" "unprognostic (4.55e-3)" "unprognostic (2.00e-2)" "unprognostic (6.54e-4)" "unprognostic (1.87e-2)" "unprognostic (1.06e-2)" "unprognostic (1.02e-1)" "unprognostic (1.20e-2)" "unprognostic (5.62e-2)" "unprognostic (3.76e-1)" "unprognostic (6.31e-2)" "unprognostic (1.74e-1)" "unprognostic (2.94e-2)" "unprognostic (1.30e-2)" "unprognostic (2.30e-2)" "unprognostic (1.65e-1)" "unprognostic (2.31e-4)" 5.4 4.7 6.5 1.8 8.3 0.5 3.0 8.5 11.2 4.8 2.0 10.4 1.5 1.2 5.0 3.0 1.9 3.4 3.1 4.8 6.3 5.9 2.0 2.7 3.6 0.9 5.6 8.1 5.8 6.7 8.5 3.4 2.8 6.1 4.1 1.4 3.5 4.3 4.2 1.5 1.8 1.2 5.0 5.9 1.3 1.4 2.7 4.0 0.0 2.6 2.7 0.9 2.3 2.5 0.3 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.2 1.0 0.6 4.5 10.3 0.0 5.7 4.6 0.3 1.1 0.0 0.1 1.0 2.0 4.8 1.8 0.1 0.2 0.2 0.6 0.0 0.5 0.0 0.0 0.0 1.8 0.0 0.4 6.0 0.2 0.1 0.0 3.5 5.7 0.0 0.2 0.3 2.4 0.8 0.3 0.2 0.2 0.0 0.3 0.3 1.6 0.1 0.3 0.0 0.8 1.7 0.3 0.3 1.1 0.5 2.2 0.0 3.7 2.4 0.7 3.2 0.5 0.2 0.3 0.2 8.2 0.0 1.6 0.0 0.0 0.0 0.0 0.0 1.9 0.2 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.5 8.3 8.5 9.3 6.3 5.9 5.6 8.1 6.1 4.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 PCDHGA5 "CDH-GAMMA-A5, ME3, PCDH-GAMMA-A5" ENSG00000253485 "Protocadherin gamma subfamily A, 5" Q9Y5G8 5 141364232-141512979 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 19.1" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 10.6;Horizontal cells: 9.5;Sertoli cells: 6.5" "Cancer enhanced" "Detected in single" "prostate cancer: 1.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 7 "ASC diff: 18.9;ASC TERT1: 7.5" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (3.61e-2)" "unprognostic (1.04e-2)" "unprognostic (5.28e-2)" "unprognostic (4.83e-1)" "unprognostic (6.60e-3)" "unprognostic (5.71e-2)" "unprognostic (8.46e-2)" "unprognostic (6.53e-3)" "unprognostic (4.07e-1)" "unprognostic (9.40e-2)" "unprognostic (1.38e-1)" "unprognostic (1.05e-1)" "unprognostic (1.12e-1)" "unprognostic (5.90e-2)" "unprognostic (3.93e-2)" "unprognostic (1.55e-2)" "unprognostic (8.38e-4)" 4.0 2.7 6.1 1.8 9.1 0.9 3.9 19.1 9.6 9.0 2.7 7.7 4.1 1.0 7.6 3.2 3.3 4.7 4.5 4.9 6.9 4.0 1.5 1.2 3.3 1.3 3.2 3.8 6.6 1.7 3.3 3.7 2.7 4.6 5.6 1.6 4.1 2.5 4.0 1.5 3.0 1.5 4.3 6.3 1.4 1.7 1.7 3.7 0.0 1.8 0.9 1.0 2.5 4.2 0.9 0.8 1.6 0.6 1.9 0.7 0.2 0.0 0.5 0.3 0.1 18.9 7.5 0.0 0.8 0.2 0.1 0.4 0.0 0.0 0.9 0.4 0.3 1.0 0.0 0.0 0.3 0.2 0.0 0.2 0.0 0.2 0.1 0.2 0.1 0.1 1.8 0.2 0.0 0.0 0.4 0.6 0.0 0.1 0.6 0.8 0.3 0.5 0.7 0.1 0.0 0.3 0.9 0.7 0.1 0.0 0.0 0.2 0.3 0.1 0.3 0.3 0.3 1.6 0.0 1.0 0.7 0.2 1.0 0.7 0.1 1.0 0.1 0.3 0.2 0.8 1.5 0.6 0.6 0.7 0.3 0.3 0.6 0.6 0.4 0.1 0.9 0.7 0.7 1.6 1.9 0.2 0.8 0.4 0.2 6.1 9.1 19.1 9.6 6.9 4.0 3.2 3.8 4.6 3.7 0.0 0.6 0.0 0.6 0.1 10.6 1.6 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.2 0.0 0.4 0.3 1.1 0.0 0.1 9.5 0.0 1.8 0.3 0.0 3.4 0.0 0.0 0.0 0.0 3.3 0.2 0.0 1.8 0.0 1.1 6.5 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 PCDHGA6 PCDH-GAMMA-A6 ENSG00000253731 "Protocadherin gamma subfamily A, 6" Q9Y5G7 5 141373914-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.6" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 9.7;Cardiomyocytes: 4.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HSkMC: 5.8;SCLC-21H: 11.2;T-47d: 6.5;WM-115: 14.0" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (4.49e-2)" "unprognostic (8.91e-3)" "unprognostic (5.45e-2)" "unprognostic (1.43e-1)" "unprognostic (1.15e-1)" "unprognostic (1.49e-2)" "unprognostic (1.16e-1)" "unprognostic (1.18e-1)" "unprognostic (1.25e-1)" "unprognostic (2.07e-2)" "unprognostic (3.86e-3)" "unprognostic (2.02e-2)" "unprognostic (5.26e-2)" "unprognostic (7.44e-2)" "unprognostic (5.21e-2)" "unprognostic (1.11e-1)" "unprognostic (4.19e-3)" 4.1 3.8 6.1 2.3 8.4 0.8 2.9 19.6 10.8 7.9 3.4 8.3 2.9 1.0 6.9 4.7 2.6 4.3 3.6 3.7 5.0 4.3 2.8 1.7 3.3 1.4 2.9 4.7 9.7 2.5 2.5 4.5 6.9 3.3 4.0 1.6 5.8 4.1 5.3 2.1 4.7 1.5 6.1 2.8 2.8 1.7 2.2 2.9 0.2 3.8 1.2 1.5 4.6 3.6 1.3 0.7 2.8 0.6 0.5 0.8 0.2 0.1 0.4 3.2 0.5 1.6 5.4 0.1 2.3 0.8 1.2 1.2 0.0 0.2 2.2 3.1 3.7 1.2 0.5 0.1 0.5 0.8 0.0 0.3 0.0 0.3 0.3 0.9 0.1 0.1 5.8 0.4 0.3 0.1 1.1 1.8 0.1 0.3 1.3 0.4 0.5 0.7 1.8 0.3 0.1 0.1 1.5 0.4 0.0 0.4 0.1 11.2 0.9 0.1 0.3 0.7 0.7 6.5 0.1 5.5 0.9 0.4 0.9 0.8 0.4 1.8 0.4 0.9 0.8 14.0 1.8 0.6 0.3 0.8 0.3 0.3 0.8 0.6 0.2 0.1 1.3 0.3 0.5 2.8 0.5 0.3 0.7 0.5 0.2 6.1 8.4 19.6 10.8 5.0 4.3 2.9 4.7 3.3 2.9 0.0 2.1 0.5 0.5 0.0 9.7 4.5 2.5 1.4 1.2 0.0 0.0 0.0 0.0 0.3 0.4 1.0 0.0 0.0 1.3 0.1 0.3 0.4 0.0 0.5 0.1 1.6 0.0 1.8 0.0 0.0 1.1 0.3 0.0 0.0 0.0 1.9 0.5 0.0 2.1 0.0 1.0 0.0 0.5 0.1 0.2 0.0 0.2 0.0 0.0 0.1 PCDHGA7 PCDH-GAMMA-A7 ENSG00000253537 "Protocadherin gamma subfamily A, 7" Q9Y5G6 5 141382739-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.9" "Cell type enhanced" "Detected in some" 22 "Bipolar cells: 3.5;Cardiomyocytes: 1.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 9.9;BJ hTERT+: 17.3;hTERT-RPE1: 9.3;SH-SY5Y: 15.5;T-47d: 6.8" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (1.00e-2)" "unprognostic (4.73e-3)" "unprognostic (1.42e-1)" "unprognostic (7.49e-2)" "unprognostic (2.10e-1)" "unprognostic (6.85e-2)" "unprognostic (2.61e-1)" "unprognostic (1.50e-1)" "unprognostic (1.85e-1)" "unprognostic (5.78e-2)" "unprognostic (3.72e-2)" "unprognostic (1.66e-1)" "unprognostic (3.56e-1)" "unprognostic (4.21e-3)" "unprognostic (6.30e-2)" "unprognostic (4.99e-2)" "unprognostic (1.42e-3)" 1.7 2.0 3.1 1.3 9.0 0.6 2.1 5.3 14.9 3.5 3.0 7.1 2.1 1.0 4.2 4.1 2.2 3.3 1.9 3.0 5.1 3.3 3.2 1.9 2.2 1.0 5.1 6.6 4.7 2.5 4.6 3.4 4.8 5.4 3.7 1.5 5.8 2.6 3.3 1.6 3.8 1.2 3.0 6.3 1.3 1.4 2.1 5.1 0.0 6.6 1.5 1.0 2.4 2.5 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.4 1.9 0.0 5.8 9.9 0.0 2.6 17.3 3.5 5.2 0.0 0.0 0.4 4.3 0.5 0.1 0.1 0.0 0.1 2.9 0.0 0.3 0.0 0.4 0.1 1.0 0.0 0.0 4.3 0.1 0.0 0.6 9.3 1.4 0.0 0.0 0.1 0.0 0.1 0.5 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 15.5 0.0 0.1 0.1 3.3 6.8 0.0 5.2 0.1 0.1 2.5 0.0 0.1 1.5 0.0 0.4 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 3.1 9.0 5.3 7.7 5.1 3.3 5.1 6.6 5.4 5.1 0.0 0.0 0.0 0.4 0.0 3.5 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.1 0.6 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.3 PCDHGA8 "KIAA0327, PCDH-GAMMA-A8" ENSG00000253767 "Protocadherin gamma subfamily A, 8" Q9Y5G5 5 141390157-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "ductus deferens: 7.1" "Cell type enhanced" "Detected in some" 17 "Bipolar cells: 10.4;Cardiomyocytes: 2.5;Horizontal cells: 3.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "basophil: 2.9;neutrophil: 2.8" "Lineage enriched" "Detected in single" 4 "granulocytes: 2.9" "Low cell line specificity" "Detected in some" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (3.28e-2)" "unprognostic (2.27e-2)" "unprognostic (4.86e-2)" "unprognostic (3.38e-2)" "unprognostic (2.80e-1)" "unprognostic (4.10e-2)" "unprognostic (7.68e-2)" "unprognostic (2.30e-2)" "unprognostic (1.83e-2)" "unprognostic (2.23e-1)" "unprognostic (1.24e-1)" "unprognostic (1.35e-2)" "unprognostic (1.49e-3)" "unprognostic (7.59e-2)" "unprognostic (3.92e-2)" "unprognostic (3.38e-1)" "unprognostic (1.99e-3)" 0.6 0.7 0.8 0.7 0.6 2.5 0.7 2.3 2.2 1.2 1.2 1.0 7.1 0.4 2.3 1.5 2.1 0.7 0.9 2.0 1.4 0.5 0.5 0.9 1.1 0.7 0.5 0.4 2.6 0.6 0.2 1.9 1.4 3.5 0.9 0.8 0.4 0.8 0.5 2.2 2.5 1.1 0.7 1.6 0.7 0.7 1.0 1.3 1.1 2.4 0.4 0.6 0.6 1.2 0.7 0.4 2.9 0.4 0.5 0.3 0.1 0.3 0.2 1.1 0.6 1.1 2.6 0.6 2.4 1.5 1.7 0.7 0.2 0.4 1.1 1.0 1.8 0.3 0.4 0.0 0.0 1.3 0.3 0.2 0.3 0.5 0.3 0.1 0.4 0.8 1.4 0.1 0.5 0.1 0.5 0.4 0.2 0.2 0.9 0.2 0.2 0.5 0.7 2.6 0.0 0.1 1.0 0.2 0.1 0.1 0.3 0.7 0.6 0.3 0.9 0.4 2.4 1.2 1.7 2.5 2.6 0.9 0.6 0.2 0.3 0.3 0.4 1.3 0.4 1.3 2.9 0.4 0.5 0.3 0.2 0.2 0.4 0.3 0.2 0.1 0.7 0.2 0.3 2.8 0.5 0.3 0.4 0.2 0.1 0.8 0.6 2.3 2.2 1.4 0.5 0.5 0.4 3.5 1.3 0.0 1.1 0.0 0.8 0.0 10.4 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.1 3.2 0.0 0.6 0.8 0.0 2.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 1.4 0.0 1.7 0.0 0.2 0.6 0.9 0.0 0.0 0.0 0.0 0.4 PCDHGA9 PCDH-GAMMA-A9 ENSG00000261934 "Protocadherin gamma subfamily A, 9" Q9Y5G4 5 141402932-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 3.7;Club cells: 1.2;Horizontal cells: 3.2;Muller glia cells: 1.3" "Cancer enhanced" "Detected in some" "glioma: 3.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 4.1;HSkMC: 4.6;hTERT-RPE1: 19.1;TIME: 5.0;U-87 MG: 5.8" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (1.98e-2)" "unprognostic (7.47e-3)" "unprognostic (9.86e-3)" "unprognostic (2.22e-1)" "unprognostic (4.68e-2)" "unprognostic (4.96e-2)" "unprognostic (1.61e-1)" "unprognostic (2.15e-1)" "unprognostic (2.39e-1)" "unprognostic (1.87e-3)" "unprognostic (2.26e-1)" "unprognostic (1.79e-1)" "unprognostic (4.48e-3)" "unprognostic (1.94e-2)" "unprognostic (8.83e-2)" "unprognostic (2.71e-1)" "unprognostic (1.83e-2)" 5.6 5.4 12.0 2.6 12.6 0.9 3.7 11.5 17.3 6.9 2.7 11.2 0.1 2.1 7.6 3.9 4.8 6.3 6.5 3.2 10.3 8.5 3.0 2.8 5.0 2.1 9.6 7.1 9.1 3.0 3.8 3.0 3.6 10.9 5.2 2.7 7.7 3.8 7.3 1.9 5.5 2.0 5.9 13.0 3.6 2.9 2.0 5.9 0.0 4.6 1.4 2.5 4.8 3.7 0.5 0.3 1.0 0.5 0.2 1.0 0.0 0.0 0.2 0.7 1.8 0.1 0.3 0.2 0.8 0.0 0.7 0.7 0.3 0.4 1.4 4.1 2.2 0.3 0.1 0.1 0.2 0.8 0.0 0.3 0.0 0.1 0.0 1.3 0.0 0.3 4.6 0.2 0.4 0.3 19.1 1.1 0.1 0.1 0.2 0.4 0.4 0.2 0.5 0.2 0.1 0.0 0.2 0.5 0.0 0.2 0.2 0.5 1.2 0.4 0.1 0.6 0.5 1.1 0.5 5.0 0.3 0.3 0.1 2.7 0.2 0.1 0.1 5.8 0.1 1.0 1.0 0.5 0.3 1.0 0.3 0.6 0.3 0.4 0.2 0.1 0.5 0.4 0.7 1.0 0.2 0.2 0.3 0.1 0.0 12.0 12.6 11.5 16.2 10.3 8.5 9.6 7.1 10.9 5.9 0.0 0.0 0.0 0.1 0.2 3.7 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 PCDHGB1 PCDH-GAMMA-B1 ENSG00000254221 "Protocadherin gamma subfamily B, 1" Q9Y5G3 5 141350102-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "brain: 32.2;pituitary gland: 13.7" "Group enriched" "Detected in some" 17 "Early spermatids: 5.4;Late spermatids: 5.9;Melanocytes: 1.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 14 "naive CD8 T-cell: 1.3" "Lineage enriched" "Detected in single" 14 "T-cells: 1.3" "Cell line enhanced" "Detected in many" "ASC diff: 14.7;ASC TERT1: 7.7;hTERT-RPE1: 8.0;T-47d: 9.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580, HPA076182" Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane,Focal adhesion sites,Midbody" Yes No "Vesicles, Plasma membrane" "Nucleoplasm, Focal adhesion sites, Midbody" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA076182: AB_2686783" "unprognostic (1.53e-2)" "unprognostic (1.94e-3)" "unprognostic (3.21e-1)" "unprognostic (4.38e-3)" "unprognostic (2.98e-1)" "unprognostic (8.36e-3)" "unprognostic (2.37e-1)" "unprognostic (9.57e-2)" "unprognostic (8.57e-2)" "unprognostic (1.06e-1)" "unprognostic (3.44e-2)" "unprognostic (4.78e-2)" "unprognostic (6.33e-2)" "unprognostic (3.15e-2)" "unprognostic (8.75e-2)" "unprognostic (1.93e-1)" "unprognostic (7.63e-3)" 2.3 2.7 8.2 1.4 7.5 1.0 2.1 4.3 32.2 2.5 1.4 9.4 0.1 1.2 3.7 2.0 1.7 1.9 2.1 2.2 7.6 5.7 2.1 1.3 2.4 1.2 5.5 5.0 4.1 2.8 1.4 13.7 1.6 7.0 2.5 1.4 2.6 1.7 3.1 1.1 1.4 1.3 3.0 6.9 1.4 1.2 1.5 5.6 0.0 2.5 0.0 1.2 1.4 1.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 2.0 1.8 0.0 14.7 7.7 0.1 1.4 3.6 0.5 0.8 0.2 0.5 0.5 4.7 0.5 3.5 0.6 0.4 0.2 0.5 0.0 0.9 0.0 0.2 1.3 0.2 0.0 0.1 1.2 0.0 0.0 0.0 8.0 0.1 0.0 0.2 0.2 3.3 1.8 0.4 0.3 0.2 0.0 0.0 0.0 2.7 0.1 0.0 0.0 1.1 0.8 0.0 0.9 0.1 1.5 9.6 0.0 1.1 0.2 1.6 1.2 0.0 0.0 2.6 0.3 2.9 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 8.2 7.5 4.3 9.6 7.6 5.7 5.5 5.0 7.0 5.6 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 1.7 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 PCDHGB3 PCDH-GAMMA-B3 ENSG00000262209 "Protocadherin gamma subfamily B, 3" Q9Y5G1 5 141370264-141512979 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 13.5;ASC TERT1: 10.9;TIME: 6.8" "HPA008755, HPA010580, HPA035822, HPA035823" Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Vesicles, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA035822: , HPA035823: AB_2674802" "unprognostic (6.93e-3)" "unprognostic (9.10e-4)" "unprognostic (1.35e-1)" "unprognostic (7.05e-2)" "unprognostic (1.51e-1)" "unprognostic (1.06e-1)" "unprognostic (1.24e-1)" "unprognostic (7.83e-2)" "unprognostic (1.92e-1)" "unprognostic (6.08e-2)" "unprognostic (2.04e-1)" "unprognostic (3.51e-2)" "unprognostic (5.81e-2)" "unprognostic (3.11e-1)" "unprognostic (3.62e-2)" "unprognostic (3.89e-2)" "unprognostic (2.80e-3)" 4.1 1.7 3.3 1.6 6.5 0.5 3.1 3.5 5.6 3.0 3.0 7.2 0.7 0.7 4.9 3.7 3.3 3.3 2.9 4.6 3.3 2.3 2.9 2.0 2.5 3.7 1.9 3.8 5.2 4.2 4.6 5.4 2.3 2.6 2.6 2.2 3.1 6.6 2.6 1.9 3.3 1.4 4.3 2.9 2.4 2.3 1.5 2.8 0.3 3.4 3.2 3.5 2.7 4.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.5 0.3 13.5 10.9 0.2 1.4 2.5 0.9 1.1 0.0 0.0 2.2 0.4 4.3 0.8 0.6 0.0 0.3 0.7 0.0 0.3 0.0 0.3 0.1 0.6 0.1 0.0 2.7 0.6 0.2 0.1 0.2 1.2 0.0 0.3 1.0 0.3 0.4 0.7 1.1 0.1 0.0 0.1 1.9 0.7 0.0 0.2 0.1 3.0 0.6 0.0 0.1 0.3 0.4 0.8 0.0 6.8 0.6 0.1 0.7 0.7 0.3 2.1 0.2 0.6 0.6 1.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.3 6.5 3.5 5.6 3.3 2.3 1.9 3.8 2.6 2.8 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHGC3 "PC-43, PC43, PCDH-GAMMA-C3, PCDH2" ENSG00000240184 "Protocadherin gamma subfamily C, 3" Q9UN70 5 141475947-141512979 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 99.3" "Group enriched" "Detected in some" 7 "Bipolar cells: 6.9;Horizontal cells: 11.1;Muller glia cells: 4.9" "Group enriched" "Detected in all" 6 "glioma: 55.0;melanoma: 20.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 22 "plasmacytoid DC: 15.2" "Lineage enriched" "Detected in single" 22 "dendritic cells: 15.2" "Cell line enhanced" "Detected in many" "ASC diff: 43.5;ASC TERT1: 41.7;HSkMC: 40.8;U-138 MG: 52.4;WM-115: 78.0" "HPA008755, HPA010580, HPA077289" Approved Approved "Plasma membrane" NA NA 74000 "Plasma membrane" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA077289: AB_2686832" "unprognostic (2.52e-1)" "unprognostic (4.83e-3)" "unprognostic (1.17e-1)" "unprognostic (6.76e-2)" "unprognostic (3.76e-1)" "unprognostic (3.44e-2)" "unprognostic (4.30e-1)" "unprognostic (1.87e-1)" "unprognostic (1.70e-1)" "prognostic unfavorable (6.19e-4)" "unprognostic (2.03e-1)" "unprognostic (2.22e-1)" "prognostic unfavorable (8.18e-4)" "unprognostic (3.72e-2)" "unprognostic (5.66e-2)" "unprognostic (9.55e-2)" "prognostic unfavorable (6.00e-4)" 14.9 15.0 52.8 7.0 49.0 0.5 11.2 30.1 99.3 28.0 8.7 38.9 2.4 3.8 20.6 27.6 12.8 15.7 14.6 11.0 40.2 25.2 7.1 8.0 20.9 4.2 32.0 24.9 16.6 4.4 18.8 7.9 17.7 25.8 17.1 10.2 17.3 8.4 20.1 5.8 18.3 5.6 19.8 28.1 5.3 6.6 4.8 24.1 0.9 5.4 6.4 7.1 8.6 11.1 0.6 15.2 0.0 0.0 0.0 0.1 0.0 2.8 1.6 10.8 2.9 43.5 41.7 0.1 14.2 37.9 7.0 7.6 0.0 2.7 9.4 9.2 24.7 26.5 10.3 1.4 4.4 6.7 0.0 4.3 0.0 0.2 0.2 13.4 0.1 0.3 40.8 6.8 10.6 8.7 25.8 4.7 0.0 0.0 0.3 17.7 5.2 0.2 1.0 0.4 0.1 0.0 6.3 21.9 0.0 3.7 3.0 3.5 15.4 3.8 0.1 23.3 4.0 8.8 13.1 5.7 52.4 2.7 10.2 15.3 0.0 0.1 0.1 12.5 0.0 78.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 15.2 0.0 0.0 52.8 49.0 30.1 38.9 40.2 25.2 32.0 24.9 25.8 24.1 0.0 0.0 0.0 0.4 0.2 6.9 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.9 0.6 0.0 0.0 0.2 0.1 0.7 0.3 0.0 0.0 0.2 11.1 0.0 0.6 0.3 0.4 1.1 0.0 0.0 0.0 0.0 4.9 0.5 0.0 0.4 0.0 0.9 0.0 0.1 0.0 0.0 0.1 0.6 0.0 0.0 0.5 PCDHGC5 PCDH-GAMMA-C5 ENSG00000240764 "Protocadherin gamma subfamily C, 5" Q9Y5F6 5 141489121-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "brain: 43.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "glioma: 3.1;head and neck cancer: 0.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 5.0;SuSa: 8.4;U-138 MG: 16.0;U-251 MG: 6.8;U-87 MG: 9.8" "Group enriched" "Detected in many" 5 "amygdala: 129.6;basal ganglia: 118.6;cerebral cortex: 130.2;hippocampal formation: 113.0;olfactory region: 85.4" "HPA008755, HPA010580, HPA076140" Supported Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA076140: " "unprognostic (2.86e-3)" "unprognostic (7.63e-4)" "unprognostic (2.00e-1)" "unprognostic (3.52e-3)" "unprognostic (5.42e-2)" "unprognostic (1.14e-1)" "unprognostic (5.65e-2)" "unprognostic (2.38e-2)" "unprognostic (2.14e-1)" "unprognostic (3.16e-2)" "unprognostic (3.90e-1)" "unprognostic (1.66e-2)" "unprognostic (1.01e-9)" "unprognostic (6.87e-3)" "unprognostic (3.89e-2)" "unprognostic (3.13e-1)" "unprognostic (3.77e-3)" 1.0 1.1 7.4 1.1 34.5 0.9 1.1 3.0 43.7 1.1 1.0 2.8 0.0 0.9 1.4 1.3 1.0 1.2 1.2 2.8 11.8 2.8 0.9 0.9 1.1 0.9 2.2 10.0 1.1 1.0 1.0 1.1 1.0 2.3 1.3 1.0 0.0 0.9 1.6 1.6 1.5 0.9 2.0 0.8 1.0 1.0 1.3 1.1 0.0 1.0 0.0 1.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.4 1.7 0.2 0.8 0.6 0.5 0.6 0.0 0.0 0.5 1.6 2.4 0.1 0.1 0.0 0.4 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 3.5 0.0 5.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.9 0.8 0.3 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 8.4 0.1 0.2 0.1 16.0 0.2 0.2 6.8 0.0 0.0 0.0 9.8 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 34.5 3.0 39.2 11.8 2.8 2.2 10.0 2.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCLO "ACZ, DKFZp779G1236, KIAA0559" ENSG00000186472 "Piccolo presynaptic cytomatrix protein" Q9Y6V0 7 82754013-83162930 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Neurodegeneration "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 50.3" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 95.6;Cone photoreceptor cells: 123.7;Horizontal cells: 81.0;Intestinal endocrine cells: 57.6;Rod photoreceptor cells: 84.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 28 "REH: 62.4;U-2 OS: 71.7" "Low region specificity" "Detected in all" "HPA015858, HPA029579, CAB079012" Approved Supported Approved "Nuclear speckles,Plasma membrane" NA NA "Nuclear speckles, Plasma membrane" "CAB079012: , HPA015858: AB_1855071, HPA029579: AB_10602044" "unprognostic (1.32e-2)" "unprognostic (1.99e-1)" "unprognostic (9.33e-2)" "unprognostic (1.31e-1)" "unprognostic (2.08e-2)" "unprognostic (1.52e-1)" "unprognostic (4.49e-3)" "unprognostic (6.14e-2)" "unprognostic (4.61e-2)" "unprognostic (1.82e-1)" "unprognostic (3.00e-1)" "unprognostic (1.56e-1)" "unprognostic (4.79e-6)" "unprognostic (5.15e-2)" "unprognostic (2.42e-2)" "unprognostic (1.36e-5)" "unprognostic (6.62e-5)" 3.1 7.9 8.8 0.8 26.3 0.4 4.7 50.3 19.4 3.2 3.9 1.6 0.4 2.9 1.0 7.3 2.3 2.0 1.9 2.2 9.8 5.7 8.2 0.6 1.8 0.6 4.6 12.6 1.9 4.0 11.4 19.2 1.0 9.1 4.9 3.5 3.6 2.5 5.0 0.6 2.6 2.4 0.7 5.3 1.1 2.9 4.5 4.4 0.0 8.4 0.0 0.8 1.0 2.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.3 0.4 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.2 1.9 0.1 1.4 0.5 0.6 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.4 0.0 2.4 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.4 0.2 1.1 62.4 1.0 0.0 0.4 0.2 1.2 0.8 0.0 0.6 0.1 0.3 0.8 0.1 0.0 0.0 71.7 0.3 0.1 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.8 26.3 50.3 19.4 9.8 5.7 4.6 12.6 9.1 4.4 8.9 14.1 0.0 8.3 2.3 95.6 24.6 20.4 9.4 18.2 1.8 123.7 0.9 6.6 4.6 9.0 4.1 14.6 0.0 4.4 0.3 0.4 5.3 0.0 0.0 1.3 81.0 57.6 0.0 0.0 5.6 2.6 0.0 0.0 0.0 12.3 17.5 2.5 14.4 6.0 16.7 84.6 0.0 0.3 3.9 13.8 3.0 0.6 0.0 7.7 4.8 PCMTD1 FLJ10883 ENSG00000168300 "Protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1" Q96MG8 8 51817575-51899186 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025696, HPA061444" Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA025696: AB_1855077, HPA061444: AB_2684519" "unprognostic (3.16e-2)" "unprognostic (1.24e-1)" "unprognostic (1.47e-1)" "unprognostic (2.79e-1)" "unprognostic (1.41e-1)" "unprognostic (6.73e-3)" "unprognostic (2.58e-2)" "unprognostic (2.53e-1)" "unprognostic (1.05e-1)" "unprognostic (1.66e-1)" "unprognostic (2.18e-2)" "unprognostic (8.38e-2)" "unprognostic (3.73e-1)" "unprognostic (2.48e-2)" "unprognostic (1.13e-1)" "unprognostic (3.11e-3)" "unprognostic (3.11e-3)" 22.0 24.1 13.1 18.2 17.1 9.0 41.1 24.3 21.7 22.8 24.4 11.7 33.2 14.8 29.0 24.5 21.6 21.5 22.1 26.1 13.5 12.6 21.5 16.7 29.2 21.0 18.4 11.4 33.3 53.8 57.9 34.2 19.2 15.6 22.8 14.8 15.0 39.8 38.8 45.7 18.0 18.7 38.5 18.9 24.3 19.6 10.4 16.9 27.8 33.6 23.6 15.5 28.4 28.6 16.5 15.4 32.4 12.1 22.3 15.2 10.6 6.5 4.2 14.5 2.6 21.4 20.1 8.3 8.7 15.5 3.7 5.9 1.9 15.1 6.3 12.2 11.6 6.2 16.2 2.5 10.2 6.5 8.0 4.9 7.2 7.5 4.4 28.3 2.6 7.4 19.9 19.5 4.6 12.7 22.7 17.5 9.4 5.5 20.7 5.8 2.7 15.1 6.6 5.6 9.7 1.9 4.7 2.8 8.1 15.1 13.0 9.6 8.1 6.1 8.0 8.7 12.1 7.9 4.0 14.3 3.3 4.4 5.0 3.1 12.6 9.4 2.2 9.9 6.3 4.0 19.6 9.6 22.9 10.2 12.1 12.4 16.2 13.0 12.1 9.7 16.5 15.2 13.4 32.4 22.3 12.1 15.4 13.8 10.6 13.1 17.1 24.3 21.7 13.5 12.6 18.4 11.4 15.6 16.9 107.2 59.0 50.0 62.9 48.0 67.0 80.0 43.3 58.9 44.3 80.3 9.8 30.3 54.7 23.7 3.8 68.6 25.0 46.7 35.1 30.0 62.0 88.3 49.9 30.5 22.5 55.6 44.9 57.1 47.5 4.7 96.4 57.4 67.4 34.3 40.3 112.9 43.4 28.1 112.8 59.7 23.9 38.8 59.7 9.3 14.7 51.8 57.3 41.5 27.0 64.6 PDCD7 "ES18, HES18" ENSG00000090470 "Programmed cell death 7" Q8N8D1 15 65117379-65133836 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 165.8;Cone photoreceptor cells: 208.1;Rod photoreceptor cells: 177.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049388 Approved Approved "Nucleoli,Plasma membrane" NA NA "Plasma membrane" Nucleoli "HPA049388: AB_2680741" "unprognostic (7.71e-3)" "unprognostic (3.25e-1)" "unprognostic (4.09e-1)" "unprognostic (1.52e-1)" "unprognostic (1.54e-1)" "unprognostic (1.22e-1)" "unprognostic (6.68e-3)" "unprognostic (2.36e-2)" "unprognostic (3.18e-3)" "unprognostic (8.18e-2)" "unprognostic (3.28e-2)" "unprognostic (5.36e-2)" "prognostic unfavorable (1.00e-4)" "unprognostic (5.29e-2)" "unprognostic (3.42e-2)" "unprognostic (1.44e-1)" "unprognostic (1.62e-2)" 16.0 16.8 22.4 17.6 26.9 13.1 23.8 43.7 28.5 19.0 19.4 21.3 12.6 14.6 23.8 19.8 23.2 18.6 12.7 14.4 21.0 16.3 13.7 15.6 21.5 19.5 22.9 24.7 26.5 16.6 16.5 15.7 17.4 20.6 17.4 14.3 15.0 14.2 19.0 17.5 16.4 15.4 20.4 17.5 18.7 15.1 27.4 32.1 19.7 18.0 12.7 21.5 18.4 18.6 5.9 4.0 4.0 3.2 7.1 4.5 1.4 8.8 7.4 12.6 13.0 12.7 17.9 7.6 10.2 11.3 12.6 9.7 8.9 9.9 17.1 11.1 8.1 9.4 16.9 32.0 7.3 9.1 10.3 8.6 16.6 6.3 7.8 11.7 22.5 11.2 10.4 11.2 6.9 13.1 12.1 9.9 12.8 21.1 14.0 10.9 6.7 23.6 16.1 15.3 10.3 6.7 20.9 16.2 19.0 7.6 14.2 10.4 12.4 11.4 9.7 14.9 14.4 7.8 18.6 10.1 13.1 12.8 7.5 15.7 25.1 28.6 12.3 11.8 25.0 6.6 4.0 3.2 1.8 4.5 2.6 3.8 4.8 4.3 4.1 2.8 5.9 4.5 4.5 0.8 7.1 2.5 4.0 3.1 1.4 22.4 26.9 43.7 28.5 21.0 16.3 22.9 24.7 20.6 32.1 0.0 11.0 24.3 63.5 33.8 165.8 15.9 15.3 9.4 14.8 27.9 208.1 49.6 24.9 7.2 4.9 27.4 10.0 0.0 7.0 25.2 28.2 37.6 19.6 16.1 20.7 71.5 13.8 16.5 21.8 6.6 53.8 17.5 11.8 5.4 17.4 63.4 6.5 10.5 45.3 17.1 177.0 45.3 24.4 137.9 102.2 34.9 59.7 40.6 21.3 41.6 PDE3A CGI-PDE ENSG00000172572 "Phosphodiesterase 3A" Q14432 12 20369245-20684381 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins" Hydrolase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 62.2" "Cell type enhanced" "Detected in many" 15 "Bipolar cells: 41.0;Cardiomyocytes: 107.8;Horizontal cells: 49.3;Smooth muscle cells: 51.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 7.9;HEL: 14.6;HeLa: 39.5;HUVEC TERT2: 7.1;SH-SY5Y: 14.8;U-138 MG: 11.4" "Low region specificity" "Detected in some" "Region enhanced" "Detected in many" "cerebellum: 35.4" "HPA014492, HPA074258" Approved Approved "Plasma membrane" NA NA 23000 "Plasma membrane" "HPA014492: AB_1855120, HPA074258: " "unprognostic (2.59e-2)" "unprognostic (2.94e-2)" "unprognostic (1.25e-1)" "unprognostic (3.23e-1)" "unprognostic (2.27e-1)" "unprognostic (1.21e-1)" "unprognostic (3.50e-2)" "unprognostic (1.67e-2)" "unprognostic (8.14e-2)" "unprognostic (1.49e-1)" "unprognostic (4.25e-1)" "unprognostic (3.37e-1)" "prognostic unfavorable (1.72e-6)" "unprognostic (5.58e-2)" "unprognostic (5.94e-2)" "unprognostic (4.28e-2)" "unprognostic (2.76e-4)" 7.1 1.0 1.7 4.7 2.0 0.0 3.8 3.5 1.4 7.8 15.9 1.0 2.0 2.1 7.8 3.5 9.1 4.9 5.5 62.2 1.6 1.4 3.7 1.8 3.9 3.3 1.9 1.1 7.1 6.5 1.0 2.8 13.8 2.7 6.3 9.0 12.0 7.8 4.2 2.0 1.4 21.4 6.0 1.8 2.1 5.5 2.3 0.7 0.0 2.8 1.9 0.9 4.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 7.9 0.0 1.8 1.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 14.6 39.5 0.2 0.6 0.0 0.0 1.8 0.0 0.4 0.1 0.1 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 1.1 0.0 0.0 0.0 2.2 0.0 0.1 14.8 0.0 0.0 0.0 3.5 0.0 0.0 0.2 11.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.7 2.0 3.5 1.4 1.6 1.4 1.9 1.1 2.7 0.7 0.0 0.0 0.0 0.1 0.2 41.0 107.8 5.1 0.0 1.2 0.0 0.0 0.0 0.0 3.7 0.2 2.2 24.6 0.0 0.4 0.0 3.5 0.5 16.2 0.0 0.5 49.3 4.1 0.6 0.0 0.0 1.4 0.0 1.7 0.0 7.4 2.5 0.5 24.6 0.7 2.6 2.2 6.5 51.8 0.2 0.4 0.3 0.0 0.0 13.9 0.2 PDHX "DLDBP, E3BP, OPDX, PDX1, proX" ENSG00000110435 "Pyruvate dehydrogenase complex component X" O00330 11 34915829-35020591 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 70.5" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 117.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038484, HPA038485" Enhanced Approved "Nucleoplasm,Plasma membrane,Mitochondria" NA NA "Nucleoplasm, Plasma membrane" Mitochondria "HPA038484: AB_10669645, HPA038485: AB_10669540" "unprognostic (1.60e-1)" "unprognostic (1.91e-1)" "unprognostic (1.42e-2)" "unprognostic (1.06e-1)" "unprognostic (2.03e-1)" "unprognostic (8.34e-3)" "unprognostic (3.56e-3)" "unprognostic (1.94e-1)" "unprognostic (2.14e-1)" "unprognostic (5.41e-2)" "unprognostic (2.60e-2)" "unprognostic (2.08e-1)" "prognostic favorable (1.83e-5)" "unprognostic (2.24e-1)" "unprognostic (8.28e-2)" "unprognostic (9.53e-2)" "unprognostic (2.82e-1)" 13.5 14.9 13.4 8.6 17.2 4.2 10.4 13.9 23.3 9.2 13.3 10.6 9.3 12.2 8.9 8.6 10.9 6.7 7.7 46.1 14.4 12.8 15.0 25.7 7.8 6.8 14.7 14.1 7.7 13.1 14.6 14.7 15.8 22.1 12.0 12.7 8.9 12.4 14.1 70.5 8.8 12.3 11.5 12.0 6.6 13.7 15.7 9.0 5.9 9.1 19.0 8.7 13.0 10.7 12.8 19.5 12.1 21.7 15.0 14.9 9.8 9.1 24.0 13.9 5.5 10.2 12.1 13.6 17.1 14.0 19.4 18.9 31.0 8.5 12.6 11.2 14.4 22.7 17.8 26.9 14.4 19.3 11.3 22.5 11.8 25.3 35.6 22.2 22.3 14.0 12.3 17.9 10.6 14.5 11.2 14.0 10.8 25.3 11.6 15.2 15.6 13.8 13.8 11.3 25.2 14.4 12.1 24.9 10.9 29.0 24.1 14.7 10.7 15.1 22.9 23.4 14.5 25.7 13.8 9.7 14.4 16.2 14.8 18.9 11.1 22.0 15.6 11.3 11.0 14.5 8.6 13.6 12.1 11.5 15.0 10.8 12.8 10.9 9.4 19.5 11.7 13.3 9.6 2.8 15.0 21.7 5.2 14.9 9.8 13.4 17.2 13.9 23.3 14.4 12.8 14.7 14.1 22.1 9.0 32.8 21.1 9.0 18.1 23.1 25.5 117.0 20.4 18.7 19.4 5.2 27.5 53.6 54.7 18.3 35.0 10.9 12.8 23.3 12.6 28.3 19.4 19.1 5.7 22.1 23.1 19.1 8.6 9.8 15.0 31.1 10.0 15.5 20.3 28.9 16.0 18.1 13.9 14.4 12.7 22.7 23.2 0.0 20.9 40.9 33.4 22.2 69.5 10.4 19.0 16.9 PDLIM1 "CLIM1, CLP-36, CLP36, hCLIM1" ENSG00000107438 "PDZ and LIM domain 1" O00151 10 95237572-95291024 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Basal glandular cells: 648.1;Enterocytes: 781.7;Paneth cells: 737.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "eosinophil: 39.1;memory B-cell: 49.1;naive B-cell: 44.9" "Group enriched" "Detected in many" 6 "B-cells: 49.1;granulocytes: 39.1" "Cell line enhanced" "Detected in many" "HaCaT: 96.9;HHSteC: 94.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA017010, CAB072838, CAB072840" Approved Supported "Plasma membrane,Cell Junctions,Actin filaments" NA NA 210000000 "Actin filaments" "Plasma membrane, Cell Junctions" "CAB072838: , CAB072840: , HPA017010: AB_1855147" "unprognostic (1.61e-1)" "unprognostic (2.87e-2)" "unprognostic (2.58e-2)" "prognostic favorable (1.14e-5)" "unprognostic (3.18e-2)" "unprognostic (7.54e-2)" "unprognostic (2.07e-1)" "unprognostic (8.99e-2)" "unprognostic (2.26e-1)" "unprognostic (2.82e-3)" "unprognostic (5.77e-2)" "unprognostic (6.56e-2)" "unprognostic (1.27e-2)" "unprognostic (2.00e-1)" "unprognostic (1.97e-1)" "unprognostic (4.21e-3)" "unprognostic (1.11e-1)" 60.9 6.4 2.9 32.3 3.7 2.7 69.9 3.6 3.7 30.6 78.8 3.0 24.3 27.8 30.0 35.6 48.3 28.0 38.4 107.5 3.0 2.4 19.8 49.0 78.8 91.6 6.3 2.2 23.3 20.5 11.7 6.7 53.0 16.5 34.7 34.7 12.8 34.5 27.4 150.1 26.4 96.3 27.2 8.6 52.9 28.3 14.3 3.6 23.4 76.9 54.9 41.9 65.0 38.9 49.1 6.8 39.1 0.5 1.7 3.2 9.2 34.5 22.3 1.6 0.0 8.2 5.6 36.0 10.6 33.0 27.6 45.4 47.1 53.7 0.0 3.0 28.6 14.0 96.9 11.3 61.3 28.0 0.0 17.5 34.4 6.7 76.3 94.4 0.0 1.8 16.1 32.3 14.0 50.9 29.6 49.3 3.0 7.4 8.8 6.5 6.1 0.1 0.6 3.2 16.7 18.0 29.0 1.3 12.1 14.2 32.9 6.2 2.5 11.4 10.5 0.1 38.8 8.6 15.2 43.4 10.8 2.5 0.0 0.0 4.2 0.0 11.3 11.9 0.0 5.1 0.0 0.5 39.1 2.8 0.1 0.0 49.1 0.5 3.2 6.8 44.9 0.1 2.0 1.7 1.7 0.3 0.7 0.4 9.2 2.9 3.7 3.6 3.7 3.0 2.4 6.3 2.2 16.5 3.6 71.5 92.6 110.2 648.1 325.4 6.5 205.6 201.2 180.7 158.1 48.8 27.5 481.5 13.3 337.3 7.0 238.0 781.7 23.3 152.6 92.5 136.8 121.0 11.6 70.6 44.6 1.6 97.3 328.4 20.6 5.3 4.6 29.4 38.8 5.4 406.4 7.0 203.4 737.0 0.7 62.7 43.8 310.4 177.4 0.5 42.4 173.0 97.8 33.0 340.8 482.4 PDZD8 "bA129M16.2, FLJ34427, PDZK8" ENSG00000165650 "PDZ domain containing 8" Q8NEN9 10 117277274-117375467 "Predicted intracellular proteins" "Host-virus interaction, Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 61.7" "Cell type enhanced" "Detected in all" 11 "Early spermatids: 174.2;Late spermatids: 366.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 52.1" "Low region specificity" "Detected in all" "HPA015716, HPA051610" Uncertain Approved "Nucleoli fibrillar center,Plasma membrane" "Intracellular and membrane" NA NA "Nucleoli fibrillar center" "Plasma membrane" "HPA015716: AB_1855162, HPA051610: AB_2681549" "unprognostic (1.12e-1)" "unprognostic (2.87e-1)" "unprognostic (9.65e-3)" "unprognostic (2.75e-2)" "unprognostic (6.29e-2)" "unprognostic (3.36e-2)" "unprognostic (2.42e-1)" "unprognostic (1.43e-1)" "unprognostic (2.53e-1)" "unprognostic (3.10e-2)" "prognostic unfavorable (6.10e-4)" "unprognostic (1.90e-2)" "unprognostic (5.37e-3)" "unprognostic (7.60e-3)" "unprognostic (1.44e-2)" "unprognostic (3.18e-2)" "unprognostic (2.01e-2)" 8.1 7.8 12.2 5.1 13.3 61.7 8.2 8.7 12.9 9.1 14.8 11.4 32.8 14.0 10.7 15.1 11.4 7.7 10.3 7.0 12.0 10.4 13.5 21.1 7.4 3.7 14.7 7.4 10.1 20.1 18.9 8.6 6.0 12.9 7.3 12.0 6.3 12.4 21.3 6.7 6.6 13.7 7.6 14.8 5.0 10.6 23.2 12.4 8.9 7.5 5.4 4.2 8.0 15.3 1.0 1.7 5.7 2.0 2.5 2.5 0.5 5.2 9.0 3.3 6.3 5.7 5.1 1.8 5.0 4.4 2.3 1.8 4.5 7.0 6.2 4.6 7.6 2.6 7.9 5.7 5.4 4.5 3.9 5.1 52.1 3.7 4.4 4.2 21.7 4.9 5.0 6.4 4.1 12.3 8.5 4.0 5.1 4.7 6.5 5.6 2.1 4.2 2.8 2.6 2.7 8.1 3.4 12.7 2.6 6.7 3.8 2.6 4.2 5.4 2.3 3.9 3.1 1.6 3.2 6.4 3.8 4.2 6.8 8.6 3.5 2.9 4.5 4.7 10.0 3.3 2.7 1.4 5.7 2.2 1.1 2.5 0.9 1.8 1.8 1.7 1.0 1.5 2.0 5.6 2.5 2.0 1.3 0.8 0.5 12.2 13.3 8.7 12.9 12.0 10.4 14.7 7.4 12.9 12.4 11.9 27.8 8.8 17.7 26.4 29.3 16.7 43.3 38.8 25.0 17.4 21.6 8.3 8.3 27.0 174.2 17.8 23.8 23.3 70.7 5.7 19.5 25.1 41.7 45.8 6.8 30.2 32.4 16.5 12.3 366.0 21.9 15.2 21.9 9.0 31.7 24.9 56.7 21.0 26.9 23.1 40.1 25.8 18.9 16.9 29.3 28.2 5.6 18.7 39.0 34.2 PEBP1 "HCNP, PBP, PEBP, RKIP" ENSG00000089220 "Phosphatidylethanolamine binding protein 1" P30086 12 118135858-118145584 "Plasma proteins, Predicted intracellular proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 260.7" "Cell type enhanced" "Detected in all" 7 "Distal tubular cells: 3140.1;Proximal tubular cells: 3872.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA008819, CAB009906, CAB013493, HPA063904" Enhanced Approved "Plasma membrane,Cytosol" NA NA 62000000 "Plasma membrane, Cytosol" "CAB009906: AB_2163173, CAB013493: AB_2533305, HPA008819: AB_1855173, HPA063904: AB_2732708" "unprognostic (4.57e-1)" "unprognostic (1.03e-3)" "unprognostic (3.28e-2)" "unprognostic (3.39e-3)" "unprognostic (2.05e-1)" "unprognostic (1.59e-1)" "unprognostic (1.24e-2)" "unprognostic (7.35e-3)" "unprognostic (5.67e-2)" "unprognostic (3.55e-2)" "prognostic favorable (1.52e-4)" "unprognostic (1.63e-1)" "prognostic favorable (2.15e-13)" "unprognostic (2.17e-1)" "unprognostic (7.72e-2)" "unprognostic (7.96e-2)" "unprognostic (8.80e-2)" 26.8 207.3 83.0 15.2 82.3 13.5 32.3 63.3 102.7 35.5 50.4 58.0 18.9 75.3 22.9 52.8 24.3 28.5 22.6 57.6 77.6 69.7 132.7 260.7 22.1 16.0 77.8 71.5 43.5 46.2 139.2 30.8 16.5 59.1 35.4 25.4 41.2 43.6 33.1 65.1 20.9 75.4 23.4 79.1 15.3 20.6 22.7 43.5 8.7 94.9 26.1 19.7 20.2 17.8 45.2 37.3 3.0 12.1 20.9 45.3 36.4 32.2 27.6 39.1 40.6 61.7 30.2 60.8 25.7 30.0 40.6 20.9 16.4 11.1 52.0 25.9 38.4 16.2 23.2 57.8 23.9 31.7 13.0 55.3 26.1 31.1 114.3 35.7 47.2 11.4 29.9 39.7 24.0 16.7 46.7 18.8 27.8 43.3 19.4 40.6 38.2 25.7 95.7 37.9 27.1 33.4 50.8 29.1 94.8 49.8 31.5 46.9 36.4 53.4 37.1 50.3 25.0 53.4 32.2 20.4 31.2 17.8 30.5 25.8 19.0 33.7 26.8 36.7 35.4 33.8 0.7 11.0 3.0 26.9 12.1 42.4 45.2 45.3 33.3 33.3 32.5 43.9 35.3 1.2 20.9 10.3 37.3 41.2 36.4 83.0 82.3 63.3 102.7 77.6 69.7 77.8 71.5 59.1 43.5 375.2 339.6 254.0 392.9 282.7 501.7 637.3 598.7 327.9 273.0 743.2 90.3 819.2 3140.1 396.3 35.6 178.6 306.2 116.8 213.3 686.7 314.8 422.6 353.3 1736.5 486.8 681.7 307.9 178.0 167.5 50.5 502.8 218.5 705.2 448.2 324.1 1385.1 201.0 263.6 687.7 3872.6 306.7 362.2 321.6 273.2 133.6 284.3 514.8 194.5 466.9 324.1 PFDN1 PFD1 ENSG00000113068 "Prefoldin subunit 1" O60925 5 140245039-140303121 "Predicted intracellular proteins, Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006499 Approved Approved "Nucleoli,Plasma membrane,Cytosol" NA NA 10000 "Plasma membrane, Cytosol" Nucleoli "HPA006499: AB_1079596" "unprognostic (2.73e-1)" "unprognostic (1.48e-1)" "unprognostic (1.37e-1)" "unprognostic (3.00e-2)" "unprognostic (6.11e-2)" "unprognostic (5.66e-3)" "prognostic unfavorable (8.81e-5)" "unprognostic (2.12e-2)" "unprognostic (2.19e-1)" "unprognostic (1.89e-1)" "unprognostic (1.50e-1)" "unprognostic (2.33e-1)" "unprognostic (4.10e-1)" "unprognostic (8.60e-3)" "unprognostic (2.53e-1)" "unprognostic (3.53e-2)" "unprognostic (3.00e-1)" 36.1 24.8 39.5 18.8 38.8 26.4 25.8 28.5 48.7 23.1 27.0 29.3 15.8 20.9 28.2 29.6 26.8 22.5 18.6 46.7 38.2 34.7 32.7 20.2 24.2 21.6 38.8 35.3 20.6 18.1 26.5 19.9 26.9 45.6 24.3 23.0 19.8 23.1 24.4 69.5 20.9 22.0 32.1 37.1 23.1 19.2 19.6 24.1 23.7 24.4 28.7 25.5 23.0 19.2 38.9 36.3 45.6 46.4 39.5 45.1 37.2 39.1 18.4 32.8 18.9 21.5 22.1 31.7 53.6 26.7 41.2 45.9 39.1 25.1 26.4 54.2 28.5 43.1 14.6 23.8 52.6 48.6 27.9 24.0 23.4 18.8 25.2 25.3 48.1 18.4 23.5 28.0 35.0 36.9 26.7 45.2 31.1 20.9 17.3 34.6 17.5 32.7 33.0 21.7 16.0 27.6 23.2 46.7 19.4 46.0 18.0 18.6 19.6 40.1 35.3 30.6 32.1 24.1 28.5 58.1 29.1 28.9 17.1 47.9 16.9 43.3 68.4 29.4 31.8 33.7 43.2 31.1 45.6 33.4 46.4 35.3 38.9 38.4 38.4 36.3 35.9 38.5 34.6 5.1 39.5 44.1 33.9 45.1 37.2 39.5 38.8 28.5 48.7 38.2 34.7 38.8 35.3 45.6 24.1 62.5 27.0 57.4 56.0 33.8 39.1 71.1 56.0 54.9 56.9 62.8 43.2 99.5 104.5 108.2 2.6 70.9 60.6 70.0 88.5 69.1 54.6 45.1 52.1 56.2 74.9 23.8 44.7 68.2 54.4 9.4 48.3 63.8 70.9 117.2 33.8 53.2 101.0 51.8 49.1 83.4 38.8 64.7 38.1 20.0 47.7 30.6 71.6 50.7 39.3 59.1 PGAP3 "CAB2, MGC9753, PER1, PERLD1, PP1498" ENSG00000161395 "Post-GPI attachment to proteins 3" Q96FM1 17 39671122-39696797 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 6 "OE19: 133.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA016591 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA016591: AB_1855203" "unprognostic (1.29e-1)" "unprognostic (8.64e-2)" "unprognostic (1.65e-1)" "unprognostic (6.53e-3)" "unprognostic (9.19e-2)" "unprognostic (1.68e-2)" "prognostic favorable (3.94e-4)" "unprognostic (1.61e-2)" "unprognostic (1.90e-2)" "prognostic unfavorable (6.82e-4)" "unprognostic (1.57e-2)" "unprognostic (7.79e-2)" "prognostic favorable (3.89e-4)" "unprognostic (5.16e-2)" "unprognostic (1.31e-1)" "unprognostic (9.05e-2)" "unprognostic (1.94e-2)" 6.8 8.2 8.9 7.6 14.3 3.4 10.2 6.4 17.3 11.3 19.2 10.0 15.1 12.5 8.3 16.5 16.2 14.0 19.7 9.9 11.3 7.3 13.7 20.7 9.5 6.5 6.3 10.7 9.7 22.7 16.0 10.1 39.2 6.1 11.2 11.7 14.2 16.7 15.6 5.0 16.0 20.7 7.3 5.5 8.1 13.4 9.0 7.3 4.4 20.3 8.7 15.8 8.1 8.9 7.8 5.3 4.0 10.5 9.0 15.1 6.3 0.6 1.6 1.3 1.2 1.4 1.4 1.3 0.7 1.7 1.1 1.0 0.9 4.0 0.6 3.3 1.3 0.3 2.1 0.4 0.4 0.5 1.4 1.3 0.8 0.9 1.5 1.8 2.1 2.2 2.6 2.6 0.5 1.1 1.3 0.3 0.3 0.7 1.6 1.0 1.4 0.4 1.9 1.3 133.7 0.3 0.5 0.8 1.9 1.8 2.0 1.2 0.8 1.9 22.9 1.1 0.1 1.9 2.0 0.5 1.2 1.3 0.6 0.5 1.4 0.3 0.2 1.4 0.8 1.3 2.4 6.7 4.0 15.1 10.5 8.3 7.8 10.6 12.3 5.3 7.6 10.5 10.1 1.7 9.0 3.8 3.6 5.1 6.3 8.9 14.3 6.4 17.3 11.3 7.3 6.3 10.7 6.1 7.3 3.0 12.2 0.0 3.5 3.4 12.1 5.2 12.7 4.0 9.1 14.0 7.9 6.8 1.7 6.0 0.1 4.3 16.0 0.0 9.6 5.2 6.7 4.9 9.2 7.7 4.0 12.7 8.1 4.3 2.7 0.0 2.8 3.5 1.7 1.8 16.3 7.8 5.1 11.5 1.4 3.5 21.6 0.0 2.3 0.7 2.0 2.5 8.7 1.7 13.0 2.5 PGLYRP4 "PGLYRPIbeta, PGRP-Ibeta, PGRPIB, SBBI67" ENSG00000163218 "Peptidoglycan recognition protein 4" Q96LB8 1 153330120-153348840 "Predicted secreted proteins" "Immunity, Innate immunity" "Antibiotic, Antimicrobial" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 8.1;skin 1: 19.5;tongue: 13.7;vagina: 8.5" "Cell type enhanced" "Detected in some" 15 "Basal keratinocytes: 1.8;Early spermatids: 1.6;Melanocytes: 1.7;Suprabasal keratinocytes: 3.0" "Group enriched" "Detected in some" 9 "cervical cancer: 2.7;head and neck cancer: 7.8;lung cancer: 1.9;melanoma: 1.6;urothelial cancer: 2.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 8 "neutrophil: 1.3" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.3" "Cell line enhanced" "Detected in some" "HaCaT: 8.2;HDLM-2: 5.3;hTCEpi: 1.7;Karpas-707: 4.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" CAB025879 Approved "Vesicles,Plasma membrane" "Secreted in other tissues" NA NA "Vesicles, Plasma membrane" "CAB025879: " "unprognostic (2.76e-2)" "unprognostic (1.19e-1)" "unprognostic (6.10e-2)" "unprognostic (1.34e-2)" "unprognostic (3.61e-3)" "unprognostic (1.46e-1)" "unprognostic (3.13e-1)" "unprognostic (5.42e-2)" "unprognostic (3.99e-2)" "unprognostic (1.07e-2)" "unprognostic (2.15e-1)" "unprognostic (1.81e-1)" "unprognostic (1.88e-1)" 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 8.1 0.0 0.0 0.0 0.1 2.0 0.0 7.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.3 0.0 1.2 0.0 0.2 0.2 0.0 1.5 0.0 0.1 19.5 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 13.7 6.5 0.0 8.5 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 5.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.9 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.2 0.0 0.0 0.1 PGRMC2 "DG6, PMBP" ENSG00000164040 "Progesterone receptor membrane component 2" O15173 4 128269237-128288829 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Syncytiotrophoblasts: 229.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HHSteC: 87.8" "Low region specificity" "Detected in all" "HPA041172, HPA058652" Approved Approved "Nuclear bodies,Plasma membrane,Cytosol" NA NA 64000 "Nuclear bodies, Plasma membrane, Cytosol" "HPA041172: AB_2677345, HPA058652: AB_2683786" "unprognostic (6.16e-2)" "unprognostic (1.35e-1)" "unprognostic (1.41e-2)" "prognostic favorable (3.62e-4)" "unprognostic (6.03e-2)" "unprognostic (6.57e-3)" "unprognostic (2.53e-2)" "unprognostic (2.57e-1)" "unprognostic (1.31e-1)" "unprognostic (8.24e-2)" "unprognostic (9.04e-2)" "unprognostic (3.80e-2)" "prognostic favorable (9.60e-4)" "unprognostic (3.12e-2)" "unprognostic (1.82e-1)" "unprognostic (2.51e-2)" "unprognostic (6.03e-2)" 47.9 29.5 18.3 13.3 20.4 12.8 38.3 17.7 19.3 27.3 46.6 14.8 42.5 46.8 26.1 20.2 32.8 21.1 31.2 27.2 18.4 18.4 36.5 64.7 22.4 13.6 17.4 18.5 24.1 41.6 25.6 34.4 95.6 18.0 29.4 24.8 22.0 29.8 33.4 17.9 46.0 69.1 29.5 16.3 16.7 35.1 19.3 19.2 15.3 33.1 15.7 16.2 35.1 33.8 3.2 6.0 4.7 2.5 2.6 4.8 1.4 23.4 8.6 16.0 12.8 69.4 36.5 16.1 32.2 36.0 23.9 32.0 8.9 24.2 16.5 37.8 41.4 27.8 13.7 14.6 15.9 30.1 9.4 8.4 11.1 22.8 16.9 87.8 16.0 8.3 28.7 32.3 20.0 24.8 55.8 21.4 10.8 18.4 20.9 34.3 7.2 14.8 7.4 12.5 28.5 7.8 11.9 12.8 11.3 35.3 8.3 12.6 12.0 18.0 20.5 18.3 27.5 15.7 7.3 39.6 20.2 16.5 20.7 14.9 24.2 19.6 17.7 22.1 14.4 13.8 4.7 2.5 4.6 3.9 2.1 1.9 3.2 4.8 3.9 1.4 2.7 4.4 4.0 2.2 2.6 1.8 6.0 4.7 1.4 18.3 20.4 17.7 19.3 18.4 18.4 17.4 18.5 18.0 19.2 50.6 34.2 23.8 45.7 89.0 20.4 51.2 48.4 24.1 39.8 41.8 9.8 66.3 24.9 50.1 71.9 50.2 83.0 70.0 64.9 109.7 60.6 46.0 11.5 114.3 31.8 11.1 34.1 27.6 12.7 27.3 42.8 25.2 64.1 18.0 64.6 72.5 60.7 56.1 35.3 99.8 34.3 12.9 59.7 27.7 25.9 97.7 229.9 23.5 49.5 29.8 PHACTR4 "FLJ13171, PPP1R124" ENSG00000204138 "Phosphatase and actin regulator 4" Q8IZ21 1 28369582-28500369 "Predicted intracellular proteins" Neurogenesis "Actin-binding, Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028985 Approved Approved "Plasma membrane,Intermediate filaments,Cytosol" NA Yes "Plasma membrane, Cytosol" "Intermediate filaments" "HPA028985: AB_10602142" "unprognostic (1.55e-1)" "unprognostic (2.61e-2)" "unprognostic (4.50e-3)" "unprognostic (1.73e-1)" "unprognostic (5.27e-1)" "prognostic favorable (1.05e-4)" "unprognostic (9.65e-3)" "unprognostic (8.77e-2)" "unprognostic (2.03e-2)" "unprognostic (1.61e-1)" "unprognostic (1.05e-1)" "unprognostic (1.04e-1)" "unprognostic (2.94e-2)" "unprognostic (3.08e-1)" "unprognostic (4.81e-2)" "unprognostic (3.03e-2)" "unprognostic (2.26e-2)" 11.0 12.3 10.0 17.2 17.4 11.5 11.6 18.7 15.2 17.2 14.2 16.5 11.7 9.9 22.7 12.1 37.0 15.1 12.6 10.7 11.4 7.9 16.4 18.7 13.8 10.4 15.3 8.9 15.3 15.4 22.3 18.1 11.6 12.1 13.7 15.8 15.4 18.1 10.3 14.9 19.1 15.4 15.7 13.6 14.4 12.1 15.7 18.5 17.8 15.2 18.1 30.0 12.1 20.6 5.3 5.6 4.0 6.3 4.8 7.7 3.4 12.4 8.6 19.3 13.9 4.9 5.5 2.9 9.0 9.2 19.7 20.5 8.2 14.2 12.0 8.2 10.7 12.4 8.9 13.3 9.0 17.7 9.0 7.4 25.0 14.7 12.7 7.4 14.9 28.9 4.9 8.4 12.6 22.3 7.3 25.9 9.3 12.6 8.3 12.5 3.9 10.5 3.7 14.6 6.8 5.9 11.1 18.4 8.9 10.2 11.3 10.2 12.8 20.1 8.3 10.4 8.0 11.2 5.5 16.8 9.6 18.0 6.7 17.3 6.4 9.1 10.1 9.3 12.6 10.1 3.4 4.6 4.0 7.7 4.1 6.8 3.3 5.9 7.2 4.5 5.3 4.0 5.4 3.5 4.8 6.3 5.6 2.7 3.4 10.0 17.4 18.7 15.2 11.4 7.9 15.3 8.9 12.1 18.5 65.5 49.1 30.2 22.5 34.3 33.3 35.0 28.1 81.7 67.1 22.7 19.6 15.0 14.9 29.8 4.7 40.9 48.1 23.3 31.5 14.3 20.1 21.0 45.2 50.0 20.2 22.3 47.4 41.1 23.6 5.9 17.8 29.3 16.9 19.0 49.8 18.4 39.7 31.6 28.0 40.8 37.3 38.8 26.8 48.3 31.1 47.3 12.7 29.4 44.9 29.8 PHF20L1 "CGI-72, FLJ13649, FLJ21615, MGC64923, TDRD20B" ENSG00000129292 "PHD finger protein 20 like 1" A8MW92 8 132775358-132848807 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025060, HPA028417" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA025060: AB_10599822, HPA028417: AB_10602278" "unprognostic (9.12e-3)" "unprognostic (2.29e-1)" "unprognostic (2.77e-1)" "unprognostic (2.10e-3)" "unprognostic (1.25e-1)" "unprognostic (1.51e-1)" "unprognostic (2.79e-2)" "unprognostic (7.53e-2)" "unprognostic (9.66e-2)" "unprognostic (1.24e-2)" "unprognostic (8.85e-2)" "unprognostic (1.19e-1)" "unprognostic (1.70e-2)" "unprognostic (1.58e-1)" "unprognostic (1.78e-1)" "unprognostic (2.24e-2)" "unprognostic (7.83e-2)" 14.5 19.9 15.3 15.7 26.6 27.1 17.6 22.2 22.0 15.7 14.2 12.6 11.7 11.6 17.6 13.0 16.0 12.4 13.6 22.5 15.9 10.5 13.6 16.4 12.9 13.5 11.8 14.8 16.9 12.7 22.4 18.6 15.1 12.9 13.1 12.9 10.0 14.9 14.6 27.0 9.5 12.9 14.5 12.9 15.4 12.8 15.9 13.7 38.9 28.5 9.2 14.7 14.7 16.9 2.4 4.0 14.7 4.3 3.0 3.4 1.6 10.1 10.2 16.7 9.6 13.1 15.7 6.0 14.9 11.7 10.3 10.1 5.7 7.0 11.6 13.1 14.9 8.9 6.0 11.3 7.9 12.8 19.5 8.0 12.5 12.1 4.0 13.8 9.9 8.9 11.7 9.9 10.7 16.0 10.0 11.3 18.6 15.3 18.3 15.3 10.1 32.3 4.4 7.4 11.6 13.6 15.8 11.2 10.0 8.4 8.8 41.5 12.1 9.5 6.8 12.0 7.3 13.3 11.3 14.7 16.7 13.4 10.9 14.2 10.9 14.2 14.9 14.8 17.6 14.8 3.7 4.3 7.5 2.5 2.5 2.5 2.2 2.3 2.9 4.0 2.4 3.4 2.7 14.7 3.0 3.8 3.3 2.6 1.6 15.3 26.6 22.2 22.0 15.9 10.5 11.8 14.8 12.9 13.7 23.8 45.9 43.8 43.6 29.9 53.6 77.9 17.8 29.4 46.6 34.9 41.2 23.1 19.9 33.0 47.6 43.8 33.8 23.3 27.3 24.9 37.5 35.9 58.9 30.1 32.0 50.9 42.0 35.6 44.0 39.6 37.2 48.6 21.9 31.5 24.8 47.4 32.7 24.1 40.3 22.0 52.6 45.3 42.3 61.6 42.6 31.7 37.6 42.1 22.2 54.3 PHLDB3 FLJ40193 ENSG00000176531 "Pleckstrin homology like domain family B member 3" Q6NSJ2 19 43474954-43504935 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Syncytiotrophoblasts: 48.5;Urothelial cells: 40.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA043425 Approved Approved "Nuclear speckles,Plasma membrane,Cytosol" NA NA "Nuclear speckles" "Plasma membrane, Cytosol" "HPA043425: AB_10797142" "unprognostic (2.50e-2)" "unprognostic (4.22e-3)" "unprognostic (3.06e-2)" "unprognostic (4.13e-2)" "unprognostic (1.02e-1)" "unprognostic (5.22e-3)" "unprognostic (4.43e-1)" "unprognostic (1.93e-1)" "unprognostic (2.15e-1)" "unprognostic (3.60e-2)" "prognostic favorable (6.36e-6)" "unprognostic (4.62e-2)" "prognostic unfavorable (4.11e-5)" "prognostic unfavorable (5.77e-4)" "unprognostic (2.06e-1)" "unprognostic (2.05e-1)" "unprognostic (2.37e-1)" 2.7 8.5 6.6 11.7 5.9 3.6 6.0 2.1 5.2 8.7 4.8 1.8 7.1 5.8 8.8 6.5 28.4 7.3 15.9 4.5 5.2 2.9 4.8 9.6 4.0 7.8 3.5 5.8 9.5 7.7 6.8 7.9 6.4 3.2 11.7 2.2 6.7 11.1 7.6 9.0 28.7 9.4 7.5 3.0 6.4 5.4 18.7 3.0 12.2 5.7 15.2 23.2 9.3 14.8 4.4 8.1 0.9 3.3 2.6 5.5 2.3 5.3 5.6 2.3 5.8 2.1 4.4 15.2 3.8 3.4 3.8 2.7 5.7 5.6 3.2 12.1 2.3 3.0 6.2 1.7 6.7 0.7 7.5 5.3 3.5 5.3 6.8 5.3 1.3 6.8 3.7 8.5 4.1 2.5 3.0 3.4 8.0 6.2 4.9 1.9 8.3 5.4 0.3 1.4 12.7 4.6 6.4 3.1 2.1 1.8 18.0 0.1 5.1 4.9 10.7 4.6 1.5 7.6 4.5 4.3 2.5 6.6 3.0 3.6 12.6 13.7 3.5 2.3 2.6 4.1 0.3 3.3 0.5 4.0 2.3 2.9 3.7 3.7 3.0 6.9 4.4 5.5 4.8 0.9 2.6 0.2 8.1 3.6 2.3 6.6 5.9 2.1 5.2 5.2 2.9 3.5 5.8 3.2 3.0 0.0 1.7 13.7 24.7 25.8 1.0 1.7 7.6 10.7 2.3 8.7 0.0 18.0 1.7 4.8 7.6 5.0 6.4 0.0 2.1 4.1 8.5 20.4 5.7 9.5 3.2 0.0 2.9 4.9 3.7 7.4 3.4 4.1 5.0 5.4 3.9 3.7 2.4 3.1 3.2 5.5 1.8 6.5 15.5 20.7 5.3 33.5 48.5 6.9 3.3 40.7 PHOSPHO1 ENSG00000173868 "Phosphoethanolamine/phosphocholine phosphatase" Q8TCT1 17 49223362-49230766 "Enzymes, Predicted intracellular proteins" "Mineral balance" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 80.0;testis: 52.3" "Cell type enriched" "Detected in some" 6 "Late spermatids: 1098.7" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in many" 4 "cerebral cortex: 10.2;pons and medulla: 8.2" "Group enriched" "Detected in some" 171 "eosinophil: 30.6;neutrophil: 80.0" "Lineage enriched" "Detected in single" 248 "granulocytes: 80.0" "Cell line enhanced" "Detected in some" "Daudi: 8.6;EFO-21: 5.8;HDLM-2: 6.1;SuSa: 8.9" "Low region specificity" "Detected in all" HPA065025 Approved "Plasma membrane,Actin filaments" NA NA "Actin filaments" "Plasma membrane" "HPA065025: AB_2732727" "unprognostic (1.37e-1)" "unprognostic (3.01e-3)" "unprognostic (7.53e-2)" "unprognostic (4.41e-3)" "unprognostic (1.57e-1)" "unprognostic (4.70e-2)" "unprognostic (1.44e-1)" "unprognostic (1.39e-2)" "unprognostic (2.04e-1)" "unprognostic (6.88e-2)" "unprognostic (1.02e-2)" "unprognostic (2.88e-1)" "unprognostic (2.03e-1)" "unprognostic (1.45e-1)" "unprognostic (1.62e-1)" "unprognostic (1.08e-1)" "unprognostic (1.87e-1)" 2.5 1.3 1.1 2.9 1.9 15.3 0.7 1.0 10.2 0.6 0.6 0.2 0.2 2.5 0.9 2.7 0.9 1.3 2.1 1.0 1.7 1.3 1.0 0.9 2.5 2.0 2.1 1.5 1.1 1.0 0.1 0.8 7.6 8.2 0.9 0.0 1.6 0.9 0.5 2.2 1.1 2.6 0.3 1.5 12.6 0.7 52.3 0.1 0.0 0.8 0.1 0.1 1.4 1.3 0.0 0.0 80.0 0.3 0.0 0.0 0.1 0.0 1.1 0.0 2.0 0.1 0.2 0.0 0.3 0.4 0.0 0.1 2.7 0.0 8.6 5.8 0.0 3.3 0.0 1.6 0.5 0.1 6.1 0.2 1.2 1.1 0.4 0.0 0.0 1.1 0.4 0.0 0.6 0.0 0.6 0.0 1.1 0.0 0.0 0.6 0.1 0.0 0.4 0.0 0.3 1.6 1.7 3.2 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 8.9 0.2 0.1 3.5 0.4 2.8 1.9 0.0 0.2 0.3 0.6 2.5 3.3 0.3 0.0 0.1 30.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 80.0 0.0 0.3 0.0 0.0 0.1 1.1 1.9 1.0 10.2 1.7 1.3 2.1 1.5 8.2 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.4 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 185.3 0.1 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 2.3 0.0 0.0 0.6 0.0 1098.7 7.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 5.6 0.0 0.4 0.0 0.0 8.2 3.8 0.0 198.7 0.0 0.0 0.0 PHPT1 "bA216L13.10, CGI-202, DKFZp564M173, HSPC141, PHP14" ENSG00000054148 "Phosphohistidine phosphatase 1" Q9NRX4 9 136848724-136851027 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013584, HPA020952" Approved Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA NA 430000 Cytosol "Nucleoplasm, Nuclear bodies, Plasma membrane" "CAB013584: , HPA020952: AB_1855331" "unprognostic (7.34e-2)" "unprognostic (9.21e-2)" "unprognostic (7.90e-2)" "unprognostic (1.57e-2)" "unprognostic (3.76e-2)" "unprognostic (2.30e-1)" "unprognostic (4.64e-2)" "unprognostic (1.69e-2)" "unprognostic (3.23e-2)" "unprognostic (1.82e-1)" "unprognostic (1.26e-3)" "unprognostic (5.85e-2)" "unprognostic (9.66e-3)" "unprognostic (1.11e-2)" "unprognostic (2.01e-1)" "unprognostic (3.95e-2)" "unprognostic (8.49e-2)" 15.8 26.4 31.5 12.1 28.0 11.7 15.3 14.7 27.2 19.2 15.7 18.5 13.7 14.7 11.2 21.7 13.7 21.1 14.2 59.1 22.7 19.3 18.4 12.6 12.1 12.7 27.0 21.0 13.7 46.5 15.6 21.2 14.7 20.8 20.2 11.6 14.1 30.5 22.6 86.0 9.2 16.3 16.9 24.3 10.3 13.4 13.8 18.6 7.5 20.7 19.8 10.4 12.0 9.8 24.9 48.8 3.3 35.4 20.0 24.3 32.1 7.1 52.0 29.7 18.9 19.2 34.9 43.7 16.6 21.2 20.3 18.1 18.9 16.3 15.2 20.2 20.5 24.3 18.9 6.4 37.5 6.4 13.6 13.2 4.8 34.2 41.5 23.9 9.5 19.5 43.5 30.9 11.6 14.0 18.4 26.6 11.9 11.5 14.1 31.4 40.6 13.8 20.0 23.5 47.6 22.4 11.5 13.0 25.1 32.1 11.9 14.6 13.8 17.9 21.0 8.6 14.8 15.9 26.4 21.6 42.5 13.2 11.7 15.3 9.4 9.1 9.3 24.0 6.9 25.4 2.9 35.4 3.3 24.3 34.2 20.9 24.9 21.1 21.9 37.5 16.5 15.0 21.3 1.7 20.0 24.0 48.8 22.9 32.1 31.5 28.0 14.7 27.2 22.7 19.3 27.0 21.0 20.8 18.6 89.3 132.7 80.4 156.2 133.5 37.9 336.8 191.1 136.5 125.1 205.9 21.6 300.5 633.3 164.3 214.6 110.1 411.5 70.0 220.3 372.9 227.8 244.3 120.2 179.9 249.5 63.5 254.7 94.5 103.8 640.4 189.8 148.3 317.2 367.9 241.4 126.9 202.0 354.2 210.0 509.4 53.8 84.1 248.0 93.6 149.9 141.4 220.8 93.5 262.8 160.3 PI3 "cementoin, ELAFIN, ESI, SKALP, WAP3, WFDC14" ENSG00000124102 "Peptidase inhibitor 3" P19957 20 45174876-45176544 "Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 157.1;esophagus: 200.8;lymphoid tissue: 173.5;tongue: 468.6" "Cell type enhanced" "Detected in many" 21 "Enterocytes: 69.5;Exocrine glandular cells: 290.8;Pancreatic endocrine cells: 135.9" "Cancer enhanced" "Detected in many" "head and neck cancer: 2666.5" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 1121 "neutrophil: 157.1" "Lineage enriched" "Detected in single" 1571 "granulocytes: 157.1" "Group enriched" "Detected in some" 5 "EFO-21: 26.6;HaCaT: 32.3;OE19: 29.6;PC-3: 55.0" "CAB009449, HPA017737" Enhanced Approved "Plasma membrane" "Secreted to blood" NA NA 2100000 "Plasma membrane" "CAB009449: AB_2252354, HPA017737: AB_1848107" "prognostic favorable (6.94e-4)" "unprognostic (3.61e-2)" "unprognostic (1.00e-1)" "unprognostic (8.30e-2)" "unprognostic (7.34e-2)" "unprognostic (1.85e-1)" "unprognostic (3.20e-3)" "unprognostic (5.53e-3)" "unprognostic (1.75e-1)" "prognostic unfavorable (3.84e-6)" "prognostic unfavorable (6.89e-4)" "unprognostic (8.54e-3)" "prognostic unfavorable (1.94e-8)" "unprognostic (1.23e-1)" "unprognostic (7.38e-2)" "unprognostic (1.04e-2)" "unprognostic (5.91e-3)" 0.4 0.0 0.2 8.8 0.2 0.0 0.7 0.2 0.2 85.3 9.3 0.2 0.4 0.1 7.7 0.2 200.8 0.3 4.8 0.6 0.2 0.0 0.3 0.6 3.1 0.8 0.2 0.2 0.3 0.4 0.0 0.2 0.6 0.3 1.0 3.7 0.3 35.6 0.4 0.2 6.4 3.2 0.6 0.2 1.4 0.7 5.1 0.2 23.4 0.2 468.6 173.5 1.6 118.7 0.0 0.0 157.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.9 0.6 0.4 26.6 0.0 0.3 32.3 0.0 6.6 0.0 0.3 0.0 0.1 2.0 0.2 0.0 0.2 0.0 0.0 6.3 5.2 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 29.6 55.0 0.0 0.2 0.0 6.3 0.1 0.0 0.0 4.5 0.6 0.0 0.0 0.0 0.0 0.2 0.3 3.2 0.0 0.2 0.1 0.4 0.1 4.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 157.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.3 0.2 0.0 11.3 0.5 5.2 0.1 0.0 0.0 7.6 0.0 13.6 17.4 0.0 0.0 0.0 14.9 0.1 0.1 69.5 0.0 290.8 0.0 0.3 25.8 4.6 0.0 0.1 0.0 16.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 9.4 0.0 135.9 29.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.3 0.0 0.0 33.5 18.7 PI4K2A "DKFZP761G1923, PI4KII, PIK42A" ENSG00000155252 "Phosphatidylinositol 4-kinase type 2 alpha" Q9BTU6 10 97640686-97676434 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Hofbauer cells: 32.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB030649, HPA076857" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "CAB030649: , HPA076857: AB_2686817" "unprognostic (1.34e-1)" "unprognostic (3.50e-2)" "prognostic unfavorable (4.21e-5)" "unprognostic (1.80e-2)" "unprognostic (2.12e-1)" "unprognostic (1.75e-2)" "unprognostic (2.84e-3)" "unprognostic (1.60e-2)" "unprognostic (1.39e-3)" "unprognostic (1.38e-2)" "unprognostic (1.02e-2)" "unprognostic (1.65e-1)" "unprognostic (9.92e-2)" "unprognostic (1.27e-1)" "unprognostic (1.80e-1)" "unprognostic (1.45e-1)" "unprognostic (2.90e-1)" 17.2 23.0 13.8 10.7 21.2 22.8 9.5 16.8 33.8 12.0 9.1 16.8 9.5 10.9 12.8 15.5 18.3 8.9 16.1 15.2 14.5 17.9 14.7 17.1 15.0 11.0 15.9 15.7 10.6 9.5 23.2 15.5 19.9 30.7 10.3 10.2 23.8 10.1 12.7 11.3 15.3 9.9 15.0 9.9 14.4 8.8 14.9 7.5 8.2 12.0 8.8 11.8 13.6 11.2 4.1 3.7 1.1 3.4 1.9 4.0 1.6 12.1 9.2 7.6 13.5 16.3 11.8 6.1 12.2 27.0 19.3 20.5 8.3 12.1 4.4 7.2 15.4 14.2 11.8 8.4 24.3 16.1 5.3 7.2 3.9 6.5 7.5 15.7 3.5 5.6 12.4 20.8 20.2 36.0 21.2 9.8 8.7 6.1 7.3 13.3 6.2 7.7 2.7 4.9 6.3 8.7 3.6 7.9 4.3 13.2 11.4 2.6 8.4 10.3 2.6 15.2 11.2 7.2 5.6 10.8 9.2 6.9 10.9 9.4 6.5 7.6 7.2 17.1 2.1 3.0 0.0 3.4 0.0 4.0 2.3 2.8 4.1 1.7 3.4 3.7 1.9 1.4 2.6 1.1 1.9 1.6 1.7 3.1 1.6 13.8 21.2 16.8 33.8 14.5 17.9 15.9 15.7 30.7 7.5 3.0 4.8 4.7 4.1 11.8 12.9 9.8 10.2 1.4 2.3 5.2 11.8 11.6 3.3 4.0 1.9 5.0 8.3 0.0 4.2 5.3 9.4 4.3 1.1 9.3 32.1 11.1 2.9 3.1 11.0 1.7 4.0 17.5 10.1 22.6 2.5 6.9 5.7 0.0 8.5 6.2 14.2 6.5 5.9 9.1 5.6 12.5 22.7 7.0 2.5 7.1 PI4KA "PI4K-ALPHA, pi4K230, PIK4CA" ENSG00000241973 "Phosphatidylinositol 4-kinase alpha" P42356 22 20707691-20859417 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 48.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 52.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009092, HPA075515" Approved Approved "Nucleoplasm,Plasma membrane" NA NA 18000 Nucleoplasm "Plasma membrane" "CAB009092: AB_2164033, HPA075515: AB_2686753" "unprognostic (8.06e-2)" "unprognostic (1.53e-1)" "unprognostic (1.20e-2)" "unprognostic (4.45e-2)" "unprognostic (1.21e-1)" "unprognostic (5.01e-3)" "unprognostic (3.19e-2)" "prognostic favorable (5.24e-4)" "unprognostic (2.08e-1)" "unprognostic (4.21e-2)" "unprognostic (1.88e-2)" "unprognostic (1.29e-1)" "prognostic favorable (7.22e-5)" "unprognostic (1.37e-1)" "unprognostic (1.33e-1)" "unprognostic (2.35e-1)" "unprognostic (1.50e-1)" 7.7 9.2 28.8 10.5 34.2 12.5 6.5 14.1 48.0 9.7 8.8 10.1 4.9 9.1 9.7 6.1 8.3 8.4 8.0 8.5 30.4 19.2 9.0 12.6 9.0 11.2 19.0 25.9 10.2 8.6 25.6 12.5 10.4 19.3 9.8 8.9 10.8 6.8 10.6 7.1 6.6 10.0 13.2 6.8 10.2 9.9 13.1 8.2 17.9 9.9 2.9 10.2 8.4 4.8 5.0 12.5 7.6 5.5 9.1 7.7 2.9 9.9 8.4 7.4 11.1 21.2 12.8 10.6 9.0 13.7 13.3 13.1 6.5 4.2 18.7 5.4 18.1 13.1 8.8 14.0 8.7 8.2 15.9 21.5 19.2 11.3 7.4 10.6 19.0 15.4 11.4 5.5 11.3 6.3 8.7 10.8 5.7 52.4 15.9 10.3 13.7 16.6 6.5 5.8 17.8 8.7 16.7 16.2 3.4 7.4 15.9 18.2 13.3 11.8 13.8 9.4 10.8 11.6 8.7 10.9 24.3 12.6 8.9 7.6 12.2 12.4 14.9 16.0 13.7 10.1 3.1 5.5 7.3 5.1 5.4 4.9 4.6 5.6 6.1 3.6 5.0 5.7 7.7 7.6 9.1 4.6 12.5 5.8 2.9 28.8 34.2 14.1 48.0 30.4 19.2 19.0 25.9 19.3 8.2 11.9 25.4 14.0 5.7 9.0 32.8 25.7 25.5 6.7 9.1 7.0 45.2 15.6 1.7 8.5 30.2 12.8 18.2 0.0 5.5 16.0 10.8 10.3 11.5 15.5 17.4 35.0 18.4 14.7 15.5 19.2 18.4 16.5 10.1 6.4 16.8 22.8 7.1 10.5 22.6 9.1 23.8 25.8 10.5 32.1 28.9 8.5 16.7 13.3 12.7 7.0 PIEZO2 "C18orf30, C18orf58, FAM38B, FAM38B2, FLJ23144, FLJ23403, FLJ34907, HsT748, HsT771" ENSG00000154864 "Piezo type mechanosensitive ion channel component 2" Q9H5I5 18 10666483-11148762 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sensory transduction, Transport" "Ion channel" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.3" "Cell type enhanced" "Detected in some" 10 "Cholangiocytes: 10.2;Ciliated cells: 13.4;Early spermatids: 23.3;Ito cells: 22.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 9.6;BJ hTERT+ SV40 Large T+: 10.7;BJ hTERT+ SV40 Large T+ RasG12V: 14.9;HeLa: 23.8;U-266/70: 15.2;U-698: 9.9" "Low region specificity" "Detected in single" "HPA015986, HPA031974, HPA040616" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA015986: AB_1848395, HPA031974: AB_10603675, HPA040616: AB_2677043" "unprognostic (1.36e-1)" "unprognostic (1.92e-1)" "unprognostic (9.21e-2)" "unprognostic (2.53e-2)" "unprognostic (7.84e-2)" "unprognostic (3.16e-2)" "unprognostic (3.87e-2)" "unprognostic (4.34e-3)" "unprognostic (6.55e-2)" "unprognostic (3.89e-2)" "unprognostic (6.06e-2)" "unprognostic (2.23e-1)" "prognostic unfavorable (9.57e-7)" "unprognostic (1.12e-3)" "unprognostic (1.09e-1)" "unprognostic (9.04e-2)" "unprognostic (1.83e-2)" 0.9 0.3 3.1 0.9 2.3 0.0 1.9 0.1 3.6 0.9 3.3 0.0 0.3 1.6 5.8 0.8 5.9 0.0 5.2 2.1 0.9 4.5 7.4 0.5 5.8 0.6 1.7 0.0 0.6 0.0 3.4 1.3 0.0 3.3 0.0 0.8 0.9 1.9 10.3 2.7 1.4 0.9 1.3 0.2 4.6 0.4 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 1.2 9.6 0.0 0.0 0.0 0.0 0.5 2.8 10.7 14.9 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 6.9 0.0 0.3 0.0 23.8 5.6 3.4 0.0 0.0 0.0 0.2 2.7 0.7 0.1 3.3 0.3 0.0 0.2 1.7 0.0 0.1 0.0 3.0 4.1 0.0 0.0 0.0 4.2 0.0 3.3 8.3 0.0 0.1 0.0 0.5 4.5 0.0 2.7 0.0 0.0 3.8 0.2 0.5 15.2 0.1 9.9 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.4 0.7 0.0 1.4 10.2 13.4 1.2 0.0 0.0 0.0 0.0 0.1 23.3 0.9 0.0 0.0 0.2 0.0 3.1 0.1 4.7 4.5 0.7 0.0 0.0 22.1 4.0 8.6 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.5 0.4 0.0 0.4 0.6 0.3 0.0 0.0 0.0 PIGW "FLJ37433, Gwt1" ENSG00000277161 "Phosphatidylinositol glycan anchor biosynthesis class W" Q7Z7B1 17 36535020-36539310 "Disease related genes, Predicted membrane proteins" "GPI-anchor biosynthesis" "Acyltransferase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023499 Approved "Plasma membrane" No Yes "Plasma membrane" "HPA023499: " "unprognostic (4.96e-3)" "unprognostic (3.84e-2)" "unprognostic (5.40e-3)" "unprognostic (7.39e-2)" "unprognostic (2.32e-1)" "unprognostic (7.71e-2)" "unprognostic (8.14e-3)" "unprognostic (1.05e-1)" "unprognostic (1.89e-1)" "unprognostic (4.62e-2)" "unprognostic (1.98e-1)" "unprognostic (3.29e-1)" "unprognostic (1.73e-2)" "unprognostic (1.41e-1)" "unprognostic (8.96e-2)" "unprognostic (1.08e-3)" "unprognostic (1.88e-1)" 3.0 2.4 2.5 4.9 2.9 3.0 4.5 1.8 6.4 2.5 3.8 2.4 0.4 3.3 3.2 4.4 5.7 2.0 2.7 3.5 2.3 6.7 12.0 2.9 4.7 3.6 2.2 4.3 4.8 3.3 6.0 2.6 6.3 2.1 4.8 3.7 3.7 2.8 6.5 5.0 3.9 3.1 3.2 4.3 3.3 3.4 2.2 4.0 4.1 8.1 5.5 2.4 1.2 4.4 6.2 1.1 4.9 4.8 5.8 3.3 7.3 9.7 6.8 6.2 2.9 2.6 8.9 8.9 3.9 8.1 6.7 8.5 7.7 11.0 2.7 4.9 8.9 10.4 11.9 5.0 11.1 6.1 12.6 9.5 6.1 6.8 2.3 19.5 10.5 3.0 5.8 8.9 4.0 1.8 4.5 3.6 16.0 7.0 5.6 5.4 9.6 5.8 9.7 4.3 6.6 8.6 16.0 10.8 4.3 9.7 13.5 10.2 12.7 4.7 6.3 6.4 17.0 3.0 6.1 13.9 16.9 13.4 15.7 5.9 18.6 13.2 3.7 9.9 12.5 1.1 2.8 0.5 3.6 4.2 5.6 2.5 4.7 3.6 6.2 4.4 5.8 5.2 0.9 4.8 4.9 2.9 2.4 3.3 3.0 1.9 1.5 7.4 3.1 2.0 1.2 10.2 2.7 3.4 0.0 0.0 5.2 6.6 4.6 0.1 2.8 1.4 0.0 5.5 5.1 3.7 4.9 0.0 5.3 4.0 3.2 1.2 1.3 2.1 0.2 2.6 2.7 0.0 2.8 3.5 5.6 4.7 3.1 2.1 3.8 2.7 0.0 3.1 2.6 7.3 5.9 3.4 4.3 5.0 4.8 PIGX FLJ20522 ENSG00000163964 "Phosphatidylinositol glycan anchor biosynthesis class X" Q8TBF5 3 196639775-196736007 "Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 15.5;eosinophil: 34.5;neutrophil: 8.6" "Lineage enriched" "Detected in all" 8 "granulocytes: 34.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029409, HPA073301" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA029409: AB_10610280, HPA073301: " "unprognostic (8.83e-2)" "prognostic favorable (2.12e-4)" "unprognostic (2.14e-1)" "unprognostic (2.42e-3)" "unprognostic (9.25e-2)" "unprognostic (2.00e-1)" "prognostic unfavorable (7.45e-5)" "unprognostic (1.91e-1)" "unprognostic (3.97e-2)" "unprognostic (1.11e-2)" "unprognostic (3.18e-2)" "unprognostic (4.02e-1)" "unprognostic (1.30e-1)" "unprognostic (1.15e-1)" "unprognostic (1.53e-1)" "unprognostic (1.46e-1)" "unprognostic (2.01e-1)" 19.1 13.7 25.1 12.7 25.5 9.3 19.2 16.9 25.8 13.1 15.5 13.1 7.8 12.3 15.2 18.5 16.6 12.6 12.7 13.9 23.2 25.4 18.1 12.5 15.6 27.0 24.8 13.4 10.9 16.0 28.1 18.2 17.7 14.5 18.6 17.1 16.3 12.9 18.5 18.6 12.3 11.8 17.1 21.7 18.4 10.6 9.0 14.2 24.6 15.5 10.6 14.7 13.6 10.7 1.7 3.2 34.5 4.4 3.6 2.1 1.5 22.3 10.2 13.4 9.4 14.2 10.8 7.6 10.1 12.2 12.4 12.9 9.8 14.6 11.0 33.9 10.1 15.4 12.3 11.4 9.6 15.4 10.0 10.6 9.1 7.1 6.6 13.1 10.2 17.0 8.1 15.0 10.0 9.5 9.9 6.7 18.0 6.2 22.1 11.3 20.3 26.3 13.3 6.0 17.8 11.6 14.3 15.8 15.9 12.8 7.5 13.0 14.4 17.0 11.7 13.9 10.5 40.5 9.5 3.5 11.9 5.2 13.0 15.5 27.9 32.1 20.8 10.8 12.6 12.3 15.5 3.0 34.5 1.5 4.4 1.3 1.7 1.4 2.1 3.2 1.7 1.6 1.4 8.6 3.6 4.4 1.4 1.7 1.5 25.1 25.5 16.9 25.8 23.2 25.4 24.8 13.4 14.5 14.2 17.9 21.8 19.9 24.6 15.1 31.0 10.7 20.4 9.4 11.4 27.9 45.2 17.1 29.9 6.9 19.9 15.7 18.7 0.0 4.9 17.4 22.4 27.9 11.5 14.4 17.0 31.8 15.1 17.8 18.3 17.2 25.9 19.4 20.3 10.8 17.7 33.8 5.4 14.4 32.9 29.9 34.6 25.8 19.4 21.4 33.5 13.9 9.7 17.8 26.3 16.3 PIK3AP1 "BCAP, FLJ35564" ENSG00000155629 "Phosphoinositide-3-kinase adaptor protein 1" Q6ZUJ8 10 96593312-96720514 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 38.9;liver: 38.4;lymphoid tissue: 32.0;salivary gland: 29.7" "Cell type enhanced" "Detected in many" 11 "Hepatocytes: 66.5;Kupffer cells: 114.3;Macrophages: 53.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "intermediate monocyte: 15.5;memory B-cell: 17.5;naive B-cell: 16.2;non-classical monocyte: 38.9" "Group enriched" "Detected in all" 6 "B-cells: 17.5;monocytes: 38.9" "Cell line enhanced" "Detected in some" "Daudi: 24.7;NB-4: 17.8;REH: 52.8;THP-1: 26.9;U-698: 33.7;U-937: 27.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB026136, HPA038452" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" No No Cytosol "Nucleoplasm, Plasma membrane" "CAB026136: , HPA038452: AB_2676019" "unprognostic (2.83e-2)" "unprognostic (4.61e-3)" "unprognostic (7.32e-2)" "unprognostic (1.70e-1)" "unprognostic (1.79e-1)" "unprognostic (1.49e-1)" "unprognostic (4.60e-2)" "unprognostic (1.10e-1)" "unprognostic (2.33e-1)" "unprognostic (1.31e-1)" "unprognostic (1.96e-1)" "unprognostic (2.10e-1)" "unprognostic (5.11e-2)" "unprognostic (1.28e-1)" "unprognostic (4.69e-2)" "unprognostic (5.45e-1)" "unprognostic (1.13e-1)" 5.8 2.2 2.9 16.8 7.1 14.7 4.8 1.0 3.0 1.4 2.2 3.2 0.0 1.9 1.3 2.3 1.3 2.0 8.5 3.3 3.1 2.4 6.2 38.4 6.0 19.5 5.3 0.5 3.3 16.1 0.3 3.0 10.9 5.1 1.8 2.7 1.6 29.7 0.8 1.1 1.5 6.6 2.4 7.3 32.0 1.9 1.7 4.3 2.0 2.4 0.6 19.2 4.1 2.2 17.5 4.4 4.7 38.9 4.5 4.8 4.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.8 0.4 24.7 2.5 0.0 0.4 0.0 5.2 0.0 0.2 13.7 0.9 3.7 0.0 0.4 0.0 10.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.1 0.3 17.8 0.2 7.0 0.3 52.8 1.2 5.8 0.0 0.0 1.1 0.6 0.0 0.0 0.3 0.1 0.0 26.9 0.0 0.0 0.8 0.0 0.2 0.2 0.0 33.7 0.0 27.7 0.0 1.7 5.4 3.3 4.8 15.5 1.7 17.5 0.1 1.5 4.4 16.2 0.0 1.2 4.7 4.5 38.9 3.9 0.1 4.2 2.9 7.1 1.0 3.0 3.1 2.4 5.3 0.5 5.1 4.3 3.0 3.8 29.6 0.0 1.3 0.2 2.2 28.1 1.4 3.4 1.8 2.0 0.4 1.7 26.1 3.3 1.4 2.6 0.0 25.2 0.7 1.0 0.5 13.9 66.5 41.2 0.0 1.7 8.0 114.3 0.4 1.1 53.7 5.0 2.8 2.5 0.2 22.8 18.4 2.1 12.8 3.3 0.0 1.7 0.2 0.2 1.0 1.9 27.7 2.9 0.1 PIK3R6 "C17orf38, FLJ34500, HsT41028, p87PIKAP" ENSG00000276231 "Phosphoinositide-3-kinase regulatory subunit 6" Q5UE93 17 8802723-8867677 "Predicted intracellular proteins" Angiogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 32.1;lymphoid tissue: 12.2" "Cell type enhanced" "Detected in some" 26 "Early spermatids: 8.7;granulocytes: 45.2;Late spermatids: 13.8" "Low cancer specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "eosinophil: 32.1" "Lineage enriched" "Detected in many" 7 "granulocytes: 32.1" "Cell line enriched" "Detected in some" 8 "HMC-1: 58.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA023077 Approved Approved "Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Golgi apparatus" "Plasma membrane, Cytosol" "HPA023077: AB_1854909" "unprognostic (4.29e-2)" "unprognostic (8.56e-3)" "unprognostic (9.39e-2)" "unprognostic (5.96e-3)" "unprognostic (2.46e-1)" "unprognostic (5.25e-3)" "unprognostic (4.50e-3)" "unprognostic (2.29e-2)" "unprognostic (3.12e-2)" "unprognostic (3.14e-1)" "unprognostic (2.20e-2)" "unprognostic (1.38e-1)" "prognostic unfavorable (1.50e-6)" "unprognostic (3.45e-1)" "unprognostic (3.91e-2)" "unprognostic (2.68e-1)" "unprognostic (8.98e-2)" 2.2 0.0 2.1 12.2 5.4 5.3 1.0 0.0 3.7 1.5 1.9 2.5 1.4 3.5 2.6 2.3 1.2 0.4 6.6 2.6 3.1 0.0 0.6 3.4 4.4 2.5 0.0 0.3 0.8 0.3 0.0 1.4 3.2 2.4 1.5 1.4 0.9 0.7 1.0 1.8 5.2 2.2 3.1 6.3 2.3 1.1 2.7 6.9 0.0 0.8 6.4 3.0 3.3 1.3 4.9 32.1 4.3 0.5 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 7.5 0.0 0.0 0.0 0.0 58.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 7.7 3.4 32.1 0.2 4.3 0.2 1.3 0.0 0.1 4.9 0.1 0.0 0.1 0.5 0.5 3.3 0.0 0.0 1.4 0.0 2.2 0.0 0.0 0.5 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.1 0.2 0.0 45.2 0.0 6.3 0.0 0.0 0.0 2.6 13.8 0.0 3.2 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 1.5 0.0 0.0 PIP4K2C "FLJ22055, PIP5K2C" ENSG00000166908 "Phosphatidylinositol-5-phosphate 4-kinase type 2 gamma" Q8TBX8 12 57591174-57603418 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 112.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RH-30: 49.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028658 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA028658: AB_10601245" "unprognostic (7.84e-3)" "unprognostic (1.51e-1)" "unprognostic (2.42e-1)" "unprognostic (2.77e-2)" "unprognostic (2.49e-2)" "unprognostic (3.37e-2)" "prognostic unfavorable (7.98e-4)" "unprognostic (3.17e-2)" "unprognostic (6.00e-2)" "unprognostic (5.51e-2)" "unprognostic (1.75e-1)" "unprognostic (1.88e-1)" "prognostic favorable (2.06e-6)" "unprognostic (1.87e-1)" "unprognostic (2.16e-1)" "unprognostic (3.27e-1)" "unprognostic (3.42e-1)" 9.3 13.3 13.9 9.2 25.9 16.7 15.0 18.9 45.5 12.5 17.5 14.6 15.8 11.6 14.2 62.0 20.0 20.0 12.1 10.8 15.4 10.9 26.9 14.4 14.4 9.2 14.3 21.2 12.3 14.9 29.6 13.7 11.1 18.8 16.7 19.4 17.4 18.6 14.6 9.4 18.4 13.3 11.9 12.7 10.7 27.6 25.6 12.1 5.9 17.9 8.5 13.1 14.6 14.1 6.8 5.4 29.7 8.4 9.4 16.1 6.5 19.1 13.5 5.5 6.6 0.0 0.0 17.8 8.0 15.0 14.5 13.5 17.2 27.7 4.1 17.6 9.3 17.9 17.5 9.0 15.7 11.7 6.2 10.1 7.5 6.5 12.1 12.8 6.9 13.5 5.0 26.7 5.5 10.3 17.8 7.3 4.6 9.6 12.6 7.5 18.9 6.2 6.0 10.5 11.7 11.8 0.1 49.9 6.2 15.2 32.8 9.3 11.5 17.2 11.5 10.9 19.4 31.6 6.4 1.6 7.3 10.1 10.7 8.4 9.7 11.3 9.3 14.4 5.9 12.1 29.7 5.2 15.3 16.1 6.2 10.7 5.9 9.9 12.0 5.4 6.8 9.6 11.5 10.2 9.4 8.4 2.3 12.1 6.5 13.9 25.9 18.9 45.5 15.4 10.9 14.3 21.2 18.8 12.1 8.9 7.5 3.0 5.7 11.0 13.1 112.2 15.3 13.4 9.1 33.2 17.7 9.3 18.3 16.2 23.8 3.5 18.0 0.0 17.1 13.6 4.9 9.9 3.5 11.6 7.9 7.9 21.4 9.8 2.9 35.3 6.4 4.1 11.8 8.2 16.1 6.5 28.1 13.6 4.9 10.1 8.3 19.4 6.4 11.9 7.1 11.2 14.5 8.7 8.6 7.1 PITPNM3 "ACKR6, CORD5, NIR1, RDGBA3" ENSG00000091622 "PITPNM family member 3" Q9BZ71 17 6451264-6556494 "Disease related genes, Predicted intracellular proteins" "Cone-rod dystrophy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.0;lymphoid tissue: 43.3;ovary: 24.2" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 2: 16.8;Ito cells: 35.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 58 "neutrophil: 5.8" "Lineage enriched" "Detected in single" 58 "granulocytes: 5.8" "Cell line enhanced" "Detected in some" "HaCaT: 11.3;HeLa: 8.8;hTCEpi: 33.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022432, HPA059005" Enhanced Approved "Plasma membrane" NA NA "Plasma membrane" "HPA022432: AB_2670936, HPA059005: AB_2683876" "unprognostic (2.97e-2)" "unprognostic (8.60e-3)" "unprognostic (1.45e-2)" "unprognostic (1.52e-1)" "unprognostic (2.69e-2)" "prognostic favorable (3.67e-6)" "unprognostic (1.25e-2)" "unprognostic (6.86e-2)" "unprognostic (3.66e-2)" "unprognostic (3.01e-2)" "unprognostic (2.99e-3)" "unprognostic (3.58e-2)" "unprognostic (2.41e-1)" "unprognostic (9.60e-2)" "unprognostic (1.61e-1)" "unprognostic (3.55e-1)" "unprognostic (2.63e-1)" 1.1 2.4 17.9 1.2 18.8 0.5 1.7 18.7 23.0 2.4 4.5 0.7 3.4 1.5 1.9 3.4 9.4 4.3 3.8 0.8 7.2 5.2 1.5 1.6 3.1 0.6 2.9 11.9 24.2 0.9 1.9 0.7 0.6 2.5 2.7 3.6 2.3 1.9 8.3 1.1 14.3 1.4 3.8 0.9 43.3 3.2 2.4 1.5 0.0 2.4 0.7 2.1 1.3 2.5 0.0 0.0 5.8 0.0 0.0 0.0 0.0 5.6 0.6 0.4 0.2 0.0 0.1 0.4 0.4 0.1 0.5 0.4 0.3 4.0 0.1 2.1 0.1 1.5 11.3 0.2 2.3 0.2 0.2 0.4 0.1 8.8 0.1 0.6 0.2 0.4 0.1 33.0 0.6 1.9 2.7 0.3 0.4 0.1 0.0 0.3 0.5 0.1 0.1 0.6 2.8 1.6 0.2 1.2 0.0 0.8 0.1 0.3 0.3 5.2 2.4 0.1 0.2 0.8 0.0 0.2 0.3 2.1 0.4 1.3 0.3 0.1 0.0 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 17.9 18.8 18.7 23.0 7.2 5.2 2.9 11.9 2.5 1.5 3.0 16.8 0.0 1.7 4.5 6.9 2.2 7.6 8.1 9.1 1.8 3.9 0.0 0.0 2.2 3.8 2.7 5.4 0.0 0.5 0.0 0.6 1.5 5.7 0.9 0.1 4.8 1.2 35.0 4.9 1.3 0.6 0.0 0.0 0.0 3.6 0.5 5.9 5.8 0.0 0.0 10.2 0.0 0.5 2.1 1.6 5.1 0.1 0.8 6.0 3.6 PKD2L2 TRPP5 ENSG00000078795 "Polycystin 2 like 2, transient receptor potential cation channel" Q9NZM6 5 137887968-137942747 "Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 7.5;testis: 29.3" "Group enriched" "Detected in many" 5 "Early spermatids: 25.9;Spermatocytes: 19.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 5.9;U-266/70: 4.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA041903, HPA043634" Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA041903: AB_2677734, HPA043634: AB_2678591" "unprognostic (7.53e-3)" "unprognostic (2.21e-2)" "unprognostic (1.90e-1)" "unprognostic (3.59e-1)" "unprognostic (4.04e-1)" "unprognostic (1.21e-2)" "unprognostic (3.06e-1)" "unprognostic (1.40e-4)" "unprognostic (1.64e-2)" "unprognostic (2.13e-2)" "unprognostic (3.00e-2)" "unprognostic (5.85e-2)" "unprognostic (1.05e-3)" "unprognostic (2.21e-2)" "unprognostic (1.12e-1)" "unprognostic (1.28e-2)" "unprognostic (1.22e-1)" 0.5 1.5 2.0 0.6 2.5 2.2 1.2 1.7 1.9 0.5 0.3 0.7 0.7 0.3 0.5 1.0 0.5 0.4 0.6 1.7 1.0 0.8 0.4 0.3 0.4 1.3 1.2 1.3 0.6 1.1 0.0 1.5 0.2 1.8 0.5 0.1 0.2 0.7 0.0 3.3 0.8 0.3 0.0 0.7 1.0 0.6 29.3 0.4 0.0 1.0 0.0 0.2 0.4 0.6 3.9 3.5 7.5 1.7 1.9 1.9 0.8 1.6 1.2 0.2 0.1 0.4 0.5 1.8 0.6 0.0 0.0 0.0 0.1 3.2 2.3 3.5 0.0 0.1 0.7 0.1 0.0 0.1 1.5 1.1 1.3 4.2 0.1 0.0 0.4 1.8 0.1 0.2 0.0 0.0 0.7 0.6 3.3 1.5 5.9 0.8 0.5 1.1 2.4 0.6 0.1 1.0 0.0 0.1 0.0 0.0 2.3 0.8 0.9 1.5 0.2 0.9 0.7 0.4 0.5 0.5 1.0 1.8 0.7 1.0 4.6 3.4 0.4 2.3 0.7 1.8 7.1 1.7 3.0 1.8 1.2 1.0 2.5 1.6 1.4 0.9 3.9 1.9 1.7 7.5 1.9 1.0 3.5 1.1 0.8 2.0 2.5 1.7 1.9 1.0 0.8 1.2 1.3 1.8 0.4 3.0 2.1 0.5 1.6 1.9 2.3 1.5 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.1 25.9 0.8 0.0 0.0 0.0 0.1 1.3 1.3 1.1 0.2 0.2 3.2 0.0 1.3 0.6 4.7 0.6 0.2 3.3 0.0 0.0 0.9 0.1 0.0 0.4 0.2 3.9 0.0 1.2 19.5 2.2 1.0 0.1 0.7 0.0 0.5 PKN1 "DBK, MGC46204, PAK1, PKN, PRK1, PRKCL1" ENSG00000123143 "Protein kinase N1" Q16512 19 14433053-14471867 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003982, CAB010278" Approved Approved "Plasma membrane,Focal adhesion sites,Cytokinetic bridge" NA NA "Plasma membrane" "Focal adhesion sites, Cytokinetic bridge" "CAB010278: AB_2163965, HPA003982: AB_1855440" "unprognostic (3.83e-2)" "unprognostic (2.14e-1)" "unprognostic (4.13e-2)" "unprognostic (1.13e-2)" "unprognostic (1.94e-1)" "unprognostic (4.58e-1)" "unprognostic (1.30e-2)" "unprognostic (1.45e-1)" "unprognostic (1.43e-1)" "unprognostic (8.55e-3)" "unprognostic (4.08e-3)" "unprognostic (2.11e-1)" "unprognostic (1.45e-2)" "unprognostic (1.70e-1)" "unprognostic (8.66e-2)" "unprognostic (4.08e-1)" "unprognostic (2.24e-2)" 28.8 19.5 19.1 27.6 26.7 39.6 25.3 21.9 19.2 19.2 26.0 20.9 16.5 10.0 25.4 19.7 16.6 22.2 22.5 38.3 17.1 17.6 17.9 16.3 27.9 42.2 19.5 16.3 21.7 32.3 15.8 18.7 22.7 19.2 22.6 6.9 21.5 22.6 22.7 43.2 7.6 16.9 22.5 19.4 39.7 24.2 21.5 18.9 39.2 17.8 13.8 24.0 22.1 30.5 11.5 17.0 24.1 30.6 13.5 20.7 15.2 37.7 22.5 8.4 17.4 13.6 16.1 13.8 13.6 16.3 14.4 13.8 8.8 21.7 36.1 35.2 23.3 18.0 8.8 13.4 6.0 5.6 29.2 17.4 43.2 14.4 18.6 45.1 17.0 27.1 11.5 4.4 8.7 13.7 16.4 33.4 19.2 19.1 25.1 10.6 15.5 25.5 15.7 15.2 13.7 25.8 34.3 11.5 25.9 7.1 6.2 30.6 43.4 8.4 10.8 22.0 4.2 9.7 29.6 49.9 28.6 12.3 34.6 20.6 33.0 30.0 19.7 18.8 34.1 22.4 15.4 17.3 24.1 20.7 24.2 15.7 10.7 14.0 14.2 17.0 11.5 13.1 14.3 21.3 13.5 30.6 11.1 15.9 15.2 19.1 26.7 21.9 17.3 17.1 17.6 19.5 16.3 19.2 18.9 3.0 2.1 24.5 5.5 3.3 36.7 3.5 25.5 1.4 1.2 33.2 15.7 1.9 1.7 23.7 4.1 29.5 2.6 0.0 25.6 12.9 16.0 10.2 2.3 9.6 49.5 46.1 38.6 51.0 56.2 6.7 18.4 27.1 16.9 29.7 12.0 47.4 49.8 9.5 21.5 12.7 25.3 25.8 16.5 6.3 26.6 2.4 3.1 48.4 6.6 3.2 PKN2 "Pak-2, PRK2, PRKCL2, STK7" ENSG00000065243 "Protein kinase N2" Q16513 1 88684222-88836255 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell adhesion, Cell cycle, Cell division, Cilium biogenesis/degradation, Host-virus interaction, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "neutrophil: 35.7" "Lineage enriched" "Detected in all" 8 "granulocytes: 35.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034861, HPA057913" Approved Supported "Nucleoplasm,Nuclear bodies,Plasma membrane,Intermediate filaments,Centrosome,Cytosol" Yes No "Nucleoplasm, Intermediate filaments" "Nuclear bodies, Plasma membrane, Centrosome, Cytosol" "HPA034861: AB_2674363, HPA057913: AB_2732617" "unprognostic (7.52e-2)" "unprognostic (1.46e-1)" "prognostic favorable (5.67e-4)" "unprognostic (5.95e-2)" "unprognostic (3.39e-2)" "unprognostic (2.51e-2)" "unprognostic (4.64e-3)" "unprognostic (1.38e-1)" "unprognostic (4.43e-2)" "unprognostic (1.27e-2)" "unprognostic (2.90e-3)" "unprognostic (1.23e-1)" "unprognostic (1.51e-2)" "unprognostic (5.98e-2)" "unprognostic (2.38e-1)" "unprognostic (1.01e-2)" "unprognostic (1.99e-1)" 21.9 20.7 12.2 21.2 13.7 33.5 27.6 25.6 16.6 28.6 39.3 12.6 15.1 22.9 20.0 20.2 28.2 17.1 13.3 16.2 10.3 8.9 15.9 15.9 26.0 16.4 13.7 8.7 27.2 18.9 24.6 29.7 20.8 13.3 19.6 23.6 14.1 19.5 25.1 15.9 17.5 49.0 17.5 12.5 18.0 15.9 12.4 16.2 29.1 20.3 14.4 13.1 21.9 22.0 4.0 3.7 35.7 4.5 1.4 3.0 1.0 23.7 9.3 18.5 11.1 12.4 14.1 12.0 14.1 13.0 15.8 16.5 9.9 17.1 9.4 16.8 13.4 19.5 18.8 18.0 10.7 21.7 3.3 13.1 6.9 19.4 8.4 10.9 6.8 2.1 11.6 11.1 12.4 15.0 12.6 18.0 7.5 11.5 6.9 17.0 4.8 7.8 5.9 9.3 9.0 10.9 7.5 28.2 3.8 14.0 46.8 9.0 5.9 21.1 12.2 18.1 14.6 9.1 6.2 16.8 13.5 12.1 17.2 14.7 3.8 3.2 6.4 5.6 6.7 5.0 4.9 4.5 6.8 2.6 2.5 2.3 3.3 2.3 2.4 2.1 4.0 3.0 2.6 35.7 1.4 3.2 3.7 1.8 1.0 12.2 13.7 25.6 16.6 10.3 8.9 13.7 8.7 13.3 16.2 38.7 52.6 24.5 42.6 42.9 83.6 41.1 40.8 45.5 39.8 66.3 84.4 37.5 10.0 51.4 2.1 51.2 79.8 70.0 52.5 29.4 35.1 52.3 15.1 32.6 20.4 62.0 42.5 51.0 34.3 2.9 50.3 29.0 30.4 41.5 55.9 64.3 62.0 87.7 45.3 22.4 151.6 38.8 29.8 35.8 18.8 45.8 31.2 21.0 50.9 118.4 PKP1 B6P ENSG00000081277 "Plakophilin 1" Q13835 1 201283452-201332993 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Developmental protein" "Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 80.1;skin 1: 137.6;tongue: 129.6" "Group enriched" "Detected in many" 5 "Basal keratinocytes: 124.1;Suprabasal keratinocytes: 357.5" "Cancer enhanced" "Detected in many" "head and neck cancer: 295.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HaCaT: 45.1;HBEC3-KT: 27.6;hTCEpi: 98.2;hTERT-HME1: 26.1;PC-3: 37.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA027221, CAB033130" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA 2700000 "Nucleoplasm, Plasma membrane" "CAB033130: AB_2164139, HPA027221: AB_10599737" "unprognostic (3.55e-3)" "unprognostic (7.63e-2)" "unprognostic (1.99e-1)" "unprognostic (2.13e-1)" "unprognostic (1.03e-1)" "unprognostic (7.17e-2)" "unprognostic (2.40e-2)" "unprognostic (3.48e-2)" "unprognostic (1.49e-1)" "unprognostic (5.02e-2)" "unprognostic (2.20e-3)" "unprognostic (2.67e-1)" "unprognostic (9.17e-3)" "unprognostic (2.52e-2)" "unprognostic (1.61e-1)" "unprognostic (1.45e-1)" "unprognostic (6.59e-3)" 10.1 0.1 0.0 0.1 0.0 0.1 7.0 0.0 0.4 19.7 0.5 0.0 2.5 0.1 1.5 1.9 80.1 0.3 0.1 0.1 0.0 0.0 0.1 0.1 1.4 0.1 0.0 0.2 0.1 0.1 0.1 0.0 1.6 0.0 6.8 0.1 4.9 10.1 3.9 2.1 137.6 0.2 0.1 0.0 0.1 0.1 0.1 0.0 9.2 0.1 129.6 37.2 1.2 27.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 45.1 0.0 27.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 98.2 1.1 26.1 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 37.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 46.2 124.1 6.7 1.3 0.0 0.0 4.5 0.0 2.0 0.0 0.0 0.9 0.0 1.6 0.0 0.0 1.0 0.0 7.1 21.9 0.0 0.0 0.1 4.8 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.0 1.2 3.2 9.4 0.0 0.0 0.0 37.2 0.0 3.9 0.0 0.0 357.5 0.1 0.0 0.0 44.2 PLCB1 "KIAA0581, PLC-I, PLC154" ENSG00000182621 "Phospholipase C beta 1" Q9NQ66 20 8077251-8968360 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" Epilepsy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 56.7" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 29.3;Distal tubular cells: 28.2;Endothelial cells: 30.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 22.0;Hep G2: 33.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004275, CAB005334, HPA034743, HPA057910" Enhanced Approved "Plasma membrane" NA NA 5400 "Plasma membrane" "CAB004275: AB_628118, CAB005334: AB_632196, HPA034743: AB_2674311, HPA057910: AB_2683552" "unprognostic (2.32e-1)" "unprognostic (1.02e-1)" "unprognostic (6.63e-2)" "unprognostic (9.77e-2)" "unprognostic (9.87e-2)" "unprognostic (2.37e-1)" "unprognostic (1.27e-4)" "unprognostic (1.13e-1)" "unprognostic (3.16e-2)" "unprognostic (1.91e-1)" "unprognostic (7.12e-3)" "unprognostic (6.57e-2)" "unprognostic (2.87e-3)" "unprognostic (3.20e-2)" "unprognostic (4.41e-2)" "unprognostic (1.71e-2)" "unprognostic (2.12e-1)" 5.6 7.0 13.8 4.4 27.7 3.4 5.9 7.5 31.1 6.5 9.9 2.1 20.6 5.5 8.0 10.3 4.5 7.4 6.6 8.6 15.7 9.1 10.0 3.1 4.0 1.6 9.3 14.5 3.2 10.8 56.7 4.6 14.2 5.5 10.4 3.6 1.3 19.7 22.2 9.8 2.3 4.5 12.3 4.0 2.9 5.5 2.6 8.0 4.1 3.1 1.9 1.1 8.6 6.3 0.5 0.8 2.8 3.3 2.4 5.2 0.4 0.0 0.6 2.3 0.1 4.3 8.3 3.2 9.8 6.5 2.6 1.6 22.0 2.4 1.0 4.1 1.9 0.1 0.0 1.8 0.0 1.9 0.0 2.1 0.4 1.6 33.1 1.1 0.5 0.3 0.5 0.4 3.5 0.0 3.3 5.2 6.3 3.3 12.9 0.0 2.9 0.5 1.6 7.4 5.1 3.6 7.0 0.0 5.8 2.0 8.1 8.5 3.6 0.0 2.0 0.4 8.9 9.8 3.2 0.9 8.5 3.8 0.6 6.1 9.7 11.2 16.6 4.3 6.1 14.5 0.8 3.3 2.8 3.6 0.7 5.2 0.2 1.0 1.3 0.4 0.5 0.5 1.1 2.1 2.4 0.4 0.8 0.2 0.4 13.8 27.7 7.5 30.8 15.7 9.1 9.3 14.5 5.5 8.0 0.0 4.3 0.8 17.4 1.6 0.8 29.3 5.1 16.0 3.4 15.7 0.0 1.9 28.2 0.9 7.6 30.5 0.3 0.0 11.3 1.9 7.9 21.8 1.1 2.1 0.7 1.6 0.0 21.5 4.6 3.1 3.1 2.5 6.8 1.0 1.9 16.3 2.4 0.0 3.5 7.9 3.7 0.0 13.0 3.1 4.3 1.5 1.5 5.1 1.2 16.2 PLCB2 FLJ38135 ENSG00000137841 "Phospholipase C beta 2" Q00722 15 40278176-40307935 "Enzymes, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 30.5;lymphoid tissue: 36.3" "Group enriched" "Detected in many" 4 "Alveolar cells type 2: 25.1;granulocytes: 25.5;Hofbauer cells: 26.0;Kupffer cells: 49.0;Macrophages: 28.1;T-cells: 15.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 31.5;HMC-1: 39.3;THP-1: 11.4;U-937: 21.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB009443, HPA041298, HPA068595, HPA069308" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB009443: AB_632197, HPA041298: AB_2677395, HPA068595: , HPA069308: " "unprognostic (5.52e-2)" "unprognostic (4.96e-3)" "unprognostic (6.09e-3)" "unprognostic (1.88e-2)" "unprognostic (1.31e-1)" "prognostic favorable (3.00e-4)" "unprognostic (1.66e-1)" "unprognostic (3.08e-2)" "unprognostic (1.28e-1)" "unprognostic (2.34e-1)" "unprognostic (1.42e-1)" "unprognostic (2.75e-1)" "prognostic unfavorable (7.20e-5)" "unprognostic (9.89e-2)" "unprognostic (2.06e-3)" "unprognostic (5.81e-2)" "unprognostic (1.13e-1)" 6.3 3.6 8.1 17.6 11.6 30.5 2.9 1.1 7.5 2.9 3.3 16.2 1.7 4.0 2.8 3.2 2.4 4.6 6.5 3.3 6.9 5.1 3.3 4.2 12.5 17.2 12.7 2.4 1.6 2.0 1.3 2.9 4.6 9.3 3.2 5.5 4.1 5.2 2.9 1.3 1.5 10.2 4.8 17.9 36.3 3.6 1.4 10.9 12.2 2.8 1.8 17.6 6.9 2.5 1.0 4.5 8.5 4.3 1.8 3.1 2.0 0.1 0.0 0.2 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 7.8 0.6 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.5 0.0 0.0 0.0 6.7 39.3 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.3 1.7 0.0 0.0 1.8 3.6 0.4 0.0 0.1 5.5 0.8 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 2.3 0.0 11.4 4.1 0.0 3.8 0.0 0.0 0.0 0.0 1.5 0.0 21.6 0.0 2.7 4.2 8.5 3.1 4.3 2.0 0.7 1.6 1.6 4.5 1.0 1.6 1.8 6.9 1.8 4.2 1.6 2.9 2.0 8.1 11.6 1.1 7.5 6.9 5.1 12.7 2.4 9.3 10.9 6.0 25.1 3.4 0.1 0.8 0.0 2.8 2.5 6.7 5.7 1.8 0.0 0.4 0.0 0.1 1.0 0.4 0.0 0.0 0.0 0.4 1.0 0.0 25.5 0.2 26.0 0.0 0.0 1.8 49.0 0.4 0.3 28.1 3.3 0.0 0.8 0.0 0.2 0.0 0.0 0.7 0.2 0.0 0.3 0.2 2.1 0.5 0.3 15.9 1.2 0.0 PLCD3 ENSG00000161714 "Phospholipase C delta 3" Q8N3E9 17 45108967-45133354 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 63.6" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 138.0;Paneth cells: 62.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "OE19: 40.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025711, HPA053665" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA025711: AB_1855320, HPA053665: AB_2732580" "unprognostic (3.58e-2)" "unprognostic (1.66e-1)" "unprognostic (2.77e-2)" "unprognostic (1.27e-2)" "unprognostic (2.66e-1)" "unprognostic (4.14e-3)" "unprognostic (8.13e-3)" "prognostic unfavorable (2.89e-6)" "unprognostic (2.96e-1)" "unprognostic (9.53e-2)" "unprognostic (1.34e-3)" "unprognostic (6.21e-2)" "unprognostic (3.18e-2)" "unprognostic (2.07e-1)" "unprognostic (1.62e-1)" "prognostic favorable (4.28e-4)" "unprognostic (3.34e-3)" 5.7 12.0 10.1 4.8 16.5 2.4 6.6 12.2 12.9 5.0 24.9 14.0 2.8 2.9 6.3 6.4 8.9 5.8 9.4 13.1 11.6 6.6 3.6 1.2 4.5 1.7 13.9 11.4 9.9 2.7 1.5 3.0 5.7 19.5 5.8 13.7 10.3 4.7 5.7 63.6 9.9 2.8 12.9 15.0 2.0 17.9 5.4 14.6 0.0 2.3 20.1 2.8 17.5 10.5 1.3 0.9 2.9 1.5 1.3 0.9 0.5 8.4 21.1 1.5 3.1 2.3 5.0 10.7 4.6 10.4 4.3 4.1 5.1 15.5 0.3 16.7 10.8 3.5 19.3 2.4 19.9 1.7 4.2 7.9 0.3 22.2 6.6 11.9 0.4 1.2 5.4 8.0 3.9 5.3 11.0 2.6 0.9 1.8 0.6 4.6 13.2 1.3 1.9 1.8 40.6 20.8 3.0 3.5 0.5 13.6 16.9 0.4 2.7 5.0 8.4 4.5 3.4 17.9 0.9 5.3 2.7 14.8 3.5 5.4 0.8 0.9 0.6 4.4 0.5 2.1 2.3 1.5 2.4 0.9 1.5 0.6 1.0 0.7 0.6 0.5 1.3 0.9 0.8 2.9 1.3 0.3 0.9 0.6 0.5 10.1 16.5 12.2 11.5 11.6 6.6 13.9 11.4 19.5 14.6 11.9 2.2 0.0 10.9 6.8 27.2 23.8 12.7 1.4 2.3 7.0 23.6 2.5 1.7 7.0 12.5 9.2 138.0 0.0 2.9 7.2 8.2 9.8 1.1 0.4 1.5 6.4 4.7 8.6 0.3 3.6 18.4 0.3 3.3 1.0 13.0 6.8 18.3 62.6 31.1 1.7 37.9 6.5 4.2 1.9 6.6 5.0 6.1 0.0 26.3 40.1 PLCD4 ENSG00000115556 "Phospholipase C delta 4" Q9BRC7 2 218607765-218637184 "Enzymes, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Guanine-nucleotide releasing factor, Hydrolase, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "retina: 23.0;skeletal muscle: 62.5;smooth muscle: 33.1" "Group enriched" "Detected in some" 8 "Bipolar cells: 81.4;Cone photoreceptor cells: 231.7;Rod photoreceptor cells: 181.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "SH-SY5Y: 21.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009914, HPA038139, HPA038140" Enhanced Supported "Endoplasmic reticulum,Plasma membrane,Cytosol" NA NA Cytosol "Endoplasmic reticulum, Plasma membrane" "CAB009914: AB_2252306, HPA038139: AB_2675855, HPA038140: AB_2675856" "unprognostic (2.11e-1)" "unprognostic (1.72e-1)" "unprognostic (1.76e-2)" "unprognostic (5.65e-5)" "unprognostic (7.77e-2)" "unprognostic (1.45e-2)" "unprognostic (7.06e-3)" "unprognostic (2.86e-2)" "unprognostic (3.15e-1)" "unprognostic (8.87e-3)" "unprognostic (7.54e-5)" "unprognostic (3.28e-2)" "unprognostic (2.49e-1)" "unprognostic (1.86e-1)" "unprognostic (6.32e-2)" "unprognostic (8.46e-3)" "unprognostic (3.09e-1)" 1.1 2.5 1.5 1.0 1.6 0.5 1.0 0.9 2.4 0.6 6.4 0.3 3.8 0.9 0.8 1.1 3.7 0.6 0.9 0.9 1.0 1.5 3.9 0.5 0.7 0.7 1.6 1.0 0.7 0.4 1.4 4.7 0.6 2.6 6.4 1.5 23.0 1.4 0.6 62.5 0.8 1.4 33.1 1.1 0.5 3.5 3.9 0.5 0.0 1.4 6.8 0.5 9.6 5.3 0.9 1.2 0.3 0.4 0.9 0.9 1.0 0.6 1.6 2.2 0.4 0.2 1.4 1.2 1.2 2.6 0.4 1.4 2.4 0.3 1.4 1.8 0.4 1.0 1.0 0.0 1.5 0.3 0.5 1.8 1.2 3.6 1.9 0.2 1.2 0.6 3.0 0.1 2.0 0.5 4.8 2.8 0.8 1.0 1.1 2.3 1.8 0.4 1.2 0.7 0.2 3.4 0.9 0.8 0.5 4.4 3.0 2.3 21.5 1.0 0.8 0.3 1.3 2.6 0.5 6.1 1.6 1.2 0.7 0.7 0.5 0.8 0.9 4.7 0.3 1.6 0.0 0.4 0.0 0.5 0.0 0.1 0.0 0.3 0.9 0.3 0.9 0.7 0.8 0.3 0.9 0.0 1.2 0.7 1.0 1.5 1.6 0.9 2.4 1.0 1.5 1.6 1.0 2.6 0.5 0.0 1.4 0.0 0.2 0.5 81.4 0.8 0.0 0.0 0.0 0.0 231.7 0.1 0.0 0.2 14.2 1.1 0.0 0.0 0.0 12.6 0.6 0.0 0.0 0.0 0.5 7.9 0.0 0.0 0.0 22.0 0.3 0.0 0.0 0.0 0.0 8.8 0.4 0.0 0.0 1.4 181.4 0.0 1.4 2.2 0.8 0.1 0.7 0.0 0.0 0.1 PLEKHA4 PEPP1 ENSG00000105559 "Pleckstrin homology domain containing A4" Q9H4M7 19 48837097-48868632 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Peritubular cells: 50.2;Smooth muscle cells: 103.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 28.0;ASC TERT1: 19.1;BJ hTERT+ SV40 Large T+ RasG12V: 22.3;SK-MEL-30: 32.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" "HPA042978, HPA048473" Uncertain Approved "Plasma membrane,Cytokinetic bridge,Centriolar satellite,Cytosol" Yes No "Plasma membrane, Cytosol" "Cytokinetic bridge, Centriolar satellite" "HPA042978: AB_2678249, HPA048473: AB_2680409" "prognostic favorable (1.97e-4)" "unprognostic (4.39e-1)" "unprognostic (8.16e-2)" "unprognostic (2.85e-2)" "unprognostic (3.98e-1)" "unprognostic (4.20e-2)" "prognostic unfavorable (8.68e-4)" "unprognostic (5.09e-2)" "unprognostic (1.01e-2)" "unprognostic (1.17e-1)" "unprognostic (1.18e-2)" "unprognostic (2.95e-1)" "unprognostic (3.84e-2)" "unprognostic (1.35e-1)" "unprognostic (1.67e-1)" "unprognostic (1.08e-3)" "unprognostic (6.38e-2)" 14.0 10.2 5.0 10.1 7.7 0.3 11.4 4.5 5.5 9.4 14.6 6.1 3.5 4.7 13.2 5.6 8.7 10.2 9.7 19.3 3.9 3.0 9.7 10.8 9.6 5.7 28.9 2.6 22.8 11.4 3.1 13.3 5.2 12.4 9.7 3.4 12.5 6.0 8.1 8.9 5.9 5.1 23.3 13.5 8.0 7.9 6.2 4.4 7.4 12.9 5.8 6.3 11.0 7.3 7.4 2.0 1.4 0.7 1.2 5.3 1.6 3.8 0.2 4.4 28.0 6.5 19.1 3.5 3.0 10.9 12.0 22.3 2.5 1.1 0.1 5.3 4.2 4.7 1.2 1.5 1.5 1.9 0.0 1.5 1.0 0.6 2.8 5.0 0.0 6.4 9.8 1.0 6.9 0.4 4.9 3.5 4.9 4.0 2.3 3.2 2.3 1.3 0.2 0.6 2.5 0.3 0.1 14.0 0.2 3.6 0.0 0.0 4.9 1.3 1.1 32.2 1.1 1.7 1.3 0.5 3.8 3.1 4.9 0.7 12.7 10.5 2.2 4.5 0.3 10.1 0.0 0.6 1.4 3.1 0.7 2.3 3.0 3.0 2.0 0.2 7.4 5.3 4.7 0.3 1.2 0.5 2.0 1.0 1.6 5.0 7.7 4.5 5.5 3.9 3.0 28.9 2.6 12.4 4.4 0.0 18.9 0.0 26.3 8.5 0.7 29.1 5.1 28.1 43.3 7.0 0.0 2.7 1.7 16.3 0.4 6.6 1.0 0.0 4.4 4.2 39.8 15.0 0.0 12.1 2.4 0.0 1.2 5.5 0.3 0.4 38.3 2.8 11.8 1.8 1.0 8.4 6.8 0.0 50.2 9.9 0.7 6.5 103.2 3.5 2.5 8.5 2.4 1.3 1.8 19.6 PLEKHH2 "KIAA2028, PLEKHH1L" ENSG00000152527 "Pleckstrin homology, MyTH4 and FERM domain containing H2" Q8IVE3 2 43637273-43767987 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 35.7;Collecting duct cells: 62.8;Peritubular cells: 47.4;Sertoli cells: 45.3" "Cancer enhanced" "Detected in many" "renal cancer: 6.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 10.3;RPTEC TERT1: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077225 Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "Nucleoplasm, Nuclear bodies" "HPA077225: AB_2686828" "unprognostic (1.11e-1)" "unprognostic (1.05e-1)" "unprognostic (3.49e-2)" "unprognostic (1.59e-1)" "unprognostic (2.16e-1)" "unprognostic (4.27e-3)" "unprognostic (1.77e-1)" "unprognostic (2.32e-2)" "unprognostic (2.94e-2)" "unprognostic (6.99e-2)" "unprognostic (2.81e-1)" "unprognostic (2.53e-2)" "unprognostic (1.92e-3)" "unprognostic (3.03e-2)" "unprognostic (1.29e-1)" "unprognostic (8.57e-3)" "unprognostic (1.82e-2)" 10.1 2.7 3.7 9.2 6.5 0.3 7.5 5.4 5.6 27.2 8.5 2.9 3.6 4.1 30.0 9.5 5.2 9.8 8.1 3.7 4.2 2.7 8.7 1.8 21.7 3.0 3.4 3.3 19.4 2.5 9.6 1.8 4.2 8.3 7.9 5.0 7.4 3.8 7.8 5.4 6.9 5.7 13.1 9.7 4.7 4.1 4.2 4.0 0.0 4.7 4.7 4.3 11.1 8.6 0.8 0.6 1.4 0.4 0.7 1.0 0.0 0.6 5.2 2.1 0.1 4.3 10.3 0.4 0.7 2.7 1.1 2.8 0.0 1.8 1.3 0.3 0.9 4.5 3.5 0.6 0.8 2.0 0.1 1.5 0.1 0.7 0.2 0.7 0.0 0.7 3.0 0.8 2.6 0.1 1.5 2.3 2.1 4.9 0.2 0.9 1.4 1.0 0.2 1.2 0.8 5.2 0.0 6.2 0.1 8.5 0.3 1.7 0.8 0.5 0.0 5.2 1.6 0.7 0.2 0.2 6.1 1.8 0.3 1.8 1.2 0.3 0.0 2.5 0.0 0.6 0.8 0.4 0.4 0.4 0.2 0.4 0.3 0.7 0.5 0.2 0.8 1.0 0.6 1.4 0.7 0.3 0.6 0.5 0.0 3.7 6.5 5.4 5.6 4.2 2.7 3.4 3.3 8.3 4.0 35.7 8.3 0.5 14.5 7.7 0.7 1.2 10.2 8.1 15.9 62.8 5.9 0.3 5.0 4.0 1.3 2.9 0.0 0.0 1.2 0.3 31.9 6.8 1.1 0.0 0.7 0.0 0.0 3.7 0.3 2.5 33.1 1.1 11.8 0.0 0.0 7.2 4.4 0.0 47.4 2.2 4.1 45.3 15.1 4.3 6.1 7.3 0.5 1.3 0.0 7.2 PLEKHO2 "DKFZp761K2312, PLEKHQ1, PP1628, pp9099" ENSG00000241839 "Pleckstrin homology domain containing O2" Q8TD55 15 64841883-64868007 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 57.9" "Cell type enhanced" "Detected in many" 7 "Hofbauer cells: 56.4;Ito cells: 42.4;Kupffer cells: 40.1;Muller glia cells: 62.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 10.4;granulocytes: 30.2;monocytes: 26.6" "Cell line enhanced" "Detected in many" "ASC diff: 31.3" HPA040055 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 450000 "Plasma membrane, Cytosol" Nucleoplasm "HPA040055: AB_10793954" "unprognostic (4.32e-2)" "unprognostic (7.32e-3)" "unprognostic (8.60e-2)" "unprognostic (9.10e-2)" "unprognostic (1.11e-1)" "unprognostic (2.90e-2)" "unprognostic (3.05e-2)" "unprognostic (2.80e-1)" "unprognostic (7.70e-2)" "unprognostic (2.05e-2)" "unprognostic (8.67e-2)" "unprognostic (1.02e-1)" "unprognostic (3.08e-3)" "unprognostic (1.12e-1)" "unprognostic (4.20e-2)" "unprognostic (1.78e-1)" "unprognostic (5.85e-3)" 22.1 17.4 12.9 19.9 16.6 29.4 12.4 6.2 9.9 10.3 12.2 11.5 5.2 6.8 11.9 13.3 10.7 13.0 17.4 9.3 13.3 8.0 8.1 8.2 22.4 19.6 10.1 8.7 10.4 5.7 5.1 6.4 22.6 17.2 10.5 5.6 17.0 6.1 10.2 5.9 6.0 9.4 16.9 14.5 57.9 10.2 7.0 11.3 5.1 18.6 6.6 13.8 17.1 14.1 4.0 10.4 30.2 26.6 2.7 5.4 10.3 2.7 1.8 3.5 3.4 31.3 18.0 8.3 8.1 12.2 8.7 8.9 2.2 1.7 7.4 4.3 16.5 8.8 1.0 4.0 3.3 5.1 11.4 1.2 7.4 0.8 2.5 24.1 8.3 11.1 13.0 2.9 10.8 3.5 7.5 12.0 1.5 2.2 26.5 11.5 0.8 1.7 9.0 6.7 1.4 1.7 6.4 8.5 5.3 1.4 1.9 0.3 3.0 3.4 1.2 11.1 6.0 1.2 11.3 15.5 6.7 6.2 6.3 3.3 9.9 15.5 2.5 7.2 10.8 3.9 7.0 14.3 9.2 5.4 20.4 5.0 4.0 3.1 5.0 10.4 2.6 1.3 2.7 30.2 2.7 26.6 1.2 4.1 10.3 12.9 16.6 6.2 9.9 13.3 8.0 10.1 8.7 17.2 11.3 0.0 9.3 8.6 2.1 4.9 0.7 2.6 2.5 1.4 2.3 8.7 0.0 3.3 3.3 2.2 3.2 18.3 0.0 0.0 1.3 4.0 9.3 2.4 18.4 0.8 56.4 0.0 0.0 42.4 40.1 1.8 17.0 30.6 13.5 6.4 0.1 62.2 2.1 0.0 24.1 2.1 3.2 12.9 8.0 0.9 1.9 3.9 5.0 11.5 0.2 3.1 PLPPR5 "LPPR5, PAP2, PAP2D, PRG5" ENSG00000117598 "Phospholipid phosphatase related 5" Q32ZL2 1 98890245-99005032 "Predicted membrane proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "brain: 18.6;testis: 5.5" "Group enriched" "Detected in some" 4 "Bipolar cells: 7.2;Horizontal cells: 3.2" "Group enriched" "Detected in some" 13 "glioma: 2.7;renal cancer: 1.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "PC-3: 12.3;SH-SY5Y: 22.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018072, HPA059085" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA018072: AB_1854958, HPA059085: AB_2732631" "unprognostic (2.57e-1)" "unprognostic (1.63e-2)" "unprognostic (1.68e-1)" "unprognostic (1.68e-2)" "unprognostic (2.01e-1)" "unprognostic (2.26e-1)" "unprognostic (1.11e-1)" "unprognostic (3.18e-1)" "unprognostic (1.43e-1)" "unprognostic (2.07e-1)" "prognostic unfavorable (6.22e-4)" "unprognostic (1.81e-2)" "unprognostic (1.28e-1)" "unprognostic (2.33e-1)" 0.5 1.8 7.8 0.7 8.7 0.5 0.5 0.8 18.6 1.4 0.6 2.1 0.0 0.7 0.7 0.5 0.6 0.5 0.6 0.5 8.0 6.6 0.7 0.5 0.7 0.5 2.5 4.5 0.6 1.6 0.5 0.3 0.5 3.6 0.6 0.8 1.8 0.5 1.0 0.9 0.6 0.7 0.6 1.0 0.5 0.7 5.5 1.8 0.0 0.5 0.0 0.5 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 12.3 0.0 0.0 0.0 0.5 0.1 0.4 22.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.8 8.7 0.8 11.6 8.0 6.6 2.5 4.5 3.6 1.8 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.7 0.2 1.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 PLS3 T-plastin ENSG00000102024 "Plastin 3" P13797 X 115561174-115650861 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 196.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "NK-cell: 4.2;plasmacytoid DC: 13.1" "Group enriched" "Detected in many" 6 "dendritic cells: 13.1;NK-cells: 4.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020433, HPA076083" Approved Approved "Plasma membrane,Cytosol" NA NA 110000000 "Plasma membrane, Cytosol" "HPA020433: AB_2670440, HPA076083: AB_2686773" "unprognostic (1.32e-1)" "unprognostic (1.85e-2)" "unprognostic (6.10e-2)" "unprognostic (4.37e-2)" "unprognostic (9.63e-2)" "prognostic unfavorable (6.07e-5)" "unprognostic (2.40e-1)" "unprognostic (1.71e-1)" "unprognostic (1.83e-2)" "unprognostic (1.31e-1)" "prognostic unfavorable (4.59e-4)" "unprognostic (2.23e-1)" "prognostic unfavorable (1.01e-4)" "unprognostic (5.15e-2)" "unprognostic (1.54e-1)" "prognostic favorable (3.72e-4)" "prognostic unfavorable (7.04e-4)" 41.9 11.0 11.8 9.8 12.5 0.2 24.6 3.6 16.7 43.8 14.3 13.9 24.1 6.0 37.4 27.6 54.4 21.5 23.6 18.8 12.2 8.2 40.7 100.5 64.7 6.0 14.7 13.7 44.4 8.9 2.7 4.6 21.9 22.7 21.6 9.2 10.6 16.6 31.4 17.7 38.4 8.2 34.6 14.5 31.6 13.3 14.9 13.0 5.1 64.8 34.7 12.5 38.7 29.0 0.0 13.1 0.4 0.1 4.2 1.5 0.2 28.1 29.0 25.4 7.3 25.7 24.0 38.8 29.4 33.2 28.2 34.2 31.4 23.5 0.1 85.2 24.2 20.9 36.3 26.9 47.9 45.9 0.4 33.7 2.7 36.0 13.1 23.3 0.0 1.4 15.2 23.0 43.6 30.8 45.6 61.1 2.3 0.0 0.0 26.9 8.2 0.0 0.3 33.7 12.2 34.8 0.0 17.0 0.6 33.7 15.3 0.0 5.3 61.8 15.4 12.4 38.4 8.5 0.4 66.8 45.8 7.8 46.6 58.8 1.1 4.1 0.5 20.0 0.1 18.9 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.1 0.4 0.0 0.0 0.0 0.1 4.2 0.0 13.1 1.5 0.2 11.8 12.5 3.6 16.7 12.2 8.2 14.7 13.7 22.7 13.0 196.5 74.7 2.9 91.8 110.9 0.2 12.5 20.4 13.4 73.9 94.2 0.0 2.1 11.6 57.0 8.6 106.8 2.5 0.0 46.9 97.6 65.4 15.9 0.0 74.6 3.6 0.0 12.7 79.2 6.3 6.5 48.1 4.7 54.0 1.0 5.7 24.0 49.2 4.3 77.8 17.5 1.2 51.8 106.6 1.2 20.9 117.2 3.8 4.3 11.8 92.1 PLVAP "FELS, gp68, PV-1, PV1" ENSG00000130300 "Plasmalemma vesicle associated protein" Q9BX97 19 17351448-17377350 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 128.3" "Cell type enhanced" "Detected in many" 12 "Basal keratinocytes: 20.4;Endothelial cells: 32.1;Ito cells: 41.7;Melanocytes: 21.9;Suprabasal keratinocytes: 14.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 6 "plasmacytoid DC: 22.1" "Lineage enriched" "Detected in many" 6 "dendritic cells: 22.1" "Cell line enriched" "Detected in some" 28 "EFO-21: 112.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA002279 Supported Approved "Plasma membrane,Centrosome,Cytosol" NA NA 53000 Cytosol "Plasma membrane, Centrosome" "HPA002279: AB_1079636" "unprognostic (3.19e-1)" "unprognostic (8.22e-2)" "unprognostic (7.87e-2)" "unprognostic (2.38e-2)" "unprognostic (1.93e-2)" "unprognostic (2.49e-3)" "unprognostic (4.17e-3)" "unprognostic (1.01e-1)" "unprognostic (2.35e-1)" "unprognostic (1.43e-1)" "unprognostic (1.53e-2)" "unprognostic (8.96e-2)" "unprognostic (4.24e-3)" "unprognostic (4.70e-3)" "unprognostic (1.51e-1)" "unprognostic (2.58e-1)" "unprognostic (8.17e-2)" 128.3 9.8 0.8 16.4 0.9 0.0 56.3 0.4 1.5 28.7 29.8 3.2 12.8 20.2 32.0 19.8 27.4 16.6 43.1 18.9 1.1 0.4 33.7 4.6 13.1 34.6 0.9 0.5 14.3 22.9 13.8 16.1 12.6 2.7 26.1 5.2 26.3 16.0 10.4 20.7 11.5 23.7 13.5 1.2 77.8 22.1 9.5 0.7 3.8 88.3 13.9 15.2 30.1 87.7 0.0 22.1 0.0 3.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 112.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.0 0.0 0.4 0.0 0.0 0.1 0.4 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.6 22.1 0.0 0.3 0.8 0.9 0.4 1.5 1.1 0.4 0.9 0.5 2.7 0.7 6.0 0.0 0.0 0.7 20.4 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 1.7 32.1 0.0 0.0 2.3 0.1 5.6 1.4 0.0 0.0 1.4 0.0 0.0 41.7 2.7 0.6 0.0 3.8 21.9 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 10.8 0.4 0.4 14.6 0.1 0.0 0.0 1.7 PLXNA3 "6.3, Plxn3, PLXN4, SEX, XAP-6" ENSG00000130827 "Plexin A3" P51805 X 154458281-154477779 "Plasma proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 19.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058989 Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA 58000 "Vesicles, Plasma membrane" Nucleoplasm "HPA058989: AB_2683872" "unprognostic (2.79e-2)" "unprognostic (3.03e-1)" "unprognostic (1.04e-3)" "unprognostic (8.04e-3)" "unprognostic (1.63e-1)" "unprognostic (9.05e-3)" "unprognostic (1.06e-2)" "unprognostic (2.25e-1)" "unprognostic (2.42e-1)" "unprognostic (6.26e-2)" "unprognostic (1.05e-1)" "unprognostic (4.10e-2)" "unprognostic (1.38e-3)" "unprognostic (2.30e-1)" "unprognostic (3.00e-1)" "unprognostic (4.33e-2)" "unprognostic (5.73e-2)" 6.9 7.6 9.8 6.6 9.3 3.5 13.3 25.9 7.4 8.1 6.2 13.8 7.3 7.2 8.6 9.2 5.3 8.3 7.9 6.6 10.5 8.0 5.1 2.5 7.2 7.1 8.7 3.6 16.4 9.9 5.1 35.2 7.4 8.2 9.2 4.8 6.1 13.8 7.5 2.9 19.5 7.2 8.2 8.4 7.0 10.0 5.8 9.8 4.6 9.3 1.8 7.2 6.3 16.4 1.8 0.5 2.7 0.5 2.1 1.0 0.3 8.2 1.6 4.9 12.4 5.2 6.6 6.6 11.8 2.5 2.8 3.8 6.2 3.5 1.5 6.4 12.7 6.6 7.3 4.9 5.7 1.0 0.7 3.7 1.5 19.3 3.4 4.1 0.8 6.9 8.9 4.2 4.1 0.3 9.7 3.1 2.4 3.8 1.3 4.3 10.2 1.4 6.3 1.6 2.6 3.7 5.3 0.4 0.5 3.7 5.5 10.3 5.3 4.4 7.9 2.0 3.6 4.8 1.8 7.8 6.1 5.6 0.6 5.0 0.9 0.1 2.2 11.4 1.1 1.6 2.7 0.5 0.8 0.8 0.4 0.6 1.8 1.0 0.8 0.1 1.2 0.6 0.8 1.4 2.1 0.3 0.5 0.7 0.3 9.8 9.3 25.9 7.4 10.5 8.0 8.7 3.6 8.2 9.8 11.9 11.4 0.9 8.3 7.7 18.3 4.5 2.5 10.7 5.7 10.4 11.8 2.9 0.0 11.1 0.0 3.7 8.0 0.0 5.0 4.9 9.1 8.5 8.1 0.9 7.4 4.8 6.9 3.7 4.3 0.4 10.6 6.4 13.5 7.2 11.4 5.2 13.0 10.5 8.1 0.7 8.9 12.9 6.2 0.2 2.2 6.5 7.8 6.4 7.1 6.5 PLXNA4 "DKFZp434G0625PRO34003, FAYV2820, KIAA1550, PLXNA4A, PLXNA4B" ENSG00000221866 "Plexin A4" Q9HCM2 7 132123332-132648688 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 23.2;breast: 34.7" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 9.9;Cardiomyocytes: 9.5;Collecting duct cells: 12.2;Cone photoreceptor cells: 15.7;Early spermatids: 9.9;Leydig cells: 13.0;Muller glia cells: 10.0" "Cancer enhanced" "Detected in many" "glioma: 3.3" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "plasmacytoid DC: 6.1" "Lineage enriched" "Detected in many" 5 "dendritic cells: 6.1" "Cell line enhanced" "Detected in some" "ASC diff: 15.0;HMC-1: 10.0;hTERT-RPE1: 12.9;RH-30: 10.7;TIME: 32.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029919, HPA052141, HPA075592" Approved Approved "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "HPA029919: AB_10671093, HPA052141: AB_2681745, HPA075592: AB_2732297" "unprognostic (2.05e-2)" "unprognostic (3.59e-2)" "unprognostic (2.08e-2)" "prognostic unfavorable (1.61e-6)" "unprognostic (5.76e-2)" "unprognostic (1.21e-2)" "unprognostic (1.28e-2)" "unprognostic (2.43e-2)" "unprognostic (2.19e-1)" "unprognostic (7.99e-2)" "unprognostic (7.64e-2)" "unprognostic (1.14e-1)" "unprognostic (1.69e-5)" "unprognostic (1.67e-1)" "unprognostic (2.28e-1)" "unprognostic (5.90e-2)" "unprognostic (1.42e-3)" 23.2 5.1 8.7 3.5 9.0 1.1 34.7 3.9 15.1 16.2 2.0 1.0 0.8 1.5 2.3 1.0 7.7 3.0 4.2 6.9 9.7 7.2 2.0 1.3 1.8 2.5 4.0 6.6 6.2 1.0 1.0 1.6 6.7 6.6 1.4 2.1 0.7 1.2 2.4 1.7 4.1 1.4 5.1 1.5 2.4 2.8 2.4 1.8 0.0 3.3 0.0 1.3 2.1 9.4 0.0 6.1 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.1 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 10.0 0.1 0.0 0.0 0.0 12.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 10.7 1.1 0.0 0.0 0.2 5.6 0.0 0.0 0.0 0.1 0.0 0.0 32.6 3.3 0.1 0.7 0.2 0.0 0.0 0.0 3.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 1.1 0.0 6.1 0.0 0.0 8.7 9.0 3.9 15.1 9.7 7.2 4.0 6.6 6.6 1.8 0.0 0.0 0.0 0.1 0.6 9.9 9.5 0.0 0.0 0.0 12.2 15.7 0.0 0.0 0.0 9.9 0.7 0.0 0.0 0.0 0.1 5.4 0.2 1.1 0.0 0.1 0.0 1.2 1.8 0.0 5.9 13.0 0.0 6.8 0.0 0.0 10.0 0.4 0.0 6.7 0.3 1.4 0.0 1.4 0.2 0.1 1.1 0.0 0.0 0.0 0.5 PNCK "CaMK1b, MGC45419" ENSG00000130822 "Pregnancy up-regulated nonubiquitous CaM kinase" Q6P2M8 X 153669730-153689010 "Enzymes, Predicted intracellular proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.4;seminal vesicle: 38.5" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 16.5;Cone photoreceptor cells: 21.6;Extravillous trophoblasts: 44.0;Rod photoreceptor cells: 19.4;Syncytiotrophoblasts: 41.4" "Cancer enhanced" "Detected in many" "renal cancer: 15.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "AN3-CA: 27.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007458 Approved Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA007458: AB_1079644" "unprognostic (1.56e-1)" "unprognostic (2.56e-1)" "unprognostic (1.16e-2)" "unprognostic (5.95e-3)" "unprognostic (1.83e-2)" "unprognostic (3.98e-2)" "unprognostic (2.15e-4)" "unprognostic (1.72e-1)" "unprognostic (1.08e-1)" "unprognostic (1.46e-2)" "unprognostic (3.60e-1)" "unprognostic (1.27e-1)" "prognostic unfavorable (1.04e-6)" "unprognostic (2.86e-3)" "unprognostic (1.43e-1)" "unprognostic (2.66e-1)" "unprognostic (6.26e-3)" 1.6 1.8 21.4 2.2 35.4 0.6 0.9 3.7 24.9 0.9 21.9 0.9 6.9 3.8 4.2 3.1 14.5 2.9 2.9 3.8 19.5 17.0 1.0 0.5 0.7 0.6 6.1 15.5 0.7 0.5 1.4 0.3 2.4 3.8 12.6 4.2 0.4 0.7 38.5 2.2 1.4 5.2 15.3 2.6 0.7 5.5 4.7 1.7 0.0 0.5 0.0 0.7 10.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.4 27.1 0.0 0.0 2.9 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.2 0.3 0.4 0.0 0.0 0.0 3.3 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.3 0.2 0.1 0.5 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.2 3.2 0.0 0.1 2.2 0.8 0.3 0.3 0.0 0.2 1.1 0.0 0.2 0.2 0.0 0.2 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.4 35.4 3.7 23.2 19.5 17.0 6.1 15.5 3.8 1.7 0.0 0.0 0.0 0.4 0.6 16.5 2.8 0.0 0.0 0.0 0.0 21.6 8.3 0.0 0.2 0.2 0.3 2.0 0.0 0.3 44.0 0.2 0.2 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.7 0.0 0.4 2.7 4.8 0.0 0.4 0.1 19.4 0.0 0.4 0.5 0.6 0.5 41.4 0.0 0.0 0.9 PNISR "bA98I9.2, C6orf111, DKFZp564B0769, FLJ14752, SFRS18, SRrp130" ENSG00000132424 "PNN interacting serine and arginine rich protein" Q8TF01 6 99398051-99425331 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038796, HPA075076" Approved Supported "Nuclear speckles,Plasma membrane,Cytosol" NA NA "Nuclear speckles" "Plasma membrane, Cytosol" "HPA038796: AB_10672652, HPA075076: " "unprognostic (2.95e-1)" "unprognostic (2.29e-1)" "unprognostic (2.11e-1)" "unprognostic (9.72e-3)" "unprognostic (1.68e-2)" "unprognostic (8.55e-3)" "unprognostic (4.41e-2)" "unprognostic (1.58e-3)" "unprognostic (5.82e-2)" "unprognostic (4.32e-3)" "prognostic favorable (5.27e-4)" "unprognostic (1.47e-2)" "prognostic unfavorable (1.41e-4)" "unprognostic (3.43e-2)" "unprognostic (2.59e-1)" "unprognostic (8.89e-2)" "prognostic favorable (1.09e-4)" 24.7 28.5 48.9 28.3 49.8 53.7 29.9 123.3 69.7 35.5 38.3 22.8 39.9 26.7 43.1 58.7 19.8 29.4 22.3 31.0 46.9 17.5 25.5 21.7 26.6 42.2 48.0 29.8 49.3 24.7 34.7 83.9 21.7 41.0 34.1 28.2 24.1 30.8 34.5 39.4 31.9 34.4 31.5 61.0 39.3 28.2 17.4 57.1 32.1 44.7 18.0 30.7 29.5 30.3 18.0 13.1 20.4 7.4 15.6 12.3 2.2 11.1 7.5 40.3 27.6 14.4 21.4 18.7 17.6 9.7 10.5 13.1 13.5 20.2 34.1 11.8 9.9 12.3 17.0 20.2 15.4 21.4 28.0 22.6 19.8 37.4 13.5 10.9 27.4 28.0 21.0 21.9 11.7 15.3 38.3 15.4 18.1 23.0 22.4 13.9 11.1 13.0 31.5 22.5 10.2 7.0 26.3 11.4 12.2 20.7 19.3 16.3 21.6 8.8 11.4 15.1 33.0 15.3 24.2 16.9 10.6 12.6 10.3 15.0 15.6 10.7 31.3 16.0 28.2 12.3 6.9 7.4 6.6 8.6 4.2 8.5 12.0 8.4 6.8 3.3 18.0 12.3 11.8 20.4 15.6 4.8 13.1 7.7 2.2 48.9 49.8 123.3 69.7 46.9 17.5 48.0 29.8 41.0 57.1 172.7 197.8 329.9 282.6 173.4 521.3 112.2 109.5 187.4 202.4 169.3 420.2 132.4 63.0 108.9 13.5 170.1 148.0 70.0 90.8 86.5 187.1 270.2 182.8 89.8 87.1 470.4 237.9 98.8 88.1 13.3 549.4 181.7 158.6 221.0 84.6 269.4 105.3 147.3 414.8 35.6 432.5 245.8 215.3 310.7 171.1 151.8 151.3 236.8 126.4 254.3 POU2F3 "Epoc-1, OCT11, PLA-1, Skn-1a" ENSG00000137709 "POU class 2 homeobox 3" Q9UKI9 11 120236640-120319944 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "ductus deferens: 36.5;seminal vesicle: 13.2;skin 1: 38.2" "Cell type enhanced" "Detected in many" 12 "Basal keratinocytes: 18.5;Pancreatic endocrine cells: 12.7;Suprabasal keratinocytes: 33.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.2;EFO-21: 2.7;SK-BR-3: 5.3;T-47d: 9.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA019652, HPA073468" Enhanced Approved "Nucleoplasm,Nucleoli,Nuclear bodies,Plasma membrane,Cytosol" NA NA Nucleoplasm "Nucleoli, Nuclear bodies, Plasma membrane, Cytosol" "HPA019652: AB_1855585, HPA073468: " "unprognostic (1.75e-1)" "unprognostic (2.12e-2)" "unprognostic (6.37e-2)" "unprognostic (2.41e-4)" "unprognostic (2.60e-1)" "unprognostic (4.46e-3)" "unprognostic (8.56e-3)" "unprognostic (9.34e-2)" "unprognostic (3.45e-2)" "unprognostic (1.12e-1)" "unprognostic (1.40e-3)" "unprognostic (2.08e-1)" "unprognostic (1.27e-2)" "unprognostic (9.69e-3)" "unprognostic (1.70e-1)" "prognostic favorable (8.14e-4)" "unprognostic (1.45e-1)" 0.2 0.2 0.1 0.2 0.1 0.0 1.6 0.1 0.1 1.2 0.9 0.0 36.5 0.7 0.4 1.2 2.5 0.3 0.4 0.2 0.1 0.1 0.3 0.2 1.6 0.4 0.1 0.0 0.2 0.3 6.4 1.3 4.4 0.1 1.1 0.1 0.0 1.1 13.2 0.1 38.2 1.0 0.2 0.1 0.2 0.4 0.6 0.0 0.4 4.5 4.8 2.2 0.7 2.6 1.0 0.7 2.1 0.5 0.9 0.6 0.2 2.5 0.0 0.0 0.2 0.0 0.0 0.8 0.3 0.6 0.0 0.0 0.1 7.2 0.3 2.7 0.0 0.1 1.3 0.0 0.4 0.0 0.3 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.7 0.4 0.2 0.0 0.1 0.0 1.4 0.0 0.1 0.1 0.2 0.3 0.1 0.6 0.0 0.0 0.1 0.0 1.9 0.5 0.1 0.1 5.3 0.0 0.9 9.7 0.4 0.8 0.0 0.2 0.4 0.1 0.1 0.1 0.0 1.1 0.2 0.1 1.4 0.4 0.5 0.5 0.3 0.5 0.5 0.6 0.4 0.1 1.0 0.6 0.6 2.1 0.9 0.5 0.7 0.4 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 5.1 0.0 9.0 18.5 0.0 0.8 0.0 1.4 2.3 10.4 0.0 1.2 0.0 3.6 1.7 0.0 0.3 0.0 1.2 0.2 0.2 5.0 0.0 0.4 0.1 0.0 2.9 0.0 0.0 3.8 0.0 0.0 5.0 0.0 0.0 0.2 12.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 33.0 6.6 0.0 0.5 10.1 PPFIBP1 "hSGT2, hSgt2p, L2, SGT2" ENSG00000110841 "PPFIA binding protein 1" Q86W92 12 27523431-27695564 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 154.9;Endothelial cells: 139.6;Ito cells: 144.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 7.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SuSa: 53.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA001924 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA001924: AB_1079665" "unprognostic (5.27e-2)" "unprognostic (5.71e-2)" "unprognostic (3.10e-2)" "prognostic unfavorable (6.29e-4)" "unprognostic (4.73e-2)" "unprognostic (6.94e-2)" "unprognostic (1.47e-1)" "prognostic unfavorable (5.11e-4)" "unprognostic (7.33e-2)" "unprognostic (3.84e-2)" "prognostic unfavorable (2.56e-4)" "unprognostic (1.92e-2)" "prognostic favorable (5.11e-7)" "unprognostic (8.54e-2)" "unprognostic (7.54e-2)" "unprognostic (2.64e-1)" "unprognostic (4.09e-2)" 21.3 17.1 15.5 8.0 16.8 2.2 22.6 4.9 25.0 18.3 15.4 13.3 13.0 7.1 28.1 9.3 17.1 16.5 12.2 43.3 17.1 9.0 23.8 15.7 25.0 7.8 13.1 16.4 53.1 13.7 12.7 22.2 34.5 15.3 15.3 11.1 8.1 14.2 18.4 13.7 17.8 10.0 20.5 11.2 16.6 15.1 7.1 13.3 6.2 23.9 14.9 6.2 17.2 18.4 7.0 2.0 1.5 0.6 0.3 1.8 0.6 4.4 8.9 7.3 6.2 12.1 33.8 13.0 16.1 18.1 9.5 13.7 23.4 13.5 3.3 18.8 32.6 12.7 11.1 3.9 14.7 17.1 7.6 2.2 7.4 6.8 3.4 5.3 2.2 4.1 26.2 10.3 27.6 28.4 18.6 32.4 4.5 3.8 3.4 33.7 3.4 2.1 0.6 13.0 6.3 6.9 3.4 18.1 1.2 14.1 9.8 0.6 3.0 8.0 4.3 22.4 53.2 5.5 3.4 31.5 26.8 9.0 14.6 16.4 0.0 0.0 0.2 29.8 3.2 42.2 1.5 0.6 0.3 0.7 0.2 1.4 0.7 1.3 0.7 0.6 7.0 1.3 1.3 1.5 0.3 0.2 2.0 1.8 0.6 15.5 16.8 4.9 25.0 17.1 9.0 13.1 16.4 15.3 13.3 92.3 20.3 24.3 55.3 36.5 2.3 154.9 2.5 9.4 14.8 76.8 3.9 28.5 10.0 37.2 2.6 139.6 7.0 0.0 21.6 18.9 41.3 34.7 3.5 12.7 8.3 42.9 17.9 144.9 21.5 3.1 19.5 6.4 59.1 3.6 14.6 7.5 26.9 14.4 39.6 16.6 1.7 19.4 44.8 1.7 9.1 24.1 76.9 5.9 11.5 75.3 PPM1A "MGC9201, PP2CA, PP2Calpha" ENSG00000100614 "Protein phosphatase, Mg2+/Mn2+ dependent 1A" P35813 14 60245752-60299087 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 362.9;Late spermatids: 423.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029209 Approved Supported "Plasma membrane,Cytosol" NA NA 850000 Cytosol "Plasma membrane" "HPA029209: AB_2672951" "unprognostic (3.14e-1)" "unprognostic (2.14e-1)" "unprognostic (5.64e-2)" "unprognostic (1.85e-1)" "unprognostic (4.00e-2)" "unprognostic (2.30e-2)" "unprognostic (4.50e-2)" "unprognostic (1.11e-1)" "unprognostic (3.43e-1)" "unprognostic (2.89e-2)" "unprognostic (7.96e-2)" "unprognostic (1.29e-1)" "prognostic favorable (1.57e-9)" "unprognostic (1.58e-2)" "unprognostic (1.12e-1)" "unprognostic (1.57e-2)" "unprognostic (1.37e-1)" 16.2 11.7 13.8 15.0 18.3 64.0 15.1 20.5 28.6 15.5 32.4 13.3 9.4 19.1 17.4 12.7 15.2 10.7 10.8 37.1 13.5 16.1 22.8 26.7 14.6 11.8 15.6 19.1 12.1 13.3 18.2 12.2 15.8 24.3 16.5 19.4 12.3 18.7 13.5 56.1 16.7 25.2 15.0 13.8 11.6 14.9 29.7 12.7 23.4 13.3 11.6 13.4 15.2 16.5 4.0 2.7 8.0 2.1 4.7 4.5 1.9 48.6 11.0 9.6 8.1 14.7 13.6 12.2 13.4 15.7 10.0 9.5 6.2 14.4 29.3 12.8 15.1 7.4 10.8 9.9 13.8 17.5 26.3 5.6 18.0 7.8 9.6 12.3 20.4 12.9 11.5 16.6 11.7 16.0 11.7 9.7 15.0 9.9 23.3 12.1 21.3 26.5 4.8 9.0 9.7 9.3 9.5 22.2 9.4 12.0 23.4 16.3 12.2 13.9 16.3 11.3 9.1 16.4 8.9 13.4 20.8 20.8 9.1 9.5 18.2 10.3 34.3 9.5 8.1 10.5 6.7 1.8 5.1 3.5 1.8 3.8 1.7 2.8 3.1 2.7 4.0 2.2 2.1 8.0 4.7 2.1 1.6 4.5 1.9 13.8 18.3 20.5 28.6 13.5 16.1 15.6 19.1 24.3 12.7 14.9 23.5 24.8 36.4 68.7 40.5 85.1 38.2 9.4 15.9 36.6 60.9 27.7 28.2 22.7 362.9 29.7 97.1 70.0 21.2 20.1 41.4 73.1 26.5 65.2 24.8 55.6 58.3 21.5 27.7 423.8 39.1 33.5 57.3 16.2 52.8 37.7 29.2 66.2 49.1 73.2 62.7 38.8 44.2 46.9 24.8 72.0 61.4 35.5 36.5 38.6 PPM1F "CAMKP, CaMKPase, FEM-2, KIAA0015, POPX2" ENSG00000100034 "Protein phosphatase, Mg2+/Mn2+ dependent 1F" P49593 22 21919420-21952837 "Enzymes, Plasma proteins, Predicted intracellular proteins" Apoptosis "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Ito cells: 61.4;Kupffer cells: 32.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 17.7" "Group enriched" "Detected in many" 7 "dendritic cells: 5.5;granulocytes: 17.7;monocytes: 13.9" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 36.5;K-562: 55.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030989, HPA030990" Approved Approved "Nucleoplasm,Plasma membrane" NA NA 780000 Nucleoplasm "Plasma membrane" "HPA030989: AB_10669549, HPA030990: AB_10601249" "unprognostic (6.26e-2)" "unprognostic (2.50e-1)" "unprognostic (1.82e-1)" "unprognostic (2.11e-1)" "unprognostic (2.51e-1)" "unprognostic (4.77e-3)" "unprognostic (4.88e-3)" "unprognostic (1.94e-1)" "unprognostic (1.70e-1)" "unprognostic (1.65e-2)" "unprognostic (1.45e-2)" "unprognostic (4.81e-2)" "prognostic unfavorable (6.03e-5)" "unprognostic (6.44e-2)" "unprognostic (3.02e-2)" "unprognostic (3.30e-1)" "unprognostic (4.11e-2)" 25.0 15.6 14.0 21.8 14.3 24.3 18.4 16.9 16.3 18.1 13.2 7.6 12.5 9.6 17.6 9.7 23.6 12.3 13.1 17.0 13.9 14.9 13.2 8.5 21.6 15.1 11.6 10.1 14.4 10.7 8.3 7.7 28.1 14.5 15.6 4.9 11.2 11.2 16.5 15.8 15.5 11.1 15.4 15.5 31.4 10.5 6.7 10.9 6.2 10.9 15.1 10.2 15.8 37.6 0.7 5.5 17.7 13.9 1.7 1.4 2.8 9.2 9.9 6.4 6.2 3.5 6.3 8.1 10.6 6.3 9.4 6.5 4.5 3.7 5.6 13.3 7.4 4.0 11.2 2.8 6.6 3.3 8.0 9.0 21.7 4.6 4.3 5.9 8.0 5.9 5.9 2.0 9.1 4.3 6.7 36.5 5.6 55.2 2.4 12.0 8.6 4.7 6.2 2.7 2.9 10.9 7.1 16.5 1.6 3.2 3.9 2.6 10.0 10.0 3.3 8.6 2.6 4.1 5.6 30.7 11.3 11.5 10.3 10.1 4.7 3.7 6.2 11.4 15.3 21.6 0.0 7.7 3.3 1.0 12.9 0.7 0.7 0.7 0.6 5.5 0.6 0.7 0.8 17.7 1.7 13.9 1.4 1.4 2.8 14.0 14.3 16.9 16.3 13.9 14.9 11.6 10.1 14.5 10.9 6.0 5.9 5.1 4.4 7.2 7.0 13.1 15.3 4.0 3.4 1.8 2.0 13.3 3.3 4.9 1.1 31.9 2.0 0.0 4.3 7.2 7.7 3.9 3.5 5.5 17.5 7.9 5.8 61.4 32.9 1.1 6.6 18.0 6.8 8.2 3.9 3.8 5.6 0.0 6.3 3.4 6.5 6.5 5.7 7.4 10.5 5.0 2.5 5.7 3.8 5.4 PPP1CA "PP-1A, PP1A, PP1alpha, PPP1A" ENSG00000172531 "Protein phosphatase 1 catalytic subunit alpha" P62136 11 67398183-67421183 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Cell cycle, Cell division, Glycogen metabolism, Host-virus interaction" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 177.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004545, HPA046833" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 8100000 "Nucleoplasm, Plasma membrane, Cytosol" "CAB004545: AB_628177, HPA046833: AB_2679829" "unprognostic (1.03e-1)" "unprognostic (5.82e-3)" "unprognostic (1.10e-1)" "unprognostic (2.67e-1)" "unprognostic (2.09e-1)" "unprognostic (1.51e-2)" "unprognostic (3.15e-3)" "unprognostic (3.93e-2)" "unprognostic (2.07e-1)" "unprognostic (3.89e-2)" "unprognostic (5.05e-3)" "unprognostic (8.00e-2)" "unprognostic (1.66e-1)" "unprognostic (9.96e-2)" "unprognostic (7.69e-2)" "prognostic favorable (1.17e-4)" "unprognostic (7.60e-2)" 28.4 35.4 24.2 42.0 32.3 42.1 25.1 19.6 33.4 23.9 39.6 22.1 29.9 33.9 19.6 25.8 59.7 22.8 28.6 33.0 21.8 17.1 43.7 55.0 27.6 49.3 19.9 19.9 20.1 53.3 23.1 21.6 44.0 19.3 27.2 33.2 23.2 49.7 31.1 39.0 34.4 47.3 20.5 21.3 53.7 35.1 15.7 19.4 77.7 38.5 40.5 63.9 25.5 25.7 78.8 76.6 126.2 118.0 68.2 113.9 177.2 45.3 52.4 31.1 45.8 15.5 19.0 31.7 22.5 26.4 45.4 34.5 74.9 54.8 39.1 38.4 34.1 33.8 39.8 35.9 46.8 27.9 41.1 24.4 37.5 24.7 39.2 33.9 47.6 48.5 21.4 31.0 38.6 22.8 21.6 45.5 38.3 34.8 32.4 36.7 103.5 60.3 93.6 51.6 86.5 41.5 42.9 43.0 33.8 44.6 37.6 24.3 40.4 26.1 46.9 69.4 24.3 56.1 33.0 32.4 35.1 35.9 41.3 29.1 32.5 30.1 44.4 42.0 32.7 36.9 81.4 80.1 126.2 88.6 100.5 69.3 78.8 79.8 90.5 76.6 77.0 49.1 69.2 93.3 68.2 118.0 54.4 113.9 177.2 24.2 32.3 19.6 33.4 21.8 17.1 19.9 19.9 19.3 19.4 71.5 93.0 166.0 108.0 88.8 35.0 7.9 117.2 41.5 46.6 82.0 9.8 320.7 180.8 238.7 1.8 77.3 292.4 23.3 272.4 398.0 69.2 127.9 107.3 102.4 338.5 41.3 93.0 87.2 194.1 5.3 45.5 157.2 129.9 390.5 160.1 42.9 250.4 210.5 26.9 236.5 23.6 97.0 60.9 13.0 106.5 106.3 357.3 222.6 164.6 168.4 PPP1R12B "MGC131980, MGC87886, MYPT2, PP1bp55" ENSG00000077157 "Protein phosphatase 1 regulatory subunit 12B" O60237 1 202348699-202592706 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "endometrium 1: 105.2" "Cell type enriched" "Detected in many" 7 "Cardiomyocytes: 719.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "neutrophil: 15.9" "Lineage enriched" "Detected in many" 7 "granulocytes: 15.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024171, HPA024640" Enhanced Approved "Plasma membrane,Actin filaments" NA NA "Plasma membrane, Actin filaments" "HPA024171: AB_1854266, HPA024640: AB_1854265" "unprognostic (5.24e-2)" "unprognostic (8.59e-2)" "unprognostic (1.38e-1)" "unprognostic (2.75e-2)" "unprognostic (3.04e-1)" "unprognostic (5.45e-3)" "unprognostic (3.12e-2)" "unprognostic (9.13e-3)" "unprognostic (4.05e-2)" "unprognostic (3.74e-2)" "unprognostic (2.79e-2)" "unprognostic (1.80e-1)" "unprognostic (3.60e-3)" "unprognostic (6.98e-3)" "unprognostic (1.27e-1)" "unprognostic (1.28e-1)" "unprognostic (1.19e-1)" 10.6 2.8 6.9 8.1 9.0 1.8 7.7 13.9 10.5 55.3 62.0 15.0 31.0 5.8 105.2 9.4 37.4 21.9 17.4 83.1 5.8 4.5 5.0 2.9 8.1 4.2 10.1 9.2 18.7 2.3 2.0 4.5 8.4 9.5 36.4 16.3 13.7 5.7 50.3 17.6 5.3 14.1 59.5 7.3 6.9 20.8 3.4 11.1 1.3 5.0 11.2 3.5 35.1 11.4 2.3 1.7 15.9 1.8 0.7 1.7 0.5 2.6 5.3 4.1 3.9 5.8 4.2 6.7 2.1 2.1 2.2 2.1 2.2 4.7 3.0 1.0 3.9 5.3 8.4 6.0 3.2 2.4 3.8 3.7 3.0 7.7 1.4 1.4 6.3 3.4 3.3 3.7 3.1 3.3 11.3 1.8 3.4 4.4 3.5 3.8 2.0 4.7 4.0 2.8 2.9 1.1 3.1 10.5 4.3 1.8 9.6 5.0 3.8 4.0 4.8 2.4 5.6 4.2 2.9 2.3 3.1 1.9 2.3 1.8 5.2 4.8 3.2 2.9 5.2 12.3 1.8 1.8 1.3 1.7 0.9 1.4 1.7 1.1 1.0 1.4 2.3 1.4 1.0 15.9 0.7 1.4 1.7 1.6 0.5 6.9 9.0 13.9 10.5 5.8 4.5 10.1 9.2 9.5 11.1 11.9 17.5 3.7 31.2 15.3 56.6 719.4 12.7 16.0 18.2 12.2 70.7 12.7 10.0 7.2 30.9 9.2 21.3 0.0 11.3 7.2 19.0 16.4 17.4 6.8 7.8 25.4 23.1 20.9 18.5 10.9 11.2 6.0 8.5 1.8 14.0 11.8 6.3 11.5 48.1 4.5 32.3 32.3 105.4 11.9 13.7 9.5 21.3 11.5 30.2 28.9 PPP1R16A "MGC14333, MYPT3" ENSG00000160972 "Protein phosphatase 1 regulatory subunit 16A" Q96I34 8 144477969-144502121 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 23.3" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 167.9;Proximal tubular cells: 269.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 26.1" "Low region specificity" "Detected in all" HPA023755 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA023755: AB_1854268" "unprognostic (9.63e-2)" "unprognostic (4.51e-2)" "unprognostic (5.45e-3)" "unprognostic (3.11e-1)" "unprognostic (5.60e-2)" "unprognostic (3.75e-2)" "unprognostic (4.64e-3)" "unprognostic (2.65e-1)" "unprognostic (3.68e-2)" "unprognostic (2.20e-2)" "unprognostic (1.52e-2)" "unprognostic (1.35e-1)" "unprognostic (1.05e-1)" "unprognostic (1.29e-2)" "unprognostic (1.03e-1)" "unprognostic (9.45e-2)" "unprognostic (2.79e-2)" 3.0 3.8 6.5 3.1 6.8 2.2 3.0 3.3 4.8 3.0 11.1 3.0 3.0 20.5 3.0 3.0 3.0 6.7 3.0 3.0 6.5 4.6 6.5 5.3 3.0 3.0 3.1 3.0 3.0 5.7 4.0 10.2 3.0 3.0 3.4 1.6 3.0 5.4 4.5 3.4 3.7 23.3 3.0 3.0 3.0 7.8 7.4 3.0 3.0 6.8 3.0 3.0 3.0 3.0 2.5 3.2 0.7 4.1 0.7 3.2 2.1 15.8 12.9 2.1 8.2 0.9 1.5 10.6 4.4 2.8 3.4 2.8 3.4 11.4 2.6 11.6 1.6 3.1 10.5 1.1 3.6 0.5 5.3 6.4 3.1 12.5 3.5 2.6 2.2 4.3 1.5 4.9 4.0 1.1 2.2 2.4 4.4 12.3 3.3 1.2 26.1 7.9 10.4 4.0 8.2 16.4 8.3 1.0 5.2 3.1 5.3 6.8 13.1 8.0 7.4 6.6 0.5 17.5 4.8 4.1 3.9 18.4 10.8 8.3 2.2 2.1 0.9 12.6 4.3 3.5 0.0 2.3 0.0 3.2 3.4 2.8 2.5 2.3 2.9 3.2 0.5 1.7 3.1 0.7 0.7 4.1 1.8 1.7 2.1 6.5 6.8 3.3 4.8 6.5 4.6 3.1 3.0 3.0 3.0 3.0 12.5 7.3 31.2 38.4 23.1 75.5 101.9 32.1 17.0 38.4 13.7 6.0 102.8 26.8 8.2 10.5 167.9 0.0 36.4 19.6 9.1 37.1 3.5 156.2 5.4 28.6 49.5 10.4 7.6 9.5 21.0 12.3 8.5 2.8 69.6 87.7 27.8 95.1 14.5 269.6 48.8 6.5 13.3 58.4 27.0 54.1 5.6 6.2 83.9 21.8 PPP1R18 "KIAA1949, phostensin" ENSG00000146112 "Protein phosphatase 1 regulatory subunit 18" Q6NYC8 6 30676389-30687895 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 54.5" "Cell type enhanced" "Detected in many" 7 "Hofbauer cells: 175.4;monocytes: 233.6;T-cells: 186.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "eosinophil: 54.5" "Lineage enriched" "Detected in all" 5 "granulocytes: 54.5" "Cell line enhanced" "Detected in many" "HMC-1: 35.0;U-937: 36.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044745, HPA051000" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA044745: AB_2679070, HPA051000: AB_2681304" "unprognostic (3.25e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (4.71e-4)" "unprognostic (1.01e-1)" "unprognostic (2.11e-2)" "unprognostic (1.59e-2)" "unprognostic (2.90e-2)" "unprognostic (3.37e-2)" "unprognostic (2.44e-1)" "unprognostic (1.18e-1)" "unprognostic (3.61e-2)" "unprognostic (2.40e-1)" "prognostic unfavorable (1.11e-16)" "unprognostic (1.73e-1)" "unprognostic (4.42e-2)" "unprognostic (9.33e-2)" "unprognostic (4.76e-2)" 17.2 7.1 5.6 24.7 7.9 34.0 16.1 1.7 4.7 12.6 15.9 6.2 4.6 5.3 17.5 7.3 11.5 10.9 13.9 10.1 6.5 3.4 6.1 8.3 20.2 44.9 7.2 1.8 14.9 4.0 2.3 2.9 13.3 6.0 11.2 3.7 7.3 7.9 6.1 6.6 9.5 11.3 13.9 9.8 37.4 9.1 4.9 6.2 48.2 7.8 7.8 23.6 18.2 18.0 4.2 3.4 54.5 4.1 10.2 11.9 5.2 10.0 1.6 6.0 7.2 4.3 11.6 0.2 6.0 7.0 5.3 3.6 1.2 2.0 9.8 5.5 10.5 12.0 6.7 3.0 6.6 2.8 8.2 0.6 23.6 2.9 1.2 3.4 6.1 35.0 7.1 7.7 13.1 11.8 6.3 4.3 16.6 4.3 4.9 6.2 1.1 8.7 12.1 0.0 0.3 0.4 27.8 5.3 8.0 3.1 0.6 0.4 2.0 5.6 2.2 11.1 0.3 1.6 8.4 14.2 21.0 5.3 0.0 14.9 1.8 9.6 12.1 6.0 36.4 24.5 8.1 2.8 54.5 11.7 4.1 8.5 3.1 5.7 11.9 1.8 4.2 4.7 9.0 13.2 10.2 3.0 3.4 9.4 5.2 5.6 7.9 1.7 4.7 6.5 3.4 7.2 1.8 6.0 6.2 3.0 20.7 66.3 25.5 96.9 1.3 2.8 10.2 6.7 4.5 8.7 0.0 2.5 0.0 20.1 23.9 64.4 0.4 0.0 7.1 17.8 32.0 15.2 51.9 7.8 175.4 3.2 1.7 30.7 131.5 14.6 25.6 119.9 37.1 233.6 0.5 0.9 18.0 0.0 21.9 1.3 2.9 25.8 79.5 0.5 1.4 52.1 3.3 186.8 0.4 22.5 PPP1R27 "DYSFIP1, toonin" ENSG00000182676 "Protein phosphatase 1 regulatory subunit 27" Q86WC6 17 81833492-81835050 "Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "skeletal muscle: 211.0" "Cell type enriched" "Detected in some" 10 "Early spermatids: 22.1" "Cancer enriched" "Detected in single" 10 "head and neck cancer: 3.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 3.2" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 23 "HL-60: 63.9;THP-1: 123.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA042227, HPA048632" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA042227: , HPA048632: AB_2680469" "unprognostic (3.35e-2)" "unprognostic (1.12e-4)" "unprognostic (1.48e-1)" "unprognostic (1.08e-1)" "unprognostic (1.29e-1)" "unprognostic (1.85e-2)" "unprognostic (1.37e-1)" "unprognostic (2.21e-2)" "unprognostic (7.07e-2)" "unprognostic (1.32e-1)" "unprognostic (5.38e-2)" "unprognostic (8.70e-2)" "unprognostic (4.98e-6)" "unprognostic (7.97e-2)" "unprognostic (1.21e-1)" "unprognostic (2.19e-3)" "unprognostic (1.30e-1)" 1.8 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.7 0.0 0.0 1.7 0.0 211.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 9.6 1.2 0.0 0.0 0.8 0.4 3.2 0.4 0.7 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 63.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 123.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.6 0.4 0.3 0.3 0.2 0.3 0.4 0.2 0.2 0.3 0.8 0.3 0.4 3.2 0.7 0.3 0.4 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.7 0.6 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 22.1 0.0 2.0 0.0 0.4 2.1 0.2 0.1 0.0 1.0 0.5 0.0 1.2 0.0 0.0 0.5 0.9 0.2 0.0 0.0 0.7 0.1 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.7 0.7 0.1 1.1 0.0 0.9 0.1 PPP1R9A "FLJ20068, KIAA1222, Neurabin-I" ENSG00000158528 "Protein phosphatase 1 regulatory subunit 9A" Q9ULJ8 7 94907202-95296415 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Actin-binding, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 109.7;Rod photoreceptor cells: 85.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 5.8;NK-cell: 10.9" "Group enriched" "Detected in many" 6 "granulocytes: 5.8;NK-cells: 10.9" "Cell line enhanced" "Detected in many" "HAP1: 10.5;RH-30: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027726, HPA075591" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA027726: AB_1855653, HPA075591: AB_2732296" "unprognostic (1.05e-1)" "unprognostic (6.59e-2)" "unprognostic (5.90e-2)" "unprognostic (1.63e-2)" "unprognostic (1.35e-1)" "unprognostic (1.12e-1)" "unprognostic (8.62e-2)" "unprognostic (6.19e-2)" "unprognostic (1.45e-1)" "prognostic favorable (7.17e-4)" "unprognostic (2.26e-2)" "unprognostic (1.89e-1)" "prognostic favorable (8.63e-6)" "unprognostic (2.74e-1)" "unprognostic (4.85e-2)" "unprognostic (8.47e-2)" "unprognostic (8.79e-3)" 2.9 11.7 11.0 1.9 23.5 0.8 8.1 10.9 19.7 5.2 8.7 7.4 7.7 3.0 5.4 9.2 3.2 9.6 4.4 8.2 11.5 9.7 8.2 1.1 6.4 0.9 8.1 13.7 5.0 14.3 16.5 15.5 4.5 12.7 4.2 6.8 5.7 14.2 5.3 6.7 1.1 3.0 5.1 9.1 3.2 6.2 10.0 11.2 0.0 10.9 1.3 1.0 4.2 1.4 1.3 0.3 5.8 0.1 10.9 0.2 0.2 0.0 9.4 6.0 6.7 0.0 0.0 4.8 0.4 0.1 0.9 0.7 5.2 3.1 0.0 8.0 0.4 0.6 0.0 10.5 0.0 1.2 0.0 4.0 9.6 3.8 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.7 4.0 0.1 0.0 4.9 4.3 1.7 0.0 10.5 0.0 9.8 7.8 6.4 6.6 0.0 0.8 1.3 3.9 2.0 0.0 0.0 0.1 3.9 0.1 3.4 6.4 9.2 0.0 0.1 0.0 0.7 5.8 0.0 0.5 0.0 0.0 0.2 0.9 0.0 0.0 0.0 1.3 0.0 0.0 0.0 10.9 0.1 0.3 0.0 0.2 11.0 23.5 10.9 18.3 11.5 9.7 8.1 13.7 12.7 11.2 38.7 49.4 0.0 0.8 0.3 51.3 109.7 7.6 33.5 26.1 45.4 53.0 16.9 3.3 20.0 13.6 2.2 8.8 0.0 6.1 2.0 1.4 8.0 5.7 1.3 1.5 1.6 37.3 8.0 0.0 12.2 2.3 0.4 6.8 0.0 13.4 56.5 7.0 10.5 0.7 6.2 85.0 0.0 3.1 18.2 10.2 0.6 27.7 0.0 16.4 1.0 PPP2R1B "PP2A-Abeta, PR65B" ENSG00000137713 "Protein phosphatase 2 scaffold subunit Abeta" P30154 11 111726908-111766427 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 94.9" "Group enriched" "Detected in all" 5 "Early spermatids: 249.6;Hepatocytes: 68.4;Late spermatids: 93.2;Spermatocytes: 71.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 60.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004034, HPA018908" Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB004034: AB_490763, HPA018908: AB_1855655" "unprognostic (8.37e-2)" "unprognostic (3.87e-2)" "unprognostic (4.84e-3)" "unprognostic (3.27e-3)" "unprognostic (3.43e-1)" "unprognostic (4.93e-2)" "prognostic favorable (3.80e-4)" "unprognostic (4.58e-1)" "unprognostic (8.20e-3)" "unprognostic (2.26e-1)" "unprognostic (1.72e-1)" "unprognostic (8.41e-2)" "unprognostic (1.25e-3)" "unprognostic (1.25e-1)" "unprognostic (5.30e-1)" "unprognostic (2.12e-2)" "unprognostic (1.22e-1)" 31.6 7.2 7.1 7.6 9.8 7.7 13.5 14.8 7.1 7.9 8.2 13.6 5.7 7.7 6.3 5.6 7.9 5.0 7.8 4.6 7.4 5.0 10.3 94.9 5.4 6.2 12.6 3.4 8.7 18.5 5.4 19.4 6.7 9.8 4.6 8.5 6.6 8.8 4.0 6.2 6.7 9.4 5.9 8.7 4.2 11.9 28.6 13.9 10.1 6.1 7.2 9.4 6.0 5.1 11.5 14.7 9.9 11.9 14.1 14.3 12.0 13.0 8.8 12.7 8.6 12.8 6.9 12.8 13.0 9.1 9.7 8.9 29.7 13.8 16.6 9.8 8.4 9.2 12.4 18.8 10.7 12.4 11.5 5.8 16.2 5.2 12.9 6.3 18.9 12.9 7.8 6.5 10.9 8.0 6.8 11.9 17.4 19.6 22.1 10.6 4.2 20.4 7.7 15.6 14.2 9.6 15.7 8.4 20.3 14.4 14.5 4.1 11.3 11.6 10.7 2.1 14.3 12.4 7.1 12.8 11.3 13.7 5.6 8.2 2.3 5.8 60.8 4.0 22.1 14.3 5.4 10.0 9.9 13.7 11.9 13.4 10.4 13.9 12.7 14.7 11.5 12.3 13.1 2.5 14.1 10.7 6.3 14.3 12.0 7.1 9.8 14.8 7.1 7.4 5.0 12.6 3.4 9.8 13.9 17.9 8.0 12.6 9.8 12.7 4.9 3.0 10.2 16.0 6.8 12.2 7.9 11.5 11.6 16.5 249.6 12.3 16.1 23.3 20.0 14.9 9.4 9.7 8.1 68.4 8.4 1.6 15.0 8.6 7.8 93.2 6.1 5.6 8.5 11.8 11.5 9.1 21.0 7.0 7.1 15.9 10.5 12.9 9.5 71.5 18.5 12.8 14.8 7.5 11.5 13.6 PPP3R1 "CALNB1, CNB, CNB1" ENSG00000221823 "Protein phosphatase 3 regulatory subunit B, alpha" P63098 2 68178857-68256237 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 78.2" "Cell type enhanced" "Detected in all" 5 "Rod photoreceptor cells: 86.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 6.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005610, HPA047157" Approved Approved "Plasma membrane,Cytosol" NA NA 43000 "Plasma membrane, Cytosol" "CAB005610: AB_325975, HPA047157: AB_2679960" "unprognostic (2.12e-1)" "unprognostic (2.09e-2)" "unprognostic (1.55e-1)" "prognostic unfavorable (9.08e-6)" "unprognostic (5.90e-2)" "unprognostic (1.86e-1)" "prognostic unfavorable (5.37e-4)" "unprognostic (3.59e-1)" "unprognostic (3.96e-2)" "unprognostic (1.28e-1)" "unprognostic (1.13e-2)" "unprognostic (1.74e-1)" "prognostic unfavorable (1.70e-5)" "unprognostic (5.24e-3)" "unprognostic (5.35e-1)" "unprognostic (8.70e-2)" "unprognostic (1.24e-1)" 25.8 20.1 43.3 15.9 66.2 32.3 25.7 47.9 78.2 14.8 14.0 7.7 6.9 13.1 16.6 14.2 15.7 10.5 14.7 10.2 56.2 28.7 11.3 29.6 15.5 18.8 23.7 45.1 13.6 9.8 9.4 8.9 18.5 25.4 14.3 14.8 6.8 12.1 16.6 41.7 17.1 12.0 18.5 21.6 16.5 12.6 10.4 16.5 12.7 12.6 7.7 20.1 14.4 13.3 1.0 1.8 6.4 1.4 0.9 1.4 0.9 17.8 15.2 20.6 14.1 14.2 16.5 21.0 25.9 22.1 29.3 25.9 21.9 16.2 24.9 8.9 17.5 20.9 12.1 21.7 18.7 35.8 17.5 15.5 80.8 12.4 20.1 28.1 31.7 27.3 16.6 17.0 22.7 23.3 16.6 19.6 21.1 19.5 28.5 21.3 15.4 26.8 27.9 24.2 15.0 13.0 19.6 27.2 39.6 18.1 19.0 27.2 19.2 14.9 21.2 18.6 14.0 10.0 14.8 20.5 25.3 23.2 19.1 22.3 16.1 17.7 36.9 18.4 33.4 15.8 3.2 1.2 2.9 0.7 0.8 1.4 0.5 0.8 0.5 1.3 1.0 0.9 1.4 6.4 0.9 1.4 1.8 0.9 0.9 43.3 66.2 47.9 78.2 56.2 28.7 23.7 45.1 25.4 16.5 8.9 16.7 16.6 10.6 66.4 21.5 16.1 10.2 2.7 6.8 15.7 49.1 9.8 10.0 5.9 11.6 21.5 14.4 23.3 7.5 14.8 14.0 14.4 19.6 18.5 21.1 11.1 14.6 15.4 42.9 6.5 9.2 22.7 33.7 4.6 14.0 20.4 10.5 10.1 8.1 12.9 86.2 12.9 17.3 2.6 5.3 61.6 10.1 20.3 12.0 16.8 PPP3R2 PPP3RL ENSG00000188386 "Protein phosphatase 3 regulatory subunit B, beta" Q96LZ3 9 101591615-101595021 "FDA approved drug targets, Predicted intracellular proteins" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 90 "testis: 81.9" "Group enriched" "Detected in some" 25 "Early spermatids: 271.7;Late spermatids: 141.7;Spermatocytes: 319.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Karpas-707: 1.3" "Low region specificity" "Detected in single" HPA047157 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA047157: AB_2679960" "unprognostic (8.81e-2)" "unprognostic (2.65e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 81.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 271.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 141.7 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 6.5 0.0 319.9 3.0 0.0 0.0 0.0 0.0 0.0 PPP4C "PP4, PPX" ENSG00000149923 "Protein phosphatase 4 catalytic subunit" P60510 16 30075978-30085377 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043837 Supported Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA043837: AB_2678695" "unprognostic (1.20e-1)" "unprognostic (1.33e-2)" "unprognostic (2.68e-1)" "unprognostic (4.74e-2)" "unprognostic (2.16e-1)" "unprognostic (5.79e-3)" "unprognostic (3.28e-3)" "unprognostic (2.60e-3)" "unprognostic (3.82e-1)" "unprognostic (1.29e-1)" "unprognostic (2.52e-1)" "unprognostic (3.17e-2)" "unprognostic (1.98e-2)" "unprognostic (3.78e-2)" "unprognostic (9.36e-2)" "unprognostic (9.96e-2)" "unprognostic (1.88e-1)" 24.7 26.6 13.5 26.1 14.1 26.7 18.6 16.0 15.9 19.2 28.4 14.5 20.5 22.5 19.2 28.4 39.1 17.7 31.9 28.5 12.6 12.1 28.9 52.3 27.4 25.3 12.5 12.8 22.5 26.3 23.9 16.2 51.6 11.9 18.3 17.4 18.8 22.0 14.9 26.0 26.1 38.8 15.9 11.9 36.2 22.6 39.0 9.5 59.7 27.1 26.5 37.9 22.2 21.1 19.5 30.3 57.3 28.2 12.4 23.6 12.0 30.8 34.6 23.1 32.2 21.9 18.5 36.0 27.5 30.7 36.2 40.2 30.4 40.3 24.0 35.4 32.4 23.6 25.2 28.6 34.1 21.4 30.1 51.2 16.3 21.5 67.2 33.3 22.9 30.9 26.8 30.2 33.0 21.0 21.7 42.0 31.3 31.8 22.0 27.6 88.9 39.9 41.8 44.0 24.5 18.4 44.7 24.0 41.8 34.2 31.8 22.5 33.3 13.5 40.8 23.5 20.2 37.6 39.0 26.7 21.2 22.3 17.1 21.1 37.8 41.5 28.1 30.2 29.6 25.6 21.4 26.9 57.3 18.3 28.2 13.1 17.0 19.2 20.6 30.3 19.5 17.2 15.2 56.9 12.4 24.5 23.5 23.6 12.0 13.5 14.1 16.0 15.9 12.6 12.1 12.5 12.8 11.9 9.5 47.6 33.1 81.7 96.8 130.7 20.0 9.3 89.2 54.9 23.9 73.3 27.5 268.8 134.3 208.0 127.6 84.2 174.4 0.0 169.7 278.1 71.4 111.6 69.1 85.6 210.3 33.4 120.5 58.9 91.3 98.3 58.1 124.3 75.9 252.5 114.3 41.8 254.7 168.4 49.1 156.3 25.7 71.1 65.1 231.9 141.6 150.8 352.1 111.4 129.3 192.9 PPTC7 TA-PP2C ENSG00000196850 "PTC7 protein phosphatase homolog" Q8NI37 12 110533245-110583320 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 53.8" "Cell type enhanced" "Detected in all" 4 "Cardiomyocytes: 96.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039335, HPA040614" Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039335: AB_10805474, HPA040614: AB_10795526" "unprognostic (2.44e-1)" "unprognostic (2.38e-2)" "unprognostic (1.11e-1)" "unprognostic (9.44e-2)" "unprognostic (2.38e-1)" "unprognostic (3.46e-2)" "unprognostic (2.14e-1)" "unprognostic (3.51e-2)" "unprognostic (1.47e-2)" "prognostic unfavorable (1.43e-5)" "prognostic unfavorable (6.76e-4)" "unprognostic (1.09e-1)" "prognostic favorable (4.48e-5)" "unprognostic (5.34e-2)" "unprognostic (2.83e-1)" "unprognostic (5.01e-3)" "unprognostic (1.83e-1)" 10.4 15.3 6.5 10.3 9.6 26.2 10.3 8.3 12.9 9.7 11.8 5.7 4.9 7.5 9.3 4.6 12.6 7.8 8.8 35.3 9.0 9.0 12.6 11.9 13.1 10.9 10.4 6.8 8.9 7.5 13.0 12.7 6.9 15.3 7.7 9.8 8.0 12.9 8.2 53.8 13.4 11.7 13.1 7.4 9.4 8.4 8.2 6.5 16.1 8.0 15.5 13.1 12.4 12.4 2.1 1.4 6.1 1.7 1.7 2.4 0.6 12.2 7.0 6.0 6.3 15.0 13.2 8.6 5.6 7.5 6.2 6.2 7.9 4.8 21.5 5.9 5.5 8.9 11.9 12.0 13.1 12.6 15.6 10.0 19.0 7.5 8.5 14.3 21.0 15.7 11.4 21.6 8.8 25.9 9.3 11.7 15.0 14.1 6.1 10.0 3.1 18.5 18.0 8.5 6.6 13.1 15.5 8.1 13.1 25.7 13.7 9.7 7.6 10.7 14.8 12.4 6.1 7.0 11.3 13.4 5.7 6.1 17.3 9.5 17.8 19.7 24.0 9.6 11.6 11.2 0.1 1.7 1.3 2.3 1.5 2.4 1.3 1.9 1.8 1.3 2.1 2.2 1.9 6.1 1.7 1.1 1.4 1.3 0.6 6.5 9.6 8.3 12.9 9.0 9.0 10.4 6.8 15.3 6.5 20.8 21.2 21.7 47.9 81.6 8.5 96.6 15.3 25.4 22.7 8.7 13.7 6.3 14.9 6.8 29.6 22.2 18.4 23.3 7.1 7.0 37.6 42.4 23.1 24.9 15.0 12.7 16.1 14.7 25.1 17.5 10.6 19.9 32.1 10.0 14.2 3.9 11.1 14.4 9.2 10.5 24.1 12.9 39.1 12.5 22.5 91.1 5.6 20.8 13.8 64.3 PRC1 ASE1 ENSG00000198901 "Protein regulator of cytokinesis 1" O43663 15 90966038-90995629 "Predicted intracellular proteins" "Cell cycle, Cell division" Oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 43.3;lymphoid tissue: 44.5;testis: 44.3" "Group enriched" "Detected in many" 4 "Erythroid cells: 70.0;Extravillous trophoblasts: 59.0;Spermatocytes: 129.3;Spermatogonia: 60.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "basophil: 18.9;T-reg: 5.8" "Group enriched" "Detected in many" 6 "granulocytes: 18.9;T-cells: 5.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA034521, HPA048816" Enhanced Supported "Nucleoplasm,Plasma membrane,Microtubules,Cytokinetic bridge,Midbody" Yes Yes "Plasma membrane, Microtubules, Cytokinetic bridge, Midbody" Nucleoplasm "HPA034521: AB_10670169, HPA048816: " "unprognostic (1.14e-1)" "unprognostic (3.98e-2)" "unprognostic (9.21e-2)" "unprognostic (1.75e-3)" "unprognostic (2.39e-1)" "unprognostic (3.43e-2)" "prognostic unfavorable (2.11e-4)" "unprognostic (1.24e-3)" "unprognostic (3.86e-3)" "unprognostic (1.65e-2)" "prognostic unfavorable (2.76e-5)" "unprognostic (2.49e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (3.09e-2)" "unprognostic (1.79e-1)" "unprognostic (7.90e-2)" "unprognostic (3.92e-2)" 3.2 2.8 3.5 13.0 3.8 43.3 3.6 12.5 5.8 3.4 9.3 1.6 0.2 6.1 3.5 4.7 15.0 2.6 2.8 3.5 5.1 4.9 2.3 1.9 5.8 9.2 3.4 4.7 3.6 3.8 1.6 1.5 10.4 5.2 2.4 9.9 2.7 3.9 1.0 2.5 9.9 6.6 5.4 3.5 5.8 5.0 44.3 0.8 44.5 1.8 15.3 16.5 3.5 4.9 0.9 2.0 18.9 0.4 2.0 5.8 0.7 32.9 40.2 33.7 22.8 3.5 6.0 18.1 47.4 28.0 52.5 40.3 26.8 32.1 12.5 18.9 30.2 32.5 44.9 38.3 20.3 49.8 23.2 42.5 26.0 52.6 24.6 0.9 12.8 22.5 1.5 2.6 29.8 30.6 11.7 29.4 20.3 21.6 26.9 48.8 28.6 13.1 19.5 13.2 43.1 17.3 13.8 42.0 16.8 23.4 25.0 30.7 24.3 45.1 25.1 16.3 24.3 30.1 25.3 17.6 34.7 30.7 28.6 68.2 8.7 23.1 15.5 15.2 31.8 53.0 18.9 0.4 2.0 0.5 0.0 0.3 0.9 1.0 1.0 1.8 0.4 0.9 0.4 0.2 2.0 0.2 2.0 5.8 0.7 3.5 3.8 12.5 5.8 5.1 4.9 3.4 4.7 5.2 0.8 0.0 1.9 12.3 5.2 14.7 6.8 2.4 0.0 4.0 10.3 3.5 0.0 9.5 0.0 2.9 17.7 3.2 2.0 70.0 2.5 59.0 7.4 5.1 9.2 1.6 17.6 3.2 5.2 9.8 8.6 12.3 3.4 7.0 3.3 9.0 4.5 4.5 1.7 2.6 1.8 0.0 3.5 6.5 10.3 129.3 60.0 12.4 12.2 6.9 7.4 5.4 PRDX6 "1-Cys, aiPLA2, AOP2, KIAA0106, MGC46173, NSGPx, p29, PRX" ENSG00000117592 "Peroxiredoxin 6" P30041 1 173477266-173488807 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Antioxidant, Hydrolase, Multifunctional enzyme, Oxidoreductase, Peroxidase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006983, CAB008663" Supported Supported "Plasma membrane,Cytosol" NA NA 180000000 "Plasma membrane, Cytosol" "CAB008663: AB_1620994, HPA006983: AB_1079595" "unprognostic (9.92e-2)" "unprognostic (1.50e-1)" "unprognostic (3.67e-1)" "unprognostic (2.99e-3)" "unprognostic (1.96e-1)" "prognostic unfavorable (1.23e-5)" "unprognostic (5.71e-3)" "unprognostic (2.80e-2)" "unprognostic (5.27e-3)" "unprognostic (3.96e-3)" "unprognostic (3.19e-3)" "unprognostic (1.59e-1)" "prognostic unfavorable (9.51e-4)" "unprognostic (2.50e-1)" "unprognostic (7.12e-2)" "unprognostic (1.15e-1)" "unprognostic (4.73e-3)" 80.0 42.1 32.8 30.8 38.9 21.8 106.3 19.8 32.8 27.2 46.7 37.4 35.8 12.1 30.8 54.1 39.9 40.2 22.3 70.5 29.0 23.9 45.9 116.1 29.2 37.5 34.0 28.2 31.5 39.3 63.9 19.1 36.9 30.3 40.0 56.0 21.3 22.6 35.4 128.0 25.7 20.2 40.5 19.7 23.1 33.2 44.9 24.1 17.4 46.9 68.6 25.7 36.5 46.2 17.2 37.9 14.3 23.9 12.0 25.0 30.6 52.1 16.0 26.6 29.5 103.2 50.5 22.5 106.5 36.3 44.5 31.6 30.2 35.1 33.9 34.1 87.2 16.4 30.5 34.8 34.3 36.2 29.8 32.1 22.5 27.4 34.1 58.2 23.5 7.4 41.8 34.8 24.4 34.2 28.0 43.6 14.2 50.0 7.0 50.5 10.7 15.9 31.0 58.5 28.7 99.6 19.1 30.8 34.6 66.6 11.9 12.4 23.0 36.7 43.2 24.4 40.0 36.5 33.2 29.3 17.3 19.9 26.2 28.9 10.6 15.7 27.9 20.8 20.5 15.8 13.9 23.9 12.9 17.0 20.6 18.9 17.2 17.6 21.1 29.3 13.6 23.2 25.0 14.3 12.0 17.5 37.9 20.4 30.6 32.8 38.9 19.8 32.8 29.0 23.9 34.0 28.2 30.3 24.1 163.8 131.5 140.0 350.9 209.2 31.5 477.5 249.7 195.4 161.5 263.5 27.5 589.1 729.5 163.2 193.0 183.6 264.7 256.9 175.5 640.5 290.3 337.6 341.6 875.0 302.1 42.9 136.4 174.3 152.8 441.3 315.2 140.2 173.7 230.0 253.4 390.8 159.2 306.9 391.7 634.8 41.0 181.1 254.2 113.1 58.3 231.0 805.7 161.9 278.6 280.8 PRIMA1 PRIMA ENSG00000175785 "Proline rich membrane anchor 1" Q86XR5 14 93718298-93788481 "Predicted membrane proteins" "Neurotransmitter degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 26.2" "Cell type enriched" "Detected in some" 11 "Muller glia cells: 33.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 7.5;Hep G2: 4.8;NTERA-2: 3.0;SCLC-21H: 13.2;SH-SY5Y: 7.5" "Region enhanced" "Detected in many" "basal ganglia: 16.2" "Low region specificity" "Detected in all" "HPA046671, HPA060047" Approved Approved "Nucleoli,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoli, Cytosol" "HPA046671: AB_2679744, HPA060047: AB_2684194" "unprognostic (3.60e-2)" "unprognostic (1.97e-1)" "unprognostic (7.54e-2)" "prognostic unfavorable (6.99e-5)" "unprognostic (1.03e-2)" "unprognostic (3.73e-2)" "unprognostic (1.07e-1)" "unprognostic (5.81e-2)" "unprognostic (2.93e-1)" "unprognostic (1.05e-1)" "unprognostic (8.94e-2)" "unprognostic (6.61e-3)" "prognostic unfavorable (2.62e-7)" "unprognostic (2.33e-2)" "unprognostic (2.67e-1)" "unprognostic (7.94e-4)" "unprognostic (4.57e-3)" 4.6 6.0 4.2 5.9 16.7 0.4 2.4 4.5 8.2 7.7 26.2 21.7 4.2 4.6 7.9 7.9 13.7 10.7 3.3 4.8 5.8 3.3 1.2 0.7 1.0 0.7 20.2 4.0 6.9 1.2 0.6 0.3 2.2 15.5 8.6 7.6 9.9 4.6 10.2 0.7 2.1 11.6 14.9 24.3 0.7 12.1 1.8 14.7 0.0 1.3 0.9 4.4 4.7 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 7.5 0.0 0.0 0.2 0.4 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 13.2 7.5 0.4 0.0 0.0 0.5 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 16.7 4.5 8.2 5.8 3.3 20.2 4.0 15.5 14.7 0.0 0.0 0.0 1.0 0.5 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.1 0.0 0.0 3.1 0.0 0.4 2.6 0.0 0.0 0.0 0.0 33.7 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.2 0.3 0.0 0.0 0.0 0.1 PRKCH "PKC-L, PKCL, PRKCL" ENSG00000027075 "Protein kinase C eta" P24723 14 61187559-61550976 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Differentiation "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Endothelial cells: 56.0;Erythroid cells: 70.0;Ito cells: 55.9;T-cells: 137.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 12 "gdT-cell: 30.0;MAIT T-cell: 23.9;memory CD4 T-cell: 23.0;memory CD8 T-cell: 35.3;naive CD4 T-cell: 28.5;naive CD8 T-cell: 27.6;NK-cell: 27.3;T-reg: 18.6" "Group enriched" "Detected in many" 14 "NK-cells: 27.3;T-cells: 35.3" "Cell line enhanced" "Detected in many" "BEWO: 30.4;HUVEC TERT2: 39.9;MOLT-4: 26.5;RT4: 16.8;TIME: 26.1" "Group enriched" "Detected in many" 6 "basal ganglia: 25.0;thalamus: 19.5" "Low region specificity" "Detected in many" "HPA026294, HPA053709" Approved Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA026294: AB_10603988, HPA053709: AB_2682237" "unprognostic (1.42e-1)" "unprognostic (3.89e-3)" "unprognostic (1.78e-1)" "unprognostic (1.96e-3)" "unprognostic (1.04e-1)" "prognostic favorable (8.55e-6)" "unprognostic (1.14e-2)" "unprognostic (2.97e-2)" "unprognostic (4.14e-1)" "unprognostic (1.94e-1)" "unprognostic (7.96e-2)" "unprognostic (1.60e-1)" "unprognostic (1.52e-3)" "unprognostic (1.13e-1)" "unprognostic (4.14e-2)" "unprognostic (6.98e-2)" "unprognostic (4.73e-3)" 17.5 5.4 5.0 21.6 22.0 11.2 14.7 2.8 6.1 13.6 10.3 6.2 6.9 5.1 19.1 7.0 20.1 8.6 12.7 10.1 6.8 4.4 8.1 5.5 24.1 27.6 5.9 2.5 7.1 5.9 8.8 15.5 22.7 7.2 9.8 5.0 9.1 24.7 10.8 9.1 15.9 16.0 10.5 5.7 25.9 6.0 4.3 6.4 54.6 15.1 10.6 34.6 13.2 14.4 0.4 2.2 1.5 0.7 27.3 35.3 17.9 6.4 2.2 0.3 1.7 1.0 0.2 30.4 0.1 0.5 0.3 0.3 0.7 3.8 0.1 4.6 0.0 0.6 4.4 0.2 4.9 0.5 0.8 2.9 0.0 0.7 0.2 0.4 0.0 0.9 0.8 5.1 0.2 3.5 0.4 39.9 12.9 0.0 0.1 2.3 11.7 26.5 0.2 0.5 4.6 3.1 2.2 1.1 0.0 0.0 16.8 1.1 1.9 0.7 5.9 3.6 5.6 5.8 0.5 26.1 0.7 5.2 0.8 0.3 0.5 0.1 0.2 1.1 0.4 1.3 0.1 0.7 0.5 30.0 0.4 23.9 0.4 23.0 35.3 2.2 0.3 28.5 27.6 1.5 27.3 0.2 0.7 18.6 17.9 5.0 22.0 2.8 6.1 6.8 4.4 5.9 2.5 7.2 6.4 6.0 10.7 4.6 15.8 16.7 0.2 3.9 10.2 10.7 18.2 0.0 0.0 23.4 3.3 4.6 25.5 56.0 1.7 70.0 5.9 16.9 3.7 13.1 1.1 1.0 5.6 0.0 11.3 55.9 11.1 3.6 1.7 9.0 15.1 5.4 2.6 9.3 4.4 2.9 6.3 0.8 0.3 0.0 4.1 0.0 2.1 23.3 40.4 137.1 0.7 24.4 PRKCZ PKC2 ENSG00000067606 "Protein kinase C zeta" Q05513 1 2050470-2185395 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Inflammatory response" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 43.6;placenta: 93.0" "Group enriched" "Detected in many" 4 "Late spermatids: 539.8;Syncytiotrophoblasts: 926.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "eosinophil: 15.0" "Lineage enriched" "Detected in many" 6 "granulocytes: 15.0" "Cell line enhanced" "Detected in many" "BEWO: 23.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021851 Enhanced Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA021851: AB_1855433" "unprognostic (1.25e-2)" "unprognostic (2.61e-1)" "unprognostic (5.10e-2)" "unprognostic (1.14e-2)" "unprognostic (2.08e-1)" "unprognostic (3.61e-2)" "unprognostic (1.73e-2)" "unprognostic (5.13e-2)" "unprognostic (1.18e-1)" "unprognostic (3.10e-1)" "unprognostic (1.12e-1)" "unprognostic (2.86e-1)" "prognostic favorable (1.64e-9)" "unprognostic (3.57e-2)" "unprognostic (3.27e-2)" "unprognostic (1.39e-1)" "unprognostic (7.85e-2)" 1.2 7.8 15.9 3.0 31.8 1.4 3.9 39.8 43.6 3.2 8.6 17.1 2.3 20.0 1.7 5.5 10.1 6.5 3.1 6.4 15.5 6.4 11.3 6.8 22.3 5.0 12.2 23.6 1.9 8.5 9.8 12.0 93.0 27.3 5.8 7.5 2.6 7.0 3.0 0.4 8.8 18.4 1.2 8.4 6.9 6.1 17.5 13.5 0.6 14.1 0.9 5.0 4.0 4.6 0.4 0.3 15.0 0.3 0.8 2.6 0.3 7.3 4.7 1.7 8.7 0.0 0.0 23.0 0.5 0.2 5.5 0.3 11.9 16.0 0.0 14.6 1.8 4.8 12.9 9.9 12.3 3.9 0.5 11.0 0.0 7.6 15.8 1.6 0.0 5.7 0.3 7.4 0.0 4.2 0.0 0.0 1.9 3.2 0.1 0.1 9.0 0.4 0.0 3.3 20.2 11.4 0.0 0.0 2.5 9.4 7.8 12.0 9.7 6.0 13.4 2.5 14.9 9.4 2.0 0.0 0.0 6.9 0.0 0.0 3.5 0.6 0.1 0.6 0.1 8.3 0.3 0.0 15.0 0.6 0.3 2.6 0.3 1.0 0.6 0.0 0.4 0.8 0.4 1.2 0.8 0.0 0.3 0.8 0.3 15.9 31.8 39.8 43.6 15.5 6.4 12.2 23.6 27.3 13.5 113.2 71.1 0.8 10.2 11.6 22.8 1.2 2.5 21.4 26.1 7.0 3.9 84.1 6.6 10.9 181.6 6.0 56.7 0.0 9.3 48.8 3.1 16.4 8.1 12.5 12.7 58.8 9.8 6.7 1.0 539.8 8.9 3.3 6.8 5.4 22.1 15.6 12.2 31.6 8.1 19.0 21.6 0.0 2.2 15.8 26.8 11.7 926.6 7.7 25.3 11.9 PROM2 ENSG00000155066 "Prominin 2" Q8N271 2 95274453-95291308 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Cholangiocytes: 45.9;Collecting duct cells: 31.4;Urothelial cells: 37.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 23.8;CAPAN-2: 42.0;HaCaT: 22.6;hTCEpi: 24.6;MCF7: 18.6;RT4: 25.6;SK-BR-3: 36.7" "Low region specificity" "Detected in single" "Not detected" "Not detected" "CAB046005, HPA063728" Enhanced Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Nucleoplasm, Plasma membrane" "Cell Junctions" "CAB046005: AB_2284371, HPA063728: AB_2685104" "prognostic unfavorable (2.16e-4)" "unprognostic (1.60e-1)" "unprognostic (1.41e-1)" "unprognostic (1.86e-2)" "unprognostic (1.76e-1)" "unprognostic (7.30e-2)" "unprognostic (2.23e-1)" "unprognostic (1.70e-2)" "unprognostic (1.37e-1)" "unprognostic (1.12e-1)" "prognostic unfavorable (2.90e-4)" "unprognostic (1.26e-1)" "prognostic unfavorable (1.55e-6)" "unprognostic (1.46e-2)" "unprognostic (4.59e-1)" "unprognostic (5.24e-2)" "unprognostic (2.50e-2)" 0.3 0.2 0.5 2.9 0.6 0.0 9.3 1.1 0.5 11.4 5.2 0.3 22.2 4.4 1.4 22.5 42.6 2.2 37.2 0.5 0.6 0.5 18.8 0.4 1.3 0.3 0.6 0.3 1.5 8.6 8.1 1.5 12.5 0.3 11.6 4.2 0.3 35.6 20.0 1.3 26.7 2.6 2.7 0.7 0.4 11.5 1.8 0.3 1.7 5.7 21.6 22.2 20.0 14.8 0.0 0.2 0.6 0.0 0.0 0.3 0.0 23.8 0.0 0.0 0.2 0.1 0.0 12.1 0.0 0.0 0.1 0.1 0.2 42.0 0.0 0.0 0.0 0.0 22.6 0.0 13.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 24.6 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 18.6 0.1 0.1 0.0 1.1 0.1 0.0 0.0 0.0 0.0 25.6 0.2 0.0 0.0 36.7 0.0 0.3 11.5 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.2 0.2 0.0 0.5 0.6 1.1 0.5 0.6 0.5 0.6 0.3 0.3 0.3 3.0 3.4 0.0 20.8 6.0 0.2 1.4 45.9 6.7 11.4 31.4 3.9 15.3 10.0 12.0 0.4 0.0 2.6 0.0 9.6 2.3 0.8 11.1 0.0 0.0 2.0 0.0 3.5 0.0 0.0 1.1 0.3 0.0 6.8 1.0 10.5 0.0 12.7 7.0 0.7 0.0 0.9 0.0 1.0 0.7 0.0 11.2 9.4 0.0 12.4 37.6 PRR32 CXorf64 ENSG00000183631 "Proline rich 32" B1ATL7 X 126819764-126821786 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 5 "heart muscle: 8.9;tongue: 26.7" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 5 "glioma: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 13 "THP-1: 1.3" "Group enriched" "Detected in many" 4 "basal ganglia: 3.5;hippocampal formation: 12.0;pons and medulla: 14.2;thalamus: 8.8" "Low region specificity" "Detected in many" HPA048386 Uncertain Approved "Nuclear speckles,Plasma membrane,Centrosome" NA NA "Plasma membrane" "Nuclear speckles, Centrosome" "HPA048386: AB_2680380" "unprognostic (7.10e-3)" "unprognostic (7.97e-2)" "unprognostic (3.79e-1)" "unprognostic (2.98e-2)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.3 0.0 0.0 0.4 0.0 1.1 3.4 0.0 8.9 0.2 0.1 0.0 0.3 0.3 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 1.7 0.0 3.1 0.1 0.0 0.3 0.5 0.3 0.0 0.0 0.1 0.0 0.0 26.7 3.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.2 0.1 0.2 0.2 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRRG1 PRGP1 ENSG00000130962 "Proline rich and Gla domain 1" O14668 X 37349275-37457295 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 43.4" "Cell type enhanced" "Detected in many" 5 "Collecting duct cells: 31.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 39.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078129 Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" Nucleoplasm "HPA078129: AB_2686878" "unprognostic (8.82e-2)" "prognostic unfavorable (4.65e-4)" "unprognostic (8.34e-2)" "unprognostic (2.08e-3)" "unprognostic (1.92e-1)" "unprognostic (5.11e-3)" "unprognostic (2.24e-2)" "unprognostic (7.23e-3)" "unprognostic (1.01e-2)" "unprognostic (1.74e-2)" "prognostic unfavorable (1.22e-4)" "unprognostic (8.21e-2)" "prognostic favorable (2.05e-7)" "unprognostic (1.43e-2)" "unprognostic (1.81e-1)" "unprognostic (1.08e-2)" "unprognostic (1.48e-1)" 11.6 5.5 12.0 3.1 22.0 0.7 5.8 2.6 18.7 6.7 5.7 35.9 4.6 4.1 6.2 2.5 5.9 4.0 12.4 8.5 17.9 10.7 14.9 10.7 6.3 2.5 31.0 9.9 6.2 2.6 1.2 2.3 10.6 21.3 5.1 6.0 3.0 3.9 11.6 19.3 3.1 4.3 7.5 43.4 4.0 3.4 2.4 23.7 0.0 11.6 2.9 1.6 5.9 4.5 0.6 0.2 2.6 1.7 0.2 0.4 0.1 15.0 3.4 2.8 2.8 9.4 7.6 1.2 6.4 8.6 2.3 4.0 8.2 9.7 0.0 11.1 5.0 4.3 4.9 7.6 4.8 4.0 0.0 2.4 2.7 3.6 2.8 11.5 0.0 3.5 11.8 4.0 4.5 3.8 4.6 11.9 0.0 1.2 0.0 8.0 1.1 0.0 0.0 3.3 2.4 7.2 0.0 6.2 0.0 39.4 0.7 0.0 0.0 4.7 7.5 2.8 7.7 0.0 1.6 8.5 3.6 2.2 7.0 1.9 0.0 0.0 0.0 3.6 0.0 3.3 2.6 1.7 0.1 0.2 0.5 0.2 0.6 0.1 0.3 0.1 0.4 0.2 0.4 0.8 0.2 0.2 0.2 0.2 0.1 12.0 22.0 2.6 13.9 17.9 10.7 31.0 9.9 21.3 23.7 6.0 3.4 0.0 4.2 10.1 1.8 7.6 12.7 0.0 0.0 31.4 0.0 5.5 6.6 5.9 0.6 16.5 5.6 0.0 2.7 11.7 8.7 5.9 1.1 15.3 3.8 17.5 2.9 14.7 5.1 0.0 4.4 1.4 3.3 1.0 4.8 1.9 12.9 8.0 2.5 7.3 0.2 6.5 5.6 0.9 3.6 5.5 8.7 0.0 4.1 7.4 PRRT3 FLJ33674 ENSG00000163704 "Proline rich transmembrane protein 3" Q5FWE3 3 9945542-9952394 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 26.0;fallopian tube: 10.8;parathyroid gland: 24.7;pituitary gland: 6.9" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 23.6;Rod photoreceptor cells: 22.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 12.7;MCF7: 16.1;SK-BR-3: 24.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035127, HPA035128, HPA069859" Enhanced Approved "Nucleoplasm,Plasma membrane" "Intracellular and membrane" NA NA 18000 "Plasma membrane" Nucleoplasm "HPA035127: AB_10602822, HPA035128: AB_2674482, HPA069859: " "unprognostic (1.55e-1)" "unprognostic (8.41e-2)" "unprognostic (3.42e-1)" "unprognostic (2.38e-3)" "unprognostic (1.27e-1)" "unprognostic (3.41e-2)" "unprognostic (1.15e-4)" "unprognostic (2.27e-3)" "unprognostic (1.37e-2)" "unprognostic (2.76e-2)" "unprognostic (2.20e-3)" "unprognostic (3.60e-1)" "unprognostic (1.01e-4)" "unprognostic (2.25e-1)" "unprognostic (1.39e-1)" "unprognostic (4.64e-2)" "unprognostic (2.09e-1)" 1.4 2.9 8.4 1.8 11.9 2.1 2.0 13.4 26.0 2.4 1.4 4.2 0.0 1.0 2.0 2.2 1.7 10.8 1.9 1.6 5.9 3.2 1.5 0.9 1.4 1.8 2.7 8.3 2.9 2.9 24.7 6.9 0.8 11.4 4.0 0.8 1.8 2.0 2.9 1.5 2.5 1.2 1.7 2.3 1.5 1.5 3.9 3.2 1.2 3.4 0.0 2.0 2.1 1.8 1.8 1.5 0.9 0.6 1.7 3.8 1.0 0.2 0.7 2.6 3.4 12.7 1.7 0.8 1.2 2.4 1.5 3.3 0.2 2.4 1.3 0.3 3.0 1.5 0.2 0.9 3.2 0.6 6.8 1.4 0.5 1.3 0.0 1.3 0.3 1.2 3.2 0.2 1.2 0.5 7.1 0.6 4.3 0.7 3.4 1.8 16.1 3.0 0.2 6.2 0.1 1.5 1.8 0.3 1.3 0.7 0.2 4.9 3.2 1.2 24.2 0.4 1.0 6.5 0.3 0.6 0.3 3.5 0.6 0.9 4.4 4.5 0.4 8.0 0.2 0.9 0.9 0.6 0.5 3.3 0.3 3.7 1.6 3.4 3.3 0.2 1.8 3.8 3.5 0.8 1.7 0.4 1.5 0.6 1.0 8.4 11.9 13.4 26.0 5.9 3.2 2.7 8.3 11.4 3.2 0.0 1.3 3.0 3.6 2.4 23.6 2.5 7.6 8.1 1.2 10.4 13.7 0.6 3.3 2.6 3.1 2.8 4.2 0.0 4.4 0.4 4.8 3.6 1.1 2.4 3.1 14.3 10.9 1.8 1.3 2.7 5.2 2.1 1.7 17.2 4.7 9.8 3.2 0.0 2.5 6.2 22.5 0.0 4.7 9.7 5.7 1.9 0.3 4.6 3.6 2.0 PRRT4 ENSG00000224940 "Proline rich transmembrane protein 4" C9JH25 7 128350325-128361685 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "bone marrow: 49.0" "Cell type enriched" "Detected in some" 8 "Horizontal cells: 9.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 5 "SH-SY5Y: 72.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA046373, HPA052681" Uncertain Approved "Nucleoplasm,Peroxisomes,Plasma membrane" "Intracellular and membrane" NA NA Nucleoplasm "Peroxisomes, Plasma membrane" "HPA046373: AB_2679642, HPA052681: AB_2681912" "unprognostic (1.72e-1)" "unprognostic (4.55e-2)" "unprognostic (5.36e-3)" "unprognostic (1.20e-4)" "unprognostic (2.60e-1)" "unprognostic (7.81e-2)" "unprognostic (1.88e-1)" "unprognostic (1.56e-1)" "unprognostic (5.62e-3)" "unprognostic (1.61e-1)" "unprognostic (2.48e-4)" "unprognostic (9.11e-2)" "unprognostic (3.73e-4)" "unprognostic (5.28e-3)" "unprognostic (9.09e-2)" "unprognostic (1.22e-2)" "unprognostic (1.27e-2)" 12.1 1.9 2.0 5.9 11.3 49.0 6.8 6.5 3.1 1.6 2.7 0.6 0.0 0.6 0.7 0.5 1.9 1.0 1.1 2.4 1.7 6.2 0.5 0.7 0.8 0.6 1.6 2.4 1.0 0.6 0.8 0.0 0.6 2.9 0.8 0.7 3.4 1.9 1.3 4.2 1.5 0.8 1.0 2.8 1.3 1.6 0.7 1.5 0.7 0.7 1.7 1.0 2.0 3.2 0.0 0.4 0.4 0.4 0.0 1.5 0.4 0.0 0.0 0.1 0.1 0.4 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 2.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.3 0.7 14.1 0.3 0.0 0.0 3.9 0.2 0.3 0.0 0.0 0.1 72.0 0.1 0.0 0.1 0.5 0.0 1.9 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.2 0.5 0.0 0.0 1.5 0.7 0.4 0.0 0.0 0.4 0.0 0.4 2.0 11.3 6.5 3.1 1.7 6.2 1.6 2.4 2.9 1.5 0.0 0.0 0.0 0.0 0.6 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 9.5 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.4 0.3 0.2 0.0 0.0 0.0 PRTG "FLJ25756, IGDCC5" ENSG00000166450 Protogenin Q2VWP7 15 55611546-55743090 "Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 16.5;thyroid gland: 23.9" "Group enriched" "Detected in many" 7 "Cone photoreceptor cells: 180.6;Rod photoreceptor cells: 63.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 18 "non-classical monocyte: 1.7" "Lineage enriched" "Detected in single" 18 "monocytes: 1.7" "Group enriched" "Detected in some" 7 "AF22: 47.4;SuSa: 57.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA032138 Approved "Vesicles,Plasma membrane,Cytosol" NA NA Cytosol "Vesicles, Plasma membrane" "HPA032138: AB_10669675" "unprognostic (2.80e-1)" "unprognostic (2.42e-2)" "unprognostic (1.32e-1)" "unprognostic (4.64e-2)" "unprognostic (2.07e-2)" "unprognostic (4.96e-4)" "unprognostic (1.82e-4)" "unprognostic (1.31e-1)" "unprognostic (3.19e-1)" "unprognostic (4.76e-3)" "unprognostic (1.37e-1)" "unprognostic (5.32e-2)" "unprognostic (5.67e-2)" "unprognostic (2.42e-6)" "unprognostic (8.81e-2)" "unprognostic (3.17e-2)" "unprognostic (2.70e-1)" 1.3 2.2 1.5 1.1 1.8 0.6 2.4 1.2 2.2 4.7 1.4 3.6 1.1 0.7 11.0 4.6 0.7 2.4 1.0 1.3 1.6 1.6 2.6 0.6 5.0 0.6 3.0 2.0 4.5 0.6 6.4 2.7 6.5 4.3 1.4 0.9 16.5 0.9 1.4 3.9 0.6 0.9 2.9 3.5 0.5 1.5 6.5 2.3 0.0 23.9 0.8 0.9 1.2 1.6 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.4 1.0 47.4 1.0 0.0 0.0 4.8 0.4 1.4 1.2 1.7 7.9 0.2 0.0 2.0 0.0 1.8 0.0 0.1 0.1 1.7 0.0 2.5 0.3 0.3 3.0 0.3 0.3 0.0 0.1 0.0 0.5 0.8 0.9 0.8 0.0 0.8 0.0 0.7 0.6 0.0 0.0 1.9 0.0 1.1 0.0 7.5 0.0 0.9 0.1 0.6 2.7 0.4 0.6 2.6 57.9 0.2 0.1 0.0 0.6 0.5 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 1.5 1.8 1.2 2.2 1.6 1.6 3.0 2.0 4.3 2.3 8.9 13.2 0.0 0.0 0.2 9.5 4.6 0.0 0.0 4.5 15.7 180.6 18.0 0.0 0.0 13.5 5.3 0.0 0.0 0.2 4.2 1.9 0.1 0.0 0.0 1.5 0.0 0.0 2.5 0.0 18.8 4.9 0.0 0.0 0.0 0.0 2.8 0.4 0.0 2.5 1.1 63.9 0.0 1.0 7.2 13.4 0.0 5.0 0.0 0.0 0.1 PRX KIAA1620 ENSG00000105227 Periaxin Q9BXM0 19 40393768-40413366 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 42.1;lung: 31.7;retina: 20.6" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 10.8" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "midbrain: 42.1" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Region enriched" "Detected in single" 21 "midbrain: 24.7" HPA001868 Enhanced Approved "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Golgi apparatus, Vesicles, Plasma membrane" "HPA001868: AB_2172440" "unprognostic (1.29e-2)" "unprognostic (3.04e-1)" "unprognostic (2.72e-2)" "unprognostic (9.72e-3)" "unprognostic (2.92e-1)" "unprognostic (1.74e-1)" "unprognostic (1.39e-1)" "unprognostic (3.54e-2)" "unprognostic (5.82e-2)" "unprognostic (3.23e-2)" "unprognostic (2.07e-2)" "unprognostic (3.28e-2)" "unprognostic (2.03e-3)" "unprognostic (4.42e-2)" "unprognostic (2.29e-1)" "unprognostic (1.38e-1)" "unprognostic (9.97e-2)" 3.4 4.4 4.8 1.0 4.1 1.1 2.7 2.2 5.4 3.0 2.3 1.8 2.8 1.2 3.8 2.0 2.2 3.2 2.4 2.9 4.0 2.2 4.3 0.6 31.7 1.3 42.1 3.7 7.5 5.4 7.3 1.1 6.0 10.3 3.2 0.8 20.6 3.9 4.4 5.4 2.2 1.5 3.3 11.0 1.7 2.4 1.6 3.6 0.0 7.2 6.7 0.9 3.1 2.0 0.3 0.4 0.0 0.3 0.1 1.2 0.2 2.5 2.7 3.3 4.3 2.7 7.0 4.1 2.0 2.3 2.9 2.1 2.3 2.7 0.8 2.6 1.9 1.5 1.3 1.1 1.0 1.0 1.2 1.4 0.5 0.9 0.7 3.2 0.2 3.6 5.0 4.9 1.9 1.6 3.3 1.5 4.5 3.0 0.8 1.5 3.2 1.1 0.8 0.7 5.6 2.5 4.8 2.8 2.4 0.5 1.3 0.3 1.5 3.9 3.4 3.0 1.5 4.9 1.2 2.2 5.9 4.6 2.3 1.2 8.4 7.3 1.1 1.8 1.3 1.3 0.0 0.3 0.0 0.6 0.2 0.2 0.0 0.4 0.6 0.0 0.3 0.3 1.2 0.0 0.1 0.0 0.4 0.3 0.2 4.8 4.1 2.2 5.4 4.0 2.2 42.1 3.7 10.3 3.6 3.0 5.1 0.0 1.0 5.6 0.0 10.8 5.1 0.0 1.2 1.8 0.0 0.8 0.0 0.3 0.0 4.4 0.5 0.0 0.5 0.6 2.5 2.1 0.0 1.0 0.9 0.0 0.0 4.9 1.8 0.0 3.1 1.2 3.3 0.0 0.3 2.7 0.5 0.9 4.2 1.3 0.0 0.0 2.6 0.2 0.7 3.6 2.3 1.3 1.4 0.9 PSD "EFA6, EFA6A, KIAA2011, PSD1, TYL" ENSG00000059915 "Pleckstrin and Sec7 domain containing" A5PKW4 10 102402617-102421539 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 66.8" "Group enriched" "Detected in many" 4 "Bipolar cells: 51.6;Cone photoreceptor cells: 90.3;Rod photoreceptor cells: 65.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HSkMC: 10.3;MOLT-4: 5.5;SCLC-21H: 9.7;SH-SY5Y: 8.5;U-2 OS: 4.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059237 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA059237: AB_2683954" "unprognostic (2.43e-1)" "unprognostic (1.74e-1)" "unprognostic (5.62e-3)" "unprognostic (1.53e-1)" "unprognostic (3.16e-2)" "unprognostic (2.90e-2)" "unprognostic (7.73e-3)" "unprognostic (1.75e-1)" "unprognostic (9.59e-2)" "unprognostic (7.59e-2)" "unprognostic (2.24e-3)" "unprognostic (4.71e-2)" "unprognostic (1.52e-1)" "unprognostic (2.61e-2)" "unprognostic (8.50e-2)" "unprognostic (2.24e-2)" "unprognostic (5.50e-2)" 1.2 9.8 48.7 4.3 59.4 1.6 1.5 8.0 66.8 6.7 21.5 1.7 0.0 6.7 23.9 2.4 3.2 11.1 9.4 1.9 48.7 12.2 1.5 1.4 1.7 1.8 7.6 26.7 5.6 4.7 2.5 13.6 1.8 4.2 6.2 4.4 3.7 1.5 2.2 1.2 2.1 5.8 20.7 1.8 1.5 4.8 4.6 7.0 0.0 1.2 0.0 1.5 11.7 3.0 0.8 0.0 1.1 0.2 0.9 1.3 0.0 0.3 0.1 3.9 3.5 1.4 0.8 0.3 0.3 0.0 0.1 0.0 2.7 0.4 0.3 2.5 0.1 0.3 0.2 0.2 0.0 0.0 0.3 0.2 0.1 0.1 0.1 2.2 0.0 0.1 10.3 0.3 0.6 0.1 1.7 0.0 1.4 0.6 0.9 0.0 2.1 5.5 0.3 0.5 0.3 0.0 1.5 0.0 0.1 0.0 0.2 9.7 8.5 0.1 0.1 0.2 0.3 0.6 0.5 0.0 2.9 4.7 0.2 0.0 2.5 0.3 0.1 0.3 0.2 0.1 0.0 0.2 0.3 0.0 0.0 0.2 0.2 0.2 0.3 0.0 0.8 0.3 1.3 1.1 0.9 0.0 0.0 0.0 0.0 48.7 59.4 8.0 41.2 48.7 12.2 7.6 26.7 4.2 7.0 3.0 0.3 0.0 0.2 0.6 51.6 1.2 5.1 0.0 2.3 0.0 90.3 0.2 1.7 0.1 4.1 0.3 0.8 0.0 1.7 0.1 1.7 0.3 0.0 0.5 0.6 12.7 17.2 0.0 0.0 2.0 3.4 0.0 0.0 0.0 0.6 8.6 0.7 0.6 3.9 0.7 65.1 0.0 0.3 3.7 3.4 0.1 0.6 0.0 0.8 0.1 PSD2 "DKFZp761B0514, EFA6C" ENSG00000146005 "Pleckstrin and Sec7 domain containing 2" Q9BQI7 5 139795821-139844466 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 14 "brain: 52.4" "Cell type enhanced" "Detected in some" 18 "Bipolar cells: 1.5;Muller glia cells: 2.7;Spermatocytes: 1.4" "Cancer enriched" "Detected in single" 43 "glioma: 19.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 3.6;SCLC-21H: 2.2;SH-SY5Y: 3.6;U-2 OS: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054625 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA054625: " "unprognostic (3.76e-2)" "unprognostic (1.90e-1)" "unprognostic (1.34e-3)" "unprognostic (2.48e-3)" "unprognostic (1.34e-2)" "unprognostic (5.01e-2)" "unprognostic (1.22e-2)" "unprognostic (6.55e-2)" "unprognostic (2.42e-1)" "unprognostic (2.17e-1)" "unprognostic (2.53e-1)" "unprognostic (4.02e-1)" "unprognostic (4.16e-3)" "unprognostic (3.40e-2)" "unprognostic (2.28e-1)" "unprognostic (3.07e-1)" "unprognostic (2.12e-3)" 1.3 1.7 21.1 1.3 28.9 1.3 1.7 12.6 52.4 1.9 1.3 15.2 0.0 1.4 1.4 3.6 1.3 1.6 1.3 1.4 16.1 15.2 1.3 1.3 1.3 1.3 18.9 14.4 1.3 1.6 1.3 0.2 1.3 24.7 1.4 1.3 0.0 3.5 1.7 1.4 1.3 1.3 1.4 12.8 1.4 1.3 2.2 17.0 0.0 1.3 0.0 1.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.1 0.0 0.6 0.0 0.1 0.2 0.9 0.1 0.2 0.0 0.0 0.2 0.3 0.9 1.4 0.0 0.2 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.3 0.1 0.2 0.1 0.4 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.1 2.2 3.6 0.0 0.7 0.1 0.3 0.0 0.2 0.0 0.2 1.7 0.0 0.0 1.0 0.0 1.5 1.1 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.1 28.9 12.6 17.5 16.1 15.2 18.9 14.4 24.7 17.0 0.0 0.0 0.0 0.0 0.0 1.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.7 0.1 0.0 0.0 0.0 0.4 0.0 0.0 1.4 0.4 0.0 0.0 0.0 0.0 0.0 PSMC6 p42 ENSG00000100519 "Proteasome 26S subunit, ATPase 6" P62333 14 52707172-52728587 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042823 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" No No 190000 "Nucleoplasm, Cytosol" "Plasma membrane" "HPA042823: AB_2678188" "unprognostic (2.38e-2)" "unprognostic (2.72e-2)" "unprognostic (9.18e-2)" "unprognostic (1.29e-1)" "unprognostic (1.19e-2)" "unprognostic (4.26e-3)" "unprognostic (3.14e-3)" "unprognostic (6.30e-2)" "unprognostic (1.06e-1)" "unprognostic (2.79e-2)" "unprognostic (3.50e-2)" "unprognostic (1.00e-2)" "unprognostic (1.52e-2)" "unprognostic (5.00e-2)" "unprognostic (2.68e-1)" "unprognostic (4.13e-2)" "unprognostic (4.67e-1)" 30.4 31.1 29.1 23.0 36.8 19.9 30.7 30.1 40.9 26.4 26.4 19.7 29.8 25.6 27.8 27.0 38.0 26.1 19.3 39.7 30.6 28.3 36.1 45.7 21.6 25.7 29.9 35.0 27.8 25.2 26.5 34.7 37.1 44.0 25.5 28.8 14.7 23.4 25.3 73.3 23.0 26.4 29.5 30.1 28.2 24.9 15.5 31.1 30.0 28.6 44.9 32.9 31.6 24.5 37.6 43.1 37.0 40.9 29.8 48.5 40.6 47.1 30.6 36.8 27.3 25.8 27.0 39.8 37.2 35.8 60.4 45.5 38.3 38.8 41.1 46.6 32.2 30.5 36.0 46.8 32.6 63.6 39.4 20.4 30.1 25.2 40.8 31.2 42.6 29.3 20.0 32.6 30.5 30.9 33.0 37.9 20.7 44.7 17.8 44.0 43.2 33.2 29.6 29.7 44.7 42.1 28.4 64.7 18.3 39.8 48.1 26.5 19.7 33.1 20.7 31.7 34.6 42.6 31.2 29.0 33.7 47.3 26.1 38.1 12.6 32.1 46.0 21.8 29.3 30.5 35.8 36.5 37.0 32.1 40.9 37.1 37.6 39.6 34.9 43.1 34.2 38.2 37.3 30.6 29.8 39.9 22.4 48.5 40.6 29.1 36.8 30.1 40.9 30.6 28.3 29.9 35.0 44.0 31.1 65.5 57.0 70.1 126.5 76.5 60.1 71.1 58.6 97.7 95.5 54.1 64.8 139.1 114.4 111.7 19.5 70.0 62.6 46.7 92.7 114.5 84.1 71.0 64.8 74.2 82.7 58.8 67.5 44.2 77.8 18.3 62.2 71.9 75.9 72.1 50.7 62.8 96.7 45.6 61.5 108.8 98.3 71.1 100.0 39.9 74.1 63.0 198.6 69.5 59.8 107.7 PSMD9 "p27, Rpn4" ENSG00000110801 "Proteasome 26S subunit, non-ATPase 9" O00233 12 121888731-121918297 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA040512, HPA044220" Enhanced Supported "Plasma membrane,Cytosol" NA NA 330000 Cytosol "Plasma membrane" "HPA040512: AB_2677014, HPA044220: AB_2678860" "unprognostic (2.24e-1)" "unprognostic (2.48e-3)" "unprognostic (2.12e-1)" "unprognostic (3.36e-1)" "unprognostic (1.20e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (1.32e-5)" "unprognostic (1.86e-1)" "unprognostic (6.80e-2)" "unprognostic (1.01e-1)" "unprognostic (1.46e-1)" "unprognostic (1.30e-1)" "unprognostic (9.64e-3)" "unprognostic (3.17e-2)" "unprognostic (5.73e-2)" "unprognostic (6.19e-2)" "unprognostic (8.63e-2)" 25.6 10.7 11.5 12.9 12.1 27.8 18.7 15.3 12.0 9.6 22.1 9.2 14.8 19.5 14.4 13.6 12.3 10.7 12.5 13.9 10.6 11.2 19.2 19.8 12.3 14.8 10.6 9.0 13.0 28.6 4.9 8.3 8.7 12.7 9.5 4.8 9.4 15.3 14.2 28.6 12.4 16.3 15.7 11.6 14.8 24.7 13.6 8.7 13.8 10.9 17.1 9.2 8.2 11.8 24.5 36.7 29.6 26.3 14.9 25.9 27.3 20.5 31.6 2.6 4.8 4.4 4.5 5.5 21.1 6.8 10.6 6.0 23.1 2.5 15.4 17.9 10.8 3.6 8.4 7.5 11.1 6.3 29.6 16.7 12.5 14.7 11.4 11.0 8.8 8.9 8.0 5.3 11.8 4.5 3.8 6.3 9.6 11.2 2.2 6.6 24.1 17.6 6.6 5.5 2.6 24.7 13.4 7.2 9.4 5.1 20.7 5.5 7.7 21.1 3.1 11.3 2.3 9.1 4.4 16.7 10.1 11.6 19.8 14.7 12.0 26.0 22.4 18.1 11.5 9.2 20.3 26.3 29.6 20.9 25.4 16.7 24.5 20.1 18.9 22.2 19.5 15.8 13.6 24.1 14.9 22.0 36.7 25.9 27.3 11.5 12.1 15.3 12.0 10.6 11.2 10.6 9.0 12.7 8.7 44.7 31.8 34.3 9.8 53.8 6.7 7.1 30.6 33.5 38.7 33.2 17.7 25.4 44.7 101.5 24.4 23.2 71.9 93.5 106.1 25.7 39.1 8.6 43.8 24.3 35.7 14.3 44.7 28.8 45.7 8.3 35.1 46.2 52.3 130.8 56.1 12.5 112.4 56.1 36.4 69.8 12.6 38.8 43.4 26.5 32.8 62.6 31.6 49.0 62.2 9.2 PSTPIP2 ENSG00000152229 "Proline-serine-threonine phosphatase interacting protein 2" Q9H939 18 45983536-46072272 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 38.1;bone marrow: 36.9;lymphoid tissue: 46.7" "Cell type enhanced" "Detected in many" 5 "granulocytes: 41.7;Kupffer cells: 40.3;Macrophages: 35.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 38.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 37.7;HMC-1: 41.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040923, HPA040944" Enhanced Approved "Nucleoplasm,Plasma membrane,Mitochondria" No No 7100000 "Plasma membrane, Mitochondria" Nucleoplasm "HPA040923: AB_10794429, HPA040944: AB_10795485" "unprognostic (1.61e-1)" "unprognostic (9.08e-2)" "unprognostic (1.21e-1)" "unprognostic (1.53e-2)" "unprognostic (2.57e-2)" "unprognostic (1.60e-1)" "unprognostic (1.17e-2)" "unprognostic (4.80e-3)" "unprognostic (1.87e-1)" "unprognostic (1.33e-1)" "unprognostic (5.83e-2)" "unprognostic (3.06e-1)" "prognostic unfavorable (2.39e-7)" "unprognostic (5.21e-2)" "unprognostic (3.55e-1)" "unprognostic (1.61e-1)" "unprognostic (1.93e-1)" 4.6 3.3 1.8 6.1 3.1 36.9 4.9 0.6 2.1 3.4 3.4 0.9 2.7 2.0 2.7 2.8 4.4 2.9 4.4 4.0 4.5 1.2 3.3 8.6 7.4 11.5 3.4 0.4 3.1 3.9 2.2 3.9 11.6 3.5 5.8 3.0 3.5 4.5 8.8 16.6 5.9 3.1 4.1 4.6 46.7 4.3 1.9 3.2 3.0 1.8 6.5 5.6 4.6 3.0 0.0 8.9 38.1 12.4 0.9 3.9 6.3 1.0 0.0 1.4 0.0 0.3 2.6 7.9 5.6 2.8 2.0 1.7 4.3 1.5 0.0 0.3 1.8 0.0 13.7 7.7 10.6 2.5 0.0 1.2 37.7 1.9 0.0 2.3 2.2 41.9 1.9 13.2 1.9 6.3 1.8 4.0 0.0 9.0 0.0 8.8 1.3 0.3 0.0 0.9 0.0 0.0 0.0 2.9 1.8 4.2 13.8 0.1 0.8 0.9 3.9 0.1 11.4 12.4 4.4 2.9 0.2 3.2 0.3 0.0 0.0 0.1 0.0 0.5 0.0 0.1 20.7 9.0 38.1 3.9 12.4 1.3 0.0 2.3 2.8 8.9 0.0 2.8 3.3 4.9 0.9 11.9 0.3 1.4 6.3 1.8 3.1 0.6 2.1 4.5 1.2 3.4 0.4 3.5 3.2 11.9 15.2 6.9 15.7 12.2 0.6 2.8 2.5 2.7 13.6 0.0 0.0 21.1 3.3 8.8 1.9 2.2 0.4 0.0 3.3 2.5 3.8 21.9 41.7 16.3 12.6 0.0 1.2 10.4 40.3 5.0 2.6 35.6 6.8 6.4 2.6 9.5 20.5 0.0 2.1 2.9 0.2 6.5 6.2 0.5 1.1 8.9 7.3 12.5 2.2 17.0 PTCHD4 "C6orf138, dJ402H5.2, FLJ41841, PTCH53" ENSG00000244694 "Patched domain containing 4" Q6ZW05 6 47878028-48068689 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.3" "Cell type enhanced" "Detected in some" 12 "Ciliated cells: 1.4;Collecting duct cells: 1.8" "Group enriched" "Detected in some" 6 "melanoma: 1.1;renal cancer: 1.6;thyroid cancer: 4.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 10.1;BEWO: 13.5;Hep G2: 22.5;LHCN-M2: 10.7;SuSa: 22.9;TIME: 11.4;WM-115: 9.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041276 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA041276: AB_10796570" "unprognostic (1.35e-4)" "unprognostic (1.66e-2)" "unprognostic (3.25e-1)" "unprognostic (3.11e-3)" "unprognostic (1.07e-2)" "unprognostic (1.57e-3)" "unprognostic (7.94e-2)" "unprognostic (3.59e-3)" "unprognostic (2.80e-1)" "unprognostic (1.50e-1)" "unprognostic (2.55e-1)" "unprognostic (1.92e-1)" "prognostic favorable (1.49e-6)" "unprognostic (5.03e-4)" "unprognostic (9.84e-2)" "unprognostic (1.57e-2)" "unprognostic (5.56e-3)" 2.1 0.7 4.6 0.1 7.4 0.2 1.3 2.7 11.3 3.8 1.2 0.3 0.0 0.6 1.7 3.7 1.9 3.2 1.4 1.4 2.2 1.3 2.2 2.1 3.1 0.2 1.4 5.5 1.1 1.1 0.4 3.9 1.9 1.8 2.3 1.2 1.6 2.1 6.4 0.6 0.3 0.4 1.9 1.3 0.2 0.5 0.9 0.8 0.0 3.6 0.0 0.3 2.8 1.3 0.4 0.4 0.8 0.2 0.1 0.2 0.0 0.0 0.0 10.1 0.0 1.7 5.0 13.5 1.5 3.2 0.1 0.4 0.0 0.6 0.0 0.0 0.8 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.3 22.5 0.5 0.0 0.0 7.4 7.2 0.0 0.1 5.4 1.5 2.3 0.0 0.0 10.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.4 0.5 0.0 0.0 0.0 22.9 0.0 0.0 11.4 2.5 1.6 0.0 0.2 0.0 0.0 0.0 3.4 0.0 9.9 0.8 0.1 0.5 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.4 0.2 0.2 0.8 0.1 0.2 0.4 0.0 0.0 4.6 7.4 2.7 11.3 2.2 1.3 1.4 5.5 1.8 0.8 0.0 0.6 0.0 0.0 0.1 0.4 0.2 0.0 1.4 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 PTK6 BRK ENSG00000101213 "Protein tyrosine kinase 6" Q13882 20 63528001-63537370 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 44.0;intestine: 24.2;skin 1: 24.2" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 2: 34.1;Enterocytes: 90.1;Mucus-secreting cells: 39.1;Paneth cells: 65.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 10.6;CAPAN-2: 20.4;HaCaT: 16.6;hTCEpi: 22.5;OE19: 27.4;RT4: 13.0;T-47d: 12.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB032952, HPA036070, HPA036071" Approved Supported "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Plasma membrane, Cytosol" "CAB032952: AB_634461, HPA036070: AB_10602292, HPA036071: AB_10669982" "unprognostic (2.32e-2)" "unprognostic (1.36e-1)" "unprognostic (1.05e-1)" "unprognostic (2.42e-2)" "unprognostic (1.41e-1)" "unprognostic (1.35e-1)" "unprognostic (1.04e-1)" "unprognostic (2.29e-1)" "unprognostic (3.03e-1)" "unprognostic (3.72e-2)" "prognostic unfavorable (1.96e-4)" "unprognostic (1.28e-1)" "prognostic unfavorable (1.26e-9)" "unprognostic (4.19e-2)" "unprognostic (1.74e-1)" "unprognostic (1.73e-1)" "unprognostic (4.24e-2)" 0.7 0.0 0.4 5.3 0.4 0.0 1.7 0.4 0.4 7.6 18.1 0.5 0.8 13.6 0.6 0.5 44.0 0.0 11.7 0.4 0.4 0.0 0.8 1.7 1.1 0.4 0.4 0.4 0.4 1.4 0.0 0.4 0.6 0.4 2.2 7.4 0.4 7.6 0.4 0.4 24.2 24.2 0.9 0.4 0.4 12.5 0.4 0.4 0.4 0.4 18.9 17.2 6.5 15.0 1.3 4.5 1.2 2.4 0.3 1.9 0.9 10.6 1.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 20.4 0.0 3.6 0.0 0.0 16.6 0.0 0.0 0.0 2.6 0.2 0.0 4.3 0.0 0.0 0.0 3.4 0.0 22.5 0.0 0.1 0.1 0.0 0.0 0.1 1.2 0.1 5.9 0.0 0.1 0.1 27.4 7.7 0.0 0.6 0.2 0.0 13.0 0.1 1.1 1.2 4.0 0.0 0.0 12.5 0.8 0.1 0.1 0.2 0.4 0.1 0.2 0.0 0.0 0.2 0.2 0.5 1.2 2.4 0.4 0.5 1.7 1.9 1.2 0.4 0.1 4.5 1.3 0.4 0.6 1.2 0.3 1.3 0.3 0.5 0.9 0.4 0.4 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 11.9 34.1 0.0 2.8 5.3 2.0 0.4 12.7 9.4 17.0 0.0 2.0 0.2 0.0 1.4 0.0 0.3 90.1 0.0 1.4 0.1 0.4 1.3 9.2 1.5 0.7 0.0 5.2 0.6 4.1 0.0 0.3 2.8 0.0 0.0 39.1 2.4 10.3 65.1 0.0 0.1 3.9 0.0 0.4 0.2 0.2 13.6 0.1 0.0 18.8 13.8 PTPN12 "PTP-PEST, PTPG1" ENSG00000127947 "Protein tyrosine phosphatase, non-receptor type 12" Q05209 7 77537275-77640071 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007097 Approved Approved "Plasma membrane,Cytosol" NA NA 1100000 "Plasma membrane, Cytosol" "HPA007097: AB_1079689" "unprognostic (2.28e-1)" "prognostic unfavorable (1.15e-4)" "unprognostic (1.35e-1)" "unprognostic (3.35e-2)" "unprognostic (1.40e-3)" "unprognostic (4.48e-3)" "prognostic unfavorable (8.78e-4)" "unprognostic (1.29e-1)" "unprognostic (5.83e-2)" "unprognostic (2.64e-1)" "prognostic unfavorable (2.01e-4)" "unprognostic (1.09e-1)" "prognostic unfavorable (7.27e-6)" "unprognostic (4.99e-2)" "unprognostic (2.97e-1)" "unprognostic (1.81e-1)" "unprognostic (3.21e-1)" 29.6 15.1 14.3 20.5 19.6 29.7 25.1 15.7 22.7 20.0 28.9 8.1 13.8 8.8 20.7 9.6 22.0 18.1 19.8 45.6 17.3 12.6 16.9 14.8 34.7 17.4 15.3 13.4 19.0 10.7 12.4 19.8 36.0 18.6 14.1 13.8 9.9 12.8 17.1 17.6 17.6 14.6 23.0 24.0 25.0 14.4 13.9 17.7 9.7 16.7 11.9 12.9 23.2 61.2 2.5 3.9 9.9 4.9 12.8 3.8 2.8 17.2 10.6 25.2 12.8 17.7 18.5 13.5 18.0 23.0 14.2 20.3 5.2 27.0 2.0 5.8 21.0 31.1 12.3 8.4 18.0 28.7 5.0 4.7 10.8 10.7 21.2 17.4 6.1 7.2 15.1 20.1 30.9 39.9 25.5 30.0 0.5 12.9 3.0 45.2 11.8 0.8 17.1 20.3 23.5 12.2 3.6 20.2 1.0 24.4 9.3 3.1 16.7 22.1 20.3 17.5 45.3 9.8 22.5 21.8 30.8 18.6 11.2 33.9 3.1 1.7 5.3 18.1 15.9 53.3 3.7 4.2 6.6 3.6 2.9 1.4 2.5 1.2 2.7 3.9 1.1 0.6 3.8 9.9 12.8 4.9 0.3 1.5 2.8 14.3 19.6 15.7 22.7 17.3 12.6 15.3 13.4 18.6 17.7 65.5 54.6 13.7 41.5 61.1 15.5 35.1 22.9 16.0 46.6 19.2 7.9 34.1 3.3 38.7 2.6 99.1 17.1 0.0 34.2 48.2 53.7 44.4 13.9 19.2 45.4 33.4 11.6 98.8 74.4 5.4 43.1 86.9 33.7 25.2 19.9 63.0 55.1 20.1 44.2 15.8 14.3 64.7 55.6 14.7 57.8 88.7 60.3 26.2 18.0 78.6 PTPN21 "PTPD1, PTPRL10" ENSG00000070778 "Protein tyrosine phosphatase, non-receptor type 21" Q16825 14 88465778-88554733 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 53.6;Syncytiotrophoblasts: 85.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RH-30: 23.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB011468, HPA073999" Approved Approved "Nucleoplasm,Golgi apparatus,Plasma membrane,Centriolar satellite,Cytosol" NA NA "Plasma membrane, Cytosol" "Nucleoplasm, Golgi apparatus, Centriolar satellite" "CAB011468: AB_442979, HPA073999: AB_2732247" "unprognostic (2.18e-1)" "unprognostic (4.21e-2)" "unprognostic (7.60e-2)" "unprognostic (3.09e-2)" "unprognostic (4.60e-2)" "unprognostic (5.71e-2)" "unprognostic (6.55e-2)" "unprognostic (5.19e-3)" "unprognostic (6.62e-2)" "unprognostic (1.02e-2)" "unprognostic (8.71e-3)" "unprognostic (3.04e-3)" "prognostic favorable (3.16e-9)" "unprognostic (6.52e-2)" "unprognostic (2.69e-1)" "unprognostic (2.56e-1)" "unprognostic (7.67e-2)" 10.5 4.7 5.3 8.6 7.3 0.0 13.2 4.4 5.8 10.7 8.7 10.7 7.4 4.9 10.6 10.7 8.9 8.3 12.7 17.4 7.4 4.2 8.1 6.0 15.3 1.6 6.6 4.2 15.8 7.8 10.6 3.9 15.6 6.4 11.9 6.5 12.6 6.5 10.5 8.8 24.2 10.5 15.7 7.3 3.7 7.4 15.2 6.5 0.8 16.0 8.4 3.1 12.0 26.1 0.8 0.0 0.0 0.1 0.0 0.1 0.0 3.6 2.9 7.7 3.0 8.2 7.2 8.0 9.8 7.5 5.8 8.1 5.2 6.6 0.0 2.4 12.4 5.2 3.4 1.1 3.4 8.5 0.2 1.7 0.0 3.2 2.1 9.2 0.0 0.1 4.7 6.8 4.8 5.8 7.5 4.7 0.0 1.1 0.1 14.8 3.0 0.0 0.1 2.2 3.9 5.6 0.0 23.1 0.0 5.0 2.6 0.5 9.0 5.6 14.1 3.2 6.8 6.9 1.5 9.2 10.8 8.5 4.4 6.7 0.3 1.2 0.0 4.0 0.1 4.3 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.3 7.3 4.4 5.8 7.4 4.2 6.6 4.2 6.4 6.5 53.6 5.9 0.0 4.0 9.3 7.3 31.1 5.1 9.4 7.9 7.0 33.4 7.6 0.0 4.4 12.7 4.5 9.3 0.0 7.2 4.4 9.3 7.8 2.3 9.0 1.6 1.6 4.6 7.4 1.2 3.5 15.8 0.7 0.0 0.0 14.6 4.9 8.2 5.8 25.5 3.3 9.0 0.0 8.5 12.1 6.1 10.5 85.2 0.0 4.6 4.7 PTPN22 "Lyp, Lyp1, Lyp2, PTPN8" ENSG00000134242 "Protein tyrosine phosphatase, non-receptor type 22" Q9Y2R2 1 113813811-113871759 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Autophagy, Immunity" "Hydrolase, Protein phosphatase" "Diabetes mellitus, Disease mutation, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 23.6;lymphoid tissue: 46.0" "Cell type enhanced" "Detected in many" 15 "B-cells: 29.6;granulocytes: 26.6;Kupffer cells: 19.2;Macrophages: 20.5;T-cells: 65.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 33.5;HL-60: 13.3;U-266/70: 14.4;U-698: 18.0;U-937: 13.6" "Region enriched" "Detected in single" 10 "cerebellum: 5.9" "Not detected" "Not detected" "HPA004912, CAB012209, HPA013350" Approved Uncertain "Nucleoplasm,Vesicles,Plasma membrane" NA NA Nucleoplasm "Vesicles, Plasma membrane" "CAB012209: , HPA004912: AB_10602069, HPA013350: AB_10601570" "unprognostic (2.25e-2)" "unprognostic (5.31e-3)" "unprognostic (3.48e-1)" "unprognostic (3.33e-4)" "unprognostic (9.14e-2)" "unprognostic (2.47e-3)" "unprognostic (9.60e-2)" "unprognostic (8.14e-2)" "unprognostic (3.71e-1)" "unprognostic (1.82e-1)" "unprognostic (1.62e-1)" "unprognostic (3.02e-1)" "unprognostic (2.75e-6)" "unprognostic (3.19e-1)" "unprognostic (1.10e-1)" "unprognostic (1.61e-1)" "unprognostic (3.22e-2)" 4.2 1.4 0.5 17.1 0.8 23.6 1.9 1.0 0.5 2.4 3.3 0.3 1.0 4.1 2.0 2.2 2.0 1.7 3.2 2.5 0.6 0.7 3.4 1.8 9.0 14.9 0.7 0.4 1.5 2.4 0.0 0.9 0.9 1.0 1.7 2.8 1.3 2.7 3.0 0.6 1.0 9.9 0.9 2.1 19.0 3.1 1.1 0.4 46.0 1.5 2.4 12.8 4.8 1.7 7.2 6.2 17.2 3.5 7.5 14.9 4.6 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.2 0.0 0.3 0.0 0.2 33.5 0.0 0.1 0.0 0.0 0.0 0.0 0.2 3.1 0.0 4.7 0.0 0.0 0.1 13.3 10.5 3.0 0.0 1.4 0.1 2.7 5.2 8.4 0.0 7.7 5.1 0.1 9.4 7.5 0.0 0.0 0.0 0.5 3.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.8 2.4 8.0 0.1 0.1 0.2 14.4 3.0 18.0 5.5 13.6 0.0 10.2 3.5 17.2 12.8 0.9 14.9 7.2 6.5 10.1 6.2 4.7 3.9 9.4 1.7 7.5 0.4 3.7 10.0 4.6 0.5 0.8 1.0 0.5 0.6 0.7 0.7 0.4 1.0 0.4 0.0 9.2 29.6 0.2 2.3 0.4 0.5 0.0 4.0 0.0 1.8 2.0 0.0 0.0 0.0 0.3 0.0 2.3 0.0 0.5 0.2 0.9 0.2 26.6 0.6 7.1 0.0 0.0 0.6 19.2 0.6 0.0 20.5 3.3 1.8 1.0 0.0 0.6 0.0 0.0 0.0 0.4 12.9 0.9 0.3 0.2 2.4 0.1 65.4 1.7 0.2 PTPN4 PTPMEG ENSG00000088179 "Protein tyrosine phosphatase, non-receptor type 4" P29074 2 119759631-119983818 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Bipolar cells: 53.9;Cone photoreceptor cells: 98.2;Horizontal cells: 152.6;Rod photoreceptor cells: 80.5;T-cells: 90.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 16 "NK-cells: 12.2;T-cells: 19.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019351 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA019351: AB_1855928" "unprognostic (1.45e-1)" "unprognostic (1.22e-1)" "unprognostic (1.07e-1)" "unprognostic (7.63e-2)" "unprognostic (9.00e-2)" "unprognostic (9.57e-2)" "unprognostic (2.34e-1)" "prognostic favorable (5.16e-4)" "unprognostic (3.31e-2)" "unprognostic (3.34e-3)" "unprognostic (3.13e-1)" "unprognostic (1.10e-1)" "unprognostic (3.34e-2)" "unprognostic (1.74e-1)" "unprognostic (1.87e-1)" "unprognostic (4.08e-2)" "unprognostic (1.81e-1)" 6.8 6.9 10.0 5.9 12.2 7.3 7.2 37.4 16.9 9.6 5.5 7.2 5.2 8.1 7.2 6.6 6.9 8.9 6.3 8.9 10.2 8.4 12.0 6.6 8.0 7.9 7.3 13.1 8.9 6.3 11.6 16.3 4.1 8.3 6.2 4.0 7.1 7.9 6.6 11.2 5.8 5.5 4.7 7.3 9.2 8.9 7.7 6.5 18.9 22.5 6.8 6.5 5.3 5.8 0.5 0.3 0.9 0.4 12.2 19.3 4.7 7.4 4.4 5.8 7.7 5.2 5.4 9.9 3.4 9.6 1.9 5.3 6.6 11.6 5.4 8.2 3.8 5.8 6.6 4.5 5.3 5.2 12.6 3.8 3.7 4.2 6.2 3.5 3.8 2.8 4.9 10.0 9.0 4.1 6.6 8.5 5.5 6.4 5.5 5.1 5.7 5.2 4.4 7.6 4.2 7.2 3.6 10.0 7.6 7.0 10.2 7.6 9.4 4.7 6.0 3.9 5.1 2.9 2.4 10.6 0.3 6.7 2.3 4.1 9.5 13.2 6.8 5.1 0.2 3.2 0.2 0.2 0.9 19.3 0.3 15.6 0.5 9.6 15.1 0.3 0.5 3.2 11.0 0.7 12.2 0.4 0.3 5.6 4.7 10.0 12.2 37.4 16.9 10.2 8.4 7.3 13.1 8.3 6.5 3.0 10.5 14.0 12.8 7.2 53.9 13.9 10.2 6.7 6.8 15.7 98.2 8.5 6.6 6.1 3.8 12.8 8.1 0.0 6.3 9.0 7.6 8.7 11.5 9.0 3.6 152.6 8.7 13.5 5.6 7.1 16.1 5.3 8.5 7.2 7.8 23.6 5.5 10.1 13.4 10.4 80.5 0.0 5.0 21.2 20.6 5.8 3.1 90.0 10.6 7.8 PTPRB PTPB ENSG00000127329 "Protein tyrosine phosphatase, receptor type B" P23467 12 70515866-70637440 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Angiogenesis "Hydrolase, Protein phosphatase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 6 "Endothelial cells: 113.4;Ito cells: 448.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "memory B-cell: 3.5" "Lineage enriched" "Detected in single" 7 "B-cells: 3.5" "Cell line enhanced" "Detected in some" "EFO-21: 11.3;hTERT-RPE1: 9.1;HUVEC TERT2: 28.0;TIME: 40.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004782, HPA067868" Uncertain Approved "Vesicles,Plasma membrane,Cell Junctions" NA NA 6700000 "Plasma membrane" "Vesicles, Cell Junctions" "CAB004782: , HPA067868: AB_2685911" "unprognostic (3.18e-1)" "unprognostic (2.99e-6)" "unprognostic (1.56e-1)" "unprognostic (1.80e-1)" "unprognostic (3.55e-2)" "unprognostic (1.77e-2)" "prognostic favorable (6.05e-4)" "unprognostic (4.59e-1)" "unprognostic (2.22e-2)" "unprognostic (1.85e-1)" "unprognostic (2.28e-2)" "unprognostic (1.40e-1)" "prognostic favorable (1.02e-4)" "unprognostic (2.91e-2)" "unprognostic (7.18e-2)" "unprognostic (1.31e-1)" "unprognostic (1.38e-1)" 23.5 7.0 4.5 5.5 7.0 0.1 22.9 3.6 6.1 11.3 8.0 4.3 7.1 5.3 17.1 8.5 5.8 8.2 11.4 17.6 6.2 5.1 18.7 12.0 39.9 3.3 6.9 4.6 5.5 4.4 4.9 5.7 23.3 7.8 6.1 8.2 16.0 3.6 7.1 11.8 4.7 7.4 13.3 7.3 22.9 5.2 3.7 4.3 0.7 14.0 12.2 2.6 6.5 14.7 3.5 0.1 0.2 0.0 0.4 0.3 0.2 1.9 0.1 0.8 0.1 0.0 0.0 0.4 0.4 1.9 1.0 2.4 0.0 1.5 0.7 11.3 0.3 0.1 6.9 0.1 0.3 3.6 0.6 0.3 0.1 0.8 0.5 0.1 0.3 0.0 0.0 0.3 2.8 0.0 9.1 28.0 0.0 1.5 0.5 0.6 0.0 0.0 0.0 1.0 1.9 0.4 0.0 0.7 0.4 5.2 0.8 0.0 0.4 0.7 0.0 1.6 0.2 0.0 0.6 40.9 0.4 0.4 0.1 2.4 0.5 0.4 0.3 0.2 0.5 0.0 0.2 0.0 0.0 0.2 0.0 0.0 3.5 0.0 0.3 0.0 0.3 0.1 0.0 0.1 0.4 0.0 0.1 0.0 0.2 4.5 7.0 3.6 6.1 6.2 5.1 6.9 4.6 7.8 4.3 0.0 19.9 13.7 0.8 3.3 5.4 9.2 17.8 0.0 1.2 3.5 0.0 0.0 0.0 1.4 4.3 113.4 4.3 46.7 0.8 0.0 1.9 0.6 23.3 2.0 0.3 4.8 0.0 448.7 26.3 2.5 1.1 2.0 5.0 0.0 4.8 0.3 7.2 14.4 0.0 0.0 0.8 0.0 0.9 0.7 0.5 1.4 0.0 1.7 5.2 0.6 PTPRG "PTPG, RPTPG" ENSG00000144724 "Protein tyrosine phosphatase, receptor type G" P23470 3 61561569-62297613 "Enzymes, Plasma proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 91.5;Horizontal cells: 146.2;Ito cells: 89.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory B-cell: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 36.2;HSkMC: 26.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000546, HPA064237" Uncertain Approved "Plasma membrane" NA NA 520000000 "Plasma membrane" "HPA000546: , HPA064237: AB_2685221" "unprognostic (1.47e-1)" "unprognostic (1.03e-1)" "unprognostic (1.31e-2)" "unprognostic (1.93e-1)" "unprognostic (8.73e-2)" "unprognostic (3.26e-1)" "unprognostic (5.38e-2)" "unprognostic (1.18e-2)" "unprognostic (5.84e-2)" "unprognostic (2.28e-1)" "unprognostic (2.86e-1)" "unprognostic (1.14e-1)" "prognostic favorable (3.10e-6)" "unprognostic (9.91e-2)" "unprognostic (3.25e-1)" "unprognostic (1.19e-1)" "unprognostic (2.63e-2)" 22.2 18.0 12.9 10.1 10.7 1.2 26.1 8.1 16.4 17.2 13.9 5.2 12.0 5.6 15.8 19.0 6.4 13.1 15.7 12.4 24.5 9.9 20.2 8.2 38.9 10.2 8.3 10.5 16.6 6.0 58.6 11.9 13.1 15.1 11.3 8.9 23.3 7.9 17.2 19.2 6.6 8.4 17.4 12.7 9.2 8.7 11.4 5.0 0.1 21.7 7.0 3.2 10.0 14.6 1.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 2.1 11.7 0.0 36.2 18.5 5.7 7.2 11.8 7.7 10.4 5.4 0.2 0.2 4.2 8.5 6.1 0.1 5.6 5.6 12.2 0.6 3.2 0.5 0.0 6.2 12.2 3.0 0.0 26.8 2.3 10.9 13.2 2.5 8.3 0.8 0.0 7.2 6.9 3.1 0.0 0.0 7.2 0.0 0.0 4.7 3.6 0.2 7.9 3.3 0.9 1.9 1.7 0.0 2.8 5.0 0.0 0.1 18.9 10.8 10.3 17.2 6.0 2.3 2.6 0.0 8.2 1.3 13.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 12.9 10.7 8.1 16.4 24.5 9.9 8.3 10.5 15.1 5.0 11.9 25.9 0.8 5.2 8.1 91.5 10.4 7.6 2.7 5.7 21.0 5.9 7.6 5.0 7.9 2.9 41.3 11.0 0.0 1.6 0.6 33.6 7.0 0.0 26.0 15.0 146.2 23.6 89.0 2.2 2.5 61.5 1.8 16.9 1.0 7.6 38.3 4.5 7.0 53.4 13.3 4.8 71.1 52.3 1.0 6.1 4.3 10.5 0.9 11.0 2.2 PTPRM "hR-PTPu, PTPRL1, RPTPU" ENSG00000173482 "Protein tyrosine phosphatase, receptor type M" P28827 18 7566782-8406861 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Hydrolase, Protein phosphatase, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Endothelial cells: 47.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory CD8 T-cell: 7.2" "Group enriched" "Detected in many" 50 "dendritic cells: 2.7;T-cells: 7.2" "Cell line enhanced" "Detected in many" "ASC diff: 35.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003891, CAB022442, CAB022443" Supported Approved "Plasma membrane" NA NA 76000000 "Plasma membrane" "CAB022442: , CAB022443: , HPA003891: AB_2667073" "unprognostic (2.59e-1)" "prognostic unfavorable (8.65e-5)" "unprognostic (4.89e-2)" "unprognostic (1.00e-1)" "unprognostic (1.13e-1)" "unprognostic (1.46e-1)" "unprognostic (1.80e-1)" "unprognostic (3.41e-2)" "unprognostic (7.62e-2)" "unprognostic (2.74e-2)" "unprognostic (1.56e-2)" "unprognostic (9.64e-2)" "unprognostic (5.63e-2)" "unprognostic (3.11e-3)" "unprognostic (9.41e-2)" "unprognostic (2.63e-2)" "prognostic favorable (1.07e-4)" 31.4 14.1 9.5 6.3 22.2 0.6 23.6 10.4 17.2 11.0 13.6 6.2 28.1 4.7 15.4 10.9 8.1 13.6 18.1 33.5 10.5 15.0 16.9 6.5 22.0 7.8 8.5 12.0 15.7 7.6 16.3 21.9 18.3 23.2 10.6 6.6 18.3 7.4 21.8 26.0 7.3 8.7 14.1 9.3 12.1 11.0 12.2 9.1 2.9 31.1 7.3 6.3 18.6 25.3 0.0 2.7 0.0 0.0 0.0 7.2 1.4 1.5 11.4 5.5 0.0 35.1 24.4 13.3 14.0 12.3 9.4 14.0 10.4 2.4 0.0 13.8 16.7 0.2 0.1 0.0 4.9 13.1 0.1 2.5 0.0 7.6 5.0 10.0 0.0 0.1 27.6 10.3 5.2 14.9 18.1 9.4 0.0 0.0 4.8 7.5 0.2 4.5 0.1 0.9 3.3 2.5 0.1 4.7 21.1 23.1 19.6 0.5 3.0 0.4 0.0 11.7 9.1 0.0 0.0 9.7 19.4 12.2 9.2 2.4 0.4 0.1 0.0 16.6 0.0 3.6 0.0 0.0 0.0 4.5 0.0 1.8 0.0 6.0 7.2 0.1 0.0 1.7 3.1 0.0 0.0 0.0 2.7 1.0 1.4 9.5 22.2 10.4 17.2 10.5 15.0 8.5 12.0 23.2 9.1 41.7 29.0 0.9 6.8 5.4 24.2 24.1 17.8 22.7 9.1 5.2 2.0 10.4 1.7 15.5 24.0 47.4 0.5 0.0 7.1 2.7 10.2 7.0 2.3 20.2 8.2 0.0 1.7 38.1 8.0 34.9 2.6 5.2 28.7 1.0 1.3 2.8 12.6 0.3 4.9 11.3 1.9 6.5 8.0 3.6 9.8 2.5 10.5 2.5 0.8 5.4 PTX3 "TNFAIP5, TSG-14" ENSG00000163661 "Pentraxin 3" P26022 3 157436789-157443628 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 61.7;skeletal muscle: 67.7;urinary bladder: 77.0" "Cell type enhanced" "Detected in some" 10 "Ductal cells: 6.0;Fibroblasts: 10.1;Macrophages: 5.9;Melanocytes: 13.5" "Cancer enhanced" "Detected in many" "glioma: 22.5" "Group enriched" "Detected in some" 6 "hippocampal formation: 1.1;pons and medulla: 3.6" "Cell type enhanced" "Detected in some" "eosinophil: 3.2" "Group enriched" "Detected in many" 20 "dendritic cells: 1.3;granulocytes: 3.2;monocytes: 1.2" "Cell line enhanced" "Detected in many" "ASC diff: 86.4;ASC TERT1: 125.2;BJ hTERT+: 82.2;HHSteC: 160.8;HSkMC: 167.5;hTEC/SVTERT24-B: 88.5;TIME: 119.2;U-2197: 111.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" HPA069320 Approved Approved "Plasma membrane" "Secreted to blood" NA NA 1090000 310000 "Plasma membrane" "HPA069320: AB_2686118" "unprognostic (1.93e-2)" "unprognostic (4.96e-3)" "unprognostic (1.35e-1)" "prognostic unfavorable (8.35e-9)" "unprognostic (5.79e-3)" "prognostic unfavorable (6.36e-4)" "unprognostic (6.03e-3)" "prognostic unfavorable (8.75e-6)" "unprognostic (2.45e-1)" "unprognostic (6.69e-2)" "unprognostic (7.60e-2)" "unprognostic (2.63e-1)" "unprognostic (2.76e-9)" "unprognostic (6.03e-3)" "unprognostic (5.98e-2)" "unprognostic (2.15e-4)" "unprognostic (1.92e-3)" 61.7 3.4 0.3 16.7 0.2 31.6 35.3 0.2 0.7 0.8 13.2 0.3 0.6 0.5 0.5 0.8 2.0 6.5 3.5 14.7 1.1 0.0 3.0 0.6 22.5 7.0 0.3 0.1 6.8 18.0 0.3 1.0 4.9 3.6 2.5 1.2 5.2 1.8 0.4 67.7 6.0 1.9 6.4 0.9 9.6 4.9 0.9 0.2 0.3 2.7 0.4 0.4 77.0 2.5 0.0 1.3 3.2 1.2 0.0 0.0 0.1 0.0 0.0 52.1 0.0 86.4 125.2 0.0 9.0 82.2 3.9 4.2 0.0 0.5 0.0 32.1 10.6 6.1 0.0 0.0 0.0 7.7 0.0 0.0 0.1 0.0 0.0 160.8 0.1 0.0 167.5 0.0 88.5 30.1 7.7 18.2 0.0 0.0 0.0 26.0 0.0 0.0 0.1 0.7 0.0 0.3 0.0 0.0 0.0 0.3 3.5 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.1 119.2 17.7 0.8 111.1 1.5 0.0 0.0 0.0 3.7 0.4 5.0 0.0 1.2 3.2 0.0 1.2 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.3 0.2 0.2 0.2 1.1 0.0 0.3 0.1 3.6 0.2 0.0 1.7 0.0 1.1 1.4 0.8 0.4 0.0 0.0 2.3 0.0 0.0 0.1 0.0 6.0 1.9 2.0 0.0 0.0 0.0 0.0 10.1 0.4 0.0 0.0 2.6 0.0 0.0 3.1 4.6 0.8 0.3 5.9 13.5 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.4 0.0 4.2 0.0 0.4 0.9 0.2 0.0 0.0 0.1 PURG "PURG-A, PURG-B" ENSG00000172733 "Purine rich element binding protein G" Q9UJV8 8 30995802-31033715 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.7" "Group enriched" "Detected in some" 7 "Bipolar cells: 11.8;Early spermatids: 11.1;Horizontal cells: 19.1;Late spermatids: 16.8;Muller glia cells: 11.3" "Cancer enhanced" "Detected in some" "glioma: 1.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 8.7;JURKAT: 6.1;NTERA-2: 6.8;SH-SY5Y: 8.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047746 Enhanced Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" Nucleoli "HPA047746: AB_2680145" "unprognostic (3.37e-1)" "unprognostic (2.15e-1)" "unprognostic (6.69e-2)" "unprognostic (7.33e-3)" "unprognostic (3.65e-2)" "unprognostic (1.78e-1)" "unprognostic (3.51e-3)" "unprognostic (1.10e-2)" "unprognostic (1.49e-1)" "unprognostic (1.62e-1)" "unprognostic (4.79e-2)" "unprognostic (8.72e-2)" "unprognostic (1.46e-3)" "unprognostic (1.03e-1)" "unprognostic (1.27e-1)" "unprognostic (1.83e-2)" "unprognostic (5.30e-2)" 1.3 1.9 11.0 1.2 10.3 0.6 0.9 14.7 13.5 2.4 1.0 2.4 0.5 1.0 5.6 2.6 1.5 1.6 3.0 1.6 9.4 6.2 1.7 0.7 1.4 1.3 4.9 7.3 1.6 0.7 0.6 3.9 1.5 6.2 1.9 1.1 1.7 1.6 2.6 1.0 0.9 1.0 5.0 4.5 2.5 1.3 8.1 6.4 0.0 0.8 0.0 1.0 1.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.2 0.1 0.0 0.0 0.2 0.4 0.7 1.8 0.0 0.0 0.2 0.0 0.0 3.0 0.0 2.9 0.0 1.0 0.0 4.4 1.6 0.0 0.2 0.0 0.0 0.2 1.3 0.0 1.3 0.0 1.0 4.3 6.1 0.4 0.5 0.2 0.0 0.9 0.0 6.8 0.0 0.3 2.2 1.2 0.0 0.0 0.0 1.2 8.2 0.0 0.0 0.0 3.3 0.0 0.0 2.6 2.9 3.7 0.0 0.4 0.3 0.0 0.2 2.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 10.3 14.7 8.9 9.4 6.2 4.9 7.3 6.2 6.4 0.0 0.0 0.0 0.0 0.0 11.8 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 11.1 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 16.8 0.6 0.0 0.0 0.0 0.0 11.3 0.0 0.0 1.4 0.0 1.8 0.0 0.3 1.7 1.1 0.0 0.0 0.0 0.0 0.0 PXDC1 C6orf145 ENSG00000168994 "PX domain containing 1" Q5TGL8 6 3722614-3752026 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 79.6" "Cell type enhanced" "Detected in many" 5 "Basal glandular cells: 93.5;Extravillous trophoblasts: 114.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "memory B-cell: 4.2" "Lineage enriched" "Detected in single" 4 "B-cells: 4.2" "Cell line enhanced" "Detected in many" "HHSteC: 43.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA019246 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA019246: AB_2670113" "unprognostic (1.55e-1)" "unprognostic (1.87e-2)" "prognostic unfavorable (3.64e-4)" "prognostic unfavorable (1.14e-4)" "unprognostic (2.82e-2)" "unprognostic (3.80e-2)" "unprognostic (2.95e-1)" "unprognostic (1.48e-1)" "unprognostic (6.73e-2)" "unprognostic (6.08e-2)" "unprognostic (2.32e-1)" "unprognostic (2.13e-1)" "unprognostic (2.01e-2)" "unprognostic (6.17e-3)" "unprognostic (1.10e-1)" "unprognostic (2.97e-1)" "unprognostic (2.84e-1)" 26.3 5.5 5.9 5.9 6.5 0.4 30.6 3.2 6.6 11.1 10.3 6.4 5.3 10.7 10.1 14.4 13.9 8.3 18.5 10.8 6.5 4.4 13.4 79.6 14.2 5.8 7.5 3.1 6.2 10.0 3.4 4.3 32.9 6.2 9.1 3.1 7.5 12.3 8.1 11.9 11.7 16.9 20.6 7.0 6.1 8.9 3.9 6.9 1.0 16.8 11.5 5.8 14.9 21.0 4.2 0.3 0.5 0.0 0.0 0.9 0.3 11.7 5.0 8.2 5.5 26.0 19.7 26.4 21.4 16.5 18.3 14.2 8.3 2.3 0.0 13.9 35.0 13.5 8.8 1.6 5.9 8.7 11.9 1.6 0.0 3.6 7.4 43.5 0.0 0.0 17.8 19.4 11.3 24.4 15.1 20.0 0.8 0.0 1.5 14.3 0.7 0.0 0.1 0.3 2.3 6.0 0.6 4.4 0.4 6.9 9.9 0.9 0.4 14.2 14.6 28.7 11.4 1.2 0.7 20.8 15.5 6.6 6.0 14.5 0.0 0.0 0.0 3.5 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.3 4.2 0.1 0.0 0.3 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.9 0.3 5.9 6.5 3.2 6.6 6.5 4.4 7.5 3.1 6.2 6.9 44.7 10.4 4.2 93.5 42.8 0.4 6.9 15.3 5.3 12.5 7.0 0.0 26.6 10.0 30.2 0.4 37.0 1.3 0.0 44.5 114.0 36.1 45.1 3.5 57.1 21.2 0.0 0.0 36.2 9.1 0.2 21.0 17.8 23.6 37.9 0.8 14.3 55.0 0.0 17.0 16.8 0.7 0.0 31.6 0.5 3.8 29.0 65.6 2.9 0.0 38.2 RAB27B ENSG00000041353 "RAB27B, member RAS oncogene family" O00194 18 54717860-54895516 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.0;stomach 1: 36.6" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 200.3;granulocytes: 234.0;Late spermatids: 149.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "gdT-cell: 4.6;NK-cell: 5.0" "Group enriched" "Detected in many" 4 "NK-cells: 5.0;T-cells: 4.6" "Cell line enhanced" "Detected in many" "HEL: 20.9;hTCEpi: 16.0;hTERT-HME1: 19.4;U-87 MG: 56.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB017712, HPA019849" Enhanced Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA 37000000 "Golgi apparatus, Plasma membrane" Cytosol "CAB017712: , HPA019849: AB_1856000" "unprognostic (1.59e-1)" "unprognostic (5.20e-2)" "unprognostic (9.89e-3)" "unprognostic (7.51e-2)" "unprognostic (8.89e-2)" "unprognostic (1.84e-2)" "unprognostic (1.52e-1)" "unprognostic (2.73e-3)" "unprognostic (6.82e-2)" "unprognostic (8.12e-2)" "prognostic unfavorable (2.13e-4)" "unprognostic (1.39e-2)" "unprognostic (1.20e-3)" "unprognostic (1.42e-1)" "unprognostic (1.84e-2)" "unprognostic (5.75e-1)" "unprognostic (1.29e-1)" 1.1 2.4 13.8 2.3 11.3 1.0 10.8 0.8 30.0 4.5 4.4 0.3 0.0 4.5 1.1 0.7 17.0 1.3 9.8 0.9 12.0 7.9 0.8 1.4 6.2 0.7 4.6 18.4 0.7 5.3 1.3 3.6 2.4 8.6 18.0 4.8 0.0 12.8 3.3 0.6 13.2 4.3 1.1 2.1 1.8 36.6 4.8 0.4 0.1 0.7 13.9 5.9 6.8 7.1 0.0 0.0 1.1 0.0 5.0 4.6 3.4 2.5 7.4 0.2 0.0 0.5 6.8 0.0 0.5 4.5 0.6 0.4 0.0 2.9 0.4 0.0 1.3 5.8 4.9 0.0 3.0 0.1 0.0 0.2 20.9 1.8 0.0 0.9 1.1 2.3 5.4 16.0 8.8 19.4 7.3 0.2 0.1 0.0 1.3 5.5 2.5 0.0 2.4 0.1 4.6 5.0 0.0 0.0 0.1 1.4 9.6 0.0 3.6 0.7 4.5 0.0 0.0 2.8 0.1 0.1 6.5 0.2 3.3 0.6 0.1 0.0 0.0 56.8 11.9 0.3 1.1 0.0 0.2 4.6 0.0 1.1 0.0 1.5 2.3 0.0 0.0 0.6 2.3 0.5 5.0 0.0 0.0 0.0 3.4 13.8 11.3 0.8 30.0 12.0 7.9 4.6 18.4 8.6 0.4 44.7 32.8 0.0 6.7 22.8 1.7 0.4 15.3 6.7 21.6 5.2 2.0 5.4 1.7 5.2 200.3 0.7 3.1 0.0 35.6 4.0 2.5 73.1 234.0 0.8 0.6 6.4 4.1 3.1 0.8 149.0 2.0 2.4 6.8 1.8 17.2 1.3 24.0 17.5 0.4 0.0 0.4 6.5 1.3 2.2 1.2 43.0 2.4 20.1 8.1 27.8 RAB3GAP2 "DKFZP434D245, KIAA0839, RAB3-GAP150, SPG69" ENSG00000118873 "RAB3 GTPase activating non-catalytic protein subunit 2" Q9H2M9 1 220148293-220272454 "Disease related genes, Predicted intracellular proteins" "GTPase activation" "Cataract, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026273, HPA027299" Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA026273: AB_1856007, HPA027299: AB_1856008" "prognostic unfavorable (3.05e-4)" "unprognostic (2.80e-3)" "unprognostic (1.76e-2)" "unprognostic (6.07e-2)" "unprognostic (5.20e-2)" "unprognostic (1.69e-1)" "unprognostic (2.40e-2)" "unprognostic (7.00e-2)" "unprognostic (4.61e-2)" "unprognostic (1.75e-1)" "unprognostic (4.63e-2)" "unprognostic (2.13e-1)" "unprognostic (7.75e-2)" "unprognostic (1.27e-1)" "unprognostic (1.17e-1)" "unprognostic (3.99e-2)" "unprognostic (1.56e-1)" 16.7 16.2 14.9 19.6 18.7 14.3 17.8 24.2 22.4 15.6 13.5 14.3 13.9 12.2 16.8 14.9 15.6 12.8 12.8 15.3 16.5 18.8 18.9 15.6 14.3 18.2 17.1 15.6 16.2 14.5 35.6 28.3 19.8 21.9 14.2 13.5 11.6 15.6 15.8 19.9 13.1 15.0 14.9 15.2 14.9 14.5 10.1 15.5 26.1 20.5 11.9 21.7 16.0 15.8 7.1 5.2 12.3 5.1 3.6 8.9 4.6 13.9 10.6 12.9 9.7 14.8 17.7 14.6 14.4 13.7 13.0 15.4 9.7 11.6 17.3 10.2 13.8 9.8 13.3 13.3 11.0 15.1 14.5 8.7 13.5 14.1 9.1 19.6 19.3 13.9 14.0 12.6 12.6 19.7 14.6 11.8 7.6 23.3 11.3 14.6 3.9 14.8 6.8 27.7 7.5 6.3 8.1 17.8 15.4 11.1 11.5 12.9 15.6 14.9 14.5 23.3 14.5 15.2 18.4 17.1 14.3 6.7 9.8 15.3 10.0 12.1 15.3 12.2 16.3 16.7 12.3 3.9 7.5 7.1 4.9 8.6 7.1 7.0 8.9 5.2 5.5 6.3 7.4 2.5 3.6 5.1 3.3 8.0 4.6 14.9 18.7 24.2 22.4 16.5 18.8 17.1 15.6 21.9 15.5 38.7 21.6 17.1 12.0 10.3 54.4 31.3 22.9 12.0 23.9 24.4 64.8 15.7 5.0 16.3 2.6 17.6 16.9 0.0 14.3 11.2 17.7 17.2 18.5 20.3 21.2 39.7 34.0 25.8 29.8 1.6 16.7 20.6 13.5 16.2 20.3 46.1 17.6 14.0 24.4 14.5 51.3 6.5 14.4 15.6 11.8 8.5 19.3 19.3 18.8 11.3 RAB43 "ISY1, RAB11B, RAB41" ENSG00000172780 "RAB43, member RAS oncogene family" Q86YS6 3 129087569-129122801 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "liver: 73.9" "Cell type enhanced" "Detected in single" 13 "Club cells: 1.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 13.3" "Group enriched" "Detected in all" 5 "granulocytes: 13.3;T-cells: 3.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046840, HPA060085" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA046840: , HPA060085: AB_2684199" "unprognostic (3.01e-1)" "unprognostic (1.14e-2)" "unprognostic (3.08e-1)" "unprognostic (1.01e-1)" "unprognostic (5.08e-2)" "unprognostic (1.91e-1)" "unprognostic (9.36e-2)" "unprognostic (3.17e-2)" "unprognostic (4.16e-1)" "unprognostic (8.68e-2)" "unprognostic (3.14e-1)" "unprognostic (3.08e-1)" "unprognostic (2.46e-2)" "unprognostic (9.32e-2)" "unprognostic (5.82e-3)" "unprognostic (1.42e-1)" "unprognostic (2.71e-2)" 5.4 6.2 3.9 8.0 3.3 14.6 5.3 6.0 3.6 6.4 7.0 3.2 7.2 5.8 5.4 6.8 4.1 5.3 12.0 3.8 2.8 2.0 9.1 73.9 11.4 12.1 2.7 1.6 7.8 7.4 2.5 8.0 4.7 3.7 7.3 1.7 7.7 7.4 4.7 1.9 3.0 5.9 4.9 2.7 9.9 5.7 5.2 2.1 17.3 17.1 2.6 13.6 6.6 6.0 1.3 1.1 13.3 1.6 1.5 3.5 1.3 15.6 4.3 1.0 4.1 2.0 0.9 6.2 5.4 3.6 3.1 2.6 6.7 6.7 0.4 12.6 4.0 4.2 6.6 0.4 6.2 0.7 7.9 4.2 1.0 0.7 8.7 19.4 3.6 9.3 5.3 3.8 1.6 0.4 1.3 6.2 9.4 1.7 7.9 4.3 6.6 3.5 6.9 5.0 3.6 7.0 7.5 2.3 4.5 10.1 13.3 0.3 1.9 2.4 5.0 10.0 1.7 2.1 3.8 8.9 6.9 4.9 5.6 2.0 12.4 6.5 2.4 6.2 0.7 7.4 0.5 1.5 2.6 1.9 1.6 0.9 0.6 1.8 1.5 0.7 1.3 3.5 3.0 13.3 1.5 0.7 1.1 2.7 1.3 3.9 3.3 6.0 3.6 2.8 2.0 2.7 1.6 3.7 2.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 RAD52 ENSG00000002016 "RAD52 homolog, DNA repair protein" P43351 12 912077-990053 "Cancer-related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA028957 Approved "Nuclear speckles,Plasma membrane" NA NA "Nuclear speckles" "Plasma membrane" "HPA028957: AB_2672842" "unprognostic (4.53e-1)" "unprognostic (8.08e-3)" "unprognostic (4.68e-2)" "unprognostic (5.27e-2)" "unprognostic (7.37e-2)" "unprognostic (1.42e-2)" "unprognostic (1.82e-3)" "unprognostic (1.88e-1)" "unprognostic (2.80e-2)" "unprognostic (8.43e-2)" "unprognostic (1.03e-2)" "unprognostic (3.27e-1)" "prognostic unfavorable (2.22e-6)" "unprognostic (1.54e-1)" "unprognostic (1.61e-1)" "unprognostic (1.68e-1)" "unprognostic (3.74e-2)" 7.4 8.5 12.4 8.1 15.1 5.0 10.0 18.8 15.9 12.6 11.7 14.5 13.6 9.4 12.5 14.2 8.2 11.0 9.0 7.8 14.3 7.3 9.9 10.5 6.9 8.9 15.0 9.6 17.6 11.4 9.6 15.6 8.5 15.0 10.5 11.7 9.5 8.4 11.0 16.5 14.9 10.4 12.8 17.0 10.3 8.8 6.8 20.9 9.4 14.6 4.3 9.7 9.7 13.3 7.0 9.6 7.4 3.8 4.0 6.0 1.4 3.1 12.2 9.5 10.7 10.4 7.8 10.2 6.3 5.9 7.0 7.0 11.7 11.2 10.0 2.0 6.3 6.1 9.4 7.2 4.2 6.2 13.4 6.4 11.1 11.7 8.1 5.9 11.9 3.4 4.5 7.5 7.4 22.7 14.0 5.9 9.8 7.4 5.7 6.7 6.6 8.1 11.9 12.4 7.9 7.9 8.3 9.3 3.7 7.3 5.7 3.4 3.9 8.1 8.8 4.5 14.6 8.2 5.8 5.8 9.8 11.9 7.7 6.6 2.2 3.4 10.4 5.1 5.0 3.6 7.4 3.4 2.0 4.6 2.9 6.0 4.8 4.9 4.0 4.4 7.0 5.7 5.2 2.8 4.0 3.8 9.6 4.4 1.4 12.4 15.1 18.8 15.9 14.3 7.3 15.0 9.6 15.0 20.9 3.0 5.1 0.0 1.1 1.5 3.7 3.1 0.0 1.4 4.5 3.5 2.0 3.6 1.7 1.9 3.2 3.0 4.0 0.0 1.4 2.2 2.2 1.3 5.7 2.1 2.3 3.2 1.7 0.6 1.0 4.5 0.6 2.2 0.0 2.8 2.3 1.9 0.6 2.9 0.7 1.4 2.3 6.5 3.1 4.6 4.1 0.9 1.7 1.3 2.9 0.9 RAI2 ENSG00000131831 "Retinoic acid induced 2" Q9Y5P3 X 17800049-17861337 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Leydig cells: 45.5;Peritubular cells: 66.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "naive CD4 T-cell: 1.5;naive CD8 T-cell: 5.1" "Lineage enriched" "Detected in single" 11 "T-cells: 5.1" "Cell line enriched" "Detected in some" 10 "ASC diff: 49.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051054 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA051054: AB_2681328" "unprognostic (3.45e-2)" "unprognostic (9.61e-2)" "unprognostic (2.41e-1)" "unprognostic (2.03e-2)" "unprognostic (1.98e-1)" "unprognostic (2.49e-2)" "unprognostic (4.10e-2)" "unprognostic (2.51e-2)" "unprognostic (1.44e-1)" "unprognostic (1.49e-1)" "prognostic favorable (2.77e-4)" "unprognostic (1.31e-2)" "prognostic favorable (3.39e-14)" "unprognostic (1.57e-2)" "unprognostic (2.33e-1)" "unprognostic (1.82e-2)" "unprognostic (2.80e-2)" 23.6 9.7 2.5 10.1 4.0 0.0 28.5 4.0 4.9 41.0 13.7 1.7 15.0 3.5 29.6 17.8 12.2 27.9 21.2 16.1 2.4 2.7 9.4 1.9 14.5 12.9 2.4 1.8 32.7 7.7 4.6 11.1 7.1 2.9 28.3 4.5 10.7 6.6 18.7 7.2 8.3 8.8 20.4 2.7 2.4 12.0 16.2 2.1 2.0 15.1 6.3 5.9 24.2 53.6 0.0 0.0 0.0 0.0 0.4 5.1 0.4 0.0 0.0 0.1 0.0 49.6 4.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 2.7 0.0 0.5 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.5 5.1 0.0 0.4 0.0 0.0 0.0 0.4 2.5 4.0 4.0 4.9 2.4 2.7 2.4 1.8 2.9 2.1 11.9 5.0 0.0 8.6 3.7 13.8 11.2 7.6 8.1 1.2 21.0 0.0 0.0 5.0 6.8 0.2 14.6 0.3 0.0 8.8 0.1 13.2 11.3 0.0 0.0 0.4 25.4 26.5 9.8 0.0 1.1 45.5 0.0 5.0 1.0 0.0 13.7 4.1 0.0 66.4 1.6 2.8 0.0 6.2 0.5 1.1 2.5 0.0 0.0 0.0 4.8 RALGAPA2 "AS250, C20orf74, dJ1049G11.4, KIAA1272, RapGAPalpha2" ENSG00000188559 "Ral GTPase activating protein catalytic alpha subunit 2" Q2PPJ7 20 20389552-20712488 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 47.7;SCLC-21H: 26.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042707, HPA043622" Uncertain Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA042707: AB_2678124, HPA043622: AB_2678585" "unprognostic (7.40e-2)" "unprognostic (1.71e-1)" "unprognostic (1.69e-2)" "unprognostic (1.09e-2)" "unprognostic (2.36e-1)" "unprognostic (3.34e-2)" "unprognostic (3.36e-1)" "unprognostic (3.29e-2)" "unprognostic (1.95e-1)" "unprognostic (3.56e-2)" "unprognostic (1.74e-1)" "unprognostic (8.23e-2)" "prognostic favorable (3.77e-5)" "unprognostic (6.52e-2)" "unprognostic (1.54e-1)" "unprognostic (3.48e-1)" "unprognostic (5.33e-2)" 26.5 7.0 7.3 9.9 8.1 19.4 16.9 11.4 8.7 10.6 12.7 9.6 14.9 10.5 15.2 9.6 8.9 10.7 13.0 7.8 8.3 4.2 11.0 26.4 26.5 13.0 10.8 4.4 8.0 18.5 14.1 20.9 18.5 7.4 13.2 13.5 8.2 22.6 12.8 26.0 15.3 10.0 9.6 8.4 8.2 18.1 8.6 9.3 8.2 23.2 6.0 10.2 13.9 15.7 1.7 2.0 7.0 2.1 2.6 2.4 0.6 3.5 2.3 4.7 2.5 2.4 1.9 5.3 0.9 0.9 1.2 1.5 1.9 4.9 1.6 3.1 1.4 5.1 3.7 4.9 4.0 2.2 7.1 2.4 5.4 1.2 3.3 0.9 6.9 3.2 1.7 3.1 1.9 0.9 2.0 6.7 7.5 1.1 3.0 1.8 2.3 2.6 9.2 2.0 11.3 2.1 3.8 3.2 2.2 4.1 47.7 26.7 2.3 3.6 2.6 3.0 4.7 1.8 6.6 1.7 1.9 1.8 1.4 1.3 1.7 1.2 0.7 1.6 4.5 2.6 5.9 2.1 6.0 1.7 0.7 2.4 1.4 1.1 1.6 1.0 1.7 2.1 1.5 7.0 2.6 1.6 2.0 1.4 0.6 7.3 8.1 11.4 8.7 8.3 4.2 10.8 4.4 7.4 9.3 6.0 34.4 5.2 8.3 9.4 35.1 8.9 48.4 26.8 14.8 14.0 25.5 7.9 1.7 18.0 18.9 55.4 19.6 0.0 21.5 4.6 5.2 14.5 8.1 37.6 10.2 49.3 23.6 58.3 18.1 6.4 1.7 8.1 8.5 4.6 24.1 10.1 20.9 21.0 6.3 9.2 13.0 12.9 6.2 8.6 10.7 14.4 9.4 9.6 26.2 25.0 RAPSN "CMS1D, CMS1E, RNF205" ENSG00000165917 "Receptor associated protein of the synapse" Q13702 11 47437757-47449178 "Disease related genes, Predicted intracellular proteins" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "skeletal muscle: 45.3;tongue: 14.8" "Cell type enriched" "Detected in some" 4 "Late spermatids: 10.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.6" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "RH-30: 72.9" "Low region specificity" "Detected in single" HPA039475 Approved Approved "Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane, Centrosome, Cytosol" "HPA039475: AB_10794196" "unprognostic (5.37e-2)" "unprognostic (1.02e-1)" "unprognostic (7.34e-2)" "unprognostic (4.58e-2)" "unprognostic (2.95e-2)" "unprognostic (1.44e-1)" "unprognostic (2.62e-2)" "unprognostic (1.77e-3)" "unprognostic (1.35e-1)" "unprognostic (5.38e-2)" "unprognostic (4.81e-2)" "unprognostic (2.89e-2)" "unprognostic (1.08e-2)" "unprognostic (1.64e-4)" "unprognostic (3.83e-1)" "unprognostic (4.73e-3)" "unprognostic (4.48e-2)" 1.7 0.8 0.2 0.1 0.2 0.2 0.1 0.0 0.2 0.0 0.4 0.0 0.0 0.1 0.0 2.7 0.7 0.1 0.1 1.4 0.4 0.0 0.1 0.2 0.2 0.1 0.7 0.0 0.0 0.1 0.0 0.0 1.2 0.3 0.4 0.0 0.3 0.8 0.0 45.3 0.2 0.2 0.1 0.2 0.3 0.1 0.2 0.1 0.1 0.4 14.8 0.4 0.0 0.0 0.2 0.1 2.6 0.5 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 72.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.2 0.6 0.0 0.2 0.0 0.1 0.1 0.0 0.2 0.7 0.0 2.6 0.0 0.1 0.1 0.0 0.0 0.2 0.2 0.0 0.2 0.4 0.0 0.7 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.4 2.4 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.3 10.0 0.0 0.0 0.0 1.0 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.1 RASAL1 RASAL ENSG00000111344 "RAS protein activator like 1" O95294 12 113098819-113136239 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" Differentiation "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 64.0" "Cell type enriched" "Detected in many" 9 "Collecting duct cells: 34.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 8.5;EFO-21: 11.1;REH: 12.3;RPMI-8226: 27.4;RPTEC TERT1: 10.9;U-698: 23.3" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "amygdala: 21.7;cerebral cortex: 20.9;hippocampal formation: 33.7" HPA041650 Enhanced Approved "Plasma membrane,Cell Junctions,Cytosol" NA NA "Plasma membrane, Cytosol" "Cell Junctions" "HPA041650: AB_2677598" "unprognostic (9.95e-2)" "unprognostic (1.11e-2)" "unprognostic (5.44e-3)" "prognostic unfavorable (3.26e-5)" "unprognostic (1.27e-2)" "unprognostic (7.73e-3)" "unprognostic (1.57e-2)" "unprognostic (1.43e-2)" "unprognostic (2.65e-1)" "unprognostic (3.02e-3)" "unprognostic (3.16e-2)" "unprognostic (2.53e-1)" "unprognostic (1.74e-2)" "unprognostic (2.85e-3)" "unprognostic (1.15e-1)" "unprognostic (3.34e-2)" "unprognostic (2.64e-1)" 0.9 10.4 8.6 2.5 11.2 1.2 1.6 0.4 18.2 2.5 2.1 18.8 3.7 1.2 0.9 0.9 16.9 2.2 1.8 0.8 11.8 4.9 7.4 0.9 0.9 1.7 7.3 10.9 0.8 1.4 64.0 3.9 1.0 4.0 0.9 1.7 0.0 22.4 7.4 0.8 8.0 1.1 0.9 1.8 1.0 9.6 1.1 8.4 0.0 8.0 6.0 5.0 1.0 3.7 0.4 0.2 1.3 0.2 0.3 1.6 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 2.2 8.5 11.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 2.3 0.0 0.0 0.3 3.0 0.0 12.3 0.0 27.4 10.9 0.0 0.3 0.0 0.0 4.1 0.0 0.0 1.7 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 23.3 0.0 0.0 0.0 1.3 0.2 0.1 0.1 0.0 1.6 0.2 0.9 0.4 0.0 0.4 1.2 0.5 0.4 0.3 0.0 0.2 0.4 0.3 8.6 11.2 0.4 18.2 11.8 4.9 7.3 10.9 4.0 8.4 0.0 0.0 0.5 0.0 0.5 0.5 3.5 2.5 0.0 0.0 34.9 0.0 1.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 2.3 0.0 0.3 0.0 1.2 0.0 0.0 0.0 0.0 2.1 1.7 1.8 4.1 2.3 3.0 3.5 0.0 3.9 0.0 0.0 0.1 0.0 0.3 1.0 1.0 0.0 2.3 0.4 RASAL2 nGAP ENSG00000075391 "RAS protein activator like 2" Q9UJF2 1 178094141-178484147 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 143.3;Rod photoreceptor cells: 179.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-HME1: 30.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018805, HPA020453" Enhanced Approved "Plasma membrane,Focal adhesion sites" NA NA "Plasma membrane, Focal adhesion sites" "HPA018805: AB_1856085, HPA020453: AB_1856086" "unprognostic (5.55e-3)" "unprognostic (6.49e-2)" "unprognostic (2.65e-1)" "unprognostic (6.33e-2)" "unprognostic (3.40e-2)" "unprognostic (5.59e-2)" "unprognostic (5.91e-2)" "unprognostic (1.72e-2)" "unprognostic (2.91e-1)" "unprognostic (2.92e-2)" "unprognostic (3.16e-3)" "unprognostic (2.03e-1)" "unprognostic (1.06e-2)" "unprognostic (4.98e-2)" "unprognostic (2.45e-1)" "unprognostic (8.36e-2)" "prognostic unfavorable (2.05e-4)" 13.5 3.8 4.2 2.8 5.1 0.4 7.1 2.7 8.5 9.5 4.2 3.7 4.2 2.4 10.9 5.5 24.4 5.8 9.0 15.5 3.8 5.9 7.1 2.7 9.2 1.5 4.0 6.5 6.3 5.0 6.1 6.7 21.2 5.6 5.0 4.3 10.7 9.6 4.5 8.3 7.5 3.3 7.1 3.8 2.9 3.7 9.0 2.7 0.0 5.0 13.1 4.8 5.6 13.2 2.1 0.5 1.4 0.6 0.3 0.1 0.0 16.3 5.4 7.1 2.3 4.8 6.5 9.9 8.2 8.0 7.0 5.3 8.6 8.7 0.0 13.7 8.0 11.5 13.8 5.7 13.1 6.5 0.0 3.1 0.0 5.7 3.4 5.7 2.3 0.3 20.4 2.6 8.3 30.0 7.3 6.3 0.0 0.5 0.0 9.7 1.7 0.0 1.9 5.3 3.1 1.0 0.1 2.9 0.0 3.8 2.2 5.5 2.7 6.4 5.0 5.0 6.3 5.8 2.6 11.9 9.3 9.5 9.7 10.9 3.6 0.0 0.0 7.3 1.2 6.6 1.4 0.4 0.1 0.1 0.3 0.0 0.6 0.0 0.0 0.2 2.1 0.1 0.1 0.8 0.3 0.6 0.5 0.0 0.0 4.2 5.1 2.7 7.1 3.8 5.9 4.0 6.5 5.6 2.7 71.5 11.7 1.4 7.8 14.2 47.0 33.2 17.8 37.5 14.8 15.7 143.3 11.6 5.0 19.0 12.3 41.2 5.2 0.0 10.9 12.1 14.7 18.7 7.0 5.4 15.0 79.4 32.7 43.0 2.5 5.1 18.1 13.1 3.3 12.6 14.6 22.8 23.0 2.9 21.5 5.7 179.6 64.7 27.8 28.6 32.2 21.1 35.0 0.7 12.8 29.3 RASD1 "AGS1, DEXRAS1" ENSG00000108551 "Ras related dexamethasone induced 1" Q9Y272 17 17494437-17496395 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Mucus-secreting cells: 239.8;Muller glia cells: 245.0;Peritubular cells: 441.6;Sertoli cells: 556.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 47 "plasmacytoid DC: 48.0" "Lineage enriched" "Detected in many" 47 "dendritic cells: 48.0" "Cell line enhanced" "Detected in some" "ASC diff: 34.4;HSkMC: 8.4;REH: 32.9" "Group enriched" "Detected in many" 5 "basal ganglia: 77.3;hippocampal formation: 60.2;thalamus: 58.1" "Low region specificity" "Detected in all" HPA047896 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA047896: AB_10960535" "unprognostic (1.59e-1)" "unprognostic (1.32e-1)" "unprognostic (3.28e-2)" "unprognostic (3.31e-2)" "unprognostic (6.40e-2)" "unprognostic (8.13e-2)" "unprognostic (8.65e-2)" "unprognostic (7.60e-2)" "unprognostic (5.50e-2)" "unprognostic (2.11e-1)" "unprognostic (3.17e-3)" "unprognostic (2.92e-1)" "unprognostic (7.40e-2)" "unprognostic (1.11e-2)" "unprognostic (1.38e-1)" "unprognostic (1.30e-1)" "unprognostic (1.38e-2)" 79.6 24.3 14.0 6.2 23.2 8.3 30.4 11.6 32.0 49.1 7.1 8.5 18.6 5.9 19.9 17.1 10.9 11.6 11.8 20.1 14.7 15.5 30.2 85.9 5.6 3.7 10.0 22.5 33.5 17.5 7.2 81.3 2.6 22.2 17.8 6.9 6.6 49.4 51.8 37.2 9.1 6.1 4.3 19.6 12.2 6.1 13.8 8.9 9.1 37.7 9.2 2.5 6.2 5.5 0.0 48.0 0.0 1.0 0.0 0.1 0.3 0.0 0.1 0.1 0.0 34.4 1.9 0.1 0.4 0.6 0.0 0.1 1.4 0.0 0.0 3.9 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.1 0.1 3.8 0.2 0.0 0.1 8.4 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.1 3.4 6.2 0.6 0.7 0.6 2.1 32.9 0.0 0.0 0.7 0.0 6.2 0.2 0.5 0.4 7.2 1.0 0.0 0.0 1.9 0.0 0.3 0.2 0.1 7.0 0.2 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 48.0 0.0 0.3 14.0 23.2 11.6 32.0 14.7 15.5 10.0 22.5 22.2 8.9 26.8 30.8 3.7 47.7 15.2 21.5 61.3 12.7 8.1 40.9 141.3 3.9 2.5 11.6 55.0 2.1 17.5 18.7 0.0 1.1 2.2 69.9 113.7 8.1 13.2 3.4 6.4 213.7 10.4 3.7 4.2 101.5 8.8 28.7 3.6 239.8 245.0 13.9 15.8 441.6 3.8 20.0 556.2 153.3 1.6 1.6 11.5 5.6 6.9 22.1 20.7 RASD2 "MGC:4834, Rhes, TEM2" ENSG00000100302 "RASD family member 2" Q96D21 22 35540868-35554001 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 71.0;seminal vesicle: 25.2" "Cell type enriched" "Detected in some" 4 "Sertoli cells: 45.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "basal ganglia: 71.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 4.3;hTERT-RPE1: 13.4;SK-BR-3: 7.6;U-2 OS: 4.4;U-87 MG: 5.5" "Region enriched" "Detected in many" 8 "basal ganglia: 527.8" "Region enriched" "Detected in all" 8 "basal ganglia: 265.8" HPA005839 Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA005839: AB_1079745" "unprognostic (1.76e-2)" "unprognostic (1.98e-1)" "unprognostic (3.33e-2)" "unprognostic (7.00e-2)" "unprognostic (1.43e-1)" "unprognostic (7.07e-3)" "unprognostic (9.76e-2)" "unprognostic (5.49e-2)" "unprognostic (2.06e-1)" "unprognostic (1.12e-1)" "unprognostic (1.04e-1)" "unprognostic (9.00e-3)" "prognostic unfavorable (2.22e-5)" "unprognostic (3.75e-2)" "unprognostic (1.61e-1)" "unprognostic (8.42e-3)" "unprognostic (6.22e-2)" 1.6 7.9 8.6 2.5 71.0 3.4 1.3 1.8 23.5 1.1 8.3 2.2 3.2 2.5 3.5 16.4 5.2 6.2 2.5 2.8 4.1 5.0 0.8 0.5 1.5 0.6 3.4 8.0 0.8 1.0 0.9 1.0 0.4 2.1 9.6 4.4 3.5 4.0 25.2 13.6 0.8 3.4 7.5 2.2 0.4 1.8 0.6 15.3 0.0 1.4 0.1 1.4 3.8 1.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 2.8 0.0 0.5 0.0 0.0 0.1 0.7 0.2 1.1 0.9 0.1 0.5 0.0 0.2 2.4 4.3 0.1 0.2 0.0 1.0 0.0 0.7 0.0 0.1 0.0 1.4 0.0 0.0 0.2 3.3 2.2 0.3 13.4 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.2 0.2 0.3 1.3 0.0 0.9 0.0 0.0 2.0 0.3 2.2 7.6 0.0 0.2 0.6 0.2 0.1 1.8 4.4 0.2 0.8 1.9 0.6 0.0 5.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 8.6 71.0 1.8 23.5 4.1 5.0 3.4 8.0 2.1 15.3 0.0 0.0 0.0 0.2 0.0 0.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.4 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.2 0.7 0.0 0.1 45.3 4.1 0.0 0.1 0.1 0.0 0.0 0.2 0.1 RASSF2 "CENP-34, KIAA0168" ENSG00000101265 "Ras association domain family member 2" P50749 20 4780023-4823645 "Predicted intracellular proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 106.1" "Cell type enhanced" "Detected in many" 9 "Kupffer cells: 93.0;monocytes: 117.2;Peritubular cells: 140.7;Rod photoreceptor cells: 154.5" "Cancer enhanced" "Detected in all" "glioma: 48.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 19.6;BEWO: 20.6;Daudi: 21.0;HL-60: 24.6;NB-4: 31.8;U-937: 39.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051200 Uncertain Supported "Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Plasma membrane, Cytosol" "HPA051200: AB_2681386" "unprognostic (6.51e-2)" "unprognostic (3.67e-3)" "unprognostic (5.31e-2)" "unprognostic (1.47e-2)" "unprognostic (3.15e-1)" "unprognostic (1.46e-3)" "unprognostic (2.80e-1)" "unprognostic (7.01e-2)" "unprognostic (1.38e-2)" "unprognostic (2.41e-2)" "unprognostic (4.93e-2)" "unprognostic (3.90e-1)" "prognostic unfavorable (7.82e-4)" "unprognostic (3.51e-2)" "unprognostic (1.35e-1)" "unprognostic (3.49e-1)" "unprognostic (6.46e-2)" 8.3 5.1 26.5 21.5 26.9 38.6 3.6 10.2 45.8 14.9 4.1 59.5 0.1 2.7 13.0 11.6 5.2 9.8 7.8 2.4 33.2 22.4 2.0 3.0 10.1 26.2 54.7 8.7 3.5 1.7 0.7 2.6 4.5 39.7 3.9 5.0 19.8 2.0 4.8 1.2 2.2 5.7 18.6 106.1 14.9 3.3 9.9 27.3 4.7 2.5 0.6 34.2 10.7 2.7 7.9 14.1 42.1 17.9 2.4 4.7 10.6 0.0 4.9 12.1 19.6 0.1 0.0 20.6 1.2 3.4 0.2 0.0 1.1 0.0 21.0 1.9 1.0 0.4 0.0 1.7 0.0 0.3 7.5 0.7 13.7 0.0 0.2 0.0 24.6 14.0 0.0 0.0 0.4 0.0 0.4 8.0 2.4 0.0 8.3 0.0 0.0 3.6 31.8 2.7 0.0 0.4 5.6 1.3 8.0 0.0 9.7 0.1 0.9 0.0 0.3 0.6 2.7 0.0 15.7 0.2 0.5 2.6 0.2 1.5 0.1 1.9 12.9 0.1 39.2 0.1 21.1 17.9 29.5 2.4 15.4 4.7 7.9 3.9 3.3 14.1 5.3 2.6 2.1 42.1 2.4 16.8 9.4 3.4 10.6 26.5 26.9 10.2 19.3 33.2 22.4 54.7 8.7 39.7 27.3 0.0 14.9 27.7 0.0 4.1 37.9 1.6 2.5 0.0 3.4 0.0 25.5 2.4 1.7 1.0 5.0 12.7 0.0 0.0 0.8 4.8 8.2 0.8 51.0 0.8 24.8 6.4 0.0 16.0 93.0 15.3 30.8 38.0 8.5 117.2 0.0 12.7 0.4 0.0 140.7 0.2 154.5 0.0 3.3 0.7 0.6 2.3 1.1 10.2 0.0 0.9 RASSF3 ENSG00000153179 "Ras association domain family member 3" Q86WH2 12 64507001-64697567 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 6 "neutrophil: 44.4" "Lineage enriched" "Detected in all" 6 "granulocytes: 44.4" "Cell line enhanced" "Detected in all" "SK-MEL-30: 51.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022664, CAB034035, HPA038469" Supported Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB022664: , CAB034035: AB_2176848, HPA038469: AB_10671743" "unprognostic (1.63e-1)" "unprognostic (1.33e-1)" "unprognostic (1.35e-1)" "unprognostic (1.47e-1)" "unprognostic (1.55e-1)" "unprognostic (2.37e-2)" "unprognostic (2.55e-3)" "unprognostic (3.73e-1)" "unprognostic (2.37e-1)" "unprognostic (6.21e-2)" "unprognostic (3.66e-2)" "unprognostic (1.49e-1)" "unprognostic (1.45e-3)" "unprognostic (7.16e-2)" "unprognostic (2.01e-1)" "unprognostic (6.98e-2)" "unprognostic (1.59e-2)" 22.4 13.8 4.2 24.0 4.5 5.9 48.4 2.5 4.5 15.3 64.1 6.5 21.6 8.3 18.5 12.5 27.0 9.4 30.1 37.4 4.6 4.4 5.8 6.4 19.4 22.2 7.4 2.9 13.6 10.0 1.0 4.3 16.0 7.6 26.5 17.8 14.1 18.9 21.2 16.0 5.0 18.0 80.1 10.8 25.7 25.6 6.9 5.5 7.6 5.3 6.3 14.5 57.4 30.9 5.5 3.2 44.4 6.6 4.1 7.9 0.9 9.8 11.1 3.5 6.8 3.8 5.6 21.6 4.3 22.4 5.8 6.9 7.9 10.5 15.5 9.2 3.1 7.0 4.3 10.7 4.5 7.1 12.7 4.1 10.1 4.9 9.0 10.5 10.7 7.1 3.7 3.9 13.3 9.9 17.1 24.7 7.5 5.4 7.7 6.8 9.3 7.0 7.0 7.8 23.4 6.7 11.3 11.4 6.5 7.6 12.0 8.0 8.4 7.2 1.4 51.3 8.9 6.3 6.8 35.6 4.8 5.8 4.9 4.6 7.2 7.6 10.1 5.7 9.4 13.7 5.9 6.6 4.2 5.1 6.3 4.2 5.5 7.6 5.6 3.2 3.7 7.7 7.9 44.4 4.1 5.9 3.0 7.7 0.9 4.2 4.5 2.5 4.5 4.6 4.4 7.4 2.9 7.6 5.5 3.0 19.1 15.9 14.0 14.4 0.0 43.1 30.6 2.7 9.1 5.2 0.0 27.0 0.0 11.5 0.3 26.6 22.5 46.7 18.3 14.0 12.2 23.2 5.8 3.9 22.4 0.0 25.3 16.5 63.0 0.4 2.3 34.1 45.5 33.3 14.0 2.5 20.7 15.3 13.4 1.1 0.0 12.9 28.9 0.6 24.9 10.5 16.5 26.7 15.2 21.6 RBM46 "CT68, MGC27016" ENSG00000151962 "RNA binding motif protein 46" Q8TBY0 4 154781213-154828813 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 73 "testis: 34.5" "Group enriched" "Detected in some" 13 "Spermatocytes: 74.4;Spermatogonia: 75.5" "Cancer enriched" "Detected in single" 15 "testis cancer: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "NTERA-2: 2.7;SuSa: 5.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA079488 Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA079488: " "unprognostic (4.79e-1)" "unprognostic (1.14e-2)" "unprognostic (3.23e-1)" "unprognostic (1.59e-2)" "unprognostic (3.33e-3)" "unprognostic (1.13e-1)" "unprognostic (8.11e-2)" "unprognostic (2.24e-2)" "unprognostic (2.99e-7)" "unprognostic (4.86e-2)" "unprognostic (7.31e-2)" "unprognostic (4.27e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 34.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.1 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.6 0.0 5.7 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 74.4 75.5 0.0 0.0 0.0 0.0 0.0 RCSD1 "CapZIP, MGC21854, MK2S4" ENSG00000198771 "RCSD domain containing 1" Q6JBY9 1 167630093-167706249 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 56.4;lymphoid tissue: 70.8;skeletal muscle: 52.3" "Cell type enhanced" "Detected in many" 9 "B-cells: 128.0;Kupffer cells: 116.2;monocytes: 64.1;Sertoli cells: 77.6;T-cells: 84.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 48.3;REH: 48.5;RPMI-8226: 33.1;THP-1: 25.5;U-266/70: 32.4;U-698: 31.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016597, HPA073490" Enhanced Approved "Plasma membrane" NA NA 150000 "Plasma membrane" "HPA016597: AB_2669397, HPA073490: " "unprognostic (2.13e-2)" "unprognostic (7.38e-3)" "unprognostic (6.50e-3)" "unprognostic (1.37e-3)" "unprognostic (1.08e-1)" "prognostic favorable (2.97e-4)" "unprognostic (5.51e-2)" "unprognostic (8.90e-3)" "unprognostic (3.65e-1)" "unprognostic (8.48e-2)" "unprognostic (1.01e-1)" "unprognostic (6.33e-2)" "unprognostic (2.53e-3)" "unprognostic (3.19e-1)" "unprognostic (3.58e-2)" "unprognostic (6.94e-2)" "unprognostic (3.97e-2)" 8.5 2.9 3.5 33.3 4.8 19.2 7.3 1.2 3.1 3.0 8.4 3.6 1.3 3.6 2.7 5.4 4.1 3.1 8.8 18.4 3.9 3.6 4.2 3.7 9.0 45.6 5.1 2.2 2.5 1.5 0.8 2.0 7.0 3.1 3.7 5.0 3.1 6.5 2.5 52.3 2.3 20.1 7.4 6.9 40.6 4.9 3.7 3.4 70.8 4.8 12.7 29.2 7.4 4.5 51.0 22.1 56.4 38.2 26.6 27.8 26.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 20.3 0.0 0.3 0.0 0.0 0.0 8.3 0.9 0.1 0.0 0.1 0.0 0.0 0.0 19.7 15.5 14.2 6.5 0.0 15.3 11.9 0.4 0.0 0.0 48.5 0.2 33.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 25.5 0.1 0.0 0.1 0.0 0.0 32.4 9.6 31.8 0.0 15.8 0.0 48.4 38.2 56.4 15.2 25.1 18.3 45.6 19.8 18.9 22.1 51.0 17.2 15.9 38.5 26.6 24.1 12.8 27.8 26.3 3.5 4.8 1.2 3.1 3.9 3.6 5.1 2.2 3.1 3.4 3.0 10.7 128.0 1.2 1.0 0.6 40.7 0.0 0.0 5.7 1.8 0.0 0.4 0.0 0.1 0.4 17.9 0.0 0.0 0.0 0.2 3.1 0.7 12.8 1.7 37.5 0.0 0.0 27.0 116.2 1.5 0.9 47.2 5.0 64.1 0.0 0.0 0.1 0.0 0.4 0.3 0.7 77.6 21.5 0.0 0.1 1.5 1.0 84.1 0.0 0.3 REPS1 ENSG00000135597 "RALBP1 associated Eps domain containing 1" Q96D71 6 138903493-138988261 "Predicted intracellular proteins" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029961, HPA029962" Approved Approved "Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane, Cytosol" "HPA029961: AB_10603233, HPA029962: AB_2673269" "unprognostic (1.72e-3)" "unprognostic (9.61e-2)" "unprognostic (5.82e-3)" "unprognostic (2.77e-2)" "unprognostic (6.30e-3)" "unprognostic (1.90e-1)" "prognostic unfavorable (9.47e-4)" "unprognostic (3.79e-1)" "unprognostic (2.49e-1)" "unprognostic (9.71e-3)" "unprognostic (4.29e-3)" "unprognostic (4.42e-2)" "unprognostic (2.69e-1)" "unprognostic (1.51e-1)" "unprognostic (1.27e-1)" "unprognostic (3.83e-2)" "unprognostic (2.69e-2)" 9.5 9.4 18.9 11.5 22.0 15.5 18.4 25.9 25.5 12.9 12.9 14.8 15.3 11.7 17.5 32.5 20.9 14.6 14.0 17.7 17.7 17.6 12.1 23.1 11.5 13.3 15.1 19.4 17.0 13.9 32.8 28.3 14.0 20.0 13.6 13.7 13.6 21.6 13.4 12.1 22.6 12.2 16.3 10.8 15.8 12.4 27.7 11.7 30.7 13.9 13.5 18.4 14.7 14.3 4.6 6.2 8.0 7.5 5.2 6.9 2.0 12.8 10.1 19.4 24.2 11.0 19.7 21.2 12.5 13.8 14.7 17.8 24.0 11.2 15.5 10.6 17.4 17.5 15.1 22.0 18.9 19.6 16.5 19.0 13.1 6.1 14.5 16.6 41.2 21.2 16.0 15.5 26.9 32.7 14.0 15.1 23.1 17.4 16.0 18.8 21.7 23.3 22.6 18.5 16.5 9.7 27.4 11.9 8.8 12.1 19.5 17.4 17.2 11.5 17.7 16.5 29.9 8.4 28.5 14.7 8.2 13.7 22.2 17.1 15.8 14.3 21.8 9.8 17.0 12.0 8.0 2.3 3.2 4.2 6.5 6.9 4.6 5.4 5.8 3.4 3.4 5.5 6.5 1.5 5.2 7.5 6.2 5.4 2.0 18.9 22.0 25.9 25.5 17.7 17.6 15.1 19.4 20.0 11.7 17.9 6.1 13.7 10.2 11.8 11.3 25.0 12.7 17.4 13.6 5.2 15.7 22.4 6.6 7.0 9.2 9.3 8.3 0.0 6.1 24.3 8.0 9.3 16.1 34.5 11.5 12.7 5.8 17.2 21.9 5.1 6.6 11.5 5.0 3.6 14.7 32.3 7.5 10.5 8.1 6.9 14.7 19.4 7.6 35.6 32.8 13.0 23.9 20.0 14.5 15.4 RFLNB "Cfm1, FAM101B, MGC45871, RefilinB" ENSG00000183688 "Refilin B" Q8N5W9 17 439978-445939 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 48.4;bone marrow: 40.9" "Cell type enhanced" "Detected in some" 25 "Alveolar cells type 2: 5.5;Hofbauer cells: 30.7;monocytes: 10.0" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 48.4" "Lineage enriched" "Detected in many" 16 "granulocytes: 48.4" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 28.0;HMC-1: 67.5;NB-4: 21.5;U-937: 18.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030879, HPA060388" Enhanced Approved "Plasma membrane,Actin filaments,Cytosol" NA NA "Actin filaments" "Plasma membrane, Cytosol" "HPA030879: AB_2673643, HPA060388: AB_2732649" "unprognostic (1.52e-1)" "unprognostic (1.12e-1)" "unprognostic (2.87e-1)" "unprognostic (3.14e-1)" "unprognostic (3.52e-2)" "unprognostic (2.34e-1)" "unprognostic (1.31e-1)" "unprognostic (1.48e-1)" "unprognostic (1.94e-1)" "unprognostic (2.87e-2)" "unprognostic (2.48e-2)" "unprognostic (1.31e-1)" "prognostic unfavorable (1.54e-4)" "unprognostic (3.45e-2)" "unprognostic (9.22e-2)" "unprognostic (1.43e-1)" "unprognostic (9.03e-3)" 6.8 1.6 1.9 4.1 2.3 40.9 5.6 1.1 1.5 2.6 4.9 1.8 4.2 2.2 1.1 2.1 2.7 3.7 2.1 1.5 2.7 1.7 5.2 2.9 1.8 1.8 1.0 0.8 1.3 6.3 3.6 1.1 1.2 1.7 2.8 1.9 3.2 3.6 2.3 4.1 3.2 0.9 3.0 2.7 4.5 1.4 0.0 2.5 48.4 2.1 0.5 3.0 1.0 8.8 2.3 1.2 5.6 4.0 2.9 6.3 14.5 6.3 4.8 2.3 0.1 0.3 0.0 0.3 28.0 2.1 0.8 3.3 0.3 4.4 0.0 1.9 0.4 0.4 0.6 5.9 3.2 67.5 1.6 0.1 1.5 0.6 1.8 4.8 1.4 1.3 0.1 5.4 0.1 0.1 21.5 2.6 0.2 0.0 0.9 2.6 0.0 0.8 0.0 0.1 13.2 5.8 0.0 5.1 4.7 0.1 10.1 0.9 3.7 3.4 2.2 0.0 2.1 2.2 0.0 0.0 18.7 5.8 48.4 2.1 21.6 1.8 1.4 1.8 0.0 1.8 1.5 0.6 0.0 3.0 2.7 10.2 0.5 1.8 2.5 1.1 1.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 2.7 3.4 1.8 0.0 0.5 0.0 1.2 0.0 0.0 0.0 0.0 0.8 0.8 0.0 0.0 1.1 0.0 30.7 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 10.0 0.0 0.0 1.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 RFPL1 RNF78 ENSG00000128250 "Ret finger protein like 1" O75677 22 29438583-29442455 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 20.4" "Cell type enhanced" "Detected in some" 28 "Early spermatids: 6.5;Ito cells: 12.9;Kupffer cells: 2.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 11.2;HMC-1: 4.3;Karpas-707: 4.7;SH-SY5Y: 5.8;SiHa: 2.8;THP-1: 5.3" "HPA048320, HPA072380" Approved "Nuclear speckles,Plasma membrane" NA NA "Nuclear speckles" "Plasma membrane" "HPA048320: AB_2680356, HPA072380: AB_2686515" "unprognostic (4.54e-1)" "unprognostic (6.63e-8)" "unprognostic (3.14e-3)" "unprognostic (1.89e-1)" 0.0 3.3 0.2 0.1 0.7 0.0 0.0 0.4 20.4 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.3 0.0 1.9 0.0 0.1 0.4 2.8 0.0 0.0 0.6 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 4.5 0.0 0.0 0.0 0.4 1.6 0.9 0.0 1.8 0.0 1.2 0.5 0.0 0.2 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 11.2 0.7 0.0 1.0 0.0 0.0 0.1 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 4.7 0.0 0.2 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 5.8 2.8 0.0 0.0 0.3 0.0 5.3 2.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.2 1.2 0.8 0.0 0.6 1.0 0.9 1.6 0.1 1.1 0.0 0.0 1.8 0.0 1.2 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 12.9 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RFPL2 RNF79 ENSG00000128253 "Ret finger protein like 2" O75678 22 32190435-32203477 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "brain: 7.9;prostate: 10.8" "Cell type enriched" "Detected in single" 4 "Glandular cells: 3.1" "Cancer enriched" "Detected in single" 15 "prostate cancer: 5.6" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 2.5;OE19: 1.1;REH: 1.0;SCLC-21H: 1.8;SK-MEL-30: 1.2" "HPA046608, HPA048320, HPA072380" Approved Approved "Nuclear speckles,Plasma membrane" NA NA "Nuclear speckles" "Plasma membrane" "HPA046608: , HPA048320: AB_2680356, HPA072380: AB_2686515" "unprognostic (3.81e-2)" "unprognostic (4.05e-2)" "unprognostic (8.29e-2)" "unprognostic (9.66e-3)" "unprognostic (2.54e-1)" "unprognostic (9.90e-2)" "unprognostic (2.59e-1)" "unprognostic (6.02e-3)" "unprognostic (2.22e-2)" "unprognostic (3.44e-2)" "unprognostic (8.64e-3)" "prognostic favorable (4.16e-4)" "unprognostic (2.04e-4)" "unprognostic (6.02e-2)" "unprognostic (3.28e-2)" "unprognostic (5.62e-7)" "unprognostic (3.50e-2)" 0.1 0.3 2.3 0.2 3.9 1.1 0.1 2.7 7.9 0.1 0.1 0.2 0.1 0.1 0.3 0.1 0.1 0.1 3.1 5.6 0.2 0.5 0.1 0.4 1.9 0.1 0.1 0.1 0.0 0.1 10.8 0.1 0.1 0.1 0.1 0.4 0.2 0.1 0.4 0.2 0.2 0.2 0.2 0.1 0.1 0.0 0.0 0.5 0.0 0.8 0.0 1.2 0.2 0.0 2.5 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.0 0.4 0.0 0.3 0.0 1.1 0.0 1.0 0.1 0.0 0.0 0.2 1.8 0.0 0.3 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.1 0.0 0.8 0.0 0.0 0.1 0.8 0.0 1.2 1.2 0.5 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RFPL3 RNF120 ENSG00000128276 "Ret finger protein like 3" O75679 22 32354885-32361161 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "testis: 23.4" "Cell type enriched" "Detected in single" 7 "Early spermatids: 1.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory CD4 T-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 3.8;NB-4: 4.8;U-266/70: 5.6;U-266/84: 5.5" "HPA048320, HPA072380" Approved "Nuclear speckles,Plasma membrane" NA NA "Nuclear speckles" "Plasma membrane" "HPA048320: AB_2680356, HPA072380: AB_2686515" "unprognostic (1.63e-1)" "unprognostic (9.90e-2)" "unprognostic (1.10e-1)" "unprognostic (1.05e-1)" "unprognostic (1.52e-2)" "unprognostic (1.97e-1)" "unprognostic (3.25e-2)" "unprognostic (4.31e-2)" "unprognostic (1.90e-1)" "unprognostic (6.32e-2)" 0.0 0.0 0.3 0.0 0.3 1.0 0.0 0.7 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.1 0.1 0.0 0.4 0.2 0.6 0.5 0.0 0.2 0.0 0.3 0.0 0.4 0.0 0.3 1.1 0.2 0.0 0.1 0.5 0.0 23.4 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.3 0.0 1.1 0.2 0.1 0.8 2.4 0.7 0.0 0.0 3.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.1 0.0 0.0 0.0 0.3 2.4 1.1 0.1 0.1 0.0 1.5 0.5 0.0 0.0 0.0 0.0 1.4 0.0 1.8 0.1 1.8 0.0 0.9 1.4 4.8 0.2 0.3 0.1 2.4 0.5 0.6 0.0 0.4 1.8 0.5 0.1 0.4 1.3 0.6 0.0 0.4 0.0 0.0 0.9 0.4 0.0 5.6 5.5 0.1 0.1 1.7 0.8 0.0 0.3 0.0 0.0 0.0 0.1 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 RGS14 ENSG00000169220 "Regulator of G protein signaling 14" O43566 5 177357837-177372601 "Predicted intracellular proteins" "Cell cycle, Cell division" "GTPase activation, Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 43.9;brain: 76.1" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 61.1;Proximal tubular cells: 68.0;Suprabasal keratinocytes: 100.6" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 4 "basal ganglia: 76.1" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 40.7;HMC-1: 36.4;NB-4: 16.0;RPMI-8226: 21.0" "Group enriched" "Detected in many" 11 "amygdala: 68.3;basal ganglia: 58.1;cerebral cortex: 46.1;hippocampal formation: 102.5" "Low region specificity" "Detected in all" "HPA046847, HPA061819" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Intermediate filaments" No No Nucleoplasm "Vesicles, Plasma membrane, Intermediate filaments" "HPA046847: AB_2679836, HPA061819: " "unprognostic (6.05e-3)" "unprognostic (1.65e-2)" "unprognostic (8.57e-2)" "unprognostic (2.61e-1)" "prognostic unfavorable (6.97e-4)" "unprognostic (7.27e-2)" "prognostic unfavorable (1.84e-6)" "unprognostic (1.95e-2)" "unprognostic (4.34e-2)" "unprognostic (2.04e-3)" "unprognostic (2.71e-1)" "unprognostic (1.28e-1)" "unprognostic (9.95e-2)" "unprognostic (3.17e-2)" "unprognostic (1.66e-1)" "unprognostic (1.17e-2)" "unprognostic (2.78e-2)" 1.9 1.5 7.7 12.5 76.1 17.5 1.3 0.4 8.8 1.7 2.6 1.9 0.6 5.1 1.3 1.4 3.2 6.6 3.4 0.7 17.1 1.9 2.1 6.9 4.3 15.5 2.5 3.6 0.8 1.5 0.1 0.9 1.0 0.8 1.2 0.5 0.7 5.2 1.8 1.6 3.5 5.7 1.2 0.7 12.8 3.7 0.7 4.4 24.2 4.3 1.7 12.9 4.9 1.6 9.2 12.2 43.9 12.3 6.5 20.7 12.4 1.9 0.4 0.7 0.4 0.0 0.0 1.2 0.0 0.0 0.1 0.2 1.2 3.8 4.8 2.7 0.0 0.4 3.9 0.0 1.2 0.0 40.7 0.1 7.5 0.1 1.5 0.2 5.8 36.4 0.6 0.3 0.2 0.2 0.0 0.2 5.5 1.3 9.8 0.0 0.1 7.8 16.0 0.6 1.9 1.0 3.6 0.0 21.0 0.4 0.1 0.1 0.7 0.0 0.1 3.0 0.0 1.3 9.2 0.3 0.0 0.7 0.0 3.5 5.2 2.5 2.1 0.6 11.0 0.9 18.6 12.3 43.9 20.5 11.4 20.7 9.2 19.1 18.7 12.2 8.0 16.0 14.3 43.0 6.5 11.6 5.4 18.2 12.4 7.7 76.1 0.4 8.8 17.1 1.9 2.5 3.6 0.8 4.4 6.0 4.1 20.7 25.0 61.1 0.4 1.6 40.8 14.7 4.5 10.4 2.0 3.2 26.6 10.5 0.5 6.0 7.5 0.0 14.4 8.2 5.3 12.3 24.3 55.7 21.0 0.0 4.6 7.4 13.7 0.8 2.6 16.9 20.3 0.0 5.3 8.0 12.8 14.4 2.1 68.0 1.9 0.0 5.1 0.0 15.1 100.6 2.7 40.0 3.3 13.7 RGS7BP R7BP ENSG00000186479 "Regulator of G protein signaling 7 binding protein" Q6MZT1 5 64506257-64612312 "Predicted intracellular proteins" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.1" "Cell type enhanced" "Detected in some" 14 "Ito cells: 20.3;Leydig cells: 6.6;Peritubular cells: 13.1;Sertoli cells: 6.5;Smooth muscle cells: 7.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "HUVEC TERT2: 16.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039600 Approved Uncertain "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane, Cytosol" "Actin filaments" "HPA039600: AB_2676591" "unprognostic (2.93e-1)" "unprognostic (3.39e-1)" "unprognostic (7.35e-2)" "unprognostic (4.77e-2)" "unprognostic (7.57e-2)" "unprognostic (8.59e-2)" "unprognostic (5.22e-2)" "unprognostic (8.81e-3)" "unprognostic (1.86e-2)" "unprognostic (7.64e-2)" "unprognostic (5.49e-3)" "unprognostic (1.83e-1)" "unprognostic (1.65e-3)" "unprognostic (3.39e-3)" "unprognostic (2.06e-3)" "unprognostic (6.46e-2)" "unprognostic (8.50e-3)" 2.8 4.7 10.2 1.1 22.6 0.4 1.1 10.4 31.1 6.0 1.3 1.5 0.5 1.6 3.7 5.7 2.7 10.9 2.7 3.7 10.8 4.3 3.3 1.7 2.2 0.8 4.0 16.0 3.8 0.8 0.7 1.7 0.4 8.2 7.8 1.4 1.8 2.7 10.9 0.7 1.0 1.7 2.3 1.9 1.3 1.5 1.5 6.7 0.0 1.0 0.0 0.6 2.0 1.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 22.6 10.4 25.1 10.8 4.3 4.0 16.0 8.2 6.7 0.0 0.0 0.0 0.1 0.0 4.3 1.8 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 20.3 0.0 1.3 6.6 0.0 0.0 0.0 0.0 2.5 0.0 0.0 13.1 0.0 1.7 6.5 7.1 0.0 0.2 0.0 0.0 0.0 0.0 0.3 RGS9BP "FLJ45744, PERRS, R9AP, RGS9" ENSG00000186326 "Regulator of G protein signaling 9 binding protein" Q6ZS82 19 32675407-32678300 "Disease related genes, Predicted membrane proteins" "Sensory transduction, Vision" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "retina: 38.3;skeletal muscle: 15.8" "Group enriched" "Detected in some" 13 "Bipolar cells: 30.8;Cone photoreceptor cells: 53.0;Rod photoreceptor cells: 70.9" "Not detected" "Not detected" "Region enriched" "Detected in many" 6 "pons and medulla: 6.8" "Cell type enhanced" "Detected in some" "gdT-cell: 1.4;memory CD8 T-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HEL: 10.7;HMC-1: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA049791 Enhanced Approved "Plasma membrane" NA NA "Plasma membrane" "HPA049791: AB_2680884" "unprognostic (2.82e-2)" "unprognostic (6.99e-3)" "unprognostic (2.44e-3)" "unprognostic (1.20e-7)" "unprognostic (1.49e-1)" "unprognostic (1.21e-2)" "unprognostic (1.17e-2)" "unprognostic (1.32e-1)" "unprognostic (2.80e-1)" "unprognostic (6.71e-2)" "unprognostic (6.74e-2)" "unprognostic (3.89e-2)" "unprognostic (1.63e-3)" "unprognostic (2.29e-1)" "unprognostic (8.22e-2)" "unprognostic (5.23e-2)" "unprognostic (5.34e-2)" 0.4 0.5 0.8 0.3 1.1 0.3 0.4 0.2 0.7 0.3 0.4 1.4 0.2 0.4 0.3 0.6 1.1 0.4 0.3 6.7 1.0 0.8 0.9 0.3 0.9 0.3 1.1 0.3 0.3 0.4 0.4 0.6 0.4 6.8 1.3 0.3 38.3 0.5 0.6 15.8 0.6 0.3 7.4 1.3 0.4 0.4 0.9 0.9 0.1 0.4 4.3 0.3 2.3 1.0 0.0 0.3 0.0 0.9 0.5 1.5 0.0 0.2 0.2 0.0 0.9 0.5 0.2 0.5 0.0 0.5 0.4 0.2 0.2 0.3 0.4 0.5 0.1 0.5 0.1 1.8 0.1 0.1 0.5 0.2 10.7 0.3 0.0 0.2 0.3 2.8 0.0 0.5 0.0 0.4 0.2 0.0 0.1 0.9 1.5 0.2 0.5 0.0 1.7 0.0 0.1 2.0 0.2 0.4 0.2 0.0 0.1 0.4 0.1 0.0 1.1 0.1 0.0 1.1 0.5 0.0 0.5 0.7 0.2 0.3 0.6 0.7 0.1 0.3 0.6 0.8 0.0 0.3 0.0 1.4 0.9 0.0 0.0 0.2 1.5 0.3 0.0 0.0 0.4 0.0 0.5 0.3 0.0 0.0 0.0 0.8 1.1 0.2 0.7 1.0 0.8 1.1 0.3 6.8 0.9 0.0 0.0 0.0 0.1 0.0 30.8 3.9 0.0 0.0 0.0 1.8 53.0 0.1 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.2 1.6 0.0 0.6 0.8 0.9 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.4 70.9 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.2 0.0 RHD "CD240D, DIIIc, RH, Rh30a, Rh4, RhII, RhPI" ENSG00000187010 "Rh blood group D antigen" Q02161 1 25272393-25330445 "Blood group antigen proteins, CD markers, Predicted membrane proteins, Transporters" "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 10.0;bone marrow: 16.5;salivary gland: 7.1" "Cell type enriched" "Detected in some" 20 "Erythroid cells: 23.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "neutrophil: 10.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 10.0" "Group enriched" "Detected in some" 6 "HEL: 28.2;K-562: 8.7" "HPA060951, HPA077385" Supported Uncertain "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA060951: , HPA077385: " "unprognostic (4.75e-3)" "unprognostic (7.70e-2)" "unprognostic (1.34e-1)" "unprognostic (1.38e-1)" "unprognostic (1.09e-2)" "unprognostic (4.84e-2)" "unprognostic (1.11e-2)" "unprognostic (5.25e-2)" "unprognostic (1.11e-2)" "unprognostic (1.91e-1)" "unprognostic (1.27e-2)" "unprognostic (1.89e-1)" "unprognostic (4.96e-3)" "unprognostic (1.93e-1)" "unprognostic (8.09e-2)" "unprognostic (5.53e-2)" "unprognostic (4.92e-3)" 0.3 0.3 0.3 0.5 0.5 16.5 0.3 1.5 1.4 0.6 0.3 0.3 0.3 0.3 0.4 0.3 0.3 0.3 0.4 0.9 0.3 0.2 0.3 0.3 2.5 0.8 0.3 0.3 0.9 0.3 0.1 0.4 0.3 1.1 0.5 0.0 0.3 7.1 0.3 4.1 2.5 0.4 0.3 0.4 1.8 0.3 0.5 0.3 0.3 0.4 2.3 0.3 0.3 0.3 2.0 0.6 10.0 1.4 1.4 1.4 1.2 0.1 0.0 0.2 0.2 0.1 0.0 0.4 0.1 0.1 0.1 0.0 0.1 0.3 0.4 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.5 0.1 28.2 0.7 0.2 0.0 0.3 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 8.7 0.7 0.0 0.1 0.2 0.2 3.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.5 0.3 0.1 0.2 0.1 0.1 0.2 0.5 0.4 0.5 0.2 0.4 0.1 0.3 0.1 0.1 0.5 0.2 0.1 4.9 1.4 2.8 1.0 0.6 1.1 1.3 1.3 0.8 0.2 2.0 1.4 1.3 10.0 1.4 0.8 0.6 0.9 1.2 0.3 0.5 1.5 1.4 0.3 0.2 0.3 0.3 1.1 0.3 0.0 0.3 0.0 0.1 0.1 0.2 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 23.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 RHOBTB2 "DBC2, KIAA0717" ENSG00000008853 "Rho related BTB domain containing 2" Q9BYZ6 8 22987417-23020199 "Predicted intracellular proteins" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 59.6;Alveolar cells type 2: 57.6;Bipolar cells: 30.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 31.8;hTCEpi: 28.3;RT4: 47.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060938 Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA060938: AB_2684391" "unprognostic (2.67e-3)" "unprognostic (1.64e-1)" "unprognostic (1.64e-1)" "unprognostic (7.94e-2)" "unprognostic (7.83e-3)" "unprognostic (2.13e-2)" "unprognostic (8.13e-2)" "unprognostic (8.17e-2)" "unprognostic (3.47e-3)" "unprognostic (1.93e-2)" "unprognostic (1.60e-2)" "unprognostic (1.46e-2)" "prognostic favorable (2.98e-4)" "unprognostic (2.01e-1)" "unprognostic (1.09e-1)" "unprognostic (8.89e-3)" "unprognostic (2.43e-1)" 5.9 7.4 14.8 6.4 33.2 2.0 5.3 5.1 36.9 4.4 8.1 7.2 24.4 7.7 6.3 5.2 4.6 6.6 6.0 17.6 14.0 9.1 6.0 1.9 31.0 12.2 9.8 14.4 15.9 7.2 5.8 9.0 10.0 8.0 5.7 2.5 11.2 5.6 22.6 10.9 3.5 19.7 6.1 4.0 10.4 6.9 7.0 6.5 5.5 14.9 2.8 14.5 13.7 3.4 7.8 2.9 4.5 1.6 4.4 2.8 1.1 2.5 4.9 4.0 6.4 4.9 3.4 5.4 3.5 4.6 5.5 4.1 12.7 2.5 31.8 5.3 5.0 7.1 5.0 1.9 19.5 2.6 2.7 1.1 3.4 6.7 3.5 2.3 2.0 7.1 4.4 28.3 5.7 2.9 3.8 3.9 2.3 0.8 3.1 3.6 7.3 1.3 3.2 4.2 7.3 3.5 1.7 6.4 2.1 3.9 47.6 2.6 4.8 2.6 8.1 5.3 3.1 1.5 5.2 4.8 6.9 5.0 12.3 3.9 8.0 7.7 11.4 6.7 2.9 5.3 4.5 1.0 1.3 2.8 1.6 1.9 7.8 0.8 1.3 1.0 7.1 1.1 1.1 0.2 4.4 1.6 2.9 1.4 1.1 14.8 33.2 5.1 36.9 14.0 9.1 9.8 14.4 8.0 6.5 59.6 57.6 5.2 2.3 2.6 30.1 10.1 5.1 4.0 14.8 7.0 3.9 12.8 1.7 1.5 0.5 4.0 0.7 0.0 3.3 6.5 4.6 1.0 4.6 0.8 12.1 15.9 5.8 8.0 2.2 0.2 5.8 4.3 1.7 1.0 3.4 6.0 3.5 0.2 6.0 3.7 5.8 0.0 3.7 0.9 1.7 0.5 4.7 2.2 0.4 0.6 RHOJ "ARHJ, FLJ14445, RASL7B, TCL" ENSG00000126785 "Ras homolog family member J" Q9H4E5 14 63204114-63293219 "Predicted intracellular proteins" Angiogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 18 "Endothelial cells: 65.7;Ito cells: 34.4;Peritubular cells: 15.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 15.6;HUVEC TERT2: 90.5;TIME: 24.0;WM-115: 26.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003050 Uncertain Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Nucleoli" "HPA003050: AB_1079812" "unprognostic (7.24e-2)" "unprognostic (1.72e-1)" "unprognostic (4.37e-2)" "unprognostic (2.42e-1)" "unprognostic (6.71e-2)" "unprognostic (1.77e-2)" "unprognostic (2.89e-1)" "unprognostic (2.33e-2)" "unprognostic (2.19e-1)" "unprognostic (3.04e-3)" "unprognostic (1.42e-2)" "unprognostic (7.07e-2)" "prognostic unfavorable (1.31e-4)" "unprognostic (3.50e-3)" "unprognostic (4.84e-2)" "unprognostic (1.86e-2)" "unprognostic (1.06e-3)" 17.0 2.9 11.4 6.4 12.0 0.2 14.3 7.3 15.8 15.1 12.0 3.4 7.9 5.8 22.8 14.7 12.4 15.6 20.0 13.0 11.3 4.6 7.3 4.0 18.6 7.0 8.0 9.8 11.9 3.6 3.3 6.5 7.3 6.8 15.9 8.8 14.8 7.2 11.8 5.8 6.0 8.4 25.3 5.4 9.4 9.4 4.7 8.5 0.0 13.1 13.9 3.9 16.9 9.2 1.2 0.9 2.6 0.8 1.4 0.6 0.1 0.0 0.0 15.6 0.0 0.0 0.0 0.0 2.5 10.5 0.9 1.5 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.9 8.9 90.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.5 0.2 0.0 0.0 24.0 0.0 0.2 0.2 1.4 0.0 0.0 0.0 0.0 0.0 26.0 1.0 0.8 0.6 0.5 0.4 0.3 0.7 0.4 0.4 0.2 1.2 0.6 0.6 2.6 1.4 0.2 0.9 0.2 0.1 11.4 12.0 7.3 15.8 11.3 4.6 8.0 9.8 6.8 8.5 0.0 2.2 0.0 0.2 5.3 0.0 2.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.4 0.4 65.7 0.0 0.0 0.7 0.0 11.6 0.5 0.0 0.0 0.1 0.0 0.0 34.4 1.0 0.5 10.9 1.7 3.3 0.0 0.0 9.1 0.1 0.0 15.2 0.0 0.2 6.5 8.0 0.1 0.4 4.3 0.1 0.0 0.0 0.5 RHOXF2 "CT107, PEPP-2, PEPP2, THG1" ENSG00000131721 "Rhox homeobox family member 2" Q9BQY4 X 120158561-120165630 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "testis: 23.0" "Group enriched" "Detected in some" 60 "Spermatocytes: 5.2;Spermatogonia: 6.8" "Cancer enhanced" "Detected in single" "testis cancer: 0.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HL-60: 10.1;K-562: 62.2;NB-4: 46.0;THP-1: 17.3;U-266/84: 27.6" "HPA003314, CAB020794" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "CAB020794: , HPA003314: AB_1855193" "unprognostic (1.60e-1)" "unprognostic (5.04e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 23.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 1.0 0.5 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.2 0.0 0.0 0.0 0.0 46.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.3 0.2 0.0 0.0 0.0 0.0 0.0 27.6 0.0 0.0 0.0 0.0 1.0 0.3 0.4 0.4 0.4 0.4 0.2 0.3 0.2 0.2 0.3 0.3 0.4 0.7 1.1 0.5 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 6.8 0.0 0.0 0.0 0.0 0.0 RHOXF2B ENSG00000203989 "Rhox homeobox family member 2B" P0C7M4 X 120070672-120077705 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 2.6;testis: 9.4" "Cell type enriched" "Detected in single" 20 "Spermatogonia: 2.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 348 "HL-60: 47.1;K-562: 47.2;NB-4: 76.4" HPA003314 Supported Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA003314: AB_1855193" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.2 0.0 9.4 0.0 0.0 0.0 0.0 1.0 1.6 2.6 1.3 1.7 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.2 0.0 0.0 0.0 0.0 76.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.6 0.7 0.8 0.5 0.9 1.0 0.7 0.5 0.7 0.7 1.0 0.7 0.7 1.4 1.7 1.3 1.6 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 RIC8A "synembryn, synembryn-A" ENSG00000177963 "RIC8 guanine nucleotide exchange factor A" Q9NPQ8 11 207511-215113 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041491, CAB046012" Approved Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "CAB046012: AB_11129402, HPA041491: AB_2677510" "unprognostic (3.93e-2)" "unprognostic (8.69e-2)" "unprognostic (1.62e-1)" "prognostic favorable (8.60e-4)" "unprognostic (1.61e-2)" "unprognostic (2.21e-1)" "prognostic unfavorable (1.11e-6)" "unprognostic (2.13e-3)" "unprognostic (8.70e-2)" "unprognostic (7.68e-2)" "unprognostic (1.56e-1)" "unprognostic (8.35e-2)" "unprognostic (2.63e-3)" "unprognostic (5.35e-2)" "unprognostic (2.57e-1)" "unprognostic (2.14e-1)" "unprognostic (1.60e-1)" 30.9 30.2 31.4 27.1 35.4 28.8 27.5 27.8 51.7 29.3 31.4 25.9 32.5 24.1 35.8 36.6 36.5 35.4 33.2 31.9 27.0 25.5 33.9 39.5 28.4 28.7 23.8 30.0 35.1 38.0 34.9 30.2 43.7 27.4 29.8 26.1 33.2 29.4 36.1 22.5 32.2 35.1 41.3 21.2 32.5 28.4 40.3 18.6 43.9 33.2 24.9 33.3 33.3 27.3 31.3 20.7 40.2 26.6 31.9 40.1 37.2 51.4 25.1 20.4 20.3 28.1 23.2 14.2 37.3 30.1 51.1 35.5 21.6 36.6 20.6 15.6 56.4 38.8 28.0 23.2 39.5 28.6 24.8 23.2 11.6 17.8 19.9 22.7 19.3 38.8 25.3 35.0 31.6 28.7 26.4 25.0 22.0 19.8 20.1 39.1 20.8 23.0 15.4 18.6 21.9 31.2 21.7 20.2 14.0 29.6 13.6 21.3 19.2 28.9 32.7 19.9 20.6 23.1 15.6 28.0 33.9 29.9 12.4 34.6 22.3 33.0 19.8 33.4 17.6 25.3 27.5 19.7 40.2 40.1 23.0 39.3 31.3 35.9 34.6 20.7 27.2 31.1 31.4 28.8 31.9 26.6 17.0 29.8 37.2 31.4 35.4 27.8 51.7 27.0 25.5 23.8 30.0 27.4 18.6 14.9 19.7 27.6 17.9 15.8 27.4 23.6 22.9 14.7 18.2 24.4 9.8 34.7 23.2 48.4 11.7 22.4 23.8 23.3 38.3 50.5 25.4 17.7 17.3 14.7 40.7 30.2 19.4 23.4 24.1 12.3 28.4 15.8 27.0 47.7 15.8 41.3 55.2 21.0 37.4 18.6 28.2 19.4 27.4 85.8 53.0 16.9 27.1 34.1 21.0 14.8 RIC8B "FLJ10620, hSyn, RIC8" ENSG00000111785 "RIC8 guanine nucleotide exchange factor B" Q9NVN3 12 106774595-106889316 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Rod photoreceptor cells: 42.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039970, HPA042746" Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039970: , HPA042746: AB_2678143" "unprognostic (1.18e-1)" "unprognostic (1.61e-1)" "unprognostic (9.87e-3)" "unprognostic (5.43e-2)" "unprognostic (3.28e-2)" "unprognostic (8.09e-2)" "unprognostic (5.74e-2)" "unprognostic (2.60e-1)" "unprognostic (1.99e-2)" "unprognostic (3.83e-1)" "unprognostic (1.10e-3)" "unprognostic (5.13e-2)" "unprognostic (3.65e-3)" "unprognostic (2.21e-1)" "unprognostic (3.18e-2)" "unprognostic (1.34e-1)" "unprognostic (1.01e-2)" 7.4 6.4 10.9 6.0 32.3 1.7 6.1 13.0 12.7 8.0 6.3 5.1 11.5 4.3 7.9 6.4 4.6 8.2 8.1 9.9 6.6 7.5 10.5 6.9 5.3 3.3 6.5 6.7 8.7 6.2 20.4 13.1 5.3 8.2 6.6 5.6 7.5 4.2 12.5 8.3 3.1 4.2 9.4 5.8 5.4 4.4 5.1 17.2 8.7 13.4 0.9 4.1 5.9 7.2 1.1 3.6 3.3 4.0 2.4 6.0 2.8 2.8 8.9 16.9 6.8 8.1 10.2 2.0 9.6 7.6 8.7 8.0 2.9 2.3 1.7 6.6 5.7 3.4 5.0 6.8 3.8 10.3 20.1 8.4 6.2 4.6 3.9 6.8 6.5 4.4 5.7 4.2 6.2 2.9 10.1 7.9 6.3 3.6 0.1 7.6 2.3 6.3 5.9 8.6 4.5 9.0 5.6 9.9 5.6 7.1 3.3 12.4 8.0 6.7 4.3 5.0 6.7 3.8 4.7 7.6 6.9 3.8 4.6 6.6 5.1 10.6 0.1 3.3 3.9 10.2 2.3 4.0 3.3 5.1 2.0 6.0 1.1 2.9 2.6 3.6 0.6 2.2 2.3 1.7 2.4 1.8 2.2 3.1 2.8 10.9 32.3 13.0 12.7 6.6 7.5 6.5 6.7 8.2 17.2 6.0 5.6 3.9 3.8 3.0 12.6 27.4 20.4 10.7 5.7 3.5 9.8 5.8 6.6 17.9 4.6 10.0 6.2 0.0 3.5 3.1 6.5 1.8 8.1 7.3 3.1 6.4 17.9 16.5 7.1 4.0 11.8 4.7 6.8 1.0 7.2 5.7 5.5 3.5 18.0 5.9 42.2 12.9 7.2 16.2 9.2 2.5 1.1 7.5 6.2 1.0 RILPL1 FLJ39378 ENSG00000188026 "Rab interacting lysosomal protein like 1" Q5EBL4 12 123470054-123533718 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "brain: 21.1;heart muscle: 43.8;skeletal muscle: 66.2" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 35.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041314 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA041314: AB_10795587" "unprognostic (2.21e-1)" "unprognostic (1.26e-1)" "unprognostic (3.71e-2)" "unprognostic (5.36e-2)" "unprognostic (3.12e-2)" "unprognostic (2.99e-3)" "unprognostic (1.94e-2)" "unprognostic (1.61e-1)" "unprognostic (2.65e-1)" "unprognostic (1.75e-1)" "unprognostic (2.30e-2)" "unprognostic (8.30e-2)" "unprognostic (4.25e-2)" "unprognostic (2.98e-1)" "unprognostic (2.32e-1)" "unprognostic (6.07e-3)" "unprognostic (2.81e-1)" 6.1 5.7 9.9 3.5 12.3 3.0 3.7 5.2 11.3 4.8 4.7 12.6 4.4 2.1 6.6 5.0 4.8 5.0 4.3 43.8 9.6 7.5 3.8 3.0 5.5 2.3 21.1 5.8 7.2 3.2 5.7 3.6 7.1 11.1 6.2 2.2 4.9 8.0 7.8 66.2 6.2 2.7 9.8 14.4 3.8 3.0 2.9 15.1 0.3 8.2 9.7 1.9 4.7 5.3 1.6 1.2 4.6 1.2 1.2 2.0 0.7 5.9 8.4 7.6 5.9 8.6 8.1 8.0 10.8 6.1 5.9 5.3 5.2 1.4 0.3 5.4 10.5 4.3 6.5 5.6 5.2 2.4 6.1 10.3 0.8 5.4 7.6 15.1 0.3 2.3 9.2 10.3 6.6 9.6 14.8 6.0 1.1 4.7 0.4 5.9 9.9 0.6 1.9 5.6 1.7 8.9 1.0 4.2 0.3 4.2 6.3 1.2 7.1 5.8 5.1 12.9 4.4 6.7 0.2 11.8 7.8 3.9 11.2 6.8 1.3 0.6 0.2 8.0 0.1 4.8 1.4 1.0 0.7 0.9 0.5 0.8 0.9 1.0 0.8 0.3 1.6 2.0 1.6 4.6 1.2 1.2 1.2 0.9 0.7 9.9 12.3 5.2 9.9 9.6 7.5 21.1 5.8 11.1 15.1 35.7 13.2 0.0 4.3 4.0 13.4 9.2 5.1 5.3 11.4 10.4 5.9 7.9 1.7 1.8 1.3 4.6 0.0 0.0 1.8 5.2 5.6 3.2 1.1 1.3 4.4 22.3 0.0 10.4 1.3 0.9 14.4 1.0 5.0 1.0 1.0 20.0 2.1 0.0 7.8 1.8 6.2 6.5 6.1 0.9 2.3 3.3 7.8 1.3 0.5 2.6 RIMS2 "KIAA0751, OBOE, RAB3IP3, RIM2" ENSG00000176406 "Regulating synaptic membrane exocytosis 2" Q9UQ26 8 103500748-104256094 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 51.1;brain: 28.7" "Group enriched" "Detected in many" 10 "Bipolar cells: 397.4;Cone photoreceptor cells: 665.6;Rod photoreceptor cells: 1047.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 6.0;Daudi: 11.7;RT4: 8.4;SCLC-21H: 20.8;SuSa: 8.3" "Low region specificity" "Detected in all" "HPA046538, HPA066498, CAB079049" Enhanced Supported Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB079049: , HPA046538: , HPA066498: AB_2685678" "unprognostic (2.98e-2)" "unprognostic (7.14e-2)" "unprognostic (4.47e-2)" "unprognostic (5.51e-2)" "unprognostic (2.82e-1)" "unprognostic (7.09e-3)" "unprognostic (2.02e-2)" "unprognostic (1.16e-2)" "unprognostic (7.61e-2)" "unprognostic (8.01e-3)" "unprognostic (1.40e-2)" "unprognostic (6.34e-2)" "unprognostic (1.67e-5)" "unprognostic (8.12e-4)" "unprognostic (1.04e-1)" "unprognostic (1.61e-1)" "unprognostic (9.08e-2)" 0.9 51.1 15.8 1.0 21.8 1.1 1.8 14.5 28.7 8.5 0.9 0.5 0.9 1.2 1.4 1.7 1.0 6.3 1.7 0.9 10.3 4.9 1.1 0.9 1.0 1.1 3.1 17.5 2.8 1.6 0.9 12.4 1.1 8.6 2.8 1.0 5.8 1.0 1.8 1.0 1.0 1.4 2.0 4.0 0.9 1.7 3.9 8.7 0.0 2.9 0.0 1.0 1.5 1.6 0.7 0.7 2.9 0.6 1.6 0.6 0.2 3.7 0.0 6.0 0.0 0.0 0.0 0.0 0.4 0.3 1.1 1.4 0.1 0.3 11.7 0.1 0.0 1.2 0.3 1.8 0.7 1.9 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.9 2.1 0.0 1.3 0.1 0.5 0.0 0.5 0.8 0.0 4.6 0.0 0.6 0.0 0.0 0.0 0.0 8.4 20.8 5.1 0.0 0.1 0.5 8.3 0.3 0.2 0.0 0.0 5.6 0.1 0.1 1.5 0.0 0.1 0.4 0.2 0.2 2.7 0.6 0.6 0.6 0.3 0.4 0.4 0.3 0.4 0.1 0.7 0.3 0.5 2.9 1.6 0.4 0.7 0.3 0.2 15.8 21.8 14.5 28.7 10.3 4.9 3.1 17.5 8.6 8.7 26.8 32.3 0.0 1.6 0.2 397.4 0.7 2.5 18.7 29.6 0.0 665.6 0.5 1.7 0.0 29.0 0.5 0.0 0.0 0.0 0.2 0.8 4.9 15.1 0.0 0.2 63.5 8.1 0.6 0.3 13.5 66.7 0.4 1.7 0.0 0.2 71.8 0.4 0.0 27.6 0.1 1047.7 0.0 0.3 15.3 9.9 0.4 0.1 0.5 0.0 0.9 RIOK2 FLJ11159 ENSG00000058729 "RIO kinase 2" Q9BVS4 5 97160867-97183260 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Ribosome biogenesis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA005681 Uncertain Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA005681: AB_1856286" "unprognostic (6.36e-2)" "unprognostic (1.21e-1)" "unprognostic (1.13e-2)" "unprognostic (8.04e-2)" "unprognostic (1.38e-1)" "unprognostic (4.51e-2)" "unprognostic (2.71e-3)" "unprognostic (3.08e-1)" "unprognostic (3.90e-2)" "unprognostic (1.11e-1)" "unprognostic (8.76e-2)" "unprognostic (6.63e-2)" "unprognostic (1.26e-3)" "unprognostic (3.60e-1)" "unprognostic (9.98e-2)" "unprognostic (1.43e-2)" "unprognostic (1.39e-2)" 22.2 20.1 14.8 17.1 17.5 24.4 19.7 26.3 18.6 19.1 17.0 8.9 14.0 17.3 17.5 17.1 17.0 15.0 10.7 19.6 15.7 13.4 21.0 23.6 13.3 17.6 20.0 11.1 20.7 21.5 15.1 37.5 15.8 19.7 19.5 17.3 10.3 18.7 16.6 24.9 13.3 20.2 16.3 20.7 22.5 16.4 14.8 18.6 25.8 21.7 20.7 17.4 20.7 21.0 15.2 17.8 9.4 18.7 17.8 24.1 13.5 8.8 10.4 9.7 18.8 12.8 14.0 15.5 22.3 13.8 15.8 21.0 14.2 15.6 19.6 25.4 10.0 24.9 10.5 16.5 13.0 21.7 13.8 9.1 9.8 20.1 19.8 11.5 18.6 13.8 9.2 10.2 19.3 19.6 12.1 12.8 14.6 14.8 12.7 18.1 14.8 21.8 22.3 11.5 5.3 11.2 24.5 18.9 28.8 12.4 8.1 12.1 9.0 13.5 14.1 15.4 15.1 14.7 17.8 13.7 20.3 14.1 16.1 24.3 12.5 16.2 44.0 12.1 19.1 18.5 7.0 16.0 9.4 16.3 18.7 22.3 15.2 20.7 17.8 17.8 11.0 22.5 24.1 3.2 17.8 13.4 17.8 18.5 13.5 14.8 17.5 26.3 18.6 15.7 13.4 20.0 11.1 19.7 18.6 8.9 10.9 13.0 14.3 23.5 16.4 15.9 12.7 10.7 11.4 7.0 11.8 16.7 14.9 14.2 1.1 14.0 7.0 0.0 13.1 19.4 15.8 9.9 27.6 7.8 15.9 12.7 9.2 6.2 11.0 1.8 12.4 11.5 5.0 13.6 11.2 12.3 10.5 10.5 15.2 12.2 17.2 6.5 21.7 20.7 20.2 16.6 14.5 14.4 12.1 11.4 RIOK3 SUDD ENSG00000101782 "RIO kinase 3" O14730 18 23452823-23486603 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity, Ribosome biogenesis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001620, HPA024184" Approved Approved "Golgi apparatus,Plasma membrane,Centriolar satellite,Cytosol" NA NA "Plasma membrane, Cytosol" "Golgi apparatus, Centriolar satellite" "HPA001620: AB_1079815, HPA024184: AB_1856289" "unprognostic (7.99e-2)" "unprognostic (1.71e-2)" "unprognostic (2.39e-1)" "unprognostic (3.03e-2)" "unprognostic (1.05e-1)" "unprognostic (7.48e-2)" "unprognostic (8.98e-3)" "unprognostic (1.01e-1)" "unprognostic (5.10e-2)" "unprognostic (4.20e-1)" "prognostic unfavorable (4.10e-4)" "prognostic unfavorable (5.80e-4)" "unprognostic (3.90e-2)" "unprognostic (1.46e-1)" "unprognostic (5.44e-2)" "unprognostic (1.39e-1)" "unprognostic (2.71e-2)" 10.1 8.7 6.9 11.7 7.7 52.4 10.9 8.9 10.1 14.7 21.4 8.5 5.9 15.6 8.8 9.3 41.0 7.8 10.7 11.5 6.1 5.5 10.5 19.9 10.1 10.7 9.1 6.2 7.6 10.7 7.5 11.6 21.4 11.6 6.8 14.7 6.0 14.9 7.0 40.0 13.3 36.5 15.2 10.5 8.9 12.9 22.7 7.6 11.1 7.3 16.0 16.5 13.7 21.5 11.7 11.0 21.7 21.5 8.3 11.2 10.0 14.8 5.8 6.1 7.9 11.1 12.4 11.0 14.9 11.0 10.6 10.2 6.7 16.1 10.3 19.6 16.6 10.8 19.5 10.3 17.0 16.4 10.2 4.3 9.6 10.9 8.4 27.8 27.0 8.4 14.8 32.4 18.8 26.0 12.1 14.7 6.5 13.9 13.0 15.9 7.9 9.3 4.4 5.6 21.7 11.7 10.5 12.7 12.5 12.1 19.5 14.2 10.2 19.1 8.7 10.9 15.9 7.7 14.6 23.1 17.5 4.4 7.7 9.6 23.5 19.7 15.3 10.3 12.5 13.1 21.7 13.5 8.0 9.1 19.6 6.9 8.2 7.6 7.9 11.0 11.7 6.1 6.9 9.3 8.3 21.5 5.1 11.2 10.0 6.9 7.7 8.9 10.1 6.1 5.5 9.1 6.2 11.6 7.6 74.5 51.9 21.7 78.2 107.0 43.0 61.7 43.3 56.2 67.1 24.4 53.0 38.5 21.6 40.3 191.3 39.6 193.3 116.8 45.8 56.7 46.6 92.4 61.2 72.5 37.1 27.0 60.3 33.7 55.0 227.3 20.8 49.5 40.5 47.7 85.9 17.1 98.8 75.8 28.3 40.3 43.8 6.5 38.7 23.6 9.5 125.6 73.9 34.1 42.3 194.9 RNF114 "PSORS12, ZNF313" ENSG00000124226 "Ring finger protein 114" Q9Y508 20 49936336-49953892 "Enzymes, Predicted intracellular proteins" "Differentiation, Spermatogenesis, Ubl conjugation pathway" "Developmental protein, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 1239.3;Late spermatids: 628.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 110.4" "Low region specificity" "Detected in all" HPA021184 Enhanced Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA021184: AB_1859185" "unprognostic (8.38e-2)" "unprognostic (3.56e-2)" "unprognostic (5.62e-2)" "prognostic unfavorable (8.10e-6)" "unprognostic (1.56e-1)" "unprognostic (2.96e-1)" "prognostic unfavorable (3.11e-4)" "unprognostic (2.50e-2)" "unprognostic (1.03e-2)" "unprognostic (2.12e-1)" "unprognostic (3.99e-1)" "unprognostic (2.70e-2)" "unprognostic (2.54e-3)" "unprognostic (1.33e-1)" "unprognostic (1.76e-1)" "prognostic favorable (3.01e-4)" "unprognostic (1.36e-2)" 23.2 21.3 24.4 18.3 25.7 31.2 20.6 26.7 23.1 24.0 29.7 32.6 21.1 29.5 20.3 23.4 20.2 23.6 20.1 21.9 23.0 25.3 30.3 31.6 24.4 24.0 28.3 19.4 28.4 36.8 16.1 21.6 40.6 23.7 24.5 21.3 27.1 27.8 24.1 43.8 15.2 33.9 17.6 29.3 36.3 24.2 101.9 24.1 28.3 37.9 20.0 24.1 22.6 25.0 28.5 32.5 43.4 44.6 23.7 29.4 34.9 15.9 15.7 8.1 8.5 16.7 11.5 23.8 14.3 16.2 29.6 12.6 46.6 13.1 7.7 28.6 7.5 18.1 12.8 12.0 14.4 10.3 14.0 8.8 9.8 10.5 32.7 14.7 17.8 11.8 10.0 13.3 11.3 7.8 10.1 7.0 13.4 18.4 9.1 8.6 53.8 14.9 18.5 8.3 12.5 22.6 16.3 8.5 14.0 15.6 13.0 12.4 8.9 17.5 110.4 22.1 6.9 29.4 16.6 9.2 26.8 12.5 14.0 16.4 18.7 19.5 14.7 15.2 11.6 14.8 38.5 42.5 35.7 22.0 39.2 24.6 28.2 24.6 22.4 32.5 28.5 29.4 23.7 43.4 23.7 44.6 26.7 28.8 34.9 24.4 25.7 26.7 23.1 23.0 25.3 28.3 19.4 23.7 24.1 44.7 50.1 53.6 105.2 95.2 25.2 37.5 28.1 32.1 28.4 66.3 11.8 79.1 61.3 83.5 1239.3 54.7 64.9 23.3 88.7 65.1 64.6 89.9 43.9 57.8 95.3 38.1 58.0 44.8 69.1 628.0 65.3 62.5 67.4 101.0 68.6 36.1 81.0 69.1 56.3 87.7 19.7 38.8 75.9 206.1 156.2 76.2 104.4 48.0 73.6 96.0 RNF145 FLJ31951 ENSG00000145860 "Ring finger protein 145" Q96MT1 5 159157409-159210053 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036562 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA036562: AB_10696657" "unprognostic (1.57e-1)" "unprognostic (9.02e-3)" "unprognostic (4.11e-2)" "unprognostic (3.88e-2)" "unprognostic (3.24e-2)" "unprognostic (2.93e-2)" "prognostic unfavorable (1.64e-6)" "unprognostic (1.35e-1)" "unprognostic (1.02e-2)" "unprognostic (1.54e-1)" "unprognostic (3.53e-1)" "unprognostic (1.67e-1)" "unprognostic (8.92e-3)" "unprognostic (1.49e-1)" "unprognostic (1.00e-1)" "unprognostic (1.10e-1)" "unprognostic (1.39e-1)" 13.3 20.1 23.9 15.6 23.0 7.1 24.1 30.2 27.3 11.3 11.7 5.7 5.3 4.7 12.6 13.6 26.7 11.4 20.8 16.8 22.0 8.4 8.2 6.1 30.7 36.3 17.5 9.7 14.1 6.0 26.9 29.0 21.9 18.5 11.8 12.6 10.2 17.8 14.8 5.5 14.9 11.0 13.8 12.4 12.7 11.2 7.9 18.0 12.4 14.3 8.0 19.6 19.3 15.7 8.9 2.7 14.4 2.6 2.1 6.2 1.3 20.3 20.1 31.0 37.2 32.8 14.6 6.0 16.3 28.5 15.1 24.6 6.9 16.9 7.0 29.4 14.3 28.8 26.7 24.4 21.5 26.7 28.8 8.7 14.7 22.9 5.7 14.1 9.7 14.1 9.0 38.9 14.1 20.7 21.2 14.8 17.1 14.6 27.1 14.2 0.5 11.0 3.0 13.4 6.4 10.3 14.7 13.5 14.0 20.2 7.0 11.3 20.9 16.5 17.7 26.8 22.1 12.4 8.9 15.8 17.0 15.6 13.6 28.9 6.0 8.3 6.5 19.8 12.1 36.3 2.8 2.6 14.4 3.2 2.5 3.7 8.9 4.7 3.8 1.9 4.4 6.2 4.3 9.7 2.1 2.2 2.7 5.7 1.3 23.9 23.0 30.2 27.3 22.0 8.4 17.5 9.7 18.5 18.0 104.2 213.5 76.8 93.4 109.1 103.7 10.0 79.0 48.2 106.9 34.9 55.0 2.7 16.6 63.7 22.1 50.7 48.5 46.7 99.7 20.5 58.0 100.6 68.1 16.3 39.0 108.1 52.0 127.7 90.9 29.9 42.8 54.8 62.4 223.6 41.8 63.1 90.1 51.8 48.8 8.4 48.6 45.3 49.5 14.9 33.0 86.9 9.2 73.0 57.2 150.2 RNF149 FLJ90504 ENSG00000163162 "Ring finger protein 149" Q8NC42 2 101271219-101308701 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 123.7" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 255.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 6 "neutrophil: 123.7" "Lineage enriched" "Detected in all" 6 "granulocytes: 123.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011424 Approved Approved "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA011424: AB_1079825" "unprognostic (2.56e-2)" "unprognostic (4.70e-2)" "unprognostic (1.96e-1)" "unprognostic (3.49e-2)" "unprognostic (3.17e-2)" "unprognostic (5.17e-3)" "unprognostic (4.16e-2)" "unprognostic (4.77e-3)" "unprognostic (5.61e-2)" "unprognostic (1.43e-2)" "unprognostic (5.69e-3)" "unprognostic (1.51e-1)" "prognostic unfavorable (2.04e-8)" "unprognostic (1.39e-1)" "unprognostic (6.16e-2)" "unprognostic (2.70e-1)" "prognostic favorable (2.91e-4)" 20.3 13.4 7.9 29.0 10.9 32.9 13.5 7.9 10.8 12.5 16.6 10.8 11.4 12.3 11.3 12.8 28.9 14.3 14.5 12.1 9.5 9.4 15.1 19.6 24.5 47.4 13.7 6.2 14.3 21.1 14.3 10.6 19.4 11.2 11.1 12.0 12.8 15.8 8.1 8.8 20.2 16.8 9.6 13.9 65.0 13.8 15.2 9.7 17.0 12.7 13.1 24.4 14.9 17.2 2.1 9.3 123.7 21.3 2.3 9.0 9.9 9.7 5.8 4.4 5.5 16.5 16.6 25.7 12.1 15.9 16.4 18.5 14.5 25.8 2.9 14.7 11.9 21.7 19.9 6.2 12.3 15.3 8.4 8.5 6.0 5.1 24.5 22.1 6.5 9.8 15.1 20.3 19.4 12.9 12.6 29.8 6.4 5.3 9.1 16.4 8.3 8.7 6.5 3.0 13.2 10.5 5.7 7.3 11.2 19.3 23.9 5.8 4.3 7.3 18.1 17.5 5.0 4.9 8.8 19.7 8.3 4.7 12.4 2.6 18.4 10.8 0.1 2.7 9.1 6.1 5.8 13.0 14.8 8.2 20.4 7.4 2.1 7.3 8.1 4.8 1.5 5.1 5.3 123.7 2.3 21.3 9.3 9.0 9.9 7.9 10.9 7.9 10.8 9.5 9.4 13.7 6.2 11.2 9.7 44.7 56.9 34.7 63.4 68.3 20.3 10.6 48.4 24.1 23.9 52.4 53.0 48.5 1.7 48.9 61.2 33.8 33.9 0.0 36.5 60.6 44.7 62.7 37.1 38.9 76.7 7.9 8.2 28.8 255.2 27.7 28.4 171.2 38.8 16.2 35.9 11.9 49.2 36.6 18.4 25.1 19.7 58.2 44.3 31.2 36.2 80.0 107.1 69.8 31.9 137.0 RNF165 "ARKL2, RNF111L2" ENSG00000141622 "Ring finger protein 165" Q6ZSG1 18 46326809-46463140 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.6" "Group enriched" "Detected in many" 8 "Bipolar cells: 36.3;Cone photoreceptor cells: 94.2;Horizontal cells: 76.3;Rod photoreceptor cells: 51.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "MAIT T-cell: 1.1;NK-cell: 3.9;plasmacytoid DC: 1.5" "Group enriched" "Detected in many" 4 "dendritic cells: 1.5;NK-cells: 3.9;T-cells: 1.1" "Cell line enhanced" "Detected in some" "AF22: 12.7;HaCaT: 7.0;HeLa: 6.9;RPMI-8226: 6.7;SCLC-21H: 13.2;SH-SY5Y: 15.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041615, HPA047798" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA041615: AB_2677582, HPA047798: AB_2680158" "unprognostic (6.46e-3)" "unprognostic (7.25e-2)" "unprognostic (4.55e-2)" "unprognostic (1.24e-5)" "unprognostic (3.43e-1)" "unprognostic (4.57e-2)" "unprognostic (5.18e-2)" "unprognostic (1.69e-1)" "unprognostic (1.04e-3)" "unprognostic (1.95e-1)" "unprognostic (1.23e-1)" "unprognostic (2.07e-1)" "unprognostic (1.87e-5)" "unprognostic (3.53e-3)" "unprognostic (1.90e-1)" "unprognostic (1.29e-1)" "unprognostic (1.64e-1)" 1.9 1.7 9.9 1.0 9.5 0.9 2.1 28.6 13.8 1.0 0.8 1.7 1.7 0.4 1.0 8.4 2.7 3.0 1.0 2.5 6.1 4.4 2.3 8.3 1.0 0.9 2.2 7.2 0.5 1.0 13.1 4.8 0.8 2.0 3.6 0.6 2.7 1.4 3.9 3.6 3.5 1.0 0.7 1.7 5.3 0.7 1.3 1.0 1.7 8.8 1.2 1.3 1.2 1.0 0.0 1.5 0.5 0.0 3.9 1.1 0.0 1.5 0.1 12.7 0.1 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.2 7.0 0.5 1.0 0.0 0.0 1.0 0.1 6.9 0.0 0.0 2.9 0.0 0.0 0.8 0.0 0.0 0.3 0.0 2.2 0.0 0.2 0.0 0.0 2.3 1.0 1.7 0.3 1.2 2.4 0.5 6.7 0.8 2.1 13.2 15.0 2.3 0.0 0.0 0.9 0.3 0.6 0.0 0.0 0.9 0.0 0.4 0.0 0.0 0.0 0.0 4.1 0.4 0.0 0.0 0.5 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 3.9 0.0 1.5 0.0 0.0 9.9 9.5 28.6 13.8 6.1 4.4 2.2 7.2 2.0 1.0 3.0 1.7 0.0 8.3 2.4 36.3 7.9 0.0 0.0 3.4 0.0 94.2 0.1 3.3 0.0 2.7 1.9 0.0 0.0 0.0 0.2 1.5 1.7 0.0 5.7 0.1 76.3 0.0 0.6 0.8 3.1 2.3 0.0 1.7 0.0 0.0 3.7 0.1 0.0 3.9 0.0 51.7 0.0 0.8 0.5 0.5 1.8 0.2 2.9 0.0 1.6 RNF166 "MGC14381, MGC2647" ENSG00000158717 "Ring finger protein 166" Q96A37 16 88696495-88706421 "Predicted intracellular proteins" "Autophagy, Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 63.9" "Cell type enhanced" "Detected in many" 7 "Kupffer cells: 37.7;Macrophages: 37.5;T-cells: 66.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 44.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042970 Approved "Nucleoplasm,Plasma membrane,Cytosol" No No Nucleoplasm "Plasma membrane, Cytosol" "HPA042970: AB_10796682" "unprognostic (3.01e-2)" "unprognostic (6.98e-3)" "unprognostic (3.96e-2)" "unprognostic (5.36e-3)" "unprognostic (1.23e-1)" "unprognostic (2.71e-2)" "unprognostic (6.52e-2)" "unprognostic (5.86e-2)" "unprognostic (4.88e-2)" "unprognostic (2.38e-2)" "prognostic favorable (1.04e-4)" "unprognostic (3.22e-2)" "prognostic unfavorable (9.45e-6)" "unprognostic (1.54e-1)" "unprognostic (3.91e-2)" "unprognostic (1.28e-1)" "unprognostic (2.69e-2)" 9.2 8.1 9.2 22.8 8.9 63.9 10.5 13.7 15.3 6.7 7.2 11.2 3.7 12.0 8.1 8.3 6.4 9.1 12.3 10.0 8.6 7.3 9.6 9.7 20.8 30.5 8.9 6.5 9.7 11.4 5.3 8.5 7.5 8.4 8.9 4.9 11.0 12.1 6.0 14.8 8.2 16.0 8.3 11.1 47.2 10.9 9.2 9.1 21.6 8.8 7.8 23.8 9.7 6.7 2.0 11.8 28.7 12.5 5.5 17.1 9.7 4.2 6.8 5.3 8.4 2.6 2.2 10.1 4.3 2.8 5.1 2.3 4.6 2.7 5.1 5.6 2.5 2.9 4.7 3.1 2.8 2.0 2.6 9.2 6.9 5.0 7.7 6.9 6.8 8.8 2.6 2.7 4.0 3.3 2.8 5.3 8.7 11.5 3.8 2.1 8.3 15.9 44.6 8.7 1.8 9.1 14.9 3.3 13.2 2.3 1.9 4.9 5.5 9.8 2.0 5.3 2.7 5.8 23.3 7.3 3.8 5.7 5.7 5.1 8.6 5.0 12.4 3.4 25.9 5.3 3.0 12.5 28.7 17.1 9.1 14.8 2.0 10.4 14.8 11.8 1.9 8.7 12.5 20.4 5.5 10.5 7.3 10.5 9.7 9.2 8.9 13.7 15.3 8.6 7.3 8.9 6.5 8.4 9.1 8.9 5.1 15.7 4.7 4.2 10.1 2.4 7.6 1.4 3.4 7.0 5.9 7.4 8.3 5.2 1.1 8.0 2.0 0.0 8.0 7.5 8.2 3.6 20.7 4.0 34.7 7.9 4.7 10.4 37.7 1.8 8.6 37.5 10.1 11.8 2.7 8.9 4.6 0.0 7.4 5.6 8.6 6.5 7.1 9.4 8.6 5.1 3.1 66.8 4.1 1.3 RNF39 "HZFw1, LIRF" ENSG00000204618 "Ring finger protein 39" Q9H2S5 6 30070266-30075887 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 28.3;skin 1: 26.4" "Group enriched" "Detected in many" 4 "Basal glandular cells: 43.3;Glandular cells: 56.0;Urothelial cells: 159.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.3" "Cell line enhanced" "Detected in some" "OE19: 8.8;U-266/84: 6.7" "Group enriched" "Detected in some" 4 "cerebral cortex: 8.0;hippocampal formation: 4.2" "Group enriched" "Detected in some" 5 "cerebellum: 17.9;cerebral cortex: 9.3;hippocampal formation: 5.7" "CAB019278, HPA047115" Uncertain Approved "Vesicles,Plasma membrane,Centrosome" NA NA "Vesicles, Plasma membrane, Centrosome" "CAB019278: , HPA047115: AB_2679938" "unprognostic (1.05e-2)" "unprognostic (3.75e-2)" "unprognostic (1.73e-1)" "unprognostic (1.53e-2)" "unprognostic (5.72e-3)" "unprognostic (3.08e-2)" "unprognostic (4.05e-2)" "unprognostic (1.38e-1)" "unprognostic (2.22e-2)" "unprognostic (1.59e-2)" "unprognostic (4.45e-3)" "unprognostic (3.61e-2)" "unprognostic (2.06e-4)" "unprognostic (5.61e-2)" "unprognostic (1.31e-1)" "unprognostic (2.04e-1)" "unprognostic (2.57e-2)" 0.3 0.2 0.1 0.3 0.3 0.4 5.1 0.3 0.9 7.3 0.7 0.0 1.1 0.9 0.8 0.3 28.3 0.8 1.1 0.2 0.2 0.1 0.3 0.3 3.6 0.3 0.2 0.0 0.6 2.3 0.4 0.4 9.7 0.3 8.1 0.4 0.6 10.2 0.6 0.4 26.4 0.4 1.0 0.2 0.2 4.3 0.8 0.0 0.3 0.4 10.1 11.7 7.8 12.4 0.0 0.0 1.3 0.0 0.2 0.0 0.0 2.4 0.0 0.6 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.1 1.4 0.0 1.2 0.0 0.4 2.2 1.0 0.2 0.0 0.0 0.1 0.3 0.0 1.6 0.0 0.1 1.4 0.0 1.8 0.6 0.5 0.0 0.8 0.0 1.1 0.0 8.8 0.0 0.3 0.3 0.0 1.6 0.3 0.2 0.0 0.0 0.2 0.2 0.1 0.2 0.0 0.0 0.4 0.5 0.0 0.2 1.6 6.7 0.6 0.5 0.1 1.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.4 0.2 0.1 0.2 0.0 0.3 0.0 3.0 2.4 0.0 43.3 15.9 0.5 0.3 5.1 1.4 3.4 0.0 0.0 0.0 0.0 5.5 0.4 0.0 0.4 0.0 2.9 0.0 0.4 56.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 3.3 1.0 1.7 0.0 14.8 0.0 1.1 0.0 0.5 0.0 0.9 0.0 0.2 20.8 0.6 0.0 0.5 159.5 ROBO3 "FLJ21044, HGPPS, HGPS, RBIG1" ENSG00000154134 "Roundabout guidance receptor 3" Q96MS0 11 124865386-124881470 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Chemotaxis, Differentiation, Neurogenesis" "Developmental protein, Receptor" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 20.1" "Cell type enhanced" "Detected in many" 11 "Muller glia cells: 42.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "eosinophil: 1.4" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 11 "AF22: 20.5" "Region enhanced" "Detected in single" "cerebral cortex: 2.0" "Low region specificity" "Detected in all" HPA071053 Approved "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA071053: " "unprognostic (1.30e-1)" "unprognostic (2.17e-1)" "unprognostic (4.95e-3)" "unprognostic (3.42e-2)" "unprognostic (3.84e-2)" "unprognostic (6.25e-2)" "unprognostic (6.95e-3)" "unprognostic (9.65e-2)" "unprognostic (1.56e-2)" "unprognostic (1.18e-1)" "unprognostic (1.32e-1)" "unprognostic (7.15e-2)" "unprognostic (3.75e-8)" "unprognostic (7.27e-3)" "unprognostic (2.21e-1)" "unprognostic (1.47e-1)" "unprognostic (4.91e-3)" 2.4 1.5 1.5 0.5 1.4 1.3 1.7 0.5 3.1 0.8 0.9 0.5 0.5 1.9 1.8 20.1 0.5 2.1 0.5 1.5 1.5 0.6 0.7 0.5 1.7 0.8 1.1 1.1 7.4 0.5 0.2 0.5 1.5 1.0 1.0 0.2 1.0 1.7 0.5 2.6 0.2 2.2 4.5 0.7 3.0 0.8 1.0 0.5 0.8 1.1 0.5 0.5 0.5 1.0 0.0 1.3 1.4 0.3 0.0 0.8 0.0 0.0 0.0 20.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 1.5 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 1.2 0.0 0.0 1.7 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.2 0.0 0.1 0.0 0.0 0.4 0.3 0.0 0.1 0.2 0.4 0.0 0.1 0.1 0.0 0.8 1.1 0.0 1.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 1.4 0.0 0.3 0.4 0.0 0.6 0.3 0.0 0.0 0.2 0.0 0.2 0.0 0.2 1.3 0.8 0.0 1.5 1.4 0.5 2.7 1.5 0.6 1.1 1.1 1.0 0.5 0.0 5.3 0.0 13.5 2.6 0.6 2.8 0.0 0.0 5.7 12.2 0.0 0.1 0.0 6.6 0.2 10.3 1.1 0.0 0.7 0.1 7.6 6.0 9.2 0.0 1.5 0.0 3.4 4.9 2.1 0.0 12.4 8.5 3.3 1.8 0.9 42.6 1.1 2.9 7.8 0.4 1.7 0.0 4.9 3.2 5.9 0.9 0.1 1.7 2.3 5.6 ROBO4 "ECSM4, FLJ20798, MRB" ENSG00000154133 "Roundabout guidance receptor 4" Q8WZ75 11 124883691-124898500 "Plasma proteins, Predicted membrane proteins" "Angiogenesis, Differentiation" "Developmental protein, Receptor" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 13 "Endothelial cells: 62.4;Ito cells: 172.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "myeloid DC: 1.2" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 10 "HUVEC TERT2: 64.9;TIME: 58.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065212 Approved "Plasma membrane" NA NA 340000000 "Plasma membrane" "HPA065212: AB_2685434" "unprognostic (2.86e-1)" "unprognostic (9.35e-2)" "unprognostic (2.67e-1)" "unprognostic (1.07e-1)" "unprognostic (3.82e-2)" "unprognostic (6.97e-2)" "prognostic favorable (4.85e-4)" "unprognostic (7.94e-2)" "unprognostic (2.27e-1)" "unprognostic (1.43e-1)" "unprognostic (1.73e-3)" "unprognostic (2.17e-1)" "unprognostic (1.17e-2)" "prognostic unfavorable (8.73e-4)" "unprognostic (1.55e-1)" "unprognostic (4.63e-1)" "unprognostic (5.15e-2)" 33.3 4.5 4.0 5.6 4.5 0.6 21.6 2.0 5.5 11.1 4.4 4.3 3.7 2.8 10.8 7.8 5.3 7.7 8.5 15.5 4.9 3.0 10.6 6.5 24.9 5.8 4.7 2.8 5.9 3.5 3.8 3.8 23.6 5.5 6.0 1.8 9.2 2.9 4.5 12.5 4.5 4.7 8.4 3.6 33.3 4.3 3.9 3.3 1.0 11.6 9.8 2.5 6.2 5.9 0.0 1.2 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.8 0.1 0.3 0.0 0.0 0.0 6.2 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.7 0.1 64.9 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.2 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 4.0 4.5 2.0 5.5 4.9 3.0 4.7 2.8 5.5 3.3 0.0 6.2 2.4 0.6 1.9 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 62.4 0.0 0.0 0.2 0.0 1.1 0.2 2.3 0.6 0.1 0.0 0.0 172.5 9.1 0.9 4.0 2.0 1.7 0.0 0.0 1.4 0.1 0.0 1.1 0.0 3.6 0.0 0.8 0.0 0.1 1.1 0.0 0.0 0.0 0.1 ROM1 "ROM, TSPAN23" ENSG00000149489 "Retinal outer segment membrane protein 1" Q03395 11 62611722-62615120 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Sensory transduction, Vision" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "retina: 108.1" "Cell type enriched" "Detected in many" 4 "Rod photoreceptor cells: 2384.7" "Cancer enriched" "Detected in all" 6 "glioma: 14.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 5.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HSkMC: 17.9;U-266/84: 18.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA028910, HPA073279" Enhanced Approved "Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "HPA028910: AB_2672824, HPA073279: " "unprognostic (1.54e-2)" "unprognostic (1.37e-2)" "unprognostic (4.24e-2)" "unprognostic (1.11e-1)" "unprognostic (1.65e-1)" "unprognostic (2.02e-1)" "unprognostic (4.05e-1)" "prognostic favorable (2.20e-4)" "unprognostic (2.20e-1)" "unprognostic (9.87e-2)" "unprognostic (7.65e-3)" "unprognostic (3.50e-2)" "prognostic unfavorable (2.85e-6)" "unprognostic (2.61e-1)" "unprognostic (4.65e-1)" "unprognostic (1.02e-1)" "unprognostic (7.24e-2)" 9.4 4.6 16.3 2.3 15.0 0.9 3.6 5.7 18.8 4.9 3.1 5.1 3.3 2.0 3.8 5.7 4.7 7.4 5.2 2.7 14.7 9.2 2.4 3.2 3.0 2.3 18.1 4.7 13.2 3.2 4.8 2.1 1.6 8.7 3.8 3.0 108.1 2.5 5.9 2.2 3.7 1.7 6.3 21.6 2.5 2.4 3.7 7.7 0.7 3.0 2.2 2.6 3.1 9.2 1.1 0.8 0.8 1.2 5.6 3.2 1.4 2.1 1.2 2.2 4.6 3.2 15.7 0.4 1.4 2.5 3.1 2.0 0.6 3.6 2.0 10.0 8.1 1.3 2.8 1.0 2.8 0.8 3.6 1.8 1.8 5.4 2.6 9.3 0.7 0.6 17.9 4.1 3.2 6.4 10.5 4.8 0.9 2.7 4.6 6.2 5.4 1.1 1.5 0.5 1.1 3.3 1.1 1.8 12.8 3.4 1.2 2.3 3.4 3.5 4.1 1.6 0.3 5.6 0.9 5.4 5.1 1.9 6.0 1.6 2.1 18.8 1.6 9.5 2.1 1.0 0.0 1.2 0.8 0.9 0.3 2.4 0.7 3.2 0.8 0.6 1.1 1.5 1.8 0.4 5.6 1.1 0.8 0.9 1.4 16.3 15.0 5.7 8.4 14.7 9.2 18.1 4.7 8.7 7.7 0.0 4.1 0.0 4.4 3.3 268.3 2.4 0.0 2.7 1.2 5.2 559.6 0.8 1.7 1.3 2.1 8.0 1.6 0.0 2.7 0.2 3.5 2.6 1.1 0.6 1.0 162.1 4.1 11.1 1.8 5.9 17.5 1.0 3.3 1.0 2.8 315.6 1.7 3.4 5.3 4.0 2384.7 0.0 3.4 0.9 2.7 0.9 0.6 0.0 2.9 2.0 RPE ENSG00000197713 Ribulose-5-phosphate-3-epimerase Q96AT9 2 210002565-210022259 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA036498, HPA036499" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA036498: AB_2675157, HPA036499: AB_10670109" "unprognostic (5.07e-2)" "unprognostic (8.15e-2)" "unprognostic (3.06e-1)" "unprognostic (2.34e-3)" "unprognostic (2.00e-1)" "unprognostic (2.53e-2)" "prognostic unfavorable (1.42e-6)" "unprognostic (1.59e-3)" "unprognostic (1.69e-2)" "unprognostic (1.28e-1)" "prognostic unfavorable (7.00e-6)" "unprognostic (2.33e-2)" "unprognostic (2.55e-2)" "unprognostic (1.10e-1)" "unprognostic (1.95e-1)" "unprognostic (2.89e-1)" "unprognostic (5.84e-2)" 19.4 26.9 20.6 16.7 28.0 14.6 22.6 26.4 27.7 18.7 19.7 23.3 20.7 17.4 27.8 21.5 24.0 17.6 17.3 17.2 21.1 21.0 26.7 23.3 19.4 21.6 21.7 21.7 22.9 14.1 14.8 41.9 24.4 18.6 20.5 26.6 18.9 18.3 27.9 12.3 17.2 16.0 27.1 25.8 15.6 19.8 11.9 19.7 23.5 25.2 14.5 23.2 24.1 20.2 8.6 28.9 8.0 20.5 30.5 10.7 11.3 20.6 26.8 17.4 17.5 28.3 27.4 29.9 27.2 21.8 25.9 34.8 38.5 31.7 13.9 17.9 21.0 35.1 20.3 25.6 29.0 39.6 16.7 18.1 25.8 39.3 35.9 38.6 27.3 19.9 19.2 28.9 29.7 38.7 23.6 33.7 13.9 25.9 19.4 21.2 32.9 14.8 23.8 25.5 41.7 19.6 18.7 20.8 19.9 29.9 30.9 20.9 12.0 23.0 22.5 18.2 32.8 19.4 31.4 27.6 34.8 23.2 16.9 25.1 11.7 14.8 29.9 25.2 27.0 22.5 6.9 17.3 8.0 10.2 20.5 8.9 8.6 8.0 9.6 28.9 8.4 10.7 9.6 1.7 30.5 13.7 10.6 10.7 11.3 20.6 28.0 26.4 27.7 21.1 21.0 21.7 21.7 18.6 19.7 6.0 6.9 14.7 13.5 14.7 12.5 5.3 7.6 13.4 19.4 17.4 19.6 32.4 26.6 20.5 8.8 11.9 12.3 23.3 15.1 36.8 15.5 12.1 5.8 15.5 33.1 9.5 9.8 17.2 17.6 9.3 10.3 20.4 13.5 16.2 14.2 8.2 17.4 14.0 13.8 37.0 12.9 6.5 14.1 16.4 16.1 17.8 21.4 11.4 18.9 12.0 RPEL1 ENSG00000235376 "Ribulose-5-phosphate-3-epimerase like 1" Q2QD12 10 103245887-103248016 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism" Isomerase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.4;brain: 1.2;pituitary gland: 1.2" "Cell type enhanced" "Detected in some" 16 "Bipolar cells: 2.9;Cone photoreceptor cells: 7.9;Rod photoreceptor cells: 2.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HeLa: 1.1;NB-4: 1.1" "HPA036498, HPA036499" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA036498: AB_2675157, HPA036499: AB_10670109" "unprognostic (7.52e-2)" "unprognostic (1.69e-1)" "unprognostic (4.78e-2)" "unprognostic (1.54e-1)" "unprognostic (1.45e-1)" "unprognostic (1.83e-1)" "unprognostic (6.01e-2)" "unprognostic (1.15e-1)" "unprognostic (8.91e-2)" "unprognostic (6.59e-2)" "unprognostic (4.34e-1)" "unprognostic (1.14e-1)" "unprognostic (5.69e-2)" "unprognostic (1.62e-1)" "unprognostic (6.72e-2)" "unprognostic (5.06e-2)" 0.0 0.1 0.1 1.0 0.3 0.1 0.1 1.2 0.2 0.0 0.0 0.3 0.4 0.4 0.1 0.0 0.0 0.1 0.1 0.3 0.3 0.0 0.0 0.4 0.1 0.0 0.8 0.0 1.2 0.2 0.1 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.2 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.4 1.0 0.3 0.7 1.4 0.6 0.2 0.5 0.5 0.1 0.0 0.0 0.0 0.2 0.3 0.2 0.0 0.2 0.4 0.7 0.1 0.4 0.0 0.1 0.2 0.0 0.0 0.0 0.6 0.0 0.3 1.1 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.2 1.1 0.7 0.2 0.0 0.0 0.1 0.3 0.5 0.2 0.3 0.1 0.3 0.4 0.2 0.1 0.1 0.4 0.0 0.1 0.9 0.1 0.2 0.3 0.1 0.3 0.7 0.4 0.1 0.3 0.7 0.2 0.5 0.7 0.5 0.4 0.4 0.3 1.0 0.4 0.5 0.6 0.0 1.4 0.4 0.3 0.4 0.2 0.0 0.0 0.0 0.1 0.1 2.9 1.5 0.0 0.0 1.2 0.0 7.9 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.4 0.2 0.0 0.0 0.0 0.5 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.6 0.0 0.2 0.0 0.0 0.0 2.6 0.0 0.9 0.0 0.2 0.3 0.3 0.0 0.7 0.0 RPGRIP1L "CORS3, FTM, JBTS7, KIAA1005, MKS5, NPHP8, PPP1R134" ENSG00000103494 "RPGRIP1 like" Q68CZ1 16 53598153-53703938 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease mutation, Joubert syndrome, Meckel syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 25.8" "Cell type enhanced" "Detected in many" 14 "Ciliated cells: 109.7;Spermatocytes: 38.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039405, HPA040530" Uncertain Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039405: AB_10794636, HPA040530: AB_2677023" "prognostic unfavorable (6.93e-4)" "unprognostic (1.52e-1)" "unprognostic (2.19e-3)" "unprognostic (2.26e-2)" "unprognostic (3.43e-2)" "unprognostic (1.46e-2)" "unprognostic (1.26e-4)" "unprognostic (1.24e-1)" "unprognostic (1.05e-1)" "unprognostic (3.63e-1)" "unprognostic (1.05e-1)" "unprognostic (3.31e-1)" "prognostic unfavorable (5.95e-4)" "unprognostic (5.22e-3)" "unprognostic (1.52e-1)" "unprognostic (4.92e-4)" "unprognostic (5.95e-2)" 3.0 6.5 8.0 3.8 13.8 2.7 6.1 5.3 12.7 6.3 3.3 2.4 6.8 2.4 7.3 7.8 3.9 11.7 4.9 3.3 9.1 9.9 5.5 2.2 3.5 3.1 5.9 13.2 6.5 3.2 18.5 25.8 3.8 9.0 5.2 3.5 1.7 3.4 5.3 2.3 3.6 2.0 6.3 3.5 1.9 3.5 20.9 4.7 3.1 7.6 2.3 3.1 4.4 3.6 4.9 2.0 1.8 1.0 2.1 5.6 1.3 9.1 11.3 10.2 9.4 12.3 12.0 4.5 10.2 6.7 9.5 2.7 6.2 7.4 6.1 7.4 10.4 6.4 10.6 8.5 9.7 16.9 3.7 5.9 2.2 9.6 6.2 5.1 5.5 4.2 7.5 6.0 10.6 6.6 10.4 7.1 8.5 5.6 3.5 14.0 3.5 9.0 3.9 6.5 3.2 5.4 15.4 14.0 7.3 12.3 2.4 17.8 6.7 12.6 5.3 4.6 6.5 8.0 4.4 6.4 10.4 7.4 8.5 9.0 4.6 5.3 10.8 15.7 3.3 6.1 1.7 0.9 1.1 3.6 1.0 3.5 3.2 2.6 3.3 0.8 4.9 2.6 5.6 1.8 2.1 1.0 2.0 2.1 1.3 8.0 13.8 5.3 12.7 9.1 9.9 5.9 13.2 9.0 4.7 6.0 3.7 3.2 2.8 4.0 5.1 7.3 0.0 109.7 19.4 10.4 7.9 4.6 14.9 6.5 13.1 2.5 0.1 0.0 2.7 6.2 9.3 1.4 6.9 3.8 2.4 3.2 0.0 3.7 1.2 9.0 4.4 2.8 1.7 2.8 3.8 6.1 3.5 0.0 6.0 14.2 8.4 6.5 4.1 38.1 11.0 4.6 1.4 1.0 3.8 2.1 RPL36A "L36A, RPL44" ENSG00000241343 "Ribosomal protein L36a" P83881 X 101390824-101396154 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Undifferentiated cells: 3155.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA063979, HPA077586" Uncertain Supported "Endoplasmic reticulum,Plasma membrane,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "Plasma membrane" "HPA063979: AB_2685164, HPA077586: AB_2686846" "unprognostic (3.38e-2)" "unprognostic (2.11e-2)" "unprognostic (7.04e-2)" "unprognostic (2.06e-1)" "unprognostic (1.02e-2)" "unprognostic (4.19e-3)" "unprognostic (4.15e-3)" "unprognostic (1.28e-1)" "unprognostic (2.86e-2)" "unprognostic (2.77e-1)" "unprognostic (2.19e-2)" "unprognostic (8.17e-2)" "prognostic unfavorable (8.81e-11)" "unprognostic (1.87e-2)" "unprognostic (4.50e-3)" "unprognostic (3.57e-3)" "unprognostic (4.06e-2)" 62.9 40.7 50.7 81.5 53.8 139.8 136.1 27.7 46.8 65.3 71.0 25.1 53.4 45.6 67.5 71.4 77.1 59.0 60.6 54.9 43.1 31.1 47.3 60.1 43.4 190.1 42.1 50.6 165.3 171.4 15.0 35.1 44.7 41.8 55.9 68.3 26.1 158.1 71.5 125.7 96.5 54.1 65.5 44.6 67.9 54.6 26.3 32.6 60.8 69.3 118.6 104.0 71.9 74.0 162.9 113.2 13.7 74.2 86.7 175.5 199.2 121.6 65.9 101.2 49.8 124.8 224.0 64.8 93.8 102.9 123.1 188.1 78.0 62.6 235.8 93.9 77.8 75.9 82.2 151.3 131.4 128.3 83.0 166.0 109.0 116.2 71.9 179.5 198.3 105.1 212.5 248.1 99.7 184.9 165.2 113.8 103.1 131.7 126.8 99.1 175.3 91.8 236.6 134.6 252.8 134.0 86.2 221.6 184.8 112.5 50.8 68.0 135.7 87.6 98.4 167.8 84.2 47.5 224.4 105.0 36.6 89.6 101.0 95.0 108.0 154.1 186.4 45.0 295.6 39.0 12.5 74.2 13.7 86.6 73.6 140.3 162.9 162.3 120.6 111.4 134.0 175.5 156.7 7.2 86.7 70.4 113.2 84.9 199.2 50.7 53.8 27.7 46.8 43.1 31.1 42.1 50.6 41.8 32.6 408.0 871.7 1431.2 350.0 815.0 25.3 12.6 713.4 501.9 1443.4 165.7 13.7 675.4 368.1 934.6 6.2 708.2 731.9 397.1 2614.9 904.3 568.3 225.8 1204.1 656.9 533.8 14.3 1058.9 1162.0 2037.4 20.4 977.8 917.6 497.7 1450.9 2170.9 77.3 2295.7 1329.1 393.5 579.9 33.5 232.8 598.3 23.3 110.3 980.8 628.4 1100.0 3155.0 282.8 RPL36A-HNRNPH2 ENSG00000257529 "RPL36A-HNRNPH2 readthrough" X 101391011-101412297 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 18 "Alveolar cells type 2: 29.9;Ciliated cells: 33.5;Club cells: 53.4;granulocytes: 25.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ: 14.8" HPA077586 Approved "Endoplasmic reticulum,Plasma membrane,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "Plasma membrane" "HPA077586: AB_2686846" "unprognostic (3.69e-1)" "unprognostic (1.44e-2)" "unprognostic (2.91e-1)" "unprognostic (4.65e-3)" "unprognostic (1.63e-1)" "unprognostic (2.96e-1)" "unprognostic (1.79e-1)" "unprognostic (5.34e-2)" "unprognostic (2.27e-2)" "unprognostic (2.15e-2)" "unprognostic (2.56e-1)" "unprognostic (1.49e-3)" "unprognostic (2.04e-4)" "unprognostic (1.56e-1)" "unprognostic (4.81e-2)" "unprognostic (3.94e-1)" 6.7 6.0 3.7 8.5 5.0 7.2 6.1 15.3 5.2 5.9 9.9 1.4 4.9 1.5 6.7 7.2 6.9 4.5 5.8 5.1 3.7 5.4 4.3 5.8 4.5 22.1 4.6 4.6 12.7 19.7 1.5 3.6 4.2 3.5 5.2 4.5 1.5 18.1 7.2 14.0 5.3 4.4 6.4 5.0 6.5 4.3 2.5 2.3 5.9 6.9 13.1 6.2 7.3 7.5 16.2 19.8 13.6 16.1 10.6 14.3 22.4 3.7 0.0 5.1 1.0 2.3 5.2 1.7 14.8 0.7 3.0 2.2 0.0 2.2 3.5 4.6 2.1 0.2 0.4 4.4 0.6 1.0 4.4 1.7 4.1 2.7 1.3 4.0 3.6 1.7 5.6 2.8 1.6 1.1 3.8 1.8 2.2 1.4 4.3 4.0 0.6 5.7 2.3 0.4 1.9 2.0 7.2 5.3 2.8 1.3 0.6 3.2 4.6 1.8 1.6 1.8 1.3 1.8 2.0 2.1 0.5 2.8 2.5 2.6 3.7 6.4 1.2 1.4 3.5 3.1 7.5 14.9 13.6 13.1 16.1 11.5 16.2 12.3 12.4 19.8 15.4 14.3 13.6 4.7 10.6 9.9 10.7 9.0 22.4 3.7 5.0 15.3 5.2 3.7 5.4 4.6 4.6 3.5 2.3 11.9 29.9 0.0 0.0 0.0 0.0 0.0 0.0 33.5 53.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RPL36AL RPL36A ENSG00000165502 "Ribosomal protein L36a like" Q969Q0 14 49618519-49620685 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA077586 Approved "Endoplasmic reticulum,Plasma membrane,Cytosol" NA Yes "Endoplasmic reticulum, Cytosol" "Plasma membrane" "HPA077586: AB_2686846" "unprognostic (1.55e-2)" "unprognostic (2.44e-2)" "unprognostic (8.73e-2)" "unprognostic (3.15e-3)" "unprognostic (1.52e-1)" "unprognostic (2.55e-2)" "unprognostic (1.31e-1)" "unprognostic (6.37e-2)" "unprognostic (4.18e-2)" "unprognostic (1.38e-3)" "unprognostic (2.29e-1)" "unprognostic (4.72e-1)" "unprognostic (1.16e-3)" "unprognostic (8.32e-2)" "unprognostic (2.80e-1)" "prognostic favorable (2.83e-4)" "unprognostic (1.00e-1)" 60.3 55.8 45.9 46.5 40.9 68.2 66.5 35.9 37.7 69.3 74.3 29.2 56.6 52.1 54.9 102.1 61.8 45.9 31.5 48.2 38.0 34.4 69.9 139.2 54.8 63.6 45.3 34.1 105.3 131.9 35.7 62.0 56.9 40.3 62.9 50.5 30.8 85.2 68.6 82.4 40.8 99.8 71.1 48.0 78.8 61.8 36.7 41.8 65.4 72.5 67.6 71.0 87.6 63.9 105.8 112.7 119.5 66.7 84.5 132.0 139.8 73.4 55.4 40.1 23.2 57.7 79.8 23.5 60.7 67.1 56.9 64.5 57.6 50.9 96.9 57.9 50.2 40.1 53.0 34.0 51.8 66.6 33.2 39.2 60.7 58.5 74.3 73.1 96.9 52.2 81.6 79.4 43.5 58.8 67.6 72.0 43.8 38.5 86.3 43.7 94.8 57.0 87.0 22.5 52.9 57.0 36.1 63.1 51.9 86.3 111.8 35.1 21.7 53.4 42.4 60.8 39.8 91.8 53.9 55.4 35.7 56.8 46.4 46.7 52.6 53.7 97.8 25.8 43.9 33.9 119.5 66.7 99.6 98.6 63.2 132.0 105.8 129.3 123.0 68.7 79.9 120.7 112.6 74.0 84.5 55.9 112.7 118.2 139.8 45.9 40.9 35.9 37.7 38.0 34.4 45.3 34.1 40.3 41.8 285.9 358.6 508.2 1190.5 840.1 106.5 561.0 550.3 325.2 378.7 296.6 23.6 568.2 843.9 636.4 440.5 541.3 862.9 397.1 1188.0 608.8 559.0 968.4 688.3 743.7 689.7 76.3 351.4 449.9 649.0 160.8 672.0 707.1 799.7 1234.5 570.5 159.8 1112.3 813.6 502.0 790.1 95.2 478.6 799.2 285.3 135.9 733.7 431.8 698.8 483.1 1226.2 RRAD "RAD, REM3" ENSG00000166592 "RRAD, Ras related glycolysis inhibitor and calcium channel regulator" P55042 16 66921679-66925644 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "skeletal muscle: 246.0" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 2: 183.7;Cardiomyocytes: 231.4;Sertoli cells: 109.9;Smooth muscle cells: 182.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "HDLM-2: 62.2;U-87 MG: 18.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA041755 Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Golgi apparatus" "HPA041755: AB_2677655" "unprognostic (1.40e-2)" "unprognostic (2.78e-2)" "unprognostic (9.77e-2)" "unprognostic (3.84e-2)" "unprognostic (1.36e-2)" "unprognostic (1.11e-1)" "unprognostic (3.74e-2)" "unprognostic (2.37e-1)" "unprognostic (1.66e-1)" "unprognostic (2.46e-2)" "unprognostic (2.12e-2)" "unprognostic (1.08e-1)" "unprognostic (2.06e-3)" "unprognostic (3.46e-2)" "unprognostic (3.33e-2)" "unprognostic (2.04e-2)" "unprognostic (4.80e-3)" 7.3 2.1 0.4 2.4 2.7 1.3 5.0 1.2 1.7 4.7 2.0 3.2 1.8 1.2 3.3 8.5 20.4 6.3 4.1 61.2 0.7 0.6 5.6 0.8 6.3 1.3 1.5 0.8 4.7 0.7 1.0 2.0 10.7 4.6 4.2 0.4 3.9 4.3 1.4 246.0 2.2 1.2 5.7 1.7 0.8 1.7 2.3 1.2 0.3 3.9 14.7 4.3 4.5 5.7 0.0 0.0 0.0 0.1 0.0 0.8 0.1 0.0 2.8 0.0 0.0 0.0 0.3 0.1 1.6 0.1 0.2 1.4 0.7 1.9 0.0 1.6 0.1 0.5 0.1 0.0 0.1 0.2 62.2 0.1 0.0 0.0 0.7 2.8 0.0 0.2 0.8 0.3 5.0 0.0 1.2 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.1 0.2 0.0 0.1 0.2 0.1 0.0 0.3 0.0 0.1 0.2 1.5 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.1 0.1 2.0 0.0 0.1 18.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.4 2.7 1.2 1.0 0.7 0.6 1.5 0.8 4.6 1.2 65.5 183.7 3.5 1.9 8.4 12.5 231.4 0.0 83.0 19.4 64.6 9.8 1.0 19.9 33.7 1.5 14.0 4.9 0.0 2.7 2.7 26.9 9.8 33.5 0.0 1.3 1.6 10.2 1.3 1.5 0.4 0.6 14.2 21.9 1.0 2.7 1.5 34.5 1.7 4.9 5.8 3.0 109.9 182.3 1.7 1.9 8.8 4.7 2.2 3.0 2.6 RSBN1L "FLJ42526, FLJ45813, MGC71764" ENSG00000187257 "Round spermatid basic protein 1 like" Q6PCB5 7 77696443-77783022 "Cancer-related genes, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 337.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 31.5" "Lineage enriched" "Detected in all" 4 "granulocytes: 31.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020406, HPA020413" Approved Supported "Nuclear speckles,Plasma membrane" NA NA "Nuclear speckles" "Plasma membrane" "HPA020406: AB_1856488, HPA020413: AB_2253910" "unprognostic (2.02e-1)" "unprognostic (2.61e-2)" "unprognostic (2.41e-1)" "unprognostic (1.72e-1)" "unprognostic (1.34e-1)" "unprognostic (3.62e-2)" "unprognostic (2.43e-2)" "prognostic favorable (3.74e-4)" "unprognostic (1.27e-2)" "unprognostic (3.78e-2)" "unprognostic (1.25e-1)" "unprognostic (9.02e-2)" "unprognostic (7.30e-3)" "unprognostic (1.93e-1)" "unprognostic (1.46e-1)" "unprognostic (2.25e-3)" "unprognostic (1.53e-3)" 12.9 10.6 15.0 22.1 14.6 9.5 15.5 28.7 17.0 22.8 23.5 8.9 12.1 11.1 17.2 13.6 15.0 14.2 13.4 10.6 12.4 10.3 12.0 14.9 15.7 18.2 11.1 11.0 19.2 14.9 19.5 16.2 12.2 11.8 18.8 15.1 13.9 14.0 15.4 13.6 11.7 14.9 18.0 11.0 20.7 14.3 29.8 13.8 34.5 21.1 6.7 18.0 23.6 28.2 7.2 7.0 31.5 4.0 3.0 5.2 1.2 9.0 7.0 11.7 20.5 8.2 10.5 5.7 6.7 7.3 9.6 11.0 8.6 16.2 18.6 2.6 6.9 12.1 7.9 15.8 8.7 13.8 10.1 8.5 14.8 11.0 8.4 6.9 18.1 14.0 7.5 6.4 8.8 9.7 7.3 7.9 12.4 20.1 19.6 9.9 10.4 15.5 18.3 8.3 11.7 6.3 16.2 11.7 19.5 6.0 11.9 13.8 14.4 10.2 18.6 7.3 12.4 11.3 9.7 7.5 14.4 13.3 8.6 10.2 8.8 9.3 29.9 6.8 16.9 9.4 9.1 4.0 6.4 5.2 2.9 3.9 5.4 4.5 3.8 2.2 7.2 4.3 4.7 31.5 3.0 3.2 7.0 4.5 1.2 15.0 14.6 28.7 17.0 12.4 10.3 11.1 11.0 11.8 13.8 53.6 44.7 77.1 91.4 69.9 234.2 15.9 38.2 69.6 80.8 52.4 221.9 45.1 33.2 32.4 254.3 67.5 45.0 0.0 43.8 30.0 64.1 42.7 68.2 48.3 38.0 149.4 74.4 43.0 41.9 50.1 94.0 54.7 60.8 45.1 68.1 88.8 31.9 58.5 112.4 18.0 337.1 71.1 85.6 98.9 156.4 65.7 32.4 99.1 57.8 72.2 RSPH3 "dJ111C20.1, RSHL2, RSP3" ENSG00000130363 "Radial spoke head 3 homolog" Q86UC2 6 158972871-159000187 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 113.8;Early spermatids: 110.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 13.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039109, HPA040230" Approved Approved "Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane, Cytosol" "HPA039109: AB_10794423, HPA040230: AB_10796119" "unprognostic (6.18e-3)" "unprognostic (3.62e-3)" "unprognostic (4.54e-2)" "unprognostic (6.20e-2)" "unprognostic (1.88e-1)" "unprognostic (9.18e-2)" "unprognostic (1.14e-2)" "unprognostic (1.65e-1)" "unprognostic (1.15e-1)" "unprognostic (6.74e-3)" "unprognostic (6.98e-2)" "unprognostic (2.52e-1)" "prognostic favorable (2.19e-4)" "unprognostic (5.89e-2)" "unprognostic (1.67e-1)" "unprognostic (5.14e-2)" "unprognostic (1.79e-2)" 4.9 9.0 7.1 3.8 9.8 3.1 6.2 6.3 12.7 6.8 8.2 7.0 14.3 11.3 7.4 12.8 15.5 10.7 6.0 6.6 8.0 6.8 10.7 5.4 8.5 2.6 4.8 10.6 7.3 8.6 25.9 14.4 5.5 10.4 8.9 6.5 5.5 10.3 14.9 3.8 7.6 12.2 6.6 6.0 3.9 7.5 24.3 7.0 2.1 12.8 5.1 3.9 9.1 8.4 2.3 5.8 13.0 7.7 1.8 1.8 1.6 9.8 5.1 2.3 5.4 5.4 6.9 2.9 7.0 8.2 2.8 3.7 2.0 6.0 2.1 6.5 7.5 7.6 7.5 1.5 6.6 3.1 4.8 4.4 2.7 5.0 3.4 5.2 2.5 1.9 8.5 11.8 4.5 8.9 10.7 2.7 2.7 3.1 3.4 4.6 5.6 1.5 3.1 1.5 4.3 3.4 2.4 0.4 2.1 8.8 3.2 3.5 4.4 13.2 4.4 2.5 2.9 5.4 6.2 6.4 2.9 7.4 5.6 3.8 3.6 6.9 1.8 12.4 3.3 4.6 0.7 5.2 0.6 0.8 3.6 1.8 1.3 1.2 1.6 5.4 2.3 1.0 1.4 13.0 1.8 7.7 5.8 1.4 1.6 7.1 9.8 6.3 12.7 8.0 6.8 4.8 10.6 10.4 7.0 23.8 13.2 0.5 14.8 6.5 12.2 15.9 15.3 113.8 25.0 21.0 33.4 9.0 11.6 12.7 110.2 5.8 27.3 0.0 9.0 8.8 8.9 17.9 2.3 7.5 9.2 3.2 12.6 6.7 10.3 47.9 13.0 11.6 6.8 1.0 18.0 13.4 10.9 14.4 16.6 16.5 29.6 6.5 6.1 45.3 8.7 7.8 4.9 8.7 10.0 19.7 RTL3 "FLJ38865, Mar3, Mart3, SIRH9, ZCCHC5, ZHC5" ENSG00000179300 "Retrotransposon Gag like 3" Q8N8U3 X 78656069-78659328 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "endometrium 1: 2.5;intestine: 2.6;smooth muscle: 2.7;stomach 1: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+ RasG12V: 2.6;fHDF/TERT166: 4.0;GAMG: 3.2;HBF TERT88: 5.4;hTEC/SVTERT24-B: 3.9;RH-30: 4.7;U-251 MG: 3.4" "HPA051991, HPA053174, HPA075136" Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA Nucleoplasm "Golgi apparatus, Plasma membrane" "HPA051991: AB_2681683, HPA053174: AB_2682069, HPA075136: AB_2686737" "unprognostic (3.43e-1)" "unprognostic (1.06e-1)" "unprognostic (1.29e-1)" "unprognostic (6.74e-2)" "unprognostic (5.11e-2)" "unprognostic (8.64e-2)" "unprognostic (1.23e-1)" "unprognostic (1.69e-2)" "unprognostic (2.85e-1)" "unprognostic (4.00e-6)" "unprognostic (1.53e-2)" "unprognostic (3.64e-1)" "unprognostic (2.49e-1)" 0.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 2.6 0.2 2.5 0.2 0.5 0.4 0.5 2.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.5 0.7 0.0 0.1 0.3 1.1 2.7 0.0 0.0 3.2 0.0 0.1 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.9 2.4 2.6 0.0 0.0 0.0 0.1 4.0 3.2 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.9 0.0 0.6 0.0 0.6 0.0 0.1 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.2 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.8 0.0 0.1 1.4 0.2 3.4 0.2 0.0 0.0 1.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RTL4 "FLJ46608, Mar4, Mart4, SIRH11, ZCCHC16" ENSG00000187823 "Retrotransposon Gag like 4" Q6ZR62 X 112454500-112457112 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "kidney: 3.5;liver: 4.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "testis cancer: 1.4;thyroid cancer: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.8;SuSa: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA003272 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA003272: AB_2257414" "unprognostic (9.86e-2)" "unprognostic (2.04e-4)" "unprognostic (6.35e-2)" "unprognostic (5.33e-3)" 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 3.5 4.7 0.0 0.0 0.7 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 S100A13 ENSG00000189171 "S100 calcium binding protein A13" Q99584 1 153618787-153631360 "Predicted intracellular proteins, Predicted secreted proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Leydig cells: 714.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 19.4" "Group enriched" "Detected in many" 5 "dendritic cells: 8.4;NK-cells: 19.4" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 94.7;SuSa: 111.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019592, CAB025494" Approved Approved "Nucleoplasm,Nucleoli,Plasma membrane,Cytosol" "Secreted in other tissues" NA NA "Plasma membrane, Cytosol" "Nucleoplasm, Nucleoli" "CAB025494: , HPA019592: AB_10601499" "unprognostic (1.50e-2)" "unprognostic (9.09e-2)" "unprognostic (2.08e-2)" "unprognostic (1.45e-1)" "unprognostic (7.77e-2)" "unprognostic (9.72e-3)" "unprognostic (1.75e-3)" "unprognostic (9.93e-2)" "unprognostic (6.48e-2)" "unprognostic (1.67e-1)" "unprognostic (1.21e-2)" "unprognostic (4.83e-3)" "prognostic unfavorable (1.97e-4)" "unprognostic (3.43e-2)" "unprognostic (8.10e-2)" "unprognostic (1.82e-3)" "unprognostic (1.72e-2)" 38.2 20.9 49.6 13.8 48.3 1.2 61.8 11.5 28.2 39.1 32.3 25.0 13.9 9.4 23.5 25.0 19.9 34.5 32.0 56.3 30.3 32.0 28.0 20.2 23.3 12.7 54.2 32.7 29.9 13.9 45.9 9.7 21.6 37.7 23.0 19.3 21.1 19.8 21.7 73.8 14.1 13.7 27.2 38.9 13.7 11.9 10.3 28.5 2.4 79.0 28.2 14.6 21.1 16.0 2.6 8.4 3.0 1.5 19.4 0.9 0.8 21.1 17.7 20.5 13.0 18.1 53.1 7.4 29.4 46.6 17.8 20.5 17.2 23.6 0.5 55.9 49.8 2.6 20.2 8.5 18.2 15.8 0.0 7.9 1.3 22.2 14.6 12.0 0.6 4.6 42.7 6.9 15.9 17.2 52.5 40.2 0.1 6.8 0.0 55.3 74.9 0.0 0.3 16.5 18.2 53.5 3.3 21.2 0.1 94.7 16.2 6.3 0.2 62.8 32.4 63.5 111.1 26.4 0.7 56.9 12.3 6.9 16.4 35.3 0.2 0.5 0.9 22.0 0.3 7.2 3.0 1.5 0.1 0.3 0.7 0.6 2.6 0.3 0.2 5.0 1.6 0.5 0.3 0.2 19.4 0.9 8.4 0.9 0.8 49.6 48.3 11.5 28.2 30.3 32.0 54.2 32.7 37.7 28.5 26.8 88.4 17.1 154.8 98.1 2.0 108.1 175.8 60.2 93.3 441.4 0.0 118.0 210.5 277.9 6.5 300.3 126.3 46.7 281.2 170.7 294.9 188.4 23.1 34.1 128.8 0.0 119.8 371.4 32.4 21.5 714.6 43.9 226.0 20.8 107.7 97.5 336.0 115.8 295.2 330.9 5.7 0.0 84.3 7.5 18.3 66.1 62.5 8.6 64.8 157.7 S100A14 "BCMP84, S100A15" ENSG00000189334 "S100 calcium binding protein A14" Q9HCY8 1 153614255-153616986 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 256.0;tongue: 189.3" "Cell type enhanced" "Detected in many" 15 "Basal keratinocytes: 2079.3;Enterocytes: 1153.1;Suprabasal keratinocytes: 3157.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 11 "plasmacytoid DC: 1.1" "Lineage enriched" "Detected in single" 11 "dendritic cells: 1.1" "Cell line enhanced" "Detected in some" "A-431: 61.0;HaCaT: 84.7;HBEC3-KT: 120.1;hTCEpi: 179.0;OE19: 129.5;SK-BR-3: 126.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA027613 Enhanced Approved "Nuclear bodies,Plasma membrane,Cell Junctions,Cytosol" NA NA 110000 "Nuclear bodies, Plasma membrane, Cell Junctions, Cytosol" "HPA027613: AB_10602298" "unprognostic (1.73e-1)" "unprognostic (1.85e-1)" "unprognostic (1.48e-1)" "unprognostic (3.94e-2)" "unprognostic (1.75e-2)" "unprognostic (6.27e-2)" "unprognostic (2.30e-2)" "unprognostic (9.48e-2)" "unprognostic (2.50e-1)" "unprognostic (2.16e-1)" "unprognostic (2.75e-3)" "unprognostic (2.89e-1)" "unprognostic (3.16e-3)" "unprognostic (8.41e-2)" "unprognostic (1.80e-1)" "unprognostic (4.81e-2)" "unprognostic (9.53e-2)" 0.6 0.0 0.6 4.3 0.6 0.0 6.4 0.6 0.6 38.0 19.2 0.6 3.9 21.4 5.7 2.6 256.0 1.2 7.9 0.6 0.6 0.0 2.4 1.2 7.5 0.6 0.6 0.6 0.7 4.6 6.6 0.8 1.4 0.7 1.9 19.6 0.7 41.8 3.1 0.6 41.4 23.8 1.0 0.6 0.6 9.4 0.9 0.6 8.9 9.6 189.3 71.0 2.2 79.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 61.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 7.6 11.1 0.0 0.1 0.0 0.0 84.7 0.0 120.1 0.0 0.0 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.0 179.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 129.5 0.1 0.0 0.0 0.2 0.6 4.0 0.0 0.0 0.1 126.4 0.1 3.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.6 0.6 0.6 0.6 0.6 0.0 0.6 0.6 0.7 0.6 56.6 133.0 0.5 298.4 2079.3 0.0 4.4 214.0 18.7 91.0 33.2 0.0 0.6 41.4 164.9 0.0 0.2 1153.1 0.0 59.6 1.7 22.4 341.3 28.7 5.8 0.3 0.0 147.3 1.3 0.0 0.0 0.0 5.3 229.5 3.6 470.4 0.0 202.6 775.0 0.0 3.1 0.0 0.0 33.3 0.0 0.0 3157.3 0.2 0.7 410.3 819.7 S100A16 "DT1P1A7, MGC17528, S100F" ENSG00000188643 "S100 calcium binding protein A16" Q96FQ6 1 153606886-153613145 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 223.9;tongue: 102.1" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 744.7;Glandular cells: 697.0;Pancreatic endocrine cells: 790.1;Suprabasal keratinocytes: 794.3;Urothelial cells: 1359.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "plasmacytoid DC: 2.0" "Lineage enriched" "Detected in single" 20 "dendritic cells: 2.0" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 117.9;SK-BR-3: 142.9" "Low region specificity" "Detected in all" HPA045841 Enhanced Approved "Plasma membrane,Cytosol" NA NA 92000 Cytosol "Plasma membrane" "HPA045841: AB_10966282" "unprognostic (9.86e-3)" "unprognostic (1.69e-1)" "unprognostic (2.23e-2)" "unprognostic (3.06e-1)" "unprognostic (1.71e-1)" "unprognostic (7.03e-2)" "prognostic unfavorable (3.18e-4)" "prognostic unfavorable (3.14e-5)" "unprognostic (1.70e-1)" "unprognostic (4.59e-1)" "prognostic unfavorable (2.04e-4)" "unprognostic (2.60e-1)" "prognostic unfavorable (3.91e-5)" "unprognostic (1.01e-1)" "unprognostic (1.92e-1)" "unprognostic (3.45e-2)" "unprognostic (5.29e-3)" 20.1 5.5 9.3 8.0 7.2 0.0 11.9 3.4 8.3 37.2 21.1 8.3 3.2 16.2 8.7 7.2 223.9 7.6 18.2 9.5 6.7 5.4 14.3 27.0 18.3 7.5 7.1 5.7 15.3 4.1 6.5 3.3 14.9 7.2 9.3 14.5 5.1 35.5 5.4 9.8 43.1 31.2 10.6 5.9 13.4 10.6 12.3 4.6 3.2 11.3 102.1 87.5 11.3 51.3 0.0 2.0 0.0 0.0 0.0 0.0 0.0 56.4 27.2 1.4 3.2 9.4 35.7 3.7 32.3 29.7 26.6 23.6 25.5 31.6 0.0 51.9 48.3 6.0 41.5 0.0 72.5 15.6 0.1 0.0 0.0 23.7 7.5 10.8 0.0 0.0 16.9 69.7 64.4 50.7 34.8 117.9 0.0 0.6 0.0 58.5 75.0 0.0 0.1 6.0 100.1 73.6 0.0 16.4 0.1 100.2 20.3 0.0 0.1 23.8 142.9 4.7 12.9 44.4 0.3 63.2 16.0 25.6 15.4 73.0 0.0 0.2 0.1 47.6 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 9.3 7.2 3.4 8.3 6.7 5.4 7.1 5.7 7.2 4.6 35.7 18.0 15.1 744.7 563.0 0.4 29.7 119.8 26.8 103.5 102.9 2.0 12.3 61.3 584.7 3.2 283.5 336.2 0.0 172.2 7.2 105.8 697.0 19.5 109.5 4.7 0.0 133.3 333.3 22.5 10.0 62.2 11.1 106.3 12.6 178.6 38.3 790.1 294.7 57.7 126.7 1.8 6.5 41.5 1.7 1.2 794.3 6.9 12.8 201.3 1359.9 S100A2 "CAN19, S100L" ENSG00000196754 "S100 calcium binding protein A2" P29034 1 153561108-153567890 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "esophagus: 224.8;tongue: 246.5" "Cell type enhanced" "Detected in many" 20 "Basal glandular cells: 2667.8;Basal keratinocytes: 10183.7;Suprabasal keratinocytes: 3170.0;Urothelial cells: 4604.3" "Cancer enhanced" "Detected in all" "head and neck cancer: 1229.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "basophil: 11.9" "Lineage enriched" "Detected in many" 4 "granulocytes: 11.9" "Group enriched" "Detected in some" 5 "HBEC3-KT: 671.5;RT4: 262.5" "Not detected" "Not detected" "CAB002600, CAB047340, HPA062451" Enhanced Approved "Nucleoplasm,Nucleoli,Plasma membrane,Cytosol" NA NA 130000 "Nucleoplasm, Cytosol" "Nucleoli, Plasma membrane" "CAB002600: , CAB047340: , HPA062451: AB_2684767" "unprognostic (8.47e-3)" "unprognostic (5.54e-2)" "unprognostic (1.57e-2)" "unprognostic (1.42e-3)" "unprognostic (1.98e-1)" "unprognostic (3.20e-1)" "unprognostic (4.21e-4)" "unprognostic (9.00e-2)" "unprognostic (1.64e-1)" "unprognostic (1.23e-2)" "prognostic unfavorable (2.04e-4)" "unprognostic (3.52e-2)" "unprognostic (8.91e-2)" "unprognostic (1.35e-1)" "unprognostic (2.70e-1)" "unprognostic (1.39e-1)" "unprognostic (2.68e-1)" 0.4 0.0 0.4 0.5 0.4 0.0 2.1 0.4 0.5 16.9 0.4 0.4 0.9 0.0 1.8 1.9 224.8 0.5 0.4 0.4 0.4 0.0 16.6 0.4 1.6 0.4 0.4 0.4 0.4 0.4 0.0 0.5 0.6 0.6 3.3 0.0 0.4 23.3 2.1 0.7 27.5 0.4 1.5 0.5 0.4 0.0 0.5 0.4 0.7 1.0 246.5 48.4 36.2 43.8 0.5 2.6 11.9 0.6 0.0 2.9 0.7 25.4 0.2 0.0 0.0 0.3 0.1 0.0 0.3 0.3 0.2 0.2 0.0 0.8 0.0 13.5 0.5 0.5 63.2 0.0 671.5 0.3 0.1 0.1 0.1 1.7 0.1 0.1 0.0 0.0 0.2 89.4 0.7 102.0 0.7 0.4 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.6 4.9 0.0 16.0 0.0 15.9 262.5 0.5 0.0 1.1 0.1 0.2 0.2 0.1 0.1 0.1 0.4 22.2 2.9 8.6 0.0 0.0 0.1 0.8 0.0 0.7 11.9 0.5 0.0 2.9 0.0 1.8 0.5 2.0 1.6 0.4 0.0 0.6 0.5 5.0 0.0 0.6 2.6 1.8 0.7 0.4 0.4 0.4 0.5 0.4 0.0 0.4 0.4 0.6 0.4 8.9 15.9 2.2 2667.8 10183.7 0.0 2.0 2.5 307.9 1714.1 207.6 0.0 0.1 1039.5 26.2 3.0 3.6 1.3 0.0 24.2 0.9 117.2 609.3 16.2 0.0 1.8 0.0 1.7 0.6 1.5 3.8 0.6 38.5 720.4 9.0 1.7 1.0 390.7 2.9 0.7 9.8 0.0 0.0 213.2 0.2 2.3 3170.0 0.2 1.3 1.5 4604.3 SAMHD1 "AGS5, HDDC1, Mg11, MOP-5, SBBI88" ENSG00000101347 "SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1" Q9Y3Z3 20 36889773-36951901 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, DNA damage, DNA repair, DNA replication, Host-virus interaction, Immunity, Innate immunity" "Allosteric enzyme, Hydrolase" "Aicardi-Goutieres syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Hofbauer cells: 131.6;Kupffer cells: 243.3;Macrophages: 175.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 46.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 58.1;BJ hTERT+ SV40 Large T+: 24.6;BJ hTERT+ SV40 Large T+ RasG12V: 26.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047072 Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA 100000 Nucleoplasm "Plasma membrane" "HPA047072: AB_2679921" "unprognostic (1.09e-1)" "unprognostic (7.30e-3)" "unprognostic (1.65e-2)" "unprognostic (3.85e-2)" "unprognostic (1.28e-1)" "unprognostic (1.91e-2)" "unprognostic (2.15e-1)" "unprognostic (4.07e-2)" "unprognostic (2.03e-1)" "unprognostic (3.63e-1)" "unprognostic (1.88e-1)" "unprognostic (1.04e-1)" "prognostic unfavorable (5.12e-4)" "unprognostic (1.44e-1)" "unprognostic (9.06e-2)" "unprognostic (3.18e-2)" "unprognostic (2.72e-2)" 54.3 18.6 8.7 31.8 13.0 9.9 35.9 4.9 9.7 14.5 21.2 9.0 8.7 15.8 13.5 20.2 24.1 33.4 15.3 25.4 8.7 6.0 12.5 12.4 25.7 48.3 14.5 4.9 22.1 18.1 4.9 22.4 13.7 10.2 14.0 13.2 11.6 14.7 9.7 9.2 11.4 20.6 21.3 13.7 40.7 19.2 15.1 15.0 9.7 14.9 10.7 18.5 23.2 50.2 0.4 46.7 2.8 23.4 6.0 10.9 19.1 3.9 1.5 0.7 1.5 58.1 11.0 0.7 2.3 4.2 24.6 26.4 4.9 1.3 8.3 3.3 1.6 15.0 3.0 6.1 2.9 5.2 2.4 2.0 0.4 2.1 2.6 5.1 4.7 1.5 13.5 0.1 8.6 0.2 1.4 3.2 0.0 1.5 2.0 0.5 1.2 0.0 1.8 0.7 2.4 3.2 0.2 4.0 3.2 0.9 0.6 3.0 0.4 3.0 1.1 2.9 0.2 1.4 7.6 0.8 1.9 2.1 2.0 3.4 1.2 3.0 3.5 1.6 0.4 0.6 0.2 19.4 0.6 6.1 23.4 5.6 0.4 6.9 6.4 46.7 0.4 8.5 6.3 2.8 6.0 20.4 11.0 10.9 19.1 8.7 13.0 4.9 9.7 8.7 6.0 14.5 4.9 10.2 15.0 26.8 30.5 23.8 1.9 5.7 5.3 16.9 25.5 83.0 53.4 1.8 3.9 2.5 0.0 9.3 2.3 36.5 1.1 0.0 8.6 2.8 23.4 2.7 11.6 17.4 131.6 6.4 5.8 47.9 243.3 2.3 76.2 175.7 5.0 16.2 4.3 30.6 11.1 20.1 90.5 1.2 2.6 58.2 29.8 5.1 5.4 5.1 2.4 54.9 4.5 4.7 SAMSN1 "HACS1, NASH1, SASH2, SH3D6B, SLy2" ENSG00000155307 "SAM domain, SH3 domain and nuclear localization signals 1" Q9NSI8 21 14485228-14658821 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 53.6;bone marrow: 72.1;lymphoid tissue: 43.6" "Group enriched" "Detected in many" 6 "granulocytes: 1107.2;monocytes: 1399.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 53.6;eosinophil: 49.9" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 4 "HEL: 60.9;K-562: 72.4;Karpas-707: 31.6" "Region enriched" "Detected in some" 7 "olfactory region: 25.4" "Low region specificity" "Detected in all" "HPA010645, HPA017055, HPA046639" Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA010645: AB_1856559, HPA017055: AB_1856560, HPA046639: AB_2679732" "unprognostic (7.62e-3)" "unprognostic (1.46e-2)" "unprognostic (1.03e-2)" "unprognostic (3.11e-2)" "unprognostic (2.44e-1)" "unprognostic (3.91e-2)" "unprognostic (1.41e-1)" "unprognostic (1.01e-1)" "unprognostic (2.17e-1)" "unprognostic (6.13e-2)" "unprognostic (2.10e-2)" "unprognostic (1.28e-1)" "prognostic unfavorable (4.52e-6)" "unprognostic (9.14e-2)" "unprognostic (3.05e-2)" "unprognostic (2.17e-1)" "unprognostic (1.68e-2)" 14.4 3.9 5.8 33.0 10.4 72.1 4.2 1.1 5.1 2.9 4.7 4.9 0.0 3.1 3.4 4.6 4.1 6.8 10.1 5.1 4.4 3.4 5.9 7.2 27.9 28.3 11.1 1.4 3.3 2.3 1.0 2.7 6.7 6.7 4.1 7.0 3.4 3.4 1.2 1.6 1.9 13.6 4.7 17.5 43.6 5.0 2.4 7.1 12.6 2.6 2.8 16.7 11.8 4.5 6.5 5.6 53.6 17.3 3.7 12.9 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 3.1 0.0 60.9 0.0 0.0 0.0 7.1 2.9 0.0 0.0 0.0 9.0 2.4 0.8 1.1 72.4 31.6 0.0 0.0 3.4 8.7 0.0 0.0 0.0 5.9 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 7.9 0.0 0.0 0.0 0.0 13.6 0.1 0.0 0.3 4.6 0.0 53.6 8.8 49.9 5.3 11.6 3.6 6.5 10.3 7.8 5.6 2.6 6.6 4.6 11.0 3.7 17.3 0.2 12.9 6.8 5.8 10.4 1.1 5.1 4.4 3.4 11.1 1.4 6.7 7.1 20.8 87.5 39.7 0.8 13.9 54.7 1.2 2.5 14.7 20.5 34.9 0.0 0.4 0.0 0.4 0.0 7.1 0.0 23.3 5.4 0.5 6.2 0.4 1107.2 0.9 57.4 0.0 0.0 3.1 159.2 0.0 0.6 220.5 20.3 1399.5 0.1 1.5 0.6 0.0 0.0 0.4 4.2 0.0 3.3 0.0 0.0 11.5 0.5 120.4 0.0 0.7 SASH3 "753P9, CXorf9, HACS2, SH3D6C, SLY" ENSG00000122122 "SAM and SH3 domain containing 3" O75995 X 129779979-129795201 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 61.8;bone marrow: 33.2;lymphoid tissue: 85.3" "Cell type enhanced" "Detected in some" 12 "B-cells: 45.6;Hofbauer cells: 45.7;Kupffer cells: 59.2;T-cells: 75.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 43.6;JURKAT: 31.2;MOLT-4: 31.1;NB-4: 23.7;REH: 23.3;U-698: 39.8;U-937: 30.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001085 Enhanced Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Nuclear bodies" "HPA001085: AB_2184289" "unprognostic (1.88e-2)" "unprognostic (5.82e-3)" "unprognostic (1.49e-3)" "prognostic favorable (3.15e-4)" "unprognostic (1.12e-1)" "unprognostic (1.19e-3)" "unprognostic (1.67e-1)" "unprognostic (3.23e-3)" "unprognostic (7.92e-3)" "unprognostic (3.45e-1)" "unprognostic (8.75e-2)" "unprognostic (2.16e-1)" "prognostic unfavorable (6.51e-5)" "unprognostic (3.30e-1)" "unprognostic (3.56e-2)" "unprognostic (3.17e-2)" "unprognostic (1.53e-1)" 7.8 3.4 2.8 34.6 5.2 33.2 2.7 0.7 2.2 2.0 3.3 4.0 0.2 3.9 1.9 2.1 2.9 3.4 3.6 2.0 3.3 2.4 3.3 3.0 10.6 38.2 5.2 1.1 1.3 1.8 0.2 1.8 2.5 4.2 2.7 3.5 1.6 7.8 0.8 0.9 1.1 18.8 2.4 6.2 55.7 4.2 0.8 4.0 85.3 2.5 2.0 38.6 7.0 2.0 22.0 27.6 53.7 44.2 33.4 46.9 61.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.2 0.0 3.7 0.0 0.0 31.1 23.7 0.0 0.0 0.0 23.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.1 0.0 0.1 0.0 0.0 0.0 8.8 39.8 0.0 30.9 0.0 7.9 29.4 53.7 46.9 44.1 38.7 19.1 26.7 43.1 27.6 22.0 19.3 30.0 29.1 33.4 44.2 12.7 32.3 61.8 2.8 5.2 0.7 2.2 3.3 2.4 5.2 1.1 4.2 4.0 0.0 5.1 45.6 0.0 0.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 23.3 0.0 0.5 0.4 0.0 21.9 0.9 45.7 0.0 0.0 3.7 59.2 0.0 0.3 20.3 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.5 75.2 0.0 0.0 SC5D SC5DL ENSG00000109929 Sterol-C5-desaturase O75845 11 121292453-121308694 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 143.5" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 117.3;Ito cells: 163.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066283, HPA070248" Enhanced Approved "Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol" No No "Nucleoplasm, Endoplasmic reticulum" "Plasma membrane, Cytosol" "HPA066283: AB_2685648, HPA070248: AB_2686240" "unprognostic (4.78e-2)" "unprognostic (7.29e-2)" "unprognostic (2.26e-2)" "unprognostic (2.36e-1)" "unprognostic (3.98e-2)" "prognostic unfavorable (3.30e-4)" "unprognostic (2.79e-2)" "unprognostic (7.96e-2)" "prognostic unfavorable (3.98e-4)" "unprognostic (4.03e-2)" "unprognostic (3.18e-2)" "unprognostic (1.01e-1)" "prognostic favorable (1.07e-7)" "unprognostic (4.29e-2)" "unprognostic (2.51e-1)" "unprognostic (2.29e-1)" "unprognostic (1.98e-1)" 10.9 15.3 16.9 5.5 18.4 2.7 23.3 10.4 26.9 9.4 9.4 17.8 24.5 17.4 6.8 30.1 19.5 7.2 7.4 9.4 18.7 19.6 19.7 143.5 10.1 5.5 20.8 17.8 7.8 8.9 17.5 14.7 6.3 40.8 40.3 8.6 8.2 9.5 24.0 3.9 7.7 13.4 7.6 43.4 4.1 8.8 9.7 16.0 3.7 10.4 8.2 8.1 14.0 14.6 6.0 9.8 7.5 6.3 6.8 10.0 3.8 6.8 3.4 51.8 11.0 20.1 17.5 7.3 7.7 14.5 5.2 9.2 21.6 25.5 6.5 24.4 8.4 41.5 25.7 16.1 19.5 5.1 3.2 22.0 9.6 22.6 17.2 16.4 6.0 3.3 14.3 16.0 16.4 16.9 4.4 7.8 6.4 6.2 9.4 24.0 7.1 2.4 7.9 16.1 19.8 11.0 3.4 13.0 5.5 36.5 30.8 13.7 7.7 17.7 4.0 10.1 36.2 16.2 10.4 14.9 5.0 8.1 8.8 3.6 1.8 2.9 8.7 1.9 13.4 8.6 7.5 4.8 1.2 5.0 6.3 8.5 6.0 6.8 6.0 8.5 6.0 10.0 9.5 0.4 6.8 4.5 9.8 6.9 3.8 16.9 18.4 10.4 26.9 18.7 19.6 20.8 17.8 40.8 16.0 17.9 26.4 26.2 53.7 8.7 21.9 17.8 15.3 14.7 18.2 19.2 29.5 13.8 5.0 17.3 2.2 8.4 23.5 0.0 25.4 14.2 17.3 59.7 17.3 117.3 17.9 22.3 13.8 163.9 25.6 1.0 17.8 15.1 18.6 22.6 12.7 40.5 14.5 11.4 15.9 14.6 29.6 12.9 16.7 6.0 13.0 13.6 15.6 21.7 11.9 45.5 SCAMP4 FLJ33847 ENSG00000227500 "Secretory carrier membrane protein 4" Q969E2 19 1905214-1926013 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043284 Approved Approved "Golgi apparatus,Vesicles,Lipid droplets,Plasma membrane" NA NA "Golgi apparatus, Vesicles" "Lipid droplets, Plasma membrane" "HPA043284: AB_10806501" "unprognostic (1.60e-1)" "unprognostic (3.62e-1)" "unprognostic (5.04e-2)" "prognostic favorable (4.40e-6)" "unprognostic (2.58e-1)" "unprognostic (4.58e-1)" "prognostic unfavorable (1.92e-5)" "unprognostic (2.04e-1)" "unprognostic (1.58e-1)" "unprognostic (2.55e-1)" "unprognostic (3.01e-3)" "unprognostic (5.66e-2)" "prognostic favorable (3.56e-4)" "unprognostic (6.16e-2)" "unprognostic (1.58e-1)" "unprognostic (3.93e-2)" "unprognostic (1.03e-1)" 17.3 16.5 17.1 16.0 21.7 10.2 18.4 16.5 28.2 19.5 13.2 46.3 21.1 19.3 16.3 20.4 22.0 37.2 19.4 8.5 19.3 19.5 19.9 21.5 19.3 13.9 22.1 14.6 23.7 28.0 12.7 23.2 24.2 27.6 19.5 9.8 21.4 41.1 21.4 9.1 19.2 18.9 12.1 42.1 17.2 21.8 15.9 20.3 10.3 23.8 10.6 18.2 15.7 13.9 6.4 14.2 2.5 5.9 7.1 5.0 3.7 23.1 23.1 10.6 25.7 21.3 13.3 12.6 15.0 14.0 16.5 20.1 18.8 22.3 9.5 14.7 12.0 9.4 27.7 10.0 15.3 6.1 15.0 9.0 6.6 8.2 18.0 27.3 6.6 10.2 20.3 9.7 14.3 8.7 13.5 11.2 10.6 15.0 10.8 9.5 27.8 8.8 12.8 17.3 12.0 7.8 11.0 7.7 14.4 20.3 20.6 15.0 19.8 9.5 22.9 12.6 7.7 22.4 17.3 11.9 20.3 14.1 36.3 15.8 26.3 25.9 8.5 26.9 11.1 13.0 1.9 5.2 2.0 5.0 5.9 2.7 6.4 3.5 3.2 5.7 4.6 2.1 3.7 2.5 7.1 5.0 14.2 2.7 3.7 17.1 21.7 16.5 28.2 19.3 19.5 22.1 14.6 27.6 20.3 8.9 8.2 23.1 21.9 15.1 18.6 2.2 17.8 10.7 5.7 47.1 70.7 33.6 6.6 18.8 0.6 14.4 42.4 23.3 11.0 30.8 21.6 30.1 17.3 10.4 33.3 20.6 18.0 14.7 18.8 0.4 20.1 12.3 20.3 15.4 27.2 30.6 13.6 20.1 16.3 9.0 49.3 0.0 10.8 16.3 29.8 17.7 49.3 13.3 21.0 23.3 SCHIP1 SCHIP-1 ENSG00000151967 "Schwannomin interacting protein 1" P0DPB3 3 159839861-159897360 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 55.0;heart muscle: 65.9;skeletal muscle: 54.5" "Cell type enhanced" "Detected in many" 9 "Cardiomyocytes: 11.3;Horizontal cells: 14.3" "Cancer enriched" "Detected in single" 7 "glioma: 2.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 9.7" "Group enriched" "Detected in many" 58 "dendritic cells: 9.7;granulocytes: 3.1" "Cell line enhanced" "Detected in some" "AF22: 9.5;AN3-CA: 17.3;HUVEC TERT2: 20.5;NTERA-2: 10.5;SH-SY5Y: 59.6" "HPA003243, HPA069824" Uncertain Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Cell Junctions,Cytosol" NA NA "Plasma membrane, Cell Junctions, Cytosol" "Nucleoplasm, Nuclear bodies" "HPA003243: AB_1079877, HPA069824: AB_2732142" "unprognostic (1.07e-1)" "unprognostic (3.27e-2)" "unprognostic (1.37e-2)" "unprognostic (2.36e-5)" "prognostic favorable (2.80e-4)" "unprognostic (6.25e-2)" "unprognostic (4.56e-3)" "unprognostic (1.11e-1)" "unprognostic (7.81e-2)" "unprognostic (1.38e-1)" "unprognostic (6.45e-3)" "unprognostic (4.67e-2)" "unprognostic (2.12e-1)" "unprognostic (4.66e-4)" "unprognostic (2.30e-1)" "unprognostic (4.52e-2)" "unprognostic (4.96e-1)" 6.1 3.9 30.1 1.5 22.0 2.0 1.9 23.9 55.0 3.7 3.6 21.1 0.0 2.2 4.7 2.0 4.2 3.4 3.0 65.9 29.6 17.9 3.5 1.9 3.1 1.7 22.8 24.1 1.8 1.6 1.4 6.0 10.3 15.6 6.2 2.3 0.7 2.9 2.6 54.5 1.4 1.9 5.9 28.9 5.1 2.0 2.7 24.3 0.0 2.0 7.6 1.6 1.9 0.6 0.0 9.7 3.1 0.0 0.1 0.0 0.1 0.0 0.0 9.5 17.3 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.8 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.0 0.4 0.1 4.0 0.1 20.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 10.5 0.0 0.0 0.0 1.9 0.0 0.4 0.0 0.0 59.6 0.0 0.0 0.0 2.6 0.0 1.0 3.7 0.2 0.5 0.1 0.8 0.7 0.0 0.0 0.2 0.7 0.4 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.1 0.0 9.7 0.0 0.1 30.1 22.0 23.9 28.9 29.6 17.9 22.8 24.1 15.6 24.3 6.0 1.7 0.0 4.6 0.3 4.2 11.3 0.0 4.0 3.4 3.5 2.0 1.0 0.0 0.2 0.0 4.6 0.0 0.0 0.2 0.4 0.6 0.5 0.0 0.5 0.2 14.3 0.0 1.8 0.0 0.0 0.0 0.0 3.3 0.0 0.0 4.9 0.9 0.0 0.0 0.7 0.5 0.0 1.8 0.0 0.4 0.5 0.7 0.0 0.0 1.4 SCN9A "ETHA, Nav1.7, NE-NA, NENA, PN1" ENSG00000169432 "Sodium voltage-gated channel alpha subunit 9" Q15858 2 166195185-166376001 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Exocrine glandular cells: 27.7;Hofbauer cells: 50.6;Intestinal endocrine cells: 31.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 17 "plasmacytoid DC: 18.6" "Lineage enriched" "Detected in single" 24 "dendritic cells: 18.6" "Cell line enhanced" "Detected in many" "BJ: 17.2;BJ hTERT+: 12.8;HHSteC: 14.8;hTERT-RPE1: 12.0" "Region enriched" "Detected in some" 5 "hypothalamus: 10.9" "Low region specificity" "Detected in all" "CAB013679, HPA061843" Uncertain Approved "Plasma membrane,Actin filaments,Focal adhesion sites" NA NA "Plasma membrane, Actin filaments, Focal adhesion sites" "CAB013679: , HPA061843: AB_2684625" "unprognostic (2.10e-1)" "unprognostic (2.83e-1)" "unprognostic (1.13e-1)" "unprognostic (8.98e-5)" "unprognostic (1.47e-3)" "unprognostic (9.43e-3)" "unprognostic (2.28e-2)" "unprognostic (2.24e-1)" "unprognostic (2.23e-1)" "unprognostic (3.64e-1)" "unprognostic (1.45e-1)" "unprognostic (2.27e-1)" "prognostic unfavorable (2.30e-5)" "unprognostic (1.69e-3)" "unprognostic (6.74e-2)" "unprognostic (2.46e-2)" "unprognostic (2.46e-1)" 6.6 4.2 3.8 2.8 9.1 4.2 2.7 0.9 4.4 1.8 10.2 0.5 0.1 1.4 0.9 3.8 2.6 1.2 5.8 2.9 2.8 15.9 4.8 8.3 4.5 3.5 4.1 2.3 2.1 4.8 0.6 11.3 9.2 7.3 2.0 7.0 1.7 1.8 1.9 0.9 1.8 4.2 5.2 2.5 12.4 1.7 16.2 0.4 10.3 1.4 1.9 1.2 3.6 1.8 0.0 18.6 0.7 0.1 0.4 0.0 0.0 0.0 1.9 0.1 0.0 7.4 6.5 0.0 17.2 12.8 4.0 1.3 0.5 0.0 0.0 0.0 2.1 0.2 0.0 4.9 0.6 6.6 0.0 1.6 1.3 1.5 1.4 14.8 0.0 0.0 0.4 0.2 6.8 1.3 12.0 0.8 0.9 4.3 5.0 0.6 0.0 2.6 0.0 1.5 0.0 0.5 0.7 2.5 6.5 1.8 7.2 0.8 7.2 0.0 0.0 0.3 3.8 0.2 0.0 0.0 0.0 1.1 0.1 0.3 0.1 0.0 0.0 2.5 0.0 1.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.7 0.4 0.1 18.6 0.0 0.0 3.8 9.1 0.9 4.4 2.8 15.9 4.1 2.3 7.3 0.4 11.9 18.4 0.9 0.2 0.9 0.2 1.6 5.1 4.0 7.9 5.2 0.0 0.2 3.3 14.9 1.7 2.2 11.3 0.0 27.7 0.4 1.2 0.2 3.5 6.0 50.6 0.0 31.7 20.3 1.5 1.9 1.1 4.3 3.3 0.0 14.6 1.3 18.8 8.6 0.0 12.2 0.0 0.0 1.0 0.0 0.4 0.4 0.9 0.0 10.7 0.1 SCUBE3 "CEGF3, FLJ34743" ENSG00000146197 "Signal peptide, CUB domain and EGF like domain containing 3" Q8IX30 6 35214419-35253079 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 38.0" "Cell type enhanced" "Detected in many" 8 "Horizontal cells: 9.5;Intestinal endocrine cells: 10.4;Rod photoreceptor cells: 6.1" "Cancer enhanced" "Detected in many" "thyroid cancer: 9.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 10.6;ASC diff: 32.4;ASC TERT1: 43.5;HSkMC: 20.3;hTEC/SVTERT24-B: 12.4;U-138 MG: 12.1;WM-115: 10.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040606 Uncertain Approved "Plasma membrane" "Secreted to blood" NA NA 1890000 110000 "Plasma membrane" "HPA040606: AB_10795383" "unprognostic (1.45e-1)" "unprognostic (1.79e-2)" "unprognostic (2.22e-1)" "unprognostic (2.41e-3)" "unprognostic (1.52e-1)" "unprognostic (1.27e-1)" "unprognostic (4.43e-2)" "unprognostic (5.01e-2)" "unprognostic (2.00e-2)" "unprognostic (7.41e-2)" "unprognostic (1.57e-1)" "unprognostic (2.64e-2)" "unprognostic (4.83e-8)" "unprognostic (1.54e-2)" "unprognostic (2.12e-1)" "prognostic unfavorable (1.38e-4)" "unprognostic (3.06e-3)" 1.6 2.6 0.5 1.1 0.4 0.2 0.3 0.3 0.7 1.6 3.3 0.0 2.8 0.2 1.3 7.0 1.5 0.7 0.7 6.4 0.3 0.5 2.3 0.2 1.3 0.2 0.4 0.6 0.9 0.2 0.3 1.6 0.9 0.6 7.0 1.1 6.8 1.1 5.3 0.8 0.7 0.8 13.8 0.6 0.3 1.2 1.7 0.0 0.0 38.0 0.3 0.3 11.4 2.5 1.1 1.6 2.5 0.7 1.1 1.1 0.1 0.0 0.0 10.6 0.1 32.4 43.5 0.1 2.6 1.3 0.0 0.0 0.2 0.0 0.0 0.4 6.2 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 20.3 0.0 12.4 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.3 0.7 4.4 0.2 0.0 0.6 12.1 0.5 0.0 0.1 0.0 0.0 0.0 1.9 0.0 10.2 1.4 0.7 1.3 1.1 0.5 0.3 0.8 0.7 0.3 0.1 1.1 0.8 0.8 2.5 1.1 0.5 1.6 0.8 0.1 0.5 0.4 0.3 0.7 0.3 0.5 0.4 0.6 0.6 0.0 0.0 1.1 0.0 0.2 0.0 2.5 3.3 0.0 1.4 3.4 1.8 2.0 0.8 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.2 1.0 0.1 1.1 0.0 0.3 9.5 10.4 0.0 1.2 2.2 0.9 0.0 1.7 0.0 0.0 2.0 0.1 0.0 3.5 0.0 6.1 0.0 4.7 0.2 1.9 0.0 0.6 0.0 0.0 0.1 SDC2 "CD362, fibroglycan, HSPG, HSPG1, SYND2" ENSG00000169439 "Syndecan 2" P34741 8 96493351-96611780 "CD markers, Predicted membrane proteins" "Differentiation, Neurogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 115.1;thyroid gland: 111.2" "Cell type enhanced" "Detected in many" 5 "Fibroblasts: 194.4;Hepatocytes: 184.9;Smooth muscle cells: 188.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "neutrophil: 13.9" "Lineage enriched" "Detected in many" 7 "granulocytes: 13.9" "Cell line enhanced" "Detected in many" "AF22: 102.6;EFO-21: 48.2;fHDF/TERT166: 44.4;RPTEC TERT1: 53.6;U-138 MG: 49.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025123, HPA044416" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB025123: , HPA044416: AB_2678934" "unprognostic (1.25e-1)" "unprognostic (1.04e-1)" "unprognostic (1.25e-1)" "unprognostic (3.61e-2)" "unprognostic (6.52e-3)" "unprognostic (4.18e-2)" "unprognostic (2.43e-1)" "unprognostic (2.35e-2)" "unprognostic (2.89e-2)" "unprognostic (4.56e-1)" "unprognostic (1.48e-1)" "unprognostic (6.16e-2)" "unprognostic (1.56e-2)" "unprognostic (1.45e-3)" "unprognostic (1.91e-1)" "unprognostic (2.50e-2)" "unprognostic (1.23e-1)" 43.2 9.9 13.9 9.1 16.9 2.5 17.0 12.7 8.4 43.4 18.7 7.3 21.2 5.8 21.9 15.3 13.3 21.0 15.0 19.1 12.0 12.6 23.9 115.1 14.4 4.4 9.7 9.3 45.9 16.8 1.6 24.0 31.3 10.7 25.9 10.7 51.4 6.3 28.1 9.4 6.5 9.6 34.3 9.5 7.5 11.9 8.7 9.3 0.5 111.2 13.8 3.5 35.9 26.3 0.0 1.3 13.9 1.9 0.0 0.2 0.5 0.0 0.0 102.6 0.0 37.1 34.7 0.1 14.8 17.6 8.6 9.6 3.0 0.0 0.0 48.2 44.4 1.2 0.0 17.7 0.2 7.4 0.0 6.9 0.0 9.9 37.7 1.2 0.2 0.4 13.3 0.4 19.5 0.5 33.3 0.3 0.0 9.7 0.0 3.6 0.8 0.0 2.5 10.8 0.0 0.1 0.1 16.1 0.3 53.6 8.7 3.0 8.0 0.0 0.0 0.7 35.9 4.4 11.4 8.0 49.7 15.2 0.2 8.2 0.9 0.0 0.1 15.8 0.0 15.5 0.0 1.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.2 0.0 13.9 0.0 0.1 0.0 0.0 0.5 13.9 16.9 12.7 8.4 12.0 12.6 9.7 9.3 10.7 9.3 53.6 30.2 4.7 67.2 47.9 22.0 25.8 33.1 5.3 3.4 54.1 11.8 1.8 24.9 11.7 25.6 10.2 0.1 23.3 13.2 2.0 194.4 44.9 1.1 184.9 114.7 4.8 3.4 20.3 22.0 14.5 48.6 87.0 59.1 118.2 0.5 18.4 12.7 0.0 98.6 44.8 10.2 32.3 188.5 3.2 57.1 34.4 3.2 3.2 1.2 14.5 SDC4 "amphiglycan, ryudocan, SYND4" ENSG00000124145 "Syndecan 4" P31431 20 45325288-45348424 "Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 141.1" "Cell type enhanced" "Detected in many" 4 "Exocrine glandular cells: 450.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 75.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005716, CAB013240" Enhanced Approved "Golgi apparatus,Plasma membrane" "Secreted to blood" NA NA "Golgi apparatus" "Plasma membrane" "CAB013240: AB_2533250, HPA005716: AB_1080160" "unprognostic (1.34e-2)" "unprognostic (1.80e-1)" "unprognostic (1.71e-2)" "unprognostic (2.16e-1)" "unprognostic (5.39e-2)" "unprognostic (6.59e-3)" "unprognostic (1.16e-1)" "unprognostic (5.93e-2)" "unprognostic (2.68e-1)" "unprognostic (2.95e-2)" "prognostic unfavorable (4.20e-4)" "unprognostic (1.97e-1)" "prognostic favorable (2.44e-7)" "unprognostic (3.00e-1)" "unprognostic (2.18e-1)" "prognostic favorable (2.67e-4)" "unprognostic (7.42e-2)" 15.9 26.2 19.9 15.7 24.3 3.5 40.5 6.9 20.1 20.4 24.8 19.2 9.0 13.3 17.6 14.7 42.4 27.4 26.2 19.5 19.8 12.1 56.6 141.1 56.7 4.8 23.5 20.5 14.7 36.6 6.2 12.5 23.0 30.9 19.5 22.3 21.8 47.6 17.5 25.5 45.5 13.8 38.7 23.0 9.0 46.9 33.7 15.7 2.0 26.5 25.2 23.5 34.4 16.4 0.7 2.8 2.0 3.1 1.4 8.1 1.2 23.0 3.0 1.6 0.1 41.2 25.4 71.1 29.5 40.3 33.5 24.0 35.1 58.9 0.0 13.2 37.1 33.8 30.0 1.2 75.0 40.8 6.6 1.1 0.7 2.4 13.7 44.9 0.1 1.2 34.1 50.4 13.8 33.8 18.6 4.4 0.5 1.1 0.0 19.2 22.9 0.0 2.0 3.0 20.1 9.3 0.0 14.9 0.0 55.0 30.8 0.6 2.3 40.6 25.2 7.2 19.6 18.2 1.4 8.2 25.6 21.3 2.5 19.0 1.2 0.9 0.1 40.2 2.3 15.2 2.0 3.1 0.7 1.3 1.1 4.1 0.6 4.1 1.6 2.8 0.7 0.9 1.1 1.6 1.4 1.1 2.5 8.1 1.2 19.9 24.3 6.9 20.1 19.8 12.1 23.5 20.5 30.9 15.7 271.0 364.7 7.8 299.2 332.0 10.3 49.5 201.2 113.8 195.7 179.7 11.8 27.4 54.7 239.6 0.5 9.0 87.8 0.0 450.4 202.4 50.9 254.2 12.8 232.3 18.5 0.0 52.9 14.7 15.1 2.9 3.7 36.5 72.6 56.9 103.4 8.5 443.3 93.4 4.9 128.2 23.3 0.0 42.6 0.9 2.8 413.3 56.3 18.8 79.5 364.0 SEC16B "LZTR2, PGPR-p117, RGPR, Sec16S" ENSG00000120341 "SEC16 homolog B, endoplasmic reticulum export factor" Q96JE7 1 177923956-177984303 "Predicted intracellular proteins" "ER-Golgi transport, Peroxisome biogenesis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "intestine: 43.4;liver: 47.4" "Group enriched" "Detected in many" 4 "Hepatocytes: 57.2;Late spermatids: 36.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 8.5;CAPAN-2: 9.0;EFO-21: 6.9;HDLM-2: 6.9;Karpas-707: 6.1;RPMI-8226: 7.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA054292, HPA072913" Enhanced Approved "Endoplasmic reticulum,Plasma membrane,Actin filaments" NA NA "Endoplasmic reticulum, Plasma membrane" "Actin filaments" "HPA054292: AB_2682439, HPA072913: AB_2732213" "unprognostic (2.31e-1)" "unprognostic (1.90e-1)" "unprognostic (6.78e-3)" "unprognostic (6.07e-2)" "unprognostic (1.69e-1)" "unprognostic (1.33e-1)" "unprognostic (6.39e-3)" "unprognostic (1.22e-1)" "unprognostic (2.27e-2)" "unprognostic (1.50e-2)" "unprognostic (4.76e-3)" "unprognostic (2.43e-1)" "unprognostic (7.34e-4)" "unprognostic (6.67e-2)" "unprognostic (1.66e-1)" "unprognostic (1.37e-1)" "unprognostic (1.05e-1)" 1.4 1.8 1.1 3.2 0.9 0.0 1.5 0.9 2.3 1.7 19.6 0.9 0.9 14.3 1.3 0.9 0.9 1.6 2.5 2.2 0.9 0.4 2.5 47.4 0.9 0.9 0.9 0.9 1.8 4.8 0.1 1.4 0.9 1.0 0.9 1.6 0.9 1.4 0.9 3.9 0.9 43.4 0.9 0.9 2.7 4.0 0.9 0.9 0.9 1.4 0.9 1.0 0.9 1.0 0.0 0.7 0.0 0.7 0.0 0.0 0.2 2.3 1.9 0.1 1.9 2.5 8.5 0.1 1.9 0.6 0.1 0.9 1.3 9.0 0.8 6.9 1.5 0.1 0.0 0.5 0.2 0.1 6.9 0.1 0.0 0.0 4.2 0.2 0.1 0.0 5.0 0.6 0.3 0.1 0.2 2.7 0.0 0.0 6.1 4.8 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.7 7.8 0.1 0.2 0.8 1.6 0.1 0.2 1.0 0.0 0.1 1.6 0.9 1.3 0.2 0.8 0.0 2.0 0.8 0.1 3.4 0.3 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 1.1 0.9 0.9 2.3 0.9 0.4 0.9 0.9 1.0 0.9 0.0 1.3 0.5 0.2 0.2 1.0 0.4 10.2 2.7 2.3 1.8 2.0 0.3 0.0 0.4 9.0 1.4 1.0 0.0 1.0 0.0 0.8 0.1 1.1 57.2 0.6 11.1 3.5 4.3 2.7 36.6 2.3 0.6 1.7 0.0 4.4 0.8 1.2 3.7 1.1 1.7 4.3 0.0 1.4 0.3 0.9 0.9 0.0 0.0 4.3 0.1 SEMA3C "SEMAE, SemE" ENSG00000075223 "Semaphorin 3C" Q99985 7 80742538-80922359 "Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 109.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 8 "basophil: 25.8" "Lineage enriched" "Detected in many" 8 "granulocytes: 25.8" "Cell line enhanced" "Detected in many" "GAMG: 49.5;hTERT-RPE1: 43.2;RT4: 45.2;T-47d: 51.2;U-2197: 66.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA042418 Approved "Golgi apparatus,Plasma membrane,Cytosol" "Secreted in other tissues" NA NA "Golgi apparatus, Cytosol" "Plasma membrane" "HPA042418: AB_10797389" "unprognostic (1.93e-2)" "unprognostic (2.54e-3)" "unprognostic (4.94e-1)" "unprognostic (9.86e-2)" "unprognostic (6.74e-2)" "prognostic unfavorable (5.72e-5)" "unprognostic (9.28e-3)" "unprognostic (1.91e-3)" "unprognostic (1.39e-2)" "unprognostic (9.01e-2)" "prognostic unfavorable (4.08e-5)" "unprognostic (2.07e-2)" "unprognostic (1.55e-3)" "unprognostic (1.78e-2)" "unprognostic (1.57e-1)" "unprognostic (1.37e-2)" "unprognostic (1.92e-2)" 27.1 4.1 3.7 11.9 5.6 0.2 25.1 1.2 6.8 37.0 31.7 7.6 21.6 4.3 26.9 25.1 20.0 7.1 16.4 12.4 5.2 6.1 5.8 1.1 12.3 0.3 13.1 3.0 23.5 1.5 0.0 4.1 5.9 25.5 29.6 14.1 27.4 13.6 19.7 7.3 9.7 10.6 48.8 8.5 8.9 13.3 11.6 6.0 0.2 2.5 15.2 1.5 35.5 14.5 0.0 2.0 25.8 3.2 0.0 0.0 0.8 1.1 14.6 30.4 0.1 6.8 16.5 0.0 9.9 11.4 5.0 6.4 2.3 27.6 0.0 0.4 3.3 49.5 5.9 0.1 8.9 8.2 0.0 3.0 1.8 13.1 0.1 8.2 0.1 0.0 7.2 5.9 12.4 12.2 43.2 0.0 0.0 0.1 0.0 8.4 21.1 0.0 0.0 0.2 4.1 2.3 0.0 14.7 0.2 26.3 45.2 0.1 15.7 27.8 7.2 1.7 13.5 51.2 0.0 23.8 27.5 12.6 66.4 17.4 0.2 0.0 0.0 10.4 0.0 27.2 25.8 3.2 0.5 0.0 1.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 1.5 0.0 1.0 1.8 0.0 0.8 3.7 5.6 1.2 6.8 5.2 6.1 13.1 3.0 25.5 6.0 8.9 12.8 0.0 33.4 23.5 0.0 35.1 0.0 109.7 19.4 7.0 5.9 0.3 1.7 3.6 0.4 3.5 25.9 0.0 5.8 0.5 25.3 36.0 4.7 0.0 9.3 0.0 5.8 1.3 2.6 1.7 7.2 8.6 52.3 4.6 16.2 1.3 40.1 15.8 49.1 0.1 0.3 0.0 16.2 0.3 0.2 16.6 0.2 0.0 23.4 52.9 SEMA3D "coll-2, Sema-Z2" ENSG00000153993 "Semaphorin 3D" O95025 7 84995553-85186855 "Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 33.8;thyroid gland: 33.0" "Cell type enhanced" "Detected in many" 20 "Early spermatids: 137.5;Leydig cells: 48.6;Peritubular cells: 58.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "amygdala: 17.1" "Cell type enriched" "Detected in single" 5 "naive B-cell: 2.0" "Lineage enriched" "Detected in single" 5 "B-cells: 2.0" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 17.0;HaCaT: 17.3;TIME: 26.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037522 Uncertain Approved "Golgi apparatus,Plasma membrane" "Secreted in other tissues" NA NA 77000 "Golgi apparatus" "Plasma membrane" "HPA037522: AB_10672494" "unprognostic (7.05e-2)" "unprognostic (1.24e-1)" "unprognostic (2.40e-1)" "unprognostic (1.44e-2)" "unprognostic (1.54e-1)" "unprognostic (2.51e-1)" "unprognostic (7.58e-3)" "unprognostic (4.02e-3)" "unprognostic (9.94e-2)" "unprognostic (5.62e-2)" "unprognostic (1.63e-1)" "unprognostic (9.46e-2)" "unprognostic (1.17e-2)" "unprognostic (1.26e-3)" "unprognostic (1.63e-1)" "unprognostic (2.75e-3)" "unprognostic (5.25e-3)" 4.1 2.2 17.1 1.9 2.3 0.1 4.3 0.8 2.8 4.6 2.9 1.8 2.5 1.4 1.9 7.4 1.3 3.9 1.4 2.0 3.6 2.7 3.0 1.0 3.6 6.1 2.4 3.1 4.1 0.8 0.4 1.5 0.6 5.4 6.2 2.6 2.6 5.6 2.9 0.7 2.1 2.7 3.2 4.8 33.8 2.4 4.3 2.5 0.0 33.0 0.6 1.1 4.7 3.9 2.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.3 4.6 5.0 5.4 2.6 0.0 0.0 0.0 1.4 17.0 0.1 17.3 1.9 0.0 3.6 0.0 3.5 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 4.4 6.3 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 4.5 1.2 5.5 4.0 1.7 0.0 0.1 0.6 0.0 0.0 0.2 8.9 0.2 0.0 26.5 0.0 1.7 0.2 0.0 3.3 1.9 0.0 0.1 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 17.1 2.3 0.8 2.2 3.6 2.7 2.4 3.1 5.4 2.5 0.0 3.5 0.8 2.3 3.2 1.5 0.8 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 137.5 5.2 0.0 0.0 0.2 0.0 6.7 7.1 2.3 0.0 0.9 1.6 25.4 1.8 0.0 14.9 48.6 0.8 11.8 0.0 0.0 0.9 0.0 0.0 58.7 4.5 4.1 0.0 2.1 0.7 0.7 2.0 0.0 0.0 0.1 0.4 SEMA4F "SEMAM, SEMAW" ENSG00000135622 "Ssemaphorin 4F" O95754 2 74654228-74683853 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 11.8;Horizontal cells: 11.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064095, HPA065969" Approved Approved "Nucleoplasm,Plasma membrane,Centrosome" NA NA Nucleoplasm "Plasma membrane, Centrosome" "HPA064095: AB_2732710, HPA065969: AB_2685590" "unprognostic (9.69e-2)" "unprognostic (8.88e-3)" "unprognostic (1.58e-2)" "prognostic unfavorable (5.94e-5)" "prognostic unfavorable (6.96e-4)" "unprognostic (1.23e-2)" "unprognostic (1.61e-3)" "unprognostic (6.95e-2)" "unprognostic (9.01e-3)" "unprognostic (6.53e-2)" "unprognostic (2.21e-2)" "unprognostic (1.54e-1)" "prognostic unfavorable (9.74e-6)" "unprognostic (2.60e-2)" "unprognostic (8.08e-2)" "prognostic favorable (6.94e-4)" "unprognostic (4.69e-2)" 8.1 5.1 15.5 3.5 15.5 1.3 5.7 12.9 21.3 5.2 3.8 3.3 2.3 1.9 6.6 6.7 2.7 5.6 3.5 4.9 17.2 12.2 4.8 2.1 8.1 5.1 5.3 16.5 9.1 4.6 13.7 10.2 3.5 7.8 5.2 4.2 3.6 5.0 5.7 3.0 4.9 3.0 7.0 5.7 4.7 4.3 7.2 3.8 2.9 4.7 1.3 4.9 3.5 4.7 2.8 0.2 1.4 0.4 2.5 5.6 2.1 6.5 4.4 4.8 6.8 7.8 4.4 3.0 4.5 9.4 8.2 7.6 1.8 3.8 2.2 4.9 7.2 19.8 1.9 7.0 7.7 9.1 5.7 5.9 3.8 1.8 3.6 2.8 0.8 6.1 4.0 6.7 5.5 2.9 18.7 3.5 5.0 0.2 0.1 4.8 1.9 3.5 0.7 2.6 3.7 4.3 0.0 6.2 0.0 6.4 3.0 3.0 7.2 6.6 2.7 8.2 6.0 3.2 0.5 3.8 14.1 6.8 3.4 8.2 5.3 5.2 0.3 17.2 0.3 7.5 0.5 0.2 1.4 5.6 0.1 3.2 2.8 3.0 4.9 0.2 2.1 3.3 3.9 0.8 2.5 0.4 0.1 2.2 2.1 15.5 15.5 12.9 21.3 17.2 12.2 5.3 16.5 7.8 3.8 0.0 6.2 0.0 1.5 0.3 8.8 1.4 10.2 1.4 7.9 5.2 11.8 0.7 1.7 2.0 3.1 1.6 0.4 0.0 1.4 2.0 1.2 1.5 2.3 0.6 0.7 11.1 6.9 2.5 0.0 2.4 0.9 0.7 0.0 1.8 0.7 4.1 2.7 0.9 1.4 0.2 5.7 6.5 0.4 3.1 9.8 0.4 0.3 2.5 1.0 1.1 SEMA6D "FLJ11598, KIAA1479" ENSG00000137872 "Semaphorin 6D" Q8NFY4 15 47184101-47774223 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 40.8;placenta: 36.7" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 1: 47.6;Cone photoreceptor cells: 108.0;Enterocytes: 37.0;Horizontal cells: 74.7" "Cancer enhanced" "Detected in many" "glioma: 8.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ hTERT+: 13.4;SCLC-21H: 11.9;SH-SY5Y: 11.0;SuSa: 13.2;U-266/70: 8.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043109 Approved "Golgi apparatus,Plasma membrane" "Intracellular and membrane" NA NA 480000 "Plasma membrane" "Golgi apparatus" "HPA043109: AB_10793941" "unprognostic (2.00e-1)" "unprognostic (4.62e-2)" "unprognostic (3.10e-2)" "unprognostic (3.83e-3)" "unprognostic (1.38e-1)" "unprognostic (3.85e-2)" "unprognostic (1.98e-1)" "unprognostic (2.17e-3)" "unprognostic (1.24e-1)" "unprognostic (5.36e-2)" "unprognostic (7.96e-4)" "unprognostic (1.42e-1)" "prognostic favorable (5.96e-5)" "unprognostic (3.74e-2)" "unprognostic (8.56e-2)" "unprognostic (3.30e-3)" "unprognostic (2.39e-4)" 5.3 1.9 10.3 3.7 16.7 0.8 5.3 5.4 17.1 5.3 14.7 15.3 4.3 18.9 2.1 2.9 2.0 5.2 4.0 8.3 10.3 11.2 14.2 3.0 8.2 2.2 14.0 13.6 25.0 14.8 16.2 6.1 36.7 15.9 4.8 12.0 10.0 4.4 8.5 15.6 3.1 40.8 3.4 12.7 2.5 3.4 2.6 11.0 0.2 6.3 1.5 1.1 3.1 9.6 0.5 0.0 1.9 0.6 0.0 0.8 0.0 0.0 0.0 2.2 0.0 1.3 1.1 0.2 0.5 13.4 0.3 0.0 0.3 0.1 1.8 0.0 3.4 0.0 7.0 2.8 0.9 0.0 0.9 1.6 0.0 4.1 0.0 3.6 0.0 0.1 1.0 7.3 0.0 0.4 0.0 0.9 4.8 0.1 2.9 0.4 0.7 2.2 0.5 4.2 0.0 0.0 1.3 0.0 2.0 1.0 0.9 11.9 11.0 0.1 0.9 3.7 13.2 0.4 0.0 0.0 6.2 0.3 0.2 0.0 8.8 0.0 2.0 1.6 0.2 1.6 0.0 0.6 0.0 0.5 0.0 0.0 0.5 0.3 0.8 0.0 0.0 0.1 0.2 1.9 0.0 0.0 0.0 0.0 0.0 10.3 16.7 5.4 17.1 10.3 11.2 14.0 13.6 15.9 11.0 47.6 1.0 0.0 4.0 1.8 3.3 9.4 0.0 0.0 3.4 10.4 108.0 14.7 5.0 1.0 0.1 6.7 37.0 0.0 0.2 1.2 6.7 0.9 3.5 0.8 2.3 74.7 16.7 4.9 0.0 0.0 21.6 0.0 8.5 0.0 2.6 14.3 0.4 6.0 12.7 0.2 2.0 0.0 12.2 0.7 5.1 1.0 3.9 0.0 9.8 1.4 SEPT2 "DIFF6, hNedd5, KIAA0158, NEDD5, Pnutl3" ENSG00000168385 "Septin 2" Q15019 2 241315100-241354027 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB017190, HPA018481" Supported Enhanced "Nucleoplasm,Plasma membrane,Actin filaments,Cytokinetic bridge" Yes No 8800000 "Actin filaments" "Nucleoplasm, Plasma membrane, Cytokinetic bridge" "CAB017190: , HPA018481: AB_1856684" "unprognostic (6.31e-2)" "unprognostic (5.27e-2)" "unprognostic (2.95e-2)" "unprognostic (4.03e-2)" "prognostic favorable (8.21e-4)" "unprognostic (3.32e-1)" "prognostic unfavorable (3.66e-4)" "unprognostic (1.96e-3)" "unprognostic (1.83e-2)" "unprognostic (5.69e-2)" "unprognostic (1.11e-3)" "unprognostic (3.16e-1)" "unprognostic (9.58e-3)" "unprognostic (8.11e-2)" "unprognostic (9.53e-2)" "unprognostic (1.40e-1)" "unprognostic (2.17e-2)" 64.2 46.4 76.5 42.9 69.9 29.1 58.7 34.9 61.8 69.3 48.4 85.2 57.4 37.8 59.5 59.8 46.8 48.2 54.0 56.2 65.8 55.4 64.6 31.4 51.2 51.3 76.5 52.7 63.4 73.0 56.6 56.3 58.9 60.7 53.7 53.3 48.8 43.6 64.7 39.5 32.0 42.2 81.8 100.8 51.5 45.6 67.7 57.2 36.2 64.2 39.0 47.5 56.5 42.6 25.5 51.2 38.5 50.5 51.3 36.9 59.4 32.3 29.2 79.5 52.0 74.1 80.8 41.2 71.7 70.7 46.1 58.7 16.4 35.2 13.2 17.1 82.0 25.0 28.8 51.9 48.5 75.9 33.2 36.9 52.9 29.2 60.1 45.3 50.3 32.4 71.9 31.8 38.4 37.1 52.9 80.2 33.8 47.2 19.3 67.8 23.3 29.8 30.8 57.9 29.2 21.4 29.5 100.0 27.8 68.4 49.6 57.1 38.4 49.7 34.3 47.3 59.1 20.6 45.5 75.8 56.5 24.0 54.5 42.4 38.2 33.2 46.4 48.6 30.8 78.1 38.5 46.0 26.3 30.3 50.5 36.9 25.5 29.6 31.2 51.2 21.6 26.2 27.4 16.3 51.3 37.2 38.6 29.5 59.4 76.5 69.9 34.9 52.3 65.8 55.4 76.5 52.7 60.7 57.2 142.9 106.2 90.8 0.0 77.2 51.5 114.7 71.4 117.8 135.4 89.0 70.7 118.8 114.4 0.0 157.8 127.2 51.6 46.7 0.0 159.0 147.1 0.0 333.1 52.1 119.3 54.0 85.8 135.1 100.6 140.6 121.7 111.3 82.7 0.0 73.4 155.1 0.0 79.8 174.6 96.3 58.2 109.9 144.2 131.8 84.2 80.8 116.3 82.9 87.9 0.0 SEPT3 SEP3 ENSG00000100167 "Septin 3" Q9UH03 22 41969475-41998221 "Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 101.6" "Cell type enhanced" "Detected in some" 10 "Bipolar cells: 17.5;Early spermatids: 10.9;Extravillous trophoblasts: 21.5;Horizontal cells: 14.3;Late spermatids: 20.4" "Cancer enhanced" "Detected in many" "glioma: 24.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.1" "Group enriched" "Detected in many" 5 "dendritic cells: 1.2;granulocytes: 2.1" "Cell line enhanced" "Detected in many" "AF22: 13.8;SCLC-21H: 37.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003548, CAB017633" Supported Supported Approved "Nucleoplasm,Plasma membrane,Actin filaments" NA NA "Nucleoplasm, Plasma membrane" "Actin filaments" "CAB017633: AB_2301476, HPA003548: AB_1079908" "unprognostic (2.10e-1)" "unprognostic (4.67e-2)" "unprognostic (1.16e-2)" "prognostic unfavorable (1.78e-4)" "unprognostic (4.56e-2)" "unprognostic (1.13e-1)" "unprognostic (7.07e-3)" "unprognostic (2.37e-1)" "unprognostic (2.67e-3)" "unprognostic (3.09e-2)" "unprognostic (1.30e-2)" "unprognostic (6.30e-2)" "unprognostic (2.51e-2)" "unprognostic (9.15e-2)" "unprognostic (6.68e-2)" "unprognostic (5.50e-2)" "unprognostic (1.04e-1)" 1.3 4.4 31.3 1.4 26.9 1.3 2.0 35.9 101.6 1.4 1.5 5.6 0.0 1.4 1.4 2.2 1.3 1.2 1.5 1.2 28.9 17.2 1.4 1.2 1.7 1.5 13.2 24.3 1.2 2.0 10.7 1.0 4.9 13.4 2.1 1.5 1.0 1.3 1.2 1.2 2.2 1.4 1.4 7.3 1.3 1.5 2.4 5.3 0.0 1.7 0.0 1.5 1.4 0.1 0.3 1.2 2.1 0.0 0.1 0.2 0.0 0.7 0.8 13.8 10.3 0.1 0.0 6.9 0.1 0.1 0.9 0.4 0.2 1.6 11.1 0.4 0.1 5.9 0.0 7.2 0.0 0.3 4.6 2.3 0.0 0.2 0.0 0.1 0.0 0.5 0.1 0.5 0.0 0.0 0.0 0.0 6.2 0.0 1.7 0.0 1.2 1.8 0.1 9.4 0.1 0.3 8.9 0.0 0.6 0.0 1.3 37.2 7.7 5.5 0.0 9.1 1.4 1.3 3.3 0.0 0.0 4.9 0.4 0.5 7.3 6.4 0.1 0.1 4.5 1.4 2.1 0.0 0.1 0.1 0.0 0.2 0.3 0.2 0.0 1.2 0.0 0.2 0.1 0.0 0.1 0.0 0.9 0.2 0.0 31.3 26.9 35.9 42.1 28.9 17.2 13.2 24.3 13.4 5.3 0.0 0.0 0.0 0.0 0.3 17.5 0.4 0.0 0.0 2.3 0.0 3.9 1.5 0.0 0.0 10.9 0.0 0.0 0.0 0.0 21.5 0.1 0.0 0.0 0.0 1.4 14.3 1.2 0.0 0.0 20.4 0.3 0.3 1.7 0.0 0.0 0.9 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 1.6 0.3 4.6 0.0 0.0 0.0 SERINC2 "FKSG84, PRO0899, TDE2, TDE2L" ENSG00000168528 "Serine incorporator 2" Q96SA4 1 31409565-31434680 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 113.9" "Cell type enhanced" "Detected in many" 7 "Ductal cells: 546.6;Enterocytes: 427.6;Pancreatic endocrine cells: 386.0;Syncytiotrophoblasts: 373.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 4 "plasmacytoid DC: 12.0" "Lineage enriched" "Detected in many" 4 "dendritic cells: 12.0" "Cell line enhanced" "Detected in many" "CAPAN-2: 47.3;HaCaT: 53.9;HBEC3-KT: 85.2;hTCEpi: 48.5;RT4: 58.3;SK-BR-3: 48.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA005974 Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA005974: AB_10603239" "unprognostic (1.41e-1)" "unprognostic (3.70e-3)" "unprognostic (8.78e-3)" "prognostic favorable (1.69e-7)" "unprognostic (6.78e-2)" "unprognostic (5.31e-2)" "prognostic unfavorable (2.11e-4)" "prognostic unfavorable (5.70e-4)" "unprognostic (3.12e-2)" "unprognostic (3.19e-2)" "unprognostic (1.11e-2)" "unprognostic (1.09e-2)" "unprognostic (3.74e-2)" "unprognostic (1.39e-1)" "unprognostic (2.48e-1)" "unprognostic (4.63e-3)" "unprognostic (2.67e-2)" 2.0 6.6 0.6 13.5 1.2 1.1 12.1 0.8 0.8 17.3 32.9 0.8 52.1 27.4 3.7 26.5 32.5 4.3 34.4 2.0 1.0 0.6 57.5 113.9 10.3 7.1 1.8 0.5 1.7 12.9 5.7 5.1 33.9 1.4 17.0 12.8 5.0 58.6 74.4 20.2 14.2 73.0 6.7 1.2 1.7 20.7 3.5 0.8 5.7 13.1 12.7 19.1 31.1 19.9 0.2 12.0 2.3 2.7 0.0 0.0 0.5 13.0 3.1 2.7 8.9 6.0 8.1 7.6 25.2 18.7 1.6 2.0 4.7 47.3 8.6 33.2 23.6 2.0 53.9 0.3 85.2 0.3 0.8 2.0 0.0 2.7 2.4 6.8 0.0 10.1 7.4 48.5 10.4 22.9 7.2 1.0 1.0 0.3 0.0 2.8 2.1 0.3 0.3 2.8 26.1 6.6 0.0 5.4 2.9 9.0 58.3 1.2 6.7 6.4 48.8 1.0 1.4 28.5 1.5 6.2 0.4 2.1 0.2 0.5 0.4 0.3 0.4 0.2 0.2 2.1 0.0 2.7 2.3 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.1 12.0 0.0 0.5 0.6 1.2 0.8 0.8 1.0 0.6 1.8 0.5 1.4 0.8 14.9 6.2 0.5 97.8 11.0 0.0 0.6 127.4 8.1 21.6 111.7 0.0 323.0 61.3 546.6 3.9 4.4 427.6 0.0 288.5 86.2 3.3 137.4 0.0 45.6 43.7 0.0 111.9 8.6 7.6 6.6 2.0 6.8 38.8 83.8 168.4 0.6 386.0 170.9 0.0 57.4 0.0 0.0 1.4 0.6 3.6 18.4 373.5 0.0 116.2 257.8 SERPINB3 "HsT1196, SCC, SCCA1, T4-A" ENSG00000057149 "Serpin family B member 3" P29508 18 63655197-63661963 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "cervix, uterine: 50.7;esophagus: 140.0;vagina: 80.0" "Group enriched" "Detected in some" 8 "Ciliated cells: 141.8;Club cells: 465.2;Urothelial cells: 238.3" "Cancer enhanced" "Detected in many" "cervical cancer: 186.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.6;HaCaT: 9.1;HBEC3-KT: 2.2;SiHa: 5.6;U-2197: 11.6" "CAB018772, CAB036006, CAB036007, HPA048341, HPA049988, HPA055992" Enhanced Approved "Plasma membrane,Cytosol" NA NA 11000000 Cytosol "Plasma membrane" "CAB018772: AB_2285759, CAB036006: , CAB036007: , HPA048341: AB_2680364, HPA049988: AB_2680985, HPA055992: AB_2682998" "unprognostic (2.95e-3)" "unprognostic (1.66e-1)" "unprognostic (2.03e-1)" "unprognostic (2.91e-2)" "unprognostic (2.11e-1)" "prognostic unfavorable (3.19e-4)" "unprognostic (6.68e-2)" "unprognostic (2.58e-1)" "unprognostic (4.19e-3)" 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 50.7 0.2 0.2 0.2 0.0 3.8 0.2 140.0 0.0 0.2 0.2 0.2 0.0 0.2 0.2 5.4 0.2 0.2 0.2 0.2 0.2 0.0 2.4 0.2 0.2 1.1 0.0 0.2 13.0 0.2 0.2 7.1 0.2 0.2 0.2 0.2 0.0 0.2 0.2 1.4 0.2 21.3 3.1 13.1 80.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.1 0.2 9.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 10.3 0.0 15.8 0.0 0.0 0.0 0.0 141.8 465.2 0.0 0.0 0.0 0.0 3.7 24.6 0.0 0.0 0.0 7.4 0.0 0.0 36.6 2.3 0.0 0.1 0.0 0.0 0.0 0.0 33.0 1.1 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 238.3 SFSWAP "SFRS8, SWAP" ENSG00000061936 "Splicing factor SWAP" Q12872 12 131711081-131799737 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039362, HPA040063" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA039362: AB_10794089, HPA040063: AB_10795413" "unprognostic (1.33e-2)" "unprognostic (2.53e-2)" "unprognostic (1.39e-3)" "unprognostic (2.04e-1)" "unprognostic (4.45e-2)" "unprognostic (2.39e-3)" "unprognostic (7.41e-3)" "unprognostic (2.31e-1)" "prognostic unfavorable (1.10e-4)" "unprognostic (3.44e-1)" "unprognostic (1.50e-2)" "unprognostic (3.30e-2)" "prognostic unfavorable (3.33e-8)" "unprognostic (7.50e-2)" "unprognostic (2.93e-2)" "unprognostic (3.48e-1)" "unprognostic (3.66e-2)" 20.2 15.0 17.7 23.2 24.0 47.1 17.9 31.1 23.8 16.6 15.7 31.1 11.6 20.4 25.7 15.1 15.7 15.7 16.5 11.9 20.5 15.9 15.7 12.3 16.4 20.7 27.0 17.2 21.4 19.8 19.5 18.0 16.6 16.6 14.7 9.9 16.9 22.1 15.5 27.4 30.0 19.0 17.3 21.1 23.7 18.4 17.5 26.4 21.9 17.1 15.9 16.8 16.7 20.5 6.6 11.0 8.5 6.4 8.4 5.5 2.6 13.8 12.5 8.9 9.4 7.1 5.9 20.0 10.8 7.5 12.8 8.8 12.2 6.7 17.1 10.1 8.0 6.6 13.0 12.5 9.9 7.5 5.2 19.7 15.5 6.8 14.2 7.6 19.9 15.3 6.7 11.4 11.5 14.0 10.2 7.9 13.3 21.4 6.8 5.7 17.4 16.7 30.3 23.2 7.5 20.9 19.6 9.0 13.4 7.3 10.2 14.0 15.8 10.2 8.6 12.8 7.3 12.4 15.6 10.1 10.6 14.0 8.2 12.0 19.5 21.2 17.2 10.5 13.7 14.2 3.0 6.4 2.6 5.2 4.4 5.0 3.5 4.6 4.2 4.5 6.6 4.9 5.5 8.5 8.4 5.0 11.0 3.8 2.6 17.7 24.0 31.1 23.8 20.5 15.9 27.0 17.2 16.6 26.4 68.5 35.6 23.8 31.0 34.6 46.7 18.0 30.6 41.5 52.4 14.0 62.8 26.1 0.0 18.1 18.1 30.8 17.4 0.0 22.9 26.0 25.5 26.3 36.9 13.9 19.7 39.7 20.7 21.5 25.9 9.6 27.9 25.3 21.9 30.7 20.8 35.2 22.5 16.7 28.0 9.9 59.1 45.3 25.8 31.1 42.7 40.9 36.5 37.1 19.3 46.4 SGCE DYT11 ENSG00000127990 "Sarcoglycan epsilon" O43556 7 94524204-94656572 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Sertoli cells: 84.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 2.9;memory B-cell: 6.4;naive B-cell: 9.2" "Group enriched" "Detected in many" 4 "B-cells: 9.2;T-cells: 2.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074790 Approved "Nucleoplasm,Golgi apparatus,Vesicles,Plasma membrane" Yes No 50000 "Vesicles, Plasma membrane" "Nucleoplasm, Golgi apparatus" "HPA074790: AB_2686713" "unprognostic (3.16e-3)" "unprognostic (9.06e-2)" "unprognostic (1.20e-1)" "unprognostic (1.20e-3)" "unprognostic (1.12e-1)" "prognostic unfavorable (1.61e-5)" "unprognostic (1.19e-2)" "unprognostic (2.82e-2)" "unprognostic (6.93e-2)" "unprognostic (3.37e-1)" "unprognostic (6.80e-3)" "unprognostic (9.69e-2)" "unprognostic (5.71e-2)" "prognostic unfavorable (1.35e-4)" "unprognostic (1.43e-1)" "unprognostic (2.04e-1)" "unprognostic (2.44e-2)" 22.4 35.7 16.9 7.5 19.0 0.6 23.2 23.6 18.5 22.5 20.5 16.8 14.0 5.3 23.6 16.8 11.1 17.1 19.0 19.3 17.7 14.3 12.9 8.9 17.3 9.0 21.5 12.9 59.3 12.9 8.7 23.1 31.9 15.0 15.6 9.7 11.2 11.9 22.7 6.1 3.5 8.0 28.1 20.9 15.8 11.2 13.2 17.5 2.9 15.4 6.9 4.4 22.7 16.1 9.2 0.3 0.6 0.1 1.4 2.9 0.5 3.7 11.9 12.0 19.4 19.2 36.0 2.1 14.3 29.0 12.2 18.6 7.4 22.5 3.5 20.4 25.3 25.5 2.5 18.1 6.4 16.7 0.6 9.8 0.3 11.7 8.0 15.0 1.1 0.0 29.1 8.9 18.0 23.5 33.3 8.6 0.0 0.0 28.4 14.2 11.8 0.0 0.0 9.2 2.2 9.4 5.4 14.9 7.5 23.8 3.7 7.6 6.1 0.0 15.9 18.2 14.6 5.5 0.1 0.0 38.8 13.0 3.6 22.1 14.7 18.3 4.3 14.4 0.0 21.8 0.6 0.1 0.1 2.9 0.1 1.2 6.4 0.9 1.4 0.1 9.2 0.3 1.0 0.5 1.4 0.1 0.3 0.2 0.5 16.9 19.0 23.6 18.5 17.7 14.3 21.5 12.9 15.0 17.5 65.5 26.6 5.2 18.8 4.4 16.7 15.1 17.8 22.7 43.3 19.2 3.9 75.6 5.0 31.9 1.1 15.0 0.0 0.0 3.9 20.1 52.5 6.3 2.3 7.2 5.5 19.1 1.2 44.8 4.8 1.9 69.9 2.3 49.0 0.0 0.0 27.8 2.8 0.0 54.8 14.7 28.3 84.1 46.2 9.1 3.4 3.4 69.2 0.9 0.0 2.0 SGK494 ENSG00000167524 "Uncharacterized serine/threonine-protein kinase SgK494" 17 28607964-28614200 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.8" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 89.8;Rod photoreceptor cells: 106.4;Spermatocytes: 85.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" HPA046590 Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" Nucleoplasm "HPA046590: AB_2679710" "unprognostic (1.83e-1)" "unprognostic (9.42e-2)" "unprognostic (2.84e-2)" "unprognostic (2.30e-2)" "unprognostic (2.11e-1)" "unprognostic (2.06e-3)" "unprognostic (9.33e-3)" "unprognostic (2.63e-1)" "unprognostic (8.62e-4)" "unprognostic (2.09e-2)" "unprognostic (6.81e-2)" "unprognostic (3.45e-5)" "unprognostic (1.20e-7)" "unprognostic (2.67e-1)" "unprognostic (1.10e-1)" "unprognostic (1.28e-2)" "unprognostic (4.66e-3)" 1.6 4.7 10.3 3.5 25.3 10.6 2.3 17.8 25.8 1.9 1.8 0.9 0.4 0.7 2.0 4.5 1.3 2.4 0.8 2.1 8.6 3.7 5.6 1.6 3.2 3.3 2.5 10.7 3.7 1.3 2.0 5.6 3.1 11.2 2.3 4.0 6.3 1.9 3.2 3.8 6.3 2.3 1.9 2.9 3.4 1.3 8.5 4.1 0.1 2.5 0.1 3.5 1.9 2.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.4 5.1 6.1 5.7 1.9 2.5 4.4 0.8 0.3 2.1 1.9 6.1 0.7 7.0 0.9 2.8 3.1 3.1 4.5 2.4 2.7 3.9 6.7 7.3 4.0 3.6 0.2 9.8 5.2 1.2 7.3 7.4 4.2 1.7 2.3 9.7 7.0 0.6 1.3 7.1 2.4 6.5 6.1 3.2 0.9 7.1 8.7 4.6 1.2 6.7 3.7 3.5 4.3 2.4 3.6 8.6 3.6 5.5 3.0 4.1 3.5 4.1 5.0 3.8 3.6 8.5 3.0 7.1 3.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 25.3 17.8 25.8 8.6 3.7 2.5 10.7 11.2 4.1 0.0 1.3 5.2 5.5 0.0 89.8 0.3 10.2 0.0 1.2 5.2 21.6 5.6 0.0 2.0 10.6 2.9 4.2 0.0 1.3 2.0 1.0 5.8 0.0 5.8 3.6 33.4 1.2 8.6 5.7 2.2 2.0 3.2 0.0 3.6 2.7 6.8 1.9 7.0 1.8 1.4 106.4 0.0 0.3 85.6 14.7 0.0 20.7 5.0 3.2 3.4 SH3BGR 21-GARP ENSG00000185437 "SH3 domain binding glutamate rich protein" P55822 21 39445855-39515506 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 219.7" "Cell type enhanced" "Detected in many" 14 "Cardiomyocytes: 161.5;Early spermatids: 91.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 11.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 15.6;U-87 MG: 48.5" "Group enriched" "Detected in many" 5 "cerebellum: 34.0;midbrain: 14.7;olfactory region: 12.3;pons and medulla: 29.7" "Low region specificity" "Detected in all" "CAB003685, HPA030690" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB003685: AB_425682, HPA030690: AB_2673570" "unprognostic (3.41e-2)" "unprognostic (1.26e-1)" "unprognostic (5.84e-3)" "unprognostic (1.68e-3)" "unprognostic (6.05e-2)" "unprognostic (6.12e-3)" "unprognostic (3.89e-2)" "unprognostic (9.78e-2)" "unprognostic (2.06e-1)" "unprognostic (6.97e-3)" "unprognostic (3.59e-2)" "unprognostic (4.75e-1)" "unprognostic (5.98e-3)" "unprognostic (7.16e-2)" "unprognostic (4.60e-2)" "unprognostic (1.68e-2)" "unprognostic (2.06e-2)" 2.4 5.2 7.2 1.2 7.3 0.9 2.9 1.1 4.3 2.9 6.1 3.0 2.0 1.9 2.1 6.6 5.3 2.1 5.0 30.0 6.6 5.4 3.2 2.8 1.5 0.9 7.5 5.0 1.8 2.8 2.1 4.5 1.1 6.1 5.8 2.0 1.2 3.2 5.2 219.7 0.9 1.4 12.4 7.9 1.2 2.9 3.7 5.9 0.1 3.9 41.5 2.2 7.3 8.6 2.7 11.5 2.6 1.7 2.8 4.0 1.2 1.1 1.3 1.7 2.5 3.8 4.4 0.5 2.0 0.9 0.9 0.7 0.7 2.2 3.4 5.2 5.1 7.0 0.1 0.9 1.5 1.4 2.0 3.5 3.4 0.6 1.4 7.7 1.2 0.7 3.6 6.3 3.2 6.4 3.2 1.0 6.5 2.6 4.4 3.6 4.1 2.2 2.0 1.7 2.9 2.9 3.6 6.5 2.1 4.7 0.8 5.0 2.1 3.0 2.4 3.1 1.6 9.2 0.6 0.8 2.6 0.3 1.5 3.8 15.6 3.3 3.4 48.5 3.0 3.3 2.3 0.7 0.0 1.2 1.7 3.1 2.7 1.1 1.8 1.9 1.4 4.0 3.0 2.6 2.8 1.7 11.5 0.7 1.2 7.2 7.3 1.1 4.3 6.6 5.4 7.5 5.0 6.1 5.9 3.0 3.8 0.9 6.0 2.4 2.1 161.5 5.1 5.3 2.3 5.2 3.9 3.1 39.7 3.5 91.7 1.8 1.3 0.0 19.1 1.3 3.5 3.4 4.6 6.4 2.2 4.8 1.2 1.8 2.1 20.4 2.0 1.3 11.8 1.8 1.9 14.0 5.8 1.9 5.3 11.9 6.1 6.5 27.4 23.3 21.1 1.5 1.6 1.9 3.2 4.8 SHANK3 "KIAA1650, prosap2, PSAP2, SPANK-2" ENSG00000251322 "SH3 and multiple ankyrin repeat domains 3" 22 50674415-50733298 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.4" "Cell type enriched" "Detected in some" 5 "Ito cells: 90.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 6.4;TIME: 10.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003446 Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA003446: AB_1079958" "unprognostic (3.62e-1)" "unprognostic (1.08e-2)" "prognostic unfavorable (7.40e-4)" "unprognostic (6.02e-2)" "unprognostic (4.17e-1)" "unprognostic (1.72e-3)" "unprognostic (3.41e-2)" "unprognostic (3.13e-1)" "unprognostic (9.67e-2)" "unprognostic (5.62e-2)" "unprognostic (2.09e-2)" "unprognostic (7.52e-2)" "unprognostic (2.47e-2)" "unprognostic (7.81e-2)" "unprognostic (1.19e-1)" "unprognostic (4.89e-2)" "unprognostic (1.41e-1)" 9.5 5.4 23.5 1.3 26.1 2.6 8.7 13.0 32.4 3.5 2.0 2.4 0.1 5.2 3.8 3.4 2.5 2.8 1.1 4.4 21.6 2.4 2.9 5.1 5.3 2.9 2.5 18.1 1.6 7.6 7.9 1.0 1.7 2.6 1.9 1.9 0.6 8.5 3.4 3.6 3.1 6.6 1.5 2.0 12.3 1.3 3.4 6.4 0.2 4.1 1.4 2.6 5.3 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.9 0.6 2.9 0.5 0.5 0.0 0.6 0.0 0.2 0.0 0.6 1.7 0.0 1.2 0.2 1.7 0.6 0.9 0.4 0.0 0.0 0.0 6.4 0.4 1.7 1.5 0.8 0.3 1.6 1.1 0.1 0.3 0.1 2.0 0.7 0.1 0.1 0.1 0.9 0.5 0.2 1.3 0.7 1.8 1.7 0.0 0.7 0.3 0.5 1.3 1.9 1.7 0.0 0.8 0.4 0.3 0.4 10.2 0.2 1.7 0.7 0.4 0.1 0.1 0.0 0.1 0.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.5 26.1 13.0 32.4 21.6 2.4 2.5 18.1 2.6 6.4 0.0 1.4 0.0 0.0 0.2 0.5 19.6 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.0 1.8 16.8 0.0 0.0 0.0 0.0 0.2 0.1 0.0 5.6 0.3 0.0 2.4 90.2 5.6 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.4 0.7 0.0 0.0 0.9 0.2 0.4 0.3 0.0 0.0 0.0 0.3 SHARPIN "DKFZP434N1923, SIPL1" ENSG00000179526 "SHANK associated RH domain interactor" Q9H0F6 8 144098633-144108124 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 99.4" "Group enriched" "Detected in many" 5 "Early spermatids: 302.5;Late spermatids: 974.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 46.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024825, HPA044453" Approved Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA024825: , HPA044453: AB_10962490" "unprognostic (4.91e-2)" "unprognostic (3.47e-2)" "unprognostic (1.35e-2)" "unprognostic (7.88e-2)" "unprognostic (3.32e-2)" "unprognostic (9.54e-2)" "unprognostic (1.31e-3)" "unprognostic (6.58e-2)" "unprognostic (1.74e-1)" "unprognostic (4.13e-3)" "unprognostic (5.44e-2)" "unprognostic (7.91e-2)" "unprognostic (1.84e-3)" "unprognostic (2.87e-2)" "unprognostic (1.55e-1)" "unprognostic (2.24e-1)" "unprognostic (1.00e-1)" 12.0 14.5 15.8 7.9 11.7 13.2 10.9 9.0 15.3 11.3 12.3 13.7 17.3 11.5 11.4 14.7 11.4 12.9 10.3 14.7 14.0 8.9 14.1 25.7 10.0 9.3 14.6 11.3 11.9 14.0 11.7 10.2 9.6 13.3 12.2 7.2 10.5 16.8 11.8 25.5 13.5 10.7 9.4 9.2 12.5 12.0 99.4 12.3 6.1 10.9 10.8 7.1 10.1 9.5 12.7 22.4 26.1 21.2 17.3 22.1 11.0 8.7 12.8 7.2 5.6 11.7 12.0 8.3 8.1 9.6 10.8 10.8 9.0 14.1 3.8 14.9 9.8 6.3 10.0 3.5 12.2 3.1 11.3 9.6 9.5 14.6 10.7 20.7 3.3 8.8 13.5 20.2 9.1 10.3 13.3 11.5 12.2 6.3 8.9 9.9 14.3 11.2 9.4 2.9 18.4 46.6 7.8 5.4 12.6 11.4 10.0 7.3 11.3 13.9 21.0 13.3 6.1 22.0 12.2 9.7 8.5 13.5 12.1 10.9 11.0 8.3 5.0 12.4 8.1 6.7 12.5 18.1 26.1 16.7 21.2 18.6 12.7 16.6 22.1 16.6 12.3 13.8 15.0 9.3 17.3 18.4 22.4 16.5 11.0 15.8 11.7 9.0 15.3 14.0 8.9 14.6 11.3 13.3 12.3 8.9 17.8 26.6 26.7 21.3 23.2 18.2 17.8 4.0 9.1 33.2 3.9 48.0 101.2 49.2 302.5 33.1 72.2 0.0 43.4 40.8 41.3 29.5 12.7 33.1 51.8 46.1 34.0 30.7 32.4 974.5 45.5 32.9 43.9 73.9 40.9 35.3 67.6 63.1 41.1 69.5 24.9 51.8 34.4 141.6 64.2 28.2 36.0 45.7 50.7 29.1 SHISA6 FLJ45455 ENSG00000188803 "Shisa family member 6" Q6ZSJ9 17 11241263-11564063 "Predicted membrane proteins, Transporters" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.6;cervix, uterine: 22.4" "Group enriched" "Detected in some" 4 "Late spermatids: 9.9;Peritubular cells: 27.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 22 "OE19: 34.1" "Low region specificity" "Detected in many" HPA023440 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA023440: AB_1848945" "unprognostic (1.70e-1)" "unprognostic (2.78e-2)" "unprognostic (1.44e-1)" "unprognostic (2.39e-3)" "prognostic unfavorable (8.41e-4)" "unprognostic (3.11e-2)" "unprognostic (1.71e-1)" "unprognostic (8.80e-2)" "unprognostic (1.84e-1)" "unprognostic (1.11e-1)" "unprognostic (9.63e-2)" "unprognostic (1.27e-1)" "unprognostic (2.40e-4)" "unprognostic (1.14e-1)" "unprognostic (1.32e-1)" "unprognostic (4.20e-2)" "unprognostic (2.47e-2)" 2.2 0.7 5.8 0.6 5.5 0.2 1.2 9.8 7.5 22.4 0.9 2.5 1.9 0.4 4.2 2.4 0.9 1.7 0.5 1.1 12.1 9.9 2.5 0.2 1.5 0.2 11.8 2.9 0.6 1.4 6.0 0.0 0.3 13.6 5.9 0.8 0.8 0.2 10.1 1.0 0.5 0.4 1.2 9.6 0.2 6.0 2.9 2.1 0.0 0.7 0.0 0.2 0.6 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 34.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 5.5 9.8 4.9 12.1 9.9 11.8 2.9 13.6 2.1 0.0 0.0 0.0 0.0 0.1 2.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.2 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.1 0.0 1.2 0.0 0.0 9.9 4.6 0.0 1.7 0.0 0.0 0.4 0.0 0.0 27.3 0.0 0.1 0.0 0.1 0.5 1.9 0.1 0.0 0.0 0.0 0.1 SHROOM2 APXL ENSG00000146950 "Shroom family member 2" Q13796 X 9786456-9949443 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 17 "Cone photoreceptor cells: 45.2;Peritubular cells: 78.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "RT4: 12.8;SuSa: 13.4;WM-115: 15.6" "Low region specificity" "Detected in many" HPA051646 Approved Approved "Plasma membrane,Cell Junctions,Cytosol" No No "Plasma membrane, Cell Junctions" Cytosol "HPA051646: AB_2681562" "unprognostic (8.65e-3)" "unprognostic (1.36e-3)" "unprognostic (4.68e-2)" "unprognostic (4.06e-2)" "unprognostic (6.99e-3)" "unprognostic (8.05e-2)" "unprognostic (9.96e-2)" "unprognostic (1.28e-1)" "unprognostic (2.51e-1)" "unprognostic (6.54e-2)" "unprognostic (2.82e-2)" "unprognostic (9.73e-2)" "prognostic favorable (1.35e-7)" "unprognostic (1.56e-1)" "unprognostic (3.34e-1)" "unprognostic (1.93e-1)" "unprognostic (7.67e-3)" 1.3 3.6 6.8 1.3 7.7 0.5 2.5 2.8 17.0 4.7 3.2 3.7 4.6 1.8 3.3 5.8 7.2 3.6 6.3 1.5 7.4 5.5 5.3 7.6 8.1 1.0 5.7 9.1 13.8 7.2 5.5 6.1 14.3 5.8 10.6 3.0 3.6 6.0 5.8 0.7 7.9 1.4 2.1 7.9 1.7 2.6 5.8 2.5 1.8 3.1 3.4 3.4 6.4 4.3 0.0 0.9 1.1 0.0 0.0 0.2 0.0 4.0 0.5 7.5 1.0 0.4 1.2 4.2 0.4 1.3 1.6 2.6 4.9 0.0 0.0 1.4 1.0 0.3 3.2 3.8 10.7 1.9 0.0 2.9 0.0 0.0 0.8 2.5 0.0 5.1 0.2 7.5 12.3 0.5 2.7 9.2 0.0 0.0 0.0 2.6 4.3 0.0 0.0 6.6 0.0 0.0 0.0 8.3 0.0 7.0 12.8 1.1 0.6 0.3 0.1 12.0 13.4 4.4 0.2 4.3 12.0 1.5 0.0 0.4 0.0 0.0 0.0 7.9 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.9 0.0 0.0 6.8 7.7 2.8 17.0 7.4 5.5 5.7 9.1 5.8 2.5 0.0 1.0 0.0 2.7 1.6 5.1 3.1 5.1 1.4 2.3 3.5 45.2 7.7 3.3 2.7 0.5 5.8 0.3 0.0 0.0 1.0 0.5 5.4 0.0 4.9 0.5 1.6 1.2 11.6 0.6 0.0 3.4 0.0 0.0 0.0 0.5 1.8 1.5 0.0 78.1 0.9 17.7 0.0 0.9 0.0 1.3 1.8 1.7 0.5 0.4 4.8 SHTN1 "KIAA1598, shootin-1, shootin1" ENSG00000187164 "Shootin 1" A0MZ66 10 116881482-117126586 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 67.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 31 "classical monocyte: 14.0;intermediate monocyte: 8.8;myeloid DC: 13.2;non-classical monocyte: 4.0;plasmacytoid DC: 8.9" "Group enriched" "Detected in many" 43 "dendritic cells: 13.2;monocytes: 14.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037942, HPA037943" Enhanced Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA037942: AB_2675748, HPA037943: AB_10671637" "unprognostic (1.00e-1)" "unprognostic (2.50e-2)" "unprognostic (6.77e-3)" "unprognostic (2.81e-1)" "unprognostic (7.85e-2)" "unprognostic (1.61e-1)" "unprognostic (2.42e-2)" "unprognostic (1.03e-1)" "unprognostic (2.56e-1)" "unprognostic (1.35e-1)" "unprognostic (2.49e-1)" "prognostic unfavorable (5.07e-4)" "unprognostic (2.17e-2)" "unprognostic (1.48e-1)" "unprognostic (2.47e-1)" "unprognostic (1.85e-1)" "prognostic unfavorable (5.08e-6)" 3.5 6.5 51.5 6.8 50.1 1.6 8.7 9.8 34.1 5.5 7.0 42.3 0.3 6.7 4.4 8.4 5.4 5.2 6.5 2.6 58.9 37.0 7.8 12.1 9.8 4.5 67.8 22.7 6.8 10.9 18.6 20.4 5.4 36.3 7.3 8.6 2.0 9.9 3.0 0.9 9.6 7.8 3.8 67.4 7.0 9.0 9.9 54.5 0.4 11.9 1.4 4.1 4.0 2.4 0.0 13.2 0.3 14.0 0.0 0.2 3.5 15.8 8.9 0.9 1.9 0.0 0.0 8.9 1.3 3.5 2.7 5.2 10.0 10.5 0.0 2.7 4.9 8.1 8.2 7.1 6.0 2.8 0.0 7.4 0.0 9.4 6.2 1.2 2.8 2.5 0.4 5.3 2.7 5.2 7.2 6.6 4.3 4.3 0.0 1.9 6.3 0.0 0.1 3.4 3.0 6.0 0.0 12.0 3.5 7.4 2.2 9.9 3.9 10.7 15.6 9.7 10.9 12.5 2.5 11.3 0.9 6.7 0.0 7.8 1.7 0.0 0.0 4.9 0.0 4.9 0.0 14.0 0.1 0.0 8.8 0.0 0.0 0.0 0.0 13.2 0.0 0.1 0.0 0.3 0.0 4.0 8.9 0.2 3.5 51.5 50.1 9.8 30.2 58.9 37.0 67.8 22.7 36.3 54.5 71.5 33.1 2.4 13.5 0.0 78.9 3.4 28.1 33.5 43.3 22.7 58.9 35.1 18.3 40.5 5.8 1.3 14.6 0.0 45.7 25.7 3.1 31.7 2.3 42.7 35.4 46.1 16.4 3.1 79.2 9.0 10.3 62.9 0.0 91.0 20.8 13.1 41.7 50.9 4.9 44.5 55.6 12.9 3.5 17.4 41.4 0.0 16.7 0.0 17.7 11.9 SIGLEC6 "CD327, CD33L, CD33L1, OB-BP1, SIGLEC-6" ENSG00000105492 "Sialic acid binding Ig like lectin 6" O43699 19 51519525-51531856 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "placenta: 87.4" "Group enriched" "Detected in some" 12 "Cytotrophoblasts: 56.9;granulocytes: 52.1;Syncytiotrophoblasts: 157.8" "Cancer enhanced" "Detected in some" "thyroid cancer: 2.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory B-cell: 6.5;plasmacytoid DC: 6.8" "Group enriched" "Detected in many" 33 "B-cells: 6.5;dendritic cells: 6.8;granulocytes: 2.3" "Cell line enriched" "Detected in some" 7 "HMC-1: 103.0" "HPA008945, HPA009084, HPA018198" Enhanced Approved "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane, Cytosol" "HPA008945: , HPA009084: AB_1079967, HPA018198: AB_1856868" "unprognostic (1.97e-1)" "unprognostic (1.41e-1)" "unprognostic (2.38e-3)" "unprognostic (9.31e-3)" "unprognostic (8.46e-4)" "unprognostic (2.91e-1)" "unprognostic (2.02e-2)" "unprognostic (2.64e-1)" "unprognostic (8.96e-2)" "unprognostic (2.03e-1)" "unprognostic (6.89e-2)" "unprognostic (1.10e-2)" "unprognostic (4.15e-2)" "unprognostic (4.42e-2)" "unprognostic (3.28e-2)" "unprognostic (5.57e-3)" 1.8 0.0 0.0 5.6 0.0 0.1 0.8 0.0 0.1 1.2 1.7 0.0 0.3 0.9 2.0 1.2 1.5 0.5 8.6 0.4 0.0 0.0 0.4 0.1 4.2 1.5 0.0 0.0 0.1 0.3 0.1 0.1 87.4 0.0 3.7 1.5 0.5 1.4 1.0 0.2 1.3 6.0 3.1 0.0 1.3 1.7 1.0 0.0 0.3 0.2 1.0 2.6 2.2 1.9 6.5 6.8 2.3 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.0 0.0 0.0 0.2 103.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 1.4 2.8 0.0 0.0 0.0 0.1 0.0 6.8 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 56.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.1 0.0 52.1 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 157.8 0.0 0.0 0.0 SIGLEC7 "CD328, p75/AIRM1, QA79, SIGLEC-7, SIGLEC19P, SIGLECP2" ENSG00000168995 "Sialic acid binding Ig like lectin 7" Q9Y286 19 51142299-51153526 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 51.5;lymphoid tissue: 29.4" "Group enriched" "Detected in some" 5 "Hofbauer cells: 29.4;Kupffer cells: 51.3;Macrophages: 24.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 51.5" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 9 "Karpas-707: 31.5;RPMI-8226: 18.3;U-937: 19.4" HPA075513 Approved "Vesicles,Plasma membrane" "Intracellular and membrane" NA NA 1100000 "Plasma membrane" Vesicles "HPA075513: " "unprognostic (3.14e-1)" "unprognostic (5.87e-2)" "unprognostic (1.03e-1)" "unprognostic (2.66e-1)" "unprognostic (3.90e-2)" "unprognostic (1.85e-1)" "unprognostic (2.53e-1)" "unprognostic (2.78e-1)" "unprognostic (1.69e-1)" "unprognostic (4.95e-2)" "unprognostic (1.10e-1)" "unprognostic (2.66e-1)" "unprognostic (8.27e-2)" "unprognostic (6.61e-2)" "unprognostic (1.14e-3)" "unprognostic (2.58e-1)" "unprognostic (2.26e-2)" 6.9 3.7 1.6 10.0 5.8 3.7 3.0 0.3 2.2 0.9 1.6 1.0 0.6 1.4 0.9 2.1 1.1 1.8 2.4 1.9 0.8 1.0 2.8 9.8 4.7 18.4 3.3 0.0 1.3 0.9 0.2 0.9 5.9 2.9 1.0 2.3 0.7 2.3 0.2 0.4 0.5 2.3 3.5 3.3 29.4 1.1 1.8 2.5 0.7 1.0 0.0 2.1 3.2 1.7 0.6 14.9 51.5 32.0 20.0 4.4 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.5 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.0 0.1 19.4 0.0 0.5 32.0 51.5 2.5 23.0 4.4 0.6 0.0 1.1 14.9 0.0 0.0 1.0 26.8 20.0 9.1 0.6 0.0 15.8 1.6 5.8 0.3 2.2 0.8 1.0 3.3 0.0 2.9 2.5 0.0 2.1 1.4 0.0 0.1 0.0 0.0 0.0 1.4 1.2 1.8 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 1.1 0.6 29.4 0.0 0.0 7.4 51.3 0.0 1.4 24.5 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 2.2 0.0 0.0 SIN3B KIAA0700 ENSG00000127511 "SIN3 transcription regulator family member B" O75182 19 16829400-16880353 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Peritubular cells: 62.6;Syncytiotrophoblasts: 104.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050329 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA050329: AB_2681089" "unprognostic (2.71e-3)" "unprognostic (8.89e-2)" "unprognostic (1.32e-3)" "unprognostic (6.22e-2)" "unprognostic (1.24e-1)" "unprognostic (2.05e-2)" "unprognostic (5.44e-2)" "unprognostic (9.89e-2)" "unprognostic (5.42e-3)" "unprognostic (2.77e-1)" "prognostic favorable (4.37e-4)" "prognostic unfavorable (3.58e-4)" "unprognostic (1.18e-3)" "unprognostic (8.45e-2)" "unprognostic (1.49e-1)" "unprognostic (9.36e-2)" "unprognostic (1.06e-1)" 19.1 17.9 22.2 17.2 28.1 9.8 21.5 25.1 38.6 24.4 16.0 20.8 50.0 12.8 37.5 21.5 14.5 23.3 17.3 15.7 24.2 20.8 15.9 9.8 21.7 20.8 16.5 30.4 32.5 16.2 60.8 17.7 53.2 24.8 22.7 11.0 15.5 20.2 54.7 17.1 22.7 17.7 26.5 14.8 25.1 13.7 30.2 13.4 9.3 22.5 9.6 15.8 17.2 22.2 4.8 2.6 6.1 6.7 1.9 2.0 2.3 14.7 7.9 13.4 17.2 11.1 10.2 42.4 12.6 10.4 17.5 15.6 19.4 13.9 13.3 14.1 14.5 14.8 12.7 11.1 11.3 16.2 13.8 20.0 14.2 17.3 8.8 14.6 8.3 11.5 16.8 14.9 11.7 10.1 13.9 15.8 10.7 11.5 8.2 12.2 17.7 11.2 13.4 16.6 7.7 25.4 14.9 12.3 8.7 9.9 12.6 9.9 12.4 15.9 12.3 9.9 18.8 8.6 7.8 20.7 17.0 10.4 24.5 14.0 11.8 8.6 13.3 11.8 10.9 12.6 0.1 6.7 6.1 1.8 6.0 1.2 4.8 1.7 2.0 2.1 3.8 2.0 1.4 3.3 1.9 5.3 2.6 0.5 2.3 22.2 28.1 25.1 38.6 24.2 20.8 16.5 30.4 24.8 13.4 20.8 14.8 10.7 8.6 7.0 18.1 6.9 2.5 5.3 7.9 3.5 13.7 17.1 3.3 9.2 7.9 11.7 4.7 0.0 7.4 24.5 8.6 10.0 4.7 5.6 15.1 9.5 4.7 8.0 13.0 18.2 46.9 6.6 5.0 10.0 7.9 8.7 12.5 3.5 62.6 4.5 15.7 6.5 6.6 9.3 10.4 7.0 104.5 6.4 5.8 11.2 SIPA1 SPA1 ENSG00000213445 "Signal-induced proliferation-associated 1" Q96FS4 11 65638097-65650930 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 47.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020833, HPA039867" Enhanced Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Plasma membrane" NA NA Nucleoli "Nucleoplasm, Golgi apparatus, Plasma membrane" "CAB020833: , HPA039867: AB_2676716" "unprognostic (6.10e-2)" "unprognostic (1.75e-1)" "prognostic unfavorable (9.42e-4)" "unprognostic (1.35e-2)" "unprognostic (2.93e-1)" "unprognostic (2.32e-2)" "unprognostic (3.35e-2)" "unprognostic (1.09e-1)" "unprognostic (3.30e-2)" "unprognostic (6.44e-2)" "unprognostic (5.85e-2)" "unprognostic (4.86e-2)" "prognostic unfavorable (3.52e-6)" "unprognostic (1.60e-1)" "unprognostic (2.78e-2)" "unprognostic (1.14e-2)" "unprognostic (1.49e-1)" 10.5 9.1 7.5 27.1 12.0 29.8 10.0 2.6 8.7 8.9 10.8 9.4 2.9 7.7 10.9 3.0 7.6 9.0 9.9 8.0 8.4 4.6 9.5 7.8 17.6 33.2 11.5 4.7 7.7 4.6 2.7 4.2 11.9 10.3 8.6 3.9 8.2 8.7 6.8 5.4 4.2 17.2 9.0 14.3 47.1 8.1 3.0 10.5 25.3 7.7 4.6 32.7 8.5 7.8 6.6 2.8 14.1 5.2 5.8 7.4 3.0 0.7 6.2 4.5 9.6 2.6 5.5 10.6 7.2 6.1 5.6 5.5 1.9 6.9 9.9 16.2 3.5 0.2 3.6 1.6 2.4 1.9 10.7 4.0 24.2 9.2 3.4 4.7 9.8 10.5 5.6 1.1 7.8 1.0 5.6 16.4 10.4 13.7 4.6 2.8 2.7 3.9 16.7 3.0 2.5 5.8 17.8 2.5 8.8 2.1 0.5 1.7 10.3 3.5 6.1 14.6 4.3 4.6 15.1 23.0 6.9 14.1 7.6 1.4 6.9 5.4 22.3 9.5 15.6 20.1 4.0 4.1 10.2 7.4 4.8 5.5 5.3 3.7 4.8 2.8 6.6 2.9 4.4 14.1 5.8 5.2 2.7 3.5 3.0 7.5 12.0 2.6 8.7 8.4 4.6 11.5 4.7 10.3 10.5 6.0 6.9 45.9 21.9 6.1 1.7 3.7 25.5 0.0 2.3 22.7 0.0 7.8 31.5 18.4 2.6 16.8 17.3 23.3 13.0 17.8 8.2 22.9 6.9 19.8 31.9 4.8 20.2 39.9 38.3 5.4 7.5 26.7 10.1 10.8 11.7 4.8 23.9 11.5 12.4 14.6 1.6 12.9 14.0 0.7 17.9 9.7 11.3 33.2 11.4 27.8 SKAP1 "SCAP1, SKAP55" ENSG00000141293 "Src kinase associated phosphoprotein 1" Q86WV1 17 48133440-48430275 "Predicted intracellular proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 50.9;lymphoid tissue: 52.1" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 48.5;granulocytes: 113.6;Late spermatids: 118.7;T-cells: 123.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 19.3;HDLM-2: 9.9;HMC-1: 8.5;JURKAT: 14.5;Karpas-707: 10.5;RPMI-8226: 12.4;RPTEC TERT1: 15.4;U-266/70: 9.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA002969, CAB025882, CAB055513" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane" Cytosol "CAB025882: , CAB055513: , HPA002969: AB_1079870" "prognostic favorable (5.07e-4)" "unprognostic (1.10e-2)" "unprognostic (2.19e-2)" "unprognostic (1.80e-2)" "unprognostic (2.28e-2)" "unprognostic (1.43e-2)" "unprognostic (2.61e-2)" "unprognostic (1.57e-2)" "unprognostic (8.39e-2)" "unprognostic (1.81e-1)" "unprognostic (3.38e-1)" "unprognostic (1.71e-1)" "unprognostic (5.71e-2)" "unprognostic (6.20e-2)" "unprognostic (2.72e-1)" "unprognostic (1.94e-1)" "prognostic favorable (3.14e-4)" 1.9 9.4 0.5 28.0 0.6 2.9 4.5 0.4 0.6 5.9 3.8 0.6 10.9 1.1 2.2 10.6 2.1 8.0 6.2 2.1 1.3 1.1 12.9 2.0 5.2 20.0 0.7 0.4 2.4 2.8 11.6 17.5 0.7 1.2 3.0 2.4 1.6 10.2 7.4 0.5 1.2 6.1 1.2 1.9 11.7 2.2 7.8 0.6 52.1 1.8 1.3 27.7 5.1 4.3 11.9 0.1 2.1 0.2 22.3 50.9 22.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 19.3 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.2 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 14.5 0.0 10.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 15.4 0.0 0.0 0.0 1.0 0.0 0.1 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 9.6 6.8 0.0 0.0 0.0 0.0 2.1 0.1 0.3 35.9 0.0 30.1 2.8 29.6 32.2 0.1 11.9 26.1 28.9 0.7 22.3 0.2 0.1 50.9 22.3 0.5 0.6 0.4 0.6 1.3 1.1 0.7 0.4 1.2 0.6 3.0 14.6 10.4 0.1 1.8 0.0 0.6 0.0 2.7 5.7 8.7 0.0 0.1 39.7 0.2 48.5 1.6 0.3 0.0 1.6 0.1 1.3 0.3 113.6 25.1 0.2 0.0 1.2 6.2 3.7 118.7 1.4 1.7 1.7 0.0 0.6 2.0 1.5 0.0 0.7 1.1 0.3 6.5 0.3 34.8 4.1 1.1 0.2 123.7 0.1 0.4 SLAMF6 "CD352, KALI, KALIb, Ly108, NTB-A, NTBA, SF2000" ENSG00000162739 "SLAM family member 6" Q96DU3 1 160485030-160523262 "CD markers, Predicted membrane proteins" "Adaptive immunity, Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.6;lymphoid tissue: 51.9" "Cell type enhanced" "Detected in some" 15 "B-cells: 8.3;Early spermatids: 9.3;Late spermatids: 16.5;T-cells: 20.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "Daudi: 33.3;U-698: 49.0" "HPA051363, HPA051903" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA051363: AB_2681454, HPA051903: AB_2681658" "prognostic favorable (9.42e-4)" "prognostic favorable (2.78e-4)" "unprognostic (8.65e-2)" "prognostic favorable (9.53e-4)" "unprognostic (5.85e-2)" "prognostic favorable (7.34e-5)" "unprognostic (3.16e-3)" "unprognostic (9.78e-2)" "prognostic favorable (1.25e-4)" "unprognostic (2.31e-3)" "unprognostic (2.09e-1)" "unprognostic (1.57e-1)" "prognostic unfavorable (2.09e-6)" "unprognostic (2.78e-1)" "unprognostic (1.01e-1)" "unprognostic (2.33e-2)" "unprognostic (8.21e-3)" 3.9 0.8 0.4 21.0 0.4 1.2 1.0 0.4 0.4 1.1 3.8 0.3 0.4 1.1 1.0 0.6 2.3 1.6 2.8 1.2 0.4 0.4 2.1 1.6 4.7 51.9 0.6 0.4 0.6 0.8 0.0 0.6 1.7 0.7 1.4 1.5 1.5 5.6 1.0 0.5 0.7 11.9 0.4 0.8 29.6 2.3 0.9 0.2 12.9 1.8 0.6 30.4 4.1 1.3 15.2 0.3 8.4 1.0 15.9 28.6 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 2.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.3 0.0 0.0 0.0 8.0 0.5 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 5.2 49.0 0.0 0.2 0.0 2.5 0.1 8.4 22.9 0.3 15.8 14.7 14.6 28.6 0.1 15.2 8.2 16.4 1.0 15.9 1.0 0.3 16.8 7.4 0.4 0.4 0.4 0.4 0.4 0.4 0.6 0.4 0.7 0.2 0.0 2.2 8.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.2 0.0 0.0 0.2 1.1 0.8 0.9 0.0 0.0 3.7 3.8 16.5 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 20.8 0.0 0.0 SLC10A5 ENSG00000253598 "Solute carrier family 10 member 5" Q5PT55 8 81693607-81696174 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 5.1;liver: 10.3" "Cell type enhanced" "Detected in some" 11 "Ciliated cells: 6.7;Enterocytes: 5.2;Intestinal endocrine cells: 3.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "OE19: 6.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA025966 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA025966: AB_1856959" "unprognostic (6.42e-2)" "unprognostic (3.89e-1)" "unprognostic (1.25e-2)" "unprognostic (2.34e-2)" "unprognostic (8.13e-3)" "unprognostic (1.91e-1)" "unprognostic (5.71e-2)" "unprognostic (5.63e-2)" "unprognostic (3.67e-1)" "unprognostic (2.41e-1)" "unprognostic (1.37e-1)" "unprognostic (3.22e-1)" "unprognostic (8.95e-2)" "unprognostic (2.51e-1)" "unprognostic (2.24e-1)" "unprognostic (1.67e-1)" "unprognostic (2.82e-7)" 0.0 0.3 0.9 0.1 2.3 0.0 0.2 5.1 1.8 0.3 2.5 2.9 0.3 0.9 0.2 0.3 1.4 0.1 0.9 2.1 1.8 10.3 0.3 0.0 0.8 0.4 1.0 0.3 1.9 0.0 0.5 3.5 0.3 0.2 0.1 0.4 3.5 0.2 0.3 0.3 3.4 0.0 0.8 0.0 0.3 0.1 0.0 0.5 0.0 0.0 0.3 0.4 0.0 0.7 0.3 0.9 0.9 0.7 1.4 0.7 0.9 0.4 0.3 0.5 0.4 0.5 0.9 1.3 0.2 0.2 0.9 1.1 0.8 1.3 0.7 2.4 1.8 2.6 1.4 0.4 0.1 0.3 0.4 2.2 0.7 1.7 1.5 0.4 0.6 1.6 1.2 1.3 0.7 0.5 1.2 0.4 6.5 0.5 0.3 0.3 0.6 1.2 3.1 2.1 0.9 0.7 0.6 0.3 0.5 1.6 0.6 0.9 1.1 1.5 1.4 1.4 1.5 2.2 0.1 1.1 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 6.7 0.0 0.0 0.0 0.0 1.7 0.3 0.0 0.0 5.2 0.0 1.0 0.1 0.0 0.2 0.0 2.1 0.0 0.0 3.5 0.6 0.3 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.5 1.7 0.0 1.8 0.3 0.0 0.2 0.0 0.0 0.1 0.0 0.0 2.0 0.4 SLC12A2 "BSC, BSC2, NKCC1, PPP1R141" ENSG00000064651 "Solute carrier family 12 member 2" P55011 5 128083766-128189688 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Symport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 50.7;salivary gland: 61.2" "Cell type enhanced" "Detected in many" 8 "Glandular cells: 203.2;Mucus-secreting cells: 402.7;Undifferentiated cells: 269.5" "Cancer enhanced" "Detected in all" "colorectal cancer: 54.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 9.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "OE19: 55.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020130, HPA063697" Approved Approved "Vesicles,Plasma membrane" NA NA Vesicles "Plasma membrane" "HPA020130: AB_1854502, HPA063697: AB_2685094" "unprognostic (4.61e-2)" "unprognostic (2.63e-1)" "unprognostic (4.20e-3)" "prognostic favorable (8.60e-4)" "unprognostic (3.99e-1)" "unprognostic (5.65e-3)" "unprognostic (1.44e-3)" "unprognostic (1.81e-1)" "unprognostic (3.30e-1)" "unprognostic (2.95e-2)" "unprognostic (7.22e-2)" "unprognostic (1.39e-1)" "prognostic favorable (7.09e-4)" "unprognostic (1.63e-1)" "unprognostic (2.30e-1)" "unprognostic (3.79e-1)" "unprognostic (3.88e-3)" 5.5 11.0 10.8 9.4 24.1 2.7 26.2 11.4 18.1 5.1 28.5 37.2 0.0 24.6 5.7 1.9 3.8 4.1 50.7 4.1 15.5 9.9 4.5 2.9 6.5 3.5 36.1 13.5 5.6 5.3 11.2 5.5 3.3 30.0 14.8 36.3 8.5 61.2 2.1 8.5 23.0 28.8 6.6 27.7 2.9 36.3 5.5 26.7 2.0 5.6 6.8 18.3 4.2 3.6 3.6 9.8 0.5 1.2 3.6 3.0 0.4 4.8 24.1 24.8 9.6 6.2 4.0 5.1 4.5 3.4 3.2 3.4 9.6 7.7 7.2 6.1 3.9 2.9 14.7 4.7 5.2 5.0 7.2 5.9 2.0 4.3 1.4 1.9 2.6 3.6 4.2 1.9 7.2 4.3 2.4 5.3 3.1 3.3 4.9 5.0 5.1 4.6 2.2 2.9 55.9 7.9 2.5 7.0 2.9 3.8 16.5 4.4 2.8 9.1 4.0 3.5 2.8 2.2 1.3 8.8 8.1 5.4 6.1 5.7 4.1 3.7 8.0 4.2 1.5 6.5 0.5 0.7 0.2 1.9 1.2 3.0 2.7 1.8 2.3 0.9 3.6 2.0 2.7 0.3 3.6 0.8 9.8 1.6 0.4 10.8 24.1 11.4 18.1 15.5 9.9 36.1 13.5 30.0 26.7 14.9 37.4 13.4 18.3 20.4 45.1 14.0 99.3 10.7 38.7 31.4 119.8 0.9 1.7 45.3 45.7 23.6 29.9 0.0 41.4 2.1 14.8 203.2 18.4 7.4 3.6 76.3 71.5 6.7 7.3 70.8 79.1 10.2 194.0 0.0 402.7 27.8 49.2 77.2 27.3 9.6 76.9 71.1 24.5 27.0 21.5 26.2 1.1 12.1 269.5 16.9 SLC16A2 "AHDS, DXS128, MCT7, MCT8, MRX22, XPCT" ENSG00000147100 "Solute carrier family 16 member 2" P36021 X 74421461-74533917 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 43.6" "Cell type enhanced" "Detected in many" 13 "Hepatocytes: 50.8;Peritubular cells: 19.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "gdT-cell: 1.0" "Lineage enriched" "Detected in single" 11 "T-cells: 1.0" "Cell line enhanced" "Detected in many" "BJ: 34.4;GAMG: 27.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072719 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA072719: AB_2686552" "prognostic unfavorable (8.88e-5)" "unprognostic (2.48e-1)" "unprognostic (1.99e-1)" "unprognostic (2.90e-3)" "unprognostic (1.49e-1)" "unprognostic (1.58e-2)" "unprognostic (1.58e-3)" "unprognostic (2.47e-2)" "unprognostic (1.48e-1)" "unprognostic (2.54e-1)" "unprognostic (5.67e-2)" "unprognostic (3.51e-1)" "prognostic unfavorable (1.83e-4)" "unprognostic (2.15e-2)" "unprognostic (1.89e-1)" "unprognostic (6.89e-3)" "prognostic unfavorable (3.16e-4)" 13.5 24.4 10.9 5.4 12.2 0.7 4.9 5.9 14.3 9.9 5.5 8.4 1.8 4.1 9.4 2.7 5.2 6.7 10.5 10.7 8.0 5.9 9.4 43.6 6.0 1.6 4.2 8.0 14.7 6.6 12.7 12.6 10.0 8.2 9.2 2.6 11.1 5.8 7.0 3.5 2.2 3.0 7.6 4.1 1.9 4.2 1.8 5.1 6.4 13.6 4.3 3.0 5.0 5.8 0.0 0.0 0.0 0.0 0.0 1.0 0.0 3.2 4.0 2.9 16.6 7.9 4.2 0.0 34.4 10.6 14.0 8.0 0.0 0.3 0.0 0.5 13.3 27.0 0.6 0.4 14.6 8.2 2.3 1.3 0.0 0.0 0.0 0.6 0.0 0.0 6.2 3.5 7.2 8.5 5.3 0.0 0.0 0.0 0.0 3.2 0.0 0.2 1.0 11.0 0.0 3.0 6.6 7.9 0.0 6.9 0.0 0.7 5.1 3.8 19.3 0.1 1.0 0.2 0.4 0.0 13.6 3.6 14.9 17.1 0.0 0.0 0.0 15.0 0.0 0.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 10.9 12.2 5.9 14.3 8.0 5.9 4.2 8.0 8.2 5.1 0.0 1.1 0.0 3.2 0.7 4.5 3.5 5.1 4.0 3.4 3.5 0.0 4.2 3.3 3.7 0.0 2.7 0.0 0.0 2.1 2.7 4.8 3.2 2.3 50.8 0.8 3.2 8.1 2.5 1.5 0.0 14.1 0.0 3.3 1.0 0.0 6.1 3.1 0.0 19.4 5.4 1.1 12.9 5.6 0.1 0.0 1.1 1.7 0.0 0.0 4.8 SLC19A1 "FOLT, RFC1" ENSG00000173638 "Solute carrier family 19 member 1" P41440 21 45493572-45544411 "Cancer-related genes, Predicted membrane proteins, Transporters" "Antiport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 37.6" "Group enriched" "Detected in many" 5 "Cytotrophoblasts: 133.1;Syncytiotrophoblasts: 303.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 37.6" "Lineage enriched" "Detected in many" 6 "granulocytes: 37.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024802 Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA024802: AB_10602892" "unprognostic (4.31e-3)" "prognostic unfavorable (4.15e-4)" "unprognostic (5.23e-2)" "unprognostic (2.02e-1)" "unprognostic (3.11e-1)" "unprognostic (3.04e-2)" "unprognostic (7.34e-2)" "unprognostic (2.87e-3)" "unprognostic (4.04e-2)" "unprognostic (4.09e-2)" "unprognostic (2.85e-1)" "unprognostic (2.39e-1)" "prognostic unfavorable (1.07e-10)" "unprognostic (1.44e-1)" "unprognostic (2.31e-1)" "unprognostic (7.97e-5)" "unprognostic (3.10e-1)" 9.0 7.8 7.1 8.2 13.5 10.5 12.5 9.6 8.9 5.0 9.7 6.0 9.4 31.2 4.3 4.6 2.3 4.6 3.5 3.2 7.1 6.1 4.7 14.1 13.9 14.1 8.7 4.4 8.1 5.4 1.8 3.5 32.9 11.5 4.7 2.0 17.8 6.0 3.5 3.5 6.1 16.5 2.3 5.9 11.7 5.7 3.4 3.4 11.8 9.6 2.8 4.1 3.1 3.1 0.9 4.9 37.6 6.4 0.4 1.1 2.4 10.6 9.7 1.9 7.9 0.6 0.8 15.9 5.0 0.8 4.6 2.9 22.4 9.9 9.9 9.9 1.2 3.9 5.5 3.9 3.6 1.1 9.1 19.3 20.8 5.2 15.5 2.7 13.5 3.2 1.0 2.8 4.9 1.6 1.3 3.8 10.6 24.8 4.3 1.6 11.9 18.3 12.6 11.4 4.7 11.3 25.0 2.2 28.7 2.1 6.4 11.8 10.4 5.6 9.3 4.3 2.7 7.0 16.0 4.6 6.0 7.5 1.6 8.1 1.8 6.6 9.0 2.7 22.1 4.8 0.6 6.4 8.5 0.3 6.0 1.1 0.9 0.5 0.7 4.9 0.3 0.8 0.5 37.6 0.4 3.7 1.5 1.0 2.4 7.1 13.5 9.6 8.9 7.1 6.1 8.7 4.4 11.5 3.4 44.7 4.6 0.8 1.7 2.2 18.0 2.4 2.5 1.4 10.3 0.0 0.0 133.1 0.0 7.8 3.3 2.8 9.3 0.0 4.2 16.2 2.9 3.6 1.1 10.9 24.0 7.9 0.0 1.8 11.6 3.2 6.1 5.9 3.3 0.0 3.1 8.6 6.8 5.3 10.6 1.9 3.6 0.0 3.8 1.2 4.1 1.4 303.1 2.2 7.6 0.9 SLC19A3 THTR2 ENSG00000135917 "Solute carrier family 19 member 3" Q9BZV2 2 227683763-227718031 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 48.2;breast: 78.2;placenta: 27.5" "Group enriched" "Detected in many" 8 "Cytotrophoblasts: 45.5;Syncytiotrophoblasts: 134.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 8.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "ASC diff: 14.3;BEWO: 7.4;CACO-2: 18.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038898 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA038898: AB_10673481" "unprognostic (3.37e-2)" "unprognostic (3.59e-5)" "unprognostic (1.95e-3)" "unprognostic (1.24e-2)" "unprognostic (1.22e-1)" "unprognostic (6.82e-2)" "unprognostic (1.93e-2)" "unprognostic (1.67e-1)" "unprognostic (1.19e-1)" "unprognostic (2.04e-1)" "unprognostic (4.67e-2)" "unprognostic (3.12e-3)" "unprognostic (7.28e-2)" "unprognostic (8.20e-2)" "unprognostic (1.68e-1)" "unprognostic (1.71e-2)" "unprognostic (7.01e-3)" 48.2 0.6 2.2 1.8 2.4 1.2 78.2 1.5 1.9 0.5 6.1 1.0 0.5 7.7 0.6 0.4 0.6 0.6 8.9 1.9 2.3 2.4 2.1 16.0 5.6 1.3 3.0 0.7 0.9 1.3 0.2 0.3 27.5 2.6 0.5 1.6 0.7 0.9 0.2 0.7 1.6 4.5 0.5 2.6 0.5 0.5 0.6 1.5 0.0 0.5 0.4 0.4 1.0 2.3 2.6 1.8 8.6 1.8 4.3 1.1 0.4 0.3 1.6 0.3 1.0 14.3 0.4 7.4 0.1 0.2 0.3 0.6 18.7 0.5 0.4 0.2 0.1 4.6 0.5 0.5 0.5 0.8 0.1 1.2 0.1 1.0 0.8 1.7 0.2 0.2 3.3 0.4 0.1 0.9 0.3 0.0 0.3 0.2 0.9 0.0 1.8 0.1 0.7 3.2 0.6 0.3 0.3 0.2 0.2 0.2 0.3 1.1 0.1 0.6 2.1 0.5 2.7 0.3 0.2 0.5 0.5 0.5 4.2 0.4 0.2 0.1 0.7 1.4 0.3 0.5 8.6 1.8 1.7 1.0 1.2 0.6 1.6 0.8 0.9 0.4 2.6 1.0 1.1 6.1 4.3 1.1 1.8 0.4 0.4 2.2 2.4 1.5 1.9 2.3 2.4 3.0 0.7 2.6 1.5 8.9 3.2 0.0 0.4 0.0 2.9 0.3 0.0 0.0 0.0 1.8 0.0 45.5 1.7 1.7 0.3 0.5 6.4 0.0 0.0 7.0 0.9 0.3 0.0 11.4 4.6 0.0 1.2 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.3 0.8 0.6 0.0 0.0 2.2 0.1 0.0 1.0 0.0 0.1 0.0 134.3 0.0 5.6 0.3 SLC22A16 "CT2, FLIPT2, OAT6, OKB1" ENSG00000004809 "Solute carrier family 22 member 16" Q86VW1 6 110424687-110476641 "Predicted membrane proteins" "Differentiation, Ion transport, Spermatogenesis, Transport" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 9.5;bone marrow: 16.0;parathyroid gland: 9.6;testis: 26.4" "Group enriched" "Detected in some" 5 "Early spermatids: 28.2;Erythroid cells: 23.3;Late spermatids: 23.1;Spermatocytes: 35.7" "Cancer enriched" "Detected in single" 5 "endometrial cancer: 0.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "classical monocyte: 9.5" "Group enriched" "Detected in many" 66 "dendritic cells: 5.1;granulocytes: 5.0;monocytes: 9.5" "Group enriched" "Detected in some" 18 "NB-4: 9.8;REH: 9.0;THP-1: 31.3;U-937: 18.4" "Low region specificity" "Detected in all" HPA036902 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA036902: AB_10672274" "unprognostic (1.01e-1)" "unprognostic (1.88e-2)" "unprognostic (5.11e-3)" "unprognostic (2.19e-3)" "unprognostic (2.70e-4)" "unprognostic (1.45e-1)" "unprognostic (8.15e-2)" "unprognostic (6.93e-2)" "unprognostic (1.48e-2)" "unprognostic (4.98e-2)" "unprognostic (1.02e-3)" "unprognostic (2.49e-1)" "unprognostic (2.61e-6)" "unprognostic (5.78e-4)" "unprognostic (2.72e-2)" "unprognostic (2.74e-2)" "unprognostic (2.65e-2)" 3.5 0.2 0.2 0.4 0.2 16.0 0.2 0.1 0.2 0.1 0.7 0.0 0.0 0.0 4.9 0.8 0.1 0.3 0.7 0.1 0.2 0.1 1.1 0.3 1.6 0.0 0.2 0.0 0.9 0.1 9.6 0.1 0.3 0.2 0.2 0.0 0.0 0.6 0.0 0.2 0.3 0.1 1.6 0.2 0.8 0.2 26.4 0.0 2.2 0.1 0.8 0.1 0.1 0.1 0.0 5.1 5.0 9.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 31.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 18.4 0.0 5.0 9.5 1.6 0.0 2.1 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.7 0.2 0.2 0.1 0.2 0.2 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 28.2 0.0 0.0 23.3 0.0 0.1 0.2 0.0 0.0 0.0 2.3 0.0 0.0 0.0 2.2 23.1 1.4 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 35.7 0.2 0.4 0.0 0.0 0.0 0.0 SLC24A4 NCKX4 ENSG00000140090 "Solute carrier family 24 member 4" Q8NFF2 14 92322581-92501483 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Olfaction, Potassium transport, Sensory transduction, Sodium transport, Symport, Transport" "Amelogenesis imperfecta, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 11.6;brain: 28.1" "Group enriched" "Detected in some" 8 "Bipolar cells: 223.9;Cone photoreceptor cells: 188.5" "Group enriched" "Detected in some" 5 "glioma: 0.5;melanoma: 0.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "classical monocyte: 7.9;intermediate monocyte: 11.6;non-classical monocyte: 9.4" "Lineage enriched" "Detected in many" 5 "monocytes: 11.6" "Cell line enhanced" "Detected in some" "Daudi: 2.7;SCLC-21H: 5.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA063206 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA063206: " "unprognostic (1.53e-1)" "unprognostic (1.41e-1)" "unprognostic (2.22e-1)" "unprognostic (1.18e-1)" "unprognostic (1.06e-1)" "unprognostic (3.43e-3)" "unprognostic (1.34e-1)" "unprognostic (2.04e-3)" "unprognostic (3.40e-2)" "unprognostic (1.32e-1)" "unprognostic (2.48e-3)" "unprognostic (3.21e-1)" "unprognostic (1.48e-3)" "unprognostic (1.25e-1)" "unprognostic (1.08e-1)" "unprognostic (1.90e-2)" "unprognostic (1.58e-2)" 1.8 1.0 4.9 3.8 6.0 8.6 0.6 1.1 11.7 0.8 0.9 9.6 6.3 0.9 0.6 0.7 0.8 0.8 1.9 0.9 4.7 3.2 0.5 0.7 2.3 2.7 10.8 4.7 1.0 0.6 0.5 1.8 1.2 28.1 0.7 1.0 4.6 0.7 1.2 2.4 0.8 1.2 1.4 14.2 5.0 0.9 2.9 5.7 0.0 0.6 0.0 1.4 1.5 0.8 0.1 2.3 1.3 11.6 0.2 0.2 2.0 0.1 0.2 0.1 0.3 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.6 2.7 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.2 0.7 0.4 0.4 0.2 0.0 0.2 0.3 0.0 0.2 0.3 0.0 0.2 0.0 0.2 0.1 0.6 0.0 0.4 0.0 0.3 1.1 0.0 0.3 0.1 0.1 0.3 0.0 0.3 5.2 0.0 0.2 0.2 0.5 0.1 0.3 1.2 0.6 0.2 1.5 0.3 0.1 0.4 0.1 0.1 0.2 0.3 0.3 0.2 7.9 0.0 0.0 11.6 0.2 0.0 0.0 0.0 2.3 0.1 0.0 0.0 1.3 0.2 9.4 0.4 0.0 2.0 4.9 6.0 1.1 7.3 4.7 3.2 10.8 4.7 28.1 5.7 0.0 3.4 0.0 0.1 0.0 223.9 1.2 0.0 1.4 0.0 0.0 188.5 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 3.5 0.0 0.0 1.8 26.6 4.6 0.3 4.0 0.0 0.0 0.0 2.1 0.1 0.0 0.4 0.0 8.2 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.1 SLC27A1 "ACSVL5, FATP, FATP1, FLJ00336, MGC71751" ENSG00000130304 "Solute carrier family 27 member 1" Q6PCB7 19 17468769-17506168 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Fatty acid metabolism, Lipid metabolism, Lipid transport, Transport" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 17.6;SK-MEL-30: 29.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076520 Approved "Plasma membrane,Mitochondria,Cytosol" NA NA "Plasma membrane" "Mitochondria, Cytosol" "HPA076520: AB_2732311" "unprognostic (1.48e-3)" "unprognostic (3.03e-2)" "unprognostic (5.72e-3)" "unprognostic (5.84e-2)" "unprognostic (2.16e-3)" "unprognostic (4.36e-2)" "unprognostic (8.56e-2)" "unprognostic (3.36e-2)" "unprognostic (9.03e-2)" "unprognostic (1.85e-2)" "unprognostic (1.12e-1)" "unprognostic (2.28e-1)" "prognostic favorable (4.70e-4)" "unprognostic (5.01e-2)" "unprognostic (2.25e-1)" "unprognostic (1.02e-1)" "unprognostic (1.12e-1)" 14.5 14.3 13.1 5.2 13.9 2.0 9.3 20.1 19.3 11.8 6.4 44.1 10.1 4.6 8.9 6.4 5.9 14.7 11.0 18.3 12.9 10.0 5.2 5.2 8.5 6.7 22.0 17.2 23.2 14.5 26.1 9.8 7.5 16.1 11.0 2.6 9.6 26.7 13.0 24.2 13.7 3.7 5.5 13.4 7.1 10.9 9.6 19.3 1.3 9.9 4.7 5.3 6.9 8.8 0.5 7.4 0.3 9.9 1.7 3.2 4.6 3.6 1.8 2.5 6.1 17.6 9.8 2.1 2.6 7.0 3.0 4.5 0.2 11.3 1.2 5.0 4.4 2.8 4.4 0.2 4.1 0.7 1.4 0.8 0.7 0.2 1.3 3.4 0.3 4.0 9.0 2.9 3.0 1.2 12.5 2.0 2.4 0.4 0.7 1.9 1.5 2.0 2.9 0.7 3.6 3.2 2.8 2.0 0.8 1.9 1.1 0.8 1.8 1.8 0.9 29.1 1.6 3.2 0.9 1.2 5.9 3.9 4.7 1.8 2.5 1.8 0.4 6.1 3.2 4.1 0.0 9.9 0.3 1.7 4.7 3.2 0.5 1.2 2.1 7.2 0.3 1.6 2.1 0.0 1.7 1.8 7.4 0.7 4.6 13.1 13.9 20.1 19.3 12.9 10.0 22.0 17.2 16.1 19.3 3.0 14.0 1.5 14.9 6.0 8.2 16.7 10.2 4.0 9.1 8.7 25.5 3.7 1.7 9.3 0.7 4.7 0.1 0.0 4.1 14.7 9.7 10.3 2.3 5.8 24.7 6.4 5.2 9.2 20.6 1.7 19.8 9.1 8.5 5.4 2.6 9.7 4.9 0.0 11.0 2.7 17.6 6.5 5.2 8.1 4.3 4.0 1.9 6.1 1.3 7.0 SLC2A14 "GLUT14, SLC2A3P3" ENSG00000173262 "Solute carrier family 2 member 14" Q8TDB8 12 7812512-7891148 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Differentiation, Spermatogenesis, Sugar transport, Transport" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 52.4" "Cell type enriched" "Detected in many" 7 "Spermatocytes: 60.6" "Cancer enriched" "Detected in single" 35 "testis cancer: 7.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "neutrophil: 6.9" "Lineage enriched" "Detected in many" 4 "granulocytes: 6.9" "Cell line enhanced" "Detected in some" "BEWO: 12.6;CACO-2: 20.4;Hep G2: 5.3;SuSa: 25.2" HPA006539 Supported Approved "Plasma membrane" NA NA "Plasma membrane" "HPA006539: AB_1078984" "unprognostic (2.52e-1)" "unprognostic (4.74e-3)" "unprognostic (1.79e-1)" "unprognostic (1.29e-1)" "unprognostic (3.35e-2)" "unprognostic (1.82e-3)" "unprognostic (8.62e-2)" "unprognostic (7.15e-2)" "unprognostic (1.89e-1)" "unprognostic (9.91e-3)" "unprognostic (1.23e-1)" "unprognostic (1.27e-1)" "unprognostic (8.46e-4)" "unprognostic (3.92e-2)" "unprognostic (3.41e-1)" "unprognostic (3.26e-2)" "unprognostic (1.22e-2)" 0.4 3.1 0.1 0.1 0.6 3.0 0.4 0.1 0.2 0.4 0.4 0.3 0.1 0.0 0.3 0.8 0.8 0.1 0.3 0.1 0.2 0.3 0.1 2.0 0.2 0.2 0.1 0.1 2.7 7.4 0.0 0.6 0.5 0.3 0.6 0.2 0.1 0.1 0.1 0.1 0.1 0.7 0.2 0.1 0.1 0.0 52.4 0.2 0.1 0.1 0.1 0.1 0.6 0.1 0.6 0.4 6.9 0.7 1.3 1.7 0.2 0.0 0.3 0.3 0.2 0.2 0.6 12.6 0.0 0.0 0.0 0.2 20.4 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 2.1 0.5 5.3 0.0 0.0 3.0 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.9 0.1 0.0 0.1 0.1 0.1 2.3 0.0 0.0 0.1 0.1 0.1 0.0 0.3 0.1 0.0 0.0 0.4 0.0 25.2 0.0 1.3 0.3 0.1 0.5 0.3 0.1 0.1 0.1 0.2 0.3 0.0 0.3 5.5 0.7 1.8 1.0 0.2 1.2 0.5 1.0 0.8 0.4 0.6 0.7 0.9 6.9 1.3 0.2 0.3 1.7 0.2 0.1 0.6 0.1 0.2 0.2 0.3 0.1 0.1 0.3 0.2 0.0 0.6 0.0 0.0 0.6 0.0 1.4 0.0 0.0 0.0 0.0 3.9 0.2 0.0 0.0 3.7 2.3 0.0 0.0 1.3 0.9 1.9 0.0 9.2 0.4 0.2 0.0 0.0 8.0 4.4 0.9 0.3 3.1 1.7 0.0 0.0 0.0 0.5 5.8 2.5 0.0 0.4 0.0 4.2 60.6 2.7 0.1 0.3 3.2 0.0 0.0 SLC2A3 GLUT3 ENSG00000059804 "Solute carrier family 2 member 3" P11169 12 7919230-7936275 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 166.3" "Cell type enhanced" "Detected in many" 7 "granulocytes: 462.0" "Cancer enriched" "Detected in all" 7 "testis cancer: 107.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 30.2;neutrophil: 55.6" "Lineage enriched" "Detected in all" 9 "granulocytes: 55.6" "Group enriched" "Detected in many" 5 "BEWO: 143.6;CACO-2: 154.0;SuSa: 113.9" "CAB002763, HPA006539" Approved Approved "Plasma membrane" NA NA 33000000 "Plasma membrane" "CAB002763: , HPA006539: AB_1078984" "unprognostic (9.20e-2)" "unprognostic (9.63e-3)" "prognostic unfavorable (8.58e-4)" "unprognostic (2.65e-1)" "unprognostic (5.29e-3)" "unprognostic (2.16e-3)" "unprognostic (1.12e-1)" "unprognostic (8.27e-2)" "unprognostic (2.35e-1)" "unprognostic (3.83e-2)" "unprognostic (8.47e-3)" "unprognostic (5.40e-2)" "prognostic unfavorable (6.36e-8)" "prognostic unfavorable (2.89e-5)" "unprognostic (1.70e-1)" "unprognostic (1.14e-2)" "unprognostic (2.91e-3)" 48.8 10.0 9.5 25.2 10.5 166.3 26.4 13.1 24.3 9.4 10.0 6.8 1.8 4.2 10.3 8.2 13.2 8.0 25.6 22.8 10.8 13.6 10.3 14.1 32.4 12.8 13.3 3.3 18.8 6.1 6.9 10.9 43.9 13.7 15.0 6.9 14.8 3.8 3.9 13.6 7.4 5.8 18.7 15.4 16.4 7.0 10.6 12.5 3.3 15.7 7.0 13.6 51.8 10.5 1.8 2.4 55.6 4.6 3.6 6.4 3.5 0.0 0.7 6.6 2.5 2.4 8.5 143.6 2.3 2.5 2.3 5.4 154.0 1.0 0.1 0.0 1.6 3.2 0.0 0.2 0.3 4.2 4.5 0.1 8.9 0.6 20.2 6.7 3.2 13.0 3.5 0.2 6.1 2.8 5.4 2.1 0.7 4.1 2.1 2.1 0.0 0.2 3.4 29.1 0.1 0.0 0.2 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.2 3.0 113.9 0.0 0.4 2.1 2.9 1.5 5.6 0.2 0.0 6.2 0.4 8.5 1.5 1.5 30.2 4.6 7.0 6.4 0.5 5.3 1.8 4.4 4.9 2.4 1.7 2.8 3.8 55.6 3.6 0.2 0.1 5.8 3.5 9.5 10.5 13.1 13.3 10.8 13.6 13.3 3.3 13.7 12.5 134.0 147.7 116.7 2.9 115.1 27.9 8.4 7.6 18.7 48.9 3.5 58.9 41.5 0.0 0.2 2.4 227.7 0.0 0.0 0.0 218.4 149.1 3.8 462.0 1.0 97.9 4.8 1.2 85.3 85.8 1.9 9.5 229.2 173.7 1.0 0.0 19.2 0.8 0.2 7.4 1.2 68.8 116.4 236.4 1.4 0.6 71.6 93.1 133.8 0.0 2.8 SLC31A2 "COPT2, CTR2, hCTR2" ENSG00000136867 "Solute carrier family 31 member 2" O15432 9 113150942-113164137 "Predicted membrane proteins, Transporters" "Copper transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 60.2;salivary gland: 125.5" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 80.2;Kupffer cells: 82.1;Macrophages: 93.6;monocytes: 89.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 12 "classical monocyte: 36.6;intermediate monocyte: 50.5;myeloid DC: 21.2;neutrophil: 54.5;non-classical monocyte: 60.2" "Group enriched" "Detected in many" 36 "dendritic cells: 21.2;granulocytes: 54.5;monocytes: 60.2" "Cell line enhanced" "Detected in many" "ASC diff: 22.2;hTCEpi: 33.7;hTERT-HME1: 23.1;LHCN-M2: 26.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA014861 Approved Approved "Nuclear speckles,Plasma membrane,Intermediate filaments" NA NA "Nuclear speckles" "Plasma membrane, Intermediate filaments" "HPA014861: AB_1857098" "unprognostic (2.26e-1)" "unprognostic (7.20e-2)" "unprognostic (3.79e-3)" "unprognostic (1.09e-1)" "unprognostic (1.10e-1)" "unprognostic (4.81e-3)" "unprognostic (5.63e-2)" "unprognostic (3.31e-2)" "unprognostic (2.24e-1)" "unprognostic (3.44e-2)" "unprognostic (1.47e-1)" "unprognostic (1.86e-1)" "unprognostic (6.05e-3)" "unprognostic (1.76e-1)" "unprognostic (3.56e-2)" "unprognostic (1.25e-1)" "unprognostic (8.89e-2)" 15.7 8.0 10.0 8.1 20.5 7.0 8.5 3.2 15.0 3.0 8.4 45.1 27.1 5.2 2.0 6.0 4.6 3.0 4.5 3.4 18.2 9.4 9.8 11.2 10.0 6.2 34.3 10.5 2.8 7.8 17.9 1.2 10.2 22.3 2.1 4.4 1.0 125.5 21.8 6.7 18.5 9.9 3.8 48.5 14.1 4.5 5.4 26.2 1.2 2.8 2.9 5.8 3.9 4.1 0.3 21.2 54.5 60.2 0.2 1.2 13.4 5.5 2.5 1.4 2.0 22.2 9.1 4.8 4.2 5.4 5.1 4.9 1.8 1.7 0.3 0.8 3.5 8.3 20.6 2.0 12.0 4.8 2.8 0.8 0.3 1.2 2.9 8.5 2.2 1.2 10.2 33.7 11.9 23.1 2.7 2.7 2.7 1.6 3.0 26.6 5.3 2.1 1.3 0.7 2.8 2.3 0.4 20.1 0.4 1.7 3.4 1.3 2.2 5.8 17.8 1.7 1.2 6.4 2.0 2.5 2.8 1.9 9.2 3.6 1.9 3.9 0.2 8.8 2.9 2.8 0.8 36.6 3.6 0.9 50.5 1.2 0.2 1.0 1.0 21.2 0.3 0.8 0.8 54.5 0.2 60.2 0.5 0.6 13.4 10.0 20.5 3.2 15.0 18.2 9.4 34.3 10.5 22.3 26.2 8.9 8.6 18.0 5.3 33.0 6.9 0.4 2.5 10.7 5.7 1.8 33.4 80.2 3.3 10.7 2.3 6.7 17.4 0.0 6.6 5.8 13.3 7.9 0.0 18.7 55.9 6.4 3.4 17.2 82.1 2.0 14.7 93.6 0.0 89.2 3.2 8.2 13.8 7.0 8.9 17.4 9.1 19.4 8.9 30.6 5.1 33.5 36.0 8.3 3.5 4.2 SLC36A4 "FLJ38932, PAT4" ENSG00000180773 "Solute carrier family 36 member 4" Q6YBV0 11 93144171-93197964 "Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017887 Enhanced Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Golgi apparatus, Plasma membrane, Cytosol" "HPA017887: AB_2190238" "unprognostic (1.23e-2)" "unprognostic (1.08e-1)" "unprognostic (2.17e-3)" "unprognostic (1.32e-3)" "unprognostic (3.66e-2)" "unprognostic (8.77e-2)" "unprognostic (1.08e-3)" "unprognostic (7.83e-3)" "unprognostic (3.06e-2)" "unprognostic (7.97e-2)" "unprognostic (2.09e-2)" "unprognostic (8.04e-3)" "unprognostic (7.07e-2)" "unprognostic (4.40e-2)" "unprognostic (1.74e-1)" "unprognostic (9.45e-3)" "unprognostic (4.20e-2)" 8.0 11.0 16.0 12.6 19.3 24.1 6.5 20.7 20.2 8.0 7.3 8.7 2.1 3.0 10.4 3.6 7.8 6.2 8.4 9.2 14.2 14.8 13.7 11.0 8.2 7.0 16.8 10.3 8.6 8.0 8.0 17.2 8.7 17.6 7.5 9.4 5.4 5.4 9.1 3.4 5.9 4.2 11.5 20.0 5.7 6.4 6.0 13.4 5.6 12.7 2.3 9.2 8.6 7.7 1.6 2.9 8.1 7.7 0.8 2.6 1.8 5.1 9.3 19.0 3.8 6.7 13.7 10.7 9.0 15.0 13.4 16.3 7.4 17.0 6.3 5.2 8.3 7.0 6.4 5.8 3.3 12.3 10.5 6.8 7.2 19.5 4.9 5.3 18.1 10.8 6.6 10.4 7.7 4.9 6.3 7.1 9.0 0.6 0.1 13.6 1.3 7.9 13.7 7.6 2.0 9.4 3.6 11.3 2.6 4.5 7.7 17.6 22.9 13.1 5.1 3.2 14.5 9.3 5.3 7.9 25.3 7.8 14.9 13.0 2.6 5.2 0.0 5.7 7.6 13.0 0.2 7.7 8.1 1.3 3.9 1.8 1.3 1.0 1.6 2.9 1.6 2.6 1.7 2.5 0.8 2.5 1.1 0.8 1.8 16.0 19.3 20.7 20.2 14.2 14.8 16.8 10.3 17.6 13.4 11.9 8.6 18.2 35.2 27.2 21.1 7.7 12.7 21.4 6.8 19.2 21.6 9.5 29.9 19.1 1.7 18.0 0.7 0.0 37.9 21.2 11.6 37.1 4.6 6.4 13.1 25.4 26.5 10.4 59.0 3.1 16.7 44.6 20.3 10.0 17.4 13.3 27.9 5.8 14.5 12.3 23.0 6.5 17.6 6.2 2.7 28.0 13.6 10.7 4.3 23.7 SLC38A5 "JM24, SN2" ENSG00000017483 "Solute carrier family 38 member 5" Q8WUX1 X 48458537-48470256 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "pancreas: 87.7" "Cell type enhanced" "Detected in many" 14 "Exocrine glandular cells: 67.4;Pancreatic endocrine cells: 93.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 35.6;HBEC3-KT: 54.3;HeLa: 53.5;hTCEpi: 40.4;Karpas-707: 47.8;RPMI-8226: 87.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047411 Enhanced Approved "Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" Cytosol "HPA047411: AB_10964355" "unprognostic (2.81e-1)" "unprognostic (4.87e-2)" "unprognostic (7.92e-3)" "unprognostic (1.58e-1)" "unprognostic (1.29e-3)" "unprognostic (1.26e-1)" "unprognostic (7.75e-2)" "unprognostic (5.79e-2)" "unprognostic (1.52e-1)" "unprognostic (3.80e-3)" "prognostic unfavorable (2.13e-4)" "unprognostic (2.99e-2)" "prognostic unfavorable (2.22e-16)" "unprognostic (1.27e-3)" "unprognostic (1.45e-1)" "unprognostic (2.86e-1)" "unprognostic (2.20e-1)" 1.5 0.9 5.3 4.7 7.1 17.3 0.9 3.5 11.6 4.0 4.9 7.7 0.1 5.1 1.8 1.3 3.7 2.0 1.5 2.4 6.9 5.7 0.7 0.4 9.4 3.3 7.0 2.7 3.7 87.7 0.4 0.4 2.8 14.6 5.1 6.4 1.5 4.4 3.7 0.4 8.0 3.5 2.8 7.3 4.8 4.5 0.5 4.6 2.4 7.9 3.6 3.4 4.8 3.1 7.4 8.3 0.3 0.4 5.4 16.2 5.7 23.0 0.0 0.0 0.2 0.4 2.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 24.2 0.0 10.2 0.0 35.6 27.6 54.3 0.0 7.7 0.0 13.1 53.5 16.6 4.0 26.8 0.0 3.8 40.4 0.5 0.1 0.0 0.4 5.9 24.1 47.8 5.4 0.0 5.8 9.3 12.5 0.0 0.1 21.3 0.1 87.9 0.0 0.0 2.2 0.1 0.0 0.1 0.0 0.1 0.0 1.1 0.7 0.1 0.0 0.0 0.0 0.0 0.1 8.7 0.2 0.1 0.1 0.0 0.2 0.2 11.5 0.4 16.2 7.4 12.6 10.8 1.5 4.7 6.0 7.7 0.3 5.4 0.0 8.3 13.0 5.7 5.3 7.1 3.5 11.6 6.9 5.7 7.0 2.7 14.6 4.6 0.0 1.1 0.8 1.6 23.7 0.6 0.4 0.0 1.4 0.0 5.2 17.7 0.1 0.0 4.9 0.4 3.1 2.3 23.3 67.4 0.4 5.6 0.9 4.6 0.4 2.5 0.0 0.0 0.0 0.0 0.7 2.3 1.1 8.5 2.8 12.3 0.0 93.7 3.5 1.1 0.0 0.2 0.0 1.0 0.0 0.0 7.4 0.0 8.5 19.1 0.9 SLC38A6 NAT-1 ENSG00000139974 "Solute carrier family 38 member 6" Q8IZM9 14 60981114-61083733 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 130.6;Hofbauer cells: 89.9;Late spermatids: 97.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 33.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018508 Approved Approved "Plasma membrane,Cell Junctions,Microtubules" NA NA "Cell Junctions" "Plasma membrane, Microtubules" "HPA018508: AB_2190518" "unprognostic (7.08e-2)" "unprognostic (4.14e-2)" "unprognostic (1.75e-1)" "unprognostic (3.49e-1)" "unprognostic (1.00e-1)" "unprognostic (1.74e-2)" "prognostic unfavorable (9.47e-6)" "unprognostic (9.89e-3)" "unprognostic (2.38e-1)" "unprognostic (2.18e-2)" "unprognostic (2.20e-1)" "unprognostic (5.13e-2)" "prognostic unfavorable (1.37e-5)" "unprognostic (1.73e-1)" "unprognostic (4.63e-2)" "unprognostic (1.47e-1)" "unprognostic (2.90e-1)" 26.1 16.9 8.3 6.7 16.6 4.0 11.4 9.7 14.0 8.1 7.1 5.2 5.5 4.5 10.0 20.5 5.0 8.4 14.4 5.4 8.8 8.6 16.9 9.2 12.2 9.6 8.6 10.9 9.9 6.1 23.8 21.5 13.7 14.3 8.1 10.1 10.9 11.7 6.4 4.1 4.6 5.6 8.0 7.6 10.8 6.4 10.9 6.5 8.8 9.7 7.1 7.2 11.6 8.1 2.4 5.2 0.2 8.6 0.7 5.2 3.4 7.1 10.0 3.2 5.9 33.9 12.3 2.2 5.4 16.2 5.1 4.8 2.5 19.6 1.7 9.3 4.9 10.8 6.3 3.1 5.5 4.8 2.4 1.4 3.0 4.1 6.5 11.1 1.5 5.8 9.7 2.3 5.0 5.9 21.1 6.8 2.7 4.1 3.7 17.9 4.0 2.7 3.9 2.0 4.3 6.6 0.5 9.5 5.5 15.0 4.0 1.5 1.2 4.5 3.3 8.7 4.7 4.7 2.6 7.2 8.0 3.4 9.3 3.0 0.7 2.1 0.6 16.4 1.3 6.3 0.0 8.4 0.1 2.2 8.6 2.6 2.4 4.0 2.9 4.4 2.2 3.3 4.3 0.2 0.7 5.4 5.2 5.2 3.4 8.3 16.6 9.7 14.0 8.8 8.6 8.6 10.9 14.3 6.5 20.8 4.1 2.7 10.8 4.6 18.5 2.8 5.1 34.8 5.7 5.2 21.6 5.0 1.7 4.1 130.6 6.7 2.2 0.0 2.5 7.9 8.5 6.5 5.8 4.0 89.9 4.8 4.1 3.7 20.7 97.9 10.0 19.2 5.0 1.8 2.3 14.2 6.0 2.0 5.6 16.8 25.0 0.0 6.6 15.1 10.6 2.5 5.6 4.4 2.8 5.9 SLC38A7 FLJ10815 ENSG00000103042 "Solute carrier family 38 member 7" Q9NVC3 16 58665109-58685104 "Predicted membrane proteins, Transporters" "Amino-acid transport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 14 "Early spermatids: 273.8;Late spermatids: 600.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041777 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA041777: AB_10796782" "unprognostic (2.16e-3)" "unprognostic (2.30e-2)" "unprognostic (6.23e-3)" "prognostic favorable (6.87e-4)" "unprognostic (3.49e-1)" "unprognostic (8.08e-3)" "unprognostic (9.76e-3)" "unprognostic (6.34e-3)" "unprognostic (1.98e-2)" "unprognostic (2.02e-1)" "unprognostic (2.77e-1)" "unprognostic (4.90e-2)" "prognostic favorable (2.87e-4)" "unprognostic (1.85e-1)" "unprognostic (4.38e-2)" "unprognostic (7.50e-2)" "unprognostic (4.93e-3)" 7.0 11.1 10.6 6.7 10.0 2.7 7.2 7.7 13.7 6.2 5.3 10.6 6.8 4.8 6.0 7.4 6.0 4.2 6.5 13.8 7.2 7.2 7.4 12.1 5.2 4.3 6.1 11.0 4.7 5.0 16.9 10.2 8.4 8.3 5.2 6.9 8.9 6.1 5.6 9.6 5.3 4.9 8.5 5.8 10.3 5.4 27.1 6.6 4.2 8.0 8.1 5.1 6.5 6.3 2.8 6.1 2.5 8.6 2.3 5.2 6.6 4.4 7.0 6.9 10.6 14.4 8.7 13.0 10.5 12.2 14.8 10.3 6.5 6.9 2.8 6.0 14.6 11.9 10.8 6.6 7.3 8.8 1.8 6.0 3.2 5.8 10.5 21.9 6.6 9.2 17.4 15.4 10.3 6.8 8.0 15.1 6.7 9.4 4.3 10.7 5.3 2.6 3.9 7.5 4.7 10.4 9.6 7.5 7.6 6.5 10.2 5.1 7.7 15.8 10.8 4.6 9.7 5.1 2.8 11.8 8.1 6.2 14.0 3.1 6.3 4.1 3.2 11.0 4.0 6.0 0.2 8.6 2.5 5.2 8.4 3.1 1.9 3.3 3.8 6.1 2.8 2.7 2.9 0.8 2.3 7.5 2.1 2.2 6.6 10.6 10.0 7.7 13.7 7.2 7.2 6.1 11.0 8.3 6.6 3.0 4.1 0.5 3.9 3.4 9.7 11.2 2.5 4.0 3.4 10.4 11.8 7.3 3.3 12.6 273.8 4.7 3.9 0.0 7.4 7.9 5.7 3.0 1.1 8.5 31.3 15.9 12.6 8.6 8.6 600.3 8.9 7.1 8.5 2.8 3.6 8.0 10.5 3.5 8.1 4.6 7.1 6.5 5.1 6.2 6.1 3.8 12.8 1.8 5.1 2.7 SLC39A10 "DKFZp564L2123, FLJ90515, KIAA1265" ENSG00000196950 "Solute carrier family 39 member 10" Q9ULF5 2 195575977-195737702 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 41.0;thyroid gland: 39.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036512, HPA036513, HPA066087" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 49000 "Nucleoplasm, Cytosol" "Plasma membrane" "HPA036512: AB_2675165, HPA036513: AB_10670801, HPA066087: AB_2685613" "unprognostic (1.06e-1)" "unprognostic (3.87e-3)" "unprognostic (5.33e-2)" "unprognostic (1.33e-3)" "prognostic favorable (1.46e-5)" "unprognostic (7.40e-2)" "prognostic unfavorable (4.39e-5)" "unprognostic (2.10e-2)" "unprognostic (8.73e-2)" "unprognostic (2.84e-2)" "prognostic unfavorable (3.23e-4)" "unprognostic (8.46e-2)" "unprognostic (9.71e-2)" "unprognostic (1.34e-2)" "unprognostic (3.68e-1)" "unprognostic (2.47e-2)" "unprognostic (6.89e-2)" 6.6 10.9 16.0 6.0 24.8 3.7 6.2 10.8 41.0 9.8 3.8 4.2 4.9 3.6 9.4 3.3 3.5 8.5 7.6 4.7 15.0 11.2 7.8 2.1 6.3 6.5 8.5 24.4 7.4 5.7 5.8 5.7 10.7 15.7 16.7 4.0 1.4 4.8 6.5 3.3 5.7 5.7 6.7 10.2 14.4 4.3 7.9 6.2 10.6 39.9 1.7 6.4 6.1 4.9 9.4 18.4 19.3 2.7 11.0 4.6 1.5 2.9 9.9 18.9 5.2 3.7 8.8 9.8 13.7 6.7 6.6 3.3 14.8 10.6 4.1 20.9 7.8 5.1 4.2 11.5 12.6 8.4 2.1 8.6 4.6 15.4 12.1 4.1 16.8 1.9 5.2 1.8 7.3 8.4 23.4 14.8 4.2 13.3 5.8 10.6 2.8 4.8 5.2 22.0 17.2 7.8 11.3 6.6 10.2 28.8 4.9 7.3 10.0 13.7 28.0 7.2 34.5 4.5 10.5 14.5 12.1 14.0 7.9 7.1 2.0 1.2 2.4 9.7 7.9 12.2 19.3 2.7 1.9 4.5 2.5 3.5 6.8 4.0 3.7 3.3 9.4 3.5 4.6 0.5 11.0 1.8 18.4 3.9 1.5 16.0 24.8 10.8 39.7 15.0 11.2 8.5 24.4 15.7 6.2 3.0 10.9 18.2 9.3 22.8 21.9 7.3 7.6 6.7 29.6 34.9 7.9 41.3 1.7 17.6 23.2 27.0 2.9 23.3 9.5 54.8 20.3 18.5 12.7 2.5 21.6 7.9 15.0 24.5 18.1 11.5 17.5 29.7 6.8 8.2 5.1 15.6 17.5 2.9 17.7 14.9 19.9 12.9 13.8 47.8 27.0 17.9 19.6 21.5 4.5 6.4 SLC39A14 "KIAA0062, NET34, ZIP14" ENSG00000104635 "Solute carrier family 39 member 14" Q15043 8 22367249-22434129 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport, Zinc transport" "Disease mutation, Dystonia, Neurodegeneration, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 135.5;pancreas: 77.2" "Cell type enriched" "Detected in many" 8 "Hepatocytes: 491.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "BJ hTERT+: 66.5" "Low region specificity" "Detected in all" "HPA016508, HPA056732" Enhanced Approved "Endoplasmic reticulum,Golgi apparatus,Plasma membrane" NA NA 950000 "Endoplasmic reticulum, Golgi apparatus, Plasma membrane" "HPA016508: AB_1857148, HPA056732: " "unprognostic (1.67e-1)" "unprognostic (6.67e-3)" "prognostic favorable (5.00e-5)" "unprognostic (9.83e-3)" "unprognostic (9.21e-3)" "unprognostic (8.99e-3)" "unprognostic (1.99e-1)" "unprognostic (2.91e-2)" "unprognostic (4.95e-2)" "unprognostic (5.66e-2)" "unprognostic (6.64e-2)" "unprognostic (1.53e-1)" "prognostic unfavorable (3.79e-7)" "unprognostic (4.88e-2)" "unprognostic (8.73e-2)" "unprognostic (1.63e-2)" "unprognostic (1.11e-3)" 15.0 16.1 2.6 7.7 5.4 0.1 45.5 2.4 6.1 3.6 13.7 1.9 2.8 31.6 6.7 2.8 3.9 5.6 9.8 41.1 2.8 2.4 10.4 135.5 4.8 5.3 3.7 1.9 10.6 77.2 3.0 6.4 4.0 9.2 5.1 11.4 4.1 20.2 4.4 46.1 4.4 18.2 14.1 4.7 2.3 16.2 5.9 2.8 0.7 25.1 2.1 1.4 11.3 19.0 5.0 1.8 2.5 0.5 2.9 8.7 3.9 10.4 13.9 3.9 7.8 14.0 11.8 8.5 15.0 66.5 23.5 37.1 46.2 9.9 10.4 8.5 17.6 61.2 11.5 19.2 18.7 38.8 10.8 11.0 8.3 11.1 46.5 33.3 5.7 9.1 12.5 15.3 41.6 29.1 11.9 10.4 7.5 7.2 10.7 11.9 4.8 8.6 3.6 23.7 16.6 10.7 12.3 7.3 22.2 8.6 4.5 6.6 10.3 15.3 6.6 31.0 8.7 5.2 8.3 5.7 29.2 14.9 18.4 15.4 6.2 5.6 13.6 41.3 7.6 17.0 0.0 0.5 2.5 8.3 0.1 8.7 5.0 4.8 6.3 1.8 2.6 5.7 7.6 0.2 2.9 0.1 0.8 3.8 3.9 2.6 5.4 2.4 6.1 2.8 2.4 3.7 1.9 9.2 2.8 3.0 4.8 3.7 8.8 29.7 7.1 50.1 50.9 0.0 3.4 7.0 2.0 0.2 1.7 48.7 0.4 31.6 63.6 0.0 63.9 2.1 30.9 17.2 0.0 491.4 1.5 46.1 32.0 31.9 15.9 1.8 22.2 1.6 42.2 4.6 51.4 4.6 55.6 28.8 39.3 21.4 7.4 0.0 46.7 0.0 2.4 18.3 0.5 4.9 33.7 9.8 SLC39A2 ZIP2 ENSG00000165794 "Solute carrier family 39 member 2" Q9NP94 14 20999255-21001871 "Predicted membrane proteins" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 44.3;seminal vesicle: 50.6;skin 1: 23.8" "Cell type enriched" "Detected in some" 4 "Muller glia cells: 21.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 67 "HaCaT: 23.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA030489, HPA073231" Uncertain Approved "Plasma membrane,Cytoplasmic bodies" NA NA "Plasma membrane" "Cytoplasmic bodies" "HPA030489: AB_10601488, HPA073231: " "unprognostic (2.76e-2)" "unprognostic (4.86e-2)" "unprognostic (9.72e-2)" "unprognostic (2.37e-1)" "unprognostic (2.46e-1)" "unprognostic (2.71e-1)" "unprognostic (3.42e-1)" "unprognostic (1.70e-1)" "unprognostic (4.43e-1)" "unprognostic (6.20e-3)" "unprognostic (3.31e-1)" "unprognostic (2.80e-1)" "unprognostic (3.62e-2)" "unprognostic (1.91e-1)" "unprognostic (5.80e-2)" "unprognostic (3.71e-1)" "unprognostic (2.30e-3)" 0.1 0.1 0.1 0.0 0.1 0.0 1.3 0.3 0.4 5.6 1.2 0.0 44.3 0.0 0.8 0.0 13.0 0.3 0.1 0.2 0.4 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.4 0.2 1.0 0.2 8.5 0.8 0.4 2.7 50.6 0.1 23.8 0.1 0.2 0.1 0.1 0.0 0.1 0.0 1.3 0.1 6.1 3.3 1.2 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 23.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.4 0.4 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 1.5 0.7 0.0 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 3.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.3 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 5.3 0.2 0.0 0.8 4.2 SLC43A1 "PB39, POV1, R00504" ENSG00000149150 "Solute carrier family 43 member 1" O75387 11 57484534-57515786 "Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "gallbladder: 27.0;liver: 91.8;pancreas: 100.5" "Cell type enhanced" "Detected in many" 14 "Cholangiocytes: 40.8;Hepatocytes: 109.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 23.8;NB-4: 28.3;U-937: 27.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA018813, HPA018826" Enhanced Approved "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Golgi apparatus, Vesicles, Plasma membrane" "HPA018813: AB_1857164, HPA018826: AB_1857165" "unprognostic (3.04e-1)" "unprognostic (1.15e-1)" "unprognostic (9.19e-2)" "prognostic favorable (3.19e-4)" "unprognostic (2.51e-2)" "unprognostic (5.48e-2)" "unprognostic (2.32e-1)" "unprognostic (6.71e-3)" "unprognostic (1.63e-1)" "unprognostic (3.12e-2)" "unprognostic (6.06e-2)" "unprognostic (2.72e-1)" "prognostic unfavorable (2.97e-5)" "unprognostic (1.39e-2)" "unprognostic (1.48e-1)" "prognostic unfavorable (5.27e-4)" "unprognostic (7.30e-2)" 4.7 3.3 0.8 2.2 0.8 9.3 7.4 0.7 1.3 6.0 4.8 0.9 3.9 2.5 5.0 6.8 4.1 3.3 27.0 3.2 0.7 0.6 3.4 91.8 2.9 3.3 0.8 1.1 6.5 100.5 0.1 1.3 1.8 0.7 6.2 2.8 11.4 14.9 2.1 7.5 5.6 2.6 7.0 0.9 2.5 7.6 3.1 0.7 0.8 7.4 2.9 3.1 7.6 3.5 3.1 8.2 8.1 6.0 6.9 11.1 5.2 0.4 0.6 0.7 8.0 10.5 7.7 0.1 4.2 5.4 1.2 3.1 2.5 1.1 23.0 1.1 3.1 1.5 0.3 7.1 0.4 1.5 1.1 1.8 11.8 0.2 23.8 13.8 20.7 2.9 9.7 1.7 2.0 9.3 2.9 5.3 13.8 16.5 4.3 1.5 0.8 0.1 28.3 2.6 10.4 5.4 19.7 3.9 10.2 0.2 0.0 9.4 1.4 0.7 0.1 9.2 0.2 0.6 10.5 2.1 1.2 2.9 10.6 0.6 4.8 1.5 13.5 0.6 27.3 1.6 8.1 6.0 0.7 11.1 2.4 9.5 3.1 5.2 8.0 8.2 1.7 5.1 7.2 0.5 6.9 0.1 1.9 9.1 5.2 0.8 0.8 0.7 1.3 0.7 0.6 0.8 1.1 0.7 0.7 0.0 8.2 0.8 1.6 6.3 5.0 4.9 40.8 1.4 1.2 0.0 0.0 0.1 3.3 2.5 22.9 4.6 0.9 23.3 30.5 0.4 5.4 1.9 3.5 109.6 6.1 0.0 5.8 14.7 7.6 11.8 14.4 1.8 5.0 0.0 6.1 0.0 18.0 0.0 7.4 0.0 0.3 6.5 6.2 0.5 0.4 3.1 0.1 6.4 9.8 0.9 SLC43A3 "DKFZp762A227, Eeg1, FOAP-13, PRO1659, SEEEG-1" ENSG00000134802 "Solute carrier family 43 member 3" Q8NBI5 11 57406954-57427580 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 149.9;thyroid gland: 69.0" "Cell type enhanced" "Detected in many" 5 "granulocytes: 63.7;Hofbauer cells: 71.5;Sertoli cells: 64.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HL-60: 71.0;HMC-1: 62.7;RPMI-8226: 80.1;WM-115: 76.4" "Region enriched" "Detected in many" 4 "olfactory region: 12.7" "Low region specificity" "Detected in all" "HPA030551, HPA077244" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA Vesicles "Nucleoplasm, Plasma membrane" "HPA030551: AB_10604094, HPA077244: AB_2732335" "unprognostic (2.64e-1)" "unprognostic (7.63e-2)" "unprognostic (9.67e-3)" "unprognostic (7.41e-3)" "unprognostic (6.59e-3)" "unprognostic (5.30e-3)" "unprognostic (1.29e-1)" "unprognostic (4.91e-2)" "unprognostic (1.36e-1)" "unprognostic (2.26e-1)" "unprognostic (5.73e-2)" "unprognostic (3.97e-2)" "prognostic unfavorable (3.97e-13)" "unprognostic (8.16e-2)" "unprognostic (1.77e-1)" "unprognostic (8.34e-2)" "unprognostic (1.00e-1)" 32.3 6.3 2.5 12.4 4.3 18.8 16.8 2.2 3.0 11.9 9.6 3.6 2.4 2.7 10.1 6.5 12.6 8.9 11.4 12.5 3.1 1.5 4.2 149.9 16.5 8.8 4.0 1.8 16.0 7.2 1.2 1.8 5.1 3.4 11.6 4.2 9.4 12.2 3.1 15.4 11.0 6.2 10.3 4.7 11.6 6.9 6.8 2.3 10.4 69.0 11.5 13.8 20.3 15.4 2.7 23.6 6.1 36.8 1.1 7.8 14.0 40.0 0.0 2.3 0.0 7.8 11.5 0.1 3.1 13.3 4.6 7.9 0.0 8.8 23.1 1.4 7.3 2.4 23.1 6.7 4.1 9.3 0.1 0.0 36.0 13.7 0.0 15.9 71.0 62.7 34.5 0.1 44.6 0.5 3.3 12.9 10.7 41.1 22.4 17.8 0.0 14.9 45.6 3.5 0.0 0.7 30.9 0.4 80.1 11.0 0.0 5.5 0.0 8.8 0.2 37.4 0.2 3.4 10.8 6.8 0.2 12.0 30.4 8.7 0.0 0.1 5.8 27.5 25.8 76.4 3.2 28.8 6.1 5.7 34.5 6.5 2.7 4.0 7.8 23.6 2.0 3.1 3.2 2.5 1.1 36.8 23.6 6.9 14.0 2.5 4.3 2.2 3.0 3.1 1.5 4.0 1.8 3.4 2.3 14.9 41.4 4.5 6.7 41.6 0.5 2.8 30.6 5.3 34.2 1.8 0.0 0.5 0.0 47.0 1.0 23.3 0.0 0.0 5.5 2.2 20.2 3.4 63.7 53.8 71.5 0.0 0.0 11.6 17.3 1.4 9.2 55.1 28.7 0.0 0.5 0.9 10.9 0.0 11.7 0.0 0.0 64.7 18.4 1.0 0.2 15.4 0.7 15.0 0.6 2.5 SLC45A4 KIAA1126 ENSG00000022567 "Solute carrier family 45 member 4" Q5BKX6 8 141207166-141308305 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 32.9;Collecting duct cells: 47.1;Cone photoreceptor cells: 51.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "eosinophil: 9.4;neutrophil: 8.6" "Lineage enriched" "Detected in single" 19 "granulocytes: 9.4" "Cell line enhanced" "Detected in many" "HMC-1: 15.6;OE19: 23.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023154 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA023154: AB_2191204" "unprognostic (7.79e-3)" "unprognostic (1.06e-1)" "unprognostic (4.30e-2)" "unprognostic (1.44e-1)" "unprognostic (6.06e-2)" "unprognostic (3.96e-2)" "unprognostic (1.26e-1)" "unprognostic (4.49e-3)" "unprognostic (1.02e-1)" "unprognostic (5.31e-2)" "unprognostic (2.12e-1)" "unprognostic (1.84e-1)" "prognostic favorable (1.73e-6)" "unprognostic (8.79e-3)" "unprognostic (1.13e-1)" "unprognostic (1.77e-2)" "unprognostic (2.40e-2)" 5.6 3.9 6.9 7.6 7.0 10.2 4.3 10.0 19.1 14.2 6.6 2.7 8.5 5.4 6.7 8.9 5.0 11.6 6.9 9.3 8.2 5.9 12.2 1.6 10.1 7.6 5.1 8.4 5.0 14.2 5.4 20.6 17.8 11.5 9.5 3.9 11.4 15.6 16.3 6.4 7.4 6.0 4.3 3.0 6.8 24.4 28.5 2.9 6.6 8.7 1.8 6.4 7.8 4.4 0.0 0.4 9.4 0.1 0.2 0.5 0.1 3.7 8.6 3.1 4.9 0.2 0.2 13.8 2.1 1.3 1.9 1.5 5.4 10.0 0.8 9.4 0.8 2.7 3.1 1.7 1.0 0.9 5.9 2.5 2.4 2.5 0.0 1.5 0.9 15.6 0.7 1.4 1.5 0.8 0.4 1.3 4.0 4.6 0.6 0.5 9.2 8.4 1.9 4.1 23.2 3.5 2.6 0.2 2.4 6.8 6.8 4.9 3.9 2.3 0.8 3.6 2.2 1.6 5.6 0.7 0.0 2.1 3.3 4.1 3.1 9.9 1.0 1.9 3.7 3.6 1.3 0.1 9.4 0.2 0.1 0.2 0.0 0.2 0.5 0.1 0.0 0.2 0.2 8.6 0.2 0.1 0.4 0.2 0.1 6.9 7.0 10.0 19.1 8.2 5.9 5.1 8.4 11.5 2.9 8.9 10.1 0.0 5.7 2.4 32.9 11.1 10.2 17.4 6.8 47.1 51.1 7.1 0.0 6.2 9.5 1.4 9.5 0.0 2.4 0.6 2.0 6.0 1.1 0.0 5.6 3.2 2.4 0.6 2.7 4.1 2.0 2.7 3.3 0.0 6.3 2.8 5.6 5.8 2.1 3.3 9.3 0.0 2.1 4.2 1.9 2.0 13.6 1.5 3.3 9.5 SLC46A3 "DKFZp686A1775, FLJ42613" ENSG00000139508 "Solute carrier family 46 member 3" Q7Z3Q1 13 28700064-28718970 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 62.9;liver: 50.0" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 58.8;Hepatocytes: 50.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 20.5;T-47d: 15.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039930 Approved Approved "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane, Cytosol" "Actin filaments" "HPA039930: AB_10673263" "unprognostic (5.16e-2)" "unprognostic (1.01e-1)" "unprognostic (1.15e-1)" "unprognostic (2.61e-1)" "unprognostic (3.88e-1)" "unprognostic (1.22e-1)" "unprognostic (4.53e-3)" "prognostic favorable (7.09e-4)" "unprognostic (3.13e-1)" "unprognostic (3.33e-1)" "unprognostic (1.26e-1)" "unprognostic (5.69e-2)" "unprognostic (7.35e-2)" "unprognostic (1.14e-1)" "unprognostic (5.60e-2)" "unprognostic (9.14e-3)" "unprognostic (6.47e-3)" 6.9 14.2 3.8 5.9 5.7 1.4 6.4 7.6 6.5 8.3 19.6 6.9 2.8 24.0 5.2 7.4 3.1 4.1 12.7 8.1 4.2 4.2 10.4 50.0 6.0 11.4 4.7 3.9 5.0 5.5 4.2 18.2 5.0 6.6 5.3 10.1 17.4 10.3 5.6 8.2 4.0 62.9 4.5 5.1 11.6 4.8 9.3 3.7 11.8 6.8 3.0 6.9 6.1 4.7 9.1 10.4 22.6 15.9 5.6 11.2 7.4 0.0 2.0 0.0 5.5 4.5 1.8 0.1 2.0 11.1 2.2 3.2 0.1 4.7 3.8 3.7 2.8 8.4 0.4 2.5 1.0 3.3 2.8 4.9 2.5 0.0 0.0 8.4 0.0 3.3 7.2 2.1 3.3 5.4 2.2 4.0 11.3 2.7 0.0 10.5 2.0 6.2 0.4 0.2 5.6 1.7 2.6 9.9 0.1 20.5 0.6 0.9 0.3 0.0 10.2 4.0 2.4 15.0 3.3 1.5 1.1 2.1 0.3 11.7 3.1 1.5 0.5 0.6 0.0 2.0 22.6 8.0 3.0 9.8 11.5 8.4 6.6 7.9 9.6 10.4 9.1 11.2 10.6 8.2 5.6 15.9 9.7 9.2 7.4 3.8 5.7 7.6 6.5 4.2 4.2 4.7 3.9 6.6 3.7 0.0 4.8 5.1 0.0 1.6 22.0 7.7 17.8 10.7 1.2 8.7 7.9 0.5 1.7 11.8 3.0 8.9 58.8 0.0 4.9 0.2 5.4 0.6 24.4 50.6 9.7 20.6 3.5 19.6 25.4 1.7 1.4 14.5 6.8 4.6 7.0 14.1 3.8 5.8 2.1 8.4 9.5 0.0 2.8 2.3 0.5 1.5 0.6 10.0 10.0 0.1 SLC4A2 "AE2, BND3L, EPB3L1, HKB3, NBND3" ENSG00000164889 "Solute carrier family 4 member 2" P04920 7 151057210-151076527 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Anion exchange, Antiport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 94.2;retina: 100.7" "Cell type enhanced" "Detected in many" 5 "Syncytiotrophoblasts: 76.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 7 "pons and medulla: 73.3" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA019339 Enhanced Approved "Nuclear speckles,Plasma membrane,Cytosol" NA NA "Nuclear speckles, Plasma membrane" Cytosol "HPA019339: AB_1844825" "unprognostic (1.19e-1)" "unprognostic (3.33e-3)" "unprognostic (8.12e-3)" "unprognostic (1.10e-1)" "unprognostic (1.20e-1)" "unprognostic (1.49e-1)" "prognostic unfavorable (9.04e-6)" "unprognostic (1.24e-1)" "unprognostic (4.23e-1)" "unprognostic (3.30e-1)" "unprognostic (1.07e-1)" "unprognostic (3.21e-1)" "prognostic favorable (1.26e-4)" "unprognostic (4.67e-3)" "unprognostic (1.22e-1)" "unprognostic (1.28e-1)" "unprognostic (2.36e-2)" 9.9 13.5 4.7 10.4 7.4 6.7 10.5 3.0 8.6 12.4 18.6 29.0 6.0 12.1 16.2 6.3 7.7 10.8 14.1 11.9 10.1 3.8 35.5 94.2 12.3 7.2 10.4 4.8 12.6 34.1 30.6 5.3 31.4 73.3 10.5 4.0 100.7 11.9 8.3 8.7 9.5 26.0 10.7 10.4 10.1 27.1 6.5 8.5 8.8 9.7 7.0 5.9 11.7 10.6 2.5 5.6 2.1 4.2 0.5 2.7 1.9 15.9 52.8 10.4 21.4 10.4 6.1 23.8 19.4 10.5 15.9 13.8 30.0 25.6 9.6 42.6 9.2 23.4 15.7 10.6 9.4 2.9 27.6 15.8 12.6 25.7 15.2 17.0 6.5 40.6 8.9 8.3 18.0 4.6 17.1 8.8 13.6 38.9 8.1 12.3 30.6 18.6 11.2 24.7 21.5 19.6 14.7 5.7 11.2 13.0 12.1 8.6 31.2 17.7 33.5 16.5 8.2 13.8 12.8 19.0 21.4 10.9 21.0 28.5 8.8 11.8 5.4 32.7 16.3 42.9 0.0 4.2 2.1 2.7 3.9 1.9 2.5 2.1 1.8 2.4 1.0 2.4 2.4 1.0 0.5 2.5 5.6 1.0 1.9 4.7 7.4 3.0 8.6 10.1 3.8 10.4 4.8 73.3 8.5 8.9 10.9 6.7 4.5 9.8 7.9 3.6 17.8 1.4 2.3 19.2 23.6 28.5 14.9 31.0 0.6 9.8 17.3 0.0 30.9 9.0 16.2 5.0 48.3 31.4 23.1 14.3 26.5 14.7 15.1 1.3 12.7 9.9 25.3 9.0 11.1 22.3 39.3 14.0 18.7 18.9 8.8 12.9 15.5 3.2 7.7 6.0 76.5 8.3 18.9 3.1 SLC4A8 NBC3 ENSG00000050438 "Solute carrier family 4 member 8" Q2Y0W8 12 51391317-51515763 "Predicted membrane proteins" "Anion exchange, Antiport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.6;pituitary gland: 20.0;testis: 15.3" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 85.2;Cone photoreceptor cells: 168.9;Horizontal cells: 109.7;Spermatocytes: 91.6" "Group enriched" "Detected in some" 6 "breast cancer: 1.7;glioma: 2.7;testis cancer: 4.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 17.6;HMC-1: 12.4;SCLC-21H: 13.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077895 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA077895: " "unprognostic (4.01e-1)" "unprognostic (8.15e-2)" "unprognostic (2.49e-2)" "unprognostic (6.39e-2)" "unprognostic (1.29e-1)" "unprognostic (1.96e-2)" "unprognostic (3.46e-2)" "unprognostic (7.72e-4)" "unprognostic (3.13e-2)" "unprognostic (7.03e-3)" "unprognostic (1.07e-4)" "unprognostic (1.70e-1)" "unprognostic (9.60e-6)" "unprognostic (1.35e-1)" "unprognostic (2.57e-1)" "unprognostic (3.21e-2)" "unprognostic (2.47e-1)" 1.0 6.5 5.8 2.2 13.3 1.7 3.1 9.2 22.9 2.7 1.1 9.8 0.0 1.4 1.2 5.4 0.7 3.7 1.1 1.0 10.9 5.6 3.2 0.8 2.8 3.0 6.0 9.3 7.3 2.4 1.0 20.0 1.0 28.6 1.4 1.4 2.2 1.5 1.7 0.8 1.0 2.0 1.1 4.7 2.2 3.0 15.3 5.1 0.0 0.8 0.0 2.7 1.0 0.7 1.1 2.6 3.4 3.1 1.7 1.7 0.7 0.2 0.8 9.9 0.1 0.4 0.5 17.6 2.7 4.5 4.4 2.8 5.8 0.2 3.6 0.4 3.6 2.4 0.1 3.9 0.2 4.1 0.7 0.5 1.8 0.3 0.0 0.0 0.6 12.4 0.1 0.2 2.2 0.5 2.6 5.1 1.6 0.1 6.4 2.2 2.1 5.2 1.1 4.3 1.1 2.9 0.1 0.0 0.0 0.5 0.1 13.2 8.9 1.0 1.4 0.0 3.2 1.6 0.4 4.7 2.8 1.5 0.2 3.4 3.2 1.0 0.2 3.9 0.5 0.4 1.3 2.1 3.4 1.7 1.4 0.4 0.6 0.6 1.6 2.6 1.1 0.6 1.0 2.3 1.7 3.1 1.0 0.3 0.7 5.8 13.3 9.2 22.9 10.9 5.6 6.0 9.3 28.6 5.1 0.0 8.3 0.5 0.6 0.0 85.2 1.7 0.0 38.8 9.1 1.8 168.9 1.0 6.6 0.1 48.8 1.1 0.3 0.0 1.2 4.3 0.5 1.0 7.0 0.0 2.1 109.7 5.8 0.6 1.2 22.8 2.6 3.3 1.7 0.0 0.2 13.6 0.1 2.9 3.5 0.8 18.4 0.0 0.8 91.6 6.4 0.1 0.3 2.5 0.0 1.0 SLC5A6 SMVT ENSG00000138074 "Solute carrier family 5 member 6" Q9Y289 2 27199587-27212958 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 64.0;placenta: 51.7" "Cell type enhanced" "Detected in many" 12 "Cytotrophoblasts: 98.8;Extravillous trophoblasts: 89.2;monocytes: 78.5;Syncytiotrophoblasts: 190.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 69.3;SK-BR-3: 74.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036958 Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA036958: AB_10672343" "unprognostic (5.85e-2)" "unprognostic (8.32e-3)" "unprognostic (1.38e-1)" "unprognostic (2.61e-3)" "unprognostic (9.38e-2)" "unprognostic (7.14e-2)" "unprognostic (3.20e-3)" "unprognostic (7.92e-2)" "unprognostic (6.96e-2)" "unprognostic (9.80e-2)" "unprognostic (2.05e-2)" "unprognostic (7.46e-2)" "prognostic unfavorable (3.60e-7)" "unprognostic (2.40e-3)" "unprognostic (1.20e-2)" "unprognostic (4.56e-3)" "unprognostic (4.18e-2)" 20.9 4.6 5.0 7.6 8.5 8.5 15.9 7.9 8.1 4.0 6.4 5.6 6.4 10.9 7.4 36.7 5.5 5.9 6.3 3.5 5.3 5.7 5.9 64.0 6.0 6.4 7.0 8.1 5.6 6.0 4.5 4.2 51.7 7.1 4.8 6.6 5.6 6.7 10.6 7.9 4.6 7.6 4.9 4.4 4.8 4.8 17.5 6.1 5.8 5.1 4.3 13.0 4.6 10.1 6.8 10.0 2.0 9.0 6.3 10.4 5.8 16.7 17.4 11.1 14.6 10.3 3.7 69.3 6.1 4.1 9.3 6.4 25.6 6.0 11.6 9.3 3.3 10.1 9.4 23.7 7.0 6.5 9.0 13.9 20.6 7.4 39.2 12.2 26.4 10.8 12.9 6.0 11.4 8.9 2.6 8.3 9.5 30.1 4.8 5.9 34.4 8.9 12.9 32.0 19.4 6.4 15.1 13.1 16.8 5.3 16.1 9.4 13.9 6.6 74.6 8.8 11.3 16.6 5.7 3.8 10.3 14.1 6.2 16.3 8.0 18.3 18.5 5.6 18.6 14.4 0.1 6.5 2.0 8.5 7.3 10.4 6.8 8.3 8.2 9.7 6.7 8.5 10.1 0.3 6.3 9.0 10.0 8.2 5.8 5.0 8.5 7.9 8.1 5.3 5.7 7.0 8.1 7.1 6.1 0.0 4.1 13.4 6.8 7.1 4.5 5.9 7.6 4.0 2.3 7.0 3.9 98.8 1.7 9.6 11.6 3.8 6.0 0.0 7.0 89.2 5.4 7.1 0.0 36.0 19.5 11.1 5.2 7.4 10.0 25.3 6.6 6.5 0.0 78.5 6.8 3.9 6.2 2.9 13.1 3.6 3.4 12.9 5.9 31.1 18.5 5.5 190.6 7.5 13.3 6.4 SLC7A6 "KIAA0245, LAT-2, LAT3, y+LAT-2" ENSG00000103064 "Solute carrier family 7 member 6" Q92536 16 68264516-68301823 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Antiport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 58.8" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 1: 38.7;Syncytiotrophoblasts: 40.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050713 Uncertain Approved "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA050713: AB_2681218" "unprognostic (6.35e-2)" "unprognostic (4.63e-2)" "unprognostic (1.41e-1)" "unprognostic (1.40e-2)" "unprognostic (2.41e-1)" "unprognostic (5.02e-2)" "unprognostic (1.24e-3)" "unprognostic (1.16e-1)" "unprognostic (1.48e-1)" "unprognostic (5.16e-2)" "unprognostic (1.11e-1)" "unprognostic (2.76e-2)" "unprognostic (1.89e-3)" "unprognostic (7.82e-2)" "unprognostic (2.66e-1)" "unprognostic (4.79e-3)" "prognostic unfavorable (1.84e-4)" 25.9 7.6 5.4 12.9 6.7 6.9 18.7 9.0 8.0 5.3 7.1 3.4 6.7 3.6 5.5 14.0 4.0 7.1 4.7 13.1 5.3 3.3 5.4 2.3 9.8 16.3 3.3 4.6 3.0 3.2 2.5 11.1 16.3 5.4 6.6 10.8 9.0 5.8 5.1 58.8 8.4 9.4 8.3 3.4 9.4 5.3 5.2 3.7 31.8 15.0 8.0 19.6 5.7 8.0 7.2 16.2 5.9 3.6 6.7 12.6 1.7 9.4 9.7 7.2 7.7 21.4 12.8 20.3 11.1 8.1 16.6 13.9 41.3 7.2 18.8 8.8 14.2 4.8 14.5 14.0 13.9 18.1 3.8 10.0 10.0 19.1 13.1 3.9 11.8 9.1 8.6 12.2 12.9 6.5 5.3 11.1 9.8 14.7 3.4 9.0 5.1 15.3 8.2 5.4 6.4 3.5 19.5 4.5 15.8 5.8 8.3 10.6 5.8 32.1 9.0 3.8 6.3 13.5 6.4 16.3 11.0 8.4 9.2 13.9 7.2 13.5 21.5 7.0 8.7 7.4 2.5 3.6 3.0 4.9 1.7 6.1 6.6 7.3 4.6 3.4 7.2 12.6 7.4 5.9 6.7 1.4 16.2 3.1 1.7 5.4 6.7 9.0 8.0 5.3 3.3 3.3 4.6 5.4 3.7 38.7 16.8 11.1 8.0 17.4 3.7 17.3 0.0 8.1 3.4 17.4 35.3 20.4 0.0 3.0 4.0 9.0 4.2 0.0 3.4 1.6 10.5 3.0 4.6 1.3 12.0 9.5 2.4 7.4 6.7 14.6 5.5 7.5 10.1 3.6 8.9 2.1 4.1 6.2 3.5 0.3 2.6 0.0 7.3 14.2 9.4 19.2 40.0 17.5 6.9 2.3 SLC9A3R1 "EBP50, NHERF, NHERF1" ENSG00000109062 "SLC9A3 regulator 1" O14745 17 74748652-74769353 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Wnt signaling pathway" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 372.3;Proximal tubular cells: 352.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 78.7;SK-BR-3: 64.2;T-47d: 124.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001962, HPA009672, HPA027247" Enhanced Approved "Vesicles,Plasma membrane,Centriolar satellite" NA Yes 9600000 "Plasma membrane" "Vesicles, Centriolar satellite" "CAB001962: , HPA009672: AB_1857215, HPA027247: AB_10601162" "unprognostic (1.29e-1)" "unprognostic (4.58e-2)" "unprognostic (1.73e-2)" "unprognostic (5.51e-2)" "unprognostic (5.83e-2)" "unprognostic (1.73e-1)" "prognostic unfavorable (9.83e-5)" "unprognostic (7.41e-2)" "unprognostic (5.61e-2)" "unprognostic (5.38e-2)" "unprognostic (7.53e-2)" "unprognostic (4.49e-2)" "unprognostic (1.56e-3)" "unprognostic (7.81e-3)" "unprognostic (5.53e-2)" "unprognostic (3.84e-2)" "unprognostic (2.08e-2)" 5.4 33.3 19.8 9.9 23.3 22.6 15.2 21.9 15.1 12.5 30.6 15.2 35.9 57.6 5.4 12.0 74.3 20.5 30.8 5.6 14.2 8.8 36.1 64.9 8.6 13.5 14.3 14.0 5.0 26.5 12.5 4.9 8.3 12.8 10.1 13.4 22.9 41.8 23.3 1.5 11.2 73.3 3.1 12.1 13.8 14.8 5.4 14.1 18.4 5.6 24.3 30.3 7.1 20.3 9.8 14.3 72.7 24.8 45.1 70.4 44.3 13.9 11.5 5.7 5.9 3.5 2.5 25.9 3.3 3.1 8.6 8.4 36.0 8.4 3.0 3.4 7.1 4.6 20.1 9.8 6.5 4.1 3.7 9.4 23.0 31.1 47.9 7.1 15.0 15.6 2.1 3.6 6.8 2.9 18.0 7.1 9.2 7.3 16.5 13.2 78.7 35.3 33.7 5.1 39.5 6.8 3.8 6.5 13.9 11.9 10.0 4.9 6.5 3.5 64.2 7.2 16.6 124.2 12.0 2.3 2.7 7.8 6.3 5.5 28.6 12.9 5.6 4.3 20.0 1.5 72.7 14.1 65.3 70.4 20.6 46.6 9.8 43.2 59.3 13.7 8.6 25.5 45.2 50.3 45.1 24.8 14.3 47.0 44.3 19.8 23.3 21.9 15.1 14.2 8.8 14.3 14.0 12.8 14.1 6.0 18.8 36.3 18.8 41.0 1.9 14.9 206.4 41.5 14.8 29.6 3.9 67.4 56.3 154.8 9.9 11.7 372.3 0.0 86.0 43.0 16.6 31.5 24.3 159.6 66.7 4.8 18.0 4.9 23.7 8.2 8.1 24.4 27.0 7.2 41.8 82.0 78.1 101.7 39.3 352.2 4.7 6.5 14.4 6.0 20.7 50.2 93.3 101.5 27.5 31.5 SLC9A4 NHE4 ENSG00000180251 "Solute carrier family 9 member A4" Q6AI14 2 102473303-102533972 "Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "gallbladder: 23.2;kidney: 12.3;stomach 1: 33.9" "Cell type enriched" "Detected in some" 8 "Collecting duct cells: 24.4" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 3.9;OE19: 11.4;RT4: 7.1" "Group enriched" "Detected in some" 18 "hippocampal formation: 11.6;olfactory region: 8.3" "Not detected" "Not detected" HPA036096 Supported Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA036096: AB_2674939" "unprognostic (1.41e-1)" "unprognostic (3.76e-2)" "unprognostic (9.31e-2)" "unprognostic (3.09e-3)" "unprognostic (7.58e-2)" "unprognostic (1.46e-1)" "unprognostic (7.17e-2)" "unprognostic (5.35e-1)" "unprognostic (9.44e-3)" "unprognostic (3.26e-2)" "unprognostic (1.30e-1)" "unprognostic (2.46e-2)" "unprognostic (3.12e-1)" "unprognostic (5.04e-1)" "unprognostic (2.50e-1)" "unprognostic (1.98e-2)" 0.0 0.1 0.1 0.0 0.1 0.4 0.1 0.1 0.1 0.2 0.1 0.3 0.0 1.1 0.1 0.0 1.3 0.1 23.2 0.2 0.1 0.1 12.3 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.7 0.0 0.0 3.7 2.4 0.7 0.2 0.2 0.0 0.1 0.1 33.9 0.3 0.0 0.2 0.1 0.5 0.4 0.6 0.2 1.5 0.9 1.8 0.8 1.2 1.2 0.1 0.2 0.2 0.2 0.6 0.0 0.0 0.1 0.2 0.0 0.0 0.0 1.1 0.4 0.1 2.4 0.0 0.3 0.3 0.0 0.0 0.0 3.9 0.1 0.2 0.4 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.9 0.0 0.4 0.1 0.1 1.1 11.4 0.4 0.2 0.5 0.3 0.0 7.1 0.2 0.2 0.1 0.4 0.0 0.3 0.2 0.1 0.5 0.4 1.1 0.7 0.2 0.2 0.2 0.0 0.5 0.1 0.1 1.6 0.7 1.1 1.2 0.6 0.8 0.8 0.9 0.9 0.5 1.5 1.0 1.2 1.8 1.2 0.8 0.9 0.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 3.0 2.7 0.0 0.0 0.0 0.0 0.2 0.0 2.7 1.2 24.4 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.3 SLC9C2 "MGC43026, SLC9A11" ENSG00000162753 "Solute carrier family 9 member C2 (putative)" Q5TAH2 1 173500464-173603094 "Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 24.9" "Cell type enhanced" "Detected in some" 13 "Club cells: 2.3;Cone photoreceptor cells: 5.9;Early spermatids: 4.2;Late spermatids: 2.3;Spermatocytes: 4.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 17 "plasmacytoid DC: 1.7" "Lineage enriched" "Detected in single" 17 "dendritic cells: 1.7" "Group enriched" "Detected in some" 4 "BEWO: 1.8;THP-1: 3.7" "Low region specificity" "Detected in all" "HPA059122, HPA079529" Enhanced Approved "Nuclear speckles,Plasma membrane" NA NA "Plasma membrane" "Nuclear speckles" "HPA059122: , HPA079529: " "unprognostic (2.10e-1)" "unprognostic (2.69e-1)" "unprognostic (8.52e-2)" "unprognostic (5.88e-3)" "unprognostic (3.24e-2)" "unprognostic (2.21e-1)" "unprognostic (1.29e-3)" "unprognostic (1.19e-1)" "unprognostic (4.21e-2)" "unprognostic (4.92e-1)" "unprognostic (1.88e-1)" "unprognostic (1.18e-6)" "unprognostic (1.66e-1)" "unprognostic (1.01e-2)" "unprognostic (2.98e-1)" "unprognostic (1.81e-1)" 0.4 0.1 0.3 0.0 1.3 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.5 0.0 0.1 0.4 0.0 1.7 0.0 0.1 0.5 0.3 0.2 0.0 0.4 0.1 0.0 0.4 0.8 0.3 0.1 0.4 0.5 0.5 0.1 0.0 0.1 0.0 2.7 0.0 0.0 0.0 0.1 0.3 1.0 0.3 24.9 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.3 1.3 0.0 1.6 0.5 0.3 0.0 0.4 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 2.3 0.0 5.9 0.1 0.0 0.0 4.2 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.4 0.0 0.1 0.0 0.0 0.0 SLCO4C1 "OATP-H, OATP4C1, OATPX, SLC21A20" ENSG00000173930 "Solute carrier organic anion transporter family member 4C1" Q6ZQN7 5 102233986-102296549 "Predicted membrane proteins, Transporters" "Differentiation, Ion transport, Spermatogenesis, Transport" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "kidney: 55.9" "Group enriched" "Detected in some" 4 "Alveolar cells type 2: 38.8;Proximal tubular cells: 28.3" "Cancer enriched" "Detected in many" 5 "renal cancer: 22.4" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "neutrophil: 10.0" "Group enriched" "Detected in many" 5 "granulocytes: 10.0;NK-cells: 2.6;T-cells: 4.3" "Cell line enhanced" "Detected in some" "Karpas-707: 8.1;RPTEC TERT1: 45.9;U-937: 11.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA058249 Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA058249: " "unprognostic (1.63e-2)" "unprognostic (2.47e-2)" "unprognostic (4.48e-4)" "unprognostic (5.70e-6)" "unprognostic (7.43e-2)" "unprognostic (7.71e-3)" "unprognostic (3.24e-3)" "unprognostic (2.05e-3)" "unprognostic (2.13e-1)" "unprognostic (7.12e-2)" "unprognostic (3.87e-3)" "unprognostic (5.83e-2)" "prognostic favorable (1.12e-4)" "unprognostic (3.29e-2)" "unprognostic (1.07e-1)" "unprognostic (5.91e-2)" "unprognostic (8.22e-2)" 0.4 0.4 0.3 0.7 0.7 5.4 0.3 0.2 1.8 0.3 1.9 0.0 5.2 1.4 0.2 0.6 0.3 0.3 1.6 1.1 0.3 0.4 55.9 5.2 11.0 0.2 0.3 1.0 0.3 0.9 0.0 0.7 0.1 0.2 0.4 0.5 0.0 3.2 11.8 0.3 0.6 2.1 0.0 0.3 1.6 0.4 1.3 0.0 1.5 1.0 0.3 0.1 0.7 1.1 0.1 0.4 10.0 1.1 2.6 4.3 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.5 0.0 0.4 0.1 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.5 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.5 45.9 0.0 0.3 0.2 0.0 0.1 0.0 1.1 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 11.6 0.0 7.9 1.1 7.5 4.3 0.0 0.4 0.0 0.7 2.3 0.4 0.1 0.2 1.5 10.0 2.6 0.0 0.3 0.0 1.0 0.3 0.7 0.2 1.8 0.3 0.4 0.3 1.0 0.2 0.0 6.0 38.8 0.0 0.1 0.0 0.0 0.3 0.0 4.0 6.8 5.2 0.0 0.0 1.7 0.2 8.3 0.0 1.2 0.0 0.7 0.0 0.0 0.0 5.7 5.5 0.2 0.0 0.0 0.0 0.0 0.4 0.3 0.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 28.3 0.0 0.0 0.0 1.7 0.7 0.0 0.0 2.2 1.2 0.3 SLIT1 "MEGF4, SLIL1, Slit-1, slit1, SLIT3" ENSG00000187122 "Slit guidance ligand 1" O75093 10 96998038-97185920 "Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 44.3" "Group enriched" "Detected in some" 6 "Early spermatids: 27.2;Late spermatids: 15.4" "Group enriched" "Detected in many" 10 "glioma: 9.2;prostate cancer: 2.2;thyroid cancer: 10.2" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "myeloid DC: 1.6;plasmacytoid DC: 1.6" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 10 "JURKAT: 12.4;MOLT-4: 41.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA006879 Approved "Plasma membrane" "Secreted in brain" NA NA "Plasma membrane" "HPA006879: AB_1078197" "unprognostic (2.72e-1)" "unprognostic (2.25e-2)" "unprognostic (5.67e-3)" "unprognostic (1.43e-5)" "unprognostic (8.40e-2)" "unprognostic (2.60e-3)" "unprognostic (4.57e-2)" "unprognostic (1.81e-2)" "unprognostic (3.53e-1)" "unprognostic (6.06e-2)" "unprognostic (2.28e-3)" "unprognostic (1.46e-1)" "unprognostic (1.08e-5)" "unprognostic (1.66e-1)" "unprognostic (2.18e-1)" "unprognostic (1.21e-1)" "unprognostic (4.39e-3)" 1.2 0.8 13.4 0.9 16.1 0.9 0.8 0.4 44.3 0.8 0.9 0.5 0.0 0.9 0.8 0.7 0.8 1.0 0.8 0.8 13.9 10.5 0.8 0.7 1.0 0.9 4.6 13.2 0.8 1.4 0.8 8.0 0.8 2.2 1.1 0.8 0.3 0.8 0.7 0.9 0.8 0.9 0.8 1.4 0.9 1.1 2.0 0.3 3.3 3.6 0.0 0.9 0.8 0.0 0.0 1.6 0.4 0.7 0.0 0.0 0.2 0.0 0.0 2.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.3 0.0 0.1 41.4 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.6 1.1 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.4 0.0 0.4 1.6 0.0 0.2 13.4 16.1 0.4 24.8 13.9 10.5 4.6 13.2 2.2 0.3 0.0 0.0 0.0 0.0 0.0 2.0 0.7 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 27.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 1.7 0.0 0.3 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 3.4 1.4 0.0 0.0 0.0 0.0 0.1 SLK "KIAA0204, se20-9, STK2" ENSG00000065613 "STE20 like kinase" Q9H2G2 10 103967201-104029233 "Enzymes, Plasma proteins, Predicted intracellular proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Urothelial cells: 181.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015757 Approved Approved "Plasma membrane,Cytosol" NA NA 17000 "Plasma membrane, Cytosol" "HPA015757: AB_1857236" "unprognostic (1.89e-1)" "unprognostic (1.80e-1)" "unprognostic (1.38e-1)" "unprognostic (8.28e-2)" "unprognostic (1.01e-1)" "unprognostic (3.64e-1)" "unprognostic (8.67e-2)" "unprognostic (6.85e-2)" "unprognostic (1.01e-1)" "unprognostic (2.31e-1)" "prognostic unfavorable (2.77e-5)" "unprognostic (1.95e-1)" "prognostic favorable (3.95e-5)" "unprognostic (8.48e-2)" "unprognostic (3.95e-1)" "unprognostic (3.09e-2)" "unprognostic (1.07e-1)" 15.2 11.2 13.7 11.0 36.7 14.6 16.1 16.7 13.1 16.6 19.0 9.9 10.9 9.1 17.0 12.1 40.2 12.1 13.6 17.2 10.6 7.1 14.9 12.2 17.1 10.1 11.2 13.4 17.2 12.5 22.6 13.1 17.4 12.8 19.3 13.6 11.4 19.8 12.7 19.3 16.6 15.5 29.8 13.0 12.1 15.7 10.2 12.8 12.0 15.8 21.6 12.5 24.9 23.6 1.4 2.2 6.5 1.4 1.3 3.6 0.7 21.6 12.7 15.1 10.8 16.4 22.9 6.4 13.5 18.0 10.1 9.5 8.0 23.3 11.5 8.5 13.9 8.6 23.6 8.0 17.1 14.8 9.2 11.0 11.7 10.4 6.7 12.3 13.9 10.1 11.7 22.5 13.6 39.9 14.1 18.1 7.5 14.6 8.0 13.2 7.5 9.7 7.7 3.7 14.0 8.1 9.5 18.6 6.0 13.2 25.0 3.5 6.2 11.7 11.4 11.2 8.0 5.9 10.1 27.3 7.4 7.8 13.6 15.8 9.7 11.8 7.3 11.0 18.8 4.7 1.2 1.4 3.3 3.6 1.2 3.6 1.1 2.2 2.2 1.2 1.4 1.5 2.5 6.5 1.3 1.0 2.2 1.4 0.7 13.7 36.7 16.7 13.1 10.6 7.1 11.2 13.4 12.8 12.8 166.7 108.1 23.8 57.3 50.6 27.3 89.7 28.1 66.9 138.8 41.8 23.6 27.8 3.3 28.4 6.3 53.4 45.3 23.3 46.5 11.5 39.3 60.5 32.5 21.7 17.3 23.8 17.7 41.7 24.0 11.0 43.1 31.1 8.5 37.9 31.8 23.4 61.5 54.9 59.4 11.3 24.1 6.5 34.9 42.3 39.1 59.8 43.8 21.8 29.4 181.1 SMAP1 "FLJ13159, SMAP-1" ENSG00000112305 "Small ArfGAP 1" Q8IYB5 6 70667776-70862015 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 261.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030574 Approved Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "Golgi apparatus" "HPA030574: AB_10601589" "unprognostic (1.55e-1)" "unprognostic (2.66e-3)" "unprognostic (1.01e-3)" "unprognostic (2.98e-3)" "unprognostic (7.06e-2)" "unprognostic (2.90e-2)" "unprognostic (1.66e-3)" "unprognostic (3.46e-1)" "unprognostic (6.50e-2)" "unprognostic (3.75e-2)" "unprognostic (7.80e-2)" "unprognostic (2.40e-2)" "unprognostic (1.32e-1)" "unprognostic (4.73e-2)" "unprognostic (6.08e-2)" "unprognostic (2.85e-1)" "unprognostic (1.22e-1)" 18.7 14.8 19.9 17.8 25.1 15.1 15.3 20.7 30.2 14.4 25.2 14.5 18.5 24.5 16.2 17.7 29.3 10.5 16.3 20.5 20.5 18.6 14.1 17.2 14.4 18.3 19.2 18.1 15.2 33.9 27.1 11.5 14.8 25.0 17.2 27.0 13.0 18.6 15.2 32.6 21.0 29.6 18.7 15.7 14.8 20.7 29.6 13.0 26.6 20.0 17.5 20.1 18.9 16.6 12.5 11.7 24.0 15.5 20.2 21.9 16.3 26.7 8.5 13.5 16.4 12.5 16.5 21.8 12.0 13.8 10.1 9.9 12.6 8.0 14.0 13.1 14.7 14.6 8.5 12.7 12.8 17.2 16.1 17.7 15.5 8.0 10.6 8.4 11.3 13.2 10.8 14.9 11.3 13.8 19.0 15.8 7.4 14.7 17.2 15.8 15.7 8.4 13.8 9.9 14.2 9.9 16.0 50.1 23.1 18.2 16.5 18.9 13.5 7.7 11.0 7.6 12.0 14.5 17.1 15.1 8.2 14.1 5.3 10.6 16.0 14.3 7.2 6.2 13.3 11.2 24.0 13.7 14.6 16.3 15.0 18.5 12.5 21.9 18.6 11.7 11.1 11.2 14.4 19.3 20.2 15.5 11.5 20.5 16.3 19.9 25.1 20.7 30.2 20.5 18.6 19.2 18.1 25.0 13.0 35.7 32.5 47.6 31.8 59.4 49.5 34.1 66.2 16.0 30.7 36.6 35.3 22.2 46.4 68.3 261.7 39.6 88.7 0.0 131.9 35.0 39.4 71.6 48.4 36.8 51.8 52.4 40.2 63.3 52.2 208.7 46.9 47.5 30.4 54.1 58.5 64.5 87.9 63.4 62.9 42.1 36.2 64.7 46.2 64.2 85.5 67.5 26.5 51.7 60.3 38.6 SMOC1 ENSG00000198732 "SPARC related modular calcium binding 1" Q9H4F8 14 69854131-70032366 "Disease related genes, Predicted secreted proteins" Differentiation "Developmental protein" "Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 62.2;liver: 48.0" "Group enriched" "Detected in many" 4 "Hepatocytes: 78.8;Peritubular cells: 125.2;Syncytiotrophoblasts: 33.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 12 "plasmacytoid DC: 4.9" "Lineage enriched" "Detected in single" 50 "dendritic cells: 4.9" "Cell line enhanced" "Detected in some" "AF22: 19.8;HeLa: 54.5;HSkMC: 16.0;SiHa: 32.1;SK-BR-3: 14.1;U-266/70: 20.3;U-87 MG: 20.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004153, CAB034427" Approved Approved "Plasma membrane" "Secreted to extracellular matrix" NA NA 27000 "Plasma membrane" "CAB034427: AB_2193382, HPA004153: AB_1080035" "unprognostic (3.31e-1)" "unprognostic (2.17e-3)" "unprognostic (8.17e-2)" "unprognostic (1.96e-2)" "unprognostic (1.89e-2)" "unprognostic (4.04e-1)" "unprognostic (6.75e-3)" "unprognostic (2.09e-3)" "unprognostic (4.76e-2)" "unprognostic (2.80e-2)" "unprognostic (5.10e-2)" "unprognostic (5.63e-2)" "unprognostic (4.09e-2)" "unprognostic (3.92e-1)" "unprognostic (2.57e-1)" "unprognostic (1.34e-1)" "unprognostic (1.87e-1)" 7.4 10.7 23.0 1.4 10.8 1.1 2.9 5.2 62.2 8.6 2.2 32.0 19.4 3.0 2.2 10.3 1.3 7.1 1.5 4.7 22.6 16.2 2.1 48.0 1.4 1.8 23.8 8.5 1.8 26.4 1.1 2.4 9.0 21.7 42.9 2.0 14.7 3.6 35.8 8.7 1.2 2.3 1.9 15.0 19.5 3.5 24.7 16.9 0.0 2.9 0.6 1.5 1.7 3.6 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 1.4 19.8 0.0 4.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 7.7 0.0 54.5 8.0 0.0 0.0 0.0 16.0 4.6 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.8 0.1 32.1 14.1 0.0 0.1 0.0 0.0 0.1 0.1 1.4 0.0 0.0 20.3 0.0 0.0 20.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 23.0 10.8 5.2 11.2 22.6 16.2 23.8 8.5 21.7 16.9 0.0 0.0 0.9 0.0 0.2 1.5 1.7 10.2 1.4 0.0 0.0 15.7 18.5 0.0 0.2 4.1 1.3 0.0 0.0 1.9 0.8 4.2 0.0 0.0 78.8 2.5 0.0 15.0 2.5 2.7 13.2 7.2 0.0 0.0 0.0 0.0 0.2 5.8 0.0 125.2 0.0 0.2 0.0 0.7 1.5 3.3 0.4 33.6 0.0 0.0 0.0 SMPD2 "ISC1, nSMase" ENSG00000135587 "Sphingomyelin phosphodiesterase 2" O60906 6 109440763-109443919 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 151.6;Late spermatids: 248.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA018110, HPA018125" Uncertain Approved "Vesicles,Plasma membrane,Cell Junctions" NA NA "Vesicles, Plasma membrane" "Cell Junctions" "HPA018110: AB_1857292, HPA018125: AB_1857293" "unprognostic (1.61e-1)" "unprognostic (8.01e-2)" "unprognostic (1.97e-1)" "unprognostic (8.79e-3)" "unprognostic (3.88e-2)" "unprognostic (2.38e-1)" "prognostic unfavorable (1.17e-4)" "unprognostic (7.08e-2)" "unprognostic (7.59e-2)" "unprognostic (1.41e-1)" "prognostic favorable (1.00e-3)" "unprognostic (3.60e-2)" "unprognostic (2.14e-3)" "unprognostic (7.94e-2)" "unprognostic (2.25e-1)" "unprognostic (1.45e-2)" "prognostic favorable (1.70e-4)" 6.0 6.8 4.2 20.2 4.9 8.5 8.5 5.4 6.4 9.0 12.6 9.8 16.4 10.5 6.1 16.0 17.2 17.4 12.6 5.1 4.9 3.7 10.2 7.8 8.4 9.4 4.7 4.2 6.7 15.5 17.9 8.8 19.5 4.8 10.1 10.2 8.4 16.6 11.9 3.3 16.9 15.4 7.8 4.3 10.1 11.1 35.1 4.7 18.3 10.5 13.5 23.0 6.3 10.1 18.3 13.4 9.3 7.8 6.2 8.0 5.3 8.9 10.4 5.5 8.6 9.7 5.3 18.3 3.0 11.2 7.6 7.2 9.8 7.3 4.9 6.4 6.4 16.0 11.5 5.5 13.2 4.6 6.2 14.2 5.7 10.7 6.0 8.1 6.2 6.7 5.6 15.3 6.7 13.3 8.5 6.9 8.7 11.0 8.7 3.7 12.9 10.0 13.5 1.5 11.9 5.0 7.1 2.6 5.3 13.7 15.3 7.2 6.0 5.7 17.9 13.5 4.6 5.7 12.0 4.4 3.4 4.9 2.7 11.2 5.9 1.5 3.1 6.6 6.0 6.0 5.7 7.8 9.3 6.6 7.5 7.3 12.8 7.4 8.0 10.2 18.3 5.6 5.7 2.3 6.2 6.6 13.4 7.2 5.3 4.2 4.9 5.4 6.4 4.9 3.7 4.7 4.2 4.8 4.7 11.9 7.4 4.2 8.5 8.8 1.3 2.0 12.7 58.9 7.9 12.2 3.9 8.2 1.7 14.7 151.6 3.8 27.2 0.0 17.1 16.1 6.0 12.7 0.0 3.2 8.5 0.0 8.1 4.3 6.6 248.2 8.6 10.8 8.5 11.8 21.2 2.3 13.7 24.6 8.5 7.9 5.2 12.9 2.8 36.6 10.6 16.3 14.2 4.9 13.8 13.7 SMPX "DFN6, DFNX4" ENSG00000091482 "Small muscle protein, X-linked" Q9UHP9 X 21705972-21758163 "Disease related genes, Predicted intracellular proteins" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 23 "heart muscle: 108.8;skeletal muscle: 155.8;tongue: 74.5" "Cell type enriched" "Detected in single" 2069 "Cardiomyocytes: 810.3" "Cancer enhanced" "Detected in many" "head and neck cancer: 7.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "GAMG: 22.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" HPA077360 Approved "Plasma membrane" NA NA 45000 "Plasma membrane" "HPA077360: AB_2732342" "unprognostic (7.29e-2)" "unprognostic (1.78e-1)" "unprognostic (2.63e-1)" "unprognostic (1.28e-1)" "unprognostic (1.45e-1)" "prognostic unfavorable (3.04e-5)" "unprognostic (1.39e-2)" "unprognostic (7.46e-2)" "unprognostic (5.27e-1)" "unprognostic (1.96e-2)" "unprognostic (3.97e-2)" "unprognostic (3.58e-2)" "unprognostic (2.67e-2)" "unprognostic (2.82e-1)" "unprognostic (8.38e-2)" 1.4 0.0 0.1 0.6 0.1 0.0 0.2 0.6 0.9 0.1 4.0 0.0 0.0 0.1 0.1 4.7 4.0 0.1 0.1 108.8 0.1 0.2 0.0 0.2 0.0 0.1 0.7 0.3 0.2 0.1 0.0 0.0 0.0 0.0 1.6 0.5 0.0 3.6 0.1 155.8 0.0 0.9 1.8 0.1 0.0 1.5 0.1 0.0 0.0 1.0 74.5 4.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 22.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.2 0.0 0.0 0.0 0.4 3.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.4 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.9 0.1 0.2 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 810.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 SNAP25 "bA416N4.2, dJ1068F16.2, RIC-4, RIC4, SEC9, SNAP, SNAP-25" ENSG00000132639 "Synaptosome associated protein 25" P60880 20 10218830-10307418 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Transporters" "Congenital myasthenic syndrome, Disease mutation, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 22 "brain: 356.9" "Cell type enhanced" "Detected in many" 23 "Bipolar cells: 497.2;Cone photoreceptor cells: 100.1;Rod photoreceptor cells: 186.3" "Group enriched" "Detected in many" 6 "glioma: 28.9;pancreatic cancer: 6.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.6" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in many" 4 "Karpas-707: 11.0;SCLC-21H: 36.6;SH-SY5Y: 21.8;U-87 MG: 26.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000360, HPA001830, HPA071013" Enhanced Supported Approved "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "CAB000360: AB_2286342, HPA001830: AB_1080039, HPA071013: " "unprognostic (1.64e-3)" "unprognostic (7.26e-3)" "unprognostic (4.36e-2)" "unprognostic (2.49e-7)" "unprognostic (6.86e-3)" "unprognostic (5.87e-3)" "unprognostic (1.15e-2)" "unprognostic (9.94e-2)" "unprognostic (3.13e-1)" "unprognostic (5.82e-3)" "unprognostic (4.80e-3)" "unprognostic (8.06e-2)" "unprognostic (1.09e-1)" "unprognostic (6.18e-3)" "unprognostic (2.48e-1)" "unprognostic (6.28e-3)" "unprognostic (1.02e-2)" 2.2 16.4 81.0 3.3 60.0 2.1 3.4 202.9 356.9 2.2 2.8 3.4 3.7 3.2 4.6 6.4 2.2 4.0 2.8 2.4 86.5 37.1 2.5 2.3 2.6 2.2 46.7 65.2 3.7 4.1 2.1 5.5 2.3 97.7 3.1 2.8 4.0 2.2 11.9 2.1 2.2 3.3 4.7 13.9 2.1 4.3 3.2 7.4 0.0 2.3 0.0 2.2 2.6 0.1 0.0 1.6 0.7 0.0 0.0 0.6 0.3 0.0 2.1 1.8 0.0 0.2 0.0 0.0 0.9 0.0 2.2 0.6 0.0 0.0 0.0 2.0 0.0 1.6 0.4 0.2 0.0 4.5 0.2 0.1 0.0 3.0 0.3 1.6 0.0 0.2 2.1 0.0 1.8 0.0 5.0 0.0 1.3 0.0 11.0 0.7 0.0 0.0 0.0 0.4 1.3 0.0 0.0 0.0 0.0 0.4 0.0 36.6 21.8 0.3 0.0 0.0 1.1 0.0 2.9 0.0 2.3 3.1 0.0 1.0 0.0 5.6 0.0 26.3 0.0 2.1 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.6 0.6 0.3 81.0 60.0 202.9 163.5 86.5 37.1 46.7 65.2 97.7 7.4 0.0 0.0 0.0 1.7 0.7 497.2 0.4 7.6 0.0 0.0 0.0 100.1 0.0 0.0 0.1 16.5 0.6 0.0 0.0 0.0 0.1 1.0 0.5 0.0 0.0 0.1 62.0 41.6 0.0 0.0 56.7 15.8 0.2 1.7 0.0 0.0 42.9 1.6 0.2 64.7 1.4 186.3 0.0 1.0 0.9 0.3 0.6 0.0 0.0 0.0 0.0 SNRK "FLJ20224, HSNFRK, KIAA0096" ENSG00000163788 "SNF related kinase" Q9NRH2 3 43286512-43424764 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ito cells: 86.5;Sertoli cells: 122.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 51.9;TIME: 30.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042163 Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions" NA NA "Vesicles, Plasma membrane, Cell Junctions" Nucleoplasm "HPA042163: AB_10794645" "prognostic favorable (9.28e-4)" "unprognostic (8.46e-2)" "unprognostic (2.79e-3)" "unprognostic (6.41e-2)" "unprognostic (1.14e-1)" "unprognostic (1.16e-3)" "unprognostic (2.00e-2)" "unprognostic (1.08e-1)" "unprognostic (2.63e-3)" "unprognostic (4.25e-1)" "unprognostic (2.32e-1)" "unprognostic (4.68e-2)" "prognostic favorable (9.41e-5)" "unprognostic (9.21e-3)" "unprognostic (2.04e-1)" "unprognostic (7.06e-3)" "unprognostic (7.38e-2)" 31.5 8.8 9.8 13.1 14.4 41.0 22.6 34.5 21.1 17.6 14.4 7.9 5.9 12.8 20.9 10.5 16.2 11.5 16.4 13.9 11.0 11.0 16.8 20.3 24.7 19.8 11.4 10.6 15.1 18.0 18.4 16.2 26.2 22.5 12.1 9.9 14.7 10.7 9.4 12.5 24.5 17.0 18.7 9.8 25.4 11.2 13.9 7.2 48.4 24.8 13.5 14.4 15.8 19.3 3.2 3.0 20.9 5.5 8.1 10.7 6.5 3.3 2.0 3.8 3.6 11.3 4.0 3.6 3.6 6.1 3.9 3.8 2.8 4.8 5.3 2.8 4.5 2.6 2.1 4.4 7.7 4.1 6.0 3.6 6.0 3.8 3.2 5.9 6.7 6.7 4.5 5.3 4.4 7.5 4.0 51.9 6.1 2.6 6.1 3.5 1.7 6.8 5.9 4.2 1.8 9.3 4.7 2.8 5.5 10.1 5.7 2.7 5.6 3.1 3.3 4.3 3.4 2.3 8.6 30.2 3.4 3.5 3.9 4.1 9.9 7.1 4.5 2.4 8.1 4.9 4.8 2.8 5.4 7.6 5.5 10.7 2.8 6.7 7.6 3.0 3.2 10.1 10.1 20.9 8.1 5.0 0.9 7.1 6.5 9.8 14.4 34.5 21.1 11.0 11.0 11.4 10.6 22.5 7.2 29.8 30.3 12.9 9.7 46.9 49.8 14.5 22.9 16.0 18.2 15.7 15.7 6.3 10.0 9.2 40.0 52.3 28.4 0.0 7.8 2.7 11.8 9.9 13.9 21.3 11.3 28.6 10.4 86.5 27.6 4.9 11.5 16.6 21.9 4.6 8.9 15.6 8.4 8.2 11.0 10.4 17.2 122.9 26.4 10.7 15.7 44.8 6.9 41.7 8.5 15.4 SOCS3 "CIS3, Cish3, SOCS-3, SSI-3" ENSG00000184557 "Suppressor of cytokine signaling 3" O14543 17 78356778-78360077 "Disease related genes, Predicted intracellular proteins" "Growth regulation, Ubl conjugation pathway" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Endothelial cells: 259.3;Smooth muscle cells: 425.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 11.6" "Group enriched" "Detected in many" 6 "granulocytes: 11.6;T-cells: 4.3" "Cell line enhanced" "Detected in many" "HDLM-2: 49.9;HSkMC: 25.4;U-266/70: 25.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB012220, HPA068569" Approved Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "CAB012220: AB_443287, HPA068569: AB_2686008" "prognostic favorable (4.80e-4)" "unprognostic (2.67e-1)" "unprognostic (5.05e-2)" "unprognostic (1.64e-3)" "unprognostic (4.41e-3)" "unprognostic (2.48e-3)" "unprognostic (1.81e-1)" "unprognostic (1.46e-1)" "unprognostic (6.88e-2)" "unprognostic (9.61e-3)" "unprognostic (1.84e-1)" "unprognostic (2.00e-2)" "prognostic unfavorable (9.34e-9)" "unprognostic (1.08e-2)" "unprognostic (8.80e-2)" "unprognostic (7.59e-3)" "unprognostic (8.40e-2)" 94.9 16.8 6.3 42.5 21.4 33.9 25.7 3.0 12.8 27.6 26.6 5.6 1.9 6.2 13.9 9.2 22.7 88.0 59.6 23.5 11.4 5.1 13.5 30.4 52.1 30.2 13.9 0.1 31.2 14.5 13.9 13.4 23.5 38.0 20.8 9.2 10.3 9.2 6.7 26.0 12.1 15.6 39.0 29.6 36.7 32.2 12.1 8.7 5.6 14.2 40.9 10.3 38.1 41.1 0.0 1.3 11.6 1.3 0.4 4.3 0.6 2.0 3.3 2.4 1.3 0.9 15.5 6.5 10.4 9.5 10.9 4.6 2.1 1.4 0.0 2.2 2.4 6.9 0.6 0.5 1.0 4.3 49.9 0.3 1.9 7.3 0.4 5.0 0.0 0.9 25.4 0.8 8.4 3.2 6.6 4.7 0.1 5.5 19.6 5.0 1.0 1.0 0.3 1.7 0.3 4.3 0.0 12.5 0.3 17.3 2.0 0.1 1.5 3.1 0.8 0.4 9.5 0.9 0.4 2.7 21.5 6.1 7.5 6.0 25.9 14.5 0.0 17.6 0.2 1.4 0.0 1.3 0.3 1.0 0.1 2.6 0.0 2.8 1.2 1.3 0.0 4.3 0.8 11.6 0.4 0.0 1.2 1.6 0.6 6.3 21.4 3.0 12.8 11.4 5.1 13.9 0.1 38.0 8.7 44.7 145.2 37.8 106.0 146.0 1.0 23.1 5.1 20.1 55.7 36.6 2.0 8.0 5.0 34.0 0.6 259.3 21.3 0.0 34.0 41.1 225.0 61.7 33.7 14.4 86.4 0.0 31.8 133.8 82.4 0.2 72.5 182.0 81.0 48.7 21.3 2.0 36.2 24.3 2.1 6.8 1.6 12.9 425.2 0.5 0.2 116.2 51.9 47.9 36.7 70.2 SOCS5 "CIS6, Cish5, CISH6, KIAA0671, SOCS-5" ENSG00000171150 "Suppressor of cytokine signaling 5" O75159 2 46698952-46763129 "Predicted intracellular proteins" "Growth regulation, Ubl conjugation pathway" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ hTERT+: 45.7;fHDF/TERT166: 44.5;U-138 MG: 30.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020884, CAB025510" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" No No Cytosol "Nucleoplasm, Plasma membrane" "CAB025510: , HPA020884: AB_1857356" "unprognostic (1.69e-1)" "unprognostic (1.98e-2)" "unprognostic (5.71e-2)" "unprognostic (1.64e-2)" "unprognostic (2.20e-2)" "unprognostic (2.67e-1)" "prognostic unfavorable (7.28e-4)" "unprognostic (4.52e-2)" "unprognostic (9.13e-2)" "prognostic unfavorable (7.53e-4)" "unprognostic (2.10e-3)" "unprognostic (3.01e-1)" "unprognostic (1.47e-3)" "unprognostic (8.29e-2)" "unprognostic (1.71e-1)" "unprognostic (1.17e-1)" "unprognostic (1.29e-1)" 12.2 10.1 16.9 5.6 24.9 6.2 21.3 26.4 14.9 13.6 9.4 6.3 7.6 4.8 14.0 8.8 8.2 9.6 11.2 11.2 11.9 8.1 9.1 6.3 10.1 9.9 9.1 10.8 23.8 6.0 14.8 9.0 6.9 11.8 9.9 6.5 5.8 9.3 13.0 8.8 6.9 6.8 13.6 10.8 8.1 7.2 9.5 8.8 10.9 9.8 5.0 6.1 9.4 9.0 4.8 1.3 6.3 3.7 2.3 3.3 1.6 5.2 4.0 3.5 5.1 11.2 16.2 4.3 24.7 45.7 12.1 7.1 3.8 2.6 2.7 4.8 44.5 3.7 2.6 3.8 3.9 15.4 2.6 3.5 4.2 3.7 4.5 7.0 2.4 4.7 12.8 5.9 10.3 4.1 13.5 4.1 1.1 3.6 2.9 7.7 1.8 2.1 3.9 3.9 5.5 3.3 2.8 5.9 3.4 4.9 4.0 2.7 7.5 6.0 4.0 4.6 3.5 1.6 3.5 4.6 30.2 6.8 10.0 4.8 3.7 2.2 2.3 13.8 4.8 9.3 1.2 1.1 6.3 2.4 1.0 3.0 4.5 1.5 1.6 1.2 4.8 2.7 3.3 1.1 2.3 3.7 1.3 2.5 1.6 16.9 24.9 26.4 14.9 11.9 8.1 9.1 10.8 11.8 8.8 3.0 6.7 6.0 6.3 14.7 12.1 13.6 15.3 5.3 9.1 3.5 21.6 3.1 5.0 6.3 8.5 22.4 6.3 0.0 5.9 1.9 12.1 8.8 16.2 6.4 4.0 17.5 10.4 20.3 6.3 5.1 16.1 7.2 6.8 6.4 7.6 8.9 5.5 7.0 15.9 6.3 5.3 12.9 17.9 11.9 15.6 12.7 2.3 4.4 6.0 4.8 SORCS1 sorCS1 ENSG00000108018 "Sortilin related VPS10 domain containing receptor 1" Q8WY21 10 106573663-107164534 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 18.5" "Cell type enriched" "Detected in some" 4 "Muller glia cells: 59.3" "Cancer enhanced" "Detected in some" "melanoma: 3.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 24 "intermediate monocyte: 2.4" "Lineage enriched" "Detected in single" 24 "monocytes: 2.4" "Group enriched" "Detected in some" 12 "RH-30: 33.9;SH-SY5Y: 44.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011948 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA011948: AB_1857366" "unprognostic (5.86e-3)" "unprognostic (8.45e-3)" "unprognostic (1.55e-2)" "unprognostic (1.67e-1)" "unprognostic (1.13e-1)" "unprognostic (1.36e-1)" "unprognostic (1.05e-2)" "unprognostic (2.92e-2)" "unprognostic (3.52e-2)" "unprognostic (5.58e-2)" "unprognostic (6.82e-3)" "unprognostic (5.81e-2)" "unprognostic (6.48e-4)" "unprognostic (2.51e-2)" "unprognostic (8.89e-3)" "unprognostic (2.22e-1)" "unprognostic (2.69e-4)" 1.4 5.8 6.0 4.5 14.1 0.4 1.8 0.5 13.2 2.2 10.7 1.1 1.9 1.4 2.1 1.2 2.0 3.2 2.8 4.2 2.6 4.7 8.0 0.5 0.5 1.9 2.1 6.6 1.2 3.0 0.6 1.2 0.4 3.3 2.7 3.6 6.5 2.4 4.9 0.8 2.3 4.5 2.7 2.1 1.7 3.4 2.3 2.7 0.2 18.5 1.1 2.7 4.7 3.8 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 33.9 0.0 0.0 0.0 0.0 44.4 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 14.1 0.5 11.3 2.6 4.7 2.1 6.6 3.3 2.7 0.0 0.3 0.0 0.0 0.6 1.8 1.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.6 14.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 1.6 0.0 0.0 0.3 3.4 0.0 0.0 1.7 0.0 0.0 59.3 0.1 0.0 0.4 2.2 1.7 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 SPAG16 "DKFZp666P1710, FLJ22724, PF20, WDR29" ENSG00000144451 "Sperm associated antigen 16" Q8N0X2 2 213284379-214410501 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Ciliated cells: 261.0;Early spermatids: 200.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "T-47d: 33.9" "Low region specificity" "Detected in many" HPA037542 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA037542: AB_10672353" "unprognostic (4.20e-2)" "unprognostic (2.73e-1)" "unprognostic (2.67e-1)" "unprognostic (9.79e-2)" "unprognostic (1.83e-1)" "unprognostic (1.30e-1)" "unprognostic (2.04e-2)" "unprognostic (1.76e-1)" "unprognostic (1.23e-1)" "unprognostic (1.15e-1)" "unprognostic (2.66e-1)" "prognostic unfavorable (4.90e-4)" "prognostic favorable (3.82e-4)" "unprognostic (1.10e-2)" "unprognostic (1.01e-1)" "unprognostic (3.41e-1)" "unprognostic (1.17e-1)" 11.1 13.0 28.2 5.4 29.8 1.7 15.8 12.0 22.0 16.7 11.5 21.9 23.1 13.7 14.0 24.8 16.0 34.8 17.0 15.7 27.7 24.6 22.6 13.8 8.1 7.7 31.5 22.0 20.2 11.2 24.0 32.8 7.3 25.7 17.1 13.1 11.1 11.8 19.8 6.1 18.2 7.9 14.3 36.9 5.7 19.2 34.3 18.1 10.5 19.9 11.4 9.8 14.8 11.9 7.5 4.1 1.1 1.1 12.1 10.6 3.0 12.4 5.0 14.3 0.0 9.8 17.6 0.1 6.8 8.2 8.9 9.5 9.8 13.8 5.2 8.2 7.5 14.3 8.8 6.4 8.3 19.0 0.0 5.1 2.7 12.7 12.7 10.9 2.9 0.0 15.0 11.5 7.9 4.6 12.3 3.6 5.5 8.7 6.0 8.9 0.0 9.8 0.0 7.9 0.0 4.2 10.5 15.0 0.2 14.3 12.2 10.4 12.3 7.9 7.3 9.6 12.9 33.9 1.2 3.8 8.6 5.2 4.5 7.1 9.8 4.4 0.2 14.0 0.0 3.8 1.1 0.2 0.7 7.1 1.1 10.1 7.5 8.0 8.9 2.5 7.3 10.6 9.2 0.4 12.1 0.8 4.1 7.4 3.0 28.2 29.8 12.0 22.0 27.7 24.6 31.5 22.0 25.7 18.1 14.9 17.9 11.0 36.9 37.5 34.4 59.6 58.6 261.0 58.0 38.4 90.3 41.9 64.6 34.0 200.5 21.0 10.6 23.3 21.5 17.0 30.9 34.4 9.3 16.0 10.0 38.1 36.7 9.2 4.5 48.7 38.3 6.9 21.9 49.5 35.2 69.4 27.0 10.5 42.1 72.5 64.3 12.9 31.9 158.7 19.0 49.3 19.7 12.1 36.5 43.0 SPANXN4 "CT11.9, SPANX-N4" ENSG00000189326 "SPANX family member N4" Q5MJ08 X 143025918-143034702 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "testis: 23.7" "Cell type enriched" "Detected in some" 4 "Late spermatids: 233.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 16 "neutrophil: 1.5" "Lineage enriched" "Detected in single" 16 "granulocytes: 1.5" "Cell line enhanced" "Detected in some" "HEL: 2.4;HeLa: 4.2;hTERT-HME1: 1.0" "HPA045730, HPA059094" Uncertain Approved "Nuclear membrane,Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "Nuclear membrane" "HPA045730: AB_10961036, HPA059094: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 4.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 233.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 SPART "KIAA0610, SPG20, TAHCCP1" ENSG00000133104 Spartin Q8N0X7 13 36301638-36370180 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 120.5;Club cells: 73.9;Proximal tubular cells: 72.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "basophil: 45.8" "Lineage enriched" "Detected in all" 5 "granulocytes: 45.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039053, HPA039054" Approved Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA039053: AB_10672769, HPA039054: AB_2676323" "unprognostic (3.73e-2)" "unprognostic (9.39e-2)" "unprognostic (3.06e-2)" "unprognostic (4.60e-2)" "unprognostic (2.21e-2)" "unprognostic (1.10e-2)" "unprognostic (9.18e-3)" "unprognostic (9.58e-2)" "unprognostic (3.36e-2)" "unprognostic (2.22e-1)" "unprognostic (7.62e-2)" "unprognostic (8.14e-2)" "unprognostic (1.54e-1)" "unprognostic (9.26e-2)" "unprognostic (1.22e-1)" "unprognostic (1.54e-2)" "unprognostic (5.79e-2)" 28.7 34.7 23.2 12.1 28.0 14.5 44.9 21.3 26.7 37.1 22.5 23.1 26.2 9.1 29.9 48.4 17.7 26.1 26.2 17.5 24.7 22.3 33.7 13.7 18.4 12.9 31.8 19.4 46.1 10.3 13.2 29.8 32.2 28.9 26.6 10.0 17.2 11.9 27.0 20.6 12.4 9.7 37.0 35.7 20.2 14.4 18.3 32.5 7.0 25.1 8.7 7.8 31.4 58.7 3.2 6.0 45.8 6.8 4.1 8.3 5.3 0.0 5.9 16.1 0.0 35.4 29.8 11.5 14.4 21.7 14.5 14.4 0.0 0.0 0.0 9.0 17.3 26.7 8.3 21.7 10.0 15.7 1.1 12.5 17.9 7.7 3.8 35.6 18.6 36.3 29.4 16.1 12.0 16.9 36.0 21.2 5.0 7.8 3.1 26.1 1.3 5.5 31.2 8.1 0.0 2.1 0.0 27.0 0.6 16.9 7.4 1.6 3.9 12.2 4.9 15.2 24.2 2.8 22.1 17.5 10.9 5.5 15.0 8.4 3.8 0.0 0.0 12.1 16.2 18.9 45.8 6.7 8.7 4.4 6.7 4.3 3.2 6.2 1.8 4.8 3.2 8.3 4.4 10.6 4.1 6.8 6.0 1.5 5.3 23.2 28.0 21.3 26.7 24.7 22.3 31.8 19.4 28.9 32.5 32.8 45.1 0.0 0.0 0.0 0.0 0.0 0.0 120.5 73.9 26.2 0.0 37.7 56.3 22.0 0.0 0.0 0.0 0.0 13.1 50.7 0.0 0.0 53.5 0.0 37.0 0.0 0.0 0.0 0.0 0.0 0.0 17.0 0.0 42.3 0.0 0.0 15.2 0.0 0.0 72.6 0.0 0.0 0.0 0.0 0.0 0.0 53.8 0.0 0.0 0.0 SPATA12 ENSG00000186451 "Spermatogenesis associated 12" Q7Z6I5 3 57060441-57075432 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 11 "testis: 26.6" "Group enriched" "Detected in some" 125 "Early spermatids: 496.6;Late spermatids: 837.5" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 10 "classical monocyte: 1.0" "Lineage enriched" "Detected in single" 10 "monocytes: 1.0" "Cell line enhanced" "Detected in some" "GAMG: 5.4;HUVEC TERT2: 2.4;RH-30: 3.1" "HPA043323, HPA075578" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" No No "Nucleoplasm, Cytosol" "Plasma membrane" "HPA043323: AB_10796792, HPA075578: " "unprognostic (2.31e-1)" "unprognostic (2.18e-4)" "unprognostic (3.47e-4)" "unprognostic (2.21e-2)" "unprognostic (2.66e-1)" "unprognostic (8.79e-3)" "unprognostic (1.69e-3)" "unprognostic (3.82e-2)" "unprognostic (1.35e-1)" "unprognostic (1.29e-1)" "unprognostic (6.80e-2)" "unprognostic (1.76e-2)" "unprognostic (4.71e-3)" "unprognostic (7.29e-2)" "unprognostic (1.62e-2)" "unprognostic (1.14e-1)" "unprognostic (2.44e-3)" 0.2 0.4 0.0 0.0 0.4 0.0 0.1 0.0 0.2 0.1 0.1 0.4 0.0 0.0 0.1 0.8 0.1 0.3 2.4 0.0 0.0 0.0 0.1 0.0 0.3 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.2 0.3 0.0 0.2 0.0 0.1 0.1 0.0 0.1 1.1 0.1 0.4 26.6 0.0 0.0 0.0 1.1 0.3 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.3 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.4 0.5 0.5 0.0 5.4 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.7 0.6 0.0 0.0 1.1 0.2 0.5 0.0 0.0 1.1 2.4 0.0 0.0 0.6 0.2 0.1 0.0 0.0 1.5 1.2 1.5 0.0 3.1 0.1 2.0 1.2 0.0 0.0 0.2 0.0 1.3 0.6 0.0 0.0 0.8 0.0 2.0 0.4 0.3 0.0 0.2 1.0 0.6 0.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 496.6 0.1 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 3.2 0.0 0.0 0.0 0.3 837.5 4.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 5.3 0.0 0.0 0.0 0.0 4.6 2.3 0.0 0.0 0.0 0.0 0.3 SPATC1L C21orf56 ENSG00000160284 "Spermatogenesis and centriole associated 1 like" Q9H0A9 21 46161148-46184476 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 174.7;Late spermatids: 364.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 23.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 24.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA018979, HPA019165, HPA029394" Approved Approved "Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane, Cytosol" "HPA018979: AB_1845696, HPA019165: AB_1845697, HPA029394: AB_10601148" "unprognostic (1.46e-2)" "unprognostic (3.88e-2)" "unprognostic (3.95e-2)" "unprognostic (4.86e-2)" "unprognostic (6.36e-2)" "unprognostic (1.71e-1)" "unprognostic (4.45e-3)" "unprognostic (2.16e-1)" "unprognostic (1.23e-1)" "unprognostic (1.27e-1)" "prognostic favorable (2.16e-4)" "unprognostic (5.56e-2)" "unprognostic (2.35e-3)" "unprognostic (1.07e-1)" "unprognostic (1.47e-1)" "unprognostic (1.91e-2)" "unprognostic (2.58e-1)" 4.7 11.5 21.5 4.2 31.7 5.1 4.3 13.1 19.0 8.2 5.1 5.6 8.9 5.3 5.3 6.5 4.6 4.0 5.7 5.5 14.4 9.4 4.3 1.5 4.4 5.7 7.8 16.5 10.9 11.7 5.8 7.8 4.7 7.5 16.7 3.6 2.6 9.5 10.1 8.8 7.0 6.3 5.6 5.2 8.1 8.3 23.5 13.6 2.2 3.7 5.0 4.3 4.4 6.4 4.8 5.9 23.6 4.2 4.0 6.9 2.7 1.8 0.0 2.5 4.6 1.4 3.3 1.3 2.7 1.5 1.5 1.1 0.0 1.2 5.9 5.5 3.4 1.8 0.3 0.0 2.1 0.4 5.3 4.4 14.0 0.8 3.3 0.1 0.0 5.9 3.5 1.0 0.0 0.0 2.9 4.9 6.8 24.3 8.9 2.1 3.7 4.5 1.6 10.1 2.6 12.0 10.1 3.3 6.5 2.4 0.5 0.7 4.7 2.1 1.2 5.4 1.8 3.8 5.4 0.3 4.5 5.4 6.4 4.0 14.9 7.9 4.3 5.9 7.8 4.2 1.0 3.9 23.6 3.0 4.2 3.9 4.7 4.4 4.3 5.9 4.8 6.9 6.8 0.2 4.0 2.9 4.8 4.2 2.7 21.5 31.7 13.1 19.0 14.4 9.4 7.8 16.5 7.5 13.6 0.0 0.0 6.0 12.9 20.9 5.7 1.2 17.8 1.4 2.3 3.5 0.0 2.8 13.3 16.5 174.7 13.2 5.4 0.0 17.4 11.5 17.2 25.0 0.0 0.5 11.6 3.2 58.0 8.0 7.3 364.6 30.0 15.4 27.0 5.4 16.3 5.2 14.9 2.9 29.7 9.2 3.4 19.4 12.3 11.2 8.9 35.0 2.6 16.0 17.5 3.7 SPERT "CBY2, NURIT" ENSG00000174015 "Spermatid associated" Q8NA61 13 45702311-45714559 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "testis: 66.5" "Group enriched" "Detected in some" 81 "Early spermatids: 730.0;Late spermatids: 1376.0" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 3.2" "Lineage enriched" "Detected in single" 32 "T-cells: 3.2" "Cell line enhanced" "Detected in some" "EFO-21: 1.8;HDLM-2: 3.5;hTCEpi: 1.2;JURKAT: 1.1;MCF7: 1.3;SCLC-21H: 1.2;SK-BR-3: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA039359, HPA040046" Enhanced Approved "Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" "HPA039359: AB_10794088, HPA040046: AB_10796117" "unprognostic (2.86e-1)" "unprognostic (3.38e-1)" "unprognostic (1.64e-2)" "unprognostic (1.65e-1)" "unprognostic (3.76e-2)" "unprognostic (4.19e-4)" "unprognostic (8.52e-2)" "unprognostic (8.87e-2)" "unprognostic (1.23e-1)" "unprognostic (4.38e-1)" "unprognostic (2.38e-2)" "unprognostic (1.21e-1)" "unprognostic (1.56e-2)" "unprognostic (1.97e-2)" "unprognostic (4.15e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 66.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.8 0.8 0.0 0.0 0.1 0.0 0.0 3.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.0 2.5 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.7 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 3.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 730.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1376.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 12.9 0.0 7.4 5.3 0.0 0.0 0.0 0.0 0.0 SPINK13 "HESPINTOR, LiESP6, MGC149260, SPINK5L3" ENSG00000214510 "Serine peptidase inhibitor, Kazal type 13 (putative)" Q1W4C9 5 148268180-148286254 "Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 14 "ductus deferens: 85.5;epididymis: 86.8;seminal vesicle: 26.7" "Group enriched" "Detected in some" 7 "Leydig cells: 36.8;Peritubular cells: 25.1" "Group enriched" "Detected in some" 6 "cervical cancer: 0.9;lung cancer: 0.9;renal cancer: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 20 "HeLa: 102.0" HPA036456 Uncertain Approved "Nucleoplasm,Plasma membrane" "Secreted in male reproductive system" NA NA "Plasma membrane" Nucleoplasm "HPA036456: AB_10673496" "unprognostic (5.22e-2)" "unprognostic (2.03e-1)" "unprognostic (1.44e-1)" "unprognostic (2.51e-1)" "unprognostic (1.22e-1)" "unprognostic (1.41e-2)" "unprognostic (6.43e-3)" "unprognostic (1.25e-3)" "unprognostic (5.01e-3)" "unprognostic (1.25e-1)" "prognostic unfavorable (4.03e-10)" "unprognostic (4.31e-2)" "unprognostic (1.72e-1)" "unprognostic (2.43e-1)" "unprognostic (2.95e-2)" 0.1 4.6 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 2.2 0.0 85.5 0.0 0.4 86.8 0.1 1.0 0.1 0.8 0.0 0.1 2.1 0.0 0.1 0.1 0.0 0.0 1.4 0.4 0.0 1.0 0.1 0.0 4.0 0.0 0.0 0.1 26.7 0.1 0.2 0.0 0.1 0.0 0.0 2.9 2.7 0.0 0.0 0.4 0.1 0.1 0.4 0.1 0.4 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 102.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 5.1 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.4 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.2 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 36.8 0.0 0.0 0.0 0.0 0.0 1.7 0.0 25.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPN "CD43, GPL115, LSN" ENSG00000197471 Sialophorin P16150 16 29662979-29670876 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "blood: 52.1;bone marrow: 33.1;lung: 25.0;lymphoid tissue: 79.7" "Group enriched" "Detected in many" 4 "Alveolar cells type 2: 22.9;Erythroid cells: 23.3;granulocytes: 42.7;Hofbauer cells: 27.4;Kupffer cells: 21.5;Macrophages: 52.4;T-cells: 85.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "non-classical monocyte: 52.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 56.1;HL-60: 49.8;HMC-1: 28.1;K-562: 17.4;MOLT-4: 19.3;REH: 17.4;THP-1: 27.0;U-937: 35.5" "CAB002666, HPA055244" Enhanced Approved "Plasma membrane" NA NA "Plasma membrane" "CAB002666: , HPA055244: AB_2682756" "prognostic favorable (1.40e-4)" "unprognostic (1.63e-3)" "unprognostic (3.14e-2)" "prognostic favorable (3.08e-5)" "unprognostic (2.68e-2)" "unprognostic (2.49e-3)" "unprognostic (4.02e-2)" "unprognostic (4.17e-2)" "prognostic favorable (1.88e-4)" "unprognostic (1.70e-1)" "unprognostic (4.67e-2)" "unprognostic (2.68e-1)" "unprognostic (2.61e-2)" "unprognostic (4.52e-2)" "unprognostic (4.14e-2)" "unprognostic (5.85e-2)" "unprognostic (4.72e-2)" 5.7 1.0 1.2 12.9 2.7 33.1 1.6 0.7 1.5 1.3 2.8 2.6 0.0 2.3 1.5 0.6 1.9 1.7 2.8 3.9 1.2 1.4 1.8 1.9 25.0 18.3 3.7 0.2 1.0 1.6 0.2 1.0 0.8 2.3 1.6 2.6 1.6 5.0 0.6 0.8 1.6 6.8 1.0 4.6 15.9 2.0 0.6 1.9 79.7 1.6 1.7 17.4 2.6 1.4 1.0 8.8 3.5 52.1 17.5 26.5 10.7 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 56.1 0.0 0.4 0.0 49.8 28.1 0.0 0.0 0.0 0.0 0.0 0.0 10.9 17.4 13.7 0.1 0.0 19.3 12.5 0.0 0.0 0.0 17.4 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.0 0.1 0.0 0.0 0.0 0.0 0.1 1.0 7.3 0.0 35.5 0.0 2.4 5.5 3.5 26.5 24.3 14.5 1.0 10.7 18.1 8.8 0.3 7.6 13.2 0.9 17.5 52.1 7.0 9.1 10.7 1.2 2.7 0.7 1.5 1.2 1.4 3.7 0.2 2.3 1.9 8.9 22.9 9.3 0.5 1.9 0.6 5.1 0.0 2.7 4.5 1.8 0.0 0.2 0.0 0.0 0.0 0.7 0.0 23.3 0.0 0.3 2.6 0.4 42.7 0.9 27.4 1.6 0.0 4.3 21.5 0.0 0.0 52.4 1.7 1.8 0.0 0.4 0.0 0.0 0.0 0.3 1.9 0.0 1.7 0.2 0.6 1.8 0.2 85.3 0.0 0.7 SPRYD3 FLJ14800 ENSG00000167778 "SPRY domain containing 3" Q8NCJ5 12 53064316-53079420 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039426, HPA039685" Enhanced Approved "Nucleoplasm,Vesicles,Plasma membrane,Actin filaments,Cytosol" NA NA "Nucleoplasm, Cytosol" "Vesicles, Plasma membrane, Actin filaments" "HPA039426: AB_10673358, HPA039685: AB_2676623" "unprognostic (7.73e-3)" "unprognostic (6.55e-2)" "unprognostic (1.37e-2)" "unprognostic (5.05e-3)" "unprognostic (1.52e-2)" "prognostic unfavorable (9.46e-4)" "unprognostic (1.27e-3)" "unprognostic (2.58e-1)" "unprognostic (1.83e-2)" "unprognostic (1.43e-2)" "unprognostic (2.64e-2)" "unprognostic (3.14e-2)" "prognostic favorable (1.78e-15)" "unprognostic (9.82e-2)" "unprognostic (5.27e-2)" "unprognostic (7.44e-3)" "unprognostic (1.41e-1)" 16.8 15.7 30.4 10.1 51.9 3.3 11.6 27.1 59.3 15.3 11.4 14.9 10.6 10.8 14.1 21.7 15.9 26.8 11.7 23.1 28.3 27.0 11.3 8.0 13.1 8.8 21.5 34.9 26.4 20.4 26.5 20.3 8.0 34.2 18.3 10.0 15.6 23.3 25.1 7.4 13.0 9.8 18.3 14.0 9.8 13.4 4.9 12.2 3.7 20.2 6.6 11.4 12.4 11.4 9.4 9.4 26.7 18.4 9.7 21.0 15.6 12.5 19.6 2.5 5.2 20.9 10.4 3.3 19.4 10.0 7.3 4.7 3.2 10.6 8.1 16.1 23.6 8.9 11.7 3.4 14.7 4.8 8.8 5.2 5.2 11.9 7.3 15.7 9.7 9.2 9.4 23.2 10.4 16.1 14.5 15.0 4.3 4.4 20.6 12.7 27.2 6.9 5.0 1.4 10.2 13.8 3.1 4.3 16.7 9.2 10.1 4.4 4.2 16.6 15.4 7.8 1.4 14.4 7.6 20.8 8.3 8.5 18.8 13.1 11.6 10.3 2.4 24.5 8.6 10.1 15.5 9.8 26.7 21.0 17.5 20.1 9.4 14.5 16.9 9.4 7.5 12.5 14.6 15.5 9.7 18.4 4.5 8.0 15.6 30.4 51.9 27.1 59.3 28.3 27.0 21.5 34.9 34.2 12.2 3.0 8.5 12.3 16.4 5.0 40.6 16.7 22.9 21.4 9.1 17.4 7.9 5.4 10.0 26.1 0.2 16.6 10.3 0.0 31.6 11.7 12.3 17.1 9.3 8.1 10.7 41.3 11.1 15.4 10.0 1.1 15.0 8.1 10.1 16.2 11.7 29.5 23.5 8.2 31.1 12.6 20.2 19.4 23.4 3.0 4.5 8.3 3.5 10.2 7.3 13.7 SPTBN2 SCA5 ENSG00000173898 "Spectrin beta, non-erythrocytic 2" O15020 11 66685248-66729226 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 46.7;skin 1: 36.9" "Cell type enhanced" "Detected in many" 13 "Collecting duct cells: 82.0;Cone photoreceptor cells: 98.2;Late spermatids: 50.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 20.3;NTERA-2: 23.5;SCLC-21H: 23.9;SK-BR-3: 16.7;T-47d: 19.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009844, HPA039293, HPA043529" Enhanced Approved "Plasma membrane,Cell Junctions" NA NA 4800000 "Plasma membrane" "Cell Junctions" "CAB009844: AB_2194521, HPA039293: AB_2676430, HPA043529: AB_2678531" "unprognostic (9.34e-2)" "unprognostic (5.71e-2)" "unprognostic (4.89e-2)" "unprognostic (3.41e-3)" "unprognostic (4.91e-1)" "unprognostic (6.05e-3)" "unprognostic (4.45e-2)" "unprognostic (1.38e-2)" "unprognostic (7.25e-2)" "unprognostic (1.67e-2)" "prognostic unfavorable (3.14e-5)" "unprognostic (1.64e-1)" "unprognostic (1.05e-3)" "unprognostic (1.34e-1)" "unprognostic (1.84e-1)" "unprognostic (3.99e-2)" "unprognostic (1.00e-3)" 0.8 4.9 26.2 1.0 38.3 1.7 4.5 29.6 46.7 9.6 0.9 2.0 0.0 1.0 1.1 1.2 12.7 2.6 1.2 0.7 19.7 8.2 12.7 7.1 0.9 0.5 6.5 24.7 0.8 8.3 12.2 3.9 0.7 14.4 6.8 0.7 1.7 13.4 3.1 0.7 36.9 0.9 1.2 1.9 0.9 1.2 18.9 6.2 0.0 0.5 0.1 3.3 1.1 3.6 0.1 0.0 0.4 0.0 0.0 0.0 0.0 6.5 3.4 1.6 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 2.2 8.1 0.0 1.8 0.0 0.3 7.8 11.9 1.1 0.0 0.0 4.7 0.0 20.3 1.1 0.3 3.3 0.3 0.1 5.5 0.0 3.5 1.9 2.9 2.4 3.3 0.0 0.0 12.8 2.6 1.5 23.5 9.2 10.5 10.9 1.3 6.7 4.5 1.1 23.9 14.1 6.6 16.7 1.5 1.3 19.1 0.9 0.6 0.0 4.2 0.6 5.2 0.3 1.2 7.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 26.2 38.3 29.6 46.7 19.7 8.2 6.5 24.7 14.4 6.2 3.0 0.6 0.0 1.7 3.3 7.4 1.6 2.5 1.4 2.3 82.0 98.2 0.8 0.0 2.4 24.4 0.6 0.0 0.0 8.7 0.3 0.5 3.1 0.0 20.2 0.1 0.0 2.9 1.3 0.0 50.4 1.7 0.0 0.0 1.0 1.6 1.4 6.9 0.0 1.4 1.2 21.0 0.0 0.0 2.7 8.6 10.9 0.2 0.0 0.6 1.4 SRD5A3 "FLJ13352, SRD5A2L, SRD5A2L1" ENSG00000128039 "Steroid 5 alpha-reductase 3" Q9H8P0 4 55346109-55373096 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" Oxidoreductase "Cataract, Congenital disorder of glycosylation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Exocrine glandular cells: 92.9;Extravillous trophoblasts: 88.2;Pancreatic endocrine cells: 133.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 42.6" "Low region specificity" "Detected in all" HPA027006 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA027006: AB_1857469" "unprognostic (1.12e-2)" "unprognostic (1.01e-1)" "unprognostic (4.02e-2)" "prognostic favorable (9.39e-4)" "unprognostic (1.50e-2)" "unprognostic (4.81e-2)" "prognostic unfavorable (1.80e-6)" "unprognostic (9.31e-2)" "unprognostic (5.28e-2)" "unprognostic (1.81e-2)" "unprognostic (3.29e-3)" "unprognostic (1.18e-1)" "prognostic unfavorable (4.85e-10)" "unprognostic (4.16e-2)" "unprognostic (1.42e-1)" "unprognostic (1.43e-2)" "unprognostic (9.52e-2)" 13.8 12.2 11.5 5.9 13.4 6.6 17.8 7.3 18.3 22.9 11.3 20.3 3.5 6.9 13.8 9.6 24.4 5.9 22.6 10.5 13.2 10.7 12.3 15.0 12.4 10.1 15.5 12.0 3.5 26.8 14.0 7.0 8.8 13.6 8.9 10.9 6.8 16.3 6.6 5.8 15.6 8.3 6.2 22.1 6.9 13.8 4.0 15.3 10.0 7.6 9.9 12.1 12.1 12.1 5.9 28.4 10.3 25.2 3.6 9.2 10.3 4.8 3.2 5.8 5.5 19.5 12.5 2.9 5.3 6.2 2.2 3.6 3.2 10.1 11.5 6.0 8.3 6.2 3.8 4.1 4.9 2.8 3.3 7.3 6.3 3.6 8.6 5.2 11.6 3.5 11.4 9.1 3.8 3.5 4.8 9.0 21.5 10.7 25.8 12.6 6.3 17.0 5.1 7.3 27.6 4.3 5.5 1.8 6.5 7.4 5.2 9.0 5.0 5.6 42.6 3.8 6.0 5.2 10.2 4.4 14.2 2.6 1.0 4.0 13.8 7.6 4.2 18.0 16.0 13.8 10.3 16.5 4.9 7.9 25.1 9.2 5.9 6.0 7.4 14.1 5.2 5.3 7.1 0.8 3.6 25.2 28.4 5.8 10.3 11.5 13.4 7.3 18.3 13.2 10.7 15.5 12.0 13.6 15.3 8.9 15.7 3.0 9.5 12.0 4.6 4.6 45.9 12.0 12.5 5.2 3.9 22.7 3.3 67.0 2.0 14.3 8.4 0.0 92.9 88.2 17.0 22.1 13.9 17.1 62.0 9.5 11.5 17.8 20.9 0.0 1.7 27.9 23.6 24.4 19.3 18.6 133.4 5.8 5.3 12.2 3.8 12.9 9.5 2.1 18.8 26.0 6.3 4.9 20.9 49.7 SRPK1 SFRSK1 ENSG00000096063 "SRSF protein kinase 1" Q96SB4 6 35832966-35921342 "Enzymes, Predicted intracellular proteins" "Chromosome partition, Differentiation, Host-virus interaction, mRNA processing, mRNA splicing" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 8 "Early spermatids: 311.7;Late spermatids: 401.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016431, HPA056486" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA016431: AB_1857478, HPA056486: AB_2683148" "unprognostic (4.65e-3)" "unprognostic (6.82e-3)" "unprognostic (2.54e-3)" "unprognostic (1.01e-3)" "unprognostic (7.74e-2)" "unprognostic (3.31e-2)" "prognostic unfavorable (7.90e-6)" "unprognostic (1.23e-2)" "unprognostic (2.54e-3)" "unprognostic (2.36e-2)" "prognostic unfavorable (6.53e-5)" "unprognostic (7.28e-2)" "unprognostic (2.21e-3)" "unprognostic (9.24e-2)" "unprognostic (4.43e-1)" "unprognostic (1.01e-1)" "unprognostic (7.55e-3)" 13.5 7.1 8.1 15.4 11.7 32.1 11.7 22.5 17.8 12.8 23.8 7.8 10.8 20.3 15.2 7.9 24.9 8.9 10.8 8.7 8.9 7.8 17.8 18.9 14.9 14.6 8.0 8.3 9.5 26.0 11.7 17.7 27.9 9.6 10.5 28.7 12.4 17.6 9.4 19.9 26.2 25.7 11.3 7.9 19.0 13.9 32.7 7.6 21.0 8.5 17.0 19.8 15.2 15.7 4.3 2.8 24.6 3.4 5.0 6.7 2.9 29.9 11.4 16.8 25.0 9.4 12.3 21.2 18.4 17.8 17.2 18.3 32.0 10.1 40.0 15.6 11.3 20.0 15.4 32.8 21.9 31.0 27.3 23.6 21.0 13.4 27.7 8.3 31.1 10.4 7.9 12.0 19.8 26.0 13.7 21.6 22.9 44.5 17.0 14.4 10.6 32.0 24.2 13.7 18.3 12.5 22.5 20.1 24.7 17.3 50.4 35.8 13.1 18.9 18.0 12.7 17.8 10.1 20.7 15.6 16.2 12.7 11.0 23.1 10.0 22.1 37.6 6.4 36.1 14.4 24.5 2.1 13.7 4.3 2.5 6.1 4.3 5.7 5.7 2.8 3.3 4.8 5.2 24.6 5.0 3.4 1.6 6.7 2.9 8.1 11.7 22.5 17.8 8.9 7.8 8.0 8.3 9.6 7.6 8.9 26.3 24.4 65.1 37.5 33.6 21.8 12.7 32.1 38.7 21.0 35.3 43.2 24.9 50.7 311.7 24.1 38.6 23.3 58.8 43.3 21.3 68.6 7.0 40.0 19.1 9.5 44.4 11.1 17.1 401.7 20.4 16.9 15.1 36.1 44.8 13.4 78.7 42.1 23.3 44.4 84.4 6.5 23.1 154.9 90.6 36.5 33.2 34.8 87.4 132.9 SRPRB "APMCF1, SR-beta" ENSG00000144867 "SRP receptor beta subunit" Q9Y5M8 3 133784033-133825772 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 104.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011173 Approved Approved "Plasma membrane" NA NA 54000 "Plasma membrane" "HPA011173: AB_1857484" "unprognostic (5.44e-2)" "unprognostic (1.32e-1)" "unprognostic (6.40e-2)" "unprognostic (1.58e-2)" "unprognostic (2.61e-1)" "unprognostic (2.02e-2)" "prognostic unfavorable (3.12e-5)" "unprognostic (1.99e-1)" "unprognostic (3.60e-2)" "unprognostic (6.07e-3)" "unprognostic (8.45e-2)" "unprognostic (1.31e-2)" "unprognostic (3.79e-2)" "unprognostic (5.08e-2)" "unprognostic (7.37e-2)" "unprognostic (6.47e-2)" "unprognostic (2.26e-2)" 10.4 15.7 8.7 10.2 9.3 5.8 12.5 5.2 10.2 14.4 11.3 5.1 33.2 8.9 8.0 25.6 16.8 9.1 11.0 10.9 9.0 10.7 17.2 56.3 9.2 17.3 10.4 7.7 8.9 104.0 11.7 15.6 7.7 8.8 9.5 13.4 7.6 53.3 29.9 10.6 8.6 7.4 10.3 7.4 9.5 12.5 14.7 5.4 6.3 16.5 10.2 13.7 8.7 10.4 15.4 20.0 3.8 15.2 14.3 29.0 18.0 12.1 9.9 6.3 20.0 26.3 18.3 11.8 25.8 13.5 14.4 12.5 18.0 9.5 23.1 38.2 19.7 14.5 17.8 19.6 13.9 13.7 15.6 15.7 20.7 9.8 17.0 32.0 32.3 16.8 16.5 23.5 13.1 38.8 8.0 12.2 11.8 17.5 26.9 15.4 17.7 11.1 15.4 11.9 32.4 17.1 13.5 11.7 49.3 17.3 8.4 20.8 8.6 19.8 18.4 7.2 5.0 20.9 15.0 12.1 14.2 8.4 22.3 13.8 34.7 34.5 34.9 12.7 21.5 15.8 3.8 11.6 1.4 21.4 15.2 29.0 15.4 18.3 19.0 13.2 13.4 18.0 21.2 0.8 14.3 9.9 20.0 10.6 18.0 8.7 9.3 5.2 10.2 9.0 10.7 10.4 7.7 8.8 5.4 14.9 22.3 15.6 21.0 33.5 6.2 22.2 43.3 20.1 19.4 34.9 11.8 58.0 10.0 42.5 49.3 24.9 15.5 0.0 58.0 60.5 38.5 38.7 32.3 77.2 46.0 6.4 30.9 17.8 19.9 31.5 29.7 19.3 33.7 10.0 36.2 15.6 40.9 21.0 26.2 24.9 8.8 12.9 23.7 52.8 41.9 27.6 43.3 20.8 32.9 21.4 SRRM3 FLJ37078 ENSG00000177679 "Serine/arginine repetitive matrix 3" 7 76201900-76287288 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "brain: 43.2" "Group enriched" "Detected in many" 13 "Bipolar cells: 127.8;Cone photoreceptor cells: 451.6;Horizontal cells: 162.1;Rod photoreceptor cells: 475.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "SCLC-21H: 14.4;SH-SY5Y: 10.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019337 Approved "Plasma membrane,Intermediate filaments,Microtubules" NA NA "Plasma membrane" "Intermediate filaments, Microtubules" "HPA019337: AB_1848909" "unprognostic (1.65e-1)" "unprognostic (1.96e-1)" "unprognostic (8.37e-3)" "unprognostic (4.93e-2)" "unprognostic (1.81e-1)" "unprognostic (1.39e-1)" "unprognostic (8.53e-2)" "unprognostic (6.51e-2)" "unprognostic (1.89e-3)" "unprognostic (1.62e-2)" "unprognostic (5.07e-3)" "unprognostic (6.37e-2)" "unprognostic (3.73e-3)" "unprognostic (5.05e-1)" "unprognostic (2.98e-1)" "unprognostic (1.84e-1)" "unprognostic (5.15e-2)" 0.6 6.2 8.1 0.7 18.1 0.4 0.4 43.2 14.6 0.4 0.6 0.0 0.0 0.9 0.7 1.1 0.5 0.5 0.5 0.5 5.1 0.5 0.4 0.5 0.4 0.0 10.9 0.6 0.5 0.5 4.4 0.4 10.0 0.5 0.7 1.8 0.6 0.5 0.6 0.5 0.6 0.5 0.6 0.4 1.6 2.9 2.9 0.0 0.4 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.3 0.2 0.4 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 10.6 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 1.8 127.8 6.9 0.0 0.0 0.0 0.0 451.6 0.3 0.0 1.4 18.9 0.0 0.0 0.0 2.1 7.0 2.7 1.2 0.0 0.0 0.4 162.1 11.6 0.6 0.0 23.9 2.0 0.0 3.3 0.0 0.0 14.5 1.2 0.0 2.1 0.3 475.2 0.0 1.4 5.4 2.6 1.0 1.8 0.0 0.0 4.7 SSFA2 "CS-1, KIAA1927, KRAP, SPAG13" ENSG00000138434 "Sperm specific antigen 2" P28290 2 181891833-181930738 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 85.5" "Cell type enhanced" "Detected in many" 4 "Suprabasal keratinocytes: 167.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 4 "dendritic cells: 3.8;granulocytes: 8.1;monocytes: 6.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034665, HPA039989" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA034665: AB_2674271, HPA039989: AB_2676788" "unprognostic (1.68e-1)" "unprognostic (3.27e-2)" "unprognostic (2.17e-2)" "unprognostic (4.70e-2)" "unprognostic (8.77e-2)" "unprognostic (8.87e-2)" "unprognostic (2.13e-1)" "unprognostic (4.74e-2)" "unprognostic (5.63e-2)" "unprognostic (1.23e-2)" "prognostic unfavorable (8.19e-4)" "unprognostic (6.95e-2)" "prognostic favorable (2.91e-5)" "unprognostic (3.39e-1)" "unprognostic (5.54e-2)" "unprognostic (4.95e-2)" "prognostic unfavorable (5.79e-5)" 14.2 10.1 23.3 11.8 27.0 16.1 21.6 25.8 22.5 17.7 24.4 26.2 9.4 17.5 13.0 8.9 12.0 10.7 18.7 13.6 23.7 19.1 22.8 36.0 23.0 11.2 31.3 17.7 7.2 85.5 10.5 10.2 40.9 24.8 18.1 24.1 22.3 29.2 10.0 16.6 50.6 19.5 14.2 27.8 14.7 26.0 16.7 23.8 9.3 19.6 12.2 7.9 14.3 23.5 1.2 3.8 8.1 6.4 1.0 1.4 1.8 16.4 8.2 24.0 4.0 21.0 17.4 6.8 29.2 28.4 10.3 13.7 8.5 19.1 0.4 9.5 20.5 12.7 14.3 5.8 14.0 19.9 7.5 6.6 16.6 35.3 6.8 15.5 8.5 15.6 10.3 20.7 17.7 24.1 24.4 53.7 8.0 7.4 9.2 28.6 8.3 7.5 11.9 1.6 15.3 19.4 5.6 9.7 5.7 29.0 5.0 4.2 3.7 17.1 6.1 26.1 9.5 4.4 18.6 21.3 24.4 11.8 8.7 15.1 6.3 2.7 6.6 11.4 5.1 18.2 8.1 3.9 5.7 1.4 3.9 0.9 0.6 1.0 0.9 3.8 1.2 1.3 1.1 6.6 1.0 6.4 3.1 0.6 1.8 23.3 27.0 25.8 22.5 23.7 19.1 31.3 17.7 24.8 23.8 134.0 40.6 11.2 36.2 97.1 18.5 23.0 35.7 33.5 35.2 31.4 35.3 19.9 14.9 15.8 9.0 52.6 132.6 0.0 62.2 21.0 25.9 46.7 22.0 89.3 18.4 25.4 105.7 36.8 47.5 13.4 17.5 29.8 55.6 15.4 57.0 17.2 54.1 41.9 16.3 36.3 33.6 38.8 24.5 22.3 25.4 167.2 27.9 12.9 39.3 84.6 SSH3 "FLJ10928, FLJ20515" ENSG00000172830 "Slingshot protein phosphatase 3" Q8TE77 11 67303448-67312607 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 10.8;eosinophil: 10.5" "Lineage enriched" "Detected in many" 5 "granulocytes: 10.8" "Cell line enhanced" "Detected in many" "HaCaT: 23.8;RT4: 36.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA019949, HPA019957" Approved Approved "Nuclear speckles,Plasma membrane,Actin filaments,Cytosol" NA NA "Nuclear speckles, Cytosol" "Plasma membrane, Actin filaments" "HPA019949: AB_1857498, HPA019957: AB_1857499" "unprognostic (4.38e-2)" "unprognostic (1.37e-1)" "unprognostic (3.50e-3)" "unprognostic (3.73e-2)" "unprognostic (2.61e-3)" "unprognostic (9.30e-2)" "unprognostic (2.99e-1)" "unprognostic (1.84e-1)" "unprognostic (1.63e-1)" "unprognostic (2.45e-2)" "prognostic unfavorable (2.89e-4)" "unprognostic (1.50e-1)" "unprognostic (2.06e-2)" "unprognostic (1.47e-1)" "unprognostic (3.20e-1)" "unprognostic (4.94e-3)" "unprognostic (6.78e-3)" 8.6 5.5 5.6 6.8 9.7 8.1 13.5 17.8 9.4 14.6 15.9 15.4 19.5 12.4 10.1 10.6 27.0 15.2 20.5 7.7 6.0 6.1 10.3 7.5 9.0 3.5 13.6 5.4 17.1 12.0 11.3 7.4 20.0 8.5 19.8 9.2 11.9 19.1 30.5 5.2 18.2 13.6 13.1 9.3 6.9 13.9 4.2 9.7 0.8 12.8 14.0 13.2 33.3 18.6 0.3 1.6 10.8 2.3 1.5 2.2 1.0 6.2 6.7 0.1 0.2 4.8 4.9 7.4 4.1 5.4 2.1 2.0 7.3 16.5 0.3 12.6 3.7 4.5 23.8 2.2 17.2 1.2 1.3 2.5 1.6 10.9 2.9 3.3 0.3 6.1 4.3 15.9 3.1 3.3 5.0 2.4 0.1 0.0 0.6 2.5 21.0 0.2 3.0 1.5 17.0 5.4 7.7 0.2 1.1 7.0 36.0 1.4 2.2 9.5 14.1 4.4 2.6 19.8 5.2 3.9 1.7 3.7 4.8 1.1 0.7 0.3 0.2 4.9 2.7 1.6 10.8 1.4 10.5 2.2 2.3 1.7 0.3 2.1 1.8 1.6 0.2 0.8 0.9 4.5 1.5 1.1 1.1 1.8 1.0 5.6 9.7 17.8 9.4 6.0 6.1 13.6 5.4 8.5 9.7 3.0 5.4 0.0 20.7 6.3 1.1 3.4 15.3 8.1 10.3 15.7 0.0 12.6 3.3 16.4 0.0 3.9 17.2 0.0 19.0 20.2 6.2 13.1 3.5 4.3 6.8 1.6 3.5 4.3 8.6 0.0 12.0 2.9 8.5 12.6 14.7 4.6 16.4 17.5 11.3 6.3 0.4 0.0 8.3 0.3 0.0 9.2 13.2 4.3 18.5 22.9 ST8SIA5 SIAT8E ENSG00000101638 "ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5" O15466 18 46667821-46759257 "Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 12.8;brain: 36.4" "Cell type enhanced" "Detected in some" 16 "Cardiomyocytes: 6.9;Collecting duct cells: 1.8;Early spermatids: 2.7;Late spermatids: 5.2" "Cancer enriched" "Detected in single" 8 "glioma: 2.6" "Region enhanced" "Detected in many" "cerebellum: 36.4" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 8 "WM-115: 52.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043813, HPA046771" Approved Approved "Plasma membrane,Midbody" NA NA "Plasma membrane, Midbody" "HPA043813: AB_2678683, HPA046771: AB_2679798" "unprognostic (3.19e-2)" "unprognostic (1.16e-1)" "unprognostic (2.47e-2)" "unprognostic (1.33e-4)" "unprognostic (2.99e-2)" "unprognostic (4.83e-2)" "unprognostic (1.90e-2)" "unprognostic (1.39e-2)" "unprognostic (1.35e-1)" "unprognostic (1.36e-1)" "unprognostic (1.57e-2)" "unprognostic (1.84e-2)" "unprognostic (6.55e-2)" "unprognostic (8.85e-2)" "unprognostic (1.18e-1)" "unprognostic (1.12e-1)" "unprognostic (1.79e-2)" 0.6 12.8 3.6 0.6 7.8 0.9 0.5 36.4 16.1 0.5 0.5 1.0 0.0 0.7 0.5 0.9 0.4 0.7 0.6 7.2 4.0 1.8 1.5 0.4 0.5 0.5 2.0 6.9 0.7 0.4 4.9 0.7 0.4 4.1 0.6 0.5 0.0 0.4 0.5 8.2 0.7 0.5 0.5 2.5 0.5 0.7 0.9 0.7 0.0 0.6 0.0 0.5 0.5 0.1 0.8 0.4 1.5 0.4 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 3.6 3.1 0.1 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 52.9 1.0 0.4 0.2 0.2 0.2 0.2 0.4 0.2 0.2 0.0 0.8 0.3 0.3 1.5 0.5 0.2 0.4 0.1 0.0 3.6 7.8 36.4 16.1 4.0 1.8 2.0 6.9 4.1 0.7 0.0 0.0 0.0 0.0 0.0 1.0 6.9 0.0 0.0 0.0 1.8 0.0 0.0 1.7 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.4 0.0 0.7 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 STAB1 "CLEVER-1, FEEL-1, FELE-1, FEX1, KIAA0246, SCARH2, STAB-1" ENSG00000010327 "Stabilin 1" Q9NY15 3 52495338-52524495 "Predicted membrane proteins" "Inflammatory response" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 90.8" "Cell type enriched" "Detected in many" 5 "Ito cells: 1114.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 68 "classical monocyte: 10.8;intermediate monocyte: 6.6;myeloid DC: 2.8" "Group enriched" "Detected in many" 69 "dendritic cells: 2.8;monocytes: 10.8" "Group enriched" "Detected in some" 47 "HUVEC TERT2: 33.9;NB-4: 46.8;TIME: 41.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA005434 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 60000000 Cytosol "Nucleoplasm, Plasma membrane" "HPA005434: AB_1080097" "unprognostic (1.18e-1)" "unprognostic (2.89e-1)" "prognostic unfavorable (7.59e-4)" "unprognostic (3.63e-2)" "unprognostic (1.21e-1)" "unprognostic (1.49e-2)" "unprognostic (1.08e-2)" "unprognostic (2.23e-1)" "unprognostic (2.38e-1)" "unprognostic (4.00e-3)" "unprognostic (2.66e-2)" "unprognostic (3.19e-1)" "prognostic unfavorable (3.88e-7)" "unprognostic (3.16e-2)" "unprognostic (9.40e-2)" "unprognostic (4.70e-2)" "unprognostic (1.08e-1)" 39.5 37.6 8.0 26.7 12.8 6.5 41.3 3.2 6.8 13.1 23.4 6.9 4.2 16.1 13.6 26.4 9.7 15.5 16.8 19.7 5.4 4.2 19.2 35.8 21.7 80.7 9.1 2.7 9.9 7.1 4.9 11.9 32.1 10.2 13.5 18.0 23.7 10.4 9.7 8.0 5.1 18.7 18.3 7.2 90.8 11.6 9.7 8.7 2.6 11.9 11.4 11.1 15.9 15.4 0.0 2.8 0.0 10.8 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 33.9 0.0 0.1 0.0 0.0 0.0 0.0 46.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 41.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 6.6 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 8.0 12.8 3.2 6.8 5.4 4.2 9.1 2.7 10.2 8.7 0.0 6.7 12.3 0.5 5.4 1.0 2.0 12.7 0.0 0.0 3.5 0.0 1.3 0.0 0.0 0.4 14.5 0.0 46.7 0.0 1.5 3.8 0.0 17.4 8.3 103.3 0.0 1.2 1114.7 238.9 1.9 4.0 46.3 11.8 0.0 0.0 0.5 0.0 0.0 19.1 0.3 0.0 19.4 1.5 0.7 1.1 4.3 1.8 4.3 0.0 0.2 STAC2 24b2 ENSG00000141750 "SH3 and cysteine rich domain 2" Q6ZMT1 17 39210536-39225872 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 94.0;seminal vesicle: 101.5" "Cell type enriched" "Detected in many" 11 "Muller glia cells: 446.6" "Group enriched" "Detected in many" 7 "breast cancer: 15.0;endometrial cancer: 3.2;glioma: 10.4;ovarian cancer: 4.2;renal cancer: 10.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 8.3;HeLa: 25.8;hTEC/SVTERT24-B: 3.8;U-87 MG: 11.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA076925 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA076925: " "unprognostic (1.70e-3)" "unprognostic (1.05e-1)" "unprognostic (3.09e-2)" "prognostic unfavorable (4.05e-5)" "prognostic unfavorable (5.61e-4)" "unprognostic (1.42e-1)" "unprognostic (8.66e-2)" "unprognostic (2.94e-2)" "unprognostic (1.17e-2)" "prognostic unfavorable (6.66e-4)" "unprognostic (1.12e-2)" "unprognostic (5.16e-2)" "unprognostic (2.35e-3)" "unprognostic (2.05e-2)" "unprognostic (1.94e-1)" "unprognostic (3.54e-2)" "unprognostic (3.17e-1)" 2.4 0.9 4.2 1.0 7.4 0.7 29.7 9.5 21.9 4.0 0.9 0.0 94.0 0.9 2.5 13.9 0.8 1.4 0.8 1.0 6.8 3.2 4.8 0.7 0.9 0.8 3.5 6.6 1.2 1.1 0.7 0.5 1.0 13.1 1.8 0.9 8.2 7.8 101.5 0.8 20.1 0.8 1.7 1.4 0.8 0.8 0.9 0.2 0.0 0.7 0.0 0.8 0.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 8.3 0.0 3.3 0.0 0.0 0.0 0.4 0.0 25.8 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.0 0.2 2.7 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 11.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 7.4 9.5 21.7 6.8 3.2 3.5 6.6 13.1 0.2 3.0 8.0 0.0 1.2 0.3 4.8 2.9 0.0 2.7 4.5 3.5 9.8 0.1 5.0 0.0 0.1 0.4 0.0 0.0 0.0 0.2 0.6 0.3 0.0 0.0 0.1 17.5 0.0 0.0 0.0 0.0 2.6 0.0 40.5 0.0 0.0 446.6 0.0 0.0 0.0 0.0 11.1 0.0 3.4 0.2 0.9 1.5 0.2 0.0 0.0 0.1 STAMBPL1 "ALMalpha, AMSH-FP, AMSH-LP, bA399O19.2, FLJ31524, KIAA1373" ENSG00000138134 "STAM binding protein like 1" Q96FJ0 10 88879734-88975153 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 18.6" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 37.8;Spermatocytes: 27.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040202 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA040202: AB_10805708" "unprognostic (2.73e-1)" "unprognostic (1.95e-1)" "unprognostic (7.56e-2)" "unprognostic (4.25e-2)" "unprognostic (6.46e-2)" "unprognostic (6.27e-2)" "unprognostic (1.68e-2)" "unprognostic (1.05e-2)" "unprognostic (4.67e-2)" "unprognostic (8.20e-2)" "unprognostic (2.78e-1)" "unprognostic (6.57e-2)" "prognostic unfavorable (1.08e-5)" "unprognostic (4.41e-2)" "unprognostic (4.06e-2)" "unprognostic (1.50e-1)" "unprognostic (4.40e-3)" 3.9 15.9 3.7 6.8 5.1 2.8 2.1 12.4 8.9 2.0 5.8 3.4 1.5 4.5 2.7 1.5 2.7 1.2 2.9 4.8 3.3 3.4 1.5 1.7 2.9 11.3 2.6 14.8 8.5 1.8 2.2 6.6 1.5 4.1 1.9 8.0 1.5 1.5 1.5 1.5 3.4 6.1 1.8 3.1 6.0 3.1 18.6 3.2 1.5 1.5 1.5 9.5 3.9 2.7 10.5 15.2 4.3 0.6 13.1 14.7 4.5 6.8 8.1 0.5 0.3 8.1 15.6 0.0 14.4 14.2 9.3 8.3 0.3 13.1 8.4 1.0 7.8 6.2 3.4 2.0 2.9 9.4 7.4 5.1 2.1 5.8 0.4 5.5 9.2 3.0 5.5 0.7 15.5 4.9 10.6 0.2 10.1 0.0 3.8 24.9 1.4 15.3 10.9 3.0 6.5 6.3 1.5 6.1 1.8 3.5 2.6 4.7 5.6 1.8 0.6 16.4 2.0 1.0 1.9 2.1 8.3 6.0 9.9 9.0 8.9 8.4 7.8 9.1 9.4 7.8 4.3 0.6 4.2 6.3 0.6 8.2 10.5 9.2 7.9 0.9 7.0 9.9 5.9 0.9 13.1 0.3 15.2 14.7 4.5 3.7 5.1 12.4 8.9 3.3 3.4 2.6 14.8 4.1 3.2 0.0 5.0 9.3 4.1 8.5 3.7 5.0 0.0 8.1 0.0 5.2 0.0 0.1 0.0 0.8 37.8 2.2 7.4 0.0 1.6 0.1 5.1 1.5 4.7 1.9 3.0 6.4 8.7 1.8 1.0 13.9 6.6 3.5 0.0 1.0 8.1 10.6 1.2 0.0 1.4 0.5 0.2 0.0 6.7 27.6 2.4 9.9 0.1 14.9 13.3 1.6 STARD4 ENSG00000164211 "StAR related lipid transfer domain containing 4" Q96DR4 5 111496033-111512590 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046177, HPA048081" Approved Approved "Plasma membrane" NA Yes "Plasma membrane" "HPA046177: AB_2679570, HPA048081: AB_2680253" "unprognostic (1.13e-1)" "unprognostic (7.07e-3)" "unprognostic (1.53e-2)" "unprognostic (1.64e-1)" "unprognostic (1.01e-1)" "unprognostic (1.21e-2)" "prognostic unfavorable (4.80e-5)" "unprognostic (1.31e-1)" "unprognostic (1.11e-1)" "unprognostic (4.26e-1)" "unprognostic (6.27e-2)" "unprognostic (1.39e-1)" "prognostic unfavorable (5.89e-5)" "unprognostic (2.00e-1)" "unprognostic (3.82e-3)" "unprognostic (4.01e-3)" "prognostic unfavorable (2.84e-4)" 5.2 12.4 9.7 11.2 27.3 12.6 3.2 20.7 17.5 8.5 11.0 6.8 5.5 30.0 6.4 12.9 8.4 4.6 7.6 11.0 12.5 12.5 8.2 25.3 22.0 8.8 10.5 7.3 6.6 4.7 17.2 10.8 27.8 25.5 16.5 13.1 7.1 5.9 8.0 1.6 2.6 29.9 5.4 17.0 8.8 13.2 5.1 16.3 5.1 7.7 5.7 7.4 5.2 8.8 2.8 2.8 11.0 3.1 2.9 4.2 2.1 6.8 3.4 16.7 10.0 15.0 30.1 5.7 7.0 16.0 10.6 31.6 12.6 20.5 8.2 2.9 4.5 31.0 3.0 8.4 24.4 10.1 7.8 3.6 6.3 10.9 7.6 16.7 3.1 4.0 16.0 16.8 22.4 16.7 12.4 19.4 8.0 3.5 15.9 7.1 1.3 7.7 5.7 5.7 0.2 1.8 1.8 18.6 7.5 15.4 2.2 9.5 37.1 0.0 4.2 6.3 11.6 5.5 10.1 28.7 8.9 8.1 5.9 2.9 5.5 5.0 7.3 8.5 11.8 4.5 11.0 2.1 1.5 4.2 3.1 2.2 2.8 2.0 3.0 2.8 2.7 2.1 3.1 0.0 2.9 2.2 1.9 1.2 2.1 9.7 27.3 20.7 17.5 12.5 12.5 10.5 7.3 25.5 16.3 23.8 33.3 11.0 1.2 0.9 9.5 17.7 12.7 1.4 4.5 8.7 7.9 13.3 1.7 6.8 6.1 14.6 33.7 0.0 8.1 5.1 5.1 3.1 31.2 16.4 16.3 6.4 20.5 4.9 18.3 7.0 6.6 18.3 3.3 6.4 21.7 6.0 7.4 17.5 7.4 5.3 7.3 19.4 8.7 7.7 9.7 2.3 11.8 8.6 15.5 2.8 STIL "MCPH7, SIL" ENSG00000123473 "STIL, centriolar assembly protein" Q15468 1 47250139-47314147 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Developmental protein" "Cancer-related genes, Disease mutation, Mental retardation, Primary microcephaly, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 36.0;testis: 23.8" "Cell type enhanced" "Detected in many" 9 "Spermatocytes: 18.6;Spermatogonia: 17.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA046543 Approved "Plasma membrane,Cytosol" NA Yes "Plasma membrane, Cytosol" "HPA046543: AB_2679692" "unprognostic (2.07e-1)" "unprognostic (6.29e-2)" "unprognostic (5.54e-3)" "unprognostic (2.67e-3)" "unprognostic (1.76e-1)" "unprognostic (1.56e-2)" "unprognostic (2.90e-5)" "unprognostic (7.35e-3)" "unprognostic (4.04e-3)" "unprognostic (1.41e-1)" "prognostic unfavorable (1.33e-4)" "unprognostic (5.81e-2)" "unprognostic (3.36e-14)" "unprognostic (5.76e-3)" "unprognostic (2.58e-1)" "unprognostic (1.64e-1)" "unprognostic (2.28e-1)" 1.2 1.4 1.3 10.8 2.4 11.0 2.9 1.4 2.2 1.2 4.1 0.9 2.5 3.6 1.5 2.2 5.8 0.9 1.7 2.0 1.4 1.2 1.5 1.6 1.7 5.0 1.3 1.5 1.2 1.5 0.9 0.9 5.5 1.1 1.7 6.4 0.8 3.6 0.5 0.8 4.2 4.0 1.3 1.2 3.4 2.2 23.8 1.0 36.0 1.1 3.5 7.1 1.3 2.1 1.9 1.6 5.4 0.7 3.3 1.2 0.5 16.9 9.1 13.1 11.7 0.9 2.3 8.4 15.0 7.2 16.8 17.7 9.8 8.4 20.0 7.1 7.5 17.3 11.3 15.3 7.9 18.1 14.9 6.9 22.5 11.3 8.6 0.5 18.2 11.5 0.8 1.3 14.4 9.4 2.1 11.1 15.3 15.9 19.1 12.6 7.7 17.6 5.7 15.9 9.4 7.5 11.5 21.4 9.6 4.7 10.2 11.7 7.0 16.1 11.9 7.8 16.3 7.7 10.4 6.5 15.9 16.1 11.4 20.3 6.3 13.1 19.7 7.4 13.9 14.7 4.3 0.7 1.1 1.1 0.4 0.5 1.7 1.2 1.0 0.5 1.9 0.8 0.8 5.4 3.3 0.3 1.6 1.1 0.5 1.3 2.4 1.4 2.2 1.4 1.2 1.3 1.5 1.1 1.0 3.0 0.3 2.2 0.5 0.8 1.2 0.5 0.0 6.7 2.3 0.0 3.9 1.2 0.0 1.2 0.7 0.9 1.8 0.0 0.4 3.8 0.8 1.2 2.3 0.5 2.3 0.0 1.7 1.8 1.9 1.3 0.3 1.2 0.0 4.6 4.3 0.8 1.8 1.5 0.7 0.3 0.7 0.0 0.0 18.6 17.8 2.0 0.7 0.8 3.4 1.4 STIP1 "HOP, STI1" ENSG00000168439 "Stress induced phosphoprotein 1" P31948 11 64185272-64204543 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 168.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017448, HPA039291, HPA044062" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 3700000 "Nucleoplasm, Plasma membrane" Cytosol "CAB017448: AB_10618972, HPA039291: AB_2676428, HPA044062: AB_2678795" "unprognostic (2.49e-3)" "unprognostic (6.04e-2)" "unprognostic (1.57e-1)" "unprognostic (4.65e-2)" "unprognostic (1.03e-1)" "prognostic unfavorable (1.23e-4)" "prognostic unfavorable (6.18e-8)" "unprognostic (2.16e-3)" "unprognostic (4.56e-2)" "unprognostic (1.12e-2)" "unprognostic (3.56e-2)" "unprognostic (3.04e-3)" "unprognostic (1.70e-1)" "unprognostic (6.72e-2)" "unprognostic (8.23e-2)" "unprognostic (7.16e-2)" "unprognostic (2.99e-2)" 27.3 49.7 32.2 32.0 40.5 25.8 41.5 45.3 41.9 28.3 25.5 29.2 20.6 19.2 30.1 25.2 31.5 36.2 21.6 34.4 32.2 42.8 24.7 27.8 25.4 31.9 47.7 22.5 34.1 24.1 39.1 38.3 37.0 40.7 30.1 28.5 20.3 22.6 29.5 51.9 27.6 20.7 33.2 39.7 26.5 24.4 56.4 49.0 29.8 46.1 23.4 41.2 26.0 168.2 32.2 26.8 20.9 39.6 39.5 35.9 39.5 49.3 77.1 48.7 40.5 27.1 18.1 43.8 44.9 24.2 65.2 38.0 56.4 42.4 59.1 52.9 35.5 77.2 52.5 122.1 44.9 71.8 46.4 49.8 83.2 51.8 51.9 23.6 43.9 52.6 18.4 28.3 54.0 40.7 26.6 45.9 44.1 82.2 34.0 37.4 72.3 66.0 59.9 58.6 47.6 65.2 65.0 46.4 59.8 45.5 43.8 39.7 35.3 51.2 54.2 41.7 53.4 57.6 30.4 41.1 41.5 51.3 54.1 60.4 31.0 66.9 62.4 53.7 44.2 59.6 19.0 25.3 20.9 35.9 36.2 35.7 32.2 27.2 32.0 26.8 26.0 30.5 33.8 7.7 39.5 39.6 22.2 24.0 39.5 32.2 40.5 45.3 41.9 32.2 42.8 47.7 22.5 40.7 49.0 41.7 29.9 44.0 125.4 71.4 35.5 38.9 30.6 104.4 56.9 19.2 39.3 105.5 41.4 70.8 21.1 33.5 27.4 23.3 47.8 125.3 57.5 60.1 78.4 24.1 80.9 60.4 64.5 15.4 15.0 52.9 25.3 54.0 59.1 71.3 20.5 32.1 57.8 21.6 37.4 29.8 29.8 25.8 88.2 82.3 133.5 63.0 176.4 42.1 24.4 89.5 STK10 "LOK, PRO2729" ENSG00000072786 "Serine/threonine kinase 10" O94804 5 172042073-172188386 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 40.9" "Cell type enhanced" "Detected in many" 7 "Kupffer cells: 78.5;T-cells: 70.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 27.5" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "WM-115: 52.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015083, CAB020840" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA 24000 "Nucleoplasm, Plasma membrane" "CAB020840: , HPA015083: AB_2669151" "unprognostic (1.17e-1)" "unprognostic (5.43e-2)" "prognostic favorable (2.76e-4)" "unprognostic (2.88e-1)" "unprognostic (6.96e-3)" "unprognostic (1.02e-1)" "unprognostic (5.25e-3)" "unprognostic (3.07e-2)" "unprognostic (1.07e-1)" "unprognostic (1.03e-1)" "unprognostic (2.65e-1)" "unprognostic (3.43e-1)" "prognostic unfavorable (1.63e-4)" "unprognostic (1.09e-1)" "unprognostic (1.01e-2)" "unprognostic (3.10e-1)" "unprognostic (1.84e-1)" 15.0 4.7 2.6 25.8 4.4 38.3 13.5 27.5 3.0 3.6 5.0 4.8 3.4 4.7 4.4 4.4 3.6 4.2 11.0 9.0 2.4 2.5 5.3 4.5 15.4 40.9 5.4 1.9 3.5 4.1 2.5 3.7 16.2 4.5 4.3 4.0 5.6 7.8 2.5 3.1 9.0 12.2 5.7 4.6 33.0 6.2 13.1 3.5 20.6 4.6 3.1 23.7 9.5 11.3 5.0 10.3 22.3 30.8 7.4 18.0 15.6 7.8 7.3 4.5 6.8 5.3 6.6 11.6 10.2 8.5 7.4 6.9 3.8 10.4 9.5 5.4 12.6 15.7 9.2 2.0 12.5 4.8 12.3 3.4 11.4 3.0 2.1 7.6 11.5 13.5 6.5 2.7 10.1 8.4 2.7 6.4 3.7 1.0 13.3 5.2 12.6 8.2 25.8 1.8 3.9 5.8 13.6 3.6 6.2 3.0 9.9 3.1 3.8 5.9 8.3 28.0 5.9 2.9 24.4 8.9 8.3 4.2 5.8 5.5 11.2 16.5 6.0 10.9 17.7 52.3 7.1 10.8 10.0 18.0 21.4 13.3 5.0 9.4 12.8 10.3 4.4 5.6 9.6 22.3 7.4 30.8 3.2 12.2 15.6 2.6 4.4 27.5 3.0 2.4 2.5 5.4 1.9 4.5 3.5 3.0 12.8 25.0 7.9 6.0 3.8 3.6 2.5 5.3 5.7 1.8 5.9 2.8 1.7 4.4 1.7 17.8 8.4 0.0 5.3 25.1 7.4 6.7 26.7 2.1 30.8 44.5 11.5 20.3 78.5 2.7 2.6 39.2 8.5 9.0 15.0 3.1 7.9 7.0 1.4 1.5 2.2 12.9 8.2 5.7 6.8 3.6 4.2 70.5 4.7 9.5 STK17A DRAK1 ENSG00000164543 "Serine/threonine kinase 17a" Q9UEE5 7 43582758-43626786 "Enzymes, Plasma proteins, Predicted membrane proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 43.3" "Cell type enhanced" "Detected in many" 10 "Basal glandular cells: 549.3;Urothelial cells: 279.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "HPA018138, HPA037979" Uncertain Supported "Nuclear speckles,Plasma membrane" Yes No "Nuclear speckles" "Plasma membrane" "HPA018138: AB_2669784, HPA037979: AB_10795247" "unprognostic (1.81e-3)" "unprognostic (1.08e-2)" "unprognostic (2.67e-1)" "unprognostic (5.41e-2)" "unprognostic (5.11e-2)" "unprognostic (3.35e-2)" "unprognostic (1.03e-2)" "unprognostic (9.15e-3)" "unprognostic (2.07e-1)" "unprognostic (6.34e-2)" "unprognostic (1.36e-2)" "unprognostic (6.61e-2)" "unprognostic (2.99e-3)" "unprognostic (3.76e-2)" "unprognostic (3.08e-1)" "unprognostic (1.97e-3)" "unprognostic (3.66e-1)" 7.1 10.1 6.1 43.3 8.2 20.2 8.4 7.9 7.2 4.8 9.3 3.7 2.0 6.1 5.3 4.2 10.1 4.7 8.6 17.7 5.7 5.6 6.7 8.1 15.2 36.6 6.6 2.6 7.3 14.3 1.5 6.3 37.2 5.7 6.2 5.3 3.6 8.6 3.4 10.7 4.8 12.3 5.8 5.3 27.8 11.0 9.0 2.8 30.1 7.3 6.8 37.7 10.3 8.1 10.8 1.4 11.5 0.9 12.7 11.4 2.9 4.4 5.5 5.0 3.4 6.3 8.3 2.1 15.9 17.3 8.7 8.9 4.8 3.2 7.1 25.1 13.3 17.8 9.1 3.8 21.2 12.2 17.5 4.3 6.3 4.1 5.9 4.7 10.8 4.2 6.8 25.0 11.5 10.6 34.5 16.3 7.7 7.4 24.4 10.0 2.0 17.6 5.0 7.7 2.6 18.1 6.1 3.2 14.0 15.2 3.3 2.7 6.1 7.2 3.3 4.6 10.7 3.8 5.5 16.3 19.0 7.2 11.2 17.8 14.8 7.3 10.2 19.3 9.6 30.2 0.7 0.4 11.5 5.8 0.2 5.8 10.8 6.1 9.7 0.3 10.1 11.4 10.2 6.4 12.7 0.9 1.4 3.2 2.9 6.1 8.2 7.9 5.9 5.7 5.6 6.6 2.6 5.7 2.8 113.2 27.8 121.1 549.3 161.6 3.0 25.4 5.1 52.2 81.9 19.2 9.8 44.4 28.2 110.3 36.3 19.4 29.1 0.0 82.8 19.7 31.9 134.1 39.1 7.7 15.8 0.0 6.9 16.5 16.2 8.8 5.5 19.9 33.7 55.1 27.8 8.1 75.9 56.1 2.5 9.7 25.2 6.5 55.6 45.1 29.6 118.9 55.8 186.8 10.0 279.4 STX18 Ufe1 ENSG00000168818 "Syntaxin 18" Q9P2W9 4 4415742-4542346 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "cervix, uterine: 98.6" "Low cell type specificity" "Detected in many" "Cancer enhanced" "Detected in all" "endometrial cancer: 43.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003019 Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA003019: AB_1857622" "unprognostic (2.33e-1)" "unprognostic (1.65e-1)" "prognostic favorable (2.84e-4)" "prognostic favorable (6.33e-8)" "unprognostic (4.21e-1)" "unprognostic (6.77e-2)" "unprognostic (6.17e-3)" "unprognostic (2.95e-2)" "unprognostic (7.53e-2)" "unprognostic (3.22e-3)" "unprognostic (1.21e-1)" "unprognostic (1.07e-2)" "prognostic favorable (7.03e-4)" "unprognostic (1.92e-2)" "unprognostic (1.55e-1)" "unprognostic (7.44e-2)" "prognostic favorable (4.69e-4)" 14.0 17.6 12.4 16.0 18.4 9.2 11.0 11.2 15.9 98.6 19.7 19.5 12.2 15.0 46.5 11.9 11.5 38.9 16.1 11.0 11.3 14.2 24.2 14.0 9.8 10.4 14.5 12.3 12.4 18.5 12.2 24.1 17.5 17.3 12.3 11.9 12.7 12.2 14.7 19.0 11.0 19.6 13.5 14.8 14.2 15.0 28.5 10.3 18.1 10.1 9.8 15.0 11.8 12.3 11.2 25.5 7.1 13.0 10.8 13.4 9.3 14.3 9.3 11.1 11.3 9.6 14.0 14.9 16.5 15.2 15.8 13.2 19.6 20.9 19.1 39.8 15.3 14.4 7.8 19.6 9.7 15.6 8.0 9.8 12.0 12.3 23.7 14.3 20.8 10.1 13.1 8.5 13.4 9.8 8.9 13.3 15.4 11.5 17.0 11.2 7.6 18.8 14.8 14.7 11.9 19.4 17.0 8.3 15.2 16.3 8.7 14.1 12.5 12.4 8.3 14.4 10.0 12.2 10.1 15.1 9.6 10.5 8.7 17.7 12.2 18.5 22.0 11.7 16.0 11.9 4.8 10.6 7.1 10.9 10.4 13.4 11.2 10.1 9.9 16.0 9.3 8.5 9.8 2.1 10.8 13.0 25.5 9.1 9.3 12.4 18.4 11.2 15.9 11.3 14.2 14.5 12.3 17.3 10.3 29.8 7.0 10.4 7.5 7.0 20.2 18.3 10.2 34.8 25.0 19.2 19.6 25.1 59.7 27.4 58.7 11.9 28.7 0.0 24.4 16.2 18.5 12.5 8.1 8.3 24.9 9.5 4.7 6.7 14.5 62.0 13.0 16.9 13.5 30.7 19.0 22.5 28.8 24.6 13.8 18.3 16.1 6.5 11.3 58.5 33.4 8.4 26.5 10.7 17.5 10.5 STXBP4 "MGC50337, Synip" ENSG00000166263 "Syntaxin binding protein 4" Q6ZWJ1 17 54968727-55173632 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 36.3" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 39.3;Sertoli cells: 32.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007760, HPA022138, HPA022888, HPA024227" Approved Approved "Plasma membrane,Cytosol" No No "Plasma membrane" Cytosol "CAB007760: AB_562350, HPA022138: AB_1857628, HPA022888: AB_1857629, HPA024227: AB_1857630" "unprognostic (5.89e-2)" "unprognostic (2.50e-2)" "unprognostic (1.30e-3)" "unprognostic (9.27e-2)" "unprognostic (1.03e-3)" "unprognostic (1.48e-1)" "unprognostic (5.00e-5)" "unprognostic (4.11e-2)" "unprognostic (1.53e-1)" "unprognostic (1.28e-2)" "unprognostic (3.45e-2)" "unprognostic (2.11e-1)" "unprognostic (1.60e-2)" "unprognostic (2.98e-2)" "unprognostic (1.65e-1)" "unprognostic (1.31e-1)" "unprognostic (1.44e-1)" 7.7 6.4 5.5 4.3 6.0 3.4 5.2 10.6 4.7 9.9 6.4 4.2 7.5 6.3 12.0 7.2 5.1 7.3 6.6 5.9 6.7 4.7 14.5 3.8 8.0 3.2 4.2 4.5 9.9 5.4 19.3 36.3 4.7 6.8 9.5 4.6 7.6 4.5 9.4 4.0 3.7 5.1 13.2 8.6 5.0 5.5 5.6 5.1 7.2 7.9 2.7 3.5 9.6 8.2 3.2 2.9 4.0 1.2 5.1 2.9 0.7 5.5 8.3 7.7 6.8 6.5 6.4 3.1 4.3 4.2 5.7 5.6 4.9 3.0 3.8 9.3 4.3 5.0 3.3 9.8 4.3 10.5 5.7 5.6 4.9 5.7 10.0 2.7 3.1 1.5 7.3 1.3 8.1 2.0 2.6 5.6 3.3 7.9 3.0 6.7 2.5 10.2 2.0 5.5 4.7 6.0 4.3 8.9 2.3 10.0 3.4 7.4 5.6 6.7 1.1 3.6 4.3 9.7 2.1 4.3 8.0 6.3 4.9 4.5 2.7 2.5 6.5 5.2 4.1 4.7 4.0 1.1 0.1 2.6 0.8 2.9 2.1 2.3 1.7 1.4 3.2 2.1 2.7 0.3 5.1 1.2 2.9 2.1 0.7 5.5 6.0 10.6 4.7 6.7 4.7 4.2 4.5 6.8 5.1 0.0 7.8 0.8 2.2 0.8 5.5 8.1 5.1 22.7 6.8 8.7 39.3 1.3 8.3 5.7 5.2 2.1 2.6 0.0 2.3 1.7 2.8 2.6 7.0 4.0 1.9 7.9 5.8 6.2 2.5 4.6 16.4 2.6 6.8 1.8 1.6 6.6 3.3 2.3 11.0 6.3 19.0 32.3 3.9 8.6 5.8 2.6 0.2 2.9 3.0 1.0 STYK1 "DKFZp761P1010, NOK, SuRTK106" ENSG00000060140 "Serine/threonine/tyrosine kinase 1" Q6J9G0 12 10618939-10674318 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Transferase, Tyrosine-protein kinase" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 15.8;stomach 1: 16.0" "Cell type enhanced" "Detected in some" 8 "Ciliated cells: 8.1;Enterocytes: 12.5;Mucus-secreting cells: 8.3;Paneth cells: 9.5;Undifferentiated cells: 6.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 7 "NK-cell: 12.5" "Lineage enriched" "Detected in many" 7 "NK-cells: 12.5" "Cell line enhanced" "Detected in many" "CAPAN-2: 18.5;HDLM-2: 10.9;HMC-1: 12.1;HUVEC TERT2: 16.6;TIME: 15.4" "Region enhanced" "Detected in single" "basal ganglia: 2.3" "Not detected" "Not detected" "HPA040468, HPA048569" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA040468: AB_2676998, HPA048569: AB_2680446" "unprognostic (2.30e-1)" "unprognostic (2.22e-1)" "unprognostic (1.21e-1)" "unprognostic (1.75e-1)" "unprognostic (3.11e-2)" "unprognostic (3.35e-2)" "unprognostic (6.85e-2)" "unprognostic (5.08e-3)" "unprognostic (3.37e-1)" "unprognostic (3.50e-1)" "unprognostic (2.21e-3)" "unprognostic (1.02e-1)" "unprognostic (1.70e-14)" "unprognostic (5.18e-3)" "unprognostic (1.22e-1)" "unprognostic (2.33e-1)" "unprognostic (1.45e-2)" 0.6 0.3 2.6 2.3 10.6 1.0 3.8 0.1 13.4 2.2 14.4 0.7 0.5 2.1 0.5 1.1 8.9 1.9 6.2 0.1 1.8 1.6 0.5 0.3 1.2 2.4 1.8 4.2 0.4 0.3 0.0 8.4 3.4 2.1 10.6 15.8 0.0 7.8 2.6 0.2 2.6 10.3 0.6 0.6 1.0 16.0 0.3 0.7 0.0 0.4 0.6 2.8 4.3 3.6 0.0 0.0 0.4 0.0 12.5 1.9 0.2 3.0 0.1 0.0 0.4 0.0 0.0 0.9 4.9 0.5 2.3 2.2 1.6 18.5 0.2 3.1 1.2 2.9 0.8 1.0 5.1 4.9 10.9 0.3 0.7 1.3 0.1 0.0 1.4 12.1 0.2 0.3 3.4 0.2 0.4 16.6 0.1 0.2 0.2 5.3 1.7 0.1 0.8 2.7 7.5 1.3 0.0 1.4 0.2 1.6 9.5 0.6 0.0 2.8 2.9 0.0 4.5 2.3 0.3 15.4 0.6 2.6 0.3 0.6 0.0 0.6 0.1 2.1 0.1 3.6 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.3 0.4 12.5 0.0 0.0 0.0 0.2 2.6 10.6 0.1 13.4 1.8 1.6 1.8 4.2 2.1 0.7 0.0 2.1 0.0 0.6 0.2 0.4 0.4 2.5 8.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 12.5 0.0 0.2 0.5 0.0 5.9 1.1 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 3.6 9.5 0.0 0.0 0.3 0.0 0.1 0.0 0.9 0.9 0.2 0.7 6.8 4.8 SUCLG1 ENSG00000163541 "Succinate-CoA ligase alpha subunit" P53597 2 84423523-84460045 "Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Tricarboxylic acid cycle" Ligase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 125.6" "Cell type enhanced" "Detected in all" 10 "Distal tubular cells: 792.5;Proximal tubular cells: 1327.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036683, HPA036684" Enhanced Approved "Plasma membrane,Mitochondria,Cytosol" "Intracellular and membrane" NA NA 330000 Mitochondria "Plasma membrane, Cytosol" "HPA036683: AB_10671708, HPA036684: AB_2675248" "unprognostic (6.84e-3)" "unprognostic (7.16e-3)" "unprognostic (2.58e-3)" "prognostic unfavorable (5.23e-4)" "unprognostic (1.02e-1)" "unprognostic (2.11e-1)" "unprognostic (3.63e-2)" "unprognostic (3.49e-2)" "unprognostic (1.02e-1)" "unprognostic (2.00e-1)" "unprognostic (2.36e-2)" "unprognostic (9.24e-2)" "prognostic favorable (2.21e-8)" "unprognostic (4.94e-2)" "unprognostic (2.08e-1)" "unprognostic (2.81e-2)" "unprognostic (1.23e-1)" 26.1 23.3 18.0 15.0 18.9 10.6 23.8 18.9 19.5 14.1 50.1 17.7 23.2 53.9 13.9 19.6 25.0 13.5 14.0 57.7 17.4 17.3 125.6 44.1 12.8 13.3 19.2 17.0 12.7 33.9 36.2 16.3 13.8 17.3 17.1 39.4 16.9 39.3 24.9 57.6 15.6 71.6 26.5 17.1 12.1 21.9 13.3 16.0 16.9 28.8 42.8 15.2 24.3 16.3 26.6 43.5 31.6 40.3 35.2 39.1 46.8 20.8 23.0 18.2 22.1 34.2 23.1 31.5 23.8 20.4 30.7 22.5 52.6 17.3 28.8 16.5 28.5 24.7 30.5 37.4 28.1 36.5 27.7 34.0 25.0 19.8 29.9 29.0 25.4 20.4 27.4 23.0 25.9 35.3 18.8 27.3 23.6 25.3 23.7 27.9 31.9 36.0 23.2 9.5 78.5 41.2 22.9 42.2 31.5 41.2 25.4 22.1 12.3 19.0 39.5 37.9 17.8 24.1 20.0 22.1 24.1 23.4 29.5 29.2 20.8 29.5 24.8 28.2 35.3 21.2 31.6 34.4 28.7 31.4 40.3 34.6 26.6 29.2 35.1 43.5 20.2 32.4 34.2 18.5 35.2 40.0 23.7 39.1 46.8 18.0 18.9 18.9 19.5 17.4 17.3 19.2 17.0 17.3 16.0 59.6 67.8 89.4 89.8 31.5 32.1 379.6 132.5 91.0 108.1 134.3 21.6 202.1 792.5 102.4 24.5 56.3 282.3 23.3 99.5 100.2 83.9 68.7 90.0 177.6 116.1 42.9 102.0 59.5 64.6 28.6 50.6 82.9 113.1 78.5 140.8 56.0 65.8 217.5 69.6 1327.5 31.0 51.8 72.6 79.7 46.4 36.1 157.6 70.5 304.8 88.9 SUCLG2 ENSG00000172340 "Succinate-CoA ligase GDP-forming beta subunit" Q96I99 3 67360460-67654614 "Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins" "Tricarboxylic acid cycle" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 90.9" "Cell type enhanced" "Detected in all" 4 "Hepatocytes: 290.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046705, HPA051998" Enhanced Approved "Plasma membrane,Mitochondria" NA NA 290000 Mitochondria "Plasma membrane" "HPA046705: AB_2679762, HPA051998: AB_2681687" "unprognostic (1.69e-1)" "unprognostic (2.31e-1)" "prognostic favorable (1.08e-4)" "unprognostic (2.12e-1)" "unprognostic (3.10e-1)" "unprognostic (5.32e-2)" "unprognostic (1.87e-2)" "unprognostic (1.69e-1)" "unprognostic (3.88e-1)" "unprognostic (3.26e-2)" "unprognostic (4.61e-3)" "unprognostic (5.59e-2)" "prognostic favorable (2.79e-10)" "unprognostic (3.08e-2)" "unprognostic (2.79e-1)" "unprognostic (1.07e-1)" "unprognostic (1.38e-1)" 17.0 19.3 8.8 26.5 10.0 3.4 12.4 2.4 7.2 15.3 38.9 9.5 16.4 31.4 11.5 18.3 18.6 9.9 27.9 23.6 6.6 6.2 38.3 90.9 14.6 21.1 9.8 6.5 16.5 20.9 5.9 8.5 8.5 7.6 14.0 34.5 9.6 21.0 17.3 57.0 9.3 42.4 23.5 8.6 24.7 25.4 6.5 8.1 9.6 16.4 27.0 16.7 19.9 13.2 19.2 10.2 5.8 18.2 27.1 31.1 18.9 12.8 11.2 11.1 13.5 18.7 32.4 13.5 15.4 22.5 18.1 20.3 12.3 28.7 16.4 5.0 21.6 11.9 6.6 8.6 21.2 23.5 6.9 5.9 14.8 10.1 19.2 24.1 19.5 10.4 24.2 18.5 14.2 32.6 22.5 19.2 12.6 11.3 15.0 39.4 9.0 7.3 6.2 10.4 58.8 6.9 5.1 17.2 24.5 30.7 19.9 2.2 7.5 24.4 28.2 20.3 7.8 21.7 12.5 16.7 18.0 11.9 19.7 18.2 10.3 15.0 11.5 26.5 15.3 21.1 5.8 15.3 5.2 13.8 18.2 16.7 19.2 20.0 17.4 10.2 16.7 31.1 23.7 0.7 27.1 14.8 4.0 18.5 18.9 8.8 10.0 2.4 7.2 6.6 6.2 9.8 6.5 7.6 8.1 32.8 40.3 57.4 34.0 33.0 2.6 146.2 84.1 61.6 42.1 76.8 7.9 46.8 207.2 71.1 2.4 35.8 224.3 46.7 70.7 37.8 47.4 43.6 29.0 290.2 50.0 4.8 55.9 44.8 60.1 4.1 38.3 46.7 40.5 32.5 187.4 22.3 55.1 140.3 44.6 211.1 3.8 32.3 67.3 1.4 6.8 43.2 31.8 55.8 241.0 45.3 SUGT1 SGT1 ENSG00000165416 "SGT1 homolog, MIS12 kinetochore complex assembly cochaperone" Q9Y2Z0 13 52652709-52700909 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015942, HPA043949" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "CAB015942: , HPA043949: AB_2678745" "unprognostic (3.66e-2)" "unprognostic (3.98e-2)" "unprognostic (3.57e-1)" "unprognostic (1.22e-1)" "unprognostic (3.77e-2)" "prognostic unfavorable (8.69e-4)" "unprognostic (2.24e-1)" "unprognostic (2.96e-1)" "unprognostic (3.76e-1)" "unprognostic (1.96e-3)" "unprognostic (9.51e-2)" "unprognostic (1.12e-1)" "unprognostic (6.83e-2)" "unprognostic (2.82e-3)" "unprognostic (9.05e-2)" "unprognostic (2.93e-2)" "unprognostic (1.56e-1)" 22.7 29.9 40.0 23.1 44.8 26.2 27.9 39.7 42.7 17.9 24.0 23.0 14.9 25.8 19.4 20.6 27.1 19.2 18.9 33.8 34.0 28.8 30.8 34.3 19.8 23.5 35.9 28.9 20.8 28.6 14.0 39.8 24.4 36.0 18.1 26.5 14.2 22.5 16.8 26.1 23.1 24.8 21.4 31.1 21.3 23.1 31.2 43.5 15.2 21.6 19.5 27.4 21.8 48.3 17.5 23.4 29.0 19.1 17.5 25.3 13.6 14.4 15.8 23.4 17.7 23.2 19.0 22.5 31.8 21.1 19.9 16.0 34.4 36.4 31.8 9.0 19.7 29.0 25.0 28.9 18.3 29.4 26.2 12.0 29.5 20.7 26.0 16.9 22.9 22.2 13.2 16.7 20.6 15.7 25.7 33.4 20.5 27.5 10.5 30.4 10.2 21.3 42.1 27.4 57.1 15.2 24.5 13.6 13.7 34.6 16.3 7.8 9.9 16.4 13.5 14.9 28.0 13.9 21.9 23.9 16.7 19.5 19.1 27.1 8.3 11.7 28.3 10.0 18.4 24.0 29.0 16.8 26.8 14.9 19.1 14.6 17.5 19.4 20.0 18.6 16.3 14.9 16.5 2.3 17.5 18.2 23.4 25.3 13.6 40.0 44.8 39.7 42.7 34.0 28.8 35.9 28.9 36.0 43.5 35.7 29.0 35.8 53.8 35.3 49.1 109.5 25.5 52.2 44.3 48.8 23.6 57.7 66.3 74.9 142.6 65.3 46.8 70.0 78.0 119.0 50.9 41.8 35.8 37.6 84.7 47.7 32.7 35.6 39.5 64.1 54.4 48.2 45.5 144.3 43.5 84.8 75.8 48.9 56.3 76.3 51.1 25.8 66.5 100.6 92.8 37.8 62.2 49.8 45.0 44.3 SUPT6H "KIAA0162, SPT6H" ENSG00000109111 "SPT6 homolog, histone chaperone" Q7KZ85 17 28662091-28702684 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012416, HPA036382" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "CAB012416: , HPA036382: AB_2675094" "unprognostic (8.18e-2)" "unprognostic (2.27e-1)" "unprognostic (2.72e-1)" "unprognostic (1.75e-2)" "unprognostic (1.06e-1)" "unprognostic (8.23e-2)" "prognostic unfavorable (3.68e-5)" "unprognostic (1.02e-1)" "unprognostic (2.18e-2)" "unprognostic (9.97e-3)" "unprognostic (1.29e-2)" "unprognostic (1.17e-1)" "prognostic favorable (4.36e-5)" "unprognostic (4.75e-2)" "unprognostic (1.05e-1)" "unprognostic (4.17e-2)" "unprognostic (1.06e-2)" 27.6 30.0 30.0 24.1 32.8 56.3 25.6 31.9 35.7 28.0 30.1 28.5 23.2 19.9 38.6 28.4 24.4 24.1 25.0 23.8 25.7 22.0 24.1 32.6 26.3 26.0 25.7 32.8 33.1 28.8 40.7 34.5 31.9 24.3 26.9 21.8 33.2 28.2 29.2 50.1 38.6 28.7 40.0 29.8 33.1 28.5 23.4 29.0 27.2 27.6 18.4 29.4 30.7 27.1 5.7 8.2 14.4 6.1 5.4 5.6 3.4 18.0 37.8 19.0 21.7 23.2 15.6 14.7 24.8 26.6 29.3 26.3 35.1 8.1 19.2 13.0 24.8 22.6 21.6 27.8 18.0 30.5 35.7 24.7 26.8 30.6 21.7 19.4 28.1 30.0 21.4 10.9 31.1 20.8 19.4 19.2 18.9 26.3 22.8 20.8 21.5 27.7 12.0 14.7 15.9 12.3 14.2 35.0 15.6 14.5 35.8 14.5 19.2 29.1 46.0 15.7 27.3 28.2 20.0 30.2 23.2 19.2 22.0 31.6 29.0 22.2 28.2 26.2 12.7 19.1 14.4 5.9 5.4 5.2 3.9 5.5 5.6 4.3 5.6 4.8 5.7 4.4 3.8 9.0 5.4 6.1 8.2 3.8 3.4 30.0 32.8 31.9 35.7 25.7 22.0 25.7 32.8 24.3 29.0 35.7 51.4 21.7 18.1 19.9 27.9 43.2 22.9 33.5 36.4 19.2 53.0 21.0 5.0 19.2 3.9 24.0 22.2 23.3 18.3 17.3 18.8 16.3 47.6 30.2 20.6 28.6 29.7 19.0 21.5 14.4 23.9 20.4 8.5 27.9 19.2 20.5 25.9 16.7 25.1 9.4 40.8 32.3 22.2 18.4 16.2 21.2 41.6 20.8 17.7 21.8 SUSD2 "BK65A6.2, FLJ22778" ENSG00000099994 "Sushi domain containing 2" Q9UGT4 22 24181259-24189110 "Predicted membrane proteins" Receptor "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 100.1" "Group enriched" "Detected in many" 5 "Alveolar cells type 1: 232.3;Alveolar cells type 2: 121.0" "Cancer enhanced" "Detected in all" "testis cancer: 64.5" "Region enhanced" "Detected in many" "pons and medulla: 9.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 31 "SK-BR-3: 138.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA004117 Enhanced Approved "Plasma membrane" NA NA 3600000 "Plasma membrane" "HPA004117: AB_1857674" "unprognostic (5.24e-3)" "unprognostic (1.60e-1)" "unprognostic (1.74e-1)" "unprognostic (7.30e-2)" "unprognostic (1.27e-2)" "unprognostic (5.40e-2)" "unprognostic (5.20e-2)" "unprognostic (1.89e-2)" "unprognostic (5.87e-2)" "unprognostic (1.20e-2)" "unprognostic (9.74e-3)" "unprognostic (8.97e-2)" "prognostic unfavorable (3.29e-5)" "unprognostic (2.72e-2)" "unprognostic (2.82e-2)" "unprognostic (1.88e-2)" "unprognostic (3.33e-3)" 6.0 4.2 0.3 1.4 0.9 0.5 11.3 3.8 1.4 10.5 10.5 2.5 1.3 7.8 7.1 8.3 2.8 6.9 5.3 10.8 0.6 2.9 19.5 1.2 100.1 1.4 0.6 2.6 2.6 2.4 1.3 3.6 3.5 9.6 2.8 1.0 2.2 7.9 4.0 3.0 11.8 32.4 2.4 3.0 1.6 2.5 1.9 0.7 0.1 12.7 5.9 1.5 2.3 4.7 0.7 0.2 0.0 0.0 0.0 0.2 0.0 0.7 1.5 0.0 0.0 3.0 3.9 0.1 0.3 0.0 0.0 0.0 1.1 0.0 0.2 3.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 1.2 0.0 0.0 3.4 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.2 2.1 0.1 138.9 0.0 0.6 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 3.8 1.4 0.6 2.9 0.6 2.6 9.6 0.7 232.3 121.0 0.0 0.2 0.2 0.0 2.8 0.0 5.3 33.0 1.8 0.0 14.1 5.0 0.0 0.0 0.3 1.6 0.0 0.0 0.4 3.5 0.8 3.5 0.0 0.9 0.0 1.7 4.3 0.0 0.0 0.6 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 24.9 0.0 0.0 15.1 0.9 0.9 2.4 22.1 0.0 0.0 0.5 SYK ENSG00000165025 "Spleen associated tyrosine kinase" P43405 9 90801787-90898549 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Adaptive immunity, Angiogenesis, Host-virus interaction, Immunity, Innate immunity" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 38.5" "Cell type enhanced" "Detected in many" 6 "B-cells: 53.8;Hofbauer cells: 63.0;Kupffer cells: 79.3;Macrophages: 66.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 15 "classical monocyte: 21.4;eosinophil: 23.3;intermediate monocyte: 19.0;memory B-cell: 23.1;myeloid DC: 24.9;naive B-cell: 17.5;neutrophil: 32.8;NK-cell: 8.7;non-classical monocyte: 16.4;plasmacytoid DC: 18.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 39.4;HEL: 22.7;HL-60: 31.3;HMC-1: 20.9;REH: 26.2;THP-1: 24.1;U-698: 18.6;U-937: 22.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA001384, CAB007773" Enhanced Approved "Vesicles,Plasma membrane,Cytosol" No NA 1000000 "Plasma membrane, Cytosol" Vesicles "CAB007773: AB_562232, HPA001384: AB_1080144" "unprognostic (1.01e-1)" "unprognostic (5.45e-2)" "unprognostic (2.10e-1)" "unprognostic (2.69e-2)" "unprognostic (2.31e-1)" "unprognostic (7.92e-2)" "unprognostic (1.06e-1)" "unprognostic (1.34e-1)" "unprognostic (6.41e-2)" "unprognostic (1.78e-2)" "unprognostic (7.20e-2)" "unprognostic (9.93e-2)" "unprognostic (2.55e-3)" "unprognostic (8.77e-2)" "unprognostic (5.36e-3)" "unprognostic (3.41e-2)" "unprognostic (1.06e-2)" 7.2 3.3 6.0 38.1 9.6 18.2 6.7 1.1 4.5 3.7 10.3 6.7 1.5 12.3 2.3 6.7 16.2 6.9 6.6 5.5 7.2 3.2 8.6 2.5 13.7 36.4 9.1 2.5 2.1 8.9 25.9 3.1 5.0 6.1 4.1 8.3 2.8 8.9 1.8 1.4 8.3 22.2 3.5 11.3 38.5 7.4 5.5 7.9 30.5 18.1 7.8 32.2 8.6 7.5 23.1 24.9 32.8 21.4 8.7 0.1 10.2 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 39.4 1.1 0.0 1.3 6.1 0.8 3.2 0.0 0.0 5.4 22.7 0.0 0.0 0.0 31.3 20.9 0.0 4.5 0.0 0.4 0.0 0.0 4.9 0.6 3.2 0.0 4.8 0.0 13.7 0.2 14.8 0.0 26.2 0.0 10.8 0.8 5.9 2.1 1.8 0.0 2.8 0.0 0.1 2.5 24.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 18.6 0.0 22.1 0.0 1.4 21.4 23.3 0.1 19.0 0.1 23.1 0.0 0.0 24.9 17.5 0.0 0.0 32.8 8.7 16.4 18.5 0.0 10.2 6.0 9.6 1.1 4.5 7.2 3.2 9.1 2.5 6.1 7.9 11.9 22.7 53.8 3.7 3.1 0.9 1.6 12.7 12.0 17.0 14.0 0.0 1.2 13.3 12.6 5.5 1.1 18.4 0.0 10.9 1.3 1.1 1.8 40.6 0.9 63.0 0.0 9.9 4.9 79.3 4.7 0.6 66.0 11.8 24.4 23.8 0.0 15.3 28.1 0.0 0.3 0.1 6.5 1.0 0.7 0.7 5.0 1.1 5.3 24.7 6.5 SYNC "SYNC1, SYNCOILIN" ENSG00000162520 "Syncoilin, intermediate filament protein" Q9H7C4 1 32680360-32703596 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 51.0" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 69.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "non-classical monocyte: 1.8" "Lineage enriched" "Detected in single" 5 "monocytes: 1.8" "Cell line enhanced" "Detected in many" "BJ hTERT+: 26.8;fHDF/TERT166: 38.9;hTERT-RPE1: 23.8;U-138 MG: 34.1;WM-115: 22.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028311, HPA063549" Enhanced Approved "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Plasma membrane" "Golgi apparatus, Vesicles" "HPA028311: AB_2672554, HPA063549: " "unprognostic (3.99e-1)" "unprognostic (6.04e-3)" "unprognostic (2.02e-2)" "unprognostic (7.60e-3)" "unprognostic (1.99e-2)" "unprognostic (5.07e-2)" "unprognostic (5.05e-2)" "unprognostic (5.44e-3)" "unprognostic (1.71e-1)" "unprognostic (1.79e-2)" "unprognostic (5.04e-2)" "unprognostic (3.71e-1)" "unprognostic (1.32e-4)" "unprognostic (1.56e-2)" "unprognostic (1.33e-1)" "unprognostic (1.45e-1)" "unprognostic (8.15e-4)" 4.2 3.2 3.7 5.8 3.9 0.1 6.8 1.1 4.2 5.9 7.2 3.7 1.2 1.5 7.7 7.7 15.6 5.3 4.8 7.9 3.5 3.9 1.4 1.1 4.6 0.6 3.6 2.6 7.9 0.9 2.7 2.8 1.1 3.5 6.1 4.8 4.6 4.1 8.4 51.0 1.6 4.0 28.5 4.5 1.9 6.5 5.4 1.9 0.0 1.9 23.6 2.3 7.8 2.5 0.0 0.3 0.0 1.8 0.0 0.3 0.0 0.0 1.3 0.1 0.0 6.5 10.2 0.0 10.5 26.8 9.1 6.6 0.1 0.1 0.0 0.5 38.9 11.0 0.4 0.3 0.2 5.5 0.0 0.0 0.2 4.4 0.9 5.2 0.0 0.0 15.7 0.9 10.1 0.3 23.8 2.9 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.1 0.1 0.9 0.0 2.0 0.0 10.6 0.0 0.1 0.1 10.6 2.2 0.0 2.1 0.6 0.0 1.7 34.1 1.5 18.1 2.7 0.0 0.0 0.0 9.5 0.1 22.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 3.7 3.9 1.1 4.2 3.5 3.9 3.6 2.6 3.5 1.9 8.9 6.0 18.0 11.4 19.6 44.6 0.8 17.8 5.3 13.6 8.7 37.3 7.3 5.0 10.7 8.6 8.7 7.8 23.3 4.7 7.6 12.4 10.4 21.9 16.1 4.8 69.9 7.0 20.3 20.5 12.4 38.6 9.9 32.1 4.6 7.0 16.9 6.8 8.0 60.5 7.8 52.5 19.4 12.0 30.1 26.0 19.4 4.2 21.3 8.9 8.5 SYNGR3 ENSG00000127561 "Synaptogyrin 3" O43761 16 1989660-1994275 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 55.3" "Cell type enhanced" "Detected in some" 8 "Cardiomyocytes: 3.9;Horizontal cells: 6.4;monocytes: 4.6;Spermatogonia: 8.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 3.7;NK-cells: 4.6;T-cells: 2.7" "Cell line enhanced" "Detected in many" "HDLM-2: 25.7;HMC-1: 16.6;Karpas-707: 14.0;SK-BR-3: 17.5;U-266/70: 22.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034278, HPA042842" Enhanced Approved "Plasma membrane" NA NA "Plasma membrane" "CAB034278: AB_2200905, HPA042842: AB_2678198" "unprognostic (8.89e-3)" "prognostic favorable (6.92e-4)" "unprognostic (6.07e-3)" "unprognostic (2.94e-3)" "unprognostic (2.92e-2)" "unprognostic (8.06e-3)" "unprognostic (2.52e-1)" "unprognostic (5.70e-2)" "unprognostic (2.84e-2)" "unprognostic (1.06e-1)" "unprognostic (3.69e-3)" "unprognostic (1.05e-1)" "prognostic favorable (7.12e-7)" "unprognostic (1.03e-1)" "unprognostic (1.19e-1)" "unprognostic (2.79e-1)" "unprognostic (8.78e-2)" 1.1 11.1 20.3 3.7 21.8 1.6 1.1 24.2 55.3 1.5 2.3 2.6 0.0 2.2 1.0 1.0 1.3 1.1 1.3 1.4 14.6 40.8 1.7 1.0 1.3 4.0 27.1 20.1 1.5 1.0 9.4 3.1 5.4 28.2 1.3 2.2 0.9 2.1 1.1 0.9 1.1 2.5 1.7 4.4 2.2 2.1 4.2 2.0 0.0 1.0 0.0 4.7 1.4 0.2 3.7 0.7 0.0 0.8 4.6 2.7 0.9 0.4 2.1 2.0 0.2 0.2 0.2 2.4 1.0 1.7 0.8 0.7 3.3 1.6 3.2 0.7 0.7 2.2 1.8 2.2 0.3 0.2 25.7 1.5 0.0 2.8 1.6 1.2 0.0 16.6 0.5 0.1 0.0 0.5 3.9 0.2 1.0 9.2 14.0 0.4 2.4 0.1 0.1 10.3 0.3 0.9 0.0 0.3 2.5 1.3 0.0 4.6 5.8 2.3 17.5 0.2 1.1 2.4 0.2 0.4 0.5 8.1 0.0 0.3 22.1 2.5 3.7 0.3 2.9 0.3 0.0 0.8 0.0 0.9 0.3 2.1 3.2 1.7 2.7 0.7 3.7 2.0 0.8 0.0 4.6 0.7 0.0 1.6 0.9 20.3 21.8 24.2 39.3 14.6 40.8 27.1 20.1 28.2 2.0 0.0 1.1 0.0 0.7 0.2 2.6 3.9 0.0 0.0 0.0 0.0 2.0 0.4 1.7 1.7 0.4 0.3 0.0 0.0 0.4 0.6 0.6 0.8 1.1 0.0 0.2 6.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 4.6 0.4 0.8 1.2 0.0 0.0 0.0 0.5 0.0 0.2 2.3 8.1 0.3 2.6 2.2 0.0 0.6 SYPL2 Mg29 ENSG00000143028 "Synaptophysin like 2" Q5VXT5 1 109466628-109482137 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "skeletal muscle: 102.5;tongue: 25.6" "Cell type enhanced" "Detected in some" 11 "Cardiomyocytes: 8.5;Collecting duct cells: 3.5;Hepatocytes: 4.5;Late spermatids: 8.5;Proximal tubular cells: 4.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 20.2;ASC TERT1: 8.5;BJ: 8.6;BJ hTERT+: 27.3;fHDF/TERT166: 14.1;HAP1: 7.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA076657 Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA076657: " "unprognostic (1.82e-2)" "unprognostic (1.81e-1)" "unprognostic (2.90e-4)" "unprognostic (6.63e-2)" "unprognostic (1.35e-1)" "unprognostic (9.36e-3)" "unprognostic (2.84e-2)" "unprognostic (2.57e-1)" "unprognostic (2.35e-1)" "unprognostic (3.11e-1)" "unprognostic (2.34e-1)" "unprognostic (1.08e-1)" "prognostic favorable (3.05e-4)" "unprognostic (2.54e-3)" "unprognostic (3.40e-1)" "unprognostic (9.46e-3)" "unprognostic (6.39e-4)" 0.9 3.9 0.8 0.3 0.7 0.1 1.4 0.5 1.2 1.6 1.9 0.3 0.8 0.3 2.5 4.3 1.6 0.4 1.1 7.4 0.8 0.2 6.0 4.7 0.6 0.3 0.3 0.0 1.1 3.2 3.7 0.4 1.2 0.8 1.2 0.5 1.7 1.6 2.2 102.5 0.2 0.6 3.5 0.1 0.4 1.1 6.0 0.2 0.0 5.1 25.6 1.2 2.5 2.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.1 20.2 8.5 0.0 8.6 27.3 2.7 1.0 0.0 0.0 0.0 0.0 14.1 0.3 0.0 7.3 0.0 0.5 0.0 3.1 0.0 0.2 0.1 0.4 0.0 0.7 0.8 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.9 2.1 1.4 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.5 1.2 0.8 0.2 0.3 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.1 0.0 8.5 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.2 1.5 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 4.5 0.1 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.7 4.9 0.0 0.0 2.3 0.4 1.5 0.0 0.1 0.0 0.0 0.0 SYT4 "HsT1192, KIAA1342" ENSG00000132872 "Synaptotagmin 4" Q9H2B2 18 43267878-43277650 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 60.8;pituitary gland: 31.5" "Group enriched" "Detected in some" 4 "Bipolar cells: 60.4;Cone photoreceptor cells: 21.6;Intestinal endocrine cells: 27.5" "Cancer enhanced" "Detected in some" "pancreatic cancer: 4.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "SH-SY5Y: 74.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010574 Approved Approved "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA010574: AB_2668309" "unprognostic (2.91e-3)" "unprognostic (2.03e-1)" "unprognostic (2.37e-2)" "unprognostic (2.87e-1)" "unprognostic (7.67e-3)" "unprognostic (5.30e-3)" "unprognostic (3.95e-2)" "unprognostic (1.23e-3)" "unprognostic (3.61e-1)" "unprognostic (3.80e-2)" 1.4 17.5 5.7 2.2 24.1 1.0 0.9 60.8 54.6 0.9 1.7 0.9 0.0 1.7 0.9 0.9 1.0 0.9 1.0 1.4 12.9 19.9 1.0 0.9 1.8 1.0 5.9 16.0 1.3 4.7 0.9 31.5 1.0 22.3 1.5 1.7 0.4 1.0 9.8 0.9 1.0 1.7 1.5 5.0 0.9 4.6 2.4 1.4 0.0 1.3 0.0 0.9 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 74.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 24.1 60.8 35.7 12.9 19.9 5.9 16.0 22.3 1.4 0.0 1.4 0.0 0.0 0.1 60.4 2.8 0.0 1.4 4.5 0.0 21.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 1.6 27.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.8 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TACR2 "NK2R, NKNAR, SKR, TAC2R" ENSG00000075073 "Tachykinin receptor 2" P21452 10 69403903-69416867 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 56.3;smooth muscle: 35.5" "Cell type enhanced" "Detected in some" 14 "Ciliated cells: 2.7;Horizontal cells: 6.4;Kupffer cells: 2.2;Leydig cells: 2.6" "Cancer enhanced" "Detected in many" "stomach cancer: 6.7" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "intermediate monocyte: 4.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "SK-MEL-30: 8.7;U-87 MG: 5.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA076573 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA076573: AB_2732313" "unprognostic (2.83e-1)" "unprognostic (1.58e-3)" "unprognostic (2.48e-2)" "unprognostic (1.67e-1)" "unprognostic (4.22e-1)" "unprognostic (2.30e-1)" "unprognostic (1.30e-2)" "unprognostic (1.96e-2)" "unprognostic (3.72e-1)" "unprognostic (6.14e-2)" "unprognostic (2.45e-2)" "unprognostic (3.16e-2)" "unprognostic (9.88e-4)" "unprognostic (5.59e-3)" "unprognostic (4.31e-3)" "unprognostic (1.25e-3)" "unprognostic (1.32e-1)" 1.6 0.1 0.5 3.1 0.5 0.1 1.2 0.5 1.1 11.1 56.3 0.2 0.4 4.1 12.3 0.9 19.6 7.2 1.2 1.9 0.5 0.3 0.2 0.5 0.8 0.5 0.2 0.4 2.0 0.8 0.0 0.1 0.1 0.4 14.9 8.2 0.2 0.4 0.9 1.1 0.4 14.2 35.5 0.8 0.5 16.5 0.9 0.5 0.1 0.4 0.8 0.4 19.4 3.1 1.2 2.0 0.5 4.2 0.1 0.8 0.3 2.0 1.2 0.4 0.7 3.1 0.2 0.2 0.5 0.3 0.5 0.7 0.7 0.4 0.2 0.5 0.5 0.7 0.8 0.1 0.1 0.0 0.4 0.5 1.6 0.6 1.9 0.3 0.0 3.1 0.5 0.7 0.0 0.1 0.8 0.2 0.1 0.4 2.5 0.0 0.8 0.1 0.5 0.4 1.7 1.9 0.1 0.0 0.0 0.0 1.0 0.8 0.6 1.3 2.7 8.7 0.4 1.2 0.2 0.8 3.1 0.4 1.3 1.1 1.2 1.3 0.2 5.0 0.3 1.8 0.5 1.5 0.1 0.3 4.2 0.4 1.2 0.8 0.3 2.0 0.6 0.4 0.2 0.2 0.1 1.7 0.3 0.1 0.3 0.5 0.5 0.5 1.1 0.5 0.3 0.2 0.4 0.4 0.5 0.0 0.3 0.0 0.2 0.6 0.2 0.5 0.0 2.7 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.0 1.1 6.4 0.0 1.3 2.2 0.0 2.6 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.3 0.0 1.2 0.2 0.1 0.1 0.0 0.0 0.4 0.4 TASP1 "C20orf13, dJ585I14.2, FLJ20212" ENSG00000089123 "Taspase 1" Q9H6P5 20 13389392-13638940 "Predicted intracellular proteins" "Hydrolase, Protease, Threonine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030824, HPA030825" Uncertain Approved "Plasma membrane" No No "Plasma membrane" "HPA030824: AB_10600327, HPA030825: AB_10601575" "unprognostic (1.29e-1)" "unprognostic (1.68e-1)" "unprognostic (8.61e-2)" "unprognostic (1.20e-1)" "unprognostic (2.47e-1)" "unprognostic (6.46e-2)" "unprognostic (3.44e-3)" "unprognostic (9.85e-2)" "unprognostic (9.85e-2)" "unprognostic (6.95e-2)" "unprognostic (1.59e-1)" "unprognostic (3.13e-2)" "unprognostic (2.21e-1)" "unprognostic (1.04e-1)" "unprognostic (2.70e-1)" "prognostic unfavorable (6.78e-4)" "unprognostic (1.67e-2)" 12.1 8.0 6.0 9.1 11.9 6.8 11.4 8.9 15.3 10.7 8.3 6.3 13.4 5.7 21.7 14.2 8.7 13.4 7.2 9.1 6.8 6.4 9.9 7.2 10.5 8.7 4.8 8.1 10.1 11.1 14.6 28.5 10.3 8.2 8.9 9.6 10.8 16.3 11.1 5.0 9.6 9.6 8.4 5.2 9.1 8.9 11.3 4.4 31.3 12.9 9.0 12.2 8.5 11.1 9.7 15.1 3.5 4.8 10.7 15.8 5.6 9.4 5.7 2.4 2.9 2.8 4.3 4.5 3.9 5.6 4.6 5.5 11.6 9.9 4.2 2.7 5.1 5.0 12.7 3.7 13.6 5.5 2.5 4.5 8.6 3.6 14.9 5.7 11.5 3.1 4.9 9.2 4.8 11.4 2.8 4.5 7.7 7.5 0.2 4.0 11.3 21.8 6.4 3.1 8.5 2.6 3.4 9.6 6.5 6.4 7.5 6.2 4.3 6.1 11.8 6.9 3.5 6.2 4.4 4.3 4.4 3.1 4.4 5.5 8.6 11.9 3.0 2.4 2.6 4.1 1.7 3.5 3.5 10.3 4.8 7.3 9.7 10.7 8.1 3.9 8.6 15.8 12.2 1.9 10.7 4.7 15.1 9.8 5.6 6.0 11.9 8.9 15.3 6.8 6.4 4.8 8.1 8.2 4.4 6.0 10.6 9.3 9.6 12.6 12.9 5.2 10.2 24.1 6.8 5.2 9.8 9.8 6.6 9.6 11.6 4.9 3.8 0.0 5.4 10.7 11.8 7.8 15.0 4.9 4.1 11.1 3.5 3.1 1.0 2.7 3.1 4.1 10.1 1.0 9.0 6.3 7.2 10.5 3.2 9.8 15.4 6.5 15.1 23.7 8.1 10.7 5.8 7.9 7.8 5.5 TAZ "BTHS, CMD3A, EFE, EFE2, G4.5, TAZ1, XAP-2" ENSG00000102125 Tafazzin Q16635 X 154411518-154421726 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039557 Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA039557: AB_10672899" "unprognostic (1.14e-1)" "prognostic favorable (5.70e-4)" "unprognostic (4.94e-3)" "unprognostic (1.43e-1)" "unprognostic (8.29e-2)" "unprognostic (7.84e-2)" "unprognostic (1.56e-2)" "unprognostic (8.21e-3)" "unprognostic (1.69e-1)" "unprognostic (1.62e-1)" "unprognostic (4.68e-2)" "unprognostic (8.39e-2)" "prognostic unfavorable (1.22e-7)" "unprognostic (4.00e-3)" "unprognostic (4.20e-1)" "unprognostic (1.41e-1)" "unprognostic (3.79e-2)" 11.9 8.7 12.1 15.0 13.6 36.8 11.7 12.4 13.5 10.9 15.4 15.6 12.1 13.9 10.8 13.0 15.1 9.9 14.1 25.9 11.0 8.4 13.3 14.0 14.3 17.3 16.7 9.6 12.6 16.3 10.7 8.9 9.1 13.1 11.1 10.8 12.2 12.7 14.5 27.9 18.6 15.0 11.7 12.8 25.4 12.8 3.4 15.1 17.2 11.8 13.4 14.4 10.8 19.5 16.7 14.7 13.8 10.3 12.3 17.2 7.8 11.0 12.5 4.6 5.1 9.0 5.4 8.8 3.9 7.7 6.0 8.3 4.1 13.8 13.1 21.3 5.7 20.0 16.8 6.5 7.2 4.2 11.2 9.6 2.6 8.0 6.4 10.1 5.0 6.2 5.5 13.2 5.2 11.8 5.6 9.0 16.8 5.2 13.9 5.2 6.7 12.6 15.8 1.3 9.7 13.1 10.5 7.0 17.6 8.2 3.2 5.8 8.2 2.5 7.4 10.7 5.0 4.5 8.9 6.5 4.9 6.3 12.0 5.9 32.4 12.8 27.3 6.0 17.6 5.6 5.7 10.3 13.8 12.1 9.3 11.0 11.3 17.2 15.5 14.7 16.7 14.4 12.5 9.4 12.3 7.4 7.3 12.2 7.8 12.1 13.6 12.4 13.5 11.0 8.4 16.7 9.6 13.1 15.1 6.0 10.2 10.7 6.9 9.6 21.3 18.9 12.7 5.3 13.6 8.7 17.7 4.9 5.0 12.0 0.5 15.0 12.3 0.0 14.5 8.0 9.9 5.6 18.4 7.8 21.2 9.5 5.8 16.0 22.1 1.3 10.6 15.9 13.5 23.4 12.9 15.1 10.8 10.2 8.5 4.4 23.8 12.9 9.2 5.1 0.6 9.8 2.4 23.6 13.6 4.8 TBC1D2 "Armus, PARIS1, TBC1D2A" ENSG00000095383 "TBC1 domain family member 2" Q9BYX2 9 98198999-98255721 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 53.6;Hofbauer cells: 31.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 18.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 27.5;HaCaT: 36.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA030871, HPA076521" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA Yes "Nucleoplasm, Plasma membrane, Cytosol" "HPA030871: AB_10670046, HPA076521: " "unprognostic (2.32e-2)" "unprognostic (1.11e-1)" "unprognostic (1.06e-2)" "unprognostic (6.36e-3)" "unprognostic (2.02e-2)" "prognostic unfavorable (2.77e-4)" "unprognostic (1.86e-1)" "unprognostic (2.11e-1)" "unprognostic (1.74e-1)" "unprognostic (9.21e-3)" "unprognostic (6.40e-3)" "unprognostic (2.30e-1)" "unprognostic (6.07e-2)" "unprognostic (4.32e-1)" "prognostic unfavorable (5.62e-4)" "unprognostic (1.30e-2)" "unprognostic (4.30e-1)" 13.1 4.1 6.6 7.0 15.6 14.5 7.6 7.7 7.6 7.8 12.0 17.8 6.0 15.5 4.4 4.3 25.3 4.4 5.3 2.2 9.5 7.4 4.6 12.6 27.4 4.5 15.2 5.3 4.3 3.0 4.5 3.1 11.9 9.0 8.1 5.9 6.2 10.1 8.8 3.3 18.8 15.2 5.7 14.3 6.7 5.1 3.1 12.2 4.7 7.1 14.7 16.8 14.7 11.6 0.9 7.0 8.1 18.4 0.7 3.9 6.4 27.5 4.0 0.2 0.9 3.1 6.1 9.1 12.2 6.8 8.9 7.4 2.6 12.1 0.4 9.3 7.1 1.9 36.4 0.2 13.6 3.1 0.9 0.5 0.2 14.1 2.0 14.6 0.6 1.1 8.4 22.5 8.9 22.3 15.8 3.1 0.7 0.8 0.3 7.0 3.5 0.1 1.6 0.6 2.7 2.3 0.4 1.8 0.0 13.6 17.2 0.3 0.5 4.1 9.1 1.2 0.6 3.0 0.9 19.0 10.9 3.3 1.8 4.9 0.6 0.5 0.2 11.1 1.0 1.2 1.1 18.4 5.5 1.9 10.8 1.3 0.9 2.8 1.6 7.0 0.6 1.2 1.4 8.1 0.7 8.0 0.9 3.9 6.4 6.6 15.6 7.7 7.6 9.5 7.4 15.2 5.3 9.0 12.2 53.6 12.2 1.9 11.4 7.3 2.4 0.6 7.6 5.3 20.5 3.5 0.0 18.5 3.3 3.7 1.5 3.1 15.0 0.0 2.8 9.4 2.1 3.8 0.0 4.7 31.3 1.6 7.5 0.6 19.8 1.0 1.7 9.3 3.3 3.6 11.1 2.9 8.7 7.0 0.7 2.5 2.2 0.0 2.0 1.6 2.8 9.5 14.5 1.9 4.2 11.1 TBC1D9B "GRAMD9B, KIAA0676" ENSG00000197226 "TBC1 domain family member 9B" Q66K14 5 179862066-179907859 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038350 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Nucleoli fibrillar center" "HPA038350: AB_10673170" "unprognostic (5.06e-2)" "unprognostic (1.37e-1)" "unprognostic (1.60e-2)" "unprognostic (9.53e-2)" "unprognostic (9.45e-3)" "unprognostic (4.25e-1)" "unprognostic (1.06e-1)" "unprognostic (2.84e-1)" "unprognostic (1.10e-1)" "unprognostic (5.08e-2)" "unprognostic (2.01e-1)" "unprognostic (2.28e-2)" "unprognostic (3.95e-2)" "unprognostic (1.86e-1)" "unprognostic (4.01e-2)" "prognostic unfavorable (3.99e-4)" "unprognostic (8.22e-2)" 30.4 28.7 31.2 14.3 29.8 17.0 21.2 27.0 37.9 21.7 17.8 36.7 20.6 16.4 18.9 24.5 21.7 20.7 19.0 15.2 31.4 26.6 20.7 22.4 18.3 16.8 34.9 23.3 24.8 24.6 22.7 13.3 14.8 29.0 18.2 14.5 17.5 25.6 21.9 20.3 24.0 18.9 19.1 42.3 18.0 16.1 12.2 24.1 12.0 23.3 12.5 17.2 17.4 19.7 5.4 9.4 5.0 8.1 3.7 5.5 4.9 10.7 16.6 7.6 17.6 23.3 14.9 17.7 13.1 13.6 13.2 13.2 11.1 10.8 7.4 16.2 15.9 17.3 10.3 9.1 30.6 6.1 24.6 10.2 6.6 12.2 7.4 12.5 8.7 23.0 17.2 13.3 10.4 7.5 12.3 14.5 14.8 4.4 8.7 11.8 27.0 5.6 7.2 5.3 8.2 9.5 9.7 5.8 7.3 12.4 17.6 10.9 8.0 12.4 14.8 15.0 8.5 11.7 14.1 14.7 19.3 8.6 9.2 11.5 4.4 5.7 5.8 18.3 11.2 13.6 4.5 5.9 5.0 5.5 8.1 4.5 5.4 4.0 4.7 7.8 5.1 3.9 3.1 0.8 3.7 7.9 9.4 3.4 4.9 31.2 29.8 27.0 37.9 31.4 26.6 34.9 23.3 29.0 24.1 20.8 19.2 17.1 8.5 14.7 25.0 8.4 17.8 10.7 9.1 26.2 7.9 15.5 11.6 18.4 1.7 23.8 22.6 0.0 15.6 18.8 15.9 12.8 10.5 30.0 27.4 58.8 17.3 23.4 26.1 5.4 30.0 21.0 15.1 19.0 21.9 15.8 21.8 23.0 26.9 18.1 17.7 25.8 11.0 6.9 17.5 13.7 11.8 13.1 18.2 11.9 TCIM "C8orf4, hTC-1, TC-1, TC1" ENSG00000176907 "Transcriptional and immune response regulator" Q9NR00 8 40153455-40155308 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 21 "Alveolar cells type 2: 796.6;Collecting duct cells: 190.1;Distal tubular cells: 164.2;Ductal cells: 262.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 14.6;AF22: 41.5;BJ: 15.6;BJ hTERT+: 40.9;EFO-21: 27.2;HeLa: 26.1;RPTEC TERT1: 20.7;SuSa: 16.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA027188 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA027188: AB_10601150" "unprognostic (8.88e-2)" "unprognostic (2.76e-2)" "unprognostic (7.89e-3)" "unprognostic (7.95e-2)" "unprognostic (7.33e-3)" "unprognostic (1.87e-3)" "unprognostic (2.11e-1)" "unprognostic (2.32e-1)" "unprognostic (2.93e-2)" "unprognostic (8.15e-2)" "unprognostic (6.23e-2)" "unprognostic (8.19e-2)" "unprognostic (2.54e-2)" "unprognostic (5.32e-3)" "unprognostic (1.39e-1)" "unprognostic (9.13e-3)" "unprognostic (4.48e-2)" 23.5 5.9 1.8 23.2 4.5 0.0 16.0 0.6 5.9 32.1 24.1 1.0 15.6 6.0 14.3 20.3 22.2 4.3 22.1 38.3 2.0 1.7 44.5 54.7 96.5 5.0 2.7 4.3 11.9 24.4 28.9 6.2 50.2 2.3 29.6 15.2 7.9 89.9 16.3 20.2 4.0 21.2 72.4 4.3 26.7 10.7 4.9 1.4 1.3 15.8 14.4 4.8 35.8 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 41.5 0.0 0.0 0.0 0.1 15.6 40.9 0.0 0.2 0.2 0.0 0.0 27.2 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 26.1 6.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 20.7 0.0 0.0 0.0 0.0 1.4 0.0 16.3 0.0 0.0 13.1 0.0 0.4 0.1 0.2 0.3 0.4 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 4.5 0.6 5.9 2.0 1.7 2.7 4.3 2.3 1.4 92.3 796.6 0.0 0.0 0.0 0.0 0.0 0.0 16.0 142.1 190.1 0.0 1.4 164.2 262.6 0.0 0.0 0.0 0.0 95.4 11.4 0.0 0.0 24.4 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 8.2 0.0 0.0 112.8 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 TDP1 "FLJ11090, SCAN1" ENSG00000042088 "Tyrosyl-DNA phosphodiesterase 1" Q9NUW8 14 89954939-90044768 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Exonuclease, Hydrolase, Nuclease" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 97.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071317 Approved Supported "Nucleoplasm,Plasma membrane" No No Nucleoplasm "Plasma membrane" "HPA071317: AB_2686388" "unprognostic (5.60e-3)" "unprognostic (3.53e-1)" "unprognostic (7.03e-3)" "unprognostic (1.34e-1)" "unprognostic (7.45e-2)" "unprognostic (7.22e-2)" "prognostic unfavorable (8.99e-5)" "unprognostic (2.61e-1)" "unprognostic (1.46e-2)" "unprognostic (5.84e-3)" "unprognostic (2.51e-1)" "unprognostic (6.46e-2)" "unprognostic (1.10e-1)" "unprognostic (3.41e-1)" "unprognostic (1.64e-1)" "unprognostic (2.91e-2)" "unprognostic (1.26e-1)" 5.5 6.3 6.9 10.8 10.4 11.4 8.3 11.0 10.8 6.6 7.1 7.3 8.4 5.9 9.1 5.6 11.1 8.8 6.2 3.5 5.5 6.3 6.8 5.9 5.5 16.1 6.2 8.1 6.8 7.0 5.5 11.0 7.5 6.3 5.7 9.6 6.1 8.1 4.2 3.1 7.7 7.9 5.8 5.7 11.7 7.0 23.3 3.7 29.8 4.5 4.4 21.0 7.6 7.0 16.4 11.2 15.5 10.6 16.3 23.2 10.7 13.8 7.9 17.6 15.9 4.4 6.1 14.0 13.3 11.0 16.5 15.0 5.7 15.0 17.7 10.0 9.1 5.5 14.3 7.7 12.4 24.1 17.9 8.3 17.9 7.2 6.9 3.8 29.9 10.4 4.4 5.6 11.6 10.8 9.5 20.9 24.3 12.3 18.6 19.5 14.6 22.8 16.1 4.2 16.5 18.6 17.4 33.3 14.0 10.6 11.4 13.2 9.0 11.3 33.2 4.2 12.2 13.2 12.8 16.6 7.2 6.8 9.8 11.9 13.7 23.8 21.6 15.4 13.5 10.4 15.5 6.6 10.7 14.5 10.6 14.3 16.4 15.7 16.3 10.4 13.5 17.7 18.2 4.5 16.3 9.7 11.2 23.2 10.7 6.9 10.4 11.0 10.8 5.5 6.3 6.2 8.1 6.3 3.7 0.0 1.4 6.7 4.6 4.1 3.0 1.1 2.5 12.0 3.4 14.0 7.9 9.1 5.0 7.3 97.8 2.7 2.3 0.0 4.8 12.5 3.9 3.6 2.3 2.9 7.8 3.2 3.5 4.3 5.6 25.8 2.6 6.1 1.7 9.0 5.0 0.6 5.0 3.2 2.8 5.7 2.2 0.0 4.7 26.1 23.8 4.0 8.5 8.7 7.6 2.6 TES "DKFZP586B2022, TESS-2, TESTIN" ENSG00000135269 "Testin LIM domain protein" Q9UGI8 7 116210493-116258783 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 226.3;Early spermatids: 327.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 51.4;hTCEpi: 58.1;SK-BR-3: 58.3" "Low region specificity" "Detected in single" "HPA015269, HPA018123" Approved Supported "Plasma membrane,Cell Junctions,Focal adhesion sites,Cytosol" NA NA "Focal adhesion sites, Cytosol" "Plasma membrane, Cell Junctions" "HPA015269: AB_1857899, HPA018123: AB_1857900" "unprognostic (9.81e-2)" "unprognostic (5.53e-3)" "unprognostic (4.79e-2)" "unprognostic (1.31e-1)" "unprognostic (4.01e-1)" "unprognostic (6.08e-3)" "unprognostic (1.84e-3)" "unprognostic (4.81e-3)" "unprognostic (8.81e-3)" "unprognostic (6.19e-3)" "prognostic unfavorable (1.20e-5)" "unprognostic (1.60e-2)" "prognostic favorable (8.71e-5)" "unprognostic (1.50e-1)" "unprognostic (5.47e-2)" "unprognostic (2.36e-2)" "unprognostic (3.86e-1)" 12.1 2.9 1.2 36.4 1.5 8.6 22.1 0.8 1.2 42.4 53.1 1.5 43.9 9.3 47.6 21.2 22.6 19.5 15.3 7.9 1.6 1.4 14.3 4.6 16.8 20.3 1.9 0.7 17.1 12.3 3.1 4.2 21.2 3.3 26.1 16.8 5.0 19.0 50.9 5.2 9.1 27.4 84.5 3.0 19.1 25.2 18.4 0.7 17.1 26.3 11.2 18.4 71.6 33.9 26.8 21.9 56.8 39.6 49.0 40.5 34.7 24.4 5.2 5.9 0.0 2.6 6.7 13.8 12.8 6.2 2.4 2.3 12.9 27.3 0.0 51.4 8.9 0.3 25.2 3.1 18.8 5.9 12.1 10.1 2.4 12.1 6.3 15.7 11.1 0.0 14.9 58.1 8.3 21.1 16.6 6.7 0.0 2.5 8.6 0.6 5.0 0.0 0.1 3.9 28.4 14.9 0.0 0.0 9.6 24.2 9.4 2.7 25.5 18.7 58.3 14.1 17.9 0.0 4.5 11.3 0.1 0.3 18.9 0.1 20.5 9.9 0.2 1.6 5.7 19.4 56.8 20.2 53.4 40.5 32.6 39.0 26.8 31.0 36.6 21.9 23.8 31.0 35.0 10.5 49.0 39.6 5.4 31.5 34.7 1.2 1.5 0.8 1.2 1.6 1.4 1.9 0.7 3.3 0.7 226.3 36.4 52.3 147.2 177.9 2.3 14.5 38.2 84.3 97.8 34.9 11.8 16.7 18.3 104.8 327.4 24.0 101.5 0.0 97.9 69.1 27.0 83.0 17.4 9.9 14.9 1.6 48.4 15.4 52.9 82.2 1.7 62.3 27.0 36.1 57.8 23.0 142.2 58.6 0.4 10.3 12.6 6.5 20.6 18.2 9.7 107.3 24.4 57.4 44.4 125.3 TEX14 CT113 ENSG00000121101 "Testis expressed 14, intercellular bridge forming factor" Q8IWB6 17 58556678-58692055 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 35 "testis: 52.7" "Cell type enhanced" "Detected in many" 15 "Early spermatids: 13.5;Spermatocytes: 29.0;Spermatogonia: 15.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 9.1;Karpas-707: 11.9;MCF7: 4.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA030620, HPA077020" Enhanced Approved "Vesicles,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Vesicles "HPA030620: AB_10601598, HPA077020: AB_2732327" "unprognostic (1.21e-2)" "unprognostic (2.12e-1)" "unprognostic (2.06e-1)" "unprognostic (9.49e-2)" "unprognostic (2.48e-1)" "unprognostic (1.23e-2)" "unprognostic (1.10e-1)" "unprognostic (6.17e-2)" "unprognostic (2.07e-2)" "unprognostic (1.61e-3)" "unprognostic (2.67e-2)" "unprognostic (8.10e-2)" "unprognostic (1.76e-9)" "unprognostic (1.77e-1)" "unprognostic (2.54e-1)" "unprognostic (5.00e-3)" "unprognostic (5.88e-2)" 0.1 0.1 0.2 0.1 0.3 1.5 0.1 0.9 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.2 0.1 0.1 0.3 0.2 0.1 0.1 0.2 0.1 0.2 0.1 0.3 0.1 0.0 0.1 0.1 0.4 0.2 0.0 0.1 0.1 0.1 0.3 0.1 0.2 0.1 0.5 0.2 0.0 52.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.8 0.2 0.1 0.0 0.2 2.6 0.0 0.0 0.3 0.0 0.0 0.1 0.3 0.0 0.0 0.7 0.2 0.0 0.2 0.0 0.4 0.0 0.2 9.1 1.4 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.2 0.0 0.1 0.0 0.5 0.1 11.9 0.0 4.8 0.4 0.1 0.6 0.1 0.1 0.5 0.4 1.8 0.0 0.1 1.4 0.2 0.0 0.1 0.6 0.4 0.4 0.1 0.0 0.1 0.3 0.0 0.0 2.1 0.5 1.1 0.1 0.1 0.1 0.0 0.2 0.0 0.2 0.0 0.5 0.0 0.8 0.4 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.9 0.2 0.3 0.2 0.2 0.1 0.4 0.1 0.0 0.0 0.0 1.2 0.8 0.4 1.4 5.1 0.0 2.3 1.8 0.0 0.9 0.0 0.0 13.5 0.2 0.0 0.0 0.0 0.7 0.6 0.6 1.1 0.4 3.1 0.0 0.0 1.8 1.2 3.6 0.3 2.4 3.3 0.0 0.0 0.5 0.1 0.0 0.4 0.0 1.1 0.0 0.9 29.0 15.8 0.1 0.9 0.0 0.0 0.3 TEX9 ENSG00000151575 "Testis expressed 9" Q8N6V9 15 56244009-56445997 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 49.7" "Cell type enhanced" "Detected in many" 14 "Ciliated cells: 165.9;Early spermatids: 67.3;Spermatocytes: 52.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "basophil: 4.1;memory B-cell: 14.4;naive B-cell: 6.8" "Group enriched" "Detected in many" 11 "B-cells: 14.4;granulocytes: 4.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039415 Uncertain Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA039415: AB_10672775" "unprognostic (3.27e-1)" "unprognostic (2.77e-2)" "unprognostic (2.25e-1)" "unprognostic (4.71e-3)" "unprognostic (2.34e-1)" "unprognostic (5.13e-2)" "unprognostic (1.54e-2)" "unprognostic (1.22e-1)" "unprognostic (3.75e-2)" "unprognostic (8.85e-2)" "unprognostic (6.91e-3)" "unprognostic (2.00e-2)" "unprognostic (1.24e-2)" "unprognostic (8.00e-2)" "unprognostic (1.15e-1)" "unprognostic (1.06e-1)" "unprognostic (1.24e-1)" 1.7 5.4 5.3 9.0 14.8 2.0 7.6 4.0 2.3 7.0 4.6 7.8 6.0 8.5 5.7 11.6 7.3 21.6 6.2 1.6 6.1 7.5 11.9 1.2 5.8 4.1 4.0 3.2 7.5 4.1 13.5 49.7 1.0 25.2 5.4 3.5 9.2 9.0 4.5 0.9 4.1 9.6 2.3 4.9 5.5 9.0 19.3 4.0 2.0 14.8 2.0 8.2 2.7 2.2 14.4 0.3 4.1 0.6 0.4 0.8 0.8 5.8 5.3 11.7 10.4 2.9 8.5 1.5 1.3 4.9 3.7 4.4 1.4 5.2 11.7 5.6 0.9 6.4 5.2 5.0 5.5 4.3 1.4 6.1 6.7 5.4 3.8 0.9 3.0 1.3 4.6 10.2 4.1 3.1 5.3 0.1 8.4 3.8 1.3 1.9 3.3 4.8 2.6 5.6 9.7 2.3 1.9 5.5 4.2 12.3 3.3 18.7 7.5 6.5 4.0 4.0 9.0 11.1 3.4 0.6 15.7 4.8 5.0 4.7 1.6 11.8 8.9 6.2 1.3 3.0 4.1 0.1 0.1 0.3 0.6 0.1 14.4 0.4 0.3 0.2 6.8 0.2 0.8 0.3 0.4 0.3 0.3 0.5 0.8 5.3 14.8 4.0 2.3 6.1 7.5 4.0 3.2 25.2 4.0 6.0 6.9 13.7 6.8 3.8 5.1 0.4 2.5 165.9 35.2 10.4 11.8 1.4 18.3 11.8 67.3 2.6 2.6 0.0 6.1 0.4 2.3 2.9 1.1 0.0 1.1 1.6 7.5 1.8 0.0 28.6 4.4 1.1 3.3 1.8 2.5 4.8 3.9 4.3 3.5 15.3 35.9 0.0 3.1 52.4 32.6 1.9 0.2 0.0 3.0 5.2 TGM1 "ICR2, LI, LI1, TGASE, TGK" ENSG00000092295 "Transglutaminase 1" P22735 14 24249114-24264432 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Keratinization "Acyltransferase, Transferase" "Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "esophagus: 106.0;lymphoid tissue: 70.0;tongue: 86.8" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 1: 11.9;Club cells: 6.8;Distal tubular cells: 24.9" "Cancer enhanced" "Detected in many" "head and neck cancer: 78.3" "Region enriched" "Detected in single" 11 "cerebellum: 3.0" "Cell type enhanced" "Detected in single" "memory CD4 T-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BEWO: 13.1;HaCaT: 18.0;HeLa: 11.8;MCF7: 12.9;SK-BR-3: 16.0" "Not detected" "Not detected" "Not detected" "Not detected" "CAB015159, HPA040171" Enhanced Approved "Vesicles,Plasma membrane" NA NA 430000 "Vesicles, Plasma membrane" "CAB015159: AB_2202870, HPA040171: AB_2676869" "unprognostic (2.95e-2)" "unprognostic (8.79e-2)" "unprognostic (2.92e-2)" "unprognostic (1.89e-2)" "unprognostic (2.36e-1)" "unprognostic (1.10e-1)" "unprognostic (4.04e-2)" "unprognostic (1.12e-2)" "unprognostic (2.39e-1)" "unprognostic (3.01e-2)" "unprognostic (6.72e-2)" "unprognostic (2.15e-1)" "unprognostic (1.94e-7)" "unprognostic (7.11e-2)" "unprognostic (7.38e-2)" "unprognostic (2.22e-3)" "unprognostic (1.86e-2)" 2.9 0.2 0.2 0.4 0.2 0.2 0.7 3.0 0.3 10.1 1.0 0.2 0.2 0.3 0.5 2.0 106.0 1.3 0.2 0.6 0.2 0.0 0.6 0.3 0.9 0.4 0.2 0.2 0.7 1.3 0.2 0.2 0.9 0.2 0.5 0.3 0.4 12.8 1.4 0.7 9.3 0.3 0.2 0.2 0.4 0.2 0.4 0.2 0.5 0.4 86.8 70.0 0.4 17.2 0.4 0.5 0.0 0.5 0.0 1.1 0.2 0.8 1.5 0.8 0.7 0.0 0.6 13.1 0.3 0.2 0.7 1.3 0.9 1.3 0.8 1.7 1.0 0.2 18.0 2.1 1.5 0.5 1.4 2.5 1.0 11.8 4.1 0.6 0.6 1.1 1.1 7.1 0.4 1.5 0.4 0.5 2.5 0.7 0.8 0.5 12.9 0.5 1.4 0.2 0.8 1.6 0.8 0.1 0.8 0.5 1.5 0.9 1.2 0.2 16.0 0.0 1.1 1.1 0.8 0.6 0.8 3.8 1.5 0.6 1.1 1.2 0.2 0.3 1.5 0.9 0.0 0.5 0.0 0.5 0.0 0.0 0.0 1.1 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.2 0.5 0.0 0.2 0.2 0.2 3.0 0.2 0.2 0.0 0.2 0.2 0.2 0.2 11.9 1.4 0.0 4.2 0.2 0.8 0.8 0.0 0.0 6.8 0.0 0.0 1.1 24.9 1.9 0.1 0.0 0.0 0.0 0.8 0.6 0.6 3.1 4.6 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.6 0.0 0.0 0.0 0.0 0.3 1.5 0.0 0.4 0.1 0.6 0.0 0.3 0.0 0.8 1.6 1.0 0.0 0.0 4.6 TGM2 TGC ENSG00000198959 "Transglutaminase 2" P21980 20 38127387-38166578 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 187.6;placenta: 212.7" "Cell type enhanced" "Detected in many" 7 "Cytotrophoblasts: 276.1;Ito cells: 326.6;Pancreatic endocrine cells: 240.4;Syncytiotrophoblasts: 312.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "intermediate monocyte: 2.5;memory B-cell: 1.9;myeloid DC: 2.4" "Group enriched" "Detected in many" 23 "B-cells: 1.9;dendritic cells: 2.4;monocytes: 2.5" "Group enriched" "Detected in many" 4 "CAPAN-2: 155.5;EFO-21: 52.3;hTERT-RPE1: 102.6;HUVEC TERT2: 70.7;TIME: 92.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB002598, HPA021019, HPA029518" Enhanced Approved "Plasma membrane,Cytosol" Yes No 1700000 Cytosol "Plasma membrane" "CAB002598: , HPA021019: AB_1858247, HPA029518: AB_10603133" "unprognostic (7.80e-2)" "unprognostic (1.51e-1)" "unprognostic (5.22e-2)" "unprognostic (1.40e-2)" "unprognostic (1.56e-2)" "unprognostic (5.61e-3)" "unprognostic (2.81e-1)" "unprognostic (3.32e-3)" "unprognostic (3.29e-2)" "unprognostic (9.78e-3)" "prognostic unfavorable (2.97e-4)" "unprognostic (6.99e-2)" "prognostic unfavorable (1.67e-7)" "unprognostic (1.60e-2)" "unprognostic (1.93e-2)" "unprognostic (6.70e-2)" "unprognostic (6.40e-2)" 33.3 9.5 6.0 18.3 8.1 1.0 7.7 4.3 7.5 94.3 12.6 4.0 4.7 8.4 54.6 21.7 15.8 58.7 62.8 77.1 7.5 3.4 25.3 187.6 61.2 16.4 6.9 3.0 18.7 5.0 5.2 25.6 212.7 8.5 33.6 6.3 57.4 1.9 17.1 19.3 0.7 12.8 43.9 5.7 20.4 13.6 7.4 6.4 0.8 17.0 3.4 3.1 38.2 21.6 1.9 2.4 0.0 2.5 0.0 0.0 0.2 6.3 4.7 0.0 0.1 4.9 0.5 2.4 9.6 4.6 0.0 0.1 7.8 155.5 0.0 52.3 0.1 11.1 0.1 0.0 22.5 0.3 0.0 0.0 1.0 0.2 3.4 20.3 0.0 0.0 0.5 0.0 4.1 0.0 102.6 70.7 0.0 2.1 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 6.9 0.0 0.0 0.1 22.6 0.0 0.8 3.3 0.2 0.0 92.1 0.1 5.9 0.7 4.5 0.0 0.0 0.0 6.3 0.0 1.8 0.0 0.2 0.0 0.0 2.5 0.0 1.9 0.0 0.0 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 6.0 8.1 4.3 7.5 7.5 3.4 6.9 3.0 8.5 6.4 8.9 28.9 15.2 9.8 0.5 0.0 156.9 48.4 16.0 27.3 14.0 2.0 276.1 3.3 184.1 2.3 166.8 4.2 93.5 124.7 21.8 45.8 45.4 2.3 137.1 49.2 0.0 0.0 326.6 22.9 3.5 1.1 11.4 0.0 10.8 0.0 0.4 240.4 0.0 5.6 19.0 0.5 0.0 65.7 0.5 4.9 0.0 312.9 1.3 0.4 12.3 THBS1 "THBS, THBS-1, TSP, TSP-1, TSP1" ENSG00000137801 "Thrombospondin 1" P07996 15 39581079-39599466 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Cell adhesion, Unfolded protein response" Heparin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Fibroblasts: 194.3;granulocytes: 164.5;Smooth muscle cells: 246.9" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basal ganglia: 3.4;pons and medulla: 8.1" "Cell type enhanced" "Detected in some" "eosinophil: 14.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 164.7;HUVEC TERT2: 160.1;LHCN-M2: 119.5;TIME: 233.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB033678, HPA059756" Approved Approved "Plasma membrane" "Secreted to extracellular matrix" NA NA 16000000000 1600000000 "Plasma membrane" "CAB033678: AB_793044, HPA059756: AB_2684121" "unprognostic (1.72e-2)" "unprognostic (9.55e-3)" "unprognostic (7.49e-2)" "unprognostic (3.31e-1)" "unprognostic (4.34e-2)" "unprognostic (1.03e-3)" "unprognostic (3.60e-1)" "unprognostic (1.53e-2)" "unprognostic (1.22e-1)" "unprognostic (2.07e-1)" "unprognostic (6.40e-2)" "unprognostic (9.16e-2)" "prognostic unfavorable (8.47e-5)" "prognostic unfavorable (8.50e-4)" "unprognostic (1.00e-1)" "unprognostic (9.25e-3)" "unprognostic (1.48e-3)" 79.6 15.2 0.9 81.4 3.4 19.3 41.0 0.7 1.3 25.7 42.7 2.5 6.6 5.0 72.8 30.5 22.7 40.8 57.7 49.0 1.0 1.0 23.4 27.2 118.4 38.8 1.1 0.8 60.9 14.0 1.3 7.7 38.1 8.1 31.9 18.3 8.4 38.0 13.2 22.6 9.2 23.0 63.5 4.5 58.0 46.5 27.5 0.2 0.6 14.0 21.4 18.4 111.8 78.9 0.0 0.5 14.1 7.4 7.5 2.6 8.6 11.7 4.0 3.1 1.1 13.3 15.7 0.0 68.0 55.6 18.7 12.3 11.6 8.9 0.0 25.7 164.7 3.6 41.9 0.1 33.2 9.5 3.0 0.0 3.0 2.3 2.9 2.9 0.0 0.9 35.0 2.4 15.5 35.1 73.9 160.1 0.1 0.1 0.1 119.5 0.9 0.0 0.2 0.5 1.1 1.4 0.0 8.3 0.0 28.1 29.9 0.0 0.0 19.3 1.1 1.1 4.1 11.9 0.2 233.4 65.5 15.5 77.1 78.1 0.1 0.1 0.1 2.1 0.0 70.0 0.2 7.4 14.1 0.8 0.8 2.6 0.0 0.4 0.5 0.5 0.0 0.1 0.1 1.4 7.5 0.1 0.3 0.0 8.6 0.9 3.4 0.7 1.0 1.0 1.0 1.1 0.8 8.1 0.2 23.8 25.3 10.7 130.6 85.1 0.0 35.0 25.5 14.7 26.1 66.3 5.9 2.2 0.0 18.5 0.2 39.3 91.3 0.0 111.9 1.8 194.3 54.9 164.5 7.2 5.9 0.0 3.5 67.5 123.1 0.0 1.7 83.3 37.1 3.6 27.1 0.0 117.5 21.5 0.4 50.2 0.8 6.5 246.9 0.2 0.3 44.5 1.7 5.7 29.3 27.8 THBS2 TSP2 ENSG00000186340 "Thrombospondin 2" P35442 6 169215780-169254044 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Cell adhesion" Heparin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 84.6;urinary bladder: 67.4" "Cell type enhanced" "Detected in some" 13 "Basal keratinocytes: 77.0;Fibroblasts: 41.1;Ito cells: 25.2;Melanocytes: 54.0;Smooth muscle cells: 28.6;Suprabasal keratinocytes: 36.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 83.6;ASC TERT1: 57.4;BJ hTERT+ SV40 Large T+ RasG12V: 27.8;HHSteC: 23.4;HSkMC: 31.0;hTEC/SVTERT24-B: 29.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB017716, HPA044304" Approved Approved "Nuclear speckles,Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA 22000000 "Plasma membrane" "Nuclear speckles, Cytosol" "CAB017716: , HPA044304: AB_2678891" "unprognostic (2.85e-2)" "unprognostic (1.41e-1)" "unprognostic (5.87e-2)" "unprognostic (8.90e-2)" "unprognostic (3.64e-2)" "unprognostic (8.73e-2)" "unprognostic (2.93e-1)" "unprognostic (5.10e-3)" "unprognostic (1.39e-1)" "unprognostic (4.71e-2)" "unprognostic (4.00e-2)" "unprognostic (2.56e-1)" "prognostic unfavorable (3.77e-6)" "unprognostic (2.19e-3)" "unprognostic (4.38e-2)" "unprognostic (4.16e-2)" "unprognostic (2.48e-3)" 43.5 4.0 4.3 10.1 7.8 0.4 84.6 1.1 9.0 24.3 17.0 6.3 3.3 1.9 26.1 16.1 9.8 14.8 43.0 21.9 5.5 3.6 4.6 5.9 8.4 3.8 8.1 1.4 26.2 5.9 1.5 4.4 2.0 14.8 10.5 3.4 0.7 3.9 2.8 14.6 22.7 3.8 22.0 16.0 2.8 2.6 12.5 5.2 0.0 13.2 10.6 4.8 67.4 29.4 0.4 0.7 0.2 0.8 0.1 0.3 0.0 0.0 0.0 0.6 0.3 83.6 57.4 0.0 15.9 21.9 22.1 27.8 0.1 0.0 0.0 0.0 19.0 0.1 0.0 0.7 0.8 12.6 0.0 0.0 0.0 0.0 0.0 23.4 0.0 0.0 31.0 0.0 29.8 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.8 3.4 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 10.1 0.1 22.5 1.9 0.0 0.3 0.0 6.2 0.1 0.5 0.0 0.8 0.2 0.2 0.5 0.0 0.4 0.1 0.0 0.2 0.3 0.1 0.3 0.0 0.1 0.5 0.7 0.2 0.0 4.3 7.8 1.1 3.1 5.5 3.6 8.1 1.4 14.8 5.2 6.0 0.0 0.0 1.2 77.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.5 0.0 0.0 0.0 0.0 41.1 1.1 0.0 0.0 0.2 0.0 0.0 25.2 0.0 0.0 7.5 0.9 54.0 0.0 0.0 0.3 0.8 0.0 15.2 0.3 0.3 0.0 28.6 0.0 0.0 36.9 0.1 0.0 0.0 0.7 THEGL ENSG00000249693 "Theg spermatid protein like" P0DJG4 4 56530609-56603507 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 8.9;vagina: 10.7" "Group enriched" "Detected in some" 58 "Early spermatids: 18.2;Late spermatids: 14.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HHSteC: 1.8;HSkMC: 3.7;hTEC/SVTERT24-B: 2.3;K-562: 3.0;SH-SY5Y: 2.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA066627, HPA068093" Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA066627: , HPA068093: AB_2685951" "unprognostic (4.33e-2)" "unprognostic (2.88e-3)" "unprognostic (7.97e-2)" "unprognostic (1.19e-1)" "unprognostic (3.69e-2)" "unprognostic (3.26e-1)" "unprognostic (1.90e-2)" "unprognostic (6.55e-2)" "unprognostic (1.61e-1)" "unprognostic (1.37e-1)" "unprognostic (4.70e-2)" "unprognostic (4.49e-2)" "unprognostic (1.73e-1)" "unprognostic (8.41e-2)" 0.1 0.2 0.6 0.1 0.5 0.8 1.9 0.1 1.1 1.7 0.7 0.6 1.0 0.1 0.4 1.3 0.2 0.4 0.8 0.1 0.2 0.4 0.1 0.1 0.1 0.0 0.2 0.3 0.5 0.1 0.0 0.3 0.0 0.8 0.7 0.1 0.2 0.2 0.5 0.1 1.2 0.2 1.8 0.2 0.1 0.3 8.9 0.4 0.0 0.1 0.0 0.1 3.0 10.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.4 0.1 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 1.1 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.3 3.7 0.0 2.3 0.0 0.5 0.4 0.0 3.0 0.0 0.9 0.0 0.8 0.0 0.2 0.0 0.4 0.4 0.4 0.0 0.0 0.0 0.1 2.0 0.8 0.0 0.2 0.0 0.0 0.1 0.0 0.0 1.1 0.3 0.8 0.1 0.3 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.1 1.1 0.2 0.4 0.2 0.3 0.8 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 THY1 CD90 ENSG00000154096 "Thy-1 cell surface antigen" P04216 11 119417378-119424985 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 97.7;smooth muscle: 91.5" "Cell type enhanced" "Detected in many" 8 "Fibroblasts: 117.3;Leydig cells: 89.2;Muller glia cells: 84.4;Peritubular cells: 72.9;Proximal tubular cells: 127.2;Smooth muscle cells: 114.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.7" "Lineage enriched" "Detected in single" 17 "T-cells: 1.7" "Cell line enhanced" "Detected in many" "ASC diff: 53.5;BJ: 83.7;BJ hTERT+: 93.7;fHDF/TERT166: 146.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003733, CAB068243, CAB068244" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA 9800000 Nucleoplasm "Plasma membrane" "CAB068243: AB_2665687, CAB068244: AB_2665688, HPA003733: AB_1846340" "unprognostic (9.98e-2)" "unprognostic (2.71e-1)" "unprognostic (5.13e-2)" "unprognostic (2.61e-1)" "prognostic unfavorable (6.87e-4)" "unprognostic (7.43e-2)" "unprognostic (1.43e-3)" "unprognostic (2.38e-2)" "unprognostic (1.29e-1)" "unprognostic (2.90e-3)" "unprognostic (3.38e-2)" "unprognostic (3.52e-1)" "prognostic unfavorable (2.40e-6)" "unprognostic (1.75e-2)" "unprognostic (1.90e-2)" "unprognostic (3.03e-2)" "unprognostic (1.14e-2)" 28.7 5.9 42.0 23.2 72.4 0.4 7.0 17.6 97.7 26.9 9.0 7.2 2.1 3.5 20.3 13.9 9.8 7.5 31.6 4.3 63.4 41.1 46.6 2.6 6.5 10.9 29.8 34.8 3.2 5.0 7.3 5.5 19.1 53.8 4.6 13.6 8.5 2.9 15.7 1.4 4.2 4.6 91.5 9.3 6.7 5.7 4.0 6.9 3.1 12.0 1.0 10.8 36.9 7.2 0.0 0.0 0.0 0.0 0.0 1.7 0.3 0.0 0.3 12.5 0.0 53.5 38.7 0.0 83.7 93.7 30.0 33.3 0.0 0.0 0.0 0.0 146.5 14.5 0.1 0.4 0.1 22.9 7.1 0.0 4.4 1.5 0.0 16.5 0.0 0.0 28.7 0.0 38.1 1.3 41.7 0.0 2.6 0.0 0.0 23.1 0.0 0.0 0.0 20.0 0.0 0.1 0.0 5.9 0.0 0.0 0.0 2.1 5.7 0.0 0.0 0.0 4.0 0.1 0.2 0.0 43.2 14.4 12.4 12.3 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 42.0 72.4 17.6 97.7 63.4 41.1 29.8 34.8 53.8 6.9 0.0 2.6 0.0 0.4 15.8 13.9 0.8 0.0 0.0 0.0 8.7 0.0 1.5 18.3 1.1 0.8 14.3 0.0 0.0 0.0 2.3 117.3 0.2 1.1 0.0 3.6 30.2 0.0 27.0 0.0 0.9 89.2 1.4 16.9 0.0 0.0 84.4 0.5 0.0 72.9 127.2 19.0 32.3 114.6 0.4 0.4 15.4 3.3 0.0 0.0 0.1 TIMD4 ENSG00000145850 "T cell immunoglobulin and mucin domain containing 4" Q96H15 5 156919282-156963255 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "liver: 32.0;lymphoid tissue: 83.9;testis: 58.9" "Group enriched" "Detected in some" 24 "Early spermatids: 1044.9;Late spermatids: 1409.2" "Cancer enriched" "Detected in some" 10 "renal cancer: 6.2" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "memory CD4 T-cell: 2.3;memory CD8 T-cell: 4.5;naive CD4 T-cell: 3.0;naive CD8 T-cell: 3.0;T-reg: 6.4" "Lineage enriched" "Detected in single" 14 "T-cells: 6.4" "Group enriched" "Detected in some" 18 "U-266/70: 46.8;U-266/84: 12.7" "HPA015625, CAB026027" Approved Approved "Plasma membrane" NA NA 18000000 "Plasma membrane" "CAB026027: , HPA015625: AB_1858018" "unprognostic (2.92e-1)" "unprognostic (1.06e-2)" "unprognostic (1.73e-1)" "unprognostic (2.31e-1)" "unprognostic (1.80e-1)" "unprognostic (3.01e-2)" "unprognostic (1.10e-1)" "unprognostic (3.11e-1)" "unprognostic (3.42e-1)" "unprognostic (8.42e-2)" "unprognostic (1.10e-1)" "unprognostic (6.90e-2)" "prognostic favorable (3.37e-4)" "unprognostic (1.31e-2)" "unprognostic (4.07e-1)" "unprognostic (3.27e-2)" "unprognostic (2.08e-2)" 6.7 0.4 0.4 3.5 0.4 5.3 0.5 0.4 0.4 0.4 1.3 0.0 0.0 0.0 0.4 1.0 1.5 0.4 0.3 0.8 0.4 0.4 1.7 32.0 0.6 83.9 0.5 0.0 0.4 0.4 0.0 0.4 2.8 0.0 1.1 0.1 0.0 6.5 0.0 0.7 0.4 1.1 0.2 0.5 12.5 0.4 58.9 0.0 21.7 0.8 0.2 8.5 5.3 0.4 0.4 0.0 0.0 0.0 0.0 6.4 1.4 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 46.8 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 2.3 4.5 0.0 0.0 3.0 3.0 0.0 0.0 0.0 0.0 6.4 1.4 0.4 0.4 0.4 0.4 0.4 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 5.0 0.0 1044.9 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 34.7 0.0 0.0 0.0 52.0 1409.2 13.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.6 0.0 12.9 0.0 10.9 4.3 0.0 0.2 0.0 0.0 0.0 TM2D2 BLP1 ENSG00000169490 "TM2 domain containing 2" Q9BX73 8 38988808-38996824 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Hofbauer cells: 172.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047152, HPA050547" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Nucleoplasm, Vesicles, Plasma membrane" "HPA047152: AB_2679957, HPA050547: AB_2681168" "prognostic unfavorable (7.49e-4)" "unprognostic (1.49e-1)" "prognostic favorable (1.71e-4)" "unprognostic (2.55e-2)" "unprognostic (7.02e-2)" "unprognostic (2.98e-1)" "unprognostic (5.17e-2)" "unprognostic (1.41e-1)" "unprognostic (3.69e-2)" "unprognostic (2.43e-3)" "unprognostic (4.58e-2)" "unprognostic (1.18e-2)" "unprognostic (1.14e-1)" "unprognostic (1.41e-1)" "unprognostic (1.61e-1)" "unprognostic (1.07e-2)" "unprognostic (8.61e-2)" 21.6 26.2 19.9 14.9 24.3 11.3 24.5 18.8 29.6 21.0 15.3 18.4 25.4 17.5 20.1 27.6 17.2 17.9 22.9 19.4 18.7 20.4 32.6 29.0 21.1 18.1 20.5 17.3 23.3 26.8 25.9 17.5 32.6 25.7 22.8 16.6 22.9 18.8 23.4 14.6 18.5 20.7 17.7 16.4 24.3 19.2 26.1 13.9 11.1 39.7 14.9 14.9 16.7 19.5 14.4 33.5 27.2 18.8 17.4 22.8 19.2 14.0 22.7 10.6 14.6 24.8 16.7 14.6 29.9 18.4 22.7 20.6 17.3 12.2 4.9 23.6 22.1 25.5 15.3 11.2 18.1 24.8 5.9 8.6 11.3 13.3 18.6 22.0 3.3 14.7 20.3 17.8 17.8 8.7 16.6 29.1 8.4 12.4 14.7 30.2 8.7 8.2 11.4 13.4 21.2 9.0 7.0 13.7 8.3 25.9 11.2 3.5 6.9 11.4 8.0 14.7 19.6 19.6 7.1 26.1 18.4 13.8 26.8 15.0 10.3 22.7 8.7 14.0 7.7 12.8 27.2 16.2 14.5 18.0 18.8 19.6 14.3 21.2 19.6 17.0 14.4 20.2 19.6 4.5 17.4 15.6 33.5 22.8 19.2 19.9 24.3 18.8 29.6 18.7 20.4 20.5 17.3 25.7 13.9 11.9 14.3 17.6 48.8 31.1 21.6 15.1 30.6 20.1 20.5 48.8 19.6 78.2 24.9 57.6 44.6 26.6 11.9 0.0 33.5 82.1 36.1 49.2 21.9 33.7 172.6 22.3 9.9 66.3 32.3 35.5 33.4 33.8 25.3 106.4 10.7 40.2 58.6 15.2 23.3 48.2 29.3 0.0 18.1 33.0 59.4 13.6 66.8 22.0 14.9 50.4 TM4SF4 il-TMP ENSG00000169903 "Transmembrane 4 L six family member 4" P48230 3 149473974-149503281 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "gallbladder: 196.0;intestine: 126.4;liver: 81.8" "Cell type enriched" "Detected in many" 5 "Cholangiocytes: 2236.9" "Group enriched" "Detected in many" 10 "liver cancer: 249.4;pancreatic cancer: 130.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "intermediate monocyte: 1.3" "Lineage enriched" "Detected in single" 13 "monocytes: 1.3" "Group enriched" "Detected in some" 6 "A549: 15.4;OE19: 14.2;RPTEC TERT1: 24.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA046430 Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA046430: AB_2679662" "unprognostic (1.91e-2)" "unprognostic (1.71e-1)" "unprognostic (2.15e-1)" "unprognostic (1.66e-1)" "unprognostic (2.27e-1)" "unprognostic (1.67e-1)" "unprognostic (1.33e-1)" "unprognostic (4.96e-2)" "unprognostic (2.73e-1)" "unprognostic (1.98e-1)" "unprognostic (7.60e-2)" "unprognostic (1.83e-1)" "unprognostic (4.66e-2)" "unprognostic (1.91e-2)" "unprognostic (4.97e-1)" 0.3 0.3 0.2 0.2 0.2 0.0 0.3 0.2 0.2 0.2 68.2 0.0 0.0 70.3 0.2 0.1 0.3 0.3 196.0 0.2 0.2 0.2 0.4 81.8 0.3 0.0 0.2 0.0 0.2 24.2 0.0 0.3 0.1 0.0 0.2 0.0 0.1 0.2 0.0 0.2 0.2 126.4 0.0 0.2 0.3 2.3 0.3 0.0 0.0 0.3 0.1 0.0 0.2 0.2 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 1.1 0.5 0.0 0.0 0.0 0.3 0.2 0.2 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.6 0.1 14.2 0.0 0.0 0.3 0.9 24.0 0.0 0.5 0.9 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 3.0 0.3 0.0 0.0 0.1 0.0 3.4 2236.9 0.0 1.2 0.0 0.0 0.0 0.0 20.8 0.8 0.0 2.6 23.3 1.7 0.1 0.0 0.0 0.0 475.7 0.1 0.0 2.9 8.0 11.0 0.0 0.0 0.0 0.0 1.8 0.9 0.0 7.6 0.0 0.0 2.1 0.0 0.0 1.1 3.6 0.1 0.0 0.1 0.0 0.1 0.1 TMC5 FLJ13593 ENSG00000103534 "Transmembrane channel like 5" Q6UXY8 16 19410496-19499113 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "intestine: 108.7" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 547.4;Club cells: 299.1;Pancreatic endocrine cells: 236.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "CAPAN-2: 37.3;OE19: 21.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA040810, HPA042037" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA040810: AB_10795627, HPA042037: AB_10804126" "unprognostic (2.47e-2)" "unprognostic (3.68e-1)" "unprognostic (3.50e-2)" "unprognostic (2.74e-3)" "unprognostic (1.01e-1)" "unprognostic (3.64e-2)" "prognostic unfavorable (7.96e-4)" "unprognostic (1.21e-1)" "unprognostic (1.59e-1)" "unprognostic (9.74e-2)" "unprognostic (3.27e-2)" "unprognostic (3.71e-1)" "unprognostic (2.28e-2)" "unprognostic (2.69e-1)" "unprognostic (7.88e-2)" "unprognostic (8.88e-3)" "unprognostic (1.75e-1)" 0.7 0.3 0.3 4.8 0.3 0.1 5.6 0.3 0.7 3.8 66.1 0.6 0.6 19.1 2.1 16.9 1.4 1.9 15.9 0.4 0.4 0.3 0.3 1.8 17.6 0.2 0.3 0.4 1.8 5.4 4.5 1.0 3.7 1.0 8.4 9.8 1.7 18.9 0.2 0.3 0.8 108.7 0.3 0.2 0.3 19.5 2.6 0.2 0.2 0.8 1.7 4.1 1.5 1.1 0.5 0.7 2.2 0.6 0.9 0.8 0.3 3.5 5.8 0.0 0.1 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 37.3 0.0 0.2 0.0 0.1 2.3 0.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.1 1.3 21.6 1.6 0.0 0.0 1.3 0.1 0.1 0.3 0.1 0.0 1.1 0.0 0.6 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.6 0.2 0.3 0.3 0.2 0.4 0.8 0.3 0.2 0.5 0.2 0.3 2.2 0.9 0.4 0.7 0.1 0.3 0.3 0.3 0.3 0.7 0.4 0.3 0.3 0.4 1.0 0.2 145.9 125.6 0.0 19.6 0.7 0.1 0.8 122.3 547.4 299.1 21.0 2.0 31.1 0.0 107.5 21.7 0.4 170.3 0.0 144.9 1.6 0.8 88.4 5.7 0.0 2.3 3.2 37.4 0.6 0.0 28.2 0.3 0.9 1.7 1.8 97.1 0.1 236.7 190.0 0.7 0.4 1.5 0.0 0.9 1.8 1.1 1.5 13.6 0.0 77.1 46.1 TMED8 FAM15B ENSG00000100580 "Transmembrane p24 trafficking protein family member 8" Q6PL24 14 77335021-77377109 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 102.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Daudi: 31.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001205 Approved Approved "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA001205: AB_2204460" "unprognostic (1.07e-1)" "unprognostic (4.70e-2)" "unprognostic (4.85e-2)" "unprognostic (2.39e-1)" "unprognostic (1.13e-1)" "unprognostic (7.82e-2)" "unprognostic (1.68e-2)" "unprognostic (3.74e-2)" "unprognostic (1.22e-1)" "unprognostic (2.01e-1)" "unprognostic (2.81e-2)" "unprognostic (1.04e-1)" "unprognostic (1.03e-3)" "unprognostic (2.23e-3)" "unprognostic (1.12e-1)" "unprognostic (5.88e-2)" "unprognostic (2.77e-1)" 8.2 12.8 13.4 16.3 18.3 10.3 12.1 15.0 16.1 9.7 7.0 6.5 8.0 5.3 10.4 8.3 5.9 8.6 6.6 7.6 11.3 21.2 15.7 5.9 7.1 23.6 12.4 16.6 11.6 8.6 19.3 26.0 6.8 16.9 9.4 7.6 11.6 7.3 9.7 4.3 7.6 8.8 8.7 13.9 12.0 9.4 12.4 11.8 12.6 16.4 2.4 27.2 7.9 8.5 5.3 2.3 4.8 2.2 1.2 1.6 1.0 7.7 6.4 7.6 6.8 4.8 4.3 6.5 4.9 3.2 5.2 5.6 4.0 4.4 31.0 4.2 4.0 4.3 5.4 5.6 5.6 8.1 9.7 3.4 10.3 5.0 4.2 3.3 5.0 28.6 4.5 4.0 6.7 6.1 5.2 7.3 25.8 5.2 8.4 5.1 7.6 7.9 7.4 3.8 5.7 6.5 6.4 7.0 2.5 5.4 4.8 9.5 5.7 8.5 5.1 6.2 6.1 8.3 8.4 5.2 5.4 3.5 9.6 5.7 6.8 12.9 15.7 6.1 9.4 7.8 3.7 1.6 4.8 0.8 2.2 1.0 4.9 1.2 1.0 1.4 5.3 0.7 1.2 2.6 1.2 1.9 2.3 1.6 1.0 13.4 18.3 15.0 16.1 11.3 21.2 12.4 16.6 16.9 11.8 3.0 5.6 18.2 4.3 6.0 30.4 14.6 10.2 25.4 3.4 21.0 102.1 8.9 5.0 5.1 3.8 6.0 4.1 23.3 4.1 8.8 7.5 6.5 0.0 8.5 6.8 27.0 42.6 8.0 20.3 6.3 13.6 8.4 5.0 7.2 6.9 14.1 5.4 3.5 13.4 17.4 36.4 12.9 7.1 6.5 14.1 7.9 3.4 5.3 5.9 3.7 TMEM101 "FLJ23987, MGC4251" ENSG00000091947 "Transmembrane protein 101" Q96IK0 17 44011188-44023946 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039739, HPA075651" Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA039739: AB_2676657, HPA075651: " "unprognostic (1.40e-3)" "unprognostic (1.75e-1)" "unprognostic (1.67e-1)" "prognostic favorable (4.29e-4)" "unprognostic (5.91e-2)" "unprognostic (3.91e-3)" "prognostic unfavorable (7.10e-4)" "unprognostic (1.80e-2)" "unprognostic (2.43e-1)" "unprognostic (2.03e-1)" "unprognostic (1.53e-1)" "unprognostic (1.61e-1)" "prognostic favorable (4.10e-5)" "unprognostic (1.59e-2)" "unprognostic (2.02e-1)" "unprognostic (1.48e-1)" "unprognostic (2.32e-2)" 11.0 10.9 8.4 7.3 14.2 5.1 58.9 6.3 16.5 22.7 11.4 13.7 7.7 8.4 33.3 14.5 15.1 19.2 15.4 12.4 8.7 8.6 37.2 12.0 11.4 16.1 9.5 9.4 13.0 27.8 10.7 8.5 17.8 11.6 13.9 8.6 11.5 20.9 59.7 15.5 13.8 9.5 11.6 10.1 11.0 13.6 16.9 8.9 10.0 25.4 12.9 13.2 12.5 11.6 23.8 25.9 11.7 25.0 23.8 27.2 17.8 9.8 24.2 8.6 7.2 20.6 19.9 8.7 10.3 15.7 20.5 19.6 17.9 25.7 11.1 2.9 10.6 16.0 15.2 10.0 17.9 15.7 12.0 20.2 8.3 19.4 36.2 17.8 13.4 14.5 17.8 20.5 14.5 20.6 18.5 17.9 19.5 17.1 21.9 12.7 13.2 14.4 15.4 4.0 10.8 27.3 12.5 18.8 20.1 17.1 8.0 11.3 9.0 6.6 0.2 24.5 11.4 11.9 25.8 10.7 18.8 12.7 8.2 20.2 22.8 15.7 5.1 19.7 12.7 16.7 11.7 24.9 8.6 19.4 25.0 21.8 22.7 24.5 22.3 25.9 23.8 27.2 22.1 9.1 23.8 17.8 25.2 25.1 17.8 8.4 14.2 6.3 16.5 8.7 8.6 9.5 9.4 11.6 8.9 17.9 12.5 26.3 26.3 18.3 10.4 28.5 20.4 22.7 13.6 38.4 5.9 59.3 31.5 30.3 10.8 20.2 20.8 0.0 43.1 35.2 18.8 20.8 23.0 18.6 33.4 11.1 22.5 31.3 25.9 8.7 12.0 20.9 32.1 47.7 31.6 16.0 40.2 17.5 11.7 25.6 11.4 6.5 16.0 48.6 17.9 19.7 37.3 17.9 43.5 22.6 TMEM108 "CT124, MGC3040" ENSG00000144868 "Transmembrane protein 108" Q6UXF1 3 133038391-133397792 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 25.6" "Cell type enhanced" "Detected in many" 15 "Cone photoreceptor cells: 96.2;Early spermatids: 57.1;Late spermatids: 29.1;Rod photoreceptor cells: 56.3" "Cancer enhanced" "Detected in many" "glioma: 4.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HMC-1: 11.8;LHCN-M2: 6.6;SCLC-21H: 10.3;SH-SY5Y: 45.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063350 Enhanced Approved "Nucleoli,Vesicles,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane, Cytosol" "Nucleoli, Vesicles" "HPA063350: AB_2684993" "unprognostic (4.75e-2)" "unprognostic (1.73e-2)" "unprognostic (9.00e-2)" "unprognostic (1.92e-2)" "unprognostic (3.07e-3)" "unprognostic (3.17e-1)" "unprognostic (1.28e-1)" "unprognostic (3.65e-2)" "unprognostic (2.06e-4)" "unprognostic (2.08e-1)" "unprognostic (7.27e-4)" "unprognostic (1.11e-1)" "unprognostic (3.03e-4)" "unprognostic (1.60e-3)" "unprognostic (1.61e-2)" "unprognostic (6.12e-2)" "unprognostic (1.36e-2)" 2.2 15.1 12.7 2.2 13.8 0.7 2.4 15.6 21.7 3.2 1.8 7.5 0.2 1.1 3.7 1.3 12.7 2.4 1.6 8.4 10.0 8.1 1.0 0.6 12.1 2.5 5.3 13.7 0.8 1.0 6.1 2.8 9.1 4.9 4.0 2.2 16.1 1.8 3.2 25.6 2.2 2.0 10.4 4.4 2.0 2.2 16.8 4.3 0.0 4.1 1.5 3.3 12.0 1.3 0.8 0.4 1.0 0.4 0.6 0.8 0.6 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.3 0.5 0.8 4.0 0.0 0.0 0.0 0.0 11.8 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 6.6 0.3 0.0 0.1 1.8 0.0 0.0 0.0 2.3 0.0 0.5 0.0 10.3 45.3 0.0 0.0 0.1 2.8 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.6 0.0 0.3 0.9 0.0 1.7 1.0 0.3 0.2 0.5 0.3 0.3 0.3 0.2 0.5 0.0 0.8 0.3 0.4 0.9 0.6 0.4 0.4 0.8 0.6 12.7 13.8 15.6 21.7 10.0 8.1 5.3 13.7 4.9 4.3 3.0 2.9 0.0 0.5 2.2 11.4 1.2 0.0 0.0 9.1 0.0 96.2 1.8 0.0 0.0 57.1 1.4 0.0 0.0 0.3 7.2 1.1 0.2 1.1 0.0 0.2 1.6 0.0 0.0 0.0 29.1 0.9 0.0 0.0 0.0 0.0 4.7 0.2 0.0 0.7 0.0 56.3 0.0 1.4 19.1 8.0 1.4 0.9 0.0 0.0 0.3 TMEM121B CECR6 ENSG00000183307 "Transmembrane protein 121B" Q9BXQ6 22 17116299-17121367 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.1;prostate: 14.1" "Group enriched" "Detected in some" 8 "granulocytes: 1.1;Hofbauer cells: 2.2" "Cancer enhanced" "Detected in some" "prostate cancer: 6.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 3.2;intermediate monocyte: 1.4;neutrophil: 4.3" "Group enriched" "Detected in many" 7 "granulocytes: 4.3;monocytes: 3.2" "Cell line enhanced" "Detected in some" "AF22: 6.3;SCLC-21H: 15.0;THP-1: 12.1;U-937: 10.0" "Group enriched" "Detected in many" 8 "amygdala: 22.5;basal ganglia: 24.0;cerebral cortex: 29.3;hippocampal formation: 26.2;olfactory region: 20.0" "Low region specificity" "Detected in many" HPA068790 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA Vesicles "Nucleoplasm, Plasma membrane" "HPA068790: AB_2686036" "unprognostic (2.30e-1)" "unprognostic (1.05e-1)" "unprognostic (7.11e-3)" "unprognostic (4.49e-3)" "unprognostic (3.36e-1)" "unprognostic (7.14e-3)" "unprognostic (1.12e-3)" "unprognostic (5.32e-2)" "unprognostic (1.97e-1)" "unprognostic (2.01e-2)" "unprognostic (6.88e-4)" "unprognostic (6.08e-2)" "unprognostic (3.10e-4)" "unprognostic (1.02e-2)" "unprognostic (4.37e-2)" "unprognostic (3.49e-3)" "unprognostic (1.71e-1)" 1.3 1.8 7.4 2.2 12.0 2.2 2.0 8.1 19.1 1.0 0.8 2.4 0.0 1.1 1.1 2.3 0.8 1.2 1.0 2.3 7.1 4.0 0.8 0.8 0.9 0.8 2.9 6.9 0.9 2.7 0.8 2.0 1.9 2.3 14.1 1.0 0.2 1.2 1.0 2.8 1.5 0.9 1.3 2.5 1.1 1.0 2.4 4.2 0.0 0.6 0.0 0.8 1.0 0.3 0.0 0.5 4.3 3.2 0.0 0.0 0.6 0.0 0.0 6.3 0.9 0.0 0.0 0.0 0.1 0.1 0.3 0.4 0.2 0.0 0.2 0.1 0.0 0.2 0.0 0.7 0.0 0.2 0.1 1.0 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.1 0.1 0.3 0.0 0.8 3.2 2.2 0.0 0.1 0.2 3.1 0.0 0.3 0.1 15.0 2.3 0.0 0.0 0.3 0.9 0.0 12.1 0.6 0.7 0.3 0.2 0.0 0.2 0.3 0.9 0.0 10.0 0.3 0.0 3.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.6 7.4 12.0 8.1 18.0 7.1 4.0 2.9 6.9 2.3 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM139 FLJ90586 ENSG00000178826 "Transmembrane protein 139" Q8IV31 7 143279957-143288048 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 25.1;kidney: 22.6;placenta: 28.0" "Cell type enhanced" "Detected in many" 7 "Collecting duct cells: 48.8;Ductal cells: 42.9;Enterocytes: 54.0;Proximal tubular cells: 67.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "intermediate monocyte: 3.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 9.7;CAPAN-2: 18.3;EFO-21: 12.9;RPTEC TERT1: 32.2;SK-BR-3: 11.3;T-47d: 31.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA036982, HPA036983" Approved Approved "Plasma membrane,Focal adhesion sites" NA NA "Plasma membrane" "Focal adhesion sites" "HPA036982: AB_2675413, HPA036983: AB_10672275" "unprognostic (2.58e-1)" "unprognostic (4.38e-1)" "unprognostic (6.62e-3)" "unprognostic (1.41e-1)" "unprognostic (2.10e-1)" "unprognostic (2.16e-3)" "unprognostic (2.83e-2)" "unprognostic (4.90e-2)" "unprognostic (1.60e-1)" "unprognostic (2.82e-2)" "prognostic unfavorable (1.66e-4)" "unprognostic (2.89e-1)" "prognostic favorable (3.05e-5)" "unprognostic (1.73e-1)" "unprognostic (1.42e-2)" "unprognostic (2.83e-2)" "unprognostic (9.08e-3)" 1.5 2.2 0.9 2.8 1.9 0.0 2.1 0.6 1.6 6.3 14.7 6.0 1.5 22.7 1.6 3.5 0.4 4.6 4.8 2.3 1.6 1.1 22.6 7.8 5.5 0.1 4.2 0.7 0.9 9.6 6.4 2.0 28.0 4.8 1.6 2.9 1.4 6.1 2.2 0.1 1.1 25.1 0.4 13.4 0.8 2.0 3.0 2.1 0.1 8.8 0.4 0.7 2.1 2.4 0.5 0.3 0.9 3.2 0.0 2.0 0.4 9.7 0.7 0.1 0.0 0.0 0.0 6.5 0.1 0.0 0.0 0.0 2.3 18.3 0.1 12.9 0.0 0.8 8.3 0.0 4.2 0.0 0.1 0.0 0.0 1.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.2 0.0 0.6 0.7 0.4 0.0 0.2 0.7 0.1 0.1 0.0 32.2 2.5 0.1 0.0 0.5 11.3 0.0 0.2 31.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.9 0.0 3.2 0.0 0.5 1.3 0.8 0.0 0.0 1.1 0.6 0.0 0.0 2.4 0.3 2.0 0.4 0.9 1.9 0.6 1.6 1.6 1.1 4.2 0.7 4.8 2.1 14.9 5.1 0.0 2.4 0.1 0.0 2.0 35.7 2.7 5.7 48.8 0.0 26.6 29.9 42.9 12.0 0.3 54.0 0.0 4.0 4.7 0.3 0.3 0.0 13.4 1.7 0.0 3.5 1.3 0.6 8.8 0.0 0.1 5.0 1.8 4.3 8.3 23.3 23.0 0.0 67.4 0.0 0.0 0.0 0.0 0.1 0.0 5.4 0.0 7.4 1.2 TMEM176B "LR8, MS4B2" ENSG00000106565 "Transmembrane protein 176B" Q3YBM2 7 150791285-150801360 "Predicted membrane proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 92.3;liver: 247.9" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 572.0;Hepatocytes: 1056.4;monocytes: 841.4;Paneth cells: 725.5;Proximal tubular cells: 817.7" "Cancer enhanced" "Detected in all" "liver cancer: 537.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 92.3;intermediate monocyte: 68.0" "Lineage enriched" "Detected in many" 5 "monocytes: 92.3" "Group enriched" "Detected in some" 17 "HSkMC: 120.5;THP-1: 38.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047509 Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Golgi apparatus" "Nucleoplasm, Plasma membrane" "HPA047509: AB_2680072" "unprognostic (5.21e-2)" "unprognostic (7.86e-2)" "unprognostic (1.30e-2)" "unprognostic (8.27e-2)" "unprognostic (3.35e-2)" "unprognostic (6.96e-2)" "unprognostic (7.23e-2)" "unprognostic (2.74e-2)" "unprognostic (5.31e-2)" "unprognostic (1.47e-1)" "unprognostic (5.72e-3)" "unprognostic (7.50e-2)" "unprognostic (3.11e-3)" "unprognostic (5.56e-2)" "unprognostic (2.17e-2)" "unprognostic (1.53e-1)" "unprognostic (4.05e-2)" 13.9 5.5 7.8 19.8 10.7 1.1 11.7 2.1 6.3 8.6 27.6 5.7 2.0 18.3 3.8 15.2 9.6 9.0 50.2 26.8 7.6 5.2 62.9 247.9 11.2 22.9 10.5 3.3 20.3 6.8 0.3 3.2 12.5 8.4 6.1 27.9 22.0 5.1 3.2 2.5 4.2 53.1 10.7 13.2 23.5 10.6 5.2 8.7 4.3 4.9 7.0 10.5 14.7 11.6 0.2 20.0 5.7 92.3 0.0 0.4 42.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 4.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 120.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.0 38.4 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 92.3 5.7 0.2 68.0 0.4 0.2 0.0 0.0 20.0 0.0 0.0 0.0 1.1 0.0 36.2 0.9 0.0 42.0 7.8 10.7 2.1 6.3 7.6 5.2 10.5 3.3 8.4 8.7 3.0 12.4 33.9 0.5 11.2 135.3 52.1 175.8 12.0 19.4 355.9 2.0 0.8 140.9 63.8 13.3 17.2 572.0 0.0 29.9 1.1 82.5 3.5 52.1 1056.4 94.1 6.4 123.0 27.0 68.8 9.8 40.3 84.1 15.1 841.4 193.4 69.9 82.8 725.5 3.2 817.7 17.3 0.0 22.6 3.2 3.4 13.7 2.3 14.6 213.0 1.0 TMEM183A C1orf37 ENSG00000163444 "Transmembrane protein 183A" Q8IXX5 1 203007386-203024848 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072607 Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Nucleoplasm, Cell Junctions" "HPA072607: AB_2686539" "unprognostic (2.94e-3)" "unprognostic (1.60e-1)" "unprognostic (1.30e-1)" "unprognostic (1.33e-1)" "unprognostic (3.41e-2)" "unprognostic (5.99e-2)" "prognostic unfavorable (2.62e-4)" "unprognostic (6.46e-2)" "unprognostic (3.21e-2)" "unprognostic (4.82e-3)" "unprognostic (5.28e-2)" "unprognostic (7.84e-2)" "unprognostic (4.83e-2)" "unprognostic (6.01e-3)" "unprognostic (9.55e-2)" "unprognostic (3.65e-2)" "unprognostic (1.32e-1)" 12.2 12.6 22.4 13.5 20.8 50.1 17.2 31.9 30.4 14.4 21.1 12.4 6.7 20.0 13.6 15.2 19.3 12.0 15.0 11.5 19.8 21.0 16.0 21.1 13.4 20.2 19.3 14.8 15.0 29.9 12.0 8.2 10.9 20.8 15.0 23.6 11.1 22.2 13.6 8.8 16.1 18.8 17.6 12.4 14.5 15.8 27.7 12.3 23.3 20.5 14.8 17.7 15.3 20.7 17.4 27.2 35.6 24.4 26.4 23.7 24.3 12.7 12.4 15.9 26.1 21.1 15.9 26.3 12.8 12.7 14.9 13.1 15.0 13.5 31.9 9.3 16.5 6.0 16.2 21.3 18.0 12.4 10.3 25.9 15.7 14.5 16.5 15.3 28.1 13.9 15.6 20.1 12.2 24.8 15.1 18.7 25.8 32.2 11.6 13.8 28.4 22.9 28.9 43.8 17.3 19.8 17.7 27.2 25.6 23.0 12.5 20.5 25.7 19.2 32.1 18.4 26.5 22.9 22.2 13.8 10.1 14.1 17.2 14.0 11.8 18.9 24.7 11.1 21.9 10.6 21.1 24.4 35.6 18.1 20.4 17.9 16.6 20.5 20.5 27.2 17.4 23.7 19.3 21.3 26.4 18.5 19.5 21.2 24.3 22.4 20.8 31.9 30.4 19.8 21.0 19.3 14.8 20.8 12.3 14.9 15.6 44.9 49.0 65.3 20.7 10.9 48.4 28.1 28.4 33.2 9.8 46.3 59.7 71.4 117.2 35.8 68.3 23.3 66.2 74.0 37.9 74.7 17.3 45.7 54.3 17.5 50.6 32.5 53.2 96.3 25.0 47.0 37.1 59.5 68.9 18.9 55.2 56.1 27.6 74.5 26.2 19.4 47.6 72.3 76.8 71.8 43.1 44.7 83.1 77.4 TMEM218 ENSG00000150433 "Transmembrane protein 218" A2RU14 11 125096545-125111763 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038489 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA038489: AB_10672748" "unprognostic (3.70e-2)" "unprognostic (1.16e-1)" "unprognostic (7.60e-2)" "unprognostic (2.41e-3)" "unprognostic (8.86e-2)" "unprognostic (1.60e-1)" "prognostic unfavorable (1.93e-5)" "unprognostic (3.63e-2)" "unprognostic (7.09e-3)" "unprognostic (2.18e-1)" "unprognostic (6.45e-2)" "unprognostic (1.09e-1)" "unprognostic (9.95e-2)" "prognostic favorable (5.50e-4)" "unprognostic (6.53e-2)" "unprognostic (1.42e-1)" "unprognostic (6.72e-2)" 24.2 19.0 14.0 13.2 15.7 7.0 13.5 11.9 12.4 14.7 12.3 16.8 12.3 12.5 17.5 16.3 12.8 20.8 16.5 10.4 14.1 9.3 13.1 13.6 11.9 13.7 13.6 10.0 17.8 19.7 12.8 17.4 8.8 10.5 17.4 9.4 18.0 15.0 11.1 9.7 8.8 12.4 14.7 11.7 17.5 13.3 7.8 11.3 10.0 13.0 12.0 12.4 14.2 13.6 18.0 28.7 18.5 25.2 19.1 14.0 15.4 7.6 15.1 9.6 11.6 8.9 12.4 5.8 7.7 5.9 6.0 7.8 1.5 22.8 9.7 19.4 4.7 9.2 9.0 6.0 7.3 8.0 13.5 8.6 21.7 4.1 6.1 8.8 6.8 8.1 9.7 9.8 10.6 12.7 9.7 8.7 12.1 8.7 12.4 10.3 3.9 1.7 14.3 7.8 21.1 14.4 10.0 11.6 7.4 5.3 7.7 8.3 12.5 10.5 4.2 5.4 5.9 20.0 9.8 11.1 7.3 6.7 8.6 8.3 7.2 6.0 8.0 5.9 14.2 12.9 18.5 25.2 10.1 14.0 18.8 12.2 18.0 13.3 13.2 28.7 13.7 11.5 13.5 9.6 19.1 17.4 24.9 11.7 15.4 14.0 15.7 11.9 12.4 14.1 9.3 13.6 10.0 10.5 11.3 17.9 12.0 16.9 15.8 10.8 6.9 7.7 10.2 20.1 6.8 14.0 0.0 24.0 23.2 17.4 1.1 15.8 5.2 0.0 14.1 15.6 17.7 11.9 3.5 13.9 37.3 22.3 10.4 17.2 20.5 1.1 9.5 19.0 16.9 21.6 10.0 21.8 12.4 0.0 15.6 16.2 12.2 25.8 16.5 14.6 10.2 12.4 8.1 13.6 13.3 15.2 TMEM222 "C1orf160, DKFZP564D0478" ENSG00000186501 "Transmembrane protein 222" Q9H0R3 1 27322145-27336400 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016579, HPA059374" Approved Approved "Plasma membrane,Cell Junctions,Cytosol" NA NA "Plasma membrane, Cytosol" "Cell Junctions" "HPA016579: AB_2669392, HPA059374: AB_2683995" "unprognostic (3.65e-1)" "unprognostic (5.27e-2)" "unprognostic (1.08e-1)" "unprognostic (1.39e-3)" "unprognostic (1.52e-1)" "unprognostic (1.33e-1)" "unprognostic (4.11e-2)" "unprognostic (1.16e-1)" "unprognostic (2.51e-2)" "unprognostic (1.96e-2)" "unprognostic (2.62e-2)" "unprognostic (1.45e-1)" "unprognostic (3.29e-3)" "unprognostic (5.28e-2)" "unprognostic (1.56e-1)" "unprognostic (3.83e-2)" "unprognostic (7.80e-2)" 18.4 22.0 28.0 12.0 31.4 19.5 17.8 23.2 45.4 18.1 17.1 32.1 13.2 14.4 16.5 25.0 22.8 29.8 21.3 27.5 28.9 30.8 20.6 35.0 18.8 15.0 26.0 20.8 22.3 24.6 19.9 22.4 20.0 26.7 22.9 14.3 26.4 21.7 25.2 19.9 15.6 21.3 18.6 21.5 15.2 16.7 20.7 16.4 19.4 24.0 14.9 19.1 17.8 13.3 22.8 19.9 36.5 21.0 19.2 23.2 15.7 12.2 14.9 12.5 20.5 19.6 14.2 10.1 19.0 21.9 26.0 22.2 6.1 25.8 7.8 14.9 20.2 12.1 17.0 13.7 18.5 10.9 10.3 26.3 13.0 12.4 14.0 29.1 12.9 13.0 24.8 10.5 24.9 14.2 12.0 17.3 15.6 9.8 18.1 16.2 10.9 18.5 13.6 23.5 12.7 18.7 15.4 8.7 15.7 25.2 7.2 27.0 23.8 14.7 20.8 18.3 4.7 20.5 20.9 15.8 15.4 13.0 24.7 17.9 19.5 17.3 8.1 23.3 25.1 22.1 19.3 13.7 17.0 22.3 20.3 17.0 22.8 20.7 17.0 12.0 18.9 20.9 21.4 36.5 19.2 21.0 19.9 23.2 15.7 28.0 31.4 23.2 45.4 28.9 30.8 26.0 20.8 26.7 16.4 8.9 15.7 15.7 11.9 10.4 39.6 7.7 10.2 5.3 5.7 12.2 13.7 26.0 33.2 33.2 19.8 15.4 22.2 23.3 35.0 28.5 23.5 15.6 16.2 11.3 24.4 41.3 28.7 9.2 9.1 60.6 18.7 11.4 25.3 29.7 17.4 52.7 36.4 17.5 18.7 17.0 17.1 12.9 14.6 18.9 17.7 11.8 25.7 22.3 19.1 10.1 TMEM229A ENSG00000234224 "Transmembrane protein 229A" B2RXF0 7 124030916-124033023 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.6;intestine: 16.4;testis: 10.6" "Cell type enhanced" "Detected in some" 18 "Bipolar cells: 3.3;Cytotrophoblasts: 1.9;Muller glia cells: 1.3" "Cancer enhanced" "Detected in some" "glioma: 2.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 44 "SH-SY5Y: 55.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056391 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA056391: AB_2683114" "unprognostic (2.52e-2)" "unprognostic (3.04e-2)" "unprognostic (2.30e-1)" "unprognostic (2.50e-1)" "unprognostic (2.89e-2)" "unprognostic (8.21e-2)" "unprognostic (4.74e-2)" "unprognostic (2.31e-1)" "unprognostic (4.31e-3)" 0.4 1.5 6.9 0.5 7.6 0.4 0.4 1.3 9.0 0.8 0.5 7.6 0.0 16.4 0.7 1.2 0.4 1.7 0.6 0.9 8.0 4.6 0.5 0.4 0.5 0.4 10.6 4.9 1.0 0.4 2.5 1.0 0.6 5.6 0.8 0.6 0.6 0.7 0.5 0.4 0.4 7.7 0.7 7.3 0.6 3.7 10.6 8.7 0.0 0.5 0.0 0.4 1.1 0.1 0.0 0.0 0.3 0.0 0.2 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.3 0.2 0.0 0.0 0.1 0.0 6.9 7.6 1.3 6.1 8.0 4.6 10.6 4.9 5.6 8.7 0.0 0.0 0.0 0.0 0.0 3.3 0.4 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.1 TMEM245 "C9orf5, CG-2" ENSG00000106771 "Transmembrane protein 245" Q9H330 9 109015152-109119945 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023892 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA023892: AB_1845828" "unprognostic (1.56e-2)" "unprognostic (1.65e-1)" "unprognostic (1.29e-1)" "unprognostic (9.58e-2)" "unprognostic (1.63e-1)" "unprognostic (6.43e-2)" "unprognostic (1.66e-1)" "unprognostic (5.96e-2)" "unprognostic (1.18e-1)" "unprognostic (1.03e-1)" "unprognostic (2.05e-1)" "unprognostic (1.85e-1)" "prognostic favorable (4.46e-9)" "unprognostic (6.11e-2)" "unprognostic (2.44e-1)" "unprognostic (2.41e-1)" "unprognostic (2.24e-2)" 16.5 35.5 14.4 7.2 18.1 4.0 24.2 15.7 20.6 14.0 19.2 14.7 22.0 7.7 18.4 17.3 14.6 18.7 15.3 25.2 12.6 14.9 29.0 16.2 20.5 12.3 14.5 14.8 29.0 20.3 43.2 14.9 17.5 13.7 16.4 10.7 22.1 14.5 22.3 29.8 9.2 16.8 23.1 13.6 10.4 17.2 12.2 14.3 12.3 52.1 8.9 7.5 20.8 11.2 3.5 3.5 6.3 3.3 5.4 9.0 2.7 13.7 18.4 13.6 4.6 32.0 18.4 30.0 19.9 15.4 21.5 17.0 24.6 27.7 12.5 20.4 15.1 20.9 21.8 17.2 12.8 25.5 16.1 7.4 15.4 15.4 14.5 14.0 11.7 12.2 19.6 13.1 20.9 19.4 23.2 17.9 13.8 10.3 13.8 24.4 9.1 15.5 5.4 15.1 18.6 16.6 8.9 27.0 7.7 22.9 13.5 7.5 7.4 13.1 13.2 13.1 21.1 17.5 6.6 19.6 16.8 12.6 15.6 22.6 9.2 23.8 4.0 23.3 6.3 24.3 6.3 2.6 2.2 4.0 1.8 4.9 2.7 6.8 5.6 2.5 3.5 9.0 6.2 1.0 5.4 3.3 3.5 6.5 2.7 14.4 18.1 15.7 20.6 12.6 14.9 14.5 14.8 13.7 14.3 107.2 79.6 16.9 16.5 22.3 43.1 117.8 63.7 32.1 31.8 82.0 100.1 40.7 3.3 19.7 5.9 48.2 31.1 93.5 27.0 14.5 19.9 23.7 30.1 82.0 15.7 60.4 30.0 48.5 21.0 5.4 38.0 15.7 21.9 10.0 34.9 49.9 24.5 34.3 48.1 28.4 30.3 45.3 36.0 28.7 40.4 24.8 12.6 17.3 34.3 19.9 TMEM254 "bA369J21.6, C10orf57, FLJ13263" ENSG00000133678 "Transmembrane protein 254" Q8TBM7 10 80078646-80092557 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA029105, HPA072613" Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA029105: AB_2672909, HPA072613: AB_2732205" "unprognostic (9.40e-2)" "unprognostic (1.76e-1)" "unprognostic (9.52e-2)" "unprognostic (5.74e-3)" "unprognostic (5.39e-2)" "unprognostic (6.04e-2)" "unprognostic (3.66e-1)" "unprognostic (3.90e-1)" "unprognostic (1.64e-2)" "unprognostic (1.87e-3)" "unprognostic (3.68e-2)" "unprognostic (1.46e-1)" "unprognostic (7.65e-2)" "unprognostic (2.46e-1)" "unprognostic (1.21e-1)" "unprognostic (3.45e-3)" "unprognostic (5.96e-2)" 8.4 13.4 10.8 6.0 14.1 4.7 15.9 6.9 13.5 14.1 13.1 11.7 14.7 10.1 12.4 40.1 35.8 17.3 10.5 4.8 9.4 6.3 10.0 30.8 6.8 9.0 7.7 9.0 8.7 12.1 8.3 10.1 14.8 9.5 25.8 13.7 10.7 16.3 9.1 3.0 43.9 13.4 6.6 8.2 6.9 9.0 21.5 8.8 8.6 11.8 12.4 15.4 13.0 20.5 12.6 14.7 27.7 18.1 9.8 22.9 11.9 7.3 7.0 11.9 9.1 14.6 18.3 18.1 7.1 5.2 5.2 5.3 5.3 22.7 5.6 12.1 9.0 4.9 7.8 4.8 5.9 5.5 9.2 8.5 1.5 2.3 7.4 6.6 6.9 7.5 11.8 26.9 4.6 4.0 11.3 4.6 4.8 4.1 12.2 5.2 14.9 5.6 5.1 6.4 6.4 23.0 6.9 1.4 4.8 7.2 6.1 4.2 6.9 6.6 16.5 7.1 8.3 23.4 4.6 6.7 4.1 7.1 6.9 4.0 8.4 11.9 0.4 10.3 7.1 3.4 27.7 16.2 7.4 11.9 18.1 14.9 12.6 13.8 12.3 13.2 9.6 22.9 15.6 1.7 9.8 17.6 14.7 16.0 11.9 10.8 14.1 6.9 13.5 9.4 6.3 7.7 9.0 9.5 8.8 8.9 8.1 6.0 5.0 7.2 7.4 2.6 15.3 37.5 14.8 8.7 15.7 33.9 18.3 12.1 3.1 5.2 10.5 0.0 7.5 30.9 5.3 21.9 5.7 28.8 17.1 15.9 8.1 5.5 11.1 5.9 8.6 9.2 3.3 16.2 22.8 14.5 9.5 18.2 11.0 17.0 11.1 12.9 3.8 24.2 8.7 21.0 19.0 6.9 18.7 6.5 TMEM258 C11orf10 ENSG00000134825 "Transmembrane protein 258" P61165 11 61768501-61792802 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044602 Approved Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA044602: AB_10961423" "unprognostic (6.35e-2)" "unprognostic (1.70e-1)" "unprognostic (7.49e-2)" "unprognostic (4.99e-3)" "unprognostic (9.95e-2)" "unprognostic (1.24e-2)" "unprognostic (3.18e-2)" "unprognostic (1.24e-1)" "unprognostic (8.48e-2)" "prognostic favorable (4.37e-4)" "unprognostic (1.34e-3)" "unprognostic (7.39e-2)" "unprognostic (4.75e-3)" "unprognostic (2.59e-2)" "unprognostic (1.02e-1)" "unprognostic (3.34e-2)" "unprognostic (2.58e-1)" 15.3 23.1 18.9 16.5 22.5 23.9 31.0 16.2 25.2 28.2 21.6 19.7 34.6 17.7 21.2 81.8 18.1 26.7 22.4 36.6 19.5 15.8 19.0 32.0 33.2 35.9 24.7 19.0 32.2 117.2 6.8 29.1 19.8 18.8 20.0 24.5 13.3 54.0 31.0 22.2 14.0 16.1 18.4 20.1 19.7 21.2 19.9 19.4 17.3 25.3 24.8 22.9 15.7 19.1 53.3 107.7 87.4 51.7 31.0 51.4 50.2 24.4 42.4 36.9 29.3 57.5 56.0 20.5 19.7 32.3 19.5 22.7 36.5 44.2 17.4 37.4 46.2 38.2 26.5 32.0 37.8 25.8 25.5 28.5 14.6 46.5 56.1 54.3 30.5 17.0 47.4 58.3 24.1 63.6 49.7 36.0 39.7 36.0 66.9 31.7 81.3 21.4 53.3 45.9 57.0 29.1 24.0 24.8 111.2 40.5 40.2 29.1 30.6 17.6 37.5 34.6 35.1 41.6 61.1 17.8 22.4 20.2 28.7 14.0 43.6 34.3 28.7 31.6 18.7 23.2 87.4 51.7 59.1 40.6 43.7 49.7 53.3 48.3 45.1 42.6 42.3 41.6 41.1 39.8 31.0 42.2 107.7 51.4 50.2 18.9 22.5 16.2 25.2 19.5 15.8 24.7 19.0 18.8 19.4 95.3 210.6 191.2 192.8 203.3 34.4 466.4 425.4 301.2 234.3 301.8 17.7 370.2 250.4 433.9 186.9 238.5 290.8 23.3 568.5 499.5 345.7 260.4 219.6 452.5 405.4 35.0 298.8 324.7 368.7 111.6 310.7 338.3 539.9 431.0 448.2 326.7 464.8 390.9 201.5 405.8 52.5 168.1 247.3 313.1 426.1 243.9 424.8 226.6 405.7 222.4 TMEM268 "C9orf91, DKFZp547P234, FLJ38045" ENSG00000157693 "Transmembrane protein 268" Q5VZI3 9 114611206-114646422 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 21 "Alveolar cells type 2: 9.3;Ciliated cells: 8.1;Hofbauer cells: 7.8;monocytes: 33.3;Syncytiotrophoblasts: 7.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 8.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 30.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017199 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA017199: AB_1845845" "unprognostic (8.57e-2)" "unprognostic (3.37e-1)" "unprognostic (8.33e-2)" "prognostic favorable (3.61e-4)" "unprognostic (2.09e-1)" "unprognostic (7.16e-2)" "unprognostic (3.55e-2)" "unprognostic (1.26e-1)" "unprognostic (1.87e-1)" "unprognostic (2.26e-2)" "unprognostic (2.22e-3)" "unprognostic (1.44e-1)" "unprognostic (6.67e-2)" "unprognostic (6.10e-2)" "unprognostic (7.65e-3)" "unprognostic (1.09e-2)" "unprognostic (1.47e-1)" 9.1 9.0 9.6 8.5 15.8 3.8 9.7 4.4 31.0 7.3 6.6 5.1 3.4 4.3 7.7 7.6 4.8 5.7 4.8 3.7 12.5 9.1 3.8 6.3 6.6 10.6 8.5 15.3 10.2 5.6 15.1 4.6 5.9 8.7 15.9 6.8 11.1 8.9 9.1 5.0 4.3 6.4 8.8 7.7 15.5 7.5 4.8 5.0 10.3 7.9 2.0 11.4 7.8 5.4 4.3 8.4 2.3 2.5 1.5 1.9 0.9 2.6 4.6 2.2 4.7 6.3 4.6 1.7 2.6 4.5 3.6 3.6 3.5 1.0 11.6 2.2 2.9 10.2 4.5 4.3 2.1 3.0 5.9 2.9 3.6 3.4 2.1 10.8 7.5 1.8 4.1 3.8 4.9 5.2 4.5 2.3 14.9 7.1 30.3 2.5 7.8 8.7 2.2 5.7 3.3 4.6 9.9 2.5 9.8 2.0 2.1 7.5 4.8 8.5 11.2 22.9 1.4 14.9 7.0 1.3 3.5 4.1 1.4 4.6 16.8 15.7 12.5 1.9 6.4 6.4 0.5 2.5 0.5 1.3 2.1 0.5 2.3 1.3 0.7 1.4 4.3 1.9 1.5 2.3 1.5 1.8 8.4 0.2 0.9 9.6 15.8 4.4 31.0 12.5 9.1 8.5 15.3 8.7 5.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 8.1 2.3 0.0 0.0 3.8 0.0 1.5 0.0 0.0 0.0 0.0 4.0 0.9 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 33.3 0.0 0.0 1.8 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 TMEM50A SMP1 ENSG00000183726 "Transmembrane protein 50A" O95807 1 25337917-25362361 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065192 Approved "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane" "Actin filaments, Cytosol" "HPA065192: AB_2685429" "unprognostic (2.41e-2)" "unprognostic (2.74e-1)" "unprognostic (5.17e-3)" "prognostic favorable (8.64e-5)" "unprognostic (1.45e-1)" "unprognostic (2.04e-2)" "prognostic unfavorable (3.34e-4)" "unprognostic (7.39e-2)" "unprognostic (7.92e-3)" "unprognostic (2.53e-1)" "unprognostic (1.02e-2)" "unprognostic (2.44e-2)" "unprognostic (2.39e-3)" "unprognostic (6.66e-2)" "unprognostic (2.91e-1)" "unprognostic (3.91e-3)" "unprognostic (3.44e-2)" 36.2 45.6 29.2 23.2 39.1 19.4 43.4 30.5 29.4 29.7 32.7 21.5 25.6 26.5 29.4 31.5 36.7 23.5 30.9 32.6 30.9 23.6 39.1 31.8 34.2 36.3 29.3 18.5 22.6 29.7 21.7 13.6 40.4 19.9 32.8 38.6 19.1 56.5 33.0 21.5 25.7 39.6 27.8 38.1 39.4 26.5 17.5 20.4 32.7 39.2 29.6 28.1 37.1 31.0 13.0 14.0 56.5 26.8 19.2 25.0 23.1 8.5 9.8 16.5 8.5 31.0 27.9 5.8 17.4 27.9 33.1 37.1 7.9 21.5 9.9 9.8 61.9 12.4 12.5 12.9 14.2 36.2 26.1 18.5 21.2 10.8 12.0 22.9 16.1 17.2 30.4 20.9 24.5 14.2 15.7 23.8 11.2 14.1 15.6 31.2 6.0 10.5 19.7 19.3 14.1 8.1 9.3 18.1 17.5 33.3 6.3 13.8 8.8 18.0 12.7 13.9 15.6 6.5 10.6 35.2 18.5 7.7 30.2 7.2 10.9 11.8 9.1 24.1 24.2 10.2 56.5 19.1 26.3 24.0 23.0 25.0 13.0 21.1 24.4 14.0 10.1 15.5 21.1 39.7 19.2 26.8 13.0 23.4 23.1 29.2 39.1 30.5 29.4 30.9 23.6 29.3 18.5 19.9 20.4 134.0 76.3 88.7 152.8 225.1 40.2 88.4 119.8 104.4 70.5 160.5 25.5 94.3 43.1 257.7 13.8 175.4 107.8 46.7 188.7 283.9 172.6 238.9 122.5 56.8 203.7 23.8 79.6 140.6 162.8 8.4 140.7 195.1 189.0 268.7 149.5 99.5 250.4 140.3 93.0 82.3 29.5 207.0 211.1 93.4 46.0 277.7 151.8 110.7 95.4 208.9 TMPRSS15 "ENTK, MGC133046, PRSS7" ENSG00000154646 "Transmembrane serine protease 15" P98073 21 18269116-18485879 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 67 "intestine: 154.6" "Cell type enriched" "Detected in single" 11 "Early spermatids: 4.2" "Group enriched" "Detected in some" 12 "liver cancer: 0.7;pancreatic cancer: 1.5;stomach cancer: 1.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 2.3" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 20 "U-138 MG: 20.3;U-87 MG: 56.6" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "olfactory region: 9.3" "HPA015611, HPA034857, HPA072934" Enhanced Approved "Nucleoli,Plasma membrane" NA NA "Plasma membrane" Nucleoli "HPA015611: AB_1855791, HPA034857: , HPA072934: AB_2732214" "unprognostic (9.26e-2)" "unprognostic (4.14e-1)" "unprognostic (3.52e-1)" "unprognostic (8.33e-2)" "unprognostic (1.19e-1)" "unprognostic (7.20e-2)" "unprognostic (4.70e-2)" "unprognostic (6.35e-2)" "unprognostic (5.92e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 80.5 0.0 0.0 154.6 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 42.4 0.0 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.3 0.0 0.5 0.1 0.6 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.3 0.0 0.1 0.0 0.3 0.0 0.1 56.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.3 0.1 0.5 0.6 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 TMTC2 DKFZp762A217 ENSG00000179104 "Transmembrane and tetratricopeptide repeat containing 2" Q8N394 12 82686880-83134870 "Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Bipolar cells: 30.2;Melanocytes: 30.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 3.1;myeloid DC: 2.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 16.6;WM-115: 40.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026954, HPA026955" Uncertain Approved "Plasma membrane,Actin filaments" No No "Plasma membrane" "Actin filaments" "HPA026954: AB_2256025, HPA026955: AB_10602282" "unprognostic (1.56e-1)" "unprognostic (5.62e-2)" "unprognostic (9.61e-2)" "unprognostic (7.38e-2)" "unprognostic (2.60e-2)" "unprognostic (3.66e-2)" "unprognostic (1.05e-2)" "unprognostic (1.58e-1)" "unprognostic (1.25e-1)" "unprognostic (7.16e-2)" "unprognostic (1.73e-3)" "unprognostic (5.06e-2)" "prognostic favorable (2.84e-5)" "unprognostic (1.10e-1)" "unprognostic (1.60e-1)" "unprognostic (2.06e-2)" "unprognostic (8.06e-2)" 4.7 1.7 9.1 8.9 19.7 2.9 5.9 8.1 15.7 8.1 12.5 27.3 15.2 4.6 8.5 7.4 11.4 15.4 11.9 3.1 13.4 8.7 10.6 1.7 9.6 2.8 17.6 15.3 3.1 6.6 6.5 4.7 5.1 14.3 9.9 9.1 2.5 8.3 30.3 2.0 7.4 6.2 10.4 22.5 2.2 13.1 4.6 18.0 0.4 7.9 1.1 4.3 10.5 11.5 0.8 2.6 0.0 3.1 0.0 0.3 0.9 0.8 3.3 16.6 0.1 2.2 2.1 1.5 1.0 0.3 0.9 0.1 0.2 1.7 0.0 0.3 5.9 0.6 1.4 4.8 2.5 0.2 3.7 2.8 0.0 2.5 0.1 0.2 1.1 0.5 0.6 2.2 0.1 0.8 1.7 1.4 1.8 0.0 2.2 0.2 1.7 0.8 4.3 0.6 3.0 2.8 0.0 0.7 0.3 1.5 7.2 4.4 8.0 1.5 2.4 10.8 3.0 2.5 0.2 0.8 2.9 0.9 3.7 1.3 4.1 2.8 0.6 0.6 1.9 40.4 0.0 3.1 0.0 0.1 1.0 0.3 0.8 0.3 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.9 9.1 19.7 8.1 11.6 13.4 8.7 17.6 15.3 14.3 18.0 8.9 6.2 2.4 14.8 12.8 30.2 1.1 15.3 10.7 15.9 14.0 7.9 9.2 0.0 3.9 5.6 8.0 2.6 0.0 7.1 1.6 7.9 11.3 0.0 1.0 1.8 7.9 2.4 1.3 9.8 4.0 5.5 5.5 30.4 1.8 8.2 12.1 8.1 2.9 1.1 1.4 1.6 6.5 2.1 0.4 0.9 10.0 3.4 1.3 4.8 12.8 TNFRSF10D "CD264, DcR2, TRAILR4, TRUNDD" ENSG00000173530 "TNF receptor superfamily member 10d" Q9UBN6 8 23135588-23164030 "Cancer-related genes, CD markers, Predicted membrane proteins" Apoptosis Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Endothelial cells: 31.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 9.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 24.5;LHCN-M2: 61.9;WM-115: 58.8" HPA070971 Approved "Plasma membrane,Actin filaments" NA NA "Plasma membrane, Actin filaments" "HPA070971: AB_2686330" "unprognostic (1.49e-1)" "prognostic unfavorable (1.70e-4)" "unprognostic (1.41e-1)" "unprognostic (8.78e-2)" "unprognostic (8.13e-2)" "unprognostic (7.49e-2)" "unprognostic (2.69e-1)" "unprognostic (7.06e-2)" "unprognostic (3.56e-2)" "unprognostic (1.66e-1)" "unprognostic (1.61e-2)" "unprognostic (1.32e-1)" "unprognostic (2.12e-2)" "unprognostic (2.70e-1)" "unprognostic (1.35e-2)" "unprognostic (6.32e-2)" "unprognostic (1.72e-1)" 16.0 3.1 4.9 7.3 10.0 10.5 10.2 3.4 10.3 5.9 8.5 2.6 5.5 6.2 8.9 5.7 4.1 8.0 11.5 6.5 7.0 3.4 12.1 31.5 12.5 5.1 9.0 0.9 9.8 5.2 2.5 4.3 4.1 9.0 9.0 10.9 3.9 3.9 4.4 3.9 3.1 11.2 10.9 6.3 6.9 7.2 4.3 9.2 2.9 6.0 6.8 6.6 7.3 26.0 2.1 4.5 2.4 3.3 0.3 9.0 2.4 3.5 3.1 4.0 2.3 3.1 12.3 0.0 19.2 7.3 1.4 2.0 5.9 3.0 0.0 4.0 11.4 0.0 1.2 3.3 16.8 12.7 0.0 3.0 1.0 1.8 5.0 13.5 0.6 1.3 15.4 18.8 5.1 3.5 18.0 24.5 0.1 0.0 0.0 61.9 0.0 0.0 1.9 3.2 10.6 0.0 0.7 0.0 0.9 4.7 1.6 0.0 0.0 2.0 0.0 0.0 9.5 0.0 2.4 14.5 0.0 0.0 1.1 0.0 0.0 0.0 0.0 16.0 0.9 58.8 2.4 3.3 1.5 0.0 1.4 0.1 2.1 3.2 1.1 4.5 0.8 9.0 3.5 2.2 0.3 1.9 0.0 1.0 2.4 4.9 10.0 3.4 10.3 7.0 3.4 9.0 0.9 9.0 9.2 0.0 12.7 0.5 3.2 4.4 0.0 1.4 2.5 5.3 5.7 1.8 0.0 0.1 0.0 5.7 0.4 31.4 5.9 0.0 1.8 0.2 2.5 4.7 7.0 6.6 2.6 0.0 1.7 11.6 9.8 0.0 0.3 3.6 8.5 1.0 4.8 0.3 8.4 2.9 0.4 2.1 0.0 0.0 11.7 0.7 2.7 2.0 0.1 1.3 6.3 3.3 TNFRSF12A "CD266, FN14, TweakR" ENSG00000006327 "TNF receptor superfamily member 12A" Q9NP84 16 3018445-3022383 "Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Angiogenesis, Apoptosis, Cell adhesion, Differentiation" "Developmental protein, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 81.3" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 1094.9;Ductal cells: 954.3;Exocrine glandular cells: 607.7;Pancreatic endocrine cells: 874.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 5 "pons and medulla: 25.0" "Group enriched" "Detected in many" 8 "eosinophil: 38.1;neutrophil: 29.9" "Lineage enriched" "Detected in many" 9 "granulocytes: 38.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA007853 Approved Approved "Plasma membrane,Cytosol" NA Yes 170000 "Plasma membrane, Cytosol" "HPA007853: AB_1858463" "unprognostic (1.44e-1)" "unprognostic (2.46e-3)" "unprognostic (8.90e-2)" "unprognostic (2.60e-1)" "unprognostic (4.06e-3)" "prognostic unfavorable (5.50e-4)" "unprognostic (7.04e-3)" "unprognostic (1.98e-3)" "unprognostic (4.17e-3)" "unprognostic (2.85e-1)" "unprognostic (5.02e-3)" "unprognostic (3.88e-1)" "prognostic unfavorable (8.78e-4)" "unprognostic (2.98e-2)" "unprognostic (6.00e-2)" "unprognostic (2.80e-3)" "unprognostic (2.17e-2)" 10.8 14.2 2.4 11.3 5.1 2.7 21.2 0.9 3.0 8.0 18.9 3.2 4.1 14.5 11.6 10.2 10.7 6.4 28.1 27.0 5.0 2.6 50.4 36.2 23.0 2.6 4.8 0.5 6.4 47.0 51.1 20.0 81.3 25.0 11.1 1.9 2.8 17.3 6.9 23.3 5.0 31.0 16.8 4.3 3.9 13.2 5.3 3.3 1.2 11.5 11.5 4.7 14.8 5.2 0.0 4.1 38.1 3.5 2.0 2.4 1.1 24.5 19.9 2.2 4.1 4.1 9.3 13.2 51.8 37.5 44.4 28.6 8.6 43.9 0.1 68.6 34.4 51.6 27.2 0.5 37.9 17.0 0.9 1.3 0.1 6.7 7.2 28.0 0.4 1.8 8.6 26.3 46.6 55.9 38.3 12.8 0.0 2.7 0.3 46.7 46.5 0.0 3.3 10.7 11.0 43.8 0.2 24.9 1.0 44.9 4.9 2.5 0.9 36.9 17.2 30.5 7.7 9.0 0.7 22.5 80.0 36.9 52.9 84.9 0.8 0.3 0.3 25.0 2.3 62.8 3.5 3.5 38.1 1.8 2.0 2.4 0.0 0.8 1.5 4.1 0.0 0.4 0.8 29.9 2.0 1.3 0.1 1.0 1.1 2.4 5.1 0.9 3.0 5.0 2.6 4.8 0.5 25.0 3.3 95.3 43.1 5.0 1094.9 544.0 0.9 57.7 163.1 50.9 130.8 172.7 2.0 112.5 54.7 954.3 0.6 22.7 41.3 0.0 607.7 131.7 179.4 600.3 58.8 15.3 38.1 0.0 26.1 28.8 4.6 0.4 5.8 29.4 106.3 16.2 4.6 20.6 874.5 25.8 6.3 93.5 5.1 6.5 212.1 7.7 4.1 314.4 158.1 8.6 12.4 560.0 TNFRSF25 "APO-3, DDR3, DR3, LARD, TNFRSF12, TR3, TRAMP, WSL-1, WSL-LR" ENSG00000215788 "TNF receptor superfamily member 25" Q93038 1 6461151-6466195 "Predicted membrane proteins, Predicted secreted proteins" Apoptosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.2;lymphoid tissue: 26.0;skin 1: 24.1" "Cell type enhanced" "Detected in many" 7 "Suprabasal keratinocytes: 25.0;T-cells: 36.2;Undifferentiated cells: 28.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 11 "cerebellum: 19.2" "Cell type enhanced" "Detected in many" "T-reg: 9.5" "Lineage enriched" "Detected in single" 10 "T-cells: 9.5" "Cell line enhanced" "Detected in many" "HDLM-2: 20.2;NB-4: 8.0;RPMI-8226: 19.7" "Group enriched" "Detected in some" 6 "amygdala: 1.2;cerebral cortex: 1.3;hippocampal formation: 2.3" "Not detected" "Not detected" HPA069834 Approved "Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites" "Secreted - unknown location" NA NA "Plasma membrane, Actin filaments, Focal adhesion sites" Nucleoplasm "HPA069834: " "unprognostic (8.09e-3)" "unprognostic (6.91e-3)" "prognostic unfavorable (4.46e-4)" "unprognostic (1.97e-1)" "unprognostic (9.63e-3)" "prognostic favorable (3.09e-4)" "unprognostic (2.16e-1)" "unprognostic (1.46e-1)" "unprognostic (2.04e-1)" "unprognostic (2.07e-1)" "unprognostic (6.01e-2)" "unprognostic (3.98e-2)" "prognostic unfavorable (1.65e-7)" "unprognostic (1.21e-1)" "unprognostic (1.61e-1)" "unprognostic (3.44e-1)" "unprognostic (8.68e-3)" 2.2 1.6 1.2 20.3 1.6 0.4 1.4 19.2 1.8 1.4 13.4 0.7 0.6 2.8 1.2 0.6 4.1 2.4 2.1 2.3 1.8 0.9 1.4 2.3 6.3 13.9 1.1 0.6 1.1 0.6 1.4 14.0 4.1 1.3 1.9 1.3 1.1 10.5 2.3 0.8 24.1 11.2 0.6 0.6 18.9 0.8 1.0 0.8 11.7 1.1 3.2 26.0 3.2 1.5 0.0 0.4 0.0 0.9 0.6 9.5 1.3 1.4 0.3 0.8 1.6 0.0 0.4 0.8 0.6 0.4 0.2 0.0 1.3 2.2 0.0 3.0 0.0 1.0 3.2 0.4 3.7 0.0 20.2 1.5 0.8 1.1 0.0 0.6 0.0 0.0 0.0 2.4 1.2 3.2 1.9 3.2 0.9 0.0 0.0 0.0 1.6 0.0 8.0 1.0 1.1 5.5 0.6 0.2 19.7 0.8 0.5 3.9 5.4 0.0 1.9 0.1 0.3 1.7 2.2 1.7 1.0 1.5 0.0 1.5 0.0 3.6 0.0 1.9 0.0 0.0 0.0 0.0 0.0 1.7 0.3 8.0 0.0 6.9 3.2 0.4 0.0 6.4 1.1 0.0 0.6 0.9 0.0 9.5 1.3 1.2 1.6 19.2 1.8 1.8 0.9 1.1 0.6 1.3 0.8 3.0 5.3 0.5 1.8 21.9 0.8 0.8 2.5 2.7 2.3 1.8 2.0 0.4 0.0 0.1 0.3 5.5 16.9 0.0 0.4 1.6 3.2 1.1 6.9 1.1 3.2 4.8 6.4 9.8 1.6 0.0 2.6 2.1 6.8 1.0 17.6 11.2 0.9 11.5 8.9 0.3 9.3 0.0 0.8 0.5 1.1 25.0 0.1 36.2 28.4 6.7 TNFRSF9 "4-1BB, CD137, ILA" ENSG00000049249 "TNF receptor superfamily member 9" Q07011 1 7915894-7943165 "Cancer-related genes, CD markers, Predicted membrane proteins" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "blood: 13.5;lymphoid tissue: 18.3" "Group enriched" "Detected in some" 4 "granulocytes: 62.3;monocytes: 53.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 5 "memory CD8 T-cell: 8.0;neutrophil: 6.6;NK-cell: 4.1;T-reg: 13.5" "Group enriched" "Detected in many" 5 "granulocytes: 6.6;NK-cells: 4.1;T-cells: 13.5" "Cell line enriched" "Detected in some" 8 "HDLM-2: 47.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA071425 Approved "Nucleoli,Plasma membrane" NA NA "Plasma membrane" Nucleoli "HPA071425: AB_2686394" "unprognostic (7.23e-2)" "unprognostic (1.72e-2)" "unprognostic (8.26e-3)" "unprognostic (1.32e-3)" "unprognostic (1.10e-1)" "unprognostic (1.98e-2)" "unprognostic (2.52e-1)" "unprognostic (1.04e-1)" "unprognostic (1.19e-4)" "unprognostic (9.47e-3)" "unprognostic (2.17e-2)" "unprognostic (2.02e-1)" "prognostic unfavorable (2.69e-8)" "unprognostic (1.64e-2)" "unprognostic (2.25e-2)" "unprognostic (1.19e-1)" "unprognostic (9.55e-2)" 0.8 1.0 0.3 11.0 0.3 1.9 0.5 0.2 0.3 0.4 0.5 0.1 0.1 0.6 0.3 0.1 0.6 0.8 1.6 1.8 0.3 1.0 0.7 0.7 2.1 10.8 0.3 0.1 0.3 0.6 0.0 0.5 0.2 0.5 0.4 0.7 0.3 2.1 0.1 0.3 0.5 2.3 0.1 0.3 7.9 0.7 0.5 0.1 18.3 0.7 0.9 17.5 1.4 0.4 0.5 1.1 6.6 1.5 4.1 13.5 1.1 1.2 0.4 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 1.0 0.4 0.1 0.4 0.0 0.8 0.2 0.0 0.2 0.5 47.0 0.1 0.2 0.2 0.0 0.9 0.0 0.5 0.1 0.3 0.1 0.1 0.2 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.2 0.1 0.1 0.1 0.2 0.1 0.0 0.7 0.0 0.2 0.2 0.2 1.6 0.1 0.2 0.1 0.1 0.1 5.8 0.2 0.0 1.1 1.5 0.2 1.5 0.4 0.2 0.2 1.0 8.0 1.1 0.5 0.3 1.6 6.6 4.1 0.1 0.3 13.5 1.1 0.3 0.3 0.2 0.3 0.3 1.0 0.3 0.1 0.5 0.1 0.0 1.7 0.0 0.4 0.2 0.0 0.3 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.8 0.0 0.7 0.0 0.0 1.0 0.0 0.4 0.3 62.3 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.0 1.8 5.0 53.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.4 0.0 12.9 0.0 0.3 TNNI2 "AMCD2B, DA2B, FSSV" ENSG00000130598 "Troponin I2, fast skeletal type" P48788 11 1838989-1841680 "Disease related genes, Predicted intracellular proteins" "Actin-binding, Muscle protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "skeletal muscle: 635.0;tongue: 527.7" "Group enriched" "Detected in many" 4 "Extravillous trophoblasts: 241.7;Syncytiotrophoblasts: 72.9" "Group enriched" "Detected in many" 10 "cervical cancer: 12.7;head and neck cancer: 33.6;pancreatic cancer: 12.9;urothelial cancer: 39.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 46.4" "Group enriched" "Detected in many" 4 "dendritic cells: 46.4;granulocytes: 26.7" "Group enriched" "Detected in some" 6 "CAPAN-2: 23.2;hTCEpi: 66.7" "Not detected" "Not detected" "Not detected" "Not detected" "CAB018697, HPA055938" Enhanced Approved "Plasma membrane,Intermediate filaments" NA NA 29000 "Plasma membrane" "Intermediate filaments" "CAB018697: AB_628400, HPA055938: AB_2682976" "unprognostic (2.03e-2)" "unprognostic (1.13e-1)" "unprognostic (1.29e-2)" "unprognostic (3.70e-1)" "unprognostic (1.85e-1)" "unprognostic (1.02e-2)" "unprognostic (9.99e-3)" "unprognostic (1.01e-1)" "unprognostic (1.73e-1)" "unprognostic (1.51e-1)" "unprognostic (1.10e-1)" "unprognostic (2.70e-1)" "unprognostic (1.23e-3)" "unprognostic (5.92e-3)" "unprognostic (5.62e-2)" "unprognostic (1.77e-1)" "unprognostic (2.79e-2)" 13.9 0.1 0.1 0.1 0.1 0.5 0.6 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 16.5 11.6 0.1 0.6 0.1 0.1 0.1 0.1 0.1 0.5 0.2 0.1 0.0 0.1 0.5 0.0 0.1 0.3 0.0 1.2 0.1 0.0 15.7 0.4 635.0 4.8 0.2 0.1 0.2 0.4 0.1 0.1 0.0 0.0 3.0 527.7 11.5 2.1 0.1 2.3 46.4 26.7 8.6 0.2 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.5 23.2 0.6 0.1 0.0 0.0 1.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.1 5.6 66.7 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 2.0 0.0 0.0 0.8 1.5 0.0 0.6 0.0 0.6 0.0 0.4 0.0 0.0 8.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 6.1 3.1 26.7 0.0 6.5 0.0 1.9 0.0 0.0 4.3 2.3 0.0 0.0 21.1 0.2 8.6 46.4 0.0 1.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 3.0 4.1 7.2 0.5 22.2 0.0 4.9 20.4 10.7 3.4 0.0 0.0 31.7 0.0 1.2 0.0 0.7 0.0 0.0 0.5 241.7 2.3 0.0 10.4 0.0 38.5 0.0 0.0 0.0 18.2 0.0 0.3 18.6 0.0 3.6 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 5.6 72.9 0.9 0.0 0.5 TOGARAM2 "Crescerin-2, FAM179A, FLJ43249, LOC165186" ENSG00000189350 "TOG array regulator of axonemal microtubules 2" Q6ZUX3 2 28956611-29061373 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.3;epididymis: 14.4;fallopian tube: 15.7;lung: 14.2" "Cell type enriched" "Detected in some" 5 "Ciliated cells: 56.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 3.7" "Lineage enriched" "Detected in single" 5 "T-cells: 3.7" "Cell line enhanced" "Detected in some" "HMC-1: 3.8;NB-4: 3.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA037561, HPA037562, HPA075216" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA037561: AB_10670384, HPA037562: AB_2675545, HPA075216: " "unprognostic (8.35e-5)" "unprognostic (2.85e-3)" "unprognostic (1.41e-1)" "unprognostic (7.01e-3)" "unprognostic (6.41e-2)" "unprognostic (1.23e-2)" "unprognostic (1.11e-1)" "unprognostic (2.53e-3)" "unprognostic (3.93e-1)" "unprognostic (6.83e-2)" "unprognostic (2.32e-3)" "unprognostic (5.92e-2)" "unprognostic (3.94e-11)" "unprognostic (3.75e-2)" "unprognostic (4.46e-1)" "unprognostic (2.01e-2)" "unprognostic (2.81e-3)" 0.3 2.3 3.0 1.7 8.4 2.6 0.4 3.4 1.7 0.6 0.6 7.1 0.0 0.8 1.1 14.4 0.7 15.7 0.5 2.6 3.3 3.9 0.3 0.5 14.2 1.1 2.1 2.0 4.5 0.8 0.1 6.1 0.6 15.3 0.5 0.4 0.1 0.5 0.1 1.7 0.6 0.7 0.8 2.5 2.2 1.5 3.2 6.1 0.0 0.3 0.3 1.3 0.4 0.3 0.3 0.3 0.6 0.3 0.6 3.7 1.0 0.2 0.2 0.3 0.2 0.3 0.0 0.7 0.1 2.3 0.7 2.2 0.4 0.3 0.3 0.3 0.0 0.3 0.9 0.4 0.0 0.7 0.4 1.4 0.2 2.0 0.5 0.9 2.0 3.8 0.2 0.3 0.0 0.0 0.8 0.3 2.7 0.3 1.0 0.8 0.2 0.8 3.6 2.7 1.2 0.7 0.1 0.7 1.5 1.1 0.3 2.6 1.8 0.1 0.1 0.1 0.4 0.4 0.2 0.2 0.2 0.5 0.2 0.3 0.5 0.5 0.2 1.7 1.3 0.1 0.5 0.3 0.3 3.7 0.1 2.0 0.2 0.6 2.9 0.1 0.3 0.4 1.0 0.6 0.6 0.2 0.3 1.5 1.0 3.0 8.4 3.4 1.2 3.3 3.9 2.1 2.0 15.3 6.1 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 56.2 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 TOLLIP IL-1RAcPIP ENSG00000078902 "Toll interacting protein" Q9H0E2 11 1274371-1309654 "Plasma proteins, Predicted intracellular proteins" "Autophagy, Immunity, Inflammatory response, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Late spermatids: 368.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038621, HPA038622" Enhanced Approved "Plasma membrane,Cytosol" NA NA 34000 "Plasma membrane, Cytosol" "HPA038621: AB_10673177, HPA038622: AB_10675946" "unprognostic (8.39e-2)" "unprognostic (1.89e-1)" "unprognostic (2.18e-2)" "unprognostic (6.08e-2)" "prognostic unfavorable (5.45e-4)" "unprognostic (8.89e-2)" "unprognostic (2.51e-1)" "unprognostic (8.53e-2)" "unprognostic (2.17e-1)" "unprognostic (1.55e-2)" "unprognostic (1.90e-2)" "unprognostic (2.74e-1)" "prognostic favorable (1.11e-16)" "unprognostic (2.72e-1)" "unprognostic (1.46e-1)" "unprognostic (3.21e-2)" "unprognostic (1.29e-2)" 15.3 16.7 31.2 8.8 32.5 9.0 11.9 28.3 63.0 10.7 12.7 12.9 8.6 18.6 8.3 10.3 29.4 10.7 13.7 15.8 28.0 20.3 20.9 37.1 12.3 9.6 18.1 32.1 12.8 41.8 13.7 18.7 9.9 17.4 15.6 6.6 12.9 15.9 16.8 23.4 24.0 15.7 9.0 13.5 13.2 15.1 24.5 11.8 5.9 12.6 11.8 10.9 14.6 14.8 13.9 26.9 49.0 34.8 11.1 12.6 18.3 15.5 16.5 8.4 9.5 18.0 11.3 7.3 13.8 12.6 16.3 14.5 17.8 9.9 7.3 13.4 12.7 24.9 14.1 7.5 16.9 4.4 14.9 15.3 5.9 3.5 26.7 25.7 11.2 15.1 17.0 19.9 9.6 9.3 8.9 10.1 11.1 9.7 19.8 13.3 13.0 14.2 13.8 10.2 16.9 21.9 10.8 8.6 7.2 10.7 20.8 22.6 13.3 12.4 15.1 15.2 4.5 11.9 12.8 18.4 17.7 7.6 7.4 7.9 20.2 17.9 8.9 27.8 7.4 13.8 9.5 34.8 35.9 9.6 30.0 8.0 10.9 10.3 8.9 26.9 13.9 8.1 7.6 49.0 11.1 27.5 14.1 12.6 18.3 31.2 32.5 28.3 63.0 28.0 20.3 18.1 32.1 17.4 11.8 8.9 20.0 26.9 36.3 59.4 38.5 20.3 48.4 8.1 11.4 22.7 7.9 44.1 59.7 60.5 147.2 26.6 50.7 0.0 59.7 34.1 29.7 40.2 38.0 95.4 77.7 69.9 49.7 36.8 41.9 368.3 20.1 32.1 67.4 51.3 30.4 38.6 64.1 38.6 29.0 95.9 16.9 6.5 26.9 57.0 27.2 86.4 87.3 22.3 24.9 55.4 TOM1 ENSG00000100284 "Target of myb1 membrane trafficking protein" O60784 22 35299275-35347994 "Cancer-related genes, Predicted intracellular proteins" "Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 83.8" "Cell type enhanced" "Detected in many" 6 "Syncytiotrophoblasts: 142.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000818, HPA001749" Approved Approved "Plasma membrane,Centriolar satellite,Cytosol" NA NA 14000 Cytosol "Plasma membrane, Centriolar satellite" "HPA000818: AB_2666101, HPA001749: AB_1080323" "unprognostic (3.75e-1)" "unprognostic (8.07e-2)" "unprognostic (5.18e-2)" "prognostic favorable (2.20e-5)" "unprognostic (1.11e-2)" "unprognostic (7.55e-2)" "unprognostic (4.07e-3)" "unprognostic (2.24e-1)" "unprognostic (9.92e-2)" "unprognostic (2.32e-1)" "unprognostic (3.71e-1)" "unprognostic (8.16e-2)" "prognostic favorable (3.72e-5)" "unprognostic (1.22e-1)" "unprognostic (1.30e-1)" "unprognostic (7.54e-3)" "unprognostic (3.31e-2)" 17.0 21.2 9.5 10.2 13.8 31.1 13.7 10.2 24.6 16.0 14.6 12.0 7.5 17.4 14.1 15.5 31.6 11.7 15.4 19.1 8.8 15.2 16.1 27.4 17.5 8.2 11.6 11.3 12.1 11.8 21.8 16.8 39.0 23.2 10.2 6.4 17.5 37.0 10.1 83.8 29.1 18.6 7.1 8.4 10.6 8.4 13.6 8.7 10.0 14.8 25.9 19.9 12.1 17.6 4.6 15.2 40.9 31.2 4.6 14.7 17.0 6.7 6.8 3.9 6.4 28.4 16.9 18.8 6.7 20.1 12.9 14.5 9.4 6.3 2.7 12.4 20.7 8.4 3.1 4.1 7.0 4.6 7.6 9.3 2.2 7.7 19.7 26.8 4.3 10.2 22.8 8.7 18.2 6.3 8.8 9.0 5.1 4.4 6.7 6.3 6.5 3.4 10.1 3.0 8.4 4.0 6.3 5.7 5.7 5.1 5.1 6.8 5.2 15.1 15.6 14.8 3.5 8.0 7.1 9.3 15.4 13.3 11.7 3.2 7.8 4.9 7.0 20.6 4.5 5.0 5.9 31.2 13.1 6.4 18.9 5.3 4.6 9.8 6.1 15.2 4.0 7.9 5.3 40.9 4.6 19.4 8.1 14.7 17.0 9.5 13.8 10.2 24.6 8.8 15.2 11.6 11.3 23.2 8.7 20.8 37.5 13.7 9.2 11.3 9.7 19.8 10.2 14.7 20.5 12.2 11.8 57.0 23.2 33.4 21.6 14.1 43.9 0.0 34.2 48.4 23.6 12.1 22.0 27.7 54.8 11.1 15.5 14.7 31.9 17.5 10.6 37.8 18.6 22.6 16.2 19.9 27.7 15.3 12.0 28.5 8.1 6.5 16.7 9.9 5.3 19.2 142.3 10.9 12.7 9.1 TPD52L1 "D53, hD53" ENSG00000111907 "Tumor protein D52 like 1" Q16890 6 125119049-125264407 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 95.2;salivary gland: 104.6" "Cell type enhanced" "Detected in many" 6 "Collecting duct cells: 118.7;Distal tubular cells: 149.2;Exocrine glandular cells: 97.5;Extravillous trophoblasts: 106.8;Melanocytes: 124.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 52.5;hTCEpi: 46.2;MCF7: 68.6;RPTEC TERT1: 53.2;SK-BR-3: 37.1;T-47d: 31.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027915, HPA027916" Enhanced Approved "Plasma membrane,Cell Junctions,Cytosol" NA NA "Plasma membrane, Cell Junctions, Cytosol" "HPA027915: AB_10602074, HPA027916: AB_10601860" "unprognostic (1.44e-1)" "unprognostic (2.01e-2)" "unprognostic (2.76e-2)" "unprognostic (1.26e-1)" "unprognostic (1.39e-1)" "unprognostic (2.87e-2)" "unprognostic (1.38e-2)" "unprognostic (2.14e-1)" "unprognostic (7.85e-2)" "unprognostic (7.80e-2)" "unprognostic (9.42e-3)" "unprognostic (1.76e-1)" "prognostic favorable (3.26e-4)" "unprognostic (1.06e-1)" "unprognostic (6.83e-2)" "prognostic favorable (3.97e-4)" "prognostic unfavorable (5.34e-4)" 10.3 95.2 31.5 4.3 47.5 1.0 25.7 2.6 32.9 10.5 8.5 9.2 31.0 4.3 6.2 27.6 43.3 13.9 10.8 26.0 21.4 9.5 11.7 22.0 4.7 2.9 15.4 12.8 9.0 18.0 10.3 8.7 4.0 16.1 16.6 5.8 13.0 104.6 32.7 34.4 11.8 4.6 27.1 5.5 1.4 10.3 2.6 18.2 0.0 23.5 20.1 11.0 18.1 14.6 1.1 0.9 5.9 1.2 5.3 1.7 1.0 7.0 8.0 0.0 52.5 0.4 0.1 12.5 1.2 1.1 0.0 0.1 12.8 9.0 0.0 27.0 5.9 1.7 16.2 1.6 11.2 0.0 0.1 11.2 0.1 11.3 0.1 1.1 0.0 0.0 1.4 46.2 0.0 6.1 16.4 0.0 0.0 5.6 0.1 0.9 68.6 0.0 0.1 0.8 6.9 4.4 0.0 0.0 0.0 53.2 1.8 1.7 0.0 13.5 37.1 0.8 2.0 31.6 0.1 0.0 0.3 1.1 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.1 2.7 1.2 0.8 0.8 0.6 0.8 0.8 1.3 0.6 0.5 1.1 1.7 1.2 5.9 5.3 0.3 0.9 0.4 1.0 31.5 47.5 2.6 32.9 21.4 9.5 15.4 12.8 16.1 18.2 0.0 21.2 0.5 40.2 17.4 1.7 40.6 17.8 13.4 13.6 118.7 3.9 27.1 149.2 28.9 5.4 30.1 4.6 0.0 97.5 106.8 3.1 35.2 2.3 56.3 9.5 0.0 15.5 4.3 1.9 3.4 16.1 4.1 124.9 1.0 9.1 3.2 37.3 0.0 34.3 26.2 1.3 0.0 15.6 2.8 5.3 32.5 12.0 2.9 9.7 17.9 TPRN "C9orf75, DFNB79, FLJ90254" ENSG00000176058 Taperin Q4KMQ1 9 137191617-137204193 "Disease related genes, Predicted intracellular proteins" Hearing "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 32.8;pancreas: 45.3" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 109.1;Mucus-secreting cells: 43.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 27.8;T-47d: 26.9" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 40.9" "HPA020899, HPA076667" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA020899: AB_1845835, HPA076667: " "unprognostic (5.41e-2)" "prognostic favorable (2.13e-4)" "unprognostic (2.94e-1)" "unprognostic (9.28e-2)" "unprognostic (1.68e-1)" "unprognostic (2.61e-2)" "unprognostic (3.59e-3)" "unprognostic (8.20e-2)" "unprognostic (9.96e-2)" "unprognostic (1.21e-1)" "unprognostic (1.89e-2)" "unprognostic (4.77e-2)" "prognostic favorable (5.16e-9)" "unprognostic (1.96e-3)" "unprognostic (6.35e-2)" "unprognostic (1.51e-1)" "unprognostic (5.44e-2)" 3.2 3.8 8.5 5.0 16.8 3.2 3.3 26.1 17.9 3.4 18.5 32.8 2.3 23.6 2.8 1.8 8.2 4.2 4.8 3.6 11.2 7.0 12.1 10.0 5.8 3.0 25.3 7.1 4.7 45.3 2.8 2.7 4.3 11.0 4.4 8.1 13.1 8.7 4.8 5.0 8.0 29.0 2.4 11.9 3.7 10.8 4.7 21.7 0.2 2.5 2.3 3.5 3.8 2.7 1.2 2.3 0.2 2.9 2.9 2.2 0.6 4.5 5.2 1.7 7.9 2.5 2.6 14.1 3.2 2.0 3.3 1.8 17.4 5.6 8.4 4.8 1.6 4.3 14.0 3.6 1.8 0.4 5.3 5.1 3.9 7.8 11.4 3.7 6.0 5.1 2.2 3.5 2.9 2.0 2.1 2.0 3.8 7.1 3.0 0.9 27.8 3.9 13.0 6.3 25.0 6.8 11.8 4.2 12.7 7.3 9.6 11.5 4.2 4.9 23.2 5.7 1.4 26.9 9.5 2.3 6.0 2.8 9.4 6.8 2.5 4.8 4.3 4.3 5.4 3.3 0.0 2.9 0.2 1.3 2.6 0.4 1.1 1.3 1.8 2.1 1.2 0.6 1.2 0.0 2.9 1.5 2.3 2.2 0.6 8.5 16.8 26.1 17.9 11.2 7.0 25.3 7.1 11.0 21.7 17.9 5.6 2.7 1.1 1.5 15.5 7.3 12.7 1.4 1.2 15.7 5.9 4.7 6.6 7.1 2.3 1.9 109.1 23.3 38.5 1.1 1.6 2.8 1.1 14.4 3.1 11.1 8.6 4.3 3.2 3.8 3.1 2.1 5.0 1.8 43.9 10.9 16.4 23.2 4.2 16.6 5.9 6.5 1.7 1.0 5.5 2.5 1.6 0.0 21.2 1.7 TRAF7 "DKFZp586I021, MGC7807, RFWD1, RNF119" ENSG00000131653 "TNF receptor associated factor 7" Q6Q0C0 16 2155698-2178129 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation, Ubl conjugation pathway" Transferase "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041229 Approved Supported "Vesicles,Plasma membrane" NA NA Vesicles "Plasma membrane" "HPA041229: AB_10794194" "unprognostic (1.94e-1)" "unprognostic (5.97e-2)" "unprognostic (1.13e-1)" "unprognostic (4.23e-2)" "unprognostic (1.09e-1)" "unprognostic (1.03e-1)" "unprognostic (1.65e-2)" "unprognostic (2.77e-3)" "unprognostic (7.08e-2)" "unprognostic (3.52e-2)" "unprognostic (1.52e-2)" "unprognostic (1.08e-1)" "unprognostic (9.23e-2)" "unprognostic (6.07e-2)" "unprognostic (2.99e-2)" "unprognostic (2.43e-1)" "unprognostic (8.48e-2)" 16.0 18.2 18.3 22.3 20.6 28.5 39.1 28.7 25.6 22.1 29.4 9.1 21.1 37.3 20.4 18.3 32.9 21.9 36.9 21.0 18.3 14.8 21.3 47.3 18.3 40.9 13.4 14.7 19.3 41.6 17.7 20.3 19.5 12.8 16.2 16.9 13.0 24.4 23.1 25.5 32.2 37.8 28.8 14.1 21.4 25.1 13.2 10.6 26.1 20.3 30.9 21.9 21.9 28.9 6.7 12.3 7.7 13.9 3.0 7.1 5.2 20.7 26.6 15.2 27.2 15.8 29.8 17.9 16.0 20.2 18.9 17.1 32.3 26.8 13.3 19.0 20.4 12.1 24.4 14.2 28.4 7.2 21.0 18.2 19.0 35.4 24.7 20.9 20.2 27.6 29.5 23.8 18.2 23.9 15.6 36.5 26.4 20.3 18.0 18.0 47.5 20.7 23.5 29.9 28.7 13.0 38.7 25.3 26.7 15.2 11.2 30.7 25.5 13.4 25.8 17.5 8.3 29.3 24.9 27.5 23.0 32.4 21.4 17.4 26.1 19.3 17.6 13.1 13.1 17.8 3.7 10.0 7.7 5.4 13.9 5.0 6.7 5.3 5.7 12.3 4.9 3.8 4.5 6.9 3.0 9.4 6.0 7.1 5.2 18.3 20.6 28.7 25.6 18.3 14.8 13.4 14.7 12.8 10.6 0.0 8.6 11.9 15.5 25.5 14.6 3.4 17.8 4.0 4.5 14.0 5.9 20.5 14.9 35.4 3.8 23.9 60.0 0.0 51.6 30.1 20.0 27.8 9.2 26.1 37.6 35.0 32.6 23.4 38.3 9.1 23.0 18.8 10.1 35.1 35.9 10.5 45.1 40.3 20.8 18.9 8.9 6.5 16.0 4.8 21.5 28.4 22.3 12.9 33.8 29.6 TRAPPC13 "C5orf44, FLJ13611, FLJ26957, MGC48585" ENSG00000113597 "Trafficking protein particle complex 13" A5PLN9 5 65624716-65666233 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037777 Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA037777: AB_10672464" "unprognostic (3.66e-2)" "unprognostic (3.27e-1)" "unprognostic (1.54e-2)" "unprognostic (7.22e-2)" "unprognostic (4.79e-2)" "unprognostic (1.16e-2)" "unprognostic (2.55e-2)" "unprognostic (2.49e-2)" "unprognostic (5.70e-2)" "unprognostic (5.75e-2)" "unprognostic (3.49e-2)" "unprognostic (1.92e-1)" "prognostic favorable (8.66e-4)" "unprognostic (2.89e-1)" "unprognostic (2.58e-2)" "unprognostic (2.53e-2)" "unprognostic (6.25e-2)" 10.4 12.9 16.1 10.3 22.5 7.5 14.0 14.5 22.7 12.1 11.3 12.8 10.2 9.8 11.9 10.4 13.4 9.7 9.8 17.7 17.1 17.7 21.6 16.9 11.0 10.2 17.3 14.2 10.1 8.2 20.6 22.4 11.8 19.5 20.6 14.3 10.5 9.9 12.4 15.2 8.0 13.3 13.9 18.9 10.7 11.0 10.6 15.1 18.0 18.7 11.7 10.8 11.5 9.9 6.6 10.1 14.7 13.7 9.1 13.1 9.8 12.8 8.7 13.8 24.8 10.7 13.7 13.3 15.3 13.9 18.9 20.8 7.4 18.2 13.1 16.9 12.3 20.4 11.9 15.6 15.9 22.4 9.1 11.5 8.4 10.9 6.8 14.6 10.2 12.7 9.7 12.6 14.7 19.0 11.5 16.7 19.2 10.0 12.5 16.7 13.5 17.0 3.9 6.3 7.6 4.7 14.9 17.3 15.2 13.8 14.7 17.4 12.5 18.7 11.3 14.0 8.0 16.4 13.4 11.4 6.7 9.3 14.8 15.4 8.3 16.0 20.9 14.1 18.5 12.7 14.7 9.4 3.8 10.1 10.1 13.1 6.6 9.9 8.4 10.1 5.4 9.9 9.9 3.6 9.1 13.7 7.6 10.4 9.8 16.1 22.5 14.5 22.7 17.1 17.7 17.3 14.2 19.5 15.1 17.9 10.9 3.7 6.2 5.0 12.2 5.9 15.3 9.4 6.8 7.0 9.8 10.4 13.3 10.8 15.5 11.2 7.9 0.0 9.3 8.2 8.5 9.8 3.5 9.7 10.9 12.7 14.9 8.6 12.6 7.9 6.9 9.9 6.8 10.0 8.4 11.8 8.6 3.5 12.4 18.9 14.3 6.5 10.1 15.1 8.0 5.9 12.7 8.3 8.3 10.8 TRDN ENSG00000186439 Triadin Q13061 6 123216339-123637093 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 52.8;skeletal muscle: 215.5;tongue: 80.1" "Group enriched" "Detected in some" 21 "Cardiomyocytes: 855.7;Muller glia cells: 805.6" "Cancer enhanced" "Detected in some" "head and neck cancer: 2.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 30 "basophil: 2.9" "Lineage enriched" "Detected in single" 30 "granulocytes: 2.9" "Cell line enhanced" "Detected in some" "HAP1: 1.6;K-562: 1.8;MCF7: 6.1;SCLC-21H: 1.2;SK-BR-3: 2.0" "Region enriched" "Detected in single" 10 "olfactory region: 13.6" "HPA038226, HPA058226" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA038226: AB_10795574, HPA058226: AB_2683643" "unprognostic (1.05e-2)" "unprognostic (1.99e-1)" "unprognostic (9.20e-2)" "unprognostic (3.06e-3)" "unprognostic (2.40e-1)" "unprognostic (2.38e-1)" "unprognostic (2.42e-1)" "unprognostic (8.42e-2)" "unprognostic (8.71e-2)" "unprognostic (9.93e-3)" "unprognostic (2.12e-1)" "unprognostic (2.55e-2)" "unprognostic (3.97e-2)" 3.8 0.4 0.4 0.0 0.5 0.0 0.3 0.2 0.2 0.3 0.1 0.0 0.7 0.1 0.3 9.2 3.0 1.9 0.1 52.8 1.6 1.3 0.1 0.1 0.1 0.1 1.6 0.1 1.5 0.1 0.0 3.2 0.1 1.3 1.9 0.1 1.3 2.0 0.2 215.5 0.1 0.1 0.2 3.4 0.1 0.1 0.7 0.5 0.0 1.2 80.1 1.6 0.1 0.1 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.2 0.0 6.1 0.0 0.0 0.2 0.8 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 2.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.0 0.2 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.2 0.2 1.6 1.3 1.6 0.1 1.3 0.5 0.0 0.0 0.0 0.0 0.0 5.8 855.7 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 40.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 22.9 12.0 0.0 1.7 0.0 0.0 805.6 0.0 0.0 10.6 0.0 13.4 0.0 0.8 0.1 0.5 0.0 0.0 0.0 0.0 0.0 TRIB1 "C8FW, GIG2, TRB1" ENSG00000173334 "Tribbles pseudokinase 1" Q96RU8 8 125430321-125438405 "Enzymes, Predicted intracellular proteins" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 84.2;thyroid gland: 90.7" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 2: 192.3;Basal glandular cells: 267.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "eosinophil: 10.8;neutrophil: 5.8;non-classical monocyte: 3.7;T-reg: 3.1" "Group enriched" "Detected in many" 11 "granulocytes: 10.8;monocytes: 3.7;T-cells: 3.1" "Cell line enhanced" "Detected in many" "HEL: 55.1;U-266/70: 33.8;U-266/84: 33.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063982 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA063982: AB_2685165" "unprognostic (1.90e-3)" "unprognostic (1.45e-1)" "unprognostic (8.80e-3)" "unprognostic (1.34e-2)" "unprognostic (3.56e-1)" "unprognostic (2.32e-1)" "unprognostic (2.00e-1)" "unprognostic (4.57e-2)" "unprognostic (4.12e-2)" "unprognostic (1.62e-2)" "unprognostic (6.81e-3)" "unprognostic (9.36e-2)" "unprognostic (2.97e-3)" "unprognostic (1.94e-1)" "unprognostic (1.04e-2)" "unprognostic (5.55e-2)" "unprognostic (2.08e-2)" 26.7 6.5 5.9 17.6 6.5 84.2 13.3 4.3 6.1 10.4 12.4 4.4 6.6 4.9 6.2 6.7 10.9 10.9 21.0 11.1 4.3 4.0 16.6 63.5 28.9 14.6 4.2 3.9 6.4 23.6 20.9 7.2 15.5 4.5 12.1 13.3 15.0 14.5 9.1 22.3 10.4 16.9 11.3 3.1 15.9 18.5 5.6 3.1 9.2 90.7 17.6 12.1 12.4 9.0 0.2 0.5 10.8 3.7 0.0 3.1 0.1 4.1 4.7 0.6 1.3 1.3 2.7 7.5 2.7 3.8 2.0 0.6 6.3 5.5 7.5 2.5 1.9 12.1 3.1 2.0 2.6 1.7 3.3 9.9 55.1 2.1 12.3 3.5 27.5 5.0 2.6 4.0 8.2 18.8 9.8 5.8 0.1 4.8 24.0 0.2 4.4 2.5 4.3 4.6 9.9 9.2 5.2 0.9 8.2 16.2 15.8 4.0 1.5 6.6 7.2 26.2 4.3 1.9 1.3 3.0 2.2 2.8 2.1 3.3 33.8 33.7 10.5 3.9 0.2 5.1 0.0 0.9 10.8 0.0 1.2 0.0 0.2 0.1 0.0 0.5 0.0 0.0 0.0 5.8 0.0 3.7 0.3 3.1 0.1 5.9 6.5 4.3 6.1 4.3 4.0 4.2 3.9 4.5 3.1 125.0 192.3 11.2 267.7 89.0 20.4 14.4 17.8 33.5 64.8 15.7 0.0 9.2 10.0 31.3 0.4 32.9 172.0 0.0 21.2 17.2 32.4 153.9 29.9 128.8 29.9 20.6 107.4 8.6 53.9 1.4 0.3 47.3 54.0 40.5 87.2 21.4 42.4 51.5 0.4 21.6 3.4 0.0 14.4 0.0 1.3 56.1 25.6 4.5 56.6 79.9 TRIM16 EBBP ENSG00000221926 "Tripartite motif containing 16" O95361 17 15627960-15684311 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 52.9" "Cell type enhanced" "Detected in many" 8 "Pancreatic endocrine cells: 96.1;Suprabasal keratinocytes: 67.9;Urothelial cells: 116.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "T-reg: 25.1" "Lineage enriched" "Detected in many" 11 "T-cells: 25.1" "Cell line enhanced" "Detected in many" "A549: 58.6;HaCaT: 47.3;HeLa: 42.7;OE19: 74.3" "HPA023623, HPA066431" Uncertain Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA023623: AB_1858273, HPA066431: AB_2685668" "unprognostic (2.14e-1)" "unprognostic (1.95e-1)" "unprognostic (9.61e-2)" "unprognostic (1.31e-2)" "unprognostic (6.19e-2)" "unprognostic (1.21e-1)" "prognostic unfavorable (3.94e-4)" "unprognostic (1.94e-3)" "unprognostic (3.75e-2)" "unprognostic (4.65e-1)" "unprognostic (3.31e-3)" "unprognostic (1.70e-1)" "unprognostic (2.16e-3)" "unprognostic (2.08e-1)" "unprognostic (8.48e-2)" "unprognostic (9.21e-3)" "prognostic unfavorable (6.71e-4)" 6.1 13.5 7.4 4.8 12.8 7.0 6.7 7.4 11.7 16.0 5.0 7.8 6.6 10.2 7.0 2.8 52.9 4.0 7.5 6.5 8.0 4.4 5.7 2.2 6.2 10.9 11.3 5.6 3.7 6.2 1.9 5.7 15.8 9.8 4.1 5.2 5.0 14.7 5.7 11.4 15.6 5.5 5.4 5.9 4.6 14.4 5.5 7.8 4.7 7.4 5.3 16.3 11.7 23.3 0.4 1.5 0.6 2.3 0.5 25.1 1.3 18.3 58.6 1.8 4.0 8.7 10.0 2.0 3.0 10.8 3.8 5.3 3.5 24.0 2.0 11.6 13.3 22.7 47.3 5.3 13.6 2.5 24.3 3.4 0.9 42.7 1.9 14.5 1.0 2.0 5.5 8.6 8.3 4.8 10.6 8.1 2.3 1.1 9.6 10.2 6.5 4.0 2.3 2.7 74.3 3.5 1.7 15.1 1.4 19.4 23.9 1.3 3.8 13.4 15.2 4.5 11.1 2.3 2.5 12.5 4.8 5.7 2.3 10.4 2.3 2.5 0.1 7.4 2.5 12.1 0.1 2.3 0.6 0.8 0.6 0.5 0.3 3.0 0.9 1.5 0.4 0.8 1.6 0.5 0.5 0.3 0.3 25.1 1.3 7.4 12.8 7.4 11.7 8.0 4.4 11.3 5.6 9.8 7.8 35.7 1.6 3.7 46.8 27.4 6.4 8.8 10.2 5.3 12.5 10.4 17.7 12.0 0.0 46.8 0.8 16.1 4.3 0.0 15.3 6.7 10.5 16.4 4.6 2.4 3.5 3.2 4.1 3.7 2.6 2.0 6.6 4.4 6.8 18.0 16.5 6.7 96.1 24.6 4.2 3.7 8.7 6.5 8.3 7.6 11.5 67.9 3.9 5.7 13.3 116.8 TRIM16L TRIM70 ENSG00000108448 "Tripartite motif containing 16 like" Q309B1 17 18697998-18736118 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 22.5" "Cell type enhanced" "Detected in many" 5 "Pancreatic endocrine cells: 21.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 44.3;HaCaT: 22.6;HeLa: 35.4;OE19: 51.5" HPA066431 Uncertain Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA066431: AB_2685668" "unprognostic (1.20e-1)" "unprognostic (1.46e-1)" "unprognostic (2.00e-1)" "unprognostic (7.89e-3)" "unprognostic (5.66e-2)" "unprognostic (3.97e-2)" "prognostic unfavorable (2.87e-4)" "unprognostic (7.08e-2)" "unprognostic (5.79e-2)" "unprognostic (6.28e-2)" "unprognostic (2.34e-1)" "unprognostic (3.11e-1)" "unprognostic (1.37e-1)" "unprognostic (5.74e-2)" "unprognostic (1.42e-1)" "prognostic unfavorable (2.29e-5)" "unprognostic (1.13e-2)" 2.8 4.4 2.0 1.0 3.1 0.5 7.1 1.0 3.0 2.2 3.6 1.3 1.0 2.0 1.4 3.2 10.5 3.3 8.1 16.8 2.0 2.5 3.5 2.8 2.4 1.0 4.7 1.0 1.3 1.3 0.1 1.0 1.8 3.1 3.6 1.0 2.1 2.6 3.7 22.5 0.8 1.1 6.5 4.7 1.0 3.0 2.9 1.4 1.0 4.5 12.7 3.4 6.7 11.8 1.5 0.8 0.4 1.4 2.7 2.1 1.8 4.7 44.3 0.2 1.9 5.4 2.2 3.5 0.4 3.7 1.6 3.3 0.8 19.1 0.5 3.5 12.7 8.8 22.6 0.5 1.0 0.8 0.1 0.6 0.3 35.4 0.4 13.3 0.0 0.4 2.3 1.3 2.4 0.9 7.0 0.5 0.4 0.0 0.0 4.3 4.7 0.1 0.5 0.4 51.5 0.9 0.5 2.3 0.0 3.2 2.8 0.1 1.0 5.0 1.0 2.7 0.3 2.3 0.3 9.9 1.1 5.7 1.8 6.3 0.5 0.5 0.0 3.7 0.4 8.4 0.1 0.7 0.4 0.7 1.4 1.0 1.5 1.0 0.6 0.8 1.1 1.6 1.5 0.3 2.7 0.5 0.2 2.1 1.8 2.0 3.1 1.0 1.9 2.0 2.5 4.7 1.0 3.1 1.4 6.0 3.2 0.8 8.5 3.4 2.7 5.5 10.2 8.1 1.2 1.8 7.9 2.0 3.3 9.0 0.5 2.6 0.9 0.0 5.3 3.7 2.5 3.8 3.5 2.5 1.4 3.2 2.4 2.5 3.4 0.7 3.4 2.1 0.0 15.4 3.2 3.5 21.6 0.0 1.8 6.8 2.4 0.0 2.8 3.2 5.6 5.6 0.9 1.3 3.4 6.3 TRIM38 "RNF15, RORET" ENSG00000112343 "Tripartite motif containing 38" O00635 6 25962802-25991226 "Enzymes, Predicted intracellular proteins" "Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "B-cells: 100.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA031685 Approved Approved "Plasma membrane,Cell Junctions,Centrosome" NA NA Centrosome "Plasma membrane, Cell Junctions" "HPA031685: AB_10603218" "unprognostic (6.62e-2)" "unprognostic (1.65e-3)" "unprognostic (3.34e-1)" "unprognostic (2.72e-2)" "unprognostic (1.25e-1)" "unprognostic (6.51e-2)" "unprognostic (7.79e-2)" "unprognostic (3.27e-2)" "unprognostic (2.78e-2)" "prognostic favorable (8.95e-5)" "unprognostic (2.81e-2)" "unprognostic (6.28e-2)" "unprognostic (2.73e-1)" "unprognostic (3.36e-1)" "unprognostic (4.49e-2)" "prognostic favorable (8.20e-5)" "prognostic favorable (4.94e-9)" 13.3 8.4 2.5 15.7 2.3 12.0 7.9 1.1 3.4 17.2 12.1 3.1 20.5 6.7 26.2 22.3 15.7 8.9 9.2 5.8 2.8 2.3 26.1 8.8 14.0 14.4 3.7 1.8 11.5 4.3 1.0 4.3 10.3 3.5 15.5 7.8 9.2 9.8 16.5 9.0 5.3 14.6 13.1 4.5 17.6 6.6 5.3 2.9 16.6 13.7 9.5 20.1 18.0 15.4 16.5 10.1 12.1 12.9 6.7 7.9 6.3 3.5 2.0 0.3 4.3 10.4 13.9 3.6 4.5 9.0 8.8 14.6 1.6 3.8 7.9 7.4 5.5 8.5 5.6 2.7 4.4 5.2 8.0 1.8 3.6 3.3 1.4 13.8 4.2 7.4 13.9 3.3 5.4 1.9 7.3 7.6 3.9 2.3 4.4 10.4 1.7 4.0 4.8 1.4 0.0 2.7 6.2 4.3 8.2 10.4 7.1 0.1 0.1 3.4 7.1 12.0 0.5 1.0 5.5 7.7 1.6 2.7 2.7 3.0 5.1 3.7 8.9 4.3 5.2 9.7 10.1 10.6 4.7 7.6 12.9 7.4 14.3 6.5 6.8 10.1 16.5 6.2 6.7 12.1 6.7 11.4 9.5 7.9 6.3 2.5 2.3 1.1 3.4 2.8 2.3 3.7 1.8 3.5 2.9 23.8 43.9 100.5 47.4 13.3 0.6 3.5 22.9 17.4 29.6 43.6 0.0 19.8 14.9 19.1 0.9 42.0 39.9 0.0 13.0 17.5 17.0 35.9 34.6 14.8 28.8 0.0 17.4 27.0 84.3 2.2 18.4 61.3 10.1 49.5 29.9 0.3 17.8 40.3 17.7 62.8 0.7 6.5 18.9 0.2 0.2 8.2 17.7 36.2 23.3 78.5 TRIM4 RNF87 ENSG00000146833 "Tripartite motif containing 4" Q9C037 7 99876958-99919600 "Enzymes, Predicted intracellular proteins" "Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA019356, HPA029461" Approved Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA019356: AB_1856376, HPA029461: AB_10600834" "unprognostic (1.88e-1)" "unprognostic (2.97e-2)" "unprognostic (3.37e-1)" "unprognostic (3.46e-2)" "unprognostic (1.80e-2)" "unprognostic (7.06e-2)" "unprognostic (1.22e-1)" "unprognostic (5.42e-2)" "unprognostic (3.85e-2)" "unprognostic (2.67e-3)" "unprognostic (2.48e-2)" "unprognostic (1.60e-1)" "prognostic favorable (7.36e-6)" "unprognostic (1.00e-1)" "unprognostic (2.38e-1)" "unprognostic (7.46e-2)" "unprognostic (5.65e-2)" 19.1 22.6 13.5 22.1 15.9 6.7 22.1 20.1 15.5 19.5 17.3 12.4 22.5 13.9 21.9 18.8 16.4 19.0 19.8 11.1 13.3 9.3 16.6 17.9 21.1 22.4 15.3 8.8 35.0 23.2 18.9 27.4 16.1 12.2 21.9 15.7 18.4 19.4 33.8 9.4 20.7 18.3 18.1 11.9 18.2 17.4 16.2 14.5 18.4 20.5 11.9 18.8 20.0 28.9 18.6 17.0 20.0 19.2 13.9 30.3 17.4 9.7 11.7 7.0 5.8 18.4 17.3 3.1 16.4 20.0 13.7 16.0 6.2 9.6 14.2 0.1 13.9 12.1 11.6 9.2 10.1 14.0 14.4 0.7 11.6 6.2 9.7 26.0 16.7 16.6 18.4 21.5 10.6 27.0 18.7 11.9 7.2 16.9 22.0 11.4 12.1 12.3 15.0 5.3 14.7 10.1 7.0 10.0 16.2 15.2 12.6 8.2 5.8 12.5 19.2 19.5 10.7 8.8 9.6 14.5 15.2 13.6 29.1 15.7 18.5 20.2 11.5 10.0 18.8 20.1 20.0 19.2 15.3 20.6 19.2 23.8 18.6 21.6 23.5 17.0 18.6 30.3 22.2 8.2 13.9 16.6 12.7 21.5 17.4 13.5 15.9 20.1 15.5 13.3 9.3 15.3 8.8 12.2 14.5 23.8 15.3 18.2 24.1 22.2 20.2 4.8 12.7 16.0 10.3 21.0 17.7 13.3 8.3 12.8 5.2 16.1 9.7 23.3 11.3 5.9 15.1 19.8 27.6 17.5 12.8 6.4 8.6 17.8 20.0 8.4 28.7 15.4 21.9 18.0 10.3 34.3 12.7 11.8 25.8 13.4 20.0 0.0 23.1 19.3 8.2 20.1 13.6 18.7 12.1 22.0 TRIM44 "DIPB, MC7" ENSG00000166326 "Tripartite motif containing 44" Q96DX7 11 35662805-35818007 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049053, HPA057633" Approved Approved "Vesicles,Plasma membrane" NA NA Vesicles "Plasma membrane" "HPA049053: AB_2680613, HPA057633: AB_2683484" "unprognostic (2.73e-1)" "unprognostic (2.74e-1)" "unprognostic (1.37e-1)" "unprognostic (5.53e-2)" "unprognostic (3.91e-2)" "unprognostic (1.81e-1)" "prognostic unfavorable (5.24e-5)" "unprognostic (9.06e-2)" "unprognostic (5.29e-2)" "unprognostic (2.67e-1)" "unprognostic (1.02e-1)" "unprognostic (8.57e-2)" "unprognostic (1.49e-3)" "unprognostic (2.15e-2)" "unprognostic (1.59e-1)" "unprognostic (1.52e-1)" "unprognostic (3.00e-1)" 18.8 18.1 25.2 17.7 31.5 8.2 17.3 34.8 35.1 18.4 18.0 25.1 12.6 16.2 19.4 16.7 14.5 17.9 18.1 17.5 25.8 23.0 28.1 21.9 18.1 18.1 26.7 31.9 17.0 23.5 23.0 21.7 20.2 32.0 16.9 17.7 13.3 16.1 18.8 20.3 11.8 17.9 19.2 29.7 20.3 17.0 12.3 25.1 12.8 23.4 7.2 19.5 19.7 19.4 4.1 4.9 0.9 3.7 3.2 3.4 1.5 10.4 9.0 14.4 6.6 10.9 16.6 0.0 9.9 11.8 12.4 11.4 10.4 7.1 14.0 9.4 12.9 14.1 8.2 4.9 11.3 14.0 9.1 9.4 15.0 11.9 5.9 14.5 11.7 13.0 12.5 12.7 7.3 19.9 13.8 13.0 4.9 23.3 5.0 13.0 6.3 12.4 5.7 8.1 2.2 7.8 8.6 37.3 7.5 11.5 14.3 9.9 8.5 14.8 10.6 11.2 8.2 16.0 10.0 14.6 16.0 13.1 9.0 11.2 8.6 7.6 0.0 13.2 12.6 11.9 0.4 2.6 0.9 2.6 3.3 2.4 3.0 2.5 2.5 2.1 4.1 3.3 3.4 0.2 3.2 3.7 4.9 0.9 1.5 25.2 31.5 34.8 35.1 25.8 23.0 26.7 31.9 32.0 25.1 56.6 58.2 57.3 44.5 23.8 206.3 47.8 56.0 65.6 66.0 24.4 192.4 44.7 28.2 55.3 13.1 55.2 43.4 0.0 61.0 21.9 34.7 61.7 57.7 50.0 38.1 79.4 49.3 44.8 51.7 8.1 33.4 50.8 18.6 47.7 40.8 82.5 47.5 39.9 35.0 62.1 177.2 97.0 38.1 57.6 80.7 23.3 43.6 34.5 43.5 50.6 TRIM54 "MURF, MURF-3, RNF30" ENSG00000138100 "Tripartite motif containing 54" Q9BYV2 2 27282392-27307439 "Predicted intracellular proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 187.1" "Cell type enhanced" "Detected in some" 20 "Cardiomyocytes: 75.1;Exocrine glandular cells: 36.7;Pancreatic endocrine cells: 31.1" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebral cortex: 1.2" "Cell type enriched" "Detected in single" 16 "NK-cell: 7.0" "Lineage enriched" "Detected in single" 16 "NK-cells: 7.0" "Group enriched" "Detected in some" 9 "HAP1: 8.4;NTERA-2: 18.0" "Region enhanced" "Detected in some" "amygdala: 3.2" "Not detected" "Not detected" HPA019690 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA019690: AB_1858306" "unprognostic (6.98e-3)" "unprognostic (4.56e-3)" "unprognostic (3.22e-2)" "unprognostic (2.24e-2)" "unprognostic (1.58e-3)" "unprognostic (7.49e-2)" "unprognostic (1.25e-7)" "unprognostic (3.88e-3)" "unprognostic (2.29e-1)" "unprognostic (2.95e-1)" "unprognostic (2.56e-3)" "unprognostic (6.91e-2)" "prognostic unfavorable (6.46e-4)" "unprognostic (2.41e-2)" "unprognostic (3.19e-1)" "unprognostic (1.15e-1)" "unprognostic (6.92e-2)" 2.1 1.8 0.5 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.9 0.1 6.3 1.6 0.0 0.0 35.3 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.8 0.0 187.1 0.0 0.4 0.0 0.0 0.1 0.0 3.5 0.0 0.0 1.3 40.3 2.2 0.1 0.0 0.3 0.0 0.0 0.0 7.0 0.4 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 8.4 0.0 0.0 0.0 0.3 0.0 1.5 1.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 18.0 0.0 0.0 0.6 0.7 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.1 0.9 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 75.1 12.7 0.0 0.0 3.5 0.0 0.0 0.0 3.6 1.0 0.0 2.0 0.0 36.7 0.0 0.0 0.2 4.6 0.0 0.1 0.0 0.0 0.6 0.0 3.3 0.0 0.0 0.0 0.0 0.6 0.0 31.1 1.9 0.7 2.1 0.0 0.0 0.2 3.7 1.9 0.0 0.0 0.0 2.9 0.3 TRIM71 "LIN-41, LIN41" ENSG00000206557 "Tripartite motif containing 71" Q2Q1W2 3 32818018-32897826 "Enzymes, Predicted intracellular proteins" "RNA-mediated gene silencing, Ubl conjugation pathway" "Developmental protein, RNA-binding, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lung: 6.5;testis: 11.1" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 1: 8.9;Extravillous trophoblasts: 13.2;Spermatogonia: 12.6" "Cancer enriched" "Detected in some" 28 "testis cancer: 28.6" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 11.9;BEWO: 36.1;Hep G2: 23.3;NTERA-2: 31.9;SuSa: 30.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA038141, HPA038142" Uncertain Approved "Plasma membrane,Actin filaments,Focal adhesion sites" NA NA "Plasma membrane, Actin filaments, Focal adhesion sites" "HPA038141: AB_2675857, HPA038142: AB_10697240" "unprognostic (2.93e-2)" "unprognostic (4.29e-3)" "unprognostic (1.70e-1)" "unprognostic (1.02e-2)" "unprognostic (2.58e-2)" "unprognostic (3.27e-2)" "unprognostic (2.09e-2)" "unprognostic (1.25e-1)" "unprognostic (3.16e-2)" "unprognostic (3.04e-1)" "unprognostic (1.11e-2)" "unprognostic (3.11e-1)" "unprognostic (4.36e-6)" "unprognostic (3.92e-2)" "unprognostic (9.27e-2)" "unprognostic (8.17e-2)" "unprognostic (4.65e-2)" 0.1 0.0 0.7 0.1 1.9 0.5 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 2.7 0.7 2.2 0.0 6.5 0.0 0.2 0.0 0.1 0.0 0.0 0.5 1.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.1 0.1 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.5 0.3 0.0 0.1 0.0 0.0 0.0 11.9 0.0 0.0 0.0 36.1 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.6 0.0 23.3 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.2 2.5 31.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 30.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.3 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.7 1.9 0.0 0.5 2.7 0.7 0.2 0.0 1.9 0.0 8.9 2.6 0.0 0.0 0.0 0.4 2.8 0.0 1.4 3.4 0.0 0.0 3.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 13.2 0.3 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.9 0.4 0.0 0.0 0.3 12.6 0.0 3.3 0.0 0.0 0.0 TRIML2 "FLJ25801, SPRYD6" ENSG00000179046 "Tripartite motif family like 2" Q8N7C3 4 188091273-188109603 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "placenta: 9.8;testis: 6.2" "Cell type enhanced" "Detected in some" 17 "Cytotrophoblasts: 13.9;Early spermatids: 18.8;Extravillous trophoblasts: 5.5;Syncytiotrophoblasts: 7.4" "Cancer enriched" "Detected in some" 33 "testis cancer: 24.4" "Region enhanced" "Detected in single" "basal ganglia: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SuSa: 58.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA043838 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA043838: AB_10963835" "unprognostic (3.32e-1)" "unprognostic (1.99e-1)" "unprognostic (1.30e-1)" "unprognostic (9.82e-2)" "unprognostic (1.21e-5)" "unprognostic (3.06e-2)" "unprognostic (1.65e-3)" "unprognostic (2.65e-1)" "unprognostic (0.00e+0)" "unprognostic (2.26e-2)" "unprognostic (1.20e-1)" "unprognostic (1.28e-3)" 0.1 0.1 0.2 0.1 1.4 0.0 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 9.8 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 6.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 12.6 0.0 0.0 0.0 0.0 7.0 0.1 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.9 0.3 2.4 0.0 0.0 0.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 58.2 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.0 18.8 0.0 0.0 0.0 0.0 5.5 0.3 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 2.5 0.0 7.4 0.0 0.0 0.3 TRIP6 "MGC10556, MGC10558, MGC29959, MGC3837, MGC4423, OIP1, ZRP-1" ENSG00000087077 "Thyroid hormone receptor interactor 6" Q15654 7 100867138-100873454 "Predicted intracellular proteins" "Cell adhesion, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 7.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046454, CAB046460, HPA052813" Approved Supported "Plasma membrane,Focal adhesion sites,Cytosol" NA NA 12000 "Plasma membrane, Focal adhesion sites, Cytosol" "CAB046454: AB_10604048, CAB046460: AB_2303907, HPA052813: AB_2681961" "unprognostic (7.94e-3)" "unprognostic (1.06e-1)" "unprognostic (3.22e-3)" "unprognostic (2.84e-3)" "unprognostic (3.52e-2)" "unprognostic (2.92e-2)" "unprognostic (3.18e-2)" "unprognostic (4.61e-3)" "unprognostic (8.48e-2)" "unprognostic (4.18e-2)" "unprognostic (5.08e-2)" "unprognostic (1.42e-1)" "unprognostic (1.25e-2)" "unprognostic (5.07e-2)" "unprognostic (9.71e-2)" "unprognostic (1.92e-1)" "unprognostic (1.25e-1)" 15.5 14.7 10.9 16.2 11.2 6.0 18.1 4.2 7.3 36.7 14.6 9.4 22.5 4.4 28.2 30.8 27.2 18.5 43.5 14.5 8.7 7.7 21.6 24.1 18.4 5.8 11.7 9.4 22.0 19.2 28.0 6.5 13.6 9.7 22.1 3.9 22.7 23.0 38.2 8.3 23.9 6.5 25.5 9.7 7.9 9.9 17.5 7.8 7.3 26.6 30.6 12.6 25.0 23.6 3.1 7.7 0.2 4.7 0.0 1.7 0.5 27.0 11.2 5.8 27.7 8.8 10.2 29.1 16.9 18.1 23.2 21.8 10.5 31.2 1.1 17.8 19.0 28.9 20.2 8.5 32.5 5.9 3.9 11.5 0.1 18.6 0.1 23.2 13.0 1.6 18.5 21.4 15.4 24.2 13.7 11.9 4.1 17.0 0.2 20.0 47.5 0.2 20.5 20.0 11.1 10.0 10.2 5.8 2.7 14.3 6.7 2.1 0.3 14.1 42.7 16.8 9.0 4.5 16.6 18.2 34.1 32.1 36.9 39.4 0.2 0.4 0.1 21.2 1.6 51.3 0.0 1.9 0.2 0.2 3.0 0.6 3.1 1.5 1.3 3.1 2.5 1.7 0.7 0.2 0.0 4.7 7.7 1.3 0.5 10.9 11.2 4.2 7.3 8.7 7.7 11.7 9.4 9.7 7.8 44.7 35.0 7.5 130.2 117.2 0.0 14.4 38.2 10.7 37.5 57.6 0.0 99.2 68.0 79.4 0.8 30.6 3.6 0.0 73.3 72.2 63.2 50.1 8.1 26.8 40.2 1.6 4.7 19.6 7.0 2.2 60.9 26.5 35.4 31.5 10.3 87.6 78.1 10.5 68.2 104.6 3.3 71.1 72.2 0.9 2.5 85.9 111.1 6.1 17.5 140.8 TRMT1 "FLJ20244, TRM1" ENSG00000104907 "TRNA methyltransferase 1" Q9NXH9 19 13104902-13117567 "Enzymes, Plasma proteins, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, RNA-binding, Transferase, tRNA-binding" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 88.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041130, HPA041380" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA041130: AB_10803995, HPA041380: AB_10793873" "unprognostic (2.10e-2)" "unprognostic (2.40e-3)" "unprognostic (2.23e-2)" "unprognostic (1.01e-1)" "unprognostic (1.12e-2)" "unprognostic (5.54e-2)" "unprognostic (1.08e-3)" "unprognostic (2.19e-2)" "unprognostic (1.59e-1)" "unprognostic (7.62e-2)" "unprognostic (1.91e-2)" "unprognostic (8.74e-3)" "prognostic unfavorable (9.87e-7)" "unprognostic (1.19e-3)" "unprognostic (3.47e-2)" "unprognostic (2.22e-1)" "unprognostic (2.49e-2)" 15.5 15.0 19.1 19.8 23.5 23.1 16.6 19.5 22.6 15.0 16.3 17.3 15.5 14.9 19.2 19.0 17.6 19.6 19.4 13.2 15.7 13.4 14.4 17.3 13.5 26.8 22.1 14.7 29.1 23.8 16.3 14.4 14.4 21.9 18.1 14.5 10.9 14.9 15.6 21.4 22.1 16.1 16.5 12.4 25.0 16.3 16.8 20.1 12.2 15.6 12.1 19.6 17.3 18.8 11.2 14.9 3.1 15.7 4.3 10.2 8.5 15.4 10.4 11.3 19.2 11.5 14.8 16.2 17.4 8.7 19.2 16.7 11.1 12.7 19.4 22.8 9.3 10.0 14.3 18.9 15.3 8.9 12.6 26.4 15.4 26.8 18.7 20.9 30.8 18.2 20.9 20.6 19.9 18.8 12.3 14.1 14.5 33.3 6.2 11.9 17.1 12.5 33.3 26.8 9.8 24.5 21.1 14.6 26.7 11.9 15.7 26.9 12.2 10.8 22.6 18.1 8.6 8.8 17.3 15.6 27.7 10.8 16.7 30.4 10.8 20.8 17.9 12.9 32.7 14.4 1.2 15.7 0.5 8.1 11.9 7.7 10.4 8.6 7.7 14.9 11.2 10.2 7.7 3.1 4.3 7.5 8.8 5.6 8.5 19.1 23.5 19.5 22.6 15.7 13.4 22.1 14.7 21.9 20.1 11.9 16.2 35.0 22.3 21.3 8.0 6.4 12.7 10.7 4.5 12.2 2.0 19.4 5.0 14.1 16.4 17.5 6.3 0.0 12.8 18.8 13.9 10.4 28.9 8.6 41.5 7.9 6.9 7.4 88.1 36.5 13.0 39.6 16.9 23.4 9.6 5.8 12.2 5.8 12.0 11.2 11.1 12.9 16.5 21.7 18.3 18.1 12.9 18.7 17.4 18.4 TRMT10B "bA3J10.9, FLJ31455, RG9MTD3" ENSG00000165275 "TRNA methyltransferase 10B" Q6PF06 9 37753803-37778972 "Enzymes, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021800 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA021800: AB_1856214" "unprognostic (1.00e-2)" "unprognostic (1.78e-1)" "unprognostic (3.35e-2)" "unprognostic (3.89e-2)" "unprognostic (2.42e-2)" "unprognostic (7.68e-2)" "unprognostic (7.78e-2)" "prognostic favorable (3.91e-4)" "unprognostic (5.49e-3)" "unprognostic (1.71e-2)" "prognostic favorable (5.34e-4)" "unprognostic (1.40e-1)" "unprognostic (6.62e-2)" "unprognostic (1.76e-2)" "unprognostic (1.68e-1)" "unprognostic (9.58e-2)" "unprognostic (2.33e-3)" 7.4 10.3 9.9 10.9 10.3 10.1 9.8 13.7 12.3 10.6 11.8 12.7 12.8 8.3 17.3 9.5 10.4 9.6 10.6 7.0 9.9 9.2 8.2 8.0 8.6 13.1 16.4 9.8 15.4 10.5 9.0 13.8 7.4 10.0 14.8 7.1 12.1 10.3 12.1 7.8 20.4 9.7 11.8 12.7 12.1 10.8 5.0 10.4 10.0 12.4 5.6 13.6 14.8 10.1 9.2 4.6 6.6 5.3 4.6 7.6 2.7 5.3 6.3 8.2 7.3 5.0 4.1 3.8 5.3 3.8 5.4 4.7 3.8 4.7 10.0 3.9 4.0 3.2 6.2 3.9 6.4 4.9 4.3 6.9 8.7 15.6 3.9 9.2 8.9 6.3 4.7 6.6 4.7 9.1 6.5 5.5 12.1 7.0 4.4 4.1 3.8 9.1 7.0 7.3 5.6 7.8 9.3 2.9 5.2 5.2 4.9 11.2 10.8 4.3 5.4 4.7 5.4 5.9 6.5 5.4 4.2 6.1 6.7 4.6 5.0 6.8 7.9 2.5 7.1 8.5 6.6 5.3 2.8 6.7 4.6 7.6 6.6 6.0 6.3 2.5 9.2 7.3 6.7 5.4 4.6 3.2 4.6 3.9 2.7 9.9 10.3 13.7 12.3 9.9 9.2 16.4 9.8 10.0 10.4 3.0 6.2 23.8 10.8 6.5 15.5 7.4 10.2 8.1 9.1 3.5 5.9 13.3 10.0 9.6 1.6 12.0 7.8 23.3 11.0 7.0 7.4 11.1 13.9 6.6 7.2 15.9 13.3 9.2 11.4 0.2 13.6 12.3 10.1 7.2 12.9 12.8 8.8 7.0 22.3 6.7 12.8 25.8 8.6 4.4 3.2 6.6 10.2 19.2 9.0 7.8 TRMT13 "CCDC76, FLJ10287, FLJ11219" ENSG00000122435 "TRNA methyltransferase 13 homolog" Q9NUP7 1 100133150-100150497 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA028494 Approved Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane" "Nuclear bodies, Cytosol" "HPA028494: AB_10601254" "unprognostic (1.12e-1)" "unprognostic (3.33e-1)" "unprognostic (5.76e-2)" "unprognostic (2.37e-1)" "unprognostic (9.17e-3)" "unprognostic (4.97e-2)" "prognostic unfavorable (5.81e-5)" "unprognostic (1.16e-3)" "unprognostic (3.28e-2)" "unprognostic (8.08e-2)" "unprognostic (3.22e-1)" "unprognostic (1.02e-3)" "prognostic unfavorable (6.89e-6)" "unprognostic (3.12e-2)" "unprognostic (7.71e-2)" "unprognostic (1.99e-2)" "unprognostic (1.70e-3)" 13.0 12.2 13.9 21.7 24.1 5.9 18.3 26.5 22.5 17.4 13.1 18.2 24.2 13.6 17.4 15.4 13.7 13.9 9.6 12.0 14.4 9.0 12.1 13.0 9.6 20.9 23.1 12.8 21.4 18.1 23.8 26.8 13.2 15.6 14.9 14.4 10.8 14.3 17.4 16.9 17.9 14.2 14.3 19.4 16.5 12.6 11.1 25.8 17.8 16.5 12.0 17.6 13.9 15.8 15.1 9.6 2.2 4.5 5.4 13.6 3.9 10.7 6.3 10.6 7.4 5.7 11.3 11.7 11.4 4.5 8.7 7.3 7.5 4.5 17.8 14.2 9.0 5.8 9.8 19.5 8.8 15.1 17.9 15.5 10.6 13.9 7.2 10.4 18.3 10.0 7.8 10.1 16.4 21.7 5.5 7.9 13.3 22.2 11.5 8.7 4.1 14.9 9.7 14.8 10.4 12.7 16.0 16.1 9.7 7.1 8.6 6.9 11.6 10.5 10.1 13.4 10.9 5.9 16.3 8.2 11.6 7.8 9.7 15.1 14.8 11.9 21.1 13.1 14.7 4.4 0.1 4.5 2.2 8.5 4.4 10.4 14.8 9.0 8.3 5.2 15.1 13.6 11.1 1.9 5.4 3.5 9.6 6.2 3.9 13.9 24.1 26.5 22.5 14.4 9.0 23.1 12.8 15.6 25.8 23.8 13.4 31.3 12.1 8.7 36.7 10.0 17.8 25.4 28.4 14.0 27.5 11.7 11.6 9.2 7.7 11.7 9.1 0.0 5.2 8.8 10.8 10.7 20.8 9.9 6.7 27.0 19.5 17.2 6.1 4.3 23.0 9.9 10.1 8.2 8.1 19.7 7.8 12.5 17.3 8.4 45.1 19.4 12.2 36.3 22.8 10.5 6.1 19.7 13.2 8.4 TRO "KIAA1114, MAGE-D3, MAGED3" ENSG00000067445 Trophinin Q12816 X 54920462-54931431 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 32.1" "Cell type enhanced" "Detected in some" 8 "Bipolar cells: 4.0;Fibroblasts: 4.4;Horizontal cells: 7.9;Leydig cells: 5.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 5.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 17.9;SH-SY5Y: 16.1;SuSa: 37.2" "Low region specificity" "Detected in all" HPA071449 Approved "Vesicles,Plasma membrane,Cytosol" NA NA Vesicles "Plasma membrane, Cytosol" "HPA071449: " "unprognostic (6.18e-2)" "unprognostic (1.01e-1)" "unprognostic (2.24e-2)" "prognostic unfavorable (4.41e-5)" "unprognostic (9.09e-3)" "unprognostic (2.72e-1)" "unprognostic (5.66e-2)" "unprognostic (1.46e-1)" "unprognostic (4.67e-2)" "unprognostic (3.18e-1)" "prognostic favorable (1.93e-4)" "unprognostic (1.17e-1)" "unprognostic (3.19e-2)" "unprognostic (1.67e-4)" "unprognostic (6.33e-2)" "unprognostic (3.27e-2)" "unprognostic (6.86e-2)" 4.5 4.2 21.7 2.1 15.5 1.6 3.7 11.3 23.8 8.0 2.5 7.9 1.4 1.7 16.3 8.6 2.4 7.1 5.6 2.9 17.9 15.6 5.3 13.2 2.5 2.3 10.5 13.2 21.7 5.7 7.6 20.2 5.5 22.3 7.4 3.2 5.0 1.5 6.9 32.1 1.5 1.8 10.9 8.9 1.4 2.0 3.6 14.2 4.2 9.2 0.1 2.4 3.6 5.0 0.7 2.6 0.0 0.2 5.2 1.2 0.4 0.0 0.1 17.9 0.0 3.5 4.8 0.0 0.9 6.1 0.9 0.3 0.0 0.0 0.0 2.5 6.4 1.4 0.1 0.1 0.3 0.5 0.0 11.0 8.2 0.0 0.6 1.3 0.0 0.0 11.2 0.0 5.7 0.0 5.7 0.4 4.3 0.0 0.1 6.6 0.0 0.1 0.0 9.1 0.0 0.0 5.2 7.8 0.0 1.7 0.1 12.0 16.1 0.0 0.2 1.5 37.2 0.0 1.0 0.0 7.5 7.8 0.1 1.0 2.8 0.4 0.0 1.1 0.0 6.5 0.0 0.0 0.0 1.2 0.0 0.7 0.7 0.1 0.4 0.0 0.5 0.3 0.7 0.0 5.2 0.2 2.6 0.0 0.4 21.7 15.5 11.3 23.8 17.9 15.6 10.5 13.2 22.3 14.2 0.0 0.0 0.0 1.1 0.3 4.0 1.6 0.0 0.0 3.4 3.5 0.0 0.6 0.0 1.4 0.3 0.7 0.0 0.0 0.2 0.5 4.4 0.4 1.1 0.0 0.4 7.9 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 2.9 0.3 0.0 3.5 0.3 1.0 0.0 0.4 1.0 1.0 0.1 0.6 0.5 0.0 0.3 TRPM1 "CSNB1C, LTRPC1, MLSN1" ENSG00000134160 "Transient receptor potential cation channel subfamily M member 1" Q7Z4N2 15 31001061-31161273 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Sensory transduction, Transport, Vision" "Ion channel, Ligand-gated ion channel, Receptor" "Congenital stationary night blindness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "retina: 99.0" "Cell type enriched" "Detected in some" 5 "Bipolar cells: 705.2" "Cancer enriched" "Detected in single" 179 "melanoma: 14.6" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "naive B-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 113 "SK-MEL-30: 16.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA014779, HPA071139" Enhanced Uncertain "Golgi apparatus,Plasma membrane,Centriolar satellite" NA NA "Centriolar satellite" "Golgi apparatus, Plasma membrane" "HPA014779: AB_2669090, HPA071139: " "unprognostic (5.28e-2)" "unprognostic (1.35e-1)" "unprognostic (9.89e-2)" "unprognostic (3.07e-1)" "unprognostic (1.97e-1)" "unprognostic (1.70e-1)" "unprognostic (1.29e-3)" "unprognostic (2.83e-1)" "unprognostic (2.89e-2)" "unprognostic (1.67e-1)" "unprognostic (1.45e-2)" "unprognostic (2.58e-1)" "unprognostic (7.84e-2)" "unprognostic (6.20e-4)" "unprognostic (1.48e-1)" "unprognostic (2.63e-2)" 0.1 0.0 0.4 0.0 0.6 0.0 0.1 0.1 0.3 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.2 0.3 0.1 0.1 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 99.0 0.4 0.0 0.2 10.4 0.0 0.1 1.9 0.0 0.0 2.9 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.4 0.6 0.1 0.3 0.7 0.2 1.6 0.0 0.3 0.1 0.0 0.0 0.0 0.0 3.8 705.2 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 30.8 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 12.7 0.0 0.0 0.0 2.4 0.0 0.0 150.1 0.0 0.0 10.0 0.0 0.0 0.0 0.6 18.1 0.0 0.0 7.9 3.8 0.9 0.8 0.0 0.0 0.0 TRPM7 "CHAK1, LTRPC7, TRP-PLIK" ENSG00000092439 "Transient receptor potential cation channel subfamily M member 7" Q96QT4 15 50552473-50686815 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Necrosis, Transport" "Calcium channel, Ion channel, Kinase, Serine/threonine-protein kinase, Transferase" "Amyotrophic lateral sclerosis, Neurodegeneration, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 91.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 50.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035522, HPA052173" Enhanced Approved "Vesicles,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Vesicles, Cytosol" "HPA035522: , HPA052173: AB_2681749" "unprognostic (3.14e-2)" "unprognostic (1.86e-1)" "unprognostic (1.58e-1)" "unprognostic (1.42e-2)" "unprognostic (1.89e-1)" "unprognostic (1.60e-2)" "unprognostic (1.85e-2)" "unprognostic (2.59e-2)" "unprognostic (5.46e-3)" "unprognostic (2.64e-1)" "unprognostic (2.91e-1)" "unprognostic (1.59e-2)" "unprognostic (3.20e-2)" "unprognostic (2.08e-1)" "unprognostic (7.59e-2)" "unprognostic (9.45e-2)" "unprognostic (1.97e-1)" 13.3 10.8 6.6 14.7 9.0 12.8 12.1 19.5 9.3 11.8 11.7 8.1 9.7 9.9 16.5 10.7 9.4 11.0 8.2 19.1 5.5 4.9 16.0 20.0 10.8 10.6 12.4 5.2 16.6 11.6 91.8 14.6 14.3 10.2 9.7 10.3 28.6 11.5 13.5 10.8 11.7 12.8 12.8 9.8 11.1 10.3 6.9 10.0 14.5 12.6 6.9 12.6 12.9 12.3 7.0 4.7 4.4 3.4 5.7 7.6 2.0 8.5 8.5 7.1 7.9 20.6 15.5 8.7 10.8 15.0 6.9 9.1 11.7 4.7 18.6 5.3 12.4 17.8 14.4 9.5 7.9 9.9 10.3 5.7 14.8 13.1 6.1 18.8 15.3 11.5 14.4 9.4 7.8 14.7 10.1 5.5 11.8 16.7 14.3 12.5 13.4 9.8 7.5 5.4 11.8 5.3 10.8 9.9 9.1 9.6 20.2 5.9 7.5 7.4 11.9 14.5 13.1 7.4 16.7 8.4 11.0 5.2 50.9 12.4 9.7 21.5 17.9 11.9 31.3 10.2 3.8 3.4 3.9 6.6 3.2 7.6 5.6 4.8 4.4 3.7 7.0 4.4 5.2 4.4 5.7 3.2 4.7 4.8 2.0 6.6 9.0 19.5 9.3 5.5 4.9 12.4 5.2 10.2 10.0 17.9 25.3 18.2 14.9 28.0 22.9 21.4 28.1 24.1 7.9 12.2 11.8 18.5 3.3 9.7 25.2 18.5 16.9 23.3 11.1 8.0 17.0 21.2 16.3 35.0 12.7 20.6 17.7 15.4 18.6 17.9 24.5 17.0 18.6 14.4 17.3 9.1 12.8 12.9 19.1 9.6 21.5 12.9 13.7 13.6 19.4 21.1 13.6 17.5 16.3 9.0 TRPV3 VRL3 ENSG00000167723 "Transient receptor potential cation channel subfamily V member 3" Q8NET8 17 3510502-3557995 "Disease related genes, FDA approved drug targets, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Disease mutation, FDA approved drug targets, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 15.4;skeletal muscle: 29.1" "Cell type enhanced" "Detected in many" 10 "Basal keratinocytes: 16.7;Enterocytes: 10.8;Suprabasal keratinocytes: 21.5" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in some" "basal ganglia: 2.4" "Cell type enhanced" "Detected in some" "basophil: 2.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 3.6;BEWO: 5.4;CACO-2: 4.3;RH-30: 13.3;T-47d: 5.6;U-266/70: 3.5" "Low region specificity" "Detected in some" "Region enriched" "Detected in many" 6 "cerebellum: 14.0" HPA069550 Approved "Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane" "Centrosome, Cytosol" "HPA069550: AB_2686149" "unprognostic (1.84e-4)" "unprognostic (2.25e-1)" "unprognostic (5.22e-2)" "unprognostic (3.92e-4)" "unprognostic (4.87e-3)" "unprognostic (2.96e-2)" "unprognostic (6.66e-2)" "unprognostic (4.88e-2)" "unprognostic (7.02e-2)" "unprognostic (2.68e-1)" "unprognostic (4.88e-2)" "unprognostic (3.69e-2)" "unprognostic (0.00e+0)" "unprognostic (1.12e-1)" "unprognostic (1.77e-1)" "unprognostic (8.64e-2)" "unprognostic (2.93e-2)" 0.4 0.2 0.4 3.2 2.4 0.9 4.1 0.3 1.2 0.6 10.6 0.1 0.3 3.2 0.2 0.2 2.3 0.3 0.8 0.3 0.4 0.3 0.2 1.1 0.3 0.5 0.4 0.2 0.3 0.9 0.0 0.7 0.4 0.0 0.2 2.9 0.3 0.5 0.4 29.1 8.4 15.4 0.5 0.5 0.4 1.6 0.8 0.0 0.0 0.2 9.7 3.0 0.7 2.1 0.7 0.6 2.9 0.6 0.6 0.7 0.1 3.6 0.0 0.5 0.1 0.3 0.6 5.4 0.2 0.0 0.0 0.0 4.3 1.0 0.2 1.1 0.1 0.1 0.4 0.0 0.1 0.0 0.1 0.1 0.0 0.4 0.6 0.1 0.2 0.8 0.3 0.0 0.7 1.8 0.0 0.0 0.0 0.1 0.1 0.0 0.7 0.1 0.2 0.1 0.3 0.5 0.1 13.3 0.2 0.0 0.2 0.1 0.0 0.2 0.6 0.0 0.0 5.6 0.2 0.1 0.1 0.2 0.1 0.1 3.5 2.8 0.0 0.1 0.1 0.0 2.9 0.4 0.4 0.7 0.2 0.5 0.7 0.4 0.7 0.1 0.5 0.4 0.6 1.0 0.6 0.6 0.6 0.2 0.1 0.4 2.4 0.3 1.2 0.4 0.3 0.4 0.2 0.0 0.0 0.0 4.5 1.4 4.0 16.7 0.8 2.4 2.5 0.0 0.0 0.0 0.0 0.3 1.7 0.0 0.2 1.6 10.8 0.0 0.0 0.7 4.3 2.9 0.0 0.4 0.2 4.8 0.0 0.0 0.0 0.0 2.8 2.2 6.8 0.0 0.7 2.0 0.8 0.8 3.2 0.8 0.9 0.0 0.9 0.0 1.1 21.5 0.5 2.1 0.6 2.2 TSG101 "TSG10, VPS23" ENSG00000074319 "Tumor susceptibility 101" Q99816 11 18468336-18527232 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Growth regulation, Host-virus interaction, Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004283, HPA006161" Approved Supported "Nucleoli,Plasma membrane,Cytosol" NA NA 14000 Cytosol "Nucleoli, Plasma membrane" "CAB004283: AB_671392, HPA006161: AB_1080408" "unprognostic (1.42e-1)" "unprognostic (7.91e-2)" "unprognostic (2.11e-1)" "unprognostic (6.77e-2)" "unprognostic (1.82e-1)" "unprognostic (2.72e-3)" "prognostic unfavorable (3.74e-6)" "unprognostic (5.67e-2)" "unprognostic (2.08e-1)" "unprognostic (2.00e-2)" "unprognostic (4.15e-3)" "unprognostic (4.27e-2)" "prognostic favorable (5.52e-6)" "unprognostic (1.92e-2)" "unprognostic (1.02e-1)" "unprognostic (4.02e-3)" "unprognostic (1.06e-1)" 24.7 30.5 18.4 14.2 25.5 23.5 27.6 22.7 25.9 22.5 23.1 23.7 21.6 20.5 25.8 27.7 34.3 23.9 18.4 31.8 17.7 20.6 33.4 29.0 20.1 23.4 21.6 21.4 23.2 39.5 33.2 23.5 38.5 24.6 21.9 28.4 19.4 25.4 22.4 44.5 27.3 25.7 23.1 21.7 20.5 23.0 33.7 20.2 27.5 32.3 37.1 25.5 24.2 25.5 20.5 18.2 42.3 29.2 14.3 22.0 22.2 14.4 23.8 21.1 14.6 25.0 26.2 19.7 22.4 30.3 27.5 27.2 16.3 7.6 19.5 13.8 25.0 29.6 22.2 21.0 20.3 30.5 27.4 25.7 12.1 12.6 24.0 32.2 18.1 20.9 22.6 41.4 14.3 39.0 29.0 22.5 18.9 19.6 16.6 33.2 26.0 11.4 19.7 13.0 31.3 24.2 10.3 21.4 16.2 18.4 20.6 15.1 27.0 21.5 18.1 28.6 22.1 18.0 18.2 12.1 18.5 11.3 38.4 16.6 10.7 20.5 15.5 19.0 10.1 23.5 42.3 19.5 40.7 14.9 21.7 15.0 20.5 14.4 15.9 18.2 18.0 15.4 16.4 34.5 14.3 29.2 15.4 22.0 22.2 18.4 25.5 22.7 25.9 17.7 20.6 21.6 21.4 24.6 20.2 59.6 51.0 42.1 71.0 37.8 39.6 60.3 56.0 107.1 37.5 41.8 23.6 165.8 106.1 92.2 31.6 49.6 64.6 46.7 89.0 89.6 50.5 62.3 42.8 34.8 70.2 35.0 59.1 46.6 42.2 12.6 52.0 49.4 54.0 107.4 58.3 78.3 101.0 58.3 40.7 95.2 33.9 45.3 45.3 142.6 153.8 42.3 247.6 44.5 43.7 75.7 TSGA13 ENSG00000213265 "Testis specific 13" Q96PP4 7 130668648-130687432 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "testis: 16.5" "Group enriched" "Detected in some" 9 "Early spermatids: 62.7;Late spermatids: 126.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+ RasG12V: 1.0;THP-1: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA022968 Uncertain Approved "Vesicles,Plasma membrane,Cytosol" NA NA Vesicles "Plasma membrane, Cytosol" "HPA022968: AB_2671013" "unprognostic (1.49e-1)" "unprognostic (1.13e-2)" "unprognostic (1.86e-1)" "unprognostic (1.34e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 1.2 0.6 0.8 0.5 0.3 0.1 0.5 0.0 0.0 0.9 0.7 0.2 0.4 0.0 0.2 1.0 0.0 0.6 0.2 0.1 0.0 0.1 0.1 0.2 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.3 0.0 0.1 0.0 1.3 0.0 0.1 0.0 0.0 0.4 0.9 0.1 0.3 0.4 0.1 0.2 1.1 0.6 0.2 0.5 0.2 0.3 0.2 0.2 0.1 0.2 0.6 0.5 0.4 1.2 0.8 0.1 0.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 4.6 0.5 0.1 1.4 1.4 0.0 0.0 10.7 3.4 0.0 7.9 0.1 0.0 0.0 62.7 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.8 126.7 0.6 1.3 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 1.1 0.0 0.1 1.2 0.6 0.4 0.6 0.0 0.0 0.0 TSHZ3 "KIAA1474, TSH3, ZNF537" ENSG00000121297 "Teashirt zinc finger homeobox 3" Q63HK5 19 31274945-31349547 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Fibroblasts: 18.6;Ito cells: 19.6;Leydig cells: 16.4;Peritubular cells: 27.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.9" "Group enriched" "Detected in many" 35 "granulocytes: 4.9;monocytes: 2.2;T-cells: 3.2" "Cell line enhanced" "Detected in many" "ASC TERT1: 13.0;RH-30: 26.7;U-138 MG: 18.9;U-87 MG: 12.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "cerebral cortex: 20.4;hippocampal formation: 16.8" "HPA008834, HPA071010" Approved Enhanced "Nucleoplasm,Plasma membrane" No No Nucleoplasm "Plasma membrane" "HPA008834: AB_1080731, HPA071010: " "unprognostic (2.56e-1)" "unprognostic (3.88e-1)" "unprognostic (4.56e-2)" "unprognostic (3.66e-1)" "unprognostic (1.66e-3)" "unprognostic (4.07e-2)" "unprognostic (1.67e-1)" "unprognostic (2.46e-1)" "unprognostic (1.76e-1)" "unprognostic (3.58e-3)" "unprognostic (2.23e-1)" "unprognostic (3.91e-2)" "prognostic unfavorable (2.92e-4)" "unprognostic (8.76e-3)" "unprognostic (8.22e-2)" "unprognostic (1.91e-2)" "unprognostic (1.73e-3)" 5.7 3.3 4.4 4.0 6.6 1.0 5.2 1.1 17.3 13.0 11.6 0.7 2.4 2.5 19.4 8.5 5.6 9.5 11.5 4.6 3.3 2.0 2.8 1.3 4.9 1.2 1.6 8.0 28.0 1.5 1.1 7.2 4.8 2.8 9.5 3.7 4.9 2.8 8.9 1.6 2.5 4.3 16.4 3.3 4.5 6.1 3.3 1.2 0.0 8.5 1.7 0.7 11.1 11.4 0.0 0.0 4.9 2.2 0.0 3.2 0.7 0.0 1.1 0.4 0.0 5.9 13.0 0.0 3.4 4.9 2.1 3.8 0.0 0.7 0.0 0.0 8.4 4.4 0.5 1.5 3.1 4.7 0.0 1.3 0.0 0.0 0.0 11.4 2.8 5.3 7.6 2.8 7.8 3.9 0.0 0.0 2.5 0.0 0.0 9.8 0.5 0.0 0.0 0.5 0.0 0.0 3.3 26.7 0.0 0.0 0.0 0.0 8.1 0.0 0.0 2.6 2.7 0.0 2.0 0.0 18.9 6.0 2.1 4.8 0.0 0.0 0.0 12.2 4.9 0.5 0.0 2.2 0.0 3.2 0.8 0.1 0.0 0.9 1.0 0.0 0.0 0.3 0.8 4.9 0.0 0.4 0.0 0.7 0.7 4.4 6.6 1.1 17.3 3.3 2.0 1.6 8.0 2.8 1.2 3.0 0.6 0.0 6.8 4.2 13.9 1.6 0.0 1.4 6.8 3.5 0.0 0.3 0.0 0.3 0.1 6.7 0.0 0.0 0.6 0.2 18.6 3.3 1.1 0.0 9.1 15.9 0.0 19.6 11.6 0.0 16.4 6.1 5.0 0.0 0.0 0.2 0.5 0.0 27.6 0.0 0.1 0.0 10.3 0.0 5.0 1.5 0.7 0.5 0.0 2.4 TSPO2 "BZRPL1, dJ34B21.2" ENSG00000112212 "Translocator protein 2" Q5TGU0 6 41042554-41044337 "Predicted intracellular proteins, Predicted membrane proteins" Transport Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "bone marrow: 32.4" "Cell type enriched" "Detected in some" 84 "Erythroid cells: 210.2" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "OE19: 15.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA060691, HPA066996" Approved "Plasma membrane" NA NA "Plasma membrane" "HPA060691: , HPA066996: AB_2685761" "unprognostic (1.89e-3)" "unprognostic (8.35e-3)" "unprognostic (2.57e-3)" "unprognostic (2.29e-2)" "unprognostic (1.63e-1)" "unprognostic (2.66e-2)" "unprognostic (6.61e-3)" "unprognostic (2.29e-1)" "unprognostic (3.37e-1)" "unprognostic (2.89e-1)" "unprognostic (2.71e-1)" "unprognostic (4.92e-2)" "unprognostic (1.86e-2)" "unprognostic (2.70e-2)" "unprognostic (1.16e-1)" "unprognostic (5.37e-2)" "unprognostic (1.76e-2)" 0.1 0.0 0.1 0.1 0.1 32.4 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.8 0.1 0.1 0.1 0.0 0.4 0.1 0.1 0.0 1.3 2.5 0.4 0.1 0.1 0.1 0.1 0.4 0.0 0.1 0.9 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.3 1.3 0.1 3.3 4.5 1.3 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.4 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 1.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.1 0.0 0.3 0.2 0.5 0.0 15.8 0.0 0.4 0.0 0.0 0.3 0.1 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.4 0.2 0.8 0.2 0.2 0.0 0.4 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.3 0.0 0.3 210.2 0.8 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 TTC23 "FLJ12572, HCC-8" ENSG00000103852 "Tetratricopeptide repeat domain 23" Q5W5X9 15 99136323-99251223 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039806, HPA040369" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039806: AB_10793921, HPA040369: AB_10795381" "prognostic favorable (3.17e-4)" "unprognostic (5.41e-2)" "unprognostic (1.45e-1)" "prognostic favorable (1.07e-4)" "unprognostic (1.40e-2)" "unprognostic (6.53e-2)" "unprognostic (9.25e-3)" "unprognostic (2.56e-1)" "unprognostic (6.18e-2)" "unprognostic (1.76e-3)" "unprognostic (1.88e-1)" "unprognostic (3.24e-1)" "unprognostic (3.21e-2)" "unprognostic (1.11e-2)" "unprognostic (4.31e-1)" "unprognostic (7.99e-2)" "unprognostic (1.23e-1)" 9.5 10.7 6.0 6.1 8.6 1.0 9.7 5.4 7.5 13.2 15.5 12.2 11.9 3.7 20.3 9.9 10.7 10.6 10.4 11.9 7.7 4.7 10.6 8.2 8.1 3.0 9.8 7.5 17.5 11.7 10.7 10.2 10.0 10.5 13.7 8.7 14.0 8.4 12.0 7.8 8.6 6.4 12.3 15.7 5.2 8.7 16.2 9.0 5.1 14.1 7.7 5.0 13.0 11.4 0.5 2.4 3.8 1.3 2.0 0.5 0.1 6.8 7.1 11.0 12.6 13.1 14.8 4.6 8.5 10.4 9.1 10.3 6.1 11.9 1.7 17.1 9.6 8.2 13.3 3.5 8.4 9.9 2.2 11.7 7.3 12.5 4.8 7.6 1.6 0.5 10.4 7.6 7.1 6.8 9.9 15.2 3.3 5.6 1.0 8.5 4.1 5.8 1.8 5.9 1.8 4.9 1.8 14.3 2.6 7.3 9.2 4.8 2.1 11.1 4.5 10.3 11.5 7.6 7.6 9.9 11.5 6.9 7.7 10.8 6.0 8.1 2.3 10.3 0.5 6.8 3.8 0.5 0.6 0.3 1.3 0.3 0.4 0.4 0.5 2.4 0.5 0.3 0.3 1.8 2.0 0.5 1.9 0.4 0.1 6.0 8.6 5.4 7.5 7.7 4.7 9.8 7.5 10.5 9.0 3.0 6.5 0.0 4.3 2.2 1.7 6.9 7.6 4.0 5.7 5.2 0.0 4.1 5.0 4.5 6.9 5.3 2.9 0.0 5.5 3.7 4.8 2.4 1.1 5.1 3.4 7.9 0.0 9.2 4.3 5.6 8.3 0.8 1.7 1.0 4.8 10.0 4.0 2.9 9.6 4.4 4.7 6.5 4.0 16.8 8.1 3.4 1.6 0.0 6.0 2.4 TTC7B TTC7L1 ENSG00000165914 "Tetratricopeptide repeat domain 7B" Q86TV6 14 90524564-90816479 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 28.6;Sertoli cells: 25.8;Syncytiotrophoblasts: 25.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 7.0;eosinophil: 9.7" "Lineage enriched" "Detected in many" 8 "granulocytes: 9.7" "Cell line enhanced" "Detected in many" "HMC-1: 33.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058363, HPA059577" Enhanced Supported "Plasma membrane" NA NA 11000 "Plasma membrane" "HPA058363: AB_2683692, HPA059577: AB_2684069" "unprognostic (9.37e-2)" "unprognostic (4.20e-2)" "unprognostic (1.01e-2)" "unprognostic (2.41e-2)" "unprognostic (2.58e-1)" "unprognostic (2.67e-4)" "unprognostic (9.42e-2)" "unprognostic (2.17e-1)" "unprognostic (5.38e-2)" "unprognostic (7.60e-2)" "unprognostic (2.75e-3)" "unprognostic (2.87e-2)" "prognostic favorable (3.20e-6)" "unprognostic (2.74e-2)" "unprognostic (7.41e-2)" "unprognostic (4.48e-2)" "unprognostic (1.07e-2)" 16.2 9.0 29.1 6.6 20.1 6.7 7.1 40.6 33.7 10.0 7.9 10.9 5.6 3.8 11.0 5.0 11.8 5.7 7.0 23.8 26.0 15.9 7.7 6.7 8.9 2.8 14.7 18.3 9.9 17.2 6.7 7.0 19.2 20.3 10.1 3.6 8.8 8.6 11.1 37.4 3.2 4.2 13.1 8.8 10.6 6.1 2.7 8.1 0.3 5.9 2.5 2.1 8.1 4.8 0.4 0.7 9.7 0.6 0.5 1.2 0.7 8.5 7.8 9.2 6.7 8.6 10.2 30.3 6.9 6.0 9.3 10.1 2.0 2.3 0.1 11.0 7.8 11.0 0.1 5.9 4.8 9.1 15.5 6.4 19.3 4.0 1.8 8.6 0.4 33.7 7.6 3.3 5.0 6.2 8.6 13.3 7.6 10.7 15.9 8.9 9.1 0.2 7.5 5.2 0.5 6.7 16.7 15.2 2.8 3.0 6.4 14.1 9.7 6.9 2.9 14.7 6.1 4.1 5.9 15.2 9.6 7.6 7.0 11.2 5.4 2.7 0.1 13.8 1.8 9.3 7.0 0.3 9.7 0.2 0.6 0.3 0.3 0.3 0.2 0.4 0.4 0.3 0.2 1.4 0.5 0.2 0.7 1.2 0.7 29.1 20.1 40.6 27.8 26.0 15.9 14.7 18.3 20.3 8.1 3.0 0.6 0.0 1.8 2.5 10.9 18.1 0.0 5.3 0.0 5.2 15.7 11.0 1.7 2.2 3.9 5.8 0.0 0.0 2.0 6.5 4.1 2.6 7.0 8.1 6.9 28.6 1.2 9.2 3.9 1.1 6.4 2.8 11.8 3.6 0.0 5.4 1.2 0.0 6.7 2.8 17.7 25.8 5.2 1.5 1.6 1.8 25.2 0.5 0.0 1.0 TTLL12 KIAA0153 ENSG00000100304 "Tubulin tyrosine ligase like 12" Q14166 22 43166622-43187133 "Plasma proteins, Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Paneth cells: 54.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003054, CAB046029" Approved Approved "Plasma membrane,Cytosol" NA NA 2100000 Cytosol "Plasma membrane" "CAB046029: AB_11128395, HPA003054: AB_2666770" "unprognostic (2.45e-2)" "unprognostic (3.47e-2)" "unprognostic (7.37e-3)" "unprognostic (5.40e-2)" "unprognostic (2.65e-1)" "unprognostic (3.50e-1)" "prognostic unfavorable (2.84e-4)" "unprognostic (5.81e-3)" "unprognostic (2.24e-1)" "unprognostic (6.08e-2)" "unprognostic (4.75e-2)" "unprognostic (1.73e-1)" "unprognostic (1.15e-1)" "unprognostic (1.17e-3)" "unprognostic (1.40e-1)" "unprognostic (6.66e-2)" "unprognostic (2.81e-2)" 7.3 13.8 7.2 14.7 8.3 14.0 11.2 13.6 12.3 10.9 21.5 5.5 8.9 15.0 7.1 8.7 46.3 9.0 36.0 6.9 7.3 7.1 8.4 19.4 5.3 9.2 6.5 5.9 16.5 29.8 4.4 7.0 6.8 7.1 9.4 12.1 7.0 13.5 7.9 5.5 16.4 13.9 5.9 4.0 9.7 20.7 18.3 5.3 10.7 7.6 23.7 23.5 8.3 15.2 3.5 3.8 1.3 4.7 4.3 5.6 3.3 31.6 13.4 5.4 13.4 8.3 5.7 17.6 10.5 3.7 10.1 5.3 21.7 18.2 30.6 12.7 8.6 4.9 22.7 22.6 19.2 2.6 3.8 35.8 7.5 21.5 18.6 13.1 33.6 7.8 9.1 23.3 12.0 12.9 5.4 10.6 15.1 46.0 7.2 4.6 29.5 23.3 18.2 19.7 22.3 13.4 23.8 18.7 44.0 8.5 10.5 16.6 6.8 22.2 32.6 11.7 2.6 12.8 15.0 10.1 6.7 9.5 12.9 14.5 12.3 15.1 22.6 7.6 17.3 9.1 0.0 4.7 0.7 5.6 2.4 5.5 3.5 5.5 4.1 3.8 2.7 5.5 3.7 1.3 4.3 3.1 3.3 3.5 3.3 7.2 8.3 13.6 12.3 7.3 7.1 6.5 5.9 7.1 5.3 6.0 7.0 9.9 8.6 10.0 8.4 3.6 20.4 2.7 3.4 7.0 3.9 5.7 5.0 13.9 0.7 3.6 35.1 23.3 7.3 14.1 4.1 13.4 0.0 30.4 8.7 0.0 8.7 9.2 13.8 1.6 8.1 5.0 10.1 4.6 29.3 3.8 18.9 54.1 15.9 7.7 4.6 0.0 7.2 2.2 12.8 15.8 3.4 3.8 33.9 13.1 TXNIP "ARRDC6, EST01027, HHCPA78, THIF, VDUP1" ENSG00000265972 "Thioredoxin interacting protein" Q9H3M7 1 145992435-145996600 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Sertoli cells: 1177.1;T-cells: 976.9" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 109.0;HSkMC: 145.0;hTCEpi: 73.9;hTERT-RPE1: 87.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031085, HPA053694" Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA031085: AB_10601706, HPA053694: AB_2682232" "unprognostic (1.45e-1)" "unprognostic (1.57e-2)" "unprognostic (1.67e-2)" "unprognostic (4.16e-2)" "unprognostic (1.92e-2)" "unprognostic (3.93e-2)" "unprognostic (1.55e-2)" "unprognostic (2.51e-1)" "unprognostic (9.23e-2)" "unprognostic (1.20e-1)" "unprognostic (3.65e-2)" "unprognostic (1.19e-1)" "unprognostic (8.49e-3)" "unprognostic (1.35e-2)" "unprognostic (1.31e-1)" "unprognostic (8.19e-2)" "unprognostic (2.22e-3)" 127.7 10.6 4.1 17.0 4.6 10.5 73.6 2.5 6.0 45.9 49.8 16.1 25.0 6.3 39.3 22.8 41.0 20.3 20.4 55.3 4.8 34.8 11.7 52.3 82.6 6.5 4.2 34.1 25.8 9.3 20.2 19.1 8.3 47.4 16.1 18.8 18.5 19.5 97.0 15.3 27.7 34.6 9.2 39.0 13.6 23.1 6.0 29.0 85.3 16.0 41.5 52.5 32.3 64.9 35.5 134.9 58.3 65.3 90.0 132.5 5.9 0.0 1.4 0.1 33.1 109.0 3.3 7.1 14.4 6.5 8.9 3.8 8.1 1.6 42.4 1.9 1.0 1.6 1.4 13.5 17.4 7.8 0.7 4.8 2.1 3.4 1.5 19.9 10.2 145.0 73.9 13.2 23.2 87.5 2.5 6.7 19.3 13.4 3.3 8.1 3.3 19.0 4.0 12.0 5.3 3.0 11.9 51.8 16.9 13.3 6.8 11.1 30.7 8.9 24.4 3.0 3.2 28.5 6.1 18.0 1.1 33.6 11.6 18.8 17.9 1.5 4.4 9.2 9.4 94.7 53.3 123.0 90.0 58.3 83.1 58.8 76.5 79.9 35.5 64.9 76.0 80.3 134.9 65.3 49.9 16.7 70.6 132.5 211.4 256.3 523.2 152.7 62.8 5.2 378.6 219.1 167.3 228.6 258.2 27.5 4.8 381.3 68.3 6.0 390.7 127.9 140.2 46.4 5.0 157.0 217.7 358.0 65.3 218.0 6.4 157.7 332.7 859.8 16.4 606.1 469.7 102.9 128.0 291.4 3.4 148.2 357.3 420.4 90.8 3.3 1177.1 168.0 6.4 34.1 63.1 9.2 976.9 145.3 211.3 TYW3 "C1orf171, FLJ40918" ENSG00000162623 "TRNA-yW synthesizing protein 3 homolog" Q6IPR3 1 74733152-74766678 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029641 Approved Approved "Plasma membrane,Cytosol" No No Cytosol "Plasma membrane" "HPA029641: AB_2272535" "unprognostic (6.89e-3)" "unprognostic (1.06e-1)" "unprognostic (1.08e-1)" "unprognostic (1.09e-1)" "unprognostic (1.42e-1)" "unprognostic (7.24e-2)" "prognostic unfavorable (1.49e-7)" "unprognostic (3.79e-1)" "unprognostic (2.23e-1)" "unprognostic (2.96e-1)" "unprognostic (4.08e-2)" "unprognostic (1.59e-1)" "unprognostic (1.70e-1)" "unprognostic (1.13e-1)" "unprognostic (2.05e-1)" "unprognostic (8.90e-2)" "unprognostic (2.98e-3)" 16.5 19.7 13.7 13.5 17.7 11.9 18.3 15.0 19.9 20.4 17.7 7.5 13.7 9.5 21.0 15.2 20.6 16.4 10.0 21.1 11.1 12.9 20.4 17.0 11.3 14.3 16.2 17.2 30.0 14.4 22.2 34.3 13.5 17.0 20.7 12.3 8.6 13.8 15.7 12.3 10.5 10.9 24.7 15.6 16.0 14.8 12.3 18.1 12.3 23.5 14.3 16.9 23.5 33.3 9.7 9.0 6.0 8.0 13.6 13.9 5.2 8.6 7.3 12.6 8.9 14.3 15.7 19.1 14.9 13.7 14.3 12.6 15.4 7.4 22.7 13.7 12.8 21.0 7.1 14.4 17.2 17.9 14.1 12.4 17.8 22.3 29.8 9.4 35.6 11.6 11.9 17.4 18.2 17.6 11.5 12.7 15.8 30.8 17.5 18.3 7.3 17.3 11.9 33.5 13.0 17.0 16.4 26.3 10.2 12.2 11.3 9.8 8.3 7.1 19.4 22.9 14.3 10.6 13.1 8.2 6.3 17.3 17.1 17.8 10.1 18.3 15.9 14.2 12.9 18.2 6.0 6.0 1.6 10.3 8.0 9.9 9.7 9.1 9.3 9.0 8.8 13.2 13.9 0.5 13.6 5.9 8.7 8.4 5.2 13.7 17.7 15.0 19.9 11.1 12.9 16.2 17.2 17.0 18.1 14.9 22.9 32.0 34.6 22.8 31.3 26.5 17.8 24.1 36.4 15.7 3.9 37.5 66.3 29.4 14.9 24.8 8.0 0.0 51.1 41.5 28.2 34.8 20.7 29.2 29.0 47.7 13.3 17.8 27.2 18.5 40.3 22.8 20.3 29.7 17.0 18.0 31.2 7.0 57.7 43.8 19.9 12.9 38.0 31.8 45.3 19.8 18.7 27.7 24.9 23.3 UAP1 "AgX, AGX1, SPAG2" ENSG00000117143 "UDP-N-acetylglucosamine pyrophosphorylase 1" Q16222 1 162561506-162599842 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-HME1: 107.8;U-251 MG: 70.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014659 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" No Yes 19000 "Nucleoplasm, Plasma membrane, Cytosol" "HPA014659: AB_1857409" "unprognostic (2.32e-2)" "unprognostic (2.45e-1)" "unprognostic (2.07e-2)" "unprognostic (1.28e-2)" "unprognostic (2.71e-2)" "unprognostic (1.46e-2)" "unprognostic (1.37e-2)" "unprognostic (1.47e-1)" "unprognostic (2.09e-1)" "unprognostic (1.30e-1)" "unprognostic (1.29e-3)" "unprognostic (4.96e-2)" "prognostic unfavorable (5.12e-5)" "unprognostic (1.59e-1)" "unprognostic (2.04e-1)" "unprognostic (3.51e-1)" "unprognostic (3.45e-2)" 38.4 18.5 7.0 17.4 9.8 17.2 24.8 9.0 13.4 16.1 26.9 5.7 45.7 17.2 10.9 19.4 23.6 15.7 18.3 22.5 7.7 7.8 11.0 67.1 16.0 7.4 6.6 8.9 20.4 31.4 5.1 16.0 21.5 9.1 13.9 26.9 7.8 43.9 62.5 19.4 12.4 33.4 28.8 7.1 8.1 23.0 37.7 3.7 5.6 12.4 13.5 15.3 24.4 16.7 8.3 5.6 8.1 1.6 6.2 16.1 4.8 30.5 2.2 6.1 4.9 29.8 23.9 4.2 44.9 16.6 34.7 28.3 5.8 14.4 1.2 10.1 34.4 12.5 5.3 6.9 13.1 57.2 4.8 10.3 5.4 7.0 11.4 14.0 9.2 3.7 11.0 6.2 38.0 107.8 15.9 21.2 9.6 30.5 12.6 46.4 5.6 5.3 5.9 4.5 31.4 10.0 4.8 11.9 14.9 5.4 3.6 6.6 6.8 19.6 12.2 10.4 7.5 6.0 10.5 36.0 17.5 16.1 44.0 70.2 21.2 7.4 10.1 10.0 4.3 11.0 1.0 1.6 8.1 13.0 1.6 16.1 8.3 7.9 13.3 3.4 6.5 7.6 9.5 1.6 6.2 0.8 5.6 3.9 4.8 7.0 9.8 9.0 13.4 7.7 7.8 6.6 8.9 9.1 3.7 6.0 30.4 17.9 120.0 119.7 10.0 26.6 17.8 53.5 38.7 15.7 7.9 22.4 61.3 24.8 36.3 23.3 84.7 0.0 56.9 52.1 141.3 91.8 33.4 88.9 14.0 6.4 52.6 21.5 7.0 11.8 46.9 15.2 81.0 27.9 124.5 14.0 55.8 69.1 38.9 20.2 12.3 19.4 160.3 182.9 121.8 71.5 81.7 20.1 59.9 111.6 UBA3 "hUba3, NAE2, UBE1C" ENSG00000144744 "Ubiquitin like modifier activating enzyme 3" Q8TBC4 3 69054730-69080408 "Predicted intracellular proteins" "Cell cycle, Ubl conjugation pathway" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034873, HPA034874, HPA065335" Supported Approved "Nucleoplasm,Plasma membrane,Centrosome,Cytosol" NA NA 9600 "Plasma membrane, Cytosol" "Nucleoplasm, Centrosome" "HPA034873: AB_10670578, HPA034874: AB_2674368, HPA065335: AB_2685473" "unprognostic (2.31e-1)" "unprognostic (1.75e-1)" "unprognostic (5.56e-3)" "unprognostic (9.26e-2)" "unprognostic (9.35e-3)" "unprognostic (5.53e-2)" "prognostic unfavorable (8.57e-4)" "unprognostic (1.08e-1)" "unprognostic (6.18e-2)" "unprognostic (1.60e-3)" "unprognostic (9.40e-2)" "unprognostic (2.71e-2)" "unprognostic (1.39e-3)" "unprognostic (2.61e-3)" "unprognostic (9.24e-2)" "unprognostic (7.80e-3)" "unprognostic (2.52e-1)" 19.1 25.3 29.7 22.2 31.0 53.7 26.8 30.9 31.4 20.3 19.7 31.3 15.9 16.1 22.8 25.4 25.4 19.5 18.4 38.2 23.8 22.7 24.7 17.6 19.3 28.7 37.5 21.2 20.4 15.1 17.9 28.0 27.8 40.8 22.6 22.6 21.8 28.0 20.4 25.0 27.6 21.9 24.0 30.2 27.8 17.3 13.5 31.9 28.4 18.2 17.2 31.0 22.9 20.4 18.9 22.3 35.6 27.8 20.2 22.2 26.0 26.8 11.4 28.1 17.1 26.3 34.9 21.7 24.1 27.3 26.3 26.5 14.1 19.0 20.5 7.0 25.9 26.5 15.5 21.6 27.6 30.0 37.3 13.7 27.7 21.5 14.2 20.3 27.1 23.3 27.4 18.5 24.8 20.8 32.4 33.8 16.9 11.4 17.6 34.6 9.6 17.8 18.3 24.9 34.1 9.8 13.9 20.8 18.8 41.9 34.4 12.1 16.9 25.4 18.5 20.6 31.6 12.6 26.7 25.6 20.0 17.6 25.9 33.4 20.2 32.3 24.4 20.5 30.2 25.4 34.7 25.4 35.6 14.3 27.8 16.1 18.9 18.9 17.6 22.3 16.0 17.9 18.0 24.4 20.2 27.7 11.4 22.2 26.0 29.7 31.0 30.9 31.4 23.8 22.7 37.5 21.2 40.8 31.9 32.8 28.9 17.1 23.8 30.0 21.0 57.2 20.4 37.5 23.9 33.2 37.3 64.4 16.6 30.4 10.9 27.1 14.3 0.0 20.5 47.2 31.1 21.5 40.5 16.2 30.1 31.8 17.9 20.3 43.2 7.9 37.4 39.1 28.7 53.3 15.3 27.7 25.3 8.6 35.7 26.4 44.9 25.8 29.3 32.3 33.0 37.4 47.5 33.8 16.6 28.2 UBA52 "CEP52, HUBCEP52, L40, MGC126879, MGC126881, MGC57125, RPL40" ENSG00000221983 "Ubiquitin A-52 residue ribosomal protein fusion product 1" P62987 19 18571730-18577550 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Late spermatids: 9484.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA041344, HPA049132, HPA056624" Supported Approved "Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "Nucleoplasm, Plasma membrane" "HPA041344: AB_2677422, HPA049132: AB_2680646, HPA056624: AB_2683196" "unprognostic (1.98e-2)" "unprognostic (9.35e-2)" "unprognostic (1.46e-1)" "unprognostic (4.72e-2)" "unprognostic (5.36e-3)" "unprognostic (9.35e-2)" "unprognostic (1.74e-3)" "unprognostic (4.00e-2)" "unprognostic (7.44e-2)" "unprognostic (1.72e-1)" "unprognostic (1.27e-1)" "unprognostic (2.87e-1)" "unprognostic (2.52e-3)" "unprognostic (1.87e-1)" "unprognostic (5.61e-2)" "unprognostic (2.43e-1)" "unprognostic (2.23e-1)" 84.7 73.8 71.1 76.4 76.5 167.0 101.5 32.8 71.1 83.2 73.0 48.7 67.8 47.7 79.0 93.2 102.7 78.8 82.0 85.9 58.2 50.2 74.1 135.5 67.7 182.7 64.0 59.0 150.3 225.2 56.5 62.8 71.6 55.5 75.8 74.0 51.6 96.0 75.2 191.4 104.6 68.0 91.9 72.0 101.1 75.5 89.5 52.1 121.2 97.6 131.7 145.1 99.9 161.7 200.5 157.0 75.1 132.4 109.7 205.0 246.6 104.4 83.5 62.7 104.6 163.0 155.1 155.6 80.7 112.1 134.1 107.1 151.2 97.9 151.5 83.5 133.0 52.8 70.9 121.3 143.5 126.9 40.6 189.4 82.9 129.9 170.4 118.7 179.8 106.3 179.4 196.4 91.9 133.7 117.4 134.3 97.0 131.1 210.1 114.3 174.9 143.6 161.4 140.3 199.6 180.9 118.8 62.6 173.5 129.2 158.9 81.8 99.0 58.6 142.1 139.9 97.9 63.0 232.8 99.7 67.3 56.3 141.7 142.6 129.4 171.7 149.9 91.6 204.3 91.1 50.7 132.4 69.8 119.4 107.2 162.2 200.5 178.5 142.6 147.6 199.1 205.0 165.6 75.1 109.7 96.1 157.0 138.5 246.6 71.1 76.5 32.8 71.1 58.2 50.2 64.0 59.0 55.5 52.1 431.7 622.2 2582.1 1573.2 1686.3 110.3 294.0 1008.9 451.1 705.2 621.1 64.8 1723.9 1331.3 1227.6 2621.0 1327.6 1318.3 1448.3 1974.2 2396.3 1301.0 1468.3 776.0 1485.4 2254.1 98.5 1063.9 1146.6 2650.9 9484.0 1736.3 2494.7 1186.1 2394.1 1524.2 239.6 1703.1 1730.2 972.7 1715.5 163.6 685.6 1317.8 523.4 597.0 1957.5 1909.1 1690.5 1603.6 1847.3 UBAC1 "GBDR1, KPC2, UBADC1" ENSG00000130560 "UBA domain containing 1" Q9BSL1 9 135932969-135961380 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "skeletal muscle: 113.2" "Cell type enhanced" "Detected in all" 6 "Erythroid cells: 233.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 60.5;K-562: 76.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005651 Approved Supported "Golgi apparatus,Plasma membrane,Cytosol" NA NA 54000 "Plasma membrane, Cytosol" "Golgi apparatus" "HPA005651: AB_1858489" "unprognostic (8.41e-2)" "prognostic favorable (4.34e-6)" "unprognostic (2.10e-1)" "unprognostic (9.15e-2)" "unprognostic (4.11e-1)" "unprognostic (3.85e-2)" "unprognostic (7.68e-3)" "unprognostic (2.85e-1)" "unprognostic (4.37e-2)" "unprognostic (3.23e-1)" "unprognostic (3.92e-3)" "unprognostic (1.20e-1)" "prognostic favorable (3.58e-7)" "unprognostic (1.95e-3)" "unprognostic (9.46e-2)" "unprognostic (3.16e-2)" "unprognostic (5.78e-2)" 7.6 5.7 12.4 5.8 13.4 27.1 6.2 10.9 12.7 6.1 11.0 8.0 6.8 9.9 6.2 10.3 10.0 9.4 5.1 22.2 11.0 8.6 8.8 7.6 6.4 5.8 11.6 7.4 7.8 6.7 6.9 6.6 9.3 8.7 7.4 7.8 7.7 9.2 9.2 113.2 15.7 9.6 9.3 10.1 5.7 6.1 10.9 7.8 3.9 6.1 21.9 9.0 7.6 8.3 3.2 9.7 5.1 18.8 2.2 3.6 4.0 9.1 10.7 7.6 11.0 5.8 6.7 14.3 8.0 6.9 10.0 8.1 14.8 11.7 11.1 7.8 6.6 11.9 31.3 10.6 9.3 4.5 60.5 10.0 9.2 19.2 8.3 6.0 12.0 8.8 6.3 12.2 6.3 6.2 6.7 8.3 10.5 76.7 9.0 7.9 18.9 9.7 12.3 18.0 21.6 18.2 11.1 14.3 14.6 7.1 5.9 11.8 13.0 11.6 10.5 8.1 7.1 8.9 13.0 6.7 5.7 8.6 6.8 9.9 5.3 9.8 13.2 10.5 10.9 7.7 3.4 11.3 5.1 3.1 17.2 3.3 3.2 3.6 2.1 9.7 2.0 1.9 2.2 2.5 2.2 18.8 1.0 2.7 4.0 12.4 13.4 10.9 12.7 11.0 8.6 11.6 7.4 8.7 7.8 14.9 7.7 13.7 32.8 36.1 36.5 74.9 12.7 91.0 14.8 26.2 29.5 121.1 79.6 15.6 80.0 25.3 39.3 233.6 20.0 20.6 17.0 18.9 6.9 26.7 64.5 12.7 16.1 16.0 27.7 144.8 18.1 30.0 33.7 43.3 32.5 43.1 17.5 46.5 21.2 21.9 35.3 19.4 19.8 43.5 52.7 56.7 50.6 10.1 47.7 37.6 UBAP1 UBAP ENSG00000165006 "Ubiquitin associated protein 1" Q9NZ09 9 34179005-34252523 "Predicted intracellular proteins" "Protein transport, Transport" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019804 Approved Supported "Vesicles,Plasma membrane,Cytosol" NA NA Cytosol "Vesicles, Plasma membrane" "HPA019804: AB_1858494" "unprognostic (1.83e-1)" "unprognostic (4.30e-2)" "unprognostic (1.29e-1)" "unprognostic (1.70e-1)" "unprognostic (3.54e-1)" "unprognostic (3.29e-2)" "unprognostic (1.67e-1)" "unprognostic (1.59e-1)" "unprognostic (2.01e-2)" "unprognostic (6.53e-2)" "unprognostic (1.25e-2)" "unprognostic (3.63e-1)" "prognostic favorable (7.49e-6)" "unprognostic (1.24e-1)" "unprognostic (1.49e-1)" "unprognostic (2.46e-1)" "unprognostic (1.17e-1)" 26.4 34.6 25.7 17.5 25.0 81.9 28.6 29.1 29.5 24.2 26.0 26.5 14.5 16.6 25.3 20.0 40.5 20.4 22.9 34.4 24.0 23.6 25.6 38.6 27.7 17.3 27.0 20.0 26.8 20.7 26.7 19.2 26.8 25.5 20.4 19.0 21.5 19.4 24.3 62.3 22.6 24.6 26.4 26.3 21.4 20.9 33.5 26.0 17.2 23.6 22.1 25.4 29.2 29.5 10.5 17.8 45.9 19.6 17.4 26.5 19.2 20.9 11.8 13.6 14.8 25.3 15.7 11.5 16.8 23.7 18.9 25.8 12.8 8.8 14.7 7.6 25.1 16.1 10.8 18.9 26.5 18.3 21.1 8.5 13.1 26.5 13.3 23.1 14.5 17.5 19.4 44.0 22.4 29.5 28.8 20.9 14.5 10.0 14.7 17.6 8.8 13.4 20.4 14.8 14.5 17.7 12.1 9.7 8.5 40.5 14.0 7.8 10.9 18.7 19.5 8.6 12.7 9.5 14.5 14.8 9.7 15.0 14.5 15.6 7.3 9.1 15.5 19.5 11.8 28.5 9.0 19.6 24.1 15.4 17.1 26.5 10.5 15.5 16.1 17.8 8.8 15.1 12.3 45.9 17.4 14.5 9.9 19.1 19.2 25.7 25.0 29.1 29.5 24.0 23.6 27.0 20.0 25.5 26.0 62.5 24.2 13.9 57.1 41.7 12.9 11.4 12.7 25.4 38.7 7.0 23.6 29.1 16.6 29.7 56.8 17.9 20.6 23.3 35.1 29.2 28.2 45.4 24.4 20.8 19.3 6.4 15.4 12.9 17.1 45.7 27.0 22.9 23.6 20.8 15.4 23.6 35.8 23.0 40.0 15.8 11.4 19.4 28.6 21.7 20.6 51.6 74.9 25.4 16.8 59.0 UBASH3B "KIAA1959, STS-1, TULA-2, TULA2" ENSG00000154127 "Ubiquitin associated and SH3 domain containing B" Q8TF42 11 122655675-122814473 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.5;lymphoid tissue: 27.7" "Cell type enhanced" "Detected in many" 7 "Cytotrophoblasts: 29.2;Extravillous trophoblasts: 45.7;Hofbauer cells: 34.3;Kupffer cells: 31.7;Syncytiotrophoblasts: 39.8" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 5 "cerebellum: 32.5;pons and medulla: 21.2" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 42.6;HMC-1: 32.5;hTEC/SVTERT24-B: 26.5;REH: 25.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038605, HPA038607" Approved Approved "Plasma membrane" NA NA 2200000 "Plasma membrane" "HPA038605: AB_10669648, HPA038607: AB_2676112" "unprognostic (4.94e-2)" "unprognostic (6.03e-3)" "unprognostic (1.34e-1)" "unprognostic (2.98e-1)" "unprognostic (2.02e-1)" "unprognostic (1.49e-1)" "unprognostic (9.09e-2)" "unprognostic (4.67e-3)" "unprognostic (1.21e-1)" "unprognostic (1.95e-1)" "unprognostic (1.46e-3)" "unprognostic (6.20e-2)" "unprognostic (9.02e-3)" "unprognostic (1.54e-1)" "unprognostic (3.22e-2)" "unprognostic (2.72e-3)" "unprognostic (1.53e-1)" 4.3 1.3 2.8 5.5 4.0 7.2 1.5 32.5 4.9 4.0 1.5 0.7 0.0 1.7 1.3 0.3 1.8 1.1 2.4 1.3 3.4 3.5 1.5 1.7 5.5 10.9 5.1 1.9 0.8 1.2 0.6 0.9 16.8 21.2 1.3 1.8 0.9 1.3 0.9 1.8 4.1 2.4 2.3 2.1 27.7 1.7 2.1 0.2 23.9 2.9 1.7 3.8 3.4 1.3 1.0 1.7 9.8 11.0 6.5 4.9 1.8 4.5 11.1 2.0 2.7 0.9 1.6 10.6 16.2 9.0 6.6 5.1 4.4 2.4 1.8 1.3 8.6 6.3 2.2 0.0 5.8 10.5 0.0 0.3 42.6 0.3 3.7 2.5 5.1 32.5 1.4 0.3 26.5 9.8 7.2 4.4 1.9 0.0 0.0 6.4 0.1 6.3 3.3 0.9 4.6 2.6 25.4 1.2 0.2 10.4 3.8 4.6 0.1 4.3 0.3 3.6 4.4 0.0 1.4 11.4 8.6 4.6 5.0 6.7 0.4 0.0 5.4 4.5 7.3 15.5 0.0 1.3 9.8 2.0 6.5 2.2 0.3 2.6 1.8 1.7 1.0 3.0 1.6 2.8 6.5 11.0 0.2 4.9 1.8 2.8 4.0 32.5 4.9 3.4 3.5 5.1 1.9 21.2 0.2 0.0 6.6 0.0 3.5 6.4 0.6 1.2 0.0 0.0 1.2 3.5 0.0 29.2 0.0 9.2 1.9 4.2 0.4 0.0 8.3 45.7 4.2 2.9 12.7 0.0 34.3 11.1 0.0 4.9 31.7 2.8 0.0 19.6 1.7 0.0 0.0 0.5 16.9 0.0 0.4 0.0 1.1 0.0 4.2 0.0 0.5 5.3 39.8 7.2 0.3 2.7 UBE2D2 "UBC4, UbcH5B" ENSG00000131508 "Ubiquitin conjugating enzyme E2 D2" P62837 5 139526431-139628433 "Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003920 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA003920: AB_1858519" "unprognostic (1.14e-1)" "unprognostic (2.75e-3)" "prognostic favorable (5.09e-5)" "prognostic favorable (5.90e-4)" "unprognostic (2.33e-1)" "unprognostic (8.19e-3)" "prognostic unfavorable (9.63e-7)" "unprognostic (7.41e-3)" "unprognostic (2.17e-1)" "unprognostic (1.21e-1)" "unprognostic (9.33e-2)" "unprognostic (1.41e-3)" "prognostic unfavorable (2.09e-5)" "unprognostic (8.00e-2)" "unprognostic (1.01e-1)" "unprognostic (4.20e-1)" "unprognostic (1.07e-1)" 35.6 25.0 41.2 31.5 39.9 44.2 35.9 31.9 49.6 43.9 50.4 35.5 31.5 22.2 35.5 52.2 44.8 47.6 27.1 34.8 39.5 40.5 37.2 39.5 34.8 55.6 40.5 36.1 35.3 41.7 23.8 35.3 33.6 35.9 30.8 46.4 30.7 30.5 37.9 80.6 33.2 37.4 39.3 41.9 41.3 29.1 68.0 29.3 71.0 34.4 31.2 64.5 42.2 36.1 34.3 39.3 40.8 23.0 22.5 41.7 19.5 34.1 22.8 40.0 27.9 27.0 34.7 25.6 36.1 33.8 42.6 49.9 58.6 32.5 48.8 47.6 37.2 52.7 21.7 39.2 60.9 57.1 31.5 22.9 27.7 25.2 33.7 52.9 27.0 24.7 27.2 31.5 42.3 63.3 36.9 45.4 32.3 24.0 41.8 39.5 34.3 41.6 38.5 22.0 12.0 24.8 31.8 41.6 35.3 44.8 40.4 36.5 24.1 31.5 40.6 57.4 89.9 25.4 24.0 29.7 32.6 18.1 27.0 44.1 30.1 48.9 68.5 23.3 44.6 25.9 14.8 20.9 40.8 22.6 18.8 24.7 34.1 32.7 31.7 23.4 34.3 41.7 35.2 34.5 22.5 23.0 39.3 40.0 19.5 41.2 39.9 31.9 49.6 39.5 40.5 40.5 36.1 35.9 29.3 29.8 71.1 173.0 150.9 152.6 68.0 80.9 79.0 36.1 43.3 64.6 76.6 160.4 182.4 173.6 500.3 117.4 113.7 70.0 156.3 191.8 125.8 164.5 136.2 71.0 157.1 89.0 118.5 93.9 121.3 409.1 96.7 157.7 145.1 191.2 112.3 128.4 182.8 103.7 88.1 147.6 99.0 116.4 156.8 337.7 125.2 178.2 208.7 191.8 148.1 221.1 UBE2D4 HBUCE1 ENSG00000078967 "Ubiquitin conjugating enzyme E2 D4 (putative)" Q9Y2X8 7 43926438-43956136 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 48.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SH-SY5Y: 25.3" "Low region specificity" "Detected in all" HPA003920 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA003920: AB_1858519" "unprognostic (9.95e-3)" "unprognostic (6.76e-2)" "unprognostic (6.87e-2)" "unprognostic (8.94e-2)" "unprognostic (8.24e-2)" "unprognostic (5.24e-2)" "unprognostic (2.42e-1)" "unprognostic (3.58e-3)" "unprognostic (4.74e-2)" "unprognostic (5.04e-2)" "prognostic favorable (4.86e-4)" "prognostic favorable (5.77e-4)" "prognostic favorable (6.51e-4)" "unprognostic (1.11e-1)" "unprognostic (8.74e-3)" "unprognostic (1.89e-1)" "unprognostic (1.34e-1)" 10.1 13.1 14.7 5.0 13.3 4.5 9.1 13.8 17.4 8.8 7.6 11.4 7.9 5.3 7.5 11.2 8.0 9.0 7.2 23.8 14.2 10.0 12.7 15.3 8.4 5.3 12.1 9.4 7.9 17.4 8.7 6.9 5.9 11.9 8.7 6.2 8.1 10.6 9.1 48.6 9.4 5.3 10.3 12.8 7.3 6.5 5.1 6.1 2.7 9.6 16.1 5.7 7.7 6.5 10.7 11.8 12.9 20.5 7.7 14.0 6.7 3.8 3.2 2.0 9.1 9.4 3.8 1.5 1.9 4.7 2.4 3.2 1.7 4.6 3.7 5.3 5.0 6.8 4.4 2.5 2.1 3.7 8.3 4.2 4.0 5.0 4.4 3.5 8.7 8.2 2.9 4.4 2.7 4.2 3.5 3.0 4.6 4.4 7.8 3.3 2.5 5.1 5.0 4.4 4.7 4.2 3.2 2.8 5.8 5.1 4.7 7.4 25.3 4.0 8.1 3.0 3.8 4.0 2.6 2.6 1.6 5.1 3.4 5.5 11.2 8.4 1.8 4.8 11.4 8.9 6.3 11.7 12.9 9.3 18.4 9.5 10.3 11.6 10.5 11.8 10.7 14.0 11.5 1.1 7.7 20.5 10.2 9.4 6.7 14.7 13.3 13.8 17.4 14.2 10.0 12.1 9.4 11.9 6.1 0.0 6.2 8.8 8.1 5.6 8.3 21.8 5.1 2.7 6.8 15.7 2.0 9.7 46.4 15.9 5.0 11.9 8.4 0.0 24.7 17.3 10.8 9.8 4.6 22.2 24.7 11.1 18.0 9.2 7.3 8.0 11.2 12.9 15.1 24.4 7.1 9.1 14.6 5.8 20.5 38.0 10.4 6.5 12.0 15.1 8.3 9.8 6.4 6.9 7.9 9.3 UBE2K "HIP2, HYPG, UBC1" ENSG00000078140 "Ubiquitin conjugating enzyme E2 K" P61086 4 39698044-39782792 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028869, CAB033212, CAB033515" Supported Approved "Plasma membrane,Cytosol" NA NA 150000 Cytosol "Plasma membrane" "CAB033212: AB_2272506, CAB033515: AB_2304024, HPA028869: AB_10602487" "unprognostic (1.14e-2)" "unprognostic (6.02e-2)" "unprognostic (2.42e-3)" "unprognostic (3.06e-1)" "unprognostic (6.81e-2)" "unprognostic (2.05e-1)" "unprognostic (5.05e-3)" "unprognostic (1.44e-2)" "unprognostic (2.71e-3)" "unprognostic (1.01e-1)" "prognostic unfavorable (8.60e-4)" "unprognostic (1.08e-1)" "unprognostic (3.67e-1)" "unprognostic (4.83e-2)" "unprognostic (6.88e-2)" "unprognostic (1.22e-1)" "unprognostic (4.10e-3)" 27.2 21.8 27.0 21.2 27.6 17.3 21.6 38.6 40.7 17.0 33.2 11.8 14.1 29.1 19.9 18.5 29.9 14.9 18.5 28.1 27.7 26.8 26.6 44.5 17.1 17.9 24.1 26.4 16.9 15.8 18.9 26.9 29.8 25.2 19.7 24.0 13.4 18.4 17.3 31.8 22.0 24.6 18.8 19.2 16.9 29.3 16.0 15.9 21.3 23.6 19.7 18.8 22.8 20.4 17.6 23.7 20.6 19.9 10.9 14.1 8.9 24.2 24.9 13.4 12.7 8.4 7.9 22.8 33.4 7.1 9.0 9.4 37.6 25.0 30.3 29.4 9.4 22.1 10.2 25.8 14.6 14.4 20.3 18.5 39.2 25.2 32.5 10.6 42.1 22.2 7.4 16.5 12.6 13.6 9.4 11.7 13.3 39.8 10.9 9.2 23.5 29.3 23.4 17.8 14.0 19.0 17.3 40.3 11.3 12.5 33.8 27.9 12.3 25.0 9.5 14.9 15.5 12.2 14.1 32.0 14.0 29.7 16.6 30.7 15.4 45.0 33.3 7.3 27.0 16.4 13.9 16.6 20.6 13.5 14.3 12.7 17.6 14.1 12.6 16.6 12.5 10.7 12.0 13.3 10.9 19.9 23.7 13.7 8.9 27.0 27.6 38.6 37.7 27.7 26.8 24.1 26.4 25.2 15.9 53.6 50.8 35.6 49.5 109.2 60.1 57.3 45.9 71.0 67.1 47.1 27.5 74.8 56.3 76.3 97.5 58.3 92.6 70.0 77.7 144.5 61.6 76.6 33.5 101.0 71.4 98.5 57.3 61.4 71.5 150.7 60.4 73.4 54.0 103.6 63.5 70.2 109.4 73.0 53.0 81.7 38.2 38.8 67.9 71.4 46.9 120.6 123.3 48.4 65.5 98.3 UBE2S E2-EPF ENSG00000108106 "Ubiquitin conjugating enzyme E2 S" Q16763 19 55399745-55407777 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 68.0;lymphoid tissue: 60.2;testis: 69.4" "Cell type enhanced" "Detected in many" 4 "Extravillous trophoblasts: 226.9;Spermatocytes: 216.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015228, HPA057150" Approved Approved "Nucleoplasm,Plasma membrane" NA Yes "Plasma membrane" Nucleoplasm "CAB015228: , HPA057150: AB_2683351" "unprognostic (2.79e-1)" "unprognostic (2.42e-1)" "unprognostic (2.57e-1)" "prognostic unfavorable (2.05e-4)" "unprognostic (9.54e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (8.00e-6)" "unprognostic (1.42e-3)" "unprognostic (2.32e-1)" "unprognostic (2.31e-1)" "unprognostic (8.08e-2)" "unprognostic (4.52e-2)" "prognostic unfavorable (8.16e-8)" "unprognostic (1.05e-1)" "unprognostic (9.51e-2)" "unprognostic (1.58e-1)" "unprognostic (1.75e-1)" 10.2 9.2 18.0 19.5 15.9 68.0 4.7 11.4 21.6 6.1 12.0 9.1 4.5 8.4 7.1 7.2 17.1 6.0 9.7 18.0 18.7 18.1 5.9 5.6 6.3 22.9 13.7 14.4 6.4 6.0 3.7 12.9 9.8 12.9 7.0 7.1 6.2 4.9 5.3 7.3 6.2 7.3 10.7 15.3 11.0 10.6 69.4 8.2 60.2 5.9 14.3 21.1 10.0 7.1 4.5 3.1 6.0 1.9 0.6 2.6 0.3 60.3 32.7 28.8 22.9 1.8 2.6 5.1 49.2 14.9 30.4 27.7 22.1 21.6 58.8 20.4 12.3 36.6 17.8 28.8 12.8 13.5 46.0 95.7 35.1 18.8 7.1 5.5 42.0 34.2 2.9 3.6 22.3 21.6 6.6 11.9 32.1 34.9 41.2 19.0 16.0 56.8 21.8 72.2 16.9 55.5 50.1 22.2 21.1 8.1 12.9 73.1 39.6 62.7 15.6 27.9 9.1 11.1 22.8 18.2 18.3 52.1 15.6 116.9 33.2 79.7 69.0 19.2 29.7 66.3 1.1 1.9 2.9 1.8 1.5 1.2 4.5 2.6 2.6 1.5 1.6 2.5 1.5 6.0 0.6 0.9 3.1 1.0 0.3 18.0 15.9 11.4 21.6 18.7 18.1 13.7 14.4 12.9 8.2 0.0 4.3 37.3 136.4 144.5 56.5 2.4 7.6 0.0 0.0 19.2 51.1 34.3 13.3 44.4 86.7 31.2 25.8 70.0 26.4 226.9 94.9 63.2 18.4 9.6 55.5 30.2 88.9 22.7 24.7 27.7 16.1 39.9 70.9 55.1 28.4 76.7 57.6 28.1 11.7 14.8 59.0 12.9 96.6 216.2 140.8 101.4 50.0 44.7 30.4 121.0 UBE3C "KIAA0010, KIAA10" ENSG00000009335 "Ubiquitin protein ligase E3C" Q15386 7 157138913-157269372 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039915 Approved Approved "Nucleoplasm,Plasma membrane,Mitochondria" NA NA "Nucleoplasm, Mitochondria" "Plasma membrane" "HPA039915: AB_10795264" "unprognostic (2.83e-2)" "unprognostic (9.27e-3)" "unprognostic (2.41e-1)" "unprognostic (2.29e-1)" "unprognostic (1.19e-2)" "unprognostic (3.14e-2)" "unprognostic (1.36e-1)" "unprognostic (7.02e-2)" "unprognostic (2.34e-2)" "unprognostic (1.58e-1)" "unprognostic (3.01e-3)" "unprognostic (8.64e-2)" "prognostic favorable (9.18e-6)" "unprognostic (9.74e-2)" "unprognostic (1.86e-1)" "unprognostic (1.87e-1)" "unprognostic (3.60e-2)" 24.7 21.0 14.0 17.9 23.1 12.4 19.8 25.5 29.9 21.3 23.4 17.2 15.3 17.4 28.8 16.8 26.8 18.8 24.8 31.8 14.4 13.8 21.2 30.5 16.7 16.7 14.5 15.1 20.7 22.1 29.6 20.3 21.3 22.3 19.0 21.0 20.2 31.7 21.5 51.2 21.2 23.9 25.7 16.1 20.5 21.8 35.9 11.1 20.3 15.6 24.5 24.4 23.1 19.1 2.5 4.0 2.1 4.6 3.7 6.6 2.9 22.8 18.2 11.7 23.3 21.0 22.1 12.9 25.3 21.9 21.4 21.7 16.3 19.1 12.4 22.5 27.9 27.9 14.5 18.1 23.3 25.4 22.5 16.6 12.6 12.7 11.7 20.9 18.8 18.5 19.5 21.6 23.7 19.7 16.3 24.9 10.4 18.3 13.8 30.2 20.0 18.4 11.9 18.5 20.5 21.9 10.6 13.1 25.4 22.1 25.2 18.7 19.3 24.9 21.5 18.5 13.6 11.1 13.2 22.3 27.0 5.8 66.1 31.3 13.9 13.9 12.5 31.0 28.1 30.8 0.5 3.5 2.1 4.8 4.6 6.6 2.5 5.2 5.2 4.0 2.5 4.9 5.9 1.3 3.7 4.5 3.6 5.2 2.9 14.0 23.1 25.5 29.9 14.4 13.8 14.5 15.1 22.3 11.1 20.8 19.5 9.7 13.9 24.5 31.4 31.5 28.1 16.0 9.1 24.4 62.8 12.2 8.3 17.0 8.4 19.9 22.1 0.0 15.2 14.4 14.7 19.9 9.2 39.2 13.9 30.2 23.5 24.5 21.2 8.5 14.4 15.0 5.0 12.6 20.6 10.9 22.5 10.5 24.1 16.5 42.8 0.0 17.6 20.4 27.4 29.1 12.6 13.8 22.4 27.3 UBQLN2 "Chap1, CHAP1/DSK2, Dsk2, LIC-2, N4BP4, PLIC-2, PLIC2, RIHFB2157" ENSG00000188021 "Ubiquilin 2" Q9UHD9 X 56563639-56567868 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Autophagy "Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006431, CAB013481" Enhanced Supported "Plasma membrane,Cytosol" NA Yes 200000 Cytosol "Plasma membrane" "CAB013481: AB_2533341, HPA006431: AB_1078707" "unprognostic (1.23e-2)" "unprognostic (2.88e-1)" "unprognostic (1.47e-1)" "unprognostic (1.51e-3)" "unprognostic (1.76e-2)" "unprognostic (5.08e-2)" "prognostic unfavorable (2.29e-4)" "unprognostic (2.66e-1)" "unprognostic (1.25e-1)" "unprognostic (4.42e-1)" "unprognostic (1.55e-1)" "unprognostic (1.13e-1)" "unprognostic (8.81e-2)" "unprognostic (1.35e-1)" "unprognostic (1.45e-1)" "unprognostic (8.88e-2)" "unprognostic (8.42e-3)" 13.4 20.8 27.0 13.9 40.7 9.4 16.2 34.9 35.3 17.3 13.6 17.8 15.0 11.1 17.0 16.7 18.1 18.2 14.5 20.8 26.2 28.6 13.9 18.9 14.0 16.4 21.2 26.6 27.0 10.6 25.5 18.3 15.6 20.8 21.1 12.5 13.3 13.7 21.5 24.6 13.5 11.6 18.7 18.8 13.9 12.9 5.4 16.7 18.0 20.9 10.9 17.7 16.4 14.1 5.5 10.9 25.0 19.4 12.1 20.4 10.9 18.6 13.9 14.0 16.3 32.2 20.6 8.8 15.1 18.0 11.4 12.6 7.8 8.8 14.3 16.6 17.8 17.8 11.0 26.6 16.9 13.8 22.1 16.0 5.8 19.2 8.2 16.9 11.3 12.8 19.1 21.4 15.3 13.4 16.5 9.9 9.3 6.7 15.8 17.9 8.7 14.5 9.9 11.6 6.0 16.6 13.0 18.1 13.5 23.0 14.6 17.3 16.2 21.8 9.7 8.8 25.6 16.2 8.4 11.1 12.1 12.4 17.4 9.1 6.0 7.4 9.9 13.6 12.0 10.2 25.0 14.1 14.1 9.9 19.3 11.1 5.1 15.1 11.5 10.9 5.5 20.4 12.2 12.4 12.1 19.4 3.9 14.1 10.9 27.0 40.7 34.9 35.3 26.2 28.6 21.2 26.6 20.8 16.7 20.8 12.1 13.7 34.3 27.7 41.9 31.1 12.7 13.4 9.1 17.4 17.7 23.0 14.9 17.9 0.0 17.1 14.4 0.0 14.5 22.2 23.5 24.0 12.7 19.2 21.1 39.7 32.8 18.4 34.3 0.4 23.0 18.9 16.9 27.9 18.1 22.1 15.8 14.0 34.3 10.9 31.2 12.9 32.5 0.3 0.2 26.6 33.4 17.5 18.8 32.1 UBR2 "bA49A4.1, C6orf133, dJ392M17.3, KIAA0349" ENSG00000024048 "Ubiquitin protein ligase E3 component n-recognin 2" Q8IWV8 6 42564062-42693504 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Erythroid cells: 93.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 25.2" "Lineage enriched" "Detected in all" 4 "granulocytes: 25.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027869, HPA027880" Approved Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA027869: AB_10600416, HPA027880: AB_10601217" "unprognostic (3.26e-1)" "unprognostic (1.29e-1)" "unprognostic (8.33e-2)" "unprognostic (2.95e-2)" "unprognostic (1.08e-2)" "unprognostic (4.23e-2)" "unprognostic (1.32e-1)" "unprognostic (7.24e-2)" "unprognostic (5.05e-2)" "prognostic favorable (1.65e-4)" "unprognostic (1.12e-1)" "unprognostic (7.53e-2)" "unprognostic (1.30e-2)" "unprognostic (3.88e-1)" "unprognostic (1.81e-1)" "unprognostic (5.78e-2)" "unprognostic (7.77e-3)" 19.8 18.8 14.4 21.8 16.7 22.1 18.6 26.6 20.4 17.2 19.3 17.8 17.8 20.1 29.5 16.8 16.2 15.6 16.2 16.8 13.8 13.2 17.8 24.0 19.3 18.0 16.7 12.9 20.8 24.6 28.0 26.3 16.3 17.2 16.5 20.1 15.8 18.3 15.6 33.5 18.0 24.6 19.9 15.9 21.3 18.2 9.2 17.2 26.1 20.1 14.9 17.7 18.9 29.8 3.6 3.5 25.2 5.7 3.9 4.4 1.9 14.4 7.3 8.5 13.3 17.5 16.9 11.5 11.1 12.0 9.9 10.3 10.5 6.0 9.9 8.9 12.0 11.5 14.6 12.2 9.5 12.6 13.3 8.6 15.7 10.8 13.6 14.2 15.1 10.8 11.9 10.4 9.8 10.8 12.2 11.1 14.4 18.3 12.6 9.4 11.6 11.8 13.4 7.7 28.5 7.1 10.6 12.7 14.8 11.3 12.6 10.1 8.0 11.2 10.8 10.9 13.5 10.6 14.7 16.0 9.0 7.1 11.0 8.0 11.7 10.3 15.3 4.7 11.4 5.4 10.4 4.6 9.2 4.4 4.8 3.7 3.4 2.9 3.4 3.5 3.6 3.0 3.3 25.2 3.9 5.7 2.6 3.3 1.9 14.4 16.7 26.6 20.4 13.8 13.2 16.7 12.9 17.2 17.2 14.9 21.1 12.8 17.4 14.7 41.6 32.9 22.9 25.4 22.7 19.2 56.9 14.8 14.9 14.7 4.6 21.1 31.4 93.5 13.2 11.0 18.8 19.9 19.7 28.1 12.0 60.4 12.1 18.4 28.9 3.9 23.6 24.6 18.6 17.2 19.6 23.5 14.1 22.9 22.6 9.6 50.0 38.8 23.4 9.2 8.1 14.2 14.4 32.0 18.0 18.7 UBTD1 FLJ11807 ENSG00000165886 "Ubiquitin domain containing 1" Q9HAC8 10 97498868-97571209 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 52.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 7.5;neutrophil: 8.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034825 Uncertain Approved "Vesicles,Plasma membrane,Cytosol" NA Yes Vesicles "Plasma membrane, Cytosol" "HPA034825: AB_10602254" "unprognostic (1.52e-1)" "unprognostic (1.48e-1)" "prognostic unfavorable (5.54e-4)" "unprognostic (2.43e-1)" "unprognostic (1.78e-1)" "unprognostic (3.90e-2)" "unprognostic (3.63e-3)" "unprognostic (1.43e-2)" "unprognostic (1.66e-3)" "unprognostic (9.25e-3)" "unprognostic (2.45e-1)" "unprognostic (4.78e-1)" "unprognostic (6.62e-3)" "unprognostic (8.80e-2)" "unprognostic (1.49e-1)" "unprognostic (1.47e-3)" "unprognostic (3.50e-3)" 16.0 5.6 7.7 7.3 7.1 10.2 20.5 5.1 9.0 11.5 4.6 5.8 9.7 2.9 6.6 13.9 8.1 8.3 9.0 23.8 6.8 6.5 15.6 11.2 26.0 8.3 9.1 4.8 8.9 12.9 3.1 7.8 5.3 6.4 6.5 1.5 8.9 10.7 10.8 24.2 22.7 2.5 7.0 6.7 5.3 4.1 30.3 5.7 1.0 12.9 10.9 4.4 10.3 8.6 0.3 1.7 8.5 3.4 0.0 0.4 0.5 9.0 9.0 2.4 11.9 10.1 9.5 2.8 10.4 15.3 11.2 8.6 6.0 7.9 1.1 12.7 7.0 7.0 10.9 2.4 13.9 1.5 2.7 4.7 1.1 2.8 7.5 14.6 1.0 3.1 13.1 4.7 12.1 3.0 17.2 17.8 2.4 0.6 1.7 7.1 4.3 0.4 9.2 3.9 1.7 16.6 0.9 4.2 1.0 8.6 3.4 0.8 2.5 4.7 2.9 13.4 2.2 10.8 6.8 19.1 14.2 8.7 14.8 13.5 2.2 2.5 0.4 11.9 6.1 7.3 1.3 3.4 7.5 0.2 0.8 0.2 0.3 0.1 0.0 1.7 0.0 0.1 0.0 8.5 0.0 0.9 1.2 0.4 0.5 7.7 7.1 5.1 8.1 6.8 6.5 9.1 4.8 6.4 5.7 38.7 19.9 0.0 7.7 23.1 2.2 14.1 7.6 9.4 13.6 7.0 3.9 2.8 10.0 16.1 52.6 20.4 0.3 0.0 11.2 9.4 17.5 12.5 0.0 5.8 24.5 6.4 0.0 4.9 7.3 20.2 11.8 8.5 10.1 9.0 0.1 10.1 16.8 0.0 8.9 8.1 15.9 12.9 9.0 5.9 5.7 26.0 2.4 0.9 0.2 6.2 UCP3 SLC25A9 ENSG00000175564 "Uncoupling protein 3" P55916 11 74000281-74009435 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" Transport "Diabetes mellitus, Disease mutation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "skeletal muscle: 99.6" "Group enriched" "Detected in some" 5 "Early spermatids: 14.7;Late spermatids: 10.7" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 4 "cerebellum: 1.1" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in many" 4 "HDLM-2: 18.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB010771, HPA072225" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "CAB010771: AB_261839, HPA072225: AB_2686498" "unprognostic (3.76e-3)" "unprognostic (1.24e-1)" "unprognostic (2.82e-1)" "unprognostic (5.98e-2)" "unprognostic (1.12e-1)" "unprognostic (2.49e-2)" "unprognostic (3.95e-3)" "unprognostic (6.61e-2)" "unprognostic (1.25e-1)" "unprognostic (8.58e-2)" "unprognostic (2.13e-4)" "unprognostic (1.61e-2)" "unprognostic (3.25e-6)" "unprognostic (2.68e-1)" "unprognostic (1.66e-1)" "unprognostic (1.76e-1)" "unprognostic (2.50e-4)" 0.9 0.2 0.2 0.3 0.2 0.6 0.2 1.1 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.5 0.9 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.2 1.0 0.2 99.6 0.3 0.2 0.2 0.2 0.5 0.1 0.6 0.2 0.2 0.6 6.4 0.8 0.2 0.2 0.8 0.1 0.7 0.3 0.2 2.1 0.4 0.2 2.1 2.1 1.8 0.8 0.4 0.4 0.5 0.5 0.5 0.3 0.5 0.4 1.1 0.3 0.4 0.3 2.2 0.8 0.4 0.8 18.3 0.7 0.4 2.4 0.2 0.6 1.2 1.7 0.5 1.4 1.3 0.1 0.4 0.7 1.0 0.5 1.4 0.7 1.2 0.8 1.6 1.0 1.6 1.4 1.6 4.3 0.6 1.1 0.6 1.2 1.3 0.5 0.9 0.7 0.4 0.2 1.1 0.4 0.3 1.4 0.7 1.3 1.6 1.7 0.8 0.3 1.1 0.7 0.0 0.3 0.7 2.1 0.1 0.9 0.0 1.5 1.8 0.0 0.8 0.6 1.2 0.1 0.2 0.0 0.1 0.4 0.4 0.2 0.2 1.1 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.0 0.5 0.1 0.1 2.2 0.5 0.0 2.7 1.2 0.0 0.0 0.3 0.0 0.3 14.7 0.1 0.0 0.0 0.4 0.1 0.2 0.1 0.0 0.0 0.5 0.0 0.0 0.6 0.8 10.7 0.0 0.0 0.0 0.0 0.6 0.7 0.3 0.0 0.7 0.0 1.6 0.0 0.1 1.2 0.7 0.3 0.2 2.2 0.6 0.0 UNC5A "KIAA1976, UNC5H1" ENSG00000113763 "Unc-5 netrin receptor A" Q6ZN44 5 176810477-176880898 "Predicted membrane proteins" Apoptosis "Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 11.9;brain: 35.3" "Cell type enhanced" "Detected in some" 24 "Horizontal cells: 4.8;Late spermatids: 1.9;Muller glia cells: 10.3;Rod photoreceptor cells: 2.3" "Cancer enhanced" "Detected in many" "ovarian cancer: 7.5" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 2.8;eosinophil: 1.4" "Lineage enhanced" "Detected in single" "granulocytes: 2.8" "Cell line enriched" "Detected in some" 9 "SCLC-21H: 44.3" "Group enriched" "Detected in all" 4 "amygdala: 42.5;basal ganglia: 24.9;cerebral cortex: 36.4;hippocampal formation: 44.5;hypothalamus: 19.1" "Low region specificity" "Detected in all" HPA071450 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA071450: AB_2686397" "unprognostic (5.95e-2)" "unprognostic (1.15e-1)" "unprognostic (4.18e-3)" "prognostic unfavorable (2.23e-4)" "unprognostic (5.26e-2)" "unprognostic (2.23e-1)" "unprognostic (6.66e-3)" "unprognostic (5.06e-3)" "unprognostic (3.52e-1)" "unprognostic (1.36e-1)" "unprognostic (5.07e-1)" "unprognostic (9.95e-2)" "unprognostic (3.77e-5)" "unprognostic (6.39e-2)" "unprognostic (2.89e-1)" "unprognostic (2.27e-1)" "unprognostic (5.17e-2)" 0.9 11.9 10.5 1.1 11.1 1.2 1.4 35.3 30.9 1.1 0.7 0.4 0.0 1.3 0.8 0.9 0.7 1.5 1.0 0.7 7.6 4.6 0.7 0.7 0.9 1.7 1.6 12.6 0.9 3.2 0.6 5.1 0.6 2.1 0.8 0.7 0.3 0.9 0.7 0.6 0.7 0.9 0.8 0.8 0.6 1.2 1.3 0.5 0.0 0.8 0.0 0.7 0.9 0.2 0.0 0.0 2.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.7 1.7 0.0 0.0 0.0 1.2 5.1 0.0 44.3 1.9 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.8 0.3 1.4 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 10.5 11.1 35.3 22.2 7.6 4.6 1.6 12.6 2.1 0.5 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 10.3 0.2 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 UNC79 KIAA1409 ENSG00000133958 "Unc-79 homolog, NALCN channel complex subunit" Q9P2D8 14 93333219-93707876 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.6;pituitary gland: 18.9" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 42.7;Early spermatids: 28.8;Horizontal cells: 38.1;Late spermatids: 12.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "REH: 8.5;SCLC-21H: 6.3;SH-SY5Y: 4.0;U-937: 3.0" "Low region specificity" "Detected in all" HPA071881 Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA071881: AB_2732189" "unprognostic (8.42e-2)" "unprognostic (2.07e-1)" "unprognostic (6.70e-2)" "unprognostic (6.91e-2)" "unprognostic (1.06e-1)" "unprognostic (7.73e-2)" "unprognostic (2.99e-2)" "unprognostic (1.17e-1)" "unprognostic (2.31e-1)" "unprognostic (5.73e-3)" "unprognostic (8.03e-3)" "unprognostic (2.87e-1)" "unprognostic (3.39e-2)" "unprognostic (2.66e-2)" "unprognostic (5.57e-2)" "unprognostic (3.03e-2)" "unprognostic (7.47e-2)" 1.1 3.9 7.1 1.0 12.1 0.9 1.0 17.6 14.6 1.0 1.1 4.5 0.0 1.1 1.1 1.1 1.2 2.0 1.1 1.2 6.7 5.8 1.4 1.1 1.0 1.0 3.2 9.1 1.1 5.0 1.4 18.9 1.0 6.8 1.0 1.1 1.3 1.0 1.0 1.6 1.0 1.1 1.2 3.0 0.9 1.9 7.0 3.5 0.0 1.3 0.0 1.0 1.0 0.3 0.1 0.2 0.6 0.3 0.1 0.1 0.0 0.0 0.0 0.1 0.1 1.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 1.1 0.0 0.0 8.5 0.0 0.0 0.2 0.2 6.3 4.0 0.1 0.0 0.0 0.2 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 3.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 7.1 12.1 17.6 14.6 6.7 5.8 3.2 9.1 6.8 3.5 0.0 0.0 0.0 0.2 0.2 42.7 2.0 0.0 0.0 0.0 0.0 9.8 0.1 0.0 0.3 28.8 0.3 0.4 0.0 0.2 0.1 0.2 0.3 0.0 0.0 0.2 38.1 0.0 0.0 0.6 12.6 0.6 0.0 0.0 0.0 0.0 1.9 0.3 0.0 0.4 1.4 4.7 0.0 1.0 3.3 1.6 0.3 0.6 0.0 0.1 0.3 UQCC1 "BFZB, C20orf44, CBP3, FLJ10850, UQCC" ENSG00000101019 "Ubiquinol-cytochrome c reductase complex assembly factor 1" Q9NVA1 20 35302566-35412141 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 70.2" "Cell type enhanced" "Detected in many" 4 "Distal tubular cells: 51.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034875 Approved Approved "Nucleoplasm,Plasma membrane,Actin filaments" NA NA "Plasma membrane" "Nucleoplasm, Actin filaments" "HPA034875: AB_10603226" "unprognostic (9.66e-2)" "unprognostic (3.93e-1)" "unprognostic (3.45e-1)" "unprognostic (8.72e-3)" "unprognostic (4.01e-1)" "unprognostic (1.31e-1)" "unprognostic (5.73e-2)" "unprognostic (2.75e-1)" "unprognostic (2.82e-2)" "unprognostic (7.66e-2)" "unprognostic (3.42e-2)" "unprognostic (7.01e-2)" "unprognostic (6.72e-3)" "unprognostic (3.23e-1)" "unprognostic (3.60e-1)" "unprognostic (5.27e-2)" "unprognostic (1.34e-2)" 12.6 19.2 13.7 10.6 24.5 2.5 10.1 19.6 23.9 10.9 13.3 15.7 12.1 13.0 14.2 14.2 10.5 11.7 8.4 34.3 13.5 15.9 20.0 17.2 8.7 10.9 16.6 18.2 11.9 10.8 19.8 17.0 10.1 20.1 11.9 17.5 15.8 12.1 12.9 70.2 9.2 11.3 15.5 15.5 11.2 12.2 13.2 13.4 8.9 14.2 17.1 13.8 11.0 9.9 13.5 13.5 16.3 11.9 19.7 15.2 9.6 6.9 10.1 11.4 10.5 11.6 12.7 1.6 13.2 14.4 23.7 16.5 32.7 13.8 22.3 25.1 8.3 20.1 18.5 20.1 22.9 18.1 6.6 7.9 29.9 13.5 26.2 7.4 17.9 8.9 12.5 23.5 12.7 15.9 17.6 8.0 18.1 12.8 7.4 16.5 9.1 20.4 6.4 9.6 13.8 20.8 11.2 17.9 12.2 21.9 7.9 16.1 10.8 11.3 54.1 11.7 10.1 8.0 11.4 7.5 16.2 10.3 8.5 12.0 11.4 12.3 9.2 29.0 10.4 13.0 16.3 7.7 11.0 12.7 11.9 15.2 10.3 12.1 12.5 13.5 13.5 14.6 13.2 0.3 19.7 7.7 11.5 11.2 9.6 13.7 24.5 19.6 23.9 13.5 15.9 16.6 18.2 20.1 13.4 0.0 5.6 3.7 8.0 5.7 19.3 39.9 7.6 13.4 5.7 15.7 7.9 18.9 51.4 16.0 8.7 7.0 10.5 0.0 11.2 11.9 8.0 6.7 8.1 12.5 10.1 17.5 11.5 4.3 5.9 7.9 9.8 7.0 13.5 17.2 8.9 14.0 16.8 3.5 11.3 14.0 21.4 6.5 8.2 18.4 16.4 4.5 14.5 7.0 12.8 8.8 USP2 UBP41 ENSG00000036672 "Ubiquitin specific peptidase 2" O75604 11 119355215-119381726 "Enzymes, Predicted intracellular proteins" "Biological rhythms, Cell cycle, Myogenesis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 79.9" "Group enriched" "Detected in many" 5 "Early spermatids: 399.1;Late spermatids: 802.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.3" "Lineage enriched" "Detected in single" 13 "T-cells: 1.3" "Cell line enriched" "Detected in many" 4 "U-266/70: 35.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006777, HPA007222" Approved Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA006777: AB_1080507, HPA007222: AB_1080505" "unprognostic (6.83e-2)" "unprognostic (2.02e-2)" "unprognostic (5.54e-2)" "unprognostic (1.37e-2)" "unprognostic (1.25e-1)" "unprognostic (7.46e-3)" "unprognostic (1.00e-1)" "unprognostic (5.27e-2)" "unprognostic (1.24e-1)" "unprognostic (5.24e-3)" "unprognostic (8.02e-3)" "unprognostic (7.33e-2)" "prognostic favorable (3.09e-11)" "unprognostic (1.58e-1)" "unprognostic (1.20e-1)" "unprognostic (1.96e-2)" "unprognostic (2.66e-2)" 3.1 4.8 6.9 1.4 12.2 1.5 1.6 12.6 16.1 2.5 5.9 10.0 0.0 7.9 2.6 6.4 5.9 7.0 2.2 26.8 5.7 3.1 29.7 10.6 2.2 0.7 5.7 6.2 2.9 10.1 18.4 7.6 1.3 6.7 2.3 3.9 19.1 3.2 2.4 79.9 4.6 11.7 4.2 3.8 0.8 2.7 36.1 8.8 0.0 2.2 25.2 1.0 1.9 2.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 3.5 0.3 0.5 2.0 0.1 0.1 0.8 0.4 0.2 0.0 0.4 3.6 0.5 6.1 1.1 0.6 0.9 0.6 4.8 1.8 0.1 4.2 0.6 1.7 2.6 7.5 1.7 0.0 1.7 0.6 0.3 0.4 1.2 0.8 0.3 4.6 8.4 0.5 1.0 2.4 0.0 0.4 0.9 1.2 0.8 0.0 1.3 0.9 2.8 0.2 7.4 2.2 2.1 1.6 0.4 1.1 5.4 3.7 0.0 0.0 0.9 0.5 0.6 35.2 7.7 0.1 0.0 1.1 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.7 0.0 0.0 1.3 0.7 0.0 0.0 0.0 0.0 0.3 0.3 6.9 12.2 12.6 16.1 5.7 3.1 5.7 6.2 6.7 8.8 3.0 2.4 0.0 4.5 2.2 73.3 74.6 5.1 42.8 9.1 5.2 90.3 0.3 96.2 2.6 399.1 2.2 31.5 0.0 1.4 0.5 4.6 1.0 0.0 19.8 13.2 9.5 0.0 1.3 1.5 802.9 6.1 1.3 0.0 0.0 1.6 37.9 1.5 10.5 6.7 24.9 128.7 19.4 18.6 19.9 14.9 3.4 1.1 1.5 2.2 2.0 USP20 KIAA1003 ENSG00000136878 "Ubiquitin specific peptidase 20" Q9Y2K6 9 129834698-129881838 "Enzymes, Predicted intracellular proteins" "Endocytosis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "JURKAT: 42.3;K-562: 25.9;MOLT-4: 23.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006287, HPA007008" Uncertain Supported Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA006287: AB_1080510, HPA007008: " "unprognostic (2.64e-2)" "prognostic favorable (8.01e-4)" "prognostic unfavorable (2.48e-4)" "prognostic favorable (4.01e-4)" "unprognostic (4.69e-1)" "unprognostic (1.89e-2)" "unprognostic (2.25e-1)" "unprognostic (2.55e-3)" "unprognostic (1.24e-1)" "unprognostic (7.89e-2)" "prognostic favorable (1.54e-7)" "unprognostic (2.09e-1)" "prognostic favorable (5.65e-5)" "unprognostic (1.76e-2)" "unprognostic (1.20e-1)" "unprognostic (1.19e-2)" "unprognostic (1.24e-2)" 7.8 13.2 10.5 15.2 14.6 24.4 8.5 23.0 19.6 13.2 12.1 12.7 10.2 9.7 13.3 6.2 9.3 11.6 12.5 8.8 10.5 13.7 8.0 7.3 9.1 19.6 9.6 16.1 16.8 12.9 11.5 19.0 8.0 11.9 14.9 6.1 10.8 13.7 17.2 10.2 14.0 11.8 20.0 8.8 14.6 10.2 14.0 8.8 51.5 19.3 4.2 15.3 15.6 10.0 3.8 2.4 4.8 1.7 9.0 10.7 5.4 2.5 2.5 4.4 6.0 5.8 5.0 6.3 4.1 3.5 3.2 2.2 2.1 2.8 3.5 3.6 4.0 3.6 6.5 2.6 3.0 1.3 19.0 3.5 6.5 6.8 1.4 4.1 6.1 4.8 4.4 4.4 4.2 3.1 5.6 3.4 42.3 25.9 4.4 1.9 6.8 23.8 14.5 3.5 5.4 6.0 4.0 5.0 5.9 2.5 2.8 1.0 4.9 4.8 6.2 3.9 2.7 6.4 8.5 5.0 3.5 1.6 4.7 2.7 4.3 6.3 2.4 7.0 8.0 3.3 1.0 1.7 4.8 8.6 1.4 9.3 3.7 8.8 8.3 2.4 3.8 10.4 8.9 2.8 9.0 1.3 2.1 10.7 5.4 10.5 14.6 23.0 19.6 10.5 13.7 9.6 16.1 11.9 8.8 8.9 8.6 3.2 2.3 2.5 7.9 5.9 2.5 4.0 2.3 1.8 3.9 5.1 3.3 2.2 1.1 2.4 4.0 0.0 3.4 2.1 3.8 3.0 1.1 5.6 3.0 9.5 8.1 7.4 2.1 2.8 5.8 3.1 3.3 3.6 4.6 5.8 2.3 3.7 4.6 2.2 5.9 0.0 6.2 12.2 4.4 1.8 5.1 11.3 5.1 1.4 USP53 KIAA1350 ENSG00000145390 "Ubiquitin specific peptidase 53" Q70EK8 4 119212587-119295517 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 84.0;SK-MEL-30: 26.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035844, HPA035845" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA035844: AB_10669532, HPA035845: AB_2674817" "unprognostic (9.33e-2)" "unprognostic (1.49e-2)" "prognostic favorable (3.15e-6)" "unprognostic (4.37e-3)" "unprognostic (4.82e-2)" "unprognostic (5.03e-2)" "unprognostic (1.55e-1)" "unprognostic (9.54e-2)" "unprognostic (1.77e-1)" "unprognostic (9.81e-3)" "unprognostic (1.28e-1)" "prognostic unfavorable (7.54e-6)" "prognostic favorable (3.58e-8)" "unprognostic (9.02e-2)" "unprognostic (1.72e-1)" "unprognostic (1.58e-1)" "unprognostic (3.70e-2)" 26.7 11.9 4.6 11.2 7.9 0.7 20.7 10.9 6.2 16.5 15.0 2.9 27.4 4.5 11.6 16.1 17.9 24.7 8.2 18.6 6.4 5.3 20.2 6.6 26.1 8.7 8.8 4.0 11.4 19.3 6.2 33.9 10.4 13.4 10.7 13.1 17.2 17.7 25.8 33.7 11.3 11.2 9.0 15.5 14.1 13.6 10.2 4.9 4.8 10.7 15.6 8.0 20.5 27.0 1.9 0.8 3.1 0.0 2.2 5.1 0.9 2.8 1.7 0.6 0.0 16.1 16.2 3.5 18.0 84.0 1.6 2.1 1.8 2.6 11.5 0.6 5.3 3.1 1.4 1.4 1.3 4.2 1.5 1.1 0.7 1.3 0.6 12.6 0.9 0.1 5.4 3.9 5.7 8.2 3.1 7.6 0.7 1.7 0.4 2.1 0.6 0.7 1.3 1.7 1.7 0.9 0.2 2.9 2.2 4.2 1.8 0.9 0.7 1.0 7.1 26.0 3.6 1.8 0.6 8.2 0.5 1.8 6.8 1.6 0.8 1.2 1.9 8.2 0.4 2.0 3.1 0.0 0.2 1.3 0.0 1.4 1.7 2.6 2.0 0.4 1.9 5.1 2.7 0.6 2.2 0.0 0.8 2.2 0.9 4.6 7.9 10.9 6.2 6.4 5.3 8.8 4.0 13.4 4.9 32.8 45.2 11.8 55.8 55.0 22.5 82.3 28.1 24.1 35.2 113.4 27.5 41.0 38.1 22.7 3.3 36.0 117.1 0.0 53.9 14.3 44.2 81.1 67.2 21.7 7.6 23.8 33.3 24.5 17.1 2.6 17.5 32.4 13.5 78.5 63.2 26.1 75.8 58.3 10.3 14.2 29.1 6.5 33.5 14.1 3.0 36.9 41.6 17.0 43.2 107.0 UTP20 "1A6/DRIM, DRIM" ENSG00000120800 "UTP20, small subunit processome component" O75691 12 101280109-101386616 "Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049341 Supported "Nucleoli,Plasma membrane" No No Nucleoli "Plasma membrane" "HPA049341: AB_2680720" "unprognostic (3.04e-2)" "unprognostic (1.22e-1)" "unprognostic (3.92e-2)" "unprognostic (1.51e-2)" "unprognostic (1.39e-1)" "unprognostic (1.15e-1)" "prognostic unfavorable (1.15e-5)" "unprognostic (8.34e-2)" "unprognostic (4.30e-2)" "unprognostic (8.15e-3)" "unprognostic (2.81e-1)" "unprognostic (2.22e-2)" "prognostic favorable (8.87e-4)" "unprognostic (2.88e-1)" "unprognostic (3.44e-1)" "unprognostic (8.30e-2)" "unprognostic (6.92e-3)" 14.7 11.9 8.4 10.7 9.7 8.3 15.3 8.4 9.6 14.1 8.0 11.8 7.0 5.0 12.5 8.4 10.9 10.3 5.8 8.3 6.7 5.8 8.0 12.0 12.0 17.8 9.0 6.3 16.3 14.2 17.9 9.5 9.7 8.2 8.8 10.1 9.9 13.8 8.5 13.1 10.8 8.0 9.4 7.1 11.3 8.6 12.6 9.7 11.9 9.8 11.0 12.9 9.4 13.8 3.1 2.8 0.1 1.1 2.0 2.8 0.6 4.5 11.3 8.6 4.0 7.7 9.1 10.6 7.9 6.2 12.6 7.0 13.0 3.3 12.1 4.2 8.7 9.5 9.5 19.0 8.1 16.4 5.4 7.7 12.8 6.1 9.7 4.3 21.2 5.9 5.9 4.2 17.4 6.0 4.8 8.6 6.2 20.1 2.5 9.1 5.9 9.2 6.0 22.6 6.3 11.9 10.5 14.1 9.4 5.3 13.8 9.9 6.7 14.7 9.3 8.9 7.4 9.8 4.7 9.7 14.9 7.3 10.3 15.2 4.6 6.8 20.3 8.1 9.7 22.8 0.1 0.8 0.1 1.9 1.1 1.9 3.1 2.1 2.4 1.4 2.4 2.3 2.8 0.1 2.0 0.7 2.8 1.8 0.6 8.4 9.7 8.4 9.6 6.7 5.8 9.0 6.3 8.2 9.7 8.9 6.9 6.5 7.6 9.0 9.5 9.8 7.6 8.1 14.8 3.5 9.8 6.7 5.0 5.6 1.3 9.0 1.3 0.0 9.7 7.0 7.8 8.4 12.7 6.7 5.1 20.6 6.3 7.4 6.3 0.9 8.9 3.8 3.3 1.0 4.4 3.4 6.1 0.0 7.8 2.3 8.0 6.5 6.2 15.6 22.4 9.7 2.4 5.7 8.0 7.5 VAMP5 ENSG00000168899 "Vesicle associated membrane protein 5" O95183 2 85584408-85593412 "Predicted membrane proteins" "Differentiation, Myogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Endothelial cells: 294.0;Ito cells: 443.2;Kupffer cells: 298.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 34.3;HUVEC TERT2: 64.1;LHCN-M2: 75.3;TIME: 43.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035082 Supported Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA035082: AB_10610564" "unprognostic (1.92e-1)" "unprognostic (3.09e-2)" "unprognostic (6.09e-2)" "unprognostic (1.13e-2)" "unprognostic (4.16e-2)" "unprognostic (1.25e-3)" "unprognostic (1.28e-2)" "unprognostic (5.29e-2)" "unprognostic (1.17e-2)" "unprognostic (3.49e-2)" "unprognostic (2.22e-1)" "unprognostic (7.59e-2)" "prognostic unfavorable (1.28e-5)" "unprognostic (9.61e-3)" "unprognostic (3.46e-2)" "unprognostic (1.71e-2)" "unprognostic (2.60e-1)" 26.2 25.8 12.6 18.9 14.1 11.7 27.5 4.3 9.2 17.9 22.1 8.5 9.2 7.6 18.9 27.2 24.3 18.3 18.8 37.0 11.0 10.9 18.5 31.2 28.8 32.1 16.8 9.6 19.6 6.3 3.2 7.2 24.4 17.7 29.0 6.9 16.0 7.7 13.0 70.9 9.5 17.0 25.5 14.1 33.3 12.3 13.7 8.1 18.0 17.5 19.8 13.0 21.8 25.8 10.2 13.8 27.5 80.4 14.3 39.4 39.3 0.1 0.0 0.4 0.0 16.3 28.6 0.4 17.3 27.5 17.0 18.8 6.8 2.6 0.0 0.4 29.9 9.2 0.2 0.0 0.4 7.6 24.5 0.5 0.3 0.4 9.5 34.3 0.7 0.1 19.8 1.7 7.1 0.2 25.1 64.1 10.9 0.0 0.0 75.3 2.4 10.6 2.3 0.0 4.7 0.1 15.9 0.0 0.4 0.4 0.6 0.0 0.6 0.1 4.9 0.1 0.4 0.5 0.8 43.8 0.4 1.2 1.3 0.0 0.0 0.5 0.4 20.0 0.9 11.6 8.2 38.1 27.5 31.7 80.4 29.8 9.7 24.1 23.5 12.8 10.2 18.5 22.3 11.8 14.3 64.4 13.8 39.4 39.3 12.6 14.1 4.3 9.2 11.0 10.9 16.8 9.6 17.7 8.1 17.9 30.0 50.0 38.6 54.0 0.8 75.5 81.5 29.4 37.5 41.8 0.0 16.6 24.9 28.6 1.2 294.0 58.6 0.0 43.2 6.9 187.6 42.9 43.8 141.5 73.6 3.2 12.1 443.2 298.8 4.7 178.4 77.9 261.5 100.0 11.0 11.5 39.6 48.9 155.2 64.7 0.5 58.2 94.7 4.8 3.2 39.5 18.1 106.6 7.6 32.9 VAMP8 EDB ENSG00000118640 "Vesicle associated membrane protein 8" Q9BV40 2 85561562-85582031 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Autophagy, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 172.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HL-60: 82.0;NB-4: 128.2;THP-1: 63.7;U-937: 85.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006882, HPA007215, CAB037132, CAB037147" Enhanced Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA 210000 "Golgi apparatus, Plasma membrane" Nucleoplasm "CAB037132: AB_1080547, CAB037147: AB_1080544, HPA006882: AB_1858716, HPA007215: " "unprognostic (1.00e-1)" "unprognostic (1.16e-1)" "unprognostic (7.46e-3)" "unprognostic (1.13e-1)" "unprognostic (7.33e-2)" "unprognostic (1.31e-1)" "unprognostic (1.76e-2)" "unprognostic (3.79e-3)" "unprognostic (3.83e-2)" "unprognostic (4.15e-1)" "unprognostic (2.74e-2)" "unprognostic (8.62e-2)" "unprognostic (1.57e-3)" "unprognostic (1.92e-2)" "unprognostic (2.16e-1)" "prognostic favorable (8.07e-9)" "prognostic favorable (1.59e-6)" 16.5 8.2 7.1 20.7 11.2 27.6 24.2 1.9 6.2 16.3 49.4 5.7 43.5 24.1 6.0 25.5 65.4 17.1 28.8 13.0 4.7 3.8 67.7 46.5 53.1 48.0 10.5 3.2 7.1 58.0 15.4 8.3 108.1 11.9 22.1 31.9 7.7 90.7 40.4 9.0 43.3 87.1 6.8 10.4 53.5 28.7 5.5 8.4 24.5 47.5 35.4 34.9 20.6 30.4 39.2 172.5 37.7 69.7 41.4 51.3 100.9 23.9 3.1 0.2 0.2 0.2 0.1 23.9 0.0 0.0 0.0 0.0 17.8 22.0 5.3 17.4 0.1 1.8 17.0 0.2 42.9 0.0 21.8 16.6 27.6 10.6 20.2 0.3 82.0 28.6 0.2 30.5 0.0 7.1 0.1 5.5 0.1 19.7 1.1 9.8 33.6 0.0 128.2 0.3 30.0 2.5 0.5 0.9 36.0 49.7 36.0 0.8 0.3 11.7 62.1 1.9 13.0 22.8 63.7 11.0 0.0 1.5 0.3 0.2 0.3 13.5 31.4 0.3 85.1 0.1 37.7 69.7 25.2 40.4 57.7 38.8 39.2 46.8 39.5 63.5 37.8 37.3 39.1 4.5 41.4 34.3 172.5 51.3 100.9 7.1 11.2 1.9 6.2 4.7 3.8 10.5 3.2 11.9 8.4 345.4 256.8 171.2 244.0 230.2 1.1 5.5 331.2 341.3 271.8 347.2 0.0 869.6 648.2 536.4 20.3 29.2 900.3 0.0 637.4 386.9 34.1 294.8 263.2 244.8 1050.6 0.0 124.1 155.3 836.3 34.0 8.6 660.7 334.0 762.0 322.8 2.4 674.2 501.5 7.1 797.0 1.6 45.3 25.8 28.4 6.4 288.3 734.1 248.2 230.6 528.7 VANGL1 STB2 ENSG00000173218 "VANGL planar cell polarity protein 1" Q8TAA9 1 115641953-115698224 "Disease related genes, Predicted membrane proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 37.3;Ito cells: 31.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 8.9" "Group enriched" "Detected in many" 7 "dendritic cells: 3.5;NK-cells: 8.9;T-cells: 4.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA025235, CAB076375" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "CAB076375: AB_2665604, HPA025235: AB_1858718" "unprognostic (1.04e-2)" "unprognostic (2.04e-2)" "prognostic favorable (7.53e-4)" "unprognostic (9.94e-2)" "unprognostic (1.71e-2)" "unprognostic (5.18e-2)" "unprognostic (2.18e-3)" "unprognostic (5.11e-3)" "unprognostic (2.11e-1)" "unprognostic (6.43e-3)" "prognostic unfavorable (7.89e-4)" "unprognostic (1.88e-2)" "unprognostic (1.74e-2)" "unprognostic (7.71e-3)" "unprognostic (1.21e-1)" "unprognostic (4.50e-3)" "unprognostic (9.06e-3)" 7.0 8.6 2.2 5.8 3.1 2.0 16.4 1.2 2.5 14.0 9.3 5.3 8.3 4.0 13.2 8.8 14.4 13.7 5.3 12.7 3.2 2.3 11.8 7.1 12.1 7.4 2.1 1.9 8.9 11.5 5.5 2.2 5.3 2.4 9.4 7.1 6.6 9.5 11.0 2.1 9.8 6.6 15.9 2.0 4.7 6.6 7.9 2.6 18.0 11.8 10.0 10.0 10.2 9.4 0.3 3.5 0.0 0.8 8.9 4.3 1.4 21.5 9.2 3.0 4.0 11.2 10.1 6.0 8.4 6.1 11.0 8.8 5.3 10.8 0.0 14.5 9.7 10.4 27.3 5.0 14.9 7.3 25.2 6.1 12.0 8.5 4.3 4.1 3.5 5.2 5.3 10.5 7.8 8.4 5.8 10.9 20.6 7.2 6.7 11.0 28.8 17.6 1.4 7.5 12.6 8.8 0.0 8.7 6.2 5.1 14.5 2.7 3.6 15.1 10.0 7.2 5.9 5.1 3.9 11.6 7.6 12.0 16.5 15.2 0.9 1.0 0.0 10.2 6.3 18.5 0.0 0.8 0.0 3.0 0.5 0.8 0.3 1.9 2.9 3.5 0.0 0.7 3.3 0.0 8.9 0.8 3.0 4.3 1.4 2.2 3.1 1.2 2.5 3.2 2.3 2.1 1.9 2.4 2.6 3.0 2.7 1.9 6.3 6.5 4.0 6.3 2.5 6.7 1.2 8.7 37.3 3.7 0.0 14.9 4.6 7.7 7.7 0.0 12.1 5.8 6.4 7.0 0.0 2.4 3.8 0.0 6.4 31.9 1.5 1.9 5.5 1.8 0.0 19.0 7.9 4.2 16.1 5.8 7.8 5.7 0.7 6.5 5.7 1.0 9.4 5.6 0.3 1.8 8.3 6.5 VCPIP1 "DUBA3, FLJ23132, KIAA1850, VCIP135" ENSG00000175073 "Valosin containing protein interacting protein 1" Q96JH7 8 66628487-66667217 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023932 Uncertain Approved "Plasma membrane,Centrosome" NA NA "Plasma membrane" Centrosome "HPA023932: AB_2671373" "unprognostic (1.12e-1)" "unprognostic (1.31e-2)" "unprognostic (9.13e-2)" "unprognostic (1.10e-2)" "unprognostic (4.01e-2)" "unprognostic (5.56e-2)" "unprognostic (5.23e-2)" "unprognostic (7.21e-2)" "unprognostic (2.80e-1)" "unprognostic (3.96e-1)" "unprognostic (5.23e-3)" "unprognostic (7.28e-2)" "unprognostic (6.12e-3)" "unprognostic (2.03e-2)" "unprognostic (1.83e-1)" "unprognostic (2.13e-2)" "unprognostic (8.58e-3)" 9.5 8.7 15.7 12.6 14.5 30.9 8.9 14.4 15.1 7.5 8.4 7.0 3.8 7.0 7.8 8.7 8.1 6.9 7.0 6.7 10.2 9.2 8.3 12.3 10.5 13.6 10.3 13.7 7.8 9.0 14.0 5.9 8.0 12.3 7.0 7.8 6.0 9.0 7.1 14.8 7.3 10.0 6.3 9.6 14.7 8.0 10.8 11.7 11.6 8.0 2.8 13.3 7.9 7.0 2.6 3.4 11.3 8.8 2.8 4.3 1.7 9.0 8.2 4.2 5.6 13.0 9.2 4.1 7.3 7.4 5.6 6.5 4.8 8.5 12.2 2.1 9.7 6.9 8.0 6.8 6.1 8.0 9.0 4.9 13.5 8.1 6.0 7.8 4.5 14.6 9.9 9.0 6.1 11.1 6.9 6.0 6.7 9.1 11.8 8.2 4.4 9.7 7.8 8.0 7.6 5.7 6.3 6.6 6.1 8.1 7.1 2.5 4.8 5.6 8.6 6.3 5.6 8.8 7.5 12.0 7.4 5.5 6.5 4.8 10.5 5.1 13.1 7.3 6.5 5.5 9.2 3.2 6.7 4.3 5.2 3.6 2.0 2.7 3.1 3.4 2.6 2.2 2.9 11.3 2.8 8.8 1.3 3.3 1.7 15.7 14.5 14.4 15.1 10.2 9.2 10.3 13.7 12.3 11.7 17.9 14.6 9.0 8.1 15.0 11.1 16.5 12.7 12.0 11.4 7.0 21.6 8.8 3.3 9.7 4.3 9.9 14.0 23.3 11.7 4.8 12.3 11.3 18.5 20.2 12.4 11.1 5.8 15.4 47.5 4.5 7.5 18.0 10.1 10.8 15.0 11.8 10.8 15.3 14.9 9.9 10.8 6.5 10.8 26.8 14.7 18.1 8.2 26.6 13.3 14.2 VPS8 "FLJ32099, KIAA0804" ENSG00000156931 "VPS8, CORVET complex subunit" Q8N3P4 3 184812143-185052614 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036871 Uncertain Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA036871: AB_10672103" "unprognostic (4.36e-2)" "unprognostic (3.97e-3)" "unprognostic (1.53e-1)" "unprognostic (7.95e-2)" "unprognostic (5.11e-2)" "unprognostic (4.43e-2)" "unprognostic (1.27e-3)" "unprognostic (1.74e-1)" "unprognostic (3.21e-2)" "unprognostic (5.98e-3)" "unprognostic (1.98e-1)" "unprognostic (8.82e-2)" "unprognostic (4.74e-2)" "unprognostic (3.15e-1)" "unprognostic (2.56e-1)" "unprognostic (8.10e-3)" "unprognostic (4.97e-2)" 12.6 11.1 14.9 11.1 20.9 22.6 12.0 21.6 24.8 15.5 12.5 18.2 8.0 9.1 16.4 19.0 11.5 10.1 12.5 20.3 17.1 19.3 12.5 9.2 13.8 14.8 21.5 13.6 16.7 10.1 21.8 23.6 13.3 28.4 12.8 16.7 12.1 9.5 12.0 28.4 14.2 9.9 14.5 21.9 14.9 14.1 17.8 15.9 13.2 17.5 9.0 11.5 12.5 11.6 3.9 6.0 17.7 4.9 3.9 6.4 3.1 10.2 6.3 9.6 9.6 20.0 17.9 6.4 10.1 11.2 7.4 10.4 7.9 5.4 11.1 17.8 15.8 30.6 12.2 10.3 12.4 14.4 20.0 9.2 12.1 7.8 4.7 12.4 8.2 16.3 12.7 11.9 10.5 10.7 13.7 18.7 10.4 6.2 8.0 13.5 7.3 6.5 4.9 6.3 10.6 6.0 8.1 18.4 8.6 7.4 18.0 9.8 6.4 11.8 12.5 9.2 14.9 19.8 4.3 16.4 11.5 6.5 11.6 8.9 9.9 12.0 15.2 13.1 10.3 8.9 11.7 4.9 16.2 4.0 3.7 3.8 3.5 4.3 4.0 6.0 3.9 6.4 4.3 17.7 3.9 4.6 1.7 3.5 3.1 14.9 20.9 21.6 24.8 17.1 19.3 21.5 13.6 28.4 15.9 11.9 8.6 13.7 7.9 9.3 20.3 23.2 12.7 16.0 7.9 8.7 17.7 10.2 6.6 7.7 11.6 12.0 9.3 0.0 4.0 4.9 9.5 7.7 2.3 6.7 17.6 11.1 17.3 12.3 16.2 13.6 9.8 20.2 10.1 31.5 14.3 12.1 6.3 11.9 12.0 7.0 16.6 6.5 8.1 45.6 24.9 14.1 6.4 14.4 10.7 12.9 VWA5B1 FLJ32784 ENSG00000158816 "Von Willebrand factor A domain containing 5B1" Q5TIE3 1 20290919-20354894 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 17.6;epididymis: 6.4;testis: 6.9" "Group enriched" "Detected in some" 12 "Early spermatids: 7.7;Late spermatids: 6.0" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in many" 5 "pons and medulla: 17.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 9 "SCLC-21H: 5.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA027496, HPA028405, HPA064829" Enhanced Approved "Plasma membrane,Mitochondria,Cytosol" "Secreted in male reproductive system" NA NA Mitochondria "Plasma membrane, Cytosol" "HPA027496: AB_10599853, HPA028405: AB_10600992, HPA064829: AB_2685363" "unprognostic (2.34e-1)" "unprognostic (2.91e-1)" "unprognostic (7.78e-2)" "unprognostic (1.16e-2)" "unprognostic (4.73e-2)" "unprognostic (1.21e-2)" "unprognostic (1.09e-1)" "unprognostic (1.86e-2)" "unprognostic (4.39e-2)" "unprognostic (1.73e-1)" "unprognostic (5.41e-4)" "unprognostic (7.43e-4)" "unprognostic (1.82e-2)" "unprognostic (3.33e-2)" "unprognostic (1.03e-1)" 0.0 1.2 0.7 0.2 3.3 0.0 0.0 0.0 0.5 0.0 0.0 6.1 0.0 0.0 0.0 6.4 0.1 0.7 0.5 0.1 2.8 3.3 2.0 0.0 0.1 0.2 0.2 0.4 0.0 0.1 2.2 5.6 0.2 17.6 0.2 0.0 0.0 4.3 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 6.9 0.5 0.0 0.5 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 3.3 0.0 0.5 2.8 3.3 0.2 0.4 17.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 VWA7 "C6orf27, G7c, NG37" ENSG00000204396 "Von Willebrand factor A domain containing 7" Q9Y334 6 31765590-31777294 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 19.6;pituitary gland: 20.5" "Cell type enhanced" "Detected in some" 11 "Collecting duct cells: 1.8;Distal tubular cells: 1.7;Enterocytes: 1.8;Intestinal endocrine cells: 4.1;Paneth cells: 2.3;Proximal tubular cells: 1.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.2;HeLa: 3.4;Karpas-707: 3.0;RPTEC TERT1: 2.2;U-266/70: 4.5" "Group enriched" "Detected in some" 5 "cerebellum: 7.8;pons and medulla: 4.1" "Low region specificity" "Detected in many" "HPA046954, HPA054262" Approved Approved "Plasma membrane,Cytosol" "Secreted - unknown location" NA NA "Plasma membrane, Cytosol" "HPA046954: AB_2679875, HPA054262: AB_2682430" "unprognostic (9.13e-2)" "unprognostic (8.60e-4)" "unprognostic (9.99e-2)" "unprognostic (2.43e-1)" "unprognostic (2.85e-3)" "unprognostic (4.96e-3)" "unprognostic (6.38e-2)" "unprognostic (4.40e-2)" "unprognostic (2.68e-1)" "unprognostic (5.84e-2)" "unprognostic (1.65e-2)" "unprognostic (9.25e-2)" "prognostic favorable (4.35e-8)" "unprognostic (3.75e-2)" "unprognostic (2.37e-1)" "unprognostic (9.48e-2)" "unprognostic (7.66e-2)" 1.1 1.6 3.1 1.4 9.5 1.1 1.2 5.6 10.5 1.1 1.9 0.0 3.9 2.6 4.6 3.0 1.1 19.6 2.0 3.9 1.6 5.5 5.6 1.5 2.5 1.2 1.7 5.4 1.4 2.5 5.1 20.5 1.0 9.7 1.3 1.7 0.8 1.7 2.0 5.3 1.7 3.3 2.3 2.3 1.3 5.8 1.3 2.3 0.0 1.8 0.6 1.3 1.3 0.8 0.2 0.0 1.2 0.0 0.0 0.4 0.0 0.5 1.1 0.4 0.4 0.0 0.0 0.2 0.0 0.0 0.1 0.0 1.1 2.2 0.5 0.7 0.3 0.1 0.9 0.7 0.2 0.0 0.0 0.0 0.1 3.4 0.5 0.1 0.0 0.9 0.1 0.9 0.1 0.0 0.2 0.0 0.6 0.2 3.0 0.0 0.2 0.0 0.5 0.0 1.4 0.1 0.3 0.0 2.1 2.2 0.0 0.3 0.1 0.4 0.1 0.0 0.0 0.1 0.1 0.0 0.3 0.8 0.0 0.1 4.5 1.3 0.1 0.0 0.6 0.1 1.2 0.0 0.0 0.3 0.0 0.0 0.2 0.2 0.2 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.4 0.0 3.1 9.5 5.6 10.5 1.6 5.5 1.7 5.4 9.7 2.3 0.0 0.6 0.0 0.5 0.1 0.4 0.7 0.0 0.0 0.0 1.8 0.0 0.0 1.7 0.4 0.0 0.0 1.8 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.1 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.3 0.0 1.7 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.5 WAS "IMD2, THC, WASP, WASPA" ENSG00000015285 "Wiskott-Aldrich syndrome" P42768 X 48676596-48691427 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 30.7;lymphoid tissue: 55.9" "Cell type enhanced" "Detected in many" 8 "B-cells: 72.2;Hofbauer cells: 95.2;Kupffer cells: 94.9;Macrophages: 70.0;T-cells: 87.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 20.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 21.7;HEL: 19.1;HMC-1: 46.5;MOLT-4: 19.7;NB-4: 21.5;RPMI-8226: 26.5;THP-1: 19.5;U-266/70: 24.6;U-937: 24.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA002022, CAB004290" Enhanced Approved "Plasma membrane,Cytosol" NA NA 320000 "Plasma membrane" Cytosol "CAB004290: AB_628445, HPA002022: AB_1080581" "unprognostic (1.43e-3)" "unprognostic (2.09e-3)" "unprognostic (2.36e-2)" "prognostic favorable (4.95e-4)" "unprognostic (9.89e-2)" "prognostic favorable (3.78e-4)" "unprognostic (5.12e-3)" "unprognostic (7.60e-2)" "unprognostic (1.54e-2)" "unprognostic (2.86e-1)" "unprognostic (7.40e-2)" "unprognostic (3.60e-1)" "prognostic unfavorable (5.58e-6)" "unprognostic (2.24e-1)" "unprognostic (2.37e-2)" "unprognostic (3.55e-2)" "unprognostic (1.71e-1)" 7.6 4.0 4.9 28.9 7.8 30.7 3.3 2.0 5.1 2.7 4.4 5.9 0.5 4.8 2.4 5.6 3.7 4.5 4.4 3.0 4.6 4.1 4.1 5.0 12.6 29.9 7.6 1.3 2.6 2.2 0.7 2.6 5.4 6.0 3.2 3.2 3.5 5.4 1.9 1.4 2.2 14.3 3.7 12.8 55.9 4.1 1.7 7.3 53.2 2.8 1.4 33.2 5.8 2.5 2.1 3.5 20.3 5.3 2.1 3.2 2.0 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 21.7 0.1 0.0 0.1 0.7 0.0 0.0 0.0 12.5 0.1 19.1 0.2 0.0 0.2 9.8 46.5 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.2 13.4 0.0 2.2 19.7 21.5 0.1 0.3 0.1 17.3 0.0 26.5 0.0 0.0 0.1 0.2 0.3 0.2 0.2 0.1 0.1 19.5 0.1 0.0 0.1 0.3 0.0 24.6 12.0 15.2 0.1 24.8 0.0 1.8 4.6 20.3 3.0 5.0 2.2 1.8 2.3 2.5 3.5 2.1 2.1 2.3 18.1 2.1 5.3 1.8 3.2 2.0 4.9 7.8 2.0 5.1 4.6 4.1 7.6 1.3 6.0 7.3 3.0 21.3 72.2 0.1 2.2 0.0 0.8 0.0 2.7 0.0 0.0 0.0 0.8 1.7 0.1 0.5 0.5 0.0 23.3 0.3 0.9 1.5 0.2 46.2 0.9 95.2 0.0 1.2 5.5 94.9 0.8 0.0 70.0 3.3 45.9 0.0 0.2 0.1 0.0 0.0 1.5 0.0 0.0 0.6 1.4 1.1 1.3 1.1 87.0 0.0 0.1 WASF2 "SCAR2, WAVE2" ENSG00000158195 "WAS protein family member 2" Q9Y6W5 1 27404226-27490158 "Predicted intracellular proteins" "Host-virus interaction" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022632, HPA045288" Enhanced Approved "Plasma membrane,Cytosol" NA NA 470000 "Plasma membrane" Cytosol "CAB022632: , HPA045288: AB_2679287" "unprognostic (9.58e-2)" "unprognostic (8.93e-2)" "unprognostic (6.28e-2)" "unprognostic (1.02e-1)" "unprognostic (4.40e-1)" "unprognostic (2.27e-2)" "prognostic unfavorable (5.29e-8)" "unprognostic (3.94e-2)" "unprognostic (4.14e-2)" "prognostic unfavorable (8.48e-4)" "unprognostic (7.60e-3)" "unprognostic (1.10e-1)" "unprognostic (9.15e-3)" "unprognostic (2.24e-1)" "unprognostic (1.56e-1)" "unprognostic (1.47e-1)" "unprognostic (8.26e-2)" 36.9 23.3 22.0 23.8 30.0 30.0 28.6 13.6 24.0 31.9 28.8 33.2 13.2 15.7 36.9 16.0 55.3 28.8 22.3 20.5 22.8 13.1 20.2 11.6 29.4 31.1 32.5 12.6 38.8 24.0 21.3 14.8 29.7 23.2 26.4 23.3 22.2 25.6 26.1 11.4 35.1 26.7 42.9 31.5 34.0 26.4 20.7 32.7 32.3 21.6 22.2 35.2 39.1 30.3 18.9 21.8 36.9 38.4 8.5 12.9 16.8 24.4 11.7 27.3 24.8 19.9 26.1 15.8 20.0 18.6 22.1 19.9 10.1 26.5 17.0 19.4 31.2 15.0 19.7 21.9 32.8 26.5 23.8 13.8 37.1 20.8 11.9 26.8 29.6 21.4 23.8 35.8 24.0 45.0 24.0 27.6 19.0 29.5 8.9 29.9 8.8 22.0 13.6 21.9 12.5 18.1 46.1 33.5 17.4 15.8 13.9 13.6 15.0 34.9 15.6 26.1 17.3 13.0 18.0 36.2 18.4 19.1 38.0 15.7 18.3 24.1 22.8 21.7 36.8 20.6 14.8 23.3 18.5 12.9 29.1 10.5 14.1 10.2 8.9 14.8 18.9 10.7 8.1 36.9 8.5 38.4 21.8 10.2 16.8 22.0 30.0 13.6 24.0 22.8 13.1 32.5 12.6 23.2 32.7 62.5 51.0 92.0 173.5 131.5 24.5 30.1 86.6 64.3 69.4 85.5 13.7 174.6 53.0 89.1 42.3 188.8 120.0 46.7 88.6 107.9 114.2 242.5 56.7 41.4 133.0 19.1 104.2 120.3 180.2 47.6 152.8 97.4 72.6 162.3 79.4 56.5 119.6 91.2 171.5 37.6 19.4 135.8 119.5 121.8 114.1 170.0 120.0 87.1 89.2 299.4 WDR12 "FLJ10881, YTM1" ENSG00000138442 "WD repeat domain 12" Q9GZL7 2 202874782-203014798 "Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036389 Uncertain Approved "Nucleoli,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoli "HPA036389: AB_10670716" "unprognostic (1.08e-2)" "unprognostic (3.59e-1)" "unprognostic (8.17e-2)" "unprognostic (3.59e-3)" "unprognostic (1.24e-2)" "unprognostic (9.40e-3)" "prognostic unfavorable (2.57e-6)" "unprognostic (1.52e-1)" "unprognostic (6.14e-2)" "unprognostic (4.78e-2)" "unprognostic (4.58e-2)" "unprognostic (1.50e-1)" "unprognostic (1.69e-1)" "unprognostic (5.21e-2)" "unprognostic (2.66e-1)" "unprognostic (9.69e-3)" "unprognostic (4.48e-2)" 5.8 9.7 7.2 5.5 16.1 6.7 7.6 11.5 15.2 5.9 6.2 6.5 3.7 8.9 7.1 7.0 8.0 6.7 5.0 8.4 6.8 8.6 11.1 8.7 4.2 6.4 7.4 8.9 7.3 5.7 6.7 8.0 6.6 12.6 4.9 8.7 6.7 5.4 5.2 11.0 7.7 6.0 7.4 6.2 5.3 5.6 17.1 8.2 9.6 7.1 5.1 7.5 5.8 5.6 5.4 6.9 3.6 5.0 3.6 5.9 3.0 4.4 4.7 5.4 10.1 10.2 8.8 9.8 6.7 5.4 8.4 8.1 11.8 6.2 8.0 6.2 5.4 7.4 5.6 14.6 10.8 13.4 4.0 9.0 13.6 7.5 13.9 6.6 17.7 8.4 7.9 7.8 9.9 19.7 5.6 8.7 8.8 21.3 5.3 9.1 5.1 12.1 10.4 12.3 5.9 11.9 8.8 8.4 12.6 9.1 5.3 9.5 8.3 5.3 7.0 8.2 9.8 4.1 11.7 6.9 7.5 6.1 6.2 7.4 7.0 10.4 13.5 7.4 12.1 7.4 3.6 4.7 2.0 4.2 5.0 5.9 5.3 4.0 4.3 6.0 5.4 5.2 5.0 2.1 3.6 4.5 6.9 4.3 3.0 7.2 16.1 11.5 15.2 6.8 8.6 7.4 8.9 12.6 8.2 8.9 16.3 6.0 16.7 18.2 9.1 22.5 10.2 17.4 17.0 5.2 2.0 21.5 13.3 14.9 8.1 10.6 10.0 0.0 9.1 29.0 15.4 7.7 15.0 13.6 15.8 14.3 5.2 8.0 9.1 6.6 15.8 9.5 1.7 8.2 9.1 5.8 12.6 3.5 14.5 29.9 7.8 12.9 15.1 35.1 32.6 15.2 18.0 10.2 17.2 16.0 WDR13 ENSG00000101940 "WD repeat domain 13" Q9H1Z4 X 48590042-48608867 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000913 Supported Supported "Nucleoplasm,Plasma membrane,Centriolar satellite" NA NA Nucleoplasm "Plasma membrane, Centriolar satellite" "HPA000913: AB_1858795" "unprognostic (5.03e-2)" "unprognostic (6.53e-3)" "unprognostic (3.65e-3)" "unprognostic (2.10e-3)" "unprognostic (3.50e-1)" "unprognostic (1.54e-3)" "unprognostic (3.54e-2)" "unprognostic (6.76e-2)" "unprognostic (2.40e-2)" "unprognostic (3.48e-1)" "unprognostic (1.58e-2)" "unprognostic (1.33e-1)" "unprognostic (2.82e-1)" "unprognostic (2.99e-1)" "unprognostic (1.66e-1)" "unprognostic (2.65e-1)" "unprognostic (4.32e-2)" 24.5 30.4 39.9 13.9 36.9 15.7 19.1 14.4 33.9 18.6 25.5 17.6 41.5 23.0 26.0 41.2 23.1 30.8 21.1 49.8 30.2 18.9 24.2 50.2 19.3 11.1 20.0 35.8 35.0 74.7 21.8 24.4 23.9 17.0 19.6 14.4 16.5 30.4 35.8 48.5 21.7 22.0 20.2 17.5 17.4 22.7 11.0 20.5 8.6 21.9 21.1 10.5 17.9 19.7 16.8 21.1 29.2 28.2 17.3 13.8 15.9 15.0 22.0 11.0 34.1 15.2 22.4 8.5 10.4 19.0 12.1 11.1 13.0 24.1 10.4 10.0 21.3 9.8 12.9 5.5 22.8 4.3 12.4 9.7 7.1 26.0 23.6 34.7 6.1 19.5 21.2 32.6 17.2 31.6 21.3 16.6 6.1 7.0 13.4 16.8 21.6 8.4 10.8 8.0 6.5 17.4 8.1 11.7 18.9 21.4 12.0 12.8 15.9 11.8 24.6 24.1 8.1 15.7 11.9 27.4 12.6 18.8 19.9 10.0 15.6 5.7 3.8 18.7 9.2 17.3 29.2 23.1 12.7 11.9 24.7 9.5 16.8 12.6 11.3 21.1 13.4 10.0 11.4 16.0 17.3 28.2 13.3 13.8 15.9 39.9 36.9 14.4 33.9 30.2 18.9 20.0 35.8 17.0 20.5 41.7 42.0 25.3 61.2 31.1 44.1 67.8 58.6 60.2 33.0 19.2 51.1 39.7 87.9 76.1 5.1 50.7 69.1 0.0 103.3 29.1 47.2 41.1 30.0 41.4 38.7 31.8 48.5 54.6 33.6 15.2 47.8 29.6 55.6 47.7 52.9 50.7 86.4 59.6 40.7 122.9 50.2 45.3 55.3 9.7 15.3 26.1 59.2 20.8 54.6 57.8 WDR53 "MGC12928, MGC64882" ENSG00000185798 "WD repeat domain 53" Q7Z5U6 3 196554177-196568674 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 48.0" "Group enriched" "Detected in many" 6 "Early spermatids: 232.6;Late spermatids: 86.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016420 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA016420: AB_1858812" "unprognostic (3.29e-2)" "unprognostic (4.24e-3)" "unprognostic (9.89e-2)" "unprognostic (2.29e-3)" "unprognostic (2.26e-1)" "unprognostic (4.71e-2)" "prognostic unfavorable (1.57e-6)" "unprognostic (4.49e-2)" "prognostic unfavorable (3.09e-4)" "unprognostic (2.57e-1)" "unprognostic (2.10e-3)" "unprognostic (4.48e-3)" "unprognostic (8.01e-3)" "unprognostic (1.68e-1)" "unprognostic (1.12e-1)" "unprognostic (5.38e-2)" "unprognostic (1.97e-1)" 4.3 4.3 5.9 6.8 6.9 7.2 5.2 6.4 5.9 4.0 4.2 4.5 7.1 2.1 4.9 6.6 5.1 3.9 3.5 4.0 4.8 3.8 4.0 5.4 3.8 5.5 5.9 4.3 4.3 3.3 7.5 11.9 4.4 6.1 4.1 4.1 4.8 4.0 4.5 6.8 6.7 4.5 4.1 5.0 6.2 4.0 48.0 4.6 7.4 4.2 3.2 6.5 3.9 4.2 7.5 5.9 13.9 6.7 6.5 14.9 4.9 19.1 4.1 7.4 6.6 7.6 6.6 11.9 10.1 7.9 11.5 10.9 11.2 10.2 9.1 34.1 6.1 10.6 11.2 9.3 8.7 14.4 14.3 8.1 9.2 10.1 7.3 9.5 12.9 7.6 5.4 12.8 10.2 11.2 5.7 8.9 11.6 8.9 17.6 8.7 17.8 10.9 13.2 10.1 12.2 12.0 13.1 12.7 19.4 6.3 6.7 7.3 8.0 7.0 10.5 14.8 10.4 27.0 12.1 8.3 9.8 9.2 10.9 19.7 15.0 30.0 27.2 6.5 16.6 9.8 9.6 5.1 13.9 8.6 4.4 14.0 7.5 12.3 8.7 4.1 7.1 10.3 6.2 4.4 6.5 6.7 5.9 14.9 4.9 5.9 6.9 6.4 5.9 4.8 3.8 5.9 4.3 6.1 4.6 0.0 3.2 0.8 2.8 3.8 3.1 2.7 2.5 1.4 4.5 3.5 0.0 4.7 5.0 4.2 232.6 5.2 1.0 0.0 3.7 5.5 2.8 2.3 9.2 2.4 3.9 3.2 0.0 3.1 4.5 86.7 4.6 5.0 5.0 8.2 1.5 3.6 2.6 1.9 3.2 3.5 2.3 19.4 6.2 27.9 13.1 4.1 3.9 5.7 2.3 2.3 WDR6 ENSG00000178252 "WD repeat domain 6" Q9NNW5 3 49007062-49015953 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042622 Approved Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA042622: AB_10966784" "unprognostic (2.41e-2)" "unprognostic (2.03e-1)" "unprognostic (2.14e-1)" "unprognostic (1.26e-2)" "unprognostic (4.80e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (2.97e-6)" "unprognostic (1.79e-2)" "unprognostic (1.90e-1)" "unprognostic (1.20e-1)" "unprognostic (1.01e-3)" "unprognostic (1.94e-2)" "prognostic favorable (4.52e-5)" "unprognostic (1.13e-1)" "unprognostic (1.51e-1)" "unprognostic (1.87e-1)" "unprognostic (1.61e-2)" 15.8 36.7 21.5 26.1 23.5 14.9 19.7 29.9 29.9 32.7 31.0 30.8 56.4 27.5 39.0 37.0 18.7 33.1 32.6 20.4 20.1 20.4 26.0 22.0 21.1 28.2 22.8 26.9 60.9 46.0 56.7 55.8 24.3 22.1 39.0 22.1 34.3 33.4 54.4 23.9 26.6 28.3 40.8 17.5 29.1 24.7 23.7 22.1 26.9 50.7 20.3 25.1 31.2 24.6 12.3 14.4 10.3 12.9 11.7 18.9 12.0 17.6 24.3 40.2 34.1 27.0 22.1 27.2 26.3 21.7 29.8 24.2 21.5 25.6 28.3 16.8 41.9 22.9 20.1 32.1 36.8 21.3 22.5 21.3 26.8 59.6 28.4 27.4 27.7 12.1 39.6 26.5 27.5 20.8 41.4 21.7 30.2 15.2 30.4 26.9 35.0 32.1 31.6 35.7 16.1 22.6 18.8 17.2 17.8 35.3 52.4 19.6 36.7 19.7 16.2 11.4 30.7 28.2 22.2 28.9 22.2 35.7 21.5 34.9 53.6 22.9 24.6 30.1 35.5 15.9 3.7 9.1 10.3 16.9 12.9 18.9 12.0 12.5 12.9 11.3 12.3 14.7 10.9 3.4 11.7 6.5 14.4 10.5 12.0 21.5 23.5 29.9 29.9 20.1 20.4 22.8 26.9 22.1 22.1 20.8 44.0 22.5 20.1 15.9 23.5 2.0 28.1 22.7 38.7 45.4 45.2 35.1 8.3 25.4 3.7 17.3 21.2 0.0 22.4 17.9 19.9 24.4 27.8 38.0 22.8 35.0 69.4 23.9 14.5 4.2 35.4 16.4 11.8 20.8 31.0 44.4 24.7 21.0 26.5 25.9 45.7 25.8 16.9 22.3 17.6 9.9 47.3 24.1 30.2 15.3 WIPF1 "WASPIP, WIP" ENSG00000115935 "WAS/WASL interacting protein family member 1" O43516 2 174559572-174682916 "Disease related genes, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Kupffer cells: 132.4;monocytes: 161.5;T-cells: 221.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 45.4;HMC-1: 37.8;Karpas-707: 65.4;U-266/70: 52.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003739, CAB009737, HPA070706" Enhanced Approved "Plasma membrane,Cytosol" No No 290000 Cytosol "Plasma membrane" "CAB009737: AB_2288577, HPA003739: AB_1858783, HPA070706: AB_2686300" "unprognostic (4.76e-2)" "unprognostic (4.80e-2)" "unprognostic (1.49e-1)" "unprognostic (9.88e-2)" "unprognostic (1.87e-1)" "unprognostic (2.27e-3)" "unprognostic (2.05e-1)" "unprognostic (1.21e-1)" "unprognostic (7.22e-2)" "unprognostic (1.26e-1)" "unprognostic (3.25e-2)" "unprognostic (1.46e-1)" "prognostic unfavorable (1.14e-4)" "unprognostic (3.65e-2)" "unprognostic (5.43e-2)" "unprognostic (1.58e-1)" "unprognostic (2.50e-2)" 20.6 7.3 10.5 47.0 14.4 23.2 21.6 2.1 9.2 17.1 16.5 20.2 6.6 8.7 14.3 11.4 10.3 9.8 17.2 12.0 14.6 10.5 9.0 7.8 22.6 55.7 21.1 5.6 8.7 4.7 5.7 4.2 15.6 10.9 10.6 10.7 10.5 10.5 11.7 4.0 7.3 21.3 13.8 44.2 55.5 9.9 4.5 14.9 42.9 11.4 8.9 51.7 22.8 15.3 12.3 8.2 52.7 12.9 17.8 25.0 15.3 0.1 1.4 3.5 0.0 8.8 15.7 3.6 6.5 5.6 2.6 4.1 0.4 0.3 45.4 2.0 9.8 3.3 0.1 0.5 0.0 3.4 30.7 0.8 23.9 5.9 0.0 3.4 19.9 37.8 6.6 1.1 6.1 0.5 3.4 5.7 3.9 0.6 65.4 7.7 0.0 22.0 18.3 4.0 0.0 0.2 19.0 1.4 8.5 2.4 0.1 0.5 7.3 0.0 1.8 3.9 6.8 0.0 9.7 4.4 9.0 2.5 6.4 6.2 52.2 31.9 23.7 13.5 13.6 24.7 12.1 10.8 26.2 25.0 11.9 21.0 12.3 16.8 24.5 8.2 10.3 13.8 18.1 52.7 17.8 12.9 3.6 18.7 15.3 10.5 14.4 2.1 9.2 14.6 10.5 21.1 5.6 10.9 14.9 17.9 30.3 74.6 5.1 11.1 0.9 8.9 0.0 0.0 7.9 3.5 23.6 1.3 5.0 1.8 29.6 27.4 0.0 0.0 10.1 70.1 48.8 3.9 65.8 1.3 77.2 0.0 4.7 37.4 132.4 57.3 23.3 101.7 25.3 161.5 1.0 1.2 12.1 0.0 17.0 27.9 3.3 12.9 27.7 3.9 2.0 9.7 3.4 221.6 1.9 2.7 WWP1 "AIP5, DKFZP434D2111" ENSG00000123124 "WW domain containing E3 ubiquitin protein ligase 1" Q9H0M0 8 86342738-86478420 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023180 Approved Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA Cytosol "Golgi apparatus, Plasma membrane" "HPA023180: AB_10602587" "unprognostic (3.89e-1)" "unprognostic (6.63e-2)" "unprognostic (3.81e-2)" "unprognostic (7.91e-2)" "unprognostic (3.70e-1)" "unprognostic (1.02e-1)" "unprognostic (1.93e-1)" "unprognostic (4.24e-2)" "unprognostic (1.83e-1)" "unprognostic (9.43e-3)" "unprognostic (3.09e-3)" "unprognostic (1.48e-1)" "prognostic favorable (5.45e-5)" "unprognostic (2.35e-1)" "unprognostic (4.63e-1)" "unprognostic (3.19e-3)" "unprognostic (1.01e-1)" 15.4 9.1 9.7 15.6 14.1 5.2 20.9 8.5 9.5 11.5 16.9 7.5 21.1 8.7 11.9 19.3 11.7 7.2 22.0 40.7 8.7 8.5 16.9 37.2 10.2 15.9 10.0 7.8 10.1 11.3 40.7 7.3 15.6 12.7 17.8 11.3 8.9 11.8 9.4 58.0 13.8 13.0 18.4 9.9 19.1 11.4 10.4 9.5 11.1 11.2 18.0 12.5 14.5 12.3 3.7 2.6 6.5 2.8 2.9 10.4 2.3 22.6 10.6 7.4 5.2 9.3 9.2 6.8 8.3 8.8 6.6 7.9 7.5 14.0 9.7 5.6 14.1 9.2 19.5 10.3 13.3 11.4 12.1 8.3 11.2 9.4 17.5 6.8 4.4 5.8 8.3 16.9 7.2 13.4 10.2 29.1 11.5 5.9 11.5 11.1 11.3 10.6 3.4 4.5 31.7 12.0 7.0 8.9 8.6 14.8 17.3 2.2 5.2 8.2 41.6 8.8 16.8 12.4 4.2 33.4 9.9 11.7 10.4 4.2 13.6 8.3 10.0 12.2 0.8 7.5 6.5 2.8 4.8 7.2 2.4 6.0 3.7 8.7 7.1 1.9 3.6 10.4 6.3 1.7 2.9 2.8 2.6 8.0 2.3 9.7 14.1 8.5 9.5 8.7 8.5 10.0 7.8 12.7 9.5 23.8 19.9 7.5 24.5 31.8 24.5 71.8 45.9 10.7 17.0 27.9 55.0 21.8 36.5 16.7 18.9 25.5 14.8 0.0 32.4 2.7 17.3 35.8 3.5 77.6 43.8 38.1 22.8 64.4 64.9 9.4 30.0 17.5 28.7 10.8 25.5 21.3 37.0 14.0 34.3 38.8 48.9 6.5 13.0 10.9 14.7 34.5 19.2 20.3 18.3 32.8 XIAP "API3, BIRC4, hILP" ENSG00000101966 "X-linked inhibitor of apoptosis" P98170 X 123859724-123913979 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway, Wnt signaling pathway" "Protease inhibitor, Thiol protease inhibitor, Transferase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "CAB009203, HPA042428" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "CAB009203: AB_2257167, HPA042428: AB_2677993" "prognostic unfavorable (9.21e-4)" "unprognostic (8.43e-2)" "unprognostic (1.50e-2)" "unprognostic (2.14e-1)" "unprognostic (1.40e-1)" "unprognostic (9.41e-2)" "unprognostic (1.95e-2)" "unprognostic (8.51e-2)" "unprognostic (9.17e-2)" "unprognostic (3.90e-2)" "unprognostic (7.50e-2)" "unprognostic (4.41e-2)" "unprognostic (3.15e-3)" "unprognostic (8.21e-3)" "unprognostic (2.26e-1)" "unprognostic (4.99e-2)" "unprognostic (4.65e-2)" 17.4 14.4 20.0 18.1 20.2 12.0 15.9 21.3 18.9 17.2 19.4 14.5 22.9 16.1 17.4 17.0 18.9 12.6 14.7 15.7 18.9 22.1 19.8 19.4 16.5 15.5 18.8 14.6 13.9 19.7 36.6 26.1 18.2 15.9 15.6 16.8 16.9 14.6 22.9 21.5 14.2 23.4 17.0 19.0 15.8 16.2 7.0 12.3 13.9 24.3 11.4 14.0 15.4 20.5 5.7 4.3 11.1 3.9 3.3 5.5 1.9 11.7 10.0 7.9 6.8 9.4 12.1 10.3 12.8 9.5 7.0 6.0 4.5 13.8 11.0 19.0 10.9 13.3 4.4 11.7 8.0 12.9 11.4 6.4 7.4 8.4 6.8 11.9 13.4 15.4 8.3 12.5 11.6 15.0 8.1 9.6 8.3 11.7 12.7 13.5 12.2 7.5 6.5 6.5 11.7 7.9 8.0 9.2 11.6 10.5 17.1 5.4 7.9 17.5 10.1 10.3 7.3 6.2 6.6 11.9 0.4 4.8 21.0 14.2 10.7 10.7 12.2 14.4 9.6 8.8 11.1 2.6 3.5 5.0 2.3 4.7 4.6 3.8 5.5 1.4 5.7 4.4 3.0 8.2 3.3 3.9 4.3 2.5 1.9 20.0 20.2 21.3 18.9 18.9 22.1 18.8 14.6 15.9 12.3 74.5 82.4 26.9 28.9 23.7 71.7 36.7 56.0 46.8 63.7 50.6 90.3 15.7 23.2 32.6 2.2 45.7 74.1 0.0 46.9 25.4 27.8 42.3 57.9 73.4 26.6 71.5 45.5 66.3 41.2 1.5 39.4 43.8 8.5 27.9 52.4 42.8 52.8 48.9 48.4 48.2 129.5 64.7 27.8 10.4 19.9 31.0 31.8 33.1 39.8 58.3 XIRP1 "CMYA1, DKFZp451D042, Xin" ENSG00000168334 "Xin actin binding repeat containing 1" Q702N8 3 39183210-39192596 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "heart muscle: 95.0;skeletal muscle: 219.0" "Cell type enriched" "Detected in single" 1478 "Cardiomyocytes: 827.4" "Cancer enhanced" "Detected in some" "head and neck cancer: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HSkMC: 9.3;LHCN-M2: 2.3;RH-30: 6.2;SuSa: 1.9" "HPA016750, HPA018458, CAB026391" Enhanced Approved "Nucleoplasm,Plasma membrane,Actin filaments" NA NA "Plasma membrane, Actin filaments" Nucleoplasm "CAB026391: , HPA016750: AB_1858884, HPA018458: AB_1858885" "unprognostic (2.19e-1)" "unprognostic (6.40e-2)" "unprognostic (1.13e-1)" "unprognostic (9.75e-2)" "unprognostic (2.76e-1)" "unprognostic (2.43e-2)" "unprognostic (4.94e-2)" "unprognostic (2.66e-3)" "unprognostic (1.66e-3)" "unprognostic (1.46e-1)" "unprognostic (5.30e-2)" "unprognostic (6.26e-2)" "unprognostic (1.02e-5)" "unprognostic (2.08e-2)" "unprognostic (2.78e-2)" "unprognostic (6.86e-4)" "unprognostic (4.12e-2)" 1.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 1.7 1.9 0.0 0.4 95.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.2 0.3 1.1 0.0 0.0 1.3 0.0 219.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.1 4.9 18.2 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.6 0.1 0.0 0.0 0.0 0.0 0.0 1.1 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 827.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 XIRP2 CMYA3 ENSG00000163092 "Xin actin binding repeat containing 2" A4UGR9 2 166888487-167259753 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skeletal muscle: 292.8" "Cell type enriched" "Detected in some" 66 "Cardiomyocytes: 1858.5" "Cancer enriched" "Detected in some" 5 "head and neck cancer: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 3.3;HEL: 1.5;HUVEC TERT2: 8.7;U-2197: 6.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA034813, HPA074599" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA034813: AB_10602588, HPA074599: " "unprognostic (5.27e-4)" "unprognostic (5.96e-3)" "unprognostic (7.42e-2)" "unprognostic (2.42e-1)" "unprognostic (1.74e-1)" "unprognostic (2.56e-1)" 7.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 3.3 0.0 0.0 24.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 4.3 0.0 292.8 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 2.3 51.0 2.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 1.5 0.0 0.2 0.2 0.0 0.0 0.9 0.0 0.2 0.7 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1858.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 20.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 XPNPEP2 ENSG00000122121 "X-prolyl aminopeptidase 2" O43895 X 129738974-129769538 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "intestine: 145.6;kidney: 49.7" "Cell type enhanced" "Detected in some" 23 "Enterocytes: 21.3;Hepatocytes: 11.6;Proximal tubular cells: 49.7" "Group enriched" "Detected in many" 6 "colorectal cancer: 5.3;liver cancer: 18.3;stomach cancer: 3.9" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "gdT-cell: 7.3;intermediate monocyte: 2.1;MAIT T-cell: 2.2;memory CD4 T-cell: 2.4;memory CD8 T-cell: 4.8;naive CD8 T-cell: 3.6;non-classical monocyte: 4.4;T-reg: 2.2" "Group enriched" "Detected in many" 7 "monocytes: 4.4;T-cells: 7.3" "Cell line enhanced" "Detected in some" "ASC diff: 6.3;ASC TERT1: 33.4;HSkMC: 16.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA000339, CAB025136, CAB025269, HPA064568" Enhanced Approved "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 8900000 "Plasma membrane, Cytosol" "CAB025136: , CAB025269: , HPA000339: AB_1858894, HPA064568: " "unprognostic (7.95e-2)" "unprognostic (5.73e-2)" "unprognostic (2.56e-1)" "unprognostic (6.21e-3)" "unprognostic (3.54e-2)" "unprognostic (1.54e-1)" "unprognostic (4.04e-1)" "unprognostic (3.26e-1)" "unprognostic (3.01e-1)" "unprognostic (2.41e-2)" "unprognostic (3.07e-1)" "unprognostic (9.28e-3)" "unprognostic (2.77e-2)" "unprognostic (6.53e-2)" "unprognostic (3.18e-2)" "unprognostic (1.39e-2)" "unprognostic (3.26e-3)" 4.7 0.5 0.0 1.1 0.1 0.0 3.2 0.0 0.1 1.7 57.4 0.1 0.8 37.0 1.2 1.7 4.2 3.4 1.3 2.6 0.0 0.0 49.7 8.0 1.0 1.2 0.0 0.0 3.5 0.9 0.0 0.0 0.6 0.1 3.6 2.0 0.7 0.7 0.3 1.6 2.1 145.6 2.5 0.1 0.2 1.7 1.2 0.0 0.1 0.9 1.4 0.3 4.0 10.7 0.4 0.8 0.2 4.4 0.0 7.3 1.3 0.0 0.0 0.5 0.0 6.3 33.4 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.8 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 7.3 2.1 2.2 0.0 2.4 4.8 0.3 0.4 0.7 3.6 0.2 0.0 4.4 0.8 2.2 1.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 1.6 0.0 0.4 0.0 0.0 0.0 1.8 0.0 0.1 5.0 0.0 0.0 0.0 21.3 0.0 0.0 0.0 4.4 0.0 0.0 11.6 0.7 0.0 1.2 0.6 0.3 0.0 0.0 0.0 1.7 0.0 0.9 0.0 0.0 5.8 0.0 49.7 0.0 0.0 0.2 0.0 0.0 0.9 1.0 0.0 0.2 0.0 XPO6 "FLJ22519, KIAA0370, RANBP20" ENSG00000169180 "Exportin 6" Q96QU8 16 28097979-28211920 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 7 "neutrophil: 56.4" "Lineage enriched" "Detected in all" 9 "granulocytes: 56.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038246 Uncertain Approved "Nucleoplasm,Nucleoli,Plasma membrane,Cytosol" No No "Nucleoplasm, Nucleoli" "Plasma membrane, Cytosol" "HPA038246: AB_10674550" "unprognostic (1.17e-1)" "unprognostic (5.43e-2)" "unprognostic (1.07e-1)" "unprognostic (3.76e-1)" "unprognostic (1.38e-1)" "unprognostic (1.03e-1)" "prognostic unfavorable (3.68e-4)" "unprognostic (2.22e-1)" "unprognostic (1.41e-1)" "unprognostic (1.31e-2)" "unprognostic (4.48e-1)" "unprognostic (1.40e-1)" "unprognostic (1.01e-3)" "unprognostic (2.10e-1)" "unprognostic (5.36e-2)" "unprognostic (8.50e-2)" "prognostic unfavorable (8.80e-4)" 18.4 14.1 24.3 32.0 25.0 47.9 17.7 16.0 30.6 12.4 17.7 30.4 9.9 13.4 13.5 12.0 16.8 14.1 14.9 9.6 27.5 23.9 13.3 19.1 20.6 54.6 25.6 16.9 15.3 13.2 22.0 18.0 25.9 21.7 14.1 17.0 16.3 19.4 13.1 8.3 18.8 18.3 16.3 23.8 50.4 14.8 28.9 19.8 37.1 18.0 7.8 31.8 17.2 13.2 5.2 2.6 56.4 4.4 2.7 6.5 2.0 28.5 20.5 18.1 19.4 12.6 20.0 20.8 35.4 32.0 41.4 42.0 28.7 20.5 20.3 30.5 32.1 21.1 18.7 42.9 27.1 50.4 45.7 26.6 22.2 28.9 32.0 29.7 31.0 25.0 15.7 20.2 36.8 36.5 17.8 23.8 20.7 40.4 10.3 28.0 32.0 37.2 36.9 30.6 13.9 19.6 34.9 21.5 33.6 15.4 14.6 35.3 19.2 17.5 29.2 15.5 21.0 21.0 20.5 25.1 35.0 23.5 29.8 29.4 24.0 30.3 30.1 26.7 32.3 29.5 4.7 2.7 8.4 4.1 3.0 4.4 5.2 4.7 4.4 2.0 3.9 5.2 6.5 56.4 2.7 4.4 2.6 3.8 2.0 24.3 25.0 16.0 30.6 27.5 23.9 25.6 16.9 21.7 19.8 8.9 13.9 21.7 8.2 16.6 23.8 6.6 2.5 9.4 10.3 22.7 29.5 9.8 6.6 13.3 27.6 10.6 14.7 0.0 16.4 13.9 12.4 15.6 2.3 14.0 19.9 20.6 22.7 8.6 23.4 30.6 10.0 14.7 6.8 27.1 21.5 8.3 18.1 14.0 8.1 5.0 26.3 6.5 11.3 29.5 29.2 18.6 7.0 20.8 17.0 12.6 XYLT1 "PXYLT1, XT-I" ENSG00000103489 "Xylosyltransferase 1" Q86Y38 16 17101769-17470881 "Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins" "Glycosyltransferase, Transferase" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 21.6" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 92.3;Peritubular cells: 47.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 19.2;ASC TERT1: 11.9;U-2197: 19.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA007478, HPA007966" Approved Approved "Endoplasmic reticulum,Plasma membrane" "Secreted to blood" NA NA 30000 "Plasma membrane" "Endoplasmic reticulum" "HPA007478: AB_1080616, HPA007966: AB_1080618" "unprognostic (1.82e-1)" "unprognostic (7.17e-2)" "unprognostic (1.63e-1)" "unprognostic (1.38e-2)" "unprognostic (2.83e-1)" "unprognostic (9.12e-2)" "unprognostic (8.13e-2)" "unprognostic (9.40e-2)" "unprognostic (2.41e-3)" "unprognostic (2.82e-2)" "unprognostic (2.11e-1)" "unprognostic (1.01e-1)" "unprognostic (8.66e-3)" "unprognostic (2.49e-1)" "unprognostic (1.76e-1)" "unprognostic (2.95e-1)" "unprognostic (6.05e-2)" 5.7 5.9 6.3 21.6 3.1 5.9 7.0 3.8 6.7 8.0 7.4 1.4 0.9 3.9 7.4 3.0 4.9 3.2 4.4 3.8 6.3 4.2 1.9 0.9 2.9 7.5 4.3 2.2 5.5 2.6 0.2 1.8 5.4 2.6 4.4 4.9 3.4 2.6 4.3 1.3 4.1 4.7 5.1 3.9 6.3 3.2 3.0 2.1 4.6 2.7 6.7 6.6 4.7 4.2 1.2 0.8 1.2 3.6 0.9 0.7 0.5 0.0 0.1 2.7 0.0 19.2 11.9 3.3 8.5 4.3 1.0 0.4 0.2 0.2 2.1 0.0 10.3 0.3 0.2 0.0 1.7 1.5 4.1 0.2 2.6 0.0 0.0 0.2 3.7 3.5 4.4 0.2 5.5 0.8 1.6 0.0 0.2 0.3 8.0 1.0 0.3 0.0 4.0 2.9 1.4 0.0 1.2 0.0 0.4 0.0 3.9 0.7 5.2 0.6 2.6 0.5 2.1 0.7 2.3 0.0 9.0 1.0 19.7 0.0 9.0 0.5 3.9 10.0 4.2 7.6 0.6 0.6 1.2 0.6 2.5 0.7 1.2 0.5 0.3 0.8 1.2 0.5 0.4 0.3 0.9 3.6 0.2 0.7 0.5 6.3 3.1 3.8 5.3 6.3 4.2 4.3 2.2 2.6 2.1 3.0 4.5 7.5 1.5 7.0 13.3 2.7 0.0 0.0 1.2 0.0 92.3 9.8 0.0 1.2 0.4 2.2 5.1 0.0 1.4 16.8 16.2 3.4 2.3 0.0 3.3 0.0 12.1 2.5 8.5 0.4 11.8 8.0 3.3 2.8 3.8 1.3 2.6 7.0 47.0 0.2 4.1 6.5 5.7 0.2 2.5 16.2 11.0 4.4 6.5 4.2 YIPF1 "DJ167A19.1, FinGER1" ENSG00000058799 "Yip1 domain family member 1" Q9Y548 1 53851719-53889834 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Syncytiotrophoblasts: 108.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014716, HPA073931" Approved Supported "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Golgi apparatus, Plasma membrane" Nucleoplasm "HPA014716: AB_1847686, HPA073931: " "unprognostic (4.94e-2)" "unprognostic (4.50e-1)" "unprognostic (6.37e-2)" "unprognostic (2.06e-2)" "unprognostic (3.93e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (1.34e-4)" "unprognostic (1.96e-1)" "unprognostic (6.64e-2)" "unprognostic (2.34e-1)" "unprognostic (1.49e-1)" "unprognostic (2.76e-1)" "unprognostic (1.24e-2)" "unprognostic (7.75e-3)" "unprognostic (2.38e-1)" "unprognostic (5.39e-3)" "unprognostic (6.35e-1)" 10.1 15.6 12.8 9.1 13.9 8.0 18.2 6.9 12.8 11.2 12.1 8.8 11.5 11.0 6.6 12.2 14.0 10.2 10.8 13.4 10.6 12.1 16.1 31.8 11.9 14.1 12.4 9.1 11.8 13.7 7.2 15.5 15.4 14.4 17.8 14.4 10.2 17.1 14.3 18.7 13.9 10.6 9.4 10.6 13.3 13.0 10.8 11.1 10.3 33.5 9.8 15.7 12.9 16.2 8.1 11.4 26.7 14.5 6.9 16.0 10.2 6.9 4.2 6.7 4.7 7.9 8.9 6.0 5.0 7.9 9.3 12.2 4.8 2.1 2.3 8.5 6.0 14.3 8.3 8.8 11.1 9.6 17.6 7.0 5.8 4.7 7.2 10.9 6.4 5.5 8.9 10.5 7.4 9.0 7.9 10.0 8.7 6.0 6.7 9.0 5.9 6.5 9.3 4.9 8.2 7.0 4.1 6.3 9.9 7.9 3.6 3.0 3.8 4.7 9.0 23.0 22.1 13.9 7.2 4.5 3.8 3.9 6.7 4.3 13.5 15.4 4.3 5.8 5.3 3.3 12.5 12.5 13.2 8.5 11.3 8.0 8.1 7.3 8.5 11.4 7.7 7.1 6.7 26.7 6.9 14.5 7.8 16.0 10.2 12.8 13.9 6.9 12.8 10.6 12.1 12.4 9.1 14.4 11.1 6.0 13.0 10.7 15.1 7.6 6.5 8.5 28.1 14.7 15.9 8.7 0.0 65.7 10.0 23.6 22.9 8.7 11.7 0.0 28.3 23.0 8.3 37.4 9.2 17.4 34.5 9.5 9.2 13.5 19.9 41.4 5.5 15.8 10.1 16.2 23.0 16.2 25.6 12.9 8.9 13.5 5.4 0.0 6.2 12.7 18.3 9.5 108.4 13.8 9.5 22.0 YIPF4 "FinGER4, MGC11061" ENSG00000119820 "Yip1 domain family member 4" Q9BSR8 2 32277910-32316594 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017884 Supported Supported "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Golgi apparatus" "Vesicles, Plasma membrane" "HPA017884: AB_1853855" "unprognostic (5.61e-3)" "unprognostic (8.50e-2)" "unprognostic (3.88e-2)" "unprognostic (3.17e-3)" "unprognostic (3.05e-1)" "unprognostic (7.64e-2)" "unprognostic (3.45e-2)" "unprognostic (3.61e-2)" "unprognostic (3.69e-1)" "unprognostic (8.70e-2)" "unprognostic (4.15e-1)" "unprognostic (1.54e-1)" "unprognostic (2.29e-3)" "unprognostic (1.90e-1)" "unprognostic (1.59e-1)" "unprognostic (3.88e-2)" "unprognostic (6.11e-2)" 15.2 15.3 15.7 12.3 19.2 6.0 19.5 24.9 27.2 15.6 16.0 21.7 16.9 13.6 19.6 17.7 15.3 13.3 12.3 19.1 17.7 16.5 18.7 24.0 13.4 12.9 18.5 13.3 17.9 32.9 14.2 22.3 19.2 17.6 16.1 15.0 15.4 24.1 14.2 16.8 16.5 14.6 15.8 17.7 15.4 14.7 15.2 16.3 18.7 23.6 12.2 13.6 14.6 14.2 5.0 5.8 16.5 6.0 7.0 5.4 4.4 8.4 4.3 8.5 7.6 9.9 12.7 4.5 7.3 7.4 7.7 5.1 5.7 6.5 4.5 5.1 7.9 7.5 6.7 9.0 6.4 10.0 7.3 14.0 7.3 10.0 10.3 11.8 9.6 6.3 8.9 12.4 6.9 11.0 10.6 6.5 5.1 10.0 9.5 8.3 5.6 7.5 10.1 6.9 9.1 7.4 5.3 12.6 8.5 8.2 3.7 9.7 9.2 6.2 6.4 10.9 5.8 3.5 8.3 7.2 10.2 4.8 7.1 6.9 14.2 17.4 5.5 16.1 9.4 5.6 12.5 6.0 5.9 5.0 5.4 4.3 5.0 5.1 4.7 4.9 4.8 5.4 4.7 16.5 7.0 5.2 5.8 4.7 4.4 15.7 19.2 24.9 18.9 17.7 16.5 18.5 13.3 17.6 16.3 86.4 64.5 59.0 48.6 45.6 109.0 77.0 50.9 49.5 40.9 40.1 100.1 58.6 28.2 42.9 22.0 54.1 56.2 46.7 34.1 57.3 61.5 64.5 39.3 72.0 43.8 95.3 54.9 63.8 64.4 15.3 80.3 61.7 77.6 48.7 58.6 63.3 40.9 62.2 70.4 50.8 120.9 77.6 52.3 130.7 39.6 57.6 161.2 62.3 46.1 46.3 YTHDC1 "KIAA1966, YT521, YT521-B" ENSG00000083896 "YTH domain containing 1" Q96MU7 4 68310387-68350089 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036462 Supported Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA036462: AB_10669793" "unprognostic (1.02e-1)" "unprognostic (8.44e-3)" "unprognostic (5.74e-3)" "unprognostic (1.35e-1)" "unprognostic (7.59e-2)" "unprognostic (1.33e-3)" "unprognostic (1.52e-3)" "unprognostic (8.28e-2)" "unprognostic (1.38e-1)" "unprognostic (1.09e-1)" "unprognostic (2.35e-2)" "unprognostic (1.41e-2)" "unprognostic (6.64e-3)" "unprognostic (1.63e-2)" "unprognostic (1.70e-1)" "unprognostic (4.05e-1)" "prognostic favorable (7.29e-5)" 22.1 16.6 25.1 28.8 33.2 101.8 24.3 38.4 25.8 30.3 20.8 24.4 24.0 16.7 29.2 25.1 25.4 20.2 17.6 18.5 23.5 19.6 19.8 19.5 21.1 26.8 26.1 23.4 39.7 24.2 27.6 32.4 33.2 22.8 25.2 21.3 13.8 22.7 30.2 32.9 26.1 21.2 27.6 25.4 23.6 20.6 17.7 35.1 30.2 23.8 20.2 26.7 34.8 30.3 18.0 15.1 41.6 9.3 7.5 11.1 3.2 17.6 10.6 21.7 13.0 13.1 11.4 18.0 19.5 12.3 12.2 12.9 13.1 16.3 29.0 16.0 9.9 9.9 13.4 20.3 17.1 19.9 21.4 12.3 22.1 15.2 14.5 13.4 23.3 17.1 10.8 18.6 10.9 26.2 15.7 13.2 14.1 20.8 17.1 17.8 13.5 27.1 21.0 16.3 17.3 10.5 23.8 24.6 12.9 19.1 20.5 18.9 14.8 17.0 18.4 14.1 21.2 14.4 16.3 13.9 14.1 14.9 9.7 12.8 17.8 11.9 30.3 9.5 15.2 12.9 20.2 8.3 14.7 9.9 5.0 7.7 12.7 8.0 7.9 4.6 18.0 11.1 9.2 41.6 7.5 9.3 15.1 7.3 3.2 25.1 33.2 38.4 25.8 23.5 19.6 26.1 23.4 22.8 35.1 104.2 120.5 72.4 101.3 106.6 102.8 78.1 73.9 139.2 159.3 69.8 66.8 58.2 44.7 60.9 61.3 76.3 40.0 23.3 49.7 94.0 62.9 98.5 88.2 72.1 37.8 85.8 82.2 47.9 51.2 14.3 69.0 70.8 60.8 45.1 60.5 91.4 65.5 48.7 63.6 32.1 131.7 51.8 97.3 131.7 89.6 117.6 99.5 74.8 54.4 85.9 ZBED3 MGC15435 ENSG00000132846 "Zinc finger BED-type containing 3" Q96IU2 5 77072072-77087323 "Predicted intracellular proteins, Transcription factors" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 24.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 18.9;JURKAT: 19.6;MOLT-4: 17.8" "Low region specificity" "Detected in all" HPA055995 Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA055995: AB_2683000" "unprognostic (3.23e-2)" "unprognostic (1.17e-1)" "unprognostic (2.24e-2)" "unprognostic (1.22e-1)" "unprognostic (3.78e-2)" "unprognostic (4.02e-2)" "unprognostic (2.97e-1)" "unprognostic (1.45e-2)" "unprognostic (6.96e-3)" "unprognostic (1.82e-2)" "unprognostic (8.64e-3)" "unprognostic (3.63e-1)" "prognostic favorable (1.68e-4)" "unprognostic (2.08e-1)" "unprognostic (1.92e-1)" "unprognostic (5.41e-2)" "unprognostic (1.08e-1)" 14.4 5.2 8.0 3.0 16.6 3.4 13.0 6.7 10.8 10.5 6.9 20.5 6.4 5.7 15.8 12.7 3.8 10.6 5.3 6.5 9.5 6.2 18.0 16.2 7.3 3.3 22.7 7.2 12.2 10.9 13.9 9.0 3.6 9.5 7.8 6.5 8.3 8.3 10.3 3.7 3.9 5.0 13.0 10.5 5.0 8.7 4.0 13.7 5.2 16.4 1.6 2.8 5.4 5.8 0.2 1.8 0.3 1.1 0.1 0.8 0.2 3.2 2.6 3.4 18.9 14.5 1.0 0.2 1.1 3.2 1.7 4.5 5.6 1.5 0.0 7.1 2.1 0.7 0.4 1.8 1.1 1.5 1.0 3.5 2.5 5.7 6.4 8.6 3.3 1.0 16.2 4.4 0.8 3.3 2.7 5.3 19.6 0.0 7.0 1.0 3.2 17.8 0.5 2.3 0.8 1.6 7.5 6.6 1.0 7.8 1.2 3.8 8.0 3.8 3.2 5.4 1.4 4.8 2.4 2.1 1.5 2.9 3.3 4.4 5.1 4.8 7.3 2.3 6.5 3.4 0.0 1.1 0.3 0.4 0.4 0.4 0.1 0.3 0.5 0.9 0.2 0.8 0.8 0.3 0.1 0.1 1.8 0.0 0.2 8.0 16.6 6.7 10.8 9.5 6.2 22.7 7.2 9.5 13.7 0.0 3.2 3.0 3.4 1.1 8.3 9.6 10.2 0.0 3.4 12.2 11.8 1.3 14.9 4.1 3.4 9.0 2.0 0.0 5.1 0.2 4.8 4.4 1.1 24.6 8.2 3.2 15.5 9.2 10.2 1.5 16.4 4.6 6.8 0.0 5.1 13.8 3.7 3.5 10.6 16.5 14.4 0.0 3.3 1.4 3.3 1.3 0.2 0.0 6.4 1.4 ZBTB8OS ARCH ENSG00000176261 "Zinc finger and BTB domain containing 8 opposite strand" Q8IWT0 1 32600172-32650903 "Predicted intracellular proteins" "tRNA processing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046315 Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA046315: AB_2679623" "unprognostic (3.41e-2)" "unprognostic (1.39e-2)" "unprognostic (1.08e-1)" "unprognostic (9.08e-2)" "unprognostic (1.82e-1)" "unprognostic (8.14e-2)" "prognostic unfavorable (4.25e-4)" "unprognostic (9.63e-2)" "prognostic unfavorable (8.56e-4)" "unprognostic (5.18e-2)" "unprognostic (3.84e-1)" "unprognostic (1.40e-1)" "prognostic unfavorable (7.11e-8)" "unprognostic (1.94e-2)" "unprognostic (2.79e-1)" "unprognostic (1.68e-1)" "unprognostic (1.42e-1)" 16.1 18.8 20.9 21.2 22.3 14.5 16.7 21.7 21.1 13.1 25.6 11.9 21.4 24.9 13.9 29.5 20.6 15.5 12.2 20.7 16.9 15.8 23.2 26.6 15.5 25.9 23.5 18.6 10.4 20.3 9.2 36.6 13.6 20.9 15.9 26.8 15.3 19.0 18.5 29.5 13.4 28.6 16.2 18.0 22.3 20.6 11.1 23.0 8.4 18.7 20.3 32.5 14.8 13.5 36.0 26.1 33.8 35.4 22.4 40.1 18.0 18.4 10.7 9.5 16.1 16.8 15.4 13.1 21.0 21.2 16.8 17.1 25.2 20.7 20.6 19.4 15.3 18.6 13.9 16.6 16.4 22.5 27.4 15.3 16.7 22.2 41.9 13.9 23.9 15.5 15.3 18.0 14.7 17.8 10.5 18.2 25.3 16.4 28.0 21.4 14.5 18.2 14.0 29.6 28.8 16.6 14.7 20.6 20.0 19.9 22.0 19.3 14.9 17.0 17.1 26.3 27.1 11.7 19.9 12.9 23.4 14.2 18.8 26.1 42.6 41.7 58.0 16.8 29.9 23.1 15.8 29.2 33.8 24.4 33.9 23.5 36.0 27.0 28.9 20.4 23.1 22.5 24.2 32.5 22.4 35.4 26.1 40.1 18.0 20.9 22.3 21.7 21.1 16.9 15.8 23.5 18.6 20.9 23.0 20.8 53.8 37.9 26.7 15.2 44.5 57.6 33.1 40.2 31.8 36.6 41.2 44.3 76.3 54.3 27.3 35.0 79.9 23.3 46.1 51.1 32.5 30.0 41.7 75.0 66.3 15.9 36.1 34.4 66.8 24.3 33.9 58.6 49.0 83.8 44.2 24.2 63.5 46.3 43.5 103.7 51.5 32.3 36.3 42.1 29.1 13.7 54.5 49.8 48.8 32.5 ZDHHC2 "DHHC2, ZNF372" ENSG00000104219 "Zinc finger DHHC-type containing 2" Q9UIJ5 8 17156029-17224799 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 72.6;Rod photoreceptor cells: 80.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023331, HPA023334" Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA023331: AB_2671165, HPA023334: " "unprognostic (8.92e-2)" "unprognostic (4.23e-1)" "unprognostic (1.80e-2)" "unprognostic (2.53e-1)" "unprognostic (6.89e-2)" "unprognostic (2.25e-1)" "unprognostic (6.12e-2)" "unprognostic (1.78e-2)" "unprognostic (1.04e-1)" "unprognostic (2.37e-2)" "unprognostic (2.16e-1)" "unprognostic (1.58e-1)" "prognostic favorable (3.24e-4)" "unprognostic (5.00e-2)" "unprognostic (3.87e-1)" "unprognostic (2.87e-2)" "unprognostic (5.10e-2)" 10.1 22.5 14.8 9.4 14.5 24.4 14.8 22.8 12.2 12.9 13.4 17.5 17.4 9.3 7.0 10.5 5.3 12.8 6.4 10.1 13.0 14.0 24.2 7.5 12.7 10.3 13.6 10.9 13.0 27.0 19.2 20.2 6.1 14.7 12.0 10.3 21.2 15.9 13.7 15.9 3.4 9.1 8.8 25.9 11.2 14.1 14.2 14.5 13.8 32.3 10.4 10.2 17.3 8.7 5.3 4.6 4.9 2.7 4.4 7.0 1.5 0.9 5.2 10.2 2.1 9.0 16.1 6.0 17.6 21.4 10.0 11.9 1.6 14.7 10.6 6.9 15.3 25.2 0.6 13.7 8.7 18.6 6.9 6.9 9.6 7.6 2.1 9.0 10.1 1.1 6.7 1.4 12.5 11.4 23.1 16.4 12.7 1.1 28.6 12.0 0.2 7.4 6.1 6.5 7.8 8.1 7.4 10.2 3.9 18.1 11.3 5.5 3.6 7.5 0.0 1.6 15.9 0.4 4.6 13.5 5.1 15.6 11.2 17.5 5.7 21.3 12.5 14.1 9.3 2.3 2.6 2.6 4.9 4.1 2.7 7.0 5.3 5.1 4.9 2.2 4.6 4.7 5.0 1.8 4.4 1.6 4.6 2.6 1.5 14.8 14.5 22.8 12.2 13.0 14.0 13.6 10.9 14.7 14.5 41.7 20.1 11.5 11.9 2.7 37.3 11.3 10.2 6.7 14.8 48.8 72.6 0.5 18.3 19.5 6.7 9.0 6.3 0.0 29.1 0.9 7.4 32.3 8.1 7.3 11.7 11.1 18.9 5.5 21.8 8.2 4.6 15.5 21.9 4.6 15.0 23.4 34.3 10.5 2.8 19.8 80.1 12.9 7.6 5.5 2.5 2.4 0.3 13.4 13.7 23.7 ZDHHC5 "DHHC5, KIAA1748, ZNF375" ENSG00000156599 "Zinc finger DHHC-type containing 5" Q9C0B5 11 57667747-57701187 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014670 Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA014670: AB_2257442" "unprognostic (1.34e-1)" "unprognostic (3.47e-2)" "unprognostic (2.51e-1)" "unprognostic (2.29e-1)" "unprognostic (5.32e-2)" "unprognostic (1.70e-2)" "unprognostic (9.82e-3)" "unprognostic (1.74e-3)" "unprognostic (4.36e-2)" "unprognostic (9.78e-2)" "prognostic unfavorable (6.74e-5)" "unprognostic (1.76e-1)" "unprognostic (4.72e-3)" "unprognostic (2.16e-1)" "unprognostic (6.80e-2)" "unprognostic (2.06e-2)" "unprognostic (1.74e-3)" 19.6 18.2 6.9 14.2 16.1 13.0 17.3 12.4 19.2 20.0 18.7 14.1 20.9 14.6 19.8 15.9 45.8 16.0 19.1 18.2 8.2 8.1 27.8 24.8 18.7 18.0 8.5 8.2 16.2 21.3 31.4 13.9 31.4 12.8 15.5 18.2 19.1 29.3 18.4 31.3 33.2 25.9 15.2 8.7 21.5 16.3 35.7 7.8 26.4 25.5 23.9 39.1 23.3 26.0 9.4 13.4 15.5 11.3 6.9 13.1 9.0 28.4 31.6 12.4 12.6 27.5 21.2 23.4 26.8 32.1 22.4 16.8 19.1 35.1 19.2 34.8 31.6 19.3 40.3 19.3 31.7 20.0 23.6 8.7 16.3 14.5 17.0 30.8 30.5 27.7 29.8 28.7 33.1 33.7 18.6 25.2 16.2 21.4 24.3 28.3 17.1 17.1 8.5 15.0 21.1 19.0 17.1 25.1 23.7 25.6 42.2 9.0 11.5 24.9 28.2 26.1 17.5 30.2 17.5 29.5 29.1 15.1 30.5 18.6 17.7 21.9 16.5 21.6 15.8 25.2 15.5 8.1 9.8 11.1 10.1 13.1 9.0 10.9 9.4 8.0 9.4 11.0 11.1 10.2 6.9 11.3 13.4 9.8 9.0 6.9 16.1 12.4 19.2 8.2 8.1 8.5 8.2 12.8 7.8 14.9 10.9 5.3 10.2 14.3 17.5 18.1 12.7 14.7 20.5 12.2 35.3 8.5 3.3 13.1 15.8 11.7 31.9 0.0 15.7 8.4 8.5 14.0 19.6 13.2 11.0 12.7 11.1 13.5 16.1 6.8 10.9 12.0 1.7 9.0 16.2 9.6 19.0 19.3 7.1 10.2 45.0 0.0 9.2 6.5 6.6 17.3 15.6 8.7 15.8 15.9 ZFP41 "FLJ00028, FLJ38705, ZNF753" ENSG00000181638 "ZFP41 zinc finger protein" 8 143246821-143262705 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 7.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "HPA047232, HPA056268" Uncertain Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Plasma membrane" NA NA "Nucleoli, Nucleoli rim" "Nucleoplasm, Plasma membrane" "HPA047232: , HPA056268: AB_2683082" "unprognostic (9.16e-2)" "unprognostic (1.49e-1)" "unprognostic (1.07e-1)" "unprognostic (1.47e-2)" "unprognostic (1.10e-1)" "unprognostic (1.45e-2)" "prognostic unfavorable (3.46e-5)" "unprognostic (4.92e-2)" "unprognostic (7.18e-2)" "unprognostic (3.53e-2)" "unprognostic (4.16e-3)" "unprognostic (2.98e-1)" "unprognostic (1.55e-2)" "unprognostic (6.89e-2)" "unprognostic (1.59e-1)" "unprognostic (3.44e-2)" "unprognostic (3.20e-1)" 7.8 6.6 10.3 6.5 9.0 4.1 5.6 12.6 13.7 8.0 8.8 10.7 6.5 9.4 12.5 6.8 5.7 9.2 5.6 6.3 10.8 14.3 6.5 5.8 6.3 6.7 10.7 7.4 13.1 9.1 11.4 10.2 3.5 9.6 7.7 4.5 8.9 12.6 9.1 8.1 12.1 9.1 7.3 7.4 8.5 7.2 10.6 8.6 4.6 8.0 4.6 6.7 6.7 10.0 0.9 3.7 0.1 0.9 0.7 2.2 0.8 7.1 11.4 5.0 6.6 5.8 4.5 5.9 4.3 2.4 8.5 5.8 5.6 6.0 4.0 6.5 5.6 8.7 5.9 5.4 5.7 4.2 6.3 6.6 5.0 5.5 4.4 8.1 2.0 3.1 4.7 8.1 5.5 8.1 5.9 4.0 2.9 10.6 3.9 4.0 12.8 5.3 2.2 7.4 8.8 11.3 2.8 4.1 1.4 3.7 6.5 6.3 8.7 12.2 3.4 6.4 4.5 8.5 3.9 4.2 6.5 11.6 5.0 6.9 6.3 4.8 1.9 5.7 4.8 8.4 0.0 0.6 0.1 1.3 0.9 2.2 0.4 1.1 0.9 0.5 0.9 1.9 1.2 0.0 0.7 0.1 3.7 0.9 0.8 10.3 9.0 12.6 13.7 10.8 14.3 10.7 7.4 9.6 8.6 0.0 1.3 1.3 0.6 1.0 1.4 2.8 2.5 4.0 1.2 3.5 5.9 0.2 1.7 1.6 1.3 0.7 2.7 0.0 0.8 0.9 1.1 0.4 0.0 3.9 1.0 6.4 2.9 1.8 2.2 1.4 1.1 0.9 1.7 0.0 3.2 2.7 1.2 4.3 2.1 1.1 2.2 0.0 1.1 7.7 3.4 0.3 0.2 0.0 2.9 0.3 ZFP90 "KIAA1954, NK10, ZNF756" ENSG00000184939 "ZFP90 zinc finger protein" Q8TF47 16 68530090-68576072 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029017 Uncertain Supported "Vesicles,Plasma membrane,Centrosome" NA NA "Vesicles, Plasma membrane, Centrosome" "HPA029017: AB_10669653" "unprognostic (3.27e-1)" "unprognostic (1.71e-2)" "unprognostic (1.56e-1)" "unprognostic (1.45e-2)" "unprognostic (3.11e-1)" "unprognostic (2.47e-1)" "unprognostic (3.68e-3)" "unprognostic (1.78e-1)" "unprognostic (5.19e-2)" "unprognostic (7.33e-2)" "unprognostic (1.35e-3)" "unprognostic (3.43e-1)" "prognostic favorable (1.78e-4)" "unprognostic (1.47e-2)" "unprognostic (2.37e-1)" "unprognostic (1.33e-1)" "unprognostic (9.60e-2)" 9.6 9.0 16.9 11.5 19.3 7.8 16.2 24.0 19.5 14.2 8.9 18.9 10.4 4.4 15.8 18.2 7.6 14.3 9.5 10.3 15.5 19.8 11.6 7.9 9.6 12.4 16.7 20.5 18.1 8.7 29.1 16.5 8.3 20.0 13.1 9.3 11.4 8.7 13.6 10.0 13.2 8.3 13.6 16.1 13.2 11.2 11.6 19.6 15.8 11.0 3.6 15.5 11.3 9.6 5.8 2.6 7.8 1.9 5.2 8.8 3.0 7.0 7.7 14.5 13.8 13.0 13.9 6.5 6.7 7.7 9.2 10.7 5.4 4.8 7.6 8.7 8.5 7.8 6.7 8.9 8.6 10.6 6.7 3.7 1.9 1.5 9.1 10.1 0.0 7.2 12.0 14.1 8.5 11.9 16.6 7.4 14.7 3.8 2.9 11.3 12.7 7.6 7.3 5.5 4.2 5.8 13.9 5.1 5.0 6.3 5.1 16.6 12.6 19.2 1.4 7.2 11.3 11.6 10.1 5.2 8.7 5.2 7.3 3.9 5.5 10.3 9.3 2.9 2.7 6.9 7.8 1.7 2.8 6.4 1.9 8.8 5.8 6.0 7.4 2.4 4.1 8.7 7.5 0.5 5.2 1.3 2.6 6.8 3.0 16.9 19.3 24.0 19.5 15.5 19.8 16.7 20.5 20.0 19.6 17.9 6.2 6.4 6.3 3.1 20.5 8.5 12.7 29.4 10.3 19.2 13.7 3.0 6.6 8.7 13.2 7.1 0.9 0.0 5.4 1.7 8.2 5.2 11.5 4.3 5.7 17.5 15.4 9.8 8.2 11.3 15.3 6.1 3.3 0.0 5.2 11.8 5.8 2.9 16.6 5.7 16.9 0.0 7.5 6.3 18.3 4.0 1.1 11.4 4.5 2.7 ZFYVE28 KIAA1643 ENSG00000159733 "Zinc finger FYVE-type containing 28" Q9HCC9 4 2269582-2418663 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "brain: 63.6" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 28.4" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 4 "cerebellum: 63.6" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 11.2;NB-4: 12.1;U-266/70: 12.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038175, HPA057587" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA038175: AB_10697244, HPA057587: AB_2683477" "unprognostic (1.59e-1)" "unprognostic (4.60e-2)" "unprognostic (7.68e-2)" "unprognostic (3.08e-3)" "unprognostic (9.89e-3)" "unprognostic (3.79e-2)" "unprognostic (3.17e-1)" "unprognostic (1.31e-1)" "unprognostic (1.66e-1)" "unprognostic (4.78e-3)" "unprognostic (2.56e-2)" "unprognostic (3.64e-2)" "prognostic favorable (1.35e-6)" "unprognostic (6.05e-2)" "unprognostic (5.27e-2)" "unprognostic (2.97e-1)" "unprognostic (2.41e-2)" 4.5 8.6 7.7 5.1 15.8 3.1 3.7 63.6 15.1 3.7 7.4 4.6 1.8 10.4 4.1 3.1 3.4 4.3 5.9 2.4 7.1 5.5 5.7 4.2 4.4 6.1 7.9 8.0 3.4 7.3 7.9 7.5 1.8 9.9 2.9 5.1 5.8 9.5 5.4 4.3 5.7 11.9 2.8 9.4 7.0 7.5 7.9 6.7 1.2 5.3 3.1 4.0 4.5 3.2 3.1 0.7 0.9 0.4 0.3 4.4 1.3 0.8 1.0 0.2 3.7 2.2 0.7 0.1 1.8 3.1 1.0 0.3 0.1 6.7 0.0 1.9 3.2 2.6 3.8 1.2 0.3 0.6 9.7 1.3 0.2 4.3 0.3 4.4 0.7 11.2 3.0 0.6 1.1 0.1 7.0 3.1 1.0 1.8 8.2 0.9 2.2 0.1 12.1 0.1 2.0 8.2 0.0 0.0 3.9 1.5 0.5 5.8 0.4 1.8 0.1 1.0 0.1 2.5 0.3 0.5 1.8 0.0 5.5 0.1 12.8 9.3 0.2 5.4 2.3 1.8 0.9 0.4 0.1 4.4 0.0 1.9 0.9 2.3 3.2 0.7 3.1 3.2 3.2 0.1 0.3 0.3 0.2 4.0 1.3 7.7 15.8 63.6 15.1 7.1 5.5 7.9 8.0 9.9 6.7 0.0 1.7 0.0 3.2 5.3 10.7 3.3 5.1 1.4 3.4 10.4 17.7 0.3 6.6 2.7 28.4 4.5 16.9 0.0 2.0 0.2 1.9 1.5 9.2 4.9 1.8 7.9 2.4 5.5 1.9 5.8 1.4 7.1 6.8 4.6 5.9 1.4 2.1 9.0 2.1 3.1 16.3 0.0 2.8 2.1 9.0 4.3 0.2 21.0 5.2 4.1 ZGPAT "dJ583P15.3, FLJ14972, GPATC6, GPATCH6, KIAA1847, MGC44880, ZC3H9, ZC3HDC9, ZIP" ENSG00000197114 "Zinc finger CCCH-type and G-patch domain containing" Q8N5A5 20 63707465-63736142 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 56.1" "Cell type enhanced" "Detected in some" 9 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 4.3;Club cells: 2.3;granulocytes: 2.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056705 Supported "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA056705: AB_2683213" "unprognostic (4.50e-2)" "unprognostic (2.74e-1)" "unprognostic (5.30e-2)" "unprognostic (4.42e-2)" "unprognostic (8.58e-2)" "prognostic favorable (6.17e-5)" "unprognostic (1.06e-1)" "unprognostic (6.97e-2)" "unprognostic (2.52e-1)" "unprognostic (1.54e-1)" "unprognostic (9.31e-3)" "unprognostic (1.60e-2)" "unprognostic (3.43e-3)" "unprognostic (1.37e-1)" "unprognostic (4.11e-2)" "unprognostic (1.24e-1)" "unprognostic (9.86e-3)" 9.3 9.8 9.6 13.6 14.5 14.5 8.0 20.2 13.2 7.6 8.9 12.0 10.8 11.1 12.9 6.1 9.1 8.1 11.2 8.8 10.3 7.1 11.7 56.1 7.2 11.0 16.9 10.7 7.3 12.6 8.3 10.8 9.0 14.2 8.3 3.9 8.0 14.0 8.8 9.2 10.5 10.8 9.4 8.5 11.7 10.3 14.9 15.0 11.3 8.0 5.8 13.5 8.3 9.2 15.6 21.7 19.2 16.4 20.2 23.8 13.0 8.6 11.1 4.4 7.0 3.6 2.5 10.1 9.0 6.0 14.3 6.0 23.8 11.9 9.0 17.2 5.0 13.8 15.8 2.9 10.6 1.8 6.0 7.7 8.4 9.7 24.3 7.1 5.2 14.9 6.4 9.0 5.8 2.3 3.8 7.7 10.9 9.2 8.5 4.7 8.6 12.9 12.5 7.1 12.8 14.0 13.6 3.3 9.1 7.9 8.0 8.3 10.4 12.8 14.5 8.0 2.3 9.9 14.8 8.7 22.3 7.9 8.4 11.4 8.4 13.2 12.3 14.0 5.2 9.9 6.6 16.0 19.2 23.8 16.4 23.1 15.6 20.4 21.5 15.1 14.5 20.3 20.5 17.0 20.2 13.2 21.7 19.8 13.0 9.6 14.5 20.2 13.2 10.3 7.1 16.9 10.7 14.2 15.0 3.0 4.3 0.0 0.0 0.0 0.9 0.2 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.1 0.0 0.2 0.2 0.2 0.0 2.3 1.6 0.2 0.0 1.7 0.6 1.8 0.0 0.0 0.4 1.7 0.0 0.0 0.3 0.3 0.0 0.0 0.4 1.0 0.0 0.3 0.0 0.1 0.3 0.2 0.0 0.0 0.1 ZMYND10 "BLU, CILD22" ENSG00000004838 "Zinc finger MYND-type containing 10" O75800 3 50341110-50346852 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "fallopian tube: 55.7;testis: 99.4" "Group enriched" "Detected in many" 10 "Ciliated cells: 293.1;Early spermatids: 194.4;Late spermatids: 324.6;Spermatocytes: 352.7" "Cancer enhanced" "Detected in many" "endometrial cancer: 12.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "NK-cell: 3.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "T-47d: 10.6;U-87 MG: 7.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA035255 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA035255: AB_10601928" "unprognostic (2.93e-3)" "unprognostic (2.98e-3)" "unprognostic (1.15e-2)" "unprognostic (3.85e-3)" "unprognostic (4.44e-1)" "unprognostic (7.78e-3)" "unprognostic (4.71e-2)" "unprognostic (6.13e-2)" "unprognostic (1.15e-2)" "unprognostic (1.33e-1)" "unprognostic (3.12e-2)" "unprognostic (6.73e-2)" "prognostic favorable (6.75e-5)" "unprognostic (8.25e-2)" "unprognostic (1.26e-1)" "unprognostic (1.16e-1)" "unprognostic (1.18e-1)" 0.1 0.1 1.9 0.2 4.8 0.3 0.6 0.3 0.8 1.6 0.1 5.5 0.2 0.2 0.9 4.6 0.2 55.7 0.3 0.1 2.6 3.1 0.5 0.2 4.7 0.2 0.2 0.3 4.2 0.2 1.4 1.6 0.1 10.2 0.1 0.1 0.3 0.2 0.2 0.2 0.2 0.1 0.3 0.5 0.2 0.1 99.4 1.2 0.1 0.8 0.1 0.1 0.1 0.0 0.4 1.1 0.8 0.7 3.8 2.5 0.5 2.7 1.0 0.4 0.8 1.0 1.6 0.8 0.4 1.8 3.0 0.9 0.2 1.4 1.0 1.1 1.7 0.3 0.6 2.4 0.1 0.3 1.1 1.1 2.5 3.6 0.1 0.1 0.7 1.2 0.1 0.3 3.8 0.2 2.7 0.2 2.2 0.6 0.6 0.5 1.4 0.5 3.4 0.0 0.4 1.1 1.1 0.1 0.8 3.7 0.1 2.9 1.2 0.3 0.8 0.2 0.1 10.6 0.9 0.0 0.8 0.8 1.8 0.2 1.4 0.6 0.3 7.4 3.4 0.2 0.3 0.4 0.3 2.5 0.4 1.0 0.1 0.2 0.4 1.1 0.4 0.1 0.5 0.8 3.8 0.7 0.4 0.1 0.5 1.9 4.8 0.3 0.8 2.6 3.1 0.2 0.3 10.2 1.2 3.0 6.1 0.0 0.3 0.5 1.2 0.8 0.0 293.1 29.6 1.8 3.9 0.1 0.0 0.7 194.4 0.0 0.0 0.0 0.0 0.2 0.4 0.5 0.0 0.5 0.5 0.0 0.0 1.3 0.0 324.6 8.3 0.2 1.7 0.0 0.4 1.0 0.1 0.0 5.3 0.7 5.7 0.0 0.4 352.7 8.5 0.4 0.1 0.7 0.2 0.1 ZNF10 KOX1 ENSG00000256223 "Zinc finger protein 10" P21506 12 133130575-133159465 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 57.6" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 29.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA003204 Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" Nucleoplasm "HPA003204: AB_1080663" "unprognostic (1.55e-2)" "unprognostic (2.77e-3)" "unprognostic (4.32e-2)" "unprognostic (1.35e-1)" "unprognostic (6.48e-2)" "unprognostic (2.67e-3)" "unprognostic (1.87e-1)" "unprognostic (6.39e-3)" "unprognostic (4.02e-3)" "unprognostic (2.13e-1)" "unprognostic (3.35e-3)" "unprognostic (2.50e-2)" "unprognostic (3.94e-2)" "unprognostic (3.41e-1)" "unprognostic (1.52e-1)" "unprognostic (4.36e-2)" "unprognostic (5.13e-3)" 4.8 12.7 5.7 4.9 11.5 6.3 10.5 13.0 9.9 9.3 7.9 7.8 14.4 3.0 12.7 20.7 5.1 10.2 9.9 6.7 5.0 5.6 7.3 7.6 6.4 4.4 8.5 6.4 18.2 10.3 22.6 57.6 4.2 8.3 12.2 5.4 8.8 6.2 16.4 5.1 7.2 5.6 12.3 8.8 5.0 8.2 12.1 7.9 6.8 17.3 5.1 5.6 8.1 7.2 4.4 4.4 1.8 0.7 8.6 8.8 2.4 3.1 2.0 10.0 0.0 11.3 4.7 6.1 4.1 3.7 5.1 3.5 3.6 2.2 0.0 5.7 4.1 2.8 1.6 6.4 3.4 3.7 0.0 5.9 7.4 9.4 3.7 3.4 4.5 2.5 4.9 3.2 5.5 6.1 7.6 4.1 5.8 5.3 0.0 6.0 1.1 10.8 9.5 10.3 2.0 4.1 8.9 6.4 5.0 3.9 7.3 10.2 6.4 8.1 1.1 3.4 4.8 6.3 4.4 4.0 3.7 3.4 3.5 3.4 0.2 0.0 11.8 1.2 1.6 3.4 1.1 0.6 1.8 4.0 0.7 4.5 4.2 4.6 5.5 1.7 4.4 8.8 4.4 0.7 8.6 0.5 4.4 1.2 2.4 5.7 11.5 13.0 9.9 5.0 5.6 8.5 6.4 8.3 7.9 0.0 7.0 3.7 4.2 3.4 16.5 6.7 2.5 1.4 9.1 0.0 29.5 3.5 1.7 1.7 11.6 2.3 1.7 0.0 1.2 1.7 3.1 4.1 10.4 3.8 2.1 4.8 12.1 1.3 3.1 4.7 2.6 2.8 3.3 1.8 3.0 6.1 0.9 2.3 6.3 1.7 16.3 0.0 11.3 13.7 13.8 3.3 3.2 4.4 3.0 1.4 ZNF18 "HDSG1, KOX11, Zfp535, ZKSCAN6, ZNF535, ZSCAN38" ENSG00000154957 "Zinc finger protein 18" P17022 17 11977439-11997510 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 23.1;Late spermatids: 19.5;Spermatocytes: 11.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SuSa: 30.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006144 Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Golgi apparatus" "Plasma membrane, Cytosol" "HPA006144: AB_1080683" "unprognostic (2.99e-3)" "prognostic favorable (6.32e-4)" "unprognostic (2.32e-1)" "unprognostic (2.50e-2)" "unprognostic (4.91e-2)" "unprognostic (2.72e-3)" "unprognostic (2.28e-2)" "unprognostic (5.93e-3)" "unprognostic (1.25e-1)" "unprognostic (2.93e-2)" "prognostic favorable (5.12e-6)" "unprognostic (2.28e-1)" "prognostic unfavorable (3.06e-6)" "unprognostic (1.52e-2)" "unprognostic (9.31e-2)" "unprognostic (3.34e-2)" "unprognostic (3.53e-3)" 8.3 6.8 8.2 7.0 13.9 15.7 9.6 9.4 15.5 8.5 7.2 13.2 3.5 6.4 14.1 9.5 8.8 7.5 7.2 7.3 9.0 8.7 6.5 13.2 6.2 10.5 9.9 9.8 10.4 7.8 8.4 11.8 5.1 14.5 9.8 9.2 12.5 9.0 7.1 8.2 12.8 8.2 7.8 10.8 12.3 6.2 15.5 9.2 15.6 8.4 14.3 10.2 7.7 7.6 9.1 8.8 19.6 7.6 7.0 11.2 5.6 2.2 4.7 5.0 7.4 9.4 8.4 2.6 3.3 5.8 4.3 4.6 2.1 3.9 7.7 4.9 3.5 3.7 4.7 4.1 5.1 4.7 5.8 3.5 4.5 4.8 3.0 6.7 2.6 6.1 6.9 8.4 3.2 6.0 4.9 6.5 9.1 2.6 3.6 5.8 2.3 8.4 5.1 3.7 8.2 2.1 7.0 5.0 3.4 6.2 2.7 1.9 4.2 5.6 2.7 4.3 30.3 3.9 2.4 5.0 5.1 2.5 2.3 2.4 4.0 2.9 3.8 5.9 5.9 6.0 10.6 5.9 6.6 11.0 5.8 10.2 9.1 10.2 10.3 5.8 8.2 11.0 11.2 19.6 7.0 7.6 8.8 10.6 5.6 8.2 13.9 9.4 15.5 9.0 8.7 9.9 9.8 14.5 9.2 0.0 1.3 0.5 1.1 1.8 1.8 1.2 2.5 1.4 0.0 1.8 2.0 2.0 1.7 2.4 23.1 1.4 2.9 0.0 0.8 1.8 2.4 1.0 2.3 3.2 3.6 1.6 1.2 1.3 2.1 19.5 3.1 1.9 1.7 2.8 3.6 1.8 2.1 3.4 3.2 2.5 1.1 0.0 2.2 11.2 3.2 1.9 1.3 4.4 3.1 1.0 ZNF2 "A1-5, Zfp661, ZNF661" ENSG00000275111 "Zinc finger protein 2" Q9BSG1 2 95165432-95184317 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041358 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA041358: AB_10795539" "unprognostic (1.18e-1)" "unprognostic (6.41e-3)" "unprognostic (5.81e-2)" "unprognostic (9.29e-2)" "unprognostic (4.47e-2)" "unprognostic (6.03e-2)" "unprognostic (1.13e-3)" "prognostic favorable (4.69e-5)" "unprognostic (1.47e-2)" "unprognostic (1.78e-1)" "unprognostic (2.37e-2)" "unprognostic (2.63e-2)" "unprognostic (2.66e-3)" "unprognostic (2.57e-2)" "unprognostic (6.78e-2)" "unprognostic (1.74e-1)" "unprognostic (2.40e-2)" 5.1 4.1 5.2 3.2 6.3 0.7 4.0 6.4 6.1 5.3 2.6 6.4 2.5 3.3 5.4 5.7 3.5 4.8 2.3 4.6 5.1 4.2 2.7 3.5 4.3 5.3 5.0 6.5 2.8 6.5 7.1 3.1 5.2 4.8 2.5 4.9 3.7 5.5 4.2 4.7 2.2 4.1 6.1 4.3 3.5 4.3 5.9 4.3 5.0 4.5 5.0 4.3 4.0 7.2 5.0 15.1 6.2 4.2 8.6 4.5 5.4 5.2 6.5 10.8 9.7 7.6 4.2 6.1 8.0 8.4 11.0 5.6 3.7 3.5 4.3 5.7 5.9 4.5 6.9 4.6 8.8 7.6 5.9 8.0 4.3 7.0 7.9 4.1 5.2 6.5 6.5 7.6 11.9 9.3 7.2 6.6 5.3 2.9 8.6 4.9 5.9 5.7 2.8 4.8 7.2 5.7 11.2 4.5 4.8 3.2 5.5 7.5 5.7 8.2 6.9 5.7 5.1 6.3 5.8 10.1 5.9 8.0 5.1 5.0 4.3 4.3 6.8 5.4 7.7 5.9 4.4 15.1 8.6 6.2 6.2 7.2 7.0 7.5 5.0 6.9 8.5 8.6 3.6 4.2 4.7 4.1 7.6 4.5 0.0 1.7 0.5 0.6 0.9 2.8 2.4 2.5 4.0 2.3 1.8 0.0 1.3 5.0 1.5 1.6 1.6 0.7 0.0 1.6 1.1 1.2 0.7 1.1 1.6 2.2 1.6 0.0 1.3 3.2 0.4 2.0 1.7 0.0 0.0 0.7 3.6 0.8 0.0 2.8 2.2 2.9 6.5 1.9 4.2 6.8 1.0 1.4 2.1 1.2 0.6 ZNF20 KOX13 ENSG00000132010 "Zinc finger protein 20" P17024 19 12092843-12140407 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Ciliated cells: 32.1;Early spermatids: 34.4;Late spermatids: 39.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 18.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA020887 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA020887: AB_2218842" "unprognostic (1.77e-2)" "unprognostic (1.06e-2)" "unprognostic (1.69e-2)" "unprognostic (1.20e-3)" "unprognostic (4.00e-2)" "unprognostic (1.08e-4)" "unprognostic (1.69e-1)" "unprognostic (2.14e-2)" "unprognostic (1.57e-3)" "unprognostic (1.04e-1)" "unprognostic (4.40e-2)" "unprognostic (7.01e-2)" "unprognostic (9.23e-2)" "unprognostic (1.21e-1)" "unprognostic (1.50e-2)" "unprognostic (1.15e-2)" "unprognostic (1.21e-3)" 3.3 4.0 2.7 3.5 4.0 4.9 6.3 3.5 3.7 7.3 4.4 2.3 9.5 1.8 6.3 7.8 4.5 10.3 2.7 2.5 3.0 2.8 5.6 2.6 3.6 4.3 2.8 1.3 6.6 6.1 4.0 9.5 3.8 4.0 9.1 4.4 2.7 4.6 4.0 1.9 6.2 7.5 3.9 2.9 6.0 4.4 14.8 3.8 8.9 9.3 3.9 3.9 5.3 4.5 2.3 2.2 18.5 2.2 6.0 3.3 1.0 3.3 0.1 4.6 9.6 2.1 3.5 3.6 3.0 5.3 2.7 3.8 1.0 1.9 3.2 3.4 3.4 4.0 2.1 2.5 2.1 2.8 2.6 0.7 1.3 3.5 1.6 1.2 0.1 3.0 3.0 4.6 1.1 1.6 3.1 1.6 6.5 2.0 0.5 5.7 1.3 4.1 3.6 7.8 1.6 2.6 3.1 2.6 1.7 3.4 7.3 2.0 4.6 2.7 1.9 3.9 4.7 3.6 5.2 0.0 6.5 2.2 6.3 2.0 5.3 2.9 3.1 0.4 0.0 2.5 9.7 2.2 5.1 1.5 1.1 1.5 1.5 1.3 1.5 1.2 2.3 1.4 1.2 18.5 6.0 2.0 2.2 3.3 1.0 2.7 4.0 3.5 3.7 3.0 2.8 2.8 1.3 4.0 3.8 0.0 0.0 0.0 0.7 0.1 0.5 0.7 2.5 32.1 0.0 1.8 2.0 0.8 1.7 2.0 34.4 0.1 2.3 0.0 2.1 1.0 0.4 1.7 2.3 2.1 1.3 0.0 4.1 0.0 1.0 39.3 0.6 0.2 0.0 1.8 1.3 0.5 1.9 2.5 0.0 1.9 1.3 0.0 0.4 7.6 1.7 0.5 0.9 0.0 1.2 1.4 ZNF227 ENSG00000131115 "Zinc finger protein 227" Q86WZ6 19 44207547-44237268 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA030573 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA030573: AB_10610702" "unprognostic (3.01e-2)" "unprognostic (1.79e-2)" "unprognostic (7.14e-2)" "unprognostic (2.77e-2)" "unprognostic (4.74e-2)" "unprognostic (1.66e-2)" "unprognostic (8.05e-2)" "unprognostic (7.89e-2)" "unprognostic (1.52e-2)" "unprognostic (1.08e-1)" "unprognostic (5.68e-3)" "unprognostic (1.94e-1)" "unprognostic (4.88e-2)" "unprognostic (1.27e-1)" "unprognostic (2.21e-2)" "unprognostic (9.91e-2)" "prognostic favorable (2.64e-4)" 10.4 11.5 13.6 8.3 13.3 6.3 12.7 24.7 14.4 12.9 10.3 13.0 8.7 8.0 15.4 12.1 10.1 12.6 9.0 8.9 12.3 11.7 10.0 11.0 9.4 14.0 13.5 12.5 17.6 9.9 18.5 28.0 11.4 15.7 13.3 9.0 9.6 9.3 11.2 10.0 9.6 8.9 12.8 15.3 13.4 12.6 10.7 17.6 20.8 12.7 4.3 16.2 12.3 13.2 12.1 5.8 13.0 4.5 10.6 13.1 4.9 5.3 7.6 9.1 11.3 7.4 6.5 4.3 5.2 7.5 5.1 9.9 3.7 4.2 9.3 8.1 4.8 6.1 3.1 10.3 5.5 6.9 12.1 13.0 16.2 8.1 4.5 5.3 14.1 7.2 5.9 6.2 5.0 9.4 8.4 7.5 10.9 1.6 0.2 5.4 2.8 13.2 3.7 14.6 5.5 4.0 7.9 9.2 7.9 5.2 9.7 15.5 15.9 11.7 5.3 4.1 9.3 4.4 7.6 6.4 5.6 9.3 4.2 6.6 21.8 28.8 20.4 3.7 5.9 7.5 13.0 4.5 8.6 10.7 3.2 11.7 11.4 10.0 10.3 5.4 12.1 13.1 11.1 4.1 10.6 2.9 5.8 11.8 4.9 13.6 13.3 24.7 14.4 12.3 11.7 13.5 12.5 15.7 17.6 0.0 1.0 5.1 3.8 2.7 6.0 6.2 2.5 1.4 6.8 5.2 2.0 4.6 3.3 3.4 18.5 8.1 2.1 0.0 3.6 3.8 3.6 7.0 1.1 3.9 3.7 7.9 2.4 9.2 5.7 16.6 5.2 3.5 1.7 4.6 4.9 5.2 4.7 3.5 5.3 2.4 4.5 6.5 4.7 4.4 6.9 3.3 1.8 6.4 4.2 2.5 ZNF229 ENSG00000278318 "Zinc finger protein 229" Q9UJW7 19 44417519-44448578 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 4.8;Cone photoreceptor cells: 3.9;Rod photoreceptor cells: 4.9" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "NK-cell: 4.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-HME1: 9.1" HPA001494 Uncertain Approved "Vesicles,Plasma membrane" NA NA Vesicles "Plasma membrane" "HPA001494: AB_1080692" "unprognostic (2.59e-1)" "unprognostic (7.41e-4)" "unprognostic (2.13e-1)" "unprognostic (1.08e-1)" "unprognostic (3.90e-1)" "unprognostic (2.17e-1)" "unprognostic (3.34e-2)" "unprognostic (7.18e-3)" "unprognostic (1.17e-2)" "unprognostic (4.66e-2)" "unprognostic (4.18e-2)" "unprognostic (5.04e-3)" "prognostic favorable (8.43e-5)" "unprognostic (3.66e-3)" "unprognostic (2.01e-2)" "unprognostic (2.18e-1)" "unprognostic (4.34e-1)" 1.7 4.1 6.6 0.5 8.2 0.4 2.3 7.7 4.0 2.9 1.2 1.5 1.1 1.7 3.6 2.6 1.9 4.8 1.4 3.1 4.8 2.1 1.7 1.4 0.8 1.8 2.2 6.0 0.9 10.5 8.7 2.5 3.9 2.9 0.4 3.4 2.5 2.2 1.9 0.8 0.6 2.7 4.5 1.2 1.2 2.1 3.8 1.5 6.6 0.0 0.8 2.7 0.9 1.4 0.4 0.5 0.1 4.8 1.1 0.4 0.0 4.8 3.8 0.1 4.1 2.7 0.0 5.9 2.5 3.3 4.2 0.0 0.7 0.0 2.7 3.6 5.3 2.0 0.0 4.4 2.2 0.0 1.7 0.7 1.1 0.3 6.7 0.1 0.0 4.2 0.1 2.8 9.1 3.9 2.9 0.0 0.2 0.0 3.7 0.1 0.0 0.0 3.4 0.0 1.3 0.0 0.0 1.6 3.0 7.5 1.2 1.2 2.7 0.4 0.0 2.8 0.1 0.0 3.0 2.5 0.1 0.8 0.2 5.0 2.8 0.0 0.0 0.0 3.6 0.0 0.1 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.4 1.4 1.1 0.4 0.0 4.8 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.5 0.1 4.8 3.3 0.0 2.7 0.0 0.0 3.9 0.7 3.3 1.6 0.6 0.6 0.0 0.0 1.1 0.3 0.2 1.6 0.0 0.0 0.6 1.6 0.0 0.0 0.3 0.0 0.9 0.0 0.0 0.0 0.0 3.8 1.7 0.0 1.8 1.2 4.9 0.0 0.5 1.9 2.2 0.0 0.7 0.0 0.5 0.6 ZNF276 "CENP-Z, CENPZ, MGC45417, ZADT, ZFP276, ZNF477" ENSG00000158805 "Zinc finger protein 276" Q8N554 16 89720400-89740903 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021309, HPA022255" Uncertain Approved "Nucleoplasm,Nucleoli,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nucleoli, Plasma membrane" "HPA021309: AB_1859024, HPA022255: AB_1859025" "unprognostic (1.45e-2)" "unprognostic (7.05e-2)" "unprognostic (1.17e-2)" "unprognostic (8.25e-3)" "unprognostic (1.17e-1)" "unprognostic (2.95e-3)" "unprognostic (1.27e-1)" "unprognostic (3.70e-2)" "unprognostic (1.92e-1)" "unprognostic (7.85e-2)" "unprognostic (1.59e-2)" "unprognostic (1.36e-3)" "prognostic unfavorable (3.37e-4)" "unprognostic (2.65e-2)" "unprognostic (4.14e-1)" "unprognostic (1.26e-1)" "unprognostic (1.62e-3)" 9.7 9.8 9.0 18.6 13.1 25.5 7.9 20.2 12.3 10.8 11.1 30.6 9.4 16.0 9.0 8.4 14.5 11.4 9.5 6.7 9.8 7.3 8.4 10.1 9.6 21.7 21.3 11.2 13.5 10.9 11.0 11.6 7.4 12.6 10.2 8.8 8.1 11.3 11.4 11.4 18.5 15.3 6.8 9.9 22.2 12.2 6.4 18.4 11.1 10.1 8.1 15.1 9.5 10.3 2.9 2.0 4.5 1.9 5.0 10.1 2.4 5.0 4.3 3.5 9.1 2.8 3.9 6.1 3.5 2.1 3.2 1.2 5.5 5.4 6.7 4.4 3.7 1.6 9.4 4.4 3.9 2.4 4.1 23.5 6.0 8.0 2.1 5.5 5.8 7.9 5.4 5.2 4.3 3.6 3.2 4.9 6.0 11.0 5.7 1.5 7.1 7.3 13.3 2.6 5.0 9.6 11.8 3.8 4.5 4.0 3.0 9.5 8.0 7.6 6.9 4.2 2.2 9.3 8.4 5.5 5.4 7.3 4.2 3.0 20.8 6.7 3.5 4.3 9.7 5.3 4.3 1.7 2.8 10.1 1.9 4.8 2.0 5.5 7.6 1.8 2.9 5.6 7.2 4.5 5.0 1.2 2.0 4.0 2.4 9.0 13.1 20.2 11.3 9.8 7.3 21.3 11.2 12.6 18.4 8.9 14.1 17.5 7.4 10.2 13.9 2.0 5.1 4.0 10.3 10.4 19.6 4.0 1.7 7.1 1.6 10.0 16.3 0.0 5.8 3.4 6.9 7.2 11.6 9.8 8.0 6.4 6.9 20.3 10.5 1.3 10.6 15.3 8.5 5.4 11.8 12.3 6.8 11.5 9.9 2.4 23.5 12.9 5.6 15.1 10.6 14.1 3.3 34.9 14.0 8.9 ZNF277 "NRIF4, ZNF277P" ENSG00000198839 "Zinc finger protein 277" Q9NRM2 7 112206588-112343096 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027307 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA027307: AB_1859164" "unprognostic (2.04e-1)" "unprognostic (1.43e-1)" "unprognostic (1.07e-1)" "unprognostic (3.95e-2)" "unprognostic (7.76e-2)" "unprognostic (3.17e-2)" "unprognostic (1.43e-1)" "unprognostic (4.18e-2)" "unprognostic (4.60e-2)" "unprognostic (7.61e-2)" "unprognostic (1.88e-2)" "unprognostic (2.85e-1)" "prognostic favorable (9.47e-4)" "unprognostic (1.05e-1)" "unprognostic (2.64e-2)" "unprognostic (2.46e-1)" "unprognostic (1.06e-1)" 15.2 14.8 11.2 12.9 16.2 10.9 20.1 9.3 13.8 13.6 13.9 8.4 8.8 13.7 14.7 8.8 18.4 12.6 14.3 14.4 11.8 9.1 22.7 30.0 19.2 14.3 11.3 11.9 15.4 23.5 13.5 16.4 8.1 11.6 17.1 14.2 5.5 14.9 12.9 12.7 17.7 13.4 15.9 16.1 13.7 14.6 10.2 14.1 23.9 22.4 11.1 15.6 26.6 13.6 13.3 10.4 9.5 14.3 12.4 17.2 9.1 5.9 6.2 8.3 10.3 13.7 38.1 6.4 5.8 12.8 4.9 10.4 5.7 9.3 13.3 11.6 6.2 11.1 5.0 5.2 10.1 11.6 7.0 8.0 5.4 6.1 12.6 13.4 10.3 7.9 21.9 18.1 9.4 12.4 19.8 16.9 14.7 9.5 14.2 9.2 9.6 14.4 20.1 4.9 7.9 6.4 8.0 9.8 13.8 14.4 6.8 6.3 12.7 7.1 13.7 14.1 13.3 5.5 11.0 10.4 6.8 4.1 17.7 5.5 10.4 8.4 13.2 5.8 10.2 7.6 7.1 11.6 9.5 11.2 14.3 15.9 13.3 15.2 17.2 10.4 11.2 16.3 13.5 9.3 12.4 11.6 10.1 17.0 9.1 11.2 16.2 9.3 13.8 11.8 9.1 11.3 11.9 11.6 14.1 35.7 18.2 13.7 16.1 18.3 10.0 11.8 22.9 10.7 18.2 5.2 2.0 10.4 23.2 20.2 37.5 16.5 11.8 0.0 27.0 13.8 12.7 16.7 7.0 17.3 19.2 30.2 17.7 10.4 39.5 4.4 15.8 26.3 11.8 36.9 21.0 5.8 24.3 21.0 23.7 25.9 11.4 19.4 13.3 20.6 7.8 21.2 11.6 28.4 22.1 18.1 ZNF337 dJ694B14.1 ENSG00000130684 "Zinc finger protein 337" Q9Y3M9 20 25674215-25696841 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 22.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA044303, HPA064219" Approved Approved "Nuclear speckles,Plasma membrane" NA NA "Plasma membrane" "Nuclear speckles" "HPA044303: AB_2678890, HPA064219: AB_2685215" "unprognostic (2.14e-1)" "unprognostic (2.19e-2)" "unprognostic (1.65e-2)" "unprognostic (1.80e-1)" "unprognostic (1.30e-1)" "unprognostic (5.81e-3)" "unprognostic (4.54e-3)" "unprognostic (6.99e-2)" "unprognostic (2.34e-1)" "unprognostic (1.34e-2)" "unprognostic (3.15e-2)" "unprognostic (9.36e-4)" "prognostic unfavorable (2.87e-6)" "unprognostic (1.29e-1)" "unprognostic (1.54e-1)" "unprognostic (3.93e-2)" "unprognostic (8.82e-3)" 10.4 9.8 11.7 9.0 14.3 10.8 13.6 49.5 14.8 17.9 14.6 16.1 13.3 7.0 19.8 19.4 9.6 18.0 9.0 8.4 10.9 9.8 9.4 6.9 13.5 12.3 15.1 14.2 23.1 8.4 20.3 19.0 9.3 11.2 16.6 10.9 11.0 8.6 17.2 11.9 12.9 11.1 15.4 9.4 13.4 8.7 7.0 14.9 19.0 12.2 6.0 11.0 14.3 26.1 3.8 3.9 4.8 3.9 5.3 9.6 3.8 7.8 14.4 11.5 8.0 9.4 11.9 9.7 6.8 6.1 5.4 6.7 2.9 7.4 10.0 6.5 6.2 11.1 12.9 7.7 22.2 7.3 3.6 6.1 6.2 9.3 12.5 8.3 5.5 6.7 11.1 19.9 6.2 18.4 13.8 8.3 13.2 5.4 8.9 10.3 8.8 15.0 10.1 3.1 4.4 10.2 9.4 10.8 4.9 5.5 8.7 9.4 10.0 7.0 11.0 9.2 14.8 6.4 7.7 11.0 11.5 6.1 7.6 8.9 12.5 6.7 3.6 5.5 4.7 9.2 0.0 2.4 4.8 7.2 3.9 7.9 3.8 6.0 6.8 3.9 3.2 8.4 9.6 0.1 5.3 2.2 3.9 3.9 3.8 11.7 14.3 49.5 14.8 10.9 9.8 15.1 14.2 11.2 14.9 6.0 12.5 1.5 4.6 1.8 8.8 0.8 5.1 22.7 17.0 3.5 2.0 2.8 3.3 3.3 0.8 4.6 1.1 0.0 2.7 1.9 3.1 3.9 4.7 2.9 2.7 6.4 5.2 3.1 4.8 0.0 6.6 1.6 1.7 2.8 4.3 9.2 2.6 0.0 5.3 1.7 13.0 0.0 3.1 5.6 9.6 2.0 1.9 4.8 2.4 1.5 ZNF397 "MGC13250, ZNF47, ZSCAN15" ENSG00000186812 "Zinc finger protein 397" Q8NF99 18 35241030-35267133 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026087 Uncertain Approved "Nucleoli,Plasma membrane,Microtubules,Cytosol" NA NA "Nucleoli, Plasma membrane, Cytosol" Microtubules "HPA026087: AB_1859243" "unprognostic (1.97e-1)" "unprognostic (2.82e-2)" "unprognostic (2.12e-1)" "unprognostic (3.09e-1)" "unprognostic (6.35e-2)" "unprognostic (1.15e-2)" "unprognostic (1.74e-3)" "unprognostic (1.45e-2)" "unprognostic (1.48e-2)" "unprognostic (3.28e-2)" "prognostic favorable (9.44e-4)" "unprognostic (2.46e-2)" "unprognostic (2.17e-3)" "unprognostic (3.83e-2)" "unprognostic (4.44e-2)" "unprognostic (1.06e-1)" "unprognostic (2.09e-3)" 15.1 17.7 20.3 16.8 31.1 5.7 20.6 23.9 26.4 16.2 15.0 27.9 16.7 13.3 22.7 16.5 13.4 15.2 12.9 14.6 20.2 13.8 14.9 12.7 13.6 18.8 34.8 19.3 23.6 17.1 25.3 24.8 14.7 25.6 18.4 18.0 13.8 17.5 16.3 15.0 17.2 15.9 18.9 30.5 19.0 16.7 11.9 35.1 22.0 20.2 8.3 19.2 17.3 16.8 13.3 8.1 12.4 9.4 4.8 9.4 2.2 2.9 5.8 13.8 12.5 15.3 13.0 6.6 6.1 6.1 3.0 4.0 2.1 4.2 15.1 5.5 4.8 4.2 8.1 8.9 6.6 4.3 9.5 5.5 0.6 7.6 6.1 5.1 7.2 5.5 5.8 9.0 3.6 10.6 10.9 1.9 11.7 8.8 10.6 7.8 6.4 12.1 5.6 11.9 2.3 2.3 12.8 4.0 10.7 6.3 7.9 15.0 12.9 9.9 5.3 5.9 12.6 9.2 5.4 3.0 10.2 5.7 3.4 2.7 17.2 6.4 8.8 9.0 5.1 9.6 9.4 5.1 8.4 6.6 8.0 4.8 10.3 6.3 5.3 3.6 13.3 9.4 6.5 12.4 4.8 9.4 8.1 3.2 2.2 20.3 31.1 23.9 26.4 20.2 13.8 34.8 19.3 25.6 35.1 32.8 16.0 27.0 17.0 3.7 46.9 14.4 12.7 21.4 22.7 14.0 33.4 18.5 11.6 16.1 39.6 17.9 14.2 0.0 9.5 11.4 15.4 13.7 11.5 11.3 9.2 31.8 29.7 25.2 15.6 39.9 17.3 10.9 8.5 14.4 12.0 27.7 9.7 16.5 21.2 8.6 46.3 32.3 7.2 26.0 19.1 4.0 12.2 15.2 13.4 9.7 ZNF407 "FLJ13839, FLJ20307, KIAA1703" ENSG00000215421 "Zinc finger protein 407" Q9C0G0 18 74597870-75065671 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028255, HPA041673" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA028255: AB_10603466, HPA041673: AB_2677610" "unprognostic (3.96e-1)" "unprognostic (1.95e-1)" "unprognostic (2.48e-1)" "unprognostic (8.62e-2)" "unprognostic (4.61e-2)" "unprognostic (2.09e-2)" "unprognostic (1.76e-2)" "unprognostic (4.31e-1)" "unprognostic (1.19e-3)" "unprognostic (4.04e-4)" "unprognostic (3.47e-2)" "unprognostic (2.22e-1)" "prognostic favorable (9.79e-5)" "unprognostic (8.87e-2)" "unprognostic (3.07e-1)" "unprognostic (1.24e-1)" "unprognostic (3.11e-2)" 7.7 6.3 8.5 11.7 11.4 12.0 7.6 15.5 10.5 11.8 9.4 5.3 5.8 5.8 11.7 5.2 7.3 9.4 5.5 8.1 7.3 5.2 6.6 6.0 7.4 7.9 7.8 5.7 12.8 6.0 14.9 13.2 10.8 9.0 7.6 6.0 5.9 8.4 7.7 13.3 7.7 10.3 8.7 7.5 11.2 7.5 10.0 7.7 18.1 9.4 8.2 7.6 9.9 9.2 2.4 3.6 6.0 2.6 3.0 3.1 0.9 4.6 4.9 5.6 5.1 4.1 6.1 4.0 6.2 5.5 4.6 5.0 2.0 2.7 6.7 1.9 8.7 3.1 5.5 5.2 6.8 6.9 11.1 3.2 8.6 6.6 3.8 3.7 13.0 7.6 5.5 3.1 7.4 6.5 4.4 6.9 4.8 4.9 10.0 7.0 3.7 6.3 1.8 3.2 1.7 4.4 6.5 7.2 5.3 3.3 8.8 5.3 5.0 5.8 3.7 4.4 4.2 4.2 5.6 9.6 10.5 4.4 2.9 4.9 3.5 7.2 7.1 3.8 5.6 6.2 4.0 1.9 2.3 3.1 2.6 2.9 2.1 2.3 1.7 0.7 2.4 2.6 3.1 6.0 3.0 1.6 3.6 0.6 0.9 8.5 11.4 15.5 10.5 7.3 5.2 7.8 5.7 9.0 7.7 6.0 4.6 6.1 4.7 2.9 10.7 16.5 5.1 8.1 5.7 5.2 5.9 3.4 0.0 3.8 3.2 5.8 5.4 0.0 2.5 2.3 3.8 4.2 1.1 5.1 2.7 4.8 4.1 2.5 5.6 2.2 4.9 4.4 5.0 2.8 4.9 8.1 3.4 3.7 4.2 1.9 13.7 6.5 3.3 9.6 12.2 3.6 4.3 5.1 3.3 3.8 ZNF503 "FLJ45745, MGC2555, Nlz2" ENSG00000165655 "Zinc finger protein 503" Q96F45 10 75397830-75401906 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Smooth muscle cells: 105.0" "Cancer enhanced" "Detected in all" "ovarian cancer: 62.9" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "classical monocyte: 1.6;myeloid DC: 1.4" "Group enriched" "Detected in many" 16 "dendritic cells: 1.4;monocytes: 1.6" "Cell line enhanced" "Detected in many" "HEK 293: 39.0;PC-3: 50.6;U-87 MG: 15.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA026848 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA026848: AB_10610704" "unprognostic (1.18e-1)" "unprognostic (8.56e-2)" "unprognostic (8.63e-3)" "unprognostic (7.41e-2)" "unprognostic (2.82e-1)" "unprognostic (3.57e-2)" "unprognostic (9.63e-2)" "unprognostic (7.42e-2)" "unprognostic (3.42e-2)" "unprognostic (3.22e-1)" "unprognostic (6.53e-2)" "prognostic unfavorable (3.50e-4)" "prognostic favorable (1.97e-4)" "unprognostic (1.53e-1)" "unprognostic (8.28e-2)" "unprognostic (2.05e-1)" "unprognostic (1.59e-1)" 9.4 23.1 2.3 6.2 7.2 2.2 14.1 0.8 4.7 47.8 10.2 3.0 20.8 9.0 28.1 15.1 27.8 14.1 15.3 5.8 3.4 3.0 22.1 5.7 16.5 2.6 4.8 1.5 38.1 19.4 4.0 3.0 4.8 7.5 21.3 2.5 18.5 6.4 50.7 2.9 3.2 6.6 10.1 8.0 7.6 9.4 7.3 2.9 0.5 7.7 8.5 3.7 14.4 25.0 0.0 1.4 0.0 1.6 0.0 0.0 0.1 1.7 1.6 0.3 2.1 3.7 2.5 0.5 1.6 0.9 0.6 0.6 2.5 6.9 0.0 4.6 1.5 0.3 3.1 0.2 1.6 0.4 0.0 39.0 0.0 4.2 8.1 2.9 2.0 4.4 6.7 1.6 1.2 0.7 5.7 0.1 0.2 0.0 0.0 0.9 0.8 0.0 6.1 0.0 1.2 50.6 0.0 1.9 0.0 0.9 1.3 1.4 1.8 2.8 0.2 8.4 0.3 0.3 1.4 1.3 5.1 5.8 10.5 4.2 0.0 0.0 0.0 15.7 9.0 4.0 0.0 1.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 2.3 7.2 0.8 3.6 3.4 3.0 4.8 1.5 7.5 2.9 35.7 12.3 2.2 37.9 24.2 18.3 13.2 7.6 0.0 9.1 38.4 19.6 0.5 49.7 39.4 0.0 21.8 0.8 23.3 30.0 0.4 30.7 20.3 5.8 8.9 12.0 6.4 3.5 39.9 27.3 1.1 55.3 16.3 23.6 5.4 6.1 5.6 32.4 0.0 46.3 28.3 21.2 38.8 105.0 0.2 2.4 12.2 0.2 0.0 7.2 12.7 ZNF510 KIAA0972 ENSG00000081386 "Zinc finger protein 510" Q9Y2H8 9 96755865-96778129 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 15.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049139 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA049139: AB_2680651" "unprognostic (2.70e-2)" "unprognostic (3.44e-1)" "unprognostic (1.07e-1)" "unprognostic (6.92e-2)" "unprognostic (2.01e-2)" "unprognostic (1.43e-2)" "unprognostic (3.78e-1)" "unprognostic (1.21e-2)" "unprognostic (8.50e-3)" "unprognostic (3.90e-2)" "unprognostic (1.06e-1)" "unprognostic (4.34e-2)" "prognostic favorable (5.94e-4)" "unprognostic (1.02e-2)" "unprognostic (1.17e-1)" "unprognostic (5.17e-2)" "unprognostic (2.18e-2)" 9.1 9.2 10.9 6.5 15.7 5.7 12.7 23.0 13.9 14.4 8.8 6.3 11.6 4.6 11.5 8.1 7.9 10.7 6.5 7.4 11.5 10.3 8.9 8.5 8.4 11.4 8.6 12.3 14.9 10.7 13.5 19.8 6.9 10.1 12.6 9.3 5.2 7.5 11.2 9.2 6.2 6.8 11.3 9.2 10.1 6.8 8.2 9.1 14.9 11.2 4.3 13.3 13.9 10.7 5.9 1.3 3.8 2.9 6.4 7.7 2.1 5.1 5.2 11.5 8.5 9.8 9.2 5.9 5.8 11.4 9.7 8.6 4.9 3.8 6.7 3.1 6.1 9.5 11.2 3.3 5.4 8.7 10.7 5.5 9.4 9.7 2.5 5.8 3.6 6.2 7.9 7.2 8.3 10.4 9.1 9.3 12.9 9.6 6.5 9.4 4.6 10.4 4.8 8.1 7.5 5.3 6.8 18.8 3.3 5.1 4.9 11.9 9.5 11.2 5.2 5.7 8.4 3.8 6.8 8.2 6.2 5.9 7.0 6.7 11.4 12.0 4.9 3.5 2.5 6.2 2.3 1.2 3.8 3.8 1.9 7.7 3.6 5.0 3.0 1.0 5.9 5.7 5.2 0.4 6.4 2.9 1.3 7.1 2.1 10.9 15.7 23.0 13.9 11.5 10.3 8.6 12.3 10.1 9.1 3.0 2.7 2.0 1.4 1.4 10.5 4.4 0.0 4.0 3.4 3.5 2.0 2.0 1.7 1.9 5.0 2.7 1.0 0.0 2.3 1.2 1.7 1.4 1.1 1.0 1.7 15.9 1.2 5.5 3.4 5.6 5.5 2.2 5.0 1.0 1.8 3.8 1.3 1.7 3.9 1.5 7.0 6.5 1.4 3.2 4.9 1.3 0.7 3.2 1.4 1.0 ZNF571 HSPC059 ENSG00000180479 "Zinc finger protein 571" Q7Z3V5 19 37554782-37594790 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 61.8" "Cell type enhanced" "Detected in many" 4 "granulocytes: 15.0;Rod photoreceptor cells: 16.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA054762 Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Nucleoplasm, Nucleoli" "Plasma membrane" "HPA054762: " "unprognostic (1.16e-1)" "unprognostic (3.01e-2)" "unprognostic (3.92e-2)" "unprognostic (1.19e-1)" "unprognostic (5.21e-2)" "unprognostic (1.88e-2)" "unprognostic (1.19e-1)" "unprognostic (9.03e-4)" "unprognostic (5.77e-2)" "unprognostic (9.82e-2)" "unprognostic (1.22e-3)" "unprognostic (3.90e-2)" "unprognostic (2.14e-2)" "unprognostic (8.93e-2)" "unprognostic (2.62e-1)" "unprognostic (4.89e-2)" "unprognostic (2.71e-4)" 6.5 6.7 8.6 3.2 12.9 6.1 12.5 12.5 12.8 5.9 4.2 9.8 4.4 2.3 6.7 8.7 3.9 6.0 4.5 4.2 10.4 7.2 6.4 4.2 4.1 4.4 15.3 9.4 8.5 3.8 11.5 12.2 4.8 13.4 7.1 3.4 5.1 3.6 4.5 3.5 7.1 3.7 7.7 14.3 4.8 3.5 8.5 15.8 3.7 61.8 3.3 5.0 6.6 5.3 9.4 4.1 4.9 1.3 3.7 8.4 3.2 1.8 1.0 6.3 9.1 4.7 4.8 2.0 2.7 4.4 6.6 8.2 1.9 1.7 9.6 8.6 2.8 4.6 2.4 2.0 2.9 11.0 2.1 7.9 5.1 2.7 1.1 5.4 1.9 5.8 2.6 5.3 6.3 5.8 4.7 1.3 8.7 2.4 0.8 5.3 1.7 9.6 2.1 15.8 2.9 3.5 4.8 3.0 5.1 9.1 11.6 13.6 9.5 6.4 2.1 3.2 13.2 9.7 1.3 0.8 3.0 3.9 3.3 6.9 7.7 15.8 13.2 0.5 0.8 6.6 1.8 0.8 4.9 6.7 1.3 6.1 8.7 6.3 6.5 2.7 9.4 7.8 8.4 1.5 3.7 1.2 4.1 4.2 3.2 8.6 12.9 12.5 12.8 10.4 7.2 15.3 9.4 13.4 15.8 0.0 1.3 4.5 1.1 1.5 9.3 1.1 2.5 4.0 5.7 5.2 9.8 1.8 3.3 1.7 10.5 2.5 0.8 0.0 1.4 1.3 2.3 1.7 15.0 0.8 1.4 12.7 1.2 2.5 1.3 2.5 4.0 1.3 5.0 0.0 2.1 4.5 0.8 0.0 2.5 2.6 16.6 12.9 1.7 7.2 5.7 2.3 1.0 6.2 1.3 0.5 ZNF598 "FLJ00086, HEL2" ENSG00000167962 "Zinc finger protein 598" 16 1997654-2009823 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041760, HPA041896" Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA041760: AB_10792490, HPA041896: AB_10796464" "unprognostic (9.43e-2)" "unprognostic (1.34e-2)" "unprognostic (8.17e-2)" "unprognostic (6.76e-3)" "unprognostic (3.44e-1)" "unprognostic (1.20e-1)" "unprognostic (2.22e-2)" "unprognostic (7.07e-3)" "unprognostic (1.22e-1)" "unprognostic (4.45e-2)" "unprognostic (1.43e-1)" "unprognostic (5.06e-2)" "unprognostic (4.69e-2)" "unprognostic (1.78e-1)" "unprognostic (1.02e-1)" "unprognostic (1.81e-2)" "unprognostic (7.81e-2)" 8.4 6.1 4.1 9.1 9.4 14.3 13.9 10.6 9.5 8.3 7.7 8.8 4.7 9.9 8.7 4.0 10.0 7.1 4.8 5.6 5.2 4.1 5.9 12.2 7.8 9.1 4.2 7.1 9.8 24.8 6.5 12.9 8.1 6.4 8.9 3.2 6.8 15.6 7.3 12.9 15.3 9.9 9.5 2.9 11.8 12.4 10.1 6.1 10.0 7.7 10.6 12.5 6.8 7.6 1.8 3.2 0.6 0.9 1.2 1.7 0.5 9.9 12.8 3.3 7.9 3.0 4.1 9.5 7.4 3.8 4.9 3.9 13.9 6.0 9.9 9.3 4.8 4.1 11.8 5.4 9.2 1.3 14.1 30.9 7.7 13.7 7.6 13.5 12.3 8.8 4.5 12.6 7.8 15.1 2.8 5.3 12.4 17.3 15.5 2.5 17.1 11.7 19.1 9.6 5.4 15.6 26.7 6.5 23.1 2.4 3.6 15.9 12.9 7.6 9.3 12.0 1.1 6.5 20.6 8.6 10.5 12.5 9.0 13.9 17.4 15.4 13.1 4.5 11.9 9.6 0.6 0.6 0.2 1.2 0.7 1.7 1.1 1.2 0.9 0.7 1.8 1.1 1.6 0.4 1.2 0.9 3.2 0.3 0.5 4.1 9.4 10.6 9.5 5.2 4.1 4.2 7.1 6.4 6.1 6.0 11.5 3.0 10.2 26.4 12.0 0.8 15.3 5.3 6.8 1.8 15.7 8.1 0.0 7.5 4.1 10.0 14.0 23.3 22.5 11.0 12.2 16.3 12.7 17.3 8.2 15.9 10.9 7.4 10.3 7.5 12.4 9.1 1.7 7.2 31.1 7.1 17.5 5.8 7.8 2.7 10.0 0.0 10.5 6.3 13.0 30.5 7.8 6.9 16.5 17.6 ZNF599 FLJ30663 ENSG00000153896 "Zinc finger protein 599" Q96NL3 19 34758076-34773229 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Distal tubular cells: 28.2;Early spermatids: 64.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014701 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA014701: AB_1859371" "unprognostic (3.52e-3)" "unprognostic (1.42e-3)" "unprognostic (1.99e-2)" "unprognostic (9.35e-3)" "unprognostic (9.20e-2)" "unprognostic (5.16e-3)" "unprognostic (3.95e-3)" "unprognostic (1.72e-2)" "unprognostic (1.70e-2)" "unprognostic (7.35e-3)" "unprognostic (1.77e-3)" "unprognostic (5.03e-2)" "unprognostic (4.42e-2)" "unprognostic (1.16e-1)" "unprognostic (1.00e-1)" "unprognostic (2.71e-2)" "unprognostic (8.12e-3)" 5.9 8.1 10.0 5.2 12.5 2.4 8.5 16.8 8.0 10.1 6.5 11.7 5.8 4.5 12.2 21.4 4.4 14.1 6.5 5.8 10.3 6.8 9.7 4.9 6.0 5.7 10.5 5.7 11.4 5.7 14.3 13.2 6.0 8.1 10.4 5.5 11.6 7.4 9.5 5.5 8.0 5.4 7.1 8.1 6.5 5.9 19.9 11.2 10.4 13.2 6.0 6.2 6.4 7.2 4.3 3.8 6.4 4.8 5.7 6.7 2.9 5.2 2.6 5.9 5.4 6.5 8.7 3.2 1.9 5.4 4.8 5.7 2.3 3.6 0.6 5.6 3.7 4.4 2.7 3.8 2.5 6.0 0.6 4.8 4.1 5.4 6.5 5.0 0.9 4.6 7.8 3.6 2.2 2.3 8.9 5.5 9.9 6.8 0.5 7.5 2.1 10.1 4.2 2.5 7.2 0.2 5.5 5.5 3.3 6.0 1.2 7.0 9.9 6.5 1.2 3.8 4.5 3.4 0.5 2.9 4.8 5.4 3.6 2.0 6.1 6.6 0.5 2.9 0.1 4.5 3.1 1.1 6.4 6.1 2.5 4.0 2.0 6.5 3.5 1.7 4.3 6.7 5.9 0.6 5.7 4.8 3.8 4.9 2.9 10.0 12.5 16.8 8.0 10.3 6.8 10.5 5.7 8.1 11.2 0.0 3.0 0.8 5.4 2.7 3.1 3.7 2.5 22.7 10.3 17.4 2.0 6.8 28.2 3.7 64.0 4.9 1.6 0.0 2.0 3.8 6.0 6.5 0.0 2.5 3.2 0.0 1.2 6.2 1.5 24.3 9.5 1.3 5.0 1.0 3.1 11.2 2.5 0.0 4.6 11.5 2.4 6.5 4.4 22.1 5.5 1.4 1.6 4.3 3.4 4.7 ZNF646 KIAA0296 ENSG00000167395 "Zinc finger protein 646" O15015 16 31074422-31084196 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 19.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 19.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042364, HPA066468" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA042364: AB_10794796, HPA066468: AB_2732746" "unprognostic (1.61e-2)" "unprognostic (2.18e-1)" "unprognostic (8.08e-2)" "unprognostic (1.18e-2)" "unprognostic (4.66e-1)" "unprognostic (6.20e-3)" "prognostic unfavorable (1.28e-6)" "unprognostic (3.23e-2)" "unprognostic (4.21e-2)" "unprognostic (6.96e-2)" "unprognostic (1.16e-2)" "unprognostic (9.83e-2)" "unprognostic (2.07e-2)" "unprognostic (2.65e-1)" "unprognostic (1.93e-1)" "unprognostic (1.07e-1)" "unprognostic (2.16e-1)" 9.8 6.4 5.9 10.4 7.6 13.4 7.3 12.2 7.8 10.2 6.8 10.4 8.2 10.6 9.8 6.8 7.5 8.6 7.6 5.9 6.8 5.5 6.9 6.1 13.5 11.3 10.6 5.6 10.3 8.2 10.1 9.4 8.0 7.2 7.9 4.9 5.8 9.8 14.2 12.4 10.6 9.6 6.5 7.4 12.9 9.1 36.1 9.2 24.7 7.7 5.2 11.5 7.8 10.8 4.0 5.2 19.8 3.7 3.4 4.3 1.5 6.1 12.9 8.5 6.6 6.1 4.8 11.2 6.8 7.2 8.2 7.6 9.4 5.9 12.0 10.9 5.7 5.4 8.3 7.0 7.4 3.2 13.8 6.6 8.9 11.4 7.8 6.3 11.4 13.9 6.1 6.8 8.8 5.0 6.4 4.9 10.3 14.1 7.1 6.2 9.8 12.6 7.8 11.4 2.8 6.7 20.4 16.6 12.1 2.6 5.9 12.3 12.4 7.8 8.3 4.1 3.9 6.9 10.0 9.8 10.4 5.9 6.9 6.3 11.9 10.9 12.2 9.4 12.4 8.1 5.9 3.7 9.4 4.3 3.3 2.2 3.3 2.0 1.7 3.5 4.0 2.2 2.5 19.8 3.4 2.1 5.2 2.0 1.5 5.9 7.6 12.2 7.8 6.8 5.5 10.6 5.6 7.2 9.2 3.0 2.2 2.4 0.9 3.0 3.0 1.2 2.5 1.4 1.2 1.8 3.9 1.5 1.7 3.8 19.8 2.9 5.2 0.0 2.9 1.7 2.1 2.2 1.1 1.5 4.1 1.6 5.8 0.6 2.4 2.7 2.6 4.4 0.0 3.6 3.7 3.7 3.6 5.8 4.2 1.9 1.0 0.0 1.1 10.4 6.7 3.4 2.1 2.2 3.5 2.0 ZNF688 ENSG00000229809 "Zinc finger protein 688" P0C7X2 16 30569346-30572734 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 7 "Early spermatids: 132.4;Late spermatids: 434.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048922 Uncertain Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA Nucleoplasm "Plasma membrane, Cell Junctions" "HPA048922: AB_2680557" "prognostic favorable (5.90e-4)" "prognostic favorable (7.74e-4)" "unprognostic (1.68e-1)" "prognostic favorable (4.58e-5)" "unprognostic (1.37e-1)" "unprognostic (1.76e-2)" "unprognostic (4.01e-1)" "prognostic favorable (3.24e-4)" "unprognostic (1.11e-1)" "unprognostic (3.26e-2)" "prognostic favorable (6.61e-4)" "unprognostic (7.75e-2)" "unprognostic (5.14e-2)" "unprognostic (7.08e-2)" "unprognostic (2.48e-1)" "unprognostic (4.12e-2)" "unprognostic (4.03e-2)" 10.7 11.9 14.2 11.8 11.8 13.7 8.0 13.8 16.7 8.8 15.3 15.5 12.1 20.5 11.5 9.6 12.0 13.5 14.5 17.2 13.1 10.6 11.2 12.4 10.3 19.9 12.1 11.5 12.9 14.7 8.4 14.0 7.8 11.2 11.8 9.0 11.0 13.8 10.1 32.5 9.5 14.4 14.2 11.0 13.9 13.0 24.6 8.3 21.6 13.7 8.3 10.0 10.4 13.3 6.1 5.4 12.6 5.4 15.1 6.8 2.8 7.8 5.9 6.0 6.3 11.4 2.9 2.5 4.5 6.2 3.8 3.0 1.8 11.9 4.1 9.1 5.6 5.2 5.8 1.7 2.8 4.1 12.2 3.6 2.8 2.3 1.4 3.0 3.9 12.7 5.9 6.3 4.0 4.9 6.5 3.8 5.6 2.9 9.6 4.2 4.7 11.1 4.3 2.2 7.7 1.9 9.5 2.4 6.2 6.6 2.5 8.6 9.6 1.6 11.8 9.9 1.8 12.9 6.5 2.9 3.3 3.6 3.8 3.5 13.8 9.6 4.4 10.1 3.4 5.6 12.6 3.9 8.3 4.8 3.9 5.8 5.5 5.6 5.4 3.9 6.1 4.8 4.4 6.0 15.1 5.4 5.4 6.8 2.8 14.2 11.8 13.8 16.7 13.1 10.6 12.1 11.5 11.2 8.3 6.0 1.9 17.1 10.5 5.7 19.5 8.5 17.8 20.1 6.8 15.7 17.7 6.3 41.4 19.2 132.4 11.1 34.5 0.0 27.4 7.9 13.1 9.8 4.7 18.7 21.4 20.6 19.5 14.1 22.9 434.2 18.4 15.6 16.9 28.9 25.1 28.0 19.6 32.3 18.7 38.4 25.5 6.5 12.5 25.3 7.9 6.1 3.9 20.3 22.1 5.7 ZNF706 HSPC038 ENSG00000120963 "Zinc finger protein 706" Q9Y5V0 8 101177878-101206193 "Predicted intracellular proteins" "Translation regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Late spermatids: 852.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042793 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA042793: AB_10795710" "unprognostic (2.05e-2)" "unprognostic (3.29e-2)" "unprognostic (2.04e-1)" "prognostic unfavorable (3.12e-5)" "unprognostic (1.60e-1)" "unprognostic (1.26e-1)" "unprognostic (2.48e-3)" "unprognostic (5.22e-2)" "unprognostic (3.19e-2)" "unprognostic (1.21e-2)" "unprognostic (1.35e-1)" "unprognostic (1.19e-1)" "prognostic unfavorable (5.90e-11)" "unprognostic (9.65e-2)" "unprognostic (1.59e-1)" "unprognostic (3.57e-1)" "unprognostic (2.17e-2)" 28.0 24.6 38.4 34.5 40.8 26.3 39.4 35.5 39.0 21.8 35.9 34.5 21.5 37.1 23.0 38.5 42.4 20.5 29.9 27.8 37.0 25.4 23.4 34.6 34.1 45.5 32.8 40.0 23.9 82.3 26.9 28.9 30.1 29.3 21.6 36.1 20.9 29.4 21.2 31.6 53.6 50.4 25.7 32.6 30.1 34.5 31.1 32.1 21.2 25.1 33.6 39.4 23.9 28.7 63.6 85.4 32.4 73.1 19.3 46.4 38.1 39.8 23.0 40.3 12.8 14.5 16.8 25.8 16.7 21.5 17.3 18.5 16.4 24.7 24.2 29.1 19.8 35.3 21.9 23.0 22.5 20.0 17.9 20.0 24.2 14.2 31.4 19.2 18.0 23.6 14.5 35.3 16.3 35.6 23.9 29.3 24.6 26.2 47.3 15.3 28.1 37.7 49.8 12.2 81.1 57.0 15.9 13.5 49.5 22.8 20.7 26.8 12.0 11.7 19.4 71.4 36.0 20.3 19.2 19.4 9.5 19.5 25.1 17.2 40.2 38.5 38.9 25.6 39.8 43.8 32.4 45.9 24.9 23.7 71.9 24.3 63.6 33.1 30.1 42.3 49.0 37.5 35.8 6.2 19.3 73.1 85.4 46.4 38.1 38.4 40.8 35.5 39.0 37.0 25.4 32.8 40.0 29.3 32.1 56.6 37.1 175.0 195.4 408.4 54.6 67.0 112.1 75.0 69.4 75.0 17.7 165.7 152.5 226.9 436.3 144.3 251.1 116.8 226.4 308.8 110.7 186.3 119.0 105.2 242.6 81.0 254.7 69.3 125.8 852.0 80.6 213.1 195.7 341.8 228.1 114.7 312.8 245.4 81.7 155.6 49.2 103.5 156.4 70.2 63.6 452.8 161.7 105.8 130.7 254.7 ZNF717 "X17, ZNF838" ENSG00000227124 "Zinc finger protein 717" 3 75709643-75785583 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 38.5" HPA044549 Uncertain Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" NA NA "Nucleoplasm, Nuclear bodies" "Plasma membrane" "HPA044549: AB_10964630" "unprognostic (2.49e-1)" "unprognostic (4.44e-2)" "unprognostic (1.52e-1)" "unprognostic (2.49e-2)" "unprognostic (2.61e-1)" "unprognostic (1.00e-1)" "unprognostic (2.18e-1)" "unprognostic (3.80e-2)" "unprognostic (3.20e-1)" "unprognostic (2.16e-2)" "unprognostic (2.36e-1)" "unprognostic (1.45e-2)" "unprognostic (3.60e-6)" "unprognostic (3.88e-2)" "unprognostic (2.08e-2)" "unprognostic (1.00e-1)" "unprognostic (1.36e-1)" 8.1 8.6 11.9 7.2 14.4 4.6 11.2 12.1 12.4 7.7 6.7 11.7 7.3 6.9 11.0 24.6 7.7 11.3 8.1 8.2 10.9 8.3 13.4 10.5 6.8 6.2 16.2 7.1 12.6 12.7 14.7 22.8 7.3 12.6 9.4 8.9 10.8 9.9 9.6 6.1 13.7 7.3 10.9 15.6 10.1 10.1 11.2 13.6 8.4 16.2 5.3 8.4 8.6 7.8 9.5 6.2 6.8 5.3 4.0 10.2 3.2 7.4 4.7 4.5 2.7 4.9 6.9 2.7 2.5 4.9 3.1 3.9 6.3 6.4 4.0 4.3 4.6 4.9 3.7 7.1 5.3 2.8 0.4 6.8 7.8 7.1 0.7 9.6 0.3 6.9 6.7 4.4 7.5 11.4 3.2 0.6 0.8 38.5 9.5 4.1 2.4 0.8 10.3 5.1 5.5 8.3 5.9 4.3 21.9 5.0 3.6 3.7 17.4 2.1 4.3 9.2 7.3 15.3 3.5 0.9 7.9 10.8 6.5 1.1 11.4 13.9 4.7 4.3 0.8 4.8 1.5 4.0 6.8 3.6 5.3 1.8 7.6 5.1 3.4 4.1 9.5 10.2 6.2 1.0 4.0 4.9 6.2 1.9 3.2 11.9 14.4 12.1 12.4 10.9 8.3 16.2 7.1 12.6 13.6 3.0 1.9 3.0 3.6 2.9 8.3 5.3 10.2 5.3 3.4 7.0 2.0 3.3 10.0 4.0 2.6 4.5 2.6 0.0 3.8 1.6 4.3 4.9 9.2 6.6 6.1 9.5 5.1 6.7 3.8 1.3 2.3 3.8 1.7 5.4 7.2 5.7 3.8 0.0 2.8 12.5 8.0 0.0 3.8 9.5 7.4 3.9 2.9 2.6 5.5 3.9 ZNF783 DKFZp667J212 ENSG00000204946 "Zinc finger family member 783" Q6ZMS7 7 149262171-149297302 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA020375 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA020375: AB_1859453" "unprognostic (3.17e-3)" "unprognostic (2.54e-1)" "unprognostic (8.40e-3)" "unprognostic (1.16e-1)" "unprognostic (6.13e-2)" "unprognostic (1.08e-3)" "unprognostic (4.28e-3)" "unprognostic (1.05e-1)" "unprognostic (4.24e-3)" "unprognostic (1.12e-1)" "unprognostic (1.02e-1)" "unprognostic (3.29e-2)" "prognostic unfavorable (2.24e-7)" "unprognostic (2.49e-2)" "unprognostic (6.05e-2)" "unprognostic (1.61e-2)" "prognostic favorable (4.11e-4)" 10.1 8.1 11.4 14.4 14.9 6.5 15.1 14.3 15.8 11.5 9.4 15.4 9.9 10.0 13.1 11.2 8.2 13.0 11.0 7.2 11.6 7.7 8.5 4.6 8.6 16.1 13.1 18.4 17.2 11.2 9.4 10.2 7.2 12.5 13.0 9.7 12.2 9.3 13.5 11.6 12.6 12.2 20.1 15.4 17.7 9.1 9.2 12.5 2.9 11.8 6.2 15.0 9.9 16.1 3.8 2.7 0.5 4.5 1.5 3.2 1.1 3.4 3.5 5.7 4.1 3.8 7.3 5.4 2.2 1.1 5.0 2.2 5.5 6.4 11.6 5.6 3.5 1.2 2.3 4.0 4.3 2.2 3.2 3.7 7.5 7.6 1.1 8.7 4.8 9.4 7.6 8.9 4.6 5.6 3.2 3.4 4.1 6.0 6.0 4.1 7.3 7.3 7.5 12.9 7.9 4.7 1.6 0.5 10.1 5.6 5.7 4.6 9.6 8.5 4.0 5.8 3.1 4.4 9.8 5.0 4.0 1.0 2.2 4.8 9.3 5.8 0.1 5.8 1.7 8.7 0.3 1.1 0.5 3.2 2.2 2.5 2.3 2.0 2.0 1.3 3.8 2.7 2.2 0.4 1.5 4.5 2.7 1.2 1.1 11.4 14.9 14.3 15.8 11.6 7.7 13.1 18.4 12.5 12.5 3.0 2.4 7.8 2.4 2.3 14.3 1.4 7.6 4.0 1.2 0.0 9.8 2.5 3.3 2.0 3.9 2.9 2.0 0.0 2.4 1.7 4.5 3.6 0.0 5.0 3.6 6.4 3.5 6.7 8.5 3.5 8.1 2.8 5.0 2.8 5.1 3.4 2.1 0.0 5.3 0.8 8.6 12.9 3.1 14.7 5.9 2.6 0.9 4.1 4.7 2.1 ZNF79 pT7 ENSG00000196152 "Zinc finger protein 79" Q15937 9 127424374-127445372 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cholangiocytes: 5.1;Spermatocytes: 5.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028977 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA028977: AB_10602359" "unprognostic (4.56e-2)" "unprognostic (3.59e-2)" "unprognostic (1.15e-1)" "prognostic favorable (6.83e-5)" "unprognostic (2.84e-2)" "unprognostic (2.45e-2)" "unprognostic (2.11e-1)" "prognostic favorable (5.96e-4)" "unprognostic (3.41e-1)" "unprognostic (1.13e-2)" "prognostic favorable (5.42e-5)" "unprognostic (4.53e-3)" "prognostic favorable (6.04e-7)" "unprognostic (6.09e-3)" "unprognostic (5.01e-1)" "unprognostic (5.23e-2)" "unprognostic (1.32e-1)" 9.9 11.0 7.6 6.7 7.8 6.7 8.1 18.3 8.5 9.2 9.6 10.3 6.9 5.6 12.9 10.4 7.0 9.4 5.6 6.8 6.8 5.3 6.8 9.5 6.8 8.3 7.5 5.2 9.1 9.5 13.2 11.8 8.1 8.4 11.2 8.2 10.7 12.2 8.3 13.2 8.7 7.7 8.3 6.1 10.2 8.8 21.1 8.6 12.8 8.5 4.8 10.5 13.3 9.9 8.5 7.5 7.4 6.0 9.4 11.8 4.9 2.3 4.6 6.2 3.6 6.9 4.1 17.2 5.7 6.9 6.8 7.9 4.9 2.1 4.9 2.3 4.2 9.1 7.1 4.6 6.9 5.4 4.9 3.0 3.4 7.4 5.4 8.1 8.0 5.4 4.1 7.8 8.4 6.9 4.4 7.1 5.7 5.7 7.4 6.4 5.0 6.2 3.0 4.9 5.7 5.9 5.2 8.5 7.0 2.9 3.3 7.0 4.7 10.8 5.6 3.2 5.5 7.4 4.6 4.9 4.4 4.0 4.3 4.4 9.9 21.2 6.3 5.6 2.5 7.2 3.3 4.9 7.4 9.3 6.0 10.6 7.4 6.4 11.8 7.0 8.5 8.4 9.1 6.5 9.4 4.0 7.5 7.9 4.9 7.6 7.8 18.3 8.5 6.8 5.3 7.5 5.2 8.4 8.6 0.0 0.3 0.0 1.0 1.3 0.8 1.6 5.1 0.0 2.3 0.0 0.0 1.8 1.7 1.7 2.1 0.7 0.6 0.0 0.5 0.6 1.1 0.5 0.0 1.0 1.7 1.6 0.0 1.3 0.6 3.7 0.6 0.9 0.0 0.0 0.6 1.3 0.4 0.0 1.8 0.7 1.4 0.0 1.2 5.1 1.3 0.9 2.2 0.8 0.9 0.7 ZNF839 C14orf131 ENSG00000022976 "Zinc finger protein 839" A8K0R7 14 102317377-102342702 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020434 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA020434: AB_10669862" "unprognostic (7.83e-2)" "unprognostic (1.96e-1)" "unprognostic (2.28e-1)" "unprognostic (8.81e-2)" "unprognostic (1.49e-1)" "unprognostic (2.33e-1)" "unprognostic (6.73e-2)" "unprognostic (5.69e-2)" "unprognostic (1.85e-1)" "unprognostic (7.10e-3)" "prognostic favorable (4.57e-4)" "unprognostic (2.40e-2)" "prognostic favorable (5.00e-4)" "unprognostic (1.32e-1)" "unprognostic (2.17e-2)" "unprognostic (1.08e-1)" "unprognostic (8.21e-2)" 8.9 9.9 10.9 10.6 14.1 11.3 15.7 11.6 16.9 11.1 10.2 14.4 9.0 8.1 15.3 11.2 8.4 19.7 7.8 8.4 11.1 10.1 9.7 13.0 6.8 11.0 8.8 13.4 12.9 15.6 14.3 13.2 9.0 8.9 10.1 9.5 13.0 11.9 13.4 18.6 21.6 10.3 10.6 8.3 15.2 8.7 39.7 7.8 11.3 12.9 8.8 11.8 7.8 9.5 1.9 2.1 3.5 1.9 0.3 2.6 0.4 8.7 8.0 10.4 18.7 4.8 8.3 17.8 6.8 5.6 8.6 7.1 3.0 7.5 9.0 5.6 4.6 3.5 8.6 6.7 17.2 6.6 12.0 12.8 6.3 7.2 5.0 4.3 5.8 5.5 6.6 13.0 16.6 15.5 13.1 11.4 12.8 13.3 11.9 12.0 16.2 8.9 9.4 13.9 4.8 8.0 19.3 6.3 5.7 7.6 7.2 5.6 17.7 5.7 7.2 6.0 10.3 16.3 9.7 4.4 5.5 5.0 7.6 6.0 11.7 8.4 10.3 4.3 7.0 9.1 0.0 0.7 2.3 2.4 1.9 2.6 1.9 1.6 1.5 1.3 1.4 2.6 2.2 3.5 0.3 0.4 2.1 2.1 0.4 10.9 14.1 11.6 16.9 11.1 10.1 8.8 13.4 8.9 7.8 0.0 7.7 0.0 2.3 2.7 6.8 2.0 5.1 6.7 4.5 10.4 7.9 4.6 10.0 3.1 12.3 1.8 3.9 23.3 2.5 2.5 2.1 2.0 3.5 4.7 2.6 3.2 1.2 5.5 2.2 1.4 4.6 2.1 3.3 1.0 5.8 6.0 2.1 0.0 3.9 5.5 9.0 0.0 0.9 12.5 12.7 2.3 4.7 2.5 5.2 1.4 ZSCAN29 "FLJ35867, Zfp690, ZNF690" ENSG00000140265 "Zinc finger and SCAN domain containing 29" Q8IWY8 15 43358172-43371025 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 81.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 6.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007241, HPA011109" Enhanced Approved "Nucleoplasm,Plasma membrane,Actin filaments" NA NA Nucleoplasm "Plasma membrane, Actin filaments" "HPA007241: AB_10600420, HPA011109: AB_10611525" "unprognostic (3.90e-2)" "unprognostic (2.70e-1)" "unprognostic (1.15e-1)" "unprognostic (4.06e-2)" "unprognostic (2.21e-2)" "unprognostic (2.02e-2)" "unprognostic (1.57e-1)" "unprognostic (5.25e-1)" "unprognostic (2.12e-2)" "unprognostic (4.77e-3)" "unprognostic (1.64e-1)" "unprognostic (1.44e-3)" "unprognostic (9.61e-2)" "unprognostic (1.30e-1)" "unprognostic (1.31e-1)" "unprognostic (8.33e-2)" "unprognostic (3.43e-2)" 8.3 8.9 13.5 14.2 14.2 6.6 9.4 15.9 15.2 11.0 9.8 12.1 9.3 11.8 12.6 12.5 11.0 9.6 11.9 7.2 14.7 8.0 8.1 10.3 9.2 13.2 19.1 12.0 10.7 15.4 12.5 13.9 13.0 15.4 9.7 10.5 7.9 11.2 9.5 13.6 7.7 13.0 9.0 13.3 11.9 11.8 20.9 15.0 16.8 11.1 9.4 13.7 11.0 12.5 2.1 1.0 6.9 1.0 2.3 1.9 0.6 7.6 8.4 19.8 12.2 7.0 7.4 10.7 6.0 9.4 10.7 11.2 13.0 5.5 7.5 10.1 7.4 8.6 22.7 14.5 7.4 9.7 19.4 8.0 16.5 12.6 10.1 7.8 11.2 14.5 6.5 13.0 7.2 10.3 7.6 5.4 11.7 15.3 9.2 8.6 4.8 10.8 9.3 9.9 11.3 6.5 16.8 11.0 9.1 6.2 9.3 14.1 15.3 9.3 15.3 7.1 10.4 10.7 17.6 6.0 12.6 10.0 9.5 10.8 17.7 24.4 14.5 7.4 11.2 9.5 1.1 0.7 6.9 1.2 1.0 1.0 2.1 1.2 0.8 1.0 1.6 0.6 1.7 1.8 2.3 0.8 0.9 1.9 0.6 13.5 14.2 15.9 15.2 14.7 8.0 19.1 12.0 15.4 15.0 6.0 9.3 2.9 2.3 3.2 8.7 6.7 2.5 5.3 10.3 7.0 25.5 4.4 0.0 5.2 81.1 2.9 7.8 0.0 6.2 3.7 4.1 3.3 0.0 6.0 4.9 12.7 5.8 4.3 9.7 13.8 6.4 4.1 5.0 3.6 7.8 5.4 7.6 5.8 5.6 2.1 18.7 0.0 2.9 9.9 6.4 2.8 3.2 4.3 6.8 1.8 ZSWIM1 "C20orf162, dJ337O18.5" ENSG00000168612 "Zinc finger SWIM-type containing 1" Q9BR11 20 45881227-45885266 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041147, HPA046751" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA041147: AB_2677329, HPA046751: AB_2679785" "unprognostic (6.27e-2)" "unprognostic (1.03e-1)" "unprognostic (1.87e-1)" "unprognostic (1.51e-2)" "unprognostic (1.69e-2)" "unprognostic (1.95e-1)" "prognostic unfavorable (5.47e-4)" "unprognostic (9.06e-2)" "unprognostic (1.18e-1)" "unprognostic (1.02e-1)" "prognostic favorable (1.77e-4)" "unprognostic (1.78e-1)" "unprognostic (2.77e-2)" "unprognostic (1.21e-1)" "unprognostic (2.78e-1)" "unprognostic (4.64e-1)" "unprognostic (4.29e-2)" 11.3 13.8 7.3 7.6 11.4 10.2 7.8 17.2 15.7 7.3 8.5 10.4 5.6 8.8 10.1 7.8 9.3 9.3 10.1 9.8 7.5 7.7 12.8 11.3 6.9 9.5 6.9 8.5 12.6 14.1 10.0 11.4 12.2 6.3 10.3 7.7 14.1 10.4 8.1 27.3 12.3 10.6 9.1 8.1 12.2 8.7 9.0 9.5 16.1 11.5 9.8 13.3 9.6 7.0 5.4 4.4 6.9 3.7 1.2 5.3 1.4 6.4 8.1 6.1 7.4 11.1 6.5 6.2 4.4 5.8 10.2 9.4 18.5 7.6 7.7 13.4 6.4 10.7 15.6 9.9 12.6 7.6 2.9 5.9 10.1 10.1 12.6 6.8 8.1 10.4 9.3 10.6 8.4 8.1 7.4 7.9 6.9 8.9 6.2 5.8 19.6 9.1 6.7 3.3 7.3 9.1 7.0 8.9 5.4 6.5 9.6 8.1 5.2 15.4 22.7 5.2 5.7 13.5 6.1 6.4 11.1 7.0 5.9 6.5 6.2 4.4 7.9 8.8 6.4 5.6 3.8 2.9 6.9 1.0 3.7 0.7 5.4 3.7 1.6 1.6 5.1 5.3 4.7 3.1 1.2 3.5 4.4 3.0 1.4 7.3 11.4 17.2 15.7 7.5 7.7 6.9 8.5 6.3 9.5 3.0 2.4 0.5 1.7 1.0 2.4 4.8 0.0 0.0 1.2 0.0 0.0 2.5 3.3 1.8 0.2 1.3 2.6 0.0 3.3 2.3 1.4 1.9 3.5 1.7 1.5 6.4 2.4 2.5 1.6 0.4 3.1 1.2 0.0 1.0 2.6 1.4 2.8 3.2 1.4 1.2 3.2 0.0 1.7 0.6 1.7 1.4 1.9 1.7 2.3 1.6 ZSWIM8 "4832404P21Rik, KIAA0913" ENSG00000214655 "Zinc finger SWIM-type containing 8" A7E2V4 10 73785582-73801797 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 64.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041244 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA041244: AB_10794269" "unprognostic (8.83e-2)" "unprognostic (2.86e-1)" "unprognostic (2.89e-3)" "unprognostic (1.44e-1)" "unprognostic (4.00e-2)" "prognostic favorable (5.61e-4)" "unprognostic (3.11e-1)" "unprognostic (1.64e-1)" "unprognostic (2.97e-1)" "unprognostic (1.69e-1)" "unprognostic (2.24e-3)" "unprognostic (1.31e-1)" "unprognostic (1.52e-1)" "unprognostic (2.41e-1)" "unprognostic (1.98e-1)" "unprognostic (2.49e-1)" "unprognostic (2.52e-1)" 22.5 30.2 27.1 17.7 27.9 35.3 20.6 29.8 32.4 21.7 27.2 38.1 29.7 25.6 25.5 43.3 33.1 19.9 24.9 19.8 25.9 20.4 28.8 43.1 22.3 20.9 34.0 24.9 26.4 23.3 39.0 50.0 28.1 28.6 29.9 17.8 29.8 30.3 28.9 19.5 48.2 34.8 27.9 20.0 36.8 21.8 29.1 37.0 22.7 30.1 15.9 22.2 21.7 24.0 3.5 6.6 9.0 4.2 1.9 5.7 1.7 5.7 9.9 12.4 20.3 29.6 14.2 7.2 7.4 20.7 10.6 12.8 8.7 4.8 3.3 5.4 12.3 10.5 9.0 4.3 8.7 5.4 5.2 9.1 4.6 10.5 11.4 22.3 3.1 18.1 23.0 15.8 13.2 15.5 29.1 12.5 7.0 6.5 6.4 12.1 8.8 4.8 9.5 3.7 4.7 31.2 5.8 5.8 1.9 15.1 12.5 3.0 13.6 6.1 18.4 10.5 11.2 12.3 6.7 12.5 12.0 7.1 5.3 7.5 16.4 8.8 2.1 13.0 4.7 6.1 4.3 4.1 3.2 5.7 2.7 3.3 3.5 2.6 2.4 3.2 2.7 1.1 3.7 9.0 1.9 4.2 6.6 3.2 1.7 27.1 27.9 29.8 32.4 25.9 20.4 34.0 24.9 28.6 37.0 3.0 8.6 4.8 6.7 11.0 29.7 1.4 25.5 6.7 4.5 19.2 64.8 10.5 1.7 10.6 3.4 15.2 26.1 0.0 12.8 7.3 12.7 15.2 0.0 26.9 15.6 33.4 19.5 38.1 23.2 2.1 20.4 12.0 15.1 15.4 15.5 20.3 15.7 17.5 22.6 10.2 47.4 12.9 10.8 32.1 14.5 12.4 24.0 10.0 9.9 12.2 ZYX ENSG00000159840 Zyxin Q15942 7 143381080-143391111 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion, Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Kupffer cells: 188.3;monocytes: 174.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 47.5" "Group enriched" "Detected in many" 4 "dendritic cells: 16.5;granulocytes: 47.5;monocytes: 22.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004835, CAB009321, HPA073497, CAB075747" Approved Supported "Plasma membrane,Actin filaments,Focal adhesion sites" NA NA 420000000 "Focal adhesion sites" "Plasma membrane, Actin filaments" "CAB009321: AB_2221290, CAB075747: AB_2665753, HPA004835: AB_1080771, HPA073497: AB_2686611" "unprognostic (1.96e-2)" "unprognostic (5.35e-2)" "unprognostic (2.36e-2)" "unprognostic (1.25e-1)" "unprognostic (1.44e-2)" "unprognostic (1.18e-1)" "unprognostic (2.21e-3)" "unprognostic (1.66e-3)" "unprognostic (2.60e-1)" "unprognostic (4.22e-1)" "unprognostic (1.98e-1)" "unprognostic (2.43e-1)" "prognostic unfavorable (7.92e-5)" "unprognostic (1.39e-1)" "unprognostic (8.12e-2)" "unprognostic (1.95e-1)" "unprognostic (6.72e-2)" 52.7 11.7 7.7 39.3 8.8 46.1 34.3 17.5 22.2 61.1 56.8 10.7 20.5 13.6 103.6 38.6 52.3 48.9 58.1 22.7 7.4 7.7 24.7 21.2 52.8 63.0 8.8 8.3 58.1 15.9 63.8 9.1 32.4 15.5 43.8 10.8 17.9 18.8 40.7 28.3 21.1 26.6 74.7 8.5 57.1 28.3 37.4 7.1 24.4 18.9 19.1 26.0 93.7 35.7 0.9 16.5 47.5 22.1 4.1 6.7 9.0 12.8 7.8 10.3 14.4 19.5 43.7 12.3 27.3 32.1 30.0 25.2 26.5 8.3 0.8 10.7 33.3 17.3 10.4 6.3 27.6 14.0 13.7 3.4 20.0 9.2 9.2 34.4 16.1 31.9 46.5 12.3 32.7 11.1 18.6 37.9 1.8 4.9 8.7 31.9 14.4 0.2 32.4 21.6 5.0 50.5 3.0 5.5 1.2 22.7 6.8 0.5 7.8 21.5 20.1 11.2 9.8 2.4 16.1 66.4 35.8 14.7 38.0 28.7 2.8 3.7 2.2 31.8 16.9 23.7 4.9 18.2 12.5 5.9 19.2 4.7 0.9 5.5 6.7 16.5 0.5 3.5 4.0 47.5 4.1 22.1 4.2 5.0 9.0 7.7 8.8 17.5 22.2 7.4 7.7 8.8 8.3 15.5 7.1 6.0 8.3 17.4 144.9 30.0 3.3 10.9 33.1 2.7 27.3 33.2 0.0 28.4 6.6 98.9 1.5 40.4 21.3 0.0 81.4 80.5 41.1 47.9 35.8 26.7 153.1 0.0 36.7 66.9 188.3 4.7 26.4 86.6 13.5 174.9 19.9 15.1 120.5 31.6 51.9 14.7 2.6 84.1 82.1 7.9 9.5 17.7 23.5 54.9 19.6 87.0